Citrus Sinensis ID: 004312

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760--
Protein Sequence
MACHLLSLLFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDIWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETGTTFIKIRKVPSGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCPWTLNITS
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccEEEEEccccccccccccccccccEEEEEEccEEEEEcccccEEEEcccccccccEEEEEEcccEEEEEcccccccccccccccccccccccccccEEEEccccccccccEEEEEEEEcccEEEEEEEccccccccccccccccccccccccEEEEEccccEEEEEEcccEEEEEEEccccccccEEEEEEcccccEEEEEEccccccccccEEEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEccccccccccccccccccHHHHHHHHHccccEEEEEEccccccccccccccccccccccccEEEEEEcccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccHHHHHHHHcccccccccccccccEEEEEccccccEEEEEEcccccHHHHHHHHHHHHHHHHHcccccccEEccccccccEEEEEEccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEEcccccccccccccccccccccccccccccccccccccEEcccccccHHHcccccEEEEEEEEEcEEEEEEEEccccccHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHcccccccccccccccEEcc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHccccccccccccccccccEEEccccEEEEEEEEEEEEEEcccccccccccEEEEcccEEEEEEccccEEEEEccccccccEEEEEccccEEEEcccccEEEEEccccccccccccccccccEEEEcccccccccccEEEEEccccccEEEEEEccccEEEEEccccccEEEEccccccccEEccccEEEEEEEccccEEEEEEEEccccEEEEEEEccccEEEEEEEcccccccEEEEEEEEccccccccccccccccHHHccccccEEccccccccccccccccccccccccccccEEcccccEccccccccccccEEEEEcccEcccccHHHHccccHHHHHHHHHHcccEEEEEEcccccccccEEEEEEEEcccccccEEEEEEHHHHcccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccEcHHHHHHHHHcHHHHccccccccEEEcEccccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccHcHHEcccccccHHHHHHHHHHHHHHHHHHHHccccEEEcccccHHHEEEcccccEEEccccHHHHcccccccccEEEEEEcccccHHHHHcccEEEcccHHHHHEEEEEEHccccccHHHHHHHHHHccccHHHccHHHcccccHHHHHHHHHHHHHHHcccccccccHHHHHHEccccccccccccccEEEEcc
Coil and Loop (DISEMBL)
MACHLLSLLFLLLLPcltaaqsngtisigqqltaaestepwlspskdfalgFHQLdiwyasgddpgpggsklrltangglvledpearEIWKSEISTGEAAFgvlydtgnflivntnserlwqtfdhptdtllptqtmerggvvssrrketdfsrgrfQFRLLEDGNAVLNTINlesgfaydaffwsntfdvnrsnagyRVVFNEsgqlyvlrenkqivsltpetvsAKENYLRATLNFDGVFIfyshpknnstgdaiwsvsdvlpenicinndirkglgsgicgfnsicsisgakrpicqcpkgfslldpddvygsckpdfilgceedgkksgEDLYYIEElrntdwptsdyeqispygkdecvssclkdcqcsaavlrddtcwkkklplsygktdrdetgttfikirkvpsggkkkvdvlIPVVSVLFGSSALINLLLVSACCLGFLVvnrkkfmrphqeeqgvsymnLRCFTYKELVEVTRGFkeelgrgafgtVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNgalasflfgdskpnwkLRTEIVMGIARGLFYLHEECCtqiihcdikpqnillddyynarisdfgLEKLLTLDqshtntairgtkgyvapewfrnmpitvkvDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCiqedpshrptmRRVTQMLEGvvevpippcpwtlnits
Flexible Loop (DISEMBL)
MACHLLSLLFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDIWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQTfdhptdtllptqtmerggvvssrrketdfsrgrfqfrlleDGNAVLNTINLESGFAYDAFFWSNTFDVNRSNAGYRVVFNESgqlyvlrenkqivsltpetvsakENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGSCKPDFILGCEEDGKKSGEDLYYIEELrntdwptsdYEQISPYGKDECVSSCLKDCQCSAavlrddtcwkkklplsygktdrdetgttfikirkvpsggkkkvdVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKkfmrphqeeqgvsymnlRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAevngigqthhkNLVRLLGYCDEGRNRLLVYEFMSNGALASflfgdskpnWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLdqshtntairgtkgyvapewfrnMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEgvvevpippcpwtlnits
Low Complexity Region (SEG)
MACHllsllfllllpclTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDIWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETGTTFIKIRKVPSGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCPWTLNITS
Disordered region (IsUnstruct)
**CHLLSLLFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDIWYASG**********RLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLL*********************RGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETGTTFIKIRKVPSGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQED******MRRVTQMLEGVVEVPIPPCPWTLN***
Disordered Region (DISOPRED)
*ACHLLSLLFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDIWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGSCK*DFI***********EDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETGTTF*******************VVSVLFGSSALINLLLVSACCLGFLVVN*******************RCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCPWTLN***
Disordered Region (DISEMBL)
MACHLLSLLFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDIWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTME************DFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETGTTFIKIRKVPSGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCPWTLNITS
Disordered Region (DISPRO)
MACHLLSLLFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDIWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETGTTFIKIRKVPSGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMR********SYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCPWTLNI**
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MACHLLSLLFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDIWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETGTTFIKIRKVPSGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCPWTLNITS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	762	2.2.26 [Sep-21-2011]
Q39202	832	G-type lectin S-receptor-	yes	no	0.968	0.887	0.447	0.0
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.942	0.823	0.329	1e-100
Q9XID3	829	G-type lectin S-receptor-	no	no	0.904	0.831	0.330	2e-98
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.860	0.799	0.319	1e-86
P17801	817	Putative receptor protein	N/A	no	0.897	0.837	0.327	8e-83
Q39203	797	G-type lectin S-receptor-	no	no	0.841	0.804	0.316	5e-78
O64477	828	G-type lectin S-receptor-	no	no	0.877	0.807	0.317	5e-77
O65238	872	G-type lectin S-receptor-	no	no	0.862	0.753	0.275	1e-70
Q9SXB3	820	G-type lectin S-receptor-	no	no	0.912	0.847	0.282	1e-64
O81906	849	G-type lectin S-receptor-	no	no	0.925	0.830	0.279	2e-64

>sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2

 Score =  656 bits (1693), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/825 (44%), Positives = 495/825 (60%), Gaps = 87/825 (10%)

Query: 1   MACHLLSLLFLLLLP---CLTAAQSNGTISIGQQLTAAESTE---PWLSPSKDFALGFHQ 54
           ++C ++ L+ +L L      +    NG++ +G+ LTA+ES +    W SPS DFA GF +
Sbjct: 4   LSCSIIHLVLILQLQTFFVFSQNIRNGSVPVGESLTASESQQISSSWRSPSGDFAFGFRK 63

Query: 55  --------LDIWYASGDDPG---------------PGGSKLRLTANGGLVLEDPEAREIW 91
                   L IW+    D                 P GSK+ LTA+GGLV+ DP  +E+W
Sbjct: 64  IQPNDGFTLSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGGLVIADPRGQELW 123

Query: 92  KSEISTGEAAFGVLYDTGNFLIVNTNSER----LWQTFDHPTDTLLPTQTMERGGVVSSR 147
           ++ +S G  + G   D GNF++    SE     LW +F++PTDTLLP Q +E G  +SSR
Sbjct: 124 RA-LSGGSVSRGRFTDDGNFVLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGRNLSSR 182

Query: 148 RKETDFSRGRFQFRLLEDGNAVLNTINLESGFA---YDAFFWSNTFDVNRSNAGYRVVFN 204
           R ET F +GRF  RL +DGN  L+++N E+      Y  ++ SNT D N  N G ++VFN
Sbjct: 183 RTETSFKKGRFSLRLEDDGNLQLHSLNAETASESDIYSQYYESNTNDPN--NPGIQLVFN 240

Query: 205 ESGQLYVLRENKQ---IVSLTPETVSAKENYLRATLNFDGVFIFYSHPKNNS--TGDAIW 259
           +SG++YVL+ N     +    P+   A   Y+       G  +    PK      G  + 
Sbjct: 241 QSGEIYVLQRNNSRFVVKDRDPDFSIAAPFYIST-----GFLLSTIIPKEARRIVGGCLL 295

Query: 260 SVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGSCK 319
            +     +N+C  +D    LG+  CG+N+ICS+   KRP C+CP+ F L DP + YG C 
Sbjct: 296 GLCR---DNMCSPDD---ALGNMACGYNNICSLGNNKRPKCECPERFVLKDPSNEYGDCL 349

Query: 320 PDF-ILGCEEDGKKSGED--LYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSA 376
           PDF +  C  + + +  D  LY    L  T+WP  DYE  + Y ++ C +SCL DC C+A
Sbjct: 350 PDFEMQTCRPENQTANSDVNLYEFITLEKTNWPFGDYESYANYDEERCKASCLSDCLCAA 409

Query: 377 AVL---RDDTCWKKKLPLSYGKTDRDETGTTFIKIRK-----VPSGGK--KKVDVLIPVV 426
            +    RD  CWKKK PLS+G+        TFIK+R      VP  G   KK+D LI   
Sbjct: 410 VIFGTNRDLKCWKKKFPLSHGERSPRGDSDTFIKVRNRSIADVPVTGNRAKKLDWLIIAC 469

Query: 427 SVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEEQG-------VSYMNLRCFTYKEL 479
           SVL G+SA +   +    C        K  M+    + G        + +NLR FTY EL
Sbjct: 470 SVLLGTSAFV---IFDTSCSYRKTKKSKNMMKNQARDIGRTTATTTANELNLRVFTYGEL 526

Query: 480 VEVTRGFKEELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT 537
            E TR F EELGRGAFG VYKG++ +  GS   VAVKKL+R+  D+EKEFK EV  IGQ 
Sbjct: 527 AEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQI 586

Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLH 597
           HHKNLVRL+G+C+EG+++++VYEF+  G LA+FLF   +P+W+ R  I + IARG+ YLH
Sbjct: 587 HHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFRRPRPSWEDRKNIAVAIARGILYLH 646

Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
           EEC  QIIHCDIKPQNILLD+YY  RISDFGL KLL ++Q++T T IRGTKGYVAPEWFR
Sbjct: 647 EECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTLTNIRGTKGYVAPEWFR 706

Query: 658 NMPITVKVDVYSYGVLLLEIICLRRT-------ILTDWAYDCYQERTLGALVENDLEAMD 710
           N PIT KVDVYSYGV+LLEI+C ++        IL +WAYDC+++  L  L E+D EAM+
Sbjct: 707 NSPITSKVDVYSYGVMLLEIVCCKKAVDLEDNVILINWAYDCFRQGRLEDLTEDDSEAMN 766

Query: 711 DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCP 755
           DM  ++R+V +AIWCIQE+   RP MR VTQMLEGV++V  PP P
Sbjct: 767 DMETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFDPPNP 811

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  365 bits (936), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 276/837 (32%), Positives = 416/837 (49%), Gaps = 119/837 (14%)

Query: 9   LFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQ--------LDIWYA 60
           LF      L +  +   I +G +L A+E    W+S +  FA+GF +        L IW+A
Sbjct: 13  LFSFFCFFLVSLATEPHIGLGSKLKASEPNRAWVSANGTFAIGFTRFKPTDRFLLSIWFA 72

Query: 61  S--GD----------DPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDT 108
              GD           P    + L L A G LVL D +   +W S  S       V+ ++
Sbjct: 73  QLPGDPTIVWSPNRNSPVTKEAVLELEATGNLVLSD-QNTVVWTSNTSNHGVESAVMSES 131

Query: 109 GNFLIVNTN---SERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLED 165
           GNFL++ T       +WQ+F  P+DTLLP Q +     ++S    +    G +  ++L+ 
Sbjct: 132 GNFLLLGTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPS--RHGHYSLKMLQQ 189

Query: 166 GNAV----LNTINLESGFAYDAFFWSN------TFDVNR---SNAGYRVVFNES--GQLY 210
             ++       INL+    Y   +WS       T DV         +++V+ ES  G +Y
Sbjct: 190 HTSLSLGLTYNINLDPHANYS--YWSGPDISNVTGDVTAVLDDTGSFKIVYGESSIGAVY 247

Query: 211 VLR----ENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLP 266
           V +    +N+   + +   ++      R  L  +G    Y    N+  G + W     +P
Sbjct: 248 VYKNPVDDNRNYNNSSNLGLTKNPVLRRLVLENNGNLRLYRW-DNDMNGSSQW-----VP 301

Query: 267 ENICINN--DIRKGLGSGICGFNSICSISGAKRPI-CQC-PKGFSLLDPDDV-YGSCKPD 321
           E   ++N  DI     +GICG N +C++   K+   C C P    L D ++    S    
Sbjct: 302 EWAAVSNPCDI-----AGICG-NGVCNLDRTKKNADCLCLPGSVKLPDQENAKLCSDNSS 355

Query: 322 FILGCEEDGKKSGEDLYYIEELRNTDWPTSD---YEQISPYGK-DECVSSCLKDCQCSAA 377
            +  CE +  ++G   + I  ++ T++  S+    E IS      +C   CL DC+C A+
Sbjct: 356 LVQECESNINRNGS--FKISTVQETNYYFSERSVIENISDISNVRKCGEMCLSDCKCVAS 413

Query: 378 V--LRDDT--CWKKKLPLSYGKTDRDETGTTFIKIRKV---------------PSGGKKK 418
           V  L D+   CW  K  L++G   RD   T F+K R                  S G ++
Sbjct: 414 VYGLDDEKPYCWILK-SLNFGGF-RDPGSTLFVKTRANESYPSNSNNNDSKSRKSHGLRQ 471

Query: 419 VDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEEQGVSYMNLRCFTYKE 478
             ++IP+V  +    AL+ +LL       +  ++RK+ ++   +   +   +   FTY++
Sbjct: 472 KVLVIPIVVGMLVLVALLGMLL-------YYNLDRKRTLKRAAKNSLILCDSPVSFTYRD 524

Query: 479 LVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH 538
           L   T  F + LG G FGTVYKG V       VAVK+L+R     E+EF  EVN IG  H
Sbjct: 525 LQNCTNNFSQLLGSGGFGTVYKGTV--AGETLVAVKRLDRALSHGEREFITEVNTIGSMH 582

Query: 539 HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP----NWKLRTEIVMGIARGLF 594
           H NLVRL GYC E  +RLLVYE+M NG+L  ++F   +     +W+ R EI +  A+G+ 
Sbjct: 583 HMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIA 642

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           Y HE+C  +IIHCDIKP+NILLDD +  ++SDFGL K++  + SH  T IRGT+GY+APE
Sbjct: 643 YFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRGYLAPE 702

Query: 655 WFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYD---------CYQERTLGA---LV 702
           W  N PITVK DVYSYG+LLLEI+  RR +  D +YD          Y+E T G     V
Sbjct: 703 WVSNRPITVKADVYSYGMLLLEIVGGRRNL--DMSYDAEDFFYPGWAYKELTNGTSLKAV 760

Query: 703 ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV-EVPIPPCPWTL 758
           +  L+ + +   + + + VA WCIQ++ S RP+M  V ++LEG   E+ +PP P T+
Sbjct: 761 DKRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMPQTI 817

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  360 bits (924), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 264/799 (33%), Positives = 391/799 (48%), Gaps = 110/799 (13%)

Query: 25  TISIGQQLTAAESTEPWLSPSKDFALGF----------------HQLDIWYASGDDPGPG 68
           TI +G  + A+ S + W SP+  F++ F                  + IW A   D    
Sbjct: 26  TIPLGSVIYASGSNQNWPSPNSTFSVSFVPSPSPNSFLAAVSFAGSVPIWSAGTVD---S 82

Query: 69  GSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQTFDHP 128
              LRL  +G L L +     +W S+        G + DTG F+++N  S  +W +FD+P
Sbjct: 83  RGSLRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSSFDNP 142

Query: 129 TDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSN 188
           TDT++ +Q    G ++ S         G + F+L   GN  L        +   A +W++
Sbjct: 143 TDTIVQSQNFTAGKILRS---------GLYSFQLERSGNLTLR-------WNTSAIYWNH 186

Query: 189 TFDVNRSNAGY--RVVFNESGQLYVLREN----KQIVSLTPETVSAKENYLRATLNFDG- 241
             + + S+     R+    +G + +   N     +IV       S    +L+  L+ DG 
Sbjct: 187 GLNSSFSSNLSSPRLSLQTNGVVSIFESNLLGGAEIVYSGDYGDSNTFRFLK--LDDDGN 244

Query: 242 VFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQ 301
           + I+ S  +N+   +A WS  D             + L  G CG   ICS +    PIC 
Sbjct: 245 LRIYSSASRNSGPVNAHWSAVD-------------QCLVYGYCGNFGICSYNDTN-PICS 290

Query: 302 CP-KGFSLLDPDDVYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYG 360
           CP + F  +D +D    CK    L  +  G  +  DL +       D P S+       G
Sbjct: 291 CPSRNFDFVDVNDRRKGCKRKVELS-DCSGNTTMLDLVHTRLFTYEDDPNSESFFA---G 346

Query: 361 KDECVSSCLKDCQCSAAVLRDD---TCWKKKLPLSY--GKTDRDETGTTFIKI------- 408
              C ++CL    C A+V   D    CW+K  P S+  G        T+++K+       
Sbjct: 347 SSPCRANCLSSVLCLASVSMSDGSGNCWQKH-PGSFFTGYQWPSVPSTSYVKVCGPVVAN 405

Query: 409 --RKVPSG--GKKKVDVLIPVVSVLFGSSALI--NLLLVSACCLG---FLVVNRKKFMRP 459
              +   G     KV + I  V+V+ G   L+   + L   CC     F  ++    +  
Sbjct: 406 TLERATKGDDNNSKVHLWIVAVAVIAGLLGLVAVEIGLWWCCCRKNPRFGTLSSHYTLLE 465

Query: 460 HQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV 519
           +     V       FTYKEL   T+ FKE+LG G FGTVY+G +   +   VAVK+L  +
Sbjct: 466 YASGAPVQ------FTYKELQRCTKSFKEKLGAGGFGTVYRGVLT--NRTVVAVKQLEGI 517

Query: 520 FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-- 577
            Q  EK+F+ EV  I  THH NLVRL+G+C +GR+RLLVYEFM NG+L +FLF       
Sbjct: 518 EQ-GEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKF 576

Query: 578 -NWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT-L 635
             W+ R  I +G A+G+ YLHEEC   I+HCDIKP+NIL+DD + A++SDFGL KLL   
Sbjct: 577 LTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPK 636

Query: 636 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTI----------L 685
           D  +  +++RGT+GY+APEW  N+PIT K DVYSYG++LLE++  +R             
Sbjct: 637 DNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKF 696

Query: 686 TDWAYDCYQERTLGALVENDL--EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQML 743
           + WAY+ +++    A+++  L  +   DM  + R V  + WCIQE P  RPTM +V QML
Sbjct: 697 SIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQML 756

Query: 744 EGVVEVPIPPCPWTLNITS 762
           EG+ E+  P CP T++  S
Sbjct: 757 EGITEIKNPLCPKTISEVS 775

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  321 bits (823), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 238/744 (31%), Positives = 367/744 (49%), Gaps = 88/744 (11%)

Query: 57  IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNT 116
           IW A+   P     K     NG +V+E     E+W+ + S   A+   L D+GN ++V+ 
Sbjct: 82  IWSANRASPVSNSDKFVFDDNGNVVME---GTEVWRLDNSGKNASRIELRDSGNLVVVSV 138

Query: 117 NSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLE 176
           +   +W++FDHPTDTL+  Q  + G  ++S    ++ +        ++ G+ VL+  +L 
Sbjct: 139 DGTSIWESFDHPTDTLITNQAFKEGMKLTSSPSSSNMTYAL----EIKSGDMVLSVNSLT 194

Query: 177 SGFAYDAFFWSNTFDVNRSNAGYRVVFNESGQL---------YVLRENKQIVSLTPETVS 227
                   +WS       +NA  R++  + G +         +   + KQ++        
Sbjct: 195 P-----QVYWS------MANARERIINKDGGVVTSSSLLGNSWRFFDQKQVLLWQFVFSD 243

Query: 228 AKENYLR--ATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICG 285
            K++     A L  +GV  F +     S  D+    S  +P ++C   +         CG
Sbjct: 244 NKDDNTTWIAVLGNNGVISFSNLGSGASAADS----STKIPSDLCGTPEP--------CG 291

Query: 286 FNSICSISGAKRPICQCPKGFSLLDPDDVYGSCKPDFILGCEEDGKKSGEDLYYIEELRN 345
              +CS  G+K  +C C  G S    D     CK      C++    +   L  +     
Sbjct: 292 PYYVCS--GSK--VCGCVSGLSRARSD-----CKTGITSPCKKTKDNATLPLQLVSAGDG 342

Query: 346 TDWPTSDYEQISPYGK----DECVSSCLKDCQCSAAVLRDDT--CWKKKLPLSYGKTDRD 399
            D+    Y    P+ K    D C   C  +C C     ++ +  C+      S+  +   
Sbjct: 343 VDYFALGYAP--PFSKKTDLDSCKEFCHNNCSCLGLFFQNSSGNCFLFDYIGSFKTSGNG 400

Query: 400 ETG-TTFIKIRKVPSGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMR 458
            +G  ++IKI    SGG    +        +     +   ++     + F +  RKK + 
Sbjct: 401 GSGFVSYIKIASTGSGGGDNGEDDGKHFPYVVIIVVVTVFIIAVLIFVAFRIHKRKKMIL 460

Query: 459 PHQEE--------QGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQ 510
              +E        + +S M +R F YK+L   T  F  +LG+G FG+VY+G +  GS  +
Sbjct: 461 EAPQESSEEDNFLENLSGMPIR-FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGS--R 517

Query: 511 VAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASF 570
           +AVKKL  + Q  +KEF+AEV+ IG  HH +LVRL G+C EG +RLL YEF+S G+L  +
Sbjct: 518 LAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERW 576

Query: 571 LF----GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISD 626
           +F    GD   +W  R  I +G A+GL YLHE+C  +I+HCDIKP+NILLDD +NA++SD
Sbjct: 577 IFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSD 636

Query: 627 FGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTI-- 684
           FGL KL+T +QSH  T +RGT+GY+APEW  N  I+ K DVYSYG++LLE+I  R+    
Sbjct: 637 FGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDP 696

Query: 685 --------LTDWAYDCYQERTLGALVENDLEAMD--DMTVLQRFVMVAIWCIQEDPSHRP 734
                      +A+   +E  L  +V+  ++ +D  D  V QR +  A+WCIQED   RP
Sbjct: 697 SETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERV-QRAMKTALWCIQEDMQTRP 755

Query: 735 TMRRVTQMLEGVVEVPIPPCPWTL 758
           +M +V QMLEGV  V  PP   T+
Sbjct: 756 SMSKVVQMLEGVFPVVQPPSSSTM 779

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2

 Score =  308 bits (790), Expect = 8e-83,   Method: Compositional matrix adjust.
 Identities = 265/808 (32%), Positives = 388/808 (48%), Gaps = 124/808 (15%)

Query: 18  TAAQSNGTISIG--QQLTAAESTEPWLSPSKDFALGFHQLDIWYASGDDPGPGG-SKLRL 74
           T   S+GT S G  +  T A +   W S + + A   ++  +W A+ D P     S L L
Sbjct: 47  TLQSSDGTFSSGFYEVYTHAFTFSVWYSKT-EAAAANNKTIVWSANPDRPVHARRSALTL 105

Query: 75  TANGGLVLEDPEAREIWKSEISTGEAAFGV----LYDTGNFLIVNTNSERLWQTFDHPTD 130
             +G +VL D +   +W+++   G    GV    L DTGN +I ++    +WQ+FD PTD
Sbjct: 106 QKDGNMVLTDYDGAAVWRAD---GNNFTGVQRARLLDTGNLVIEDSGGNTVWQSFDSPTD 162

Query: 131 TLLPTQTMERGGVVSSRRKETDFSR--GRFQFRLLEDGNAVLNTINLESGFAYDAFFWSN 188
           T LPTQ +      ++R   T  SR  G + FR  +   +VL+ I      +    +W +
Sbjct: 163 TFLPTQLI----TAATRLVPTTQSRSPGNYIFRFSD--LSVLSLIYHVPQVS--DIYWPD 214

Query: 189 TFDVNRSNAGYRVVFNESGQLYVLRENKQIVS--------LTPETVSAKENYLRATLNFD 240
             D N    G R  +N S +L +L ++  + S        L    V       R TL+ D
Sbjct: 215 P-DQNLYQDG-RNQYN-STRLGMLTDSGVLASSDFADGQALVASDVGPGVKR-RLTLDPD 270

Query: 241 GVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPIC 300
           G    YS   N+S G   WSVS V     C   +I      G+CG N IC  S    P C
Sbjct: 271 GNLRLYS--MNDSDGS--WSVSMVAMTQPC---NIH-----GLCGPNGICHYS--PTPTC 316

Query: 301 QCPKGFSLLDPDDVYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYG 360
            CP G++  +P +    C       C+   K+S   + ++  L NTD+  SD + +    
Sbjct: 317 SCPPGYATRNPGNWTEGCMAIVNTTCDRYDKRS---MRFVR-LPNTDFWGSDQQHLLSVS 372

Query: 361 KDECVSSCLKDCQCSAAVLRDDT--CWKKKLPLSYGKTDRDETGTTFIKIRKVPSGGKKK 418
              C   C+ DC C     ++ T  C+ K    S       +  T ++K+   P+G    
Sbjct: 373 LRTCRDICISDCTCKGFQYQEGTGSCYPKAYLFSGRTYPTSDVRTIYLKL---PTGVSVS 429

Query: 419 VDVLIPVVSVL------------------------------------FGSSALINLLLVS 442
            + LIP   V                                     +G  A   ++ VS
Sbjct: 430 -NALIPRSDVFDSVPRRLDCDRMNKSIREPFPDVHKTGGGESKWFYFYGFIAAFFVVEVS 488

Query: 443 ACCLGFLVVNRKKFMRPHQ---EEQGVSYM--NLRCFTYKELVEVTRGFKEELGRGAFGT 497
                +  V +++ +RP +    E+G   M  N R ++Y+ELV+ TR FK ELGRG  GT
Sbjct: 489 FISFAWFFVLKRE-LRPSELWASEKGYKAMTSNFRRYSYRELVKATRKFKVELGRGESGT 547

Query: 498 VYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLL 557
           VYKG +       VAVKKL  V Q  E  F+AE++ IG+ +H NLVR+ G+C EG +RLL
Sbjct: 548 VYKGVLE--DDRHVAVKKLENVRQGKEV-FQAELSVIGRINHMNLVRIWGFCSEGSHRLL 604

Query: 558 VYEFMSNGALASFLF---GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNI 614
           V E++ NG+LA+ LF   G+   +W+ R  I +G+A+GL YLH EC   +IHCD+KP+NI
Sbjct: 605 VSEYVENGSLANILFSEGGNILLDWEGRFNIALGVAKGLAYLHHECLEWVIHCDVKPENI 664

Query: 615 LLDDYYNARISDFGLEKLLTLDQSHTNTA-IRGTKGYVAPEWFRNMPITVKVDVYSYGVL 673
           LLD  +  +I+DFGL KLL    S  N + +RGT GY+APEW  ++PIT KVDVYSYGV+
Sbjct: 665 LLDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGTLGYIAPEWVSSLPITAKVDVYSYGVV 724

Query: 674 LLEIICLRRTIL----TDWAYDCYQE--RTLGALVENDLEAMDD------------MTVL 715
           LLE++   R       TD  +   ++  R L A +E + ++  D                
Sbjct: 725 LLELLTGTRVSELVGGTDEVHSMLRKLVRMLSAKLEGEEQSWIDGYLDSKLNRPVNYVQA 784

Query: 716 QRFVMVAIWCIQEDPSHRPTMRRVTQML 743
           +  + +A+ C++ED S RPTM    Q L
Sbjct: 785 RTLIKLAVSCLEEDRSKRPTMEHAVQTL 812

Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score =  293 bits (749), Expect = 5e-78,   Method: Compositional matrix adjust.
 Identities = 228/720 (31%), Positives = 336/720 (46%), Gaps = 79/720 (10%)

Query: 57  IWYASGDDP--GPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIV 114
           +W A+   P   P  S L LT+ G L++ +     +W+++       F    +TGN +++
Sbjct: 69  VWVANRIRPVSDPDSSTLELTSTGYLIVSNLRDGVVWQTDNKQPGTDF-RFSETGNLILI 127

Query: 115 NTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTIN 174
           N +   +WQ+FD+PTDT LP   +     ++S R   D S G +  RL    N       
Sbjct: 128 NDDGSPVWQSFDNPTDTWLPGMNVTGLTAMTSWRSLFDPSPGFYSLRLSPSFN------E 181

Query: 175 LESGFAYDAFFWSNTFDVNRSNAGYRVVFNESGQLYVLR--------ENKQIVSLTPETV 226
            +  +     +WS     N +   + V   E    Y+ R               + P   
Sbjct: 182 FQLVYKGTTPYWSTG---NWTGEAF-VGVPEMTIPYIYRFHFVNPYTPTASFWYIVPPLD 237

Query: 227 SAKENYL-RATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICG 285
           S  E  L R  +  +G    Y+      + +  W    + PE+ C   ++        CG
Sbjct: 238 SVSEPRLTRFMVGANGQLKQYTWDPQTQSWNMFW----LQPEDPCRVYNL--------CG 285

Query: 286 FNSICSISGAKRPICQCPKGFSLLDPDDVYGSCKPDFILGCEEDGKKSGEDLYYIEELRN 345
               CS S   +P C C +GF    P +       D+  GC  +   SGE     E + +
Sbjct: 286 QLGFCS-SELLKP-CACIRGFR---PRNDAAWRSDDYSDGCRRENGDSGEKSDTFEAVGD 340

Query: 346 TDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETGTTF 405
             +            K  C  +CL +  C     ++ +   K L L      ++  G   
Sbjct: 341 LRYDGDVKMSRLQVSKSSCAKTCLGNSSCVGFYHKEKSNLCKIL-LESPNNLKNSKGNI- 398

Query: 406 IKIRKVPSGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEEQG 465
                      K + +L  VV    GS +++   L+    L  L  +RK+     Q+E G
Sbjct: 399 ----------SKSIIILCSVV----GSISVLGFTLLVPLIL--LKRSRKRKKTRKQDEDG 442

Query: 466 VSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK 525
            + +NL+ F++KEL   T GF +++G G FG V+KG +  GSS  VAVK+L R     E 
Sbjct: 443 FAVLNLKVFSFKELQSATNGFSDKVGHGGFGAVFKGTLP-GSSTFVAVKRLERP-GSGES 500

Query: 526 EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP--NWKLRT 583
           EF+AEV  IG   H NLVRL G+C E  +RLLVY++M  G+L+S+L   S    +W+ R 
Sbjct: 501 EFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPKLLSWETRF 560

Query: 584 EIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA 643
            I +G A+G+ YLHE C   IIHCDIKP+NILLD  YNA++SDFGL KLL  D S     
Sbjct: 561 RIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLAT 620

Query: 644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTD---------------- 687
           +RGT GYVAPEW   +PIT K DVYS+G+ LLE+I  RR ++ +                
Sbjct: 621 MRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFF 680

Query: 688 --WAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG 745
             WA     +  + ++V++ L    +   + R   VAIWCIQ++   RP M  V +MLEG
Sbjct: 681 PPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  289 bits (740), Expect = 5e-77,   Method: Compositional matrix adjust.
 Identities = 243/766 (31%), Positives = 360/766 (46%), Gaps = 97/766 (12%)

Query: 45  SKDFALG--FHQLD---IWYASGDDP-GPGGSKLRLTANGGLVLEDPEARE-IWKSEI-- 95
           S +F +G  + QL    +W A+ D       S +   +NG L+L D   +  +W + +  
Sbjct: 55  SSNFYIGMWYKQLSQTILWVANRDKAVSDKNSSVFKISNGNLILLDGNYQTPVWSTGLNS 114

Query: 96  -STGEAAFGVLYDTGNFLIVNTNSER----LWQTFDHPTDTLLPTQTMERGGVVSSRRKE 150
            S+  A   VL D GN ++    S      LWQ+FDHP DT LP       GV     K 
Sbjct: 115 TSSVSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWLP-------GVKIRLDKR 167

Query: 151 TDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTFDVNRS---NAGYRVVFNESG 207
           T  S+    ++ LED +  L ++ L+   AY    W+ + +   S   N   R+  +   
Sbjct: 168 TGKSQRLTSWKSLEDPSPGLFSLELDESTAY-KILWNGSNEYWSSGPWNPQSRIFDSVPE 226

Query: 208 QLYVLRENKQIVSLTPE-----TVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVS 262
                  N    S T +     ++  + N  R  ++  G    ++  + N   +  WS  
Sbjct: 227 MRLNYIYNFSFFSNTTDSYFTYSIYNQLNVSRFVMDVSGQIKQFTWLEGNKAWNLFWS-- 284

Query: 263 DVLPENICINNDIRKGLGS-GICGFNSICSISGAKRPICQCPKGFSLL-----DPDDVYG 316
              P   C    + +  GS GIC        S    P C+CP+GF  +     D  D   
Sbjct: 285 --QPRQQC---QVYRYCGSFGIC--------SDKSEPFCRCPQGFRPMSQKDWDLKDYSA 331

Query: 317 SCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSA 376
            C     L C    +      + +  ++  D    + E ++      C S+C  DC C A
Sbjct: 332 GCVRKTELQCS---RGDINQFFRLPNMKLAD----NSEVLTRTSLSICASACQGDCSCKA 384

Query: 377 AVLRDDT----CWKKKLPLSYGKTDRDETGTTFI------KIRKVPSGGKKKVDVLIPVV 426
               + +     W K +       D +  G  F        +  V + GK     LI   
Sbjct: 385 YAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRLAASDVPNVGASGKSNNKGLI--- 441

Query: 427 SVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGF 486
              FG + L +L ++    L  +++ R +  +  + E+G     L  F+Y+EL   T+ F
Sbjct: 442 ---FG-AVLGSLGVIVLVLLVVILILRYRRRKRMRGEKGDG--TLSAFSYRELQNATKNF 495

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
            ++LG G FG+V+KG   +  S  +AVK+L  + Q  EK+F+ EV  IG   H NLVRL 
Sbjct: 496 SDKLGGGGFGSVFKG--ALPDSSDIAVKRLEGISQ-GEKQFRTEVVTIGTIQHVNLVRLR 552

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKP-----NWKLRTEIVMGIARGLFYLHEECC 601
           G+C EG  +LLVY++M NG+L S LF +         WKLR +I +G ARGL YLH+EC 
Sbjct: 553 GFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECR 612

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             IIHCDIKP+NILLD  +  +++DFGL KL+  D S   T +RGT+GY+APEW   + I
Sbjct: 613 DCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAI 672

Query: 662 TVKVDVYSYGVLLLEIICLRRT----------ILTDWAYDCY-QERTLGALVENDLEA-M 709
           T K DVYSYG++L E++  RR               WA     ++  + +LV+  LE   
Sbjct: 673 TAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDA 732

Query: 710 DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCP 755
            D+  + R   VA WCIQ++ SHRP M +V Q+LEGV+EV  PP P
Sbjct: 733 VDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFP 778

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2

 Score =  268 bits (686), Expect = 1e-70,   Method: Compositional matrix adjust.
 Identities = 211/766 (27%), Positives = 346/766 (45%), Gaps = 109/766 (14%)

Query: 57  IWYASGDDPGPGGSKLRLTANGGLVLEDPEAR-EIWKSEISTGEAAFGVLYDTGNFLIVN 115
           IW ++ D P      + LT  G  V+ED +++  +W + +         L D GN L+++
Sbjct: 86  IWSSNRDSPVSSSGTMNLTPQGISVIEDGKSQIPVWSTPVLASPVKSLRLTDAGNLLLLD 145

Query: 116 TNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLN---- 171
             +  LW++FD PTD+++  Q ++ G  +S     +DFS G ++F L+ + + ++     
Sbjct: 146 HLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKF-LVGESDGLMQWRGQ 204

Query: 172 ---TINLESGFAYDAFFWSNTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSA 228
               + +      D+ F      V  S      +   +G + V+R     V+L P +   
Sbjct: 205 NYWKLRMHIRANVDSNFPVEYLTVTTSGL---ALMARNGTVVVVR-----VALPPSS--- 253

Query: 229 KENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNS 288
             ++  A ++  G FI       N   +         P + C            +CG   
Sbjct: 254 --DFRVAKMDSSGKFIVSRFSGKNLVTEFSG------PMDSCQI--------PFVCGKLG 297

Query: 289 ICSISGA-KRPICQCPKGFSLLDPDDVYGSCKP-----DFILGCEEDGKKSGEDLYYIEE 342
           +C++  A +   C CP    +   D   G C P        + CE        ++ Y+E 
Sbjct: 298 LCNLDNASENQSCSCPDEMRM---DAGKGVCVPVSQSLSLPVSCE------ARNISYLEL 348

Query: 343 LRNTDWPTSDYEQISPYGKD--ECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGK----- 395
                + ++ +     +G     C   C K+C C      + +     +  S+G      
Sbjct: 349 GLGVSYFSTHFTDPVEHGLPLLACHDICSKNCSCLGVFYENTSRSCYLVKDSFGSLSLVK 408

Query: 396 ---TDRDETGTTFIKIRKV---PSGGKKKVDVLIPVVSVLF----GSSALINLLLV---S 442
               + D  G   + IRK    P G   +     PV++++     G   LI L L+    
Sbjct: 409 NSPENHDLIGYVKLSIRKTNAQPPGNNNRGGSSFPVIALVLLPCSGFFLLIALGLLWWRR 468

Query: 443 ACCLGFLVVNRKKFMRPHQEEQG-VSYMNL----RCFTYKELVEVTRGFKEELGRGAFGT 497
              + +  +  K+  RP   E G +   ++    + F ++EL + T  FK ++G G FG+
Sbjct: 469 CAVMRYSSIREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGS 528

Query: 498 VYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLL 557
           VYKG   +     +AVKK+        +EF  E+  IG   H NLV+L G+C  GR  LL
Sbjct: 529 VYKG--TLPDETLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLL 586

Query: 558 VYEFMSNGALASFLFGDSKP--NWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNIL 615
           VYE+M++G+L   LF  + P   W+ R +I +G ARGL YLH  C  +IIHCD+KP+NIL
Sbjct: 587 VYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENIL 646

Query: 616 LDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLL 675
           L D++  +ISDFGL KLL  ++S   T +RGT+GY+APEW  N  I+ K DVYSYG++LL
Sbjct: 647 LHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLL 706

Query: 676 EIICLRR---------TILTD--------------------WAYDCYQERTLGALVENDL 706
           E++  R+         ++  D                    +A D +++     L +  L
Sbjct: 707 ELVSGRKNCSFRSRSNSVTEDNNQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRL 766

Query: 707 EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIP 752
           E        ++ V +A+ C+ E+P+ RPTM  V  M EG + +  P
Sbjct: 767 EGRVTSQEAEKLVRIALCCVHEEPALRPTMAAVVGMFEGSIPLGNP 812

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB3|Y1112_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11280 OS=Arabidopsis thaliana GN=At1g11280 PE=2 SV=1

 Score =  248 bits (634), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 234/827 (28%), Positives = 361/827 (43%), Gaps = 132/827 (15%)

Query: 8   LLFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFH-------------- 53
           L   L L C  AA     I+I   LT  ++     SP   + LGF               
Sbjct: 17  LWLSLFLSCGYAA-----ITISSPLTLGQTLS---SPGGFYELGFFSPNNSQNQYVGIWF 68

Query: 54  -----QLDIWYASGDDP-GPGGSKLRLTANGGLVLEDPEAREIWKSE-ISTGEAAFGVLY 106
                ++ +W A+ + P     + L ++ NG L+L D     +W +   S        L 
Sbjct: 69  KKITPRVVVWVANREKPITTPVANLTISRNGSLILLDSSKNVVWSTRRPSISNKCHAKLL 128

Query: 107 DTGNFLIVNTNSERL-WQTFDHPTDTLLPTQTME------RGGVVSSRRKETDFSRGRFQ 159
           DTGN +IV+  SE L WQ+F++P DT+LP  ++          V+SS +  TD S G F 
Sbjct: 129 DTGNLVIVDDVSENLLWQSFENPGDTMLPYSSLMYNLATGEKRVLSSWKSHTDPSPGDFV 188

Query: 160 FRLLEDGNAVLNTINLESGFAYDAFFWSNTFD-VNRSNAGYRVVF-------NESGQLYV 211
            RL     A + T+   S +     +    F  V   +  Y   F       N +G    
Sbjct: 189 VRLTPQVPAQIVTMRGSSVYKRSGPWAKTGFTGVPLMDESYTSPFSLSQDVGNGTGLFSY 248

Query: 212 LRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICI 271
           L+ + ++       +   E YL+ T  ++G            TG   W +  + P N+C 
Sbjct: 249 LQRSSELT----RVIITSEGYLK-TFRYNG------------TG---WVLDFITPANLC- 287

Query: 272 NNDIRKGLGSGICGFNSICSISGAKRPICQCPKGF-----SLLDPDDVYGSCKPDFILGC 326
             D+      G CG   +C  S   +  C+C KGF           ++   C     L C
Sbjct: 288 --DLY-----GACGPFGLCVTSNPTK--CKCMKGFVPKYKEEWKRGNMTSGCMRRTELSC 338

Query: 327 EED----GKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSA-AVLRD 381
           + +     +  G D++Y   L N   P   YE  S    D+C   CL +C CSA A +  
Sbjct: 339 QANLSTKTQGKGVDVFY--RLANVK-PPDLYEYASFVDADQCHQGCLSNCSCSAFAYITG 395

Query: 382 DTC--WKKKLPLSYGKTDRDETGTTFIKIRKVPS--GGKKKVDVLIPVVSV------LFG 431
             C  W  +L      T R   G  F+ IR   S   G ++  +++  +S+       FG
Sbjct: 396 IGCLLWNHELI----DTIRYSVGGEFLSIRLASSELAGSRRTKIIVGSISLSIFVILAFG 451

Query: 432 SSALINLLLVSACCLGFLVVNR-----KKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGF 486
           S               +   N      K  + P QE  G+++     F    +   T  F
Sbjct: 452 SYKYWRYRAKQNVGPTWAFFNNSQDSWKNGLEP-QEISGLTF-----FEMNTIRAATNNF 505

Query: 487 K--EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVR 544
               +LG+G FG VYKG   +     +AVK+L+       +EF  E+  I +  H+NLVR
Sbjct: 506 NVSNKLGQGGFGPVYKG--TLSDKKDIAVKRLSSSSGQGTEEFMNEIKLISKLQHRNLVR 563

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDS---KPNWKLRTEIVMGIARGLFYLHEECC 601
           LLG C +G  +LL+YEF+ N +L +FLF  +   + +W  R  I+ G++RGL YLH + C
Sbjct: 564 LLGCCIDGEEKLLIYEFLVNKSLDTFLFDLTLKLQIDWPKRFNIIQGVSRGLLYLHRDSC 623

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT-AIRGTKGYVAPEWFRNMP 660
            ++IH D+K  NILLDD  N +ISDFGL ++    Q   NT  + GT GY++PE+     
Sbjct: 624 MRVIHRDLKVSNILLDDKMNPKISDFGLARMFQGTQHQDNTRKVVGTLGYMSPEYAWTGM 683

Query: 661 ITVKVDVYSYGVLLLEIICLRRT----------ILTDWAYDCYQERTLGALVENDLEAMD 710
            + K D+Y++GVLLLEII  ++            L   A++C+ E     L++ D+ +  
Sbjct: 684 FSEKSDIYAFGVLLLEIISGKKISSFCCGEEGKTLLGHAWECWLETGGVDLLDEDISSSC 743

Query: 711 DMTVLQ--RFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCP 755
               ++  R V + + CIQ+    RP + +V  M+    ++P P  P
Sbjct: 744 SPVEVEVARCVQIGLLCIQQQAVDRPNIAQVVTMMTSATDLPRPKQP 790

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  248 bits (632), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 232/831 (27%), Positives = 361/831 (43%), Gaps = 126/831 (15%)

Query: 2   ACHLLSLLFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQ------- 54
           + +L   L+  L     AA    TI  G+ L    + +P +SP K F LGF         
Sbjct: 8   SLYLSLFLYFFLYESSMAAN---TIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHR 64

Query: 55  -LDIWYASGDDPG------------PGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAA 101
            L IWY + +D                   L ++ +G LVL D +   +W S I +    
Sbjct: 65  FLGIWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTN 124

Query: 102 FG----VLYDTGNFLIVNTNSER-LWQTFDHPTDTLLPT-------QTMERGGVVSSRRK 149
                  ++DTGNF++  T+++R +W++F+HPTDT LP        QT +    V S R 
Sbjct: 125 NNNRVVSIHDTGNFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFV-SWRS 183

Query: 150 ETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWS-NTFDVNRSNAGYRVVFNESGQ 208
           ETD S G +             ++ ++   A +   W  N     RS      +F     
Sbjct: 184 ETDPSPGNY-------------SLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPN 230

Query: 209 LYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVS------ 262
           + +L        L+         Y     +   V + +    N +  +  W+ +      
Sbjct: 231 MSLLTNYLYGFKLSSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTK 290

Query: 263 -DVLPENICINNDIRKGLGSGIC---GFNSICSISGAKRPICQCPKGFSLLDPDDVYGSC 318
               P++ C  +   +    GIC   G N ICS          C  G+  +   +    C
Sbjct: 291 FQSEPDSEC--DQYNRCGKFGICDMKGSNGICS----------CIHGYEQVSVGNWSRGC 338

Query: 319 KPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAV 378
           +    L CE +     ++   ++ ++  D+   ++  + P   ++C   CL++C C+A  
Sbjct: 339 RRRTPLKCERNISVGEDEFLTLKSVKLPDFEIPEHNLVDP---EDCRERCLRNCSCNAYS 395

Query: 379 LRDD---TCWKKKLPLSYGKTDRDETGTTFIKIR----KVPSGGKKKVDVLIPVV--SVL 429
           L        W + L        + E G + + IR    +V    K K+ V++ V+   +L
Sbjct: 396 LVGGIGCMIWNQDLV----DLQQFEAGGSSLHIRLADSEVGENRKTKIAVIVAVLVGVIL 451

Query: 430 FGSSALINLLL-----VSACCLG------FLVVNRKKFMRPHQ----------EEQGVSY 468
            G  AL+         VS    G       +V +  K                E + V+ 
Sbjct: 452 IGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNT 511

Query: 469 MNLRCFTYKELVEVTRGF--KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE 526
             L  F+   +   T  F  + ELGRG FG VYKG +  G   ++AVK+L+        E
Sbjct: 512 SELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGR--EIAVKRLSGKSGQGVDE 569

Query: 527 FKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP---NWKLRT 583
           FK E+  I +  H+NLVRLLG C EG  ++LVYE+M N +L  FLF ++K    +WKLR 
Sbjct: 570 FKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRF 629

Query: 584 EIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA 643
            I+ GIARGL YLH +   +IIH D+K  N+LLD   N +ISDFG+ ++   +Q+  NT 
Sbjct: 630 SIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTV 689

Query: 644 -IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTI---------LTDWAYDCY 693
            + GT GY++PE+      +VK DVYS+GVLLLEI+  +R           L  +A+  Y
Sbjct: 690 RVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLY 749

Query: 694 QERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
                  LV+  +          R + VA+ C+Q+  + RP M  V  MLE
Sbjct: 750 THGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLE 800

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	762
255544746	800	ATP binding protein, putative [Ricinus c	0.948	0.903	0.571	0.0
224099309	801	predicted protein [Populus trichocarpa]	0.971	0.923	0.558	0.0
224057535	775	predicted protein [Populus trichocarpa]	0.952	0.936	0.556	0.0
224053032	752	predicted protein [Populus trichocarpa]	0.934	0.946	0.558	0.0
356575025	800	PREDICTED: G-type lectin S-receptor-like	0.969	0.923	0.535	0.0
224103119	799	predicted protein [Populus trichocarpa]	0.981	0.936	0.538	0.0
109676362	2037	CCHC-type integrase [Populus trichocarpa	0.930	0.348	0.558	0.0
356555135	815	PREDICTED: G-type lectin S-receptor-like	0.986	0.922	0.525	0.0
224143661	691	predicted protein [Populus trichocarpa]	0.858	0.946	0.542	0.0
356503095	807	PREDICTED: G-type lectin S-receptor-like	0.977	0.923	0.522	0.0

>gi|255544746|ref|XP_002513434.1| ATP binding protein, putative [Ricinus communis] gi|223547342|gb|EEF48837.1| ATP binding protein, putative [Ricinus communis]

 Score =  866 bits (2237), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 442/774 (57%), Positives = 537/774 (69%), Gaps = 51/774 (6%)

Query: 20  AQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD-------------------IWYA 60
           AQ+  TI +G  L AA+  E WLSPS DFA GF QL+                   +WYA
Sbjct: 23  AQNGDTIIVGDFLAAADPAESWLSPSGDFAFGFRQLENKNLYLLAICYNKISDKTIVWYA 82

Query: 61  SGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSER 120
           +GDDP P GSK+ LTA+ GLVL  P+ +EIWKS I+ G+AA G++ DTGNF IVNT  E+
Sbjct: 83  NGDDPAPTGSKVELTADRGLVLTSPQGKEIWKSGINIGDAARGMMNDTGNFRIVNTGGEK 142

Query: 121 LWQTFDHPTDTLLPTQTMERGG-VVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGF 179
           LWQTFD P DTLLP Q +ERGG ++SSR +ET+FSRGRFQFRL+ DGN VLN  NL +G 
Sbjct: 143 LWQTFDDPKDTLLPGQALERGGKILSSRLRETNFSRGRFQFRLIPDGNGVLNANNLRTGD 202

Query: 180 AYDAFFWSNTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPE-TVSAKENYLRATLN 238
           AYDA++W+NT D N SNAG R+VFNESG LY LR + +   +TPE  V   E Y R TLN
Sbjct: 203 AYDAYYWTNTVDANLSNAGLRIVFNESGYLYTLRASNKRELITPERVVPTTEYYHRVTLN 262

Query: 239 FDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRP 298
           FDGV   YSHPKN ST +  WS+    PENIC    +   +G+G CGFNS+C ++  +R 
Sbjct: 263 FDGVLTQYSHPKN-STDNGNWSIIFSAPENICF---LITDIGTGPCGFNSVCQLNADQRA 318

Query: 299 ICQCPKGFSLLDPDDVYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISP 358
           IC+CP  FS +DP D Y  CKPDF     ED   +  + Y   EL NTDWPTSDYE+   
Sbjct: 319 ICRCPPRFSSVDPGDDYAGCKPDFSTQFCEDAPSTSPEDYDFLELTNTDWPTSDYERYDS 378

Query: 359 YGKDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETGTTFIKIRK-------V 411
           Y  +EC  +C++DC C+  V R  +CWKKKLPLS G+      G  FIK+RK       +
Sbjct: 379 YNIEECQKACIQDCFCNVVVFRG-SCWKKKLPLSNGRQSEKVNGRAFIKVRKDDYMGRGL 437

Query: 412 PS----GGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEEQGVS 467
           P       K+  D L+ V+SVL GSS  IN +L+      FL    KK     Q E+   
Sbjct: 438 PPRPFPNAKEDQDSLVLVISVLLGSSVFINFILIGLVTFCFLFFYHKKSTGIPQGEKS-- 495

Query: 468 YMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEF 527
             NLRCF+YKELVE T+GFKEELGRG+FG VYKG + MG++  VAVKKL+RV +  EKE+
Sbjct: 496 --NLRCFSYKELVEATKGFKEELGRGSFGIVYKGLIEMGTTVPVAVKKLDRVVEYGEKEY 553

Query: 528 KAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
           KAEV  IGQTHHKNLV+LLG+CDEG+ +LLVYE +SNG LA+FLFGD+K +WK RT+I  
Sbjct: 554 KAEVKAIGQTHHKNLVQLLGFCDEGQQKLLVYELLSNGTLANFLFGDTKLSWKQRTQIAF 613

Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT 647
           GIARGL YLHEEC TQIIHCDIKPQNIL+D+YY+A+ISDFGL KLL LDQS T T IRGT
Sbjct: 614 GIARGLVYLHEECNTQIIHCDIKPQNILVDEYYDAKISDFGLAKLLLLDQSQTFTTIRGT 673

Query: 648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRT----------ILTDWAYDCYQERT 697
           KGYVAPEWFRN+PITVKVD YS+GVLLLEIIC RR+          ILTDWAYDCY E  
Sbjct: 674 KGYVAPEWFRNVPITVKVDAYSFGVLLLEIICSRRSVDTEISGERAILTDWAYDCYMEGR 733

Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPI 751
           +  LVEND EA+ D+  ++RF+MVAIWCIQEDP+ RPTM+ V  MLEG+++V +
Sbjct: 734 IDDLVENDEEALSDLKKVERFLMVAIWCIQEDPTLRPTMKTVILMLEGIIQVAV 787

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224099309|ref|XP_002334494.1| predicted protein [Populus trichocarpa] gi|222872794|gb|EEF09925.1| predicted protein [Populus trichocarpa]

 Score =  863 bits (2231), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 441/789 (55%), Positives = 545/789 (69%), Gaps = 49/789 (6%)

Query: 1   MACHLLSLLF--LLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD-- 56
           MA  +L L F  L++LP    +Q+ G I++G  L+ +E+T  WLSPS DFA GFH L   
Sbjct: 1   MAFPILHLSFSLLIMLPPFAVSQTGGNITVGASLSTSENTS-WLSPSGDFAFGFHPLYGN 59

Query: 57  ------------------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTG 98
                             +WYA+GD P P GSK  LTAN G+ L DP+ RE+W+SE   G
Sbjct: 60  KYLFLLAIWYDKIPEKTIVWYANGDKPAPTGSKAVLTANRGISLTDPQGRELWRSETIIG 119

Query: 99  EAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRF 158
             A+G + D GNF++ +  S++LW++F +P DTLLP+Q ++RG  +SSR+ E +FS GRF
Sbjct: 120 VVAYGAMTDKGNFVLQDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSENNFSMGRF 179

Query: 159 QFRLLEDGNAVLNTINLESGFAYDAFFWSNT-FDVNRSNAGYRVVFNESGQLYVLRENKQ 217
           Q +L +DGN  L TINL S +  + ++ S T   ++ S+ GY+VVFNESG LY+LREN Q
Sbjct: 180 QLKLTDDGNLELATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILRENDQ 239

Query: 218 IVSLTPE-TVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIR 276
           I SLT   T S  + Y RATLNFDG+F  Y HPK  STG+  W+     P+NIC  + + 
Sbjct: 240 IFSLTQRVTASTGDFYRRATLNFDGLFTQYYHPKA-STGNERWTPIWSQPDNICQASFVS 298

Query: 277 KGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGSCKPDFILGCEEDGKKSGED 336
            G  SG CGFNS+C ++  +RPIC+CP G+SLLDP D YGSC+P++   CEED     ED
Sbjct: 299 SG--SGTCGFNSVCRLNSDRRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEVAPVED 356

Query: 337 LYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRD-DTCWKKKLPLSYGK 395
           LY  EEL NTDWPTSDY  + P+ +++C  SCL DC C+ A+ R  D CWKKKLPLS G+
Sbjct: 357 LYDFEELTNTDWPTSDYALLKPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNGR 416

Query: 396 TDRDETGTTFIKIRKVP--------SGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLG 447
              +  G   +K+R+             KK  D LI V SV  G S  +N LLV A  + 
Sbjct: 417 VQTNLDGKALLKVRRSNVNPRSPYFPNNKKDRDGLILVGSVFLGCSVFVNFLLVCAIFMC 476

Query: 448 FLVVNRKKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGS 507
           F  + R++  R  Q++  V   NLRCFTY+EL E T GFKEELGRGAFG VYKG V++GS
Sbjct: 477 FFFIYRRRTKRIPQKDGAVE-TNLRCFTYQELAEATEGFKEELGRGAFGVVYKGVVHIGS 535

Query: 508 SDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGAL 567
           S  VAVKKLN V +D  +EFK EVN IGQTHHKNLVRLLG+C+EG  RLLVYEFMSNG+L
Sbjct: 536 SIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEFMSNGSL 595

Query: 568 ASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDF 627
           +SF+F D+KP WK+R +I  G+ARGL YLHEEC  QIIHCDIKPQNILLD+YYNARISDF
Sbjct: 596 SSFIFQDAKPGWKIRIQIAFGVARGLLYLHEECSNQIIHCDIKPQNILLDEYYNARISDF 655

Query: 628 GLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR----- 682
           GL KLL LDQS T+TAIRGTKGYVAPEWFRN+P+TVKVDVYSYGVLLLEIIC RR     
Sbjct: 656 GLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNLPVTVKVDVYSYGVLLLEIICCRRNVDSK 715

Query: 683 ------TILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTM 736
                  ILTDWAYDCY+E TL ALV +D  A+DD+  L+RF+M+A WCIQEDPS RPTM
Sbjct: 716 ATIEEQAILTDWAYDCYREGTLDALVGSDTGALDDIEKLERFLMIAFWCIQEDPSLRPTM 775

Query: 737 RRVTQMLEG 745
           R+VTQMLEG
Sbjct: 776 RKVTQMLEG 784

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224057535|ref|XP_002299255.1| predicted protein [Populus trichocarpa] gi|222846513|gb|EEE84060.1| predicted protein [Populus trichocarpa]

 Score =  858 bits (2218), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 441/793 (55%), Positives = 540/793 (68%), Gaps = 67/793 (8%)

Query: 9   LFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD------------ 56
            F LL P    AQ NG  ++G  LTA +    WLSP++DFA GF QLD            
Sbjct: 11  FFFLLFPSSLVAQRNGNATVGDSLTAGDEATLWLSPAEDFAFGFRQLDKKDLYLLAIWYN 70

Query: 57  -------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTG 109
                  +WYA+GD P P  S ++LTA  G+VL +P+  EIWKS    GEAA+G + DTG
Sbjct: 71  KIPDKTIVWYANGDRPAPKKSTVKLTAELGVVLNNPQGGEIWKSGPGNGEAAYGFMNDTG 130

Query: 110 NFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAV 169
           NFL+ N N E+LWQ+F+  TDTLLPTQ ME+GG++SSR  ET+FS+GRFQFRL+ DGNAV
Sbjct: 131 NFLVANANGEKLWQSFELLTDTLLPTQIMEKGGILSSRLSETNFSQGRFQFRLIPDGNAV 190

Query: 170 LNTINLESGFAYDAFFWSNTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLT-PETVSA 228
           LNTINL +GF Y+A+FWS T D N SNAGY+VVFNESG LYVLR N    +LT    V A
Sbjct: 191 LNTINLPTGFPYEAYFWSKTVDSNSSNAGYQVVFNESGYLYVLRANNTREALTLGRVVPA 250

Query: 229 KENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGL-GSGICGFN 287
            ENY RATL+FDGVF+ YSHPK NS G+  WSV   +PENIC    + +GL GSG CG+N
Sbjct: 251 TENYHRATLHFDGVFVLYSHPK-NSPGNENWSVVRTMPENICT---VVRGLKGSGPCGYN 306

Query: 288 SICSISGAKRPICQCPKGFSLLDPDDVYGSCKPDFILG-CEEDGKKSGEDLYYIEELRNT 346
            +C+IS  KR IC+CP+ FSLLDPDD YG CKPDF    C E+   + ED Y +  L N 
Sbjct: 307 GVCTISTDKRAICRCPQRFSLLDPDDPYGGCKPDFPTQVCAEEVPNAPED-YELVPLTNI 365

Query: 347 DWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETGTTFI 406
           DWP SDYE  +PY  ++C  +CL+D  C+  V  + TCWKK+LPLS G+      G +F+
Sbjct: 366 DWPESDYEMYTPYNIEDCKKACLQDFFCNVIVFGEGTCWKKRLPLSNGRQGESVNGASFM 425

Query: 407 KIRK-------VPSGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRP 459
           K+RK        P   KK     + VVSVL G S   N +LV      F  +   KF R 
Sbjct: 426 KVRKGNYTLPGPPPIPKKN----LLVVSVLLGGSVFFNFVLVGVVSFAFFFIYHNKFTRT 481

Query: 460 HQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV 519
            Q E+ V   NLRCF+YKEL+E T GFKEELGRGAFG VYKG   +GS   VA+KK++R 
Sbjct: 482 PQVERAVQ-SNLRCFSYKELMEATNGFKEELGRGAFGIVYKGLTQIGSGVPVAIKKVDRF 540

Query: 520 FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNW 579
            ++S+KEFK EV+            ++G+CDEG++R+LVYEF+SNGALASFLFGD K +W
Sbjct: 541 VKESDKEFKTEVD------------VIGFCDEGQHRMLVYEFLSNGALASFLFGDVKLSW 588

Query: 580 KLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH 639
             RT+I  GIARGL YLH+EC TQIIHCDIKPQNILLD++Y+ARI+DFGL KL       
Sbjct: 589 NQRTQIAFGIARGLLYLHDECSTQIIHCDIKPQNILLDEHYDARIADFGLAKLF------ 642

Query: 640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRT----------ILTDWA 689
            N   +GTKGYVAPEWFRNM ITVKVDVY++GVLLLEIIC RR+          ILTDWA
Sbjct: 643 RNPQHKGTKGYVAPEWFRNMLITVKVDVYNFGVLLLEIICCRRSVDTEVGEERAILTDWA 702

Query: 690 YDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
           YDCYQE  + ALVE+D EA++DM  L+RFVMVAIWCIQEDP+ RPTM+ V  MLEG+++V
Sbjct: 703 YDCYQEGMMHALVESDEEALNDMKKLERFVMVAIWCIQEDPNLRPTMKMVMLMLEGIIQV 762

Query: 750 PIPPCPWTLNITS 762
           P+PPCP   +I S
Sbjct: 763 PVPPCPSPFSIAS 775

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224053032|ref|XP_002297673.1| predicted protein [Populus trichocarpa] gi|222844931|gb|EEE82478.1| predicted protein [Populus trichocarpa]

 Score =  847 bits (2187), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 435/779 (55%), Positives = 534/779 (68%), Gaps = 67/779 (8%)

Query: 23  NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD-------------------IWYASGD 63
           NG  ++G  LTA +    WLSP++DFA GF QLD                   +WYA+GD
Sbjct: 2   NGNATVGDSLTAGDEATLWLSPAEDFAFGFRQLDKKDLYLLAIWYNKIPDKTIVWYANGD 61

Query: 64  DPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQ 123
            P P  S ++LTA  G+VL +P+  EIWKS    GEAA+G + DTGNFL+ N N E+LWQ
Sbjct: 62  RPAPKKSTVKLTAELGVVLNNPQGGEIWKSGPGNGEAAYGFMNDTGNFLVANANGEKLWQ 121

Query: 124 TFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDA 183
           +F+  TDTLLPTQ ME+GG++SSR  ET+FS+GRFQFRL+ DGNAVLNTINL +GF Y+A
Sbjct: 122 SFELLTDTLLPTQIMEKGGILSSRLSETNFSQGRFQFRLIPDGNAVLNTINLPTGFPYEA 181

Query: 184 FFWSNTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLT-PETVSAKENYLRATLNFDGV 242
           +FWS T D N SNAGY+VVFNESG LYVLR N    +LT    V A ENY RATL+FDGV
Sbjct: 182 YFWSKTVDSNSSNAGYQVVFNESGYLYVLRANNTREALTLGRVVPATENYHRATLHFDGV 241

Query: 243 FIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGL-GSGICGFNSICSISGAKRPICQ 301
           F+ YSHPK NS G+  WSV   +PENIC    + +GL GSG CG+N +C+IS  KR IC+
Sbjct: 242 FVLYSHPK-NSPGNENWSVVRTMPENICT---VVRGLKGSGPCGYNGVCTISTDKRAICR 297

Query: 302 CPKGFSLLDPDDVYGSCKPDFILG-CEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYG 360
           CP+ FSLLDPDD YG CKPDF    C E+   + ED Y +  L N DWP SDYE  +PY 
Sbjct: 298 CPQRFSLLDPDDPYGGCKPDFPTQVCAEEVPNAPED-YELVPLTNIDWPESDYEMYTPYN 356

Query: 361 KDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETGTTFIKIRK-------VPS 413
            ++C  +CL+D  C+  V  + TCWKK+LPLS G+      G +F+K+RK        P 
Sbjct: 357 IEDCKKACLQDFFCNVIVFGEGTCWKKRLPLSNGRQGESVNGASFMKVRKGNYTLPGPPP 416

Query: 414 GGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEEQGVSYMNLRC 473
             KK     + VVSVL G S   N +LV      F  +   KF R  Q E+ V   NLRC
Sbjct: 417 IPKKN----LLVVSVLLGGSVFFNFVLVGVVSFAFFFIYHNKFTRTPQVERAVQ-SNLRC 471

Query: 474 FTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG 533
           F+YKEL+E T GFKEELGRGAFG VYKG   +GS   VA+KK++R  ++S+KEFK EV+ 
Sbjct: 472 FSYKELMEATNGFKEELGRGAFGIVYKGLTQIGSGVPVAIKKVDRFVKESDKEFKTEVD- 530

Query: 534 IGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGL 593
                      ++G+CDEG++R+LVYEF+SNGALASFLFGD K +W  RT+I  GIARGL
Sbjct: 531 -----------VIGFCDEGQHRMLVYEFLSNGALASFLFGDVKLSWNQRTQIAFGIARGL 579

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAP 653
            YLH+EC TQIIHCDIKPQNILLD++Y+ARI+DFGL KL        N   +GTKGYVAP
Sbjct: 580 LYLHDECSTQIIHCDIKPQNILLDEHYDARIADFGLAKLF------RNPQHKGTKGYVAP 633

Query: 654 EWFRNMPITVKVDVYSYGVLLLEIICLRRT----------ILTDWAYDCYQERTLGALVE 703
           EWFRNM ITVKVDVY++GVLLLEIIC RR+          ILTDWAYDCYQE  + ALVE
Sbjct: 634 EWFRNMLITVKVDVYNFGVLLLEIICCRRSVDTEVGEERAILTDWAYDCYQEGMMHALVE 693

Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCPWTLNITS 762
           +D EA++DM  L+RFVMVAIWCIQEDP+ RPTM+ V  MLEG+++VP+PPCP   +I S
Sbjct: 694 SDEEALNDMKKLERFVMVAIWCIQEDPNLRPTMKMVMLMLEGIIQVPVPPCPSPFSIAS 752

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575025|ref|XP_003555643.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max]

 Score =  840 bits (2171), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 428/799 (53%), Positives = 545/799 (68%), Gaps = 60/799 (7%)

Query: 1   MACHLLSLLFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD---- 56
           + C  + LL LL LP ++A      +SIG+ L A    + WLSPS+DFA GFHQLD    
Sbjct: 7   LVCVTVILLPLLQLPYVSATN----VSIGETLVAGNGGKRWLSPSEDFAFGFHQLDNDLY 62

Query: 57  --------------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAF 102
                         IWYA+GD+P P GSKL L    GLVL+ P+  E+W S++ +G  ++
Sbjct: 63  LLAISYQNIPRDSFIWYANGDNPAPKGSKLELNQYTGLVLKSPQGVELWTSQLISGTISY 122

Query: 103 GVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRL 162
           G++ DTGNF +++ NS+ LW +F +PTDTL+PTQ ME  G +SSR+KE +FSRGRFQFRL
Sbjct: 123 GLMNDTGNFQLLDENSQVLWDSFSNPTDTLVPTQIMEVKGTLSSRQKEANFSRGRFQFRL 182

Query: 163 LEDGNAVLNTINLESGFAYDAFFWSNTFD-VNRSNAGYRVVFNESGQLYVLRENKQIVSL 221
           L DGNAVLN INL + + YDA + S T+D  N +N+G++V+F+ SG LY+L+ + + V +
Sbjct: 183 LPDGNAVLNPINLPTNYTYDAHYISATYDSTNTTNSGFQVIFDNSG-LYILKRSGEKVYI 241

Query: 222 T--PETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGL 279
           T   + +S    Y RAT+NFDG F   ++PKN ++  + W+V   LP+NIC+N     G 
Sbjct: 242 TNPKDALSTDSYYYRATINFDGTFTISNYPKNPASNPS-WTVMKTLPDNICMNLLGNTG- 299

Query: 280 GSGICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGSCKPDFILGCEEDGKKSGEDLYY 339
           GSG+CGFNSIC++   +RP C CP+G+S LD  D YGSCKP+  LGC   G+    DLY+
Sbjct: 300 GSGVCGFNSICTLKADQRPKCSCPEGYSPLDSRDEYGSCKPNLELGCGSSGQSLQGDLYF 359

Query: 340 IEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRD 399
           ++E+ NTDWP SDYE   PY  ++C +SCL+DC C+ ++ RDD+C+KKKLPLS G+ DR 
Sbjct: 360 MKEMANTDWPVSDYELYKPYNSEDCKTSCLQDCLCAVSIFRDDSCYKKKLPLSNGRRDRA 419

Query: 400 ETGTTFIKIRK-----VPSGG-------KKKVDVLIPVVSVLFGSSALINLLLVSACCLG 447
              + FIK+ K      P          KK  D LI V+SVL G S   NL  VSA  +G
Sbjct: 420 VGASAFIKLMKNGVSLSPPNPFIEEKKYKKDQDTLITVISVLLGGSVFFNL--VSAVWVG 477

Query: 448 FLVVNRKKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGS 507
           F     KK        +  +  NL  FT+ ELV+ T  FKEELGRG+ G VYKG  N+ +
Sbjct: 478 FYFYYNKK----SSTNKTATESNLCSFTFAELVQATDNFKEELGRGSCGIVYKGTTNLAT 533

Query: 508 SDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGAL 567
              +AVKKL++V +D +KEFK EVN IGQTHHK+LVRLLGYCDE ++R+LVYEF+SNG L
Sbjct: 534 ---IAVKKLDKVLKDCDKEFKTEVNVIGQTHHKSLVRLLGYCDEEQHRILVYEFLSNGTL 590

Query: 568 ASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDF 627
           A+FLFGD KPNW  R +I  GIARGL YLHEECCTQIIHCDIKPQNILLD+ YNARISDF
Sbjct: 591 ANFLFGDFKPNWNQRVQIAFGIARGLVYLHEECCTQIIHCDIKPQNILLDEQYNARISDF 650

Query: 628 GLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR----- 682
           GL KLL +++SHT T IRGTKGYVAP+WFR+ PIT KVDVYS+GVLLLEIIC RR     
Sbjct: 651 GLSKLLKINESHTETGIRGTKGYVAPDWFRSAPITTKVDVYSFGVLLLEIICCRRNVDGE 710

Query: 683 ------TILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTM 736
                  ILTDWAYDCY+   +  L+END EA+DD   L+RFVMVAIWC+QEDPS RP M
Sbjct: 711 VGNEEKAILTDWAYDCYRAGRIDILLENDDEAIDDTNRLERFVMVAIWCLQEDPSLRPPM 770

Query: 737 RRVTQMLEGVVEVPIPPCP 755
           ++V  MLEG+  V IPP P
Sbjct: 771 KKVMLMLEGIAPVTIPPSP 789

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224103119|ref|XP_002334088.1| predicted protein [Populus trichocarpa] gi|222839594|gb|EEE77931.1| predicted protein [Populus trichocarpa]

 Score =  828 bits (2138), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 430/799 (53%), Positives = 545/799 (68%), Gaps = 51/799 (6%)

Query: 1   MACHLLSLLF--LLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQL--- 55
           MA  +L L F  L++LP    +Q+ G I++G  L+ +++T  WLSPS DFA GF+QL   
Sbjct: 1   MAFPILHLSFSLLIMLPPFAVSQTGGNITVGASLSTSDNTS-WLSPSGDFAFGFYQLYGN 59

Query: 56  -----------------DIWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTG 98
                             +WYA+GD P P GSK  LTAN G+ L DP+ RE+W+SE   G
Sbjct: 60  KDLFLLAIWYDKIPDKTIVWYANGDKPAPTGSKAVLTANRGISLTDPQGRELWRSETIIG 119

Query: 99  EAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRF 158
           + A+G + DTGNF++ +  S++LW++F +P DTLLP+Q ++RG  +SSR+ ET+FS GRF
Sbjct: 120 DVAYGAMTDTGNFVLRDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSETNFSMGRF 179

Query: 159 QFRLLEDGNAVLNTINLESGFAYDAFFWSNT-FDVNRSNAGYRVVFNESGQLYVLRENKQ 217
           Q +L +DGN VL TINL S +  + ++ S T   ++ S+ GY+VVFNESG LY+LR+N Q
Sbjct: 180 QLKLRDDGNLVLATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILRKNDQ 239

Query: 218 IVSLTPE-TVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIR 276
           I SLT   T S  + Y RATLNFDGVF  Y HPK  STG+  W+     P+NIC  + + 
Sbjct: 240 IFSLTQRVTASTGDFYHRATLNFDGVFTQYYHPKA-STGNERWTPIWSQPDNICQASSVS 298

Query: 277 KGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGSCKPDFILGCEEDGKKSGED 336
            G  SG CGFNS+C ++   RPIC+CP G+SLLDP D YGSC+P++   CEED     ED
Sbjct: 299 AG--SGTCGFNSVCRLNSDGRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEVAPVED 356

Query: 337 LYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRD-DTCWKKKLPLSYGK 395
           LY  EEL NTDWPTSDY  + P+ +++C  SCL DC C+ A+ R  D CWKKKLPLS G+
Sbjct: 357 LYDFEELTNTDWPTSDYALLQPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNGR 416

Query: 396 TDRDETGTTFIKIRKVP--------SGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLG 447
                     +K+R+             KK  D LI V SV  G S  +N LLV A C+G
Sbjct: 417 VQTIVDAKALLKVRRSNVNPRSPYFPNNKKDRDGLILVGSVFLGCSVFVNFLLVCAICMG 476

Query: 448 FLVVNRKKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGS 507
           F  + R++  R  Q++  V   NLRCFTY+EL E T GFKEELGRGAFG VY+G V++GS
Sbjct: 477 FFFIYRRRTKRIPQKDGAVE-TNLRCFTYQELAEATEGFKEELGRGAFGVVYRGVVHIGS 535

Query: 508 SDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGAL 567
           S  VAVKKLN V +D  +EFK EVN IGQTHHKNLVRLLG+C+EG  RLLVYEFMSNG+L
Sbjct: 536 SIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEFMSNGSL 595

Query: 568 ASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDF 627
           +SF+F D+KP WK+R +I  G+ARGL YLHE+  +QIIHCDIKPQNILLD+  NARISDF
Sbjct: 596 SSFIFQDAKPGWKIRIQIAFGVARGLLYLHED--SQIIHCDIKPQNILLDESLNARISDF 653

Query: 628 GLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRT---- 683
           GL KLL  DQ+ T TAIRGTKGYVAPEWF+N+P+T KVD YS+G+LLLE++C R+     
Sbjct: 654 GLAKLLKTDQTKTTTAIRGTKGYVAPEWFKNLPVTTKVDTYSFGILLLELVCCRKNFEIN 713

Query: 684 -------ILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTM 736
                  +L DWA DC +E  L  LVE D EAM+DM  ++RFVMVAIWCIQEDPS RP M
Sbjct: 714 AMQEHQIVLADWACDCLKEGKLNLLVEEDEEAMEDMKRVERFVMVAIWCIQEDPSLRPGM 773

Query: 737 RRVTQMLEGVVEVPIPPCP 755
           ++V QMLEG V+V +PP P
Sbjct: 774 KKVVQMLEGGVQVSVPPDP 792

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|109676362|gb|ABG37663.1| CCHC-type integrase [Populus trichocarpa]

 Score =  816 bits (2107), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 425/761 (55%), Positives = 516/761 (67%), Gaps = 52/761 (6%)

Query: 9   LFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD------------ 56
           L ++LL  +  AQ+NG +  G  +TA + +  W S S +FA GF QL+            
Sbjct: 43  LTMVLLQLMAVAQTNGRVPTGASITATDDSPSWPSASGEFAFGFRQLENKDYFLLSIWYE 102

Query: 57  -------IWYASGDDPG-----PGGSKLRLTANGGLVLEDPEAREIWKSEISTGEA-AFG 103
                  +WYA G+DP      P GSKL LT + GL+L DP+  +IW S I  G A + G
Sbjct: 103 KIPEKTVVWYAIGEDPTDDPAVPRGSKLELTDDRGLLLADPQGNQIWSSGIPPGAAVSSG 162

Query: 104 VLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLL 163
           V+ DTGNF++ N NS RLW++F++PTDTLLPTQ ME GGVVSSRR ET+FS GRFQ RLL
Sbjct: 163 VMNDTGNFVLQNRNSFRLWESFNNPTDTLLPTQIMEVGGVVSSRRTETNFSLGRFQLRLL 222

Query: 164 EDGNAVLNTINLESGFAYDAFFWSNTFDV-NRSNAGYRVVFNESGQLYVLRENKQIVSLT 222
           ++GN VLN +NL + F YD ++ S T D  N SN+GYR++FNESG +Y+LR N  I  LT
Sbjct: 223 DNGNLVLNYMNLPTKFVYDDYYSSETSDASNSSNSGYRLIFNESGYMYILRRNGLIEDLT 282

Query: 223 PETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSG 282
              +   + Y RATLNFDGVF  Y +PK  S+G+  WS     P++IC+N  +   LGSG
Sbjct: 283 KTALPTIDFYHRATLNFDGVFTQYFYPKA-SSGNRSWSSVWSKPDDICVN--MGADLGSG 339

Query: 283 ICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGSCKPDFILGCEEDGKKSGEDLYYIEE 342
            CG+NSIC++   KRP C+CP+GFSLLD +D YGSC PDF L C +DG  S ED Y   E
Sbjct: 340 ACGYNSICNLKADKRPECKCPQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTEDQYDFVE 399

Query: 343 LRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETG 402
           L N DWPTSDYE+  P  +DEC  SCL DC CS A+ RD  CWKKKLPLS G+ D    G
Sbjct: 400 LINVDWPTSDYERYKPINEDECRKSCLNDCLCSVAIFRDG-CWKKKLPLSNGRFDIGMNG 458

Query: 403 TTFIKIRK--VP--------SGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVN 452
             F+K  K  VP         G KKK D+     SV+ G+S  +N +LV A CL    + 
Sbjct: 459 KAFLKFPKGYVPLDRPPPQLPGEKKKPDIKFITGSVVLGTSVFVNFVLVGAFCLTSSFIY 518

Query: 453 RKKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVA 512
           RKK  +  +   G+   NLR FTYKEL E T  FK+E+GRG FG VYKG +  GS+  VA
Sbjct: 519 RKKTEKVKEGGSGLE-TNLRYFTYKELAEATNDFKDEVGRGGFGVVYKGTIQAGSTRVVA 577

Query: 513 VKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF 572
           VKKL++V QD EKEFK EV  IGQTHHKNLVRLLG+CDEG+NRLLVYEF+SNG LA+FLF
Sbjct: 578 VKKLDKVVQDGEKEFKTEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSNGTLANFLF 637

Query: 573 GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL 632
           G SKPNWK RT+I  GIARGL YLHEEC TQIIHCDIKPQNILLD+YYNARISDFGL KL
Sbjct: 638 GCSKPNWKQRTQIAFGIARGLLYLHEECGTQIIHCDIKPQNILLDNYYNARISDFGLAKL 697

Query: 633 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRT--------- 683
           L +DQS T TAIRGTKGYVAPEWFRN PITVKVDVYS+GV+LLEIIC RR          
Sbjct: 698 LVMDQSKTQTAIRGTKGYVAPEWFRNRPITVKVDVYSFGVMLLEIICCRRNVDLEIGEVE 757

Query: 684 --ILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA 722
             +LTDWAYDCY + +L  L+ +D EA +D++ L+R +  A
Sbjct: 758 NPVLTDWAYDCYMDGSLDVLIGDDTEAKNDISTLERLLKPA 798

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356555135|ref|XP_003545892.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max]

 Score =  791 bits (2044), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 426/810 (52%), Positives = 534/810 (65%), Gaps = 58/810 (7%)

Query: 1   MACHLLSLLFL--LLLPCL---TAAQSNGTISIGQQLTAAESTEPWL--SPSKDFALGFH 53
           MA  LL  LFL  +LLP       AQ+   I+IG   TA  ST PWL  SPS DFA GF 
Sbjct: 1   MASPLLPFLFLSMVLLPFQHINVMAQTKSNIAIGDSHTAGASTSPWLVSSPSGDFAFGFL 60

Query: 54  QLD--------------------IWYASGDDPGPGGSKLRLTANGGLVL-EDPEAREIWK 92
            L+                    +W+A+ D P P GSK+ LTA+ GLVL   P   ++WK
Sbjct: 61  PLEDTPDHFMLCIWYAKIQDKTIVWFANRDKPAPKGSKVVLTADDGLVLITAPNGNQLWK 120

Query: 93  SEISTGEAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETD 152
           +   T   + GVL +TGNF++ + +S  +W++F    DTLLP QTMERG  +SS+ +   
Sbjct: 121 TGGLTVRVSSGVLNNTGNFVLQDGDSNTVWESFKDYRDTLLPYQTMERGQKLSSKLRRNY 180

Query: 153 FSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTFDVNRSNAGYRVVFNESGQLYVL 212
           F++GRF      DGN V+++INL SG+A + ++ S T + N S+AG ++VF+ SG +YVL
Sbjct: 181 FNKGRFVLFFQNDGNLVMHSINLPSGYANEHYYESGTVESNISSAGTQLVFDGSGDMYVL 240

Query: 213 RENKQIVSLTPETVSAKEN----YLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPEN 268
           REN +  +L+     A       YLRATL+FDGVF  Y HPK  S+G   W+     P+N
Sbjct: 241 RENNEKYNLSRGGSGASSTTQFFYLRATLDFDGVFTLYQHPKG-SSGTGGWTPVWSHPDN 299

Query: 269 ICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGSCKPDFILGCEE 328
           IC   D     GSG+CG+NSICS+   KRP C+CPK +SL+DP+D  GSCKPDF+  C  
Sbjct: 300 IC--KDYVASAGSGVCGYNSICSLRDDKRPNCKCPKWYSLVDPNDPNGSCKPDFVQACAV 357

Query: 329 DGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLR-DDTCWKK 387
           D   + +DLY  E L +TDWP SDY    P+ +++C  SC++DC CS A+ R  D+CWKK
Sbjct: 358 DELSNRKDLYDFEVLIDTDWPQSDYVLQRPFNEEQCRQSCMEDCMCSVAIFRLGDSCWKK 417

Query: 388 KLPLSYGKTDRDETGT-TFIKIRK------VPSG-GKKKVDVLIPVVSVLFGSSALINLL 439
           KLPLS G+ D    G   F+K+RK      VP+    K  +  I V SVL GSSA +NL+
Sbjct: 418 KLPLSNGRVDATLNGAKAFMKVRKDNSSLIVPTIIVNKNRNTSILVGSVLLGSSAFLNLI 477

Query: 440 LVSACCLGFLVVNR-KKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTV 498
           L+ A CL    V R KK +R       +   NLRCFTYKEL + T GF + LG+GAFG V
Sbjct: 478 LLGAICLSTSYVFRYKKKLRSIGRSDTIVETNLRCFTYKELEKATDGFDKVLGKGAFGIV 537

Query: 499 YKGFVNMGSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLL 557
           Y+G +NMGS  +VAVK+LN  + +D  KEFK E+N IG THHKNLVR+LG+C+    RLL
Sbjct: 538 YEGVINMGSDTRVAVKRLNTFLLEDVHKEFKNELNAIGLTHHKNLVRILGFCETEEKRLL 597

Query: 558 VYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL 616
           VYE+MSNG LAS LF    KP+W+LR +I +G+ARGL YLHEEC TQIIHCDIKPQNILL
Sbjct: 598 VYEYMSNGTLASLLFNILEKPSWELRLQIAIGVARGLLYLHEECSTQIIHCDIKPQNILL 657

Query: 617 DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLE 676
           DDYYNARISDFGL KLL ++QS TNTAIRGTKGYVA EWF+NMPIT KVDVYSYGVLLLE
Sbjct: 658 DDYYNARISDFGLAKLLNMNQSRTNTAIRGTKGYVALEWFKNMPITAKVDVYSYGVLLLE 717

Query: 677 IICLRRT-----------ILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWC 725
           I+  R++           IL +WAYDCY ERTL ALVE D EA+DDM  L++ VM+A+WC
Sbjct: 718 IVSCRKSVEFETEDKEKAILAEWAYDCYTERTLHALVEGDKEALDDMKNLEKLVMIALWC 777

Query: 726 IQEDPSHRPTMRRVTQMLEGVVEVPIPPCP 755
           +QEDP  RPTMR VTQMLEGVVEV +PPCP
Sbjct: 778 VQEDPDLRPTMRNVTQMLEGVVEVKVPPCP 807

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224143661|ref|XP_002336066.1| predicted protein [Populus trichocarpa] gi|222869874|gb|EEF07005.1| predicted protein [Populus trichocarpa]

 Score =  789 bits (2037), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 415/765 (54%), Positives = 490/765 (64%), Gaps = 111/765 (14%)

Query: 23  NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD-------------------IWYASGD 63
           NG++ +G  +TA +    WLS S +FA GF  L+                   +WYA+GD
Sbjct: 1   NGSMPVGAFITATDDAPSWLSSSGEFAFGFQPLEYKDHFLLSIWYAKIPEKTIVWYANGD 60

Query: 64  DPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQ 123
           +P P  SK+ L  + GLVL DP+   IW S    G  + GV+ DTGNF++ N+NS RLW+
Sbjct: 61  NPAPRESKVELRGDSGLVLTDPQGNLIWSSGSLLGTVSSGVMNDTGNFVLQNSNSFRLWE 120

Query: 124 TFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDA 183
           +F +PTDTLLPTQ ME GGVVSSRR ET+FS GRFQ RLL++GN VLN +NL + F YD 
Sbjct: 121 SFSNPTDTLLPTQIMEVGGVVSSRRTETNFSLGRFQLRLLDNGNLVLNYMNLPTKFVYDD 180

Query: 184 FFWSNTFDV-NRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGV 242
           ++ S T D  N SN+GYR++FNESG +Y+LR N  I  LT   +   + Y RATLNFD  
Sbjct: 181 YYSSETSDASNSSNSGYRLIFNESGYMYILRRNGLIEDLTKTALPTIDFYHRATLNFDA- 239

Query: 243 FIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQC 302
                                               LGSG CG+NSIC++   KRP C+C
Sbjct: 240 -----------------------------------DLGSGACGYNSICNLKADKRPECKC 264

Query: 303 PKGFSLLDPDDVYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKD 362
           P+GFSLLD +D YGSC PDF L C +DG  S ED Y   EL N DWPTSDYE+  P  +D
Sbjct: 265 PQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTEDQYDFVELINVDWPTSDYERYKPINED 324

Query: 363 ECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETGTTFIKIRKVPSGGKKKVDVL 422
           EC  SCL DC CS A+ RD  CWKKKLPLS G+ D    G  F+K    P G K +    
Sbjct: 325 ECRKSCLNDCLCSVAIFRD-GCWKKKLPLSNGRFDIGMNGKAFLKF---PKGYKTE---- 376

Query: 423 IPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEEQGVSYMNLRCFTYKELVEV 482
                V  G S L                                  NLR FTYKEL E 
Sbjct: 377 ----KVKEGGSGL--------------------------------ETNLRYFTYKELAEA 400

Query: 483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNL 542
           T  FK+E+GRG FG VYKG +  GS+  VAVKKL++V QD EKEFK EV  IGQTHHKNL
Sbjct: 401 TNDFKDEVGRGGFGVVYKGTIQAGSTRVVAVKKLDKVVQDGEKEFKTEVQVIGQTHHKNL 460

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           VRLLG+CDEG+NRLLVYEF+SNG LA+FLFG SKPNWK RT+I  GIARGL YLHEEC T
Sbjct: 461 VRLLGFCDEGQNRLLVYEFLSNGTLANFLFGCSKPNWKQRTQIAFGIARGLLYLHEECGT 520

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           QIIHCDIKPQNILLD+YYNARISDFGL KLL +DQS T TAIRGTKGYVAPEWFRN PIT
Sbjct: 521 QIIHCDIKPQNILLDNYYNARISDFGLAKLLVMDQSKTQTAIRGTKGYVAPEWFRNRPIT 580

Query: 663 VKVDVYSYGVLLLEIICLRRT-----------ILTDWAYDCYQERTLGALVENDLEAMDD 711
           VKVDVYS+GV+LLEIIC RR            +LTDWAYDCY + +L  L+ +D EA +D
Sbjct: 581 VKVDVYSFGVMLLEIICCRRNVDLEIGEVENPVLTDWAYDCYMDGSLDVLIGDDTEAKND 640

Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCPW 756
           ++ L+R + V IWCIQEDPS RPTMR+VTQMLEGVVEVP  P P+
Sbjct: 641 ISTLERLLKVGIWCIQEDPSLRPTMRKVTQMLEGVVEVPAAPNPF 685

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356503095|ref|XP_003520347.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max]

 Score =  788 bits (2034), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/806 (52%), Positives = 530/806 (65%), Gaps = 61/806 (7%)

Query: 1   MACHLLSLLFL----LLLPCLTAAQSNGTISIGQQLTAAESTEPWL--SPSKDFALGFHQ 54
           MA  LL L FL    +LLP    AQ+   I+IG   TA +ST PWL  SPS DFA GF  
Sbjct: 1   MASSLL-LFFLFCSVILLP-FVVAQTKTNIAIGDSHTAGKSTTPWLVSSPSGDFAFGFLP 58

Query: 55  LD---------IWYASGDD------------PGPGGSKLRLTANGGLVLEDPEAREIWKS 93
           L+         IWYA+  D            P P GSK+ L+A+ GLVL  P   ++W +
Sbjct: 59  LEATPDHFILCIWYANIQDRTIVWFANRDNKPAPKGSKVELSADDGLVLTAPNGDKLWNT 118

Query: 94  EISTGEAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDF 153
              T   + GV  DTGN ++++  S   W++FD   DTLLP+QTMERG  +SS+ +  DF
Sbjct: 119 GGFTARVSSGVFNDTGNLVLLDGASSSTWESFDDYRDTLLPSQTMERGQKLSSKLRRNDF 178

Query: 154 SRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTFDVNRSNAGYRVVFNESGQLYVLR 213
           + GRF+     DGN V+++INL S +    ++ S T + N S+AG ++VF+ SG +Y+LR
Sbjct: 179 NIGRFELFFQNDGNLVMHSINLPSEYVNANYYASGTIESNTSSAGTQLVFDRSGDVYILR 238

Query: 214 ENKQIVSLTPE-TVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICIN 272
           +NK+  +L+   ++S  + YLRATL+FDGVF  Y HPK  S+G   W+     P+NIC  
Sbjct: 239 DNKEKYNLSDGGSISTTQFYLRATLDFDGVFTLYQHPKG-SSGSVGWTPVWSHPDNIC-- 295

Query: 273 NDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGSCKPDFILGCEEDGKK 332
            D      SG+CG+NSICS+   KRPIC+CPK +SL+DP+D  GSCKPDF+  C ED   
Sbjct: 296 KDYLSATSSGVCGYNSICSLGDYKRPICKCPKWYSLVDPNDPNGSCKPDFVQSCSEDELS 355

Query: 333 SGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLR-DDTCWKKKLPL 391
             EDLY  E L +TDWP+SDY    P+ +++C  SC++DC CS A+ R  D+CWKKKLPL
Sbjct: 356 QREDLYDFEVLIDTDWPSSDYVLQKPFTEEQCRQSCMEDCLCSVAIFRLGDSCWKKKLPL 415

Query: 392 SYGKTDRDETGT-TFIKIRKVPSG--------GKKKVDVLIPVVSVLFGSSALINLLLVS 442
           S G+ D    G   F+K+RK  S          K   + LI    VL   SA +NL+LV 
Sbjct: 416 SNGRVDATLNGAKAFMKVRKDNSSLVVPPIIVKKNSRNTLI----VLLSGSACLNLILVG 471

Query: 443 ACCLGFLVV--NRKKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYK 500
           A CL    V   +KK  R  +    V   NLRCFTY+EL E T GF++ LG+GAFG VY+
Sbjct: 472 AICLSSFYVFWCKKKLRRVGKSGTNVE-TNLRCFTYEELEEATNGFEKVLGKGAFGIVYE 530

Query: 501 GFVNMGSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY 559
           G +NMGS   VAVK+LN  + ++ +KEFK E+N IG THHKNLVRLLG+C+    RLLVY
Sbjct: 531 GVINMGSLTLVAVKRLNTFLLEEVQKEFKNELNAIGLTHHKNLVRLLGFCETQDERLLVY 590

Query: 560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY 619
           E+MSNG LAS +F   KP+WKLR +I  G+ARGL YLHEEC TQIIHCDIKPQNILLDDY
Sbjct: 591 EYMSNGTLASLVFNVEKPSWKLRLQIATGVARGLLYLHEECSTQIIHCDIKPQNILLDDY 650

Query: 620 YNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
           YNARISDFGL K+L ++QS TNTAIRGTKGYVA EWF+NMPIT KVDVYSYGVLLLEI+ 
Sbjct: 651 YNARISDFGLAKILNMNQSRTNTAIRGTKGYVALEWFKNMPITAKVDVYSYGVLLLEIVS 710

Query: 680 LRRT----------ILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQED 729
            R++          ILT+WA+DCY E  L  LVEND EA+DDM  L++ VM+A+WC+QED
Sbjct: 711 CRKSVEFEADEEKAILTEWAFDCYTEGVLHDLVENDKEALDDMKTLEKLVMIALWCVQED 770

Query: 730 PSHRPTMRRVTQMLEGVVEVPIPPCP 755
           P  RPTMR VTQMLEGVVEV IPPCP
Sbjct: 771 PGLRPTMRNVTQMLEGVVEVQIPPCP 796

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	762
TAIR|locus:2026155	829	AT1G34300 [Arabidopsis thalian	0.917	0.843	0.340	6.1e-94
TAIR|locus:2116525	821	SD2-5 "S-domain-2 5" [Arabidop	0.863	0.801	0.334	3e-85
TAIR|locus:2059103	828	AT2G19130 [Arabidopsis thalian	0.906	0.834	0.329	1.5e-81
TAIR|locus:2182603	872	AT5G35370 [Arabidopsis thalian	0.372	0.325	0.396	1.1e-66
TAIR|locus:2197649	821	AT1G61360 [Arabidopsis thalian	0.611	0.567	0.312	1.1e-66
TAIR|locus:2197734	814	AT1G61370 [Arabidopsis thalian	0.601	0.562	0.307	4.5e-66
TAIR|locus:2197714	792	AT1G61440 [Arabidopsis thalian	0.618	0.594	0.318	1.3e-65
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.368	0.330	0.402	1.3e-65
TAIR|locus:2197729	805	SD1-29 "S-domain-1 29" [Arabid	0.619	0.586	0.314	2.9e-63
TAIR|locus:2137010	849	AT4G11900 [Arabidopsis thalian	0.828	0.743	0.296	1.4e-62

TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)]

 Score = 935 (334.2 bits), Expect = 6.1e-94, P = 6.1e-94
 Identities = 271/795 (34%), Positives = 395/795 (49%)

Query:    22 SNGTISIGQQLTAAESTEPWLSPSKDFALGF---HQLDIWYAS----GDDP----GPGGS 70
             S  TI +G  + A+ S + W SP+  F++ F      + + A+    G  P    G   S
Sbjct:    23 SFSTIPLGSVIYASGSNQNWPSPNSTFSVSFVPSPSPNSFLAAVSFAGSVPIWSAGTVDS 82

Query:    71 K--LRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQTFDHP 128
             +  LRL  +G L L +     +W S+        G + DTG F+++N  S  +W +FD+P
Sbjct:    83 RGSLRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSSFDNP 142

Query:   129 TDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSN 188
             TDT++ +Q    G ++ S         G + F+L   GN    T+   +   Y     ++
Sbjct:   143 TDTIVQSQNFTAGKILRS---------GLYSFQLERSGNL---TLRWNTSAIYWNHGLNS 190

Query:   189 TFDVNRSNAGYRVVFNESGQLYVLREN----KQIVSLTPETVSAKENYLRATLNFDGVFI 244
             +F  N S+   R+    +G + +   N     +IV       S    +L+  L+ DG   
Sbjct:   191 SFSSNLSSP--RLSLQTNGVVSIFESNLLGGAEIVYSGDYGDSNTFRFLK--LDDDGNLR 246

Query:   245 FYSHPKNNSTG-DAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCP 303
              YS    NS   +A WS  D      C        L  G CG   ICS +    PIC CP
Sbjct:   247 IYSSASRNSGPVNAHWSAVDQ-----C--------LVYGYCGNFGICSYNDTN-PICSCP 292

Query:   304 -KGFSLLDPDDVYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKD 362
              + F  +D +D    CK    L  +  G  +  DL +       D P S  E     G  
Sbjct:   293 SRNFDFVDVNDRRKGCKRKVELS-DCSGNTTMLDLVHTRLFTYEDDPNS--ESFFA-GSS 348

Query:   363 ECVSSCLKDCQCSAAVLRDD---TCWKKKLPLSY--GKTDRDETGTTFIKI--------- 408
              C ++CL    C A+V   D    CW+K  P S+  G        T+++K+         
Sbjct:   349 PCRANCLSSVLCLASVSMSDGSGNCWQKH-PGSFFTGYQWPSVPSTSYVKVCGPVVANTL 407

Query:   409 RKVPSG--GKKKVDVLIPVVSVLFGSSALINLLL-VSACCLGFLVVNRKKFMRPHQEEQG 465
              +   G     KV + I  V+V+ G   L+ + + +  CC         +F         
Sbjct:   408 ERATKGDDNNSKVHLWIVAVAVIAGLLGLVAVEIGLWWCCCR----KNPRFGTLSSHYTL 463

Query:   466 VSYMNLRC--FTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS 523
             + Y +     FTYKEL   T+ FKE+LG G FGTVY+G +   +   VAVK+L  + Q  
Sbjct:   464 LEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLT--NRTVVAVKQLEGIEQ-G 520

Query:   524 EKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG-DSKP--NWK 580
             EK+F+ EV  I  THH NLVRL+G+C +GR+RLLVYEFM NG+L +FLF  DS     W+
Sbjct:   521 EKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWE 580

Query:   581 LRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSH 639
              R  I +G A+G+ YLHEEC   I+HCDIKP+NIL+DD + A++SDFGL KLL   D  +
Sbjct:   581 YRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRY 640

Query:   640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTI----------LTDWA 689
               +++RGT+GY+APEW  N+PIT K DVYSYG++LLE++  +R             + WA
Sbjct:   641 NMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWA 700

Query:   690 YDCYQERTLGALVENDL--EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
             Y+ +++    A+++  L  +   DM  + R V  + WCIQE P  RPTM +V QMLEG+ 
Sbjct:   701 YEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGIT 760

Query:   748 EVPIPPCPWTLNITS 762
             E+  P CP T++  S
Sbjct:   761 EIKNPLCPKTISEVS 775

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 853 (305.3 bits), Expect = 3.0e-85, P = 3.0e-85
 Identities = 248/742 (33%), Positives = 374/742 (50%)

Query:    57 IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNT 116
             IW A+   P     K     NG +V+E     E+W+ + S   A+   L D+GN ++V+ 
Sbjct:    82 IWSANRASPVSNSDKFVFDDNGNVVME---GTEVWRLDNSGKNASRIELRDSGNLVVVSV 138

Query:   117 NSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRL-LEDGNAVLNTINL 175
             +   +W++FDHPTDTL+  Q  + G  ++S    ++ +     + L ++ G+ VL+  +L
Sbjct:   139 DGTSIWESFDHPTDTLITNQAFKEGMKLTSSPSSSNMT-----YALEIKSGDMVLSVNSL 193

Query:   176 ESGFAYDAFFWSNTFDVNRS-NAGYRVVFNES--GQLYVLRENKQIVSLTPETVSAKENY 232
                      +WS      R  N    VV + S  G  +   + KQ++         K++ 
Sbjct:   194 TP-----QVYWSMANARERIINKDGGVVTSSSLLGNSWRFFDQKQVLLWQFVFSDNKDDN 248

Query:   233 LR--ATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSIC 290
                 A L  +GV  F +     S  D+    S  +P ++C       G     CG   +C
Sbjct:   249 TTWIAVLGNNGVISFSNLGSGASAADS----STKIPSDLC-------GTPEP-CGPYYVC 296

Query:   291 SISGAKRPICQCPKGFSLLDPDDVYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPT 350
             S  G+K  +C C  G S    D     CK      C++    +   L  +      D+  
Sbjct:   297 S--GSK--VCGCVSGLSRARSD-----CKTGITSPCKKTKDNATLPLQLVSAGDGVDYFA 347

Query:   351 SDYEQISPYGK----DECVSSCLKDCQCSAAVLRDDT--CWKKKLPLSYGKTDRDETG-T 403
               Y    P+ K    D C   C  +C C     ++ +  C+      S+  +    +G  
Sbjct:   348 LGYAP--PFSKKTDLDSCKEFCHNNCSCLGLFFQNSSGNCFLFDYIGSFKTSGNGGSGFV 405

Query:   404 TFIKIRKVPSGGKKKVD---VLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFM--R 458
             ++IKI    SGG    +      P V ++   +  I  +L+    + F +  RKK +   
Sbjct:   406 SYIKIASTGSGGGDNGEDDGKHFPYVVIIVVVTVFIIAVLIF---VAFRIHKRKKMILEA 462

Query:   459 PHQ--EE----QGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVA 512
             P +  EE    + +S M +R F YK+L   T  F  +LG+G FG+VY+G +  GS  ++A
Sbjct:   463 PQESSEEDNFLENLSGMPIR-FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGS--RLA 519

Query:   513 VKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF 572
             VKKL  + Q  +KEF+AEV+ IG  HH +LVRL G+C EG +RLL YEF+S G+L  ++F
Sbjct:   520 VKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIF 578

Query:   573 ----GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFG 628
                 GD   +W  R  I +G A+GL YLHE+C  +I+HCDIKP+NILLDD +NA++SDFG
Sbjct:   579 RKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFG 638

Query:   629 LEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTI---- 684
             L KL+T +QSH  T +RGT+GY+APEW  N  I+ K DVYSYG++LLE+I  R+      
Sbjct:   639 LAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSE 698

Query:   685 ------LTDWAYDCYQERTLGALVENDLEAMD--DMTVLQRFVMVAIWCIQEDPSHRPTM 736
                      +A+   +E  L  +V+  ++ +D  D  V QR +  A+WCIQED   RP+M
Sbjct:   699 TSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERV-QRAMKTALWCIQEDMQTRPSM 757

Query:   737 RRVTQMLEGVVEVPIPPCPWTL 758
              +V QMLEGV  V  PP   T+
Sbjct:   758 SKVVQMLEGVFPVVQPPSSSTM 779

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)]

 Score = 818 (293.0 bits), Expect = 1.5e-81, P = 1.5e-81
 Identities = 260/788 (32%), Positives = 386/788 (48%)

Query:    25 TISIGQQLTAAESTEP--WLSP--SKDFALG--FHQLD---IWYASGDDP-GPGGSKLRL 74
             T+S  Q + +++ T    +  P  S +F +G  + QL    +W A+ D       S +  
Sbjct:    31 TLSGDQTIVSSDGTYEMGFFKPGSSSNFYIGMWYKQLSQTILWVANRDKAVSDKNSSVFK 90

Query:    75 TANGGLVLEDPEARE-IWKSEI-STGE--AAFGVLYDTGNFLIVNTNSERL-----WQTF 125
              +NG L+L D   +  +W + + ST    A   VL D GN L++ T    L     WQ+F
Sbjct:    91 ISNGNLILLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGN-LVLRTGGSSLSANVLWQSF 149

Query:   126 DHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFF 185
             DHP DT LP       GV     K T  S+    ++ LED +  L ++ L+   AY    
Sbjct:   150 DHPGDTWLP-------GVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDESTAYK-IL 201

Query:   186 WSNTFDVNRS---NAGYRVVFNESGQL---YVLRENKQIVSLTPET-----VSAKENYLR 234
             W+ + +   S   N   R+ F+   ++   Y+   N    S T ++     +  + N  R
Sbjct:   202 WNGSNEYWSSGPWNPQSRI-FDSVPEMRLNYIY--NFSFFSNTTDSYFTYSIYNQLNVSR 258

Query:   235 ATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISG 294
               ++  G    ++  + N   +  WS     P   C    + +      CG   ICS   
Sbjct:   259 FVMDVSGQIKQFTWLEGNKAWNLFWSQ----PRQQC---QVYR-----YCGSFGICS--D 304

Query:   295 AKRPICQCPKGFSLLDPDDVYGSCKPDFILGC--EEDGKKSGEDLYYIEELRNTDWPTSD 352
                P C+CP+GF  +   D     K D+  GC  + + + S  D+     L N     + 
Sbjct:   305 KSEPFCRCPQGFRPMSQKD--WDLK-DYSAGCVRKTELQCSRGDINQFFRLPNMKLADNS 361

Query:   353 YEQISPYGKDECVSSCLKDCQCSAAVLRDDT--C--WKKK-LPLSYGKTDRDETGTTFIK 407
              E ++      C S+C  DC C A    + +  C  W K  L L   + +  E    +++
Sbjct:   362 -EVLTRTSLSICASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLR 420

Query:   408 IRK--VPS-GGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEEQ 464
             +    VP+ G   K +    +   + GS  +I L+L+    +  L   R+K MR    E+
Sbjct:   421 LAASDVPNVGASGKSNNKGLIFGAVLGSLGVIVLVLLVVILI--LRYRRRKRMRG---EK 475

Query:   465 GVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE 524
             G     L  F+Y+EL   T+ F ++LG G FG+V+KG +   SSD +AVK+L  + Q  E
Sbjct:   476 GDG--TLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALP-DSSD-IAVKRLEGISQ-GE 530

Query:   525 KEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPN-----W 579
             K+F+ EV  IG   H NLVRL G+C EG  +LLVY++M NG+L S LF +         W
Sbjct:   531 KQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGW 590

Query:   580 KLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH 639
             KLR +I +G ARGL YLH+EC   IIHCDIKP+NILLD  +  +++DFGL KL+  D S 
Sbjct:   591 KLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSR 650

Query:   640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRT----------ILTDWA 689
               T +RGT+GY+APEW   + IT K DVYSYG++L E++  RR               WA
Sbjct:   651 VLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWA 710

Query:   690 YDCY-QERTLGALVENDLEA-MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
                  ++  + +LV+  LE    D+  + R   VA WCIQ++ SHRP M +V Q+LEGV+
Sbjct:   711 ATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVL 770

Query:   748 EVPIPPCP 755
             EV  PP P
Sbjct:   771 EVNPPPFP 778

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)]

 Score = 530 (191.6 bits), Expect = 1.1e-66, Sum P(3) = 1.1e-66
 Identities = 120/303 (39%), Positives = 174/303 (57%)

Query:   397 DRDETGTTFIKIRKV---PSGGKKKVDVLIPVVSVLF----GSSALINLLLV--SACC-L 446
             + D  G   + IRK    P G   +     PV++++     G   LI L L+    C  +
Sbjct:   413 NHDLIGYVKLSIRKTNAQPPGNNNRGGSSFPVIALVLLPCSGFFLLIALGLLWWRRCAVM 472

Query:   447 GFLVVNRKKFMRPHQEEQG-VSYMNL----RCFTYKELVEVTRGFKEELGRGAFGTVYKG 501
              +  +  K+  RP   E G +   ++    + F ++EL + T  FK ++G G FG+VYKG
Sbjct:   473 RYSSIREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKG 532

Query:   502 FVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF 561
                +     +AVKK+        +EF  E+  IG   H NLV+L G+C  GR  LLVYE+
Sbjct:   533 --TLPDETLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEY 590

Query:   562 MSNGALASFLFGDSKP--NWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY 619
             M++G+L   LF  + P   W+ R +I +G ARGL YLH  C  +IIHCD+KP+NILL D+
Sbjct:   591 MNHGSLEKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDH 650

Query:   620 YNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
             +  +ISDFGL KLL  ++S   T +RGT+GY+APEW  N  I+ K DVYSYG++LLE++ 
Sbjct:   651 FQPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVS 710

Query:   680 LRR 682
              R+
Sbjct:   711 GRK 713

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)]

 Score = 561 (202.5 bits), Expect = 1.1e-66, Sum P(2) = 1.1e-66
 Identities = 163/522 (31%), Positives = 261/522 (50%)

Query:   282 GICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGS------CKPDFILGCEEDG--KKS 333
             G CG   +C  SG   P+CQC KGF     D+ + S      C     L C+ +   +  
Sbjct:   284 GRCGPFGLCVRSGT--PMCQCLKGFEPKS-DEEWRSGNWSRGCVRRTNLSCQGNSSVETQ 340

Query:   334 GED---LYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSA-AVLRDDTC--WKK 387
             G+D    Y++  ++    P   YE  S   +++C   CL++C C+A + +    C  W +
Sbjct:   341 GKDRDVFYHVSNIK----PPDSYELASFSNEEQCHQGCLRNCSCTAFSYVSGIGCLVWNQ 396

Query:   388 KLPLSYGKTDRDETGTTFIKIRKVPSGGKKKVDVLIPVVSVLFGSSALINLLLVSACCL- 446
             +L  +       ET +  +++      G+K++ ++   V+ L  S  LI +L+   C   
Sbjct:   397 ELLDTVKFIGGGETLS--LRLAHSELTGRKRIKII--TVATLSLSVCLILVLVACGCWRY 452

Query:   447 -----GFLVVNRKKF---MRPHQEEQGVSYMNLRCFTYKELVEVTRGFK--EELGRGAFG 496
                  G  +V++       +   + Q VS +N   F   +L   T  F    +LG+G FG
Sbjct:   453 RVKQNGSSLVSKDNVEGAWKSDLQSQDVSGLNF--FEIHDLQTATNNFSVLNKLGQGGFG 510

Query:   497 TVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRL 556
             TVYKG +  G   ++AVK+L        +EF  E+  I +  H+NL+RLLG C +G  +L
Sbjct:   511 TVYKGKLQDGK--EIAVKRLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKL 568

Query:   557 LVYEFMSNGALASFLFGDSKP---NWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQN 613
             LVYE+M N +L  F+F   K    +W  R  I+ GIARGL YLH +   +++H D+K  N
Sbjct:   569 LVYEYMVNKSLDIFIFDLKKKLEIDWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSN 628

Query:   614 ILLDDYYNARISDFGLEKLLTLDQSHTNT-AIRGTKGYVAPEWFRNMPITVKVDVYSYGV 672
             ILLD+  N +ISDFGL +L   +Q   +T ++ GT GY++PE+      + K D+YS+GV
Sbjct:   629 ILLDEKMNPKISDFGLARLFHGNQHQDSTGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGV 688

Query:   673 LLLEIICLRRTI----------LTDWAYDCYQERTLGALVENDLEAMDDMTVLQ--RFVM 720
             L+LEII  +             L  +A+D + E     L++ DL+  D +  ++  R V 
Sbjct:   689 LMLEIITGKEISSFSYGKDNKNLLSYAWDSWSENGGVNLLDQDLDDSDSVNSVEAGRCVH 748

Query:   721 VAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCPWTLNITS 762
             + + C+Q     RP +++V  ML    ++P P  P  +  TS
Sbjct:   749 IGLLCVQHQAIDRPNIKQVMSMLTSTTDLPKPTQPMFVLETS 790

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)]

 Score = 561 (202.5 bits), Expect = 4.5e-66, Sum P(2) = 4.5e-66
 Identities = 156/507 (30%), Positives = 254/507 (50%)

Query:   284 CGFNSICSISGAKRPICQCPKGFSLLDPDDVY------GSCKPDFILGCEEDGKKSGE-- 335
             CG   +C  S    P C+C KGF +   D+ +      G C     L C+ +   + +  
Sbjct:   292 CGPFGLCIRSNP--PKCECLKGF-VPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQAN 348

Query:   336 --DLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSA-AVLRDDTC--WKKKLP 390
               D++ I  + N   P   YE +S   +++C   CL +C C+A + +    C  W ++L 
Sbjct:   349 NGDIFDI--VANVK-PPDFYEYLSLINEEDCQQRCLGNCSCTAFSYIEQIGCLVWNRELV 405

Query:   391 LSYGKTDRDETGTTFIKIRKVPSGGKKKVDVLIP-VVSVLFGSSALINLLLVSACCLGFL 449
                      ET +  I++      G  +V +++  +VS+    S  + L+  S     + 
Sbjct:   406 DVMQFVAGGETLS--IRLASSELAGSNRVKIIVASIVSI----SVFMILVFASYWYWRYK 459

Query:   450 VVNRKKFMRPHQEEQG-----VSYMNLRCFTYKELVEVTRGFKEE--LGRGAFGTVYKGF 502
                      P +  Q      +   ++  F  + ++ +T  F  E  LG+G FG VYKG 
Sbjct:   460 AKQNDSNPIPLETSQDAWREQLKPQDVNFFDMQTILTITNNFSMENKLGQGGFGPVYKG- 518

Query:   503 VNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM 562
              N+    ++A+K+L+       +EF  E+  I +  H+NLVRLLG C EG  +LL+YEFM
Sbjct:   519 -NLQDGKEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFM 577

Query:   563 SNGALASFLFGDSKP---NWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY 619
             +N +L +F+F  +K    +W  R EI+ GIA GL YLH + C +++H D+K  NILLD+ 
Sbjct:   578 ANKSLNTFIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEE 637

Query:   620 YNARISDFGLEKLLTLDQSHTNTA-IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
              N +ISDFGL ++    Q   NT  + GT GY++PE+      + K D+Y++GVLLLEII
Sbjct:   638 MNPKISDFGLARMFQGTQHQANTRRVVGTLGYMSPEYAWTGMFSEKSDIYAFGVLLLEII 697

Query:   679 CLRR----TI------LTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQE 728
               +R    TI      L ++A+D + E     L++ D+ +    + + R V + + CIQ+
Sbjct:   698 TGKRISSFTIGEEGKTLLEFAWDSWCESGGSDLLDQDISSSGSESEVARCVQIGLLCIQQ 757

Query:   729 DPSHRPTMRRVTQMLEGVVEVPIPPCP 755
                 RP + +V  ML   +++P P  P
Sbjct:   758 QAGDRPNIAQVMSMLTTTMDLPKPKQP 784

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)]

 Score = 561 (202.5 bits), Expect = 1.3e-65, Sum P(2) = 1.3e-65
 Identities = 167/524 (31%), Positives = 250/524 (47%)

Query:   259 WSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGSC 318
             W  S   P N C   DI      G+CG    C IS    P C+C KGF    P  +    
Sbjct:   264 WKSSYEGPANSC---DIY-----GVCGPFGFCVISDP--PKCKCFKGFV---PKSIEEWK 310

Query:   319 KPDFILGCEE------DGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDC 372
             + ++  GC         G  +G+D      + N   P   YE  +    + C  SCL +C
Sbjct:   311 RGNWTSGCARRTELHCQGNSTGKDANVFHTVPNIK-PPDFYEYANSVDAEGCYQSCLHNC 369

Query:   373 QCSA-AVLRDDTC--WKKKLPLSYGKTDRDETGTTFIKIRKVPSGGKKKVDVLIPVVSVL 429
              C A A +    C  W K L      T +   G   + IR   S    ++DV    ++++
Sbjct:   370 SCLAFAYIPGIGCLMWSKDLM----DTMQFSAGGEILSIRLAHS----ELDVHKRKMTIV 421

Query:   430 FGSSALINLLLVSACCLGFLVVNRKKFMRPHQEE-QGVSYMNLRCFTYKELVEVTRGFK- 487
               + +L   +++     GF   NR K     + + Q      L  F    +   T  F  
Sbjct:   422 ASTVSLTLFVILGFATFGFWR-NRVKHHDAWRNDLQSQDVPGLEFFEMNTIQTATSNFSL 480

Query:   488 -EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
               +LG G FG+VYKG +  G   ++AVK+L+   +  ++EF  E+  I +  H+NLVR+L
Sbjct:   481 SNKLGHGGFGSVYKGKLQDGR--EIAVKRLSSSSEQGKQEFMNEIVLISKLQHRNLVRVL 538

Query:   547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKP---NWKLRTEIVMGIARGLFYLHEECCTQ 603
             G C EG+ +LL+YEFM N +L +F+FG  K    +W  R +I+ GI RGL YLH +   +
Sbjct:   539 GCCVEGKEKLLIYEFMKNKSLDTFVFGSRKRLELDWPKRFDIIQGIVRGLLYLHRDSRLR 598

Query:   604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA-IRGTKGYVAPEWFRNMPIT 662
             +IH D+K  NILLD+  N +ISDFGL +L    Q    T  + GT GY++PE+      +
Sbjct:   599 VIHRDLKVSNILLDEKMNPKISDFGLARLFQGSQYQDKTRRVVGTLGYMSPEYAWTGVFS 658

Query:   663 VKVDVYSYGVLLLEIIC---LRR-------TILTDWAYDCYQERTLGA-LVENDLEAMDD 711
              K D+YS+GVLLLEII    + R         L  + ++C+ E T G  L++  L+    
Sbjct:   659 EKSDIYSFGVLLLEIISGEKISRFSYGEEGKALLAYVWECWCE-TRGVNLLDQALDDSSH 717

Query:   712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCP 755
                + R V + + C+Q  P+ RP    +  ML    ++P+P  P
Sbjct:   718 PAEVGRCVQIGLLCVQHQPADRPNTLELLSMLTTTSDLPLPKQP 761

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 490 (177.5 bits), Expect = 1.3e-65, Sum P(4) = 1.3e-65
 Identities = 120/298 (40%), Positives = 167/298 (56%)

Query:   462 EEQGVSYMNLRCFTYKELVEVTRGF-KE-ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV 519
             E + V+   L  F+   +   T  F KE ELGRG FG VYKG +  G   ++AVK+L+  
Sbjct:   505 EGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGR--EIAVKRLSGK 562

Query:   520 FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-- 577
                   EFK E+  I +  H+NLVRLLG C EG  ++LVYE+M N +L  FLF ++K   
Sbjct:   563 SGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQAL 622

Query:   578 -NWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD 636
              +WKLR  I+ GIARGL YLH +   +IIH D+K  N+LLD   N +ISDFG+ ++   +
Sbjct:   623 IDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGN 682

Query:   637 QSHTNTA-IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTI---------LT 686
             Q+  NT  + GT GY++PE+      +VK DVYS+GVLLLEI+  +R           L 
Sbjct:   683 QNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLI 742

Query:   687 DWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
              +A+  Y       LV+  +          R + VA+ C+Q+  + RP M  V  MLE
Sbjct:   743 GYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLE 800

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 546 (197.3 bits), Expect = 2.9e-63, Sum P(2) = 2.9e-63
 Identities = 166/527 (31%), Positives = 249/527 (47%)

Query:   259 WSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDVYGS- 317
             W +   LPEN C   D+      G CG   +C  S    P C+C KGF +   D+ +G  
Sbjct:   270 WKLHLSLPENPC---DLY-----GRCGPYGLCVRSDP--PKCECLKGF-VPKSDEEWGKG 318

Query:   318 -----CKPDFILGCEEDG--KKSGED--LYYIEELRNTDWPTSDYEQISPY-GKDECVSS 367
                  C     L C+     K  G+D  ++Y    R TD  T D  Q + +   ++C   
Sbjct:   319 NWTSGCVRRTKLSCQAKSSMKTQGKDTDIFY----RMTDVKTPDLHQFASFLNAEQCYQG 374

Query:   368 CLKDCQCSA-AVLRDDTC--WKKKLPLSYGKTDRDETGTTFIKIRKVPSGGKKKVDVLIP 424
             CL +C C+A A +    C  W  +L  +       E    FI++      G  +  +++ 
Sbjct:   375 CLGNCSCTAFAYISGIGCLVWNGELADTVQFLSSGEF--LFIRLASSELAGSSRRKIIVG 432

Query:   425 VVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEEQGVSYMNLRCFTYKELVEVTR 484
                 L    ++  +L+ +A  L      +    +   E Q VS +N   F    +   T 
Sbjct:   433 TTVSL----SIFLILVFAAIMLWRYRAKQNDAWKNGFERQDVSGVNF--FEMHTIRTATN 486

Query:   485 GFK--EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNL 542
              F    +LG+G FG VYKG +  G   ++ VK+L        +EF  E+  I +  H+NL
Sbjct:   487 NFSPSNKLGQGGFGPVYKGKLVDGK--EIGVKRLASSSGQGTEEFMNEITLISKLQHRNL 544

Query:   543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDS---KPNWKLRTEIVMGIARGLFYLHEE 599
             VRLLGYC +G  +LL+YEFM N +L  F+F      + +W  R  I+ GIARGL YLH +
Sbjct:   545 VRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPKRFNIIQGIARGLLYLHRD 604

Query:   600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA-IRGTKGYVAPEWFRN 658
                ++IH D+K  NILLDD  N +ISDFGL ++    Q   NT  + GT GY++PE+   
Sbjct:   605 SRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRRVVGTLGYMSPEYAWA 664

Query:   659 MPITVKVDVYSYGVLLLEIIC---LRRTILTD-------WAYDCYQERTLGALVENDLEA 708
                + K D+YS+GVL+LEII    + R I  D       + +D + E     L++ DL  
Sbjct:   665 GLFSEKSDIYSFGVLMLEIISGKRISRFIYGDESKGLLAYTWDSWCETGGSNLLDRDLTD 724

Query:   709 MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCP 755
                   + R V + + C+Q +   RP   +V  ML    ++P+P  P
Sbjct:   725 TCQAFEVARCVQIGLLCVQHEAVDRPNTLQVLSMLTSATDLPVPKQP 771

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

TAIR|locus:2137010 AT4G11900 [Arabidopsis thaliana (taxid:3702)]

 Score = 639 (230.0 bits), Expect = 1.4e-62, P = 1.4e-62
 Identities = 215/724 (29%), Positives = 344/724 (47%)

Query:    90 IWKSEI--STGEAAFGVLYDTGNFLI---VNTNSERLWQTFDHPTDTLLPTQTMERGG-V 143
             +W + +  S  +    VL+D+GN ++    N+++  LWQ+FDHP+DT LP   +  G  +
Sbjct:   142 VWSTGVNSSMSKDVQAVLFDSGNLVLRDGPNSSAAVLWQSFDHPSDTWLPGGKIRLGSQL 201

Query:   144 VSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSN--TFDVNRSNAGYRV 201
              +S     D S GR+        ++++   N    +      WS+   +D  +S  G+  
Sbjct:   202 FTSWESLIDPSPGRYSLEFDPKLHSLVTVWNRSKSY------WSSGPLYDWLQSFKGFPE 255

Query:   202 VFNESGQL-YVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYS-HPKNNSTGDAIW 259
             +  +  +L + L  ++  ++ +   V  +  Y R  +   G F+    H    S     W
Sbjct:   256 L--QGTKLSFTLNMDESYITFS---VDPQSRY-RLVMGVSGQFMLQVWHVDLQS-----W 304

Query:   260 SVSDVLPENICINNDIRKGLGS-GICGFNSICSISGAKRPICQCPKGFSLL------DPD 312
              V    P+N C   D+    GS GIC  N        + P C+C  GF         D +
Sbjct:   305 RVILSQPDNRC---DVYNSCGSFGICNENR-------EPPPCRCVPGFKREFSQGSDDSN 354

Query:   313 DVYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDC 372
             D  G CK +  L C     K  ++   IE ++    PT+     S   +  C S C+ DC
Sbjct:   355 DYSGGCKRETYLHCY----KRNDEFLPIENMKLATDPTTASVLTSGTFRT-CASRCVADC 409

Query:   373 QCSAAVLRDDTC--WKKKLPLSYGKTDRDETGTTFIKIRK--VPSGGKKKVD------VL 422
              C A     + C  W K    +  + D ++  T F+++    + +   +K +      ++
Sbjct:   410 SCQAYANDGNKCLVWTKDA-FNLQQLDANKGHTFFLRLASSNISTANNRKTEHSKGKSIV 468

Query:   423 IPVV--SVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQE-----EQGV---SYMNLR 472
             +P+V  S++  ++  + L     CC+   +  RKK  R  +      E G+   +  N+ 
Sbjct:   469 LPLVLASLVATAACFVGLY----CCISSRI-RRKKKQRDEKHSRELLEGGLIDDAGENMC 523

Query:   473 CFTYKELVEVTRGF--KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAE 530
                  +++  T  F  K++LG G FG VYKG +  G   +VA+K+L++       EFK E
Sbjct:   524 YLNLHDIMVATNSFSRKKKLGEGGFGPVYKGKLPNGM--EVAIKRLSKKSSQGLTEFKNE 581

Query:   531 VNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP---NWKLRTEIVM 587
             V  I +  HKNLVRLLGYC EG  +LL+YE+MSN +L   LF   K    +W+ R +IV 
Sbjct:   582 VVLIIKLQHKNLVRLLGYCVEGDEKLLIYEYMSNKSLDGLLFDSLKSRELDWETRMKIVN 641

Query:   588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA-IRG 646
             G  RGL YLHE    +IIH D+K  NILLDD  N +ISDFG  ++    Q   +T  I G
Sbjct:   642 GTTRGLQYLHEYSRLRIIHRDLKASNILLDDEMNPKISDFGTARIFGCKQIDDSTQRIVG 701

Query:   647 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR---RTILTDWAYD--CYQ-E---RT 697
             T GY++PE+     I+ K D+YS+GVLLLEII  +   R +  D  +    Y+ E    T
Sbjct:   702 TFGYMSPEYALGGVISEKSDIYSFGVLLLEIISGKKATRFVHNDQKHSLIAYEWESWCET 761

Query:   698 LG-ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCPW 756
              G ++++  +     +    R + +A+ C+Q+ P  RP + ++  ML     +PIP  P 
Sbjct:   762 KGVSIIDEPMCCSYSLEEAMRCIHIALLCVQDHPKDRPMISQIVYMLSNDNTLPIPKQPT 821

Query:   757 TLNI 760
               N+
Sbjct:   822 FSNV 825

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q39202	RLK1_ARATH	2, ., 7, ., 1, 1, ., 1	0.4472	0.9685	0.8870	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_scaffold_1505000001 hypothetical protein (801 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	762
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-45
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-45
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-44
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-44
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-43
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-40
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-34
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-32
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-26
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-25
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-24
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-23
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-23
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-22
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-21
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-21
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	9e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-20
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-20
pfam01453	109	pfam01453, B_lectin, D-mannose binding lectin	4e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-20
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-17
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-17
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-17
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-16
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-15
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-14
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	8e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	9e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-13
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-13
smart00108	114	smart00108, B_lectin, Bulb-type mannose-specific l	1e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-13
cd00028	116	cd00028, B_lectin, Bulb-type mannose-specific lect	2e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-13
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-12
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-12
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	9e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	9e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-07
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	4e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-04
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	0.001
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.001
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.002
pfam00954	110	pfam00954, S_locus_glycop, S-locus glycoprotein fa	0.002
smart00090	237	smart00090, RIO, RIO-like kinase	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  164 bits (417), Expect = 2e-46
 Identities = 73/211 (34%), Positives = 109/211 (51%), Gaps = 10/211 (4%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVRLLGY 548
           LG G FGTVY    +  +  +VA+K + +    S  E    E+  + + +H N+V+L G 
Sbjct: 1   LGEGGFGTVYLAR-DKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59

Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
            ++  +  LV E+   G+L   L  +    +      I++ I  GL YLH      IIH 
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHR 116

Query: 608 DIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE-WFRNMPITVKV 665
           D+KP+NILLD D    +++DFGL KLLT D+S   T I GT  Y+APE        + K 
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSEKS 175

Query: 666 DVYSYGVLLLEIICLRRTILTDWAYDCYQER 696
           D++S GV+L E+  L+  I      D  ++R
Sbjct: 176 DIWSLGVILYELPELKDLIRKMLQKD-PEKR 205

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  163 bits (415), Expect = 1e-45
 Identities = 86/261 (32%), Positives = 128/261 (49%), Gaps = 16/261 (6%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE--FKAEVNGIGQTHHKNLV 543
              +LG G+FGTVYK   + G+   VAVK L +  + S+K+   + E+  + +  H N+V
Sbjct: 3   LLRKLGSGSFGTVYKA-KHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV 61

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           RL+   ++  +  LV E+   G L  +L      +     +I + I RGL YLH      
Sbjct: 62  RLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---G 118

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW-FRNMPIT 662
           IIH D+KP+NILLD+    +I+DFGL K L    S   T   GT  Y+APE         
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYG 177

Query: 663 VKVDVYSYGVLLLEIICLRRTILT-DWAYDCYQ--ERTLGALVENDLEAMDDMT-VLQRF 718
            KVDV+S GV+L E++   +   + +   D  Q   R LG  +E D       +   +  
Sbjct: 178 PKVDVWSLGVILYELLT-GKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236

Query: 719 VMVAIWCIQEDPSHRPTMRRV 739
           +     C+ +DPS RPT   +
Sbjct: 237 I---KKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  161 bits (410), Expect = 6e-45
 Identities = 81/271 (29%), Positives = 125/271 (46%), Gaps = 28/271 (10%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSD---QVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKN 541
             ++LG GAFG VYKG +         +VAVK L     + E+ EF  E + + +  H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
           +VRLLG C +G    +V E+M  G L  FL     K   K   ++ + IA+G+ YL  + 
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN 122

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---YVAPEWFR 657
               +H D+  +N L+ +    +ISDFGL + +  D  +      G K    ++APE  +
Sbjct: 123 F---VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESLK 177

Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT---LGALVEND--LEAMDDM 712
           +   T K DV+S+GVLL EI  L            Y   +   +  L+E+   L   ++ 
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTL--------GEQPYPGMSNEEVLELLEDGYRLPRPENC 229

Query: 713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQML 743
                   + + C   DP  RPT   + + L
Sbjct: 230 P--DELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  161 bits (409), Expect = 1e-44
 Identities = 83/271 (30%), Positives = 118/271 (43%), Gaps = 29/271 (10%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSD---QVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKN 541
             ++LG GAFG VYKG +         +VAVK L     + + +EF  E   + +  H N
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLFYLHEE 599
           +V+LLG C E     +V E+M  G L S+L   ++P   L       + IARG+ YL  +
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWF 656
                IH D+  +N L+ +    +ISDFGL + L           RG K  +   APE  
Sbjct: 122 NF---IHRDLAARNCLVGENLVVKISDFGLSRDLY---DDDYYRKRGGKLPIRWMAPESL 175

Query: 657 RNMPITVKVDVYSYGVLLLEIICLRRTILTDWA---YDCYQERTLGALVEND-LEAMDDM 712
           +    T K DV+S+GVLL EI        T           E  L  L     L    + 
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEI-------FTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNC 228

Query: 713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQML 743
                   + + C  EDP  RPT   + ++L
Sbjct: 229 P--PELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  158 bits (403), Expect = 7e-44
 Identities = 80/273 (29%), Positives = 118/273 (43%), Gaps = 32/273 (11%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSD---QVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKN 541
             ++LG GAFG VYKG +         +VAVK L     + + +EF  E   + +  H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPN---WKLRTEIVMGIARGLFYLHE 598
           +V+LLG C E    ++V E+M  G L  +L   ++P            + IARG+ YL  
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ----SHTNTAIRGTKGYVAPE 654
           +     IH D+  +N L+ +    +ISDFGL + L  D           IR    ++APE
Sbjct: 122 KNF---IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPE 174

Query: 655 WFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA---YDCYQERTLGALVEND-LEAMD 710
             +    T K DV+S+GVLL E       I T              L  L +   L    
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWE-------IFTLGEEPYPGMSNAEVLEYLKKGYRLPKPP 227

Query: 711 DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQML 743
           +         + + C  EDP  RPT   + ++L
Sbjct: 228 NCP--PELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  156 bits (396), Expect = 5e-43
 Identities = 67/267 (25%), Positives = 110/267 (41%), Gaps = 28/267 (10%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVR 544
             E+LG G+FG VY    +  +   VA+K + +     ++E    E+  + +  H N+VR
Sbjct: 3   ILEKLGEGSFGKVYLA-RDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG-----IARGLFYLHEE 599
           L    ++     LV E+   G L   L    K   +L +E         I   L YLH +
Sbjct: 62  LYDVFEDEDKLYLVMEYCEGGDLFDLL----KKRGRL-SEDEARFYLRQILSALEYLHSK 116

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               I+H D+KP+NILLD+  + +++DFGL + L        T + GT  Y+APE     
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGK 171

Query: 660 PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV----L 715
                VD++S GV+L E++  +      +  D         + +                
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEA 227

Query: 716 QRFVMVAIWCIQEDPSHRPTMRRVTQM 742
           +  +      + +DP  R T     Q 
Sbjct: 228 KDLIR---KLLVKDPEKRLTAEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  147 bits (374), Expect = 6e-40
 Identities = 82/276 (29%), Positives = 120/276 (43%), Gaps = 33/276 (11%)

Query: 488 EELGRGAFGTVYKGFVNMGSSD--QVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNLVR 544
           ++LG GAFG VYKG +        +VAVK L     + E K+F  E   + +  H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFL---------FGDSKPNWKLRTEIVMGIARGLFY 595
           LLG C E     LV E+M  G L  +L            S  + K      + IA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---- 651
           L  +   + +H D+  +N L+ +    +ISDFGL + +  D  +       T G +    
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRW 173

Query: 652 -APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEA 708
            APE  ++   T K DV+S+GVLL EI  L  T      Y       +   +     L  
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT-----PYPGLSNEEVLEYLRKGYRLPK 228

Query: 709 MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
            +          + + C Q DP  RPT   + + LE
Sbjct: 229 PEYCP--DELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  131 bits (333), Expect = 2e-34
 Identities = 73/210 (34%), Positives = 110/210 (52%), Gaps = 23/210 (10%)

Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA---EVNGIGQT 537
           E TRG  E LGRG+FG+VY    +  + + +AVK +  +  DSE+E +A   E+  +   
Sbjct: 1   EWTRG--ELLGRGSFGSVYLAL-DKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSL 56

Query: 538 HHKNLVRLLG-YCDEGRNRLLVY-EFMSNGALASFLFGDSKPNWKLRTEIVMG-----IA 590
            H N+VR  G   DE +N L ++ E++S G+L+S L    K   KL  E V+      I 
Sbjct: 57  QHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL----KKFGKLP-EPVIRKYTRQIL 111

Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL-TLDQSHTNTAIRGTKG 649
            GL YLH      I+H DIK  NIL+D     +++DFG  K L  ++      ++RGT  
Sbjct: 112 EGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168

Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
           ++APE  R        D++S G  ++E+  
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMAT 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  124 bits (313), Expect = 9e-32
 Identities = 67/276 (24%), Positives = 120/276 (43%), Gaps = 45/276 (16%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA---EVNGIGQTHHKNLV 543
            +++G+G+FG VY             +K+++ +   SEKE +    EV  + + +H N++
Sbjct: 5   IKQIGKGSFGKVYLV-RRKSDGKLYVLKEID-LSNMSEKEREDALNEVKILKKLNHPNII 62

Query: 544 RLLGYCD--EGRNRLL-VYEFMSNGALASFLFGDSKPN--------WKLRTEIVMGIARG 592
           +   Y +  E + +L  V E+   G L+  +    K               ++ +     
Sbjct: 63  K---YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA---- 115

Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVA 652
           L YLH     +I+H DIKPQNI L      ++ DFG+ K+L+       T + GT  Y++
Sbjct: 116 LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLS 171

Query: 653 PEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN----DLEA 708
           PE  +N P   K D++S G +L E+  L+           ++   L  L           
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHP---------FEGENLLELALKILKGQYPP 222

Query: 709 MDDM--TVLQRFVMVAIWCIQEDPSHRPTMRRVTQM 742
           +     + L+  V      +Q+DP  RP++ ++ Q 
Sbjct: 223 IPSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  120 bits (302), Expect = 2e-30
 Identities = 57/195 (29%), Positives = 92/195 (47%), Gaps = 15/195 (7%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
            E++G+G FG VYK      +  +VA+K +    ++ +++   E+  + +  H N+V+  
Sbjct: 5   LEKIGKGGFGEVYKARHKR-TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYY 63

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFYLHEECC 601
           G   +     +V EF S G+L   L    K   +  TE     +   + +GL YLH    
Sbjct: 64  GSYLKKDELWIVMEFCSGGSLKDLL----KSTNQTLTESQIAYVCKELLKGLEYLHSN-- 117

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             IIH DIK  NILL      ++ DFGL   L+  ++       GT  ++APE     P 
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPY 174

Query: 662 TVKVDVYSYGVLLLE 676
             K D++S G+  +E
Sbjct: 175 DYKADIWSLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  116 bits (294), Expect = 3e-29
 Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 15/199 (7%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKK--LNRVFQDSEKEFKAEVNGIGQTHHKNLV 543
             + +GRGAFG VYKG +N+ + D VA+K+  L ++ +++ K    E++ +    H N+V
Sbjct: 4   LGDLIGRGAFGVVYKG-LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM----GIARGLFYLHEE 599
           + +G  +   +  ++ E+  NG+L   +    K        +V      + +GL YLHE+
Sbjct: 63  KYIGSIETSDSLYIILEYAENGSLRQII----KKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               +IH DIK  NIL       +++DFG+   L  D S  + ++ GT  ++APE     
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMS 174

Query: 660 PITVKVDVYSYGVLLLEII 678
             +   D++S G  ++E++
Sbjct: 175 GASTASDIWSLGCTVIELL 193

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  114 bits (286), Expect = 2e-27
 Identities = 65/215 (30%), Positives = 96/215 (44%), Gaps = 27/215 (12%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE---FKAEVNGIGQT--HHK 540
              +LG G+FG VY           VA+K L +  +   KE   F  E+  I  +  H  
Sbjct: 4   ILRKLGEGSFGEVYLARDRK----LVALKVLAKKLESKSKEVERFLREI-QILASLNHPP 58

Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE----IVMGIARGLFYL 596
           N+V+L  +  +  +  LV E++  G+L   L         L       I+  I   L YL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 597 HEECCTQIIHCDIKPQNILLDDYYN-ARISDFGLEKLLTLDQSHTN-----TAIRGTKGY 650
           H +    IIH DIKP+NILLD      ++ DFGL KLL    S ++     +   GT GY
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 651 VAPEWFRNM---PITVKVDVYSYGVLLLEIICLRR 682
           +APE    +     +   D++S G+ L E++    
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209

Length = 384

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 3e-27
 Identities = 67/197 (34%), Positives = 96/197 (48%), Gaps = 14/197 (7%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + +LG G FG V+ G  N   + +VAVK L       E  F  E   + +  H  LV+L 
Sbjct: 11  ERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLY 67

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQI 604
             C E     +V E+MS G+L  FL        +L   + M   IA G+ YL        
Sbjct: 68  AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NY 124

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPI 661
           IH D+  +NIL+ +    +I+DFGL +L+  D+    TA  G K    + APE       
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEY---TAREGAKFPIKWTAPEAANYGRF 181

Query: 662 TVKVDVYSYGVLLLEII 678
           T+K DV+S+G+LL EI+
Sbjct: 182 TIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  111 bits (279), Expect = 3e-27
 Identities = 75/280 (26%), Positives = 118/280 (42%), Gaps = 56/280 (20%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQTHHKNLVRLL 546
            LG+G+ G VYK   +  +    A+KK++ V  D E  K+   E+  +       +V+  
Sbjct: 8   VLGQGSSGVVYKV-RHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVVKCY 65

Query: 547 G-YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----GLFYLHEECC 601
           G +  EG   + V E+M  G+LA  L    K   K+   ++  IAR    GL YLH +  
Sbjct: 66  GAFYKEGEISI-VLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGLDYLHTK-- 118

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             IIH DIKP N+L++     +I+DFG+ K+L       NT + GT  Y++PE  +    
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESY 177

Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV 721
           +   D++S G+ LLE               C     LG              ++Q     
Sbjct: 178 SYAADIWSLGLTLLE---------------CA----LGKFPFLPPGQPSFFELMQAICDG 218

Query: 722 AIW-----------------CIQEDPSHRPTMRRVTQMLE 744
                               C+Q+DP  RP+     ++L+
Sbjct: 219 PPPSLPAEEFSPEFRDFISACLQKDPKKRPS---AAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 4e-27
 Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 13/194 (6%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
               +G+G FG V  G        +VAVK L      + + F AE + +    H NLV+L
Sbjct: 10  LGATIGKGEFGDVMLGDY---RGQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQL 65

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           LG   +G    +V E+M+ G+L  +L   G +      +    + +  G+ YL E+    
Sbjct: 66  LGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---N 122

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            +H D+  +N+L+ +   A++SDFGL K  +  Q      ++ T    APE  R    + 
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFST 178

Query: 664 KVDVYSYGVLLLEI 677
           K DV+S+G+LL EI
Sbjct: 179 KSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 8e-27
 Identities = 76/277 (27%), Positives = 128/277 (46%), Gaps = 43/277 (15%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVR 544
           + +G G FG V +G + +    +  VA+K L     D ++ +F  E + +GQ  H N++R
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           L G   + R  +++ E+M NG+L  FL   D K        ++ GIA G+ YL E     
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--- 126

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA-----IRGTKGYVAPEWFRN 658
            +H D+  +NIL++     ++SDFGL + L   ++   T      IR T    APE    
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAY 182

Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND-LEA--------- 708
              T   DV+S+G+++ E++              Y ER    +   D ++A         
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS-------------YGERPYWDMSNQDVIKAVEDGYRLPP 229

Query: 709 -MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
            MD  + L + ++    C Q+D + RPT  ++   L+
Sbjct: 230 PMDCPSALYQLML---DCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 5e-26
 Identities = 78/274 (28%), Positives = 116/274 (42%), Gaps = 40/274 (14%)

Query: 488 EELGRGAFGTVYKGFVNM--GSSDQVAVKKL-NRVFQDSEKEFKAEVNGIGQTHHKNLVR 544
           +ELG G FG+V KG   M  G   +VAVK L        +KEF  E + + Q  H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L+G C +G   +LV E    G L  +L    +       E+   +A G+ YL E      
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYL-ESK--HF 116

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG---TKGYVAPEWFRNMPI 661
           +H D+  +N+LL + + A+ISDFG+ + L     +      G    K Y APE       
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY-APECINYGKF 175

Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF--- 718
           + K DV+SYGV L             W    Y  +  G +   ++ AM +    +R    
Sbjct: 176 SSKSDVWSYGVTL-------------WEAFSYGAKPYGEMKGAEVIAMLESG--ERLPRP 220

Query: 719 ---------VMVAIWCIQEDPSHRPTMRRVTQML 743
                    +M++ W  +  P  RPT   +    
Sbjct: 221 EECPQEIYSIMLSCW--KYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  106 bits (266), Expect = 1e-25
 Identities = 71/268 (26%), Positives = 123/268 (45%), Gaps = 22/268 (8%)

Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHK 540
           E+T    +E+G G FG V+ G+       +VA+K +      SE++F  E   + +  H 
Sbjct: 5   ELT--LVQEIGSGQFGLVWLGY--WLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHP 59

Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEE 599
            LV+L G C E     LV+EFM +G L+ +L     K + +    + + +  G+ YL   
Sbjct: 60  KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               +IH D+  +N L+ +    ++SDFG+ + +  DQ  ++T  +    + +PE F   
Sbjct: 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS 176

Query: 660 PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEA----MDDMTVL 715
             + K DV+S+GVL+ E+    +T         Y+ R+   +VE  + A           
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTP--------YENRSNSEVVE-TINAGFRLYKPRLAS 227

Query: 716 QRFVMVAIWCIQEDPSHRPTMRRVTQML 743
           Q    +   C +E P  RP+   +   L
Sbjct: 228 QSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  105 bits (263), Expect = 6e-25
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 20/205 (9%)

Query: 486 FKEELGRGAFGTVYKG---FVNMGSSDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKN 541
           F ++LG G FG V       +   + +QVAVK LN   ++    +F+ E+  +    H+N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 542 LVRLLGYCDE--GRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLHE 598
           +V+  G C++  GR+  L+ E++ +G+L  +L     + N K        I +G+ YL  
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD------QSHTNTAIRGTKGYVA 652
           +   + IH D+  +NIL++     +ISDFGL K+L  D      +    + I     + A
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF----WYA 180

Query: 653 PEWFRNMPITVKVDVYSYGVLLLEI 677
           PE  R    +   DV+S+GV L E+
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 5e-24
 Identities = 75/272 (27%), Positives = 120/272 (44%), Gaps = 38/272 (13%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +ELG G FG V+ G         VA+K +      SE +F  E   + +  H NLV+L
Sbjct: 8   FLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQL 64

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
            G C + R   +V E+M+NG L ++L        KL TE ++     +   + YL     
Sbjct: 65  YGVCTKQRPIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNG- 120

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
              IH D+  +N L+ +    ++SDFGL + +  DQ    T+ +GTK    +  PE F  
Sbjct: 121 --FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKFPVKWAPPEVFDY 175

Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEA-------MDD 711
              + K DV+S+GVL+ E+    +          Y+  +   +VE+           +  
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMP--------YERFSNSEVVESVSAGYRLYRPKLAP 227

Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQML 743
             V    +M + W   E P  RP  +++   L
Sbjct: 228 TEVYT--IMYSCW--HEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score =  101 bits (253), Expect = 5e-24
 Identities = 72/194 (37%), Positives = 100/194 (51%), Gaps = 11/194 (5%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQ-VAVKKLNRVFQDS--EKEFKAEVNGIGQTHHKNLVRL 545
           ELG G FGTV KG   M  S++ VAVK L     D   + E   E N + Q  +  +VR+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
           +G C E  + +LV E    G L  FL  +     K  TE+V  ++ G+ YL E   T  +
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE---TNFV 117

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG---TKGYVAPEWFRNMPIT 662
           H D+  +N+LL   + A+ISDFGL K L  D+++      G    K Y APE       +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APECMNYYKFS 176

Query: 663 VKVDVYSYGVLLLE 676
            K DV+S+GVL+ E
Sbjct: 177 SKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  100 bits (251), Expect = 1e-23
 Identities = 79/266 (29%), Positives = 121/266 (45%), Gaps = 28/266 (10%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           ++LG G FG V+ G+ N     +VA+K L +     E  F AE N + Q  H  LVRL  
Sbjct: 12  KKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYA 68

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQII 605
              +     ++ E+M NG+L  FL         +   I M   IA G+ ++  +     I
Sbjct: 69  VVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYI 124

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPIT 662
           H D++  NIL+ +    +I+DFGL +L+  ++    TA  G K    + APE       T
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFT 181

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDM----TVLQRF 718
           +K DV+S+G+LL EI+   R          Y   T   +++N LE    M       +  
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIP--------YPGMTNPEVIQN-LERGYRMPRPDNCPEEL 232

Query: 719 VMVAIWCIQEDPSHRPTMRRVTQMLE 744
             +   C +E P  RPT   +  +LE
Sbjct: 233 YELMRLCWKEKPEERPTFEYLRSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  100 bits (251), Expect = 1e-23
 Identities = 58/195 (29%), Positives = 97/195 (49%), Gaps = 14/195 (7%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
            +LG G FG V++G     +  +VA+K L       +++F+ EV  + +  HK+L+ L  
Sbjct: 12  RKLGSGYFGEVWEGL--WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQII 605
            C  G    ++ E M  G+L +FL         + + I M   +A G+ YL E+     I
Sbjct: 70  VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSI 126

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLD---QSHTNTAIRGTKGYVAPEWFRNMPIT 662
           H D+  +NIL+ +    +++DFGL +L+  D    S      + T    APE   +   +
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAASHGTFS 182

Query: 663 VKVDVYSYGVLLLEI 677
            K DV+S+G+LL E+
Sbjct: 183 TKSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 1e-23
 Identities = 71/261 (27%), Positives = 114/261 (43%), Gaps = 13/261 (4%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
              +LG G FG V++G  N  ++  VAVK L     D  K+F AE   + +  H  L++L
Sbjct: 10  LLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQL 66

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
              C       +V E M  G+L  +L G +    KL   I M   +A G+ YL  +    
Sbjct: 67  YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---N 123

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N+L+ +    +++DFGL +++  D        +    + APE       ++
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSI 183

Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+S+G+LL EI+   R       Y       +   V+            +    + +
Sbjct: 184 KSDVWSFGILLTEIVTYGRM-----PYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIML 238

Query: 724 WCIQEDPSHRPTMRRVTQMLE 744
            C +EDP  RPT   +   LE
Sbjct: 239 DCWKEDPDDRPTFETLQWKLE 259

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 98.8 bits (246), Expect = 6e-23
 Identities = 80/272 (29%), Positives = 135/272 (49%), Gaps = 22/272 (8%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNLV 543
           +E +G G FG V +G + +    +  VA+K L   + + + ++F +E + +GQ  H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
            L G   + R  +++ EFM NGAL SFL   D +        ++ GIA G+ YL E    
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---M 125

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-TNTAIRGTK---GYVAPEWFRN 658
             +H D+  +NIL++     ++SDFGL + L  D S  T T+  G K    + APE    
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE---AMDDMTVL 715
              T   DV+SYG+++ E++           +D   +  + A +E D      MD  T L
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERPY----WDMSNQDVINA-IEQDYRLPPPMDCPTAL 240

Query: 716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
            + +M+  W  Q+D + RP   ++   L+ ++
Sbjct: 241 HQ-LMLDCW--QKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 98.1 bits (245), Expect = 9e-23
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 22/209 (10%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQ--VAVKKLN-RVFQDSEKE-FKAEVNGIGQTHHKNLV 543
           E +G+G+FGTV K       SD   +  K+++     + EK+   +EVN + +  H N+V
Sbjct: 6   ETIGKGSFGTVRKV---RRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62

Query: 544 RLLGYCDEGRNR-----LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGI----ARGLF 594
           R   Y D   +R      +V E+   G LA  +    K    +  E +  I       L+
Sbjct: 63  R---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 595 YLH--EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVA 652
             H   +    ++H D+KP NI LD   N ++ DFGL K+L  D S   T + GT  Y++
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMS 178

Query: 653 PEWFRNMPITVKVDVYSYGVLLLEIICLR 681
           PE   +M    K D++S G L+ E+  L 
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 96.8 bits (241), Expect = 2e-22
 Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 16/197 (8%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           E++G+G FG VYKG +   +   VAVK     +  D +++F  E   + Q  H N+V+L+
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTE--VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGI--ARGLFYLHEECCTQI 604
           G C + +   +V E +  G+L +FL    K    ++  + M +  A G+ YL  + C   
Sbjct: 59  GVCVQKQPIYIVMELVPGGSLLTFLRK-KKNRLTVKKLLQMSLDAAAGMEYLESKNC--- 114

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK----GYVAPEWFRNMP 660
           IH D+  +N L+ +    +ISDFG+ +    ++    T   G K     + APE      
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171

Query: 661 ITVKVDVYSYGVLLLEI 677
            T + DV+SYG+LL E 
Sbjct: 172 YTSESDVWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 77/282 (27%), Positives = 127/282 (45%), Gaps = 44/282 (15%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQ----VAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY+G        +    VA+K +N      E+ EF  E + + + +  ++V
Sbjct: 13  ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFL-----------FGDSKPNWKLRTEIVMGIARG 592
           RLLG    G+  L+V E M+ G L S+L                P  +   ++   IA G
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP-PTLQKFIQMAAEIADG 131

Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--- 649
           + YL      + +H D+  +N ++ +    +I DFG    +T D   T+   +G KG   
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFG----MTRDIYETDYYRKGGKGLLP 184

Query: 650 --YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVE 703
             ++APE  ++   T K DV+S+GV+L E+  L        A   YQ    E  L  +++
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATL--------AEQPYQGLSNEEVLKFVID 236

Query: 704 ND-LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
              L+  ++       +M   W  Q +P  RPT   +   L+
Sbjct: 237 GGHLDLPENCPDKLLELMRMCW--QYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 95.2 bits (237), Expect = 8e-22
 Identities = 76/272 (27%), Positives = 124/272 (45%), Gaps = 38/272 (13%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE-----KEFKAEVNGIGQTHHKNL 542
           E LG G+FG+VY+G  N+   D  AVK+++            K+ + E+  + +  H N+
Sbjct: 6   ELLGSGSFGSVYEGL-NLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKLRTEIVMGIARGLFYLHEE 599
           V+ LG   E  N  +  E +  G+LA  L  +G   +P  +L T     I  GL YLH+ 
Sbjct: 65  VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR---QILLGLEYLHDR 121

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---YVAPEWF 656
                +H DIK  NIL+D     +++DFG+ K     Q    +  +  KG   ++APE  
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSFKGSPYWMAPEVI 173

Query: 657 RNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN-DLEAMDDMTV 714
                  +  D++S G  +LE+     T    W+        +  +  + +L  + D   
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMA----TGKPPWS-QLEGVAAVFKIGRSKELPPIPDHLS 228

Query: 715 LQ--RFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
            +   F++    C+Q DPS RPT     ++LE
Sbjct: 229 DEAKDFILK---CLQRDPSLRPT---AAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 95.9 bits (239), Expect = 8e-22
 Identities = 77/269 (28%), Positives = 123/269 (45%), Gaps = 39/269 (14%)

Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKL-NRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K L       + KE   E   +    H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFG-----DSKP--NWKLRTEIVMGIARGLFYLHE 598
           LG C       L+ + M  G L  ++        S+   NW ++      IA+G+ YL E
Sbjct: 75  LGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN-----TAIRGTKGYVAP 653
           +   +++H D+  +N+L+    + +I+DFGL KLL +D+   +       I+    ++A 
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK----WMAL 180

Query: 654 EWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN--DLEAMDD 711
           E   +   T K DV+SYGV + E++           Y+      +  L+E    L     
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAK-----PYEGIPAVEIPDLLEKGERLPQPPI 235

Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVT 740
            T+    V+V  W I  D   RPT + + 
Sbjct: 236 CTIDVYMVLVKCWMI--DAESRPTFKELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 95.5 bits (238), Expect = 9e-22
 Identities = 72/272 (26%), Positives = 119/272 (43%), Gaps = 51/272 (18%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE----KEFKAEVNGIGQTHHKNLVRL 545
           +G G FG VY   VN+ + + +AVK++    QD++    KE   E+  +    H NLV+ 
Sbjct: 8   IGGGTFGKVYTA-VNLDTGELMAVKEIR--IQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 546 LGYCDEGRNRLLVY-EFMSNGALASFLFGDSKPNWKLRTEIVMG-----IARGLFYLHEE 599
            G  +  R ++ ++ E+ S G L   L      + ++  E V+      +  GL YLH  
Sbjct: 65  YG-VEVHREKVYIFMEYCSGGTLEELL-----EHGRILDEHVIRVYTLQLLEGLAYLHSH 118

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA------IRGTKGYVAP 653
               I+H DIKP NI LD     ++ DFG    L   +++T T       + GT  Y+AP
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKL---KNNTTTMGEEVQSLAGTPAYMAP 172

Query: 654 EWFRNMPITVK---VDVYSYGVLLLEIICLRR---TILTDWA---YDCYQER-TLGALVE 703
           E              D++S G ++LE+   +R    +  ++    +     +  +   ++
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQ 232

Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPT 735
              E  D    L R       C++ DP  RPT
Sbjct: 233 LSPEGKD---FLDR-------CLESDPKKRPT 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  100 bits (251), Expect = 1e-21
 Identities = 84/338 (24%), Positives = 150/338 (44%), Gaps = 36/338 (10%)

Query: 429 LFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEEQGVSYMNLRCFTYKELVEVT----- 483
            + +  L   L+++    GF+ +  +  +   + E       L+ F  K    +T     
Sbjct: 630 FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDIL 689

Query: 484 RGFKEE--LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
              KEE  + RG  G  YKG        Q  VK++N V  +S     +E+  +G+  H N
Sbjct: 690 SSLKEENVISRGKKGASYKGKSIKNGM-QFVVKEINDV--NSIPS--SEIADMGKLQHPN 744

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           +V+L+G C   +   L++E++    L+  L   S   W+ R +I +GIA+ L +LH  C 
Sbjct: 745 IVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLS---WERRRKIAIGIAKALRFLHCRCS 801

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             ++  ++ P+ I++D      +    L  LL  D     ++      YVAPE      I
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDI 855

Query: 662 TVKVDVYSYGVLLLEIICLRRTI---------LTDWAYDCYQERTLGALVENDLEAMDDM 712
           T K D+Y +G++L+E++  +            + +WA  CY +  L   ++  +    D+
Sbjct: 856 TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG--DV 913

Query: 713 TVLQRFVM----VAIWCIQEDPSHRPTMRRVTQMLEGV 746
           +V Q  ++    +A+ C   DP+ RP    V + LE  
Sbjct: 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951

Length = 968

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
             E++G GA G VYK   +  +  +VA+KK+ R+ + +++    E+  +    H N+V  
Sbjct: 23  NLEKIGEGASGEVYKA-TDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDY 80

Query: 546 LGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFYLHEE 599
                   + L +V E+M  G+L   +      N+    E     +   + +GL YLH  
Sbjct: 81  YD-SYLVGDELWVVMEYMDGGSLTDII----TQNFVRMNEPQIAYVCREVLQGLEYLHS- 134

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               +IH DIK  NILL    + +++DFG    LT ++S  N+ + GT  ++APE  +  
Sbjct: 135 --QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPEVIKRK 191

Query: 660 PITVKVDVYSYGVLLLEII 678
               KVD++S G++ +E+ 
Sbjct: 192 DYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 94.1 bits (235), Expect = 2e-21
 Identities = 68/205 (33%), Positives = 101/205 (49%), Gaps = 32/205 (15%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLN--RVFQDSEKEF-KAEVNGIGQTHHKNLVRL 545
           LG+G+FG V    V    + ++ A+K L   ++ +  E E    E N + + +H  +V+L
Sbjct: 1   LGKGSFGKVLL--VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 546 LGYCDEGRNRL-LVYEFMSNGALASFL-----FGDSKPNWKLRT-----EIVMGIARGLF 594
             Y  +   +L LV E+   G L S L     F +       R      EIV+ +     
Sbjct: 59  H-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE------RARFYAAEIVLALE---- 107

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           YLH      II+ D+KP+NILLD   + +++DFGL K L+ + S TNT   GT  Y+APE
Sbjct: 108 YLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPE 163

Query: 655 WFRNMPITVKVDVYSYGVLLLEIIC 679
                     VD +S GVLL E++ 
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 21/259 (8%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLN-RVFQDSEKEFKA-EVNGIGQTHHKNLVRLL 546
           LG+G++G+VYK  V   S +Q  A+K+++       E+E    E+  +   +H N++   
Sbjct: 8   LGKGSYGSVYK--VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIV----MGIARGLFYLHEECCT 602
               +G    +V E+   G L+  +    K    +  + +    + + RGL  LHE+   
Sbjct: 66  EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ--- 122

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           +I+H D+K  NILL      +I D G+ K+L   ++   T I GT  Y+APE ++  P +
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQI-GTPHYMAPEVWKGRPYS 179

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA 722
            K D++S G LL E+             D   +   G           D   LQ F+   
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQD---LQNFIR-- 234

Query: 723 IWCIQEDPSHRPTMRRVTQ 741
              +Q  P  RP   ++  
Sbjct: 235 -SMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 92.6 bits (231), Expect = 9e-21
 Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 41/224 (18%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQ-THHKN 541
           F + +G G+F TV        ++ + A+K L++     +   K  K E   + +   H  
Sbjct: 5   FGKIIGEGSFSTVVLAKEK-ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPG 63

Query: 542 LVRLLGYC---DEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKLRT-EIVMGIARGLF 594
           +++L  Y    DE  N   V E+  NG L  ++  +G   +   +    EI++ +     
Sbjct: 64  IIKL--YYTFQDEE-NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE---- 116

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR--------- 645
           YLH +    IIH D+KP+NILLD   + +I+DFG  K+L  + S  +             
Sbjct: 117 YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 646 ----------GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
                     GT  YV+PE     P     D+++ G ++ +++ 
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 92.6 bits (230), Expect = 9e-21
 Identities = 66/198 (33%), Positives = 102/198 (51%), Gaps = 17/198 (8%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQTHHKNLVR 544
           K +LG G +G VY+G V    S  VAVK L    +D+   +EF  E   + +  H NLV+
Sbjct: 11  KHKLGGGQYGEVYEG-VWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQ 66

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCT 602
           LLG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++   
Sbjct: 67  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK--- 123

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNM 659
             IH D+  +N L+ + +  +++DFGL +L+T D   T TA  G K    + APE     
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYN 180

Query: 660 PITVKVDVYSYGVLLLEI 677
             ++K DV+++GVLL EI
Sbjct: 181 KFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 92.3 bits (229), Expect = 1e-20
 Identities = 59/197 (29%), Positives = 106/197 (53%), Gaps = 13/197 (6%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLL 546
           +G G FG V++G + M    +  VA+K L   + + ++ +F +E + +GQ  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLF---GDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G   + +  +++ E+M NGAL  +L    G+    ++L   ++ GIA G+ YL +     
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSS-YQL-VGMLRGIAAGMKYLSD---MN 127

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPEWFRNMPI 661
            +H D+  +NIL++     ++SDFGL ++L  D   T T   G     + APE       
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187

Query: 662 TVKVDVYSYGVLLLEII 678
           T   DV+S+G+++ E++
Sbjct: 188 TSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 31/216 (14%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQ----VAVKKLNRV-FQDSEKEFKAEVNGIGQTHHK 540
            K ELG GAFG V+ G       +     VAVK L      D+ K+F+ E   +    H+
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGALASFL--------FGDSKPNWKLR------TEIV 586
           N+V+  G C EG   ++V+E+M +G L  FL        F  S  +           +I 
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 587 MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLD----QSHTN 641
           + IA G+ YL  +     +H D+  +N L+      +I DFG+ + + T D      HT 
Sbjct: 129 VQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185

Query: 642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 677
             IR    ++ PE       T + DV+S+GV+L EI
Sbjct: 186 LPIR----WMPPESIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 91.5 bits (227), Expect = 2e-20
 Identities = 75/256 (29%), Positives = 117/256 (45%), Gaps = 18/256 (7%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +ELG G FG V  G    G  D VA+K + +    SE EF  E   + +  H+ LV+L
Sbjct: 8   FLKELGTGQFGVVKYGKWR-GQYD-VAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQL 64

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLF-GDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
            G C + R   +V E+MSNG L ++L     +       E+   +  G+ YL  +   Q 
Sbjct: 65  YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QF 121

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWFRNMPI 661
           IH D+  +N L+DD    ++SDFGL + + LD  +T++   G+K  V    PE       
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSV--GSKFPVRWSPPEVLLYSKF 178

Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV 721
           + K DV+++GVL+ E+  L +       Y+ +        V   L         ++   +
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKM-----PYERFNNSETVEKVSQGLRLYRPHLASEKVYAI 233

Query: 722 AIWCIQEDPSHRPTMR 737
              C  E    RPT +
Sbjct: 234 MYSCWHEKAEERPTFQ 249

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 33/218 (15%)

Query: 486 FKEELGRGAFGTVYKGFV----NMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHK 540
           F EELG GAFG VYKG +       S+  VA+K L    +   ++EF+ E   +    H 
Sbjct: 9   FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDS---------------KPNWKLR-TE 584
           N+V LLG C + +   +++E++++G L  FL  +S                         
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 585 IVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL-TLD----QSH 639
           I + IA G+ YL        +H D+  +N L+ +    +ISDFGL + + + D    QS 
Sbjct: 129 IAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 677
           +   +R    ++ PE       T + D++S+GV+L EI
Sbjct: 186 SLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 34/275 (12%)

Query: 478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT 537
            L ++T G  E +G G FG V +G    G   +VAVK +      + + F  E   + + 
Sbjct: 4   NLQKLTLG--EIIGEGEFGAVLQGEY-TGQ--KVAVKNIK--CDVTAQAFLEETAVMTKL 56

Query: 538 HHKNLVRLLGYCDEGRNRL-LVYEFMSNGALASFLF--GDSKPNWKLRTEIVMGIARGLF 594
           HHKNLVRLLG      N L +V E MS G L +FL   G +  +     +  + +A G+ 
Sbjct: 57  HHKNLVRLLGVILH--NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           YL  +   +++H D+  +NIL+ +   A++SDFGL ++ ++   ++   ++ T    APE
Sbjct: 115 YLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APE 167

Query: 655 WFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN-----DLEAM 709
             ++   + K DV+SYGVLL E+    R          Y + +L  + E       +E  
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAP--------YPKMSLKEVKECVEKGYRMEPP 219

Query: 710 DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           +        +M + W  + +P  RP+  ++ + LE
Sbjct: 220 EGCPADVYVLMTSCW--ETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 91.1 bits (226), Expect = 2e-20
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 22/264 (8%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +ELG G FG V+ G     +  +VA+K +N     SE++F  E   + +  H  LV+L
Sbjct: 8   FMKELGSGQFGVVHLG--KWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQL 64

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----GLFYLHEECC 601
            G C + +   +V EFM NG L ++L    +   KL  ++++ + +    G+ YL     
Sbjct: 65  YGVCTQQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLER--- 118

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
              IH D+  +N L+      ++SDFG+ + +  D+  +++  +    +  PE F     
Sbjct: 119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKY 178

Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQERTLG-ALVENDLEAMDDMTVLQRFV 719
           + K DV+S+GVL+ E+    +      + Y+  +  + G  L    L +   MTV +  V
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLAS---MTVYE--V 233

Query: 720 MVAIWCIQEDPSHRPTMRRVTQML 743
           M + W   E P  RPT   + + +
Sbjct: 234 MYSCW--HEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin

 Score = 85.8 bits (213), Expect = 4e-20
 Identities = 40/108 (37%), Positives = 53/108 (49%), Gaps = 7/108 (6%)

Query: 54  QLDIWYASGDDP-GPGGSKLRLTANGGLVLEDPEAREIWKS-EISTGEAAFGVLYDTGNF 111
           Q  +W A+  +P       L L ++G LVL D   R +W S     G     VL D GN 
Sbjct: 2   QTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGNL 61

Query: 112 LIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRK-----ETDFS 154
           ++ + + + LWQ+FDHPTDTLLP Q      +  SRR       TD S
Sbjct: 62  VLYDNSGKVLWQSFDHPTDTLLPGQKDGNVVIGGSRRLTSWKSNTDPS 109

These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 90.5 bits (224), Expect = 4e-20
 Identities = 77/275 (28%), Positives = 122/275 (44%), Gaps = 45/275 (16%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           ++LG G FG V+ G+ N  +S +VAVK L +    S + F  E N +    H  LVRL  
Sbjct: 12  KKLGAGQFGEVWMGYYN--NSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 68

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQII 605
              +     ++ E+M+ G+L  FL  D      L   I     IA G+ Y+  +     I
Sbjct: 69  VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 125

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPIT 662
           H D++  N+L+ +    +I+DFGL +++  ++    TA  G K    + APE       T
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFT 182

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR-FVM- 720
           +K DV+S+G+LL EI+                  T G +    +   D M+ LQR + M 
Sbjct: 183 IKSDVWSFGILLYEIV------------------TYGKIPYPGMSNSDVMSALQRGYRMP 224

Query: 721 -----------VAIWCIQEDPSHRPTMRRVTQMLE 744
                      +   C +E    RPT   +  +L+
Sbjct: 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 90.6 bits (225), Expect = 4e-20
 Identities = 75/278 (26%), Positives = 118/278 (42%), Gaps = 38/278 (13%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-------RVFQDSEKEFK---AEVNGIG-Q 536
           E LG GAFG VYK        + +A+K++N       +  ++ +K      +EV  I  Q
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIAR 591
             H N+VR      E     +V + +    L    F   K   +  TE     I + +  
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 592 GLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN---TAIRGTK 648
            L YLH+E   +I+H D+ P NI+L +     I+DFGL K     Q       T++ GT 
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSVVGTI 177

Query: 649 GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLG---ALVEND 705
            Y  PE  +N P   K DV+++G +L ++  L+           Y    L     +VE  
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF--------YSTNMLSLATKIVEAV 229

Query: 706 LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQML 743
            E + +    +    V   C+  D   RP + +V+ M+
Sbjct: 230 YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 90.8 bits (225), Expect = 5e-20
 Identities = 84/285 (29%), Positives = 133/285 (46%), Gaps = 50/285 (17%)

Query: 489 ELGRGAFGTVYKGFVN---MGSSD-QVAVKKLNRVFQDSEK-EF--KAEVNGIGQTHHKN 541
           ELG+G+FG VY+G       G ++ +VAVK +N      E+ EF  +A V      HH  
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH-- 70

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLF----------GDSKPNWKLRTEIVMGIAR 591
           +VRLLG   +G+  L+V E M++G L S+L           G   P  +   ++   IA 
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 592 GLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG-- 649
           G+ YL+ +   + +H D+  +N ++   +  +I DFG    +T D   T+   +G KG  
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFG----MTRDIYETDYYRKGGKGLL 183

Query: 650 ---YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL 706
              ++APE  ++   T   D++S+GV+L EI  L        A   YQ    G   E  L
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSL--------AEQPYQ----GLSNEQVL 231

Query: 707 EAMDDMTVL-------QRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           + + D   L       +R   +   C Q +P  RPT   +  +L+
Sbjct: 232 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 91.0 bits (226), Expect = 5e-20
 Identities = 84/298 (28%), Positives = 134/298 (44%), Gaps = 37/298 (12%)

Query: 468 YMNLRCFTYKELVEVTRG---FKEELGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVF 520
           Y++     Y    E  R    F + LG GAFG V +    G     +  +VAVK L    
Sbjct: 18  YIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA 77

Query: 521 QDSEKE-FKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPN 578
             SE+E   +E+  +    +H+N+V LLG C  G   L++ E+   G L +FL    K  
Sbjct: 78  HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL--RRKRE 135

Query: 579 WKLRTEIVMG----IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT 634
             L  E ++     +A+G+ +L  + C   IH D+  +N+LL      +I DFGL + + 
Sbjct: 136 SFLTLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNVLLTHGKIVKICDFGLARDIM 192

Query: 635 LDQSHTNTAIRGTK----GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRT----ILT 686
            D   +N  ++G       ++APE   N   T + DV+SYG+LL EI  L       +  
Sbjct: 193 ND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV 249

Query: 687 DWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           D  +  Y+    G  +     A  ++      +M   W    DP  RPT +++ Q++ 
Sbjct: 250 DSKF--YKLIKEGYRMAQPEHAPAEIYD----IMKTCW--DADPLKRPTFKQIVQLIG 299

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 90.2 bits (224), Expect = 7e-20
 Identities = 70/212 (33%), Positives = 102/212 (48%), Gaps = 29/212 (13%)

Query: 490 LGRGAFGTVYKGFVNMGSSD----QVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVR 544
           LG GAFG VY+G       D    QVAVK L     +  E +F  E   + + +H+N+VR
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--------GIARGLFYL 596
           L+G   E   R ++ E M+ G L SFL  +++P  +  + + M         +A+G  YL
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132

Query: 597 HEECCTQIIHCDIKPQNILLDDYYNAR---ISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            E      IH DI  +N LL      R   I+DFG+ +    D    +   +G +     
Sbjct: 133 EEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAMLPI 185

Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICL 680
            ++ PE F +   T K DV+S+GVLL EI  L
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 80/293 (27%), Positives = 127/293 (43%), Gaps = 55/293 (18%)

Query: 490 LGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG------IGQTHH 539
           LG GAFG V      G  N   +  VAVK L      +EK+    V+       IG+  H
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGK--H 75

Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLR----------------T 583
           KN++ LLG C +     +V E+ ++G L  FL     P                      
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 584 EIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA 643
                +ARG+ +L  + C   IH D+  +N+L+ + +  +I+DFGL +    D  H +  
Sbjct: 136 SFAYQVARGMEFLASKKC---IHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYY 188

Query: 644 IRGTKG-----YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRT----ILTDWAYDCYQ 694
            + T G     ++APE   +   T + DV+S+GVLL EI  L  +    I  +  +   +
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 248

Query: 695 ERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           E   G  +E       ++  L R       C  E PS RPT +++ + L+ ++
Sbjct: 249 E---GYRMEKPQNCTQELYHLMRD------CWHEVPSQRPTFKQLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 78/275 (28%), Positives = 131/275 (47%), Gaps = 40/275 (14%)

Query: 489 ELGRGAFGTVY----KGFVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY    KG V      +VA+K +N      E+ EF  E + + + +  ++V
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLF----------GDSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L++ E M+ G L S+L             + P+ K   ++   IA G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++ + +  +I DFG    +T D   T+   +G KG    
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 185

Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            +++PE  ++   T   DV+S+GV+L EI  L        A   YQ    E+ L  ++E 
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATL--------AEQPYQGMSNEQVLRFVMEG 237

Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
            L    D      F ++ + C Q +P  RP+   +
Sbjct: 238 GLLDKPDNCPDMLFELMRM-CWQYNPKMRPSFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 88.8 bits (220), Expect = 2e-19
 Identities = 72/276 (26%), Positives = 128/276 (46%), Gaps = 38/276 (13%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLL 546
           +G G FG V  G + +    +  VA+K L   + + ++ +F +E + +GQ  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLF-GDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
           G   + +  ++V E+M NG+L +FL   D +        ++ GIA G+ YL +      +
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYV 128

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPIT 662
           H D+  +NIL++     ++SDFGL ++L  D     T  RG K    + APE       T
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT-RGGKIPIRWTAPEAIAYRKFT 187

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL-----------EAMDD 711
              DV+SYG+++ E++              Y ER    +   D+             MD 
Sbjct: 188 SASDVWSYGIVMWEVM-------------SYGERPYWEMSNQDVIKAIEEGYRLPAPMDC 234

Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
              L + ++    C Q+D + RP   ++  +L+ ++
Sbjct: 235 PAALHQLMLD---CWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 88.1 bits (218), Expect = 5e-19
 Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 41/288 (14%)

Query: 486 FKEELGRGAFGTVYKGFVNM-GSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQT-HHKNL 542
           F++ +G G FG V K  +   G     A+K++     +D  ++F  E+  + +  HH N+
Sbjct: 11  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFG----DSKPNWKL--RTEIVMG-------- 588
           + LLG C+      L  E+  +G L  FL      ++ P + +   T   +         
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 589 --IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG 646
             +ARG+ YL ++   Q IH D+  +NIL+ + Y A+I+DFGL +            ++ 
Sbjct: 131 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 180

Query: 647 TKGYVAPEWFR----NMPI-TVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQERTLGA 700
           T G +   W      N  + T   DV+SYGVLL EI+ L  T        + Y++   G 
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240

Query: 701 LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            +E  L   D++  L R       C +E P  RP+  ++   L  ++E
Sbjct: 241 RLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSLNRMLE 282

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.3 bits (217), Expect = 6e-19
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 19/198 (9%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE---FKAEVNGIGQTHHKNLVR 544
           E +G+G+FG VYK      ++  VA+K ++   +++E E    + E+  + Q     + +
Sbjct: 7   ECIGKGSFGEVYKAIDK-RTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRSPYITK 63

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----GLFYLHEEC 600
             G   +G    ++ E+   G+    L    KP  KL    +  I R    GL YLHEE 
Sbjct: 64  YYGSFLKGSKLWIIMEYCGGGSCLDLL----KPG-KLDETYIAFILREVLLGLEYLHEE- 117

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
               IH DIK  NILL +  + +++DFG+   LT   S  NT + GT  ++APE  +   
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSG 174

Query: 661 ITVKVDVYSYGVLLLEII 678
              K D++S G+  +E+ 
Sbjct: 175 YDEKADIWSLGITAIELA 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 79/264 (29%), Positives = 121/264 (45%), Gaps = 24/264 (9%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           ++LG G FG V+ G  N   + +VAVK L +    S + F  E   + +  H  LV+L  
Sbjct: 12  KKLGNGQFGEVWMGTWN--GNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYA 68

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQII 605
              E     +V E+MS G+L  FL        KL   + M   +A G+ Y+        I
Sbjct: 69  VVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYI 124

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPIT 662
           H D++  NIL+ D    +I+DFGL +L+   + +  TA +G K    + APE       T
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQRFVM 720
           +K DV+S+G+LL E++   R       Y     R +   VE    +    D  +    +M
Sbjct: 182 IKSDVWSFGILLTELVTKGRV-----PYPGMNNREVLEQVERGYRMPCPQDCPISLHELM 236

Query: 721 VAIWCIQEDPSHRPTMRRVTQMLE 744
           +  W  ++DP  RPT   +   LE
Sbjct: 237 LQCW--KKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 86.4 bits (215), Expect = 1e-18
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 36/209 (17%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT--------- 537
            E+LG G +G VYK   +  + + VA+KK   +  D+E+E      GI  T         
Sbjct: 4   LEKLGEGTYGVVYKAR-DKKTGEIVALKK---IRLDNEEE------GIPSTALREISLLK 53

Query: 538 --HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIA----R 591
              H N+V+LL      R   LV+E+     L  +L  D +P   L   ++  I     R
Sbjct: 54  ELKHPNIVKLLDVIHTERKLYLVFEYCDMD-LKKYL--DKRPG-PLSPNLIKSIMYQLLR 109

Query: 592 GLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGY 650
           GL Y H     +I+H D+KPQNIL++     +++DFGL +   +  +++T+  +  T  Y
Sbjct: 110 GLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWY 164

Query: 651 VAPEWFRNMPI-TVKVDVYSYGVLLLEII 678
            APE        +  VD++S G +  E+I
Sbjct: 165 RAPEILLGSKHYSTAVDIWSVGCIFAEMI 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 56/193 (29%), Positives = 101/193 (52%), Gaps = 8/193 (4%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
             E+LG G++G+VYK  ++  +   VA+K +  V +D + E   E++ + Q     +V+ 
Sbjct: 7   ILEKLGEGSYGSVYKA-IHKETGQVVAIKVV-PVEEDLQ-EIIKEISILKQCDSPYIVKY 63

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYLHEECCTQI 604
            G   +  +  +V E+   G+++  +   +K    +    I+    +GL YLH     + 
Sbjct: 64  YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KK 120

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           IH DIK  NILL++   A+++DFG+   LT   +  NT I GT  ++APE  + +    K
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNNK 179

Query: 665 VDVYSYGVLLLEI 677
            D++S G+  +E+
Sbjct: 180 ADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 32/209 (15%)

Query: 490 LGRGAFGTVY---KGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLV 543
           + +GA+G V+   K        D  A+K + +   + ++   +   E + + Q     +V
Sbjct: 1   ISKGAYGRVFLAKKKSTG----DIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVV 56

Query: 544 RLLGYCDEGRNRL-LVYEFMSNGALASFL--FGDSKPNW--KLRTEIVMGIARGLFYLHE 598
           +L  Y  +G+  L LV E++  G LAS L   G    +       EIV+ +     YLH 
Sbjct: 57  KLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALE----YLHS 111

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGL--------EKLLTLDQSHTNTAIRGTKGY 650
                IIH D+KP NIL+D   + +++DFGL        +  L  D+      + GT  Y
Sbjct: 112 ---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDY 167

Query: 651 VAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
           +APE       +  VD +S G +L E + 
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 84.6 bits (209), Expect = 3e-18
 Identities = 74/266 (27%), Positives = 122/266 (45%), Gaps = 32/266 (12%)

Query: 490 LGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           +G+G FG V    Y+G       ++VAVK +      + + F AE + + Q  H NLV+L
Sbjct: 14  IGKGEFGDVMLGDYRG-------NKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 64

Query: 546 LGYCDEGRNRL-LVYEFMSNGALASFLF--GDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           LG   E +  L +V E+M+ G+L  +L   G S        +  + +   + YL      
Sbjct: 65  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---N 121

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
             +H D+  +N+L+ +   A++SDFGL K  +  Q      ++ T    APE  R    +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 177

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN--DLEAMDDMTVLQRFVM 720
            K DV+S+G+LL EI    R       Y     + +   VE    ++A D    +   VM
Sbjct: 178 TKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVM 232

Query: 721 VAIWCIQEDPSHRPTMRRVTQMLEGV 746
              W +  D + RP+  ++ + LE +
Sbjct: 233 KQCWHL--DAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 85.0 bits (210), Expect = 4e-18
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 22/208 (10%)

Query: 483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKK--LNRVFQD-SEKEFKA---EVNGIGQ 536
           T+G  E LG+GA+GTVY G  N G    +AVK+  L+      +EKE++    EV+ +  
Sbjct: 3   TKG--EVLGKGAYGTVYCGLTNQG--QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS 58

Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGLF 594
             H N+V+ LG C +     +  EF+  G+++S L  FG   P      +    I  G+ 
Sbjct: 59  LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFC-KYTKQILDGVA 116

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL---TLDQSHTNT--AIRGTKG 649
           YLH  C   ++H DIK  N++L      ++ DFG  + L    L  +H+N   ++ GT  
Sbjct: 117 YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173

Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEI 677
           ++APE         K D++S G  + E+
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEM 201

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 55/197 (27%), Positives = 95/197 (48%), Gaps = 12/197 (6%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQTHHKNLVRLL 546
           ELG G  G V K  V    + ++   K  R+  +    K+   E++ + + +   +V   
Sbjct: 8   ELGAGNSGVVSK--VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 547 GYC-DEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYLHEECCTQI 604
           G   + G   + + E+M  G+L   L         ++  +I + + +GL YLHE+   +I
Sbjct: 66  GAFYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HKI 122

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           IH D+KP NIL++     ++ DFG+   L    + T     GT  Y+APE  +    +VK
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGNDYSVK 179

Query: 665 VDVYSYGVLLLEIICLR 681
            D++S G+ L+E+   R
Sbjct: 180 SDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 84.4 bits (209), Expect = 5e-18
 Identities = 60/198 (30%), Positives = 104/198 (52%), Gaps = 13/198 (6%)

Query: 490 LGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNLVRLL 546
           +G+G FG VY G +  + G     AVK LNR+    E ++F  E   +    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 547 GYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ YL  +   +
Sbjct: 63  GICLPSEG-SPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---K 118

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLL---TLDQSHTNTAIRGTKGYVAPEWFRNMP 660
            +H D+  +N +LD+ +  +++DFGL + +        H +T  +    ++A E  +   
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178

Query: 661 ITVKVDVYSYGVLLLEII 678
            T K DV+S+GVLL E++
Sbjct: 179 FTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 84.5 bits (209), Expect = 5e-18
 Identities = 73/273 (26%), Positives = 128/273 (46%), Gaps = 27/273 (9%)

Query: 490 LGRGAFGTVYKGFVNM--GSSDQVAVK--KLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG G FG+V +G ++   GS  +VAVK  KL+       +EF +E   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 546 LGYCDEGRNR------LLVYEFMSNGALASFLF----GDSKPNWKLRT--EIVMGIARGL 593
           +G C E  +       +++  FM +G L SFL     G       L+T  + ++ IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI-RGTKGYVA 652
            YL        IH D+  +N +L +     ++DFGL K +     +    I +    ++A
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183

Query: 653 PEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQERTLGALVENDLEAMDD 711
            E   +   T K DV+++GV + EI    +T       ++ Y     G  ++   + +D+
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDE 243

Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           +      +M + W  + DP  RPT  ++ ++LE
Sbjct: 244 LY----DLMYSCW--RADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 83.8 bits (207), Expect = 6e-18
 Identities = 63/197 (31%), Positives = 97/197 (49%), Gaps = 17/197 (8%)

Query: 489 ELGRGAFGTVYKGFVNMGSSD-QVAVKKLNRVFQDSEKEFKAEVNGIGQTHHK----NLV 543
           ELG G FG V KG   M      VA+K L     ++EK  + E+    +  H+     +V
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK---NENEKSVRDEMMREAEIMHQLDNPYIV 58

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFG--DSKPNWKLRTEIVMGIARGLFYLHEECC 601
           R++G C E    +LV E  S G L  FL G  D      +  E++  ++ G+ YL  +  
Sbjct: 59  RMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNV-VELMHQVSMGMKYLEGK-- 114

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--TNTAIRGTKGYVAPEWFRNM 659
              +H D+  +N+LL + + A+ISDFGL K L  D S+    +A +    + APE     
Sbjct: 115 -NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173

Query: 660 PITVKVDVYSYGVLLLE 676
             + + DV+SYG+ + E
Sbjct: 174 KFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 84.4 bits (209), Expect = 8e-18
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 23/214 (10%)

Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKK--LNRVFQDSEKEFKAEVNGI 534
           +++VE++R     LG GA G+V K    + ++  +   K        D +K+   E+   
Sbjct: 1   EKIVELSR-----LGEGAGGSVTK--CRLKNTGMIFALKTITTDPNPDLQKQILRELEIN 53

Query: 535 GQTHHKNLVRLLG-YCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMG---- 588
                  +V+  G + DE  + + +  E+   G+L S ++   K       E V+G    
Sbjct: 54  KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAE 112

Query: 589 -IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT 647
            + +GL YLH     +IIH DIKP NILL      ++ DFG+   L    + T T   GT
Sbjct: 113 SVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GT 166

Query: 648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR 681
             Y+APE  +  P ++  DV+S G+ LLE+   R
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 27/206 (13%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSEKEFKA---EVNGIGQTHHKNLVR 544
           +GRGAFG V+   +    +DQ  V +K++  V Q ++ E  A   E   +    H N++ 
Sbjct: 8   VGRGAFGIVH---LCRRKADQKLVIIKQIP-VEQMTKDERLAAQNECQVLKLLSHPNII- 62

Query: 545 LLGYCD---EGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLH 597
              Y +   E +  ++V E+   G LA ++    + N  L  + ++     I   L ++H
Sbjct: 63  --EYYENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVH 118

Query: 598 EECCTQIIHCDIKPQNILLDDYYNA-RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
            +    I+H D+K QNILLD +    +I DFG+ K+L+  +S   T + GT  Y++PE  
Sbjct: 119 TK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVV-GTPCYISPELC 173

Query: 657 RNMPITVKVDVYSYGVLLLEIICLRR 682
              P   K D+++ G +L E+  L+R
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 84/278 (30%), Positives = 126/278 (45%), Gaps = 35/278 (12%)

Query: 490 LGRGAFGTVYKG----FVNMGSSDQ-VAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           LG GAFG VY+G     +  GS    VAVK L +   D EK EF  E + +   +H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFL-------FGDSKPNWKLRTEIVMGIARGLFYL 596
           +LLG C     + ++ E M  G L S+L       FG      K   +I + +A+G  YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 597 HEECCTQIIHCDIKPQNILLD--DYYNAR---ISDFGLEKLLTLDQSHTNTAIRGTK--- 648
            +      IH D+  +N L+    Y   R   I DFGL + +     +      G     
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR---KEGEGLLP 176

Query: 649 -GYVAPEWFRNMPITVKVDVYSYGVLLLEIICL-RRTILTDWAYDCYQERTLGALVENDL 706
             ++APE   +   T + DV+S+GVL+ EI+ L ++        +  Q  T G  ++   
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPE 236

Query: 707 EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
              D +  L    M   W   +DPS RPT  R+ ++L+
Sbjct: 237 NCPDKIYQL----MTNCW--AQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 19/199 (9%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQV-AVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLV 543
             ++G+G+FG V+K  V   +  +V A+K+++    +  +  +A  E   + +     ++
Sbjct: 5   LNKIGKGSFGVVFK--VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII 62

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFL---FGDSKPN---WKLRTEIVMGIARGLFYLH 597
           R      +     +V E+  NG L   L    G   P    W+   +I++G+A    +LH
Sbjct: 63  RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----HLH 118

Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
            +   +I+H DIK  N+ LD Y N +I D G+ KLL+ + +  NT I GT  Y++PE   
Sbjct: 119 SK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCE 174

Query: 658 NMPITVKVDVYSYGVLLLE 676
           + P   K DV++ GV+L E
Sbjct: 175 DKPYNEKSDVWALGVVLYE 193

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 83.0 bits (206), Expect = 2e-17
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 40/218 (18%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
            ++G G +G VYK   N  + + VA+KK+     ++EKE        E+  + +  H N+
Sbjct: 5   AQIGEGTYGQVYKA-RNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 543 VRLLG-YCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----GLFYL 596
           VRL      +G+  + +V+E+M +  L   L     P  K     +    +    GL YL
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHD-LTGLL---DSPEVKFTESQIKCYMKQLLEGLQYL 116

Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--TNTAIRGTKGYVAPE 654
           H      I+H DIK  NIL+++    +++DFGL +  T   S   TN  I  T  Y  PE
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPE 171

Query: 655 WFRNMPI-------TVKVDVYSYGVLLLEIICLRRTIL 685
                 +         +VD++S G +L E+  L + I 
Sbjct: 172 ------LLLGATRYGPEVDMWSVGCILAELF-LGKPIF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 20/204 (9%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKK--LNRVFQDSEKEFKA-------EVNGIGQTHHK 540
           +G G+FG+VY G +N  S + +AVK+  L  V   S+   ++       E+  + +  H+
Sbjct: 8   IGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 541 NLVRLLGYCDEGRNRLLVY-EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
           N+V+ LG      + L ++ E++  G++A+ L         L    V  I +GL YLH  
Sbjct: 67  NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT-----AIRGTKGYVAPE 654
               IIH DIK  NIL+D+    +ISDFG+ K L  +   T T     +++G+  ++APE
Sbjct: 126 ---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182

Query: 655 WFRNMPITVKVDVYSYGVLLLEII 678
             +    T K D++S G L++E++
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEML 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 83.2 bits (205), Expect = 3e-17
 Identities = 83/261 (31%), Positives = 124/261 (47%), Gaps = 25/261 (9%)

Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG +V  G + +  VA+K LN      +  EF  E   +    H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNW--KLRTEIVMGIARGLFYLHEECCTQ 603
           LG C     +L V + M +G L  ++  + K N   +L     + IA+G+ YL E    +
Sbjct: 75  LGVCLSPTIQL-VTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEER---R 129

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMP 660
           ++H D+  +N+L+    + +I+DFGL +LL  D+   N    G K    ++A E      
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA--DGGKMPIKWMALECIHYRK 187

Query: 661 ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQRF 718
            T + DV+SYGV + E++           YD    R +  L+E    L      T+    
Sbjct: 188 FTHQSDVWSYGVTIWELMTFGGK-----PYDGIPTREIPDLLEKGERLPQPPICTIDVYM 242

Query: 719 VMVAIWCIQEDPSHRPTMRRV 739
           VMV  W I  D   RP  + +
Sbjct: 243 VMVKCWMI--DADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 82.2 bits (203), Expect = 3e-17
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 21/210 (10%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKK--LNRVFQDSEKE--------FKAEVNGIGQT 537
           E +G+G +G VY   +N+ + + +AVK+  L                   ++E+  +   
Sbjct: 7   ELIGKGTYGRVYLA-LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 538 HHKNLVRLLGYCDEGRNRLLVY-EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYL 596
            H N+V+ LG  +     L ++ E++  G++ S L    +   +L       +  GL YL
Sbjct: 66  DHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124

Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPE 654
           H +    I+H D+K  N+L+D     +ISDFG+ K  + D   +  N +++G+  ++APE
Sbjct: 125 HSK---GILHRDLKADNLLVDADGICKISDFGISK-KSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 655 WFRN--MPITVKVDVYSYGVLLLEIICLRR 682
              +     + KVD++S G ++LE+   RR
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 81.8 bits (202), Expect = 4e-17
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV------FQDSEKEFKAEVNGIGQTHHKN 541
           ++LG GAF + Y    ++ +   +AVK++  V       ++  +  + E+  + + +H +
Sbjct: 6   QQLGTGAFSSCY-QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGLFYLHEE 599
           ++R+LG   E  +  L  E+M+ G+++  L  +G  K    +       + RGL YLHE 
Sbjct: 65  IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN--YTEQLLRGLSYLHEN 122

Query: 600 CCTQIIHCDIKPQNILLDDY-YNARISDFGLEKLLTLDQSHTNT---AIRGTKGYVAPEW 655
              QIIH D+K  N+L+D      RI+DFG    L    +        + GT  ++APE 
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179

Query: 656 FRNMPITVKVDVYSYGVLLLEIIC 679
            R        DV+S G +++E+  
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMAT 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 82.0 bits (202), Expect = 5e-17
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 23/258 (8%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           E +G+G+FG VYKG  N  + + VA+K ++    +D  ++ + E+  + Q     + R  
Sbjct: 10  ERIGKGSFGEVYKGIDNR-TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT---EIVMGIARGLFYLHEECCTQ 603
           G   +G    ++ E++  G+    L    KP     T    I+  I +GL YLH E   +
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSE---R 121

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH DIK  N+LL +  + +++DFG+   LT  Q   NT + GT  ++APE  +      
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDF 180

Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDM--TVLQRFVMV 721
           K D++S G+  +E+             D +  R L  + +N    ++       + FV  
Sbjct: 181 KADIWSLGITAIELAKGEPP-----NSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEA 235

Query: 722 AIWCIQEDPSHRPTMRRV 739
              C+ +DP  RPT + +
Sbjct: 236 ---CLNKDPRFRPTAKEL 250

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 15/198 (7%)

Query: 491 GRGAFGTVYKGFVNMGSSDQV-AVKKLNRVFQDSEKEFKA---EVNGIGQTHHKNLVRL- 545
           G+GAFG V    V    + ++ A+K +N+     +   +    E   + + +H  LV L 
Sbjct: 9   GKGAFGKVCI--VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEECCTQI 604
             + DE  N  LV + +  G L  +         + + +  +  I   L YLH +    I
Sbjct: 67  YSFQDE-ENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GI 121

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           IH DIKP NILLD+  +  I+DF +   +T D   T+T+  GT GY+APE       +V 
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEVLCRQGYSVA 179

Query: 665 VDVYSYGVLLLEIICLRR 682
           VD +S GV   E +  +R
Sbjct: 180 VDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 82.0 bits (202), Expect = 5e-17
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 50/293 (17%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQ----VAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
            K ELG GAFG V+         +Q    VAVK L     ++ K+F  E   +    H++
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASF---------LFGDSKPNWKLRT----EIVMG 588
           +V+  G C EG   ++V+E+M +G L  F         L  +     +L       I   
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQ----SHTNTA 643
           IA G+ YL  +     +H D+  +N L+ +    +I DFG+ + + + D      HT   
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185

Query: 644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
           IR    ++ PE       T + DV+S GV+L EI               Y ++    L  
Sbjct: 186 IR----WMPPESIMYRKFTTESDVWSLGVVLWEIF-------------TYGKQPWYQLSN 228

Query: 704 ND-LEAMDDMTVLQR-------FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
           N+ +E +    VLQR          + + C Q +P  R  ++ +  +L+ + +
Sbjct: 229 NEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 81.6 bits (201), Expect = 6e-17
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 33/217 (15%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQ----VAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
            K ELG GAFG V+    +    +Q    VAVK L    + + ++F+ E   +    H++
Sbjct: 9   LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE----------------I 585
           +VR  G C EGR  L+V+E+M +G L  FL     P+ K+                   I
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHG-PDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 586 VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQ----SHT 640
              IA G+ YL        +H D+  +N L+      +I DFG+ + + + D       T
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184

Query: 641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 677
              IR    ++ PE       T + D++S+GV+L EI
Sbjct: 185 MLPIR----WMPPESILYRKFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 81.3 bits (201), Expect = 7e-17
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 19/204 (9%)

Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           F ++LG+G FG+V    Y    +  + + VAVKKL     +  ++F+ E+  +    H N
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQD-NTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDN 66

Query: 542 LVRLLGYC-DEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVM----GIARGLFY 595
           +V+  G C   GR  L LV E++  G+L  +L    K   +L    ++     I +G+ Y
Sbjct: 67  IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEY 123

Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAP 653
           L  +     +H D+  +NIL++     +I DFGL K+L  D+ +      G     + AP
Sbjct: 124 LGSKRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180

Query: 654 EWFRNMPITVKVDVYSYGVLLLEI 677
           E       +V  DV+S+GV+L E+
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 81.2 bits (200), Expect = 1e-16
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 41/225 (18%)

Query: 490 LGRGAFGTVYKGFV----NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNLVR 544
           LG G FG V K              VAVK L      SE ++  +E N + Q +H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFL------------FGDSKPNWKLRTE----IVMG 588
           L G C +    LL+ E+   G+L SFL               ++ +  L       + MG
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 589 --------IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT 640
                   I+RG+ YL E    +++H D+  +N+L+ +    +ISDFGL +    D    
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSR----DVYEE 180

Query: 641 NTAIRGTKG-----YVAPEWFRNMPITVKVDVYSYGVLLLEIICL 680
           ++ ++ +KG     ++A E   +   T + DV+S+GVLL EI+ L
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 225

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 19/200 (9%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-------HHKNL 542
           LG+GAFG VY    ++ +  ++AVK++   F     E K EVN +           H+ +
Sbjct: 10  LGQGAFGRVYL-CYDVDTGRELAVKQVP--FDPDSPETKKEVNALECEIQLLKNLQHERI 66

Query: 543 VRLLGYCDEGRNRLLVY-EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           V+  G C      L ++ E+M  G++   L         +  +    I  G+ YLH    
Sbjct: 67  VQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN-- 123

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR---GTKGYVAPEWFRN 658
             I+H DIK  NIL D   N ++ DFG  K L    S   T ++   GT  +++PE    
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG-TGMKSVTGTPYWMSPEVISG 181

Query: 659 MPITVKVDVYSYGVLLLEII 678
                K DV+S G  ++E++
Sbjct: 182 EGYGRKADVWSVGCTVVEML 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 57/241 (23%), Positives = 104/241 (43%), Gaps = 23/241 (9%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRL 545
            ++G G +G VYK   +  + + VA+KK+   F+       A  E+  + + +H N+++L
Sbjct: 5   GKIGEGTYGVVYKAR-DKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKL 63

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSK--PNWKLRTEIVMGIARGLFYLHEECCTQ 603
           L       +  LV+EFM    L   +    +  P   +++ +   + +GL + H      
Sbjct: 64  LDVFRHKGDLYLVFEFMDTD-LYKLIKDRQRGLPESLIKSYLYQ-LLQGLAFCHSH---G 118

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI-T 662
           I+H D+KP+N+L++     +++DFGL +          T    T+ Y APE        +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVVTRWYRAPELLLGDKGYS 177

Query: 663 VKVDVYSYGVLLLEIICLR-----RTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR 717
             VD++S G +  E++  R     ++ +          RTLG             T L R
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF---RTLGTPDPEV---WPKFTSLAR 231

Query: 718 F 718
            
Sbjct: 232 N 232

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 70/275 (25%), Positives = 128/275 (46%), Gaps = 27/275 (9%)

Query: 490 LGRGAFGTVYKGFVNM--GSSDQVAVKKLN-RVFQDSE-KEFKAEVNGIGQTHHKNLVRL 545
           LG+G FG+V +  +    GS  +VAVK L   +F  S+ +EF  E   + +  H N+++L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 546 LGYCDEGRNR------LLVYEFMSNGALASFLF----GDSKPNWKLRT--EIVMGIARGL 593
           +G     R +      +++  FM +G L +FL     G+      L+T    ++ IA G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL-EKLLTLDQSHTNTAIRGTKGYVA 652
            YL  +     IH D+  +N +L++     ++DFGL +K+ + D      A +    ++A
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183

Query: 653 PEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQERTLGALVENDLEAMDD 711
            E   +   T   DV+++GV + EI+   +T        + Y     G  ++   + ++D
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLED 243

Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV 746
           +  L    M   W    +P  RP+ + +   LE +
Sbjct: 244 VYEL----MCQCW--SPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 61/194 (31%), Positives = 100/194 (51%), Gaps = 15/194 (7%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L +    S + F  E   + +  H+ LV+L   
Sbjct: 13  KLGQGCFGEVWMGTWN--GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G+L  FL G+     +L   + M   IA G+ Y+        +H
Sbjct: 70  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 125

Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPITV 663
            D++  NIL+ +    +++DFGL +L+   + +  TA +G K    + APE       T+
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 664 KVDVYSYGVLLLEI 677
           K DV+S+G+LL E+
Sbjct: 183 KSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 11/194 (5%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG+G +G VY    ++ +  ++A+K++        +    E+       H+N+V+ LG  
Sbjct: 16  LGKGTYGIVYAA-RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 550 DEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
            E     +  E +  G+L++ L   +G  K N +        I  GL YLH+    QI+H
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVH 131

Query: 607 CDIKPQNILLDDYYNA-RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP--ITV 663
            DIK  N+L++ Y    +ISDFG  K L      T T   GT  Y+APE     P     
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPRGYGA 190

Query: 664 KVDVYSYGVLLLEI 677
             D++S G  ++E+
Sbjct: 191 PADIWSLGCTIVEM 204

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 76/278 (27%), Positives = 123/278 (44%), Gaps = 37/278 (13%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ-THHKNLVRL 545
            E +G G +G VYK   +  +   VA+K ++ + +D E+E K E N + + ++H N+   
Sbjct: 11  VEVIGEGTYGKVYKA-RHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKYSNHPNIATF 68

Query: 546 LG-YCDEG----RNRL-LVYEFMSNGALASFLFGDSKPNWKLRTE----IVMGIARGLFY 595
            G +  +      ++L LV E    G++   + G  K   +L+ E    I+    RGL Y
Sbjct: 69  YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           LHE    ++IH DIK QNILL      ++ DFG+   L       NT I GT  ++APE 
Sbjct: 129 LHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEV 184

Query: 656 F-----RNMPITVKVDVYSYGVLLLEIICLRRTILTDWA---YDCYQERTLGALVENDLE 707
                  +     + DV+S G+  +E        L D      D +  R L  +  N   
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIE--------LADGKPPLCDMHPMRALFKIPRNPPP 236

Query: 708 AMDDMTVL-QRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
            +       ++F      C+ ++   RP M    ++LE
Sbjct: 237 TLKSPENWSKKFNDFISECLIKNYEQRPFM---EELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 66/254 (25%), Positives = 122/254 (48%), Gaps = 15/254 (5%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           E +G+G+FG V+KG  N      VA+K ++    +D  ++ + E+  + Q     + +  
Sbjct: 10  ERIGKGSFGEVFKGIDNRTQQ-VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           G   +G    ++ E++  G+    L       +++ T ++  I +GL YLH E   + IH
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIAT-MLKEILKGLDYLHSE---KKIH 124

Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIK  N+LL +  + +++DFG+   LT  Q   NT + GT  ++APE  +      K D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKAD 183

Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM-DDMTVLQRFVMVAIWC 725
           ++S G+  +E+             D +  R L  + +N+   +  + +  + F      C
Sbjct: 184 IWSLGITAIELAKGEPP-----NSDMHPMRVLFLIPKNNPPTLTGEFS--KPFKEFIDAC 236

Query: 726 IQEDPSHRPTMRRV 739
           + +DPS RPT + +
Sbjct: 237 LNKDPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 72/265 (27%), Positives = 117/265 (44%), Gaps = 24/265 (9%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLL 546
           E +GRG FG V+ G +   ++  VAVK        D + +F  E   + Q  H N+VRL+
Sbjct: 1   ERIGRGNFGEVFSGRLRADNT-PVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEECCTQI 604
           G C + +   +V E +  G   +FL  +  P  K++  I M    A G+ YL  + C   
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHC--- 115

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK----GYVAPEWFRNMP 660
           IH D+  +N L+ +    +ISDFG+ +    ++     +  G K     + APE      
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172

Query: 661 ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDLEAMDDMTVLQRF 718
            + + DV+S+G+LL E   L      + +    +E       L   +L       +++R 
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMER- 231

Query: 719 VMVAIWCIQEDPSHRPTMRRVTQML 743
                 C + DP  RP+   V Q L
Sbjct: 232 ------CWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 72/273 (26%), Positives = 122/273 (44%), Gaps = 22/273 (8%)

Query: 478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT 537
           E+   +   +++LG G FG V+    N  +  +VAVK + +    S + F AE N +   
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHT--KVAVKTM-KPGSMSVEAFLAEANVMKTL 58

Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF---GDSKPNWKLRTEIVMGIARGLF 594
            H  LV+L     +     ++ EFM+ G+L  FL    G  +P  KL  +    IA G+ 
Sbjct: 59  QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMA 116

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYV 651
           ++ +      IH D++  NIL+      +I+DFGL +++   + +  TA  G K    + 
Sbjct: 117 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWT 170

Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD 711
           APE       T+K DV+S+G+LL+EI+   R       Y       +   +E        
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRI-----PYPGMSNPEVIRALERGYRMPRP 225

Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
               +    + + C +  P  RPT   +  +L+
Sbjct: 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 19/200 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
             + +G G +G VYK   ++ + + VA+K +     D  +  + E++ + +  H N+V  
Sbjct: 7   LIQRIGSGTYGDVYKA-RDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAY 65

Query: 546 LG-YCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----GLFYLHEE 599
            G Y    R++L +V E+   G+L         P   L    +  + R    GL YLHE 
Sbjct: 66  FGSY--LRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGLAYLHE- 119

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF--- 656
             T  IH DIK  NILL +  + +++DFG+   LT   +   + I GT  ++APE     
Sbjct: 120 --TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVE 176

Query: 657 RNMPITVKVDVYSYGVLLLE 676
           R      K D+++ G+  +E
Sbjct: 177 RKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 78.8 bits (195), Expect = 5e-16
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 39/216 (18%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT---------- 537
            E+G GA+GTVYK   ++ +   VA+KK+      SE        GI  +          
Sbjct: 5   AEIGEGAYGTVYKA-RDLNTGRFVALKKVR--VPLSE-------EGIPLSTLREIALLKQ 54

Query: 538 ----HHKNLVRLLGYCDEGRNR-----LLVYEFMSNGALASFLFGDSKPN---WKLRTEI 585
                H N+VRLL  C   R        LV+E +    LA++L    KP      ++ ++
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQD-LATYLSKCPKPGLPPETIK-DL 112

Query: 586 VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR 645
           +  + RG+ +LH     +I+H D+KPQNIL+      +I+DFGL ++ + + + T+  + 
Sbjct: 113 MRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV- 168

Query: 646 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR 681
            T  Y APE          VD++S G +  E+   R
Sbjct: 169 -TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 78.2 bits (193), Expect = 6e-16
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)

Query: 488 EELGRGAFGTVYKGFVNMGSSD--QVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVR 544
           ++LG G+FG V +G  +        VAVK L      D   +F  E   +    H+NL+R
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLFYLHEECCT 602
           L G        ++V E    G+L   L  D+  ++ + T  +  + IA G+ YL  +   
Sbjct: 61  LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK--- 116

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--TNTAIRGTKGYVAPEWFRNMP 660
           + IH D+  +NILL      +I DFGL + L  ++ H      ++    + APE  R   
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176

Query: 661 ITVKVDVYSYGVLLLEI 677
            +   DV+ +GV L E+
Sbjct: 177 FSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 77/268 (28%), Positives = 121/268 (45%), Gaps = 39/268 (14%)

Query: 490 LGRGAFGTVYKGF-VNMGSSDQ--VAVKKL-NRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG G FGTV+KG  +  G S +  VA+K + +R  + + +E    +  +G   H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLF---GDSKP----NWKLRTEIVMGIARGLFYLHE 598
           LG C  G +  LV +    G+L   +        P    NW ++      IA+G++YL E
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ-----SHTNTAIRGTKGYVAP 653
                ++H ++  +NILL      +I+DFG+  LL  D      S   T I+    ++A 
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK----WMAL 180

Query: 654 EWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDD 711
           E       T + DV+SYGV + E++           Y   +   +  L+E    L     
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAE-----PYAGMRPHEVPDLLEKGERLAQPQI 235

Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
            T+    VMV  W I E+   RPT + +
Sbjct: 236 CTIDVYMVMVKCWMIDENV--RPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 77/261 (29%), Positives = 113/261 (43%), Gaps = 20/261 (7%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H  LV L   
Sbjct: 13  KLGQGCFGEVWMGTWN--GTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAV 69

Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V EFM  G+L  FL        KL   + M   IA G+ Y+        IH
Sbjct: 70  VSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIH 125

Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPITV 663
            D++  NIL+ D    +I+DFGL +L+   + +  TA +G K    + APE       T+
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+S+G+LL E++   R       Y     R +   VE            +    +  
Sbjct: 183 KSDVWSFGILLTELVTKGRV-----PYPGMVNREVLEQVERGYRMPCPQGCPESLHELMK 237

Query: 724 WCIQEDPSHRPTMRRVTQMLE 744
            C ++DP  RPT   +   LE
Sbjct: 238 LCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 13/198 (6%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNRVFQDSEKEFKAEVNG--IGQTHHKNLVRLL 546
           LG+G FG V      + ++ ++ A KKL++      K  +  +N   I +      +  L
Sbjct: 1   LGKGGFGEVCA--CQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL 58

Query: 547 GYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
            Y  E ++ L LV   M+ G L   ++   +P +     I     I  GL +LH+    +
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---R 115

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
           I++ D+KP+N+LLDD+ N RISD GL   + L          GT GY+APE  +      
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDF 173

Query: 664 KVDVYSYGVLLLEIICLR 681
            VD ++ G  L E+I  R
Sbjct: 174 SVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 77/301 (25%), Positives = 132/301 (43%), Gaps = 51/301 (16%)

Query: 481 EVTRG---FKEELGRGAFGTVYK----GFVNMGSSDQVAVKKLNR-VFQDSEKEFKAEVN 532
           E  R    +  ++G+GAFG V++    G +       VAVK L      D + +F+ E  
Sbjct: 1   EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60

Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNW---------KLRT 583
            + +  H N+V+LLG C  G+   L++E+M+ G L  FL   S P             R 
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRS-PRAQCSLSHSTSSARK 119

Query: 584 E--------------IVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
                          I   +A G+ YL E    + +H D+  +N L+ +    +I+DFGL
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL 176

Query: 630 -EKLLTLD--QSHTNTA--IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTI 684
              + + D  ++  N A  IR    ++ PE       T + DV++YGV+L EI     + 
Sbjct: 177 SRNIYSADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIF----SY 228

Query: 685 LTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF-VMVAIWCIQEDPSHRPTMRRVTQML 743
                Y    E  +  + + ++ +  D   L+ + +M   W   + PS RP+   + ++L
Sbjct: 229 GMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCW--SKLPSDRPSFASINRIL 286

Query: 744 E 744
           +
Sbjct: 287 Q 287

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 71/266 (26%), Positives = 121/266 (45%), Gaps = 29/266 (10%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVR 544
             E +G GA   VY     + ++++VA+K+++    Q S  E + EV  + Q +H N+V+
Sbjct: 5   LIEVIGVGATAVVYAAIC-LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----GLFYLHEEC 600
                  G    LV  ++S G+L   +   S P   L   I+  + +    GL YLH   
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN- 121

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLL---TLDQSHTNTAIRGTKGYVAPEWFR 657
               IH DIK  NILL +  + +I+DFG+   L               GT  ++APE   
Sbjct: 122 --GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179

Query: 658 NMP-ITVKVDVYSYGVLLLEIICLRRTILTDWA--YDCYQERTLGALVENDLEAMDDMTV 714
            +     K D++S+G+  +E+        T  A        + L   ++ND  +++    
Sbjct: 180 QVHGYDFKADIWSFGITAIELA-------TGAAPYSKYPPMKVLMLTLQNDPPSLETGAD 232

Query: 715 LQRFV-----MVAIWCIQEDPSHRPT 735
            +++      M+++ C+Q+DPS RPT
Sbjct: 233 YKKYSKSFRKMISL-CLQKDPSKRPT 257

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 17/198 (8%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTHHKNLVRLL 546
           ELG GAFG VYK   +  +    A K +    +  E+  +F  E++ + +  H N+V L 
Sbjct: 12  ELGDGAFGKVYKA-QHKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHPNIVGLY 68

Query: 547 -GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM-GIARGLFYLHEECCTQI 604
             Y  E +  +L+ EF   GAL S +    +   + +   V   +   L +LH     ++
Sbjct: 69  EAYFYENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KV 124

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAP-----EWFRNM 659
           IH D+K  NILL    + +++DFG+           +T I GT  ++AP     E F++ 
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDN 183

Query: 660 PITVKVDVYSYGVLLLEI 677
           P   K D++S G+ L+E+
Sbjct: 184 PYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 73/268 (27%), Positives = 113/268 (42%), Gaps = 39/268 (14%)

Query: 490 LGRGAFGTVYKGFVNMGSSD---QVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG            VA+K+L       + KE   E   +    + ++ RL
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 546 LGYCDEGRNRLLVYEFMSNGALASF-------LFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           LG C     +L + + M  G L  +       +      NW ++      IA+G+ YL E
Sbjct: 75  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEE 127

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+  +N+L+    + +I+DFGL KLL  D+           G V  +W   
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK----EYHAEGGKVPIKWMAL 180

Query: 659 MPI-----TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDD 711
             I     T + DV+SYGV + E++           YD      + +++E    L     
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPI 235

Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
            T+    +MV  W I  D   RP  R +
Sbjct: 236 CTIDVYMIMVKCWMI--DADSRPKFREL 261

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 45/212 (21%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G V   F +  +  +VA+KKL+R FQ +   K    E+  +    H+N++ LL 
Sbjct: 23  VGSGAYGQVCSAF-DTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81

Query: 548 -YC-DEGRNRL----LVYEFMS---NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
            +             LV   M    N  +      D    +     +V  I RGL Y+H 
Sbjct: 82  VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-----LVYQILRGLKYIHS 136

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGL----EKLLTLDQSHTNTAIRGTKGYVAPE 654
                IIH D+KP NI +++    +I DFGL    +  +T              GYVA  
Sbjct: 137 ---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT--------------GYVATR 179

Query: 655 WFRN-------MPITVKVDVYSYGVLLLEIIC 679
           W+R        M     VD++S G ++ E++ 
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 68/269 (25%), Positives = 115/269 (42%), Gaps = 37/269 (13%)

Query: 490 LGRGAFG--TVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGI---GQTHHKNLVR 544
           LG+GAFG  T+Y+          V  K++N + + SEKE +  +N I       H N++ 
Sbjct: 8   LGKGAFGEATLYR---RTEDDSLVVWKEVN-LTRLSEKERRDALNEIVILSLLQHPNIIA 63

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASF-------LFGDSKPNWKLRTEIVMGIARGLFYLH 597
              +  +    L+  E+ + G L          LF +    W L  +IV  ++    Y+H
Sbjct: 64  YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL-FQIVSAVS----YIH 118

Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
           +     I+H DIK  NI L      ++ DFG+ K+L  + S   T + GT  Y++PE  +
Sbjct: 119 KA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQ 174

Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE---AMDDMTV 714
            +    K D+++ G +L E++ L+RT         +       LV   ++          
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRT---------FDATNPLNLVVKIVQGNYTPVVSVY 225

Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQML 743
               + +    +Q+DP  RPT   V    
Sbjct: 226 SSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 77.6 bits (191), Expect = 4e-15
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 49/285 (17%)

Query: 476 YKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS-EKEFKAEVNGI 534
             EL  V R     +G GA GTVYK  ++  +    A+K +    +D+  ++   E+  +
Sbjct: 73  LSELERVNR-----IGSGAGGTVYK-VIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL 126

Query: 535 GQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLF 594
              +H N+V+     D      ++ EFM  G+L      D +    +  +I+ GIA    
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIA---- 182

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           YLH      I+H DIKP N+L++   N +I+DFG+ ++L       N+++ GT  Y++PE
Sbjct: 183 YLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPE 238

Query: 655 WFRNMPITVKV----------DVYSYGVLLLEIICLRRTILT----DWAY----DCYQER 696
                 I   +          D++S GV +LE    R         DWA      C  + 
Sbjct: 239 -----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP 293

Query: 697 TLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ 741
                     EA    T  + F      C+Q +P+ R +  ++ Q
Sbjct: 294 P---------EA--PATASREFRHFISCCLQREPAKRWSAMQLLQ 327

Length = 353

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 5e-15
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 21/199 (10%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE---FKAE-VNGIGQTHHKNLV 543
           + + +GAFG+VY       + D  A+K L +    ++ +    KAE    + Q     + 
Sbjct: 2   KPISKGAFGSVYLA-KKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFL--FGDSKPNW--KLRTEIVMGIARGLFYLHEE 599
           +L           LV E+++ G  AS +   G    +W  +   E+V+G+      LH+ 
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVE----DLHQR 116

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH DIKP+N+L+D   + +++DFGL +         N    GT  Y+APE    +
Sbjct: 117 ---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGV 168

Query: 660 PITVKVDVYSYGVLLLEII 678
                 D +S G ++ E +
Sbjct: 169 GDDKMSDWWSLGCVIFEFL 187

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 75.0 bits (184), Expect = 6e-15
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLL 546
           E LG+G FG V+KG   +     VAVK       Q+ + +F +E   + Q  H N+V+L+
Sbjct: 1   ELLGKGNFGEVFKG--TLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLR--TEIVMGIARGLFYLHEECCTQI 604
           G C + +   +V E +  G   SFL    K   K +   +  +  A G+ YL  + C   
Sbjct: 59  GVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLESKNC--- 114

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK-GYVAPEWFRNMPITV 663
           IH D+  +N L+ +    +ISDFG+ +    D  ++++ ++     + APE       + 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQED-DGIYSSSGLKQIPIKWTAPEALNYGRYSS 173

Query: 664 KVDVYSYGVLLLEIICL 680
           + DV+SYG+LL E   L
Sbjct: 174 ESDVWSYGILLWETFSL 190

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 33/218 (15%)

Query: 486 FKEELGRGAFGTVYKGFV---NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKN 541
           F EELG  AFG +YKG +    M  +  VA+K L  +    +  EF+ E + + + HH N
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLF---------GDSKPNWKLRTEIVMG---- 588
           +V LLG   + +   +++E+++ G L  FL            S  +  +++ +  G    
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 589 ----IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLD----QSH 639
               IA G+ YL        +H D+  +NIL+ +  + +ISD GL + + + D    Q  
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 677
           +   IR    ++ PE       +   D++S+GV+L EI
Sbjct: 186 SLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 75.8 bits (186), Expect = 7e-15
 Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 32/217 (14%)

Query: 486 FKEELGRGAFGTVYKG-FVNMGSSDQ---VAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
            K ELG GAFG V+     N+  +     VAVK L      + K+F+ E   +    H++
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFG---------DSKP---NWKL----RTEI 585
           +V+  G C +G   ++V+E+M +G L  FL           D +P     +L       I
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 586 VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQ----SHT 640
              IA G+ YL  +     +H D+  +N L+      +I DFG+ + + + D      HT
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185

Query: 641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 677
              IR    ++ PE       T + DV+S+GV+L EI
Sbjct: 186 MLPIR----WMPPESIMYRKFTTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 75.0 bits (184), Expect = 9e-15
 Identities = 70/273 (25%), Positives = 121/273 (44%), Gaps = 34/273 (12%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVRLL 546
           LG G FG + +G + + S  +  VA+  L     D ++  F AE   +GQ  H N+VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM----GIARGLFYLHEECCT 602
           G    G   ++V E+MSNGAL SFL    K   +L    +M    G+A G+ YL E    
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYLSE---M 126

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
             +H  +    +L++     +IS F   +    +  +T  + +    + APE  +    +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND-LEAMDDMTVL------ 715
              DV+S+G+++ E++              Y ER    +   D ++A++D   L      
Sbjct: 187 SASDVWSFGIVMWEVM-------------SYGERPYWDMSGQDVIKAVEDGFRLPAPRNC 233

Query: 716 -QRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
                 + + C Q++   RP   ++  +L  +V
Sbjct: 234 PNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 74.8 bits (184), Expect = 9e-15
 Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 30/222 (13%)

Query: 474 FTYKELVEVTRGFKEELGRGAFGTVY----KGFVNMGSSDQVAVKKLNRV-FQDSEKEFK 528
           F    L E+T      LGRG FG V+    KG    G    V VK L +   ++ + EF+
Sbjct: 2   FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56

Query: 529 AEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------- 581
            E++   +  HKN+VRLLG C E     ++ E+   G L  FL      + KL       
Sbjct: 57  RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116

Query: 582 --RTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ-- 637
             +  +   IA G+ +L      + +H D+  +N L+      ++S   L K +   +  
Sbjct: 117 KQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173

Query: 638 SHTNTAI--RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 677
              N  I  R    ++APE  +    + K DV+S+GVL+ E+
Sbjct: 174 KLRNALIPLR----WLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 66/204 (32%), Positives = 98/204 (48%), Gaps = 22/204 (10%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNRVFQDSEKEFKA---EVNGIGQTHHKNLVRL 545
           LG+G FG V      M ++ ++ A KKLN+      K ++    E   + + H + +V L
Sbjct: 1   LGKGGFGEVSA--CQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 546 LGYCDEGRNRL-LVYEFMSNGALASFLF-------GDSKPNWKLRTEIVMGIARGLFYLH 597
             Y  + +  L LV   M+ G L   ++       G  +P     T     I  GL +LH
Sbjct: 59  -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTA---QIISGLEHLH 114

Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
           +    +II+ D+KP+N+LLD+  N RISD GL   L   QS T     GT G++APE  +
Sbjct: 115 QR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK-GYAGTPGFMAPELLQ 170

Query: 658 NMPITVKVDVYSYGVLLLEIICLR 681
                  VD ++ GV L E+I  R
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 27/205 (13%)

Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTH 538
           F + LG G+FG V    +KG     S    A+K L++   V     +    E   +    
Sbjct: 5   FIKTLGTGSFGRVMLVRHKG-----SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59

Query: 539 HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLR---TEIVMGIARGLF 594
           H  LV L G   +  N  LV E++  G L S L    + P    R    ++V+ +     
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE---- 115

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           YLH      I++ D+KP+N+LLD     +I+DFG  K +   +  T T + GT  Y+APE
Sbjct: 116 YLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYT-LCGTPEYLAPE 168

Query: 655 WFRNMPITVKVDVYSYGVLLLEIIC 679
              +      VD ++ G+L+ E++ 
Sbjct: 169 IILSKGYGKAVDWWALGILIYEMLA 193

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 22/204 (10%)

Query: 488 EELGRGAFGTV----YKGFVNMGSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNL 542
             LG G FG V    Y    N G+ + VAVK L R   Q +   +K E+N +   +H+N+
Sbjct: 10  RVLGEGHFGKVSLYCYDP-ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68

Query: 543 VRLLGYCDEGRNR--LLVYEFMSNGALASFLFGDSKPNWKLRTEIVM----GIARGLFYL 596
           V+  G C E   +   L+ E++  G+L  +L     P  KL    ++     I  G+ YL
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYL 123

Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPE 654
           H +     IH D+  +N+LLD+    +I DFGL K +     +      G     + A E
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180

Query: 655 WFRNMPITVKVDVYSYGVLLLEII 678
             +    +   DV+S+GV L E++
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 74.4 bits (182), Expect = 2e-14
 Identities = 53/191 (27%), Positives = 100/191 (52%), Gaps = 6/191 (3%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E++G+GA GTVY   +++ +  +VA+K++N   Q  ++    E+  + +  + N+V  L 
Sbjct: 25  EKIGQGASGTVYTA-IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
               G    +V E+++ G+L   +        ++   +     + L +LH     Q+IH 
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-AAVCRECLQALDFLHS---NQVIHR 139

Query: 608 DIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDV 667
           DIK  NILL    + +++DFG    +T +QS  +T + GT  ++APE         KVD+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198

Query: 668 YSYGVLLLEII 678
           +S G++ +E++
Sbjct: 199 WSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 11/195 (5%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           ELG GAFG VYK   N  +    A K ++   ++  +++  E++ +    H N+V+LL  
Sbjct: 12  ELGDGAFGKVYKA-QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70

Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIV-MGIARGLFYLHEECCTQIIHC 607
                N  ++ EF + GA+ + +    +P  + +  +V       L YLHE    +IIH 
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHR 127

Query: 608 DIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF-----RNMPIT 662
           D+K  NIL     + +++DFG+    T      ++ I GT  ++APE       ++ P  
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYD 186

Query: 663 VKVDVYSYGVLLLEI 677
            K DV+S G+ L+E+
Sbjct: 187 YKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 73.6 bits (180), Expect = 3e-14
 Identities = 66/257 (25%), Positives = 125/257 (48%), Gaps = 17/257 (6%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           E++G+G+FG V+KG  N  +   VA+K ++    +D  ++ + E+  + Q     + +  
Sbjct: 10  EKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           G   +     ++ E++  G+    L        ++ T I+  I +GL YLH E   + IH
Sbjct: 69  GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-ILREILKGLDYLHSE---KKIH 124

Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIK  N+LL ++   +++DFG+   LT  Q   NT + GT  ++APE  +      K D
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKAD 183

Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD--MTVLQRFVMVAIW 724
           ++S G+  +E   L +        + +  + L  + +N+   ++      L+ FV     
Sbjct: 184 IWSLGITAIE---LAKG--EPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA--- 235

Query: 725 CIQEDPSHRPTMRRVTQ 741
           C+ ++PS RPT + + +
Sbjct: 236 CLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 26/207 (12%)

Query: 488 EELGRGAFGTVYKG-FVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ-THHKNLVRL 545
           E +G G +G VYKG  V  G   Q+A  K+  V  D E+E K E+N + + +HH+N+   
Sbjct: 12  ELVGNGTYGQVYKGRHVKTG---QLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATY 68

Query: 546 LGYCDEGR------NRLLVYEFMSNGALASFLFGDSKPNWKLRTE----IVMGIARGLFY 595
            G   +           LV EF   G++   L  ++K N  L+ E    I   I RGL +
Sbjct: 69  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGN-TLKEEWIAYICREILRGLSH 126

Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           LH+    ++IH DIK QN+LL +    ++ DFG+   L       NT I GT  ++APE 
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEV 182

Query: 656 FR-----NMPITVKVDVYSYGVLLLEI 677
                  +     K D++S G+  +E+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 6/190 (3%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           ++G G+ G V        +  QVAVKK++   Q   +    EV  +   HH+N+V +   
Sbjct: 29  KIGEGSTGIVCIA-TEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87

Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCD 608
              G    +V EF+  GAL   +   ++ N +    + + + R L YLH +    +IH D
Sbjct: 88  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRD 143

Query: 609 IKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVY 668
           IK  +ILL      ++SDFG    ++ +     + + GT  ++APE    +P   +VD++
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDIW 202

Query: 669 SYGVLLLEII 678
           S G++++E+I
Sbjct: 203 SLGIMVIEMI 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 76.4 bits (188), Expect = 3e-14
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 20/188 (10%)

Query: 507 SSDQVAVKKLNRVFQDSEKE---FKAEVNGIGQTHHKNLVRLL--GYCDEGRNRLLVYEF 561
           +  +VA+K L     + E +   F+ E     + +H N+V LL  G    G     V+E+
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEY 60

Query: 562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL---DD 618
           +    L   L  D          +++ +   L   H +    I+H D+KPQNI++     
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGV 117

Query: 619 YYNARISDFGLEKLL-----TLDQSHTNTA-IRGTKGYVAPEWFRNMPITVKVDVYSYGV 672
             +A++ DFG+  LL         + T T  + GT  Y APE  R  P+T   D+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177

Query: 673 LLLEIICL 680
           + LE  CL
Sbjct: 178 IFLE--CL 183

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 74.1 bits (183), Expect = 4e-14
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 45/220 (20%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA-----EVNGIGQTHHKNLVR 544
           +G GA+G V    V+  +  +VA+KK++ VF D      A     E+  +    H+N++ 
Sbjct: 8   IGSGAYGVVCSA-VDKRTGRKVAIKKISNVFDD---LIDAKRILREIKLLRHLRHENIIG 63

Query: 545 LL-----GYCDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTE----IVMGIARGLF 594
           LL        ++  +  +V E M ++  L   +    K    L  +     +  I RGL 
Sbjct: 64  LLDILRPPSPEDFNDVYIVTELMETD--LHKVI----KSPQPLTDDHIQYFLYQILRGLK 117

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYVA 652
           YLH      +IH D+KP NIL++   + +I DFGL + +  D+      T       YV 
Sbjct: 118 YLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT------EYVV 168

Query: 653 PEWFR-------NMPITVKVDVYSYGVLLLEIICLRRTIL 685
             W+R       +   T  +D++S G +  E+  L R  L
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL--LTRKPL 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 75/276 (27%), Positives = 128/276 (46%), Gaps = 34/276 (12%)

Query: 490 LGRGAFGTVYKGFVNMGSSD-QVAVKKLN-RVFQDSEKE-FKAEVNGIGQTHHKNLVRLL 546
           LG G FG+V +G +N   S  +VAVK +   +   SE E F +E   + +  H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 547 GYCDEGRNR------LLVYEFMSNGALASFLF----GDSKPNW---KLRTEIVMGIARGL 593
           G C +          +++  FM +G L SFL     GD  P +   ++  + +  IA G+
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC-PQYLPTQMLVKFMTDIASGM 125

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL-EKLLTLDQSHTNTAIRGTKGYVA 652
            YL  +     IH D+  +N +L++  N  ++DFGL +K+   D        +    ++A
Sbjct: 126 EYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182

Query: 653 PEWFRNMPITVKVDVYSYGVLLLEIICLRRT----ILTDWAYDCYQERTLGALVENDLEA 708
            E   +   T K DV+S+GV + EI    +T    +     YD  ++   G  ++   + 
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ---GNRLKQPPDC 239

Query: 709 MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           +D +  L    M + W    +P  RP+   +   LE
Sbjct: 240 LDGLYSL----MSSCW--LLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 73.0 bits (179), Expect = 4e-14
 Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 35/279 (12%)

Query: 488 EELGRGAFGTVYKGFVNMG-SSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRL 545
           +E+G G FG V  G  + G S  +V VK+L       E+  F  EV    + +H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFL-------FGDSKPNWKLRTEIVMGIARGLFYLHE 598
           LG C E    LLV EF   G L ++L          ++ +   R  +   +A GL +LH+
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR--MACEVASGLLWLHQ 118

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGL------EKLLTLDQSHTNTAIRGTKGYVA 652
                 IH D+  +N  L    + +I D+GL      E        H    +R     + 
Sbjct: 119 ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHA-VPLRWLAPELV 174

Query: 653 PEWFRNM---PITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQERTLGALV-ENDLE 707
               +++     T K +++S GV + E+         D  Y D   E+ L  +V E D++
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL-----FTAADQPYPDLSDEQVLKQVVREQDIK 229

Query: 708 AMD---DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQML 743
                 D+    R+  V  +C   DP  RPT   V ++L
Sbjct: 230 LPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 73/274 (26%), Positives = 119/274 (43%), Gaps = 29/274 (10%)

Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G + +  VA+K L       + KE   E   +       + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-------NWKLRTEIVMGIARGLFYLHE 598
           LG C     +L V + M  G L  ++  +          NW ++      IA+G+ YL E
Sbjct: 75  LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS--HTNTAIRGTKGYVAPEWF 656
               +++H D+  +N+L+    + +I+DFGL +LL +D++  H +      K ++A E  
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK-WMALESI 183

Query: 657 RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ 716
            +   T + DV+SYGV + E++           YD    R +  L+E             
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAK-----PYDGIPAREIPDLLEKGERLPQPPICTI 238

Query: 717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
              M+ + C   D   RP  R +      +   P
Sbjct: 239 DVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 73.0 bits (179), Expect = 5e-14
 Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 14/195 (7%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E++G+GA GTVY   +++ +  +VA+K++N   Q  ++    E+  + +  H N+V  L 
Sbjct: 25  EKIGQGASGTVYTA-IDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLD 83

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----GLFYLHEECCTQ 603
               G    +V E+++ G+L      D      +    +  + R     L +LH     Q
Sbjct: 84  SYLVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLHSN---Q 135

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
           +IH DIK  NILL    + +++DFG    +T +QS  +T + GT  ++APE         
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGP 194

Query: 664 KVDVYSYGVLLLEII 678
           KVD++S G++ +E++
Sbjct: 195 KVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 72.5 bits (178), Expect = 6e-14
 Identities = 68/277 (24%), Positives = 114/277 (41%), Gaps = 35/277 (12%)

Query: 483 TRGFKEE--LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA----EVNGIGQ 536
              FK E  +G+G F  VYK  + +     VA+KK+ ++F+  + + +     E++ + Q
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKA-ICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLLKQ 58

Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL--------FGDSKPNWKLRTEIVMG 588
             H N+++ L    E     +V E    G L+  +            +  WK      + 
Sbjct: 59  LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY----FVQ 114

Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA--IRG 646
           +   L ++H +   +I+H DIKP N+ +      ++ D GL +  +   S T  A  + G
Sbjct: 115 LCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS---SKTTAAHSLVG 168

Query: 647 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA--YDCYQERTLGALVEN 704
           T  Y++PE         K D++S G LL E+  L+     D    Y   ++         
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY--P 226

Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ 741
            L A      L+  V     CI  DP  RP +  V Q
Sbjct: 227 PLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 6e-14
 Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 35/208 (16%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKA----EVNGIGQTHHKN 541
             +G GA+G V K   N  + + VA+KK    F++SE  ++ K     EV  + Q  H+N
Sbjct: 7   GVVGEGAYGVVLKC-RNKATGEIVAIKK----FKESEDDEDVKKTALREVKVLRQLRHEN 61

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGI----ARGLFYLH 597
           +V L           LV+E++    L      ++ P   L  + V        + + Y H
Sbjct: 62  IVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPG-GLPPDAVRSYIWQLLQAIAYCH 117

Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
                 IIH DIKP+NIL+ +    ++ DFG  + L         A   T  YVA  W+R
Sbjct: 118 SH---NIIHRDIKPENILVSESGVLKLCDFGFARAL-----RARPASPLTD-YVATRWYR 168

Query: 658 NMPITVK-------VDVYSYGVLLLEII 678
              + V        VDV++ G ++ E++
Sbjct: 169 APELLVGDTNYGKPVDVWAIGCIMAELL 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 6e-14
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 11/196 (5%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHH---KNLV 543
           E +GRGA+G VY+G  ++ +   VA+K +N    D +  + + EV  + Q       N+ 
Sbjct: 7   ELIGRGAYGAVYRG-KHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +  G   +G    ++ E+   G++ + L        K  + I+  +   L Y+H+     
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHK---VG 121

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN-MPIT 662
           +IH DIK  NIL+ +  N ++ DFG+  LL  + S  +T + GT  ++APE         
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYD 180

Query: 663 VKVDVYSYGVLLLEII 678
            K D++S G+ + E+ 
Sbjct: 181 TKADIWSLGITIYEMA 196

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 72.4 bits (178), Expect = 8e-14
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 21/214 (9%)

Query: 474 FTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVN 532
           FT ++L +       E+GRGAFGTV K  ++  S   +AVK++   V +  +K    +++
Sbjct: 1   FTAEDLKD-----LGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD 54

Query: 533 GIGQTHH-KNLVRLLGYC-DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIA 590
            + ++     +V+  G    EG +  +  E M       + +        +  EI+  IA
Sbjct: 55  VVMRSSDCPYIVKFYGALFREG-DCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIA 113

Query: 591 ----RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG 646
               + L YL EE   +IIH D+KP NILLD   N ++ DFG+   L    + T  A  G
Sbjct: 114 VATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA--G 169

Query: 647 TKGYVAPEW---FRNMPITVKVDVYSYGVLLLEI 677
            + Y+APE           V+ DV+S G+ L E+
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 72.3 bits (177), Expect = 8e-14
 Identities = 69/217 (31%), Positives = 104/217 (47%), Gaps = 33/217 (15%)

Query: 478 ELVEVTRGFKEELGRGAFGTVYKG-FVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           ELVEV       +G G +G VYKG  V  G   Q+A  K+  V +D E+E K E+N + +
Sbjct: 19  ELVEV-------VGNGTYGQVYKGRHVKTG---QLAAIKVMDVTEDEEEEIKLEINMLKK 68

Query: 537 -THHKNLVRLLGY------CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE----I 585
            +HH+N+    G               LV EF   G++   L  ++K N  L+ +    I
Sbjct: 69  YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGN-ALKEDWIAYI 126

Query: 586 VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR 645
              I RGL +LH     ++IH DIK QN+LL +    ++ DFG+   L       NT I 
Sbjct: 127 CREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI- 182

Query: 646 GTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEI 677
           GT  ++APE        +     + D++S G+  +E+
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 71.9 bits (176), Expect = 9e-14
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 27/205 (13%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLN--RVFQDS-------EKEFKAEVNGIGQTHH 539
           LG+G FG V    V + ++ ++ A KKL+  R+ + S       EKE   +VN       
Sbjct: 1   LGKGGFGEVCA--VQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSP----- 53

Query: 540 KNLVRLLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYL 596
              +  L Y  E +  L LV   M+ G L   ++   +   ++   I     I  G+ +L
Sbjct: 54  --FIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHL 111

Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
           H      I++ D+KP+N+LLDD  N R+SD GL   + L    T T   GT GY+APE  
Sbjct: 112 HS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEIL 166

Query: 657 RNMPITVKVDVYSYGVLLLEIICLR 681
           +  P +  VD ++ G  + E++  R
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 64/237 (27%), Positives = 108/237 (45%), Gaps = 42/237 (17%)

Query: 486 FKEELGRGAFGTVY-------KGFVNMGSSDQ------VAVKKLNR-VFQDSEKEFKAEV 531
            KE+LG G FG V+         F+  G+ +       VAVK L   V + +  +F  E+
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 532 NGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL----------FGDSKPNWKL 581
             + +  + N++RLLG C       ++ E+M NG L  FL            ++ P+  +
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 582 RTEIVMG--IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLD-- 636
              + M   IA G+ YL        +H D+  +N L+ ++Y  +I+DFG+ + L + D  
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185

Query: 637 --QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR----TILTD 687
             Q      IR    ++A E       T   DV+++GV L E+  L +    ++L+D
Sbjct: 186 RIQGRAVLPIR----WMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 14/171 (8%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKK--LNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA G V+K   +  + + VA+KK  L R+      +   E+  +    H  +V+LL 
Sbjct: 8   IGEGAHGIVFKA-KDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----GLFYLHEECCTQ 603
               G   +LV E+M +  L+  L  + +P   L    V    R    G+ Y+H      
Sbjct: 67  VFPHGSGFVLVMEYMPSD-LSEVLRDEERP---LPEAQVKSYMRMLLKGVAYMHAN---G 119

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           I+H D+KP N+L+      +I+DFGL +L + ++    +    T+ Y APE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin

 Score = 67.3 bits (165), Expect = 1e-13
 Identities = 33/109 (30%), Positives = 49/109 (44%), Gaps = 18/109 (16%)

Query: 37  STEPWLSPSKDFALGFHQLD-------IWYASG----------DDPGPGGSKLRLTANGG 79
           S +  +S +  F LGF  L        I Y S           D+P      L L ++G 
Sbjct: 6   SGQTLVSGNSLFELGFFTLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGN 65

Query: 80  LVLEDPEAREIWKSEISTGEAAFG-VLYDTGNFLIVNTNSERLWQTFDH 127
           LVL D + R +W S  +     +  VL D GN +I +++   LWQ+FD+
Sbjct: 66  LVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114

Length = 114

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 64/209 (30%), Positives = 89/209 (42%), Gaps = 41/209 (19%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR---------VFQDSEKEFKAEVNGIGQTHHK 540
           LG+G FG V    V   +    A KKL +             +EK+   +VN        
Sbjct: 8   LGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR------ 60

Query: 541 NLVRLLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
             V  L Y  E ++ L LV   M+ G L   ++    P +           R +FY  E 
Sbjct: 61  -FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE--------ERAVFYAAEI 111

Query: 600 CC-------TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR---GTKG 649
            C        +I++ D+KP+NILLDDY + RISD GL       +      IR   GT G
Sbjct: 112 TCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAV-----EIPEGETIRGRVGTVG 166

Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEII 678
           Y+APE  +N   T   D +  G L+ E+I
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 71.7 bits (175), Expect = 1e-13
 Identities = 51/191 (26%), Positives = 100/191 (52%), Gaps = 6/191 (3%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E++G+GA GTV+   +++ +  +VA+K++N   Q  ++    E+  + +  + N+V  L 
Sbjct: 25  EKIGQGASGTVFTA-IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLD 83

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
               G    +V E+++ G+L   +        ++   +     + L +LH     Q+IH 
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI-AAVCRECLQALEFLH---ANQVIHR 139

Query: 608 DIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDV 667
           DIK  N+LL    + +++DFG    +T +QS  +T + GT  ++APE         KVD+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198

Query: 668 YSYGVLLLEII 678
           +S G++ +E++
Sbjct: 199 WSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 65/234 (27%), Positives = 93/234 (39%), Gaps = 49/234 (20%)

Query: 486 FKEELGRGAFGTVY---------------KGFVNMGSSDQVAVKKLNRVFQDSE--KEFK 528
           F E+LG G FG V+                   N  +   VAVK L R        ++F 
Sbjct: 9   FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAREDFL 67

Query: 529 AEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL-----FGDSKPNWKL-- 581
            EV  + +    N+ RLLG C       ++ E+M NG L  FL                 
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 582 --RTEIVMG--IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLD 636
              T + M   IA G+ YL        +H D+  +N L+   Y  +I+DFG+ + L + D
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 637 QSHTNTAIRGTKGYVAPEWFRNMP--------ITVKVDVYSYGVLLLEIICLRR 682
                  ++G     AP   R M          T K DV+++GV L EI+ L R
Sbjct: 185 YYR----VQGR----APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR 230

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 71.7 bits (175), Expect = 2e-13
 Identities = 53/191 (27%), Positives = 100/191 (52%), Gaps = 6/191 (3%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E++G+GA GTVY   +++ +  +VA++++N   Q  ++    E+  + +  + N+V  L 
Sbjct: 26  EKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
               G    +V E+++ G+L   +        ++   +     + L +LH     Q+IH 
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-AAVCRECLQALEFLHS---NQVIHR 140

Query: 608 DIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDV 667
           DIK  NILL    + +++DFG    +T +QS  +T + GT  ++APE         KVD+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199

Query: 668 YSYGVLLLEII 678
           +S G++ +E+I
Sbjct: 200 WSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 27/202 (13%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-----HKNLVR 544
           LG+G FG V    V   +    A KKL +      K+ K E   + +       +   V 
Sbjct: 8   LGKGGFGEVCACQVR-ATGKMYACKKLEK---KRIKKRKGESMALNEKQILEKVNSRFVV 63

Query: 545 LLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC-- 601
            L Y  E ++ L LV   M+ G L   ++   +  ++          R +FY  E CC  
Sbjct: 64  SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEE--------GRAVFYAAEICCGL 115

Query: 602 -----TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
                 +I++ D+KP+NILLDD+ + RISD GL   + + +  T     GT GY+APE  
Sbjct: 116 EDLHQERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVV 173

Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +N   T   D ++ G LL E+I
Sbjct: 174 KNERYTFSPDWWALGCLLYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin

 Score = 67.0 bits (164), Expect = 2e-13
 Identities = 32/120 (26%), Positives = 50/120 (41%), Gaps = 18/120 (15%)

Query: 23  NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD---IWYASG----------DDPGPGG 69
           +  +S GQ L ++ S    L     F L     D   I Y             D+P    
Sbjct: 1   SNPLSSGQTLVSSGS----LFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSS 56

Query: 70  SKLRLTANGGLVLEDPEAREIWKSEISTGEAAFG-VLYDTGNFLIVNTNSERLWQTFDHP 128
             L L ++G LV+ D     +W S  +     +  VL D GN ++ +++   LWQ+FD+P
Sbjct: 57  CTLTLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 63/219 (28%), Positives = 91/219 (41%), Gaps = 46/219 (21%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-----------H 538
           LG G +  VYK      +   VA+KK+         E K   +GI  T            
Sbjct: 8   LGEGTYAVVYKARDKE-TGRIVAIKKIK------LGERKEAKDGINFTALREIKLLQELK 60

Query: 539 HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIA-------- 590
           H N++ LL       N  LV+EFM           D +   K    IV+  A        
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFME---------TDLEKVIK-DKSIVLTPADIKSYMLM 110

Query: 591 --RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL-TLDQSHTNTAIRGT 647
             RGL YLH      I+H D+KP N+L+      +++DFGL +   + ++  T+  +  T
Sbjct: 111 TLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--T 165

Query: 648 KGYVAPE-WFRNMPITVKVDVYSYGVLLLEIICLRRTIL 685
           + Y APE  F      V VD++S G +  E + LR   L
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAE-LLLRVPFL 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 71.8 bits (177), Expect = 2e-13
 Identities = 58/216 (26%), Positives = 111/216 (51%), Gaps = 42/216 (19%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQ-THHKNL 542
            ++LG+GA+G V+K  ++  + + VA+KK+   F+   D+++ F+ E+  + +   H N+
Sbjct: 12  LQKLGKGAYGIVWKA-IDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNI 69

Query: 543 VRLLGY--CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGI---------AR 591
           V+LL     +  ++  LV+E+M           ++  +  +R  I+  +          +
Sbjct: 70  VKLLNVIKAENDKDIYLVFEYM-----------ETDLHAVIRANILEDVHKRYIMYQLLK 118

Query: 592 GLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGY 650
            L Y+H      +IH D+KP NILL+     +++DFGL + L+ L+++  N  +  T  Y
Sbjct: 119 ALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL--TD-Y 172

Query: 651 VAPEWFRNMPITVK-------VDVYSYGVLLLEIIC 679
           VA  W+R   I +        VD++S G +L E++ 
Sbjct: 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 71.2 bits (174), Expect = 3e-13
 Identities = 70/254 (27%), Positives = 115/254 (45%), Gaps = 22/254 (8%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK---AEVNGIGQTHHKNLVRL 545
           E+G G+FG VY    N  +++ VAVKK++   + + ++++    EV  + Q  H N +  
Sbjct: 28  EIGHGSFGAVYFA-TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLR-TEIVMGIARGLFYLHEECCTQI 604
            G   +     LV E+   G+ +  L    KP  ++    I  G  +GL YLH      +
Sbjct: 87  KGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---M 142

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM---PI 661
           IH DIK  NILL +    +++DFG     +  +S    +  GT  ++APE    M     
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFG-----SASKSSPANSFVGTPYWMAPEVILAMDEGQY 197

Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV 721
             KVDV+S G+  +E +  R+  L    ++      L  + +ND   +        F   
Sbjct: 198 DGKVDVWSLGITCIE-LAERKPPL----FNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF 252

Query: 722 AIWCIQEDPSHRPT 735
             +C+Q+ P  RP 
Sbjct: 253 VDYCLQKIPQERPA 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 71.6 bits (175), Expect = 3e-13
 Identities = 78/290 (26%), Positives = 118/290 (40%), Gaps = 43/290 (14%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQ------VAVKKLNRVFQD-------SEKEFKAEVNGIGQ 536
           LG G FG V          D+      VAVK L     D       SE E    +  IG+
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEM---MKMIGK 76

Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP----------------NWK 580
             HKN++ LLG C +     ++ E+ S G L  +L     P                 +K
Sbjct: 77  --HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 581 LRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSH 639
                   +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D   
Sbjct: 135 DLVSCAYQVARGMEYLASQKC---IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191

Query: 640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLG 699
             T  R    ++APE   +   T + DV+S+GVLL EI  L  +      Y       L 
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS-----PYPGIPVEELF 246

Query: 700 ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
            L++                M+   C    PS RPT +++ + L+ V+ V
Sbjct: 247 KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 61/199 (30%), Positives = 89/199 (44%), Gaps = 21/199 (10%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           LG+G FG V    V   +    A KKL   R+ +   +        I +  +   V  L 
Sbjct: 8   LGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 548 YCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC----- 601
           Y  E ++ L LV   M+ G L   ++    P +  +        R +FY  E CC     
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ--------RAIFYAAELCCGLEDL 118

Query: 602 --TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
              +I++ D+KP+NILLDD  + RISD GL   + + +  T     GT GY+APE   N 
Sbjct: 119 QRERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNE 176

Query: 660 PITVKVDVYSYGVLLLEII 678
             T   D +  G L+ E+I
Sbjct: 177 KYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 70.3 bits (173), Expect = 3e-13
 Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 25/201 (12%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG G FG V    V    +   A+K + +   V    ++   +E   + + +H  +V+L 
Sbjct: 1   LGVGGFGRVELVKVK-SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59

Query: 547 GYCDEGRNRLLVY---EFMSNGALASFL-----FGDSKPNWKLRTEIVMGIARGLFYLHE 598
                 +++  +Y   E+   G L + L     F +    +      +  +     YLH 
Sbjct: 60  RTF---KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF-----YIACVVLAFEYLHN 111

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
                II+ D+KP+N+LLD     ++ DFG  K L      T T   GT  YVAPE   N
Sbjct: 112 R---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKTWTFC-GTPEYVAPEIILN 166

Query: 659 MPITVKVDVYSYGVLLLEIIC 679
                 VD +S G+LL E++ 
Sbjct: 167 KGYDFSVDYWSLGILLYELLT 187

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 69/288 (23%), Positives = 125/288 (43%), Gaps = 41/288 (14%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQT-HHKNL 542
           F++ +G G FG V +  +        A  K+ + F  ++  ++F  E+  + +  HH N+
Sbjct: 6   FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFG----DSKPNW------------KLRTEIV 586
           + LLG C+      +  E+   G L  FL      ++ P +            +   +  
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 587 MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG 646
             +A G+ YL E+   Q IH D+  +N+L+ +   ++I+DFGL +            ++ 
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVKK 175

Query: 647 TKGYVAPEWFR----NMPI-TVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQERTLGA 700
           T G +   W      N  + T K DV+S+GVLL EI+ L  T        + Y++   G 
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235

Query: 701 LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            +E      D++  L R       C ++ P  RP   +++  L  ++E
Sbjct: 236 RMEKPRNCDDEVYELMR------QCWRDRPYERPPFAQISVQLSRMLE 277

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 30/203 (14%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKA----EVNGIGQTHHKNLV 543
           +G G++G V K   +  +   VA+KK    F +SE  K  K     E+  + Q  H+NLV
Sbjct: 9   VGEGSYGMVMK-CKHKETGQIVAIKK----FLESEDDKMVKKIAMREIRMLKQLRHENLV 63

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
            L+      +   LV+EF+ +  L       +  +     + +  I RG+ + H      
Sbjct: 64  NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---N 120

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           IIH DIKP+NIL+      ++ DFG  + L    + +T+        YVA  W+R   + 
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD--------YVATRWYRAPELL 172

Query: 663 VK-------VDVYSYGVLLLEII 678
           V        VD+++ G L+ E++
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEML 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 59/199 (29%), Positives = 88/199 (44%), Gaps = 21/199 (10%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           LG+G FG V    V   +    A K+L   R+ +   +        I +  +   V  L 
Sbjct: 8   LGKGGFGEVCACQVR-ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66

Query: 548 YCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC----- 601
           Y  E ++ L LV   M+ G L   ++    P ++          R LFY  E  C     
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE--------RALFYAAEILCGLEDL 118

Query: 602 --TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
                ++ D+KP+NILLDDY + RISD GL   + + +  +     GT GY+APE   N 
Sbjct: 119 HRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQ 176

Query: 660 PITVKVDVYSYGVLLLEII 678
             T+  D +  G L+ E+I
Sbjct: 177 RYTLSPDYWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.7 bits (170), Expect = 7e-13
 Identities = 75/287 (26%), Positives = 120/287 (41%), Gaps = 41/287 (14%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQ------VAVKKLNRVFQDSEKEFKAEVNG------IGQT 537
           LG G FG V          D+      VAVK L      +EK+    V+       IG+ 
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGK- 79

Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI------------ 585
            HKN++ LLG C +     ++ E+ S G L  +L     P  +   +I            
Sbjct: 80  -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 586 ----VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHT 640
                  +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D    
Sbjct: 139 LVSCTYQVARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGA 700
            T  R    ++APE   +   T + DV+S+GVL+ EI  L  +      Y       L  
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS-----PYPGIPVEELFK 250

Query: 701 LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           L++                M+   C    PSHRPT +++ + L+ ++
Sbjct: 251 LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 8e-13
 Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 45/225 (20%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           +GRGAFG V+   V    + QV A+K L +   + ++     +AE + +       +V+L
Sbjct: 9   IGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFL--FGDSKPNWK--LRTEIVMGIARGLFYLHEECC 601
                +  +  LV E+M  G L + L                E+V+ +      +H+   
Sbjct: 67  YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD----SVHKLGF 122

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEK-------------LLTLDQSHTNTAIR--- 645
              IH DIKP NIL+D   + +++DFGL K                      N  +R   
Sbjct: 123 ---IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179

Query: 646 ------------GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
                       GT  Y+APE  R  P  ++ D +S GV+L E++
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 70.0 bits (171), Expect = 8e-13
 Identities = 61/199 (30%), Positives = 93/199 (46%), Gaps = 11/199 (5%)

Query: 485 GFKEELGRGAFGTVYKGFVNMGSSDQV-AVKKLNR--VFQDSEKEFK-AEVNGIGQTHHK 540
            F   LG+G+FG V         +D++ A+K L +  V QD + E    E   +      
Sbjct: 3   NFLMVLGKGSFGKVM--LAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 541 NLVRLLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
             +  L  C +  +RL  V E+++ G L   +    K            I+ GLF+LH  
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               II+ D+K  N++LD   + +I+DFG+ K   +D   T T   GT  Y+APE     
Sbjct: 121 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPEIIAYQ 176

Query: 660 PITVKVDVYSYGVLLLEII 678
           P    VD ++YGVLL E++
Sbjct: 177 PYGKSVDWWAYGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 69.3 bits (169), Expect = 8e-13
 Identities = 75/286 (26%), Positives = 124/286 (43%), Gaps = 42/286 (14%)

Query: 486 FKEELGRGAFGTVYKGFV---NMGSSDQ-VAVKKL-NRVFQDSEKEFKAEVNGIGQTHHK 540
           F EELG   FG VYKG +     G   Q VA+K L ++      +EFK E     +  H 
Sbjct: 9   FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHP 68

Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGALASFLF--------GDSKPNWKLRT--------E 584
           N+V LLG   + +   +++ + S+  L  FL         G +  +  +++         
Sbjct: 69  NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128

Query: 585 IVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL-EKLLTLD----QSH 639
           IV  IA G+ +L       ++H D+  +N+L+ D  N +ISD GL  ++   D      +
Sbjct: 129 IVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185

Query: 640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLG 699
           +   IR    +++PE       ++  D++SYGV+L E+            Y  Y  + + 
Sbjct: 186 SLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ-----PYCGYSNQDVI 236

Query: 700 ALVEND--LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQML 743
            ++ N   L   DD       +M+  W   E PS RP  + +   L
Sbjct: 237 EMIRNRQVLPCPDDCPAWVYTLMLECW--NEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 69.7 bits (171), Expect = 9e-13
 Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 23/201 (11%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR--VFQD-------SEKEFKAEVNGIGQTHH 539
           LG+G+FG V      +  +D++ AVK L +  + QD       +EK   A         H
Sbjct: 3   LGKGSFGKVL--LAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KH 55

Query: 540 KNLVRLLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
             L +L   C + ++RL  V E+++ G L   +    + +          I  GL +LHE
Sbjct: 56  PFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE 114

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
                II+ D+K  N+LLD   + +I+DFG+ K   L    T+T   GT  Y+APE    
Sbjct: 115 R---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEILSY 170

Query: 659 MPITVKVDVYSYGVLLLEIIC 679
            P    VD ++ GVLL E++ 
Sbjct: 171 QPYGPAVDWWALGVLLYEMLA 191

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 69.3 bits (169), Expect = 9e-13
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ-THHKNLVRLL 546
           E +G+G +G VYK   N       AVK L+ +  D ++E +AE N +    +H N+V+  
Sbjct: 28  ETIGKGTYGKVYK-VTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFY 85

Query: 547 GY---CDE--GRNRLLVYEFMSNGALASFLFGDSKPNWKLR----TEIVMGIARGLFYLH 597
           G     D+  G    LV E  + G++   + G      +L     + I+ G   GL +LH
Sbjct: 86  GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145

Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
                +IIH D+K  NILL      ++ DFG+   LT  +   NT++ GT  ++APE   
Sbjct: 146 N---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 201

Query: 658 -----NMPITVKVDVYSYGVLLLEI 677
                +     + DV+S G+  +E+
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 35/209 (16%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 25  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 84  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 138

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN- 658
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 139 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 186

Query: 659 ------MPITVKVDVYSYGVLLLEIICLR 681
                 M     VD++S G ++ E++  R
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 53/191 (27%), Positives = 95/191 (49%), Gaps = 8/191 (4%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           ++G G+ G V        +  QVAVKK++ R  Q  E  F  EV  +    H N+V +  
Sbjct: 26  KIGEGSTGIVCIATD-KSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNIVEMYS 83

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
               G    +V EF+  GAL   +   ++ N +    + + + + L +LH +    +IH 
Sbjct: 84  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHR 139

Query: 608 DIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDV 667
           DIK  +ILL      ++SDFG    ++ +     + + GT  ++APE    +P   +VD+
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEVDI 198

Query: 668 YSYGVLLLEII 678
           +S G++++E++
Sbjct: 199 WSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 74/294 (25%), Positives = 121/294 (41%), Gaps = 55/294 (18%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---------------I 534
           LG G FG V      M  +  +  +K NRV + + K  K++                  I
Sbjct: 26  LGEGCFGQVV-----MAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 80

Query: 535 GQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP----------------N 578
           G+  HKN++ LLG C +     ++ E+ S G L  +L     P                +
Sbjct: 81  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLS 138

Query: 579 WKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS 638
           +K        +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL +    D  
Sbjct: 139 FKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLAR----DIH 191

Query: 639 HTNTAIRGTKG-----YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCY 693
           H +   + T G     ++APE   +   T + DV+S+GVLL EI  L  +      Y   
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----PYPGV 246

Query: 694 QERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
               L  L++                M+   C    PS RPT +++ + L+ ++
Sbjct: 247 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 44/149 (29%), Positives = 79/149 (53%), Gaps = 15/149 (10%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---KEFKAEVNGIGQTHHKNLVR 544
           E++G G +G VYK   +  + + VA+KK+ R+  + E        E++ + + +H N+VR
Sbjct: 5   EKIGEGTYGVVYKA-RDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVR 62

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEEC 600
           LL          LV+EF+ +  L  ++  DS P   L   ++      + +G+ Y H   
Sbjct: 63  LLDVVHSENKLYLVFEFL-DLDLKKYM--DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH- 118

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGL 629
             +++H D+KPQN+L+D     +++DFGL
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGL 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 66/270 (24%), Positives = 111/270 (41%), Gaps = 30/270 (11%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQV-AVKKLNRVFQDSE-KEFKAEVNGIGQTHH-KNLVR 544
           EELGRGA+G V K  +    +  + AVK++       E K    +++   ++      V 
Sbjct: 7   EELGRGAYGVVDK--MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVT 64

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE----IVMGIARGLFYLHEEC 600
             G      +  +  E M   +L  F          +  +    I + I + L YLH + 
Sbjct: 65  FYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK- 122

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              +IH D+KP N+L++     ++ DFG+   L    + T  A  G K Y+APE  R  P
Sbjct: 123 -LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA--GCKPYMAPE--RINP 177

Query: 661 IT------VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDLEAMDDM 712
                   VK DV+S G+ ++E+   R      + YD ++   + L  +VE     +   
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGR------FPYDSWKTPFQQLKQVVEEPSPQLPAE 231

Query: 713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQM 742
                F      C++++   RP    + Q 
Sbjct: 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQH 261

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 51/190 (26%), Positives = 93/190 (48%), Gaps = 6/190 (3%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           ++G G+ G V    V   S   VAVKK++   Q   +    EV  +    H+N+V +   
Sbjct: 27  KIGEGSTGIVCIATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCD 608
              G    +V EF+  GAL   +   ++ N +    + + + + L  LH +    +IH D
Sbjct: 86  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRD 141

Query: 609 IKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVY 668
           IK  +ILL      ++SDFG    ++ +     + + GT  ++APE    +P   +VD++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDIW 200

Query: 669 SYGVLLLEII 678
           S G++++E++
Sbjct: 201 SLGIMVIEMV 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 22/207 (10%)

Query: 486 FKEELGRGAFGTVYKGFVNMGS-SDQVAVKKLNRVFQDSEKEFKA---EVNGIGQTHHKN 541
           F   +G+G++G V    V   +   Q  +KKLN +   S +E KA   E   + Q  H N
Sbjct: 4   FVRVVGKGSYGEV--SLVRHRTDGKQYVIKKLN-LRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 542 LVRLLGYCD--EGRNRLL--VYEFMSNGALASFLFGDSKPNWKLRTEIV---MGIARGLF 594
           +V    Y +  EG + LL  V  F   G L   L  + K       ++V   + IA  L 
Sbjct: 61  IV---AYRESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQ 116

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           YLHE+    I+H D+K QN+ L      ++ D G+ ++L       +T I GT  Y++PE
Sbjct: 117 YLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPE 172

Query: 655 WFRNMPITVKVDVYSYGVLLLEIICLR 681
            F N P   K DV++ G  + E+  L+
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 68.5 bits (168), Expect = 3e-12
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 24/212 (11%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRL 545
           E +G GA+G V    ++  S  +VA+KK+   F      K    E+  +    H N++ +
Sbjct: 11  ENIGSGAYGVVCSA-IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAI 69

Query: 546 LGYC----DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIV---MG-IARGLFYLH 597
                    + ++  +V + M +  L   +  D      L  E +   +  + RGL Y+H
Sbjct: 70  RDILRPPGADFKDVYVVMDLMESD-LHHIIHSDQP----LTEEHIRYFLYQLLRGLKYIH 124

Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT---LDQSHTNTAIRGTKGYVAPE 654
                 +IH D+KP N+L+++    RI DFG+ + L+    +  +  T    T+ Y APE
Sbjct: 125 SAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181

Query: 655 WFRNMP-ITVKVDVYSYGVLLLEIICLRRTIL 685
              ++P  T  +D++S G +  E++  RR + 
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEML-GRRQLF 212

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 19/199 (9%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG- 547
           ELG GAFG VYK   N  +    A K +    ++  +++  E+  +   +H  +V+LLG 
Sbjct: 19  ELGDGAFGKVYKA-KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77

Query: 548 YCDEGRNRLLVYEFMSNGALASFLF----GDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +  +G+  +++ EF   GA+ + +     G ++P  ++   I   +   L YLH     +
Sbjct: 78  FYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV---ICRQMLEALQYLHSM---K 130

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAP-----EWFRN 658
           IIH D+K  N+LL    + +++DFG+           ++ I GT  ++AP     E  ++
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKD 189

Query: 659 MPITVKVDVYSYGVLLLEI 677
            P   K D++S G+ L+E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 26/205 (12%)

Query: 490 LGRGAFGTVY--KGFVNMGSSDQVAVKKLN-RVFQDSEKEF-KAEVNGIGQTHHKNLVRL 545
           +G G+FG +Y  K   +   S+   +K+++       EKE  K EV  + +  H N+V  
Sbjct: 8   IGEGSFGKIYLAKAKSD---SEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64

Query: 546 LGYCDEGRNRLLVYEFMSNGALAS-------FLFG-DSKPNWKLRTEIVMGIARGLFYLH 597
                E     +V E+   G L          LF  D   +W ++      I+ GL ++H
Sbjct: 65  FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLGLKHIH 118

Query: 598 EECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
           +    +I+H DIK QNI L  +   A++ DFG+ + L        T + GT  Y++PE  
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEIC 174

Query: 657 RNMPITVKVDVYSYGVLLLEIICLR 681
           +N P   K D++S G +L E+  L+
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 62/204 (30%), Positives = 109/204 (53%), Gaps = 26/204 (12%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYKG  N  +   VA+KK+ R+  +SE+E        E++ + +  H N+
Sbjct: 6   EKIGEGTYGVVYKG-RNKKTGQIVAMKKI-RL--ESEEEGVPSTAIREISLLKELQHPNI 61

Query: 543 VRLLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWK-LRTEIVMG----IARGLFYL 596
           V L     +  +RL L++EF+S   L  +L  DS P  + +  E+V      I +G+ + 
Sbjct: 62  VCLQDVLMQ-ESRLYLIFEFLSMD-LKKYL--DSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEW 655
           H     +++H D+KPQN+L+D+    +++DFGL +   +  + +T+  +  T  Y APE 
Sbjct: 118 HSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEV 172

Query: 656 FRNMP-ITVKVDVYSYGVLLLEII 678
               P  +  VD++S G +  E+ 
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 54/203 (26%), Positives = 105/203 (51%), Gaps = 19/203 (9%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---KEFKAEVNGIGQTHHKNLVR 544
           E++G G +G VYK   N  + + VA+KK+ R+  ++E        E++ + + +H N+V+
Sbjct: 6   EKIGEGTYGVVYKA-RNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVK 63

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEEC 600
           LL          LV+EF+ +  L  F+  D+ P   +   ++      + +GL + H   
Sbjct: 64  LLDVIHTENKLYLVFEFL-HQDLKKFM--DASPLSGIPLPLIKSYLFQLLQGLAFCHSH- 119

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFRNM 659
             +++H D+KPQN+L++     +++DFGL +   +  +++T+  +  T  Y APE     
Sbjct: 120 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGC 175

Query: 660 PI-TVKVDVYSYGVLLLEIICLR 681
              +  VD++S G +  E++  R
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 39/213 (18%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-FKA----EVNGIGQTHHKNLV 543
           ++G G +G VYK   +  + + VA+KK   V  D+EKE F      E+  + Q +H+N+V
Sbjct: 14  QIGEGTYGQVYKA-RDKDTGELVALKK---VRLDNEKEGFPITAIREIKILRQLNHRNIV 69

Query: 544 RL----------LGYCDEGRNRLLVYEFMSN---GALASFLFGDSKPNWKLRTEIVMGIA 590
            L          L +  +     LV+E+M +   G L S L   S+ + K     +  + 
Sbjct: 70  NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK---SFMKQLL 126

Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS--HTNTAIRGTK 648
            GL Y H+      +H DIK  NILL++    +++DFGL +L   ++S  +TN  I  T 
Sbjct: 127 EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI--TL 181

Query: 649 GYVAPEWF----RNMPITVKVDVYSYGVLLLEI 677
            Y  PE      R  P    +DV+S G +L E+
Sbjct: 182 WYRPPELLLGEERYGP---AIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 12/199 (6%)

Query: 489 ELGRGAFGTVYKGFVNM---GSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNLVR 544
           +LG G FG V     +     + +QVAVK L      +   + K E+  +   +H+N+V+
Sbjct: 11  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 545 LLGYCDE--GRNRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECC 601
             G C E  G    L+ EF+ +G+L  +L  + +K N K + +  + I +G+ YL     
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR-- 128

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA--IRGTKGYVAPEWFRNM 659
            Q +H D+  +N+L++  +  +I DFGL K +  D+ +      +     + APE     
Sbjct: 129 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187

Query: 660 PITVKVDVYSYGVLLLEII 678
              +  DV+S+GV L E++
Sbjct: 188 KFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 30/206 (14%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---KEFKAEVNGIGQTHHKNLVR 544
           E++G G +G VYK   +  +++ +A+KK+ R+ Q+ E        E++ + +  H N+VR
Sbjct: 8   EKIGEGTYGVVYKA-RDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVR 65

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEEC 600
           L       +   LV+E++    L      DS P++     ++      I RG+ Y H   
Sbjct: 66  LQDVVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH- 121

Query: 601 CTQIIHCDIKPQNILLDDYYNA-RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
             +++H D+KPQN+L+D   NA +++DFGL +   +        +R     V   W+R  
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-------PVRTFTHEVVTLWYRAP 172

Query: 660 PI-------TVKVDVYSYGVLLLEII 678
            I       +  VD++S G +  E++
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMV 198

Length = 294

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 68.2 bits (167), Expect = 4e-12
 Identities = 66/218 (30%), Positives = 94/218 (43%), Gaps = 43/218 (19%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLL- 546
           +G GAFG V+    +     +VA+KK+  VFQ+  S K    E+  +    H N++  L 
Sbjct: 8   IGYGAFGVVW-SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66

Query: 547 ----GYCDEGRNRLLVYEFM---------SNGALAS-----FLFGDSKPNWKLRTEIVMG 588
                + D      +V E M         S   L+S     FL+                
Sbjct: 67  ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQ--------------- 111

Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK 648
           I RGL YLH      I+H DIKP N+L++     +I DFGL ++   D+S   T    T+
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 649 GYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLRRTIL 685
            Y APE        T  VD++S G +  E+  L R IL
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAEL--LGRRIL 204

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 66.9 bits (163), Expect = 5e-12
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 23/203 (11%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-------AEVNGIGQTHHKN 541
           E+G GA+GTVYK   +  S   VA+K + RV Q +E           A +  +    H N
Sbjct: 7   EIGVGAYGTVYKA-RDPHSGHFVALKSV-RV-QTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 542 LVRLLGYCDEGRNR-----LLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLF 594
           +VRL+  C   R        LV+E +    L ++L     P     T  +++    RGL 
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFEHVDQD-LRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           +LH  C   I+H D+KP+NIL+      +++DFGL ++ +   + T   +  T  Y APE
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPE 177

Query: 655 WFRNMPITVKVDVYSYGVLLLEI 677
                     VD++S G +  E+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 67.6 bits (165), Expect = 5e-12
 Identities = 60/196 (30%), Positives = 96/196 (48%), Gaps = 13/196 (6%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR--VFQDSEKEFK-AEVNGIGQTHHKNLVRL 545
           LG+G+FG V      +  S ++ AVK L +  + QD + E    E   +    +   +  
Sbjct: 3   LGKGSFGKVM--LARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 546 LGYCDEGRNRLL-VYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEECCTQ 603
           L  C +  +RL  V EF++ G L  F    S+   + R       I   L +LH++    
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLM-FHIQKSRRFDEARARFYAAEITSALMFLHDK---G 116

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
           II+ D+K  N+LLD   + +++DFG+ K    +   T+T   GT  Y+APE  + M    
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYGP 175

Query: 664 KVDVYSYGVLLLEIIC 679
            VD ++ GVLL E++C
Sbjct: 176 SVDWWAMGVLLYEMLC 191

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 67.0 bits (164), Expect = 5e-12
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 35/208 (16%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHH-KNLVRL 545
            E+G G  G VYK      +   +AVK++ R     E K    +++ + ++H    +V+ 
Sbjct: 21  GEIGSGTCGQVYKMRF-KKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKC 79

Query: 546 LGYCDEGRNRLLVYEFMS----------NGALASFLFGDSKPNWKLRTEIVMGIARGLFY 595
            GY     +  +  E MS           G +   + G          ++ + I + L Y
Sbjct: 80  YGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG----------KMTVAIVKALHY 129

Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           L E+    +IH D+KP NILLD   N ++ DFG+   L   ++ T +A  G   Y+APE 
Sbjct: 130 LKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCAAYMAPE- 184

Query: 656 FRNMPIT------VKVDVYSYGVLLLEI 677
            R  P        ++ DV+S G+ L+E+
Sbjct: 185 -RIDPPDPNPKYDIRADVWSLGISLVEL 211

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 25/199 (12%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLN-----RVFQDSEKEFKAEVNGIGQTHHKNLVR 544
           +G G FG V+     +      A+K +      R+ Q  E+    E   + +  H  ++R
Sbjct: 9   VGTGTFGRVHLVRDRISEH-YYALKVMAIPEVIRLKQ--EQHVHNEKRVLKEVSHPFIIR 65

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFL-----FGDSKPNWKLRTEIVMGIARGLFYLHEE 599
           L     + R   ++ E++  G L S+L     F +S   +   +EIV  +     YLH +
Sbjct: 66  LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALE----YLHSK 120

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
              +I++ D+KP+NILLD   + +++DFG  K L  D++ T   + GT  Y+APE  ++ 
Sbjct: 121 ---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-DRTWT---LCGTPEYLAPEVIQSK 173

Query: 660 PITVKVDVYSYGVLLLEII 678
                VD ++ G+L+ E++
Sbjct: 174 GHNKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 66.8 bits (163), Expect = 6e-12
 Identities = 73/267 (27%), Positives = 123/267 (46%), Gaps = 33/267 (12%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNLVR 544
             +ELG+G +G+VYK   +  +   +A+K++     +S+  +   E++ + +     +V 
Sbjct: 5   VLDELGKGNYGSVYKVL-HRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVD 63

Query: 545 LLG-YCDEGRNRLLVY---EFMSNGALASFLFGDS----KPNWKLRTEIVMGIARGLFYL 596
             G +  EG     VY   E+M  G+L     G       P   LR  I   + +GL +L
Sbjct: 64  FYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKGLKFL 118

Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
            EE    IIH D+KP N+L++     ++ DFG+   L    + TN    G + Y+APE  
Sbjct: 119 KEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPERI 173

Query: 657 R------NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMD 710
           +      N   TV+ DV+S G+ +LE+   R     +   + + +  L A+V+ D   + 
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ--LSAIVDGDPPTLP 231

Query: 711 D--MTVLQRFVMVAIWCIQEDPSHRPT 735
                  Q FV     C+ + P+ RPT
Sbjct: 232 SGYSDDAQDFVAK---CLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 19/196 (9%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQTHHKNLVRLL 546
           +LG G  G+V K  V    +  V  KK+  +   S   K+   E+  + +     +V   
Sbjct: 12  DLGAGNGGSVSK--VKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFY 69

Query: 547 G-YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIA----RGLFYLHEECC 601
           G + +E  N  +  EFM  G+L        K    +  EI+  IA     GL YL+    
Sbjct: 70  GAFLNEN-NICMCMEFMDCGSLD----RIYKKGGPIPVEILGKIAVAVVEGLTYLYNV-- 122

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
            +I+H DIKP NIL++     ++ DFG+   L    S  +T + GT  Y++PE  +    
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI--NSIADTFV-GTSTYMSPERIQGGKY 179

Query: 662 TVKVDVYSYGVLLLEI 677
           TVK DV+S G+ ++E+
Sbjct: 180 TVKSDVWSLGISIIEL 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 66.4 bits (163), Expect = 6e-12
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 30/208 (14%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE-----KEFKA--EVNGIGQTHHK 540
           ++LG G FG+VY    N  + + VA+KK+ + F   E     +E K+  ++N      H 
Sbjct: 5   KQLGDGTFGSVYLA-RNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-----EHP 58

Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP--NWKLRTEIVMGIARGLFYLHE 598
           N+V+L     E      V+E+M             KP     +R+ I+  I +GL ++H+
Sbjct: 59  NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRS-IIYQILQGLAHIHK 117

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW--- 655
                  H D+KP+N+L+      +I+DFGL +   +      T    T+ Y APE    
Sbjct: 118 ---HGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLR 172

Query: 656 --FRNMPITVKVDVYSYGVLLLEIICLR 681
               + P    VD+++ G ++ E+  LR
Sbjct: 173 STSYSSP----VDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 67.3 bits (164), Expect = 6e-12
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 41/219 (18%)

Query: 476 YKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS--EKEFKAEVNG 533
           Y++L +V        G GA+GTV    ++  +  +VA+KKL R FQ     K    E+  
Sbjct: 17  YRDLKQV--------GSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67

Query: 534 IGQTHHKNLVRLLGY--CDEGRNRL----LVYEFMSNGALASFLFGDSKPNWKLRTE--- 584
           +    H+N++ LL     D   +R     LV  FM          G    + KL  +   
Sbjct: 68  LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTD------LGKLMKHEKLSEDRIQ 121

Query: 585 -IVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA 643
            +V  + +GL Y+H      IIH D+KP N+ +++    +I DFGL +        T++ 
Sbjct: 122 FLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSE 171

Query: 644 IRG---TKGYVAPEWFRN-MPITVKVDVYSYGVLLLEII 678
           + G   T+ Y APE   N M  T  VD++S G ++ E++
Sbjct: 172 MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 15/199 (7%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEKEFKA---EVNGIGQTHHKNLVR 544
           LGRGAFG VY  + +  +  ++AVK++  +   Q++ KE  A   E+  +    H  +V+
Sbjct: 10  LGRGAFGEVYLCY-DADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 545 LLGYC--DEGRNRLLVY-EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
             G C  D    +L ++ E+M  G++   L         +       I +G+ YLH    
Sbjct: 69  YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS--- 124

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTN-TAIRGTKGYVAPEWFRNM 659
             I+H DIK  NIL D   N ++ DFG  K + T+  S T   ++ GT  +++PE     
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184

Query: 660 PITVKVDVYSYGVLLLEII 678
               K DV+S    ++E++
Sbjct: 185 GYGRKADVWSVACTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 66.2 bits (162), Expect = 9e-12
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 38/210 (18%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE------KEFKAEVNGIGQTHHKN 541
            ++G G++G V+K   N  +   VA+KK    F +SE      K    E+  + Q  H N
Sbjct: 7   SKIGEGSYGVVFK-CRNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQLKHPN 61

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGI----ARGLFYLH 597
           LV L+      R   LV+E+  +  L      +  P   +   ++  I     + + + H
Sbjct: 62  LVNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPR-GVPEHLIKKIIWQTLQAVNFCH 117

Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGYVAPEWF 656
           +  C   IH D+KP+NIL+      ++ DFG  ++LT     +T+        YVA  W+
Sbjct: 118 KHNC---IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD--------YVATRWY 166

Query: 657 RNMPITV-------KVDVYSYGVLLLEIIC 679
           R   + V        VDV++ G +  E++ 
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 21/205 (10%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGI-GQTHHKNLVRLL 546
           E +G+G +G V+K  +N  +  + AVK L+ +  D ++E +AE N +   + H N+V+  
Sbjct: 24  ETIGKGTYGKVFK-VLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFY 81

Query: 547 GY-----CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----GLFYLH 597
           G         G    LV E  + G++   + G  K   ++   I+  I      GL +LH
Sbjct: 82  GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141

Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
                + IH D+K  NILL      ++ DFG+   LT  +   NT++ GT  ++APE   
Sbjct: 142 V---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 197

Query: 658 -----NMPITVKVDVYSYGVLLLEI 677
                +     + DV+S G+  +E+
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 34/203 (16%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS--EKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GAFG V      + +   VA+KK+ + F      K    E+  +    H+N++ L  
Sbjct: 18  VGMGAFGLVCSARDQL-TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISL-- 74

Query: 548 YCD----EGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM----GIARGLFYLHEE 599
             D       +   V E +    L   L   S+P   L  + +      I RGL Y+H  
Sbjct: 75  -SDIFISPLEDIYFVTELLGTD-LHRLL--TSRP---LEKQFIQYFLYQILRGLKYVHS- 126

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE----W 655
               ++H D+KP NIL+++  + +I DFGL ++    Q    T    T+ Y APE    W
Sbjct: 127 --AGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTW 180

Query: 656 FRNMPITVKVDVYSYGVLLLEII 678
            +     V+VD++S G +  E++
Sbjct: 181 QK---YDVEVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 41/284 (14%)

Query: 490 LGRGAFGTVYKGFVNM-GSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQT-HHKNLVRLL 546
           +G G FG V K  +   G     A+K++     +D  ++F  E+  + +  HH N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFG----DSKPNW------------KLRTEIVMGIA 590
           G C+      L  E+  +G L  FL      ++ P +            +        +A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGY 650
           RG+ YL ++   Q IH D+  +NIL+ + Y A+I+DFGL +            ++ T G 
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGR 172

Query: 651 VAPEWFR----NMPI-TVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQERTLGALVEN 704
           +   W      N  + T   DV+SYGVLL EI+ L  T        + Y++   G  +E 
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 232

Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            L   D++  L R       C +E P  RP+  ++   L  ++E
Sbjct: 233 PLNCDDEVYDLMR------QCWREKPYERPSFAQILVSLNRMLE 270

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 72/263 (27%), Positives = 118/263 (44%), Gaps = 28/263 (10%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK---AEVNGIGQTHHKNLVRL 545
           E+G G+FG VY    ++ +++ VA+KK++   + S ++++    EV  + Q  H N +  
Sbjct: 22  EIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLR-TEIVMGIARGLFYLHEECCTQI 604
            G         LV E+   G+ +  L    KP  ++    I  G  +GL YLH       
Sbjct: 81  KGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---R 136

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM---PI 661
           IH DIK  NILL +    +++DFG   L+    S  N+ + GT  ++APE    M     
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLV----SPANSFV-GTPYWMAPEVILAMDEGQY 191

Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL---VENDLEAMDDMTVLQRF 718
             KVDV+S G+  +E +  R+  L       +    + AL    +ND   +        F
Sbjct: 192 DGKVDVWSLGITCIE-LAERKPPL-------FNMNAMSALYHIAQNDSPTLSSNDWSDYF 243

Query: 719 VMVAIWCIQEDPSHRPTMRRVTQ 741
                 C+Q+ P  RP+   + +
Sbjct: 244 RNFVDSCLQKIPQDRPSSEELLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 13/195 (6%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKE---FKAEVNGIGQTHHKNLVR 544
           LG+G+FG V       G+ +  A+K L +  + QD + E    +  V  +        + 
Sbjct: 8   LGKGSFGKVMLA-ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP--FLT 64

Query: 545 LLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
            L  C +  +RL  V E+++ G L   +    K            IA GLF+LH +    
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---G 121

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
           II+ D+K  N++LD   + +I+DFG+ K        T T   GT  Y+APE     P   
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAPEIIAYQPYGK 180

Query: 664 KVDVYSYGVLLLEII 678
            VD +++GVLL E++
Sbjct: 181 SVDWWAFGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 67.5 bits (165), Expect = 2e-11
 Identities = 59/224 (26%), Positives = 92/224 (41%), Gaps = 37/224 (16%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---KEFKAEVNGIGQTHHKNLVRLL 546
           +G+G  G VY  + +   S +VA+KK+     ++    K F  E        H  +V + 
Sbjct: 10  IGKGGMGEVYLAY-DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWK---LRTEIVMGIARGLFY--LHEECC 601
             C +G        ++    L S L    K  W+   L  E+    + G F    H+ C 
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLL----KSVWQKESLSKELAEKTSVGAFLSIFHKICA 124

Query: 602 T-------QIIHCDIKPQNILLDDYYNARISDFGL--------EKLLTLDQSHTNTA--- 643
           T        ++H D+KP NILL  +    I D+G         E LL +D    N     
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184

Query: 644 ------IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR 681
                 I GT  Y+APE    +P +   D+Y+ GV+L +++ L 
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS 228

Length = 932

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 24/203 (11%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKK---LNRVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           +G G+FG      V   +SDQ    K   L +     E   K  V  + +  H N+V   
Sbjct: 8   VGEGSFGRAL--LVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL-LAKMKHPNIVAFK 64

Query: 547 GYCDEGRNRLLVYEFMSNGAL--------ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
              +   +  +V E+   G L              D+   W    ++ +G+     ++HE
Sbjct: 65  ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW--FVQMCLGVQ----HIHE 118

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
           +   +++H DIK +NI L      ++ DFG  +LLT   ++  T + GT  YV PE + N
Sbjct: 119 K---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWEN 174

Query: 659 MPITVKVDVYSYGVLLLEIICLR 681
           MP   K D++S G +L E+  L+
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 23/200 (11%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR---VFQDSEKEFKAEVNG-IGQTHHKNLVR 544
           +G+G+FG V        +  +  AVK L +   + +  +K   AE N  +    H  LV 
Sbjct: 3   IGKGSFGKVL--LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 545 LLGYCDEGRNRL-LVYEFMSNGALASFL-----FGDSKPNWKLRTEIVMGIARGLFYLHE 598
           L  Y  +  ++L  V ++++ G L   L     F + +  +         IA  L YLH 
Sbjct: 61  L-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-----YAAEIASALGYLHS 114

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
                II+ D+KP+NILLD   +  ++DFGL K   ++ S T +   GT  Y+APE  R 
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRK 170

Query: 659 MPITVKVDVYSYGVLLLEII 678
            P    VD +  G +L E++
Sbjct: 171 QPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 49/229 (21%)

Query: 472 RCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA-- 529
           RC +  E  ++ R     +G G +G VY+   +  S + VA+KK   V  D+E++     
Sbjct: 2   RCRSVTEFEKLNR-----IGEGTYGIVYRA-RDTTSGEIVALKK---VRMDNERDGIPIS 52

Query: 530 ---EVNGIGQTHHKNLVRLL---------------GYCDEGRNRLLVYEFMSNGALASFL 571
              E+  +    H N+V L                 YC++    LL  + M       F 
Sbjct: 53  SLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMP----TPF- 105

Query: 572 FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK 631
              S+   K    +++ + RGL YLHE     IIH D+K  N+LL D    +I+DFGL +
Sbjct: 106 ---SESQVKC---LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156

Query: 632 LLTL-DQSHTNTAIRGTKGYVAPE-WFRNMPITVKVDVYSYGVLLLEII 678
              L  +  T   +  T  Y APE        T  +D+++ G +L E++
Sbjct: 157 TYGLPAKPMTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELL 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 32/204 (15%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---KEFKAEVNGIGQTHHKNLVRLL 546
           +G GA+G+V    ++  + ++VA+KKL+R FQ SE   K    E+  +    H+N++ LL
Sbjct: 23  VGSGAYGSVCSA-IDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLL 80

Query: 547 GY------CDEGRNRLLVYEFMSN--GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
                    DE ++  LV  +M      +      + K  +     +V  +  GL Y+H 
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKYIHS 135

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG---TKGYVAPEW 655
                IIH D+KP N+ +++    +I DFGL +       H +  + G   T+ Y APE 
Sbjct: 136 ---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEV 185

Query: 656 FRN-MPITVKVDVYSYGVLLLEII 678
             N M     VD++S G ++ E++
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEML 209

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 10/197 (5%)

Query: 487 KEELGRGAFGTVYKG-FVNM-GSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLV 543
              +G G FG VY+G +++       VAVK        S +E F  E   + Q  H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECC 601
           +L+G   E     +V E    G L S+L   +K +  L + I+    ++  L YL     
Sbjct: 71  KLIGVITE-NPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLES--- 125

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
            + +H DI  +N+L+      ++ DFGL + L  +  +  +  +    ++APE       
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185

Query: 662 TVKVDVYSYGVLLLEII 678
           T   DV+ +GV + EI+
Sbjct: 186 TSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 22/203 (10%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-------AEVNGIGQTHHKN 541
           E+G GA+G V+K          VA+K++ RV Q  E+          A +  +    H N
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRV-RV-QTGEEGMPLSTIREVAVLRHLETFEHPN 65

Query: 542 LVRLLGYC-----DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLF 594
           +VRL   C     D      LV+E +    L ++L    +P     T  +++  + RGL 
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           +LH     +++H D+KPQNIL+      +++DFGL ++ +   + T+  +  T  Y APE
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPE 179

Query: 655 WFRNMPITVKVDVYSYGVLLLEI 677
                     VD++S G +  E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 51/150 (34%), Positives = 70/150 (46%), Gaps = 12/150 (8%)

Query: 488 EELGRGAFGTVYKGFVNMG-SSDQVAVKKL--NRVFQDSEKEFKAEVNGIGQTHHKNLVR 544
           +E+G G FG V  G VN G +  QV VK+L  +   Q+ + +F  E        H NL++
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-QMKFLEEAQPYRSLQHSNLLQ 59

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSK-----PNWKLRTEIVMGIARGLFYLHEE 599
            LG C E    LLV EF   G L  +L    K     P+      +   IA GL +LH+ 
Sbjct: 60  CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGL 629
                IH D+  +N LL      +I D+GL
Sbjct: 120 ---NFIHSDLALRNCLLTADLTVKIGDYGL 146

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 38/221 (17%)

Query: 490 LGRGAFGTVYK--GF-VNMGSSDQ---VAVKKLNRVFQD-------SEKEFKAEVNGIGQ 536
           LG G FG V +   + ++    DQ   VAVK L     D       SE E    +     
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG---- 75

Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI----------- 585
             HKN++ LLG C +     ++ E+ + G L  FL     P      +I           
Sbjct: 76  -KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134

Query: 586 -----VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSH 639
                   +ARG+ YL    C   IH D+  +N+L+ +    +I+DFGL + +  +D   
Sbjct: 135 DLVSCAYQVARGMEYLESRRC---IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191

Query: 640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICL 680
             +  R    ++APE   +   T + DV+S+G+L+ EI  L
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 60/268 (22%), Positives = 118/268 (44%), Gaps = 25/268 (9%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ----DSEKEFKAEVNGIGQTHHKNL 542
           ++++GRG F  VY+    +     VA+KK+ ++F+     + ++   E++ + Q +H N+
Sbjct: 7   EKKIGRGQFSEVYRATCLL-DRKPVALKKV-QIFEMMDAKARQDCVKEIDLLKQLNHPNV 64

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFL--FGDSKPNWKLRT--EIVMGIARGLFYLHE 598
           ++ L    E     +V E    G L+  +  F   K     RT  +  + +   + ++H 
Sbjct: 65  IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS 124

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H DIKP N+ +      ++ D GL +  +   +  ++ + GT  Y++PE    
Sbjct: 125 R---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHE 180

Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN----DLEAMDDMTV 714
                K D++S G LL E+  L+     D       +  L +L +     D   +     
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGD-------KMNLFSLCQKIEQCDYPPLPTEHY 233

Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQM 742
            ++   +   CI  DP  RP +  V Q+
Sbjct: 234 SEKLRELVSMCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 63.6 bits (155), Expect = 6e-11
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 41/217 (18%)

Query: 493 GAFGTVYKGFVN---MGSSDQVAVK---------KLNRVFQDSEKEFKAEVNGIGQTHHK 540
           G FG ++ G +     G  ++V VK         ++  + Q+S   +           H+
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL--------SHQ 68

Query: 541 NLVRLLGYCDEGRNRLLV-YEFMSNGALASFL----FGDSKPNWKLRTE--IVMG--IAR 591
           N++ +L  C E      V Y +M+ G L  FL     G++     L T+  + M   IA 
Sbjct: 69  NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128

Query: 592 GLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT-----NTAIRG 646
           G+ YLH+     +IH DI  +N ++D+    +I+D  L + L     H      N  ++ 
Sbjct: 129 GMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK- 184

Query: 647 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRT 683
              ++A E   N   +   DV+S+GVLL E++ L +T
Sbjct: 185 ---WMALESLVNKEYSSASDVWSFGVLLWELMTLGQT 218

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 9/197 (4%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFK-AEVNGIGQTHHKNL 542
           F   LG+G+FG V       G+ +  A+K L +  V QD + E    E   +  +     
Sbjct: 4   FLMVLGKGSFGKVMLA-ERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62

Query: 543 VRLLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           +  L  C +  +RL  V E+++ G L   +    +            IA GLF+LH +  
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK-- 120

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             II+ D+K  N++LD   + +I+DFG+ K    D   T T   GT  Y+APE     P 
Sbjct: 121 -GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-GTPDYIAPEIIAYQPY 178

Query: 662 TVKVDVYSYGVLLLEII 678
              VD +++GVLL E++
Sbjct: 179 GKSVDWWAFGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 63.5 bits (154), Expect = 9e-11
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 5/172 (2%)

Query: 507 SSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGA 566
           S  QVAVK ++   Q   +    EV  +    H+N+V +      G    ++ EF+  GA
Sbjct: 45  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104

Query: 567 LASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISD 626
           L   +   ++ N +    +   + + L YLH +    +IH DIK  +ILL      ++SD
Sbjct: 105 LTD-IVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSD 160

Query: 627 FGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
           FG    ++ D     + + GT  ++APE     P   +VD++S G++++E++
Sbjct: 161 FGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 63.6 bits (154), Expect = 9e-11
 Identities = 70/269 (26%), Positives = 120/269 (44%), Gaps = 22/269 (8%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK---AEVNGIGQTHHKNLVRL 545
           E+G G+FG VY    ++ +++ VA+KK++   + S ++++    EV  + +  H N +  
Sbjct: 32  EIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLR-TEIVMGIARGLFYLHEECCTQI 604
            G         LV E+   G+ +  L    KP  ++    I  G  +GL YLH      +
Sbjct: 91  KGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NM 146

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM---PI 661
           IH DIK  NILL +    +++DFG   + +   S       GT  ++APE    M     
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEGQY 201

Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV 721
             KVDV+S G+  +E +  R+  L    ++      L  + +N+   +        F   
Sbjct: 202 DGKVDVWSLGITCIE-LAERKPPL----FNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256

Query: 722 AIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
              C+Q+ P  RPT   + + +  + E P
Sbjct: 257 VDSCLQKIPQDRPTSEELLKHMFVLRERP 285

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 21/200 (10%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLV 543
            E LG G+FG V +   + G+ +  A+K L +   +     +    E + + +  H  +V
Sbjct: 23  GETLGTGSFGRV-RIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81

Query: 544 RLL-GYCDEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLR---TEIVMGIARGLFYLHE 598
            ++  + DE R   L+ EF+  G L + L    + PN   +    E+V+       YLH 
Sbjct: 82  NMMCSFQDENRVYFLL-EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE----YLHS 136

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
           +    II+ D+KP+N+LLD+  + +++DFG  K +  D++ T   + GT  Y+APE  ++
Sbjct: 137 K---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-DRTFT---LCGTPEYLAPEVIQS 189

Query: 659 MPITVKVDVYSYGVLLLEII 678
                 VD ++ GVLL E I
Sbjct: 190 KGHGKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 25/206 (12%)

Query: 488 EELGRGAFGTVYKGFV--NMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLV 543
           +++G G+FG   K  +  +     Q  +K++N  ++     +E + EV  +    H N+V
Sbjct: 6   KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62

Query: 544 RLLGYCDEGRNRLLVYEFMSNGAL-------ASFLFG-DSKPNWKLRTEIVMGIARGLFY 595
           +     +E  N  +V ++   G L          LF  D   +W ++      I   L +
Sbjct: 63  QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ------ICLALKH 116

Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           +H+    +I+H DIK QNI L      ++ DFG+ ++L        T I GT  Y++PE 
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEI 172

Query: 656 FRNMPITVKVDVYSYGVLLLEIICLR 681
             N P   K D+++ G +L E+  L+
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 37/207 (17%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD---SEKEFKAEVNGIGQTHHKNLVRLL 546
           +G GA+G+V   + +     +VAVKKL+R FQ    + + ++ E+  +    H+N++ LL
Sbjct: 23  VGSGAYGSVCSAY-DTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLL 80

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHE 598
                  +     E  +   L + L G    N     KL  E    ++  + RGL Y+H 
Sbjct: 81  DVFTPATS----IENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
                IIH D+KP N+ +++    RI DFGL +    D   T        GYVA  W+R 
Sbjct: 137 ---AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMT--------GYVATRWYRA 183

Query: 659 MPITVK-------VDVYSYGVLLLEII 678
             I +        VD++S G ++ E++
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 17/203 (8%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGI-------GQTHHKNL 542
           LG+GAFG VY  + +  +  ++AVK++   F     E   EVN +           H+ +
Sbjct: 10  LGQGAFGRVYLCY-DADTGRELAVKQVQ--FDPESPETSKEVNALECEIQLLKNLLHERI 66

Query: 543 VRLLGYCDEGRNRLL--VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
           V+  G   +   R L    E M  G++   L         +  +    I  G+ YLH   
Sbjct: 67  VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS-- 124

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTN-TAIRGTKGYVAPEWFRN 658
              I+H DIK  NIL D   N ++ DFG  K L T+  S T   ++ GT  +++PE    
Sbjct: 125 -NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183

Query: 659 MPITVKVDVYSYGVLLLEIICLR 681
                K D++S G  ++E++  +
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 32/205 (15%)

Query: 490 LGRGAFGTVY--KGFVNMGSSDQVAVKKL--------NRVFQDSEKEFKAEVNGIGQTHH 539
           LG+G+FG V+  +      +    A+K L        +RV    E++  AEVN      H
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN------H 57

Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGL 593
             +V+L   +  EG+   L+ +F+  G L + L   SK    + TE      +  +A  L
Sbjct: 58  PFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRL---SKE--VMFTEEDVKFYLAELALAL 111

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAP 653
            +LH      II+ D+KP+NILLD+  + +++DFGL K  ++D      +  GT  Y+AP
Sbjct: 112 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAP 167

Query: 654 EWFRNMPITVKVDVYSYGVLLLEII 678
           E       T   D +S+GVL+ E++
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEML 192

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 15/199 (7%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEKEFKA---EVNGIGQTHHKNLVR 544
           LG+GAFG VY  + ++ +  ++A K++  +    ++ KE  A   E+  +    H+ +V+
Sbjct: 10  LGQGAFGRVYLCY-DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 545 LLGYC--DEGRNRLLVY-EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
             G C  D     L ++ E+M  G++   L         +  +    I  G+ YLH    
Sbjct: 69  YYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS--- 124

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNT-AIRGTKGYVAPEWFRNM 659
             I+H DIK  NIL D   N ++ DFG  K L T+  S T   ++ GT  +++PE     
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184

Query: 660 PITVKVDVYSYGVLLLEII 678
               K DV+S G  ++E++
Sbjct: 185 GYGRKADVWSLGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 39/125 (31%), Positives = 68/125 (54%), Gaps = 5/125 (4%)

Query: 560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY 619
           E M  G+L   L    +   ++  ++ + + RGL YL E+   QI+H D+KP NIL++  
Sbjct: 83  EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSR 140

Query: 620 YNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
              ++ DFG+   L    S  N+ + GT+ Y++PE  +    +V+ D++S G+ L+E+  
Sbjct: 141 GEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAI 197

Query: 680 LRRTI 684
            R  I
Sbjct: 198 GRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 50/231 (21%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-FKA----EVNGIGQTHHKNL 542
            +LG G FG VYK    + +   VA+KK+      +EK+ F      E+  + +  H N+
Sbjct: 14  GKLGEGTFGEVYKA-RQIKTGRVVALKKI---LMHNEKDGFPITALREIKILKKLKHPNV 69

Query: 543 VRLLGYC-----DEGRNRLLVY---EFMSNGALASFLFGDSKPNWKLRTE-----IVMGI 589
           V L+           R R  VY    +M +  L+  L     P+ KL TE      ++ +
Sbjct: 70  VPLIDMAVERPDKSKRKRGSVYMVTPYMDHD-LSGLL---ENPSVKL-TESQIKCYMLQL 124

Query: 590 ARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT------------LDQ 637
             G+ YLH      I+H DIK  NIL+D+    +I+DFGL +                 +
Sbjct: 125 LEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181

Query: 638 SHTNTAIRGTKGYVAPEWF---RNMPITVKVDVYSYGVLLLEIICLRRTIL 685
            +TN  +  T+ Y  PE     R    T  VD++  G +  E+   RR IL
Sbjct: 182 KYTNLVV--TRWYRPPELLLGERRY--TTAVDIWGIGCVFAEMF-TRRPIL 227

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 67/254 (26%), Positives = 115/254 (45%), Gaps = 22/254 (8%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK---AEVNGIGQTHHKNLVRL 545
           E+G G+FG VY    ++ +S+ VA+KK++   + S ++++    EV  + +  H N ++ 
Sbjct: 22  EIGHGSFGAVYFA-RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLR-TEIVMGIARGLFYLHEECCTQI 604
            G         LV E+   G+ +  L    KP  ++    +  G  +GL YLH      +
Sbjct: 81  RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 136

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM---PI 661
           IH D+K  NILL +    ++ DFG   ++            GT  ++APE    M     
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQY 191

Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV 721
             KVDV+S G+  +E +  R+  L    ++      L  + +N+  A+      + F   
Sbjct: 192 DGKVDVWSLGITCIE-LAERKPPL----FNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246

Query: 722 AIWCIQEDPSHRPT 735
              C+Q+ P  RPT
Sbjct: 247 VDSCLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 21/205 (10%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA G V   + +  +   VA+KKL+R FQ+    K    E+  +   +HKN++ LL 
Sbjct: 24  IGSGAQGIVCAAY-DTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLN 82

Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  LV E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 83  VFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIK----HLHS-- 136

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 137 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 193

Query: 661 ITVKVDVYSYGVLLLEIICLRRTIL 685
               VD++S G ++ E+I  R T+L
Sbjct: 194 YKENVDIWSVGCIMGEMI--RGTVL 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 48/202 (23%), Positives = 91/202 (45%), Gaps = 26/202 (12%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +GTV+K   N  + + VA+K   RV  D + E        E+  + +  HKN+
Sbjct: 6   EKIGEGTYGTVFKA-KNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKELKHKNI 61

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           VRL       +   LV+E+        F   +   + ++    +  + +GL + H     
Sbjct: 62  VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH--- 118

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI- 661
            ++H D+KPQN+L++     +++DFGL +   +        +R     V   W+R   + 
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGI-------PVRCYSAEVVTLWYRPPDVL 171

Query: 662 ------TVKVDVYSYGVLLLEI 677
                 +  +D++S G +  E+
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 61.5 bits (149), Expect = 4e-10
 Identities = 59/194 (30%), Positives = 90/194 (46%), Gaps = 11/194 (5%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKE---FKAEVNGIGQTHHKNLVR 544
           LG+G+FG V+   +  G++   A+K L +  V  D + E    +  V  +    H  L  
Sbjct: 3   LGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTH 60

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L        N   V E+++ G L   +    K +    T     I  GL +LH +    I
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GI 117

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           ++ D+K  NILLD   + +I+DFG+ K   L  + T T   GT  Y+APE          
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYNTS 176

Query: 665 VDVYSYGVLLLEII 678
           VD +S+GVLL E++
Sbjct: 177 VDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 60.7 bits (147), Expect = 5e-10
 Identities = 65/260 (25%), Positives = 116/260 (44%), Gaps = 28/260 (10%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVR 544
           ++E LG G  GTVYK +  + +   +AVK +   +  + +K+  +E+  + +     ++ 
Sbjct: 5   YQEILGHGNGGTVYKAYH-LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIG 63

Query: 545 LLG-YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
             G +  E R  +   EFM  G+L  +      P   L   I + + +GL YL      +
Sbjct: 64  FYGAFFVENRISICT-EFMDGGSLDVY---RKIPEHVL-GRIAVAVVKGLTYLWS---LK 115

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
           I+H D+KP N+L++     ++ DFG+   L    S   T + GT  Y+APE        +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYV-GTNAYMAPERISGEQYGI 172

Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--------RTLGALVENDLEAMDDMTVL 715
             DV+S G+  +E+       L  + Y   Q+        + L  +V+ D   +      
Sbjct: 173 HSDVWSLGISFMEL------ALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS 226

Query: 716 QRFVMVAIWCIQEDPSHRPT 735
           ++FV     C+++ P  RP 
Sbjct: 227 EKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 61.4 bits (149), Expect = 6e-10
 Identities = 46/169 (27%), Positives = 84/169 (49%), Gaps = 32/169 (18%)

Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK 648
           +A+G+ +L  + C   IH D+  +N+LL D   A+I DFGL + +  D   +N  ++G  
Sbjct: 221 VAQGMDFLASKNC---IHRDVAARNVLLTDGRVAKICDFGLARDIMND---SNYVVKGNA 274

Query: 649 ----GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRT----ILTDWAY-----DCYQE 695
                ++APE   +   TV+ DV+SYG+LL EI  L ++    IL +  +       YQ 
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ- 333

Query: 696 RTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
                +   D    +  ++++        C   +P+ RPT  +++Q+++
Sbjct: 334 -----MSRPDFAPPEIYSIMKM-------CWNLEPTERPTFSQISQLIQ 370

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 60.9 bits (148), Expect = 7e-10
 Identities = 33/94 (35%), Positives = 57/94 (60%), Gaps = 5/94 (5%)

Query: 584 EIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA 643
           +I + + RGL YL E+   +I+H D+KP NIL++     ++ DFG+   L    S  N+ 
Sbjct: 103 KISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF 158

Query: 644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 677
           + GT+ Y++PE  +    TV+ D++S G+ L+E+
Sbjct: 159 V-GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.7 bits (147), Expect = 7e-10
 Identities = 66/208 (31%), Positives = 93/208 (44%), Gaps = 34/208 (16%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD---SEKEF--KAEV-NGIGQTHHKNLV 543
           +G+G FG VY          QV  K   R++     S+KE   K EV + IG+     LV
Sbjct: 1   IGKGTFGQVY----------QVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGE--RNILV 48

Query: 544 R-LLGYC----------DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARG 592
           R LL                 +  LV ++MS G L   L  + + +       +  +   
Sbjct: 49  RTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA 108

Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVA 652
           L +LH+     I++ D+KP+NILLD   +  + DFGL K    D   TNT   GT  Y+A
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLA 164

Query: 653 PE-WFRNMPITVKVDVYSYGVLLLEIIC 679
           PE        T  VD +S GVL+ E+ C
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCC 192

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.9 bits (148), Expect = 7e-10
 Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 32/210 (15%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDS--------EKEFKAEVNGIGQTH 538
           ELG+GA+G V     N  +S++  VA+KK+  VF           E +      G     
Sbjct: 7   ELGQGAYGIVCSA-RNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG----- 60

Query: 539 HKNLVRLLGY---CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFY 595
           HKN+  L           N L +YE +    L   +              +  I  GL Y
Sbjct: 61  HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKY 120

Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           +H      ++H D+KP N+L++     +I DFGL +  + +       +     YVA  W
Sbjct: 121 IHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM---TEYVATRW 174

Query: 656 FR-------NMPITVKVDVYSYGVLLLEII 678
           +R           T  +DV+S G +L E++
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELL 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 61.4 bits (149), Expect = 9e-10
 Identities = 35/91 (38%), Positives = 47/91 (51%), Gaps = 1/91 (1%)

Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-HTNTAIRGTKGYV 651
           L  +H      +IH DIK  NILL      ++ DFG  K+     S        GT  YV
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICLRR 682
           APE +R  P + K D++S GVLL E++ L+R
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 11/196 (5%)

Query: 560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY 619
           E M  G+L   L    +   ++  ++ + + +GL YL E+   +I+H D+KP NIL++  
Sbjct: 83  EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSR 140

Query: 620 YNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
              ++ DFG+   L    S  N+ + GT+ Y++PE  +    +V+ D++S G+ L+E+  
Sbjct: 141 GEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAI 197

Query: 680 LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
            R  I    A +   E   G  VE D  A  + +   R     +      P  RP M  +
Sbjct: 198 GRYPIPPPDAKEL--ELMFGCPVEGD-PAESETSPRPRPPGRPL--SSYGPDSRPPM-AI 251

Query: 740 TQMLEGVVEVPIPPCP 755
            ++L+ +V  P P  P
Sbjct: 252 FELLDYIVNEPPPKLP 267

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 62/188 (32%), Positives = 91/188 (48%), Gaps = 36/188 (19%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR--VFQDSEKE-FKAE----VNG----IGQT 537
           +GRGAFG V    V M ++ QV A+K LN+  + + +E   F+ E    VNG    I   
Sbjct: 9   IGRGAFGEV--AVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL--FGDSKPNWKLR---TEIVMGIARG 592
           H+        + DE  N  LV ++   G L + L  F D  P    R    E+V+ I   
Sbjct: 67  HY-------AFQDE-NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDS- 117

Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFG-LEKLLTLDQSHTNTAIRGTKGYV 651
              +H+      +H DIKP N+LLD   + R++DFG   +LL      +N A+ GT  Y+
Sbjct: 118 ---VHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYI 170

Query: 652 APEWFRNM 659
           +PE  + M
Sbjct: 171 SPEILQAM 178

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 37/90 (41%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK 648
           IA  L YLH      I++ D+KP+NILLD   +  ++DFGL K   + QS T T   GT 
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTP 160

Query: 649 GYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
            Y+APE  R  P    VD +  G +L E++
Sbjct: 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 21/200 (10%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRL 545
           E+LG G++ TVYKG   +  + ++   K+ R+ ++    F A  E + +    H N+V L
Sbjct: 11  EKLGEGSYATVYKGKSKV--NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLL 68

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKP------NWKLRTEIVMGIARGLFYLHEE 599
                      LV+E++    L  ++  D  P      N KL    +  + RGL Y+H+ 
Sbjct: 69  HDIIHTKETLTLVFEYVHTD-LCQYM--DKHPGGLHPENVKL---FLFQLLRGLSYIHQR 122

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE-WFRN 658
               I+H D+KPQN+L+ D    +++DFGL +  ++  SHT +    T  Y  P+    +
Sbjct: 123 ---YILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLLGS 178

Query: 659 MPITVKVDVYSYGVLLLEII 678
              +  +D++  G + +E+I
Sbjct: 179 TEYSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 60/265 (22%), Positives = 116/265 (43%), Gaps = 19/265 (7%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA----EVNGIGQTHHKNL 542
           ++++GRG F  VY+    +     VA+KK+ ++F   + + +A    E++ + Q +H N+
Sbjct: 7   EKKIGRGQFSEVYRATCLLDGV-PVALKKV-QIFDLMDAKARADCIKEIDLLKQLNHPNV 64

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFL--FGDSKPNWKLRT--EIVMGIARGLFYLHE 598
           ++      E     +V E    G L+  +  F   K     +T  +  + +   L ++H 
Sbjct: 65  IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS 124

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H DIKP N+ +      ++ D GL +  +   +  ++ + GT  Y++PE    
Sbjct: 125 R---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHE 180

Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN-DLEAMDDMTVLQR 717
                K D++S G LL E+  L+     D   + Y   +L   +E  D   +      + 
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLY---SLCKKIEQCDYPPLPSDHYSEE 236

Query: 718 FVMVAIWCIQEDPSHRPTMRRVTQM 742
              +   CI  DP  RP +  V  +
Sbjct: 237 LRQLVNMCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (142), Expect = 3e-09
 Identities = 60/200 (30%), Positives = 89/200 (44%), Gaps = 24/200 (12%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNRVFQDSEKEFK---AEVNGIGQTHHKNLVRL 545
           +G+G+FG V +  V    + ++ A+K + +    S  E     AE   + Q +   +V L
Sbjct: 1   IGKGSFGKVMQ--VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT--- 602
                      LV  F++ G L             L+ E    ++R  FY  E  C    
Sbjct: 59  KFSFQSPEKLYLVLAFINGGELF----------HHLQREGRFDLSRARFYTAELLCALEN 108

Query: 603 ----QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
                +I+ D+KP+NILLD   +  + DFGL KL   D   TNT   GT  Y+APE    
Sbjct: 109 LHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLG 167

Query: 659 MPITVKVDVYSYGVLLLEII 678
              T  VD ++ GVLL E++
Sbjct: 168 HGYTKAVDWWTLGVLLYEML 187

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 60/226 (26%), Positives = 106/226 (46%), Gaps = 35/226 (15%)

Query: 476 YKELVEVTRGFKEE---------LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE 526
           Y+++V   R  + +         +GRGAFG V    V   SS +V   KL   F+  ++ 
Sbjct: 28  YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQ--LVRHKSSQKVYAMKLLSKFEMIKRS 85

Query: 527 ----FKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG-DSKPNW-K 580
               F  E + +   +   +V+L     + +   +V E+M  G L + +   D    W K
Sbjct: 86  DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK 145

Query: 581 LRT-EIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS- 638
             T E+V+     L  +H      +IH D+KP N+LLD + + +++DFG    + +D++ 
Sbjct: 146 FYTAEVVLA----LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFG--TCMKMDETG 196

Query: 639 --HTNTAIRGTKGYVAPEWFRNMP----ITVKVDVYSYGVLLLEII 678
               +TA+ GT  Y++PE  ++         + D +S GV L E++
Sbjct: 197 MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 66/230 (28%), Positives = 96/230 (41%), Gaps = 45/230 (19%)

Query: 486 FKEELGRGAFGTVY------------KGFVNMGSSDQ---VAVKKLNRVFQDSEK----E 526
           FKE+LG G FG V+            K F    S +Q   VAVK L    +D+ K    +
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLR---EDANKNARND 65

Query: 527 FKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL---------FGDSKP 577
           F  E+  + +    N++RLL  C       ++ E+M NG L  FL               
Sbjct: 66  FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125

Query: 578 NWKLRTEIVMG--IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL 635
                T I M   IA G+ YL        +H D+  +N L+   Y  +I+DFG+ + L  
Sbjct: 126 TISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNL-- 180

Query: 636 DQSHTNTAIRGTKGYVAPEWFRNMPI-----TVKVDVYSYGVLLLEIICL 680
             S     I+G +  +   W     I     T   DV+++GV L EI+ L
Sbjct: 181 -YSGDYYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTL 228

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 19/198 (9%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   F  +   + VAVKKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 29  IGSGAQGIVCAAFDTVLGIN-VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 87

Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  LV E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 88  VFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK----HLHS-- 141

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +    +   T   +  T+ Y APE    M 
Sbjct: 142 -AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILGMG 198

Query: 661 ITVKVDVYSYGVLLLEII 678
               VD++S G ++ E++
Sbjct: 199 YKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 11/194 (5%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKE---FKAEVNGIGQTHHKNLVR 544
           LG+G+FG V    +  G+++  A+K L +  V +D + E    +  V  +    H  L  
Sbjct: 3   LGKGSFGKVMLAELK-GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTH 60

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L        +   V E+++ G L   +    + +          I  GL +LH++    I
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GI 117

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           I+ D+K  N+LLD   + +I+DFG+ K     +   +T   GT  Y+APE  +       
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKYNES 176

Query: 665 VDVYSYGVLLLEII 678
           VD +S+GVLL E++
Sbjct: 177 VDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.5 bits (142), Expect = 5e-09
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 62/221 (28%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLL 546
           +GRGA+G V     N  ++++VA+KK+   F    D+++  + E+  +    H+N++ + 
Sbjct: 13  IGRGAYGIVCSA-KNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIK 70

Query: 547 GYCD----EGRNRL----LVYEFM---------SNGALAS-----FLFGDSKPNWKLRTE 584
              D      R       +VYE M         S+  L+      FL+            
Sbjct: 71  ---DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ----------- 116

Query: 585 IVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI 644
               + RGL Y+H      ++H D+KP N+LL+   + +I DFGL +        T+   
Sbjct: 117 ----LLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART-------TSEKG 162

Query: 645 RGTKGYVAPEWFRNMPI-------TVKVDVYSYGVLLLEII 678
                YV   W+R   +       T  +DV+S G +  E++
Sbjct: 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL 203

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 81/327 (24%), Positives = 123/327 (37%), Gaps = 83/327 (25%)

Query: 490 LGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSEK-----EFKAEVNGIGQTHHK 540
           LG GAFG V +    G     S + VAVK L      SE      E K  ++ IG  +H 
Sbjct: 15  LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIH-IG--NHL 71

Query: 541 NLVRLLGYCDEGRNRLLV-YEFMSNGALASFL---------FGDSKPNWKLRTEIVMGIA 590
           N+V LLG C +    L+V  EF   G L++FL         + +  P  + R   ++  +
Sbjct: 72  NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131

Query: 591 R--------------GLFYLHEECCTQ--------------------------------- 603
           R                F       T                                  
Sbjct: 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA 191

Query: 604 ---IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT-AIRGTKGYVAPEWFRNM 659
               IH D+  +NILL +    +I DFGL + +  D  +    + R    ++APE   + 
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDK 251

Query: 660 PITVKVDVYSYGVLLLEIICLRRTILTDWAYD---CYQERTLGALVENDLEAMDDMTVLQ 716
             T + DV+S+GVLL EI  L  +       +   C + +         + A ++ T   
Sbjct: 252 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-----GTRMRAPENATPEI 306

Query: 717 RFVMVAIWCIQEDPSHRPTMRRVTQML 743
             +M+A W  Q DP  RPT   + ++L
Sbjct: 307 YRIMLACW--QGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.9 bits (140), Expect = 6e-09
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 24/207 (11%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           +GRG FG V +      + D  A+K + +   + Q++   F+ E + +  ++   + +L 
Sbjct: 9   VGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 547 GYCDEGRNRLLVYEFMSNGALASFL------FGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
               +  N  LV E+   G L S L      F +    + L  E+V+ I      +H+  
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYL-AELVLAIHS----VHQ-- 120

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM- 659
               +H DIKP+N+L+D   + +++DFG    LT ++   +    GT  Y+APE    M 
Sbjct: 121 -MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179

Query: 660 -----PITVKVDVYSYGVLLLEIICLR 681
                   V+ D +S GV+  E+I  R
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 57.5 bits (139), Expect = 7e-09
 Identities = 53/202 (26%), Positives = 103/202 (50%), Gaps = 23/202 (11%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA----EVNGIGQTHHKNLV 543
           E+LG G + TVYKG  N  + + VA+K+++    D+E+   +    E++ + +  H+N+V
Sbjct: 6   EKLGEGTYATVYKG-RNRTTGEIVALKEIH---LDAEEGTPSTAIREISLMKELKHENIV 61

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFL-----FGDSKPNWKLRTEIVMGIARGLFYLHE 598
           RL          +LV+E+M    L  ++      G   PN          + +G+ + HE
Sbjct: 62  RLHDVIHTENKLMLVFEYMDKD-LKKYMDTHGVRGALDPN--TVKSFTYQLLKGIAFCHE 118

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPE-WF 656
               +++H D+KPQN+L++     +++DFGL +   +   + +N  +  T  Y AP+   
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLL 173

Query: 657 RNMPITVKVDVYSYGVLLLEII 678
            +   +  +D++S G ++ E+I
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMI 195

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 57.3 bits (139), Expect = 7e-09
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 24/203 (11%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ-------THHKNL 542
           +G G F  V K   +  +    A+K + + F+  E     +VN + +       + H N+
Sbjct: 7   IGEGTFSEVLKA-QSRKTGKYYAIKCMKKHFKSLE-----QVNNLREIQALRRLSPHPNI 60

Query: 543 VRLLGYC-DEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVM-GIARGLFYLHEE 599
           +RL+    D    RL LV+E M +  L   + G  +P  + R +  M  + + L ++H  
Sbjct: 61  LRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               I H DIKP+NIL+ D    +++DFG  +   +      T    T+ Y APE     
Sbjct: 120 ---GIFHRDIKPENILIKD-DILKLADFGSCR--GIYSKPPYTEYISTRWYRAPECLLTD 173

Query: 660 PI-TVKVDVYSYGVLLLEIICLR 681
                K+D+++ G +  EI+ L 
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLF 196

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.5 bits (139), Expect = 8e-09
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 20/200 (10%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVF----QDSEKEFKAEVNGIGQTHHKNLV 543
           LG+G +G V++     G+      A+K L +      Q      KAE N +    H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFL-----FGDSKPNWKLRTEIVMGIARGLFYLHE 598
            L+     G    L+ E++S G L   L     F +    + L +EI + +     +LH+
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYL-SEISLALE----HLHQ 118

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
           +    II+ D+KP+NILLD   + +++DFGL K    + + T+T   GT  Y+APE    
Sbjct: 119 Q---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEILMR 174

Query: 659 MPITVKVDVYSYGVLLLEII 678
                 VD +S G L+ +++
Sbjct: 175 SGHGKAVDWWSLGALMYDML 194

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 58.0 bits (140), Expect = 8e-09
 Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 18/162 (11%)

Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK 648
           +A+G+ +L  + C   IH D+  +NILL      +I DFGL + +  D   +N  ++G  
Sbjct: 223 VAKGMSFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIRND---SNYVVKGNA 276

Query: 649 ----GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDC--YQERTLGALV 702
                ++APE   N   T + DV+SYG+LL EI  L  +       D   Y+    G  +
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM 336

Query: 703 ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
            +   A  +M  + +       C   DP  RPT +++ Q++E
Sbjct: 337 LSPECAPSEMYDIMKS------CWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 57.4 bits (138), Expect = 1e-08
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 19/199 (9%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   + +      VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAY-DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90

Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  +V E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHS-- 144

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 145 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201

Query: 661 ITVKVDVYSYGVLLLEIIC 679
               VD++S G ++ E+I 
Sbjct: 202 YKENVDIWSVGCIMGEMIK 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 56/193 (29%), Positives = 89/193 (46%), Gaps = 9/193 (4%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKN--LVRL 545
           LG+G+FG V    +  G  +  AVK L +  V  D + E       +     +N  L  L
Sbjct: 3   LGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
                   +   V EF++ G L   +    + +    T     I  GL +LH +    II
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GII 118

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 665
           + D+K  N++LD   + +I+DFG+ K      +  +T   GT  Y+APE  + +  T  V
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTFSV 177

Query: 666 DVYSYGVLLLEII 678
           D +S+GVLL E++
Sbjct: 178 DWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 43/218 (19%)

Query: 488 EELGRGAFGTVYKG---------FVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH 538
           E LG+G F  +YKG          V  G    V +K L    +DS   F    + + Q  
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLS 59

Query: 539 HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPN-----WKLRTEIVMGIARGL 593
           HK+LV+L G C    N ++V E++  G L  FL    + N     WKL  ++   +A  L
Sbjct: 60  HKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFL--HREKNNVSLHWKL--DVAKQLASAL 114

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL ++   +++H ++  +NIL+  Y        GL +        ++  I  T      
Sbjct: 115 HYLEDK---KLVHGNVCGKNILVARY--------GLNEGYVPFIKLSDPGIPITVLSREE 163

Query: 650 ------YVAPEWFRNMP--ITVKVDVYSYGVLLLEIIC 679
                 ++APE  RN    +T+  D +S+G  LLEI  
Sbjct: 164 RVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICS 201

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.1 bits (138), Expect = 2e-08
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 26/203 (12%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR--VFQDSEKEFKAEVNGIGQTHHKN---LV 543
           +GRGAFG V    V   SS QV A+K L++  + + S+  F  E   I    H N   +V
Sbjct: 51  IGRGAFGEVQ--LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI--MAHANSEWIV 106

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFG-DSKPNW-KLRT-EIVMGIARGLFYLHEEC 600
           +L     + +   +V E+M  G L + +   D    W +  T E+V+ +      +H   
Sbjct: 107 QLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDA----IHS-- 160

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGL-EKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IH D+KP N+LLD   + +++DFG   K+        +TA+ GT  Y++PE  ++ 
Sbjct: 161 -MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQ 218

Query: 660 PITV----KVDVYSYGVLLLEII 678
                   + D +S GV L E++
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 53/202 (26%), Positives = 104/202 (51%), Gaps = 19/202 (9%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRL 545
           ++LG G + TVYKG   + + + VA+K++ R+  +      A  EV+ +    H N+V L
Sbjct: 12  DKLGEGTYATVYKGRSKL-TDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFL--FGDS--KPNWKLRTEIVMGIARGLFYLHEECC 601
                  ++  LV+E++    L  +L   G+S    N KL    +  + RGL Y H    
Sbjct: 70  HDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNSINMHNVKL---FLFQLLRGLNYCHRR-- 123

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPE-WFRNM 659
            +++H D+KPQN+L+++    +++DFGL +  ++  ++++N  +  T  Y  P+    + 
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGST 180

Query: 660 PITVKVDVYSYGVLLLEIICLR 681
             + ++D++  G +  E+   R
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 5/103 (4%)

Query: 585 IVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI 644
           I   I  GL YLH +   +IIH D+K +NI ++D     I D G  +   +  +    A 
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA- 217

Query: 645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTD 687
            GT    APE         K D++S G++L E++    TI  D
Sbjct: 218 -GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259

Length = 357

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 4/90 (4%)

Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK 648
           +A  + YLH      II+ D+KP+NILLD   +  ++DFGL K   ++   T +   GT 
Sbjct: 105 VASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTP 160

Query: 649 GYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
            Y+APE  R  P    VD +  G +L E++
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 52/199 (26%), Positives = 101/199 (50%), Gaps = 13/199 (6%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRL 545
           ++LG G + TV+KG   + + + VA+K++ R+  +      A  EV+ +    H N+V L
Sbjct: 11  DKLGEGTYATVFKGRSKL-TENLVALKEI-RLEHEEGAPCTAIREVSLLKNLKHANIVTL 68

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM-GIARGLFYLHEECCTQI 604
                  R   LV+E++ +  L  +L            +I M  + RGL Y H+    +I
Sbjct: 69  HDIIHTERCLTLVFEYLDSD-LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPE-WFRNMPIT 662
           +H D+KPQN+L+++    +++DFGL +  ++  ++++N  +  T  Y  P+    +   +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYS 182

Query: 663 VKVDVYSYGVLLLEIICLR 681
             +D++  G +L E+   R
Sbjct: 183 TPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 52/220 (23%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVR 544
           E +G+G++G V    ++  + ++VA+KK+N VF+   D+ +  + E+          L+R
Sbjct: 6   EVIGKGSYGVVCSA-IDTHTGEKVAIKKINDVFEHVSDATRILR-EIK---------LLR 54

Query: 545 LLGYCD--------------EGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE----IV 586
           LL + D              E ++  +V+E M      S L    K N  L  E     +
Sbjct: 55  LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-----SDLHQVIKANDDLTPEHHQFFL 109

Query: 587 MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG 646
             + R L Y+H      + H D+KP+NIL +     +I DFGL ++   D   T TAI  
Sbjct: 110 YQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFND---TPTAIFW 163

Query: 647 TKGYVAPEWFRNMPI--------TVKVDVYSYGVLLLEII 678
           T  YVA  W+R   +        T  +D++S G +  E++
Sbjct: 164 TD-YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 202

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 56.3 bits (135), Expect = 3e-08
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   + +      VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 25  IGSGAQGIVCAAY-DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  LV E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 84  VFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHS-- 137

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 138 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 194

Query: 661 ITVKVDVYSYGVLLLEIICLRRTIL 685
               VD++S G ++ E++  R  IL
Sbjct: 195 YKENVDIWSVGCIMGEMV--RHKIL 217

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 4/93 (4%)

Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT-NTAIRGT 647
           +ARG+ +L    C   IH D+  +NILL +    +I DFGL + +  D  +      R  
Sbjct: 182 VARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICL 680
             ++APE   +   T + DV+S+GVLL EI  L
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 55.1 bits (132), Expect = 3e-08
 Identities = 60/261 (22%), Positives = 114/261 (43%), Gaps = 18/261 (6%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           + +G G +G VYK   N+ + +  A+K +     +     + E+  +    H N+V   G
Sbjct: 15  QRIGSGTYGDVYKA-RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIV-MGIARGLFYLHEECCTQIIH 606
                    +  EF   G+L   ++  + P  + +   V     +GL+YLH +     +H
Sbjct: 74  SYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMH 129

Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF---RNMPITV 663
            DIK  NILL D  + +++DFG+   +T   +   + I GT  ++APE     R      
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYNQ 188

Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEA---MDDMTVLQRFVM 720
             D+++ G+  +E+  L+  +     +D +  R L  + +++ +     D M     F  
Sbjct: 189 LCDIWAVGITAIELAELQPPM-----FDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243

Query: 721 VAIWCIQEDPSHRPTMRRVTQ 741
                + ++P  RPT  ++ Q
Sbjct: 244 FVKMALTKNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 27/203 (13%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSE-KEFKAEVNGIGQTHHKNLVR 544
            ++G+G +G V+       + + VA+K++ +  +F+ +E +    E + +  T  + LV+
Sbjct: 7   TQVGQGGYGQVFLA-KKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT-- 602
           LL    +     L  E++  G   + L      N  + +E     AR  FY+ E      
Sbjct: 66  LLYAFQDDEYLYLAMEYVPGGDFRTLL-----NNLGVLSE---DHAR--FYMAEMFEAVD 115

Query: 603 -----QIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNTAIRGTKGYVAPEWF 656
                  IH D+KP+N L+D   + +++DFGL K ++T   S     + G+  Y+APE  
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVL 170

Query: 657 RNMPITVKVDVYSYGVLLLEIIC 679
           R       VD +S G +L E +C
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 61/237 (25%), Positives = 97/237 (40%), Gaps = 47/237 (19%)

Query: 486 FKEELGRGAFGTVYKGFV-------------NM--GSSDQVAVKKLN-RVFQDSEKEFKA 529
           FKE+LG G FG V+   V             N+  G    VAVK L     +++  +F  
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 530 EVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL-------------FGDSK 576
           EV  + +    N++RLLG C +     ++ E+M NG L  FL                  
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 577 ------PNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLE 630
                  ++     + + IA G+ YL        +H D+  +N L+ +    +I+DFG+ 
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 631 KLLTLD-----QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR 682
           + L        Q      IR    ++A E       T   DV+++GV L EI+ L +
Sbjct: 186 RNLYAGDYYRIQGRAVLPIR----WMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 33/208 (15%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR--VFQDSEKE-FKAE----VNGIGQTHHKN 541
           +GRGAFG V    V M  ++++ A+K LN+  + + +E   F+ E    VNG  Q     
Sbjct: 9   IGRGAFGEV--AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ----- 61

Query: 542 LVRLLGYCDEGRNRL-LVYEFMSNGALASFL--FGDSKPNWKLR---TEIVMGIARGLFY 595
            +  L Y  +  N L LV ++   G L + L  F D  P    R    E+V+ I      
Sbjct: 62  WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS---- 117

Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           +H+      +H DIKP N+LLD   + R++DFG    +  D +  ++   GT  Y++PE 
Sbjct: 118 IHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174

Query: 656 FRNMPITV-----KVDVYSYGVLLLEII 678
            + M   +     + D +S GV + E++
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 55.5 bits (133), Expect = 4e-08
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 23/203 (11%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR--VFQDSEKE-FKAEVNGIGQTHHKNLVRL 545
           +GRGAFG V    V + ++D+V A+K LN+  + + +E   F+ E + +    ++ +  L
Sbjct: 9   IGRGAFGEV--AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFL--FGDSKPNWKLR---TEIVMGIARGLFYLHEEC 600
                +  N  LV ++   G L + L  F D  P    R    E+V+ I   +  LH   
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSVHQLH--- 122

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
               +H DIKP NIL+D   + R++DFG    L  D +  ++   GT  Y++PE  + M 
Sbjct: 123 ---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179

Query: 661 -----ITVKVDVYSYGVLLLEII 678
                   + D +S GV + E++
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 4e-08
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 14/97 (14%)

Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK 648
           I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   +  HT        
Sbjct: 115 ILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT----GFLT 167

Query: 649 GYVAPEWFRNMPI-------TVKVDVYSYGVLLLEII 678
            YVA  W+R   I       T  +D++S G +L E++
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEML 204

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 55.1 bits (133), Expect = 4e-08
 Identities = 53/185 (28%), Positives = 84/185 (45%), Gaps = 31/185 (16%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-FKA----EVNGIGQTHHKNLVR 544
           +G+G FG V+K   +  +   VA+KK   V  ++EKE F      E+  +    H+N+V 
Sbjct: 20  IGQGTFGEVFKA-RHKKTKQIVALKK---VLMENEKEGFPITALREIKILQLLKHENVVN 75

Query: 545 LLGYCD-----EGRNR---LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----G 592
           L+  C        R +    LV+EF  +  LA  L   S  N K     +  + +    G
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLL---SNKNVKFTLSEIKKVMKMLLNG 131

Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK---LLTLDQSHTNTAIRGTKG 649
           L+Y+H     +I+H D+K  NIL+      +++DFGL +   L    + +  T    T  
Sbjct: 132 LYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188

Query: 650 YVAPE 654
           Y  PE
Sbjct: 189 YRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 19/198 (9%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV--AVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVR 544
           +G+G+FG V    +    +++   AVK L +   + +  EK   +E N + +      + 
Sbjct: 3   IGKGSFGKV---LLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 545 LLGYCDEGRNRL-LVYEFMSNGALASFLFGDS---KPNWKLRTEIVMGIARGLFYLHEEC 600
            L +  +  ++L  V ++++ G L   L  +    +P  +        IA  L YLH   
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF---YAAEIASALGYLHS-- 114

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              I++ D+KP+NILLD   +  ++DFGL K   ++ + T +   GT  Y+APE     P
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 661 ITVKVDVYSYGVLLLEII 678
               VD +  G +L E++
Sbjct: 173 YDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.0 bits (135), Expect = 6e-08
 Identities = 47/153 (30%), Positives = 77/153 (50%), Gaps = 16/153 (10%)

Query: 492 RGAFGTVYKGFVNMGSSDQVAVK---KLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           RGAFG VY G     +S   AVK   K + + ++   + +AE + +  +    +V L   
Sbjct: 14  RGAFGKVYLGRKK-NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYS 72

Query: 549 CDEGRNRLLVYEFMSNGALASFL--FG--DSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
                N  LV E++  G + S L  +G  D +   K  +E+ +     L YLH      I
Sbjct: 73  LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALA----LDYLHRH---GI 125

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ 637
           IH D+KP N+L+ +  + +++DFGL K +TL++
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLSK-VTLNR 157

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 54.4 bits (131), Expect = 6e-08
 Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 9/126 (7%)

Query: 557 LVYEFMSNGALASFLFGDSKPNWKL-RTEIVMG-IARGLFYLHEECCTQIIHCDIKPQNI 614
           L+ ++++ G L + L+   + ++      + +  I   L +LH+     II+ DIK +NI
Sbjct: 82  LILDYVNGGELFTHLY--QREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENI 136

Query: 615 LLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI--TVKVDVYSYGV 672
           LLD   +  ++DFGL K    ++     +  GT  Y+APE  R         VD +S GV
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGV 196

Query: 673 LLLEII 678
           L  E++
Sbjct: 197 LTFELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 51/198 (25%), Positives = 103/198 (52%), Gaps = 19/198 (9%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRL 545
           E+LG G + TV+KG   + + + VA+K++ R+  +      A  EV+ +    H N+V L
Sbjct: 12  EKLGEGTYATVFKGRSKL-TENLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFL--FGD--SKPNWKLRTEIVMGIARGLFYLHEECC 601
                  ++  LV+E++    L  ++   G+  S  N K+    +  I RGL Y H    
Sbjct: 70  HDIVHTDKSLTLVFEYLDKD-LKQYMDDCGNIMSMHNVKI---FLYQILRGLAYCHRR-- 123

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPE-WFRNM 659
            +++H D+KPQN+L+++    +++DFGL +  ++  ++++N  +  T  Y  P+    + 
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSS 180

Query: 660 PITVKVDVYSYGVLLLEI 677
             + ++D++  G +  E+
Sbjct: 181 EYSTQIDMWGVGCIFFEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 54.3 bits (131), Expect = 7e-08
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 27/163 (16%)

Query: 475 TYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVN 532
           TYK+L        ++LG G++ TVYKG   + +   VA+K++ R+  +    F A  E +
Sbjct: 6   TYKKL--------DKLGEGSYATVYKGRSKL-TGQLVALKEI-RLEHEEGAPFTAIREAS 55

Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP------NWKLRTEIV 586
            +    H N+V L       +   LV+E++    L  ++  D         N +L    +
Sbjct: 56  LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTD-LKQYM--DDCGGGLSMHNVRL---FL 109

Query: 587 MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
             + RGL Y H+    +++H D+KPQN+L+ +    +++DFGL
Sbjct: 110 FQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGL 149

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 51/197 (25%), Positives = 88/197 (44%), Gaps = 12/197 (6%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F   LG G+FG V            VA+K+  +   + Q       +E   +   +H   
Sbjct: 34  FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC 93

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V L G   +     LV EF+  G   +FL    + N +   ++    A  +  + E   +
Sbjct: 94  VNLYGSFKDESYLYLVLEFVIGGEFFTFL----RRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 603 -QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             I++ D+KP+N+LLD     +++DFG  K++    + T T + GT  Y+APE   N+  
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPEILLNVGH 205

Query: 662 TVKVDVYSYGVLLLEII 678
               D ++ G+ + EI+
Sbjct: 206 GKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 54.3 bits (130), Expect = 9e-08
 Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 11/197 (5%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNRVFQDSEKEF---KAEVNGIGQTHHKNLVRL 545
           +GRG++  V    V +  ++++ A+K + +   + +++    + E +   Q  +   +  
Sbjct: 3   IGRGSYAKVL--LVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 546 LGYCDEGRNRLL-VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L  C +  +RL  V E+++ G L   +    K   +        I+  L YLHE     I
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GI 117

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           I+ D+K  N+LLD   + +++D+G+ K   L    T +   GT  Y+APE  R       
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176

Query: 665 VDVYSYGVLLLEIICLR 681
           VD ++ GVL+ E++  R
Sbjct: 177 VDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 63/262 (24%), Positives = 119/262 (45%), Gaps = 24/262 (9%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           + +G G +G VYK   N+ + +  AVK +     D     + E+  + +  H N+V   G
Sbjct: 15  QRVGSGTYGDVYKA-RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIV-MGIARGLFYLHEECCTQIIH 606
                    +  E+   G+L   ++  + P  +L+   V     +GL YLH +     +H
Sbjct: 74  SYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMH 129

Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF---RNMPITV 663
            DIK  NILL D  + +++DFG+   +T   +   + I GT  ++APE     +N     
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYNQ 188

Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE--AMDDMT----VLQR 717
             D+++ G+  +E+  L+  +     +D +  R L  + +++ +   + D T        
Sbjct: 189 LCDIWAVGITAIELAELQPPM-----FDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243

Query: 718 FVMVAIWCIQEDPSHRPTMRRV 739
           FV ++   + ++P  RPT  R+
Sbjct: 244 FVKIS---LTKNPKKRPTAERL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 13/205 (6%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEF-KAEVNGIGQTHHKNLVRL 545
           +GRG++  V    V +  +DQ+   K+ +   V  D + ++ + E +   Q      +  
Sbjct: 3   IGRGSYAKVL--LVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 546 LGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L  C +  +RL LV E+++ G L   +    K   +        I   L +LHE     I
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GI 117

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           I+ D+K  N+LLD   + +++D+G+ K   L    T +   GT  Y+APE  R       
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEYGFS 176

Query: 665 VDVYSYGVLLLEIICLRR--TILTD 687
           VD ++ GVL+ E++  R    I+TD
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITD 201

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 16/195 (8%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKA----EVNGIGQTHHKNLV 543
           +G GA+G V K   +  + + VA+KK    F+DSE  +E K     E+  +     +N+V
Sbjct: 9   VGEGAYGVVLK-CRHKETKEIVAIKK----FKDSEENEEVKETTLRELKMLRTLKQENIV 63

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
            L           LV+E++    L       +  P  K+R+ I   I + + + H+    
Sbjct: 64  ELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLI-KAIHWCHK---N 119

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            I+H DIKP+N+L+      ++ DFG  + L+   +   T    T+ Y +PE     P  
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179

Query: 663 VKVDVYSYGVLLLEI 677
             VD++S G +L E+
Sbjct: 180 KAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 46/219 (21%)

Query: 488 EELGRGAFGTVYKG----FVNMGSSDQ--VAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           E LG+G F  ++KG      + G   +  V +K L++  ++  + F    + + Q  HK+
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPN-------WKLRTEIVMGIARGLF 594
           LV   G C  G   ++V E++  G+L ++L    K N       WKL  E+   +A  L 
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYL----KKNKNLINISWKL--EVAKQLAWALH 114

Query: 595 YLHEECCTQIIHCDIKPQNILL----DDYYNA----RISDFG-----LEKLLTLDQSHTN 641
           +L ++    + H ++  +N+LL    D         ++SD G     L K + L++    
Sbjct: 115 FLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI--- 168

Query: 642 TAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIIC 679
                   +V PE   N   +++  D +S+G  L EI  
Sbjct: 169 -------PWVPPECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 60/263 (22%), Positives = 115/263 (43%), Gaps = 31/263 (11%)

Query: 487 KEELGRGAFGTVY-------KGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHH 539
           ++ LG+G+FGTVY            +    ++ V +LN    +   +   E   + +  H
Sbjct: 5   QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELN---PNETVQANQEAQLLSKLDH 61

Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLF 594
             +V+      E     ++ E+     L      + K   K  +E       + +  G+ 
Sbjct: 62  PAIVKFHASFLERDAFCIITEYCEGRDL-DCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           Y+H+    +I+H D+K +NI L +    +I DFG+ +LL +      T   GT  Y++PE
Sbjct: 121 YMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPE 175

Query: 655 WFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLG-ALVENDLEAMDDMT 713
             ++     K D++S G +L E+ CL        A++     ++   +VE    ++ +  
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEMCCLAH------AFEGQNFLSVVLRIVEGPTPSLPETY 229

Query: 714 VLQ-RFVMVAIWCIQEDPSHRPT 735
             Q   +M ++  + +DPS RP+
Sbjct: 230 SRQLNSIMQSM--LNKDPSLRPS 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 53.2 bits (127), Expect = 2e-07
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 12/197 (6%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG V        S    A+K L +   + +D       E   +  T H  L  L 
Sbjct: 3   LGKGTFGKVIL-VREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60

Query: 547 GYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEECCTQI 604
            Y  + ++RL  V E+++ G L  F     +   + RT      I   L YLH     +I
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELF-FHLSRERVFSEDRTRFYGAEIVSALDYLHS---GKI 116

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           ++ D+K +N++LD   + +I+DFGL K    D +   T   GT  Y+APE   +      
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYGRA 175

Query: 665 VDVYSYGVLLLEIICLR 681
           VD +  GV++ E++C R
Sbjct: 176 VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 54/197 (27%), Positives = 96/197 (48%), Gaps = 17/197 (8%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR--VFQDSEKE---FKAEVNGIGQTHHKNLV 543
           LG+G+FG V      +  +D+V A+K L +  + QD + +    +  +  +   H    +
Sbjct: 3   LGKGSFGKVM--LAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKH--PFL 58

Query: 544 RLLGYCDEGRNRLL-VYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEECC 601
             L  C + ++RL  V E+++ G L  F    S+   + R+      +   L +LH    
Sbjct: 59  TALHCCFQTKDRLFFVMEYVNGGDLM-FQIQRSRKFDEPRSRFYAAEVTLALMFLHRH-- 115

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +I+ D+K  NILLD   + +++DFG+ K   +    T T   GT  Y+APE  + +  
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEILQELEY 173

Query: 662 TVKVDVYSYGVLLLEII 678
              VD ++ GVL+ E++
Sbjct: 174 GPSVDWWALGVLMYEMM 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 62/206 (30%), Positives = 90/206 (43%), Gaps = 34/206 (16%)

Query: 490 LGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVF---QD------SEKEFKAEVNGIGQ 536
           LGRG FG V    YK      + +  A+K L +     +D       EK      N    
Sbjct: 7   LGRGHFGKVLLAEYKK-----TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER- 60

Query: 537 THHKNLVRLLGYCDEGRNRL-LVYEFMSNGALASFLFGD--SKPNWKL-RTEIVMGIARG 592
             H  LV L   C +  + +  V E+ + G L   +  D  S+P        +V+G    
Sbjct: 61  --HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLG---- 113

Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVA 652
           L YLHE    +I++ D+K  N+LLD     +I+DFGL K        T+T   GT  ++A
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLA 169

Query: 653 PEWFRNMPITVKVDVYSYGVLLLEII 678
           PE       T  VD +  GVL+ E++
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEML 195

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 41/216 (18%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT---------- 537
           E++G G +G VYK   +  +   VA+KK  R+  D E        GI  T          
Sbjct: 7   EKIGEGTYGKVYKA-RDKNTGKLVALKK-TRLEMDEE--------GIPPTALREISLLQM 56

Query: 538 --HHKNLVRLLGY----CDEGRNRL-LVYEFMSNGALASFLFGDSK-PNWKLRTEIVMG- 588
                 +VRLL         G+  L LV+E++ +  L  F+  + + P   L  + +   
Sbjct: 57  LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 589 ---IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNA-RISDFGLEKLLTLD-QSHTNTA 643
              + +G+ + H+     ++H D+KPQN+L+D      +I+D GL +  ++  +S+T+  
Sbjct: 116 MYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172

Query: 644 IRGTKGYVAPE-WFRNMPITVKVDVYSYGVLLLEII 678
           +  T  Y APE    +   +  VD++S G +  E+ 
Sbjct: 173 V--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 10/157 (6%)

Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA-IRGT 647
           +A+G+ +L    C   IH D+  +NILL +    +I DFGL + +  D  +      R  
Sbjct: 188 VAKGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE 707
             ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     L E    
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKEGTRM 301

Query: 708 AMDDMTVLQRF-VMVAIWCIQEDPSHRPTMRRVTQML 743
              D T  + +  M+  W    +PS RPT   + + L
Sbjct: 302 RAPDYTTPEMYQTMLDCW--HGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 11/97 (11%)

Query: 583 TEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT 642
           TEI++G    L ++H      +++ D+KP NILLD++ + RISD GL    +  + H + 
Sbjct: 104 TEIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 156

Query: 643 AIRGTKGYVAPEWF-RNMPITVKVDVYSYGVLLLEII 678
              GT GY+APE   +        D +S G +L +++
Sbjct: 157 ---GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 47.8 bits (114), Expect = 4e-07
 Identities = 14/79 (17%), Positives = 30/79 (37%), Gaps = 3/79 (3%)

Query: 332 KSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRDD--TCWKKKL 389
                     +L +   P +    I+    +EC  +CL +C C+A    +    C     
Sbjct: 6   GGDGSTDGFLKLPDVKLPDNAS-AITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNG 64

Query: 390 PLSYGKTDRDETGTTFIKI 408
            L+  ++     GT ++++
Sbjct: 65  LLNNLRSLSSGGGTLYLRL 83

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 52.1 bits (125), Expect = 5e-07
 Identities = 48/175 (27%), Positives = 73/175 (41%), Gaps = 38/175 (21%)

Query: 517 NRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSK 576
           +RV Q++   F   +    QTH     RL   C        V E+ + G L         
Sbjct: 46  SRVLQNTRHPFLTALKYSFQTHD----RL---C-------FVMEYANGGELF-------- 83

Query: 577 PNWKLRTEIVMGIARGLFY----------LHEECCTQIIHCDIKPQNILLDDYYNARISD 626
             + L  E V    R  FY          LH      +++ D+K +N++LD   + +I+D
Sbjct: 84  --FHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITD 138

Query: 627 FGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR 681
           FGL K    D +   T   GT  Y+APE   +      VD +  GV++ E++C R
Sbjct: 139 FGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.4 bits (124), Expect = 6e-07
 Identities = 38/147 (25%), Positives = 63/147 (42%), Gaps = 17/147 (11%)

Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE----IVMGIARGL 593
            + N ++L       +  +L+ +++ +G L   L    K   KL       I+  +   L
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL----KKEGKLSEAEVKKIIRQLVEAL 122

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDY-YNARISDFGLEKLLTLDQSHTNTAIRGTKGYVA 652
             LH+     IIH DIK +N+L D       + D+GL K+       T +   GT  Y +
Sbjct: 123 NDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-----IGTPSCYDGTLDYFS 174

Query: 653 PEWFRNMPITVKVDVYSYGVLLLEIIC 679
           PE  +     V  D ++ GVL  E++ 
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLT 201

Length = 267

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.5 bits (123), Expect = 8e-07
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 22/202 (10%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR----VFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG+G FG V    V   ++ +    K+ R    + +D       E   +  T H  L  L
Sbjct: 3   LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 546 LGYCDEGRNRL-LVYEFMSNGALASFL-----FGDSKPNWKLRTEIVMGIARGLFYLHEE 599
             Y  +  +RL  V E+ + G L   L     F + +  +    EIV      L YLH  
Sbjct: 61  -KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIV----SALEYLHSR 114

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               +++ DIK +N++LD   + +I+DFGL K    D +   T   GT  Y+APE   + 
Sbjct: 115 ---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDN 170

Query: 660 PITVKVDVYSYGVLLLEIICLR 681
                VD +  GV++ E++C R
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 51.2 bits (122), Expect = 9e-07
 Identities = 51/171 (29%), Positives = 77/171 (45%), Gaps = 29/171 (16%)

Query: 517 NRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRL-LVYEFMSNGALASFL---- 571
           NRV Q+S   F   +    QTH               +RL  V E+ + G L   L    
Sbjct: 46  NRVLQNSRHPFLTALKYSFQTH---------------DRLCFVMEYANGGELFFHLSRER 90

Query: 572 -FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLE 630
            F + +  +    EIV      L YLH E    +++ D+K +N++LD   + +I+DFGL 
Sbjct: 91  VFSEDRARF-YGAEIV----SALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLC 143

Query: 631 KLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR 681
           K    D +   T   GT  Y+APE   +      VD +  GV++ E++C R
Sbjct: 144 KEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 25/203 (12%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           +G G+FG VY+  + + +S++VA+KK   V QD + + + E+  +   +H N++ L  Y 
Sbjct: 74  IGNGSFGVVYEA-ICIDTSEKVAIKK---VLQDPQYKNR-ELLIMKNLNHINIIFLKDYY 128

Query: 550 ------DEGRNRLL--VYEFMSNGALASFLFGDSKPNWKLRTEIV----MGIARGLFYLH 597
                    +N  L  V EF+    +  ++   ++ N  L   +V      + R L Y+H
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187

Query: 598 EECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE-W 655
            +    I H D+KPQN+L+D + +  ++ DFG  K L   Q   +     ++ Y APE  
Sbjct: 188 SKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC--SRFYRAPELM 242

Query: 656 FRNMPITVKVDVYSYGVLLLEII 678
                 T  +D++S G ++ E+I
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 45/163 (27%), Positives = 67/163 (41%), Gaps = 19/163 (11%)

Query: 530 EVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGI 589
           E++ +    H+ ++ L+      R +  V   M       F + D      L   I   I
Sbjct: 136 EIDILKTISHRAIINLI---HAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAIT--I 190

Query: 590 ARGLF----YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT--- 642
            R L     YLH      IIH D+K +NI LD+  NA + DFG    L    +H +T   
Sbjct: 191 QRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD---AHPDTPQC 244

Query: 643 -AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTI 684
               GT    +PE     P   K D++S G++L E+     T+
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 11/97 (11%)

Query: 583 TEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT 642
            EI++G    L ++H      +++ D+KP NILLD++ + RISD GL    +  + H + 
Sbjct: 104 AEIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 156

Query: 643 AIRGTKGYVAPEWF-RNMPITVKVDVYSYGVLLLEII 678
              GT GY+APE   + +      D +S G +L +++
Sbjct: 157 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 67/277 (24%), Positives = 111/277 (40%), Gaps = 45/277 (16%)

Query: 488 EELGRGAFGTVYKGFVNMGSSD-----------QVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           E LGRG    +Y G +N    D           +V +K L+   +D    F    + + Q
Sbjct: 1   EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60

Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP---NWKLRTEIVMGIARGL 593
             HK++V L G C      ++V EF+  G L  F+   S      WK +  +   +A  L
Sbjct: 61  VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK--VAKQLASAL 118

Query: 594 FYLHEECCTQIIHCDIKPQNILL-----DDYYNA--RISDFGLEKLLTLDQSHTNTAIRG 646
            YL ++    ++H ++  +NILL     D       ++SD G+  +  L +      I  
Sbjct: 119 SYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI-PITVLSRQECVERIP- 173

Query: 647 TKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGA---LV 702
              ++APE   +   +++  D +S+G  L EI       L D      +ER       LV
Sbjct: 174 ---WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-AEKERFYEGQCMLV 229

Query: 703 ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
               + + D+            C+  DP+ RP  R +
Sbjct: 230 TPSCKELADLMT---------HCMNYDPNQRPFFRAI 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 64/243 (26%), Positives = 94/243 (38%), Gaps = 72/243 (29%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE----FKAEVNGIGQTHHKNLVRL 545
           +GRGAFG V +      +    A+KKL R  +  EKE     +AE + + +  +  +V+L
Sbjct: 9   IGRGAFGEV-RLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 546 LGYC---DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
             Y    DE     L+ E++  G + + L           TE      R  FY+  E   
Sbjct: 67  --YYSFQDE-NYLYLIMEYLPGGDMMTLLM-----KKDTFTEEE---TR--FYI-AETIL 112

Query: 603 QI--------IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR--------- 645
            I        IH DIKP N+LLD   + ++SDFGL     L +SH     R         
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFYRILSHALPSN 170

Query: 646 ------------------------------GTKGYVAPEWFRNMPITVKVDVYSYGVLLL 675
                                         GT  Y+APE F       + D +S GV++ 
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230

Query: 676 EII 678
           E++
Sbjct: 231 EML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 17/198 (8%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRL 545
           E+LG G++ TVYKG   +  + Q+   K+  +  +    F A  E + +    H N+V L
Sbjct: 11  EKLGEGSYATVYKGISRI--NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLL 68

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLF----GDSKPNWKLRTEIVMGIARGLFYLHEECC 601
                       V+E+M    LA ++     G    N +L    +  + RGL Y+H +  
Sbjct: 69  HDIIHTKETLTFVFEYMHTD-LAQYMIQHPGGLHPYNVRL---FMFQLLRGLAYIHGQ-- 122

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE-WFRNMP 660
             I+H D+KPQN+L+      +++DFGL +  ++  S T ++   T  Y  P+       
Sbjct: 123 -HILHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVVTLWYRPPDVLLGATD 180

Query: 661 ITVKVDVYSYGVLLLEII 678
            +  +D++  G + +E++
Sbjct: 181 YSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 2e-06
 Identities = 56/235 (23%), Positives = 89/235 (37%), Gaps = 59/235 (25%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQV-AVK-----------KLNRVFQDSEKEFKAEVNGIG 535
           + LG+G  G V+   V +  + ++ A+K           K+ RV   +E+E  A ++   
Sbjct: 7   KLLGKGDVGRVF--LVRLKGTGKLFALKVLDKKEMIKRNKVKRVL--TEQEILATLD--- 59

Query: 536 QTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR---- 591
              H  L  L           LV ++   G L   L    +P   L  E+    A     
Sbjct: 60  ---HPFLPTLYASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAAEVLL 114

Query: 592 GLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT----------LDQSHTN 641
            L YLH      I++ D+KP+NILL +  +  +SDF L K                S  +
Sbjct: 115 ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171

Query: 642 TAIR------------------GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
           +                     GT+ Y+APE          VD ++ G+LL E++
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 3e-06
 Identities = 42/164 (25%), Positives = 65/164 (39%), Gaps = 33/164 (20%)

Query: 491 GRGAFGTVYKGFVNMGSSDQV-AVKKLNRVFQDSEKEFKAEVNGIGQT-----------H 538
           GRG +G VYK     G   +  A+KK         K  K +  GI Q+            
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKF--------KGDKEQYTGISQSACREIALLRELK 60

Query: 539 HKNLVRLLGYCDEGRNRL--LVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARG 592
           H+N+V L+    E  ++   L++++  +       F        +   +V      I  G
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNAR----ISDFGLEKL 632
           + YLH      ++H D+KP NIL+      R    I D GL +L
Sbjct: 121 VHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 56/229 (24%), Positives = 87/229 (37%), Gaps = 47/229 (20%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE----FKAEVNGIGQTHHKNLVRL 545
           +GRGAFG V    V    +  +   K+ R     EKE     +AE + + +     +V++
Sbjct: 9   IGRGAFGEVR--LVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
                + RN  L+ EF+  G + + L    K +          IA  +  +        I
Sbjct: 67  FYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLGFI 123

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR-------------------- 645
           H DIKP N+LLD   + ++SDFGL     L ++H     R                    
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGL--CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181

Query: 646 ----------------GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
                           GT  Y+APE F         D +S GV++ E++
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 22/167 (13%)

Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK 648
           +ARG+ +L  + C   +H D+  +N+LL      +I DFGL +    D  H +  +    
Sbjct: 246 VARGMEFLASKNC---VHRDLAARNVLLAQGKIVKICDFGLAR----DIMHDSNYVSKGS 298

Query: 649 GYVAPEW------FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDC--YQERTLGA 700
            ++  +W      F N+  T+  DV+SYG+LL EI  L  T       D   Y +   G 
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLS-DVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGY 357

Query: 701 LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
            +     A  ++      +MV  W    +P  RP+   ++ ++E ++
Sbjct: 358 RMAKPDHATQEVYD----IMVKCW--NSEPEKRPSFLHLSDIVESLL 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.4 bits (118), Expect = 4e-06
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 33/208 (15%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR-VFQD--------SEKE-FKAEVNGIGQTH 538
           +GRG++  V    V +  + ++ A+K + + +  D        +EK  F+   N      
Sbjct: 3   IGRGSYAKVL--LVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASN------ 54

Query: 539 HKNLVRLLGYCDEGRNRL-LVYEFMSNGALASFLFGDSK-PNWKLR---TEIVMGIARGL 593
           H  LV L   C +  +RL  V EF+S G L   +    K P    R    EI +     L
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----L 109

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAP 653
            +LHE     II+ D+K  N+LLD   + +++D+G+ K   +    T +   GT  Y+AP
Sbjct: 110 NFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAP 165

Query: 654 EWFRNMPITVKVDVYSYGVLLLEIICLR 681
           E  R       VD ++ GVL+ E++  R
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 48.3 bits (115), Expect = 5e-06
 Identities = 40/151 (26%), Positives = 69/151 (45%), Gaps = 15/151 (9%)

Query: 488 EELGRGAFGTVYKGFVNMGSS-DQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRL 545
           +E+G G FG V    +   +   +V VK+L       E+ EF  + +      H N+++ 
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM-------GIARGLFYLHE 598
           LG C E    LLV+E+   G L S+L   S+  W  R   ++        IA G+ ++H+
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYL---SQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
                 +H D+  +N  L      ++ D+G+
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.5 bits (115), Expect = 8e-06
 Identities = 57/229 (24%), Positives = 87/229 (37%), Gaps = 47/229 (20%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE----FKAEVNGIGQTHHKNLVRL 545
           +GRGAFG V    V    +  V   K+ R     EKE     +AE + + +     +V++
Sbjct: 9   IGRGAFGEVR--LVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
                +  N  L+ EF+  G + + L    K +     E    IA  +  +        I
Sbjct: 67  FYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLGFI 123

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR-------------------- 645
           H DIKP N+LLD   + ++SDFGL     L ++H     R                    
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGL--CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181

Query: 646 ----------------GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
                           GT  Y+APE F         D +S GV++ E++
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.2 bits (115), Expect = 9e-06
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 40/215 (18%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG G+ G V+   V+     +VAVKK+      S K    E+  I +  H N+V++    
Sbjct: 13  LGCGSNGLVFSA-VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71

Query: 550 DEGRNRL--------------LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFY 595
               + L              +V E+M    LA+ L          R   +  + RGL Y
Sbjct: 72  GPSGSDLTEDVGSLTELNSVYIVQEYMETD-LANVLEQGPLSEEHARL-FMYQLLRGLKY 129

Query: 596 LHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGY---- 650
           +H      ++H D+KP N+ ++ +    +I DFGL +++    SH        KGY    
Sbjct: 130 IHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH--------KGYLSEG 178

Query: 651 VAPEWFRNMPI-------TVKVDVYSYGVLLLEII 678
           +  +W+R+  +       T  +D+++ G +  E++
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 213

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 48.0 bits (114), Expect = 1e-05
 Identities = 37/125 (29%), Positives = 63/125 (50%), Gaps = 8/125 (6%)

Query: 557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIHCDIKPQNI 614
           L+ +++S G + + L+   + N+           I   L +LH+     I++ DIK +NI
Sbjct: 82  LILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENI 136

Query: 615 LLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK-VDVYSYGVL 673
           LLD   +  ++DFGL K    ++     +  GT  Y+APE  R      K VD +S G+L
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGIL 196

Query: 674 LLEII 678
           + E++
Sbjct: 197 IFELL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 37/174 (21%), Positives = 78/174 (44%), Gaps = 19/174 (10%)

Query: 518 RVFQDSEKEFKA-------EVNGIGQTHHKNLVRLLGY----CDEGRNRLLVYEFMSNGA 566
           R F+   K  K        E+  + +    N++++ G+     D+     L+ E+ + G 
Sbjct: 49  RTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGY 108

Query: 567 LASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISD 626
           L   L  +   ++K + ++ +   +GL+ L++   T   + ++   + L+ + Y  +I  
Sbjct: 109 LREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIIC 166

Query: 627 FGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM--PITVKVDVYSYGVLLLEII 678
            GLEK+L+         +     Y + +   ++    T+K D+YS GV+L EI 
Sbjct: 167 HGLEKILSSPPFKNVNFM----VYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216

Length = 283

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 9/97 (9%)

Query: 584 EIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA 643
           EIV+     L +LH+     II+ DIK +NILLD   +  ++DFGL K    D+     +
Sbjct: 113 EIVLA----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS 165

Query: 644 IRGTKGYVAPEWFR--NMPITVKVDVYSYGVLLLEII 678
             GT  Y+AP+  R  +      VD +S GVL+ E++
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 22/201 (10%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE----FKAEVNGIGQTHHKNLVRL 545
           +GRGAFG V    V   S+ +V   KL   F+  ++     F  E + +   +   +V+L
Sbjct: 51  IGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLR---TEIVMGIARGLFYLHEECCT 602
                + R   +V E+M  G L + +     P    R    E+V+     L  +H     
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA----LDAIHS---M 161

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFRNMP- 660
             IH D+KP N+LLD   + +++DFG    +  +     +TA+ GT  Y++PE  ++   
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 220

Query: 661 ---ITVKVDVYSYGVLLLEII 678
                 + D +S GV L E++
Sbjct: 221 DGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 37/105 (35%), Positives = 50/105 (47%), Gaps = 9/105 (8%)

Query: 476 YKELVEVTRG---FKEELGRGAFGTVYKGF-VNMGSSD---QVAVKKLNRVFQDSEKE-F 527
           Y E  E  R    F + LG GAFG V +     +G  D   +VAVK L       E+E  
Sbjct: 29  YNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREAL 88

Query: 528 KAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL 571
            +E+  +     HKN+V LLG C  G   L++ E+   G L +FL
Sbjct: 89  MSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.0 bits (109), Expect = 5e-05
 Identities = 60/247 (24%), Positives = 95/247 (38%), Gaps = 75/247 (30%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR--VFQDSE-KEFKAEVNGIGQTHHKNLVRL 545
           +G GAFG V    V    ++ + A+K L +  V   ++    KAE + + +  ++ +V+L
Sbjct: 9   IGIGAFGEVC--LVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGI-----ARGLFYLHEEC 600
                +  N   V +++  G + S L             I +GI     AR  FY+ E  
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLL-------------IRLGIFEEDLAR--FYIAELT 111

Query: 601 CT-------QIIHCDIKPQNILLDDYYNARISDFGL------------------------ 629
           C          IH DIKP NIL+D   + +++DFGL                        
Sbjct: 112 CAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSM 171

Query: 630 -----------EKLLTLDQSHTNTAIR-------GTKGYVAPEWFRNMPITVKVDVYSYG 671
                       +L  L++       R       GT  Y+APE       T   D +S G
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231

Query: 672 VLLLEII 678
           V+L E++
Sbjct: 232 VILYEML 238

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.2 bits (107), Expect = 7e-05
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 31/208 (14%)

Query: 493 GAFGTVYKGFVNMGSSDQ-VAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           GA+G VY   V    + Q  A+KK+N+   + ++  ++   E + +    +  +V +   
Sbjct: 12  GAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCS 69

Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIV-MGIAR---GLFYLHEECCTQI 604
            +  R+  +V E++  G  A+ L    K    L  ++  M  A     L YLH      I
Sbjct: 70  FETKRHLCMVMEYVEGGDCATLL----KNIGALPVDMARMYFAETVLALEYLHN---YGI 122

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKL----LT--LDQSHTNTAIR--------GTKGY 650
           +H D+KP N+L+    + +++DFGL K+    LT  L + H     R        GT  Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182

Query: 651 VAPEWFRNMPITVKVDVYSYGVLLLEII 678
           +APE          VD ++ G++L E +
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 45.1 bits (107), Expect = 7e-05
 Identities = 43/161 (26%), Positives = 71/161 (44%), Gaps = 33/161 (20%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKL------NRVFQDSEK------EFKA--EVNGIG 535
           LG G +G V K + +  +   VA+KK+      N V +D +        F    E+  + 
Sbjct: 17  LGEGTYGKVEKAY-DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 536 QTHHKNLVRLLG-YCDEGR-NRLLVYEFMSNGALASFLFGDSK-----PNWKLRTEIVMG 588
           +  H+N++ L+  Y +    N  LV + M+   L   +  D K        K    I++ 
Sbjct: 76  EIKHENIMGLVDVYVEGDFIN--LVMDIMA-SDLKKVV--DRKIRLTESQVKC---ILLQ 127

Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
           I  GL  LH+      +H D+ P NI ++     +I+DFGL
Sbjct: 128 ILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL 165

Length = 335

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 44.6 bits (105), Expect = 2e-04
 Identities = 30/110 (27%), Positives = 48/110 (43%), Gaps = 22/110 (20%)

Query: 584 EIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD----------------DYYNARISDF 627
           +I+      L Y H E    ++H D+KP+NIL++                D    RI D 
Sbjct: 235 QIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292

Query: 628 GLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 677
           G       D+ H+ TAI  T+ Y +PE    +      D++S G ++ E+
Sbjct: 293 GG----CCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338

Length = 467

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 6/96 (6%)

Query: 593 LFY-----LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-HTNTAIRG 646
           LFY     L E    +++H D+K  NI L      ++ DFG  K  +   S    ++  G
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 647 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR 682
           T  Y+APE +     + K D++S GV+L E++ L R
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 10/96 (10%)

Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK 648
           +A G+ +L  + C   +H D+  +N+L+ +    +I DFGL + +  D   +N   +G+ 
Sbjct: 248 VANGMEFLASKNC---VHRDLAARNVLICEGKLVKICDFGLARDIMRD---SNYISKGST 301

Query: 649 ----GYVAPEWFRNMPITVKVDVYSYGVLLLEIICL 680
                ++APE   N   T   DV+S+G+LL EI  L
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTL 337

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 25/152 (16%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKL--NRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           +G+GAFG V    V    + ++ A+K L  + +F+ D     KAE + + ++    +V L
Sbjct: 9   IGKGAFGEVR--LVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI- 604
                + +   L+ EF+  G L + L       +   +E V       FY+  EC   I 
Sbjct: 67  YYSFQDAQYLYLIMEFLPGGDLMTMLI-----KYDTFSEDVT-----RFYM-AECVLAIE 115

Query: 605 -------IHCDIKPQNILLDDYYNARISDFGL 629
                  IH DIKP NIL+D   + ++SDFGL
Sbjct: 116 AVHKLGFIHRDIKPDNILIDRGGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.3 bits (102), Expect = 4e-04
 Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 6/92 (6%)

Query: 486 FKEELGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQT-HH 539
           F + LG GAFG V +    G     ++  VAVK L      +E+E   +E+  +    +H
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98

Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFL 571
            N+V LLG C  G   L++ E+   G L +FL
Sbjct: 99  INIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 43.2 bits (101), Expect = 6e-04
 Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 36/222 (16%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEK-EFKAEVNGIGQTHHKNLVR 544
           +++G G FG V+   V    + +    K    R  ++ EK +   EVN + +  HKN+VR
Sbjct: 19  KKIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVR 76

Query: 545 LLG-YCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
            +  + ++   +L ++ EF   G L+  +    K   K+    ++ I R L +    C  
Sbjct: 77  YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN 136

Query: 603 --------QIIHCDIKPQNILLDDYYN-----------------ARISDFGLEKLLTLDQ 637
                   +++H D+KPQNI L                      A+I DFGL K + + +
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI-E 195

Query: 638 SHTNTAIRGTKGYVAPEWFRNMPITV--KVDVYSYGVLLLEI 677
           S  ++ + GT  Y +PE   +   +   K D+++ G ++ E+
Sbjct: 196 SMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236

Length = 1021

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 42.3 bits (99), Expect = 7e-04
 Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 27/153 (17%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG GAFG V      + +    A+K L +   + ++     KAE + + +  ++ +VRL 
Sbjct: 9   LGIGAFGEVCLA-RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLY 67

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGI---ARGLFYLHEECCT- 602
               +  N   V +++  G + S L             I MGI       FY+ E  C  
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLL-------------IRMGIFPEDLARFYIAELTCAV 114

Query: 603 ------QIIHCDIKPQNILLDDYYNARISDFGL 629
                   IH DIKP NIL+D   + +++DFGL
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 41.8 bits (98), Expect = 9e-04
 Identities = 35/95 (36%), Positives = 45/95 (47%), Gaps = 11/95 (11%)

Query: 486 FKEELGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEV---NGIGQT 537
             + LGRGAFG V +    G     S   VAVK L      SE K    E+     IG  
Sbjct: 11  LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG-- 68

Query: 538 HHKNLVRLLGYCDEGRNRLLV-YEFMSNGALASFL 571
           HH N+V LLG C +    L+V  E+   G L+++L
Sbjct: 69  HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYL 103

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 41.4 bits (98), Expect = 0.001
 Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 26/199 (13%)

Query: 493 GAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-FKA----EVNGIGQTHHKNLVRL-- 545
           G +G VY+   +  + + VA+KKL     + EKE F      E+N + +  H N+V +  
Sbjct: 16  GTYGVVYRA-RDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKLQHPNIVTVKE 71

Query: 546 --LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI---VMGIARGLFYLHEEC 600
             +G         +V E++ +  L S +  ++     L++E+   ++ +  G+ +LH+  
Sbjct: 72  VVVG--SNLDKIYMVMEYVEH-DLKSLM--ETMKQPFLQSEVKCLMLQLLSGVAHLHDN- 125

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              I+H D+K  N+LL++    +I DFGL +          T +  T  Y APE      
Sbjct: 126 --WILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVVTLWYRAPELLLGAK 182

Query: 661 I-TVKVDVYSYGVLLLEII 678
             +  +D++S G +  E++
Sbjct: 183 EYSTAIDMWSVGCIFAELL 201

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 29/93 (31%), Positives = 44/93 (47%), Gaps = 3/93 (3%)

Query: 585 IVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI 644
           I   + R + YLHE    +IIH DIK +NI ++   +  + DFG         ++     
Sbjct: 187 IERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243

Query: 645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 677
            GT    APE     P    VD++S G++L E+
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276

Length = 391

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 35/115 (30%), Positives = 52/115 (45%), Gaps = 11/115 (9%)

Query: 567 LASFLFGDSKPNWKLRTEIVMGIARGLF----YLHEECCTQIIHCDIKPQNILLDDYYNA 622
           L ++L    +P   L    V  +AR L     Y+H      IIH DIK +N+L++   + 
Sbjct: 246 LYTYLGARLRP---LGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDI 299

Query: 623 RISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLE 676
            + DFG         S   +  I GT    APE     P T  VD++S G+++ E
Sbjct: 300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 61/246 (24%), Positives = 99/246 (40%), Gaps = 69/246 (28%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG GAFG V      + +    A+K L +   + ++     KAE + + +  ++ +V+L 
Sbjct: 9   LGIGAFGEVCLA-CKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY 67

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIV-MGIARGLFYLHE-----EC 600
               +  N   V +++  G + S L         +R E+    +AR  FY+ E     E 
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLL---------IRMEVFPEVLAR--FYIAELTLAIES 116

Query: 601 CTQI--IHCDIKPQNILLDDYYNARISDFGL----------------------------- 629
             ++  IH DIKP NIL+D   + +++DFGL                             
Sbjct: 117 VHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176

Query: 630 ----------EKLLTLDQSHTNTAIR-------GTKGYVAPEWFRNMPITVKVDVYSYGV 672
                     ++L TL+Q  T    R       GT  Y+APE       T   D +S GV
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236

Query: 673 LLLEII 678
           +L E++
Sbjct: 237 ILFEML 242

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family

 Score = 38.0 bits (89), Expect = 0.002
 Identities = 24/93 (25%), Positives = 39/93 (41%), Gaps = 15/93 (16%)

Query: 214 ENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINN 273
           EN + V  T   ++    Y R TL+ +G    ++   N+      W++    P++ C   
Sbjct: 29  ENNEEVYYTY-RMTNNSIYSRLTLSSEGSLERFTWIPNSQ----DWNLFWSAPKDQC--- 80

Query: 274 DIRKGLGSGICGFNSICSISGAKRPICQCPKGF 306
           D+      G CG    C ++    P C C KGF
Sbjct: 81  DV-----YGRCGPYGYCDVN--TSPKCNCIKGF 106

In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110

>gnl|CDD|214511 smart00090, RIO, RIO-like kinase

 Score = 39.2 bits (92), Expect = 0.004
 Identities = 36/163 (22%), Positives = 62/163 (38%), Gaps = 28/163 (17%)

Query: 482 VTRGFKEELGR----GAFGTVYKGFVNMGSSDQVAVK--KLNR-VFQDSEK----EFKAE 530
           + RG    +G     G    VY      GS  + AVK  +     F+  ++    +F+ +
Sbjct: 24  LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFK 83

Query: 531 VNGIGQTH---------HKNLVRLLGY---CDEG---RNRLLVYEFMSNGALASFLFGDS 575
              I              +NL RL        +    R  +LV EF+    L +    D 
Sbjct: 84  YRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKDV 143

Query: 576 KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD 618
           +P  +   E+   I   +  L++E   +++H D+   NIL+ D
Sbjct: 144 EPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVHD 184

Length = 237

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	762
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.98
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.98
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.98
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.98
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.98
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.98
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.98
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.98
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.98
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.98
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.98
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.98
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.98
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.98
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	99.88
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	99.86
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.81
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.78
PF00954	110	S_locus_glycop: S-locus glycoprotein family; Inter	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.75
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.74
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.73
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.72
PRK10345	210	hypothetical protein; Provisional	99.72
smart00090	237	RIO RIO-like kinase.	99.7
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.69
PRK14879	211	serine/threonine protein kinase; Provisional	99.67
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.64
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.63
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.58
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.55
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.54
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.53
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.51
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.39
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.36
KOG1243	690	consensus Protein kinase [General function predict	99.19
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.19
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.19
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.16
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.13
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	99.11
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.1
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.07
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.06
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.03
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.96
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.91
KOG3087	229	consensus Serine/threonine protein kinase [General	98.87
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	98.87
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	98.87
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	98.77
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.76
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.68
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.64
COG4248	637	Uncharacterized protein with protein kinase and he	98.58
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.58
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.52
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.48
PRK09902	216	hypothetical protein; Provisional	98.45
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.25
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	98.2
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.16
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.13
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.08
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.03
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.02
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	97.96
PF01636	239	APH: Phosphotransferase enzyme family This family	97.9
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.89
PLN02876	822	acyl-CoA dehydrogenase	97.77
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.69
PRK10593	297	hypothetical protein; Provisional	97.64
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.64
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.54
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.45
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.42
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.35
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.34
cd01100	73	APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d	97.24
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.2
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.13
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.78
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.59
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.52
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.5
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.43
PRK05231	319	homoserine kinase; Provisional	96.38
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.34
PLN02236	344	choline kinase	96.23
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.13
PLN02756	418	S-methyl-5-thioribose kinase	96.04
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.84
KOG2270	520	consensus Serine/threonine protein kinase involved	95.46
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.3
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.04

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-52  Score=450.63  Aligned_cols=277  Identities=44%  Similarity=0.751  Sum_probs=241.3

Q ss_pred             cccccCHHHHHHHHhhhh--hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhc
Q 004312          470 NLRCFTYKELVEVTRGFK--EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG  547 (762)
Q Consensus       470 ~~~~~~~~el~~~t~~~~--~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g  547 (762)
                      ..+.|++.|+.++|++|.  ..||+|+||.||+|.+.++  ..||||++........++|.+|++++.+++|||+|+|+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~--~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlG  138 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG--TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLG  138 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC--CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEE
Confidence            577899999999999998  4899999999999998755  689999987654331567999999999999999999999


Q ss_pred             eeccCCc-eeEEEeccCCCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEE
Q 004312          548 YCDEGRN-RLLVYEFMSNGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARI  624 (762)
Q Consensus       548 ~~~~~~~-~~LV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl  624 (762)
                      ||.+.++ ++||||||++|+|.++|+...  .++|.+|++||.++|+||+|||..+.++||||||||+|||||+++++||
T Consensus       139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9999994 999999999999999999875  8999999999999999999999999999999999999999999999999


Q ss_pred             ecccccccccCCCCcccccc-cccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCc----------hhhHHHhh
Q 004312          625 SDFGLEKLLTLDQSHTNTAI-RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTIL----------TDWAYDCY  693 (762)
Q Consensus       625 ~Dfgla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~----------~~~~~~~~  693 (762)
                      +|||+++..... ....... .||.+|+|||++..+..|.|+|||||||+|+||+||+++..          ..|....+
T Consensus       219 sDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  219 SDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             cCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            999999765431 1111112 79999999999999999999999999999999999997643          34555666


Q ss_pred             hccccccccccccc-cCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          694 QERTLGALVENDLE-AMDDM-TVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       694 ~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      .+..+.+++|+.+. ...+. ....++..++.+|++.+|.+||+|.||+++|+.+...
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            77788899999876 44443 6788899999999999999999999999999765544

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=402.85  Aligned_cols=251  Identities=34%  Similarity=0.505  Sum_probs=212.6

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEccccccch--hHHHHHHhhhhcccccCCccchhceeccCC-ceeEEEeccC
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS--EKEFKAEVNGIGQTHHKNLVRLLGYCDEGR-NRLLVYEFMS  563 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~LV~E~~~  563 (762)
                      .+.||+|+||+||+|.+...  ..||||++.......  .++|.+|+.+|.+++|||||+++|.|.+.. ...||||||+
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~--~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGT--DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhcccCCceeEEEEEeCCc--eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            35699999999999998732  239999998654333  459999999999999999999999999988 7999999999


Q ss_pred             CCchhhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCC-eEeCCCCCCceEEcCCC-ceEEecccccccccCCCCc
Q 004312          564 NGALASFLFG--DSKPNWKLRTEIVMGIARGLFYLHEECCTQ-IIHCDIKPQNILLDDYY-NARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       564 ~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~  639 (762)
                      +|+|..+|++  ...+++..+++|+.|||+||.|||++   + ||||||||+|||++.+. ++||+|||+++...... .
T Consensus       124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~  199 (362)
T KOG0192|consen  124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T  199 (362)
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence            9999999988  57899999999999999999999999   7 99999999999999997 99999999998765332 3


Q ss_pred             ccccccccCcccCccccc--CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFR--NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~--~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      ..+...||+.|||||+++  ...++.|+|||||||+||||+||+.||........     ...++....+...+..++..
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~-----~~~v~~~~~Rp~~p~~~~~~  274 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV-----ASAVVVGGLRPPIPKECPPH  274 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHhcCCCCCCCccCCHH
Confidence            334467999999999999  56999999999999999999999999855433111     11222333344445557889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      +..++.+||+.||+.||++.+++.+|+.+..
T Consensus       275 l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  275 LSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             HHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence            9999999999999999999999999998654

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-45  Score=391.94  Aligned_cols=255  Identities=29%  Similarity=0.416  Sum_probs=220.9

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      ...+.+.||+|-||.||.|.++..  ..||||.++.. ......|.+|+.+|++|+|+|||+++|+|..++.++||||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~--~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGS--TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCC--CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence            345678899999999999999743  47999999865 444578999999999999999999999999999999999999


Q ss_pred             CCCchhhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          563 SNGALASFLFG--DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       563 ~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      ++|+|.+||..  ...+...+.+.++.|||+||+||+++   ++|||||.++|||++++..+||+|||||+....+....
T Consensus       284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            99999999987  46789999999999999999999999   99999999999999999999999999999655544444


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      .....-...|.|||.+..+.++.|||||||||+||||+| |+.|+.      .+....+.+.++.+.+...|..+++++.
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~------~msn~ev~~~le~GyRlp~P~~CP~~vY  434 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP------GMSNEEVLELLERGYRLPRPEGCPDEVY  434 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC------CCCHHHHHHHHhccCcCCCCCCCCHHHH
Confidence            444445678999999999999999999999999999998 455542      2333345556777778888889999999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      +|+..||+.+|++|||++.+...|+.+...
T Consensus       435 ~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  435 ELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             HHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            999999999999999999999999886543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-45  Score=370.74  Aligned_cols=257  Identities=26%  Similarity=0.363  Sum_probs=213.3

Q ss_pred             cCHHHHHHHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccc-cccchhHHHHHHhhhhcccccCCccchhceeccC
Q 004312          474 FTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG  552 (762)
Q Consensus       474 ~~~~el~~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  552 (762)
                      ++..|++.     ...||+|..|+|||+.++ .+++.+|+|.+.. ......+++.+|++++++.+||+||+++|.|...
T Consensus        76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk-~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~  149 (364)
T KOG0581|consen   76 ISLSDLER-----LGVLGSGNGGTVYKVRHK-PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN  149 (364)
T ss_pred             cCHHHhhh-----hhhcccCCCcEEEEEEEc-CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence            45556553     367999999999999754 5678999999953 3345567899999999999999999999999988


Q ss_pred             C-ceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          553 R-NRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       553 ~-~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                      . +..|+||||.+|+|++++...+++++....+|+.+|++||.|||+.  .+||||||||+|||++..|.+||||||.++
T Consensus       150 ~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~  227 (364)
T KOG0581|consen  150 GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSG  227 (364)
T ss_pred             CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccH
Confidence            8 5999999999999999999889999999999999999999999973  399999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCC
Q 004312          632 LLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD  711 (762)
Q Consensus       632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  711 (762)
                      .+...   .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+..........-..+..+++........
T Consensus       228 ~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~  304 (364)
T KOG0581|consen  228 ILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE  304 (364)
T ss_pred             Hhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc
Confidence            87543   445678999999999999999999999999999999999999998664100000011222333332222222


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       712 ~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ..++++++.++..||++||.+||+++|+++
T Consensus       305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            258899999999999999999999999886

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-45  Score=375.47  Aligned_cols=249  Identities=24%  Similarity=0.404  Sum_probs=207.7

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc-------hhHHHHHHhhhhcccccCCccchhceeccCCce
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD-------SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNR  555 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  555 (762)
                      .+-+.+.||+|+||.|-+|. +..+++.||||++++....       ......+|+++|++|+|||||++++++...+..
T Consensus       173 ~yii~~~LGsGafg~Vkla~-e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  173 YYIISKTLGSGAFGLVKLAY-EKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             eeEeeeeecCCceeEEEEEE-EcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            34456889999999999995 5577889999999753221       233567999999999999999999999999999


Q ss_pred             eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC---CceEEeccccccc
Q 004312          556 LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY---YNARISDFGLEKL  632 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~Dfgla~~  632 (762)
                      |||||||++|.|.+++-.++.+.+..-..++.|++.|+.|||++   ||+||||||+|||+..+   ..+||+|||+|+.
T Consensus       252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            99999999999999999999999999999999999999999999   99999999999999755   7899999999998


Q ss_pred             ccCCCCcccccccccCcccCcccccCCC---CCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccc--c
Q 004312          633 LTLDQSHTNTAIRGTKGYVAPEWFRNMP---ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL--E  707 (762)
Q Consensus       633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~  707 (762)
                      ..  ....+.+.+|||.|.|||++.+..   +..+.|+||+||+||-+++|..||..........+    ++....+  .
T Consensus       329 ~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e----QI~~G~y~f~  402 (475)
T KOG0615|consen  329 SG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE----QILKGRYAFG  402 (475)
T ss_pred             cc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH----HHhcCccccc
Confidence            75  455567789999999999998764   33588999999999999999999855432221111    1111111  1


Q ss_pred             cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       708 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .....+++++..++|.+||..||++|||+.|+++
T Consensus       403 p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  403 PLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            2234578899999999999999999999999885

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-43  Score=381.62  Aligned_cols=247  Identities=24%  Similarity=0.375  Sum_probs=216.2

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +|...+.||+|+|+.||+++. ..+++.||+|++.+..   ....+...+||++.++|+|||||+++++|++.+..|||.
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~-~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARD-LDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEE-cCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            345567899999999999975 2456899999997632   334567889999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |+|++++|..+++..+.+++.+++.+..||+.||.|||+.   +|+|||||..|++|+++.++||+|||||..+..+ .+
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-GE  173 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc-cc
Confidence            9999999999999889999999999999999999999999   9999999999999999999999999999987643 34


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ...+.+|||.|+|||++....++..+||||+||+||.|+.|+.||......+.+..........       |...+.++.
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~-------P~~ls~~A~  246 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM-------PSHLSAEAK  246 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc-------ccccCHHHH
Confidence            5567899999999999999999999999999999999999999998776655555443333222       235677889


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +||.++|+.+|.+|||+++|+.
T Consensus       247 dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  247 DLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HHHHHHhcCCcccCCCHHHHhc
Confidence            9999999999999999999985

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-44  Score=365.13  Aligned_cols=244  Identities=25%  Similarity=0.390  Sum_probs=200.6

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|+|++||+|++... +.+||||.+.+.  .....+.+..|+++|+.++|||||++++++..++..+||||||
T Consensus        13 ~~~~~iG~GsfavVykg~h~~~-~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC   91 (429)
T KOG0595|consen   13 ELSREIGSGSFAVVYKGRHKKS-GTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC   91 (429)
T ss_pred             eehhhccCcceEEEEEeEeccC-CceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence            3456799999999999998755 489999999765  4555667899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC------CceEEecccccccccCC
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY------YNARISDFGLEKLLTLD  636 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~------~~~kl~Dfgla~~~~~~  636 (762)
                      .+|+|.+||+..+.+++.+.+.++.|+|.||++||++   +||||||||+||||+..      -.+||+|||+|+.+.  
T Consensus        92 ~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~--  166 (429)
T KOG0595|consen   92 NGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ--  166 (429)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC--
Confidence            9999999999999999999999999999999999999   99999999999999854      568999999999886  


Q ss_pred             CCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          637 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      ........+|++-|||||++...+|+.|+|+||.|+|||++++|+.||......+........    .......+...+.
T Consensus       167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~----~~~~~~~~~~~s~  242 (429)
T KOG0595|consen  167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG----NEIVPVLPAELSN  242 (429)
T ss_pred             chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc----ccccCchhhhccC
Confidence            344455688999999999999999999999999999999999999998655444443321111    1112222333444


Q ss_pred             HHHHHHHHhhccCCCCCCCHHH
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRR  738 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~e  738 (762)
                      .+.+++...++.+|.+|-++.+
T Consensus       243 ~~~~Ll~~ll~~~~~~~~~~~~  264 (429)
T KOG0595|consen  243 PLRELLISLLQRNPKDRISFED  264 (429)
T ss_pred             chhhhhhHHHhcCccccCchHH
Confidence            4556666666667666655544

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.5e-44  Score=400.71  Aligned_cols=260  Identities=26%  Similarity=0.387  Sum_probs=217.9

Q ss_pred             HHHhhhhhhcCCCCcceEEEeeeeC----CCcceEEEEEccccccc-hhHHHHHHhhhhcccccCCccchhceeccCCce
Q 004312          481 EVTRGFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNR  555 (762)
Q Consensus       481 ~~t~~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  555 (762)
                      .....+.++||+|+||+||+|+...    +....||||.++..... ..++|++|+++++.++|||||+|+|.|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            3334567889999999999997653    23457999999987665 678999999999999999999999999999999


Q ss_pred             eEEEeccCCCchhhhccCC----------C----CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc
Q 004312          556 LLVYEFMSNGALASFLFGD----------S----KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN  621 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~----------~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~  621 (762)
                      ++|+|||..|+|.+||..+          .    .++..+.+.||.|||.||.||.++   .+|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence            9999999999999999632          1    278899999999999999999999   9999999999999999999


Q ss_pred             eEEecccccccccCCCCcccc-cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccc
Q 004312          622 ARISDFGLEKLLTLDQSHTNT-AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLG  699 (762)
Q Consensus       622 ~kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~  699 (762)
                      |||+||||++.....+..... .-.-..+|||||.+..++||.+||||||||+|||+++ |+.|+..-...      .+.
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------EVI  715 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------EVI  715 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH------HHH
Confidence            999999999966544433322 2224578999999999999999999999999999997 77776443322      233


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          700 ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       700 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      +.+..+.....+..++.++..|+..||+.+|++||+++||-..|+...+.
T Consensus       716 e~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  716 ECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            33333333566778999999999999999999999999999999986544

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-44  Score=392.08  Aligned_cols=270  Identities=26%  Similarity=0.454  Sum_probs=234.0

Q ss_pred             ccccCHHHHHHHHhhhh-----------hhcCCCCcceEEEeeeeCCC--cceEEEEEccccccch-hHHHHHHhhhhcc
Q 004312          471 LRCFTYKELVEVTRGFK-----------EELGRGAFGTVYKGFVNMGS--SDQVAVKKLNRVFQDS-EKEFKAEVNGIGQ  536 (762)
Q Consensus       471 ~~~~~~~el~~~t~~~~-----------~~iG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~~~~~-~~~~~~E~~~l~~  536 (762)
                      ...++|+|--++..+|.           ++||.|.||.|++|.++...  ...||||.++....++ ..+|..|+.||.+
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ  686 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ  686 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence            34578888777777664           35999999999999987644  3469999999765544 5689999999999


Q ss_pred             cccCCccchhceeccCCceeEEEeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceE
Q 004312          537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNIL  615 (762)
Q Consensus       537 l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIL  615 (762)
                      ++||||++|.|........+||+|||+||+|+.||..+ +.+++.+...|+++||.||.||.+.   ++|||||.++|||
T Consensus       687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNIL  763 (996)
T KOG0196|consen  687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNIL  763 (996)
T ss_pred             CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhee
Confidence            99999999999999999999999999999999999866 6799999999999999999999998   9999999999999


Q ss_pred             EcCCCceEEecccccccccCCCCcccccccc--cCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHh
Q 004312          616 LDDYYNARISDFGLEKLLTLDQSHTNTAIRG--TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDC  692 (762)
Q Consensus       616 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~  692 (762)
                      ++.|...|++|||++|.+.++.....+..-|  ..+|.|||.+....+|.++|||||||+|||.++ |.+|+      -.
T Consensus       764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY------Wd  837 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY------WD  837 (996)
T ss_pred             eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc------cc
Confidence            9999999999999999887666433333323  468999999999999999999999999999885 77775      33


Q ss_pred             hhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          693 YQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      +.+..+...++.+.+.+.++.++..+.+|++.||++|-.+||.+.||+.+|.+++.-
T Consensus       838 mSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  838 MSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             cchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            444455566777888888999999999999999999999999999999999997654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-42  Score=337.67  Aligned_cols=255  Identities=24%  Similarity=0.367  Sum_probs=208.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccc--cccchhHHHHHHhhhhcccccCCccchhc-eeccCCc-eeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLLG-YCDEGRN-RLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g-~~~~~~~-~~LV~  559 (762)
                      +.+.++||+|.||+|||+.. ..++..+|.|.++-  .+....++...|+.+|++|+|||||++++ -+.+..+ +.|||
T Consensus        21 y~Il~~IG~GsFg~vykv~~-~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQC-LLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHcCCcchheEEeee-ccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            55678999999999999964 35577999999873  33445578999999999999999999999 4455555 89999


Q ss_pred             eccCCCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCC-CeEeCCCCCCceEEcCCCceEEeccccccccc
Q 004312          560 EFMSNGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEECCT-QIIHCDIKPQNILLDDYYNARISDFGLEKLLT  634 (762)
Q Consensus       560 E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~  634 (762)
                      |||..|+|...++.    ++.++++.+++++.|++.||.++|.+... -|+||||||.||+|+.+|.+||+|||+++++.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            99999999998853    46789999999999999999999995332 39999999999999999999999999999986


Q ss_pred             CCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHH
Q 004312          635 LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  714 (762)
                      ..... ....+|||.||+||.+.+.+|+.|+||||+||++|||...+.||.++.-++.-....     ..+.....+...
T Consensus       180 s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~-----qgd~~~~p~~~Y  253 (375)
T KOG0591|consen  180 SKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIE-----QGDYPPLPDEHY  253 (375)
T ss_pred             chhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHH-----cCCCCCCcHHHh
Confidence            54433 334679999999999999999999999999999999999999998774333322211     112233334678


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      +.++..||..|+..||+.||+...+++.+..
T Consensus       254 S~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  254 STDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             hhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            9999999999999999999985555544433

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-41  Score=343.23  Aligned_cols=238  Identities=24%  Similarity=0.326  Sum_probs=204.2

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.++||+|+||+||.++-. .+++.+|+|.+++..   ....+...+|..+|.+++||.||+++-.+++.+.+|||+||+
T Consensus        29 ~lkviGkG~fGkV~~Vrk~-dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~  107 (357)
T KOG0598|consen   29 ILKVIGKGSFGKVFQVRKK-DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL  107 (357)
T ss_pred             eeeeeeccCCceEEEEEEc-ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence            4578999999999999765 677899999997642   234567889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      .||.|..+|.+++.+++....-++..|+.||.|||++   +||||||||+|||||++|+++|+|||+++.... .+....
T Consensus       108 ~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-~~~~t~  183 (357)
T KOG0598|consen  108 NGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-DGDATR  183 (357)
T ss_pred             CCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc-CCCccc
Confidence            9999999999999999999999999999999999999   999999999999999999999999999986543 233445


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      .++||+.|||||++....++..+|.||+|+++|||++|..||........++......      ....+.-.+.+.++++
T Consensus       184 tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k------~~~~p~~ls~~ardll  257 (357)
T KOG0598|consen  184 TFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK------LPLPPGYLSEEARDLL  257 (357)
T ss_pred             cccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc------CCCCCccCCHHHHHHH
Confidence            5899999999999999999999999999999999999999997664433333221111      1122333678899999


Q ss_pred             HHhhccCCCCCC
Q 004312          723 IWCIQEDPSHRP  734 (762)
Q Consensus       723 ~~cl~~dp~~RP  734 (762)
                      .+.|..||++|.
T Consensus       258 ~~LL~rdp~~RL  269 (357)
T KOG0598|consen  258 KKLLKRDPRQRL  269 (357)
T ss_pred             HHHhccCHHHhc
Confidence            999999999996

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=356.48  Aligned_cols=249  Identities=27%  Similarity=0.404  Sum_probs=204.0

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.||+|.||+||+|++..    .||||+++-..  .+..+.|++|+..+++-+|.||+-+.|+|..... .||+.+|+
T Consensus       396 l~~rIGsGsFGtV~Rg~whG----dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCe  470 (678)
T KOG0193|consen  396 LGERIGSGSFGTVYRGRWHG----DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCE  470 (678)
T ss_pred             ccceeccccccceeeccccc----ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhcc
Confidence            45789999999999999873    59999997533  3455789999999999999999999999998887 99999999


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC-Cccc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ-SHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-~~~~  641 (762)
                      +-+|+.+|+.. .+++..+.+.||.|||+||.|||.+   +|||||||..||+|.++++|||+|||++.....-. ....
T Consensus       471 GsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~  547 (678)
T KOG0193|consen  471 GSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL  547 (678)
T ss_pred             CchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecccccc
Confidence            99999999865 5788999999999999999999999   99999999999999999999999999987543321 2222


Q ss_pred             ccccccCcccCcccccC---CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccc----ccCCCHHH
Q 004312          642 TAIRGTKGYVAPEWFRN---MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL----EAMDDMTV  714 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~---~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  714 (762)
                      ....|..-|||||+++.   .+|+.++||||||+++|||++|..|+.....     +..+. ++..++    .......+
T Consensus       548 ~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-----dqIif-mVGrG~l~pd~s~~~s~~  621 (678)
T KOG0193|consen  548 EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-----DQIIF-MVGRGYLMPDLSKIRSNC  621 (678)
T ss_pred             CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-----hheEE-EecccccCccchhhhccC
Confidence            23447789999999863   4799999999999999999999999742211     11111 111111    01112356


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      +.++.+|+..||..++++||++.+|+.+|+.+..
T Consensus       622 pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  622 PKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             HHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            7899999999999999999999999998888655

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-41  Score=354.34  Aligned_cols=250  Identities=30%  Similarity=0.457  Sum_probs=216.5

Q ss_pred             ccccCHHHHHHHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceec
Q 004312          471 LRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCD  550 (762)
Q Consensus       471 ~~~~~~~el~~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~  550 (762)
                      +-.+.|++|.+.     +=||.|+.|.||+|+++   ++.||||+++...       .-+|+-|++|+|+||+.+.|+|.
T Consensus       118 ~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~---netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCt  182 (904)
T KOG4721|consen  118 LWEIPFEEISEL-----EWLGSGAQGAVFLGRLH---NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCT  182 (904)
T ss_pred             hccCCHHHhhhh-----hhhccCcccceeeeecc---CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeec
Confidence            445677777654     34999999999999987   5789999986432       24688899999999999999999


Q ss_pred             cCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccc
Q 004312          551 EGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLE  630 (762)
Q Consensus       551 ~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla  630 (762)
                      ...-.+||||||+.|-|.+.|+....+.......+..+||.||.|||.+   .|||||||.-||||..+..+||+|||-+
T Consensus       183 qsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS  259 (904)
T KOG4721|consen  183 QSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTS  259 (904)
T ss_pred             CCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccch
Confidence            9999999999999999999999999999999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCC
Q 004312          631 KLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMD  710 (762)
Q Consensus       631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  710 (762)
                      +.....  .....++||..|||||++++.+.++|.||||||||||||+||..|+..-     -...++..+-.+.+....
T Consensus       260 ~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV-----dssAIIwGVGsNsL~Lpv  332 (904)
T KOG4721|consen  260 KELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV-----DSSAIIWGVGSNSLHLPV  332 (904)
T ss_pred             Hhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc-----chheeEEeccCCcccccC
Confidence            876543  3445678999999999999999999999999999999999999996321     112233344445566777


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          711 DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       711 ~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      +..+++-+.-|+++||+-.|..||++.+++..|+-
T Consensus       333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            78899999999999999999999999999998853

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=383.40  Aligned_cols=255  Identities=27%  Similarity=0.424  Sum_probs=211.3

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcc----eEEEEEcccc-ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSD----QVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      .+.+.||+|+||.||+|......+.    .||||.+++. +.+...+|.+|..+|+.++|||||+++|.|.+....+|++
T Consensus       695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l  774 (1025)
T KOG1095|consen  695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL  774 (1025)
T ss_pred             EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence            3456799999999999998765543    4999999875 4555679999999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCC-------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          560 EFMSNGALASFLFGD-------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       560 E~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                      |||++|+|..||++.       ..+.....+.++.|||+|+.|||++   ++|||||..+|+||++...|||+|||||+.
T Consensus       775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArD  851 (1025)
T KOG1095|consen  775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARD  851 (1025)
T ss_pred             hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHh
Confidence            999999999999865       3578999999999999999999999   999999999999999999999999999995


Q ss_pred             ccCCCCcccccc-cccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCC-CCCchhhHHHhhhccccccccccccccCC
Q 004312          633 LTLDQSHTNTAI-RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR-RTILTDWAYDCYQERTLGALVENDLEAMD  710 (762)
Q Consensus       633 ~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  710 (762)
                      ....+....... .-...|||||.+.++.+|.|+|||||||+||||+|.. .|+......+      +...+..+-+...
T Consensus       852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~------v~~~~~~ggRL~~  925 (1025)
T KOG1095|consen  852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE------VLLDVLEGGRLDP  925 (1025)
T ss_pred             hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH------HHHHHHhCCccCC
Confidence            544333322222 2346899999999999999999999999999999855 4543332222      2221222225556


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          711 DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       711 ~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      +..+++.+.+|+..||+.+|++||++..+++.+..+..
T Consensus       926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence            77889999999999999999999999999999887643

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=344.11  Aligned_cols=252  Identities=26%  Similarity=0.404  Sum_probs=203.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCC--ceeEEEec
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR--NRLLVYEF  561 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~LV~E~  561 (762)
                      +...+.||+|+||.||++.... +++..|||.+........+.+.+|+++|.+++|||||+.+|......  ...|.|||
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~-~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKK-TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhccccCccceEEEEEEecC-CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            3455789999999999997553 36789999987653333567899999999999999999999855544  68999999


Q ss_pred             cCCCchhhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC-CCceEEecccccccccC--CC
Q 004312          562 MSNGALASFLFGDS-KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD-YYNARISDFGLEKLLTL--DQ  637 (762)
Q Consensus       562 ~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~--~~  637 (762)
                      +++|+|.+++.+.+ .+++..+..+..||++||+|||++   +|+||||||+|||++. ++.+||+|||+++....  ..
T Consensus        98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            99999999999876 799999999999999999999999   9999999999999999 79999999999987763  22


Q ss_pred             CcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      ........||+.|||||++.++ ...+++|||||||++.||+||+.|+...  ..  ....+..+.........+...+.
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~--~~~~~~~ig~~~~~P~ip~~ls~  250 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FE--EAEALLLIGREDSLPEIPDSLSD  250 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cc--hHHHHHHHhccCCCCCCCcccCH
Confidence            3344567899999999999864 3346999999999999999999986431  00  00001111111122244556788


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHh
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQML  743 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L  743 (762)
                      +..+++.+|++.+|++|||++++++..
T Consensus       251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  251 EAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             HHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            999999999999999999999999764

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=349.20  Aligned_cols=247  Identities=24%  Similarity=0.334  Sum_probs=214.1

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .|.+.||+|+|++|++++. ..+++++|||++.+..   +...+-...|-.+|.+| .||.|++|+-.|.+...+|.|+|
T Consensus        76 ~Fg~~lGeGSYStV~~A~~-~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe  154 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLARE-KATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE  154 (604)
T ss_pred             chhheeccccceeEEEeee-cCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence            4778999999999999974 4577899999997643   33345677899999999 89999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc-
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-  639 (762)
                      |+++|+|.++|++.+.+++...+.++.+|+.||+|||+.   |||||||||+|||||+|+++||+|||.|+.+...... 
T Consensus       155 ~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~  231 (604)
T KOG0592|consen  155 YAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ  231 (604)
T ss_pred             ecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence            999999999999999999999999999999999999999   9999999999999999999999999999988653322 


Q ss_pred             ---------c--cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccccc
Q 004312          640 ---------T--NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEA  708 (762)
Q Consensus       640 ---------~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  708 (762)
                               .  ...++||..|++||++.+...++.+|+|+||||||+|+.|+.||.....|-.++...-.+       -
T Consensus       232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~-------y  304 (604)
T KOG0592|consen  232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD-------Y  304 (604)
T ss_pred             cCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc-------c
Confidence                     1  144789999999999999999999999999999999999999998776666655432211       1


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          709 MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       709 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ..+...++.+.+|+.+.|..||++|+|.+||.+.
T Consensus       305 ~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  305 EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            2234456889999999999999999999998864

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=359.86  Aligned_cols=257  Identities=29%  Similarity=0.390  Sum_probs=213.6

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCc---ceEEEEEccc---cccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSS---DQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +.++||+|+||.||+|++.....   ..||||..+.   ......++|++|++++++++|||||+++|++.....++|||
T Consensus       161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm  240 (474)
T KOG0194|consen  161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM  240 (474)
T ss_pred             ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence            44789999999999999987543   2389999874   33556679999999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          560 EFMSNGALASFLFGDS-KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      |+|+||+|.++|.+.+ .++..++.+++.+.|.||+|||++   ++|||||..+|+|++.+..+||+|||+++.-..  .
T Consensus       241 El~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~--~  315 (474)
T KOG0194|consen  241 ELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ--Y  315 (474)
T ss_pred             EecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcc--e
Confidence            9999999999999886 599999999999999999999999   999999999999999999999999999875431  1


Q ss_pred             cccc-cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          639 HTNT-AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       639 ~~~~-~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      .... ...-...|+|||.+..+-++.++|||||||++||+++ |..|+......+...     .++....+...+...+.
T Consensus       316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~-----kI~~~~~r~~~~~~~p~  390 (474)
T KOG0194|consen  316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA-----KIVKNGYRMPIPSKTPK  390 (474)
T ss_pred             eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH-----HHHhcCccCCCCCCCHH
Confidence            1111 1134578999999999999999999999999999998 677765543332222     22233344444556678


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCCCC
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIP  752 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~p  752 (762)
                      ++..++.+||..+|++||+|.++.+.|+.+.....+
T Consensus       391 ~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  391 ELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            889999999999999999999999999987655443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-39  Score=353.48  Aligned_cols=257  Identities=26%  Similarity=0.373  Sum_probs=200.9

Q ss_pred             HhhhhhhcCCCCcceEEEeeee----CCCcceEEEEEcccccc-chhHHHHHHhhhhccc-ccCCccchhceeccCC-ce
Q 004312          483 TRGFKEELGRGAFGTVYKGFVN----MGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGR-NR  555 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~-~~  555 (762)
                      .+.+.+.||+|+||.||+|...    ....+.||||++..... ...+.+.+|++++.++ +||||++++++|...+ ..
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~   87 (338)
T cd05102           8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL   87 (338)
T ss_pred             HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence            3456688999999999999742    22345799999975432 3346799999999999 8999999999887644 57


Q ss_pred             eEEEeccCCCchhhhccCC-------------------------------------------------------------
Q 004312          556 LLVYEFMSNGALASFLFGD-------------------------------------------------------------  574 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~-------------------------------------------------------------  574 (762)
                      ++||||+++|+|.+++...                                                             
T Consensus        88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (338)
T cd05102          88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW  167 (338)
T ss_pred             EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence            8999999999999998642                                                             


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc-ccccccccCcccC
Q 004312          575 -SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-TNTAIRGTKGYVA  652 (762)
Q Consensus       575 -~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~a  652 (762)
                       ..+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+++........ ......+++.|+|
T Consensus       168 ~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         168 KSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence             2367788899999999999999998   9999999999999999999999999999865433221 1223346688999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCC
Q 004312          653 PEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPS  731 (762)
Q Consensus       653 PE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~  731 (762)
                      ||.+.+..++.++||||||+++|||++ |+.||..........     ..+........+...++.+.+++.+||+.||+
T Consensus       245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC-----QRLKDGTRMRAPENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH-----HHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            999999999999999999999999997 888874321111111     11111111112234567899999999999999


Q ss_pred             CCCCHHHHHHHhhcCc
Q 004312          732 HRPTMRRVTQMLEGVV  747 (762)
Q Consensus       732 ~RPt~~evl~~L~~~~  747 (762)
                      +|||+.|++++|+++.
T Consensus       320 ~RPs~~el~~~l~~~~  335 (338)
T cd05102         320 ERPTFSALVEILGDLL  335 (338)
T ss_pred             hCcCHHHHHHHHHHHH
Confidence            9999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=345.60  Aligned_cols=243  Identities=25%  Similarity=0.379  Sum_probs=210.7

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCch
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGAL  567 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL  567 (762)
                      ++||+|+.|.||.+. +..+++.||||++.......++-+.+|+.+|+..+|+|||+++..+..++++++|||||++|+|
T Consensus       279 ~kigqgaSG~vy~A~-~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL  357 (550)
T KOG0578|consen  279 KKIGQGATGGVYVAR-KISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL  357 (550)
T ss_pred             hhhccccccceeeee-eccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence            579999999999996 5566788999999887777778899999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccccccc
Q 004312          568 ASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT  647 (762)
Q Consensus       568 ~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt  647 (762)
                      .+.+.. ..+++.++..|++++++||+|||.+   +|+|||||.+|||++.++.+||+|||++..+...+. .....+||
T Consensus       358 TDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVGT  432 (550)
T KOG0578|consen  358 TDVVTK-TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVGT  432 (550)
T ss_pred             hhhhhc-ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccccCC
Confidence            998854 4489999999999999999999999   999999999999999999999999999988765554 44567799


Q ss_pred             CcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccc-ccccCCCHHHHHHHHHHHHHhh
Q 004312          648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN-DLEAMDDMTVLQRFVMVAIWCI  726 (762)
Q Consensus       648 ~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl  726 (762)
                      |.|||||+.....|.+|.||||||++++||+-|..||+.+.+...+.-     +..+ ......+...+..+.+++.+||
T Consensus       433 PYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-----Ia~ng~P~lk~~~klS~~~kdFL~~cL  507 (550)
T KOG0578|consen  433 PYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNGTPKLKNPEKLSPELKDFLDRCL  507 (550)
T ss_pred             CCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH-----HhhcCCCCcCCccccCHHHHHHHHHHh
Confidence            999999999999999999999999999999999999875433322221     1111 1223335567889999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 004312          727 QEDPSHRPTMRRVTQ  741 (762)
Q Consensus       727 ~~dp~~RPt~~evl~  741 (762)
                      +.|+++||+++|+++
T Consensus       508 ~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  508 VVDVEQRASAKELLE  522 (550)
T ss_pred             hcchhcCCCHHHHhc
Confidence            999999999999986

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2e-39  Score=342.18  Aligned_cols=245  Identities=27%  Similarity=0.392  Sum_probs=213.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.+.+.||+|.||.||||+ +.++.+.||+|.+.+..+  +..+.+.+|++++++++|||||.+++.++...+.++|.||
T Consensus         4 yhv~e~iG~Gsfg~VYKgr-rK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~   82 (808)
T KOG0597|consen    4 YHVYEMIGEGSFGRVYKGR-RKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY   82 (808)
T ss_pred             hhHHHHhcCCccceeeecc-cccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence            4566889999999999997 456778999999876433  3346789999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +.+ +|..+|...+.++++.+..|+.++..||.|||+.   +|+|||+||+|||++.++.+|++|||+|+.+.. .....
T Consensus        83 a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~vl  157 (808)
T KOG0597|consen   83 AVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSVL  157 (808)
T ss_pred             hhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cceee
Confidence            988 9999999999999999999999999999999999   999999999999999999999999999998764 34455


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      +.+.|||-|||||..++++|+..+|.||+|||+||+..|+.||............     +....  ..+.+.+..++.+
T Consensus       158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I-----~~d~v--~~p~~~S~~f~nf  230 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI-----LKDPV--KPPSTASSSFVNF  230 (808)
T ss_pred             eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH-----hcCCC--CCcccccHHHHHH
Confidence            6678999999999999999999999999999999999999999776555444322     11111  1244778899999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 004312          722 AIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~  741 (762)
                      +...|++||.+|.|..+++.
T Consensus       231 l~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  231 LQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HHHHhhcChhhcccHHHHhc
Confidence            99999999999999998875

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.8e-39  Score=339.58  Aligned_cols=260  Identities=17%  Similarity=0.304  Sum_probs=207.7

Q ss_pred             ccccCHHHHHHHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccch---hHHHHHHhhhhcccccCCccchhc
Q 004312          471 LRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLLG  547 (762)
Q Consensus       471 ~~~~~~~el~~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~g  547 (762)
                      ++.+..+++...+   ...||+|+++.||+|.+.   ++.||||+++......   .+.|.+|+.++.+++||||++++|
T Consensus        12 ~~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g   85 (283)
T PHA02988         12 IKCIESDDIDKYT---SVLIKENDQNSIYKGIFN---NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG   85 (283)
T ss_pred             ceecCHHHcCCCC---CeEEeeCCceEEEEEEEC---CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence            4445555552111   135999999999999873   5789999997643333   467889999999999999999999


Q ss_pred             eecc----CCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceE
Q 004312          548 YCDE----GRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNAR  623 (762)
Q Consensus       548 ~~~~----~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k  623 (762)
                      ++.+    ....++||||+++|+|.+++.+...+++.....++.|++.||+|||+.  .+++||||||+|||+++++.+|
T Consensus        86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~k  163 (283)
T PHA02988         86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLK  163 (283)
T ss_pred             eEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEE
Confidence            9876    346789999999999999999888899999999999999999999973  2788999999999999999999


Q ss_pred             EecccccccccCCCCcccccccccCcccCcccccC--CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccc
Q 004312          624 ISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL  701 (762)
Q Consensus       624 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~  701 (762)
                      |+|||+++.+....    ....++..|+|||++.+  ..++.++|||||||++|||++|+.||......+...     .+
T Consensus       164 l~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~-----~i  234 (283)
T PHA02988        164 IICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD-----LI  234 (283)
T ss_pred             EcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH-----HH
Confidence            99999998654321    23457899999999976  689999999999999999999999985432222111     11


Q ss_pred             cccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          702 VENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       702 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      .........+...++.+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       235 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        235 INKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            1111122223346778999999999999999999999999998753

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-39  Score=345.58  Aligned_cols=245  Identities=24%  Similarity=0.364  Sum_probs=207.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc----cc-chhHHHHHHhhhhcccc-cCCccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV----FQ-DSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~L  557 (762)
                      +.+.+.||+|.||+|++|... .+++.||||++.+.    .. ...+.+.+|+.++++++ ||||++++.+.......++
T Consensus        19 y~~~~~lG~GsfgkV~~a~~~-~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i   97 (370)
T KOG0583|consen   19 YELGRTLGSGSFGKVKLAKHR-LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI   97 (370)
T ss_pred             eeeeeeecCCCCeeEEEeeec-cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence            456678999999999999754 34589999977653    12 33456778999999998 9999999999999999999


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC-CceEEecccccccccCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY-YNARISDFGLEKLLTLD  636 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~~~  636 (762)
                      ||||+.+|+|.+++.+.+++.+.....++.|++.|++|+|++   +|+||||||+|||++.+ +++||+|||++.... .
T Consensus        98 vmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~  173 (370)
T KOG0583|consen   98 VMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-G  173 (370)
T ss_pred             EEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC-C
Confidence            999999999999999989999999999999999999999999   99999999999999999 999999999999874 3


Q ss_pred             CCcccccccccCcccCcccccCCC-CC-CcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHH
Q 004312          637 QSHTNTAIRGTKGYVAPEWFRNMP-IT-VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  714 (762)
                      ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||........+..     +.....  ..+...
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-----i~~~~~--~~p~~~  246 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-----IRKGEF--KIPSYL  246 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-----HhcCCc--cCCCCc
Confidence            344556788999999999999877 76 889999999999999999999976433333332     111111  112233


Q ss_pred             -HHHHHHHHHHhhccCCCCCCCHHHHH
Q 004312          715 -LQRFVMVAIWCIQEDPSHRPTMRRVT  740 (762)
Q Consensus       715 -~~~~~~li~~cl~~dp~~RPt~~evl  740 (762)
                       +.++..|+.+|+..+|.+|+|+.+|+
T Consensus       247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  247 LSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence             78999999999999999999999999

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.5e-39  Score=334.81  Aligned_cols=256  Identities=24%  Similarity=0.358  Sum_probs=205.9

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeC--CCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEE
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLV  558 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV  558 (762)
                      ..+.+.+.||+|+||.||+|.+..  .....||+|+++.... .....|.+|+.++.+++||||++++|++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            445567889999999999997653  3346899999876432 3345799999999999999999999999999999999


Q ss_pred             EeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          559 YEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      |||+++|+|.+++... ..+++..++.++.||+.||+|||++   +++||||||+|||++.++.+|++|||.+.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            9999999999999764 5789999999999999999999998   99999999999999999999999999876543222


Q ss_pred             CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      ........++..|+|||.+.+..++.++||||||+++||+++ |+.|+......+....      +........+..++.
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~  235 (266)
T cd05064         162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA------VEDGFRLPAPRNCPN  235 (266)
T ss_pred             hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH------HHCCCCCCCCCCCCH
Confidence            111222335678999999999999999999999999999875 8888754322221111      111111122334667


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      .+.+++.+||+.+|++||+++||.+.|+++
T Consensus       236 ~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         236 LLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=337.29  Aligned_cols=255  Identities=24%  Similarity=0.352  Sum_probs=209.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchh-HHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      -|.++||+|.||.|.+...+.  ...||||+++....... .+|.+|+++|.+++|||||+++|.|..++.+++|+|||+
T Consensus       541 ~~~ekiGeGqFGEVhLCeveg--~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE  618 (807)
T KOG1094|consen  541 RFKEKIGEGQFGEVHLCEVEG--PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME  618 (807)
T ss_pred             ehhhhhcCcccceeEEEEecC--ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence            467899999999999998763  46899999997665555 799999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc-
Q 004312          564 NGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT-  640 (762)
Q Consensus       564 ~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~-  640 (762)
                      +|+|..||..+.  .+.-..-.+|+.|||.||+||.+.   .+|||||.++|+|++.++++||+|||+++-+....... 
T Consensus       619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceee
Confidence            999999998773  345566678999999999999998   99999999999999999999999999999765554433 


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh--CCCCCchhhHHHhhhcccccccccc---ccccCCCHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC--LRRTILTDWAYDCYQERTLGALVEN---DLEAMDDMTVL  715 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  715 (762)
                      ....+-..+|||+|.+..+++|.++|||+||+++||+++  ..+|+......+..+ . ...+++.   ......+.-++
T Consensus       696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vve-n-~~~~~~~~~~~~~l~~P~~cp  773 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVE-N-AGEFFRDQGRQVVLSRPPACP  773 (807)
T ss_pred             ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHH-h-hhhhcCCCCcceeccCCCcCc
Confidence            334456789999999999999999999999999999875  566753322222111 1 1122211   12233456688


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      ..+.+++.+||+.|-.+||+++++...|++.
T Consensus       774 ~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  774 QGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            8999999999999999999999999998764

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.9e-38  Score=312.74  Aligned_cols=250  Identities=21%  Similarity=0.298  Sum_probs=201.4

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      .-++|+|+||.|||++.+ .+++.||||++.....  .-.+-.++|+++|++++|+|+|.++..|......+||+|||+.
T Consensus         7 LgkvGEGSYGvV~KCrnk-~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh   85 (396)
T KOG0593|consen    7 LGKVGEGSYGVVMKCRNK-DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH   85 (396)
T ss_pred             hhccccCcceEEEEeccC-CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch
Confidence            346999999999999754 5788999999975433  3346688999999999999999999999999999999999998


Q ss_pred             CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccc
Q 004312          565 GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI  644 (762)
Q Consensus       565 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  644 (762)
                      .-|.++-+.....+......++.|+++|+.|+|++   ++|||||||+||||+.++.+||||||.|+.+.. .+..-+..
T Consensus        86 TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDY  161 (396)
T KOG0593|consen   86 TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDY  161 (396)
T ss_pred             HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhhhh
Confidence            77776655556788999999999999999999999   999999999999999999999999999998874 44555667


Q ss_pred             cccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhh------------------hc-ccccccccc
Q 004312          645 RGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCY------------------QE-RTLGALVEN  704 (762)
Q Consensus       645 ~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~------------------~~-~~~~~~~~~  704 (762)
                      +.|..|.|||.+.+ .+|....||||.||++.||++|..-+.+....+..                  .. .....+.-+
T Consensus       162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP  241 (396)
T KOG0593|consen  162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLP  241 (396)
T ss_pred             hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecC
Confidence            78999999999877 78999999999999999999998765333221111                  11 111111111


Q ss_pred             ccccCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          705 DLEAMDD-----MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       705 ~~~~~~~-----~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ......+     +..+.-+.++++.||+.||++|++-+|++.
T Consensus       242 ~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  242 EPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1111111     234567899999999999999999999874

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-38  Score=331.17  Aligned_cols=265  Identities=23%  Similarity=0.260  Sum_probs=207.3

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccC--CceeEEEec
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--RNRLLVYEF  561 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~LV~E~  561 (762)
                      -.++||+|.||.||+++. ..+++.||+|++....  .....-..+||.+|++|+||||++|.+...+.  ...|||+||
T Consensus       121 ki~kIGeGTyg~VYkAr~-~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeY  199 (560)
T KOG0600|consen  121 KIEKIGEGTYGQVYKARD-LETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEY  199 (560)
T ss_pred             HHHHhcCcchhheeEeee-cccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEec
Confidence            346899999999999974 4567899999987543  33345678999999999999999999998776  689999999


Q ss_pred             cCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          562 MSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       562 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+. +|.-++... -.++..++..++.|++.||+|+|++   +|+|||||.+|||||.+|.+||+|||||+++.......
T Consensus       200 Mdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~  275 (560)
T KOG0600|consen  200 MDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP  275 (560)
T ss_pred             ccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCcc
Confidence            987 788888764 5799999999999999999999999   99999999999999999999999999999998887777


Q ss_pred             cccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc----------cccc--ccccc-cc
Q 004312          641 NTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE----------RTLG--ALVEN-DL  706 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~----------~~~~--~~~~~-~~  706 (762)
                      .+..+-|+.|.|||.+.+. .|+.+.|+||.||||.||+.|+..+.+....+.+..          ....  .+... .+
T Consensus       276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~  355 (560)
T KOG0600|consen  276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIF  355 (560)
T ss_pred             cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccccc
Confidence            8888899999999999875 799999999999999999999977533322111110          0000  00000 00


Q ss_pred             ccC--CC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCCCCCCCC
Q 004312          707 EAM--DD-------MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCPW  756 (762)
Q Consensus       707 ~~~--~~-------~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~p~~p~  756 (762)
                      ...  ..       ...+....+|+..+|..||.+|.|+.++++.= -+..-|.|..|.
T Consensus       356 kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se-yF~t~p~~~~p~  413 (560)
T KOG0600|consen  356 KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSE-YFTTEPLPCDPS  413 (560)
T ss_pred             CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCc-ccccCCCCCCcc
Confidence            000  01       12356678999999999999999999877521 123444444443

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=329.55  Aligned_cols=252  Identities=23%  Similarity=0.333  Sum_probs=205.2

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc--------------hhHHHHHHhhhhcccccCCccchhce
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--------------SEKEFKAEVNGIGQTHHKNLVRLLGY  548 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~H~nIv~l~g~  548 (762)
                      .+.+.+.||+|.||.|-+|.. ..+++.||||++.+....              ..+...+||.+|++++|||||+|+.+
T Consensus        98 qy~l~~eiG~G~yGkVkLar~-~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARD-EVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             heehhhhhcCCccceEEEEee-cCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            455678899999999999964 456789999999653111              12478899999999999999999999


Q ss_pred             ecc--CCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEec
Q 004312          549 CDE--GRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISD  626 (762)
Q Consensus       549 ~~~--~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  626 (762)
                      ..+  .+..|||+|||..|.+...=.....++..+.+++++++..||.|||.+   +||||||||+|+||++++.+||+|
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsD  253 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISD  253 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeec
Confidence            876  467899999999988776544444489999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCCCC----cccccccccCcccCcccccCCC----CCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccc
Q 004312          627 FGLEKLLTLDQS----HTNTAIRGTKGYVAPEWFRNMP----ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTL  698 (762)
Q Consensus       627 fgla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~  698 (762)
                      ||.+........    .......|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||..+...+.+...  
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI--  331 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI--  331 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH--
Confidence            999986632211    1223367999999999987632    458899999999999999999999888777666543  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 004312          699 GALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQML  743 (762)
Q Consensus       699 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L  743 (762)
                         +...+......++.+++.+||+++|.+||++|.++.+|....
T Consensus       332 ---vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  332 ---VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             ---hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence               333333333446778999999999999999999999887643

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=332.39  Aligned_cols=253  Identities=25%  Similarity=0.326  Sum_probs=202.9

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhH-HHHHHhhhhcccc-cCCccchhceeccCC-ceeEE
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTH-HKNLVRLLGYCDEGR-NRLLV  558 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-H~nIv~l~g~~~~~~-~~~LV  558 (762)
                      ..|...++||.|.||.||+|+-. .+++.||||++++.....++ .=.+|++.|++|. |||||++...+.+.+ .+++|
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~-~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSK-ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeec-CCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            45667789999999999999754 45678999999876555433 3468999999998 999999999998888 99999


Q ss_pred             EeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          559 YEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ||||+. +|..+++.+ +.+++..+..|+.||++||+|+|.+   |++|||+||+|||+..+..+||+|||+||....  
T Consensus        89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S--  162 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS--  162 (538)
T ss_pred             HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc--
Confidence            999955 899999876 5689999999999999999999999   999999999999999999999999999997653  


Q ss_pred             CcccccccccCcccCcccc-cCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhh---------------c------
Q 004312          638 SHTNTAIRGTKGYVAPEWF-RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ---------------E------  695 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~-~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~---------------~------  695 (762)
                      ....+..+.|+.|.|||++ +.+-|+.+.|+|++|||++||.+.+.-|.+....+.+.               +      
T Consensus       163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~  242 (538)
T KOG0661|consen  163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS  242 (538)
T ss_pred             CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence            3445567789999999986 56789999999999999999999887653332211111               0      


Q ss_pred             ---cccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          696 ---RTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       696 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                         ..+.......+....+ ..+.++.+++.+|++.||.+|||++|.++.
T Consensus       243 ~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence               0001111111111112 367889999999999999999999999875

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.7e-39  Score=336.64  Aligned_cols=249  Identities=29%  Similarity=0.469  Sum_probs=195.9

Q ss_pred             hhhhcCCCCcceEEEeeee---CCCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          486 FKEELGRGAFGTVYKGFVN---MGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~---~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.+.||.|.||.||+|.+.   ...+..|+||.++.... ...++|.+|++.+++++||||++++|+|.+.+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3467999999999999988   22346799999965333 3467899999999999999999999999988889999999


Q ss_pred             cCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC-
Q 004312          562 MSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-  638 (762)
Q Consensus       562 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-  638 (762)
                      +++|+|.++|...  ..+++..+..|+.||++||+|||+.   +++|+||+++|||+++++.+||+|||+++....... 
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            9999999999876  6789999999999999999999998   999999999999999999999999999987632222 


Q ss_pred             cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          639 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      ...........|+|||.+....++.++||||||+++|||++ |+.|+.........     ..+ ........+..++..
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~  233 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEII-----EKL-KQGQRLPIPDNCPKD  233 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHH-----HHH-HTTEETTSBTTSBHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccc-cccccceeccchhHH
Confidence            22233446789999999999889999999999999999999 56775332222111     111 122222233345678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHh
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQML  743 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~~L  743 (762)
                      +.+++.+||+.+|++||+++++++.|
T Consensus       234 ~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  234 IYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            99999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=327.81  Aligned_cols=254  Identities=23%  Similarity=0.306  Sum_probs=204.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      |++.++||.|..++||+|.... .++.||||++.-..- ...+.+.+|+..++.++||||++.+..|..+..+|+||.||
T Consensus        28 YeL~e~IG~G~sa~V~~A~c~p-~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM  106 (516)
T KOG0582|consen   28 YELQEVIGVGASAVVYLARCIP-TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM  106 (516)
T ss_pred             eeEEEEEeccceeEeeeeeecc-cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence            5677899999999999997654 458999999974322 23578999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          563 SNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       563 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      .+||+.+.++..  ..+++..+..|.+++++||.|||++   |.||||||+.||||+++|.+||+|||.+-.+.......
T Consensus       107 a~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~  183 (516)
T KOG0582|consen  107 AGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ  183 (516)
T ss_pred             cCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence            999999999764  4589999999999999999999999   99999999999999999999999999887665433211


Q ss_pred             ---cccccccCcccCcccccC--CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc---cccccccccccccCCCH
Q 004312          641 ---NTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE---RTLGALVENDLEAMDDM  712 (762)
Q Consensus       641 ---~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  712 (762)
                         ....+||+.|||||++..  ..|+.|+||||||++..||.+|..||....+....-.   +.........+......
T Consensus       184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k  263 (516)
T KOG0582|consen  184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDK  263 (516)
T ss_pred             eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhh
Confidence               144689999999999543  4799999999999999999999999844332221111   11111111112222234


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       713 ~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .....+.+++..||+.||.+|||++++++
T Consensus       264 ~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  264 KFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             hhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            45678999999999999999999999985

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-38  Score=321.46  Aligned_cols=248  Identities=22%  Similarity=0.368  Sum_probs=213.0

Q ss_pred             HHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhH---HHHHHhhhhcccccCCccchhceeccCCceeE
Q 004312          481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK---EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       481 ~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L  557 (762)
                      +..++|.+.||+|.||+|-++. +...++.||||.+++.....++   .+.+|+++++.|+||||+.++..|+..+...|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~-e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAY-EHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehh-hccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            4567888999999999999996 4456789999999875444443   57799999999999999999999999999999


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ||||..+|.|.+|+...+.+++.+.+++++||..|+.|+|.+   +++|||||.+|||||.|+++||+|||++-++..  
T Consensus       131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~--  205 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD--  205 (668)
T ss_pred             EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc--
Confidence            999999999999999999999999999999999999999999   999999999999999999999999999988753  


Q ss_pred             CcccccccccCcccCcccccCCCCC-CcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNMPIT-VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      ......++|+|-|.+||++.+.+|. +..|.|||||+||.|+.|..||.+.................        ++.+.
T Consensus       206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--------P~~PS  277 (668)
T KOG0611|consen  206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--------PETPS  277 (668)
T ss_pred             ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC--------CCCCc
Confidence            3445678999999999999998876 88999999999999999999986654333333322222221        23345


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ....||+|||.++|++|.|+++|...
T Consensus       278 dA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  278 DASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             hHHHHHHHHHhcCcccchhHHHHhhh
Confidence            67889999999999999999999875

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.4e-38  Score=348.33  Aligned_cols=255  Identities=26%  Similarity=0.377  Sum_probs=201.2

Q ss_pred             hhhhhhcCCCCcceEEEeeee----CCCcceEEEEEccccc-cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVN----MGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~L  557 (762)
                      +.+.+.||+|+||.||+|...    .++...||||+++... ....+.+.+|++++..+ +||||++++++|.+.+..++
T Consensus        37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l  116 (375)
T cd05104          37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV  116 (375)
T ss_pred             eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence            456789999999999999642    2345689999997532 23446789999999999 89999999999999999999


Q ss_pred             EEeccCCCchhhhccCC---------------------------------------------------------------
Q 004312          558 VYEFMSNGALASFLFGD---------------------------------------------------------------  574 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~---------------------------------------------------------------  574 (762)
                      ||||+++|+|.+++...                                                               
T Consensus       117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (375)
T cd05104         117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID  196 (375)
T ss_pred             eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence            99999999999988542                                                               


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc-c
Q 004312          575 ------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT-N  641 (762)
Q Consensus       575 ------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~  641 (762)
                                  ..+++..+..++.||++||+|||+.   +|+||||||+|||+++++.+||+|||+++......... .
T Consensus       197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  273 (375)
T cd05104         197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK  273 (375)
T ss_pred             cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence                        1367888999999999999999998   99999999999999999999999999998664332211 1


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |..|+.........     ...+........+...+.++.+
T Consensus       274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~  348 (375)
T cd05104         274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF-----YKMIKEGYRMLSPECAPSEMYD  348 (375)
T ss_pred             CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH-----HHHHHhCccCCCCCCCCHHHHH
Confidence            22335678999999999999999999999999999998 77776332111111     1111111111112234568899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      ++.+||+.||++||++.||+++|++.
T Consensus       349 li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         349 IMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHHccCChhHCcCHHHHHHHHHhh
Confidence            99999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-38  Score=325.01  Aligned_cols=259  Identities=27%  Similarity=0.404  Sum_probs=200.1

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcc--cccCCccchhceeccCC----ceeEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ--THHKNLVRLLGYCDEGR----NRLLV  558 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~~----~~~LV  558 (762)
                      .+.+.||+|.||.||||.+.   ++.||||++..   +..+.|++|-++++.  ++|+||+++++.-..+.    +.+||
T Consensus       213 ~l~eli~~Grfg~V~KaqL~---~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLD---NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             hhHHHhhcCccceeehhhcc---CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            35678999999999999986   47899999974   456789998888776  59999999999987666    88999


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcC------CCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC------CTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                      +||.++|+|.+||..+ .++|....+|+..+++||+|||+..      +++|+|||||.+||||.+|++..|+|||+|..
T Consensus       287 t~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~  365 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR  365 (534)
T ss_pred             eeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence            9999999999999654 5899999999999999999999873      46899999999999999999999999999999


Q ss_pred             ccCCCCccc-ccccccCcccCcccccCC-CCC-----CcchhHHHHHHHHHHHhCCCCC--------chhhHHHhhhccc
Q 004312          633 LTLDQSHTN-TAIRGTKGYVAPEWFRNM-PIT-----VKVDVYSYGVLLLEIICLRRTI--------LTDWAYDCYQERT  697 (762)
Q Consensus       633 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~-~~s-----~~~DV~S~Gvil~elltg~~p~--------~~~~~~~~~~~~~  697 (762)
                      +........ ...+||.+|||||++++. ++.     .+.||||+|.|||||++.-.-.        ...+..+.-....
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            876554332 337899999999999764 222     5799999999999999753221        1111111111111


Q ss_pred             ccc----ccccccccCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCC
Q 004312          698 LGA----LVENDLEAMDD-----MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP  750 (762)
Q Consensus       698 ~~~----~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  750 (762)
                      +.+    .+....+...+     ......+.+.+..||..||+.|.|+.=|.+++.++..+.
T Consensus       446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            111    11111122111     134567889999999999999999999998888765544

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.1e-37  Score=302.69  Aligned_cols=267  Identities=22%  Similarity=0.282  Sum_probs=205.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      |.-.++||+|.||.||+|. +..+++.||||+++....  .......+|++.|+.++|+||+.+++.+.+.+...||+||
T Consensus         4 Y~~~~~lGEG~~gvVyka~-d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    4 YEKLEKLGEGTYGVVYKAR-DTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhcCcceEEEEEEE-ecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            3345789999999999997 446788999999975422  2245788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          562 MSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       562 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+. +|+..+++. ..++..++..++.++++||+|||++   .|+||||||.|+||+++|.+||+|||+++.+...... 
T Consensus        83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-  157 (318)
T KOG0659|consen   83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-  157 (318)
T ss_pred             ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc-
Confidence            965 899999876 4688999999999999999999999   9999999999999999999999999999988654333 


Q ss_pred             cccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc----------cccc------c---
Q 004312          641 NTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE----------RTLG------A---  700 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~----------~~~~------~---  700 (762)
                      .+..+-|..|.|||.+.+ ..|+...|+||.|||+.||+.+..-|.++..-+....          +...      .   
T Consensus       158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~  237 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK  237 (318)
T ss_pred             cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence            233367999999999876 4799999999999999999987644322221111100          0000      0   


Q ss_pred             ---ccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCCCCCCCCCC
Q 004312          701 ---LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCPWTL  758 (762)
Q Consensus       701 ---~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~p~~p~~~  758 (762)
                         ...+.+.. .-...+.++.+++.+|+..||.+|++++|++++= -+...|.|-+|+-.
T Consensus       238 ~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~pt~~~~l  296 (318)
T KOG0659|consen  238 IQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLPTPPSKL  296 (318)
T ss_pred             HhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCCCChhhC
Confidence               00000110 1123456779999999999999999999988742 24445666555443

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=336.66  Aligned_cols=257  Identities=24%  Similarity=0.352  Sum_probs=222.0

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCC---CcceEEEEEccc-cccchhHHHHHHhhhhcccccCCccchhceeccCCceeE
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMG---SSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~---~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L  557 (762)
                      ....+.+.||.|-||.||+|.+...   ..-.||||..+. ...+..+.|..|..++++++|||||+|+|.|.+. ..+|
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence            3334567899999999999988653   223599999886 4455677899999999999999999999999765 5799


Q ss_pred             EEeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          558 VYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      |||.++.|-|.+||+.+ ..++......++.||..||+|||+.   ..|||||..+|||+.....+||+|||+++.+..+
T Consensus       468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            99999999999999876 5789999999999999999999999   9999999999999999999999999999998877


Q ss_pred             CCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          637 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                      .....+...-...|||||.+.-.++|.++|||.|||.+|||+. |.+||..      .....+...+.++.+.+.+++++
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg------vkNsDVI~~iEnGeRlP~P~nCP  618 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG------VKNSDVIGHIENGERLPCPPNCP  618 (974)
T ss_pred             chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc------ccccceEEEecCCCCCCCCCCCC
Confidence            6666555556779999999999999999999999999999996 7788743      23334555667777888889999


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ..+..|+.+||+.+|.+||.+.|+...|+.+++
T Consensus       619 p~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  619 PALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             hHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            999999999999999999999999988877554

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.3e-38  Score=346.04  Aligned_cols=257  Identities=27%  Similarity=0.389  Sum_probs=202.3

Q ss_pred             HhhhhhhcCCCCcceEEEeeee----CCCcceEEEEEccccc-cchhHHHHHHhhhhccc-ccCCccchhceeccCCcee
Q 004312          483 TRGFKEELGRGAFGTVYKGFVN----MGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRL  556 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  556 (762)
                      .+.+.+.||+|+||.||+|...    ..+.+.||||+++... ......+.+|+++++++ +|+||+++++.|.+....+
T Consensus        39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~  118 (374)
T cd05106          39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL  118 (374)
T ss_pred             HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence            3456788999999999998742    2233579999997543 23345688999999999 8999999999999999999


Q ss_pred             EEEeccCCCchhhhccCC--------------------------------------------------------------
Q 004312          557 LVYEFMSNGALASFLFGD--------------------------------------------------------------  574 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~--------------------------------------------------------------  574 (762)
                      +||||+++|+|.+++...                                                              
T Consensus       119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (374)
T cd05106         119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK  198 (374)
T ss_pred             EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence            999999999999988532                                                              


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc-ccccc
Q 004312          575 --------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT-NTAIR  645 (762)
Q Consensus       575 --------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~  645 (762)
                              .++++..+.+|+.||++||+|||++   +|+||||||+|||+++++.+||+|||+++......... .....
T Consensus       199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~  275 (374)
T cd05106         199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR  275 (374)
T ss_pred             chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence                    2367888999999999999999998   99999999999999999999999999998654332211 11233


Q ss_pred             ccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHH
Q 004312          646 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW  724 (762)
Q Consensus       646 gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  724 (762)
                      ++..|+|||.+.+..++.++||||||+++|||++ |+.||........     ....+........+...+.++.+++.+
T Consensus       276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~  350 (374)
T cd05106         276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-----FYKMVKRGYQMSRPDFAPPEIYSIMKM  350 (374)
T ss_pred             CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-----HHHHHHcccCccCCCCCCHHHHHHHHH
Confidence            5678999999998999999999999999999997 8888744321111     111111111111222345789999999


Q ss_pred             hhccCCCCCCCHHHHHHHhhcCc
Q 004312          725 CIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       725 cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      ||+.||++|||+++|+++|+++.
T Consensus       351 cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         351 CWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HcCCChhhCcCHHHHHHHHHHHh
Confidence            99999999999999999998853

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.7e-38  Score=334.60  Aligned_cols=257  Identities=25%  Similarity=0.358  Sum_probs=198.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC---------------CCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM---------------GSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLG  547 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~---------------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g  547 (762)
                      +.+.++||+|+||.||++.+..               +....||+|.+.... .....+|.+|++++.+++||||+++++
T Consensus         7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~   86 (304)
T cd05096           7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG   86 (304)
T ss_pred             CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence            4456789999999999997542               223469999987543 334567999999999999999999999


Q ss_pred             eeccCCceeEEEeccCCCchhhhccCC-------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCC
Q 004312          548 YCDEGRNRLLVYEFMSNGALASFLFGD-------------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCD  608 (762)
Q Consensus       548 ~~~~~~~~~LV~E~~~~gsL~~~l~~~-------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D  608 (762)
                      ++.+.+..++||||+++|+|.+++...                   ..+++..+..++.||+.||.|||+.   +|+|||
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~d  163 (304)
T cd05096          87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRD  163 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence            999999999999999999999988542                   2367888999999999999999998   999999


Q ss_pred             CCCCceEEcCCCceEEecccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhC--CCCCc
Q 004312          609 IKPQNILLDDYYNARISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICL--RRTIL  685 (762)
Q Consensus       609 lkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg--~~p~~  685 (762)
                      |||+|||+++++.+||+|||+++........ ......++..|+|||.+..+.++.++||||||+++|||+++  ..|+.
T Consensus       164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  243 (304)
T cd05096         164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG  243 (304)
T ss_pred             cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence            9999999999999999999999865432221 12223457889999999988999999999999999999974  45553


Q ss_pred             hhhHHHhhhcccccccccc---ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          686 TDWAYDCYQERTLGALVEN---DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       686 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      ..........  .......   ......+..++..+.+++.+||+.+|++|||++||.+.|++
T Consensus       244 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         244 ELTDEQVIEN--AGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             cCCHHHHHHH--HHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            2211111110  0000000   00111123456789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.7e-38  Score=337.57  Aligned_cols=242  Identities=23%  Similarity=0.264  Sum_probs=200.2

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      +.||+|+||.||++... .+++.||||++++..   ......+.+|++++++++||||+++++.+...+..+|||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREK-ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999754 456799999987532   22345678899999999999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccc
Q 004312          565 GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI  644 (762)
Q Consensus       565 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  644 (762)
                      |+|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++..... .......
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~  155 (323)
T cd05571          80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTF  155 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccce
Confidence            99999998888899999999999999999999998   9999999999999999999999999998753221 2223345


Q ss_pred             cccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHH
Q 004312          645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW  724 (762)
Q Consensus       645 ~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  724 (762)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||...........     +....  ...+...+.++.+++.+
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~-----~~~~~--~~~p~~~~~~~~~li~~  228 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-----ILMEE--IRFPRTLSPEAKSLLAG  228 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH-----HHcCC--CCCCCCCCHHHHHHHHH
Confidence            699999999999999999999999999999999999999854322221111     11111  11233456788999999


Q ss_pred             hhccCCCCCC-----CHHHHHH
Q 004312          725 CIQEDPSHRP-----TMRRVTQ  741 (762)
Q Consensus       725 cl~~dp~~RP-----t~~evl~  741 (762)
                      ||+.||++||     +++++++
T Consensus       229 ~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         229 LLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HccCCHHHcCCCCCCCHHHHHc
Confidence            9999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=329.45  Aligned_cols=244  Identities=24%  Similarity=0.361  Sum_probs=210.4

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEcccc-ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCC
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      .+.||+|.||.||||.. ..+++.||+|++.-. ......++++|+.+|.+++|+||.+.+|.+..+..++++||||.+|
T Consensus        18 ~~~IgrGsfG~Vyk~~d-~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gG   96 (467)
T KOG0201|consen   18 LELIGRGSFGEVYKAID-NKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGG   96 (467)
T ss_pred             chhccccccceeeeeee-ccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCc
Confidence            36899999999999964 456789999999743 3444578999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccccc
Q 004312          566 ALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR  645 (762)
Q Consensus       566 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  645 (762)
                      ++.+.|+....+++..+.-|+.+++.||.|||.+   +.+|||||+.|||+..+|.+||+|||++..+....... ..++
T Consensus        97 sv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfv  172 (467)
T KOG0201|consen   97 SVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFV  172 (467)
T ss_pred             chhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-cccc
Confidence            9999998888888999999999999999999999   99999999999999999999999999999887665555 6778


Q ss_pred             ccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHh
Q 004312          646 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWC  725 (762)
Q Consensus       646 gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  725 (762)
                      |||-|||||++....|+.|+||||||++.+||.+|..|+....+      -.+.-++.....+..+...+..+.+++..|
T Consensus       173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP------mrvlflIpk~~PP~L~~~~S~~~kEFV~~C  246 (467)
T KOG0201|consen  173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP------MRVLFLIPKSAPPRLDGDFSPPFKEFVEAC  246 (467)
T ss_pred             ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc------ceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence            99999999999988999999999999999999999999644322      112222323333333346778899999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 004312          726 IQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       726 l~~dp~~RPt~~evl~  741 (762)
                      |..||+.||++.++++
T Consensus       247 L~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  247 LDKNPEFRPSAKELLK  262 (467)
T ss_pred             hhcCcccCcCHHHHhh
Confidence            9999999999999885

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=331.55  Aligned_cols=243  Identities=23%  Similarity=0.265  Sum_probs=201.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||++... .+++.||+|++....   ....+.+.+|++++++++||||+++++.+.+....++||||
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   82 (291)
T cd05612           4 ERIKTVGTGTFGRVHLVRDR-ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY   82 (291)
T ss_pred             eeeeeeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence            35578999999999999754 446789999986432   22345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|+|.+++...+.+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.....    .
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~  155 (291)
T cd05612          83 VPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----T  155 (291)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC----c
Confidence            99999999998888899999999999999999999998   9999999999999999999999999999865421    2


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ....|++.|+|||.+.+..++.++||||||+++|||++|+.||............     .....  ..+...+..+.++
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i-----~~~~~--~~~~~~~~~~~~l  228 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI-----LAGKL--EFPRHLDLYAKDL  228 (291)
T ss_pred             ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----HhCCc--CCCccCCHHHHHH
Confidence            2356899999999999989999999999999999999999998654333222211     11111  1122345678999


Q ss_pred             HHHhhccCCCCCCC-----HHHHHHH
Q 004312          722 AIWCIQEDPSHRPT-----MRRVTQM  742 (762)
Q Consensus       722 i~~cl~~dp~~RPt-----~~evl~~  742 (762)
                      +.+||+.||.+||+     ++|+++.
T Consensus       229 i~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         229 IKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             HHHHcCCCHHHccCCccCCHHHHhcC
Confidence            99999999999995     8887754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-38  Score=308.34  Aligned_cols=233  Identities=25%  Similarity=0.311  Sum_probs=203.2

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchh---HHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---KEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.||.|+||.|.+++.+.. +..+|+|++++...-..   +...+|..+|+.+.||.++++.+.+.+.+..+|||||+
T Consensus        48 ~~~tlGtGSFGrV~LVr~k~~-g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv  126 (355)
T KOG0616|consen   48 RLKTLGTGSFGRVHLVREKHS-GNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYV  126 (355)
T ss_pred             heeeeccCccceEEEEEEccC-CceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEecc
Confidence            446899999999999987654 67999999986543333   34678999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ++|-|.++|++.++++++..+.+|.||+.||+|||+.   +|++|||||+|||||.+|.+||.|||.|+...    ....
T Consensus       127 ~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----~rT~  199 (355)
T KOG0616|consen  127 PGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS----GRTW  199 (355)
T ss_pred             CCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec----CcEE
Confidence            9999999999999999999999999999999999999   99999999999999999999999999999764    2356


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ..+|||.|+|||+++..++..++|-|||||++|||+.|..||....+...++..     +...+.  .|.....++.+|+
T Consensus       200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI-----~~~~v~--fP~~fs~~~kdLl  272 (355)
T KOG0616|consen  200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI-----LEGKVK--FPSYFSSDAKDLL  272 (355)
T ss_pred             EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH-----HhCccc--CCcccCHHHHHHH
Confidence            789999999999999999999999999999999999999999777654444432     222222  2445677899999


Q ss_pred             HHhhccCCCCC
Q 004312          723 IWCIQEDPSHR  733 (762)
Q Consensus       723 ~~cl~~dp~~R  733 (762)
                      .+.|+.|-.+|
T Consensus       273 ~~LL~vD~t~R  283 (355)
T KOG0616|consen  273 KKLLQVDLTKR  283 (355)
T ss_pred             HHHHhhhhHhh
Confidence            99999999999

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=334.26  Aligned_cols=238  Identities=24%  Similarity=0.282  Sum_probs=196.4

Q ss_pred             cCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCc
Q 004312          490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       490 iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      ||+|+||.||++... .+++.||+|++.+.   .......+.+|++++++++||||+++++.+.+.+..++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKR-DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            799999999999754 45678999998653   23334578899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccccc
Q 004312          567 LASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG  646 (762)
Q Consensus       567 L~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g  646 (762)
                      |.+++.....+++..+..++.||++||.|||+.   +|+||||||+|||++.++.+||+|||+++...... .......|
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g  155 (312)
T cd05585          80 LFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG  155 (312)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence            999998888899999999999999999999998   99999999999999999999999999998543222 22334569


Q ss_pred             cCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhh
Q 004312          647 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI  726 (762)
Q Consensus       647 t~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  726 (762)
                      |+.|+|||.+.+..++.++|||||||++|||++|+.||...........     +....  ...+...+.++.+++.+||
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~~~li~~~L  228 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK-----ILQEP--LRFPDGFDRDAKDLLIGLL  228 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHH-----HHcCC--CCCCCcCCHHHHHHHHHHc
Confidence            9999999999999999999999999999999999999854432222221     11111  1123345678899999999


Q ss_pred             ccCCCCCCCHHHH
Q 004312          727 QEDPSHRPTMRRV  739 (762)
Q Consensus       727 ~~dp~~RPt~~ev  739 (762)
                      +.||++||++..+
T Consensus       229 ~~dp~~R~~~~~~  241 (312)
T cd05585         229 SRDPTRRLGYNGA  241 (312)
T ss_pred             CCCHHHcCCCCCH
Confidence            9999999864333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-37  Score=322.82  Aligned_cols=253  Identities=26%  Similarity=0.410  Sum_probs=205.0

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      ....+.+.||+|++|.||+|...  ..+.||+|.++... ...+++.+|++++++++|+||+++++++...+..++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec--CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            34556688999999999999754  34679999987543 3456899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          562 MSNGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       562 ~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      +++++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||+++........
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            99999999997654  689999999999999999999998   9999999999999999999999999999876532222


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      .......+..|+|||.+....++.++||||||+++|||++ |+.|+...........      +........+...+..+
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~  233 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ------VDQGYRMPCPPGCPKEL  233 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH------HHcCCCCCCCCcCCHHH
Confidence            2222223468999999998899999999999999999999 8888744322211111      11111111223456789


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      .+++.+|++.+|++||+++++++.|+++
T Consensus       234 ~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         234 YDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            9999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-37  Score=337.88  Aligned_cols=245  Identities=22%  Similarity=0.287  Sum_probs=203.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|.........||+|++....   ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E  111 (340)
T PTZ00426         32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE  111 (340)
T ss_pred             cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence            4566889999999999998765555689999986432   2334578899999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++|+|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....    .
T Consensus       112 y~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~----~  184 (340)
T PTZ00426        112 FVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT----R  184 (340)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC----C
Confidence            999999999998888899999999999999999999998   999999999999999999999999999986532    1


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...........     +.....  ..+...+..+.+
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~-----i~~~~~--~~p~~~~~~~~~  257 (340)
T PTZ00426        185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK-----ILEGII--YFPKFLDNNCKH  257 (340)
T ss_pred             cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH-----HhcCCC--CCCCCCCHHHHH
Confidence            2345689999999999988899999999999999999999999865433222211     111111  112334567899


Q ss_pred             HHHHhhccCCCCCC-----CHHHHHHH
Q 004312          721 VAIWCIQEDPSHRP-----TMRRVTQM  742 (762)
Q Consensus       721 li~~cl~~dp~~RP-----t~~evl~~  742 (762)
                      ++.+||+.+|++|+     +++++++.
T Consensus       258 li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        258 LMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            99999999999995     89988764

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.4e-38  Score=336.30  Aligned_cols=253  Identities=23%  Similarity=0.315  Sum_probs=213.1

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||.|+.|.|-.|+. ..+++.+|||++.+..+   .....+.+|+.+|+.+.|||++++++..++..++|||.||
T Consensus        15 kLgkTLG~Gstg~vrlakh-~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   15 KLGKTLGKGSTGCVRLAKH-AETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eccccccCCCCceehhhhc-ccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            4567899999999999975 45788999999976422   2235688999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|-|.++|..++++.+.+..+++.||+.|+.|+|..   +|+||||||+|+|||++.++||+|||+|.+-.  .....
T Consensus        94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gklL  168 (786)
T KOG0588|consen   94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGKLL  168 (786)
T ss_pred             cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--CCccc
Confidence            99999999999999999999999999999999999999   99999999999999999999999999998653  33445


Q ss_pred             ccccccCcccCcccccCCCCC-CcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPIT-VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s-~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .+.||.|.|.+||++.+.+|. .++||||.|||||.|++|+.||.++.....+..-.-.       ....+.+++.++.+
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G-------~f~MPs~Is~eaQd  241 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG-------VFEMPSNISSEAQD  241 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC-------cccCCCcCCHHHHH
Confidence            567899999999999999875 8899999999999999999998654332222211111       11124567889999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHH--hhcCcCCC
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQM--LEGVVEVP  750 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~--L~~~~~~~  750 (762)
                      |+.+|+..||+.|.|++||++.  |.+...++
T Consensus       242 LLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~  273 (786)
T KOG0588|consen  242 LLRRMLDVDPSTRITTEEILKHPFLSGYTSLP  273 (786)
T ss_pred             HHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence            9999999999999999999975  44444333

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4e-37  Score=321.85  Aligned_cols=252  Identities=27%  Similarity=0.387  Sum_probs=204.5

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      ..+.+.||+|++|.||+|... ..++.||+|++... .....++.+|++++++++|+||+++++++...+..++||||++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~-~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             eEEeeecCCcccceEEEEEEe-cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            345678999999999999865 34578999998753 3345679999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|.+++...  ..+++..++.++.|+++||+|||+.   +++||||||+||++++++.+||+|||++...........
T Consensus        86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~  162 (263)
T cd05052          86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  162 (263)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence            99999999654  4589999999999999999999998   999999999999999999999999999987653322222


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |..|+......+....      +........+...+.++.+
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~  236 (263)
T cd05052         163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL------LEKGYRMERPEGCPPKVYE  236 (263)
T ss_pred             CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH------HHCCCCCCCCCCCCHHHHH
Confidence            22234668999999999999999999999999999998 7888643322221111      1111112223345678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      ++.+||+.+|++||++.+++++|+.+
T Consensus       237 li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         237 LMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHHHHccCCcccCCCHHHHHHHHHhh
Confidence            99999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=336.70  Aligned_cols=250  Identities=19%  Similarity=0.291  Sum_probs=204.3

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||+|+.. .+++.||||+++...   ......+.+|++++.+++||||+++++.+.+.+..+|||||
T Consensus         4 ~~~~~ig~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   82 (333)
T cd05600           4 QILTQVGQGGYGQVFLAKKK-DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY   82 (333)
T ss_pred             EEEEEEeecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence            35578999999999999764 446789999987542   23345788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++....    ..
T Consensus        83 ~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~  155 (333)
T cd05600          83 VPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YA  155 (333)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----cc
Confidence            99999999998888899999999999999999999998   999999999999999999999999999986532    23


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccc-ccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTL-GALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....... ...+............+.++.+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~  235 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD  235 (333)
T ss_pred             CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence            345689999999999999999999999999999999999999855433222221110 0111110011011245678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ++.+||+.+|++||+++|+++.
T Consensus       236 li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         236 LITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHHHHhhChhhhcCCHHHHHhC
Confidence            9999999999999999999965

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5e-37  Score=323.93  Aligned_cols=255  Identities=25%  Similarity=0.401  Sum_probs=206.3

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeC----CCcceEEEEEccccccc-hhHHHHHHhhhhcccccCCccchhceeccCCcee
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRL  556 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  556 (762)
                      ..+.+.+.||+|+||.||+|....    ...+.||||+++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            445677899999999999997643    23468999999765444 4578999999999999999999999999999999


Q ss_pred             EEEeccCCCchhhhccCC--------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCce
Q 004312          557 LVYEFMSNGALASFLFGD--------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNA  622 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~  622 (762)
                      +||||+++++|.+++...              ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            999999999999999653              2468889999999999999999998   99999999999999999999


Q ss_pred             EEecccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcccccc
Q 004312          623 RISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGA  700 (762)
Q Consensus       623 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~  700 (762)
                      ||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......+.....    
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~----  237 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI----  237 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----
Confidence            9999999976533221 11223345788999999999999999999999999999998 99887443222211111    


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          701 LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       701 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                        ........+...+..+.+++.+||+.+|++||+++||+++|++
T Consensus       238 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         238 --TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             --HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence              1111111223456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.8e-37  Score=325.43  Aligned_cols=254  Identities=26%  Similarity=0.418  Sum_probs=205.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCC----cceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGS----SDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLV  558 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV  558 (762)
                      ..+.+.||+|+||.||+|......    ...||+|.+..... ....+|.+|++++.+++||||+++++++......+++
T Consensus         7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   86 (283)
T cd05048           7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML   86 (283)
T ss_pred             cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence            345688999999999999765322    25799999875432 3346799999999999999999999999999999999


Q ss_pred             EeccCCCchhhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCce
Q 004312          559 YEFMSNGALASFLFGD----------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNA  622 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~  622 (762)
                      |||+++++|.+++...                ..+++..++.++.|++.||+|||+.   +++||||||+||++++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~  163 (283)
T cd05048          87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTV  163 (283)
T ss_pred             EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcE
Confidence            9999999999999654                3478889999999999999999998   99999999999999999999


Q ss_pred             EEecccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcccccc
Q 004312          623 RISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGA  700 (762)
Q Consensus       623 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~  700 (762)
                      ||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+...      
T Consensus       164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~------  237 (283)
T cd05048         164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE------  237 (283)
T ss_pred             EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH------
Confidence            9999999986543222 22233456789999999998999999999999999999998 888875433222211      


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          701 LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       701 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      .+........+..++.++.+|+.+||+.+|++||+++||++.|+++
T Consensus       238 ~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         238 MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            1111112222345678999999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.3e-37  Score=320.42  Aligned_cols=248  Identities=29%  Similarity=0.385  Sum_probs=200.9

Q ss_pred             hcCCCCcceEEEeeee-CCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCC
Q 004312          489 ELGRGAFGTVYKGFVN-MGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      +||+|+||.||+|.+. .++++.+|+|+++....  ...+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999764 33457899999865432  23568999999999999999999999885 45678999999999


Q ss_pred             chhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc--ccc
Q 004312          566 ALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT--NTA  643 (762)
Q Consensus       566 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~--~~~  643 (762)
                      +|.+++.....+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++.........  ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            9999998878899999999999999999999998   99999999999999999999999999998765433221  122


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ..++..|+|||.+....++.++||||||+++|||++ |+.||......+..      ..+........+...+.++.+++
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~------~~i~~~~~~~~~~~~~~~l~~li  231 (257)
T cd05116         158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT------QMIESGERMECPQRCPPEMYDLM  231 (257)
T ss_pred             CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHCCCCCCCCCCCCHHHHHHH
Confidence            234578999999988889999999999999999998 88887443222111      11122222222334667899999


Q ss_pred             HHhhccCCCCCCCHHHHHHHhhcC
Q 004312          723 IWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       723 ~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      .+||+.||++||++++|.++|++.
T Consensus       232 ~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         232 KLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             HHHhccCchhCcCHHHHHHHHhcc
Confidence            999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.1e-37  Score=334.08  Aligned_cols=253  Identities=22%  Similarity=0.308  Sum_probs=201.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||.||++... .++..+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   85 (331)
T cd06649           7 FERISELGAGNGGVVTKVQHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM   85 (331)
T ss_pred             ceEEEeecCCCCEEEEEEEEC-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence            344578999999999999754 456789999987542 233467999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ++++|.+++.....+++..+..++.|++.||.|||++  .+|+||||||+|||+++++.+||+|||+++.....   ...
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~  160 (331)
T cd06649          86 DGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN  160 (331)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc---ccc
Confidence            9999999998888899999999999999999999985  26999999999999999999999999998765322   223


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhh---cccc------c--------------
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ---ERTL------G--------------  699 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~---~~~~------~--------------  699 (762)
                      ...|++.|+|||.+.+..++.++||||||+++|||++|+.||......+...   ....      .              
T Consensus       161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd06649         161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPV  240 (331)
T ss_pred             cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccc
Confidence            3568999999999999999999999999999999999999985432211100   0000      0              


Q ss_pred             ------------------cccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          700 ------------------ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       700 ------------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                                        .+.............+.++.+++.+||+.||++|||++|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                              0000000000111356789999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.8e-37  Score=318.69  Aligned_cols=248  Identities=26%  Similarity=0.414  Sum_probs=200.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      .+.+.||+|+||.||++.+..  ...+|+|.+... .....++.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~--~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           7 TFMKELGSGQFGVVHLGKWRA--QIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             EEeeEecCCcCceEEEEEecc--CceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            345789999999999997653  357999988643 33456899999999999999999999999999999999999999


Q ss_pred             CchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          565 GALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       565 gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      |+|.+++... ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||+++............
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05114          84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG  160 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence            9999999754 5689999999999999999999998   99999999999999999999999999998654333222223


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ..++..|+|||.+....++.++||||||+++|||++ |+.|+......+........      .....+...+.++.+++
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~~li  234 (256)
T cd05114         161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG------FRLYRPKLASMTVYEVM  234 (256)
T ss_pred             CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC------CCCCCCCCCCHHHHHHH
Confidence            335668999999998899999999999999999999 88887544322222211100      01111222356789999


Q ss_pred             HHhhccCCCCCCCHHHHHHHhh
Q 004312          723 IWCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       723 ~~cl~~dp~~RPt~~evl~~L~  744 (762)
                      .+||+.+|++||+++++++.|.
T Consensus       235 ~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         235 YSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             HHHccCCcccCcCHHHHHHhhC
Confidence            9999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4e-37  Score=322.28  Aligned_cols=254  Identities=27%  Similarity=0.425  Sum_probs=204.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCC--CcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMG--SSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|.+...  +...||||+++... .....+|.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   85 (266)
T cd05033           6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE   85 (266)
T ss_pred             ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence            34567899999999999987543  34579999987543 3334679999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC-
Q 004312          561 FMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-  638 (762)
Q Consensus       561 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-  638 (762)
                      |+++++|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++....... 
T Consensus        86 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd05033          86 YMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT  162 (266)
T ss_pred             cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence            99999999999764 4789999999999999999999998   999999999999999999999999999987752222 


Q ss_pred             cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          639 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..|+..........      .+........+...++.
T Consensus       163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~  236 (266)
T cd05033         163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIK------AVEDGYRLPPPMDCPSA  236 (266)
T ss_pred             eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHH------HHHcCCCCCCCCCCCHH
Confidence            11222335678999999999999999999999999999998 888863321111111      11111111122345678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      +.+++.+||+.+|++||+++||+++|+++
T Consensus       237 l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         237 LYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            89999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2e-37  Score=335.23  Aligned_cols=243  Identities=23%  Similarity=0.308  Sum_probs=201.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++....   ....+.+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus        20 y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   98 (329)
T PTZ00263         20 FEMGETLGTGSFGRVRIAKHK-GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE   98 (329)
T ss_pred             eEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence            345678999999999999764 456789999987532   2234578899999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.....    
T Consensus        99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----  171 (329)
T PTZ00263         99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----  171 (329)
T ss_pred             CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC----
Confidence            999999999998888899999999999999999999998   9999999999999999999999999999865322    


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...........     +.....  ..+...+.++.+
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-----i~~~~~--~~p~~~~~~~~~  244 (329)
T PTZ00263        172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK-----ILAGRL--KFPNWFDGRARD  244 (329)
T ss_pred             cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHH-----HhcCCc--CCCCCCCHHHHH
Confidence            2235689999999999999999999999999999999999999865433322221     111111  112234567899


Q ss_pred             HHHHhhccCCCCCCC-----HHHHHH
Q 004312          721 VAIWCIQEDPSHRPT-----MRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt-----~~evl~  741 (762)
                      ++.+||+.||.+||+     ++++++
T Consensus       245 li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        245 LVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            999999999999986     677764

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.8e-37  Score=339.40  Aligned_cols=257  Identities=23%  Similarity=0.340  Sum_probs=202.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC----CCcceEEEEEcccccc-chhHHHHHHhhhhcccc-cCCccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~L  557 (762)
                      +.+.+.||+|+||.||+|+...    .....||||+++.... ...+.+.+|++++++++ ||||+++++++.+....+|
T Consensus        39 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~l  118 (400)
T cd05105          39 LVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYI  118 (400)
T ss_pred             eehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEE
Confidence            3456889999999999997532    1234699999975433 23457999999999996 9999999999999999999


Q ss_pred             EEeccCCCchhhhccCC---------------------------------------------------------------
Q 004312          558 VYEFMSNGALASFLFGD---------------------------------------------------------------  574 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~---------------------------------------------------------------  574 (762)
                      ||||+++|+|.++|...                                                               
T Consensus       119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (400)
T cd05105         119 ITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEAS  198 (400)
T ss_pred             EEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhh
Confidence            99999999999887532                                                               


Q ss_pred             ---------------------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc
Q 004312          575 ---------------------------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN  621 (762)
Q Consensus       575 ---------------------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~  621 (762)
                                                       ..+++..+..++.||++||+|||+.   +|+||||||+|||+++++.
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~  275 (400)
T cd05105         199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKI  275 (400)
T ss_pred             hhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCE
Confidence                                             1367788899999999999999998   9999999999999999999


Q ss_pred             eEEecccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccc
Q 004312          622 ARISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLG  699 (762)
Q Consensus       622 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~  699 (762)
                      +||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...........    
T Consensus       276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~----  351 (400)
T cd05105         276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN----  351 (400)
T ss_pred             EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH----
Confidence            999999999865433221 1222346788999999999899999999999999999997 8888643321111111    


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          700 ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       700 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                       .+........+...+.++.+++.+||+.+|++||++.+|.++|+.+.+
T Consensus       352 -~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         352 -KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             -HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence             111111112233456789999999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.6e-37  Score=332.31  Aligned_cols=242  Identities=24%  Similarity=0.268  Sum_probs=199.1

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      +.||+|+||.||++... .+++.||+|+++...   ......+.+|++++++++||||+++++.+...+..+|||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence            36899999999999754 456799999987532   23345678899999999999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccc
Q 004312          565 GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI  644 (762)
Q Consensus       565 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  644 (762)
                      |+|..++.....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..... .......
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~  155 (323)
T cd05595          80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTF  155 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccccc
Confidence            99999998888899999999999999999999998   9999999999999999999999999998753222 1222345


Q ss_pred             cccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHH
Q 004312          645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW  724 (762)
Q Consensus       645 ~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  724 (762)
                      .||+.|+|||.+.+..++.++||||||+++|||++|+.||............     .....  ..+...+.++.+++.+
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~-----~~~~~--~~p~~~~~~~~~li~~  228 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-----LMEEI--RFPRTLSPEAKSLLAG  228 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-----hcCCC--CCCCCCCHHHHHHHHH
Confidence            6899999999999999999999999999999999999998543222221111     11111  1223456788999999


Q ss_pred             hhccCCCCCC-----CHHHHHH
Q 004312          725 CIQEDPSHRP-----TMRRVTQ  741 (762)
Q Consensus       725 cl~~dp~~RP-----t~~evl~  741 (762)
                      ||+.||++||     ++.++++
T Consensus       229 ~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         229 LLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HccCCHHHhCCCCCCCHHHHHc
Confidence            9999999998     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.8e-37  Score=332.74  Aligned_cols=243  Identities=24%  Similarity=0.271  Sum_probs=200.4

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      +.||+|+||.||++... .+++.||||++.+..   ......+.+|++++++++||||+++++.+...+..+|||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREK-ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            35899999999999754 456799999997532   23345788999999999999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccc
Q 004312          565 GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI  644 (762)
Q Consensus       565 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  644 (762)
                      |+|..++.....+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++..... .......
T Consensus        80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~  155 (328)
T cd05593          80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTF  155 (328)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccc
Confidence            99999998888899999999999999999999998   9999999999999999999999999998754322 1222345


Q ss_pred             cccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHH
Q 004312          645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW  724 (762)
Q Consensus       645 ~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  724 (762)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||...........     +....  ...+...+.++.+++.+
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~-----~~~~~--~~~p~~~~~~~~~li~~  228 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-----ILMED--IKFPRTLSADAKSLLSG  228 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH-----hccCC--ccCCCCCCHHHHHHHHH
Confidence            699999999999999999999999999999999999999854322222111     11111  11233456788999999


Q ss_pred             hhccCCCCCC-----CHHHHHHH
Q 004312          725 CIQEDPSHRP-----TMRRVTQM  742 (762)
Q Consensus       725 cl~~dp~~RP-----t~~evl~~  742 (762)
                      ||+.||++||     +++|+++.
T Consensus       229 ~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         229 LLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HcCCCHHHcCCCCCCCHHHHhcC
Confidence            9999999997     88988753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-38  Score=332.98  Aligned_cols=250  Identities=27%  Similarity=0.394  Sum_probs=211.6

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      ..++||-|.||.||.|.|...+ -.||||.++.. .-...+|..|+.+|+.++|||+|+|+|.|..+...|||+|||.+|
T Consensus       271 MkhKLGGGQYGeVYeGvWKkys-lTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG  348 (1157)
T KOG4278|consen  271 MKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG  348 (1157)
T ss_pred             eeeccCCCcccceeeeeeeccc-eeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence            4578999999999999998543 47999999753 445679999999999999999999999999999999999999999


Q ss_pred             chhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          566 ALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       566 sL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +|.+||..-  ..++--..+.||.||+.||.||..+   .+|||||..+|.|+.++..+||+|||+++++..+.......
T Consensus       349 NLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG  425 (1157)
T KOG4278|consen  349 NLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG  425 (1157)
T ss_pred             cHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC
Confidence            999999764  3466777889999999999999999   99999999999999999999999999999997654433332


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCC-CCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR-RTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      -.-...|.|||.+....++.|+|||+|||+||||.|-. .|+..      +.-..+-.++.++.+...+..+++.+.+|+
T Consensus       426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG------idlSqVY~LLEkgyRM~~PeGCPpkVYeLM  499 (1157)
T KOG4278|consen  426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYGLLEKGYRMDGPEGCPPKVYELM  499 (1157)
T ss_pred             ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC------ccHHHHHHHHhccccccCCCCCCHHHHHHH
Confidence            33457899999999999999999999999999999844 44322      222223345556666666777899999999


Q ss_pred             HHhhccCCCCCCCHHHHHHHhhcC
Q 004312          723 IWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       723 ~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      +.||+.+|.+||++.|+.+.++.+
T Consensus       500 raCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  500 RACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             HHHhcCCcccCccHHHHHHHHHHH
Confidence            999999999999999999888765

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.8e-37  Score=321.47  Aligned_cols=251  Identities=26%  Similarity=0.396  Sum_probs=203.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.++||+|++|.||+|...  .+..||+|++.... ...+.+.+|+.++++++|+||+++++.+.+.+..++||||++
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           8 IKLVKKLGAGQFGEVWMGYYN--NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             eEEeeecCCcCCceEEEEEec--CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            345678999999999999754  34579999986532 345689999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|.+++...  ..+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||+++..........
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  161 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR  161 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence            99999999653  5688999999999999999999998   999999999999999999999999999987654332222


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....++..|+|||.+....++.++||||||+++|+|++ |+.|+............      ............+.++.+
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~  235 (261)
T cd05072         162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL------QRGYRMPRMENCPDELYD  235 (261)
T ss_pred             CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH------HcCCCCCCCCCCCHHHHH
Confidence            23345678999999998899999999999999999998 88887433222111110      001111112235678899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      ++.+||+.+|++||+++++.+.|+++
T Consensus       236 li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         236 IMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HHHHHccCCcccCcCHHHHHHHHhcC
Confidence            99999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.7e-37  Score=326.66  Aligned_cols=257  Identities=24%  Similarity=0.384  Sum_probs=206.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC----CCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      ..+.+.||+|+||.||++....    .+...+|+|.+........+.+.+|++++++++||||+++++++...+..++||
T Consensus         7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   86 (288)
T cd05093           7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF   86 (288)
T ss_pred             eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence            4456789999999999997522    234569999998765566678999999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCCC-------------CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEec
Q 004312          560 EFMSNGALASFLFGDS-------------KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISD  626 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~-------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  626 (762)
                      ||+++++|.+++....             .+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|
T Consensus        87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d  163 (288)
T cd05093          87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD  163 (288)
T ss_pred             EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEecc
Confidence            9999999999986432             489999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcccccccccc
Q 004312          627 FGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVEN  704 (762)
Q Consensus       627 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  704 (762)
                      ||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...........     +...
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~-----i~~~  238 (288)
T cd05093         164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC-----ITQG  238 (288)
T ss_pred             CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcC
Confidence            999986543221 11122335778999999998899999999999999999998 7887643322221111     1111


Q ss_pred             ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       705 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      . ....+...+.++.+++.+||+.+|.+|||++||++.|+++...
T Consensus       239 ~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         239 R-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             C-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            1 1111223456799999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.3e-37  Score=324.91  Aligned_cols=255  Identities=23%  Similarity=0.378  Sum_probs=206.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeC----CCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .+.+.||+|+||.||+|+...    .+...+++|++........+.+.+|++++++++|+||+++++++......++|||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (291)
T cd05094           8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE   87 (291)
T ss_pred             EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence            345789999999999997532    2345699999877655666789999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEE
Q 004312          561 FMSNGALASFLFGD----------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARI  624 (762)
Q Consensus       561 ~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl  624 (762)
                      |+++++|.+++...                ..+++..++.++.||+.||+|||++   +|+||||||+|||+++++.+||
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l  164 (291)
T cd05094          88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKI  164 (291)
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEE
Confidence            99999999998643                2378999999999999999999998   9999999999999999999999


Q ss_pred             ecccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcccccccc
Q 004312          625 SDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALV  702 (762)
Q Consensus       625 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  702 (762)
                      +|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+.....      
T Consensus       165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~------  238 (291)
T cd05094         165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI------  238 (291)
T ss_pred             CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------
Confidence            99999976543221 11223446788999999999999999999999999999998 88887443332222111      


Q ss_pred             ccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          703 ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       703 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ........+...+..+.+++.+||+.+|++||++++|+++|+.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            1111111122346788999999999999999999999999998744

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-37  Score=345.67  Aligned_cols=257  Identities=21%  Similarity=0.298  Sum_probs=214.2

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc-cCCccchhce-ecc------CCceeE
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGY-CDE------GRNRLL  557 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~-~~~------~~~~~L  557 (762)
                      +.+.|.+|||+.||.+....+ +.++|+|++-..++...+.+++||++|++|+ |+|||.+++. ...      .-+.+|
T Consensus        41 V~~vLAEGGFa~VYla~~~~~-~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll  119 (738)
T KOG1989|consen   41 VEKVLAEGGFAQVYLAQDVKG-GKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL  119 (738)
T ss_pred             EEEEEccCCcEEEEEEEecCC-CceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence            457899999999999987644 3789999998777888889999999999996 9999999993 211      246789


Q ss_pred             EEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          558 VYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      .||||++|.|-+++..+  ..+++.++++|+.|+++|+++||.. .++|||||||-+||||+++++.||||||.+.....
T Consensus       120 LmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~  198 (738)
T KOG1989|consen  120 LMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL  198 (738)
T ss_pred             ehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence            99999999999999754  5699999999999999999999995 77899999999999999999999999999875433


Q ss_pred             CCC-cc-------cccccccCcccCcccc---cCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccc
Q 004312          636 DQS-HT-------NTAIRGTKGYVAPEWF---RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN  704 (762)
Q Consensus       636 ~~~-~~-------~~~~~gt~~y~aPE~~---~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  704 (762)
                      ... ..       .-...-|+.|.|||++   .+.++++|+|||+|||+||-|+....||...         -...++..
T Consensus       199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s---------g~laIlng  269 (738)
T KOG1989|consen  199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES---------GKLAILNG  269 (738)
T ss_pred             CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC---------cceeEEec
Confidence            221 11       1122368999999997   5678999999999999999999999998432         13345556


Q ss_pred             ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCCCCC
Q 004312          705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPP  753 (762)
Q Consensus       705 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~p~  753 (762)
                      ....+..+.++..+.+||..||+.||.+||++-||++.+.++...+.|.
T Consensus       270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~  318 (738)
T KOG1989|consen  270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI  318 (738)
T ss_pred             cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence            6666556789999999999999999999999999999998876665443

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4e-37  Score=325.92  Aligned_cols=247  Identities=24%  Similarity=0.261  Sum_probs=198.1

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      ..+.||+|+||.||++... .+++.||||++....   ......+.+|++++++++|+||+++++.+.+.+..++||||+
T Consensus         4 ~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05631           4 HYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM   82 (285)
T ss_pred             EEEEEecCCCEEEEEEEEe-cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence            4567999999999999764 356799999986432   223346889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          563 SNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       563 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      ++|+|.+++...  ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++......  ..
T Consensus        83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~  157 (285)
T cd05631          83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--ET  157 (285)
T ss_pred             CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--Ce
Confidence            999999888543  4689999999999999999999998   9999999999999999999999999999865322  22


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....|++.|+|||.+.+..++.++|||||||++|||++|+.||..........  .+...+.. .....+...+..+.+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--~~~~~~~~-~~~~~~~~~s~~~~~  234 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE--EVDRRVKE-DQEEYSEKFSEDAKS  234 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH--HHHHHhhc-ccccCCccCCHHHHH
Confidence            234568999999999999999999999999999999999999985432111000  00000100 111123345678899


Q ss_pred             HHHHhhccCCCCCCC-----HHHHHH
Q 004312          721 VAIWCIQEDPSHRPT-----MRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt-----~~evl~  741 (762)
                      |+.+||+.||.+||+     ++++++
T Consensus       235 li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         235 ICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.5e-37  Score=323.58  Aligned_cols=254  Identities=19%  Similarity=0.230  Sum_probs=200.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.+.+.||+|+||.||+++.. .+++.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHK-ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             ceEEEEecccCCEEEEEEEEC-CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            345678999999999999764 456789999987532  23346788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      ++++.|..+......+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence            99988877765566789999999999999999999998   999999999999999999999999999987654333333


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc--c-----------------cccccc
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--R-----------------TLGALV  702 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~--~-----------------~~~~~~  702 (762)
                      ....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....  .                 ......
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR  238 (287)
T ss_pred             cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence            445689999999999988999999999999999999999998754322111100  0                 000000


Q ss_pred             cccccc------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          703 ENDLEA------MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       703 ~~~~~~------~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+....      ......+..+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000      001124567999999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.6e-36  Score=316.52  Aligned_cols=251  Identities=24%  Similarity=0.420  Sum_probs=208.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.++||.|+||.||+|....  ++.+++|.+.........++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus         8 y~~~~~ig~g~~~~vy~~~~~~--~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (261)
T cd05148           8 FTLERKLGSGYFGEVWEGLWKN--RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME   85 (261)
T ss_pred             HHHhhhhccCCCccEEEeEecC--CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence            5567899999999999998664  57899999987655566789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|.+++.+.  ..+++..+..++.||+.||+|||+.   +|+|+||||+||++++++.+||+|||++......... .
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~  161 (261)
T cd05148          86 KGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-S  161 (261)
T ss_pred             cCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc-c
Confidence            99999999764  4689999999999999999999998   9999999999999999999999999999876432221 2


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....++..|+|||.+....++.++||||||+++|+|++ |+.|+......+....      +........+...++.+.+
T Consensus       162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~  235 (261)
T cd05148         162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ------ITAGYRMPCPAKCPQEIYK  235 (261)
T ss_pred             cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH------HHhCCcCCCCCCCCHHHHH
Confidence            23345778999999998899999999999999999998 7888744322221111      1111222223455678899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      ++.+||+.+|++|||++++++.|+.+
T Consensus       236 ~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         236 IMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.4e-36  Score=371.15  Aligned_cols=261  Identities=26%  Similarity=0.496  Sum_probs=203.0

Q ss_pred             cCHHHHHHHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCC
Q 004312          474 FTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR  553 (762)
Q Consensus       474 ~~~~el~~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  553 (762)
                      ++++++.... ...+.||+|+||.||+|+.. .+++.||||+++.....    ..+|++.+++++|||||+++|+|.+.+
T Consensus       683 ~~~~~~~~~~-~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~  756 (968)
T PLN00113        683 ITINDILSSL-KEENVISRGKKGASYKGKSI-KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK  756 (968)
T ss_pred             hhHHHHHhhC-CcccEEccCCCeeEEEEEEC-CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence            3444444321 23357999999999999764 34678999998754322    235688899999999999999999999


Q ss_pred             ceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccc
Q 004312          554 NRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL  633 (762)
Q Consensus       554 ~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~  633 (762)
                      ..++||||+++|+|.++++   .++|..+.+|+.||++||+|||+.+.++|+||||||+||++++++.+++. |+.....
T Consensus       757 ~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        757 GAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             CCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            9999999999999999995   38999999999999999999998777799999999999999999988886 6665433


Q ss_pred             cCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchh---------hHHHhhhcccccccccc
Q 004312          634 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTD---------WAYDCYQERTLGALVEN  704 (762)
Q Consensus       634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~---------~~~~~~~~~~~~~~~~~  704 (762)
                      ..     .....+++.|+|||++.+..++.++|||||||++|||++|+.|+...         +.............+++
T Consensus       833 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  907 (968)
T PLN00113        833 CT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP  907 (968)
T ss_pred             cc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence            21     12235789999999999999999999999999999999999997322         11111111122223333


Q ss_pred             cccc--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          705 DLEA--MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       705 ~~~~--~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      ....  ..+.....++.+++.+||+.+|++||||+||+++|+++.+.
T Consensus       908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            3321  22345667889999999999999999999999999987553

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=296.39  Aligned_cols=258  Identities=24%  Similarity=0.282  Sum_probs=211.3

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCC-----ceeEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR-----NRLLV  558 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~LV  558 (762)
                      +.+.+.||+|||+.||.++ ...+++.+|+|++.....+..+..++|++..++++|||++++++++..+.     +.+|+
T Consensus        23 yri~~~LgeGGfsfv~LV~-~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll  101 (302)
T KOG2345|consen   23 YRIQRLLGEGGFSFVDLVK-GLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL  101 (302)
T ss_pred             EEEeeeecCCCceeeeeec-ccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence            5567889999999999987 33456789999998877788889999999999999999999999986544     48999


Q ss_pred             EeccCCCchhhhccCC----CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccccc
Q 004312          559 YEFMSNGALASFLFGD----SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT  634 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~  634 (762)
                      ++|...|+|.+.+...    ..+++.+.++|+.+|.+||.+||+. .++++||||||.|||+.+.+.++|.|||.+....
T Consensus       102 ~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~  180 (302)
T KOG2345|consen  102 LPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAP  180 (302)
T ss_pred             eehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccc
Confidence            9999999999998643    4689999999999999999999997 3469999999999999999999999999987553


Q ss_pred             CCCC--------cccccccccCcccCccccc---CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccc-ccc
Q 004312          635 LDQS--------HTNTAIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLG-ALV  702 (762)
Q Consensus       635 ~~~~--------~~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~-~~~  702 (762)
                      ..-.        +.......|..|.|||.+.   +...++++|||||||+||+|+.|..||....  +  +.+.+. .+.
T Consensus       181 i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~--~--~GgSlaLAv~  256 (302)
T KOG2345|consen  181 IQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY--Q--QGGSLALAVQ  256 (302)
T ss_pred             eEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh--h--cCCeEEEeee
Confidence            2211        1123345799999999984   5578999999999999999999999984332  1  223333 222


Q ss_pred             ccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          703 ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       703 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      ......+.....++.+.+++++|+++||.+||++.+++..++.+.
T Consensus       257 n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  257 NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            333444444458899999999999999999999999999998753

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=9.6e-37  Score=330.35  Aligned_cols=254  Identities=21%  Similarity=0.299  Sum_probs=200.7

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      ..+.+.++||+|+||.||++... .++..+|+|++.... ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEEC-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            44556788999999999999754 456789999887542 2334679999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++++|.+++.....+++.....++.|++.||.|||+.  .+|+||||||+|||+++++.+||+|||++......   .
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~  158 (333)
T cd06650          84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M  158 (333)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---c
Confidence            999999999998888899999999999999999999974  26999999999999999999999999998765321   1


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhh--c----cccc---------------
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ--E----RTLG---------------  699 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~--~----~~~~---------------  699 (762)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.|+..........  .    ....               
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence            233468999999999998899999999999999999999999975432211100  0    0000               


Q ss_pred             ------------------cccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          700 ------------------ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       700 ------------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                                        .+.............+.++.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                              000000000000113467899999999999999999999974

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-38  Score=301.68  Aligned_cols=250  Identities=24%  Similarity=0.353  Sum_probs=207.9

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcc--ccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .+.+.++||+|.|+.|++. ++..+++.+|+|++.  +......+++.+|+++-+.|+|||||+|.....+....+||+|
T Consensus        12 ~y~l~e~igkG~FSvVrRc-~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   12 NYDVKEELGKGAFSVVRRC-VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhHHHHHccCchHHHHHH-HhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            4566789999999999997 455667888988875  2334466789999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc---CCCceEEecccccccccCCC
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~~~~~  637 (762)
                      +|++++|..-|-.....++...-..+.||+++|.|+|.+   +|||||+||+|+|+.   ..-.+||+|||++..+.  .
T Consensus        91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~  165 (355)
T KOG0033|consen   91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--D  165 (355)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC--C
Confidence            999999987776666678888889999999999999999   999999999999995   34569999999999876  4


Q ss_pred             CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      ......+.|||+|||||+++..+++..+|||+.|||||-|+.|..||........++.......   +.....-..+.++
T Consensus       166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~y---d~~~~~w~~is~~  242 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAY---DYPSPEWDTVTPE  242 (355)
T ss_pred             ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcccc---CCCCcccCcCCHH
Confidence            4455567899999999999999999999999999999999999999976544444433222211   1122223467789


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ..+|+.+||..||.+|.|+.|.++
T Consensus       243 Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  243 AKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHHHHHHHhccChhhhccHHHHhC
Confidence            999999999999999999998875

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.7e-37  Score=329.23  Aligned_cols=255  Identities=25%  Similarity=0.353  Sum_probs=202.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCc---ceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSS---DQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +...+.||+|+||.||+|++.....   ..||||+++... ....+++.+|+.++++++||||++++|+|... ...+|+
T Consensus         9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~   87 (316)
T cd05108           9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   87 (316)
T ss_pred             ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence            4455789999999999998643222   248999987542 34456899999999999999999999999865 567999


Q ss_pred             eccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          560 EFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       560 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      ||+++|+|.+++... ..+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus        88 e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  164 (316)
T cd05108          88 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK  164 (316)
T ss_pred             ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence            999999999999875 4688999999999999999999998   999999999999999999999999999987654332


Q ss_pred             ccc-ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          639 HTN-TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       639 ~~~-~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      ... .....+..|+|||.+.+..++.++||||||+++|||++ |+.|+......+.      ...+........+..++.
T Consensus       165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~  238 (316)
T cd05108         165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKGERLPQPPICTI  238 (316)
T ss_pred             ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHhCCCCCCCCCCCCH
Confidence            211 12234678999999999999999999999999999998 8888744322111      111111112222233456


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ++.+++.+||+.+|++||++.+++..|..+..
T Consensus       239 ~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         239 DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            78999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-37  Score=294.45  Aligned_cols=242  Identities=25%  Similarity=0.345  Sum_probs=209.5

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.||+|.||.||.|+.+ .+...||+|++.+.   ..+.++++.+|+++-+.|+||||+++++++.+....+|++||.
T Consensus        26 igr~LgkgkFG~vYlarek-ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya  104 (281)
T KOG0580|consen   26 IGRPLGKGKFGNVYLAREK-KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA  104 (281)
T ss_pred             ccccccCCccccEeEeeec-cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence            5578999999999999765 45678999998653   2334578999999999999999999999999999999999999


Q ss_pred             CCCchhhhcc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          563 SNGALASFLF--GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       563 ~~gsL~~~l~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      ++|.|...|.  ...++++.....++.|+|.||.|+|..   +||||||||+|+|++.++..||+|||-+..-.   ...
T Consensus       105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~k  178 (281)
T KOG0580|consen  105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SNK  178 (281)
T ss_pred             CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---CCC
Confidence            9999999998  557889999999999999999999998   99999999999999999999999999987432   555


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....+||..|.+||..++...+...|+|++|++.||++.|..||......+.+.+....++       ..+..++..+.+
T Consensus       179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~-------~~p~~is~~a~d  251 (281)
T KOG0580|consen  179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL-------KFPSTISGGAAD  251 (281)
T ss_pred             ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc-------cCCcccChhHHH
Confidence            6678899999999999999999999999999999999999999976653333333222222       224567789999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~  741 (762)
                      +|.+|+..+|.+|.+..|++.
T Consensus       252 lI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  252 LISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             HHHHHhccCccccccHHHHhh
Confidence            999999999999999999887

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.2e-37  Score=346.34  Aligned_cols=249  Identities=19%  Similarity=0.234  Sum_probs=203.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|++|.||++......++.||+|.+..........+.+|+.++++++|||||++++++...+..+|||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            45667899999999999975544367889998765544555678899999999999999999999999999999999999


Q ss_pred             CCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC-
Q 004312          564 NGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-  638 (762)
Q Consensus       564 ~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-  638 (762)
                      +|+|.++|..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++.+..... 
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            9999988753    34688999999999999999999998   999999999999999999999999999987643322 


Q ss_pred             cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          639 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....     +..... ...+...+.++
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~-----~~~~~~-~~~~~~~s~~~  299 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ-----VLYGKY-DPFPCPVSSGM  299 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhCCC-CCCCccCCHHH
Confidence            223445699999999999999999999999999999999999999854332222211     111111 11223456789


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+++.+||+.+|++||++++++.
T Consensus       300 ~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        300 KALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHHHHHhccChhhCcCHHHHHh
Confidence            99999999999999999998864

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-37  Score=335.77  Aligned_cols=253  Identities=27%  Similarity=0.375  Sum_probs=216.0

Q ss_pred             hhhcCCCCcceEEEeeeeCCCc---ceEEEEEccc-cccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          487 KEELGRGAFGTVYKGFVNMGSS---DQVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .++||+|+||+||||.+--..+   -+||+|++.. ...+...++.+|+-+|++++||||+||+|+|.... ..||++||
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            3679999999999998854422   3699998864 34555689999999999999999999999998877 88999999


Q ss_pred             CCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          563 SNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       563 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      |.|+|.+|++.+ ..+..+..+.|..|||+||.|||.+   +++||||..+|||+.+-..+||.|||+++.+..+..+-.
T Consensus       780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~  856 (1177)
T KOG1025|consen  780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS  856 (1177)
T ss_pred             ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence            999999999765 5788999999999999999999999   999999999999999999999999999999876655433


Q ss_pred             ccc-cccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          642 TAI-RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       642 ~~~-~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ... .-.+.|||-|.+....+++++|||||||++||++| |.+|+.      .+..+.+..++....+...++.+..++.
T Consensus       857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~------gi~~~eI~dlle~geRLsqPpiCtiDVy  930 (1177)
T KOG1025|consen  857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYD------GIPAEEIPDLLEKGERLSQPPICTIDVY  930 (1177)
T ss_pred             ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccC------CCCHHHhhHHHhccccCCCCCCccHHHH
Confidence            332 23568999999999999999999999999999998 667753      3344455666666666777888999999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      .++.+||..|+..||+++++...+.++..-
T Consensus       931 ~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  931 MVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             HHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            999999999999999999999988876543

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.2e-36  Score=324.32  Aligned_cols=257  Identities=24%  Similarity=0.399  Sum_probs=203.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCC-cceEEEEEcccc-ccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGS-SDQVAVKKLNRV-FQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||+|...... ...+++|.++.. .....+.+.+|++++.++ +||||+++++++.+....++|+||
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~   84 (297)
T cd05089           5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY   84 (297)
T ss_pred             eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence            45678999999999999875432 235788888743 233456799999999999 799999999999999999999999


Q ss_pred             cCCCchhhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEe
Q 004312          562 MSNGALASFLFGD----------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARIS  625 (762)
Q Consensus       562 ~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~  625 (762)
                      +++++|.+++...                ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~  161 (297)
T cd05089          85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIA  161 (297)
T ss_pred             cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEEC
Confidence            9999999999643                2478899999999999999999998   99999999999999999999999


Q ss_pred             cccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcccccccccc
Q 004312          626 DFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVEN  704 (762)
Q Consensus       626 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  704 (762)
                      |||++......  ........+..|+|||.+....++.++||||||+++|||++ |+.||...........      +..
T Consensus       162 dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~------~~~  233 (297)
T cd05089         162 DFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK------LPQ  233 (297)
T ss_pred             CcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH------Hhc
Confidence            99998643211  11111223557999999998899999999999999999997 8888754433222211      111


Q ss_pred             ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCCCC
Q 004312          705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIP  752 (762)
Q Consensus       705 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~p  752 (762)
                      ......+..++..+.+++.+||+.+|.+||+++++++.|+.+.+...+
T Consensus       234 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            111112234567889999999999999999999999999987765543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.7e-36  Score=314.84  Aligned_cols=247  Identities=26%  Similarity=0.374  Sum_probs=197.6

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCc
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      +.||+|+||.||+|.... +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA-DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEec-CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            469999999999997653 46789999876532 3345679999999999999999999999999999999999999999


Q ss_pred             hhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc-cccc
Q 004312          567 LASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT-NTAI  644 (762)
Q Consensus       567 L~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~  644 (762)
                      |.+++... ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++......... ....
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            99999754 4689999999999999999999998   99999999999999999999999999987643221111 1111


Q ss_pred             cccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       645 ~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..+..|+|||.+.++.++.++||||||+++|||++ |..|+........      ...+........+...+..+.+++.
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~  230 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT------REAIEQGVRLPCPELCPDAVYRLME  230 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH------HHHHHcCCCCCCcccCCHHHHHHHH
Confidence            23457999999999999999999999999999998 7777532211111      1111111122223345678999999


Q ss_pred             HhhccCCCCCCCHHHHHHHhh
Q 004312          724 WCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       724 ~cl~~dp~~RPt~~evl~~L~  744 (762)
                      +||+.+|++|||++||.++|+
T Consensus       231 ~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         231 RCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHcCCChhhCcCHHHHHHHHh
Confidence            999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-36  Score=315.15  Aligned_cols=250  Identities=29%  Similarity=0.403  Sum_probs=201.8

Q ss_pred             hhcCCCCcceEEEeeeeCCC--cceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNMGS--SDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      ++||+|+||.||+|++...+  ...+|+|.+..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999765433  36899999875443 34568999999999999999999999876 5568999999999


Q ss_pred             CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc--c
Q 004312          565 GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--T  642 (762)
Q Consensus       565 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~--~  642 (762)
                      ++|.+++.....+++..+..++.|++.||+|||..   +++|+||||+|||+++++.+||+|||+++..........  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~  156 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT  156 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence            99999998888899999999999999999999998   999999999999999999999999999987643332211  1


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+...      .+........+...+..+.++
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~l  230 (257)
T cd05060         157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA------MLESGERLPRPEECPQEIYSI  230 (257)
T ss_pred             CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHH------HHHcCCcCCCCCCCCHHHHHH
Confidence            1223568999999998999999999999999999998 888864332211111      111111112233456788999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          722 AIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      +.+||+.+|++||++.++++.|+++.
T Consensus       231 i~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         231 MLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             HHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            99999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.7e-36  Score=320.15  Aligned_cols=254  Identities=24%  Similarity=0.324  Sum_probs=199.2

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCc---ceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSS---DQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.+.||+|+||.||+|.+.....   ..+++|++..... ....++..|+..+++++||||+++++++.. ...++++||
T Consensus        11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~   89 (279)
T cd05111          11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQL   89 (279)
T ss_pred             eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEe
Confidence            44789999999999998643222   2488888764322 234578888999999999999999999864 457899999


Q ss_pred             cCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC-c
Q 004312          562 MSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-H  639 (762)
Q Consensus       562 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~  639 (762)
                      +++|+|.+++... ..+++..+..++.||+.||+|||+.   +++||||||+|||+++++.+||+|||+++....... .
T Consensus        90 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~  166 (279)
T cd05111          90 SPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY  166 (279)
T ss_pred             CCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCccc
Confidence            9999999999764 5689999999999999999999998   999999999999999999999999999987643322 1


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      ......++..|+|||.+.++.++.++||||||+++|||++ |+.|+........      ...+........+...+..+
T Consensus       167 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05111         167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV------PDLLEKGERLAQPQICTIDV  240 (279)
T ss_pred             ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCCCcCCCCCCCCHHH
Confidence            2223456778999999998999999999999999999998 8888744322211      11111111111122234567


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      .+++.+||..+|++|||+.|+++.|..+.+-
T Consensus       241 ~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         241 YMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            8899999999999999999999999886653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1e-36  Score=328.73  Aligned_cols=243  Identities=24%  Similarity=0.281  Sum_probs=199.2

Q ss_pred             hhcCCCCcceEEEeeeeC--CCcceEEEEEccccc----cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          488 EELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVF----QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.||+|+||.||+++...  ..++.||||++++..    ......+.+|++++++++||||+++++.+..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            569999999999997532  356789999987532    22335678999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++++|.+++.....+.+..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  157 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVT  157 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Ccc
Confidence            99999999998888889999999999999999999998   99999999999999999999999999987543222 223


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ....|++.|+|||.+.+..++.++||||||+++|||++|+.||..........     .+.....  ..+...+.++.++
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~-----~~~~~~~--~~~~~~~~~~~~l  230 (323)
T cd05584         158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID-----KILKGKL--NLPPYLTPEARDL  230 (323)
T ss_pred             cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH-----HHHcCCC--CCCCCCCHHHHHH
Confidence            34568999999999998889999999999999999999999985443222111     1111111  1223346788999


Q ss_pred             HHHhhccCCCCCC-----CHHHHHH
Q 004312          722 AIWCIQEDPSHRP-----TMRRVTQ  741 (762)
Q Consensus       722 i~~cl~~dp~~RP-----t~~evl~  741 (762)
                      +.+||+.+|++||     +++++++
T Consensus       231 i~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         231 LKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HHHHcccCHhHcCCCCCCCHHHHhc
Confidence            9999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-36  Score=330.22  Aligned_cols=258  Identities=26%  Similarity=0.369  Sum_probs=202.1

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeC----CCcceEEEEEcccccc-chhHHHHHHhhhhccc-ccCCccchhceecc-CCce
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDE-GRNR  555 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~-~~~~  555 (762)
                      .+.+.+.||+|+||.||+|....    .+.+.||+|+++.... ...+.+..|+.++.++ +|+||++++++|.. +...
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~   87 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL   87 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence            45667899999999999996432    2346899999875432 2345688899999999 89999999998864 4567


Q ss_pred             eEEEeccCCCchhhhccCC-------------------------------------------------------------
Q 004312          556 LLVYEFMSNGALASFLFGD-------------------------------------------------------------  574 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~-------------------------------------------------------------  574 (762)
                      ++++||+++++|.+++...                                                             
T Consensus        88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (337)
T cd05054          88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK  167 (337)
T ss_pred             EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence            8999999999999988532                                                             


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc-cccccccCcccCc
Q 004312          575 SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT-NTAIRGTKGYVAP  653 (762)
Q Consensus       575 ~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aP  653 (762)
                      ..+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++.+....... .....++..|+||
T Consensus       168 ~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         168 EPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence            2578999999999999999999998   99999999999999999999999999998764333221 2234467789999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCC
Q 004312          654 EWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSH  732 (762)
Q Consensus       654 E~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~  732 (762)
                      |.+.+..++.++|||||||++|||++ |..|+......+...     ..+........+...+.++.+++.+||+.+|++
T Consensus       245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~  319 (337)
T cd05054         245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC-----RRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED  319 (337)
T ss_pred             HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHH-----HHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence            99999999999999999999999998 888874321111111     111111111122345578899999999999999


Q ss_pred             CCCHHHHHHHhhcCcC
Q 004312          733 RPTMRRVTQMLEGVVE  748 (762)
Q Consensus       733 RPt~~evl~~L~~~~~  748 (762)
                      ||+++||+++|+.+.+
T Consensus       320 RPs~~ell~~l~~~~~  335 (337)
T cd05054         320 RPTFSELVEILGDLLQ  335 (337)
T ss_pred             CcCHHHHHHHHHHHHh
Confidence            9999999999998654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-36  Score=316.96  Aligned_cols=248  Identities=27%  Similarity=0.398  Sum_probs=199.6

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      .+.+.||+|++|.||+|....  ...+|||.+.... ....+|.+|+.++++++||||+++++++.+....++||||+++
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~--~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           7 TFLKELGTGQFGVVKYGKWRG--QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             EEeeEecCcccceEEEEEecC--CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            456789999999999997643  3469999987542 3356799999999999999999999999999999999999999


Q ss_pred             CchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          565 GALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       565 gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      ++|.+++... ..+++..+..++.||+.||+|||+.   +++|+||||+||++++++.+||+|||+++............
T Consensus        84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05113          84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG  160 (256)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence            9999999764 4689999999999999999999998   99999999999999999999999999988664433222222


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ..++..|+|||.+....++.++||||||+++|||++ |+.|+...........     + ........+...+..+.+++
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~li  234 (256)
T cd05113         161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK-----V-SQGLRLYRPHLASEKVYAIM  234 (256)
T ss_pred             CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-----H-hcCCCCCCCCCCCHHHHHHH
Confidence            335678999999988889999999999999999998 8888643211111111     1 11111111223457889999


Q ss_pred             HHhhccCCCCCCCHHHHHHHhh
Q 004312          723 IWCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       723 ~~cl~~dp~~RPt~~evl~~L~  744 (762)
                      .+||+.+|.+||++.++++.|+
T Consensus       235 ~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         235 YSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHHcCCCcccCCCHHHHHHhhC
Confidence            9999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-36  Score=315.90  Aligned_cols=249  Identities=26%  Similarity=0.395  Sum_probs=200.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      ..+.+.||+|++|.||+|...  ....+|+|++.+.. ....++.+|++++++++|+||+++++++.+.+..++||||++
T Consensus         6 ~~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           6 LTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             cchhhhhccCCCceEEEeEec--CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            346688999999999999764  34579999986532 234578899999999999999999999999999999999999


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      +++|.+++... ..+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||+++...........
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ  159 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence            99999999754 4689999999999999999999998   9999999999999999999999999999865432222222


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ...++..|+|||.+....++.++||||||+++|||++ |+.|+......+....      +........+...+.++.++
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l  233 (256)
T cd05059         160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES------VSAGYRLYRPKLAPTEVYTI  233 (256)
T ss_pred             CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH------HHcCCcCCCCCCCCHHHHHH
Confidence            2234568999999998999999999999999999999 6777643222111111      11111112223456789999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhh
Q 004312          722 AIWCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~L~  744 (762)
                      +.+||+.+|++|||++|++++|.
T Consensus       234 i~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         234 MYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHHHhC
Confidence            99999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.7e-36  Score=321.08  Aligned_cols=265  Identities=20%  Similarity=0.269  Sum_probs=214.7

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc---hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD---SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      ...||+|+||.||+++- ..+++.+|+|++++..-.   ..+-.+.|-.+|...++|.||+|+-.|.+.+.+||||||+|
T Consensus       146 Lk~IgkGAfGeVrLarK-k~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP  224 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARK-KDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP  224 (550)
T ss_pred             heeeccccceeEEEEEE-ccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence            36799999999999974 467889999999875332   33457789999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC--------
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL--------  635 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~--------  635 (762)
                      ||++..+|...+.+++.....++.+++.|+.-||+.   |+|||||||+|+|||..|++||+||||+.-+..        
T Consensus       225 GGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~  301 (550)
T KOG0605|consen  225 GGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYR  301 (550)
T ss_pred             CccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhc
Confidence            999999999999999999999999999999999999   999999999999999999999999999853311        


Q ss_pred             --------------CCCc-----c-------------------cccccccCcccCcccccCCCCCCcchhHHHHHHHHHH
Q 004312          636 --------------DQSH-----T-------------------NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI  677 (762)
Q Consensus       636 --------------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~el  677 (762)
                                    ....     .                   ....+|||.|||||++.+..++..+|.||||||+|||
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEm  381 (550)
T KOG0605|consen  302 LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEM  381 (550)
T ss_pred             chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHH
Confidence                          0000     0                   0124699999999999999999999999999999999


Q ss_pred             HhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCC---CHHHHHHH-------hhcCc
Q 004312          678 ICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRP---TMRRVTQM-------LEGVV  747 (762)
Q Consensus       678 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP---t~~evl~~-------L~~~~  747 (762)
                      |.|-.||..+.+.+.++...-...   .+..+.....+.++.+||.+|+. ||++|.   .++||.+.       .+.+.
T Consensus       382 LvGyPPF~s~tp~~T~rkI~nwr~---~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~  457 (550)
T KOG0605|consen  382 LVGYPPFCSETPQETYRKIVNWRE---TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLR  457 (550)
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHhh---hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhh
Confidence            999999988877766655332221   11222233445889999999999 999996   47777653       34456


Q ss_pred             CCCCCCCCCCCC
Q 004312          748 EVPIPPCPWTLN  759 (762)
Q Consensus       748 ~~~~p~~p~~~~  759 (762)
                      +.++|=.|-+-+
T Consensus       458 ~~~apfvP~v~~  469 (550)
T KOG0605|consen  458 EMPAPFVPQVNS  469 (550)
T ss_pred             cCCCCCCCCCCC
Confidence            666665554433

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.1e-36  Score=320.98  Aligned_cols=254  Identities=24%  Similarity=0.386  Sum_probs=199.2

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeC----CCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeE
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L  557 (762)
                      .+.+.+.||+|+||.||+|....    .....||||++.... .....++.+|+.++++++||||+++++++.++...++
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   86 (277)
T cd05062           7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV   86 (277)
T ss_pred             HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence            34566789999999999987532    234679999986432 2344578999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhccCC----------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecc
Q 004312          558 VYEFMSNGALASFLFGD----------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDF  627 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  627 (762)
                      ||||+++++|.+++.+.          ..+++..+..++.|+++||.|||+.   +++||||||+||++++++.+||+||
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~df  163 (277)
T cd05062          87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF  163 (277)
T ss_pred             EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCC
Confidence            99999999999998642          2357888999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCCcc-cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccc
Q 004312          628 GLEKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVEND  705 (762)
Q Consensus       628 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  705 (762)
                      |+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..|+..........     ......
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~-----~~~~~~  238 (277)
T cd05062         164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR-----FVMEGG  238 (277)
T ss_pred             CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----HHHcCC
Confidence            9987654322211 112345778999999999899999999999999999999 566764322111111     011111


Q ss_pred             cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          706 LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       706 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                       ....+...+..+.+++.+||+.+|++|||+.|++++|++
T Consensus       239 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         239 -LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             -cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence             111122345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.5e-36  Score=314.79  Aligned_cols=248  Identities=26%  Similarity=0.374  Sum_probs=198.3

Q ss_pred             hcCCCCcceEEEeeeeCC-CcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCc
Q 004312          489 ELGRGAFGTVYKGFVNMG-SSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      .||+|+||.||+|.+... .+..||+|++..... ...+++.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            389999999999977533 345699999875432 23467999999999999999999999885 457899999999999


Q ss_pred             hhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc--cc
Q 004312          567 LASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TA  643 (762)
Q Consensus       567 L~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~--~~  643 (762)
                      |.+++.. ...+++..+++++.|+++||+|||++   +++||||||+|||++.++.+||+|||+++..........  ..
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            9999975 45789999999999999999999998   999999999999999999999999999986543332211  11


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ..++..|+|||.+....++.++||||||+++||+++ |+.|+......+...      .+........+...++++.+++
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li  231 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS------FIEQGKRLDCPAECPPEMYALM  231 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH------HHHCCCCCCCCCCCCHHHHHHH
Confidence            223578999999988889999999999999999996 888875432222111      1111112222334567899999


Q ss_pred             HHhhccCCCCCCCHHHHHHHhhcC
Q 004312          723 IWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       723 ~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      .+||+.+|++||++.+|.+.|+.+
T Consensus       232 ~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         232 KDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHHcCCChhhCcCHHHHHHHHhhh
Confidence            999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.2e-36  Score=321.83  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=200.9

Q ss_pred             hhhhhhcCCCCcceEEEeeee---CCCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVN---MGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~---~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      ..+.+.||+|+||.||+|...   ....+.+++|.+..... ....++.+|++++++++||||+++++++..+...++||
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   86 (283)
T cd05090           7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF   86 (283)
T ss_pred             ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence            345678999999999999752   22346899999975332 33467999999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCC-----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCce
Q 004312          560 EFMSNGALASFLFGD-----------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNA  622 (762)
Q Consensus       560 E~~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~  622 (762)
                      ||+++++|.+++...                 ..+++.....++.|++.||+|||++   +|+||||||+|||+++++.+
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~  163 (283)
T cd05090          87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHV  163 (283)
T ss_pred             EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcE
Confidence            999999999998522                 2468888999999999999999998   99999999999999999999


Q ss_pred             EEecccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcccccc
Q 004312          623 RISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGA  700 (762)
Q Consensus       623 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~  700 (762)
                      ||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..|+..........      
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~------  237 (283)
T cd05090         164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE------  237 (283)
T ss_pred             EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH------
Confidence            9999999986543221 22223345678999999988899999999999999999998 777764322211111      


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          701 LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       701 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      .+........+...+.++.+++.+||+.+|++||++.+|.++|..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            111111111223456788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.8e-36  Score=320.09  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=203.0

Q ss_pred             hhhhhcCCCCcceEEEeeee----CCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVN----MGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .+.++||+|+||.||++...    ..++..+|+|.+..........+.+|++++++++|+||+++++++.+....++|||
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (280)
T cd05092           8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE   87 (280)
T ss_pred             eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence            35678999999999999642    23456799999887666667789999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEe
Q 004312          561 FMSNGALASFLFGD---------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARIS  625 (762)
Q Consensus       561 ~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~  625 (762)
                      |+++++|.+++...               ..+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~  164 (280)
T cd05092          88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIG  164 (280)
T ss_pred             cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEEC
Confidence            99999999998654               2478999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccc
Q 004312          626 DFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVE  703 (762)
Q Consensus       626 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  703 (762)
                      |||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......+....     . .
T Consensus       165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-----~-~  238 (280)
T cd05092         165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC-----I-T  238 (280)
T ss_pred             CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH-----H-H
Confidence            99999765432211 1122335678999999999999999999999999999998 7777643222221111     1 1


Q ss_pred             cccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       704 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      .......+..++..+.+++.+||+.+|++||+++||++.|+.
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            111111223456778999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2e-36  Score=317.30  Aligned_cols=253  Identities=25%  Similarity=0.451  Sum_probs=203.3

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCC--cceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGS--SDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      ...+.||+|++|.||+|+.....  ...+|+|++.... ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (268)
T cd05063           8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY   87 (268)
T ss_pred             eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence            44578999999999999875432  2379999987542 33456799999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          562 MSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       562 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +++++|.+++... ..+++.++..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++..........
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~  164 (268)
T cd05063          88 MENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT  164 (268)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence            9999999999764 5789999999999999999999998   99999999999999999999999999998664332222


Q ss_pred             cc--cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          641 NT--AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       641 ~~--~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      ..  ....+..|+|||.+....++.++||||||+++|||++ |+.|+......+....      +............+.+
T Consensus       165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~------i~~~~~~~~~~~~~~~  238 (268)
T cd05063         165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA------INDGFRLPAPMDCPSA  238 (268)
T ss_pred             eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH------HhcCCCCCCCCCCCHH
Confidence            11  1223457999999998889999999999999999997 9999743322111111      1111111122235678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      +.+++.+||+.+|++||++.+|++.|+++
T Consensus       239 ~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         239 VYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            89999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-36  Score=332.95  Aligned_cols=247  Identities=19%  Similarity=0.237  Sum_probs=195.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||++.. ..+++.||+|+..      ...+.+|++++++++||||+++++++......++|+|++.
T Consensus        94 y~~~~~lg~G~~g~V~~~~d-~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  166 (391)
T PHA03212         94 FSILETFTPGAEGFAFACID-NKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK  166 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEE-CCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence            44567899999999999964 4567789999753      2357899999999999999999999999999999999995


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                       ++|..++.....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++............
T Consensus       167 -~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~  242 (391)
T PHA03212        167 -TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG  242 (391)
T ss_pred             -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence             68999988778899999999999999999999998   99999999999999999999999999997644333333344


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHH----------Hhhhc--------------cccc
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY----------DCYQE--------------RTLG  699 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~----------~~~~~--------------~~~~  699 (762)
                      ..||+.|+|||++....++.++||||||+++|||++|+.|+......          ..+..              ..+.
T Consensus       243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~  322 (391)
T PHA03212        243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD  322 (391)
T ss_pred             ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence            67999999999999999999999999999999999999886432100          00000              0000


Q ss_pred             ccc---------cccccc--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          700 ALV---------ENDLEA--MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       700 ~~~---------~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ...         .+....  ......+.++.+|+.+||+.||++|||++|+++
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000         000000  001134567899999999999999999999985

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.6e-36  Score=319.25  Aligned_cols=259  Identities=25%  Similarity=0.363  Sum_probs=201.2

Q ss_pred             hhhhhcCCCCcceEEEeeee---CCCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccC--CceeEE
Q 004312          485 GFKEELGRGAFGTVYKGFVN---MGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--RNRLLV  558 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~---~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~LV  558 (762)
                      .+.+.||+|+||+||++..+   ..+++.||+|.+..... .....+.+|++++++++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            45678999999999887542   23456899999875432 3456789999999999999999999988654  357899


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      |||+++++|.+++... .+++..+..++.|+++||.|||+.   +|+||||||+|||+++++.+||+|||+++.......
T Consensus        87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  162 (283)
T cd05080          87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  162 (283)
T ss_pred             ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence            9999999999999654 589999999999999999999998   999999999999999999999999999986643222


Q ss_pred             cc--cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhH-HHhhhc--------cccccccccccc
Q 004312          639 HT--NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQE--------RTLGALVENDLE  707 (762)
Q Consensus       639 ~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~-~~~~~~--------~~~~~~~~~~~~  707 (762)
                      ..  .....++..|+|||.+.+..++.++||||||+++|||++|..|+..... ......        ......++....
T Consensus       163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (283)
T cd05080         163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR  242 (283)
T ss_pred             hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence            11  1223356679999999988999999999999999999999988633211 000000        001111111111


Q ss_pred             cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       708 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      ...+...+.++.+++.+||+.+|++|||+++|+++|+.+.
T Consensus       243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1223345678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.8e-36  Score=334.63  Aligned_cols=256  Identities=22%  Similarity=0.332  Sum_probs=201.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC----CCcceEEEEEccccccch-hHHHHHHhhhhcccc-cCCccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVFQDS-EKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~L  557 (762)
                      ..+.+.||+|+||.||+|++..    ...+.||||+++...... .+.+++|++++.++. ||||+++++.|...+..++
T Consensus        39 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~i  118 (401)
T cd05107          39 LVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYI  118 (401)
T ss_pred             eehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEE
Confidence            4456889999999999998642    234579999997643322 357899999999997 9999999999999999999


Q ss_pred             EEeccCCCchhhhccCC---------------------------------------------------------------
Q 004312          558 VYEFMSNGALASFLFGD---------------------------------------------------------------  574 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~---------------------------------------------------------------  574 (762)
                      ||||+++|+|.++++..                                                               
T Consensus       119 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (401)
T cd05107         119 ITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGT  198 (401)
T ss_pred             EEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhh
Confidence            99999999999998642                                                               


Q ss_pred             -----------------------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC
Q 004312          575 -----------------------------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY  619 (762)
Q Consensus       575 -----------------------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~  619 (762)
                                                         ..+++..+..++.||+.||.|||+.   +|+||||||+|||++++
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~  275 (401)
T cd05107         199 VKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEG  275 (401)
T ss_pred             hhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCC
Confidence                                               1256677889999999999999998   99999999999999999


Q ss_pred             CceEEecccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccc
Q 004312          620 YNARISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERT  697 (762)
Q Consensus       620 ~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~  697 (762)
                      +.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |+.|+......+...   
T Consensus       276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~---  352 (401)
T cd05107         276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY---  352 (401)
T ss_pred             CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH---
Confidence            9999999999986543222 11222346788999999998889999999999999999998 787863321111111   


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       698 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                        ..+........+...+.++.+++.+||+.+|.+||+++||++.|++++
T Consensus       353 --~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         353 --NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             --HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence              111111112223345678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.8e-36  Score=326.69  Aligned_cols=243  Identities=23%  Similarity=0.330  Sum_probs=198.8

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.||+|+||.||+|+.. .+++.||||++.+..   ......+..|.+++..+ +||||+++++++.+.+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence            36999999999999754 456789999987532   23345677888888866 89999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +++|..++.....+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~  155 (321)
T cd05591          80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTT  155 (321)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccc
Confidence            999999998888899999999999999999999998   99999999999999999999999999987543222 22334


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||............     .....  ..+...+.++.+++.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i-----~~~~~--~~p~~~~~~~~~ll~  228 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI-----LHDDV--LYPVWLSKEAVSILK  228 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH-----HcCCC--CCCCCCCHHHHHHHH
Confidence            56899999999999999999999999999999999999998654333222211     11111  112234578899999


Q ss_pred             HhhccCCCCCC-------CHHHHHHH
Q 004312          724 WCIQEDPSHRP-------TMRRVTQM  742 (762)
Q Consensus       724 ~cl~~dp~~RP-------t~~evl~~  742 (762)
                      +||+.||++||       +++++++.
T Consensus       229 ~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         229 AFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             HHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            99999999999       77877743

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.2e-36  Score=325.07  Aligned_cols=241  Identities=22%  Similarity=0.317  Sum_probs=194.7

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcc-cccCCccchhceeccCCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQ-THHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.||+|+||.||+|... ++++.||||.++...   ....+.+..|.+++.. .+||||+++++.+...+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELK-GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            36999999999999764 456789999987532   2233456667777765 489999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +|+|..++.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~  155 (316)
T cd05592          80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST  155 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence            999999998888899999999999999999999998   99999999999999999999999999997643222 22334


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||...........     +...  ....+...+.++.+++.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~-----i~~~--~~~~~~~~~~~~~~ll~  228 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS-----ILND--RPHFPRWISKEAKDCLS  228 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHcC--CCCCCCCCCHHHHHHHH
Confidence            5689999999999998999999999999999999999999854432222211     1110  11122335677889999


Q ss_pred             HhhccCCCCCCCHH-HHH
Q 004312          724 WCIQEDPSHRPTMR-RVT  740 (762)
Q Consensus       724 ~cl~~dp~~RPt~~-evl  740 (762)
                      +||+.+|++||++. +++
T Consensus       229 ~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         229 KLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             HHccCCHHHcCCChHHHH
Confidence            99999999999875 454

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.6e-36  Score=325.19  Aligned_cols=237  Identities=24%  Similarity=0.351  Sum_probs=194.5

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.||+|+||.||+++.. .+++.||||++.+..   ......+..|++++.++ +||||+++++++.+.+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLK-ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence            36899999999999754 456789999987532   23345677888888876 79999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +|+|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++..... ......
T Consensus        80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~  155 (320)
T cd05590          80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTST  155 (320)
T ss_pred             CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccc
Confidence            999999998888899999999999999999999998   9999999999999999999999999998754322 222334


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||...........     +....  ...+...+.++.+++.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~-----i~~~~--~~~~~~~~~~~~~li~  228 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA-----ILNDE--VVYPTWLSQDAVDILK  228 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH-----HhcCC--CCCCCCCCHHHHHHHH
Confidence            5689999999999999999999999999999999999999854432222211     11111  1112235678899999


Q ss_pred             HhhccCCCCCCCH
Q 004312          724 WCIQEDPSHRPTM  736 (762)
Q Consensus       724 ~cl~~dp~~RPt~  736 (762)
                      +||+.||++||++
T Consensus       229 ~~L~~dP~~R~~~  241 (320)
T cd05590         229 AFMTKNPTMRLGS  241 (320)
T ss_pred             HHcccCHHHCCCC
Confidence            9999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-36  Score=315.46  Aligned_cols=252  Identities=25%  Similarity=0.407  Sum_probs=200.4

Q ss_pred             hhhhcCCCCcceEEEeeeeCC--CcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCc------e
Q 004312          486 FKEELGRGAFGTVYKGFVNMG--SSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRN------R  555 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------~  555 (762)
                      +.+.||+|+||.||+|....+  ....||||+++...  ......+.+|++.++.++||||+++++++.+.+.      .
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   82 (273)
T cd05035           3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP   82 (273)
T ss_pred             cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence            457899999999999987543  24679999987532  2334679999999999999999999999876554      7


Q ss_pred             eEEEeccCCCchhhhccCC------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccc
Q 004312          556 LLVYEFMSNGALASFLFGD------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL  629 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl  629 (762)
                      ++|+||+++++|..++...      ..+++.....++.|++.||.|||+.   +++||||||+||++++++.+||+|||+
T Consensus        83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence            8999999999999998532      3678999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCCccc-ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccc
Q 004312          630 EKLLTLDQSHTN-TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLE  707 (762)
Q Consensus       630 a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  707 (762)
                      ++.......... .....+..|+|||.+....++.++||||||+++|||++ |..|+......+...      .+.....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~------~~~~~~~  233 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD------YLRHGNR  233 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHcCCC
Confidence            987654332211 12234678999999988899999999999999999999 777764332211111      1111111


Q ss_pred             cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       708 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      ...+...+.++.+++.+||+.||++||++.|+++.|+++
T Consensus       234 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         234 LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            122334567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=311.34  Aligned_cols=258  Identities=23%  Similarity=0.338  Sum_probs=201.1

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcc--cccCCccchhceeccCC----ceeEEE
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ--THHKNLVRLLGYCDEGR----NRLLVY  559 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~~----~~~LV~  559 (762)
                      +.+.||+|.||.||+|.++   ++.||||++...   +++.+.+|.++++.  |+|+||+.+++.-..+.    .++||+
T Consensus       215 L~e~IGkGRyGEVwrG~wr---Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT  288 (513)
T KOG2052|consen  215 LQEIIGKGRFGEVWRGRWR---GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT  288 (513)
T ss_pred             EEEEecCccccceeecccc---CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence            4567999999999999997   568999999753   45678889888886  59999999999876544    578999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhc-----CCCCeEeCCCCCCceEEcCCCceEEeccccccccc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE-----CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT  634 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~  634 (762)
                      +|.+.|||.+||.. ..++....++++..+|.||+|||.+     .+|.|.|||||.+|||+..++...|+|+|||....
T Consensus       289 dYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~  367 (513)
T KOG2052|consen  289 DYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  367 (513)
T ss_pred             ecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence            99999999999976 6789999999999999999999986     46899999999999999999999999999998765


Q ss_pred             CCCC---cccccccccCcccCcccccCC------CCCCcchhHHHHHHHHHHHhC----------CCCCchhhH----HH
Q 004312          635 LDQS---HTNTAIRGTKGYVAPEWFRNM------PITVKVDVYSYGVLLLEIICL----------RRTILTDWA----YD  691 (762)
Q Consensus       635 ~~~~---~~~~~~~gt~~y~aPE~~~~~------~~s~~~DV~S~Gvil~elltg----------~~p~~~~~~----~~  691 (762)
                      .+..   ......+||.+|||||++.+.      +--..+||||||.|+||+...          +.||..-.+    .+
T Consensus       368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e  447 (513)
T KOG2052|consen  368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE  447 (513)
T ss_pred             ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence            5432   234557899999999999543      122569999999999999852          234422211    22


Q ss_pred             hhhccccccccccccc-cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCC
Q 004312          692 CYQERTLGALVENDLE-AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP  750 (762)
Q Consensus       692 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  750 (762)
                      .+.+-.-.+.+.+... .....+....+.++++.||..+|.-|.|+-.+.+.|.++.+.+
T Consensus       448 eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~  507 (513)
T KOG2052|consen  448 EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD  507 (513)
T ss_pred             HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence            2222211111111111 1123467788999999999999999999999999998876543

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.2e-36  Score=317.29  Aligned_cols=245  Identities=25%  Similarity=0.291  Sum_probs=195.0

Q ss_pred             cCCCCcceEEEeeeeCCCcceEEEEEccccccc---hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCc
Q 004312          490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD---SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       490 iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      ||+|+||+||++... .+++.+|+|++......   ..+.+..|++++++++|+||+++.+++......++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMR-ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEc-cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            799999999999754 45679999998653222   23467889999999999999999999999999999999999999


Q ss_pred             hhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          567 LASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       567 L~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      |..++..    ...+++..+..++.||+.||+|||+.   +|+||||||+||++++++.+||+|||++..+..... ...
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~  155 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK  155 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence            9988742    35689999999999999999999998   999999999999999999999999999976543322 223


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ...|++.|+|||.+.+..++.++||||||+++|||++|+.||.......... ..........  ...+...+..+.+++
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~li  232 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-ELKQRILNDS--VTYPDKFSPASKSFC  232 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH-HHHHhhcccC--CCCcccCCHHHHHHH
Confidence            3568999999999999999999999999999999999999974321110000 0001111111  112334667899999


Q ss_pred             HHhhccCCCCCC-----CHHHHHHH
Q 004312          723 IWCIQEDPSHRP-----TMRRVTQM  742 (762)
Q Consensus       723 ~~cl~~dp~~RP-----t~~evl~~  742 (762)
                      .+||+.||++||     +++++++.
T Consensus       233 ~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         233 EALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             HHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            999999999999     77777753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.2e-36  Score=314.65  Aligned_cols=253  Identities=21%  Similarity=0.284  Sum_probs=202.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+|+.. .+++.||+|++..........+.+|+.++++++||||+++++.+...+..++||||++
T Consensus        11 y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~   89 (267)
T cd06646          11 YELIQRVGSGTYGDVYKARNL-HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG   89 (267)
T ss_pred             cchhheeecCCCeEEEEEEEC-CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence            456688999999999999754 4467899999876544555678899999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +++|.+++.....+++..+..++.|++.||.|||+.   +|+||||+|+||++++++.+||+|||+++....... ....
T Consensus        90 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~  165 (267)
T cd06646          90 GGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKS  165 (267)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccCc
Confidence            999999998778899999999999999999999998   999999999999999999999999999986642221 2233


Q ss_pred             ccccCcccCccccc---CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       644 ~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ..+++.|+|||.+.   ...++.++||||||+++|||++|+.|+...................+.  .......+..+.+
T Consensus       166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  243 (267)
T cd06646         166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPK--LKDKTKWSSTFHN  243 (267)
T ss_pred             cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCC--CccccccCHHHHH
Confidence            45889999999884   345788999999999999999999997433221111100000011011  1111235678899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHh
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQML  743 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~L  743 (762)
                      ++.+||+.+|++||+++++++.|
T Consensus       244 li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         244 FVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             HHHHHhhCChhhCcCHHHHhcCC
Confidence            99999999999999999998743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.6e-36  Score=318.26  Aligned_cols=260  Identities=26%  Similarity=0.401  Sum_probs=201.7

Q ss_pred             hhhhhhcCCCCcceEEEeeee---CCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceecc--CCceeEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVN---MGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GRNRLLV  558 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~---~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~LV  558 (762)
                      ..+.+.||+|+||.||++...   ...++.||+|++........+.+.+|++++++++||||+++++++..  ....++|
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   85 (284)
T cd05081           6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV   85 (284)
T ss_pred             ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence            345578999999999999752   34567899999987655666789999999999999999999998754  3467899


Q ss_pred             EeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          559 YEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      +||+++++|.+++.+. ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++......
T Consensus        86 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  162 (284)
T cd05081          86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK  162 (284)
T ss_pred             EEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence            9999999999999764 4689999999999999999999998   99999999999999999999999999998764332


Q ss_pred             Cccc--ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHH--Hhhhccc--------cccccccc
Q 004312          638 SHTN--TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY--DCYQERT--------LGALVEND  705 (762)
Q Consensus       638 ~~~~--~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~--~~~~~~~--------~~~~~~~~  705 (762)
                      ....  ....++..|+|||.+.+..++.++||||||+++|||++|..+.......  .......        +...+...
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05081         163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN  242 (284)
T ss_pred             cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence            2111  1122345699999999889999999999999999999987664221110  0000000        00111111


Q ss_pred             cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          706 LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       706 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      .....+...+.++.+++.+||+.+|++|||++||+++|+.+
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            11122234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.9e-37  Score=329.26  Aligned_cols=243  Identities=23%  Similarity=0.256  Sum_probs=198.7

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      +.||+|+||.||++... .+++.||+|++.+..   ......+.+|++++.+++||||+++++.+...+..+|||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999744 456799999987532   22345678899999999999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          565 GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE-ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       565 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      |+|..++.....+++..+..++.||+.||+|||+ .   +|+||||||+|||+++++.+||+|||+++..... ......
T Consensus        80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~  155 (325)
T cd05594          80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKT  155 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccccc
Confidence            9999999888889999999999999999999997 6   9999999999999999999999999998754322 122234


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||............     ....  ...+...+.++.+++.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i-----~~~~--~~~p~~~~~~~~~li~  228 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-----LMEE--IRFPRTLSPEAKSLLS  228 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH-----hcCC--CCCCCCCCHHHHHHHH
Confidence            56999999999999999999999999999999999999998543222211111     1111  1112335678899999


Q ss_pred             HhhccCCCCCC-----CHHHHHHH
Q 004312          724 WCIQEDPSHRP-----TMRRVTQM  742 (762)
Q Consensus       724 ~cl~~dp~~RP-----t~~evl~~  742 (762)
                      +||+.||++|+     +++++++.
T Consensus       229 ~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         229 GLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             HHhhcCHHHhCCCCCCCHHHHhcC
Confidence            99999999996     89988753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.8e-37  Score=331.25  Aligned_cols=249  Identities=22%  Similarity=0.270  Sum_probs=201.8

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||++... .+++.||+|+++...   ....+.+.+|+.++++++|+||+++++++.+.+..+|||||
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (330)
T cd05601           4 DVKSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY   82 (330)
T ss_pred             eEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence            45678999999999999754 456799999997542   23445788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          562 MSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       562 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +++|+|.+++... ..+++..+..++.||++||.|||+.   +|+||||||+|||++.++.+||+|||++..+.......
T Consensus        83 ~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            9999999999876 6789999999999999999999998   99999999999999999999999999998765443333


Q ss_pred             cccccccCcccCccccc------CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHH
Q 004312          641 NTAIRGTKGYVAPEWFR------NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~------~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  714 (762)
                      .....||+.|+|||.+.      ...++.++||||||+++|||++|+.||........+......   ............
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~  236 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF---QRFLKFPEDPKV  236 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC---CCccCCCCCCCC
Confidence            34456899999999986      456789999999999999999999998554332222211000   000111112245


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          715 LQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +..+.+++.+|++ +|++||+++++++
T Consensus       237 ~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         237 SSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            6788999999998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.3e-36  Score=318.35  Aligned_cols=254  Identities=26%  Similarity=0.334  Sum_probs=201.7

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCC----CcceEEEEEccccccc-hhHHHHHHhhhhcccccCCccchhceeccCCceeE
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMG----SSDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L  557 (762)
                      .+.+.++||+|+||.||+|.....    ..+.||+|+++..... ....+.+|+.++.+++||||+++++++.+....++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            356678999999999999976432    2467999999754332 24568899999999999999999999999999999


Q ss_pred             EEeccCCCchhhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc
Q 004312          558 VYEFMSNGALASFLFGD----------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN  621 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~  621 (762)
                      ++||+++++|.+++...                ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            99999999999998521                2478888999999999999999998   9999999999999999999


Q ss_pred             eEEecccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccc
Q 004312          622 ARISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLG  699 (762)
Q Consensus       622 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~  699 (762)
                      +||+|||+++....... .......+++.|+|||.+.++.++.++||||||+++|||++ |..|+......+...     
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-----  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE-----  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----
Confidence            99999999886543222 11223345789999999988899999999999999999998 666654322211111     


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          700 ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       700 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      .+... .....+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       238 ~i~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 MIRNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            11111 1111233456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4e-36  Score=315.62  Aligned_cols=249  Identities=26%  Similarity=0.421  Sum_probs=197.3

Q ss_pred             hhcCCCCcceEEEeeeeCCCc-ceEEEEEccccc-cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSS-DQVAVKKLNRVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~-~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      +.||+|+||.||+|.+..... ..+++|.++... ......+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998754322 357889887532 34456899999999999 899999999999999999999999999


Q ss_pred             CchhhhccCCC----------------CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccc
Q 004312          565 GALASFLFGDS----------------KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFG  628 (762)
Q Consensus       565 gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  628 (762)
                      ++|.+++....                .+++.++..++.|++.||+|||+.   +++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            99999986432                468899999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccc
Q 004312          629 LEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLE  707 (762)
Q Consensus       629 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  707 (762)
                      ++.....  .........+..|+|||.+....++.++||||||+++|||++ |+.||......+....      +.....
T Consensus       158 l~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~------~~~~~~  229 (270)
T cd05047         158 LSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------LPQGYR  229 (270)
T ss_pred             Cccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH------HhCCCC
Confidence            9863221  111111234567999999988899999999999999999997 8888744322221111      111111


Q ss_pred             cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       708 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      ...+...+.++.+++.+||+.+|.+|||+.++++.|+++.
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         230 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            1122234567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-36  Score=319.97  Aligned_cols=261  Identities=23%  Similarity=0.313  Sum_probs=199.2

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeC-------------CCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhc
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNM-------------GSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLG  547 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~-------------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g  547 (762)
                      ..+.+.+.||+|+||.||++....             +....||+|+++... ......|.+|++++++++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            345667889999999999986532             122358999987542 333457999999999999999999999


Q ss_pred             eeccCCceeEEEeccCCCchhhhccCC------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceE
Q 004312          548 YCDEGRNRLLVYEFMSNGALASFLFGD------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNIL  615 (762)
Q Consensus       548 ~~~~~~~~~LV~E~~~~gsL~~~l~~~------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIL  615 (762)
                      ++...+..++||||+++++|.+++...            ..+++..++.++.|++.||+|||+.   +++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence            999999999999999999999998543            1368889999999999999999998   9999999999999


Q ss_pred             EcCCCceEEecccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhC--CCCCchhhHHHh
Q 004312          616 LDDYYNARISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICL--RRTILTDWAYDC  692 (762)
Q Consensus       616 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg--~~p~~~~~~~~~  692 (762)
                      +++++.+||+|||++......... ......++..|+|||.+..+.++.++||||||+++|||+++  ..|+........
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            999999999999999865432221 11223356789999999988999999999999999999984  455533221111


Q ss_pred             hhcc-ccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          693 YQER-TLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       693 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      .... ..............+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            1110 0000000001111122345789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.6e-36  Score=331.07  Aligned_cols=250  Identities=21%  Similarity=0.270  Sum_probs=196.6

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.||+|+||+||++... .+++.||||++++..   ......+.+|+.++.+++|+||+++++.+.+....+|||||+
T Consensus         5 ~~~~LG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~   83 (363)
T cd05628           5 SLKVIGRGAFGEVRLVQKK-DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL   83 (363)
T ss_pred             EeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence            4578999999999999754 456799999997532   223356888999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC----
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS----  638 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~----  638 (762)
                      ++|+|.+++.....+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++.+.....    
T Consensus        84 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          84 PGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            9999999998888899999999999999999999998   999999999999999999999999999875432110    


Q ss_pred             ------------------------------cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhh
Q 004312          639 ------------------------------HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDW  688 (762)
Q Consensus       639 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~  688 (762)
                                                    ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence                                          00123569999999999999999999999999999999999999986543


Q ss_pred             HHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhc--cCCCCCCCHHHHHHH
Q 004312          689 AYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQ--EDPSHRPTMRRVTQM  742 (762)
Q Consensus       689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~--~dp~~RPt~~evl~~  742 (762)
                      ..+........   ............++++.+++.+++.  .++..||+++||++.
T Consensus       241 ~~~~~~~i~~~---~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         241 PQETYKKVMNW---KETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             HHHHHHHHHcC---cCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            33322221100   0001111111245677788877553  233456899999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4e-36  Score=317.08  Aligned_cols=258  Identities=26%  Similarity=0.347  Sum_probs=203.8

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCc---ceEEEEEcccc-ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSS---DQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .+.+.||+|+||+||+|.....+.   ..||+|+++.. ......++.+|+.+++.++|+||+++++++.. ...++++|
T Consensus        10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~   88 (279)
T cd05109          10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQ   88 (279)
T ss_pred             eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEE
Confidence            345789999999999998653322   25899998753 23345688999999999999999999999975 45789999


Q ss_pred             ccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          561 FMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |+++|+|.+++... ..+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++........
T Consensus        89 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~  165 (279)
T cd05109          89 LMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE  165 (279)
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccce
Confidence            99999999999764 5689999999999999999999998   9999999999999999999999999999876533221


Q ss_pred             c-cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          640 T-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       640 ~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      . .....+++.|+|||.+.+..++.++||||||+++|||++ |..|+.........      ..+........+...+.+
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~  239 (279)
T cd05109         166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP------DLLEKGERLPQPPICTID  239 (279)
T ss_pred             eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH------HHHHCCCcCCCCccCCHH
Confidence            1 112234678999999998899999999999999999998 77776432221111      111111111223345678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCCCC
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIP  752 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~p  752 (762)
                      +.+++.+||+.||++||++.++++.|+.+...|.|
T Consensus       240 ~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~  274 (279)
T cd05109         240 VYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSR  274 (279)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcC
Confidence            89999999999999999999999999888766543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=332.04  Aligned_cols=250  Identities=24%  Similarity=0.326  Sum_probs=204.3

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||++... .+++.||||+++...   ......+.+|++++..++|+||+++++.+.+.+..++||||
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (350)
T cd05573           4 EVIKVIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY   82 (350)
T ss_pred             eEEEEEEeCCcEEEEEEEEC-CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence            45578999999999999754 356799999987532   23456789999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC----
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ----  637 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~----  637 (762)
                      +++++|.+++.+...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......    
T Consensus        83 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          83 MPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            99999999998888899999999999999999999998   99999999999999999999999999998665432    


Q ss_pred             ------------------------CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhh
Q 004312          638 ------------------------SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCY  693 (762)
Q Consensus       638 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~  693 (762)
                                              ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  239 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY  239 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence                                    11223456899999999999999999999999999999999999998654332222


Q ss_pred             hccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 004312          694 QERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPT-MRRVTQM  742 (762)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt-~~evl~~  742 (762)
                      .....  . ............++++.+++.+|++ +|.+||+ ++|+++.
T Consensus       240 ~~i~~--~-~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         240 NKIIN--W-KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHhc--c-CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            11100  0 0111111112256788999999998 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.1e-36  Score=321.93  Aligned_cols=255  Identities=26%  Similarity=0.378  Sum_probs=203.2

Q ss_pred             hhhhhhcCCCCcceEEEeeee----CCCcceEEEEEcccccc-chhHHHHHHhhhhccc-ccCCccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVN----MGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~L  557 (762)
                      ..+.+.||+|+||.||++...    ......||||+++.... ...+.+.+|+++++++ +|+||+++++++...+..++
T Consensus        37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  116 (302)
T cd05055          37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV  116 (302)
T ss_pred             eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence            456678999999999999752    22345799999875432 3345789999999999 89999999999999999999


Q ss_pred             EEeccCCCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          558 VYEFMSNGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ||||+++|+|.+++....  .+++.++..++.||+.||+|||++   +|+|+||||+|||+++++.+||+|||+++....
T Consensus       117 v~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  193 (302)
T cd05055         117 ITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMN  193 (302)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence            999999999999997543  389999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHH
Q 004312          636 DQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMT  713 (762)
Q Consensus       636 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  713 (762)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+....     .+........+..
T Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~  268 (302)
T cd05055         194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK-----LIKEGYRMAQPEH  268 (302)
T ss_pred             CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH-----HHHcCCcCCCCCC
Confidence            3221 1122345778999999999999999999999999999998 8888643322211111     1111111111223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          714 VLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       714 ~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      .++++.+++.+||+.+|++||++.|+++.|+++
T Consensus       269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         269 APAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            457899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.6e-36  Score=312.57  Aligned_cols=251  Identities=25%  Similarity=0.388  Sum_probs=201.5

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.++||+|++|.||+|....  ...||+|+++... ....++.+|++++++++|+||+++++.+.+ ...++||||+
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~--~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecC--CceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            35677889999999999997643  2469999997532 234679999999999999999999998754 5578999999


Q ss_pred             CCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          563 SNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       563 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      ++|+|.+++...  ..+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||.++.........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            999999999754  4578999999999999999999998   99999999999999999999999999998664333222


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.|+............      ............+..+.
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~  233 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------ERGYRMPCPPECPESLH  233 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH------hcCCCCCCccccCHHHH
Confidence            223346678999999988899999999999999999999 66676443222222111      11111122335667889


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      +++.+|++.+|++||++++++++|+..
T Consensus       234 ~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         234 DLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             HHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.6e-36  Score=310.40  Aligned_cols=246  Identities=25%  Similarity=0.368  Sum_probs=198.6

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCc
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      +.||+|+||.||+|...  ++..+|+|+++.... .....+.+|++++++++||||+++++++......++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK--DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEec--CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            36899999999999754  356899999876433 234578999999999999999999999999999999999999999


Q ss_pred             hhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccccc
Q 004312          567 LASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR  645 (762)
Q Consensus       567 L~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  645 (762)
                      |.+++... ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||++...............
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            99998754 4678999999999999999999998   9999999999999999999999999998754332222222233


Q ss_pred             ccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHH
Q 004312          646 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW  724 (762)
Q Consensus       646 gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  724 (762)
                      ++..|+|||.+....++.++||||||+++|++++ |..|+...........      +........+...+..+.+++.+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~  229 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ------VEKGYRMSCPQKCPDDVYKVMQR  229 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH------HHcCCCCCCCCCCCHHHHHHHHH
Confidence            4678999999998899999999999999999998 8888743322211111      11111111223456789999999


Q ss_pred             hhccCCCCCCCHHHHHHHhh
Q 004312          725 CIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       725 cl~~dp~~RPt~~evl~~L~  744 (762)
                      |++.+|++||++.|++++|.
T Consensus       230 ~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         230 CWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HcccCcccCCCHHHHHHHhc
Confidence            99999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5e-36  Score=314.87  Aligned_cols=252  Identities=25%  Similarity=0.380  Sum_probs=196.8

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCc-ceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccC------Ccee
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSS-DQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------RNRL  556 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~-~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~  556 (762)
                      +.+.||+|+||.||+|.+..... ..+|+|.++..  .....+.+.+|++++++++|+||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            45789999999999998754332 36999988653  233456789999999999999999999987532      2468


Q ss_pred             EEEeccCCCchhhhccC------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccc
Q 004312          557 LVYEFMSNGALASFLFG------DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLE  630 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla  630 (762)
                      +++||+++|+|.+++..      ...+++.....++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence            99999999999988742      23478999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccCCCCcc-cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcccccccccccccc
Q 004312          631 KLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEA  708 (762)
Q Consensus       631 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  708 (762)
                      +.+....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...........      +......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~------~~~~~~~  233 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY------LRQGNRL  233 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH------HHcCCCC
Confidence            8764332211 122335678999999999999999999999999999999 6777643222111111      1111111


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          709 MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       709 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      ..+...++.+.+++.+||+.+|++|||++++++.|+++
T Consensus       234 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         234 KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            12234567789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.1e-36  Score=327.10  Aligned_cols=242  Identities=23%  Similarity=0.291  Sum_probs=192.8

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.||+|+||.||++... .+++.+|+|++++..   ....+.+.+|+.++.++ +||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLK-KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence            36899999999999754 456789999987542   22345678898888776 89999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +|+|..++.....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..... ......
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~  155 (329)
T cd05618          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTST  155 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCcccc
Confidence            999999998888899999999999999999999998   9999999999999999999999999998753221 222334


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHh----hhccccccccccccccCCCHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDC----YQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||........    ........+.....  ..+...+..+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~~~~~~  233 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKAA  233 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--CCCCCCCHHHH
Confidence            5689999999999999999999999999999999999999732100000    00000001111111  12334567788


Q ss_pred             HHHHHhhccCCCCCCCH
Q 004312          720 MVAIWCIQEDPSHRPTM  736 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~  736 (762)
                      +++.+||+.||++||+.
T Consensus       234 ~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         234 SVLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHHhcCCHHHcCCC
Confidence            99999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.5e-36  Score=321.99  Aligned_cols=242  Identities=24%  Similarity=0.328  Sum_probs=196.2

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcc-cccCCccchhceeccCCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQ-THHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.||+|+||.||+|... .+++.||||+++...   ......+..|..++.+ ++||||+++++++.+.+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence            36899999999999754 456789999987542   2334566778888876 499999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +|+|.+++.....+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~  155 (316)
T cd05619          80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCT  155 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceee
Confidence            999999998878899999999999999999999998   99999999999999999999999999987532211 22234


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||......+........       ....+...+.++.+++.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-------~~~~~~~~~~~~~~li~  228 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-------NPCYPRWLTREAKDILV  228 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------CCCCCccCCHHHHHHHH
Confidence            56899999999999999999999999999999999999998544322222211110       01112235677899999


Q ss_pred             HhhccCCCCCCCHH-HHHH
Q 004312          724 WCIQEDPSHRPTMR-RVTQ  741 (762)
Q Consensus       724 ~cl~~dp~~RPt~~-evl~  741 (762)
                      +||+.+|++||++. ++.+
T Consensus       229 ~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         229 KLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             HHhccCHhhcCCChHHHHc
Confidence            99999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.3e-36  Score=313.38  Aligned_cols=253  Identities=28%  Similarity=0.422  Sum_probs=203.6

Q ss_pred             HHHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          480 VEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       480 ~~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      ....+.+.++||+|+||.||+|...  +++.||+|.+.... ....++.+|+.++++++|+||+++++++. .+..++||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~--~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC--CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            3455677789999999999999754  34689999987543 33468999999999999999999999874 45689999


Q ss_pred             eccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          560 EFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       560 E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ||+++++|.+++...  ..+++.++..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999999998654  4688999999999999999999998   99999999999999999999999999998765333


Q ss_pred             CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      ........++..|+|||.+....++.++||||||+++|||++ |+.|+......+....      +........+...+.
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~  230 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN------LERGYRMPRPDNCPE  230 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH------HHcCCCCCCCCCCCH
Confidence            222233345678999999998899999999999999999999 8888743322221111      111111112233457


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      ++.+++.+||+.+|++||+++++++.|+.
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         231 ELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            89999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=8.9e-36  Score=311.02  Aligned_cols=250  Identities=27%  Similarity=0.396  Sum_probs=200.4

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.++||+|++|.||+|...  .+..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             HhhhhheeccccCceEEEEEec--CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            3456788999999999999755  345799999876433 3567999999999999999999999885 45688999999


Q ss_pred             CCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          563 SNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       563 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      ++++|.+++...  ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++..+.......
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            999999999754  4589999999999999999999998   99999999999999999999999999998764333222


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.|+......+....      +........+...+..+.
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~  233 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ------VERGYRMPCPQDCPISLH  233 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH------HHcCCCCCCCCcCCHHHH
Confidence            222335668999999988899999999999999999999 7777644322211111      111111122334567899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      +++.+||+.+|++|||+.++.+.|++
T Consensus       234 ~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         234 ELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHHHHcccCcccCcCHHHHHHHHhc
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.6e-36  Score=326.52  Aligned_cols=247  Identities=23%  Similarity=0.291  Sum_probs=196.7

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.||+|+||.||++... .+++.||||++++..   ....+.+.+|+.++.++ +||||+++++++.+.+..+|||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELK-KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            36899999999999754 456789999997532   22335688899999988 79999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.... .......
T Consensus        80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~~~  155 (329)
T cd05588          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTTST  155 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccccc-CCCcccc
Confidence            999999998888899999999999999999999998   999999999999999999999999999874321 1222334


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHH----hhhccccccccccccccCCCHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYD----CYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||.......    ...+.....+.....  ..+...+.++.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~  233 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKAS  233 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--CCCCCCCHHHH
Confidence            679999999999999999999999999999999999999974211000    000000011111111  12234567789


Q ss_pred             HHHHHhhccCCCCCCC------HHHHHH
Q 004312          720 MVAIWCIQEDPSHRPT------MRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt------~~evl~  741 (762)
                      +++.+||+.||.+||+      ++++++
T Consensus       234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         234 SVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            9999999999999997      667764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.5e-36  Score=325.83  Aligned_cols=238  Identities=26%  Similarity=0.312  Sum_probs=192.5

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhh-hhcccccCCccchhceeccCCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVN-GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.||+|+||+||+|... .+++.||||++.+..   ....+++.+|.. +++.++||||+++++.+.+.+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHK-ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            36899999999999754 456799999987532   122344555554 5678999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +|+|.+++.....+++..+..++.||++||.|||+.   +|+||||||+|||+++++.+||+|||+++..... ......
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~  155 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTST  155 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccc
Confidence            999999998888899999999999999999999998   9999999999999999999999999998753221 223344


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....     +......  .+...+..+.+++.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-----i~~~~~~--~~~~~~~~~~~li~  228 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDN-----ILNKPLR--LKPNISVSARHLLE  228 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHH-----HHcCCCC--CCCCCCHHHHHHHH
Confidence            5689999999999999999999999999999999999999855432222211     1111111  12234678899999


Q ss_pred             HhhccCCCCCCCHH
Q 004312          724 WCIQEDPSHRPTMR  737 (762)
Q Consensus       724 ~cl~~dp~~RPt~~  737 (762)
                      +||+.||++||++.
T Consensus       229 ~~l~~~p~~R~~~~  242 (323)
T cd05575         229 GLLQKDRTKRLGAK  242 (323)
T ss_pred             HHhhcCHHhCCCCC
Confidence            99999999999884

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=332.68  Aligned_cols=249  Identities=21%  Similarity=0.277  Sum_probs=199.9

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||+++.. .+++.||||++....   ......+.+|++++..++||||+++++.+.+.+..+|||||
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (364)
T cd05599           4 ESIKVIGRGAFGEVRLVQKK-DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY   82 (364)
T ss_pred             eEEEEEEecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence            34578999999999999754 456789999997532   22345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc--
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--  639 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~--  639 (762)
                      +++|+|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+......  
T Consensus        83 ~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          83 LPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             CCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            99999999998888899999999999999999999998   9999999999999999999999999998764321110  


Q ss_pred             -----------------------------------ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 004312          640 -----------------------------------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTI  684 (762)
Q Consensus       640 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~  684 (762)
                                                         ......||+.|+|||++....++.++|||||||++|||++|+.||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence                                               011245899999999999999999999999999999999999998


Q ss_pred             chhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 004312          685 LTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPT---MRRVTQ  741 (762)
Q Consensus       685 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt---~~evl~  741 (762)
                      ......+........   ............++.+.+++.+|+. +|.+|++   ++|+++
T Consensus       240 ~~~~~~~~~~~i~~~---~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         240 CSDNPQETYRKIINW---KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCHHHHHHHHHcC---CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            654333222211000   0011111122346788899999997 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.7e-36  Score=333.07  Aligned_cols=250  Identities=23%  Similarity=0.273  Sum_probs=198.2

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.||+|+||+||+|+.. .+++.||||++.+..   ......+.+|++++++++|+||+++++.+.+.+..++||||+
T Consensus         5 ~~~~LG~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~   83 (381)
T cd05626           5 KIKTLGIGAFGEVCLACKV-DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI   83 (381)
T ss_pred             EEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence            4567999999999999754 457799999997532   233457889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC----
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS----  638 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~----  638 (762)
                      ++|+|.+++.+...+++..+..++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++.+.....    
T Consensus        84 ~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          84 PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            9999999998888899999999999999999999998   999999999999999999999999999764321100    


Q ss_pred             ------------------------------------------cccccccccCcccCcccccCCCCCCcchhHHHHHHHHH
Q 004312          639 ------------------------------------------HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLE  676 (762)
Q Consensus       639 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~e  676 (762)
                                                                .......||+.|+|||.+.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e  240 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE  240 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence                                                      00123469999999999998899999999999999999


Q ss_pred             HHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHH--hhccCCCCCCCHHHHHHH
Q 004312          677 IICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW--CIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       677 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~dp~~RPt~~evl~~  742 (762)
                      |++|+.||..............   .............+.++.+++.+  |+..++..||+++|+++.
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         241 MLVGQPPFLAPTPTETQLKVIN---WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHhCCCCCcCCCHHHHHHHHHc---cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            9999999855432221111100   00111111122356778888888  556677779999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8.1e-36  Score=316.46  Aligned_cols=252  Identities=20%  Similarity=0.270  Sum_probs=195.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||.||+|... .+++.||+|+++... ......+.+|++++++++||||+++++++......++||||+
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL   85 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEEC-CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence            345578999999999999754 456789999986432 223457889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          563 SNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       563 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      ++ +|.+++... ..+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus        86 ~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~~  160 (288)
T cd07871          86 DS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTY  160 (288)
T ss_pred             Cc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-ccc
Confidence            85 899888654 4578999999999999999999998   99999999999999999999999999997643222 222


Q ss_pred             ccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc----------cc---------cccc
Q 004312          642 TAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE----------RT---------LGAL  701 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~----------~~---------~~~~  701 (762)
                      ....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....          ..         ....
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY  240 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence            33467899999999865 5689999999999999999999999854332221110          00         0000


Q ss_pred             cccccccC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          702 VENDLEAM----DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       702 ~~~~~~~~----~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ..+.....    .....+.++.+++.+||+.||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00000000    01123567889999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.8e-36  Score=314.02  Aligned_cols=254  Identities=28%  Similarity=0.443  Sum_probs=203.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCC--cceEEEEEcccc-ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGS--SDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|......  ...||||.+... ......+|..|+.++++++||||+++++++.++...++|||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   85 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE   85 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence            456678999999999999876433  246999998754 23345689999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          561 FMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |+++++|.+++... +.+++.+++.++.|++.||.|||+.   +++|+||||+||++++++.+||+|||++.........
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~  162 (269)
T cd05065          86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD  162 (269)
T ss_pred             cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence            99999999999764 5689999999999999999999998   9999999999999999999999999998866433221


Q ss_pred             cc-cc-cc--ccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHH
Q 004312          640 TN-TA-IR--GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       640 ~~-~~-~~--gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  714 (762)
                      .. .. ..  .+..|+|||.+....++.++||||||+++||+++ |+.|+............      ........+...
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i------~~~~~~~~~~~~  236 (269)
T cd05065         163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI------EQDYRLPPPMDC  236 (269)
T ss_pred             cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH------HcCCcCCCcccC
Confidence            11 11 11  2457999999999999999999999999999886 88887443222211111      111111122344


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      +..+.+++.+||+.+|++||++++|+++|+++
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         237 PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            67789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.7e-36  Score=318.35  Aligned_cols=252  Identities=22%  Similarity=0.301  Sum_probs=191.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhccc---ccCCccchhceec-----cCC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQT---HHKNLVRLLGYCD-----EGR  553 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~-----~~~  553 (762)
                      +.+.+.||+|+||.||+|......++.||||+++...  ......+.+|+.+++++   +||||++++++|.     ...
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~   82 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   82 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence            3456789999999999997654446789999986432  22234566777776665   7999999999885     345


Q ss_pred             ceeEEEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          554 NRLLVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       554 ~~~LV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                      ..++||||++ ++|.+++...  ..+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++
T Consensus        83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            6899999997 5899988653  4588999999999999999999998   99999999999999999999999999998


Q ss_pred             cccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc----------cc--
Q 004312          632 LLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT----------LG--  699 (762)
Q Consensus       632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~----------~~--  699 (762)
                      .....  .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+......          ..  
T Consensus       159 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         159 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             eccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            65432  22334568999999999998899999999999999999999999985443222211100          00  


Q ss_pred             -----ccccccccc---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          700 -----ALVENDLEA---MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       700 -----~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                           .........   ......++.+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                 000000000   000124567789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.7e-36  Score=328.55  Aligned_cols=251  Identities=21%  Similarity=0.233  Sum_probs=199.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeC--CCcceEEEEEccccc----cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeE
Q 004312          485 GFKEELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVF----QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~L  557 (762)
                      .+.+.||+|+||.||+++...  .+++.||+|++.+..    ....+.+.+|+.++.++ +|+||+++++++.+.+..++
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (332)
T cd05614           3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL   82 (332)
T ss_pred             eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence            355789999999999987532  346789999986532    22335678899999999 59999999999999999999


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ||||+++|+|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+....
T Consensus        83 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          83 ILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            999999999999998888899999999999999999999998   99999999999999999999999999998765444


Q ss_pred             CcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      ........||+.|+|||.+.+. .++.++||||||+++|||++|+.||......... ......+...  ....+...+.
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~  236 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRILKC--DPPFPSFIGP  236 (332)
T ss_pred             CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHHHHhcC--CCCCCCCCCH
Confidence            4444456799999999999765 4889999999999999999999997422110000 0000011111  1112234567


Q ss_pred             HHHHHHHHhhccCCCCCC-----CHHHHHH
Q 004312          717 RFVMVAIWCIQEDPSHRP-----TMRRVTQ  741 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RP-----t~~evl~  741 (762)
                      .+.+++.+||+.||++||     +++++++
T Consensus       237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            789999999999999999     7777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-36  Score=326.60  Aligned_cols=238  Identities=24%  Similarity=0.310  Sum_probs=202.4

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEec
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      |..+||+|.||+|+++.+. ++++.+|||.+++..   .+..+..+.|.+++... +||.|++++.++...++++.||||
T Consensus       372 ~l~vLGkGsFGkV~lae~k-~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey  450 (694)
T KOG0694|consen  372 LLAVLGRGSFGKVLLAELK-GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY  450 (694)
T ss_pred             EEEEeccCcCceEEEEEEc-CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence            5578999999999999876 456799999998753   34456778888888877 699999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +.||+ ..++.+...+++..+.-++..|+.||+|||++   +||+||||.+|||||.+|++||+||||++... ......
T Consensus       451 ~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-~~g~~T  525 (694)
T KOG0694|consen  451 VAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-GQGDRT  525 (694)
T ss_pred             cCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC-CCCCcc
Confidence            99999 33444557899999999999999999999999   99999999999999999999999999998543 234467


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      .+++|||.|||||++.+..|+...|.|||||+||||+.|..||.++...+.+......       +...+...+.+.+.+
T Consensus       526 sTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-------~~~yP~~ls~ea~~i  598 (694)
T KOG0694|consen  526 STFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-------EVRYPRFLSKEAIAI  598 (694)
T ss_pred             ccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------CCCCCCcccHHHHHH
Confidence            7899999999999999999999999999999999999999999766544444332221       222455678899999


Q ss_pred             HHHhhccCCCCCCCH
Q 004312          722 AIWCIQEDPSHRPTM  736 (762)
Q Consensus       722 i~~cl~~dp~~RPt~  736 (762)
                      +.++|..+|++|.-+
T Consensus       599 l~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  599 MRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHhccCcccccCC
Confidence            999999999999866

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.1e-36  Score=322.07  Aligned_cols=254  Identities=27%  Similarity=0.428  Sum_probs=200.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCC-cceEEEEEccccc-cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGS-SDQVAVKKLNRVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|...... ...+++|+++... ......+.+|++++.++ +|+||+++++++.+.+..++|||
T Consensus         9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   88 (303)
T cd05088           9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   88 (303)
T ss_pred             ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEE
Confidence            345678999999999999865322 2457888876532 33456789999999999 89999999999999999999999


Q ss_pred             ccCCCchhhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEE
Q 004312          561 FMSNGALASFLFGD----------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARI  624 (762)
Q Consensus       561 ~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl  624 (762)
                      |+++++|.+++...                ..+++..++.++.||+.||+|||+.   +|+||||||+|||+++++.+||
T Consensus        89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl  165 (303)
T cd05088          89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI  165 (303)
T ss_pred             eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEe
Confidence            99999999999643                2478999999999999999999998   9999999999999999999999


Q ss_pred             ecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccc
Q 004312          625 SDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVE  703 (762)
Q Consensus       625 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  703 (762)
                      +|||+++.....  .......++..|+|||.+....++.++||||||+++|||++ |..|+......+....      +.
T Consensus       166 ~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~------~~  237 (303)
T cd05088         166 ADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------LP  237 (303)
T ss_pred             CccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH------Hh
Confidence            999998643211  11111224568999999988889999999999999999998 8888754322222111      11


Q ss_pred             cccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       704 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      .......+...+..+.+++.+||+.+|++||++++++++|+.+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            111111122345678999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-35  Score=309.26  Aligned_cols=248  Identities=26%  Similarity=0.352  Sum_probs=201.6

Q ss_pred             hhcCCCCcceEEEeeeeCCCc--ceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSS--DQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      +.||+|++|.||+|.+....+  ..||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998764333  3699999987655 556789999999999999999999999988 889999999999


Q ss_pred             CchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc--c
Q 004312          565 GALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--T  640 (762)
Q Consensus       565 gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~--~  640 (762)
                      ++|.+++.+..  .+++.....++.|+++||+|||+.   +++|+||||+||+++.++.+||+|||+++........  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997654  689999999999999999999998   9999999999999999999999999999876543221  1


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.|+......+.......     .......+...+..+.
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  231 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK-----EGERLERPEACPQDIY  231 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-----cCCcCCCCccCCHHHH
Confidence            123456789999999998899999999999999999998 9988743322221111110     0011111223467899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHhh
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~~L~  744 (762)
                      +++.+||+.+|++||++.++++.|.
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHHHhc
Confidence            9999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.6e-36  Score=322.62  Aligned_cols=241  Identities=24%  Similarity=0.336  Sum_probs=195.7

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.||+|+||.||+|... .+++.||+|++++..   ......+..|.+++... +||||+++++.+.+.+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence            36999999999999754 456789999987532   23345677788888764 89999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +|+|..++.....+++..+..++.||++||+|||+.   +|+||||||+|||+++++.+||+|||+++..... ......
T Consensus        80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~  155 (316)
T cd05620          80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAST  155 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceec
Confidence            999999998888899999999999999999999998   9999999999999999999999999998743211 222344


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||..............     .  ....+...+.++.+++.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-----~--~~~~~~~~~~~~~~li~  228 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-----D--TPHYPRWITKESKDILE  228 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----C--CCCCCCCCCHHHHHHHH
Confidence            6689999999999999999999999999999999999999854433222221111     0  01112234577899999


Q ss_pred             HhhccCCCCCCCHH-HHH
Q 004312          724 WCIQEDPSHRPTMR-RVT  740 (762)
Q Consensus       724 ~cl~~dp~~RPt~~-evl  740 (762)
                      +||+.||++||++. +++
T Consensus       229 ~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         229 KLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHccCCHHHcCCChHHHH
Confidence            99999999999984 565

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.7e-36  Score=325.68  Aligned_cols=253  Identities=21%  Similarity=0.301  Sum_probs=194.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccC-----CceeE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-----RNRLL  557 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~L  557 (762)
                      .+.+.||+|+||.||+|... .+++.||||++....  ......+.+|++++++++||||+++++++...     ...++
T Consensus         3 ~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           3 KIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             EEEEEEeecCCeEEEEEEEC-CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            45678999999999999754 456799999987432  23345788999999999999999999987543     34799


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ||||++ ++|.+++.....+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+++......
T Consensus        82 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          82 VFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT  157 (338)
T ss_pred             EEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence            999995 68999998888899999999999999999999999   99999999999999999999999999998653322


Q ss_pred             C--cccccccccCcccCcccccC--CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhh------------------hc
Q 004312          638 S--HTNTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCY------------------QE  695 (762)
Q Consensus       638 ~--~~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~------------------~~  695 (762)
                      .  .......||+.|+|||.+.+  ..++.++||||||+++|||++|+.||.........                  ..
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            2  12234568999999999865  67899999999999999999999997433211100                  00


Q ss_pred             cccccccc---cccccC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          696 RTLGALVE---NDLEAM---DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       696 ~~~~~~~~---~~~~~~---~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ......+.   ......   .....+..+.+++.+||+.+|++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00000000   000000   001234567899999999999999999999964

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.3e-35  Score=309.79  Aligned_cols=249  Identities=27%  Similarity=0.385  Sum_probs=199.5

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|++|.||++.....  ..+|+|++.... ...+.+.+|++++++++|+|++++++++. ....++||||++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~--~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           8 LRLDVKLGQGCFGEVWMGTWNGT--TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             eeeeeeecCcCCCeEEEEEEcCC--ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            45667899999999999976532  469999886532 34567899999999999999999999875 456789999999


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||++...........
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence            99999999754  3578999999999999999999998   999999999999999999999999999986643322222


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.|+......+....      +........+...+..+.+
T Consensus       161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~  234 (260)
T cd05069         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ------VERGYRMPCPQGCPESLHE  234 (260)
T ss_pred             CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------HHcCCCCCCCcccCHHHHH
Confidence            22345678999999998899999999999999999999 7878644322221111      1111111123345678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      ++.+||+.+|++||++++|++.|++
T Consensus       235 li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         235 LMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHHHccCCcccCcCHHHHHHHHhc
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-36  Score=311.03  Aligned_cols=246  Identities=28%  Similarity=0.406  Sum_probs=202.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      ..+.+.||+|++|.||+|...   ++.||||.+..... ..+++.+|+.++++++|+||+++++++.+....++||||++
T Consensus         8 ~~~~~~ig~g~~g~v~~~~~~---~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           8 LKLGATIGKGEFGDVMLGDYR---GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             ccceeeeecCCCceEEEEEec---CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            456688999999999999754   56899999976543 56789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||.++.......   
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---  157 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---  157 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence            999999997664  789999999999999999999998   999999999999999999999999999986632211   


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                       ....+..|+|||.+..+.++.++||||||+++||+++ |+.|+..........      .+........+...++.+.+
T Consensus       158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd05039         158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP------HVEKGYRMEAPEGCPPEVYK  230 (256)
T ss_pred             -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH------HHhcCCCCCCccCCCHHHHH
Confidence             2234568999999998899999999999999999997 888864332221111      11111111122345678899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      ++.+||+.+|++||+++|++++|+++
T Consensus       231 li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         231 VMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             HHHHHhccChhhCcCHHHHHHHHhcC
Confidence            99999999999999999999999763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.6e-36  Score=314.75  Aligned_cols=240  Identities=21%  Similarity=0.327  Sum_probs=189.6

Q ss_pred             hcCCCCcceEEEeeeeCC-----------------------CcceEEEEEccccccchhHHHHHHhhhhcccccCCccch
Q 004312          489 ELGRGAFGTVYKGFVNMG-----------------------SSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL  545 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~-----------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l  545 (762)
                      .||+|+||.||+|.+...                       ....|++|++..........|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            589999999999976321                       123589999876555555688999999999999999999


Q ss_pred             hceeccCCceeEEEeccCCCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC----
Q 004312          546 LGYCDEGRNRLLVYEFMSNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY----  620 (762)
Q Consensus       546 ~g~~~~~~~~~LV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----  620 (762)
                      +++|.+....++||||+++|+|..++.. .+.+++..+..++.||++||+|||++   +|+||||||+|||+++.+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999975 46789999999999999999999998   999999999999997543    


Q ss_pred             ---ceEEecccccccccCCCCcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHH-hCCCCCchhhHHHhhhc
Q 004312          621 ---NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEII-CLRRTILTDWAYDCYQE  695 (762)
Q Consensus       621 ---~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~ell-tg~~p~~~~~~~~~~~~  695 (762)
                         .+|++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+......+... 
T Consensus       159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-  232 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-  232 (274)
T ss_pred             ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-
Confidence               4899999998643221     12346788999998865 56899999999999999995 6787764332211110 


Q ss_pred             cccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 004312          696 RTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       696 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~  744 (762)
                           .......  .+......+.+++.+||+.+|++||++++|++.|+
T Consensus       233 -----~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         233 -----FYEKKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -----HHHhccC--CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                 1111111  11112356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.6e-36  Score=313.35  Aligned_cols=254  Identities=25%  Similarity=0.426  Sum_probs=203.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCC--cceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGS--SDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|.....+  ...+|+|.++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (267)
T cd05066           6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE   85 (267)
T ss_pred             eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence            345678999999999999764332  3479999987533 2334689999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          561 FMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |+++++|.+++... ..+++.++..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++..+......
T Consensus        86 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd05066          86 YMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  162 (267)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence            99999999999765 4679999999999999999999998   9999999999999999999999999999876543322


Q ss_pred             ccc--cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          640 TNT--AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       640 ~~~--~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      ...  ...++..|+|||.+.+..++.++||||||+++||+++ |+.|+......+....     +. ...........+.
T Consensus       163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~-----~~-~~~~~~~~~~~~~  236 (267)
T cd05066         163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA-----IE-EGYRLPAPMDCPA  236 (267)
T ss_pred             eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH-----Hh-CCCcCCCCCCCCH
Confidence            211  1223568999999998899999999999999999886 9988744322221111     00 1111112233567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      .+.+++.+|++.+|++||+|.++++.|+++
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         237 ALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.2e-36  Score=312.36  Aligned_cols=253  Identities=22%  Similarity=0.371  Sum_probs=203.1

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||+|+... +++.||||++...   .......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus         5 ~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08228           5 QIEKKIGRGQFSEVYRATCLL-DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL   83 (267)
T ss_pred             eeeeeeccCCCeeEEEEEEeC-CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence            456789999999999997653 4678999987542   223345789999999999999999999999999999999999


Q ss_pred             cCCCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          562 MSNGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       562 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      +++++|.+++..    ...+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999988853    34578899999999999999999998   99999999999999999999999999988664322


Q ss_pred             CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccc-ccccCCCHHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN-DLEAMDDMTVLQ  716 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  716 (762)
                      . ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+........    .....+.. ..........+.
T Consensus       161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08228         161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF----SLCQKIEQCDYPPLPTEHYSE  235 (267)
T ss_pred             H-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH----HHHHHHhcCCCCCCChhhcCH
Confidence            1 12234588899999999888899999999999999999999999743311100    00011111 111112234567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      .+.+++.+||+.+|++||++++|++.|+++
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-36  Score=327.91  Aligned_cols=240  Identities=23%  Similarity=0.244  Sum_probs=196.6

Q ss_pred             hhcCCCCcceEEEeeee--CCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVN--MGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.||+|+||.||+++..  ...++.+|+|++.....  .....+.+|++++++++||||+++++.+.+....++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            46999999999998653  23567899999875322  233467889999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +|+|.+++.+...+++..+..++.||++||+|||+.   +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~  157 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS  157 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence            999999998888899999999999999999999998   99999999999999999999999999988654321 22334


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..|++.|+|||.+.+..++.++||||||+++|||++|+.||...........     +.....  ..+...+..+.+++.
T Consensus       158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~-----i~~~~~--~~p~~~~~~~~~li~  230 (318)
T cd05582         158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM-----ILKAKL--GMPQFLSPEAQSLLR  230 (318)
T ss_pred             ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH-----HHcCCC--CCCCCCCHHHHHHHH
Confidence            5689999999999988899999999999999999999999854432222211     111111  112335678899999


Q ss_pred             HhhccCCCCCCCHHH
Q 004312          724 WCIQEDPSHRPTMRR  738 (762)
Q Consensus       724 ~cl~~dp~~RPt~~e  738 (762)
                      +||+.||++||++.+
T Consensus       231 ~~l~~~P~~R~~a~~  245 (318)
T cd05582         231 ALFKRNPANRLGAGP  245 (318)
T ss_pred             HHhhcCHhHcCCCCC
Confidence            999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=309.48  Aligned_cols=248  Identities=31%  Similarity=0.438  Sum_probs=204.9

Q ss_pred             hhcCCCCcceEEEeeeeCC--CcceEEEEEccccccch-hHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNMG--SSDQVAVKKLNRVFQDS-EKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      +.||+|+||.||++.....  ....+++|.++...... .+.+.+|++.+.+++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4699999999999987642  25689999997654433 67899999999999999999999999999999999999999


Q ss_pred             CchhhhccCC---------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          565 GALASFLFGD---------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       565 gsL~~~l~~~---------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ++|.+++...         ..+++..+..++.|+++||+|||++   +++||||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999875         7789999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHH
Q 004312          636 DQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMT  713 (762)
Q Consensus       636 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  713 (762)
                      ... .......++..|+|||.+....++.++||||||+++|||++ |..|+............      ........+..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~  231 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL------RKGYRLPKPEY  231 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------HcCCCCCCCcc
Confidence            332 22334457889999999988899999999999999999999 57776544222211111      11112222334


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 004312          714 VLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       714 ~~~~~~~li~~cl~~dp~~RPt~~evl~~L~  744 (762)
                      .+.++.+++.+||+.+|++|||++|+++.|+
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         232 CPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            5788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=7.9e-36  Score=326.00  Aligned_cols=245  Identities=24%  Similarity=0.363  Sum_probs=191.7

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      +.++||+|+||.||+|+.. .+++.||||++..... .....+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus        78 ~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  156 (353)
T PLN00034         78 RVNRIGSGAGGTVYKVIHR-PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG  156 (353)
T ss_pred             hhhhccCCCCeEEEEEEEC-CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence            4578999999999999754 4567999999865322 3346789999999999999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccc
Q 004312          565 GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI  644 (762)
Q Consensus       565 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  644 (762)
                      ++|.+..    ...+..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus       157 ~~L~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~  228 (353)
T PLN00034        157 GSLEGTH----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPCNSS  228 (353)
T ss_pred             Ccccccc----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-cccccc
Confidence            9987643    356778889999999999999998   99999999999999999999999999998764322 122345


Q ss_pred             cccCcccCcccccC-----CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          645 RGTKGYVAPEWFRN-----MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       645 ~gt~~y~aPE~~~~-----~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      .||..|+|||.+..     ...+.++|||||||++|||++|+.||......+ +... ..... .......+...+.++.
T Consensus       229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~-~~~~~-~~~~~~~~~~~~~~l~  305 (353)
T PLN00034        229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WASL-MCAIC-MSQPPEAPATASREFR  305 (353)
T ss_pred             ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHH-HHHHh-ccCCCCCCCccCHHHH
Confidence            68999999998743     234568999999999999999999975211000 0000 00000 0111112334567899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      +++.+||+.||++||+++|+++.
T Consensus       306 ~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        306 HFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             HHHHHHccCChhhCcCHHHHhcC
Confidence            99999999999999999999975

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5e-36  Score=322.69  Aligned_cols=242  Identities=25%  Similarity=0.335  Sum_probs=198.3

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.||+|+||.||++... .+++.||||++++..   ......+.+|++++..+ +||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            36899999999999764 456789999987532   23345677888888887 79999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +|+|..++.....+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~  155 (318)
T cd05570          80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTST  155 (318)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccc
Confidence            999999998888899999999999999999999998   99999999999999999999999999987532222 22234


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..|++.|+|||.+.+..++.++|||||||++|+|++|+.||...........     +....  ...+...+..+.+++.
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~-----i~~~~--~~~~~~~~~~~~~li~  228 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS-----ILEDE--VRYPRWLSKEAKSILK  228 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH-----HHcCC--CCCCCcCCHHHHHHHH
Confidence            5689999999999999999999999999999999999999854332222111     11111  1122345678899999


Q ss_pred             HhhccCCCCCCCH-----HHHHH
Q 004312          724 WCIQEDPSHRPTM-----RRVTQ  741 (762)
Q Consensus       724 ~cl~~dp~~RPt~-----~evl~  741 (762)
                      +||+.||++||++     .++++
T Consensus       229 ~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         229 SFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             HHccCCHHHcCCCCCCCHHHHhc
Confidence            9999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.6e-35  Score=310.07  Aligned_cols=255  Identities=21%  Similarity=0.328  Sum_probs=205.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|++|.||++... .+++.++||.+....   .....++.+|+.++++++|+||+++++++.+.+..+++||
T Consensus         4 y~~~~~ig~g~~g~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           4 FRIEKKIGRGQFSEVYRATCL-LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhcccCCeEEEEEeec-CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            456688999999999999754 346789999876432   2334578999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          561 FMSNGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       561 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      |+++++|.+++..    ...+++..+..++.||++||.|||+.   +++|+||||+||+++.++.++|+|||++..+...
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999998863    35689999999999999999999998   9999999999999999999999999998866432


Q ss_pred             CCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          637 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      .. ......++..|+|||.+.+..++.++||||||+++|+|++|..|+........   ...................++
T Consensus       160 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08229         160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLCKKIEQCDYPPLPSDHYSE  235 (267)
T ss_pred             Cc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH---HHhhhhhcCCCCCCCcccccH
Confidence            22 12234588999999999988999999999999999999999999743211100   000011111111112234677


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      .+.+++.+||+.+|++||||.+|+++++++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.4e-36  Score=311.77  Aligned_cols=251  Identities=25%  Similarity=0.425  Sum_probs=195.1

Q ss_pred             hhcCCCCcceEEEeeeeCC--CcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceec-cCCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVNMG--SSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCD-EGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~LV~E~~~  563 (762)
                      +.||+|+||.||+|.....  ....+|+|++.... ....+.+.+|+.+++.++||||+++++++. .+...++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            3689999999999986432  34579999986432 334568889999999999999999999875 4556789999999


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc---
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH---  639 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~---  639 (762)
                      +++|.+++.+. ..+.+..+..++.|+++||+|||+.   +++||||||+|||+++++.+||+|||+++........   
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999764 4567888899999999999999998   9999999999999999999999999999765432211   


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchh-hHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTD-WAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      ......++..|+|||.+....++.++||||||+++|||++|+.|+... .......      .+........+...+..+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~  231 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV------YLLQGRRLLQPEYCPDPL  231 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH------HHhcCCCCCCCCcCCHHH
Confidence            111234567899999998889999999999999999999976553222 1111111      111111111122345678


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      .+++.+||+.+|++||++.||++.|+++.
T Consensus       232 ~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         232 YEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            99999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.7e-36  Score=315.51  Aligned_cols=257  Identities=22%  Similarity=0.333  Sum_probs=204.7

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCC---CcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceecc-CCcee
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMG---SSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-GRNRL  556 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~  556 (762)
                      ..+.+.+.||+|+||.||+|.....   ..+.|++|++.... ......+.+|+.++++++|+||+++++++.+ ....+
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   85 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF   85 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence            3445668899999999999987652   25789999987543 2335678899999999999999999998766 56789


Q ss_pred             EEEeccCCCchhhhccCC--------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccc
Q 004312          557 LVYEFMSNGALASFLFGD--------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFG  628 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~--------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  628 (762)
                      +++||+++++|.+++...        ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||
T Consensus        86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g  162 (280)
T cd05043          86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNA  162 (280)
T ss_pred             EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCC
Confidence            999999999999998653        3578999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCCcc-cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcccccccccccc
Q 004312          629 LEKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDL  706 (762)
Q Consensus       629 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  706 (762)
                      +++.+....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.|+......+...      .+....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~------~~~~~~  236 (280)
T cd05043         163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA------YLKDGY  236 (280)
T ss_pred             CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHH------HHHcCC
Confidence            998664333221 122345678999999998899999999999999999999 888874432222111      111111


Q ss_pred             ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          707 EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       707 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      .......+++++.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            11122334678899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.6e-36  Score=317.39  Aligned_cols=253  Identities=26%  Similarity=0.378  Sum_probs=201.5

Q ss_pred             hhhhcCCCCcceEEEeeeeCC----CcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          486 FKEELGRGAFGTVYKGFVNMG----SSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.||+|+||.||+|.....    ....+++|.+..... ....++.+|+.++++++||||+++++.+...+..++|+|
T Consensus         4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (290)
T cd05045           4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE   83 (290)
T ss_pred             ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence            457899999999999975421    224689998875432 334679999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCC------------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE
Q 004312          561 FMSNGALASFLFGD------------------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL  616 (762)
Q Consensus       561 ~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl  616 (762)
                      |+++++|.+++...                        ..+++..++.++.|++.||+|||+.   +|+||||||+|||+
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill  160 (290)
T cd05045          84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLV  160 (290)
T ss_pred             ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEE
Confidence            99999999987532                        2478899999999999999999998   99999999999999


Q ss_pred             cCCCceEEecccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhh
Q 004312          617 DDYYNARISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQ  694 (762)
Q Consensus       617 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~  694 (762)
                      ++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..........
T Consensus       161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~  240 (290)
T cd05045         161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN  240 (290)
T ss_pred             cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            99999999999999865433221 1122345678999999988889999999999999999998 888764332222111


Q ss_pred             ccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          695 ERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                            .+........+...+.++.+++.+||+.+|++||++.|+++.|+++.
T Consensus       241 ------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         241 ------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             ------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence                  11111122223345678999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.4e-36  Score=320.36  Aligned_cols=261  Identities=24%  Similarity=0.346  Sum_probs=205.8

Q ss_pred             HHHhhhhhhcCCCCcceEEEeeeeC------CCcceEEEEEccccc-cchhHHHHHHhhhhccc-ccCCccchhceeccC
Q 004312          481 EVTRGFKEELGRGAFGTVYKGFVNM------GSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEG  552 (762)
Q Consensus       481 ~~t~~~~~~iG~G~~g~Vy~g~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  552 (762)
                      ...+.+.+.||+|+||.||++....      .....||+|.+.... ....+++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            3444566889999999999997421      123479999987532 33456799999999999 899999999999999


Q ss_pred             CceeEEEeccCCCchhhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE
Q 004312          553 RNRLLVYEFMSNGALASFLFGD----------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL  616 (762)
Q Consensus       553 ~~~~LV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl  616 (762)
                      ...++||||+++++|.+++...                ..+++..+..++.||++||.|||+.   +|+||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence            9999999999999999998653                2467888999999999999999998   99999999999999


Q ss_pred             cCCCceEEecccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhh
Q 004312          617 DDYYNARISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQ  694 (762)
Q Consensus       617 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~  694 (762)
                      ++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......+...
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~  250 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  250 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence            99999999999999876433222 1222345678999999988889999999999999999998 666653322111111


Q ss_pred             ccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCC
Q 004312          695 ERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP  750 (762)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  750 (762)
                      .      +........+...+..+.+++.+||+.+|++||++.|+++.|+++..+.
T Consensus       251 ~------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         251 L------LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             H------HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence            1      1111111122345678999999999999999999999999999876554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=326.93  Aligned_cols=248  Identities=23%  Similarity=0.336  Sum_probs=208.7

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCc--ceEEEEEccccccc-hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSS--DQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +-|+||+|.||.|++|.|...++  ..||||.++..... ...+|.+|+.+|.+|+|+|+++|||...+ ....||+|.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            45889999999999999976444  46999999865444 67899999999999999999999999988 7889999999


Q ss_pred             CCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          563 SNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       563 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +.|+|.+.|++.  ..+-......++.|||.||+||.++   ++|||||..+|+||-....+||+||||.+.+...+...
T Consensus       193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            999999999873  4577888889999999999999999   99999999999999999999999999999886554432


Q ss_pred             -ccc-ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhC-CCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          641 -NTA-IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICL-RRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       641 -~~~-~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                       +.. ..-...|.|||.++...++.++|||+|||+||||+++ ..|+.+-....      +-+.+|.......+..++++
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q------IL~~iD~~erLpRPk~csed  343 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ------ILKNIDAGERLPRPKYCSED  343 (1039)
T ss_pred             EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH------HHHhccccccCCCCCCChHH
Confidence             222 2235689999999999999999999999999999985 45654433333      33445555566667789999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHh
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQML  743 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~~L  743 (762)
                      +.++++.||..+|++|||+..|.+.+
T Consensus       344 IY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  344 IYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             HHHHHHHhccCCccccccHHHHHHhH
Confidence            99999999999999999999997443

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.8e-36  Score=316.14  Aligned_cols=256  Identities=25%  Similarity=0.383  Sum_probs=200.0

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeC----CCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeE
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L  557 (762)
                      .+.+.+.||+|+||.||+|....    .....||+|.+..... .....+.+|+.++++++||||+++++++.+....++
T Consensus         7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   86 (288)
T cd05061           7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV   86 (288)
T ss_pred             HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            34556789999999999997542    2345799998864432 234568899999999999999999999999999999


Q ss_pred             EEeccCCCchhhhccCC----------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecc
Q 004312          558 VYEFMSNGALASFLFGD----------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDF  627 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  627 (762)
                      ||||+++|+|.+++...          ..+++..+..++.|++.||.|||+.   +|+||||||+|||+++++.+||+||
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Df  163 (288)
T cd05061          87 VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDF  163 (288)
T ss_pred             EEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcC
Confidence            99999999999999642          2346778899999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccc
Q 004312          628 GLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVEND  705 (762)
Q Consensus       628 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  705 (762)
                      |+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |..|+......+.. +    .+....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~-~----~~~~~~  238 (288)
T cd05061         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL-K----FVMDGG  238 (288)
T ss_pred             CccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-H----HHHcCC
Confidence            999865432221 1122335678999999999999999999999999999998 56666332111111 1    111111


Q ss_pred             cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          706 LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       706 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                       ....+...+..+.+++.+||+.+|++|||+.++++.|++..
T Consensus       239 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         239 -YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence             11112234578999999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.4e-36  Score=325.04  Aligned_cols=241  Identities=26%  Similarity=0.282  Sum_probs=194.2

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhh-hhcccccCCccchhceeccCCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVN-GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.||+|+||.||+++.. .+++.+|||++.+..   ......+..|.. +++.++||||+++++.+...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRK-LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence            36899999999999754 456799999986532   223345566654 4677899999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +|+|..++.....+++..+..++.||++||+|||+.   +|+||||||+|||+++++.+||+|||+++..... ......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~  155 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTT  155 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccc
Confidence            999999998888899999999999999999999998   9999999999999999999999999998753221 222344


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.....     .....  ......+..+.+++.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~~ll~  228 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI-----LHKPL--VLRPGASLTAWSILE  228 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH-----HcCCc--cCCCCCCHHHHHHHH
Confidence            56999999999999999999999999999999999999998654333222211     11111  112234567889999


Q ss_pred             HhhccCCCCCCCHHHHH
Q 004312          724 WCIQEDPSHRPTMRRVT  740 (762)
Q Consensus       724 ~cl~~dp~~RPt~~evl  740 (762)
                      +|++.+|.+||++.+.+
T Consensus       229 ~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         229 ELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             HHhccCHHhcCCCCCCH
Confidence            99999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1e-35  Score=316.68  Aligned_cols=259  Identities=24%  Similarity=0.313  Sum_probs=201.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCC---------------cceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGS---------------SDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLG  547 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g  547 (762)
                      +.+.+.||+|+||.||++......               ...||+|++.... ....+.+.+|++++++++||||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   86 (296)
T cd05051           7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG   86 (296)
T ss_pred             CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            456688999999999998765322               2458999987543 234568999999999999999999999


Q ss_pred             eeccCCceeEEEeccCCCchhhhccCCC-----------CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE
Q 004312          548 YCDEGRNRLLVYEFMSNGALASFLFGDS-----------KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL  616 (762)
Q Consensus       548 ~~~~~~~~~LV~E~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl  616 (762)
                      ++..+...++|+||+++++|.+++....           .+++..++.++.|++.||+|||+.   +|+||||||+||++
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili  163 (296)
T cd05051          87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLV  163 (296)
T ss_pred             EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhceee
Confidence            9999999999999999999999997654           689999999999999999999998   99999999999999


Q ss_pred             cCCCceEEecccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh--CCCCCchhhHHHhh
Q 004312          617 DDYYNARISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC--LRRTILTDWAYDCY  693 (762)
Q Consensus       617 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt--g~~p~~~~~~~~~~  693 (762)
                      ++++.++|+|||+++....... .......+++.|+|||.+....++.++||||||+++|||++  +..|+........+
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~  243 (296)
T cd05051         164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI  243 (296)
T ss_pred             cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence            9999999999999986543221 12223446788999999988899999999999999999998  55565332111111


Q ss_pred             hccc-cccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          694 QERT-LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       694 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      .... .............+...++++.+++.+||+.+|++|||+.||++.|++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         244 ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            1100 000000011111122345789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-36  Score=314.93  Aligned_cols=253  Identities=25%  Similarity=0.386  Sum_probs=202.3

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC----CCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLV  558 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV  558 (762)
                      +.+.+.||+|+||.||+|....    .....||+|.+.... ......+.+|+.++++++|+||+++++++......++|
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   87 (277)
T cd05032           8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVV   87 (277)
T ss_pred             eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEE
Confidence            3455789999999999997653    223679999987543 23345789999999999999999999999999999999


Q ss_pred             EeccCCCchhhhccCC----------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccc
Q 004312          559 YEFMSNGALASFLFGD----------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFG  628 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  628 (762)
                      |||+++++|.+++...          ..+++..+..++.||+.||.|||+.   +|+||||||+||++++++.+||+|||
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg  164 (277)
T cd05032          88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFG  164 (277)
T ss_pred             EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcc
Confidence            9999999999998643          2468889999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcccccccccccc
Q 004312          629 LEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDL  706 (762)
Q Consensus       629 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  706 (762)
                      +++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...........      +....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~------~~~~~  238 (277)
T cd05032         165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF------VIDGG  238 (277)
T ss_pred             cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH------HhcCC
Confidence            9986543322 12223446789999999998899999999999999999998 7877643322221111      11111


Q ss_pred             ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          707 EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       707 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      ....+...+.++.+++.+||+.+|++|||+.++++.|++
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            111223346789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.7e-36  Score=315.14  Aligned_cols=252  Identities=28%  Similarity=0.350  Sum_probs=199.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCC----CcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMG----SSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      .+.+.||+|++|.||+|.+...    ....|++|.+.... ...+..|.+|+.++++++|+||+++++++.+....++||
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   88 (277)
T cd05036           9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL   88 (277)
T ss_pred             EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence            3457899999999999987541    35679999886433 334567999999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCCC-------CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC---ceEEecccc
Q 004312          560 EFMSNGALASFLFGDS-------KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY---NARISDFGL  629 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Dfgl  629 (762)
                      ||+++++|.+++....       .+++..++.++.||+.||+|||+.   +++||||||+||++++++   .+||+|||+
T Consensus        89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCcc
Confidence            9999999999986542       578999999999999999999998   999999999999998654   599999999


Q ss_pred             cccccCCCCcc-cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccc
Q 004312          630 EKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLE  707 (762)
Q Consensus       630 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  707 (762)
                      ++......... ......+..|+|||.+.+..++.++|||||||++|||++ |+.||.........      ..+.....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~------~~~~~~~~  239 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM------EFVTGGGR  239 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH------HHHHcCCc
Confidence            98663222111 112223568999999999999999999999999999997 88887443222111      11111112


Q ss_pred             cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       708 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      ...+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            22233456788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.8e-36  Score=315.83  Aligned_cols=262  Identities=24%  Similarity=0.370  Sum_probs=203.0

Q ss_pred             HHhhhhhhcCCCCcceEEEeeee---CCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccC--Cce
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVN---MGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--RNR  555 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~---~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  555 (762)
                      .++...+.||+|+||.||++.++   ..+++.||+|.++... ......+.+|++++++++||||+++++++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            34455678999999999999753   2345789999987543 33346799999999999999999999998775  567


Q ss_pred             eEEEeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccccc
Q 004312          556 LLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT  634 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~  634 (762)
                      ++||||+++++|.+++.+. ..+++..+..++.||+.||+|||+.   +++||||||+||++++++.+||+|||+++...
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence            8999999999999999655 4689999999999999999999998   99999999999999999999999999998764


Q ss_pred             CCCCc--ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHH--Hhh----hccc---cccccc
Q 004312          635 LDQSH--TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY--DCY----QERT---LGALVE  703 (762)
Q Consensus       635 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~--~~~----~~~~---~~~~~~  703 (762)
                      .....  ......++..|+|||.+.+..++.++||||||+++|||++++.|.......  ...    .+..   ....+.
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE  240 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence            33221  112344677899999998889999999999999999999987764221100  000    0000   000011


Q ss_pred             cccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       704 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      .......+..++.++.+++.+||+.+|++||+++++++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1111112234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.9e-36  Score=330.15  Aligned_cols=249  Identities=21%  Similarity=0.281  Sum_probs=200.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+++.. .+++.||+|++.+..   ......+.+|+.+++.++||||+++++++.++...++|||
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05596          45 FDVIKVIGRGAFGEVQLVRHK-SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME  123 (370)
T ss_pred             cEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence            445678999999999999754 456789999986432   2233567899999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++|+|.+++... .+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++.........
T Consensus       124 y~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         124 YMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence            99999999998654 578888999999999999999998   99999999999999999999999999998764433333


Q ss_pred             cccccccCcccCcccccCC----CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccc--cccCCCHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNM----PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTV  714 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~----~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  714 (762)
                      .....||+.|+|||.+.+.    .++.++|||||||++|||++|+.||........+..     +....  .........
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~-----i~~~~~~~~~~~~~~~  274 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK-----IMDHKNSLTFPDDIEI  274 (370)
T ss_pred             CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH-----HHcCCCcCCCCCcCCC
Confidence            3446799999999998653    488999999999999999999999865433222221     11111  111112245


Q ss_pred             HHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 004312          715 LQRFVMVAIWCIQEDPSH--RPTMRRVTQM  742 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~--RPt~~evl~~  742 (762)
                      +.++.+++.+||+.+|++  ||+++|+++.
T Consensus       275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         275 SKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            688999999999999987  9999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9.5e-36  Score=318.31  Aligned_cols=252  Identities=21%  Similarity=0.270  Sum_probs=192.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++..... .....+.+|++++++++||||+++++++.+....++||||+
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (303)
T cd07869           7 YEKLEKLGEGSYATVYKGKSK-VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV   85 (303)
T ss_pred             ceEeeeEEecCCEEEEEEEEC-CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence            445678999999999999754 3467899999875432 23456789999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          563 SNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       563 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      + ++|.+++... ..++...+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus        86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~  160 (303)
T cd07869          86 H-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTY  160 (303)
T ss_pred             C-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccC
Confidence            6 5777777554 5688999999999999999999998   99999999999999999999999999987543221 222


Q ss_pred             ccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHH-hhhc----------ccc------ccccc
Q 004312          642 TAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYD-CYQE----------RTL------GALVE  703 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~-~~~~----------~~~------~~~~~  703 (762)
                      ....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....          ...      .....
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP  240 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence            34568899999999865 468899999999999999999999985421110 0000          000      00000


Q ss_pred             cccccCCC---------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          704 NDLEAMDD---------MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       704 ~~~~~~~~---------~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .......+         ...+..+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00000000         012356789999999999999999999886

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.1e-35  Score=308.74  Aligned_cols=241  Identities=22%  Similarity=0.348  Sum_probs=191.2

Q ss_pred             hhcCCCCcceEEEeeeeCCC-----------cceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCcee
Q 004312          488 EELGRGAFGTVYKGFVNMGS-----------SDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRL  556 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  556 (762)
                      +.||+|+||.||+|++....           ...|++|.+..........|.+|+.++++++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            46899999999999864321           2358999887655555668899999999999999999999999999999


Q ss_pred             EEEeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc-------eEEeccc
Q 004312          557 LVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN-------ARISDFG  628 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~-------~kl~Dfg  628 (762)
                      +||||+++++|..++... ..+++..+..++.||++||+|||++   +|+||||||+|||++.++.       +|++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998754 5689999999999999999999998   9999999999999986654       8999999


Q ss_pred             ccccccCCCCcccccccccCcccCccccc-CCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcccccccccccc
Q 004312          629 LEKLLTLDQSHTNTAIRGTKGYVAPEWFR-NMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDL  706 (762)
Q Consensus       629 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  706 (762)
                      ++......     ....++..|+|||.+. ...++.++||||||+++|||++ |+.|+......+..      .......
T Consensus       158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~~~~~~~  226 (262)
T cd05077         158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE------RFYEGQC  226 (262)
T ss_pred             CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH------HHHhcCc
Confidence            98754321     2234788999999986 4678999999999999999984 66665332111110      0011111


Q ss_pred             ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 004312          707 EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       707 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~  744 (762)
                      ..  ......++.+++.+||+.||.+||++++|++.|+
T Consensus       227 ~~--~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         227 ML--VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             cC--CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            11  1123467889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-36  Score=330.94  Aligned_cols=250  Identities=22%  Similarity=0.262  Sum_probs=197.8

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||++... .+++.||||++.+..   ....+.+.+|++++++++||||+++++.+.+....+|||||
T Consensus         4 ~~~~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~   82 (377)
T cd05629           4 HTVKVIGKGAFGEVRLVQKK-DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF   82 (377)
T ss_pred             eEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence            34578999999999999754 456799999986532   22345788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc--
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--  639 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~--  639 (762)
                      +++|+|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+......  
T Consensus        83 ~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          83 LPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            99999999998888899999999999999999999998   9999999999999999999999999998643211000  


Q ss_pred             --------------------------------------------ccccccccCcccCcccccCCCCCCcchhHHHHHHHH
Q 004312          640 --------------------------------------------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLL  675 (762)
Q Consensus       640 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~  675 (762)
                                                                  ......||+.|+|||.+.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  239 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF  239 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence                                                        001246999999999999999999999999999999


Q ss_pred             HHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 004312          676 EIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHR---PTMRRVTQM  742 (762)
Q Consensus       676 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R---Pt~~evl~~  742 (762)
                      ||++|+.||......+.+......   ............+.++.+++.+|++ +|.+|   +++.|+++.
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~---~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         240 ECLIGWPPFCSENSHETYRKIINW---RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHcc---CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            999999998554333222211000   0011111112345778899999997 66665   599988874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.2e-36  Score=318.53  Aligned_cols=255  Identities=26%  Similarity=0.364  Sum_probs=202.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC----CCcceEEEEEccccc-cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~L  557 (762)
                      +.+.+.||+|+||.||++....    .....+|+|++.... .....++.+|++++.++ +|+||+++++++...+..++
T Consensus        14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   93 (293)
T cd05053          14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV   93 (293)
T ss_pred             eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence            3455789999999999997643    223579999987532 23345788999999999 89999999999999999999


Q ss_pred             EEeccCCCchhhhccC----------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc
Q 004312          558 VYEFMSNGALASFLFG----------------DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN  621 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~  621 (762)
                      +|||+++|+|.+++..                ...+++..++.++.|++.||.|||+.   +|+||||||+||++++++.
T Consensus        94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~  170 (293)
T cd05053          94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHV  170 (293)
T ss_pred             EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCe
Confidence            9999999999999853                24678999999999999999999998   9999999999999999999


Q ss_pred             eEEecccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccc
Q 004312          622 ARISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLG  699 (762)
Q Consensus       622 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~  699 (762)
                      +||+|||+++.+...... ......++..|+|||.+.+..++.++||||||+++|||++ |..|+......+....    
T Consensus       171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----  246 (293)
T cd05053         171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL----  246 (293)
T ss_pred             EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH----
Confidence            999999999876433221 1122335678999999988899999999999999999997 8888643322111111    


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          700 ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       700 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                        +........+...+..+.+++.+||+.+|++|||++|+++.|+++.
T Consensus       247 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         247 --LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence              1111111223345678899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=320.92  Aligned_cols=250  Identities=26%  Similarity=0.348  Sum_probs=212.4

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccch---hHHHHHHhhhhcccc-cCCccchhceeccCCceeE
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~L  557 (762)
                      ..+.+.+.||+|.||.||++... .+++.+|+|.+.+.....   ...+.+|+++|+++. |||||.+.+.+++....++
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~-~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREK-STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEec-CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            34566789999999999999754 457899999997654433   358999999999998 9999999999999999999


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC----CCceEEecccccccc
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD----YYNARISDFGLEKLL  633 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~Dfgla~~~  633 (762)
                      |||++.+|.|.+.+... .+++.....++.||+.++.|||+.   +|+||||||+|+|+..    ++.+|++|||++...
T Consensus       114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            99999999999999776 499999999999999999999998   9999999999999963    357999999999987


Q ss_pred             cCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHH
Q 004312          634 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMT  713 (762)
Q Consensus       634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  713 (762)
                      ..  .......+||+.|+|||++....++..+||||+|+++|.|++|..||.................   ......-..
T Consensus       190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~---~f~~~~w~~  264 (382)
T KOG0032|consen  190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF---DFTSEPWDD  264 (382)
T ss_pred             cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC---CCCCCCccc
Confidence            65  5566778999999999999999999999999999999999999999976644433332111111   122223345


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          714 VLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       714 ~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+.+++..|+..||.+|+|+.++++
T Consensus       265 is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  265 ISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             cCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            6889999999999999999999999998

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=309.93  Aligned_cols=248  Identities=22%  Similarity=0.286  Sum_probs=202.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-----chhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-----DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      ...+.||+|++|.||++... .+++.+|+|.+.....     ...+.+.+|++++++++||||+++++++.+....++|+
T Consensus         5 ~~~~~lg~g~~~~vy~~~~~-~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   83 (263)
T cd06625           5 RRGKLLGQGAFGRVYLCYDV-DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM   83 (263)
T ss_pred             cccceecCCCceEEEEEEEc-CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence            34578999999999999643 4567899998864321     12356889999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||+|+||++++++.++|+|||+++........
T Consensus        84 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          84 EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            9999999999998888889999999999999999999998   9999999999999999999999999999765432221


Q ss_pred             cc--ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          640 TN--TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       640 ~~--~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      ..  ....++..|+|||.+.+..++.++||||||+++|||++|+.||...........     ..........+...+..
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  235 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK-----IATQPTNPQLPSHVSPD  235 (263)
T ss_pred             cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH-----HhccCCCCCCCccCCHH
Confidence            11  234578899999999998999999999999999999999999754322221111     11111112223345678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +.+++.+||+.+|++|||++|+++
T Consensus       236 ~~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         236 ARNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHhh
Confidence            899999999999999999999987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.4e-36  Score=322.29  Aligned_cols=240  Identities=25%  Similarity=0.325  Sum_probs=195.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhccccc-CCccchhceeccCCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHH-KNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .+.+.||+|+||.||+|... ++++.||||++.+..   ....+.+..|++++..++| ++|+++++++.+.+..++|||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           3 NFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             eEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            35678999999999999754 456789999987532   2334568889999999865 568889999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++..... ...
T Consensus        82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~  157 (324)
T cd05587          82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GKT  157 (324)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CCc
Confidence            999999999998888899999999999999999999998   9999999999999999999999999998743221 122


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.....     ....  ...+...+.++.+
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i-----~~~~--~~~~~~~~~~~~~  230 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI-----MEHN--VSYPKSLSKEAVS  230 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-----HcCC--CCCCCCCCHHHHH
Confidence            33456899999999999999999999999999999999999998554332222211     1111  1112235678899


Q ss_pred             HHHHhhccCCCCCCCH
Q 004312          721 VAIWCIQEDPSHRPTM  736 (762)
Q Consensus       721 li~~cl~~dp~~RPt~  736 (762)
                      ++.+||+.+|.+|++.
T Consensus       231 li~~~l~~~P~~R~~~  246 (324)
T cd05587         231 ICKGLLTKHPAKRLGC  246 (324)
T ss_pred             HHHHHhhcCHHHcCCC
Confidence            9999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.6e-35  Score=308.62  Aligned_cols=252  Identities=21%  Similarity=0.312  Sum_probs=202.0

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.+.||+|+||.||+|... .+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNV-NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEc-CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            4556788999999999999754 456789999987654445567889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ++++|.+++...+.+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++...... .....
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~~~  164 (267)
T cd06645          89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKRK  164 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc-ccccc
Confidence            9999999998888899999999999999999999998   9999999999999999999999999998765422 12223


Q ss_pred             cccccCcccCccccc---CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ...|+..|+|||.+.   ...++.++||||||+++|+|++|+.|+...................+...  .....++.+.
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  242 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK--DKMKWSNSFH  242 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc--ccCCCCHHHH
Confidence            456899999999974   45688999999999999999999999743322111110000000001000  1113456789


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+||+.+|++||++++|++
T Consensus       243 ~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         243 HFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhc
Confidence            9999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.4e-36  Score=324.36  Aligned_cols=242  Identities=22%  Similarity=0.252  Sum_probs=193.2

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.||+|+||.||++... .+++.||+|++++...   ...+.+.+|+.++.++ +||||+++++++.+.+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLK-KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence            36999999999999765 4467899999975422   2345688999999888 79999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +|+|..++.....+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++..... ......
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~  155 (327)
T cd05617          80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTST  155 (327)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceec
Confidence            999999998888899999999999999999999998   9999999999999999999999999998753221 222334


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhh--hccccccccccccccCCCHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCY--QERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  .+.....+....  ...+...+..+.++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~l  233 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--IRIPRFLSVKASHV  233 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--CCCCCCCCHHHHHH
Confidence            66999999999999999999999999999999999999998421100000  000001111111  11233456778999


Q ss_pred             HHHhhccCCCCCCCH
Q 004312          722 AIWCIQEDPSHRPTM  736 (762)
Q Consensus       722 i~~cl~~dp~~RPt~  736 (762)
                      +.+||+.||++||++
T Consensus       234 i~~~L~~dP~~R~~~  248 (327)
T cd05617         234 LKGFLNKDPKERLGC  248 (327)
T ss_pred             HHHHhccCHHHcCCC
Confidence            999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-35  Score=302.90  Aligned_cols=247  Identities=23%  Similarity=0.288  Sum_probs=208.8

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.||.|.-|+||++.+. ++...+|+|++.+..   .....+.+.|-+||+.++||.+++|++.++.....+||||||
T Consensus        81 llk~LG~GdiG~VyL~~l~-~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC  159 (459)
T KOG0610|consen   81 LLKRLGCGDIGTVYLVELR-GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC  159 (459)
T ss_pred             HHHHcCCCCceeEEEEEec-CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence            4578999999999999876 445799999997643   333456788999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC-----
Q 004312          563 SNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL-----  635 (762)
Q Consensus       563 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~-----  635 (762)
                      +||+|...++++  +.+++..++.++..|+-||+|||..   |||.|||||+||||.++|++.|+||.|+.....     
T Consensus       160 pGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~  236 (459)
T KOG0610|consen  160 PGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV  236 (459)
T ss_pred             CCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence            999999999876  5789999999999999999999999   999999999999999999999999998643210     


Q ss_pred             -----------------------------CC---------------------CcccccccccCcccCcccccCCCCCCcc
Q 004312          636 -----------------------------DQ---------------------SHTNTAIRGTKGYVAPEWFRNMPITVKV  665 (762)
Q Consensus       636 -----------------------------~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~  665 (762)
                                                   ..                     ......++||-.|+|||++++...+.+.
T Consensus       237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAV  316 (459)
T KOG0610|consen  237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAV  316 (459)
T ss_pred             ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchh
Confidence                                         00                     0111235799999999999999999999


Q ss_pred             hhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 004312          666 DVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPT----MRRVTQ  741 (762)
Q Consensus       666 DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt----~~evl~  741 (762)
                      |.|+|||+||||+.|+.||.+..     .+.++..++...+.....++++..+.+||++.|.+||++|..    +.||.+
T Consensus       317 DWWtfGIflYEmLyG~TPFKG~~-----~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  317 DWWTFGIFLYEMLYGTTPFKGSN-----NKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             hHHHHHHHHHHHHhCCCCcCCCC-----chhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence            99999999999999999996653     334455566666666556678899999999999999999988    777764

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=314.31  Aligned_cols=248  Identities=26%  Similarity=0.288  Sum_probs=199.3

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      ...+.||+|+||.||++... .+++.||||++.....   .....+.+|+.++++++||||+++++.+...+..++||||
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           3 RHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             eEEEEEecCCCeEEEEEEEc-CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            34578999999999999754 4567899999865322   2235678899999999999999999999999999999999


Q ss_pred             cCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          562 MSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       562 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      +++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||+++......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence            9999999988653  4689999999999999999999998   99999999999999999999999999998654222  


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..........  .+...+... ....+...+..+.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~  233 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE--EVERRVKED-QEEYSEKFSEAAR  233 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH--HHHHHhhhc-ccccCcccCHHHH
Confidence            2223468999999999998899999999999999999999999985432211110  011111111 1122334677889


Q ss_pred             HHHHHhhccCCCCCC-----CHHHHHH
Q 004312          720 MVAIWCIQEDPSHRP-----TMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RP-----t~~evl~  741 (762)
                      +++.+||+.||++||     +++++++
T Consensus       234 ~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         234 SICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             HHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.7e-35  Score=307.69  Aligned_cols=246  Identities=23%  Similarity=0.327  Sum_probs=202.6

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|++|.||++... .+++.|++|.+...  ......++.+|++++++++||||+++++++.+.+..++||||+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           3 EILNKIGKGSFGVVFKVVRK-ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             eEeEEecCCCCeEEEEEEEc-CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            34578999999999999765 44678999988642  3345568999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          563 SNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       563 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      ++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||+++....... .
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~  157 (256)
T cd08529          82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-F  157 (256)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-h
Confidence            999999999764  5688999999999999999999998   999999999999999999999999999886653322 2


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....+++.|+|||++.+..++.++||||||+++|||++|+.|+...........     ..... ....+...+..+.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~~~  231 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK-----IIRGV-FPPVSQMYSQQLAQ  231 (256)
T ss_pred             hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHcCC-CCCCccccCHHHHH
Confidence            2334588999999999999999999999999999999999999854432221111     11111 11122245678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~  741 (762)
                      ++.+||+.+|++||++.++++
T Consensus       232 ~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         232 LIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             HHHHHccCCcccCcCHHHHhh
Confidence            999999999999999999987

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.5e-35  Score=311.00  Aligned_cols=255  Identities=23%  Similarity=0.300  Sum_probs=203.8

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCC--CcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMG--SSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      .+.+.+.||+|+||.||+|.....  ....|+||+..... ....+.+.+|+.++++++||||+++++++.+ ...++||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~   85 (270)
T cd05056           7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVM   85 (270)
T ss_pred             hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEE
Confidence            345667899999999999986543  23469999887544 3445689999999999999999999998875 4578999


Q ss_pred             eccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          560 EFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       560 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.......
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY  162 (270)
T ss_pred             EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence            999999999999764 4589999999999999999999998   999999999999999999999999999987654432


Q ss_pred             cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          639 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      .......++..|+|||.+....++.++||||||+++||+++ |+.||......+.....      ........+...+..
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~------~~~~~~~~~~~~~~~  236 (270)
T cd05056         163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI------ENGERLPMPPNCPPT  236 (270)
T ss_pred             eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------HcCCcCCCCCCCCHH
Confidence            22223334568999999988889999999999999999996 88887443222211110      111111123345678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      +.+++.+|+..+|++|||+.++++.|+++.
T Consensus       237 ~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         237 LYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=308.58  Aligned_cols=250  Identities=29%  Similarity=0.442  Sum_probs=203.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|++|.||++...  ..+.+|||.+.... ...+++.+|+.++++++|+||+++++++......++||||++
T Consensus         8 ~~i~~~ig~g~~~~v~~~~~~--~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (261)
T cd05034           8 LKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS   84 (261)
T ss_pred             eeeeeeeccCcceEEEEEEEc--CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence            445678999999999999754  34679999987542 345689999999999999999999999999899999999999


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||+++..........
T Consensus        85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (261)
T cd05034          85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR  161 (261)
T ss_pred             CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence            99999999765  3689999999999999999999998   999999999999999999999999999987643222222


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....+..|+|||.+.+..++.++||||||+++||+++ |+.|+...........      +........+...+.++.+
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~  235 (261)
T cd05034         162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ------VERGYRMPRPPNCPEELYD  235 (261)
T ss_pred             hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------HHcCCCCCCCCCCCHHHHH
Confidence            22334578999999998899999999999999999998 8888744322221111      1111111122234678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      ++.+||+.+|++||+++++.+.|+.
T Consensus       236 ~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         236 LMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHHHcccCcccCCCHHHHHHHHhc
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-35  Score=313.51  Aligned_cols=260  Identities=26%  Similarity=0.392  Sum_probs=205.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC---CCcceEEEEEccccccc-hhHHHHHHhhhhcccccCCccchhceecc--CCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM---GSSDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~---~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~L  557 (762)
                      ..+.+.||+|+||.||++.+..   ++++.+|||+++..... ...+|.+|++++++++|+||+++++++..  ....++
T Consensus         6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05038           6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL   85 (284)
T ss_pred             chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence            3456789999999999998642   34578999999765443 46789999999999999999999999877  567899


Q ss_pred             EEeccCCCchhhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          558 VYEFMSNGALASFLFGDS-KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      ||||+++++|.+++.... .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        86 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05038          86 IMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPED  162 (284)
T ss_pred             EEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence            999999999999997654 689999999999999999999998   9999999999999999999999999999876532


Q ss_pred             CCc--ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhh---------hccccccccccc
Q 004312          637 QSH--TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCY---------QERTLGALVEND  705 (762)
Q Consensus       637 ~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~---------~~~~~~~~~~~~  705 (762)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.........         ....+...+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05038         163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG  242 (284)
T ss_pred             CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC
Confidence            221  111233456799999998889999999999999999999999886432211100         000011111122


Q ss_pred             cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          706 LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       706 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      .....+..++.++.+++.+||+.+|++|||+.||+++|+++
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         243 ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            22222334557899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-35  Score=320.91  Aligned_cols=243  Identities=23%  Similarity=0.301  Sum_probs=193.9

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhh---cccccCCccchhceeccCCceeEEE
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGI---GQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +.+.||+|+||.||+|... .+++.||||++++..   ....+.+.+|++++   ++++||||+++++++.+.+..++||
T Consensus         3 i~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~   81 (324)
T cd05589           3 CLAVLGRGHFGKVLLAEYK-KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM   81 (324)
T ss_pred             EEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence            4578999999999999754 456789999997532   22234566666554   5678999999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      ||+++++|..++.. ..+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++..... ..
T Consensus        82 E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~  156 (324)
T cd05589          82 EYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GD  156 (324)
T ss_pred             cCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-CC
Confidence            99999999988854 5689999999999999999999998   9999999999999999999999999998753221 22


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...........     +.....  ..+...+..+.
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~-----i~~~~~--~~p~~~~~~~~  229 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS-----IVNDEV--RYPRFLSREAI  229 (324)
T ss_pred             cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhCCC--CCCCCCCHHHH
Confidence            23345689999999999999999999999999999999999999854432222211     111111  12234567789


Q ss_pred             HHHHHhhccCCCCCC-----CHHHHHH
Q 004312          720 MVAIWCIQEDPSHRP-----TMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RP-----t~~evl~  741 (762)
                      +++.+||+.||++||     +++++++
T Consensus       230 ~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         230 SIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            999999999999999     5666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-35  Score=323.20  Aligned_cols=258  Identities=25%  Similarity=0.354  Sum_probs=198.4

Q ss_pred             HhhhhhhcCCCCcceEEEeeee----CCCcceEEEEEccccc-cchhHHHHHHhhhhccc-ccCCccchhceeccC-Cce
Q 004312          483 TRGFKEELGRGAFGTVYKGFVN----MGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEG-RNR  555 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~~~  555 (762)
                      .+.+.+.||+|+||.||+|...    ..+.+.||||+++... ......+.+|+.++.++ +|+||+++++++... ...
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~   87 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL   87 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence            4567789999999999999642    2345689999997533 23345788999999999 789999999988654 467


Q ss_pred             eEEEeccCCCchhhhccCC-------------------------------------------------------------
Q 004312          556 LLVYEFMSNGALASFLFGD-------------------------------------------------------------  574 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~-------------------------------------------------------------  574 (762)
                      ++||||+++|+|.+++...                                                             
T Consensus        88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (343)
T cd05103          88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE  167 (343)
T ss_pred             EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence            8999999999999998532                                                             


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc-cccccccc
Q 004312          575 ------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-TNTAIRGT  647 (762)
Q Consensus       575 ------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt  647 (762)
                            ..+++..+..++.||++||+|||+.   +|+||||||+|||+++++.+||+|||++......... ......++
T Consensus       168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd05103         168 QEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  244 (343)
T ss_pred             hhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence                  1357788889999999999999998   9999999999999999999999999999865432221 11223456


Q ss_pred             CcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhh
Q 004312          648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI  726 (762)
Q Consensus       648 ~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  726 (762)
                      ..|+|||.+.+..++.++||||||+++|||++ |..|+..........     ..+........+...++++.+++.+||
T Consensus       245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~cl  319 (343)
T cd05103         245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-----RRLKEGTRMRAPDYTTPEMYQTMLDCW  319 (343)
T ss_pred             cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH-----HHHhccCCCCCCCCCCHHHHHHHHHHc
Confidence            78999999988899999999999999999997 777763321111110     111111111112223467899999999


Q ss_pred             ccCCCCCCCHHHHHHHhhcCcC
Q 004312          727 QEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       727 ~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      +.+|++||++.||++.|+.+.+
T Consensus       320 ~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         320 HGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             cCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999988654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.1e-35  Score=308.63  Aligned_cols=252  Identities=27%  Similarity=0.362  Sum_probs=191.9

Q ss_pred             hhcCCCCcceEEEeeeeCC-CcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCC
Q 004312          488 EELGRGAFGTVYKGFVNMG-SSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      +.||+|+||.||+|.+..+ ....+|+|+++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            3589999999999976532 345799999875432 33457899999999999999999999999999999999999999


Q ss_pred             chhhhccCC-----CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc-
Q 004312          566 ALASFLFGD-----SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-  639 (762)
Q Consensus       566 sL~~~l~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-  639 (762)
                      +|.+++...     ...++..+..++.|+++||+|||+.   +++|+||||+||++++++.+||+|||+++........ 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            999999643     2456778889999999999999998   9999999999999999999999999998754332221 


Q ss_pred             ccccccccCcccCcccccCC-------CCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCC
Q 004312          640 TNTAIRGTKGYVAPEWFRNM-------PITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDD  711 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~-------~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  711 (762)
                      ......++..|+|||++...       .++.++||||||+++|||++ |+.||......+..... ..............
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  236 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-VREQQLKLPKPRLK  236 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-hhcccCCCCCCccC
Confidence            12234567889999998642       35889999999999999996 88887432222211110 00000000011111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 004312          712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       712 ~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~  744 (762)
                      ...++.+.+++..|+ .+|++|||++||+..|+
T Consensus       237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            123566888999999 58999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.1e-36  Score=292.57  Aligned_cols=245  Identities=25%  Similarity=0.369  Sum_probs=201.7

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-----c---hhHHHHHHhhhhccc-ccCCccchhceeccCCcee
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-----D---SEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRL  556 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-----~---~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  556 (762)
                      -++.||+|..+.|-+...+ .++.+.|+|++.....     .   -.+.-.+|+.+|+++ .||+|+++.++++.....+
T Consensus        21 pkeilgrgvss~vrRci~k-~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~F   99 (411)
T KOG0599|consen   21 PKEILGRGVSSVVRRCIHK-ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVF   99 (411)
T ss_pred             hHHHhcccchhhhhhhhhc-ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhh
Confidence            3568999999999988544 4567899998853211     1   123466899999998 7999999999999999999


Q ss_pred             EEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      +|+|.|+.|-|.++|.+.-.++++...+|+.|+.+|+.|||.+   .||||||||+|||+|++.++||+|||.+..+.  
T Consensus       100 lVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~--  174 (411)
T KOG0599|consen  100 LVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLE--  174 (411)
T ss_pred             hhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccC--
Confidence            9999999999999999988999999999999999999999999   99999999999999999999999999998765  


Q ss_pred             CCcccccccccCcccCccccc------CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccc--cc
Q 004312          637 QSHTNTAIRGTKGYVAPEWFR------NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL--EA  708 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~  708 (762)
                      ........+|||+|+|||.++      ...|+...|+|+.|||||.|+.|-.||......     -.+..++....  ..
T Consensus       175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-----lMLR~ImeGkyqF~s  249 (411)
T KOG0599|consen  175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-----LMLRMIMEGKYQFRS  249 (411)
T ss_pred             CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-----HHHHHHHhcccccCC
Confidence            455667789999999999985      346899999999999999999999997332111     11112222211  12


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          709 MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       709 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +.-...+....+||.+||+.||.+|.|.+|++.
T Consensus       250 peWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  250 PEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             cchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            222456788999999999999999999999874

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.7e-35  Score=325.78  Aligned_cols=252  Identities=25%  Similarity=0.283  Sum_probs=198.0

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCC-----ceeEE
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR-----NRLLV  558 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~LV  558 (762)
                      +.+.||+|+||.||++... .+++.||||++....  ....+.+.+|+++++.++|+||+++++++....     ..++|
T Consensus         4 ~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   82 (372)
T cd07853           4 PDRPIGYGAFGVVWSVTDP-RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV   82 (372)
T ss_pred             ccceeeeCCCEEEEEEEEC-CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence            4578999999999999753 456799999986532  233467889999999999999999999998776     78999


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      +||++ ++|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++.......
T Consensus        83 ~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          83 TELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             eeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            99997 57888888778899999999999999999999998   999999999999999999999999999987654433


Q ss_pred             cccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc-------c----------ccc
Q 004312          639 HTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER-------T----------LGA  700 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~-------~----------~~~  700 (762)
                      .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||............       .          ...
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence            333445678999999998764 5799999999999999999999998543322111100       0          000


Q ss_pred             ccccccc-c-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          701 LVENDLE-A-------MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       701 ~~~~~~~-~-------~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      .+..... .       ......++++.+++.+||+.||++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            0000000 0       0111235678999999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.3e-36  Score=328.21  Aligned_cols=249  Identities=21%  Similarity=0.285  Sum_probs=199.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||++... .+++.+|+|.+.+..   ......+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus        45 y~~~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05621          45 YDVVKVIGRGAFGEVQLVRHK-SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME  123 (370)
T ss_pred             CeEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence            445578999999999999764 456789999986422   2234568899999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++|+|.+++... .+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||++..........
T Consensus       124 y~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~  199 (370)
T cd05621         124 YMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR  199 (370)
T ss_pred             CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence            99999999999654 578899999999999999999998   99999999999999999999999999998764333323


Q ss_pred             cccccccCcccCcccccCC----CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccc--cccCCCHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNM----PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTV  714 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~----~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  714 (762)
                      .....||+.|+|||.+...    .++.++||||||+++|||++|+.||...........     +....  .........
T Consensus       200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~-----i~~~~~~~~~p~~~~~  274 (370)
T cd05621         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK-----IMDHKNSLNFPEDVEI  274 (370)
T ss_pred             cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH-----HHhCCcccCCCCcccC
Confidence            3456799999999998654    378999999999999999999999865433222221     11111  111222345


Q ss_pred             HHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 004312          715 LQRFVMVAIWCIQEDPSH--RPTMRRVTQM  742 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~--RPt~~evl~~  742 (762)
                      +..+.+++.+|++.++.+  ||+++|+++.
T Consensus       275 s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         275 SKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            678889999999855543  8899998875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.9e-36  Score=322.67  Aligned_cols=242  Identities=24%  Similarity=0.278  Sum_probs=194.2

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhh-hhcccccCCccchhceeccCCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVN-GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.||+|+||.||++... .+++.||+|++.+..   ......+..|.. +++.++||||+++++.+.+.+..++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHK-AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            36999999999999754 456789999987532   122334455544 5677899999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +++|.+++.....+.+.....++.||++||+|||+.   +|+||||||+|||+++++.+||+|||+++..... ......
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~  155 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTST  155 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccc
Confidence            999999998888888999999999999999999998   9999999999999999999999999999754322 222334


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.+...     .....  ..+...+..+.+++.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i-----~~~~~--~~~~~~~~~~~~li~  228 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI-----LNKPL--QLKPNITNSARHLLE  228 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHH-----HhCCc--CCCCCCCHHHHHHHH
Confidence            56999999999999999999999999999999999999998554333222211     11111  112345678899999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 004312          724 WCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       724 ~cl~~dp~~RPt~~evl~  741 (762)
                      +||+.+|.+||++.+.+.
T Consensus       229 ~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         229 GLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             HHcccCHHHCCCCCCCHH
Confidence            999999999998875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.7e-35  Score=309.01  Aligned_cols=251  Identities=26%  Similarity=0.370  Sum_probs=189.6

Q ss_pred             hcCCCCcceEEEeeeeCC-CcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCc
Q 004312          489 ELGRGAFGTVYKGFVNMG-SSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      +||+|+||.||+|....+ ....+++|.+.... ......|.+|+++++.++|+||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            589999999999976443 33568899876432 2334678999999999999999999999999999999999999999


Q ss_pred             hhhhccCCC-----CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc-c
Q 004312          567 LASFLFGDS-----KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-T  640 (762)
Q Consensus       567 L~~~l~~~~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-~  640 (762)
                      |.+++....     ..++.....++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++........ .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999997542     246788899999999999999998   9999999999999999999999999998754322211 1


Q ss_pred             cccccccCcccCcccccC-------CCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCH
Q 004312          641 NTAIRGTKGYVAPEWFRN-------MPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDM  712 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~-------~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (762)
                      .....+++.|+|||++..       ..++.++||||||+++|||++ |+.|+......+........... .......+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  237 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI-KLPKPQLDL  237 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc-cCCCCcccc
Confidence            122345678999998743       357889999999999999999 66665433222111111000000 000111223


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 004312          713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       713 ~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~  744 (762)
                      ..+..+.+++..|+ .||++|||++||++.|.
T Consensus       238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         238 KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            45567788888998 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.6e-36  Score=319.28  Aligned_cols=258  Identities=25%  Similarity=0.347  Sum_probs=202.8

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCC------CcceEEEEEccccc-cchhHHHHHHhhhhccc-ccCCccchhceeccCC
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMG------SSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGR  553 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  553 (762)
                      ..+.+.+.||+|+||.||++.....      ....+|+|.++... .....++.+|+++++++ +|+||+++++++.+..
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            3456678999999999999975321      12469999987532 33445788999999999 8999999999999999


Q ss_pred             ceeEEEeccCCCchhhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc
Q 004312          554 NRLLVYEFMSNGALASFLFGD----------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD  617 (762)
Q Consensus       554 ~~~LV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~  617 (762)
                      ..++||||+++|+|.+++...                ..+++.+++.++.|++.||+|||+.   +++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence            999999999999999999653                2478899999999999999999998   999999999999999


Q ss_pred             CCCceEEecccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhc
Q 004312          618 DYYNARISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQE  695 (762)
Q Consensus       618 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~  695 (762)
                      +++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......+... 
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~-  253 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-  253 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH-
Confidence            9999999999998765422211 1112234568999999998899999999999999999998 777764322211111 


Q ss_pred             cccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          696 RTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       696 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                           .+........+...+.++.+++.+||+.+|++||++.+|++.|+.+.+
T Consensus       254 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         254 -----LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             -----HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence                 111111112233456788999999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.1e-35  Score=314.58  Aligned_cols=259  Identities=22%  Similarity=0.298  Sum_probs=198.7

Q ss_pred             hhhhhhcCCCCcceEEEeeee---------------CCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhc
Q 004312          484 RGFKEELGRGAFGTVYKGFVN---------------MGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLG  547 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~---------------~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g  547 (762)
                      +.+.+.||+|+||.||++...               .++...+|+|+++... .....++.+|++++++++|+||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~   86 (296)
T cd05095           7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA   86 (296)
T ss_pred             ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            456678999999999998532               1223469999987542 334568999999999999999999999


Q ss_pred             eeccCCceeEEEeccCCCchhhhccCCC-----------CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE
Q 004312          548 YCDEGRNRLLVYEFMSNGALASFLFGDS-----------KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL  616 (762)
Q Consensus       548 ~~~~~~~~~LV~E~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl  616 (762)
                      ++...+..++||||+++++|.+++....           .+++.++..++.|++.||+|||+.   +++||||||+|||+
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili  163 (296)
T cd05095          87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV  163 (296)
T ss_pred             EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEE
Confidence            9999999999999999999999986532           367788999999999999999998   99999999999999


Q ss_pred             cCCCceEEecccccccccCCCCcc-cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh--CCCCCchhhHHHhh
Q 004312          617 DDYYNARISDFGLEKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC--LRRTILTDWAYDCY  693 (762)
Q Consensus       617 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt--g~~p~~~~~~~~~~  693 (762)
                      ++++.+||+|||+++.+....... .....++..|+|||....+.++.++||||||+++|||++  |..|+......+..
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~  243 (296)
T cd05095         164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI  243 (296)
T ss_pred             cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence            999999999999998654322211 112234678999999888899999999999999999998  56666332221111


Q ss_pred             hcc-ccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          694 QER-TLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       694 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      ... ..............+..++..+.+++.+||+.||++||+++||++.|++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         244 ENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            100 0000000000111123355788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.3e-35  Score=320.10  Aligned_cols=238  Identities=24%  Similarity=0.273  Sum_probs=191.6

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhh-hhcccccCCccchhceeccCCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVN-GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.||+|+||.||+++.. .+++.||+|++.+..   ......+.+|+. +++.++||||+++++.+.+.+..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRK-SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            36999999999999754 456789999986532   122344555554 5788999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +++|..++.....+.+..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++..... ......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~  155 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTST  155 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccc
Confidence            999999998878889999999999999999999998   9999999999999999999999999998753222 222334


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||...........     +....  ...+...+.++.+++.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-----i~~~~--~~~~~~~~~~~~~li~  228 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDN-----ILHKP--LQLPGGKTVAACDLLV  228 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHH-----HhcCC--CCCCCCCCHHHHHHHH
Confidence            5689999999999998999999999999999999999999855432222111     11111  1122234567899999


Q ss_pred             HhhccCCCCCCCHH
Q 004312          724 WCIQEDPSHRPTMR  737 (762)
Q Consensus       724 ~cl~~dp~~RPt~~  737 (762)
                      +||+.+|.+||+..
T Consensus       229 ~~l~~~p~~R~~~~  242 (321)
T cd05603         229 GLLHKDQRRRLGAK  242 (321)
T ss_pred             HHccCCHhhcCCCC
Confidence            99999999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.2e-35  Score=306.71  Aligned_cols=254  Identities=22%  Similarity=0.347  Sum_probs=204.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|++|.||+|... .+++.||+|.++..   .....+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICL-LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEc-CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            446678999999999999765 45678999988632   22335689999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          561 FMSNGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       561 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      |+++++|.+++..    ...+++..+..++.++++||.|||+.   +|+||||+|+||++++++.++|+|||+++.+...
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            9999999999853    34578999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHH-HhhhccccccccccccccCCCHHHH
Q 004312          637 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                      .. ......+++.|+|||.+.+..++.++||||||+++|+|++|+.|+...... ....+    ...............+
T Consensus       160 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  234 (267)
T cd08224         160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----KIEKCDYPPLPADHYS  234 (267)
T ss_pred             Cc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh----hhhcCCCCCCChhhcC
Confidence            22 122345888999999999889999999999999999999999997433210 00000    0001111111122556


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      ..+.+++.+||+.+|++||++.+|+++|+++
T Consensus       235 ~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         235 EELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            7899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.7e-35  Score=311.52  Aligned_cols=252  Identities=25%  Similarity=0.355  Sum_probs=201.5

Q ss_pred             hhhhcCCCCcceEEEeeeeC----CCcceEEEEEccccccc-hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          486 FKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      ..+.||+|+||.||+|+...    +..+.+++|.+...... ...++.+|++++++++|+||+++++++.+....++|||
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   88 (275)
T cd05046           9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE   88 (275)
T ss_pred             eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence            34679999999999998643    23467999988754333 45689999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCC---------CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          561 FMSNGALASFLFGDS---------KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~---------~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                      |+++++|.+++....         .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++|+|||+++
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~  165 (275)
T cd05046          89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK  165 (275)
T ss_pred             ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccccc
Confidence            999999999997654         689999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCC
Q 004312          632 LLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMD  710 (762)
Q Consensus       632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  710 (762)
                      ..............++..|+|||.+.+...+.++||||||+++|+|++ |..|+...........     ..........
T Consensus       166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~-----~~~~~~~~~~  240 (275)
T cd05046         166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR-----LQAGKLELPV  240 (275)
T ss_pred             ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH-----HHcCCcCCCC
Confidence            554333222333446778999999988889999999999999999999 6667632211111111     1111111112


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          711 DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       711 ~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      +...+..+.+++.+||+.+|++||++.|++++|.+
T Consensus       241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            23456789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.2e-35  Score=320.51  Aligned_cols=240  Identities=25%  Similarity=0.333  Sum_probs=195.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .+.+.||+|+||.||+|... .+++.||||++.+..   ......+..|..++..+ +|++|+++++++.+.+..++|||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           3 NFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             eEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            34578999999999999754 456799999987532   22234567788888777 68999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++..... ...
T Consensus        82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~~~  157 (323)
T cd05616          82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-GVT  157 (323)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC-CCc
Confidence            999999999998888899999999999999999999998   9999999999999999999999999998754322 122


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....||+.|+|||.+....++.++|||||||++|||++|+.||...........     +....  ...+...+.++.+
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~-----i~~~~--~~~p~~~s~~~~~  230 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS-----IMEHN--VAYPKSMSKEAVA  230 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH-----HHhCC--CCCCCcCCHHHHH
Confidence            3345689999999999999999999999999999999999999865433222221     11111  1123345678899


Q ss_pred             HHHHhhccCCCCCCCH
Q 004312          721 VAIWCIQEDPSHRPTM  736 (762)
Q Consensus       721 li~~cl~~dp~~RPt~  736 (762)
                      ++.+||+.+|++|++.
T Consensus       231 li~~~l~~~p~~R~~~  246 (323)
T cd05616         231 ICKGLMTKHPGKRLGC  246 (323)
T ss_pred             HHHHHcccCHHhcCCC
Confidence            9999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.3e-36  Score=329.85  Aligned_cols=248  Identities=22%  Similarity=0.270  Sum_probs=196.1

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.||+|+||.||+|... .+++.||+|++.+..   ......+.+|++++++++|+||+++++.+.+.+..+|||||+
T Consensus         5 ~~~~LG~G~~g~Vy~a~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~   83 (382)
T cd05625           5 KIKTLGIGAFGEVCLARKV-DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI   83 (382)
T ss_pred             EEEEEEeCCCEEEEEEEEC-CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence            4568999999999999754 456789999987532   223457889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC----
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS----  638 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~----  638 (762)
                      ++|+|.+++.+.+.+++.....++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++..+.....    
T Consensus        84 ~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          84 PGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            9999999998888889999999999999999999998   999999999999999999999999999753311000    


Q ss_pred             ------------------------------------------cccccccccCcccCcccccCCCCCCcchhHHHHHHHHH
Q 004312          639 ------------------------------------------HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLE  676 (762)
Q Consensus       639 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~e  676 (762)
                                                                .......||+.|+|||.+.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence                                                      00122468999999999999999999999999999999


Q ss_pred             HHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 004312          677 IICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPT---MRRVTQ  741 (762)
Q Consensus       677 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt---~~evl~  741 (762)
                      |++|+.||..............   .............++++.+++.+++ .+|.+|++   ++|+++
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~---~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         241 MLVGQPPFLAQTPLETQMKVIN---WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHc---cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            9999999865433222111100   0011111122335667788888876 49999987   777764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.8e-35  Score=308.82  Aligned_cols=251  Identities=26%  Similarity=0.416  Sum_probs=201.1

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      ..+.+.+.||+|+||.||++...  ....+|+|.+... ......+.+|++++++++|+||+++++++.+ ...+++|||
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~--~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cceeEEeEecCccceEEEEEEec--CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            34456788999999999999754  3356999988753 2345679999999999999999999999887 778999999


Q ss_pred             cCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          562 MSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       562 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      +++++|.+++.+.  ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            9999999999763  4678899999999999999999998   9999999999999999999999999999866433222


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      ......++..|+|||.+....++.++||||||+++|++++ |+.|+...........      +............+.++
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~  232 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA------LERGYRMPRPENCPEEL  232 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH------HhCCCCCCCcccCCHHH
Confidence            2223345678999999998899999999999999999999 7878743322111111      11111111223456789


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      .+++.+||+.+|++||++.+++++|+.
T Consensus       233 ~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         233 YNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.6e-36  Score=330.15  Aligned_cols=250  Identities=21%  Similarity=0.252  Sum_probs=198.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||+++.. .+++.||||++.+..   ......+.+|++++++++|+||+++++.+.+.+..++||||
T Consensus         4 ~~~~~lG~G~~g~V~~a~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (376)
T cd05598           4 VKIKTIGIGAFGEVCLVRKV-DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (376)
T ss_pred             eEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence            34578999999999999754 456799999986532   22345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC----
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ----  637 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~----  637 (762)
                      +++|+|.+++...+.+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+....    
T Consensus        83 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          83 IPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            99999999998888889999999999999999999998   99999999999999999999999999975331100    


Q ss_pred             --------------------------------------CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh
Q 004312          638 --------------------------------------SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC  679 (762)
Q Consensus       638 --------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt  679 (762)
                                                            ........||+.|+|||++.+..++.++|||||||++|||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~  239 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence                                                  000113469999999999999999999999999999999999


Q ss_pred             CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCC---CHHHHHHH
Q 004312          680 LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRP---TMRRVTQM  742 (762)
Q Consensus       680 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP---t~~evl~~  742 (762)
                      |+.||......+........   ............+.++.+++.+|+ .+|.+|+   ++.|+++.
T Consensus       240 G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         240 GQPPFLADTPAETQLKVINW---ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             CCCCCCCCCHHHHHHHHhcc---CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99998654333222111000   001111112234567788888876 4999999   88888854

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.2e-35  Score=311.35  Aligned_cols=245  Identities=25%  Similarity=0.337  Sum_probs=193.3

Q ss_pred             cCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCc
Q 004312          490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       490 iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      ||+|+||.||++... .+++.+|+|++....   ....+.+..|++++++++||||+++++.+.++...++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVK-NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEc-cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            799999999999754 456799999986422   1234456779999999999999999999999999999999999999


Q ss_pred             hhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccc
Q 004312          567 LASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI  644 (762)
Q Consensus       567 L~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  644 (762)
                      |.+++...  ..+++..+..++.||+.||+|||+.   +|+||||||+||++++++.+||+|||++.......  .....
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~  154 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR  154 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence            99988654  3588999999999999999999998   99999999999999999999999999988654322  22334


Q ss_pred             cccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHH
Q 004312          645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW  724 (762)
Q Consensus       645 ~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  724 (762)
                      .|++.|+|||++.+..++.++|||||||++|||++|+.|+....... ............... ......+.++.+++.+
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~  232 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLEDEVK-FEHQNFTEESKDICRL  232 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhccccc-cccccCCHHHHHHHHH
Confidence            68999999999999899999999999999999999999974321100 000001111111111 1112356788999999


Q ss_pred             hhccCCCCCCCHHHHHHH
Q 004312          725 CIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       725 cl~~dp~~RPt~~evl~~  742 (762)
                      ||+.||++||+++|+++.
T Consensus       233 ~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         233 FLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             HhccCHhhCCCCccchhh
Confidence            999999999999776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.1e-36  Score=317.79  Aligned_cols=249  Identities=22%  Similarity=0.326  Sum_probs=210.0

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccc--cccchhHHHHHHhhhhcccccCCccchhceeccCCc-eeEEE
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRN-RLLVY  559 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-~~LV~  559 (762)
                      .|...+.+|+|+||.++..+.+. +...+++|++.-  ......+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~-~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKS-DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhcc-CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            35567899999999999886543 456899998863  334445578999999999999999999999999988 89999


Q ss_pred             eccCCCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          560 EFMSNGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      +|++||+|.+.|...+  .++++.+.+++.||+.|+.|||++   .|+|||||+.||+++.+..+||+|||+|+.+..+.
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999997654  578999999999999999999988   99999999999999999999999999999987554


Q ss_pred             CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      . ......||+.||.||.+++.+|..|+|||||||++|||++-+.+|............. .     ....+.+...+.+
T Consensus       161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~-~-----~~~~Plp~~ys~e  233 (426)
T KOG0589|consen  161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN-R-----GLYSPLPSMYSSE  233 (426)
T ss_pred             h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh-h-----ccCCCCCccccHH
Confidence            2 3445679999999999999999999999999999999999999986654443333211 1     1123335567889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      +..++..|++.+|..||++.+++.+
T Consensus       234 l~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  234 LRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHHHHHHhhcCCccCCCHHHHhhC
Confidence            9999999999999999999999865

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-35  Score=309.66  Aligned_cols=242  Identities=22%  Similarity=0.365  Sum_probs=191.5

Q ss_pred             hhcCCCCcceEEEeeeeCCC------cceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          488 EELGRGAFGTVYKGFVNMGS------SDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.||+|+||.||+|......      ...+++|.+........+.+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            46999999999999764321      235888888765555567889999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc--------eEEeccccccc
Q 004312          562 MSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN--------ARISDFGLEKL  632 (762)
Q Consensus       562 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~kl~Dfgla~~  632 (762)
                      +++|+|.+++... ..+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.        ++++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999765 4689999999999999999999998   9999999999999987665        69999999875


Q ss_pred             ccCCCCcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCC
Q 004312          633 LTLDQSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD  711 (762)
Q Consensus       633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  711 (762)
                      ...     .....+++.|+|||.+.+. .++.++||||||+++|||++|..++.........     .......  ...+
T Consensus       158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-----~~~~~~~--~~~~  225 (258)
T cd05078         158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-----LQFYEDR--HQLP  225 (258)
T ss_pred             cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-----HHHHHcc--ccCC
Confidence            432     1234578899999999874 5899999999999999999996443221111100     0011111  1112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 004312          712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       712 ~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~  744 (762)
                      .....++.+++.+||+.+|++|||++++++.|+
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         226 APKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            233467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.8e-35  Score=312.13  Aligned_cols=253  Identities=24%  Similarity=0.374  Sum_probs=200.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC----CCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLV  558 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV  558 (762)
                      +.+.+.||+|+||.||++....    .+...||+|++.... ....+++.+|+.++++++||||+++++++.++...++|
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv   86 (288)
T cd05050           7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL   86 (288)
T ss_pred             ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence            3455789999999999997542    245689999987543 23356799999999999999999999999999999999


Q ss_pred             EeccCCCchhhhccCC----------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE
Q 004312          559 YEFMSNGALASFLFGD----------------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL  616 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~----------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl  616 (762)
                      +||+++++|.+++...                      ..+++..++.++.|++.||+|||+.   +++||||||+||++
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~  163 (288)
T cd05050          87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLV  163 (288)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEe
Confidence            9999999999998632                      2367888999999999999999998   99999999999999


Q ss_pred             cCCCceEEecccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhh
Q 004312          617 DDYYNARISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQ  694 (762)
Q Consensus       617 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~  694 (762)
                      ++++.+||+|||+++....... ........+..|+|||.+.+..++.++||||||+++|||++ |..|+......+...
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~  243 (288)
T cd05050         164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY  243 (288)
T ss_pred             cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999876533221 11122234668999999998899999999999999999997 777764332222111


Q ss_pred             ccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          695 ERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      .     +..... ...+...+.++.+++.+||+.+|++|||++|+++.|++
T Consensus       244 ~-----~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         244 Y-----VRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             H-----HhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            1     111111 11122356789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.5e-35  Score=305.01  Aligned_cols=239  Identities=26%  Similarity=0.421  Sum_probs=190.1

Q ss_pred             hhcCCCCcceEEEeeeeCCC---------cceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEE
Q 004312          488 EELGRGAFGTVYKGFVNMGS---------SDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLV  558 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV  558 (762)
                      +.||+|+||.||+|......         ...+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999876433         135788877654333 6789999999999999999999999988 778999


Q ss_pred             EeccCCCchhhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC-------ceEEeccccc
Q 004312          559 YEFMSNGALASFLFGDS-KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY-------NARISDFGLE  630 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-------~~kl~Dfgla  630 (762)
                      |||+++|+|.+++.... .+++..+..++.||+.||+|||++   +|+||||||+|||++.++       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999998765 789999999999999999999998   999999999999999887       7999999999


Q ss_pred             ccccCCCCcccccccccCcccCcccccCC--CCCCcchhHHHHHHHHHHHhC-CCCCchhhHHHhhhccccccccccccc
Q 004312          631 KLLTLDQSHTNTAIRGTKGYVAPEWFRNM--PITVKVDVYSYGVLLLEIICL-RRTILTDWAYDCYQERTLGALVENDLE  707 (762)
Q Consensus       631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DV~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~  707 (762)
                      .....     .....++..|+|||.+...  .++.++||||||+++|||++| ..|+..........     ........
T Consensus       156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-----~~~~~~~~  225 (259)
T cd05037         156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-----FYQDQHRL  225 (259)
T ss_pred             ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-----HHhcCCCC
Confidence            86543     1223466789999999876  789999999999999999995 55542221110000     00011101


Q ss_pred             cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 004312          708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       708 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~  744 (762)
                         +......+.+++.+||+.+|.+|||+.+|++.|+
T Consensus       226 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         226 ---PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ---CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               1111278899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-36  Score=320.71  Aligned_cols=243  Identities=26%  Similarity=0.339  Sum_probs=205.6

Q ss_pred             hcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCchh
Q 004312          489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALA  568 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~  568 (762)
                      +||+|.||+||-|+.. .+...+|||-+...+....+.+.+||.+.++|+|.|||+.+|.|.+++..-|.||.+|||+|.
T Consensus       582 VLGKGTYG~VYA~RD~-~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDM-DTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccc-cceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            5999999999999754 456789999998777777788999999999999999999999999999999999999999999


Q ss_pred             hhccCC-CCC--CHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc-CCCceEEecccccccccCCCCcccccc
Q 004312          569 SFLFGD-SKP--NWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI  644 (762)
Q Consensus       569 ~~l~~~-~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~  644 (762)
                      ++|... +++  ++.++..+..||++||.|||++   .|||||||-+||||+ =.|.+||+|||-++.+.. -......+
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF  736 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF  736 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence            999875 666  7888999999999999999999   999999999999997 478999999999987642 23444556


Q ss_pred             cccCcccCcccccCC--CCCCcchhHHHHHHHHHHHhCCCCCchh-hHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          645 RGTKGYVAPEWFRNM--PITVKVDVYSYGVLLLEIICLRRTILTD-WAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       645 ~gt~~y~aPE~~~~~--~~s~~~DV~S~Gvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      -||..|||||++..+  .|..++|||||||.+.||.||+.||..- .+...+-.     .-.-...+..+.+.+.++..+
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk-----VGmyKvHP~iPeelsaeak~F  811 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK-----VGMYKVHPPIPEELSAEAKNF  811 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh-----hcceecCCCCcHHHHHHHHHH
Confidence            799999999999876  5889999999999999999999998321 11111110     011122445677889999999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 004312          722 AIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~  741 (762)
                      |.+|+.++|.+||+++++++
T Consensus       812 ilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  812 ILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHcCCCcccCccHHHhcc
Confidence            99999999999999999885

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.1e-35  Score=335.12  Aligned_cols=250  Identities=23%  Similarity=0.295  Sum_probs=200.5

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccCC-------
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR-------  553 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-------  553 (762)
                      .+.+.+.||+|+||+||+++.. .+++.||||++...  .......+.+|+..+..++|+||++++..+...+       
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRV-SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEc-CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            3556788999999999999754 45679999998643  2334467889999999999999999887764332       


Q ss_pred             -ceeEEEeccCCCchhhhccCC----CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccc
Q 004312          554 -NRLLVYEFMSNGALASFLFGD----SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFG  628 (762)
Q Consensus       554 -~~~LV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  628 (762)
                       ..++||||+++|+|.++|...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence             357999999999999998643    4688999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccc
Q 004312          629 LEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE  707 (762)
Q Consensus       629 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  707 (762)
                      +++.+..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.....     .... .
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~-----~~~~-~  262 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT-----LAGR-Y  262 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----hcCC-C
Confidence            9987643322 2234467999999999999999999999999999999999999998544322222211     1111 1


Q ss_pred             cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       708 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ...+...++++.+++.+||+.+|++||++.++++.
T Consensus       263 ~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        263 DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            11233456789999999999999999999999763

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-35  Score=303.61  Aligned_cols=247  Identities=25%  Similarity=0.380  Sum_probs=198.6

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccc-hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCc
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      ++||+|++|.||++....  ++.|++|++...... ....+.+|++++++++|+||+++++++.+....++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~--~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG--NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC--CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            368999999999998653  678999998764433 45689999999999999999999999999999999999999999


Q ss_pred             hhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc-ccc
Q 004312          567 LASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN-TAI  644 (762)
Q Consensus       567 L~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~-~~~  644 (762)
                      |.+++... ..+++..+..++.+++.||+|||++   +++||||||+||++++++.+||+|||++........... ...
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            99999654 5678999999999999999999998   999999999999999999999999999986542221111 122


Q ss_pred             cccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       645 ~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..+..|+|||.+.++.++.++||||||+++|||++ |..|+..........      .+........+...+.++.+++.
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~  229 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE------RIESGYRMPAPQLCPEEIYRLML  229 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH------HHhcCCCCCCCccCCHHHHHHHH
Confidence            34567999999998899999999999999999999 666653322111111      11111111123345678999999


Q ss_pred             HhhccCCCCCCCHHHHHHHhhc
Q 004312          724 WCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       724 ~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      +||+.+|++||+++|+++.|+.
T Consensus       230 ~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         230 QCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             HHhccChhhCcCHHHHHHHhhC
Confidence            9999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.5e-35  Score=294.44  Aligned_cols=261  Identities=22%  Similarity=0.239  Sum_probs=201.5

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceec--cCCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCD--EGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~LV~E~~~  563 (762)
                      +.|++|.||.||+|+. ..+++.||+|+++-..+  .-.-.-.+||.+|.+.+|||||.+-....  +-+..|||||||+
T Consensus        82 nrI~EGtyGiVYRakd-k~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E  160 (419)
T KOG0663|consen   82 NRIEEGTYGVVYRAKD-KKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE  160 (419)
T ss_pred             hhcccCcceeEEEecc-CCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence            5799999999999975 45678999999974321  11235689999999999999999988764  4457999999997


Q ss_pred             CCchhhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFGDS-KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      . +|.+.+...+ ++...+..-+..|+++|++|||+.   .|+||||||+|+|+.+.|.+||+|||+||.+... ....+
T Consensus       161 h-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~T  235 (419)
T KOG0663|consen  161 H-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKPYT  235 (419)
T ss_pred             h-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC-cccCc
Confidence            7 8999998765 889999999999999999999999   9999999999999999999999999999988654 34456


Q ss_pred             cccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------ccc------------
Q 004312          643 AIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------TLG------------  699 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~~~------------  699 (762)
                      ..+-|..|.|||.+.+. .|+.+.|+||+|||+.|+++++.-|.+....+.....          ...            
T Consensus       236 ~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~  315 (419)
T KOG0663|consen  236 PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMT  315 (419)
T ss_pred             ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccc
Confidence            66789999999998775 6999999999999999999988765433222211110          000            


Q ss_pred             --cccccccccCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCCCCCCC
Q 004312          700 --ALVENDLEAMDDMT-VLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCP  755 (762)
Q Consensus       700 --~~~~~~~~~~~~~~-~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~p~~p  755 (762)
                        ...-+.++...... ..+.-.+|+..+|..||.+|.|++|.++. .=..+.|.|..|
T Consensus       316 f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h-~~F~e~P~p~~P  373 (419)
T KOG0663|consen  316 FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH-EYFRETPLPIDP  373 (419)
T ss_pred             cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc-cccccCCCCCCh
Confidence              00001111111111 45778899999999999999999977652 115666666666

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.1e-35  Score=306.20  Aligned_cols=245  Identities=27%  Similarity=0.374  Sum_probs=196.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceec-cCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCD-EGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||.||++...   +..+|+|.++..  ...+.+.+|+.++++++|+|++++++++. ++...++|+||+
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~---~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           8 LKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             CeeeeeecccCCCeEEEEEEc---CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            345678999999999999654   467999988643  23567999999999999999999999764 556789999999


Q ss_pred             CCCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          563 SNGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       563 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      ++++|.+++....  .+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||+++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            9999999997643  478999999999999999999998   99999999999999999999999999987543221   


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                       ....++..|+|||.+....++.++||||||+++|||++ |+.|+...........      +........+...+..+.
T Consensus       157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~  229 (256)
T cd05082         157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR------VEKGYKMDAPDGCPPVVY  229 (256)
T ss_pred             -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------HhcCCCCCCCCCCCHHHH
Confidence             12234568999999998899999999999999999998 8888643221111111      111111112234567889


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      +++.+||+.+|++|||++++++.|+.+
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.1e-35  Score=318.57  Aligned_cols=240  Identities=25%  Similarity=0.341  Sum_probs=195.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccc-cCCccchhceeccCCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      ++.+.||+|+||.||++... .+++.||+|++.+..   ....+.+..|++++..+. |++|+++++++.+.+..++|||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             eEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            45678999999999999754 456789999987532   233456788888888874 6778889999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus        82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~  157 (323)
T cd05615          82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT  157 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence            999999999998888899999999999999999999998   99999999999999999999999999987543221 22


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...........     +.....  ..+...+.++.+
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~-----i~~~~~--~~p~~~~~~~~~  230 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS-----IMEHNV--SYPKSLSKEAVS  230 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhCCC--CCCccCCHHHHH
Confidence            3345689999999999999999999999999999999999999865433222211     111111  122335677899


Q ss_pred             HHHHhhccCCCCCCCH
Q 004312          721 VAIWCIQEDPSHRPTM  736 (762)
Q Consensus       721 li~~cl~~dp~~RPt~  736 (762)
                      ++.+||+.+|.+|++.
T Consensus       231 li~~~l~~~p~~R~~~  246 (323)
T cd05615         231 ICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHHHHcccCHhhCCCC
Confidence            9999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.5e-35  Score=309.34  Aligned_cols=256  Identities=23%  Similarity=0.290  Sum_probs=204.8

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      ..+.+.+.||+|++|+||++... .+++.||+|++.... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHI-PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEc-CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            44566789999999999999754 345789999876543 3345789999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++++|.+++...+.+++.....++.+++.||.|||+.  .+++||||+|+||++++++.++|+|||++......   .
T Consensus        84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---~  158 (284)
T cd06620          84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---I  158 (284)
T ss_pred             cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---c
Confidence            999999999998878899999999999999999999973  27999999999999999999999999998754321   1


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhh--c----cccccccccccccCCCHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ--E----RTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~~  714 (762)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..........  .    .....+.............
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF  238 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhc
Confidence            223468999999999988899999999999999999999999985432210000  0    0111111111111112235


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 004312          715 LQRFVMVAIWCIQEDPSHRPTMRRVTQML  743 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RPt~~evl~~L  743 (762)
                      +.++.+++.+||+.||++|||++|++++.
T Consensus       239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         239 PEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            67899999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.2e-35  Score=324.23  Aligned_cols=252  Identities=21%  Similarity=0.260  Sum_probs=198.7

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      .+.+.+.||+|+||.||++... .+++.+|+|++.+..   ....+.+.+|+.+++.++||||+++++.+.++...++||
T Consensus        44 ~y~i~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          44 DYEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hcEEEEEEeecCCeEEEEEEEC-CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            3445678999999999999754 456789999986422   223456789999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      ||+++|+|.+++... .++...+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++........
T Consensus       123 Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         123 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence            999999999998654 578888999999999999999998   9999999999999999999999999999876543333


Q ss_pred             ccccccccCcccCcccccCC----CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNM----PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~----~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                      ......||+.|+|||.+...    .++.++|||||||++|||++|+.||........+......   ............+
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~s  275 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH---KNSLTFPDDNDIS  275 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC---CCcccCCCcCCCC
Confidence            33456799999999998654    3789999999999999999999998654332222211100   0011111223457


Q ss_pred             HHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 004312          716 QRFVMVAIWCIQEDPSH--RPTMRRVTQM  742 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~--RPt~~evl~~  742 (762)
                      ..+.+++.+||+.++.+  ||+++|+++.
T Consensus       276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         276 KEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            78899999999844433  7899998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.5e-35  Score=312.02  Aligned_cols=247  Identities=24%  Similarity=0.335  Sum_probs=202.2

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      .+.+.||+|++|.||+|.. ..+++.|++|.+..........+.+|+.++++++|+||+++++.+..+...++||||+++
T Consensus        23 ~~~~~lg~g~~~~v~~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~  101 (296)
T cd06654          23 TRFEKIGQGASGTVYTAMD-VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (296)
T ss_pred             eeEEEecCCCCeEEEEEEE-CCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence            3456799999999999964 345678999998765555667899999999999999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccc
Q 004312          565 GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI  644 (762)
Q Consensus       565 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  644 (762)
                      ++|.+++.. ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++........ .....
T Consensus       102 ~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~  176 (296)
T cd06654         102 GSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM  176 (296)
T ss_pred             CCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCcc
Confidence            999999864 4578999999999999999999998   999999999999999999999999999876543221 12234


Q ss_pred             cccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHH
Q 004312          645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW  724 (762)
Q Consensus       645 ~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  724 (762)
                      .+++.|+|||.+.+..++.++||||||+++|+|++|+.||.............    .........+...+..+.+++.+
T Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~  252 (296)
T cd06654         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA----TNGTPELQNPEKLSAIFRDFLNR  252 (296)
T ss_pred             cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh----cCCCCCCCCccccCHHHHHHHHH
Confidence            58899999999998889999999999999999999999985543322111110    01111111233456778999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 004312          725 CIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       725 cl~~dp~~RPt~~evl~  741 (762)
                      ||..+|++||+++++++
T Consensus       253 ~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         253 CLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             HCcCCcccCcCHHHHhh
Confidence            99999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-35  Score=308.73  Aligned_cols=249  Identities=26%  Similarity=0.401  Sum_probs=201.3

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhH--HHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|+||+||+++.. .+++.+|+|++.........  ...+|+.++++++||||+++++++.+....++||||+
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    2 RLVKKLGSGGFGTVYKAKNK-KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEESSEEEEEEEET-TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             EEeEEEEeCCCEEEEEEEEC-CCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            35678999999999999754 45668999999865443332  3456999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ++++|.+++.....+++..+..++.||++||++||+.   +|+|+||||+||++++++.++|+|||.+... ........
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~~~  156 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNENFN  156 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSEBS
T ss_pred             ccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccccccc
Confidence            9999999998778899999999999999999999999   9999999999999999999999999999764 22233344


Q ss_pred             cccccCcccCccccc-CCCCCCcchhHHHHHHHHHHHhCCCCCchh---hHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFR-NMPITVKVDVYSYGVLLLEIICLRRTILTD---WAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~-~~~~s~~~DV~S~Gvil~elltg~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      ...++..|+|||.+. +...+.++||||+|+++|+|++|+.|+...   ....................   .......+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l  233 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ---SREKSEEL  233 (260)
T ss_dssp             SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS---HTTSHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc---cchhHHHH
Confidence            566899999999998 888999999999999999999999997554   11111111111111111000   11113789


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+++.+||+.||++||+++++++
T Consensus       234 ~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  234 RDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             HHHHHHHccCChhHCcCHHHHhc
Confidence            99999999999999999999986

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=8.8e-35  Score=306.52  Aligned_cols=248  Identities=25%  Similarity=0.380  Sum_probs=201.0

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+...+.||+|+||.||+|... .+++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDN-RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEc-CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            3445678999999999999754 345789999887432 33446789999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++++|.+++.. ..+++..+..++.|+++||.|||++   +++|+||+|+||++++++.+||+|||++....... ...
T Consensus        84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~  158 (277)
T cd06642          84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR  158 (277)
T ss_pred             cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc-hhh
Confidence            999999999864 5688999999999999999999998   99999999999999999999999999998654322 122


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.|+..........      .+............+..+.++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l  232 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF------LIPKNSPPTLEGQYSKPFKEF  232 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh------hhhcCCCCCCCcccCHHHHHH
Confidence            23457889999999999899999999999999999999999974332211111      111111111223456778999


Q ss_pred             HHHhhccCCCCCCCHHHHHHH
Q 004312          722 AIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~  742 (762)
                      +.+||+.+|++||++.++++.
T Consensus       233 i~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         233 VEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             HHHHccCCcccCcCHHHHHHh
Confidence            999999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3e-35  Score=316.13  Aligned_cols=255  Identities=24%  Similarity=0.353  Sum_probs=200.4

Q ss_pred             hhhhhhcCCCCcceEEEeeee------CCCcceEEEEEccccc-cchhHHHHHHhhhhccc-ccCCccchhceeccCCce
Q 004312          484 RGFKEELGRGAFGTVYKGFVN------MGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~------~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  555 (762)
                      ..+.+.||+|+||.||++...      ......+|+|+++... .....++.+|+++++++ +||||+++++++.+....
T Consensus        14 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   93 (314)
T cd05099          14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPL   93 (314)
T ss_pred             eeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCce
Confidence            345678999999999998642      1223469999987542 23345788999999999 699999999999999999


Q ss_pred             eEEEeccCCCchhhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC
Q 004312          556 LLVYEFMSNGALASFLFGD----------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY  619 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~  619 (762)
                      ++||||+++|+|.+++...                ..+++.++..++.||+.||.|||+.   +|+||||||+|||++++
T Consensus        94 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~  170 (314)
T cd05099          94 YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTED  170 (314)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCC
Confidence            9999999999999998643                3478899999999999999999998   99999999999999999


Q ss_pred             CceEEecccccccccCCCCcc-cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccc
Q 004312          620 YNARISDFGLEKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERT  697 (762)
Q Consensus       620 ~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~  697 (762)
                      +.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+....  
T Consensus       171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~--  248 (314)
T cd05099         171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL--  248 (314)
T ss_pred             CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH--
Confidence            999999999998664322211 112234567999999998899999999999999999999 7777643322111111  


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       698 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                          +........+..++.++.+++.+||+.+|++||++.|+++.|+++.
T Consensus       249 ----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         249 ----LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             ----HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence                1111111122344668889999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8.5e-35  Score=305.23  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=187.9

Q ss_pred             hcCCCCcceEEEeeeeCCC-cceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCc
Q 004312          489 ELGRGAFGTVYKGFVNMGS-SDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      +||+|+||.||+|....+. ...+++|.+.... ....+.|.+|+.++++++||||+++++.|.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            5999999999999764432 3456777766433 2345689999999999999999999999999999999999999999


Q ss_pred             hhhhccCC----CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC-Cccc
Q 004312          567 LASFLFGD----SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ-SHTN  641 (762)
Q Consensus       567 L~~~l~~~----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-~~~~  641 (762)
                      |.+++.+.    ....+..+..++.||++||+|||+.   +++||||||+|||++.++.+||+|||++....... ....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999754    3456777889999999999999998   99999999999999999999999999986432111 1122


Q ss_pred             ccccccCcccCcccccC-------CCCCCcchhHHHHHHHHHHHhCC-CCCchhhHHHhhhc---cccccccccccccCC
Q 004312          642 TAIRGTKGYVAPEWFRN-------MPITVKVDVYSYGVLLLEIICLR-RTILTDWAYDCYQE---RTLGALVENDLEAMD  710 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~-------~~~s~~~DV~S~Gvil~elltg~-~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~  710 (762)
                      ....++..|+|||++..       ..++.++||||||+++|||+++. .|+......+.+..   .......++..    
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----  234 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL----  234 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc----
Confidence            23457889999999753       24578999999999999999754 45532222111111   11111111111    


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 004312          711 DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       711 ~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~  744 (762)
                      .....+++.+++..|| .+|++||+++||+++|.
T Consensus       235 ~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         235 ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1224567888999999 57999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.5e-35  Score=306.77  Aligned_cols=246  Identities=25%  Similarity=0.366  Sum_probs=200.5

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc---------hhHHHHHHhhhhcccccCCccchhceeccCCcee
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD---------SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRL  556 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  556 (762)
                      +...||+|++|.||+|... .+++.+|+|.+......         ..+.+.+|+.++++++||||+++++++.+....+
T Consensus         4 ~~~~ig~g~~~~v~~a~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (267)
T cd06628           4 KGALIGSGSFGSVYLGMNA-SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN   82 (267)
T ss_pred             ccceeecCCCeEEEEEEec-CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence            4568999999999999754 34678999988643222         1246889999999999999999999999999999


Q ss_pred             EEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      +|+||+++++|.+++.....+++..+..++.|++.||+|||+.   +++||||+|+||++++++.+||+|||+++.....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          83 IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             EEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            9999999999999998888889999999999999999999998   9999999999999999999999999999876532


Q ss_pred             CCc-----ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCC
Q 004312          637 QSH-----TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD  711 (762)
Q Consensus       637 ~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  711 (762)
                      ...     ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........     ... ......+
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~-~~~~~~~  233 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK-----IGE-NASPEIP  233 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHH-----Hhc-cCCCcCC
Confidence            211     11234578899999999998999999999999999999999999754322111111     000 1111223


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       712 ~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ...++.+.+++.+||+.+|++||++.||++
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         234 SNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            345678899999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.6e-35  Score=307.87  Aligned_cols=248  Identities=28%  Similarity=0.417  Sum_probs=198.0

Q ss_pred             hcCCCCcceEEEeeeeCC-----CcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          489 ELGRGAFGTVYKGFVNMG-----SSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .||+|+||.||+|+....     .++.+|||.+.... .....++.+|+.++++++||||+++++++......++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            589999999999976431     22579999886543 234568999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC-------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC-----ceEEeccccc
Q 004312          563 SNGALASFLFGD-------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY-----NARISDFGLE  630 (762)
Q Consensus       563 ~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-----~~kl~Dfgla  630 (762)
                      ++++|.+++...       ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.+.     .+||+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999642       3478899999999999999999998   999999999999999877     8999999998


Q ss_pred             ccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcccccccccccccc
Q 004312          631 KLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEA  708 (762)
Q Consensus       631 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  708 (762)
                      +....... .......++..|+|||.+.++.++.++||||||+++|||++ |+.|+......+...      .+......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~------~~~~~~~~  232 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ------HVTAGGRL  232 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHH------HHhcCCcc
Confidence            76543221 11122345678999999999999999999999999999998 888874332221111      11111111


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          709 MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       709 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      ..+...+..+.+++.+||+.+|++||++++|+++|++
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         233 QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            2233456788999999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.6e-35  Score=309.11  Aligned_cols=246  Identities=24%  Similarity=0.359  Sum_probs=195.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc-ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .+.+.||+|+||.||+|... .+++.||+|++... ......++.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   82 (279)
T cd06619           4 QYQEILGHGNGGTVYKAYHL-LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD   82 (279)
T ss_pred             hheeeeccCCCeEEEEEEEc-CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence            34578999999999999754 45678999998653 23345679999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +++|..+.    .+++..+..++.|++.||+|||+.   +|+|+||||+|||++.++.+||+|||++......   ....
T Consensus        83 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~  152 (279)
T cd06619          83 GGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKT  152 (279)
T ss_pred             CCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cccC
Confidence            99997653    467888999999999999999998   9999999999999999999999999999765322   2233


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhh--hccccccccccccccCCCHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCY--QERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.||.........  .....................+.++.++
T Consensus       153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  232 (279)
T cd06619         153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF  232 (279)
T ss_pred             CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence            56899999999999989999999999999999999999997432111000  0000011111111111122345678999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 004312          722 AIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~  741 (762)
                      +.+||+.+|++||+++|+++
T Consensus       233 i~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         233 ITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             HHHHhhCChhhCCCHHHHhc
Confidence            99999999999999999987

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.8e-35  Score=303.93  Aligned_cols=248  Identities=25%  Similarity=0.427  Sum_probs=199.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      .+.+.||+|+||.||++....  ++.+|+|++.... ....+|.+|++++++++||||+++++++......++||||+++
T Consensus         7 ~~~~~ig~g~~g~v~~~~~~~--~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           7 TLVQEIGSGQFGLVWLGYWLE--KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             EEEeeecCcccceEEEEEEeC--CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            455789999999999997653  4579999987542 3346799999999999999999999999999999999999999


Q ss_pred             CchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          565 GALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       565 gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      ++|.+++... ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++............
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05112          84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG  160 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence            9999999764 5689999999999999999999998   99999999999999999999999999988654332222222


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ..++.+|+|||.+.++.++.++||||||+++|||++ |+.|+............      ........+...++++.+++
T Consensus       161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~  234 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI------NAGFRLYKPRLASQSVYELM  234 (256)
T ss_pred             CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH------hCCCCCCCCCCCCHHHHHHH
Confidence            335678999999998899999999999999999998 88887433222211111      00011111222457899999


Q ss_pred             HHhhccCCCCCCCHHHHHHHhh
Q 004312          723 IWCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       723 ~~cl~~dp~~RPt~~evl~~L~  744 (762)
                      .+||+.+|++||+++|++++|.
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         235 QHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             HHHcccChhhCCCHHHHHHhhC
Confidence            9999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1e-34  Score=306.83  Aligned_cols=250  Identities=23%  Similarity=0.303  Sum_probs=200.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+|... .++..+++|.+........+.+.+|+++++.++||||+++++.+......++|+||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNK-ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEEC-CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            445678999999999999754 4466889999876555556789999999999999999999999999999999999999


Q ss_pred             CCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      +++|..++.+ ...+++..+..++.|+++||.|||+.   +++||||||+||+++.++.+||+|||++....... ....
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~  161 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD  161 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence            9999998865 45789999999999999999999998   99999999999999999999999999987653221 2223


Q ss_pred             cccccCcccCccccc-----CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          643 AIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      ...+++.|+|||.+.     +..++.++|||||||++|||++|+.|+...............  ...  ....+...+.+
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~  237 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP--TLAQPSRWSSE  237 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc--CCC--CCCCccccCHH
Confidence            356889999999984     446788999999999999999999997443222221111000  000  11112335678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      +.+++.+||+.+|.+||+++++++.
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         238 FKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcC
Confidence            9999999999999999999998763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.7e-35  Score=303.80  Aligned_cols=249  Identities=30%  Similarity=0.439  Sum_probs=202.2

Q ss_pred             hhhhcCCCCcceEEEeeeeCCC---cceEEEEEccccccc-hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          486 FKEELGRGAFGTVYKGFVNMGS---SDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.+.||+|+||.||+++.....   ...||+|++...... ..+.+.+|++.+.+++|+||+++++++.+.+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            4578999999999999876432   478999999765433 567899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCC--CCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          562 MSNGALASFLFGDSK--PNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      +++++|.+++.....  +++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            999999999976544  89999999999999999999999   9999999999999999999999999999876544222


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      ......+++.|+|||.+....++.++||||||+++++|++ |+.|+............      ........+...+.++
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~  233 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYL------KKGYRLPKPENCPPEI  233 (258)
T ss_pred             ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------hcCCCCCCCCcCCHHH
Confidence            2222336789999999988889999999999999999998 66665432222211111      1111111222356789


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHh
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQML  743 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~~L  743 (762)
                      .+++.+|+..+|++|||++|++++|
T Consensus       234 ~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      234 YKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHHHHHHCcCChhhCcCHHHHHhhC
Confidence            9999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4e-35  Score=307.50  Aligned_cols=245  Identities=23%  Similarity=0.292  Sum_probs=196.4

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCch
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGAL  567 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL  567 (762)
                      ..||+|+||.||+|... .+++.|++|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|
T Consensus        14 ~~lg~g~~g~v~~~~~~-~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   92 (268)
T cd06624          14 VVLGKGTYGIVYAARDL-STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL   92 (268)
T ss_pred             EEEecCCceEEEEeEec-CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence            46999999999999754 34678999998876666677899999999999999999999999999999999999999999


Q ss_pred             hhhccCC-CCC--CHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC-CCceEEecccccccccCCCCccccc
Q 004312          568 ASFLFGD-SKP--NWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD-YYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       568 ~~~l~~~-~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      .+++... ..+  ++..+..++.||+.||+|||+.   +|+||||||+||+++. ++.+||+|||++....... .....
T Consensus        93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~  168 (268)
T cd06624          93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTET  168 (268)
T ss_pred             HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-Ccccc
Confidence            9999764 445  7888899999999999999998   9999999999999986 6799999999987653222 12223


Q ss_pred             ccccCcccCcccccCC--CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNM--PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~--~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ..+++.|+|||.+...  .++.++||||||+++|+|++|+.|+.........    .............+....+++.++
T Consensus       169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l  244 (268)
T cd06624         169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA----MFKVGMFKIHPEIPESLSAEAKNF  244 (268)
T ss_pred             CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh----HhhhhhhccCCCCCcccCHHHHHH
Confidence            4578999999998664  3789999999999999999999997432110000    000000011112233456789999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 004312          722 AIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~  741 (762)
                      +.+||+.+|++|||++|+++
T Consensus       245 i~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         245 ILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             HHHHcCCCchhCCCHHHHHh
Confidence            99999999999999999987

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.6e-35  Score=312.58  Aligned_cols=252  Identities=23%  Similarity=0.321  Sum_probs=199.1

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .+.+.||+|+||.||++... .+++.+|+|.++... .....++.+|++++.+++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~lg~G~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~   82 (308)
T cd06615           4 EKLGELGAGNGGVVTKVLHR-PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD   82 (308)
T ss_pred             eEEeeccCCCCeEEEEEEEc-CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence            34578999999999999754 456789999886532 2334578899999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +++|.+++.....+++..+..++.|+++||.|||+.  .+++|+||||+|||+++++.+||+|||++......   ....
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~  157 (308)
T cd06615          83 GGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS  157 (308)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc---cccc
Confidence            999999998888899999999999999999999973  28999999999999999999999999998755322   1233


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhh--cccccccc-------------------
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ--ERTLGALV-------------------  702 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~--~~~~~~~~-------------------  702 (762)
                      ..+++.|+|||.+.+..++.++||||||+++|+|++|+.|+..........  ........                   
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM  237 (308)
T ss_pred             CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence            468899999999988889999999999999999999999974332111100  00000000                   


Q ss_pred             ----------ccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          703 ----------ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       703 ----------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                                ............+.++.+++.+||+.+|++||+++||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      0000000011245678999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.4e-36  Score=321.22  Aligned_cols=245  Identities=26%  Similarity=0.403  Sum_probs=194.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEE--Eccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCc--eeEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRN--RLLV  558 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK--~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~--~~LV  558 (762)
                      .|.++||+|+|-+||||.. ..++.+||=-  ++.+..  ....+.|..|+++|+.|+|||||+++....+...  ..+|
T Consensus        43 k~~evLGrGafKtVYka~D-e~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFD-EEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             ehhhhcccccceeeeeccc-cccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            3567899999999999965 4455555522  222222  2334789999999999999999999998876655  7799


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc-CCCceEEecccccccccCCC
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~~~  637 (762)
                      +|.|..|+|..|+++.++.+.+.+..|++||++||.|||++ .|+|||||||.+||+|+ ..|.|||+|+|||.++....
T Consensus       122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            99999999999999999999999999999999999999997 78999999999999998 56899999999999875332


Q ss_pred             CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchh-hHHHhhhccccccccccccccCCCHHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTD-WAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      .   ..+.|||.|||||+.. ..|.+..||||||+.++||+|+..|+..= .+...+.. ....+....+....    ..
T Consensus       201 a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKK-V~SGiKP~sl~kV~----dP  271 (632)
T KOG0584|consen  201 A---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKK-VTSGIKPAALSKVK----DP  271 (632)
T ss_pred             c---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHH-HHcCCCHHHhhccC----CH
Confidence            2   2377999999999997 78999999999999999999999996321 11122211 11111111111111    35


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++++|.+||.. .++|||+.|+++
T Consensus       272 evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  272 EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHHHHHHHhcC-chhccCHHHHhh
Confidence            789999999999 999999999985

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=8.5e-35  Score=305.12  Aligned_cols=252  Identities=27%  Similarity=0.394  Sum_probs=200.6

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc----------ccchhHHHHHHhhhhcc-cccCCccchhceeccCC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV----------FQDSEKEFKAEVNGIGQ-THHKNLVRLLGYCDEGR  553 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~  553 (762)
                      .+.+.||+|+||.||+|......++.+|+|.+...          ......++.+|+.++.+ ++||||+++++++.+.+
T Consensus         3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   82 (269)
T cd08528           3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND   82 (269)
T ss_pred             hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence            45678999999999999877645678999987532          12223457788888865 79999999999999999


Q ss_pred             ceeEEEeccCCCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccc
Q 004312          554 NRLLVYEFMSNGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL  629 (762)
Q Consensus       554 ~~~LV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl  629 (762)
                      ..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.  .+++|+||+|+||++++++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccc
Confidence            99999999999999988742    35688999999999999999999963  2899999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccC
Q 004312          630 EKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM  709 (762)
Q Consensus       630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  709 (762)
                      +.......  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..........     ..........
T Consensus       161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~  233 (269)
T cd08528         161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT-----KIVEAVYEPL  233 (269)
T ss_pred             eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH-----HHhhccCCcC
Confidence            98765432  3344568899999999998889999999999999999999999974432211111     1111111111


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          710 DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       710 ~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      .....+..+.+++.+||+.||++||++.||.++++.
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            122345788999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.8e-35  Score=317.39  Aligned_cols=261  Identities=25%  Similarity=0.341  Sum_probs=204.1

Q ss_pred             HHHHHhhhhhhcCCCCcceEEEeeeeCC------CcceEEEEEccccc-cchhHHHHHHhhhhccc-ccCCccchhceec
Q 004312          479 LVEVTRGFKEELGRGAFGTVYKGFVNMG------SSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCD  550 (762)
Q Consensus       479 l~~~t~~~~~~iG~G~~g~Vy~g~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~  550 (762)
                      +....+.+.+.||+|+||.||++.....      ....||+|.++... ....+++.+|++++.++ +||||+++++++.
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            3344566778999999999999964321      12368999887532 23356899999999999 8999999999999


Q ss_pred             cCCceeEEEeccCCCchhhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCce
Q 004312          551 EGRNRLLVYEFMSNGALASFLFGD----------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNI  614 (762)
Q Consensus       551 ~~~~~~LV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  614 (762)
                      +....++++||+++|+|.+++...                ..+++.++..++.||+.||+|||+.   +|+||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  165 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV  165 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence            999999999999999999998642                2478899999999999999999998   999999999999


Q ss_pred             EEcCCCceEEecccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHh
Q 004312          615 LLDDYYNARISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDC  692 (762)
Q Consensus       615 Ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~  692 (762)
                      |+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+.
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  245 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  245 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            9999999999999999865432211 1122334568999999999999999999999999999998 7777643221111


Q ss_pred             hhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          693 YQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ...      +........+...+.++.+++.+||+.+|++||++.|+++.|+++..
T Consensus       246 ~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         246 FKL------LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHH------HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            111      11111111223445688999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=300.86  Aligned_cols=251  Identities=24%  Similarity=0.293  Sum_probs=199.2

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceecc-----CCceeEEE
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-----GRNRLLVY  559 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-----~~~~~LV~  559 (762)
                      .+.||+|++|.|..+... .+++.||||++...  .....++..+|+++|+.++|+||+.+++.+..     -...|+|+
T Consensus        27 ~~~iG~GAyGvVcsA~~~-~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~  105 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDK-RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF  105 (359)
T ss_pred             cccccCcceeeEEEEEEc-CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence            367999999999999754 56689999999843  33445788999999999999999999998754     45789999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC-C
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ-S  638 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-~  638 (762)
                      |+| ..+|...++.+..++......++.||++||.|+|+.   +|+||||||+|+|++++..+||+|||+|+...... .
T Consensus       106 elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~  181 (359)
T KOG0660|consen  106 ELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED  181 (359)
T ss_pred             hHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence            999 669999999888899999999999999999999999   99999999999999999999999999999875431 2


Q ss_pred             cccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhh------------------ccccc
Q 004312          639 HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ------------------ERTLG  699 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~------------------~~~~~  699 (762)
                      ...+..+-|..|.|||.+.. ..||.+.||||.|||+.||++|+.-|.+....+.+.                  .....
T Consensus       182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar  261 (359)
T KOG0660|consen  182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR  261 (359)
T ss_pred             cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence            23456778999999999754 589999999999999999999998764432221111                  00011


Q ss_pred             cccccccc-cCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          700 ALVENDLE-AMD-----DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       700 ~~~~~~~~-~~~-----~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ..+.+... ...     -+.....+++|+.+||..||.+|+|++|.++.
T Consensus       262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            11111000 000     01345678999999999999999999998853

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.5e-36  Score=305.43  Aligned_cols=243  Identities=25%  Similarity=0.309  Sum_probs=189.2

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCC---c--eeEEEecc
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR---N--RLLVYEFM  562 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~---~--~~LV~E~~  562 (762)
                      +++|.|+||.||+|++... ++.||||+.-...    +--.+|+.+|++++|||||+|+-++....   +  ..||||||
T Consensus        30 ~liG~GsFg~Vyq~~~~e~-~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   30 RLIGSGSFGVVYQAKLRET-EEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             EEEeecccceEEEEEEcCC-CceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            6799999999999998754 6799999975422    23347899999999999999998885432   2  35899999


Q ss_pred             CCCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC-CceEEecccccccccCCC
Q 004312          563 SNGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY-YNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       563 ~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~~~~  637 (762)
                      |. +|..+++.    +.+++...+.-+..||.+||+|||+.   +|+||||||+|+|+|.+ +.+||||||.|+.+...+
T Consensus       105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            87 78888864    46788888889999999999999998   99999999999999954 999999999999886544


Q ss_pred             CcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------ccc-------
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------TLG-------  699 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~~~-------  699 (762)
                      ..  .....|+-|.|||.+.+. .|+.+.||||.||++.||+-|+.-|.++...+...+.          .+.       
T Consensus       181 pn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~  258 (364)
T KOG0658|consen  181 PN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT  258 (364)
T ss_pred             Cc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence            33  445578999999998775 7999999999999999999999877555433322210          000       


Q ss_pred             -----cccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          700 -----ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       700 -----~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                           ++.............+.+..+++.++|+.+|.+|.+..|++.
T Consensus       259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                 000000000122345678999999999999999999998884

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.3e-35  Score=341.28  Aligned_cols=256  Identities=23%  Similarity=0.357  Sum_probs=201.2

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.++||+|+||.||+|... .+++.||||++.....   ...++|.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 eIi~~LGkGgfG~VYlA~d~-~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY   83 (932)
T PRK13184          5 DIIRLIGKGGMGEVYLAYDP-VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY   83 (932)
T ss_pred             EEEEEEecCCCEEEEEEEEC-CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence            44578999999999999754 4567999999875322   2345799999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCC-----------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccc
Q 004312          562 MSNGALASFLFGD-----------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLE  630 (762)
Q Consensus       562 ~~~gsL~~~l~~~-----------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla  630 (762)
                      +++++|.+++...           ...++..++.++.||++||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999988531           2356778899999999999999998   9999999999999999999999999999


Q ss_pred             ccccCCCC-----------------cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhh
Q 004312          631 KLLTLDQS-----------------HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCY  693 (762)
Q Consensus       631 ~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~  693 (762)
                      +.......                 .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            87622110                 0112246999999999999999999999999999999999999998543221111


Q ss_pred             hccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHhhcCcC
Q 004312          694 QERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRP-TMRRVTQMLEGVVE  748 (762)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-t~~evl~~L~~~~~  748 (762)
                      .....   ..+ .........+..+.+++.+||+.||++|| +++++++.|+...+
T Consensus       241 ~~~~i---~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        241 YRDVI---LSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhhhc---cCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            11111   111 01111124567788999999999999995 67888888877543

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.4e-34  Score=300.83  Aligned_cols=247  Identities=23%  Similarity=0.320  Sum_probs=202.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|++|.||+|.... +++.+++|.+.....  .+++.+|++++++++|+||+++++.+.+....++++||++
T Consensus         5 y~~~~~i~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           5 FDILEKLGEGSYGSVYKAIHKE-TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             chhhhhhcCCCCeEEEEEEEcC-CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            4566789999999999998654 457899999875432  6789999999999999999999999999999999999999


Q ss_pred             CCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      +++|.+++.. ...+++..+..++.|+++||.|||+.   +++||||+|+||++++++.+||+|||++........ ...
T Consensus        82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~  157 (256)
T cd06612          82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRN  157 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccc
Confidence            9999999975 35789999999999999999999998   999999999999999999999999999987643321 222


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|+.|+............  ...  .......+.....++.+++
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~i  233 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--PNK--PPPTLSDPEKWSPEFNDFV  233 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh--ccC--CCCCCCchhhcCHHHHHHH
Confidence            344788999999999889999999999999999999999997543222111110  000  0011112234567889999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 004312          723 IWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       723 ~~cl~~dp~~RPt~~evl~  741 (762)
                      .+||+.+|++|||++||++
T Consensus       234 ~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         234 KKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             HHHHhcChhhCcCHHHHhc
Confidence            9999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=302.58  Aligned_cols=251  Identities=23%  Similarity=0.307  Sum_probs=204.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|++|.||++.... +++.+++|.+........+.+.+|++++++++||||+++++.+.+....+++|||++
T Consensus         5 ~~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~   83 (262)
T cd06613           5 YELIQRIGSGTYGDVYKARDIA-TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG   83 (262)
T ss_pred             eEEEEEecCCCceEEEEeEecC-CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence            3455789999999999997643 456899999886655566789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      +++|.+++... ..+++..+..++.|++.||+|||+.   +|+|+||+|+||++++++.+||+|||++....... ....
T Consensus        84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~  159 (262)
T cd06613          84 GGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKRK  159 (262)
T ss_pred             CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-hccc
Confidence            99999999776 7899999999999999999999998   99999999999999999999999999987654321 1223


Q ss_pred             cccccCcccCcccccCC---CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNM---PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~---~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ...++..|+|||.+...   .++.++||||||+++|||++|+.|+...................  .........+.++.
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  237 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP--PKLKDKEKWSPVFH  237 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--ccccchhhhhHHHH
Confidence            34578899999999776   88999999999999999999999975432222111111110000  11112345677899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+||+.+|.+|||+++|+.
T Consensus       238 ~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         238 DFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHhc
Confidence            9999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-35  Score=307.52  Aligned_cols=255  Identities=27%  Similarity=0.369  Sum_probs=202.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCC---cceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGS---SDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +.+.+.||+|+||.||+|......   ...+|+|.+..... ....++.+|+.++++++||||+++++++.. ...++|+
T Consensus         9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   87 (279)
T cd05057           9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT   87 (279)
T ss_pred             cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence            345678999999999999865322   23689998875432 345688999999999999999999999987 7889999


Q ss_pred             eccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          560 EFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       560 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      ||+++|+|.+++... ..+++..+..++.||+.||+|||+.   +|+||||||+||++++++.+||+|||+++.......
T Consensus        88 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~  164 (279)
T cd05057          88 QLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK  164 (279)
T ss_pred             ecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence            999999999999765 4689999999999999999999998   999999999999999999999999999987653322


Q ss_pred             ccc-ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          639 HTN-TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       639 ~~~-~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      ... ....++..|+|||.+....++.++||||||+++||+++ |+.|+......+...      .+........+...+.
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~  238 (279)
T cd05057         165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD------LLEKGERLPQPPICTI  238 (279)
T ss_pred             ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH------HHhCCCCCCCCCCCCH
Confidence            111 11223568999999988899999999999999999998 888875432222111      1111111112223446


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      .+.+++.+||..+|++||++.++++.|+.+..
T Consensus       239 ~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         239 DVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            78899999999999999999999999988644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-35  Score=316.51  Aligned_cols=252  Identities=20%  Similarity=0.242  Sum_probs=196.3

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||+++.. .+++.||||++.+.   .....+.+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (331)
T cd05597           4 EILKVIGRGAFGEVAVVKMK-NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY   82 (331)
T ss_pred             eEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence            45678999999999999755 44678999998752   122345688999999999999999999999999999999999


Q ss_pred             cCCCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          562 MSNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       562 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +++|+|.+++.+ ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++..........
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            999999999976 45789999999999999999999999   99999999999999999999999999987654433333


Q ss_pred             cccccccCcccCcccccC-----CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRN-----MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~-----~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                      .....||+.|+|||.+..     ..++.++|||||||++|||++|+.||......+.......... ..... ......+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~-~~~~~~~  237 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-HFQFP-PDVTDVS  237 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-cccCC-CccCCCC
Confidence            334569999999999863     4578899999999999999999999855432222211100000 00000 1112356


Q ss_pred             HHHHHHHHHhhccCC--CCCCCHHHHHHH
Q 004312          716 QRFVMVAIWCIQEDP--SHRPTMRRVTQM  742 (762)
Q Consensus       716 ~~~~~li~~cl~~dp--~~RPt~~evl~~  742 (762)
                      +.+.+++.+|+..++  ..||+++++++.
T Consensus       238 ~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         238 EEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            778889998876533  347899888865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.4e-35  Score=318.00  Aligned_cols=251  Identities=19%  Similarity=0.243  Sum_probs=197.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||+++.. .+++.||+|++.+..   ......+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus         4 ~i~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey   82 (331)
T cd05624           4 EIIKVIGRGAFGEVAVVKMK-HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY   82 (331)
T ss_pred             eEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            45578999999999999754 456789999986521   22334688899999999999999999999999999999999


Q ss_pred             cCCCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          562 MSNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       562 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +++|+|.+++.. ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus        83 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          83 YVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence            999999999976 46789999999999999999999998   99999999999999999999999999998765443333


Q ss_pred             cccccccCcccCcccccC-----CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccc-cCCCHHH
Q 004312          641 NTAIRGTKGYVAPEWFRN-----MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE-AMDDMTV  714 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~-----~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  714 (762)
                      .....||+.|+|||.+..     +.++.++||||||+++|||++|+.||......+.........   .... .......
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~---~~~~~p~~~~~~  236 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE---ERFQFPSHITDV  236 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC---CcccCCCccccC
Confidence            334569999999999875     468899999999999999999999985543322221111000   0000 0001234


Q ss_pred             HHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 004312          715 LQRFVMVAIWCIQEDPSH--RPTMRRVTQM  742 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~--RPt~~evl~~  742 (762)
                      ++++.+++.+|+..++++  |++++++++.
T Consensus       237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         237 SEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            678899999999865544  4688888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-35  Score=305.90  Aligned_cols=247  Identities=22%  Similarity=0.343  Sum_probs=211.0

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .|++.+.||+|.|..|-+++. .-+++.||||++.+..-  -....+.+|++.|+.++|||||+||........+|||+|
T Consensus        19 LYDLekTlG~GHFAVVKLArH-VFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARH-VFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eehhhhhhcCCceehhhhhhh-hcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            356778999999999998864 34678999999976433  334578899999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc-CCCceEEecccccccccCCCC
Q 004312          561 FMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       561 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      .-.+|+|.+||.++ ..+.+....+++.||+.|+.|+|+.   .+|||||||+||.+- .-|-+||.|||++-.+.+  .
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P--G  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP--G  172 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC--c
Confidence            99999999999766 6789999999999999999999998   999999999999886 567899999999987653  4


Q ss_pred             cccccccccCcccCcccccCCCCC-CcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          639 HTNTAIRGTKGYVAPEWFRNMPIT-VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~~~~s-~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      ......+|...|-|||++.+..|+ ++.||||||||||.|++|+.||..     ....+.+..+++-..  ..+..++.+
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe-----ANDSETLTmImDCKY--tvPshvS~e  245 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE-----ANDSETLTMIMDCKY--TVPSHVSKE  245 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc-----ccchhhhhhhhcccc--cCchhhhHH
Confidence            556678999999999999998877 789999999999999999999832     233344555555433  246678999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      +++||..||..||.+|.+.+||+..
T Consensus       246 CrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  246 CRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             HHHHHHHHHhcCchhhccHHHHhcc
Confidence            9999999999999999999999863

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-35  Score=319.89  Aligned_cols=241  Identities=25%  Similarity=0.314  Sum_probs=191.1

Q ss_pred             cCCCCcceEEEeeeeCCCcceEEEEEccccccc---hhHHHHHHhhhhccc---ccCCccchhceeccCCceeEEEeccC
Q 004312          490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD---SEKEFKAEVNGIGQT---HHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       490 iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      ||+|+||+||+|+.. .+++.||||++.+....   ....+..|..++.+.   +||||+++++.+.+....++||||++
T Consensus         1 lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKK-DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEEC-CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence            799999999999754 45679999998653221   223455666666655   79999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +|+|.+++.....+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~  155 (330)
T cd05586          80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT  155 (330)
T ss_pred             CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence            999999998888899999999999999999999998   99999999999999999999999999987543222 22334


Q ss_pred             ccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ..||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+........     ... ......+.++.+++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-----~~~-~~~~~~~~~~~~li  229 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-----KVR-FPKNVLSDEGRQFV  229 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----CCC-CCCccCCHHHHHHH
Confidence            5699999999998764 5899999999999999999999998654333222221111     111 11123467888999


Q ss_pred             HHhhccCCCCCC----CHHHHHH
Q 004312          723 IWCIQEDPSHRP----TMRRVTQ  741 (762)
Q Consensus       723 ~~cl~~dp~~RP----t~~evl~  741 (762)
                      .+||+.+|++||    +++++++
T Consensus       230 ~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         230 KGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             HHHcCCCHHHCCCCCCCHHHHhc
Confidence            999999999998    5666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.7e-35  Score=322.64  Aligned_cols=249  Identities=21%  Similarity=0.291  Sum_probs=197.1

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.||+|+||.||++... .+++.||||+++...   ......+.+|+.++.+++|+||+++++.+.+.+..+|||||+
T Consensus         5 ~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~   83 (360)
T cd05627           5 SLKVIGRGAFGEVRLVQKK-DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL   83 (360)
T ss_pred             EEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence            4467999999999999754 456789999987532   233457888999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC----
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS----  638 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~----  638 (762)
                      ++|+|.+++.+...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......    
T Consensus        84 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          84 PGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             CCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            9999999998888899999999999999999999998   999999999999999999999999999875432110    


Q ss_pred             ------------------------------cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhh
Q 004312          639 ------------------------------HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDW  688 (762)
Q Consensus       639 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~  688 (762)
                                                    .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence                                          00123469999999999999999999999999999999999999986544


Q ss_pred             HHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 004312          689 AYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPT---MRRVTQM  742 (762)
Q Consensus       689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt---~~evl~~  742 (762)
                      ...........   ............++++.+++.+++. +|.+|++   ++|+++.
T Consensus       241 ~~~~~~~i~~~---~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         241 PQETYRKVMNW---KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             HHHHHHHHHcC---CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            33322211100   0011111112245678888888764 9999985   5666643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5e-35  Score=316.90  Aligned_cols=252  Identities=20%  Similarity=0.230  Sum_probs=196.8

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||+++.. ..++.+|+|++.+..   ......+.+|+.++..++|+||+++++.+.+.+..++||||
T Consensus         4 ~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey   82 (332)
T cd05623           4 EILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY   82 (332)
T ss_pred             eEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence            34578999999999999765 446789999986422   22234588899999999999999999999999999999999


Q ss_pred             cCCCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          562 MSNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       562 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +++|+|.+++.+ ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++..........
T Consensus        83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence            999999999976 46789999999999999999999998   99999999999999999999999999997654333333


Q ss_pred             cccccccCcccCccccc-----CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          641 NTAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                      .....||+.|+|||++.     ...++.++|||||||++|||++|+.||......+......... .... .......++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~~-~p~~~~~~s  237 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-ERFQ-FPAQVTDVS  237 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-cccc-CCCccccCC
Confidence            33456999999999986     3468899999999999999999999986543322222111000 0000 001112356


Q ss_pred             HHHHHHHHHhhccCCC--CCCCHHHHHHH
Q 004312          716 QRFVMVAIWCIQEDPS--HRPTMRRVTQM  742 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~--~RPt~~evl~~  742 (762)
                      .++.+++.+|+..+++  .|++++|+++.
T Consensus       238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         238 EDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            7888999998865444  36899988765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.2e-34  Score=304.34  Aligned_cols=247  Identities=25%  Similarity=0.374  Sum_probs=195.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceeccC------Ccee
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEG------RNRL  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~------~~~~  556 (762)
                      +.+.+.||+|+||.||+|... .+++.||+|++... ......+.+|+.++.++ +|+||+++++++...      ...+
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           8 FELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhHHHheeecCCeEEEEEEEc-CCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            445678999999999999764 45678999998654 33456788999999998 799999999998653      4578


Q ss_pred             EEEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccccc
Q 004312          557 LVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT  634 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~  634 (762)
                      +||||+++++|.+++...  ..+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.+||+|||++....
T Consensus        86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~  162 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999999999764  4688999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCcccccccccCcccCccccc-----CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccC
Q 004312          635 LDQSHTNTAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM  709 (762)
Q Consensus       635 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  709 (762)
                      ... .......|++.|+|||++.     +..++.++||||||+++|||++|+.|+...........     .........
T Consensus       163 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~-----~~~~~~~~~  236 (272)
T cd06637         163 RTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-----IPRNPAPRL  236 (272)
T ss_pred             ccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-----HhcCCCCCC
Confidence            322 2233456889999999986     34688899999999999999999999743221111110     001111111


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          710 DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       710 ~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .....+..+.+++.+||+.+|.+|||++|+++
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            12234567899999999999999999999986

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8.3e-35  Score=311.05  Aligned_cols=252  Identities=27%  Similarity=0.393  Sum_probs=197.6

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCc---ceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSS---DQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      ..+.||+|+||.||+|.......   ..+|+|.+..... ....++.+|+.++++++||||++++|++... ..++++||
T Consensus        11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~   89 (303)
T cd05110          11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL   89 (303)
T ss_pred             eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence            34679999999999997653322   2578998875432 2344789999999999999999999998754 46799999


Q ss_pred             cCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc-
Q 004312          562 MSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-  639 (762)
Q Consensus       562 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-  639 (762)
                      +++|+|.+++... ..+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++........ 
T Consensus        90 ~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  166 (303)
T cd05110          90 MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY  166 (303)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccccc
Confidence            9999999999765 3689999999999999999999998   9999999999999999999999999999876433221 


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.........      ..+........+...+..+
T Consensus       167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~  240 (303)
T cd05110         167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP------DLLEKGERLPQPPICTIDV  240 (303)
T ss_pred             ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHCCCCCCCCCCCCHHH
Confidence            1122335678999999998899999999999999999997 88887432211111      1111111111122345678


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      .+++.+||..+|++||++++++++|+.+.
T Consensus       241 ~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         241 YMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            89999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.4e-34  Score=311.20  Aligned_cols=192  Identities=21%  Similarity=0.350  Sum_probs=158.1

Q ss_pred             hhcCCCCcceEEEeeeeC-CCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceecc--CCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNM-GSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~LV~E~~~~  564 (762)
                      ++||+|+||.||+|.... ...+.+|+|++...  .....+.+|++++++++||||+++++.+..  ....++||||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH   84 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence            579999999999997643 34578999998653  233567899999999999999999998854  4567899999965


Q ss_pred             CchhhhccCC---------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE----cCCCceEEecccccc
Q 004312          565 GALASFLFGD---------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL----DDYYNARISDFGLEK  631 (762)
Q Consensus       565 gsL~~~l~~~---------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~Dfgla~  631 (762)
                       +|.+++...         ..+++..+..++.||+.||+|||++   +|+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence             777776421         2578899999999999999999998   99999999999999    456789999999998


Q ss_pred             cccCCCC--cccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCc
Q 004312          632 LLTLDQS--HTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTIL  685 (762)
Q Consensus       632 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~  685 (762)
                      .......  .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~  217 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence            7643321  122345689999999998764 58999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.1e-34  Score=309.10  Aligned_cols=248  Identities=24%  Similarity=0.332  Sum_probs=201.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|++|.||++.. ..+++.||+|.+........+.+.+|+.++++++|+||+++++++..+...++||||++
T Consensus        21 y~~~~~lg~g~~g~v~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   99 (297)
T cd06656          21 YTRFEKIGQGASGTVYTAID-IATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA   99 (297)
T ss_pred             ceeeeeeccCCCeEEEEEEE-CCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence            34557899999999999974 34567899999976555566778999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +++|.+++.+ ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++........ ....
T Consensus       100 ~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~  174 (297)
T cd06656         100 GGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST  174 (297)
T ss_pred             CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-CcCc
Confidence            9999999854 4578999999999999999999998   999999999999999999999999999876543322 1223


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..+++.|+|||.+.+..++.++||||||+++|++++|+.||...........    ...........+...+..+.+++.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~  250 (297)
T cd06656         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNGTPELQNPERLSAVFRDFLN  250 (297)
T ss_pred             ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee----eccCCCCCCCCccccCHHHHHHHH
Confidence            4578899999999998999999999999999999999999854321111100    000011111123345677889999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 004312          724 WCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       724 ~cl~~dp~~RPt~~evl~  741 (762)
                      +||+.+|++||+++++++
T Consensus       251 ~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         251 RCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             HHccCChhhCcCHHHHhc
Confidence            999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.6e-34  Score=300.59  Aligned_cols=247  Identities=21%  Similarity=0.303  Sum_probs=203.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|+||.||.++.. .+++.+++|++...  .....+++.+|++++++++|+||+++++++.+.+..++||||+
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           3 IPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             eEeeEecccCCceEEEEEEc-CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            45578999999999998754 45678999987643  2344567899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          563 SNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       563 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      ++++|.+++...  ..+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.+||+|||++........ .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~  157 (256)
T cd08221          82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M  157 (256)
T ss_pred             CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence            999999999765  4689999999999999999999998   999999999999999999999999999987644332 2


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....+++.|+|||.+.+...+.++||||||+++|||++|+.|+......+......     .... ...+...+.++.+
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-----~~~~-~~~~~~~~~~~~~  231 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV-----QGNY-TPVVSVYSSELIS  231 (256)
T ss_pred             ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-----cCCC-CCCccccCHHHHH
Confidence            234568999999999988889999999999999999999999975543332222111     1111 1112345678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ++.+||+.+|++||+++++++.
T Consensus       232 ~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         232 LVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             HHHHHcccCcccCCCHHHHhhC
Confidence            9999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2e-34  Score=306.39  Aligned_cols=245  Identities=25%  Similarity=0.373  Sum_probs=199.9

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCch
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGAL  567 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL  567 (762)
                      ..||+|+||.||++... .++..||||++........+.+.+|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus        28 ~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          28 IKIGEGSTGIVCIATEK-HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hcccCCCCeEEEEEEEC-CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            56999999999999754 34678999998765555567799999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccccccc
Q 004312          568 ASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT  647 (762)
Q Consensus       568 ~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt  647 (762)
                      .+++.. ..+++..+..++.||+.||+|||+.   +|+||||||+||++++++.+||+|||++........ ......++
T Consensus       107 ~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~  181 (292)
T cd06658         107 TDIVTH-TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGT  181 (292)
T ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecC
Confidence            998854 4688999999999999999999998   999999999999999999999999999876543222 22334588


Q ss_pred             CcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhc
Q 004312          648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQ  727 (762)
Q Consensus       648 ~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  727 (762)
                      ..|+|||.+.+..++.++||||||+++|||++|+.|+...........  +.........  .....+..+.+++.+||+
T Consensus       182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~li~~~l~  257 (292)
T cd06658         182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR--IRDNLPPRVK--DSHKVSSVLRGFLDLMLV  257 (292)
T ss_pred             ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhcCCCccc--cccccCHHHHHHHHHHcc
Confidence            999999999888999999999999999999999999854433222211  1111111111  112345678899999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 004312          728 EDPSHRPTMRRVTQM  742 (762)
Q Consensus       728 ~dp~~RPt~~evl~~  742 (762)
                      .+|++|||++|+++.
T Consensus       258 ~~P~~Rpt~~~il~~  272 (292)
T cd06658         258 REPSQRATAQELLQH  272 (292)
T ss_pred             CChhHCcCHHHHhhC
Confidence            999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.4e-34  Score=308.13  Aligned_cols=246  Identities=23%  Similarity=0.336  Sum_probs=201.4

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      +.+.||.|++|.||+|.. ..+++.|++|.+........+.+.+|+++++.++||||+++++++...+..++|+||++++
T Consensus        23 ~~~~lg~g~~g~vy~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  101 (296)
T cd06655          23 RYEKIGQGASGTVFTAID-VATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG  101 (296)
T ss_pred             EEEEEecCCCeEEEEEEE-cCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence            446799999999999964 3456789999987655556678899999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccccc
Q 004312          566 ALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR  645 (762)
Q Consensus       566 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  645 (762)
                      +|.+++.. ..+++.++..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++......... .....
T Consensus       102 ~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~  176 (296)
T cd06655         102 SLTDVVTE-TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMV  176 (296)
T ss_pred             cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCCcC
Confidence            99999864 4589999999999999999999998   9999999999999999999999999998865433221 22345


Q ss_pred             ccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHh
Q 004312          646 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWC  725 (762)
Q Consensus       646 gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  725 (762)
                      ++..|+|||.+.+..++.++||||||+++|+|++|+.||..............    ........+...+..+.+++.+|
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~  252 (296)
T cd06655         177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT----NGTPELQNPEKLSPIFRDFLNRC  252 (296)
T ss_pred             CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----cCCcccCCcccCCHHHHHHHHHH
Confidence            88899999999998899999999999999999999999855432221111000    00001112234567788999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 004312          726 IQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       726 l~~dp~~RPt~~evl~  741 (762)
                      |+.+|++||+++++++
T Consensus       253 l~~dp~~Rpt~~~il~  268 (296)
T cd06655         253 LEMDVEKRGSAKELLQ  268 (296)
T ss_pred             hhcChhhCCCHHHHhh
Confidence            9999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-34  Score=303.56  Aligned_cols=248  Identities=23%  Similarity=0.314  Sum_probs=201.5

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||.|++|.||+|.... +++.+|+|.+........+.|.+|++++++++|+||+++++.+......++||||++
T Consensus         7 ~~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (280)
T cd06611           7 WEIIGELGDGAFGKVYKAQHKE-TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD   85 (280)
T ss_pred             HHHHHHhcCCCCceEEEEEEcC-CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence            5567889999999999997653 567899999876655566789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      +++|.+++... ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++........ ...
T Consensus        86 ~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~  161 (280)
T cd06611          86 GGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRD  161 (280)
T ss_pred             CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-ccc
Confidence            99999998764 5689999999999999999999999   999999999999999999999999999876532221 223


Q ss_pred             cccccCcccCccccc-----CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccc-cccCCCHHHHH
Q 004312          643 AIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND-LEAMDDMTVLQ  716 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  716 (762)
                      ...+++.|+|||.+.     ...++.++||||||+++|||++|+.|+...........     ..... .....+...+.
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  236 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK-----ILKSEPPTLDQPSKWSS  236 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH-----HhcCCCCCcCCcccCCH
Confidence            345889999999974     34578899999999999999999999754322221111     11000 01111223567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ++.+++.+||+.+|++||+++++++
T Consensus       237 ~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         237 SFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHhc
Confidence            8899999999999999999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=302.99  Aligned_cols=247  Identities=24%  Similarity=0.377  Sum_probs=201.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||.|++|.||+|... .+++.||+|.+.... ......+.+|++++++++|+||+++++++.++...++|+||+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           3 FTLLECIGKGSFGEVYKAIDK-RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhcCCCCeEEEEEEEC-CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            345678999999999999765 456789999986543 334567899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ++++|.+++... .+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+++...... ....
T Consensus        82 ~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~  156 (274)
T cd06609          82 GGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRN  156 (274)
T ss_pred             CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc-cccc
Confidence            999999999765 789999999999999999999998   99999999999999999999999999998765432 2223


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++|+.|+..........     .+............++.++.+++
T Consensus       157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l  231 (274)
T cd06609         157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF-----LIPKNNPPSLEGNKFSKPFKDFV  231 (274)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH-----HhhhcCCCCCcccccCHHHHHHH
Confidence            3457889999999998889999999999999999999999975432211111     00101111111111567889999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 004312          723 IWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       723 ~~cl~~dp~~RPt~~evl~  741 (762)
                      .+||+.+|++|||++++++
T Consensus       232 ~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         232 SLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             HHHhhCChhhCcCHHHHhh
Confidence            9999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.3e-34  Score=302.70  Aligned_cols=250  Identities=24%  Similarity=0.368  Sum_probs=201.2

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .+.+.||+|++|.||++... .+++.+++|++.... ....+++.+|++++++++||||+++++.+......++|+||++
T Consensus         4 ~~~~~ig~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (265)
T cd06605           4 EYLGELGAGNSGVVSKVLHR-PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD   82 (265)
T ss_pred             hHHHHhcCCCCeEEEEEEEc-CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence            45678999999999999754 456789999987643 3445679999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHE-ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|.+++... ..+++..+..++.|++.||+|||+ .   +++|+||||+||++++++.+||+|||.+.........  
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--  157 (265)
T cd06605          83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--  157 (265)
T ss_pred             CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--
Confidence            99999999876 778999999999999999999999 7   9999999999999999999999999998765422221  


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                       ...++..|+|||.+.+..++.++||||||+++|+|++|+.|+..............................+.++.++
T Consensus       158 -~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (265)
T cd06605         158 -TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF  236 (265)
T ss_pred             -cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence             1568889999999998899999999999999999999999974331000000000111111111111111266789999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 004312          722 AIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~  741 (762)
                      +.+||..+|++|||+.|++.
T Consensus       237 i~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         237 VNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HHHHcCCCchhCcCHHHHhh
Confidence            99999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.3e-34  Score=311.02  Aligned_cols=252  Identities=18%  Similarity=0.203  Sum_probs=193.1

Q ss_pred             hhhhcCCC--CcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          486 FKEELGRG--AFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       486 ~~~~iG~G--~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.++||+|  +|++||++... .+++.||||++....  ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYK-PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeec-ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            45789999  78899999754 557899999987532  23345678899999999999999999999999999999999


Q ss_pred             cCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          562 MSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       562 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      +++|+|.+++..+  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||+...........
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999999653  4589999999999999999999998   9999999999999999999999999875443211110


Q ss_pred             ------ccccccccCcccCcccccC--CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc---ccccccccc----
Q 004312          640 ------TNTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE---RTLGALVEN----  704 (762)
Q Consensus       640 ------~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~---~~~~~~~~~----  704 (762)
                            ......++..|+|||.+.+  ..++.++||||||+++|||++|+.||...........   .......+.    
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence                  1112346778999999976  4689999999999999999999999753221111100   000000000    


Q ss_pred             --------------------------------ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          705 --------------------------------DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       705 --------------------------------~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                                                      ..........+..+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                                            0000011234567899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.9e-34  Score=300.33  Aligned_cols=247  Identities=23%  Similarity=0.321  Sum_probs=198.8

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc------chhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      ..+.||+|+||.||+|...  +++.+|||++.....      .....+.+|++++++++|+||+++++++.+.+..++|+
T Consensus         4 ~~~~ig~g~~~~v~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           4 KGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccceEeccCCeEEEEEEEc--CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            4467999999999999753  456899998864321      12346889999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC--
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ--  637 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~--  637 (762)
                      ||+++++|.+++.+...+++..+..++.|++.||+|||+.   +|+|+||+|+||++++++.+||+|||++.......  
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          82 EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            9999999999998877889999999999999999999998   99999999999999999999999999987653211  


Q ss_pred             ---CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHH
Q 004312          638 ---SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       638 ---~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  714 (762)
                         ........++..|+|||.+.+..++.++||||||+++|+|++|+.|+................    ......+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~  234 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR----GLMPRLPDSF  234 (265)
T ss_pred             ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc----CCCCCCCCCC
Confidence               111223458899999999998889999999999999999999999985432221111100000    0111123345


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          715 LQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ++++.+++.+||+.+|++||++.|+++
T Consensus       235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         235 SAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            678899999999999999999999876

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.4e-34  Score=303.66  Aligned_cols=249  Identities=22%  Similarity=0.304  Sum_probs=199.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.++||+|+||.||+|... .+++.+++|.+........+.+.+|++++++++|+||+++++.+......++||||++
T Consensus        14 y~i~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   92 (292)
T cd06644          14 WEIIGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP   92 (292)
T ss_pred             hhhhheecCCCCeEEEEEEEC-CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence            456678999999999999764 4467899999987666667789999999999999999999999999999999999999


Q ss_pred             CCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      +++|..++.+ ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++...... .....
T Consensus        93 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~  168 (292)
T cd06644          93 GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRRD  168 (292)
T ss_pred             CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc-ccccc
Confidence            9999988765 35689999999999999999999998   9999999999999999999999999998754322 11223


Q ss_pred             cccccCcccCccccc-----CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          643 AIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      ...+++.|+|||.+.     ...++.++||||||+++|||++|+.|+............  .....+  ....+...+.+
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~  244 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI--AKSEPP--TLSQPSKWSME  244 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH--hcCCCc--cCCCCcccCHH
Confidence            345788999999984     345788999999999999999999997433221111110  000000  11112345567


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +.+++.+||+.+|++||+++|+++
T Consensus       245 ~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         245 FRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhc
Confidence            899999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-34  Score=300.45  Aligned_cols=245  Identities=26%  Similarity=0.336  Sum_probs=200.4

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-----cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-----QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      ..+.||+|++|.||+|... .+++.|++|.+....     .+..+.+.+|++++++++|+||+++++++......++|+|
T Consensus         4 ~~~~ig~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   82 (258)
T cd06632           4 KGELLGSGSFGSVYEGLNL-DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE   82 (258)
T ss_pred             ccceeeecCCceEEEEEEc-CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence            4567999999999999764 346789999886533     2244679999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++++|.+++.+...+++..+..++.||++||+|||+.   +|+|+||+|+||++++++.+||+|||++.......  .
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~  157 (258)
T cd06632          83 LVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--F  157 (258)
T ss_pred             ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc--c
Confidence            999999999998877889999999999999999999998   99999999999999999999999999988654332  2


Q ss_pred             cccccccCcccCcccccCCC-CCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~-~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      .....++..|+|||.+.... ++.++|+||||+++|+|++|+.|+...........     ..........+......+.
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  232 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-----IGRSKELPPIPDHLSDEAK  232 (258)
T ss_pred             ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-----HHhcccCCCcCCCcCHHHH
Confidence            23455888999999997776 89999999999999999999999744322111111     0000011112234567889


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+||+.+|++||+++++++
T Consensus       233 ~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         233 DFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HHHHHHhhcCcccCcCHHHHhc
Confidence            9999999999999999999986

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.7e-34  Score=301.78  Aligned_cols=251  Identities=25%  Similarity=0.356  Sum_probs=198.2

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc----------hhHHHHHHhhhhcccccCCccchhceeccCCce
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD----------SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNR  555 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  555 (762)
                      ..+.||+|++|.||+|... .+++.+|+|.++.....          ..+.+.+|+.++++++|+||+++++++...+..
T Consensus         5 ~~~~lg~g~~~~vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   83 (272)
T cd06629           5 KGELIGKGTYGRVYLALNV-TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL   83 (272)
T ss_pred             ecceecccCceEEEEEeec-CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence            3467999999999999754 44678999987532111          124678899999999999999999999999999


Q ss_pred             eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          556 LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ++||||+++++|.+++.+...+++..+..++.||+.||.|||+.   +++||||+|+||++++++.+||+|||+++....
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          84 SIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             EEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            99999999999999998888899999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCc-ccccccccCcccCcccccCCC--CCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCH
Q 004312          636 DQSH-TNTAIRGTKGYVAPEWFRNMP--ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDM  712 (762)
Q Consensus       636 ~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (762)
                      .... ......++..|+|||.+....  ++.++||||||+++||+++|+.|+..........+... .............
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  239 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN-KRSAPPIPPDVSM  239 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc-cccCCcCCccccc
Confidence            2221 123345889999999987654  89999999999999999999999743322211111000 0000011111122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       713 ~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .++..+.+++.+||+.+|++||++++|++
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         240 NLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            35678999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-34  Score=301.28  Aligned_cols=247  Identities=20%  Similarity=0.277  Sum_probs=200.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc-ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .+.+.||+|+||.||++... .+++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+...+..++||||++
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (255)
T cd08219           3 NVLRVVGEGSFGRALLVQHV-NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD   81 (255)
T ss_pred             eEEEEeeccCCeEEEEEEEc-CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence            35578999999999999754 45678999988643 23345678899999999999999999999999999999999999


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|.+++...  ..+++.....++.|++.||.|||+.   +|+|+||||+||++++++.++|+|||++....... ...
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~  157 (255)
T cd08219          82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AYA  157 (255)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-ccc
Confidence            99999988643  4578999999999999999999998   99999999999999999999999999997664322 222


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........     ... ......+...+..+.++
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~~l  231 (255)
T cd08219         158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK-----VCQ-GSYKPLPSHYSYELRSL  231 (255)
T ss_pred             ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH-----Hhc-CCCCCCCcccCHHHHHH
Confidence            335688999999999998999999999999999999999999854322111111     111 11111233456778999


Q ss_pred             HHHhhccCCCCCCCHHHHHHH
Q 004312          722 AIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~  742 (762)
                      +.+||+.+|++||++++++..
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.4e-34  Score=301.27  Aligned_cols=247  Identities=22%  Similarity=0.306  Sum_probs=195.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-----chhHHHHHHhhhhcccccCCccchhceecc--CCceeE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-----DSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GRNRLL  557 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~L  557 (762)
                      ...+.||+|+||.||+|... .+++.|++|++.....     .....+.+|+.++++++||||+++++++.+  ....++
T Consensus         5 ~~~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   83 (266)
T cd06651           5 RRGKLLGQGAFGRVYLCYDV-DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI   83 (266)
T ss_pred             cccceecCCCCEEEEEEEEc-CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence            34578999999999999644 4567899998864321     223568899999999999999999998865  356789


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ++||+++++|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++......
T Consensus        84 ~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          84 FMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            999999999999998877889999999999999999999998   99999999999999999999999999998654321


Q ss_pred             C--cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          638 S--HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       638 ~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                      .  .......++..|+|||.+.+..++.++||||||+++|||++|+.||...........     ..........+....
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~  235 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK-----IATQPTNPQLPSHIS  235 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH-----HhcCCCCCCCchhcC
Confidence            1  112234578899999999988999999999999999999999999754322222211     111111122233445


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +.+..++ +||..+|++||+++||++
T Consensus       236 ~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         236 EHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            6667777 788899999999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.8e-34  Score=305.39  Aligned_cols=252  Identities=24%  Similarity=0.312  Sum_probs=198.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|++|.||+|... ..++.||+|++.....  ...+.+.+|++++++++||||+++++++......++|+||+
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (286)
T cd07846           4 ENLGLVGEGSYGMVMKCKHK-ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV   82 (286)
T ss_pred             eEeeeeccCCCeEEEEEEEC-CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence            45578999999999999764 3467899999865322  23467889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ++++|..+......+++..+..++.||++||+|||+.   +++|+||+|+||++++++.+||+|||++....... ....
T Consensus        83 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~  158 (286)
T cd07846          83 DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYT  158 (286)
T ss_pred             CccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccC
Confidence            9999999887777799999999999999999999998   99999999999999999999999999998654332 2223


Q ss_pred             cccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc-----cc--------------cccc
Q 004312          643 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER-----TL--------------GALV  702 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~-----~~--------------~~~~  702 (762)
                      ...++..|+|||.+.+ ..++.++||||||+++|||++|+.|+......+.....     ..              ....
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07846         159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR  238 (286)
T ss_pred             cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence            3457889999999865 45788999999999999999999887433221110000     00              0000


Q ss_pred             cccccc-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          703 ENDLEA-----MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       703 ~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+....     ......+..+.+++.+||+.+|++||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000000     001234677999999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.9e-34  Score=298.85  Aligned_cols=249  Identities=26%  Similarity=0.371  Sum_probs=201.1

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc--hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      ...+.||+|++|.||+|... .+++.|++|.++.....  ..+.+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus         3 ~~~~~lg~G~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           3 QRGNKIGGGTFGKVYTAVNL-DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             eeeeEeecCCCcEEEEEEEC-CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            34578999999999999754 34678999998765443  5678999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ++++|.+++.....+++..+..++.|++.||+|||+.   +|+|+||+|+||++++++.+||+|||++............
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          82 SGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence            9999999998877789999999999999999999998   9999999999999999999999999999876543332211


Q ss_pred             ---cccccCcccCcccccCCC---CCCcchhHHHHHHHHHHHhCCCCCchhh-HHHhhhccccccccccccccCCCHHHH
Q 004312          643 ---AIRGTKGYVAPEWFRNMP---ITVKVDVYSYGVLLLEIICLRRTILTDW-AYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       643 ---~~~gt~~y~aPE~~~~~~---~s~~~DV~S~Gvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                         ...+++.|+|||.+....   .+.++||||||+++||+++|+.||.... .......  ...  ............+
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~  234 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH--VGA--GHKPPIPDSLQLS  234 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH--Hhc--CCCCCCCcccccC
Confidence               345788999999998766   8999999999999999999999974321 1111000  000  1111111112236


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ..+.+++.+||+.+|++||+++|++.
T Consensus       235 ~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         235 PEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhc
Confidence            77889999999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.6e-34  Score=304.31  Aligned_cols=252  Identities=24%  Similarity=0.262  Sum_probs=195.9

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc-----hhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD-----SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      .+.+.||+|++|.||+|... .+++.||||++......     ....+.+|++++++++|+||+++++++.+....++||
T Consensus         3 ~~~~~lg~g~~~~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           3 EKGKKLGEGTYAVVYKARDK-ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             eeeeeeeeccccEEEEEEEC-CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            34567999999999999754 34679999999754322     2456778999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          560 EFMSNGALASFLFGDS-KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      ||+ +++|.+++.... .+++..+..++.||++||+|||+.   +|+|+||+|+||+++.++.+||+|||+++.......
T Consensus        82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            999 999999998776 799999999999999999999999   999999999999999999999999999987643321


Q ss_pred             cccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------------ccccc
Q 004312          639 HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------------TLGAL  701 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------------~~~~~  701 (762)
                       ......+++.|+|||.+.+ ..++.++||||||+++|||++|..++......+.....                .....
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (298)
T cd07841         158 -KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY  236 (298)
T ss_pred             -cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence             2223346788999999854 46789999999999999999996665332211111000                00000


Q ss_pred             cccccccC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          702 VENDLEAM-----DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       702 ~~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ........     .....+..+.+++.+||+.+|++|||++|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000000     012346788999999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.7e-34  Score=303.16  Aligned_cols=245  Identities=22%  Similarity=0.320  Sum_probs=199.5

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCch
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGAL  567 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL  567 (762)
                      ..||+|+||.||++... .+++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++|
T Consensus        27 ~~ig~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          27 IKIGEGSTGIVCIAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhcCCCCceeEEEEEEc-CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            46999999999999754 34678999998765555567789999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccccccc
Q 004312          568 ASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT  647 (762)
Q Consensus       568 ~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt  647 (762)
                      .+++.. ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++....... .......++
T Consensus       106 ~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~  180 (297)
T cd06659         106 TDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGT  180 (297)
T ss_pred             HHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceecC
Confidence            998754 5689999999999999999999998   99999999999999999999999999987554322 222335688


Q ss_pred             CcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhc
Q 004312          648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQ  727 (762)
Q Consensus       648 ~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  727 (762)
                      ..|+|||.+.+..++.++||||||+++|||++|+.|+............  ......  ........+..+.+++.+||+
T Consensus       181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~l~~~i~~~l~  256 (297)
T cd06659         181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--RDSPPP--KLKNAHKISPVLRDFLERMLT  256 (297)
T ss_pred             ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--hccCCC--CccccCCCCHHHHHHHHHHhc
Confidence            9999999999889999999999999999999999997543322222110  000000  011122345678899999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 004312          728 EDPSHRPTMRRVTQM  742 (762)
Q Consensus       728 ~dp~~RPt~~evl~~  742 (762)
                      .+|++||+++++++.
T Consensus       257 ~~P~~Rps~~~ll~~  271 (297)
T cd06659         257 REPQERATAQELLDH  271 (297)
T ss_pred             CCcccCcCHHHHhhC
Confidence            999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.5e-34  Score=302.09  Aligned_cols=252  Identities=24%  Similarity=0.376  Sum_probs=196.7

Q ss_pred             hhhhcCCCCcceEEEeeeeC--CCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCC------ce
Q 004312          486 FKEELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR------NR  555 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~  555 (762)
                      +.+.||+|+||.||+|.+..  ++++.||||++....  ....+++.+|++++++++||||+++++++....      ..
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   82 (273)
T cd05074           3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP   82 (273)
T ss_pred             chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence            45789999999999998653  345789999986532  234567899999999999999999999886532      23


Q ss_pred             eEEEeccCCCchhhhccCC------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccc
Q 004312          556 LLVYEFMSNGALASFLFGD------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL  629 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl  629 (762)
                      ++++||+++|+|.+++...      ..+++.....++.||+.||+|||+.   +|+||||||+||++++++.+||+|||+
T Consensus        83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence            7899999999999887432      2478899999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccc
Q 004312          630 EKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLE  707 (762)
Q Consensus       630 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  707 (762)
                      ++........ ......+++.|++||.+....++.++||||||+++|||++ |+.|+............     ... ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~-----~~~-~~  233 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL-----IKG-NR  233 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH-----HcC-Cc
Confidence            9866433221 1222345678999999998899999999999999999999 77776433222111110     000 01


Q ss_pred             cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       708 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      ...+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       234 ~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111223457899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-34  Score=324.75  Aligned_cols=247  Identities=22%  Similarity=0.282  Sum_probs=186.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccC--------Cce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--------RNR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--------~~~  555 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++...    .....+|+.++++++||||+++++++...        ...
T Consensus        68 y~~~~~LG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         68 YKLGNIIGNGSFGVVYEAICI-DTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             EEEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            445678999999999999754 45678999988542    22345799999999999999998876321        235


Q ss_pred             eEEEeccCCCchhhhcc----CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC-ceEEeccccc
Q 004312          556 LLVYEFMSNGALASFLF----GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY-NARISDFGLE  630 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla  630 (762)
                      ++||||+++ +|.+++.    ....+++..+..++.||+.||+|||+.   +|+||||||+||||+.++ .+||+|||++
T Consensus       143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            689999985 6666553    346789999999999999999999998   999999999999999654 7999999999


Q ss_pred             ccccCCCCcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc------------
Q 004312          631 KLLTLDQSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT------------  697 (762)
Q Consensus       631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~------------  697 (762)
                      +.+....  ......||+.|+|||.+.+. .++.++|||||||++|||++|..||......+......            
T Consensus       219 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~  296 (440)
T PTZ00036        219 KNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK  296 (440)
T ss_pred             hhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            8664322  22345689999999998654 68999999999999999999999986543222111100            


Q ss_pred             ----------cccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          698 ----------LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       698 ----------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                                ........+....+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                      00000000111112224578999999999999999999999884

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.1e-34  Score=299.67  Aligned_cols=247  Identities=24%  Similarity=0.364  Sum_probs=201.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +...+.||.|+||.||+|... ..++.||+|.+.... ......+.+|+.++++++|+||+++++++.+....++||||+
T Consensus         6 y~~~~~lg~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           6 FTKLERIGKGSFGEVFKGIDN-RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhcccCCCeEEEEEEEc-cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            344577999999999999754 345789999887432 344567999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ++++|.+++.. ..+++.....++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++........ ...
T Consensus        85 ~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~  159 (277)
T cd06640          85 GGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRN  159 (277)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccc
Confidence            99999999864 4688899999999999999999998   999999999999999999999999999976643222 222


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.|+..........      ..............+..+.+++
T Consensus       160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li  233 (277)
T cd06640         160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------LIPKNNPPTLTGEFSKPFKEFI  233 (277)
T ss_pred             cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh------hhhcCCCCCCchhhhHHHHHHH
Confidence            3457889999999998899999999999999999999999975432221111      1111112223345678899999


Q ss_pred             HHhhccCCCCCCCHHHHHHH
Q 004312          723 IWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       723 ~~cl~~dp~~RPt~~evl~~  742 (762)
                      .+||+.+|++||+++++++.
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         234 DACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             HHHcccCcccCcCHHHHHhC
Confidence            99999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.4e-34  Score=299.16  Aligned_cols=243  Identities=28%  Similarity=0.425  Sum_probs=195.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+|..   .++.+|+|+++..  .....+.+|+.++++++||||+++++++... ..++||||++
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             ceeeeeeccCCCCceEeccc---CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            44567899999999999864   3567999998653  2346789999999999999999999998664 4799999999


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|.+++...  ..+++..+..++.|+++||.|||+.   +++||||||+||+++.++.+||+|||++.......    
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----  154 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----  154 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence            99999999764  3578999999999999999999998   99999999999999999999999999987543211    


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....+..|+|||.+.+..++.++||||||+++|||++ |+.|+......+....      +........+...+..+.+
T Consensus       155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~  228 (254)
T cd05083         155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC------VEKGYRMEPPEGCPADVYV  228 (254)
T ss_pred             CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH------HhCCCCCCCCCcCCHHHHH
Confidence            12234568999999998899999999999999999998 8888644322221111      1111111122345678899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      ++.+||+.+|++||+++++++.|++
T Consensus       229 li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         229 LMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHcc
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.5e-34  Score=306.49  Aligned_cols=253  Identities=19%  Similarity=0.263  Sum_probs=201.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||++... ..++.|++|.+....   ......+.+|++++++++||||+++++.+.+++..++||||
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (305)
T cd05609           4 ETIKLISNGAYGAVYLVRHK-ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY   82 (305)
T ss_pred             eEeeEeecCCCeeEEEEEEC-CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence            34578999999999999754 456789999987543   22345788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC---
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS---  638 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~---  638 (762)
                      +++++|.+++...+.+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++.......   
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          83 VEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            99999999998888899999999999999999999998   999999999999999999999999999874211100   


Q ss_pred             -----------cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccc
Q 004312          639 -----------HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE  707 (762)
Q Consensus       639 -----------~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  707 (762)
                                 .......++..|+|||.+.+..++.++||||||+++|||++|+.||......+............+   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---  236 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP---  236 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC---
Confidence                       011123578899999999888999999999999999999999999864432222221111111111   


Q ss_pred             cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       708 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                       ......+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       237 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         237 -EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             -CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence             1112456778999999999999999997767666655

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.1e-34  Score=291.23  Aligned_cols=252  Identities=25%  Similarity=0.339  Sum_probs=195.6

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCC-ccchhceeccCC------ce
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKN-LVRLLGYCDEGR------NR  555 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~------~~  555 (762)
                      ...++||+|+||+||+|+.. .+++.||+|+++-...  .......+|+.++++++|+| ||++++++...+      ..
T Consensus        14 ~~~eklGeGtyg~Vykar~~-~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l   92 (323)
T KOG0594|consen   14 EKVEKLGEGTYGVVYKARSK-RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL   92 (323)
T ss_pred             HHHHHhCCCCceEEEEEEEe-cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence            34467999999999999765 4568999999975433  23456789999999999999 999999998877      78


Q ss_pred             eEEEeccCCCchhhhccCCC----CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          556 LLVYEFMSNGALASFLFGDS----KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                      +||+||++. +|..++....    .++...+..++.||++||+|||++   +|+||||||+||||+++|.+||+|||+|+
T Consensus        93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHH
Confidence            899999955 8999987654    467788999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc----------ccccc
Q 004312          632 LLTLDQSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE----------RTLGA  700 (762)
Q Consensus       632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~----------~~~~~  700 (762)
                      .+..+ ....+..+.|..|.|||++.+. .|+...||||+|||+.||++++.-|.++...+....          .....
T Consensus       169 a~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  169 AFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            76532 2234556689999999999876 799999999999999999998766644433222111          00000


Q ss_pred             ---ccccc--cccCC-C-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          701 ---LVEND--LEAMD-D-------MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       701 ---~~~~~--~~~~~-~-------~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                         +.+-.  ..... +       ........+++.+||+.+|.+|.|++.++++
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence               00000  00000 0       1112478999999999999999999988875

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-34  Score=319.67  Aligned_cols=251  Identities=20%  Similarity=0.218  Sum_probs=196.4

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeC-CCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNM-GSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.+.||+|+||.||++.... ...+.||||.+...     +.+.+|++++++++||||+++++.+......++|||+
T Consensus        93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~  167 (392)
T PHA03207         93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK  167 (392)
T ss_pred             ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence            45667889999999999986532 34567999987643     3456899999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC-cc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-HT  640 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~  640 (762)
                      +. ++|.+++.....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++........ ..
T Consensus       168 ~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~  243 (392)
T PHA03207        168 YK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ  243 (392)
T ss_pred             cC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence            96 68888887778899999999999999999999998   999999999999999999999999999976543322 22


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHH---hhhc-------cccc----------c
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYD---CYQE-------RTLG----------A  700 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~---~~~~-------~~~~----------~  700 (762)
                      .....||+.|+|||.+....++.++|||||||++|||++|+.||.......   .+..       ....          .
T Consensus       244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  323 (392)
T PHA03207        244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK  323 (392)
T ss_pred             ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence            234569999999999999999999999999999999999999985432100   0000       0000          0


Q ss_pred             c---ccccccc--CC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          701 L---VENDLEA--MD-----DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       701 ~---~~~~~~~--~~-----~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      .   .......  ..     ......++.+++.+||+.||++|||+.|++..
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0   0000000  00     01124567889999999999999999999873

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.8e-34  Score=297.87  Aligned_cols=246  Identities=23%  Similarity=0.314  Sum_probs=198.9

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceecc-CCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-GRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~LV~E~  561 (762)
                      .+.+.||+|++|.||++.... +++.+|+|++....  ....+.+.+|++++++++|+|++++++.+.. ....++||||
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           3 CFVRVVGKGSYGEVSLVRHRT-DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             eEEEEecCCCCeEEEEEEEcC-CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            456789999999999997653 46789999986432  2344678999999999999999999988764 4457899999


Q ss_pred             cCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          562 MSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       562 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      +++++|.+++...  ..+++.++..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++..+.... .
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~  157 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-D  157 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC-C
Confidence            9999999999763  4589999999999999999999998   99999999999999999999999999998764322 2


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ......+++.|+|||.+.+..++.++||||||+++++|++|+.|+...........     .... .....+...+.++.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~-----~~~~-~~~~~~~~~~~~~~  231 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR-----IIEG-KLPPMPKDYSPELG  231 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH-----HHhc-CCCCCccccCHHHH
Confidence            23345688999999999999999999999999999999999999754322111111     1111 11112334667899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+||+.+|++||++.++++
T Consensus       232 ~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         232 ELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             HHHHHHhccCcccCCCHHHHhc
Confidence            9999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.4e-34  Score=306.54  Aligned_cols=247  Identities=27%  Similarity=0.286  Sum_probs=196.4

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      ..+.||+|+||.||++... .+++.||||++.....   .....+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus         4 ~~~~ig~G~~g~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05630           4 QYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM   82 (285)
T ss_pred             eeEEeecCCCeEEEEEEEc-CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence            3467999999999999754 4567999999865322   22346788999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          563 SNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       563 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      ++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++.......  .
T Consensus        83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~  157 (285)
T cd05630          83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--T  157 (285)
T ss_pred             CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--c
Confidence            999999998643  3588999999999999999999998   99999999999999999999999999987653222  1


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........  .......... .........+.++.+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~  234 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKE-VQEEYSEKFSPDARS  234 (285)
T ss_pred             ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHHHHhhhhh-hhhhcCccCCHHHHH
Confidence            2234689999999999999999999999999999999999999854211000  0001111110 011112234567899


Q ss_pred             HHHHhhccCCCCCCC-----HHHHHH
Q 004312          721 VAIWCIQEDPSHRPT-----MRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt-----~~evl~  741 (762)
                      ++.+||+.||++|||     ++|+++
T Consensus       235 li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         235 LCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             HHHHHhhcCHHHccCCCCCchHHHHc
Confidence            999999999999999     888886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.4e-34  Score=308.36  Aligned_cols=252  Identities=20%  Similarity=0.279  Sum_probs=194.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||.||+|... .+++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus         8 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   86 (309)
T cd07872           8 YIKLEKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL   86 (309)
T ss_pred             eEEEEEecccCCEEEEEEEec-CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence            344578999999999999754 456789999987432 223456889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          563 SNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       563 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      ++ +|.+++... ..+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus        87 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~  161 (309)
T cd07872          87 DK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TY  161 (309)
T ss_pred             CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-cc
Confidence            85 787777654 4578999999999999999999998   999999999999999999999999999976432221 22


Q ss_pred             ccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------ccccccc-------
Q 004312          642 TAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------TLGALVE-------  703 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~~~~~~~-------  703 (762)
                      ....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.....          ....+..       
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            23457899999999865 46899999999999999999999997543221111000          0000000       


Q ss_pred             --ccccc----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          704 --NDLEA----MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       704 --~~~~~----~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                        +....    ......++++.+++.+||+.||.+|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence              00000    001134567899999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-34  Score=303.81  Aligned_cols=254  Identities=25%  Similarity=0.292  Sum_probs=201.5

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +++.+.||+|++|.||+|.... +++.||||+++...  ....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKA-TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCC-CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            3456789999999999997653 46789999987532  33346899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      ++++.|..++.+...+++..+..++.||++||+|||+.   +++|+||+|+||++++++.+||+|||++...........
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence            99988888777777799999999999999999999998   999999999999999999999999999987655443233


Q ss_pred             ccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc-------------------cccc--
Q 004312          642 TAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE-------------------RTLG--  699 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~-------------------~~~~--  699 (762)
                      ....++..|+|||++... .++.++||||||+++|+|++|+.|+......+....                   ....  
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV  238 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence            445678899999999887 889999999999999999999988743321111000                   0000  


Q ss_pred             cccccc----cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          700 ALVEND----LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       700 ~~~~~~----~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ......    .....+..++.++.+++.+||+.+|++||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            000000    000011223688999999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.7e-34  Score=300.35  Aligned_cols=249  Identities=23%  Similarity=0.353  Sum_probs=198.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc-ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +++.+.||+|+||.||++... ..++.||+|.+... .......+.+|+.++++++|+||+++++.+...+..++||||+
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHR-PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEc-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            456788999999999999754 45678999988653 2233467899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC---CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          563 SNGALASFLFGD---SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       563 ~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      ++++|..++...   ..+++..+..++.|++.||.|||++  .+|+|+||||+||+++.++.+||+|||++..+...   
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  156 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---  156 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence            999999998764   3789999999999999999999963  28999999999999999999999999998765322   


Q ss_pred             ccccccccCcccCcccccCC------CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNM------PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMT  713 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~------~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  713 (762)
                      ......+++.|+|||.+...      .++.++||||||+++|+|++|+.||..........  .+...... .....+..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~-~~~~~~~~  233 (286)
T cd06622         157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA--QLSAIVDG-DPPTLPSG  233 (286)
T ss_pred             ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH--HHHHHhhc-CCCCCCcc
Confidence            22234578899999998554      35889999999999999999999974332111111  01111111 11122334


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          714 VLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       714 ~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ++.++.+++.+||+.+|++||+++++++
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            6788999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.7e-34  Score=298.87  Aligned_cols=246  Identities=22%  Similarity=0.285  Sum_probs=196.5

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-----cchhHHHHHHhhhhcccccCCccchhceeccC--CceeEE
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-----QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--RNRLLV  558 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~LV  558 (762)
                      +.+.||+|+||.||+|... .+++.||||.+....     ....+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         6 ~~~~l~~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v   84 (265)
T cd06652           6 LGKLLGQGAFGRVYLCYDA-DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF   84 (265)
T ss_pred             EeeEEecCCceEEEEEEEc-CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence            4578999999999999754 456789999875321     12235788999999999999999999988764  457899


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      |||+++++|.+++.....+++.....++.|++.||.|||+.   +++|+||||+||++++++.+||+|||+++.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          85 MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            99999999999998777789999999999999999999998   999999999999999999999999999986543211


Q ss_pred             --cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          639 --HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       639 --~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                        .......++..|+|||.+.+..++.++||||||+++|||++|+.|+...........     ..........+.....
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  236 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-----IATQPTNPVLPPHVSD  236 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH-----HhcCCCCCCCchhhCH
Confidence              112234588999999999888899999999999999999999999754322221111     1111112223445677


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+.+++.+|+. +|++||+++||++
T Consensus       237 ~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         237 HCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            88899999995 9999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.1e-34  Score=303.79  Aligned_cols=246  Identities=25%  Similarity=0.290  Sum_probs=196.1

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .+.||+|+||+||++... .+++.+|+|.+.....   .....+.+|++++++++|+||+++++.+..++..++||||++
T Consensus         5 ~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05632           5 YRVLGKGGFGEVCACQVR-ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             EEEEecCCCeEEEEEEEC-CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence            467999999999999765 4567999999865322   223457889999999999999999999999999999999999


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||++.......  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~  158 (285)
T cd05632          84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SI  158 (285)
T ss_pred             CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--cc
Confidence            99999988643  4689999999999999999999998   99999999999999999999999999987653221  22


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ....|+..|+|||.+.+..++.++||||||+++|||++|+.||........... ........  ........+..+.++
T Consensus       159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~l  235 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE-VDRRVLET--EEVYSAKFSEEAKSI  235 (285)
T ss_pred             cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhhhcc--ccccCccCCHHHHHH
Confidence            334689999999999988999999999999999999999999854322111110 00111110  111223455678899


Q ss_pred             HHHhhccCCCCCCC-----HHHHHH
Q 004312          722 AIWCIQEDPSHRPT-----MRRVTQ  741 (762)
Q Consensus       722 i~~cl~~dp~~RPt-----~~evl~  741 (762)
                      +.+||+.+|++||+     ++++++
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         236 CKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             HHHHccCCHhHcCCCcccChHHHHc
Confidence            99999999999999     666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.8e-34  Score=307.00  Aligned_cols=192  Identities=21%  Similarity=0.341  Sum_probs=157.6

Q ss_pred             hhcCCCCcceEEEeeeeC-CCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceec--cCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNM-GSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCD--EGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~LV~E~~~~  564 (762)
                      .+||+|+||.||+|+... .....||+|++....  ....+.+|++++++++||||+++++++.  .....++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            469999999999998643 345689999987532  3356889999999999999999999884  35567899999875


Q ss_pred             CchhhhccC---------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE----cCCCceEEecccccc
Q 004312          565 GALASFLFG---------DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL----DDYYNARISDFGLEK  631 (762)
Q Consensus       565 gsL~~~l~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~Dfgla~  631 (762)
                       +|.+++..         ...+++..+..++.||+.||+|||+.   +|+||||||+|||+    ++++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             67666532         12478889999999999999999998   99999999999999    567799999999998


Q ss_pred             cccCCCC--cccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCc
Q 004312          632 LLTLDQS--HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTIL  685 (762)
Q Consensus       632 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~  685 (762)
                      .......  .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~  217 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence            7643322  12234568999999999876 458999999999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.8e-34  Score=303.33  Aligned_cols=250  Identities=24%  Similarity=0.281  Sum_probs=190.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhccc---ccCCccchhceecc-----CCc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQT---HHKNLVRLLGYCDE-----GRN  554 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~-----~~~  554 (762)
                      .+.+.||+|+||.||+|... .+++.||+|.++....  .....+.+|+.+++++   +||||+++++++..     ...
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           3 EPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             eEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            34578999999999999754 4567899999865322  2234566777777665   79999999998764     345


Q ss_pred             eeEEEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          555 RLLVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       555 ~~LV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                      .++||||+++ +|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++.
T Consensus        82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccc
Confidence            7899999985 888888654  3589999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------cccc--
Q 004312          633 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------TLGA--  700 (762)
Q Consensus       633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~~~~--  700 (762)
                      .....  ......+++.|+|||.+.+..++.++|||||||++|||++|+.||............          ....  
T Consensus       158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         158 YSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            64322  223356789999999999889999999999999999999999887443222111100          0000  


Q ss_pred             -----ccccccc---cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          701 -----LVENDLE---AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       701 -----~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                           ...+...   .......++++.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                 0000000   0001234567899999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.7e-34  Score=312.80  Aligned_cols=250  Identities=25%  Similarity=0.283  Sum_probs=191.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccCC------ce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR------NR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~  555 (762)
                      +.+.+.||+|+||.||++... .+++.||||++...  .......+.+|+.+++.++||||+++++++....      ..
T Consensus        23 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  101 (359)
T cd07876          23 YQQLKPIGSGAQGIVCAAFDT-VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV  101 (359)
T ss_pred             eEEEEEeecCCCEEEEEEEEc-CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence            445578999999999999654 45679999998653  2334567889999999999999999999886443      46


Q ss_pred             eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          556 LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ++||||+++ +|...+.  ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876         102 YLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             EEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            999999976 4655553  3478888999999999999999999   999999999999999999999999999975432


Q ss_pred             CCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc-----------------cc
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER-----------------TL  698 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~-----------------~~  698 (762)
                        ........+|+.|+|||.+.+..++.++||||||+++|+|++|+.||........+...                 ..
T Consensus       176 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         176 --NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             --CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence              22233456899999999999999999999999999999999999998533211111000                 00


Q ss_pred             ccccccc--cc----------------cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          699 GALVEND--LE----------------AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       699 ~~~~~~~--~~----------------~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      .......  ..                ...+......+.+++.+||+.||++|||+.|+++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000000  00                00011234678999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.5e-34  Score=300.49  Aligned_cols=244  Identities=23%  Similarity=0.347  Sum_probs=199.8

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCch
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGAL  567 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL  567 (762)
                      +.||+|++|.||++... .+++.+++|++........+.+.+|+.++++++||||+++++++...+..++|+||+++++|
T Consensus        25 ~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L  103 (285)
T cd06648          25 VKIGEGSTGIVCIATDK-STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL  103 (285)
T ss_pred             eEeccCCCeEEEEEEEC-CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence            57999999999999754 44678999998765555566789999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccccccc
Q 004312          568 ASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT  647 (762)
Q Consensus       568 ~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt  647 (762)
                      .+++.. .++++..+..++.|++.||+|||+.   +|+||||+|+||++++++.++|+|||++........ ......|+
T Consensus       104 ~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~  178 (285)
T cd06648         104 TDIVTH-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVGT  178 (285)
T ss_pred             HHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccCC
Confidence            999977 6789999999999999999999998   999999999999999999999999998875543222 22234588


Q ss_pred             CcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhc
Q 004312          648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQ  727 (762)
Q Consensus       648 ~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  727 (762)
                      +.|+|||.+.+..++.++||||||+++|||++|+.|+.............  ....+.  .......+..+.+++.+||+
T Consensus       179 ~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~l~~li~~~l~  254 (285)
T cd06648         179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR--DNLPPK--LKNLHKVSPRLRSFLDRMLV  254 (285)
T ss_pred             ccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH--hcCCCC--CcccccCCHHHHHHHHHHcc
Confidence            99999999988889999999999999999999999975443222221110  000001  11122356789999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 004312          728 EDPSHRPTMRRVTQ  741 (762)
Q Consensus       728 ~dp~~RPt~~evl~  741 (762)
                      .+|++||+++++++
T Consensus       255 ~~p~~Rpt~~~il~  268 (285)
T cd06648         255 RDPAQRATAAELLN  268 (285)
T ss_pred             cChhhCcCHHHHcc
Confidence            99999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.4e-34  Score=297.64  Aligned_cols=247  Identities=26%  Similarity=0.359  Sum_probs=205.1

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      ++.+.||+|++|.||++.... +++.|+||++..... .....+.+|++.+.+++|+||+++++++......++|+||++
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06623           4 ERVKVLGQGSSGVVYKVRHKP-TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD   82 (264)
T ss_pred             eeeeeeeecCCeEEEEEEEcC-CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence            345789999999999997654 567899999876543 446789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE-ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      +++|.+++.....+++..+..++.|+++||+|||+ .   +++||||+|+||++++++.++|+|||++......... ..
T Consensus        83 ~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~  158 (264)
T cd06623          83 GGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CN  158 (264)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-cc
Confidence            99999999887889999999999999999999999 8   9999999999999999999999999999876433322 12


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhh--HHHhhhccccccccccccccCCCHH-HHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDW--AYDCYQERTLGALVENDLEAMDDMT-VLQRFV  719 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  719 (762)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|+.|+....  .....    ...+...... ..+.. .+..+.
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~l~  233 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL----MQAICDGPPP-SLPAEEFSPEFR  233 (264)
T ss_pred             ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH----HHHHhcCCCC-CCCcccCCHHHH
Confidence            3457889999999999999999999999999999999999974432  11111    1111111111 12223 668899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+||+.+|++||+++|+++
T Consensus       234 ~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         234 DFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             HHHHHHccCChhhCCCHHHHHh
Confidence            9999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=304.16  Aligned_cols=247  Identities=22%  Similarity=0.261  Sum_probs=199.3

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc---hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD---SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.||+|++|.||++... ++++.+|+|.+......   ..+.+.+|++++++++|+||+++++.+.+....++||||+
T Consensus         5 ~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   83 (316)
T cd05574           5 KIKLLGKGDVGRVFLVRLK-GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC   83 (316)
T ss_pred             EeeeecCCccEEEEEEEEc-CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence            4467999999999999754 45679999998754322   4457899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc-
Q 004312          563 SNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-  639 (762)
Q Consensus       563 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-  639 (762)
                      ++++|.+++...  ..+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++......... 
T Consensus        84 ~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             CCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999998754  5689999999999999999999998   9999999999999999999999999998754321110 


Q ss_pred             ---------------------------ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHh
Q 004312          640 ---------------------------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDC  692 (762)
Q Consensus       640 ---------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~  692 (762)
                                                 ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                       11123578899999999988999999999999999999999999854432222


Q ss_pred             hhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 004312          693 YQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPT----MRRVTQ  741 (762)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt----~~evl~  741 (762)
                      +..     +.............+..+.+++.+||+.+|++||+    ++|+++
T Consensus       241 ~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         241 FSN-----ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHH-----HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            211     11122121122235788999999999999999999    777665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.1e-34  Score=297.31  Aligned_cols=250  Identities=24%  Similarity=0.362  Sum_probs=200.4

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc------chhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      ..+.||+|++|.||+|... .+++.+|+|.+.....      ...+.+.+|++.+++++|+||+++++++.+.+..++|+
T Consensus         4 ~~~~lg~g~~~~v~~~~~~-~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~   82 (268)
T cd06630           4 KGQQLGTGAFSSCYQARDV-KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV   82 (268)
T ss_pred             ccceecCcCceEEEEEEEc-CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence            3467999999999999753 4567899999864321      13467899999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC-ceEEecccccccccCCCC
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY-NARISDFGLEKLLTLDQS  638 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~  638 (762)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++ .+||+|||++..+.....
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          83 EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             eccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            9999999999998878899999999999999999999999   999999999999998765 599999999987654321


Q ss_pred             c---ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          639 H---TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       639 ~---~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                      .   ......++..|+|||.+.+..++.++||||+|+++++|++|+.|+..........  ..............+...+
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA--LIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH--HHHHHhccCCCCCCchhhC
Confidence            1   1223457889999999988889999999999999999999999974321110000  0101111111222344567


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .++.+++.+||+.+|++||++.|+++
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            88999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-33  Score=308.57  Aligned_cols=245  Identities=21%  Similarity=0.271  Sum_probs=188.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+|... ++++.||+|+....      ....|+.++++++|+||+++++++.+....++|+||+.
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~-~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  140 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKP-GQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS  140 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEEC-CCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence            455678999999999999754 45678999975432      33568999999999999999999999999999999995


Q ss_pred             CCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                       ++|.+++.. ...+++..+..|+.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus       141 -~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~  214 (357)
T PHA03209        141 -SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFL  214 (357)
T ss_pred             -CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--cccc
Confidence             588888765 46789999999999999999999998   9999999999999999999999999999754321  2223


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHH-----hhhcccccccc------ccccc----
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYD-----CYQERTLGALV------ENDLE----  707 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~-----~~~~~~~~~~~------~~~~~----  707 (762)
                      ...||+.|+|||.+.+..++.++|||||||++|||+++..++.......     ......+..++      .....    
T Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  294 (357)
T PHA03209        215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG  294 (357)
T ss_pred             cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence            4568999999999999999999999999999999999776642211000     00000000000      00000    


Q ss_pred             ----------------------cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          708 ----------------------AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       708 ----------------------~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                                            .......+..+..++.+||+.||++|||++|+++
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence                                  0000122445667999999999999999999987

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=306.89  Aligned_cols=240  Identities=26%  Similarity=0.356  Sum_probs=200.7

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccc---cccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      +.||.|+||.||.+.. ..+.+.||||++.-   .......++..|++.|.+++|||++.+-||+......+|||||| -
T Consensus        32 rEIGHGSFGAVYfArd-~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-l  109 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARD-VRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-L  109 (948)
T ss_pred             HHhcCCccceeEEeec-cCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-h
Confidence            5699999999999964 45668999999963   33445678999999999999999999999999999999999999 4


Q ss_pred             CchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          565 GALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       565 gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      |+-.++|.-+ +++.+..+..|..+.+.||+|||+.   +.||||||+.||||++.|.|||+|||.+.+..+     -..
T Consensus       110 GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----Ans  181 (948)
T KOG0577|consen  110 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----ANS  181 (948)
T ss_pred             ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-----hhc
Confidence            5777777644 6788999999999999999999999   999999999999999999999999999987643     334


Q ss_pred             ccccCcccCccccc---CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       644 ~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ++|||.|||||++.   .+.|+-|+||||||++-.||.-.+.|.+...+......     +..++.......+.++.++.
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH-----IAQNesPtLqs~eWS~~F~~  256 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-----IAQNESPTLQSNEWSDYFRN  256 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH-----HHhcCCCCCCCchhHHHHHH
Confidence            67999999999974   57899999999999999999999999765544332221     11122222235578899999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ++..||+.-|.+|||.++++..
T Consensus       257 Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  257 FVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             HHHHHHhhCcccCCcHHHHhhc
Confidence            9999999999999999988763

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7e-34  Score=312.00  Aligned_cols=250  Identities=25%  Similarity=0.286  Sum_probs=191.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccC------Cce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------RNR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~  555 (762)
                      +.+.+.||+|+||.||++... ..++.||||++....  ....+.+.+|+.+++.++||||+++++.+...      ...
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~  104 (364)
T cd07875          26 YQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  104 (364)
T ss_pred             eeEEEEeecCCCeEEEEEEEC-CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence            445578999999999999643 456789999987532  23346788999999999999999999987543      357


Q ss_pred             eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          556 LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ++||||+++ +|.+++.  ..+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+|||+++....
T Consensus       105 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         105 YIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             EEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            999999975 6666664  3478889999999999999999998   999999999999999999999999999986532


Q ss_pred             CCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc-----------------c
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT-----------------L  698 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~-----------------~  698 (762)
                      .  .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||......+.+....                 .
T Consensus       179 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (364)
T cd07875         179 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  256 (364)
T ss_pred             C--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence            2  22234568999999999999999999999999999999999999985432211111000                 0


Q ss_pred             cccccc--------------cc----ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          699 GALVEN--------------DL----EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       699 ~~~~~~--------------~~----~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ......              ..    ..........++.+++.+||+.||++|||++|+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000000              00    000011124578899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.7e-34  Score=301.42  Aligned_cols=250  Identities=22%  Similarity=0.293  Sum_probs=192.8

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.||+|++|.||+|+.. .+++.||||+++...  ....+.+.+|+.++.+++||||+++++++.++...++||||++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (285)
T cd07861           4 KIEKIGEGTYGVVYKGRNK-KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS   82 (285)
T ss_pred             EeeEecccCceEEEEEEEC-CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence            4578999999999999754 346789999986432  2234678899999999999999999999999999999999997


Q ss_pred             CCchhhhccCC---CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          564 NGALASFLFGD---SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       564 ~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                       ++|.+++...   ..+++..+..++.||++||+|||+.   +|+||||||+||++++++.+||+|||++....... ..
T Consensus        83 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~  157 (285)
T cd07861          83 -MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RV  157 (285)
T ss_pred             -CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cc
Confidence             6888887543   4689999999999999999999998   99999999999999999999999999997654322 12


Q ss_pred             cccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------c------ccc---
Q 004312          641 NTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------T------LGA---  700 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~------~~~---  700 (762)
                      .....+++.|+|||.+.+. .++.++||||||+++|||++|+.|+............          .      ...   
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence            2233568899999988654 5789999999999999999999987543221111000          0      000   


Q ss_pred             ccccccc---cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          701 LVENDLE---AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       701 ~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .......   .......++++.+++.+||+.||++|||+++|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000000   0001124577889999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.3e-34  Score=300.63  Aligned_cols=252  Identities=23%  Similarity=0.293  Sum_probs=198.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|++|.||+|... .+++.||+|++....  ....+.+.+|++++++++|+||+++++++......++||||+
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   82 (286)
T cd07847           4 EKLSKIGEGSYGVVFKCRNR-ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC   82 (286)
T ss_pred             eeeeeecccCCeEEEEEEEC-CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence            44577999999999999765 346789999886432  223457889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ++++|..++.....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........ ...
T Consensus        83 ~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~  158 (286)
T cd07847          83 DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYT  158 (286)
T ss_pred             CccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-ccc
Confidence            9999999887777899999999999999999999998   999999999999999999999999999987643321 122


Q ss_pred             cccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc------cccc-------------ccc
Q 004312          643 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE------RTLG-------------ALV  702 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~------~~~~-------------~~~  702 (762)
                      ...++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....      ....             ...
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07847         159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS  238 (286)
T ss_pred             CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence            3457889999999876 4688999999999999999999998743322111100      0000             000


Q ss_pred             ccccccCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          703 ENDLEAMDD-----MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       703 ~~~~~~~~~-----~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+......+     ...+..+.+++.+||+.+|++||++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            000000000     123577899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.9e-34  Score=312.18  Aligned_cols=250  Identities=26%  Similarity=0.306  Sum_probs=191.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccC------Cce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------RNR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~  555 (762)
                      +.+.+.||+|+||.||++... ..++.||||++....  ......+.+|+.+++.++||||+++++++...      ...
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   97 (355)
T cd07874          19 YQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV   97 (355)
T ss_pred             eeEEEEeeecCCEEEEEEEec-CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence            344578999999999999643 456789999987542  23346788999999999999999999987543      356


Q ss_pred             eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          556 LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ++||||+++ +|...+.  ..+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+|||+++....
T Consensus        98 ~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~  171 (355)
T cd07874          98 YLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_pred             EEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence            899999976 5666654  3478889999999999999999998   999999999999999999999999999986532


Q ss_pred             CCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc-----------------cc
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER-----------------TL  698 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~-----------------~~  698 (762)
                        ........+|+.|+|||.+.+..++.++||||||+++|||++|+.||........+...                 ..
T Consensus       172 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         172 --SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             --ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence              22223456899999999999989999999999999999999999997543221111000                 00


Q ss_pred             cccccc---------------cc---ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          699 GALVEN---------------DL---EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       699 ~~~~~~---------------~~---~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ...+..               ..   ..........++.+++.+||+.||++|||++|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            000000               00   000111234678999999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.4e-34  Score=302.17  Aligned_cols=251  Identities=20%  Similarity=0.294  Sum_probs=193.1

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|++|.||+|... .+++.+|+|+++...  ......+.+|++++++++|+||+++++++.+....++|+||+
T Consensus         3 ~~~~~l~~g~~~~vy~~~~~-~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           3 EKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             eeEEEecccCCeEEEEEEEC-CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            34578999999999999754 446789999986432  223456888999999999999999999999999999999999


Q ss_pred             CCCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          563 SNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       563 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      ++ +|.+++.. ...+++..+..++.||++||.|||+.   +|+||||||+||+++.++.+||+|||+++.+.... ...
T Consensus        82 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~  156 (284)
T cd07839          82 DQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCY  156 (284)
T ss_pred             CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCc
Confidence            74 77777754 46789999999999999999999998   99999999999999999999999999998654322 122


Q ss_pred             ccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHH-hhhcc-------------ccccccccc-
Q 004312          642 TAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYD-CYQER-------------TLGALVEND-  705 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~-~~~~~-------------~~~~~~~~~-  705 (762)
                      ....+++.|+|||.+.+. .++.++||||||+++|||++|+.|+....... .....             ......... 
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            234578899999998764 47899999999999999999999853321111 00000             000000000 


Q ss_pred             ---cc-----cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          706 ---LE-----AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       706 ---~~-----~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                         ..     .......++++.+++.+||+.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence               00     0011234678899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.6e-34  Score=316.81  Aligned_cols=246  Identities=20%  Similarity=0.218  Sum_probs=190.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      .+.+.||+|+||.||++... ..++.||||...      ...+.+|++++++++|+|||++++++..++..+||||++. 
T Consensus       172 ~i~~~Lg~G~~G~Vy~a~~~-~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-  243 (461)
T PHA03211        172 AIHRALTPGSEGCVFESSHP-DYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-  243 (461)
T ss_pred             EEEEEEccCCCeEEEEEEEC-CCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence            34578999999999999755 446789999642      2346789999999999999999999999999999999995 


Q ss_pred             CchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc-ccc
Q 004312          565 GALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-TNT  642 (762)
Q Consensus       565 gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~  642 (762)
                      ++|.+++... ..+++..++.|+.||++||.|||++   +|+||||||+||||+.++.+||+|||+++........ ...
T Consensus       244 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  320 (461)
T PHA03211        244 SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY  320 (461)
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence            6888888654 5689999999999999999999998   9999999999999999999999999999876433221 223


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhh-----------HHHhhhccccc--ccc---cc--
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDW-----------AYDCYQERTLG--ALV---EN--  704 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~-----------~~~~~~~~~~~--~~~---~~--  704 (762)
                      ...||+.|+|||++.+..++.++|||||||+||||++|..++....           ....+......  ...   ..  
T Consensus       321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l  400 (461)
T PHA03211        321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL  400 (461)
T ss_pred             ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence            4569999999999999999999999999999999999887643211           00011100000  000   00  


Q ss_pred             -----------cccc-C-C----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          705 -----------DLEA-M-D----DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       705 -----------~~~~-~-~----~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                                 .... . .    .......+.+|+.+||+.||++|||+.|+++
T Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence                       0000 0 0    0022346889999999999999999999997

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1e-33  Score=296.01  Aligned_cols=251  Identities=26%  Similarity=0.379  Sum_probs=201.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .+.+.||.|++|+||+|.... +++.+++|++.... ....+.+.+|+++++.++|+||+++++.+......++|+|+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   82 (267)
T cd06610           4 ELIEVIGVGATAVVYAAICLP-NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS   82 (267)
T ss_pred             eeeeeecCCCCeEEEEEEEcC-CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence            456789999999999997543 56789999986432 2345789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC---CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc-
Q 004312          564 NGALASFLFGD---SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-  639 (762)
Q Consensus       564 ~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-  639 (762)
                      +++|.+++...   ..+++.....++.|++.||+|||+.   +++||||+|+||++++++.+||+|||++..+...... 
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            99999999764   4589999999999999999999998   9999999999999999999999999999876544332 


Q ss_pred             --ccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccC-CCHHHH
Q 004312          640 --TNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM-DDMTVL  715 (762)
Q Consensus       640 --~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  715 (762)
                        ......++..|+|||.+... ..+.++|+||||+++|||++|+.|+..........+... . ..+..... .....+
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~  237 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ-N-DPPSLETGADYKKYS  237 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc-C-CCCCcCCcccccccc
Confidence              22334588999999998877 789999999999999999999999754322211111100 0 00011110 112456


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +.+.+++.+||+.+|++||+++++++
T Consensus       238 ~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         238 KSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            78899999999999999999999987

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.1e-33  Score=299.39  Aligned_cols=248  Identities=24%  Similarity=0.319  Sum_probs=193.3

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceec-----cCCceeEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCD-----EGRNRLLV  558 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~-----~~~~~~LV  558 (762)
                      .+.+.||+|+||.||++... ..++.+|+|++... .....++.+|+.+++++ +||||+++++++.     .+...++|
T Consensus        21 ~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   98 (286)
T cd06638          21 EIIETIGKGTYGKVFKVLNK-KNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV   98 (286)
T ss_pred             eeeeeeccCCCcEEEEEEEC-CCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence            34578999999999999764 34678999987653 23346788999999999 7999999999874     34568999


Q ss_pred             EeccCCCchhhhcc----CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccccc
Q 004312          559 YEFMSNGALASFLF----GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT  634 (762)
Q Consensus       559 ~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~  634 (762)
                      |||+++++|.+++.    ....+++..+..++.|+++||.|||+.   +|+||||||+||++++++.+||+|||+++...
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (286)
T cd06638          99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  175 (286)
T ss_pred             EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence            99999999998875    235688999999999999999999998   99999999999999999999999999988654


Q ss_pred             CCCCcccccccccCcccCcccccC-----CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccC
Q 004312          635 LDQSHTNTAIRGTKGYVAPEWFRN-----MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM  709 (762)
Q Consensus       635 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  709 (762)
                      .... ......|++.|+|||.+..     ..++.++||||||+++|||++|+.|+.............  .....  ...
T Consensus       176 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~--~~~~~--~~~  250 (286)
T cd06638         176 STRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP--RNPPP--TLH  250 (286)
T ss_pred             cCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc--ccCCC--ccc
Confidence            3221 2233468999999999853     457899999999999999999999975432222211100  00000  111


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          710 DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       710 ~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      .+...+.++.+++.+||+.+|++|||++|+++.
T Consensus       251 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            122245678999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=7.9e-34  Score=301.46  Aligned_cols=241  Identities=24%  Similarity=0.297  Sum_probs=199.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|++|.||++.... .++.+|+|.+....   ......+.+|++++++++||||+++++.+.++...++||||
T Consensus         4 ~~~~~ig~g~~~~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (290)
T cd05580           4 EFIKTLGTGSFGRVMLVRHKG-SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY   82 (290)
T ss_pred             EEEEEeecCCCeEEEEEEEcC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence            455789999999999997653 56789999986532   22345788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++++|.+++.....++...+..++.|+++||.|||+.   +|+|+||+|+||++++++.+||+|||+++.....    .
T Consensus        83 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~  155 (290)
T cd05580          83 VPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----T  155 (290)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----C
Confidence            99999999998888899999999999999999999998   9999999999999999999999999999876433    2


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ....+++.|+|||.+.+...+.++||||||+++|+|++|+.|+...........     .....  ...+...+..+.++
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~--~~~~~~~~~~l~~l  228 (290)
T cd05580         156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK-----ILEGK--VRFPSFFSPDAKDL  228 (290)
T ss_pred             CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HhcCC--ccCCccCCHHHHHH
Confidence            344688999999999888899999999999999999999999754322111111     11111  11222346788999


Q ss_pred             HHHhhccCCCCCC-----CHHHHH
Q 004312          722 AIWCIQEDPSHRP-----TMRRVT  740 (762)
Q Consensus       722 i~~cl~~dp~~RP-----t~~evl  740 (762)
                      +.+||+.+|.+||     +++|++
T Consensus       229 i~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         229 IRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             HHHHccCCHHHccCcccCCHHHHH
Confidence            9999999999998     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1e-33  Score=295.45  Aligned_cols=246  Identities=24%  Similarity=0.375  Sum_probs=199.9

Q ss_pred             cCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCc
Q 004312          490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       490 iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      ||+|+||.||+++.. .+++.+++|.+.....   ...+.+.+|++++++++|+||+++++.+..+...++|+||+++++
T Consensus         1 lg~g~~~~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKK-STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEEC-CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence            689999999999765 4467899999865433   345678999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC-------c
Q 004312          567 LASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-------H  639 (762)
Q Consensus       567 L~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-------~  639 (762)
                      |.+++.+...+++..+..++.||++||+|||+.   +++|+||+|+||++++++.+||+|||++........       .
T Consensus        80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            999998877899999999999999999999998   999999999999999999999999999876543221       1


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ......++..|+|||.+.....+.++||||||+++|+|++|+.|+...........     ..............+..+.
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  231 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN-----ILNGKIEWPEDVEVSDEAI  231 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HhcCCcCCCccccCCHHHH
Confidence            22334578899999999888899999999999999999999999754432222211     1111111111112367889


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHhh
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~~L~  744 (762)
                      +++.+||+.+|++|||+.++.+.|+
T Consensus       232 ~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         232 DLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             HHHHHHhcCCHhhcCCCccHHHHhc
Confidence            9999999999999999966666664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=7.8e-34  Score=296.30  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=198.9

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceecc--CCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~LV~E  560 (762)
                      .+.+.||.|+||.||++... .+++.+|+|++...  .....+.+.+|++++++++|+||+++++++..  +...+++||
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           3 EVLETIGKGSFGTVRKVRRK-SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             eeeeeeccCCCeEEEEeeec-CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            34577999999999999754 45678999988643  23344678899999999999999999997753  456789999


Q ss_pred             ccCCCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcC--CCCeEeCCCCCCceEEcCCCceEEeccccccccc
Q 004312          561 FMSNGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEEC--CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT  634 (762)
Q Consensus       561 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~  634 (762)
                      |+++++|.+++..    ...+++..+..++.||++||+|||..+  ..+++|+||+|+||++++++.+||+|||++....
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~  161 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG  161 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence            9999999999865    357899999999999999999999332  2399999999999999999999999999998765


Q ss_pred             CCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHH
Q 004312          635 LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  714 (762)
                      ..... .....+++.|+|||.+....++.++||||||+++++|++|+.|+..........      .+........+...
T Consensus       162 ~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~  234 (265)
T cd08217         162 HDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS------KIKEGKFRRIPYRY  234 (265)
T ss_pred             CCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHH------HHhcCCCCCCcccc
Confidence            43321 233468999999999999889999999999999999999999975432111111      11111112223456


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          715 LQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +.++.+++.+||+.+|++||++++|++
T Consensus       235 ~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         235 SSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            688999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=8.7e-34  Score=295.06  Aligned_cols=246  Identities=20%  Similarity=0.297  Sum_probs=200.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|+||.||++... .+++.||+|++...  .....+++.+|++++++++||||+++++++.+.+..++|+||+
T Consensus         3 ~~~~~lg~g~~g~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           3 VKVKKIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             eEEEEeccCCceEEEEEEEc-CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            34578999999999999765 35678999998643  2334468999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          563 SNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       563 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      ++++|.+++...  ..+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........ .
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~  157 (256)
T cd08218          82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-L  157 (256)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-h
Confidence            999999998754  3578999999999999999999998   999999999999999999999999999986543221 1


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....+++.|+|||.+.+...+.++||||||+++++|++|+.|+......+....     .+... ....+...+.++.+
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~~~  231 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK-----IIRGS-YPPVSSHYSYDLRN  231 (256)
T ss_pred             hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH-----HhcCC-CCCCcccCCHHHHH
Confidence            2234578899999999988999999999999999999999999754322222111     11111 11123345678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~  741 (762)
                      ++.+||+.+|++||++++|++
T Consensus       232 li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         232 LVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             HHHHHhhCChhhCcCHHHHhh
Confidence            999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.4e-33  Score=298.35  Aligned_cols=252  Identities=21%  Similarity=0.269  Sum_probs=197.6

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|++|.||+|... .+++.||||++....  ......+.+|+.++++++||||+++++++..+...++||||+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           3 KILGRIGEGAHGIVFKAKDR-ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             eEEeecccCCCcEEEEEEEC-CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            45678999999999999764 346789999987543  333568999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          563 SNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       563 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                       +++|.+++... ..+++.++..++.||++||+|||+.   +++|+||||+||++++++.++|+|||++...........
T Consensus        82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence             99999998654 5689999999999999999999998   999999999999999999999999999987654433223


Q ss_pred             ccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc--c-----------------cccc
Q 004312          642 TAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER--T-----------------LGAL  701 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~--~-----------------~~~~  701 (762)
                      ....++..|+|||.+.+. .++.++||||+|++++||++|+.++............  .                 ....
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            345688999999998654 4689999999999999999997665332211111000  0                 0000


Q ss_pred             ccccccc----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          702 VENDLEA----MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       702 ~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .......    ......+..+.+++.+||+.+|++||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0000000    000123578899999999999999999999987

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-33  Score=293.95  Aligned_cols=245  Identities=24%  Similarity=0.341  Sum_probs=198.2

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|++|.||++... .+++.+|||++...  .......+.+|++++++++||||+++++.+..++..++||||+
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           3 EKIRVVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             eEEEEecccCceEEEEEEEc-CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            45578999999999999754 45678999998653  2334567999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC-CceEEecccccccccCCCCc
Q 004312          563 SNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY-YNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       563 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~~~~~~  639 (762)
                      ++++|.+++...  ..+++..+..++.++++||+|||++   +++|+||+|+||+++++ ..+||+|||++.......  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--  156 (256)
T cd08220          82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--  156 (256)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence            999999999764  3578999999999999999999998   99999999999999854 468999999998764322  


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ......++..|+|||.+.....+.++||||||+++|+|++|+.|+...........     ..... ....+...+..+.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~l~  230 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK-----IMSGT-FAPISDRYSPDLR  230 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHH-----HHhcC-CCCCCCCcCHHHH
Confidence            22234578899999999988899999999999999999999999744322111111     11111 1111223567889


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+||+.+|++|||++|+++
T Consensus       231 ~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         231 QLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             HHHHHHccCChhhCCCHHHHhh
Confidence            9999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.6e-33  Score=299.61  Aligned_cols=249  Identities=24%  Similarity=0.327  Sum_probs=201.3

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||++... .+++.|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   99 (293)
T cd06647          21 YTRFEKIGQGASGTVYTAIDV-ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA   99 (293)
T ss_pred             ceeeeEecCCCCeEEEEEEEc-CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence            445678999999999999643 3467899999875555556788999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +++|.+++.+. .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........ ....
T Consensus       100 ~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~  174 (293)
T cd06647         100 GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST  174 (293)
T ss_pred             CCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cccc
Confidence            99999998653 578999999999999999999998   999999999999999999999999999876543322 2223


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..+++.|+|||.+....++.++||||||+++|++++|+.||...........    ...............+..+.+++.
T Consensus       175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~  250 (293)
T cd06647         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNGTPELQNPEKLSAIFRDFLN  250 (293)
T ss_pred             ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee----hhcCCCCCCCCccccCHHHHHHHH
Confidence            4588899999999888899999999999999999999999754321111100    000111111112235667889999


Q ss_pred             HhhccCCCCCCCHHHHHHH
Q 004312          724 WCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       724 ~cl~~dp~~RPt~~evl~~  742 (762)
                      +||+.+|++||++++++..
T Consensus       251 ~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         251 RCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HHccCChhhCcCHHHHhcC
Confidence            9999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-33  Score=295.31  Aligned_cols=241  Identities=23%  Similarity=0.302  Sum_probs=198.2

Q ss_pred             cCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCc
Q 004312          490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       490 iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      ||.|++|.||+++.. ..++.+|+|.+.+...   ...+.+.+|+.++++++||||+++++.+.++...++|+||+++++
T Consensus         1 lg~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVK-SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEEC-CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            799999999999864 4567899999865322   344679999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccccc
Q 004312          567 LASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG  646 (762)
Q Consensus       567 L~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g  646 (762)
                      |.+++.+...+++..+..++.||+.||.|||+.   +++|+||+|+||+++.++.+||+|||+++......  ......+
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~  154 (262)
T cd05572          80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG  154 (262)
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence            999998888899999999999999999999998   99999999999999999999999999998764332  2233467


Q ss_pred             cCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhh--HHHhhhccccccccccccccCCCHHHHHHHHHHHHH
Q 004312          647 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDW--AYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW  724 (762)
Q Consensus       647 t~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  724 (762)
                      ++.|++||.+....++.++|+||||+++|+|++|+.|+....  ......     ...........+...+.++.+++.+
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~i~~  229 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN-----DILKGNGKLEFPNYIDKAAKDLIKQ  229 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHH-----HHhccCCCCCCCcccCHHHHHHHHH
Confidence            889999999988889999999999999999999999975443  111111     1111111222233346789999999


Q ss_pred             hhccCCCCCCC-----HHHHHH
Q 004312          725 CIQEDPSHRPT-----MRRVTQ  741 (762)
Q Consensus       725 cl~~dp~~RPt-----~~evl~  741 (762)
                      ||+.+|++||+     ++|+++
T Consensus       230 ~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         230 LLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HccCChhhCcCCcccCHHHHhc
Confidence            99999999999     666655

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.4e-33  Score=297.32  Aligned_cols=249  Identities=26%  Similarity=0.344  Sum_probs=194.3

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccC--CceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--RNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~LV~E~~  562 (762)
                      +.+.||.|++|.||++.... .++.+|+|.+..... ....++.+|++++++++||||+++++++.+.  ...++||||+
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   83 (287)
T cd06621           5 ELSRLGEGAGGSVTKCRLKN-TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC   83 (287)
T ss_pred             EEEEeccCCceEEEEEEECC-CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence            34679999999999997653 567899999875322 3456799999999999999999999988543  4679999999


Q ss_pred             CCCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          563 SNGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       563 ~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      ++++|.+++..    ...+++..+..++.||+.||+|||+.   +++|+||+|+||++++++.++|+|||++....... 
T Consensus        84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-  159 (287)
T cd06621          84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-  159 (287)
T ss_pred             CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence            99999988643    35678999999999999999999998   99999999999999999999999999987543221 


Q ss_pred             cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccc---cccc--cCCCHH
Q 004312          639 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE---NDLE--AMDDMT  713 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~--~~~~~~  713 (762)
                        .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+................+..   +...  ......
T Consensus       160 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd06621         160 --AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK  237 (287)
T ss_pred             --cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence              123457889999999999999999999999999999999999975431100000000000000   0000  011123


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          714 VLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       714 ~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .++.+.+++.+||+.+|++|||+.|+++
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         238 WSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             hHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            4678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=9.2e-34  Score=321.14  Aligned_cols=249  Identities=22%  Similarity=0.296  Sum_probs=185.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc------cCCccchhceeccC-Ccee
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH------HKNLVRLLGYCDEG-RNRL  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~nIv~l~g~~~~~-~~~~  556 (762)
                      +.+.++||+|+||+||+|... ..++.||||+++... ....++..|+.++++++      |.+++++++++... ...+
T Consensus       131 y~i~~~lG~G~fg~V~~a~~~-~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        131 FKILSLLGEGTFGKVVEAWDR-KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             EEEEEEEEeccCEEEEEEEEc-CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            445678999999999999754 446789999986432 22344556666666654      45688888888654 4678


Q ss_pred             EEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC----------------
Q 004312          557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY----------------  620 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----------------  620 (762)
                      +|||++ +++|.+++.+.+.+++..+..|+.||+.||+|||++  .+|+||||||+|||++.++                
T Consensus       209 iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~  285 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC  285 (467)
T ss_pred             EEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence            999988 778999998888899999999999999999999973  2899999999999998765                


Q ss_pred             ceEEecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc--ccc
Q 004312          621 NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTL  698 (762)
Q Consensus       621 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~--~~~  698 (762)
                      .+||+|||.+...    ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+....  ..+
T Consensus       286 ~vkl~DfG~~~~~----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~  361 (467)
T PTZ00284        286 RVRICDLGGCCDE----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL  361 (467)
T ss_pred             eEEECCCCccccC----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence            4999999987532    2223456799999999999999999999999999999999999999854322111100  000


Q ss_pred             c----------------ccccc--ccccC---------------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          699 G----------------ALVEN--DLEAM---------------DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       699 ~----------------~~~~~--~~~~~---------------~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .                .+...  .+...               ........+.+|+.+||+.||++|||++|+++
T Consensus       362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            0                00000  00000               00012355789999999999999999999986

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.1e-33  Score=296.07  Aligned_cols=247  Identities=23%  Similarity=0.346  Sum_probs=199.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||.||+|... .+++.+|+|.+.... ....+.+.+|+.++.+++||||+++++++..+...++||||+
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhheeEeecCCeEEEEEEEC-CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            445678999999999999654 346789999876432 233467899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ++++|.+++.. ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~  159 (277)
T cd06641          85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRN  159 (277)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhc
Confidence            99999999864 4688999999999999999999998   99999999999999999999999999987654322 1222


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|..|+...........      +........+...+.++.+++
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~i  233 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL------IPKNNPPTLEGNYSKPLKEFV  233 (277)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH------HhcCCCCCCCcccCHHHHHHH
Confidence            34578899999999988899999999999999999999999743322211111      111111112234567788999


Q ss_pred             HHhhccCCCCCCCHHHHHHH
Q 004312          723 IWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       723 ~~cl~~dp~~RPt~~evl~~  742 (762)
                      .+||+.+|++||+++++++.
T Consensus       234 ~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         234 EACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             HHHccCChhhCcCHHHHHhC
Confidence            99999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-33  Score=295.04  Aligned_cols=247  Identities=23%  Similarity=0.344  Sum_probs=198.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc-ccchhHHHHHHhhhhcccc---cCCccchhceeccCCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTH---HKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +.+.+.||+|+||.||+|... .+++.+|+|.+... ......++.+|+.++++++   |||++++++++..+...++||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHV-PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhheeccCCceEEEEEEc-CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            345678999999999999764 45678999998654 2334567889999999986   999999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      ||+++++|.+++... .+++.....++.|++.||.|||+.   +|+|+||+|+||++++++.++|+|||++..+..... 
T Consensus        82 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06917          82 EYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-  156 (277)
T ss_pred             ecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-
Confidence            999999999998654 789999999999999999999998   999999999999999999999999999987654332 


Q ss_pred             ccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      ......|+..|+|||.+.++ .++.++||||||+++|+|++|+.|+...........  ......+   .......+.++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~--~~~~~~~---~~~~~~~~~~~  231 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML--IPKSKPP---RLEDNGYSKLL  231 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc--cccCCCC---CCCcccCCHHH
Confidence            22334688999999998754 578999999999999999999999754322211110  0000001   11111255788


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+++.+||+.+|++||++.|+++
T Consensus       232 ~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         232 REFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             HHHHHHHcCCCcccCcCHHHHhh
Confidence            99999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.4e-33  Score=289.94  Aligned_cols=246  Identities=25%  Similarity=0.364  Sum_probs=202.8

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      ..+.||+|++|.||++.... +++.+++|++........+.+.+|++.+++++|+|++++++++......++++||++++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~   82 (253)
T cd05122           4 ILEKIGKGGFGEVYKARHKR-TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG   82 (253)
T ss_pred             eeeeeccCCceEEEEEEECC-CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence            34679999999999997653 46789999998765556778999999999999999999999999999999999999999


Q ss_pred             chhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccc
Q 004312          566 ALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI  644 (762)
Q Consensus       566 sL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  644 (762)
                      +|.+++... ..+++..+..++.|+++||.|||+.   +++||||+|+||++++++.++|+|||.+........  ....
T Consensus        83 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~  157 (253)
T cd05122          83 SLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTM  157 (253)
T ss_pred             cHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccce
Confidence            999999776 6789999999999999999999998   999999999999999999999999999987654322  3345


Q ss_pred             cccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHH
Q 004312          645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW  724 (762)
Q Consensus       645 ~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  724 (762)
                      .++..|+|||.+.....+.++||||||+++++|++|+.|+..............  ...+  ........+..+.+++.+
T Consensus       158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~i~~  233 (253)
T cd05122         158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGPP--GLRNPEKWSDEFKDFLKK  233 (253)
T ss_pred             ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cCCC--CcCcccccCHHHHHHHHH
Confidence            688999999999888899999999999999999999999754321111111000  0000  111122236789999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 004312          725 CIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       725 cl~~dp~~RPt~~evl~  741 (762)
                      ||+.+|++|||+.|+++
T Consensus       234 ~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         234 CLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HccCChhhCCCHHHHhc
Confidence            99999999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.5e-33  Score=300.98  Aligned_cols=251  Identities=20%  Similarity=0.284  Sum_probs=194.3

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .+.+.||+|+||.||+|... .+++.||+|.+.... ......+.+|+.++++++||||+++++++......++||||++
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~   87 (301)
T cd07873           9 IKLDKLGEGTYATVYKGRSK-LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD   87 (301)
T ss_pred             EEeeEeccCcCEEEEEEEEc-CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence            44578999999999999754 456789999986432 2334567899999999999999999999999999999999997


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                       ++|.+++... ..+++..+..++.||++||+|||+.   +|+|+||||+||++++++.+||+|||++....... ....
T Consensus        88 -~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~  162 (301)
T cd07873          88 -KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYS  162 (301)
T ss_pred             -cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-Cccc
Confidence             5888888654 5688999999999999999999998   99999999999999999999999999997643222 1222


Q ss_pred             cccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc----------ccccccccc------c
Q 004312          643 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE----------RTLGALVEN------D  705 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~----------~~~~~~~~~------~  705 (762)
                      ...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....          ......+..      .
T Consensus       163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (301)
T cd07873         163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN  242 (301)
T ss_pred             ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence            3456889999999865 4588999999999999999999998754322111100          000000000      0


Q ss_pred             ccc-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          706 LEA-------MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       706 ~~~-------~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ...       ......+..+.+++.+||+.||.+|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000       001124567889999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.3e-34  Score=333.28  Aligned_cols=250  Identities=20%  Similarity=0.278  Sum_probs=193.8

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceecc--CCceeEE
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GRNRLLV  558 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~LV  558 (762)
                      .+.+.+.||+|+||+||++... ..++.+|+|.+...  .......|..|+.++++++|||||++++++.+  ....+||
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk-~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV   92 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHK-RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL   92 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEEC-CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence            3556678999999999999765 45678999988643  23345678999999999999999999998754  4568999


Q ss_pred             EeccCCCchhhhccCC----CCCCHHHHHHHHHHHHHHHHHhHhcCC----CCeEeCCCCCCceEEcC------------
Q 004312          559 YEFMSNGALASFLFGD----SKPNWKLRTEIVMGIARGLFYLHEECC----TQIIHCDIKPQNILLDD------------  618 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~ivH~Dlkp~NILl~~------------  618 (762)
                      |||+++|+|.++|...    ..+++..++.|+.||+.||+|||+...    .+||||||||+||||+.            
T Consensus        93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~  172 (1021)
T PTZ00266         93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA  172 (1021)
T ss_pred             EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence            9999999999998652    568999999999999999999998521    25999999999999964            


Q ss_pred             -----CCceEEecccccccccCCCCcccccccccCcccCcccccC--CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHH
Q 004312          619 -----YYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRTILTDWAYD  691 (762)
Q Consensus       619 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~  691 (762)
                           ...+||+|||++..+....  ......||+.|+|||++..  ..++.++|||||||+||||++|+.||.......
T Consensus       173 ~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~  250 (1021)
T PTZ00266        173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS  250 (1021)
T ss_pred             cccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence                 2348999999998654322  2234568999999999854  458999999999999999999999985432221


Q ss_pred             hhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          692 CYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .....     +.... .......+.++.+||..||+.+|.+||++.|+++
T Consensus       251 qli~~-----lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        251 QLISE-----LKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HHHHH-----HhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            11110     11000 0111224577899999999999999999999984

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8e-34  Score=295.81  Aligned_cols=244  Identities=27%  Similarity=0.310  Sum_probs=200.8

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||.|+||.||++... .+++.+|+|.+.+..   ....+.+.+|++++++++||||+++++.+.++...++|+||
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           3 ELLRVIGKGAFGKVCIVQKR-DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             eEEEEeccCCCceEEEEEEc-cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            45578999999999999754 456789999987532   23457899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++++|.+++.....+++..+..++.||++||.|||+.   +++|+||+|+||++++++.++|+|||++.......  ..
T Consensus        82 ~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~  156 (258)
T cd05578          82 LLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT  156 (258)
T ss_pred             CCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence            99999999998777899999999999999999999998   99999999999999999999999999988664332  22


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhH--HHhhhccccccccccccccCCCHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA--YDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.....  ......     .... .....+...+..+.
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-----~~~~-~~~~~~~~~~~~~~  230 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA-----KQET-ADVLYPATWSTEAI  230 (258)
T ss_pred             cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH-----Hhcc-ccccCcccCcHHHH
Confidence            345578899999999888899999999999999999999999754321  111111     1110 11222334568899


Q ss_pred             HHHHHhhccCCCCCCCH--HHHH
Q 004312          720 MVAIWCIQEDPSHRPTM--RRVT  740 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~--~evl  740 (762)
                      +++.+||+.+|.+||++  +|++
T Consensus       231 ~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         231 DAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             HHHHHHccCChhHcCCccHHHHh
Confidence            99999999999999999  5544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.4e-33  Score=301.78  Aligned_cols=253  Identities=25%  Similarity=0.316  Sum_probs=199.4

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      .+...+.||+|+||.||+|+... +++.+|+|++.....   .....+.+|++++++++|+|++++++++.+....++||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVR-TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcC-CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            34456789999999999997543 467899999864322   23357889999999999999999999999999999999


Q ss_pred             eccCCCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          560 EFMSNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       560 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      ||+++ +|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||+|+||++++++.+||+|||++.....   
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---  177 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP---  177 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence            99975 77777654 45689999999999999999999998   999999999999999999999999999875432   


Q ss_pred             cccccccccCcccCccccc---CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          639 HTNTAIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                        .....+++.|+|||.+.   .+.++.++||||||+++|||++|+.|+..........     ...............+
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  250 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-----HIAQNESPTLQSNEWS  250 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH-----HHHhccCCCCCCcccc
Confidence              22345788999999973   4578999999999999999999999975432211111     1111111111223456


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCC
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP  750 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  750 (762)
                      ..+.+++.+||+.+|.+||++.++++.+--....+
T Consensus       251 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         251 DYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence            77899999999999999999999998765544443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-33  Score=305.08  Aligned_cols=249  Identities=24%  Similarity=0.303  Sum_probs=189.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccC------Cce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------RNR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~  555 (762)
                      +.+.+.||+|+||.||++... .+++.||||++.....  ...+.+.+|++++++++||||+++++++...      ...
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07878          17 YQNLTPVGSGAYGSVCSAYDT-RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV   95 (343)
T ss_pred             hhhheecccCCCeEEEEEEEC-CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence            344578999999999999754 4567899999875322  2345678999999999999999999987543      456


Q ss_pred             eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          556 LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ++++|++ +++|.+++. ...+++..+..++.||++||+|||+.   +|+||||||+|||+++++.+||+|||+++....
T Consensus        96 ~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          96 YLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             EEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            8999988 778988775 45689999999999999999999998   999999999999999999999999999986532


Q ss_pred             CCCcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc------ccccccc-----
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER------TLGALVE-----  703 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~------~~~~~~~-----  703 (762)
                          ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||............      .......     
T Consensus       171 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07878         171 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE  246 (343)
T ss_pred             ----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence                1233468999999999876 57899999999999999999999997433211111000      0000000     


Q ss_pred             ------cccccCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          704 ------NDLEAMDD-------MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       704 ------~~~~~~~~-------~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                            ..+.....       ....+.+.+++.+||+.||++|||++|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                  00000000       0123457899999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-35  Score=285.61  Aligned_cols=246  Identities=23%  Similarity=0.317  Sum_probs=206.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .++.++||+|.||.||++.. ..+++.+|||++.-  ..+.+++..|+.++++.+.|++|+++|.+.....++||||||.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH-~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIH-RESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHH-hccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            34567899999999999954 45678999999864  4567899999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      .|+..+.+..+ +++++.++..++.+-++||+|||..   .=||||||+.||||+.+|.+||+|||.+..+...-.. ..
T Consensus       112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-RN  187 (502)
T KOG0574|consen  112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-RN  187 (502)
T ss_pred             CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-hC
Confidence            99999999754 6899999999999999999999998   8899999999999999999999999999877543322 33


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccc-ccCCCHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL-EAMDDMTVLQRFVMV  721 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  721 (762)
                      .+.|||-|||||+++.-.|..++||||||+...||.-|+.|+..-.+.     +.+..+..+.. ....+...+.++-++
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-----RAIFMIPT~PPPTF~KPE~WS~~F~DF  262 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-----RAIFMIPTKPPPTFKKPEEWSSEFNDF  262 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-----ceeEeccCCCCCCCCChHhhhhHHHHH
Confidence            466999999999999999999999999999999999999996432211     11122222211 122345678899999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 004312          722 AIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~  741 (762)
                      ++.||-.+|++|-|+-++++
T Consensus       263 i~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  263 IRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             HHHHhcCCHHHHHHHHHHhh
Confidence            99999999999999988776

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.4e-33  Score=297.58  Aligned_cols=244  Identities=26%  Similarity=0.335  Sum_probs=194.5

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|... .+++.||+|++.....   ...+++.+|++++++++||||+++++++.+.+..++|+|
T Consensus        17 y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   95 (307)
T cd06607          17 FTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME   95 (307)
T ss_pred             hhhheeecCCCCeEEEEEEEc-CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence            445678999999999999764 3467899998864322   234578899999999999999999999999999999999


Q ss_pred             ccCCCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          561 FMSNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |++ |+|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||+|+||++++++.+||+|||++......   
T Consensus        96 ~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---  168 (307)
T cd06607          96 YCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---  168 (307)
T ss_pred             hhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence            997 566666643 45689999999999999999999998   9999999999999999999999999998765322   


Q ss_pred             ccccccccCcccCccccc---CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                        ....+++.|+|||.+.   ...++.++||||||+++|||++|+.|+...........     ..............+.
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  241 (307)
T cd06607         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-----IAQNDSPTLSSNDWSD  241 (307)
T ss_pred             --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH-----HhcCCCCCCCchhhCH
Confidence              2345788999999874   45688999999999999999999999754322221111     0011111111234567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      .+.+++.+||+.+|++||++++|+..
T Consensus       242 ~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         242 YFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            89999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-34  Score=303.01  Aligned_cols=257  Identities=23%  Similarity=0.350  Sum_probs=208.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +++.-.||.|+||.||+++-. .++...|.|.+.........+|+-||+||+..+||+||+|++.+...+.++|..|||.
T Consensus        34 WeIiGELGDGAFGKVyKA~nk-et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNK-ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcc-cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            345567999999999999754 4455678888887777778899999999999999999999999999999999999999


Q ss_pred             CCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ||-.+..+-. ...+.+.++.-+..|++.||.|||++   .|||||||+.|||++-+|.++|+|||.+-..... .....
T Consensus       113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRD  188 (1187)
T KOG0579|consen  113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRD  188 (1187)
T ss_pred             CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-Hhhhc
Confidence            9999988765 46789999999999999999999999   9999999999999999999999999997643221 22334


Q ss_pred             cccccCcccCcccc-----cCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccc-ccCCCHHHHH
Q 004312          643 AIRGTKGYVAPEWF-----RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL-EAMDDMTVLQ  716 (762)
Q Consensus       643 ~~~gt~~y~aPE~~-----~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  716 (762)
                      .+.|||.|||||+.     .+.+|+.++||||||+.|.||..+..|-..-.+...     +..+..... ....+...+.
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV-----llKiaKSePPTLlqPS~Ws~  263 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAKSEPPTLLQPSHWSR  263 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH-----HHHHhhcCCCcccCcchhhh
Confidence            56799999999986     467899999999999999999999888321111111     111111111 1122445678


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCCCCCCCCCCCCCC
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCPWTLNITS  762 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~p~~p~~~~~~~  762 (762)
                      .+.+++.+||..||..||++.++++            |||..|+.|
T Consensus       264 ~F~DfLk~cL~Knp~~Rp~aaqll~------------Hpfv~~~~S  297 (1187)
T KOG0579|consen  264 SFSDFLKRCLVKNPRNRPPAAQLLK------------HPFVQNAPS  297 (1187)
T ss_pred             HHHHHHHHHHhcCCccCCCHHHHhh------------CcccccCCc
Confidence            8999999999999999999999987            777777654

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9e-34  Score=327.68  Aligned_cols=255  Identities=26%  Similarity=0.353  Sum_probs=208.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCC------cceEEEEEcccccc-chhHHHHHHhhhhccc-ccCCccchhceeccCCcee
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGS------SDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRL  556 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  556 (762)
                      .+.+.||+|.||.|++|......      ...||||.++.... ...+.+..|+++++.+ +|+||+.++|+|.+....+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            35568999999999999865322      45799999986543 3457899999999998 7999999999999999999


Q ss_pred             EEEeccCCCchhhhccCCC----------------CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC
Q 004312          557 LVYEFMSNGALASFLFGDS----------------KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY  620 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~  620 (762)
                      +|+||++.|+|.++|+..+                .+.....+.++.|||.||+||++.   ++|||||.++|||+.++.
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK  455 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence            9999999999999997655                378899999999999999999999   999999999999999999


Q ss_pred             ceEEecccccccccCCCCccccccc--ccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccc
Q 004312          621 NARISDFGLEKLLTLDQSHTNTAIR--GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTL  698 (762)
Q Consensus       621 ~~kl~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~  698 (762)
                      .+||+|||+++............-.  -...|||||.+....++.|+|||||||+||||++.+.+......    ....+
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~----~~~~l  531 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP----PTEEL  531 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC----cHHHH
Confidence            9999999999965544443322222  24469999999999999999999999999999986554332211    01111


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          699 GALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       699 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      .+.+.++.+...+..+.+++.++++.||+.+|++||++.|+++.++.+
T Consensus       532 ~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  532 LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            224445555555667789999999999999999999999999999883

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.6e-33  Score=294.90  Aligned_cols=247  Identities=26%  Similarity=0.370  Sum_probs=202.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|++|.||+|.... +++.+++|++..... ....+.+|++.+++++|+||+++++.+......++|+||++
T Consensus        21 ~~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   98 (286)
T cd06614          21 YKNLEKIGEGASGEVYKATDRA-TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD   98 (286)
T ss_pred             chHhHhccCCCCeEEEEEEEcc-CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence            3455789999999999997653 457899999876543 56788999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFGDS-KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      +++|.+++.... .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++........ ...
T Consensus        99 ~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~  174 (286)
T cd06614          99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRN  174 (286)
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhc
Confidence            999999998876 899999999999999999999998   999999999999999999999999999876543221 222


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccc-cCCCHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE-AMDDMTVLQRFVMV  721 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l  721 (762)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|+.|+...........     ....... .......+..+.++
T Consensus       175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~l  249 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL-----ITTKGIPPLKNPEKWSPEFKDF  249 (286)
T ss_pred             cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhcCCCCCcchhhCCHHHHHH
Confidence            33478899999999888899999999999999999999999754322211111     0011111 11122256789999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 004312          722 AIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~  741 (762)
                      +.+||+.+|.+||++.++++
T Consensus       250 i~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         250 LNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HHHHhccChhhCcCHHHHhh
Confidence            99999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.2e-33  Score=290.69  Aligned_cols=246  Identities=22%  Similarity=0.336  Sum_probs=198.6

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|+||.||+|.... ++..+|+|.+....  ....+.+.+|+.++++++|+||+++++.+.+....++|+||+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           3 EIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             eEEEEecCCCcceEEEEEEcC-CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            345789999999999997654 45689999986431  234567889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC-ceEEecccccccccCCCCc
Q 004312          563 SNGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY-NARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       563 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~  639 (762)
                      ++++|.+++....  .+++..+..++.|+++||+|||+.   +++|+||||+||++++++ .+||+|||.+....... .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~  157 (257)
T cd08225          82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-E  157 (257)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc-c
Confidence            9999999987543  578999999999999999999998   999999999999999875 57999999998664322 2


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+...........     ...... .......+..+.
T Consensus       158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~  231 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK-----ICQGYF-APISPNFSRDLR  231 (257)
T ss_pred             cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-----HhcccC-CCCCCCCCHHHH
Confidence            22234588999999999988999999999999999999999999754322222211     111111 111224457899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+||+.+|++|||++|+++
T Consensus       232 ~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         232 SLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             HHHHHHhccChhhCcCHHHHhh
Confidence            9999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.6e-33  Score=296.08  Aligned_cols=247  Identities=24%  Similarity=0.361  Sum_probs=193.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceecc------CCcee
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDE------GRNRL  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~------~~~~~  556 (762)
                      +.+.+.||+|+||.||+|... ..++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..      ....+
T Consensus        18 ~~~~~~lg~g~~~~v~~~~~~-~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          18 FELVEVVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhheeeccCCCeEEEEEEEc-CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            345578999999999999764 456789999886532 3345788999999998 79999999999853      45679


Q ss_pred             EEEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccccc
Q 004312          557 LVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT  634 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~  634 (762)
                      ++|||+++|+|.+++...  ..+++..+..++.||+.||+|||+.   +|+|+||+|+||++++++.++|+|||++....
T Consensus        96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~  172 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  172 (282)
T ss_pred             EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence            999999999999999653  4578888999999999999999998   99999999999999999999999999987653


Q ss_pred             CCCCcccccccccCcccCccccc-----CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccC
Q 004312          635 LDQSHTNTAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM  709 (762)
Q Consensus       635 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  709 (762)
                      .... ......+++.|+|||.+.     ...++.++||||||+++|||++|+.|+..........     ..........
T Consensus       173 ~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-----~~~~~~~~~~  246 (282)
T cd06636         173 RTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-----LIPRNPPPKL  246 (282)
T ss_pred             cccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-----hHhhCCCCCC
Confidence            2211 223355889999999985     3467889999999999999999999974432211111     1111111111


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          710 DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       710 ~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .....+..+.+++.+||+.||.+||++.|+++
T Consensus       247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            12235678999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.5e-33  Score=296.05  Aligned_cols=252  Identities=20%  Similarity=0.219  Sum_probs=194.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccC--CceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--RNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~LV~  559 (762)
                      +.+.+.||+|++|.||+|... .+++.+++|.++....  .....+.+|+.++.+++||||+++++++...  ...++||
T Consensus         7 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           7 YEKLNRIEEGTYGVVYRARDK-KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhcCCCCeEEEEEEEC-CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            445678999999999999764 4467899999874332  2234678899999999999999999998777  8899999


Q ss_pred             eccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          560 EFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       560 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      ||+++ +|.+++... ..+++..+..++.||++||+|||+.   +++|+||||+||++++++.+||+|||++........
T Consensus        86 e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          86 EYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             hhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            99975 898888664 4589999999999999999999998   999999999999999999999999999987654321


Q ss_pred             cccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------------ccc--
Q 004312          639 HTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------------TLG--  699 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------------~~~--  699 (762)
                       ......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+............                .+.  
T Consensus       162 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         162 -PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             -ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence             22234478899999998764 4689999999999999999999887533221111000                000  


Q ss_pred             ------cccccccccCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          700 ------ALVENDLEAMDDMT-VLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       700 ------~~~~~~~~~~~~~~-~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                            ...........+.. .++.+.+++.+||+.+|++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                  00000001111111 3677889999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-33  Score=294.99  Aligned_cols=250  Identities=24%  Similarity=0.315  Sum_probs=194.1

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.||.|++|.||+|.... +++.||+|++....  ......+.+|++++++++||||+++++++.+++..++||||++
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~   81 (283)
T cd07835           3 KVEKIGEGTYGVVYKARDKL-TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD   81 (283)
T ss_pred             hheEecCCCCeEEEEEEEcC-CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence            45789999999999997643 46789999986433  2234578899999999999999999999999999999999995


Q ss_pred             CCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                       ++|.+++....  .+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++|+|||++..+..... ..
T Consensus        82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~  156 (283)
T cd07835          82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TY  156 (283)
T ss_pred             -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-cc
Confidence             68999987665  789999999999999999999998   999999999999999999999999999976543221 12


Q ss_pred             ccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------------cccccccc
Q 004312          642 TAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------------TLGALVEN  704 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------------~~~~~~~~  704 (762)
                      ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||..........+.                ........
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            223468899999988664 5789999999999999999999987433221111000                00000000


Q ss_pred             --c----cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          705 --D----LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       705 --~----~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                        .    .........+..+.+++.+||+.+|++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              0    000001224467899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-33  Score=291.23  Aligned_cols=245  Identities=22%  Similarity=0.258  Sum_probs=192.6

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhh-hcccccCCccchhceeccCCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNG-IGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.||+|++|.||+|... ..++.||||.+.+...   .....+..|..+ ....+|+|++++++.+.+++..++|+||++
T Consensus         2 ~~l~~g~~~~v~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKR-STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEec-CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            46899999999999754 4467899999865322   122344555544 445689999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +++|.+++.....+++..+..++.|++.||.|||+.   +++||||+|+||++++++.+||+|||+++....     ...
T Consensus        81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~  152 (260)
T cd05611          81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK  152 (260)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence            999999998878899999999999999999999998   999999999999999999999999999875432     223


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..+++.|+|||.+.+..++.++||||||+++|||++|..|+................ .  .........++..+.+++.
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~i~  229 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR-I--NWPEEVKEFCSPEAVDLIN  229 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc-c--CCCCcccccCCHHHHHHHH
Confidence            457889999999988889999999999999999999999985443222221110000 0  0011112235678999999


Q ss_pred             HhhccCCCCCCCHHHHHHHhh
Q 004312          724 WCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       724 ~cl~~dp~~RPt~~evl~~L~  744 (762)
                      +||+.+|++||++.++.+.|.
T Consensus       230 ~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         230 RLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             HHccCCHHHccCCCcHHHHHc
Confidence            999999999998776666553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-33  Score=294.71  Aligned_cols=251  Identities=23%  Similarity=0.274  Sum_probs=196.1

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccC--CceeEEEec
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--RNRLLVYEF  561 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~LV~E~  561 (762)
                      +.+.||+|++|.||+|+.. .+++.+|+|++....  ......+.+|++++++++|+|++++++++...  +..++|+||
T Consensus         3 ~~~~l~~g~~~~vy~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   81 (287)
T cd07840           3 KIAQIGEGTYGQVYKARNK-KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY   81 (287)
T ss_pred             eeEEeccCCCeEEEEEEEC-CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence            4567999999999999765 345789999998653  33346788999999999999999999999888  889999999


Q ss_pred             cCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          562 MSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       562 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +++ +|.+++... ..+++..+..++.||++||+|||+.   +++|+||+|+||++++++.+||+|||++..........
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence            985 898888765 5789999999999999999999998   99999999999999999999999999998775543323


Q ss_pred             cccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------ccc---cc-----
Q 004312          641 NTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------TLG---AL-----  701 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~~~---~~-----  701 (762)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+............          ...   .+     
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            334456889999998765 46899999999999999999999987443221111100          000   00     


Q ss_pred             ccc------ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          702 VEN------DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       702 ~~~------~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ...      .........++..+.+++.+||+.+|.+||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            000      0000000112678899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-33  Score=291.75  Aligned_cols=247  Identities=25%  Similarity=0.364  Sum_probs=196.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceeccCC------cee
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGR------NRL  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~------~~~  556 (762)
                      +.+.+.||+|++|.||+|... .+++.+++|++.... ....++.+|+.+++++ +|+||+++++++....      ..+
T Consensus         8 y~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (275)
T cd06608           8 FELVEVIGEGTYGKVYKARHK-KTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW   85 (275)
T ss_pred             eeheeeecCCCCeEEEEEEEC-CCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence            445678999999999999765 346789999887543 3456799999999999 7999999999996544      489


Q ss_pred             EEEeccCCCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          557 LVYEFMSNGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                      +||||+++++|.+++..    ...+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.+||+|||++..
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            99999999999999864    35789999999999999999999998   999999999999999999999999999876


Q ss_pred             ccCCCCcccccccccCcccCcccccC-----CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccc-
Q 004312          633 LTLDQSHTNTAIRGTKGYVAPEWFRN-----MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL-  706 (762)
Q Consensus       633 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  706 (762)
                      ..... .......++..|+|||.+..     ..++.++||||||+++|+|++|+.|+...........     +..... 
T Consensus       163 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~  236 (275)
T cd06608         163 LDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK-----IPRNPPP  236 (275)
T ss_pred             cccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH-----hhccCCC
Confidence            54322 22233458899999998753     3578899999999999999999999753322111111     111111 


Q ss_pred             ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          707 EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       707 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ....+...++++.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11122335678999999999999999999999987

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.6e-33  Score=294.96  Aligned_cols=246  Identities=24%  Similarity=0.348  Sum_probs=192.4

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceeccC-----CceeEEE
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEG-----RNRLLVY  559 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-----~~~~LV~  559 (762)
                      +.+.||+|+||.||++... .+++.+|+|.+.... ....++.+|+.++.++ +|||++++++++...     ...++|+
T Consensus        26 ~~~~l~~g~~~~vy~~~~~-~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~  103 (291)
T cd06639          26 IIETIGKGTYGKVYKVTNK-KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVL  103 (291)
T ss_pred             EEEEeecCCCeEEEEEEEC-CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEE
Confidence            4467999999999999754 456789999986532 2345788899999998 899999999998653     3579999


Q ss_pred             eccCCCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          560 EFMSNGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       560 E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ||+++++|.++++.    ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++....
T Consensus       104 ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~  180 (291)
T cd06639         104 ELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  180 (291)
T ss_pred             EECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence            99999999998853    35789999999999999999999998   999999999999999999999999999886543


Q ss_pred             CCCcccccccccCcccCcccccCC-----CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCC
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRNM-----PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMD  710 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  710 (762)
                      ... ......++..|+|||.+...     .++.++||||||+++|||++|+.|+.............  ....+  ....
T Consensus       181 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~--~~~~~--~~~~  255 (291)
T cd06639         181 TRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP--RNPPP--TLLH  255 (291)
T ss_pred             ccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh--cCCCC--CCCc
Confidence            222 12234578899999998643     36899999999999999999999975432221111100  00000  1111


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          711 DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       711 ~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +......+.+++.+||+.+|++||++.|+++
T Consensus       256 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            2234567899999999999999999999987

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.4e-33  Score=294.55  Aligned_cols=249  Identities=23%  Similarity=0.321  Sum_probs=192.2

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      ..+.||.|++|.||+|+.. .+++.||||++....  ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (284)
T cd07860           4 KVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH   82 (284)
T ss_pred             eeeeecCCCceEEEEEEEC-CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence            3467999999999999754 456789999886432  2234578999999999999999999999999999999999996


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                       ++|.+++...  ..+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.+||+|||++........ ..
T Consensus        83 -~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~  157 (284)
T cd07860          83 -QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TY  157 (284)
T ss_pred             -cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-cc
Confidence             6898888653  5689999999999999999999998   999999999999999999999999999876543221 12


Q ss_pred             ccccccCcccCcccccCCC-CCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc-----------------------
Q 004312          642 TAIRGTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT-----------------------  697 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~-~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~-----------------------  697 (762)
                      ....+++.|+|||.+.+.. ++.++||||||+++|||++|+.||.............                       
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            2334688999999887644 6899999999999999999999874432211110000                       


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       698 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ........... .......++.+++.+||+.||++|||++++++
T Consensus       238 ~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         238 FPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             cccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00000000000 01123567789999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.1e-32  Score=293.10  Aligned_cols=244  Identities=23%  Similarity=0.345  Sum_probs=198.5

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCch
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGAL  567 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL  567 (762)
                      .+||+|+||.||++... .+++.||||++..........+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus        26 ~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          26 IKIGEGSTGIVCIATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHcCCCCCeEEEEEEEc-CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            57999999999999764 45679999998755555567799999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccccccc
Q 004312          568 ASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT  647 (762)
Q Consensus       568 ~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt  647 (762)
                      .+++.. ..+++.....++.|++.||+|||+.   +++||||+|+||++++++.++|+|||++....... .......++
T Consensus       105 ~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~  179 (292)
T cd06657         105 TDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGT  179 (292)
T ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccccC
Confidence            998754 4679999999999999999999998   99999999999999999999999999987654322 122334588


Q ss_pred             CcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhc
Q 004312          648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQ  727 (762)
Q Consensus       648 ~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  727 (762)
                      +.|+|||.+.+..++.++||||||+++|+|++|+.|+...........  +.........  .....+..+.+++.+||+
T Consensus       180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~l~~li~~~l~  255 (292)
T cd06657         180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM--IRDNLPPKLK--NLHKVSPSLKGFLDRLLV  255 (292)
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhhCCcccC--CcccCCHHHHHHHHHHHh
Confidence            999999999888899999999999999999999999754322221111  0001111111  112345678899999999


Q ss_pred             cCCCCCCCHHHHHH
Q 004312          728 EDPSHRPTMRRVTQ  741 (762)
Q Consensus       728 ~dp~~RPt~~evl~  741 (762)
                      .+|.+||+++++++
T Consensus       256 ~~P~~R~~~~~ll~  269 (292)
T cd06657         256 RDPAQRATAAELLK  269 (292)
T ss_pred             CCcccCcCHHHHhc
Confidence            99999999999887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-33  Score=277.06  Aligned_cols=260  Identities=23%  Similarity=0.335  Sum_probs=207.0

Q ss_pred             CHHHHHHHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceeccCC
Q 004312          475 TYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGR  553 (762)
Q Consensus       475 ~~~el~~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  553 (762)
                      +++|+.+.|.   +.||+|+++.|--++ ...++.++|||++.+..........+|++++.+- .|+||+.|+.+++++.
T Consensus        74 ~F~d~YkLt~---e~LGeGAyasVqtcv-~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   74 KFEDMYKLTS---ELLGEGAYASVQTCV-SIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             hHHHHHHhHH---HHhcCccceeeeeee-eeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            5677776665   679999999999875 4456789999999988777788999999999998 6999999999999999


Q ss_pred             ceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC---CceEEeccccc
Q 004312          554 NRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY---YNARISDFGLE  630 (762)
Q Consensus       554 ~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~Dfgla  630 (762)
                      ..|||||.|.+|+|..+|.++..+++.+..+++.+|+.||.|||.+   +|.||||||+|||..+-   ..+||+||.+.
T Consensus       150 ~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLg  226 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLG  226 (463)
T ss_pred             eEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccc
Confidence            9999999999999999999999999999999999999999999999   99999999999999643   35899999987


Q ss_pred             ccccCCC------CcccccccccCcccCccccc-----CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHH-hhhccc-
Q 004312          631 KLLTLDQ------SHTNTAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYD-CYQERT-  697 (762)
Q Consensus       631 ~~~~~~~------~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~-~~~~~~-  697 (762)
                      .-.....      .......+|+..|||||+..     ..-|+.+.|.||||||||-|++|..||.+.-..+ .+.++. 
T Consensus       227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~  306 (463)
T KOG0607|consen  227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV  306 (463)
T ss_pred             cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence            6443221      12233467888999999863     2358899999999999999999999985432110 111111 


Q ss_pred             --------cccccccccccC--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          698 --------LGALVENDLEAM--DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       698 --------~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                              ...+-+...+.+  .-..++.+..+++...+..++.+|.++.++++
T Consensus       307 Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  307 CRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                    111111111111  11346788899999999999999999998876

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.8e-33  Score=294.58  Aligned_cols=243  Identities=22%  Similarity=0.237  Sum_probs=189.8

Q ss_pred             hcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhc---ccccCCccchhceeccCCceeEEEecc
Q 004312          489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIG---QTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .||+|+||.||++... .+++.+|+|.+.+...   .....+.+|..++.   ..+||||+.+++.+...+..++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEEC-CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence            3899999999999754 4567999998865322   22234455544433   347999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ++++|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++......   ...
T Consensus        80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~  153 (279)
T cd05633          80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPH  153 (279)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc---Ccc
Confidence            9999999998888899999999999999999999998   9999999999999999999999999998755322   122


Q ss_pred             cccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ...|++.|+|||.+.. ..++.++||||||+++|||++|+.||........   ..+.... .......+...+.++.++
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~~~~l  229 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMT-LTVNVELPDSFSPELKSL  229 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH---HHHHHHh-hcCCcCCccccCHHHHHH
Confidence            3458999999999864 5689999999999999999999999743211000   0000000 011112234567789999


Q ss_pred             HHHhhccCCCCCC-----CHHHHHHH
Q 004312          722 AIWCIQEDPSHRP-----TMRRVTQM  742 (762)
Q Consensus       722 i~~cl~~dp~~RP-----t~~evl~~  742 (762)
                      +.+||+.||++||     +++|+++.
T Consensus       230 i~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         230 LEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             HHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            9999999999999     59999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.6e-33  Score=287.85  Aligned_cols=247  Identities=26%  Similarity=0.335  Sum_probs=203.6

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccC--CceeEEEec
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--RNRLLVYEF  561 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~LV~E~  561 (762)
                      ..+.||+|++|.||+|... .+++.|++|++.....  ...+.+.+|++.+++++|+||+++++.+.+.  ...++|+||
T Consensus         4 ~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   82 (260)
T cd06606           4 RGELLGRGSFGSVYLALDK-DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY   82 (260)
T ss_pred             eeeEeeecCceEEEEEEEC-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence            3467999999999999765 3567899999876442  4467899999999999999999999999988  889999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc-c
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-T  640 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-~  640 (762)
                      +++++|.+++.+...+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.+||+|||.+......... .
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          83 VSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            99999999998878899999999999999999999998   9999999999999999999999999999876543321 1


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhh-HHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDW-AYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      .....++..|+|||.+.....+.++||||||+++++|++|+.|+.... ......     ...........+...+..+.
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~  234 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY-----KIGSSGEPPEIPEHLSEEAK  234 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH-----hccccCCCcCCCcccCHHHH
Confidence            234558889999999988889999999999999999999999974432 111111     11111111222334478899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+|++.+|++||++.|+++
T Consensus       235 ~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         235 DFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             HHHHHhCcCChhhCCCHHHHhh
Confidence            9999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.4e-33  Score=295.30  Aligned_cols=255  Identities=22%  Similarity=0.234  Sum_probs=201.2

Q ss_pred             hhhhhcCCCCcceEEEeeeeC--CCcceEEEEEccccc----cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeE
Q 004312          485 GFKEELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVF----QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~L  557 (762)
                      .+.+.||+|++|.||+++...  ..++.||||.+++..    ....+.+.+|+.++.++ +||||+++++.+..+...++
T Consensus         3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l   82 (288)
T cd05583           3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL   82 (288)
T ss_pred             eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence            345789999999999987532  245689999986432    22345688999999999 69999999999999999999


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ||||+++++|.+++.....+++..+..++.|+++||.|||+.   +++||||+|+||++++++.++|+|||+++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          83 ILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            999999999999998777889999999999999999999998   99999999999999999999999999998765443


Q ss_pred             CcccccccccCcccCcccccCCC--CCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNMP--ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                      ........++..|+|||.+.+..  .+.++||||||+++|||++|+.|+.......... .........  ....+...+
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~  236 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS-EISRRILKS--KPPFPKTMS  236 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH-HHHHHHHcc--CCCCCcccC
Confidence            33333456889999999987654  7899999999999999999999974221100000 000011111  111223355


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      ..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         237 AEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            678999999999999999999988877755

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9.6e-33  Score=292.65  Aligned_cols=248  Identities=27%  Similarity=0.372  Sum_probs=191.8

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccc-cCCccchhceeccCCceeEEEeccC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.||+|+||.||++... .+++.+|+|++.... ......+.+|+.++.++. |+||+++++++..+...+++|||++
T Consensus         8 ~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~   86 (288)
T cd06616           8 DLGEIGRGAFGTVNKMLHK-PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD   86 (288)
T ss_pred             HHHHhCCCCceEEEEEEEC-CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence            3468999999999999754 456799999987533 234567899999999996 9999999999999999999999986


Q ss_pred             CCchhhh---cc--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          564 NGALASF---LF--GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       564 ~gsL~~~---l~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      . +|.++   +.  ....+++.....++.|+++||+|||+.  .+++||||||+||++++++.+||+|||+++...... 
T Consensus        87 ~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  162 (288)
T cd06616          87 I-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI-  162 (288)
T ss_pred             C-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC-
Confidence            4 44443   22  236789999999999999999999974  289999999999999999999999999997654322 


Q ss_pred             cccccccccCcccCcccccCC---CCCCcchhHHHHHHHHHHHhCCCCCchhhH-HHhhhccccccccccccccCCCHHH
Q 004312          639 HTNTAIRGTKGYVAPEWFRNM---PITVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQERTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~~---~~s~~~DV~S~Gvil~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  714 (762)
                       ......+++.|+|||.+...   .++.++||||||+++|||++|+.||..... ........  ....+.........+
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  239 (288)
T cd06616         163 -AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV--KGDPPILSNSEEREF  239 (288)
T ss_pred             -ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc--CCCCCcCCCcCCCcc
Confidence             22234578899999999776   689999999999999999999999743211 11111100  000111111122346


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          715 LQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +.++.+++.+||+.+|++|||+++|++
T Consensus       240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         240 SPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            778999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.8e-33  Score=287.95  Aligned_cols=244  Identities=24%  Similarity=0.317  Sum_probs=201.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|++|.||++... .+++.+++|++....  .....++.+|++++++++|+||+++++.+.+....++|+||+
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           3 KVLKKLGKGSYGSVYKVKRL-SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             eEeeeecCCCceeEEEEEEC-CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            34578999999999999754 456789999987532  333457889999999999999999999999999999999999


Q ss_pred             CCCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          563 SNGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       563 ~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      ++++|.+++.+    ...+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.+||+|||++......  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--  156 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN--  156 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence            99999999865    35689999999999999999999998   9999999999999999999999999999876543  


Q ss_pred             cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          639 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                       ......+++.|+|||.+.+..++.++|+||||+++|||++|+.|+...........      .........+...+.++
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~  229 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK------VQRGKYPPIPPIYSQDL  229 (256)
T ss_pred             -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HhcCCCCCCchhhCHHH
Confidence             22234578899999999998999999999999999999999999754322211111      11111112233567889


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+++.+|++.+|++||++.|+++
T Consensus       230 ~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         230 QNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             HHHHHHHcCCCcccCCCHHHHhc
Confidence            99999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.5e-33  Score=292.35  Aligned_cols=240  Identities=27%  Similarity=0.315  Sum_probs=192.7

Q ss_pred             cCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCc
Q 004312          490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       490 iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      ||+|+||+||++... .+++.+|+|.+....   ......+.+|++++++++||||+++++.+...+..++||||+++++
T Consensus         1 lg~g~~g~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVK-ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEc-CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            699999999999654 456789999986432   2234567889999999999999999999999999999999999999


Q ss_pred             hhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccc
Q 004312          567 LASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI  644 (762)
Q Consensus       567 L~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  644 (762)
                      |.+++.+..  .+++..+..++.|++.||.|||+.   +++||||+|+||++++++.+||+|||++......  ......
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~  154 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGR  154 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Cccccc
Confidence            999997654  689999999999999999999998   9999999999999999999999999998765432  122234


Q ss_pred             cccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhH---HHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA---YDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       645 ~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      .++..|+|||.+.+..++.++||||||+++|+|++|+.||.....   ........    ..  .....+...+..+.++
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~--~~~~~~~~~~~~~~~l  228 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT----LE--MAVEYPDKFSPEAKDL  228 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc----cc--ccccCCccCCHHHHHH
Confidence            578899999999888899999999999999999999999743321   11111111    10  0111223346788999


Q ss_pred             HHHhhccCCCCCC-----CHHHHHH
Q 004312          722 AIWCIQEDPSHRP-----TMRRVTQ  741 (762)
Q Consensus       722 i~~cl~~dp~~RP-----t~~evl~  741 (762)
                      +.+||+.+|++||     ++.++++
T Consensus       229 i~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         229 CEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHccCChhHccCCCcccHHHHHh
Confidence            9999999999999     5665654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.5e-33  Score=294.23  Aligned_cols=246  Identities=24%  Similarity=0.333  Sum_probs=189.8

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhh-hcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNG-IGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|+||.||++... .+++.||+|+++... .....++..|+.+ ++.++||||+++++++......++||||+
T Consensus         4 ~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~   82 (283)
T cd06617           4 EVIEELGRGAYGVVDKMRHV-PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM   82 (283)
T ss_pred             eEEEEecccCCeEEEEEEEc-CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence            34567999999999999754 457899999987542 2334566667665 55679999999999999999999999999


Q ss_pred             CCCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          563 SNGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       563 ~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      + ++|.+++..    ...+++..+..++.||+.||+|||++  .+++||||||+||++++++.+||+|||+++.....  
T Consensus        83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--  157 (283)
T cd06617          83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--  157 (283)
T ss_pred             c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc--
Confidence            7 677777643    34689999999999999999999984  37999999999999999999999999999865322  


Q ss_pred             cccccccccCcccCcccccC----CCCCCcchhHHHHHHHHHHHhCCCCCchhh-HHHhhhccccccccccccccCCCHH
Q 004312          639 HTNTAIRGTKGYVAPEWFRN----MPITVKVDVYSYGVLLLEIICLRRTILTDW-AYDCYQERTLGALVENDLEAMDDMT  713 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~----~~~s~~~DV~S~Gvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  713 (762)
                      .......++..|+|||.+.+    ..++.++|+||||+++|||++|+.|+.... ..+..     ...............
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~  232 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL-----KQVVEEPSPQLPAEK  232 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH-----HHHHhcCCCCCCccc
Confidence            12223457889999998864    457899999999999999999999974211 11111     111111111111223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          714 VLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       714 ~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .++++.+++.+||+.+|++||+++++++
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            5678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-33  Score=319.03  Aligned_cols=256  Identities=17%  Similarity=0.278  Sum_probs=185.8

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEc--------------c---ccccchhHHHHHHhhhhcccccCCccc
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKL--------------N---RVFQDSEKEFKAEVNGIGQTHHKNLVR  544 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~H~nIv~  544 (762)
                      ..+.+.+.||+|+||+||++.+.....+..++|.+              .   .........+.+|++++++++|+|||+
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            34566688999999999998765433333332211              0   011223456889999999999999999


Q ss_pred             hhceeccCCceeEEEeccCCCchhhhccCC-----CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC
Q 004312          545 LLGYCDEGRNRLLVYEFMSNGALASFLFGD-----SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY  619 (762)
Q Consensus       545 l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~  619 (762)
                      +++++.+.+..++|+|++. ++|.+++...     ..........|+.||+.||+|||++   +|+||||||+|||++.+
T Consensus       228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD  303 (501)
T ss_pred             EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC
Confidence            9999999999999999985 4676666432     2334567788999999999999998   99999999999999999


Q ss_pred             CceEEecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhh---HHHhhhcc
Q 004312          620 YNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDW---AYDCYQER  696 (762)
Q Consensus       620 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~---~~~~~~~~  696 (762)
                      +.+||+|||+++.+............||+.|+|||.+.+..++.++|||||||++|||++|+.++....   ......+.
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence            999999999998775444433445679999999999999999999999999999999999886532211   00000000


Q ss_pred             ---------cc-------ccccccc-cc----c----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          697 ---------TL-------GALVEND-LE----A----MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       697 ---------~~-------~~~~~~~-~~----~----~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                               ..       ...+... ..    .    ......+.++.+++.+||+.||++|||+.|+++
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence                     00       0000000 00    0    000112345677899999999999999999986

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.9e-33  Score=306.11  Aligned_cols=191  Identities=28%  Similarity=0.451  Sum_probs=165.4

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc-c-----CCccchhceeccCCcee
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-H-----KNLVRLLGYCDEGRNRL  556 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~g~~~~~~~~~  556 (762)
                      +|.+.+.||+|.||.|-|+. +.++++.||||+++.. ..-..+-..|+++|..|+ |     -|+|++++++...++.+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~-d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAY-DHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEE-ecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            56678899999999999994 6677899999999864 334456778999999996 4     47999999999999999


Q ss_pred             EEEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC--CCceEEeccccccc
Q 004312          557 LVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD--YYNARISDFGLEKL  632 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~Dfgla~~  632 (762)
                      ||+|.+. .+|.++|+.+  ..++...++.|+.||+.||.+||+.   +|||+||||+||||.+  ...+||+|||.+..
T Consensus       265 iVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  265 IVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence            9999994 4999999877  4688999999999999999999998   9999999999999974  44799999999986


Q ss_pred             ccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCC
Q 004312          633 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRT  683 (762)
Q Consensus       633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p  683 (762)
                      ..    +......-++.|.|||++.+.+|+.+.||||||||+.||++|..-
T Consensus       341 ~~----q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL  387 (586)
T KOG0667|consen  341 ES----QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL  387 (586)
T ss_pred             cC----CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc
Confidence            43    222245578899999999999999999999999999999999544

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-33  Score=296.19  Aligned_cols=248  Identities=21%  Similarity=0.279  Sum_probs=195.5

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccc--cccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEE
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      .|.+.+.||+||.+.||++.-.  +.+.+|+|++..  .+.+...-|.+|+..|.+| .|.+||+|++|-..++.+||||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s--~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNS--DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecC--CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            3556788999999999998532  345788887753  3445567899999999999 6999999999999999999999


Q ss_pred             eccCCCchhhhccCCCC-CCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          560 EFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      ||= .-+|..+|.+... +..-.++.+..||+.++.++|++   ||||.||||.|+|+-. |.+||+|||+|..+..+..
T Consensus       440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence            986 4589999987643 33238889999999999999999   9999999999999976 5999999999998876554


Q ss_pred             cc-cccccccCcccCcccccCC-----------CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccc
Q 004312          639 HT-NTAIRGTKGYVAPEWFRNM-----------PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL  706 (762)
Q Consensus       639 ~~-~~~~~gt~~y~aPE~~~~~-----------~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  706 (762)
                      .. ....+||+.||+||.+...           ..++++||||+|||||+|+.|+.||..-.    ..-..+..+.+++.
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~----n~~aKl~aI~~P~~  590 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII----NQIAKLHAITDPNH  590 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH----HHHHHHHhhcCCCc
Confidence            32 3456799999999998533           26789999999999999999999973211    01123445555544


Q ss_pred             ccCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          707 EAMDDM-TVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       707 ~~~~~~-~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +..++. ....+++++++.||+.||++||++.|+++
T Consensus       591 ~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  591 EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            332221 11233999999999999999999999886

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.7e-32  Score=296.66  Aligned_cols=250  Identities=23%  Similarity=0.286  Sum_probs=190.9

Q ss_pred             hhcCCC--CcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          488 EELGRG--AFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G--~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.||+|  +||+||++.. ...++.||||++....  ....+.+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus         4 ~~ig~g~~~~~~v~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARH-TPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEE-cCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            467777  8999999975 3456799999986432  2234678899999999999999999999999999999999999


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc-
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT-  640 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~-  640 (762)
                      +++|.+++...  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++||+.+.......... 
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999998764  3588999999999999999999998   99999999999999999999999998654332211110 


Q ss_pred             -----cccccccCcccCcccccCC--CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccc--------------
Q 004312          641 -----NTAIRGTKGYVAPEWFRNM--PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLG--------------  699 (762)
Q Consensus       641 -----~~~~~gt~~y~aPE~~~~~--~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~--------------  699 (762)
                           .....++..|+|||.+.+.  .++.++||||||+++|||++|+.|+...............              
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                 0112345679999999763  5789999999999999999999997543221111000000              


Q ss_pred             --------------------------cccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          700 --------------------------ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       700 --------------------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                                                ..............++..+.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                                      000011111122346778999999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-32  Score=285.10  Aligned_cols=246  Identities=25%  Similarity=0.378  Sum_probs=202.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|++|.||+++.. ..++.|++|.+.....  .....+.+|++++++++|+|++++++++.+....++||||+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNL-ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEc-CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            34578999999999999754 4457899999976543  34568999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||+|+||++++++.+||+|||++......... ..
T Consensus        82 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~  157 (254)
T cd06627          82 ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DA  157 (254)
T ss_pred             CCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cc
Confidence            9999999998888899999999999999999999998   9999999999999999999999999999876533221 23


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ...++..|+|||.......+.++||||||+++|+|++|+.|+............     . .......+...++.+.+++
T Consensus       158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~i  231 (254)
T cd06627         158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI-----V-QDDHPPLPEGISPELKDFL  231 (254)
T ss_pred             ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-----h-ccCCCCCCCCCCHHHHHHH
Confidence            345788999999998888999999999999999999999997433221111110     0 0111112334567889999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 004312          723 IWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       723 ~~cl~~dp~~RPt~~evl~  741 (762)
                      .+||+.+|++||++++++.
T Consensus       232 ~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         232 MQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HHHHhCChhhCcCHHHHhc
Confidence            9999999999999999885

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-33  Score=293.42  Aligned_cols=251  Identities=20%  Similarity=0.303  Sum_probs=191.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .+.+.||+|++|.||+|... .+++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus         8 ~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (291)
T cd07844           8 KKLDKLGEGSYATVYKGRSK-LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD   86 (291)
T ss_pred             eEEEEEeecCCeEEEEEEEc-CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence            34578999999999999754 3467899999865332 223567889999999999999999999999999999999998


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      + +|.+++... ..+++.....++.|+++||.|||+.   +|+||||||+||++++++.+||+|||+++...... ....
T Consensus        87 ~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~  161 (291)
T cd07844          87 T-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYS  161 (291)
T ss_pred             C-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-cccc
Confidence            5 899988654 4678999999999999999999998   99999999999999999999999999987543221 1112


Q ss_pred             cccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhH-HHhhh----------ccccccc------ccc
Q 004312          643 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQ----------ERTLGAL------VEN  704 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~-~~~~~----------~~~~~~~------~~~  704 (762)
                      ...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .+...          .......      ...
T Consensus       162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (291)
T cd07844         162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY  241 (291)
T ss_pred             ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccc
Confidence            2346789999999865 4689999999999999999999998743321 11000          0000000      000


Q ss_pred             ccccC---------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          705 DLEAM---------DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       705 ~~~~~---------~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .....         ........+.+++.+||+.+|++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00000         00111267789999999999999999999876

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.2e-33  Score=291.35  Aligned_cols=246  Identities=24%  Similarity=0.344  Sum_probs=202.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccc-cCCccchhceeccCCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .+.+.||+|++|.||++... .+++.||+|++...   .....+.+.+|++++++++ |+||+++++.+...+..++|||
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd05581           4 KFGKIIGEGSFSTVVLAKEK-ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE   82 (280)
T ss_pred             eEeeeecCCCceEEEEEEEc-CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence            35578999999999999765 35678999998652   2233467889999999998 9999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC--
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS--  638 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~--  638 (762)
                      |+++++|.+++.+.+.+++..+..|+.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........  
T Consensus        83 ~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          83 YAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            999999999998888899999999999999999999998   999999999999999999999999999886643321  


Q ss_pred             -----------------cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccc
Q 004312          639 -----------------HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL  701 (762)
Q Consensus       639 -----------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~  701 (762)
                                       .......++..|+|||.+.....+.++||||||++++++++|+.|+............     
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----  234 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI-----  234 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-----
Confidence                             1122345788999999998888999999999999999999999997544322222111     


Q ss_pred             cccccccCCCHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 004312          702 VENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTM----RRVTQ  741 (762)
Q Consensus       702 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~----~evl~  741 (762)
                      .  ......+...++.+.+++.+||+.+|++||++    +++++
T Consensus       235 ~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         235 L--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             H--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            1  11112233446789999999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.4e-33  Score=295.13  Aligned_cols=255  Identities=19%  Similarity=0.206  Sum_probs=183.6

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCC--cceEEEEEccccccch--h---------HHHHHHhhhhcccccCCccchhcee
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGS--SDQVAVKKLNRVFQDS--E---------KEFKAEVNGIGQTHHKNLVRLLGYC  549 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~H~nIv~l~g~~  549 (762)
                      .+.+.+.||+|+||.||+|......  ...+|+|+........  +         .....+...+..++|+||+++++++
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   92 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG   92 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence            3556788999999999999865431  3456666543221111  1         1122344456677999999999976


Q ss_pred             ccCC----ceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEe
Q 004312          550 DEGR----NRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARIS  625 (762)
Q Consensus       550 ~~~~----~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~  625 (762)
                      ....    ..++++|++.. ++.+.+......++..+..|+.|+++||+|||+.   +|+||||||+|||++.++.+||+
T Consensus        93 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l~  168 (294)
T PHA02882         93 SFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYII  168 (294)
T ss_pred             eEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEEE
Confidence            5543    34677887643 5666665545567888999999999999999998   99999999999999999999999


Q ss_pred             cccccccccCCCC------cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHh-hh---c
Q 004312          626 DFGLEKLLTLDQS------HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDC-YQ---E  695 (762)
Q Consensus       626 Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~-~~---~  695 (762)
                      |||+++.+.....      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..   .
T Consensus       169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~  248 (294)
T PHA02882        169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC  248 (294)
T ss_pred             EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence            9999987643221      112234699999999999999999999999999999999999999854311111 10   0


Q ss_pred             cccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 004312          696 RTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       696 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~  744 (762)
                      .....+......   ....+..+.+++..|++.+|++||+++++.+.|+
T Consensus       249 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        249 DFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            011111111111   1123577899999999999999999999998763

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=288.28  Aligned_cols=248  Identities=22%  Similarity=0.278  Sum_probs=198.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc-----ccchhHHHHHHhhhhcccccCCccchhceeccC--Ccee
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-----FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--RNRL  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~  556 (762)
                      +.+.+.||+|++|.||+|... .+++.||+|++...     .......+.+|++++++++|+||+++++++.+.  ...+
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDA-DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEc-CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            345678999999999999754 45678999987432     123345789999999999999999999998664  4578


Q ss_pred             EEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      +|+||+++++|.+++.....+++.....++.|++.||.|||+.   +++|+||||+||++++++.++|+|||+++.....
T Consensus        83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence            9999999999999998777789999999999999999999998   9999999999999999999999999999865321


Q ss_pred             CC--cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHH
Q 004312          637 QS--HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       637 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  714 (762)
                      ..  .......++..|+|||.+.+..++.++||||||+++|+|++|+.|+..........     ...........+...
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~p~~~  234 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF-----KIATQPTKPMLPDGV  234 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH-----HHHcCCCCCCCCccc
Confidence            11  11223458899999999998889999999999999999999999975432222221     111111222334566


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          715 LQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+.+.+++.+||+ +|..||+..+++.
T Consensus       235 ~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         235 SDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            7889999999999 5799999998775

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.4e-32  Score=291.92  Aligned_cols=251  Identities=20%  Similarity=0.259  Sum_probs=189.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .+.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.++++++|+||+++++++..+...++|+||++
T Consensus         8 ~~~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~   86 (291)
T cd07870           8 LNLEKLGEGSYATVYKGISR-INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH   86 (291)
T ss_pred             EEEEEEEecCCEEEEEEEEc-CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence            34578999999999999754 3457899999865432 233577899999999999999999999999999999999996


Q ss_pred             CCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                       ++|.+++.. ...+.+..+..++.||+.||.|||+.   +|+|+||||+||+++.++.+||+|||+++...... ....
T Consensus        87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~  161 (291)
T cd07870          87 -TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QTYS  161 (291)
T ss_pred             -CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC-CCCC
Confidence             566666644 35678888999999999999999998   99999999999999999999999999997643222 1222


Q ss_pred             cccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHH-Hhhhcc----------------cccccccc
Q 004312          643 AIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQER----------------TLGALVEN  704 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~-~~~~~~----------------~~~~~~~~  704 (762)
                      ...+++.|+|||.+.+. .++.++||||||+++|||++|+.||...... +...+.                ........
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (291)
T cd07870         162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE  241 (291)
T ss_pred             CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence            34478899999998754 5789999999999999999999997432211 100000                00000000


Q ss_pred             ccccC---------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          705 DLEAM---------DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       705 ~~~~~---------~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .....         ........+.+++.+|++.||++|||++|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00000         00012457789999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.5e-32  Score=300.13  Aligned_cols=250  Identities=25%  Similarity=0.274  Sum_probs=191.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccC------Cce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------RNR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~  555 (762)
                      +...+.||+|+||.||++... .+++.||||++.+.  .......+.+|+.++++++|+||+++++++...      ...
T Consensus        18 y~~~~~lg~g~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   96 (353)
T cd07850          18 YQNLKPIGSGAQGIVCAAYDT-VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV   96 (353)
T ss_pred             eEEEEEeccCCCEEEEEEEEC-CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence            334567999999999999754 45679999998653  223345778899999999999999999987543      357


Q ss_pred             eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          556 LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ++||||+++ +|.+.+...  ++...+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++....
T Consensus        97 ~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          97 YLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             EEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            999999964 788877544  88899999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc-----------------cc
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER-----------------TL  698 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~-----------------~~  698 (762)
                      ..  ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........+...                 ..
T Consensus       171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (353)
T cd07850         171 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV  248 (353)
T ss_pred             CC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence            22  223345788999999999999999999999999999999999987433211111000                 00


Q ss_pred             ccccc---------------ccc----ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          699 GALVE---------------NDL----EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       699 ~~~~~---------------~~~----~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      .....               ...    ........++.+.+++.+||+.||++|||++|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000               000    000012346678999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.6e-32  Score=292.10  Aligned_cols=248  Identities=19%  Similarity=0.200  Sum_probs=190.0

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      +.+|.|+++.||++..   +++.||||+++..  .....+.+.+|++++++++|+||+++++++.+.+..+++|||++++
T Consensus         8 ~~~~~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           8 KCFEDLMIVHLAKHKP---TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             HhhcCCceEEEEEecC---CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            4455556666666543   5679999998754  3344568999999999999999999999999999999999999999


Q ss_pred             chhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC-----
Q 004312          566 ALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-----  638 (762)
Q Consensus       566 sL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-----  638 (762)
                      +|.+++...  ..+++.....++.|+++||+|||+.   +|+||||||+||++++++.+||+|||.+........     
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999999754  4678999999999999999999998   999999999999999999999999998875532211     


Q ss_pred             -cccccccccCcccCcccccC--CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc---ccccccc---------
Q 004312          639 -HTNTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER---TLGALVE---------  703 (762)
Q Consensus       639 -~~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~---~~~~~~~---------  703 (762)
                       .......++..|+|||.+..  ..++.++||||||+++|||++|+.||..........+.   .....++         
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence             11123456788999999876  35889999999999999999999998533211111000   0000000         


Q ss_pred             ---------------cccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          704 ---------------NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       704 ---------------~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                                     .............++.+++.+||+.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                           00111112345678899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.3e-32  Score=285.80  Aligned_cols=246  Identities=22%  Similarity=0.361  Sum_probs=202.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|++|.||++... .+++.+++|++.....  ...+.+.+|++++++++|+|++++++.+......++|+||+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           3 EIIKQIGKGSFGKVYLVRRK-SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             eEEeeeccCCCeEEEEEEEc-CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            34567999999999999765 3567899999875433  45567899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC----CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          563 SNGALASFLFGD----SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       563 ~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      ++++|.+++...    ..+++..+..++.++++||.|||+.   +++|+||+|+||++++++.++|+|||.+....... 
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  157 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-  157 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence            999999999764    6789999999999999999999998   99999999999999999999999999998765433 


Q ss_pred             cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          639 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      .......+++.|+|||.+.+..++.++||||+|+++++|++|+.|+...........     ..... ....+...+..+
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~  231 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK-----ILKGQ-YPPIPSQYSSEL  231 (258)
T ss_pred             ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH-----HhcCC-CCCCCCCCCHHH
Confidence            122334688899999999888999999999999999999999999754422221111     11111 111122456788


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+++.+||+.+|++||+++|+++
T Consensus       232 ~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         232 RNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             HHHHHHHcCCChhhCcCHHHHhc
Confidence            99999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-33  Score=301.07  Aligned_cols=245  Identities=22%  Similarity=0.318  Sum_probs=207.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc--hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.+.+.||+|.|++|..++... ++..||||.+.+..-.  ..+.+.+|++++..+.|||||+++.+......+++||||
T Consensus        58 y~i~~tig~g~f~~V~La~~~~-t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey  136 (596)
T KOG0586|consen   58 YVIIKTIGKGNFAKVKLARHIL-TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY  136 (596)
T ss_pred             eeeeeeeccceeEEEEeeEecC-CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence            3456789999999999997654 5679999999864332  234588999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +.+|.+.+||.++++..+.....++.|+..|++|||++   .|+|||||++||||+.+.++||+|||++..+.  .....
T Consensus       137 a~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~~~l  211 (596)
T KOG0586|consen  137 ASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--YGLML  211 (596)
T ss_pred             ccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--ccccc
Confidence            99999999999999998899999999999999999999   99999999999999999999999999999875  45556


Q ss_pred             ccccccCcccCcccccCCCC-CCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ...+|++.|.|||.+.+..+ .+++|+||+|++||.|+.|..||.+....+.-...     +...++  .+...+.++.+
T Consensus       212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv-----l~gk~r--Ip~~ms~dce~  284 (596)
T KOG0586|consen  212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV-----LRGKYR--IPFYMSCDCED  284 (596)
T ss_pred             cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh-----eeeeec--ccceeechhHH
Confidence            67889999999999988765 58999999999999999999998654322221111     111111  23345678899


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++++|-.+|.+|++++++.+
T Consensus       285 lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  285 LLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             HHHHhhccCccccCCHHHhhh
Confidence            999999999999999999875

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.8e-32  Score=287.79  Aligned_cols=243  Identities=21%  Similarity=0.223  Sum_probs=189.4

Q ss_pred             hcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhh---hcccccCCccchhceeccCCceeEEEecc
Q 004312          489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNG---IGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .||+|+||.||++... .+++.||+|.+.+...   .....+.+|..+   ++..+||||+++++.+.+.+..++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEe-cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence            4899999999999754 4567999999865322   122234445443   44458999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ++++|..++.....+++..+..++.|+++||.|||+.   +|+||||||+||++++++.+||+|||++..+...   ...
T Consensus        80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~~  153 (278)
T cd05606          80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPH  153 (278)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CCc
Confidence            9999999998888899999999999999999999998   9999999999999999999999999998755322   122


Q ss_pred             cccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ...|+..|+|||.+.++ .++.++||||||+++|||++|+.|+..........   ...... ......+...+.++.++
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~-~~~~~~~~~~s~~~~~l  229 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTL-TMAVELPDSFSPELRSL  229 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH---HHHHhh-ccCCCCCCcCCHHHHHH
Confidence            34689999999999754 68999999999999999999999974431111000   000000 00111222346789999


Q ss_pred             HHHhhccCCCCCC-----CHHHHHHH
Q 004312          722 AIWCIQEDPSHRP-----TMRRVTQM  742 (762)
Q Consensus       722 i~~cl~~dp~~RP-----t~~evl~~  742 (762)
                      +.+|+..+|.+||     +++++++.
T Consensus       230 i~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         230 LEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             HHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            9999999999999     99999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.2e-32  Score=293.08  Aligned_cols=248  Identities=25%  Similarity=0.325  Sum_probs=195.2

Q ss_pred             HHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeE
Q 004312          481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       481 ~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L  557 (762)
                      ..++...+.||+|++|.||+|+.. .+++.+|+|.+...   .....+++.+|+++++.++|+|++++++++......++
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEc-CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            334445578999999999999764 34678999988642   22334578899999999999999999999999999999


Q ss_pred             EEeccCCCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          558 VYEFMSNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      ||||+. |+|.+++.. ...+++..+..++.|++.||.|||+.   +++||||+|+||++++++.+||+|||++......
T Consensus        93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            999997 577776643 45689999999999999999999998   9999999999999999999999999998765321


Q ss_pred             CCcccccccccCcccCccccc---CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHH
Q 004312          637 QSHTNTAIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMT  713 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  713 (762)
                           ....+++.|+|||.+.   ....+.++||||||+++|+|++|+.|+...........     .............
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~  238 (308)
T cd06634         169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-----IAQNESPALQSGH  238 (308)
T ss_pred             -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH-----HhhcCCCCcCccc
Confidence                 2345788999999974   35688999999999999999999999744322111111     1111111111234


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 004312          714 VLQRFVMVAIWCIQEDPSHRPTMRRVTQML  743 (762)
Q Consensus       714 ~~~~~~~li~~cl~~dp~~RPt~~evl~~L  743 (762)
                      .+..+.+++.+||+.+|++||+++++++..
T Consensus       239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             ccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            567789999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.1e-32  Score=295.78  Aligned_cols=254  Identities=22%  Similarity=0.301  Sum_probs=194.2

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhccc-ccCCccchhceeccC--CceeE
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEG--RNRLL  557 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~--~~~~L  557 (762)
                      .+.+.+.||+|+||.||+|... .+++.+|||++...  .......+.+|+.+++++ +||||+++++++...  ...++
T Consensus         8 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           8 KYEILQKLGKGAYGIVWKAIDR-RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             HHHHhHhhcCCCCeeEEEEEEc-CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            3556688999999999999754 34678999988642  223345677899999999 999999999988643  46799


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ||||++ ++|.+++... .+++..+..++.||+.||+|||+.   +|+||||||+||++++++.+||+|||+++......
T Consensus        87 v~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          87 VFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             Eecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            999997 5999988765 788999999999999999999998   99999999999999999999999999998764433


Q ss_pred             C----cccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc-----------------
Q 004312          638 S----HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE-----------------  695 (762)
Q Consensus       638 ~----~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~-----------------  695 (762)
                      .    .......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.|+...........                 
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence            2    12233568899999998765 4688999999999999999999998743221111000                 


Q ss_pred             -cccccccc----cccc--cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          696 -RTLGALVE----NDLE--AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       696 -~~~~~~~~----~~~~--~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                       .....++.    ....  .......+.++.+++.+||+.+|++|||+.++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence             00000000    0000  00011246778999999999999999999999965

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.1e-32  Score=285.67  Aligned_cols=235  Identities=20%  Similarity=0.221  Sum_probs=184.2

Q ss_pred             cCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEeccCCCchh
Q 004312          490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMSNGALA  568 (762)
Q Consensus       490 iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~  568 (762)
                      ||+|+||.||++... .+++.+|+|.+.......   .  |+.....+ +||||+++++.+...+..++||||+++++|.
T Consensus        24 lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~   97 (267)
T PHA03390         24 LIDGKFGKVSVLKHK-PTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF   97 (267)
T ss_pred             ecCCCceEEEEEEEc-CCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence            599999999999754 456789999886532111   1  22222222 7999999999999999999999999999999


Q ss_pred             hhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC-ceEEecccccccccCCCCccccccccc
Q 004312          569 SFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY-NARISDFGLEKLLTLDQSHTNTAIRGT  647 (762)
Q Consensus       569 ~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~gt  647 (762)
                      +++.....+++..+..++.||++||.|||+.   +++||||||+||+++.++ .++|+|||+++.....     ....++
T Consensus        98 ~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~  169 (267)
T PHA03390         98 DLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGT  169 (267)
T ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCCCC
Confidence            9998877899999999999999999999998   999999999999999888 9999999998765422     223578


Q ss_pred             CcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhc
Q 004312          648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQ  727 (762)
Q Consensus       648 ~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  727 (762)
                      ..|+|||.+.+..++.++||||||+++|||++|+.|+....... ............  ........+..+.+++.+||+
T Consensus       170 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~  246 (267)
T PHA03390        170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQQK--KLPFIKNVSKNANDFVQSMLK  246 (267)
T ss_pred             CcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhhcc--cCCcccccCHHHHHHHHHHhc
Confidence            99999999999899999999999999999999999975321111 000001111111  111222467889999999999


Q ss_pred             cCCCCCCC-HHHHHH
Q 004312          728 EDPSHRPT-MRRVTQ  741 (762)
Q Consensus       728 ~dp~~RPt-~~evl~  741 (762)
                      .+|.+||+ ++|+++
T Consensus       247 ~~p~~R~~~~~~~l~  261 (267)
T PHA03390        247 YNINYRLTNYNEIIK  261 (267)
T ss_pred             cChhhCCchHHHHhc
Confidence            99999995 688885

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.1e-32  Score=286.60  Aligned_cols=248  Identities=21%  Similarity=0.256  Sum_probs=189.6

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhcccc-cCCccchhceeccC--CceeEEEec
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEG--RNRLLVYEF  561 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~LV~E~  561 (762)
                      +.++||+|+||.||+|... .+++.||+|+++.... .......+|+.++.++. |+||+++++++.+.  +..++|+||
T Consensus         3 ~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~   81 (282)
T cd07831           3 ILGKIGEGTFSEVLKAQSR-KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL   81 (282)
T ss_pred             eEeeccccccceEEEEEEc-CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence            4567999999999999754 4567899999875422 22334567888899885 99999999999887  889999999


Q ss_pred             cCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          562 MSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       562 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      ++ ++|.+++... ..+++..+..++.|++.||+|||+.   +++||||+|+||++++ +.+||+|||+++.......  
T Consensus        82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~--  154 (282)
T cd07831          82 MD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP--  154 (282)
T ss_pred             CC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence            97 5777777653 5789999999999999999999998   9999999999999999 9999999999986643222  


Q ss_pred             cccccccCcccCccccc-CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc------ccc---------ccccc
Q 004312          641 NTAIRGTKGYVAPEWFR-NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER------TLG---------ALVEN  704 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~-~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~------~~~---------~~~~~  704 (762)
                      .....+++.|+|||.+. +..++.++||||||+++|||++|+.||......+.....      ...         .....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07831         155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY  234 (282)
T ss_pred             cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence            22345788999999764 456789999999999999999999887543221111000      000         00000


Q ss_pred             ccccC-------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          705 DLEAM-------DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       705 ~~~~~-------~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .....       .....+..+.+++.+||+.+|++||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            00000       01234688999999999999999999999987

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-32  Score=287.47  Aligned_cols=250  Identities=22%  Similarity=0.297  Sum_probs=196.9

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc--hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.||+|++|.||++... .+++.+++|++......  ....+.+|++++++++|+||+++++++..+...++|+||++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (283)
T cd05118           3 KLGKIGEGTYGVVYKARDK-LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD   81 (283)
T ss_pred             cceeeecCCCceEEEEEcC-CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence            3467999999999999754 34678999998754332  45678899999999999999999999999999999999997


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      + +|.+++... ..+++..+..++.|+++||.|||+.   +|+|+||||+||++++++.+||+|||.+....... ....
T Consensus        82 ~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~  156 (283)
T cd05118          82 T-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYT  156 (283)
T ss_pred             C-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cccc
Confidence            6 788877654 5789999999999999999999998   99999999999999999999999999998765433 1222


Q ss_pred             cccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------ccccccc--------
Q 004312          643 AIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------TLGALVE--------  703 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~~~~~~~--------  703 (762)
                      ...++..|+|||.+.+. ..+.++||||||+++|+|++|+.||......+.....          .......        
T Consensus       157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05118         157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS  236 (283)
T ss_pred             CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence            34578899999998776 7899999999999999999999887443221111000          0000000        


Q ss_pred             -cccc----cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          704 -NDLE----AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       704 -~~~~----~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                       +...    .......+.++.+++.+||+.||.+||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence             0000    0011235678999999999999999999999987

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.7e-32  Score=291.04  Aligned_cols=251  Identities=22%  Similarity=0.239  Sum_probs=197.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeC--CCcceEEEEEcccccc----chhHHHHHHhhhhccc-ccCCccchhceeccCCceeE
Q 004312          485 GFKEELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVFQ----DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~L  557 (762)
                      .+.+.||+|+||.||++....  .+++.||+|++.....    ...+.+.+|++++.++ +|+||+++++++..+...++
T Consensus         3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (290)
T cd05613           3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL   82 (290)
T ss_pred             eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence            345789999999999997542  2467899999875322    2345788999999999 69999999999999999999


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ||||+++++|.+++.....+++..+..++.|+++||.|||+.   +++||||+|+|||+++++.+||+|||+++......
T Consensus        83 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          83 ILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            999999999999998888889999999999999999999998   99999999999999999999999999998765433


Q ss_pred             CcccccccccCcccCcccccCC--CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNM--PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                      ........++..|+|||.+...  .++.++||||||+++|+|++|+.|+......... ..........  ....+....
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~  236 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ-AEISRRILKS--EPPYPQEMS  236 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH-HHHHHHhhcc--CCCCCccCC
Confidence            3333345688999999998753  4788999999999999999999997421100000 0000111111  111223356


Q ss_pred             HHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 004312          716 QRFVMVAIWCIQEDPSHRP-----TMRRVTQ  741 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RP-----t~~evl~  741 (762)
                      ..+.+++.+||+.+|++||     +++++++
T Consensus       237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            7788999999999999997     6677765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.1e-32  Score=289.33  Aligned_cols=251  Identities=22%  Similarity=0.300  Sum_probs=194.1

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .+.+.||+|++|.||+|+.. .+++.||||+++.... .....+.+|++++++++|+||+++++++.+.+..+|||||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (284)
T cd07836           3 KQLEKLGEGTYATVYKGRNR-TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD   81 (284)
T ss_pred             eEeeeeccCCceEEEEEEEC-CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence            34578999999999999764 4567899999875433 234577889999999999999999999999999999999998


Q ss_pred             CCchhhhccCC---CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          564 NGALASFLFGD---SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       564 ~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      + +|.+++...   ..+++..+..++.||+.||+|||+.   +++||||||+||++++++.+||+|||+++....... .
T Consensus        82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~  156 (284)
T cd07836          82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T  156 (284)
T ss_pred             c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence            5 888887653   3589999999999999999999998   999999999999999999999999999976543221 2


Q ss_pred             cccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------ccccc-----ccc
Q 004312          641 NTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------TLGAL-----VEN  704 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~~~~~-----~~~  704 (762)
                      .....+++.|++||.+.+. .++.++||||||+++|+|++|+.|+......+.....          ....+     ...
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP  236 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence            2334578899999988654 5789999999999999999999987543221111100          00000     000


Q ss_pred             cccc-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          705 DLEA-------MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       705 ~~~~-------~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ....       ......+..+.+++.+|++.+|.+||+++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000       001134567889999999999999999999886

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.3e-32  Score=296.42  Aligned_cols=254  Identities=22%  Similarity=0.315  Sum_probs=196.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceecc----CCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDE----GRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~L  557 (762)
                      +.+.+.||+|++|.||+|... .+++.||+|++.....  ...+.+.+|+.++++++||||+++++++..    ....++
T Consensus         7 y~~~~~lg~g~~g~v~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l   85 (334)
T cd07855           7 YKPIENIGSGAYGVVCSAIDT-RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV   85 (334)
T ss_pred             eeeeeeeecCCCeEEEEEEEc-CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence            344578999999999999754 4567999999875322  334677889999999999999999998753    346799


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ||||+. ++|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+||++++++.+||+|||++.......
T Consensus        86 v~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          86 VMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             EEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            999996 68999998778899999999999999999999998   99999999999999999999999999997654332


Q ss_pred             Cc---ccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhh------------------c
Q 004312          638 SH---TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ------------------E  695 (762)
Q Consensus       638 ~~---~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~------------------~  695 (762)
                      ..   ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..........                  .
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence            21   1123468899999999865 468999999999999999999999985432211100                  0


Q ss_pred             ccccccccc-ccccCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          696 RTLGALVEN-DLEAMD-----DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       696 ~~~~~~~~~-~~~~~~-----~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ..+...... ......     ....++++.+++.+||+.+|++||++++++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            000000000 000000     12346789999999999999999999998873

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-34  Score=325.46  Aligned_cols=245  Identities=25%  Similarity=0.329  Sum_probs=204.0

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      ..||.|.||.||-+. +..+++..|||-++..  .....+...+|..++..++|||+|+.+|.-.+.+..+|.||||++|
T Consensus      1241 ~~Ig~G~fG~VYtav-N~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAV-NLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             cccCCcceeeeEEee-cCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            359999999999995 5567788999977532  3344567889999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC---cccc
Q 004312          566 ALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS---HTNT  642 (762)
Q Consensus       566 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~---~~~~  642 (762)
                      +|.+.+...+..++.....+..|++.|++|||+.   +||||||||.||+|+.+|.+|++|||.|........   ....
T Consensus      1320 sLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1320 SLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred             cHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence            9999998888888888889999999999999999   999999999999999999999999999987765421   1223


Q ss_pred             cccccCcccCcccccCC---CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc-ccccccccccccCCCHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNM---PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER-TLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~---~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      ...||+.|||||++.+.   ....++||||+|||+.||+||++|+..      +..+ .+.-.+..+..+..|...+.+-
T Consensus      1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~------~dne~aIMy~V~~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAE------LDNEWAIMYHVAAGHKPQIPERLSSEG 1470 (1509)
T ss_pred             hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhh------ccchhHHHhHHhccCCCCCchhhhHhH
Confidence            46799999999999653   567899999999999999999999521      1111 1222233334445566688899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHH
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      .+++..||+.||++|.++.|+++.
T Consensus      1471 ~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             HHHHHHHHhcCchhhhHHHHHHHh
Confidence            999999999999999998888764

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-32  Score=287.07  Aligned_cols=249  Identities=25%  Similarity=0.369  Sum_probs=192.9

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhcccc-cCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|++|.||+|+.. .+++.|+||++..... .......+|+..+.+++ |+||+++++++.+.+..++||||+
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNK-ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             eeheeeccCCceEEEEEEEC-CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            35678999999999999864 3457899999875433 22335567999999998 999999999999999999999999


Q ss_pred             CCCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          563 SNGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       563 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                       +++|.+++....  .+++..+..++.|++.+|.|||+.   +++|+||+|+||++++++.++|+|||++........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             889999887654  789999999999999999999998   999999999999999999999999999986543221  


Q ss_pred             cccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc--------------------cccc
Q 004312          641 NTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--------------------RTLG  699 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~--------------------~~~~  699 (762)
                      .....++..|+|||.+.. ..++.++||||||++++||++|+.|+......+....                    ....
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            223457889999998854 5689999999999999999999988633221111100                    0000


Q ss_pred             ccccc----ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          700 ALVEN----DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       700 ~~~~~----~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ..+..    ...... .....++.+++.+||+.+|++|||++|++.
T Consensus       235 ~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         235 FRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000    000000 112467899999999999999999999986

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.3e-32  Score=290.74  Aligned_cols=251  Identities=24%  Similarity=0.314  Sum_probs=190.8

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|++|.||+|... .+++.||+|++.....  .....+.+|++++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (294)
T PLN00009          5 EKVEKIGEGTYGVVYKARDR-VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL   83 (294)
T ss_pred             EEEEEecCCCCEEEEEEEec-CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence            34578999999999999754 3567899999865322  33467889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC-CCceEEecccccccccCCCCc
Q 004312          563 SNGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD-YYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       563 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      + ++|.+++....  ..++.....++.||+.||+|||++   +++|+||+|+||++++ +..+||+|||++....... .
T Consensus        84 ~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~  158 (294)
T PLN00009         84 D-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-R  158 (294)
T ss_pred             c-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-c
Confidence            6 57877775543  357888889999999999999998   9999999999999985 5679999999997654321 1


Q ss_pred             ccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc------ccccc----------c
Q 004312          640 TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER------TLGAL----------V  702 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~------~~~~~----------~  702 (762)
                      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+.....      .....          .
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence            1223456889999999866 45789999999999999999999987543222111110      00000          0


Q ss_pred             c--ccccc----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          703 E--NDLEA----MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       703 ~--~~~~~----~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .  +....    ......++++.+++.+|++.+|++||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0  00000    001234577899999999999999999999986

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.4e-32  Score=290.44  Aligned_cols=253  Identities=22%  Similarity=0.281  Sum_probs=192.3

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCC--------
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR--------  553 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--------  553 (762)
                      +.+.+.||+|++|.||+|.... +++.||||+++...  ......+.+|++++++++||||+++++++.+..        
T Consensus         9 ~~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~   87 (302)
T cd07864           9 FDIIGQIGEGTYGQVYKARDKD-TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD   87 (302)
T ss_pred             hheeeeecccCCEEEEEEEECC-CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence            4456789999999999998653 45789999987532  223457788999999999999999999987655        


Q ss_pred             --ceeEEEeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccc
Q 004312          554 --NRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLE  630 (762)
Q Consensus       554 --~~~LV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla  630 (762)
                        ..++|+||+++ +|..++... ..+++..+..++.||+.||+|||+.   +|+|+||||+||++++++.+||+|||++
T Consensus        88 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~  163 (302)
T cd07864          88 KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLA  163 (302)
T ss_pred             CCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCccccc
Confidence              78999999987 666666543 5789999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhh---cc---c----cc
Q 004312          631 KLLTLDQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ---ER---T----LG  699 (762)
Q Consensus       631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~---~~---~----~~  699 (762)
                      ...............++..|+|||.+.+ ..++.++||||||+++|||++|+.|+......+...   ..   .    ..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (302)
T cd07864         164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP  243 (302)
T ss_pred             ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            8765433222233346788999998865 457899999999999999999998874332111110   00   0    00


Q ss_pred             ccc--------ccccc-----cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          700 ALV--------ENDLE-----AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       700 ~~~--------~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+.        +....     .......+..+.+++.+||+.+|++||+++++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000        00000     0001123578899999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-32  Score=295.96  Aligned_cols=262  Identities=22%  Similarity=0.275  Sum_probs=195.8

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCC------ceeEE
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR------NRLLV  558 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~LV  558 (762)
                      .+.||+|++|.||+|... .+++.||||++.+..  ......+.+|++++++++||||+++++++....      ..++|
T Consensus        20 ~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   98 (342)
T cd07879          20 LKQVGSGAYGSVCSAIDK-RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV   98 (342)
T ss_pred             EEEeeecCCeEEEEEEeC-CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence            357999999999999754 456789999987532  223456889999999999999999999986543      46899


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      +||+.. +|..++  ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||+++....   
T Consensus        99 ~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~---  169 (342)
T cd07879          99 MPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADA---  169 (342)
T ss_pred             eccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC---
Confidence            999974 677665  24588999999999999999999998   999999999999999999999999999875432   


Q ss_pred             cccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc------------------cc
Q 004312          639 HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT------------------LG  699 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~------------------~~  699 (762)
                       ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........+....                  ..
T Consensus       170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (342)
T cd07879         170 -EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK  248 (342)
T ss_pred             -CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence             1223457889999999876 468999999999999999999999985432211111000                  00


Q ss_pred             ccccccc-ccCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hhcCcCCCCCCCCCCCC
Q 004312          700 ALVENDL-EAMD-----DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM--LEGVVEVPIPPCPWTLN  759 (762)
Q Consensus       700 ~~~~~~~-~~~~-----~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~~~~~~~p~~p~~~~  759 (762)
                      ....... ....     ....+.++.+++.+||+.||++||+++|++..  +++..+.+..+.|+.++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~~~  316 (342)
T cd07879         249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQPYD  316 (342)
T ss_pred             HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCccc
Confidence            0000000 0000     01234678899999999999999999999954  77766655444444443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-32  Score=294.58  Aligned_cols=253  Identities=21%  Similarity=0.269  Sum_probs=191.2

Q ss_pred             hhhhhcCCCCcceEEEeeeeCC-CcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccC--CceeEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMG-SSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--RNRLLV  558 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~LV  558 (762)
                      .+.+.||+|++|.||+|+.... .++.||+|.+....   ......+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   82 (316)
T cd07842           3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL   82 (316)
T ss_pred             eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence            3456799999999999987542 56799999997632   33446788999999999999999999999888  789999


Q ss_pred             EeccCCCchhhhccCC-----CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC----CCceEEecccc
Q 004312          559 YEFMSNGALASFLFGD-----SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD----YYNARISDFGL  629 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~Dfgl  629 (762)
                      |||+++ +|.+++...     ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.    ++.+||+|||+
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            999986 565555321     3678999999999999999999998   9999999999999999    99999999999


Q ss_pred             cccccCCCC--cccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHH---------hhhc--
Q 004312          630 EKLLTLDQS--HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYD---------CYQE--  695 (762)
Q Consensus       630 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~---------~~~~--  695 (762)
                      +........  .......+++.|+|||.+.+ ..++.++||||||+++++|++|+.|+.......         ....  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            987643322  12223457889999998866 458999999999999999999998874321110         0000  


Q ss_pred             -----------------cccccccccccccCCC---------H--HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          696 -----------------RTLGALVENDLEAMDD---------M--TVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       696 -----------------~~~~~~~~~~~~~~~~---------~--~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                                       .......+.......+         .  ....++.+++.+||+.||++|||++|+++
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                             0000000000000000         0  23456889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.98  E-value=2.5e-32  Score=295.47  Aligned_cols=258  Identities=23%  Similarity=0.285  Sum_probs=202.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCC-----ceeE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR-----NRLL  557 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~L  557 (762)
                      .+.+.||+|++|.||+|+.. ..++.+|||++....  ....+.+.+|++++++++|+||+++++++....     ..++
T Consensus         3 ~i~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           3 ELLKPIGSGAYGVVCSAVDK-RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             eeeeeecCCCCeEEEEEEeC-CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            45678999999999999754 446789999987654  344568999999999999999999999998775     7899


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ||||++ ++|.+++.....+++..+..++.||++||+|||+.   +|+||||||+|||+++++.++|+|||++.......
T Consensus        82 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          82 VTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE  157 (330)
T ss_pred             Eecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence            999998 48999998878899999999999999999999998   99999999999999999999999999998765433


Q ss_pred             C--cccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc------------------
Q 004312          638 S--HTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER------------------  696 (762)
Q Consensus       638 ~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~------------------  696 (762)
                      .  .......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||......+.....                  
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence            1  122334578899999999887 8999999999999999999999987543222111100                  


Q ss_pred             cccccccc-ccccC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hhcCc
Q 004312          697 TLGALVEN-DLEAM-----DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM--LEGVV  747 (762)
Q Consensus       697 ~~~~~~~~-~~~~~-----~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~~~  747 (762)
                      .....+.. .....     .....+..+.+++.+||+.+|++||+++++++.  ++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence            00000000 00000     011245778999999999999999999999974  55543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.98  E-value=3.2e-32  Score=289.64  Aligned_cols=251  Identities=20%  Similarity=0.256  Sum_probs=189.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhccc-ccCCccchhceeccCCc-----ee
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRN-----RL  556 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~-----~~  556 (762)
                      .+.+.||+|+||.||+|... .+++.||||+++....  .....+.+|+.+++++ +|+||+++++++...+.     .+
T Consensus         4 ~~~~~lg~g~~g~vy~~~~~-~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~   82 (295)
T cd07837           4 EKLEKIGEGTYGKVYKARDK-NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY   82 (295)
T ss_pred             eEeeEecccCCeEEEEEEEC-CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence            34568999999999999764 4567899998765322  2346788999999999 56999999999877665     79


Q ss_pred             EEEeccCCCchhhhccCC-----CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC-CCceEEeccccc
Q 004312          557 LVYEFMSNGALASFLFGD-----SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD-YYNARISDFGLE  630 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla  630 (762)
                      +||||+++ +|.+++...     ..+++..+..++.||++||.|||+.   +|+||||||+||+++. ++.+||+|||++
T Consensus        83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence            99999986 788887542     3579999999999999999999998   9999999999999998 899999999998


Q ss_pred             ccccCCCCcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------ccc
Q 004312          631 KLLTLDQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------TLG  699 (762)
Q Consensus       631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~~~  699 (762)
                      +.+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..|+............          ...
T Consensus       159 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (295)
T cd07837         159 RAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP  237 (295)
T ss_pred             eecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            86533221 1122346788999998865 45799999999999999999999887543221111100          000


Q ss_pred             cc---cc----cccc----cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          700 AL---VE----NDLE----AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       700 ~~---~~----~~~~----~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ..   ..    +...    .......+.++.+++.+||+.+|++||+++|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00   00    0000    0001134677899999999999999999999886

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.98  E-value=4.9e-32  Score=288.57  Aligned_cols=248  Identities=25%  Similarity=0.376  Sum_probs=190.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccc-cCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|++|.||+|.... +++.||||+++... .....++.+|+.++.+.+ |+||+++++++.+....++||||+
T Consensus        18 ~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   96 (296)
T cd06618          18 ENLGEIGSGTCGQVYKMRFKK-TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM   96 (296)
T ss_pred             eeeeEeeccCCeEEEEEEECC-CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence            456789999999999998653 46789999987543 233456777887777764 999999999999999999999998


Q ss_pred             CCCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          563 SNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       563 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      ++ +|.+++.. ...+++..+..++.||++||+|||+.  .+|+||||+|+||++++++.+||+|||++..+.....  .
T Consensus        97 ~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~--~  171 (296)
T cd06618          97 ST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--K  171 (296)
T ss_pred             Cc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc--c
Confidence            64 66666654 35789999999999999999999973  2899999999999999999999999999976543222  2


Q ss_pred             ccccccCcccCcccccCC----CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccccc-CCCHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNM----PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEA-MDDMTVLQ  716 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~----~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  716 (762)
                      ....++..|+|||.+...    .++.++||||||+++|+|++|+.|+.........    +.......... .....+++
T Consensus       172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06618         172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV----LTKILQEEPPSLPPNEGFSP  247 (296)
T ss_pred             cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHH----HHHHhcCCCCCCCCCCCCCH
Confidence            233478899999998754    3889999999999999999999997442111000    11111111111 11113467


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ++.+++.+||+.+|++||+++++++.
T Consensus       248 ~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         248 DFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcC
Confidence            88999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.98  E-value=4e-32  Score=294.84  Aligned_cols=256  Identities=22%  Similarity=0.282  Sum_probs=196.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccC-----CceeE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-----RNRLL  557 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~L  557 (762)
                      ...+.||+|+||.||++... .+++.||||++...  .......+.+|+.++++++|+||+++++++...     ...++
T Consensus         8 ~~~~~lg~G~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l   86 (337)
T cd07858           8 VPIKPIGRGAYGIVCSAKNS-ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI   86 (337)
T ss_pred             eEEEEeccCCCeEEEEEEec-CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence            34467999999999999754 55679999998753  223345778899999999999999999988644     35799


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      |+||+. ++|.+++.....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++......
T Consensus        87 v~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          87 VYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             EEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence            999996 68999998888899999999999999999999998   99999999999999999999999999998664322


Q ss_pred             CcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhh------------------hcccc
Q 004312          638 SHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCY------------------QERTL  698 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~------------------~~~~~  698 (762)
                       .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.........                  .....
T Consensus       163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07858         163 -DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA  241 (337)
T ss_pred             -ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence             22233457889999998865 46899999999999999999999987432111000                  00000


Q ss_pred             cccccc---ccc---cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hhcC
Q 004312          699 GALVEN---DLE---AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM--LEGV  746 (762)
Q Consensus       699 ~~~~~~---~~~---~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~~  746 (762)
                      ...+..   ...   .......+.++.+++.+||+.+|++|||++|+++.  ++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            000000   000   00012356778999999999999999999999876  5443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.98  E-value=7.7e-32  Score=279.12  Aligned_cols=237  Identities=26%  Similarity=0.302  Sum_probs=195.8

Q ss_pred             cCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCc
Q 004312          490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       490 iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      ||+|++|.||++... ..++.+++|.+.....   .....+.+|++++++++|+||+++++.+..+...++||||+++++
T Consensus         1 lg~G~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKK-DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEEC-CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            699999999999764 4567899999875432   234578999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccccc
Q 004312          567 LASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG  646 (762)
Q Consensus       567 L~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g  646 (762)
                      |.+++.....+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.++|+|||++....... .......+
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~  155 (250)
T cd05123          80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG  155 (250)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence            999998887899999999999999999999998   99999999999999999999999999998764332 22334557


Q ss_pred             cCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhh
Q 004312          647 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI  726 (762)
Q Consensus       647 t~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  726 (762)
                      +..|+|||.+.+...+.++|+||||+++|++++|+.|+..........     .....  ....+...+..+.+++.+||
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~l~~~i~~~l  228 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE-----KILKD--PLRFPEFLSPEARDLISGLL  228 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH-----HHhcC--CCCCCCCCCHHHHHHHHHHh
Confidence            889999999988889999999999999999999999975432211111     11111  11122334678899999999


Q ss_pred             ccCCCCCCCHHH
Q 004312          727 QEDPSHRPTMRR  738 (762)
Q Consensus       727 ~~dp~~RPt~~e  738 (762)
                      ..+|++||++.+
T Consensus       229 ~~~p~~R~~~~~  240 (250)
T cd05123         229 QKDPTKRLGSGG  240 (250)
T ss_pred             cCCHhhCCCccc
Confidence            999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=6.7e-32  Score=284.88  Aligned_cols=250  Identities=25%  Similarity=0.320  Sum_probs=196.4

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.||+|++|.||+|+.. .+++.+|+|++....  ....+.+.+|++++++++|+||+++++++.+....++|+||++
T Consensus         3 ~~~~ig~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (282)
T cd07829           3 KLEKLGEGTYGVVYKARDK-KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD   81 (282)
T ss_pred             eehcccccCcceEEEeeec-CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence            3467999999999999764 446789999987653  3334678899999999999999999999999999999999998


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                       ++|.+++... ..+++..+..++.|+++||+|||+.   +|+||||+|+||++++++.+||+|||+++....... ...
T Consensus        82 -~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (282)
T cd07829          82 -MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYT  156 (282)
T ss_pred             -cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccC
Confidence             5899999876 5789999999999999999999998   999999999999999999999999999986643222 222


Q ss_pred             cccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------c---cccc--ccccc
Q 004312          643 AIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------T---LGAL--VENDL  706 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~---~~~~--~~~~~  706 (762)
                      ...++..|+|||.+.+. .++.++||||||+++|||++|+.|+......+.....          .   ....  .....
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence            23457789999998776 8899999999999999999998887443221111000          0   0000  00000


Q ss_pred             cc-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          707 EA-------MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       707 ~~-------~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ..       ......+..+.+++.+||+.+|++||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00       001123567999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.5e-32  Score=311.20  Aligned_cols=265  Identities=22%  Similarity=0.255  Sum_probs=220.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.++||+|+||.|..++.. .+++.+|+|++++.   ......-|.+|-.+|..-+.+=|++++-.|.+...+|+|||
T Consensus        77 feilKvIGrGaFGEV~lVr~k-~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd  155 (1317)
T KOG0612|consen   77 FEILKVIGRGAFGEVALVRHK-STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD  155 (1317)
T ss_pred             hHHHHHhcccccceeEEEEee-ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence            345678999999999999754 56779999999873   33445679999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      ||+||+|-.+|.+..++++...+.++..|..||+-||+.   |+|||||||+|||||..|++||+|||.+-.+..+..-.
T Consensus       156 Y~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~  232 (1317)
T KOG0612|consen  156 YMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR  232 (1317)
T ss_pred             cccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCCcEE
Confidence            999999999998888999999999999999999999998   99999999999999999999999999998888777666


Q ss_pred             cccccccCcccCcccccC-----CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRN-----MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~-----~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                      ....+|||.|++||+++.     +.|++.+|.||+||++|||+.|..||+.+...+-+....-.   ...+..+....++
T Consensus       233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h---k~~l~FP~~~~VS  309 (1317)
T KOG0612|consen  233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH---KESLSFPDETDVS  309 (1317)
T ss_pred             eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch---hhhcCCCcccccC
Confidence            677789999999999952     57899999999999999999999999887665555443222   1112222234578


Q ss_pred             HHHHHHHHHhhccCCCCCCC---HHHHHHH-------hhcCcCCCCCCCCC
Q 004312          716 QRFVMVAIWCIQEDPSHRPT---MRRVTQM-------LEGVVEVPIPPCPW  756 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt---~~evl~~-------L~~~~~~~~p~~p~  756 (762)
                      +++.+||.+.+. +|+.|..   ++++...       ..++.+..+|-.|-
T Consensus       310 eeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPe  359 (1317)
T KOG0612|consen  310 EEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPE  359 (1317)
T ss_pred             HHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCc
Confidence            999999999876 7888887   8888754       24456666666663

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.98  E-value=1.2e-31  Score=287.97  Aligned_cols=239  Identities=26%  Similarity=0.363  Sum_probs=190.1

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      ++||+|+||.||+|+.. .+++.|++|++.....   ...+.+.+|++++++++|||++++++++.+....++||||++ 
T Consensus        27 ~~lg~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  104 (313)
T cd06633          27 HEIGHGSFGAVYFATNS-HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-  104 (313)
T ss_pred             eeeccCCCeEEEEEEEC-CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence            56999999999999754 4467899999864322   233578899999999999999999999999999999999996 


Q ss_pred             CchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          565 GALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       565 gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      ++|.+++.. ...+++..+..++.||+.||.|||+.   +++|+||+|+||++++++.+||+|||++....     ....
T Consensus       105 ~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~~~~  176 (313)
T cd06633         105 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANS  176 (313)
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC-----CCCC
Confidence            567776654 45689999999999999999999998   99999999999999999999999999986432     1223


Q ss_pred             ccccCcccCccccc---CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       644 ~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ..++..|+|||.+.   ...++.++||||||+++|||++|+.|+..............     ...........+..+.+
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~  251 (313)
T cd06633         177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-----NDSPTLQSNEWTDSFRG  251 (313)
T ss_pred             ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----cCCCCCCccccCHHHHH
Confidence            45888999999984   45688999999999999999999999754322221111100     01111112234567889


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~  741 (762)
                      ++.+||+.+|.+||++.+++.
T Consensus       252 li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         252 FVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             HHHHHccCChhhCcCHHHHhc
Confidence            999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.98  E-value=3.9e-32  Score=294.72  Aligned_cols=252  Identities=20%  Similarity=0.215  Sum_probs=194.1

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccch--------------hHHHHHHhhhhcccccCCccchhceecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS--------------EKEFKAEVNGIGQTHHKNLVRLLGYCDE  551 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~g~~~~  551 (762)
                      +.+.||+|+||.||+|... ..++.||||++.......              ...+.+|++++++++|+||+++++++..
T Consensus        13 ~~~~ig~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   91 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDT-LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE   91 (335)
T ss_pred             hhhcccCCCceeEEEEEEC-CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence            3467999999999999754 456789999986432221              1257899999999999999999999999


Q ss_pred             CCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          552 GRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       552 ~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                      .+..++||||++ ++|.+++.....+++.....++.|++.||+|||+.   +|+|+||+|+||++++++.+||+|||+++
T Consensus        92 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~  167 (335)
T PTZ00024         92 GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLAR  167 (335)
T ss_pred             CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcccee
Confidence            999999999997 68999998878899999999999999999999998   99999999999999999999999999998


Q ss_pred             cccCCC-------------CcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc-
Q 004312          632 LLTLDQ-------------SHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER-  696 (762)
Q Consensus       632 ~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~-  696 (762)
                      ......             ........+++.|+|||.+.+. .++.++||||||+++|||++|+.|+......+..... 
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~  247 (335)
T PTZ00024        168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF  247 (335)
T ss_pred             ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            654111             1111223467889999998764 4789999999999999999999987543322211100 


Q ss_pred             -----c----ccccc-----c---cccc---cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          697 -----T----LGALV-----E---NDLE---AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       697 -----~----~~~~~-----~---~~~~---~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                           .    .....     .   ....   .......+.++.+++.+||+.+|++||+++|++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence                 0    00000     0   0000   00011235678899999999999999999999974

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.98  E-value=6.9e-32  Score=285.53  Aligned_cols=249  Identities=26%  Similarity=0.315  Sum_probs=190.6

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhccc---ccCCccchhceeccCCc-----e
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQT---HHKNLVRLLGYCDEGRN-----R  555 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~-----~  555 (762)
                      +.+.||+|+||.||+|+... +++.+|+|++.....  .....+.+|+.++.++   +|+||+++++++...+.     .
T Consensus         3 ~~~~l~~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   81 (287)
T cd07838           3 ELAEIGEGAYGTVYKARDLN-TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL   81 (287)
T ss_pred             EEEEecccCceEEEEEEECC-CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence            45679999999999998754 467899999874322  2234566787776665   69999999999988776     8


Q ss_pred             eEEEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccc
Q 004312          556 LLVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL  633 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~  633 (762)
                      +++|||+++ +|.+++...  ..+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.+||+|||++..+
T Consensus        82 ~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          82 TLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             EEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence            999999975 798888654  3589999999999999999999998   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc----c-----------
Q 004312          634 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT----L-----------  698 (762)
Q Consensus       634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~----~-----------  698 (762)
                      .....  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......+......    .           
T Consensus       158 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         158 SFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             cCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            43322  223347889999999999999999999999999999999988864332211111000    0           


Q ss_pred             --ccccccccc---cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          699 --GALVENDLE---AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       699 --~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                        .........   ..........+.+++.+||+.||++||+++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence              000000000   0001234577889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.98  E-value=7.6e-32  Score=281.24  Aligned_cols=246  Identities=23%  Similarity=0.338  Sum_probs=194.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc-----ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-----FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLV  558 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV  558 (762)
                      +.+.++||+|+||.||+++.... ...+++|.++..     ......++..|+.++++++||||+++++++.+.+..++|
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKA-VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCC-CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            34567899999999999976432 344555655432     222344677899999999999999999999999999999


Q ss_pred             EeccCCCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccccc
Q 004312          559 YEFMSNGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT  634 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~  634 (762)
                      |||+++++|.+++..    ...+++..+..++.|+++||.|||+.   +++|+||+|+||++++ +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998853    35689999999999999999999998   9999999999999976 469999999988764


Q ss_pred             CCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHH
Q 004312          635 LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  714 (762)
                      ... .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.|+...........     ... ......+...
T Consensus       157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~-----~~~-~~~~~~~~~~  229 (260)
T cd08222         157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR-----IVE-GPTPSLPETY  229 (260)
T ss_pred             CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-----HHc-CCCCCCcchh
Confidence            322 222334578899999999888899999999999999999999999754322221111     111 1111223456


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          715 LQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +.++.+++.+||+.+|++||+++|+++
T Consensus       230 ~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         230 SRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             cHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            678999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.98  E-value=6.2e-32  Score=289.66  Aligned_cols=252  Identities=24%  Similarity=0.271  Sum_probs=191.2

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccC--CceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--RNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~LV~E  560 (762)
                      .+.+.||+|+||.||+|... .+++.||+|+++....  .....+.+|+.++++++|+||+++++++.+.  +..++|||
T Consensus        10 ~~~~~ig~g~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   88 (309)
T cd07845          10 EKLNRIGEGTYGIVYRARDT-TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME   88 (309)
T ss_pred             eEeeeeeecCCEEEEEEEEC-CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence            34567999999999999764 4567899999864322  2234567899999999999999999998654  56899999


Q ss_pred             ccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          561 FMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |+++ +|.+++... ..+++..+..++.||++||+|||+.   +++||||||+||++++++.+||+|||++....... .
T Consensus        89 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~  163 (309)
T cd07845          89 YCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-K  163 (309)
T ss_pred             cCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCcc-C
Confidence            9975 788887653 6789999999999999999999999   99999999999999999999999999998765332 1


Q ss_pred             ccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc---------c----------c
Q 004312          640 TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT---------L----------G  699 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~---------~----------~  699 (762)
                      ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+......         .          .
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07845         164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG  243 (309)
T ss_pred             CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence            2223345788999999865 468999999999999999999999875432222111000         0          0


Q ss_pred             cccccccccC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          700 ALVENDLEAM----DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       700 ~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ....+.....    .....++.+.+++.+||+.||++|||++|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000000000    001135678899999999999999999998863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7.8e-33  Score=286.11  Aligned_cols=240  Identities=25%  Similarity=0.279  Sum_probs=200.1

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      ++||+|+||.||-.... .+++-+|.|++.+..   ..++....+|-.+|.+++.+.||.+--.++..+.++||+..|.|
T Consensus       191 RvlGkGGFGEV~acqvr-aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG  269 (591)
T KOG0986|consen  191 RVLGKGGFGEVCACQVR-ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG  269 (591)
T ss_pred             EEEecccccceeEEEEe-cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence            57999999999988755 456789999886532   34456788999999999999999999999999999999999999


Q ss_pred             CchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          565 GALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       565 gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      |+|.-+|.+.+  .++++....++.+|+.||++||.+   +||.|||||+|||||+.|+++|+|+|+|..+...  ....
T Consensus       270 GDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g--~~~~  344 (591)
T KOG0986|consen  270 GDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG--KPIR  344 (591)
T ss_pred             CceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCC--Cccc
Confidence            99999998765  789999999999999999999999   9999999999999999999999999999877543  3334


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ..+||.+|||||++.++.|+...|.|||||+||||+.|+.||....  +....+.+.+.+..+. ...+...++++..|.
T Consensus       345 ~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K--eKvk~eEvdrr~~~~~-~ey~~kFS~eakslc  421 (591)
T KOG0986|consen  345 GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK--EKVKREEVDRRTLEDP-EEYSDKFSEEAKSLC  421 (591)
T ss_pred             cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh--hhhhHHHHHHHHhcch-hhcccccCHHHHHHH
Confidence            4589999999999999999999999999999999999999984331  1122222332222221 223467889999999


Q ss_pred             HHhhccCCCCCCCH
Q 004312          723 IWCIQEDPSHRPTM  736 (762)
Q Consensus       723 ~~cl~~dp~~RPt~  736 (762)
                      ...|+.||++|..-
T Consensus       422 ~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  422 EGLLTKDPEKRLGC  435 (591)
T ss_pred             HHHHccCHHHhccC
Confidence            99999999999643

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-32  Score=267.82  Aligned_cols=246  Identities=24%  Similarity=0.380  Sum_probs=192.4

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhcccc-cCCccchhceeccCCceeEEEeccC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +...||.|.-|.|++..... ++..+|||.+.+... ...+++...++++.+-+ .|.||+.+|++..+...++.||.|.
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs-~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRS-TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hHHhhcCCCccceEEEEEcc-cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            34679999999999998764 467899999976533 33467777787777664 8999999999999999999999994


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      - .++.+|+.. .++++...-++...+.+||.||.++  .+|+|||+||+|||+|+.|++|+||||++..+..  +...+
T Consensus       175 ~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd--SkAht  249 (391)
T KOG0983|consen  175 T-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKAHT  249 (391)
T ss_pred             H-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeec--ccccc
Confidence            3 455555443 5678888889999999999999987  6999999999999999999999999999987754  33444


Q ss_pred             cccccCcccCcccccC---CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccc-cCCCHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRN---MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE-AMDDMTVLQRF  718 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~---~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  718 (762)
                      ...|-+.|||||.+.-   ..|+-++||||||+.|+||.||+.||..-.    ..-+.+..+++.... ......++..+
T Consensus       250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~----tdFe~ltkvln~ePP~L~~~~gFSp~F  325 (391)
T KOG0983|consen  250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK----TDFEVLTKVLNEEPPLLPGHMGFSPDF  325 (391)
T ss_pred             cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC----ccHHHHHHHHhcCCCCCCcccCcCHHH
Confidence            5568899999999854   368899999999999999999999974411    111111122221111 11122378899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+++..||+.|+.+||...++++
T Consensus       326 ~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  326 QSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HHHHHHHhhcCcccCcchHHHhc
Confidence            99999999999999999998875

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.98  E-value=7.7e-32  Score=292.52  Aligned_cols=258  Identities=22%  Similarity=0.294  Sum_probs=193.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccC-----CceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-----RNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~L  557 (762)
                      +.+.+.||+|++|.||+|... .+++.||||++.... ......+.+|+.++++++|+||+++++++...     ...++
T Consensus         7 y~i~~~lg~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   85 (336)
T cd07849           7 YQNLSYIGEGAYGMVCSATHK-PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI   85 (336)
T ss_pred             eEEEEEEEecCCeEEEEEEEc-CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence            345578999999999999754 456789999986432 23345688999999999999999999987544     35799


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      |+||+++ +|.+++. ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        86 v~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          86 VQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             Eehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            9999975 7877774 35689999999999999999999998   99999999999999999999999999998654322


Q ss_pred             Cc--ccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhh----------cccccccccc
Q 004312          638 SH--TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----------ERTLGALVEN  704 (762)
Q Consensus       638 ~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~----------~~~~~~~~~~  704 (762)
                      ..  ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||..........          ......+...
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence            21  1223468899999998754 568999999999999999999998874321111000          0000000000


Q ss_pred             c-------c--ccCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hhcCc
Q 004312          705 D-------L--EAMD-----DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM--LEGVV  747 (762)
Q Consensus       705 ~-------~--~~~~-----~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~~~  747 (762)
                      .       .  ....     ....+.++.+++.+||+.+|++|||+.|+++.  ++...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            0       0  0000     01235678999999999999999999999986  55543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.98  E-value=2e-32  Score=298.62  Aligned_cols=256  Identities=24%  Similarity=0.347  Sum_probs=195.9

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCC------ceeE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR------NRLL  557 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~L  557 (762)
                      ...+.||+|+||.||+|+. ..+++.||||.+++... ...+...+|++++++++|+|||++.+.-++..      ...+
T Consensus        16 ~~~e~LG~Ga~g~V~rgrn-ketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRN-KETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eehhhhcCCccceeeeecc-cccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            3457899999999999974 35678999999987433 33456789999999999999999999876544      5689


Q ss_pred             EEeccCCCchhhhccCC---CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc----CCCceEEeccccc
Q 004312          558 VYEFMSNGALASFLFGD---SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD----DYYNARISDFGLE  630 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~----~~~~~kl~Dfgla  630 (762)
                      |||||++|||...|.+.   ..+++.+.+.++.+++.||.|||++   +|+||||||.||++-    ....-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            99999999999999764   4689999999999999999999998   999999999999994    2335899999999


Q ss_pred             ccccCCCCcccccccccCcccCccccc-CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHH--------hhhccccccc
Q 004312          631 KLLTLDQSHTNTAIRGTKGYVAPEWFR-NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYD--------CYQERTLGAL  701 (762)
Q Consensus       631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~--------~~~~~~~~~~  701 (762)
                      +.+..+  .......||+.|++||.+. .+.++...|.|||||++||.+||..||.+.+...        ......-...
T Consensus       172 rel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  172 RELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             ccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            977543  3667788999999999998 5899999999999999999999999986554321        1111100000


Q ss_pred             c--cccc--------ccCCC----HHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHhhcC
Q 004312          702 V--ENDL--------EAMDD----MTVLQRFVMVAIWCIQEDPSHRP--TMRRVTQMLEGV  746 (762)
Q Consensus       702 ~--~~~~--------~~~~~----~~~~~~~~~li~~cl~~dp~~RP--t~~evl~~L~~~  746 (762)
                      +  ....        ..+.+    ......+-..+..+|..+|++|-  .+.+....+..+
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            0  0000        01111    22345556667778888888887  555555555444

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.98  E-value=1.5e-32  Score=270.61  Aligned_cols=242  Identities=22%  Similarity=0.261  Sum_probs=195.7

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceecc----CCceeEEEecc
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDE----GRNRLLVYEFM  562 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~----~~~~~LV~E~~  562 (762)
                      ++||-|-.|+|-... +..+++.+|+|++...     ....+|+++.-+. .|||||++++.+..    ..-+++|||.|
T Consensus        68 qvLG~GinGkV~~C~-~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m  141 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCV-HKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM  141 (400)
T ss_pred             hhhccccCCceEEEE-eccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence            679999999999885 4456788999998643     3566888876665 79999999998854    34568999999


Q ss_pred             CCCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc---CCCceEEecccccccccCCC
Q 004312          563 SNGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       563 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~~~~~  637 (762)
                      +||.|.+.+..++  .+++++...|+.||+.|+.|||+.   .|.||||||+|+|..   .|-.+||+|||.|+....  
T Consensus       142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~--  216 (400)
T KOG0604|consen  142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE--  216 (400)
T ss_pred             cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC--
Confidence            9999999998775  489999999999999999999999   999999999999996   466799999999986543  


Q ss_pred             CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccccc--CCCHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEA--MDDMTVL  715 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  715 (762)
                      .......+-||.|.|||++....++...|+||+||++|-|++|-.||..... ..+..+....+.......  ..-..++
T Consensus       217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~aispgMk~rI~~gqy~FP~pEWs~VS  295 (400)
T KOG0604|consen  217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKRRIRTGQYEFPEPEWSCVS  295 (400)
T ss_pred             CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-ccCChhHHhHhhccCccCCChhHhHHH
Confidence            3344556789999999999999999999999999999999999999876543 122222222222222221  1124578


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ++..++|+.+|..+|.+|.|++|+++
T Consensus       296 e~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  296 EAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HHHHHHHHHHhcCCchhheeHHHhhc
Confidence            99999999999999999999999886

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=9.5e-32  Score=287.89  Aligned_cols=253  Identities=21%  Similarity=0.280  Sum_probs=188.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCC--------
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR--------  553 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--------  553 (762)
                      +.+.++||+|+||.||++... .+++.||||++....  ......+.+|++++++++||||+++++++....        
T Consensus        14 y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   92 (310)
T cd07865          14 YEKLAKIGQGTFGEVFKARHK-KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG   92 (310)
T ss_pred             eEEEEEeecCCCEEEEEEEEC-CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence            445578999999999999754 456799999886432  222345678999999999999999999986654        


Q ss_pred             ceeEEEeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          554 NRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       554 ~~~LV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                      ..++||||+++ +|.+++... ..+++.++..++.||+.||+|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus        93 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  168 (310)
T cd07865          93 SFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARA  168 (310)
T ss_pred             eEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence            34999999975 777777654 4689999999999999999999998   999999999999999999999999999986


Q ss_pred             ccCCCCc---ccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhh---c-------ccc
Q 004312          633 LTLDQSH---TNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ---E-------RTL  698 (762)
Q Consensus       633 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~---~-------~~~  698 (762)
                      .......   ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+..........   .       ...
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW  248 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            6433221   12234578899999988664 47899999999999999999998874432211100   0       000


Q ss_pred             ccc-----ccc-ccccC---------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          699 GAL-----VEN-DLEAM---------DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       699 ~~~-----~~~-~~~~~---------~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ...     .+. .....         .+......+.+++.+||+.||.+|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            000     000 00000         00012356678999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-33  Score=289.80  Aligned_cols=243  Identities=24%  Similarity=0.365  Sum_probs=198.8

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      +++||.|.||+||-|+.+ .+++.||||++.+.  ....+.++.+|+.+|++++||.||.+.-.|+..+..++|||.+.+
T Consensus       569 devLGSGQFG~VYgg~hR-ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHR-KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceec-ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            367999999999999755 56889999999764  344567899999999999999999999999999999999999977


Q ss_pred             CchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC---CceEEecccccccccCCCCcc
Q 004312          565 GALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY---YNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       565 gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      .=|+-.|.++ +++++..-..++.||+.||.|||.+   +|+|+||||+|||+.+.   -.+||||||.|++.....  -
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--F  722 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--F  722 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh--h
Confidence            6666666544 7899999999999999999999999   99999999999999754   369999999999886433  3


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc-cccccccccccCCCHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT-LGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ...++|||.|+|||+++++.|.+.-|+||.|||+|.-++|..||..+.   .+.+.. -..++   .....-.+++...+
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE---dIndQIQNAaFM---yPp~PW~eis~~Ai  796 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE---DINDQIQNAAFM---YPPNPWSEISPEAI  796 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc---chhHHhhccccc---cCCCchhhcCHHHH
Confidence            345789999999999999999999999999999999999999985431   111111 01111   11122246778899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +||...|+..-++|-|+++-+.
T Consensus       797 dlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  797 DLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             HHHHHHHHHHHHHhcchHhhcc
Confidence            9999999999999998876553

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-32  Score=271.74  Aligned_cols=238  Identities=24%  Similarity=0.277  Sum_probs=200.9

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhH---HHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK---EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +|.++||+|.||+|-+++ +..+++.+|+|++++.......   --..|-++|+..+||.+..|--.+...+.++.||||
T Consensus       171 dfLKvLGkGTFGKVIL~r-EKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey  249 (516)
T KOG0690|consen  171 DFLKVLGKGTFGKVILCR-EKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY  249 (516)
T ss_pred             hHHHHhcCCccceEEEEe-ecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence            467899999999999986 4456789999999875443333   345688899999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      ..+|.|.-+|.+.+.+++...+.+-..|..||.|||++   +||.||||.+|.|+|.+|++||+|||+.+.-. ......
T Consensus       250 anGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g~t~  325 (516)
T KOG0690|consen  250 ANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYGDTT  325 (516)
T ss_pred             ccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-ccccee
Confidence            99999999999988999998889999999999999999   99999999999999999999999999998532 234556


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ..++|||.|+|||++.+..|..+.|.|.+||++|||++|+.||........+.     -++..++  ..+...+++...|
T Consensus       326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFe-----LIl~ed~--kFPr~ls~eAktL  398 (516)
T KOG0690|consen  326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFE-----LILMEDL--KFPRTLSPEAKTL  398 (516)
T ss_pred             ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHH-----HHHhhhc--cCCccCCHHHHHH
Confidence            77899999999999999999999999999999999999999986542222221     2222222  2355667889999


Q ss_pred             HHHhhccCCCCCC
Q 004312          722 AIWCIQEDPSHRP  734 (762)
Q Consensus       722 i~~cl~~dp~~RP  734 (762)
                      +...|..||.+|.
T Consensus       399 LsGLL~kdP~kRL  411 (516)
T KOG0690|consen  399 LSGLLKKDPKKRL  411 (516)
T ss_pred             HHHHhhcChHhhc
Confidence            9999999999994

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=1.1e-31  Score=287.55  Aligned_cols=253  Identities=24%  Similarity=0.271  Sum_probs=188.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc--hhHHHHHHhhhhcccccCCccchhceeccCC--------
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR--------  553 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--------  553 (762)
                      +.+.+.||+|++|.||+|... .+++.+|||++......  ....+.+|++++++++|+||+++++++.+..        
T Consensus        10 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   88 (311)
T cd07866          10 YEILGKLGEGTFGEVYKARQI-KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG   88 (311)
T ss_pred             EEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence            345578999999999999754 45678999998653222  2346789999999999999999999875433        


Q ss_pred             ceeEEEeccCCCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          554 NRLLVYEFMSNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       554 ~~~LV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                      ..++|+||+.. +|...+.. ...+++..+..++.|+++||+|||+.   +|+|+||||+||++++++.+||+|||+++.
T Consensus        89 ~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          89 SVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             eEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchh
Confidence            45999999976 56666654 45799999999999999999999998   999999999999999999999999999986


Q ss_pred             ccCCCCc----------ccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc------
Q 004312          633 LTLDQSH----------TNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE------  695 (762)
Q Consensus       633 ~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~------  695 (762)
                      .......          ......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+...........      
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  244 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG  244 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            5432221          11234568889999987654 589999999999999999999988743322111100      


Q ss_pred             ----------ccccccc----ccccccC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          696 ----------RTLGALV----ENDLEAM---DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       696 ----------~~~~~~~----~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                                ..+....    .......   ......+.+.+++.+||+.+|++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                      0000000    0000000   00122367889999999999999999999876

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=6.6e-33  Score=268.89  Aligned_cols=257  Identities=28%  Similarity=0.372  Sum_probs=198.8

Q ss_pred             ccccCHHHHHHHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhccc-ccCCccchhce
Q 004312          471 LRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGY  548 (762)
Q Consensus       471 ~~~~~~~el~~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~  548 (762)
                      .-.|+-++|+..     ..||.|+||+|+|-.. ..+++..|||+++.... ..++++..|.+...+- +.||||+++|.
T Consensus        58 ~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~h-k~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa  131 (361)
T KOG1006|consen   58 LHTFTSDNLQDL-----GEIGNGAFGTVNKMLH-KPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA  131 (361)
T ss_pred             ccccccchHHHH-----HHhcCCcchhhhhhhc-CccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence            445665665543     5699999999999754 45678999999986443 5567888898876665 78999999999


Q ss_pred             eccCCceeEEEeccCCCchhhhcc-----CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceE
Q 004312          549 CDEGRNRLLVYEFMSNGALASFLF-----GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNAR  623 (762)
Q Consensus       549 ~~~~~~~~LV~E~~~~gsL~~~l~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k  623 (762)
                      +..++..+|.||.|. .||+.+.+     ....+++...-+|..-..+||.||..+  ..|||||+||+||||+..|.+|
T Consensus       132 ~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vK  208 (361)
T KOG1006|consen  132 LFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVK  208 (361)
T ss_pred             hhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEe
Confidence            999999999999994 46665543     346788888889999999999999987  6899999999999999999999


Q ss_pred             EecccccccccCCCCcccccccccCcccCcccccCC--CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccc
Q 004312          624 ISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM--PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL  701 (762)
Q Consensus       624 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~  701 (762)
                      |||||++..+..  +...+.-.|-..|||||.+...  .++-++||||||++|+|+.||+.|+. .|..  .-+ .+.++
T Consensus       209 LCDFGIcGqLv~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr-~w~s--vfe-ql~~V  282 (361)
T KOG1006|consen  209 LCDFGICGQLVD--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR-KWDS--VFE-QLCQV  282 (361)
T ss_pred             eecccchHhHHH--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc-hHHH--HHH-HHHHH
Confidence            999999876542  3333445688899999999643  58999999999999999999999962 2211  111 12222


Q ss_pred             cccccc----cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          702 VENDLE----AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       702 ~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      +..+..    .....+.+..+.+++..|+.+|.++||...++.++
T Consensus       283 v~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  283 VIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            222111    11224577889999999999999999999987653

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=2.6e-31  Score=273.56  Aligned_cols=221  Identities=20%  Similarity=0.133  Sum_probs=179.0

Q ss_pred             CCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCchhhhcc
Q 004312          493 GAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF  572 (762)
Q Consensus       493 G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~  572 (762)
                      |.+|.||++... .+++.+|+|++....     .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~-~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDT-RTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEc-cCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            889999999754 456789999987542     34455555666679999999999999999999999999999999998


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccccccCcccC
Q 004312          573 GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVA  652 (762)
Q Consensus       573 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~a  652 (762)
                      ....+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++++|||.+......    .....++..|+|
T Consensus        78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a  150 (237)
T cd05576          78 KFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA  150 (237)
T ss_pred             HhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence            777899999999999999999999998   9999999999999999999999999987655321    122345678999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCC
Q 004312          653 PEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSH  732 (762)
Q Consensus       653 PE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~  732 (762)
                      ||.+....++.++||||+|+++|||++|+.|+......       .    ........+...++.+.+++.+||+.||++
T Consensus       151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  219 (237)
T cd05576         151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------I----NTHTTLNIPEWVSEEARSLLQQLLQFNPTE  219 (237)
T ss_pred             CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------c----ccccccCCcccCCHHHHHHHHHHccCCHHH
Confidence            99998888999999999999999999999775221000       0    000011122345678899999999999999


Q ss_pred             CCCHH
Q 004312          733 RPTMR  737 (762)
Q Consensus       733 RPt~~  737 (762)
                      ||++.
T Consensus       220 R~~~~  224 (237)
T cd05576         220 RLGAG  224 (237)
T ss_pred             hcCCC
Confidence            99973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=1.5e-31  Score=290.87  Aligned_cols=252  Identities=22%  Similarity=0.262  Sum_probs=190.5

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccC-----------
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-----------  552 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----------  552 (762)
                      +.+.+.||.|+||.||+|... .+++.||+|++........+.+.+|++++++++||||+++++.+...           
T Consensus         7 y~~~~~Lg~g~~g~vy~~~~~-~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (342)
T cd07854           7 YMDLRPLGCGSNGLVFSAVDS-DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL   85 (342)
T ss_pred             eEEEEEecCCCCEEEEEEEEC-CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence            344578999999999999754 45679999998766555667899999999999999999999876543           


Q ss_pred             ---CceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc-CCCceEEeccc
Q 004312          553 ---RNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFG  628 (762)
Q Consensus       553 ---~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfg  628 (762)
                         ...++||||++ ++|.+++.. ..+++.....++.||++||.|||+.   +|+||||||+||+++ ++..+||+|||
T Consensus        86 ~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          86 TELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             cccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcc
Confidence               35789999997 589888854 4688999999999999999999998   999999999999997 56679999999


Q ss_pred             ccccccCCCCcc--cccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc--------
Q 004312          629 LEKLLTLDQSHT--NTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT--------  697 (762)
Q Consensus       629 la~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~--------  697 (762)
                      +++.........  .....++..|+|||.+.. ..++.++||||||+++|+|++|+.||.............        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE  240 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            998654322111  122357889999998754 568899999999999999999999985432211111000        


Q ss_pred             ---------cccccc-cccccCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          698 ---------LGALVE-NDLEAMD-----DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       698 ---------~~~~~~-~~~~~~~-----~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                               ...... .......     ....+.++.+++.+||+.||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                     000000 0000000     0124567889999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=1.6e-31  Score=305.33  Aligned_cols=248  Identities=27%  Similarity=0.384  Sum_probs=184.0

Q ss_pred             Hhhhhh--hcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceec---------
Q 004312          483 TRGFKE--ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCD---------  550 (762)
Q Consensus       483 t~~~~~--~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~---------  550 (762)
                      ..+|.+  .||+||||.|||++-.. +++.+|||++.-.. ......+.+|++.|++|+|||||+++....         
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKl-DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKL-DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecc-cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            345554  69999999999997554 57899999997543 333457889999999999999999865420         


Q ss_pred             ---------------------------------------------------------------------cC---------
Q 004312          551 ---------------------------------------------------------------------EG---------  552 (762)
Q Consensus       551 ---------------------------------------------------------------------~~---------  552 (762)
                                                                                           ++         
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                 00         


Q ss_pred             --------------------------------CceeEEEeccCCCchhhhccCCCCC-CHHHHHHHHHHHHHHHHHhHhc
Q 004312          553 --------------------------------RNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYLHEE  599 (762)
Q Consensus       553 --------------------------------~~~~LV~E~~~~gsL~~~l~~~~~l-~~~~~~~i~~~ia~~L~yLH~~  599 (762)
                                                      ..+||=||||+...|.+++..+... ......+++++|++||+|+|++
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence                                            1136789999998888888766544 4667789999999999999999


Q ss_pred             CCCCeEeCCCCCCceEEcCCCceEEecccccccccC-----------------CCCcccccccccCcccCcccccCC---
Q 004312          600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL-----------------DQSHTNTAIRGTKGYVAPEWFRNM---  659 (762)
Q Consensus       600 ~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~-----------------~~~~~~~~~~gt~~y~aPE~~~~~---  659 (762)
                         +||||||||.||+|+++..|||+|||+|.....                 ......+..+||.-|+|||.+.+.   
T Consensus       717 ---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  717 ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             ---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence               999999999999999999999999999987210                 011234567899999999999765   


Q ss_pred             CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccC--CCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 004312          660 PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM--DDMTVLQRFVMVAIWCIQEDPSHRPTMR  737 (762)
Q Consensus       660 ~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~RPt~~  737 (762)
                      .|+.|+|+||+||||+||+.   ||......    ...+..+-+..+...  ........-..+|.++++.||++|||+.
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMER----a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~  866 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY---PFGTSMER----ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT  866 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc---cCCchHHH----HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence            49999999999999999995   33221111    011111111111111  1222334457899999999999999999


Q ss_pred             HHHH
Q 004312          738 RVTQ  741 (762)
Q Consensus       738 evl~  741 (762)
                      |+++
T Consensus       867 eLL~  870 (1351)
T KOG1035|consen  867 ELLN  870 (1351)
T ss_pred             HHhh
Confidence            9886

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-32  Score=293.19  Aligned_cols=237  Identities=24%  Similarity=0.273  Sum_probs=196.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+...+|.|+|+.|-++... .+.+..+||++.+.    ..+-.+|+.++.+. +||||+++.+.+.++.+.++|||.+
T Consensus       324 y~~~~~~~~gs~s~~~~~~~~-~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l  398 (612)
T KOG0603|consen  324 YEFREELGEGSFSAVKYCESS-PTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL  398 (612)
T ss_pred             hccccccCCCCccceeeeecc-ccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence            446667999999999998644 55678999999764    34556788777776 8999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE-cCCCceEEecccccccccCCCCccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL-DDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl-~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      .++-|.+.+...+... ..+..|+.+|+.|+.|||++   ++|||||||+|||+ ++.++++|+|||.++.....    .
T Consensus       399 ~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~  470 (612)
T KOG0603|consen  399 DGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----C  470 (612)
T ss_pred             cccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----h
Confidence            9999988887776665 77888999999999999999   99999999999999 58999999999999876543    3


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ...+-|..|.|||++....+++++|+||||++||+|++|+.|+.......     .+...+   ..+.....+++.+++|
T Consensus       471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-----ei~~~i---~~~~~s~~vS~~AKdL  542 (612)
T KOG0603|consen  471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-----EIHTRI---QMPKFSECVSDEAKDL  542 (612)
T ss_pred             cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH-----HHHHhh---cCCccccccCHHHHHH
Confidence            33456889999999999999999999999999999999999975442221     111111   1122235678899999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 004312          722 AIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~  741 (762)
                      +.+||+.||.+||+|.++..
T Consensus       543 l~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  543 LQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             HHHhccCChhhCcChhhhcc
Confidence            99999999999999999875

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=270.91  Aligned_cols=251  Identities=21%  Similarity=0.273  Sum_probs=205.5

Q ss_pred             hhhcCCCCcceEEEeeeeCCC----cceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceecc-CCceeEEEe
Q 004312          487 KEELGRGAFGTVYKGFVNMGS----SDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-GRNRLLVYE  560 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~LV~E  560 (762)
                      ...+-+|.||.||+|.+.+.+    .+.|-||.++.... -....+..|...+.-++|||++.+.+.+.+ ....+.+|.
T Consensus       289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~  368 (563)
T KOG1024|consen  289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP  368 (563)
T ss_pred             hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence            346889999999999776432    35688888765433 334578899999999999999999998865 456789999


Q ss_pred             ccCCCchhhhcc-----CC---CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          561 FMSNGALASFLF-----GD---SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       561 ~~~~gsL~~~l~-----~~---~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                      ++.-|+|..||.     +.   ..++..+...++.|++.|++|||..   +|||.||..+|.+||+...+||+|=.++|.
T Consensus       369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRD  445 (563)
T KOG1024|consen  369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRD  445 (563)
T ss_pred             ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccc
Confidence            999999999997     21   3467778889999999999999999   999999999999999999999999999997


Q ss_pred             ccCCCCccccc-ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCC
Q 004312          633 LTLDQSHTNTA-IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMD  710 (762)
Q Consensus       633 ~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  710 (762)
                      +.+...+.... ......||+||.+.+..++.++|||||||+||||+| |+.|+..      +........+..+.+...
T Consensus       446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae------IDPfEm~~ylkdGyRlaQ  519 (563)
T KOG1024|consen  446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE------IDPFEMEHYLKDGYRLAQ  519 (563)
T ss_pred             cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc------cCHHHHHHHHhccceecC
Confidence            76555443322 223568999999999999999999999999999998 5666432      333334455666666667


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          711 DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       711 ~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      +.++++++..++.-||+..|++||+++|++.-|.+.
T Consensus       520 P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  520 PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            888999999999999999999999999999988763

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.7e-32  Score=277.88  Aligned_cols=251  Identities=28%  Similarity=0.376  Sum_probs=199.9

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEcc--ccccchh-----HHHHHHhhhhcccccCCccchhceec-cCCceeE
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSE-----KEFKAEVNGIGQTHHKNLVRLLGYCD-EGRNRLL  557 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~--~~~~~~~-----~~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~L  557 (762)
                      +...||+|+|+.||++. +....+.||||+-.  +...+..     +-..+|.++.+.|+||.||++++++. +.+..+-
T Consensus       467 lLhLLGrGGFSEVyKAF-Dl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCT  545 (775)
T KOG1151|consen  467 LLHLLGRGGFSEVYKAF-DLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCT  545 (775)
T ss_pred             HHHHhccccHHHHHHhc-ccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccccee
Confidence            45679999999999995 44556789999743  2222221     34668999999999999999999985 4566789


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc---CCCceEEeccccccccc
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLT  634 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~~  634 (762)
                      |+|||++.+|+-||+.++.+++++.+.|++||+.||.||.+. .++|||-||||.||||.   .-|.+||.|||+++++.
T Consensus       546 VLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMd  624 (775)
T KOG1151|consen  546 VLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMD  624 (775)
T ss_pred             eeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhcc
Confidence            999999999999999999999999999999999999999986 78999999999999995   45789999999999987


Q ss_pred             CCCCc------ccccccccCcccCcccccC----CCCCCcchhHHHHHHHHHHHhCCCCCchhhHH-Hhhhccccccccc
Q 004312          635 LDQSH------TNTAIRGTKGYVAPEWFRN----MPITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQERTLGALVE  703 (762)
Q Consensus       635 ~~~~~------~~~~~~gt~~y~aPE~~~~----~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~  703 (762)
                      .+...      ......||..|++||.+--    ..++.|.||||.|||+|..+.|++||-..... +..++..+.... 
T Consensus       625 ddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAt-  703 (775)
T KOG1151|consen  625 DDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKAT-  703 (775)
T ss_pred             CCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcce-
Confidence            65432      2334579999999999843    36889999999999999999999998655433 333333332221 


Q ss_pred             cccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 004312          704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVT  740 (762)
Q Consensus       704 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl  740 (762)
                       ....+..+.++.+...+|++||+..-++|..+.++.
T Consensus       704 -EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  704 -EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             -eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence             122223456778899999999999999998777765

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=3e-31  Score=287.39  Aligned_cols=253  Identities=23%  Similarity=0.267  Sum_probs=190.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCC-CcceEEEEEccccc--cchhHHHHHHhhhhccc-ccCCccchhceeccC----Ccee
Q 004312          485 GFKEELGRGAFGTVYKGFVNMG-SSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEG----RNRL  556 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~----~~~~  556 (762)
                      .+.+.||+|+||.||++..... .+..||+|++....  ....+.+.+|+++++++ +||||+++++.+...    ...+
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~   82 (332)
T cd07857           3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY   82 (332)
T ss_pred             eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence            3457899999999999986532 15689999987532  22346788999999999 599999999875432    4568


Q ss_pred             EEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      +++||+. ++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+||++++++.+||+|||+++.....
T Consensus        83 ~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          83 LYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            8899986 68999998888899999999999999999999998   9999999999999999999999999999865432


Q ss_pred             CCc---ccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc----------ccccccc
Q 004312          637 QSH---TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE----------RTLGALV  702 (762)
Q Consensus       637 ~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~----------~~~~~~~  702 (762)
                      ...   ......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.|+...........          .....+.
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            221   1223468999999998765 4689999999999999999999988743221111100          0000000


Q ss_pred             c-----------ccccc---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          703 E-----------NDLEA---MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       703 ~-----------~~~~~---~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .           .....   .........+.+++.+||+.+|++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0           00000   000113567899999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=4.2e-31  Score=287.50  Aligned_cols=254  Identities=26%  Similarity=0.295  Sum_probs=192.1

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCC------ceeE
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR------NRLL  557 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~L  557 (762)
                      +.+.||+|++|.||++... .+++.||||++....  ......+.+|++++++++||||+++++++....      ..++
T Consensus        19 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   97 (343)
T cd07880          19 DLKQVGSGAYGTVCSALDR-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL   97 (343)
T ss_pred             EEEEeeecCCeEEEEEEEC-CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEE
Confidence            3467999999999999754 456789999986432  223456889999999999999999999886543      3589


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ||||+ +++|.+++.. ..+++..+..++.||++||+|||+.   +|+||||||+||++++++.+||+|||++...... 
T Consensus        98 v~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-  171 (343)
T cd07880          98 VMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-  171 (343)
T ss_pred             EEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccC-
Confidence            99999 6789888764 5689999999999999999999998   9999999999999999999999999999865321 


Q ss_pred             CcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc-----c-------------c
Q 004312          638 SHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER-----T-------------L  698 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~-----~-------------~  698 (762)
                         .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||............     .             .
T Consensus       172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07880         172 ---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA  248 (343)
T ss_pred             ---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence               223457889999999876 46889999999999999999999997543221111100     0             0


Q ss_pred             cccccc--cccc----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HhhcCcCC
Q 004312          699 GALVEN--DLEA----MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ--MLEGVVEV  749 (762)
Q Consensus       699 ~~~~~~--~~~~----~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~--~L~~~~~~  749 (762)
                      ......  ....    ......+.++.+++.+|++.||++|||+.++++  .++...+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence            000000  0000    001123456889999999999999999999993  34554443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=9.6e-32  Score=265.92  Aligned_cols=270  Identities=22%  Similarity=0.292  Sum_probs=196.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCc---ceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceecc-CCceeEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSS---DQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-GRNRLLV  558 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~---~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~LV  558 (762)
                      +....||+|.+|.||+++-.....   +.+|+|+++....  .-.....+|+.+++.++||||+.|...+.+ +...+|+
T Consensus        27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~  106 (438)
T KOG0666|consen   27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL  106 (438)
T ss_pred             hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence            445679999999999995433322   3799999975422  234567899999999999999999998877 7788999


Q ss_pred             EeccCCCchhhhccCC-----CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC----CceEEecccc
Q 004312          559 YEFMSNGALASFLFGD-----SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY----YNARISDFGL  629 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~Dfgl  629 (762)
                      +||.+. +|...|+-+     ..++......|+.||+.|+.|||++   -|+||||||.|||+..+    |.|||+|||+
T Consensus       107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccH
Confidence            999987 677777533     3578889999999999999999999   99999999999999876    8999999999


Q ss_pred             cccccCCCC--cccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHH-------Hhhhccccc
Q 004312          630 EKLLTLDQS--HTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAY-------DCYQERTLG  699 (762)
Q Consensus       630 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~-------~~~~~~~~~  699 (762)
                      ++++...-.  .....++-|..|.|||.+.+. .||++.|||+.|||+.||++...-|......       ..-+-..+.
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf  262 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF  262 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence            999865432  223345678999999999875 6999999999999999999866543221100       000000000


Q ss_pred             cccc-------cccccCCCH------------------H-------HHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          700 ALVE-------NDLEAMDDM------------------T-------VLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       700 ~~~~-------~~~~~~~~~------------------~-------~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      +++.       +++....+.                  .       -++...+|+.++|+.||.+|.|+++.++-. -..
T Consensus       263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~-yF~  341 (438)
T KOG0666|consen  263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP-YFT  341 (438)
T ss_pred             HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc-ccc
Confidence            0000       000000000                  0       122367899999999999999999766532 246


Q ss_pred             CCCCCCCCCCCC
Q 004312          748 EVPIPPCPWTLN  759 (762)
Q Consensus       748 ~~~~p~~p~~~~  759 (762)
                      +.+.||.|.+-+
T Consensus       342 ~d~lpp~pt~~~  353 (438)
T KOG0666|consen  342 EDPLPPLPTSDN  353 (438)
T ss_pred             cCCCCCCcccce
Confidence            677788886543

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=4.3e-31  Score=287.44  Aligned_cols=246  Identities=25%  Similarity=0.298  Sum_probs=190.5

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCc------eeE
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRN------RLL  557 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------~~L  557 (762)
                      +.+.||+|++|.||+|.... +++.||||++....  ....+.+.+|+.++++++|+||+++++++...+.      .++
T Consensus        19 ~~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   97 (343)
T cd07851          19 NLSPVGSGAYGQVCSAFDTK-TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL   97 (343)
T ss_pred             EEEEeccCCceEEEEEEECC-CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEE
Confidence            45679999999999997653 46789999986532  2234567889999999999999999998866554      899


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      |+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||++...... 
T Consensus        98 v~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-  171 (343)
T cd07851          98 VTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-  171 (343)
T ss_pred             EEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence            99999 5699998865 4689999999999999999999998   9999999999999999999999999999865322 


Q ss_pred             CcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc------c------------c
Q 004312          638 SHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER------T------------L  698 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~------~------------~  698 (762)
                         .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||............      .            .
T Consensus       172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07851         172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA  248 (343)
T ss_pred             ---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence               233457889999999865 36889999999999999999999997543222111100      0            0


Q ss_pred             cccccccc-ccC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          699 GALVENDL-EAM-----DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       699 ~~~~~~~~-~~~-----~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ...+.... ...     .....++++.+++.+||+.+|++|||++||++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            00000000 000     00123678999999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=1.4e-30  Score=281.51  Aligned_cols=248  Identities=22%  Similarity=0.272  Sum_probs=189.1

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceecc-CCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-GRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||++... .+++.||||++.+..  ....+.+.+|++++++++||||+++++++.. ....++|+||
T Consensus        13 ~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~   91 (328)
T cd07856          13 VDLQPVGMGAFGLVCSARDQ-LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL   91 (328)
T ss_pred             EEEEeecccCCeEEEEEEEC-CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence            34578999999999999644 456789999886422  2335678899999999999999999998865 5678999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      + +++|.+++.. ..+++.....++.|+++||+|||+.   +|+||||+|+||++++++.+||+|||++.....    ..
T Consensus        92 ~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----~~  162 (328)
T cd07856          92 L-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDP----QM  162 (328)
T ss_pred             h-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCC----Cc
Confidence            8 5689888854 4578888889999999999999998   999999999999999999999999999875422    12


Q ss_pred             ccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhh---h---------------cccccccc
Q 004312          642 TAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCY---Q---------------ERTLGALV  702 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~---~---------------~~~~~~~~  702 (762)
                      ....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.........   .               ........
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd07856         163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV  242 (328)
T ss_pred             CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence            23457889999999866 56899999999999999999999887433211000   0               00000000


Q ss_pred             cc-ccccCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          703 EN-DLEAMDD-----MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       703 ~~-~~~~~~~-----~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      .. ......+     ...++++.+++.+||+.+|++||++++++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00 0000001     1235788999999999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=8.6e-31  Score=285.28  Aligned_cols=256  Identities=27%  Similarity=0.325  Sum_probs=190.8

Q ss_pred             HHHHHHHhhh--hhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccC
Q 004312          477 KELVEVTRGF--KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG  552 (762)
Q Consensus       477 ~el~~~t~~~--~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  552 (762)
                      .++..+++++  .+.||+|+||.||+|... .+++.||+|++....  ....+.+.+|+.++.+++||||+++++++...
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEc-CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            3444444444  357999999999999654 456789999987532  22345788999999999999999999987533


Q ss_pred             ------CceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEec
Q 004312          553 ------RNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISD  626 (762)
Q Consensus       553 ------~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  626 (762)
                            ...++++|++ +++|.+++.. ..+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~d  163 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD  163 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEec
Confidence                  3467888876 7899888754 4689999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccCCCCcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc---------
Q 004312          627 FGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER---------  696 (762)
Q Consensus       627 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~---------  696 (762)
                      ||+++....    ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.|+............         
T Consensus       164 fg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (345)
T cd07877         164 FGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  239 (345)
T ss_pred             ccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            999875432    2233457889999999866 56889999999999999999999987432211111000         


Q ss_pred             -cccccccc-------ccccCC-------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          697 -TLGALVEN-------DLEAMD-------DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       697 -~~~~~~~~-------~~~~~~-------~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                       ....+.+.       ......       ....+.++.+++.+|++.+|.+||++.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence             00000000       000000       00134578899999999999999999998854

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=9e-31  Score=307.28  Aligned_cols=143  Identities=29%  Similarity=0.429  Sum_probs=128.2

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.++||+|+||.||+|... ..++.||||+++...   ......+.+|+.+++.++|+||+++++.+......+|||||
T Consensus         7 ~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy   85 (669)
T cd05610           7 VIVKPISRGAFGKVYLGRKK-NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY   85 (669)
T ss_pred             EEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence            34578999999999999754 456799999987532   22236788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                      +++++|.+++.....+++..++.|+.||+.||+|||..   +|+||||||+||||+.++.+||+|||+++
T Consensus        86 ~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          86 LIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999998777889999999999999999999998   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.8e-30  Score=266.33  Aligned_cols=237  Identities=26%  Similarity=0.323  Sum_probs=195.1

Q ss_pred             CcceEEEeeeeCCCcceEEEEEccccccch-hHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCchhhhcc
Q 004312          494 AFGTVYKGFVNMGSSDQVAVKKLNRVFQDS-EKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF  572 (762)
Q Consensus       494 ~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~  572 (762)
                      +||.||+|+.. ++++.+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDK-KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEEC-CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            58999999765 346789999997654444 6899999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccccccCcccC
Q 004312          573 GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVA  652 (762)
Q Consensus       573 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~a  652 (762)
                      ....+++..+..++.++++++.|||+.   +++|+||+|+||++++++.++|+|||.+.......  ......++..|++
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~  154 (244)
T smart00220       80 KRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA  154 (244)
T ss_pred             hccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence            776689999999999999999999998   99999999999999999999999999998765432  2334557889999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHH--HHHHHHHHHHHhhccCC
Q 004312          653 PEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMT--VLQRFVMVAIWCIQEDP  730 (762)
Q Consensus       653 PE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~cl~~dp  730 (762)
                      ||.+....++.++||||||+++++|++|..|+..........+     .+...........  .+.++.+++.+|+..+|
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  229 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFK-----KIGKPKPPFPPPEWKISPEAKDLIRKLLVKDP  229 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH-----HHhccCCCCccccccCCHHHHHHHHHHccCCc
Confidence            9999988899999999999999999999999754211111111     1111111111111  56789999999999999


Q ss_pred             CCCCCHHHHHH
Q 004312          731 SHRPTMRRVTQ  741 (762)
Q Consensus       731 ~~RPt~~evl~  741 (762)
                      ++||++.++++
T Consensus       230 ~~Rp~~~~~~~  240 (244)
T smart00220      230 EKRLTAEEALQ  240 (244)
T ss_pred             hhccCHHHHhh
Confidence            99999999987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-31  Score=270.12  Aligned_cols=242  Identities=25%  Similarity=0.315  Sum_probs=204.0

Q ss_pred             HHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhccc-ccCCccchhceeccCCcee
Q 004312          481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRL  556 (762)
Q Consensus       481 ~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  556 (762)
                      ....+|..+||+|+||+|.++. +.++.+.+|||++++...   ++.+--+.|-++|+.. +-|.+++++.++..-+.++
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLae-rkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             ecccceEEEeccCccceeeeec-ccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            3334788899999999999995 557778999999986422   2233456788888887 5688999999999999999


Q ss_pred             EEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      .||||+.+|+|--++..-+++.++.+..+|..||-||-+||++   +||.||||.+|||||.+|++||+|||+.+.-- -
T Consensus       427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-~  502 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-F  502 (683)
T ss_pred             eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc-c
Confidence            9999999999999999989999999999999999999999999   99999999999999999999999999997422 2


Q ss_pred             CCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          637 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      ........+|||.|+|||++...+|+...|.|||||+||||+.|+.||.++...+.++..     .+.  ....+...+.
T Consensus       503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI-----~eh--nvsyPKslSk  575 (683)
T KOG0696|consen  503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI-----MEH--NVSYPKSLSK  575 (683)
T ss_pred             CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-----HHc--cCcCcccccH
Confidence            234556789999999999999999999999999999999999999999776555444432     222  1224556778


Q ss_pred             HHHHHHHHhhccCCCCCC
Q 004312          717 RFVMVAIWCIQEDPSHRP  734 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RP  734 (762)
                      ++..+....|...|.+|.
T Consensus       576 EAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  576 EAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             HHHHHHHHHhhcCCcccc
Confidence            899999999999999994

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=3.6e-30  Score=287.69  Aligned_cols=261  Identities=20%  Similarity=0.235  Sum_probs=181.5

Q ss_pred             hhhhhcCCCCcceEEEeeee---------------CCCcceEEEEEccccccchhHHH--------------HHHhhhhc
Q 004312          485 GFKEELGRGAFGTVYKGFVN---------------MGSSDQVAVKKLNRVFQDSEKEF--------------KAEVNGIG  535 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~---------------~~~~~~vavK~~~~~~~~~~~~~--------------~~E~~~l~  535 (762)
                      .+.++||+|+||.||+|.+.               ...++.||||++........++|              ..|+.++.
T Consensus       148 ~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~  227 (507)
T PLN03224        148 QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCA  227 (507)
T ss_pred             eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHH
Confidence            34578999999999999642               12345799999865433323333              34666677


Q ss_pred             ccccCCc-----cchhceecc--------CCceeEEEeccCCCchhhhccCC------------------------CCCC
Q 004312          536 QTHHKNL-----VRLLGYCDE--------GRNRLLVYEFMSNGALASFLFGD------------------------SKPN  578 (762)
Q Consensus       536 ~l~H~nI-----v~l~g~~~~--------~~~~~LV~E~~~~gsL~~~l~~~------------------------~~l~  578 (762)
                      +++|.++     ++++++|..        ....+|||||+++++|.++|+..                        ..++
T Consensus       228 ~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~  307 (507)
T PLN03224        228 KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD  307 (507)
T ss_pred             HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence            7766554     678888753        35689999999999999998642                        1235


Q ss_pred             HHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccccccCcccCcccccC
Q 004312          579 WKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN  658 (762)
Q Consensus       579 ~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~  658 (762)
                      +..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+............+++.|+|||.+..
T Consensus       308 ~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~  384 (507)
T PLN03224        308 INVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM  384 (507)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence            778889999999999999998   99999999999999999999999999997654332222222235789999998754


Q ss_pred             CC----------------------CCCcchhHHHHHHHHHHHhCCC-CCchhhHH-Hhhhc--cc---cccccccccccC
Q 004312          659 MP----------------------ITVKVDVYSYGVLLLEIICLRR-TILTDWAY-DCYQE--RT---LGALVENDLEAM  709 (762)
Q Consensus       659 ~~----------------------~s~~~DV~S~Gvil~elltg~~-p~~~~~~~-~~~~~--~~---~~~~~~~~~~~~  709 (762)
                      ..                      ...+.||||+||++++|+++.. |+...... .....  ..   ............
T Consensus       385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~  464 (507)
T PLN03224        385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFS  464 (507)
T ss_pred             CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcc
Confidence            32                      1235799999999999999876 44211000 00000  00   000111111111


Q ss_pred             CCHHHHHHHHHHHHHhhccCC---CCCCCHHHHHHHhhcCcCCCCCCCCCCCCC
Q 004312          710 DDMTVLQRFVMVAIWCIQEDP---SHRPTMRRVTQMLEGVVEVPIPPCPWTLNI  760 (762)
Q Consensus       710 ~~~~~~~~~~~li~~cl~~dp---~~RPt~~evl~~L~~~~~~~~p~~p~~~~~  760 (762)
                      ......+...+++.++|..+|   .+|+|++|+++            |||..+|
T Consensus       465 ~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~------------Hp~f~~~  506 (507)
T PLN03224        465 LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS------------HRFFLPE  506 (507)
T ss_pred             cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC------------CCCcCCC
Confidence            223456788999999999766   68999999998            7887665

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=6.8e-30  Score=234.10  Aligned_cols=249  Identities=21%  Similarity=0.310  Sum_probs=191.7

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      .++||+|.+|+||+|+-. .+.+.||+|+++-.  ++.-.....+|+-+++.++|.|||++++....+....||+|||..
T Consensus         7 mekigegtygtvfkarn~-~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq   85 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ   85 (292)
T ss_pred             HHhhcCCcceeeEecccC-CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH
Confidence            478999999999999744 45678999998643  333346789999999999999999999999999999999999954


Q ss_pred             CchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          565 GALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       565 gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                       +|..|..+ ++.++......++.|+++||.++|++   .+.|||+||+|.||+.||+.|++|||+++.+.... .....
T Consensus        86 -dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv-rcysa  160 (292)
T KOG0662|consen   86 -DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYSA  160 (292)
T ss_pred             -HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce-Eeeec
Confidence             77777654 46788999999999999999999999   99999999999999999999999999999875432 22334


Q ss_pred             ccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc-----------c---cccccccccc
Q 004312          644 IRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT-----------L---GALVENDLEA  708 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~-----------~---~~~~~~~~~~  708 (762)
                      .+-|..|.+|+++.+. -|+...|+||.|||+.|+.....|..+.......-.+.           .   ..+.+-....
T Consensus       161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp  240 (292)
T KOG0662|consen  161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP  240 (292)
T ss_pred             eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence            4568999999998775 58999999999999999998887754332211111110           0   0111111111


Q ss_pred             CCC---------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          709 MDD---------MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       709 ~~~---------~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ..+         +.....-++++.+.+.-+|.+|.++++.++
T Consensus       241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            111         122334578888999999999999998765

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=2.1e-29  Score=288.54  Aligned_cols=250  Identities=19%  Similarity=0.186  Sum_probs=165.9

Q ss_pred             hhhhhcCCCCcceEEEeeeeCC---CcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhce------eccCCce
Q 004312          485 GFKEELGRGAFGTVYKGFVNMG---SSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY------CDEGRNR  555 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~------~~~~~~~  555 (762)
                      .+.+.||+|+||.||+|.+...   .+..||||++.....  ...+.+|  .+.+..+.+++.++..      +.+....
T Consensus       135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (566)
T PLN03225        135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY  210 (566)
T ss_pred             EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence            4457899999999999987533   156899998764321  1111121  1222223333333222      2456788


Q ss_pred             eEEEeccCCCchhhhccCCCC--------------------CCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceE
Q 004312          556 LLVYEFMSNGALASFLFGDSK--------------------PNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNIL  615 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIL  615 (762)
                      +|||||+++++|.+++.....                    .....+..++.||+.||+|||++   +|+||||||+|||
T Consensus       211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NIL  287 (566)
T PLN03225        211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNII  287 (566)
T ss_pred             EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEE
Confidence            999999999999999864321                    11234567999999999999998   9999999999999


Q ss_pred             EcC-CCceEEecccccccccCCCCcccccccccCcccCcccccCC----------------------CCCCcchhHHHHH
Q 004312          616 LDD-YYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM----------------------PITVKVDVYSYGV  672 (762)
Q Consensus       616 l~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~~DV~S~Gv  672 (762)
                      +++ ++.+||+|||+++.+............+++.|+|||.+...                      .++.++|||||||
T Consensus       288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv  367 (566)
T PLN03225        288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL  367 (566)
T ss_pred             EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence            985 68999999999987654444444556789999999965322                      2345679999999


Q ss_pred             HHHHHHhCCCCCchhhHH--Hhhhccc-----cccccccccccC------CCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 004312          673 LLLEIICLRRTILTDWAY--DCYQERT-----LGALVENDLEAM------DDMTVLQRFVMVAIWCIQEDPSHRPTMRRV  739 (762)
Q Consensus       673 il~elltg~~p~~~~~~~--~~~~~~~-----~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~dp~~RPt~~ev  739 (762)
                      +||||+++..+.......  ..+....     ......+.....      ..........+|+.+||+.||++|||++|+
T Consensus       368 iL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~  447 (566)
T PLN03225        368 IFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAA  447 (566)
T ss_pred             HHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHH
Confidence            999999987664322110  0000000     000011100000      000112345689999999999999999999


Q ss_pred             HH
Q 004312          740 TQ  741 (762)
Q Consensus       740 l~  741 (762)
                      ++
T Consensus       448 L~  449 (566)
T PLN03225        448 LA  449 (566)
T ss_pred             hC
Confidence            87

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=281.07  Aligned_cols=247  Identities=24%  Similarity=0.359  Sum_probs=203.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceec-----cCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCD-----EGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~-----~~~~~~L  557 (762)
                      ..|.++||.|.+|.||+++-. ..++.+|||++... .+...+...|.++++.. +|||++.++|++.     .++.++|
T Consensus        21 ~ei~evig~Gtygkv~k~k~~-~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL   98 (953)
T KOG0587|consen   21 FEIIEVIGNGTYGKVYKGRHV-KTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL   98 (953)
T ss_pred             cEEEEEEeeccceeEEEEeee-ecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence            356688999999999999744 45678899988653 45567888999999988 7999999999884     4578999


Q ss_pred             EEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          558 VYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      |||||.+||..+++++-  .++.|..+..|+..+++||++||..   .++|||||-.|||+++++.|||.|||++..+..
T Consensus        99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen   99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS  175 (953)
T ss_pred             EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence            99999999999998764  6789999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCcccccccccCcccCcccccC-----CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccc-ccccccC
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRN-----MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALV-ENDLEAM  709 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~  709 (762)
                      ...... ...|||.|||||++.-     ..|+.++|+||||++..||--|..|+....+...+     ..+. .+.....
T Consensus       176 T~grRn-T~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-----F~IpRNPPPkLk  249 (953)
T KOG0587|consen  176 TVGRRN-TFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----FLIPRNPPPKLK  249 (953)
T ss_pred             cccccc-CcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-----ccCCCCCCcccc
Confidence            444333 3569999999999853     35789999999999999999999997554333222     1111 2222333


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          710 DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       710 ~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+....+++.++|..||..|..+||++.++++
T Consensus       250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            45678899999999999999999999988765

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=259.10  Aligned_cols=258  Identities=21%  Similarity=0.303  Sum_probs=197.8

Q ss_pred             cCHHHHHHHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc-c-CC----ccchhc
Q 004312          474 FTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-H-KN----LVRLLG  547 (762)
Q Consensus       474 ~~~~el~~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~n----Iv~l~g  547 (762)
                      +...+.....+.+...+|+|.||.|-+.... ..+..||||+++.... -.+..+-|+++|+++. + |+    +|.+.+
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~-~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~  158 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDR-ETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRD  158 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeec-CCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence            4445555666777889999999999998654 4478999999986532 3345677999999993 2 33    788999


Q ss_pred             eeccCCceeEEEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC-------
Q 004312          548 YCDEGRNRLLVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD-------  618 (762)
Q Consensus       548 ~~~~~~~~~LV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-------  618 (762)
                      +++..++.+||+|.+ +-|+.++|..+  .+++...+..|+.|++++++|||+.   +++|-||||+|||+.+       
T Consensus       159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~  234 (415)
T KOG0671|consen  159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTY  234 (415)
T ss_pred             hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEe
Confidence            999999999999998 56999999876  4688999999999999999999999   9999999999999832       


Q ss_pred             -------------CCceEEecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCc
Q 004312          619 -------------YYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTIL  685 (762)
Q Consensus       619 -------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~  685 (762)
                                   +..+||+|||.|+.-...    ...++.|..|.|||++.+-.++.++||||+||||.|+.+|..-|.
T Consensus       235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq  310 (415)
T KOG0671|consen  235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ  310 (415)
T ss_pred             ccCCccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence                         345899999999864322    256778999999999999999999999999999999999987653


Q ss_pred             hhhHHH--hhhcccccc----c--------------cc---------------cc----cccCCCHHHHHHHHHHHHHhh
Q 004312          686 TDWAYD--CYQERTLGA----L--------------VE---------------ND----LEAMDDMTVLQRFVMVAIWCI  726 (762)
Q Consensus       686 ~~~~~~--~~~~~~~~~----~--------------~~---------------~~----~~~~~~~~~~~~~~~li~~cl  726 (762)
                      .....+  .+.+..++.    +              ++               +.    ...........++.+|+++||
T Consensus       311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL  390 (415)
T KOG0671|consen  311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML  390 (415)
T ss_pred             cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence            221111  011110000    0              00               00    000112345667999999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 004312          727 QEDPSHRPTMRRVTQ  741 (762)
Q Consensus       727 ~~dp~~RPt~~evl~  741 (762)
                      ..||.+|+|+.|++.
T Consensus       391 ~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  391 EFDPARRITLREALS  405 (415)
T ss_pred             ccCccccccHHHHhc
Confidence            999999999999886

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=265.32  Aligned_cols=261  Identities=23%  Similarity=0.276  Sum_probs=212.3

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccc---cccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      ..||-|+||.|=++...... ..+|+|++++   .....+.-...|-.+|...+.|.||+++--+.+....|+.||-|-+
T Consensus       426 aTLGvGgFGRVELV~~~~~~-~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG  504 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQK-ATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG  504 (732)
T ss_pred             hhcccCccceEEEEEecccc-hHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence            35999999999998776432 2578888765   2334445577899999999999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccc
Q 004312          565 GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI  644 (762)
Q Consensus       565 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  644 (762)
                      |.|...|.+.+.++..+...++..+++|++|||++   +||.|||||+|.+|+.+|-+||.|||.|+.+.  .+...-.+
T Consensus       505 GElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~--~g~KTwTF  579 (732)
T KOG0614|consen  505 GELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG--SGRKTWTF  579 (732)
T ss_pred             chhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc--cCCceeee
Confidence            99999999999999999999999999999999999   99999999999999999999999999999775  34555678


Q ss_pred             cccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHH
Q 004312          645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW  724 (762)
Q Consensus       645 ~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  724 (762)
                      +|||.|+|||++.+...+.++|.||||+++|||++|..||....+...+.-     ++..-.....|..+.....+|+++
T Consensus       580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~-----ILkGid~i~~Pr~I~k~a~~Lik~  654 (732)
T KOG0614|consen  580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL-----ILKGIDKIEFPRRITKTATDLIKK  654 (732)
T ss_pred             cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH-----HHhhhhhhhcccccchhHHHHHHH
Confidence            999999999999999999999999999999999999999866544332221     111111223345667788999999


Q ss_pred             hhccCCCCCCC-----HHHHHHH-------hhcC--cCCCCCCCCCCCC
Q 004312          725 CIQEDPSHRPT-----MRRVTQM-------LEGV--VEVPIPPCPWTLN  759 (762)
Q Consensus       725 cl~~dp~~RPt-----~~evl~~-------L~~~--~~~~~p~~p~~~~  759 (762)
                      ....+|.+|..     +.+|.+.       .+++  ..+++|-.|...+
T Consensus       655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~  703 (732)
T KOG0614|consen  655 LCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVAN  703 (732)
T ss_pred             HHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCC
Confidence            99999999976     5566543       1222  3466676666554

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.5e-29  Score=243.67  Aligned_cols=251  Identities=21%  Similarity=0.320  Sum_probs=186.4

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEccc--cccchhHHHHHHhhhhcccccCCccchhceeccC--------Ccee
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--------RNRL  556 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--------~~~~  556 (762)
                      ..+||+|.||.||+++... +++.||+|++--  ....-.....+|+++|..++|+|++.++..|...        ...+
T Consensus        22 ~~kigqGtfgeVFkAr~~n-~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~y  100 (376)
T KOG0669|consen   22 LAKIGQGTFGEVFKARSKN-TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFY  100 (376)
T ss_pred             HHhcCCchHHHHHHHhhcC-ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceee
Confidence            3579999999999997553 456688887532  1122234678999999999999999999999542        3478


Q ss_pred             EEEeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          557 LVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ||+.+|+. +|..+|.+. .+++..++.+++.++..||.|+|..   .|+|||+||.|+||+.++.+||+|||+++.+..
T Consensus       101 lVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~  176 (376)
T KOG0669|consen  101 LVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFST  176 (376)
T ss_pred             eeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence            99999976 788888766 6789999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCC---cccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHH--------------------
Q 004312          636 DQS---HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYD--------------------  691 (762)
Q Consensus       636 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~--------------------  691 (762)
                      ...   ...+..+-|..|.+||.+.+ .+++++.|||+.|||+.||.++..-+.......                    
T Consensus       177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~  256 (376)
T KOG0669|consen  177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV  256 (376)
T ss_pred             ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence            322   22344567999999999876 579999999999999999999865432221111                    


Q ss_pred             ----hhhccccccccccccccC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          692 ----CYQERTLGALVENDLEAM----DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       692 ----~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                          .++...+..+.....+..    .+..-.++..+|+.+++..||.+|++.++++..
T Consensus       257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence                111110000000000000    001112467899999999999999999988753

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=3e-29  Score=277.44  Aligned_cols=238  Identities=27%  Similarity=0.329  Sum_probs=184.2

Q ss_pred             hhcCCCCcce-EEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEeccCCC
Q 004312          488 EELGRGAFGT-VYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       488 ~~iG~G~~g~-Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      +.+|.|..|+ ||+|.++   +++||||++-..   ...-.++||..|+.- .||||||+++.-.+....||..|.|. -
T Consensus       515 eilG~Gs~Gt~Vf~G~ye---~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~  587 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVYE---GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-C  587 (903)
T ss_pred             HHcccCCCCcEEEEEeeC---CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-h
Confidence            5689999875 6999886   579999998532   334567899999887 79999999999999999999999994 5


Q ss_pred             chhhhccCC-C---CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC-----CCceEEecccccccccCC
Q 004312          566 ALASFLFGD-S---KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD-----YYNARISDFGLEKLLTLD  636 (762)
Q Consensus       566 sL~~~l~~~-~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~Dfgla~~~~~~  636 (762)
                      +|.++++.. .   .........+..|++.||++||+.   +||||||||+||||+.     ...++|+|||+++.+..+
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            999999874 1   112244567889999999999998   9999999999999975     357999999999988766


Q ss_pred             CCcc--cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhC-CCCCchhhHHHhhhccccccccccccccCCCHH
Q 004312          637 QSHT--NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICL-RRTILTDWAYDCYQERTLGALVENDLEAMDDMT  713 (762)
Q Consensus       637 ~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  713 (762)
                      +..-  .....||-+|+|||.+....-+.++||||+||++|..++| ..||-.....+.  .......-...+..  ...
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~--~~d  740 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEP--LPD  740 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeecc--Cch
Confidence            5432  3346699999999999998888999999999999999998 677744322211  00000000001111  111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          714 VLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       714 ~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .  +..+||.+|++++|..||++.+|+.
T Consensus       741 ~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  741 C--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             H--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            1  7889999999999999999999974

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=3.3e-28  Score=231.33  Aligned_cols=248  Identities=19%  Similarity=0.347  Sum_probs=190.6

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc-cCCccchhceeccC--CceeEE
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEG--RNRLLV  558 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~LV  558 (762)
                      ..+++.+++|+|.++.||.|. ...+.+.++||+++..   ..+.+.+|+++|..|. ||||++|++...+.  ....||
T Consensus        38 ddYeivrk~GRGKYSEVFeg~-~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGI-NITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             chHHHHHHHcCccHhhHhccc-ccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            345677899999999999995 4456678999999864   4568999999999996 99999999998764  456899


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc-CCCceEEecccccccccCCC
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~~~  637 (762)
                      +||+.+.+...+.   +.++...+...+.++++||.|+|+.   ||+|||+||.|++|| +...++|+|+|+|.++.+..
T Consensus       114 FE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             hhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            9999998776665   4577788899999999999999999   999999999999999 56789999999999887544


Q ss_pred             CcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhh-HHHhhhc-------ccccc-------c
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDW-AYDCYQE-------RTLGA-------L  701 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~-~~~~~~~-------~~~~~-------~  701 (762)
                      ..  ...+.+.-|--||.+-+- .++..-|+|||||+|..|+..+.||.... .++....       ..+..       .
T Consensus       188 eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~  265 (338)
T KOG0668|consen  188 EY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID  265 (338)
T ss_pred             ee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence            33  223456778899998664 68899999999999999999999974321 1111000       00000       0


Q ss_pred             ccccccc----------------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          702 VENDLEA----------------MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       702 ~~~~~~~----------------~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++....                ....-..+++++++.+.|..|..+|||++|.+.
T Consensus       266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            1111100                000113478899999999999999999998765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=3.6e-27  Score=235.70  Aligned_cols=210  Identities=34%  Similarity=0.534  Sum_probs=184.8

Q ss_pred             cCCCCcceEEEeeeeCCCcceEEEEEccccccc-hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCchh
Q 004312          490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALA  568 (762)
Q Consensus       490 iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~  568 (762)
                      ||+|.+|.||++.... +++++++|++...... ..+.+.+|++.+++++|++|+++++++......++++|++++++|.
T Consensus         1 l~~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKK-TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecC-CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            6899999999997653 4678999998765332 3568999999999999999999999999999999999999999999


Q ss_pred             hhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC-CCceEEecccccccccCCCCcccccccc
Q 004312          569 SFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD-YYNARISDFGLEKLLTLDQSHTNTAIRG  646 (762)
Q Consensus       569 ~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~g  646 (762)
                      +++... ..+++..+..++.+++++|++||+.   +++|+||+|+||+++. ++.++|+|||.+........ ......+
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~  155 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG  155 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence            999766 5789999999999999999999999   9999999999999999 89999999999986643321 2233457


Q ss_pred             cCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHh
Q 004312          647 TKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWC  725 (762)
Q Consensus       647 t~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  725 (762)
                      ...|++||.+... ..+.+.|+|++|+++++|                                      ..+.+++.+|
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------~~~~~~l~~~  197 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------PELKDLIRKM  197 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------HHHHHHHHHH
Confidence            8899999999887 889999999999999998                                      6788999999


Q ss_pred             hccCCCCCCCHHHHHHH
Q 004312          726 IQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       726 l~~dp~~RPt~~evl~~  742 (762)
                      ++.+|++||++.++++.
T Consensus       198 l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         198 LQKDPEKRPSAKEILEH  214 (215)
T ss_pred             hhCCcccCcCHHHHhhC
Confidence            99999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.2e-28  Score=243.71  Aligned_cols=242  Identities=23%  Similarity=0.285  Sum_probs=195.1

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccch---hHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEec
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.++||+|++.+|..+.+. .+.+.+|+|++++.....   ..-.+.|-.+..+- +||.+|.+..++..+..++.|.||
T Consensus       254 ll~vigrgsyakvl~~~~~-~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey  332 (593)
T KOG0695|consen  254 LLRVIGRGSYAKVLLVRLK-KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY  332 (593)
T ss_pred             eeeeecCcchhhhhheehc-ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence            3468999999999999765 456789999998643222   23355666666665 799999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|+|--++...++++++..+.+...|..||.|||++   |||.||||.+|||||..|++||.|+|+.+.-. ......
T Consensus       333 v~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l-~~gd~t  408 (593)
T KOG0695|consen  333 VNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-GPGDTT  408 (593)
T ss_pred             ecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC-CCCccc
Confidence            99999999999999999999999999999999999999   99999999999999999999999999998532 345566


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhh--HHHhhhcccc-ccccccccccCCCHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDW--AYDCYQERTL-GALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  718 (762)
                      ..++|||.|+|||++++..|....|.|++||+++||+.|+.||...-  ..+...+..+ .-++....+  .+...+-+.
T Consensus       409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--iprslsvka  486 (593)
T KOG0695|consen  409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--IPRSLSVKA  486 (593)
T ss_pred             ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--ccceeehhh
Confidence            78999999999999999999999999999999999999999974321  0111111111 222222222  233455667


Q ss_pred             HHHHHHhhccCCCCCC
Q 004312          719 VMVAIWCIQEDPSHRP  734 (762)
Q Consensus       719 ~~li~~cl~~dp~~RP  734 (762)
                      ..+++..|++||.+|.
T Consensus       487 s~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  487 SHVLKGFLNKDPKERL  502 (593)
T ss_pred             HHHHHHhhcCCcHHhc
Confidence            7899999999999984

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2e-28  Score=261.58  Aligned_cols=238  Identities=23%  Similarity=0.278  Sum_probs=187.1

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchh---HHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---KEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      +.||-|+||.|-++. +.++...+|.|.+++.+.-..   .-.++|-.||+.-+.+=||+|+-.|.+.+.+|.||||++|
T Consensus       635 k~iGvGAFGeV~Lv~-KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG  713 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVR-KVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG  713 (1034)
T ss_pred             eeecccccceeEEEe-ecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence            359999999999985 445677899999987544333   3467899999999999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC--------C
Q 004312          565 GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL--------D  636 (762)
Q Consensus       565 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~--------~  636 (762)
                      |++-++|.+.+.+.+...+.++..+..|+++.|..   |+|||||||+|||||.+|++||.||||..-+.=        .
T Consensus       714 GDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~  790 (1034)
T KOG0608|consen  714 GDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQE  790 (1034)
T ss_pred             ccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccccccC
Confidence            99999999999999999999999999999999998   999999999999999999999999999754310        0


Q ss_pred             CCc---------------------------------ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCC
Q 004312          637 QSH---------------------------------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRT  683 (762)
Q Consensus       637 ~~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p  683 (762)
                      ..+                                 .....+||+.|+|||++....++..+|.||.|||||||+.|+.|
T Consensus       791 gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~p  870 (1034)
T KOG0608|consen  791 GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPP  870 (1034)
T ss_pred             CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCC
Confidence            000                                 00124699999999999999999999999999999999999999


Q ss_pred             CchhhHHHhhhcc-ccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCC
Q 004312          684 ILTDWAYDCYQER-TLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRP  734 (762)
Q Consensus       684 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP  734 (762)
                      |..+.+.+..... .....    +......+.+.++.++|.+... +++.|.
T Consensus       871 f~~~tp~~tq~kv~nw~~~----l~~~~~~~ls~e~~~li~kLc~-sad~RL  917 (1034)
T KOG0608|consen  871 FLADTPGETQYKVINWRNF----LHIPYQGNLSKEALDLIQKLCC-SADSRL  917 (1034)
T ss_pred             ccCCCCCcceeeeeehhhc----cccccccccCHHHHHHHHHHhc-Chhhhh
Confidence            9766443322111 11111    2222333455666666655332 455553

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=4.6e-28  Score=227.28  Aligned_cols=191  Identities=29%  Similarity=0.407  Sum_probs=160.6

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEeccCCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      +.||+|++|.|-+-++. .++...|||++.... .+..++..+|+.+..+- .+|.+|+++|........++.||.|. .
T Consensus        52 ~elGrGayG~vekmrh~-~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-t  129 (282)
T KOG0984|consen   52 EELGRGAYGVVEKMRHI-QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-T  129 (282)
T ss_pred             hhhcCCccchhhheeec-cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-h
Confidence            57999999999876644 456789999997543 34456788899887775 89999999999999999999999994 4


Q ss_pred             chhhhc----cCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          566 ALASFL----FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       566 sL~~~l----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      ||+.+.    .....+++..+-+||..|..||.|||++  ..++|||+||+||||+.+|.+|+||||++..+.+.  -..
T Consensus       130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS--iAk  205 (282)
T KOG0984|consen  130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS--IAK  205 (282)
T ss_pred             hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh--hHH
Confidence            777664    3457889999999999999999999998  68999999999999999999999999999876432  222


Q ss_pred             ccccccCcccCccccc----CCCCCCcchhHHHHHHHHHHHhCCCCC
Q 004312          642 TAIRGTKGYVAPEWFR----NMPITVKVDVYSYGVLLLEIICLRRTI  684 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~----~~~~s~~~DV~S~Gvil~elltg~~p~  684 (762)
                      +...|-..|||||.+.    +..|+-|+||||||+.+.||.+++.|+
T Consensus       206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY  252 (282)
T KOG0984|consen  206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPY  252 (282)
T ss_pred             HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccc
Confidence            2344778899999984    347999999999999999999999996

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-28  Score=237.79  Aligned_cols=252  Identities=25%  Similarity=0.324  Sum_probs=193.7

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccC-----CceeEEE
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-----RNRLLVY  559 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~LV~  559 (762)
                      ++.||-|+||.||..... .+++.||.|++.....  ...+.+-+|+++|..++|.|++..++.-.-.     .+.|+++
T Consensus        58 DRPIGYGAFGVVWsVTDP-RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDP-RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCcccccceeEEEeccCC-CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            357999999999998644 4578999999875432  2346888999999999999999999876433     4678999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |.|.. +|...|.+...++...+.-++.||++||.|||+.   +|+||||||.|.|++.|..+||+|||+++.-..++..
T Consensus       137 ELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  137 ELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence            99965 8999998888999999999999999999999999   9999999999999999999999999999988777776


Q ss_pred             ccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHH---------------hhh---cccccc
Q 004312          640 TNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYD---------------CYQ---ERTLGA  700 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~---------------~~~---~~~~~~  700 (762)
                      .++..+-|..|.|||++.+. .|+.+.||||.|||+.||+..+.-|....+-+               .++   ++....
T Consensus       213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H  292 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH  292 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence            66767778999999999875 69999999999999999997664432111110               000   010011


Q ss_pred             ccccccc---------cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 004312          701 LVENDLE---------AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQML  743 (762)
Q Consensus       701 ~~~~~~~---------~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L  743 (762)
                      ++.....         ...+.....+...+..+++..||++|.+.++.+..+
T Consensus       293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            1111111         011112334567788889999999999988877654

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=99.94  E-value=1.3e-27  Score=214.01  Aligned_cols=98  Identities=39%  Similarity=0.663  Sum_probs=75.7

Q ss_pred             ccccCCCCCCC---CCceEEEEeCCcEEEeCCCCCEEEee-cCCCCc--eeEEEEecCCCEEEEecCCCccccccCCCcc
Q 004312           57 IWYASGDDPGP---GGSKLRLTANGGLVLEDPEAREIWKS-EISTGE--AAFGVLYDTGNFLIVNTNSERLWQTFDHPTD  130 (762)
Q Consensus        57 vW~Anr~~p~~---~~~~l~~~~~g~l~l~~~~~~~~ws~-~~~~~~--~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTD  130 (762)
                      ||+|||++|+.   ..++|.|+.||||+|++.+++++|+| ++.+.+  ..+|+|+|+|||||+|..+.++|||||||||
T Consensus         5 vW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~ptd   84 (114)
T PF01453_consen    5 VWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFDYPTD   84 (114)
T ss_dssp             -----TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTTSSS-
T ss_pred             ccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecCCCcc
Confidence            89999999993   35899999999999999999999999 555443  6899999999999999999999999999999


Q ss_pred             ccCCCccccCc------cEEEeecCCCCCC
Q 004312          131 TLLPTQTMERG------GVVSSRRKETDFS  154 (762)
Q Consensus       131 TlLpgq~l~~~------~~L~S~~s~~dps  154 (762)
                      |+||+|+|+.+      ..++||++.+|||
T Consensus        85 t~L~~q~l~~~~~~~~~~~~~sw~s~~dps  114 (114)
T PF01453_consen   85 TLLPGQKLGDGNVTGKNDSLTSWSSNTDPS  114 (114)
T ss_dssp             EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred             EEEeccCcccCCCccccceEEeECCCCCCC
Confidence            99999998873      3499999999996

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=7e-26  Score=229.94  Aligned_cols=197  Identities=30%  Similarity=0.440  Sum_probs=172.9

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc-hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      +.+.||+|++|.||++.... +++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||+++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   81 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKG-TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG   81 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcC-CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence            45679999999999997653 4578999999865444 567899999999999999999999999999999999999999


Q ss_pred             CchhhhccCCCC-CCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          565 GALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       565 gsL~~~l~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      ++|.+++..... +++..+..++.+++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.............
T Consensus        82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence            999999987766 89999999999999999999998   99999999999999999999999999998775443222334


Q ss_pred             ccccCcccCcccc-cCCCCCCcchhHHHHHHHHHHHhCCCCCch
Q 004312          644 IRGTKGYVAPEWF-RNMPITVKVDVYSYGVLLLEIICLRRTILT  686 (762)
Q Consensus       644 ~~gt~~y~aPE~~-~~~~~s~~~DV~S~Gvil~elltg~~p~~~  686 (762)
                      ..++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            5578899999998 667788899999999999999999999844

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=6.7e-27  Score=248.44  Aligned_cols=190  Identities=23%  Similarity=0.324  Sum_probs=165.6

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccc--------hhHHHHHHhhhhcccc---cCCccchhceeccCCcee
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--------SEKEFKAEVNGIGQTH---HKNLVRLLGYCDEGRNRL  556 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~  556 (762)
                      +.+|+|+||.|+.+..+.. ...|+||.+.+...-        +.-..-.|+.+|+.++   |+||+++++++++.+..+
T Consensus       567 q~lG~GAyGkV~lai~K~n-~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy  645 (772)
T KOG1152|consen  567 QPLGEGAYGKVNLAIHKEN-NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY  645 (772)
T ss_pred             eeccccccceEEEeeeccc-ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence            5699999999999976654 678999988753211        1123567999999996   999999999999999999


Q ss_pred             EEEecc-CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          557 LVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       557 LV~E~~-~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      |+||-. ++-+|.++|.-++.+++++...|+.||+.|+++||++   +|||||||-+||.++.+|-+||+|||.+.... 
T Consensus       646 l~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~k-  721 (772)
T KOG1152|consen  646 LETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK-  721 (772)
T ss_pred             EEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhhc-
Confidence            999986 5679999999999999999999999999999999999   99999999999999999999999999997654 


Q ss_pred             CCCcccccccccCcccCcccccCCCC-CCcchhHHHHHHHHHHHhCCCCC
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRTI  684 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvil~elltg~~p~  684 (762)
                        +...-.++||..|.|||++.+..| ...-|||++|++||.++....|+
T Consensus       722 --sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  722 --SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             --CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence              334456789999999999998775 46799999999999999888776

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=2.6e-26  Score=229.27  Aligned_cols=244  Identities=25%  Similarity=0.275  Sum_probs=183.9

Q ss_pred             hcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceecc------CCceeEEEe
Q 004312          489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE------GRNRLLVYE  560 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~~~LV~E  560 (762)
                      .+|.|+- .|-.+. +.-.+++||+|++...  .....+...+|..++..+.|+||++++.++.-      -.+.++|||
T Consensus        24 p~~~g~~-~v~~a~-D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e  101 (369)
T KOG0665|consen   24 PIGSGAQ-IVVAAF-DQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME  101 (369)
T ss_pred             ccCCCCc-eEEecc-hhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence            4677777 555553 3445678999998654  23445788899999999999999999998843      346799999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +|. .+|...+.  -.++.+.+..|+.|++.|+.|||+.   +|+||||||+||++..+..+||.|||+++.-..  ...
T Consensus       102 ~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~--~~~  173 (369)
T KOG0665|consen  102 LMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT--DFM  173 (369)
T ss_pred             hhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCc--ccc
Confidence            994 47888776  4577888999999999999999999   999999999999999999999999999986443  256


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhh------------------h--------
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCY------------------Q--------  694 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~------------------~--------  694 (762)
                      .+..+.|.-|.|||++.+..+.+.+||||.||++.||++|+.-|.+...-+.+                  .        
T Consensus       174 mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~  253 (369)
T KOG0665|consen  174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE  253 (369)
T ss_pred             cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh
Confidence            67788899999999999888999999999999999999987654221110000                  0        


Q ss_pred             ------ccccccc-cccccc--cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          695 ------ERTLGAL-VENDLE--AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       695 ------~~~~~~~-~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                            .....+. .|....  ...+......+++++.+||-.+|++|.+++++++.
T Consensus       254 ~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  254 NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                  0000000 000000  00111234567899999999999999999999864

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=3.2e-26  Score=247.14  Aligned_cols=247  Identities=22%  Similarity=0.303  Sum_probs=202.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      ++...+|.|.+|.|||++.. .+++..|||.++-...+..+-.+.|+-+++.-+|||||.++|-+...+..++.||||.+
T Consensus        18 ellqrvgsgTygdvyKaRd~-~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg   96 (829)
T KOG0576|consen   18 ELLQRVGSGTYGDVYKARDK-RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG   96 (829)
T ss_pred             hheeeecCCcccchhhhccc-ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence            34567999999999999754 45678999999876666777888999999999999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccc
Q 004312          565 GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI  644 (762)
Q Consensus       565 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  644 (762)
                      |+|.+..+..+.+++.++....+..++||+|||++   +=+|||||-.|||+++.+.+|++|||.+-.+...- .....+
T Consensus        97 gslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~Krksf  172 (829)
T KOG0576|consen   97 GSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AKRKSF  172 (829)
T ss_pred             CcccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-hhhhcc
Confidence            99999999999999999999999999999999999   88999999999999999999999999987654322 233456


Q ss_pred             cccCcccCcccc---cCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccc---cccCCCHHHHHHH
Q 004312          645 RGTKGYVAPEWF---RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND---LEAMDDMTVLQRF  718 (762)
Q Consensus       645 ~gt~~y~aPE~~---~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  718 (762)
                      .||+.|||||+.   +.+.+..++|||+.|+...|+--.+.|.....+....     ..+-...   ..........+.+
T Consensus       173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l-----~LmTkS~~qpp~lkDk~kws~~f  247 (829)
T KOG0576|consen  173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL-----FLMTKSGFQPPTLKDKTKWSEFF  247 (829)
T ss_pred             cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH-----HHhhccCCCCCcccCCccchHHH
Confidence            799999999986   4568999999999999999998877774332222111     1111111   1122234567788


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      -++++.|+..+|++||+++.+++
T Consensus       248 h~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhhee
Confidence            89999999999999999987653

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2e-25  Score=233.52  Aligned_cols=131  Identities=29%  Similarity=0.416  Sum_probs=109.5

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc-----c---CCccchhceec---
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-----H---KNLVRLLGYCD---  550 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~nIv~l~g~~~---  550 (762)
                      ..|.+.++||-|.|++||++ ++....+.||+|+.+.. ..-.+..+.||++|++++     |   .+||+|+++|.   
T Consensus        78 gRY~v~rKLGWGHFSTVWLa-wDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLA-WDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             ceEEEEEeccccccceeEEE-eeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            44666789999999999999 56666789999998653 233456778999999982     3   35999999985   


Q ss_pred             -cCCceeEEEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc
Q 004312          551 -EGRNRLLVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD  617 (762)
Q Consensus       551 -~~~~~~LV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~  617 (762)
                       .+.+.+||+|++ |.+|..+|...  +.++...+.+|+.||+.||.|||.+|  +|||-||||+|||+.
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence             467899999999 66888888654  67899999999999999999999996  999999999999983

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=1.4e-25  Score=235.46  Aligned_cols=262  Identities=19%  Similarity=0.220  Sum_probs=200.0

Q ss_pred             ccccCHHHHHHHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc------cCCccc
Q 004312          471 LRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH------HKNLVR  544 (762)
Q Consensus       471 ~~~~~~~el~~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~nIv~  544 (762)
                      .-.+.+.|+....|.+.-..|+|-|++|-+|.... .+..||||++... +--.+.=+.|+++|++|.      .-|+++
T Consensus       421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~-r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclr  498 (752)
T KOG0670|consen  421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA-RGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLR  498 (752)
T ss_pred             eEEEehhhhhcceeEEEeccccceeeeeeeccccC-CCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence            33466778888888777889999999999997554 4559999999764 222345568999999984      468999


Q ss_pred             hhceeccCCceeEEEeccCCCchhhhccCCC---CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC-CC
Q 004312          545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDS---KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD-YY  620 (762)
Q Consensus       545 l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~  620 (762)
                      ++-.|.+.++++||+|-+ ..+|.+.|++.+   .+..+.+..++.|+.-||..|...   +|+|.||||+|||+++ ..
T Consensus       499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~  574 (752)
T KOG0670|consen  499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN  574 (752)
T ss_pred             HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence            999999999999999987 458999997653   578899999999999999999998   9999999999999986 45


Q ss_pred             ceEEecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhh------------
Q 004312          621 NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDW------------  688 (762)
Q Consensus       621 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~------------  688 (762)
                      .+||||||.|......+   .+...-+..|.|||++.+.+|+...|+||.||.||||.||+.-|.+..            
T Consensus       575 iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K  651 (752)
T KOG0670|consen  575 ILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK  651 (752)
T ss_pred             eeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence            79999999998664332   223334567999999999999999999999999999999986542211            


Q ss_pred             ---HHHhhhccc-cccccccc--------------------------------c-----ccCCCHHHHHHHHHHHHHhhc
Q 004312          689 ---AYDCYQERT-LGALVEND--------------------------------L-----EAMDDMTVLQRFVMVAIWCIQ  727 (762)
Q Consensus       689 ---~~~~~~~~~-~~~~~~~~--------------------------------~-----~~~~~~~~~~~~~~li~~cl~  727 (762)
                         +...+..+. ..+.++.+                                +     .....+.....+.+|+.+|+.
T Consensus       652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~  731 (752)
T KOG0670|consen  652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI  731 (752)
T ss_pred             CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence               000010000 00001100                                0     011234567789999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 004312          728 EDPSHRPTMRRVTQ  741 (762)
Q Consensus       728 ~dp~~RPt~~evl~  741 (762)
                      .||++|.|.+|.++
T Consensus       732 LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  732 LDPEKRITVNQALK  745 (752)
T ss_pred             cChhhcCCHHHHhc
Confidence            99999999998876

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=2.6e-25  Score=267.50  Aligned_cols=196  Identities=16%  Similarity=0.192  Sum_probs=142.3

Q ss_pred             hccccc-CCccchhcee-------ccCCceeEEEeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCe
Q 004312          534 IGQTHH-KNLVRLLGYC-------DEGRNRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQI  604 (762)
Q Consensus       534 l~~l~H-~nIv~l~g~~-------~~~~~~~LV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  604 (762)
                      .+.++| +||+++++.+       .+....++++|++ +++|.++|... ..+++..++.++.||++||+|||++   +|
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            445667 7899999987       2334567888987 56999999764 5689999999999999999999998   99


Q ss_pred             EeCCCCCCceEEcC-------------------CCceEEecccccccccCCCC---------------cccccccccCcc
Q 004312          605 IHCDIKPQNILLDD-------------------YYNARISDFGLEKLLTLDQS---------------HTNTAIRGTKGY  650 (762)
Q Consensus       605 vH~Dlkp~NILl~~-------------------~~~~kl~Dfgla~~~~~~~~---------------~~~~~~~gt~~y  650 (762)
                      +||||||+||||+.                   ++.+||+|||+++.......               .......||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   44566777777654211000               001123578899


Q ss_pred             cCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCC
Q 004312          651 VAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDP  730 (762)
Q Consensus       651 ~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp  730 (762)
                      ||||++.+..++.++|||||||+||||++|..|+......  .... ......+.     ......+...++.+||+.+|
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~--~~~~-~~~~~~~~-----~~~~~~~~~~~~~~~L~~~P  253 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT--MSSL-RHRVLPPQ-----ILLNWPKEASFCLWLLHPEP  253 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH--HHHH-HHhhcChh-----hhhcCHHHHHHHHHhCCCCh
Confidence            9999999999999999999999999999988875322111  1000 00011110     11123445688899999999


Q ss_pred             CCCCCHHHHHH
Q 004312          731 SHRPTMRRVTQ  741 (762)
Q Consensus       731 ~~RPt~~evl~  741 (762)
                      .+||+|+|+++
T Consensus       254 ~~Rps~~eil~  264 (793)
T PLN00181        254 SCRPSMSELLQ  264 (793)
T ss_pred             hhCcChHHHhh
Confidence            99999999986

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.9e-24  Score=210.70  Aligned_cols=253  Identities=17%  Similarity=0.297  Sum_probs=187.4

Q ss_pred             cccccCHHHHHHHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhce
Q 004312          470 NLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGY  548 (762)
Q Consensus       470 ~~~~~~~~el~~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~  548 (762)
                      ++..+.+.|.    +++.+.+|+|.||.+-++..+ ++...+++|.+.+. ....++|.+|..---.| .|.||+..++.
T Consensus        16 el~kv~l~d~----y~I~k~lgeG~FgkIlL~eHr-~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~v   89 (378)
T KOG1345|consen   16 ELKKVDLEDV----YTINKQLGEGRFGKILLAEHR-QSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEV   89 (378)
T ss_pred             cccccchhhh----hhHHHHhcccceeeEEeeecc-CCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHH
Confidence            3444444443    456678999999999999754 56778999998765 34567999998765555 79999988864


Q ss_pred             -eccCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc--CCCceEEe
Q 004312          549 -CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD--DYYNARIS  625 (762)
Q Consensus       549 -~~~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~  625 (762)
                       +...+..+.++||+|.|+|.+-+.. ..+.+..-.+++.|++.||.|+|++   .+||||||.+||||-  +..++||+
T Consensus        90 aFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlc  165 (378)
T KOG1345|consen   90 AFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLC  165 (378)
T ss_pred             HhhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEee
Confidence             5666777899999999999998865 4467778889999999999999999   999999999999994  45689999


Q ss_pred             cccccccccCCCCcccccccccCcccCcccccCC-----CCCCcchhHHHHHHHHHHHhCCCCCchhh-------HHHhh
Q 004312          626 DFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM-----PITVKVDVYSYGVLLLEIICLRRTILTDW-------AYDCY  693 (762)
Q Consensus       626 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DV~S~Gvil~elltg~~p~~~~~-------~~~~~  693 (762)
                      |||+.+....    .......+..|.+||.....     ...+.+|||.||++++.++||+.|+...+       .+..+
T Consensus       166 DFG~t~k~g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w  241 (378)
T KOG1345|consen  166 DFGLTRKVGT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW  241 (378)
T ss_pred             ecccccccCc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH
Confidence            9999875431    12223346789999986432     46688999999999999999999974332       23334


Q ss_pred             hccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          694 QERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ..+......+.      -...++.+.++.++-+..++++|=-..++.++
T Consensus       242 ~~rk~~~~P~~------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  242 LKRKNPALPKK------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             hcccCccCchh------hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            43332221111      11345778888889999999999444444433

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=3.2e-24  Score=209.93  Aligned_cols=165  Identities=22%  Similarity=0.186  Sum_probs=126.2

Q ss_pred             CchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          565 GALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       565 gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      |+|.+++... ..+++.++..|+.||++||+|||++   +      ||+|||+++++.+|+  ||+++......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence            6899999864 5699999999999999999999998   4      999999999999999  99998764322      


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccc-ccCCCHHHHH--HHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL-EAMDDMTVLQ--RFVM  720 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~  720 (762)
                      ..|++.|+|||++.+..++.++||||||+++|||++|+.|+...................... ..........  ++.+
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFAD  143 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHH
Confidence            258899999999999999999999999999999999999974432211111111111110000 0011223333  6999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      ++.+||+.+|.+||++.|+++.+..+
T Consensus       144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      144 FMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHHhcccccccCHHHHHHHHHHH
Confidence            99999999999999999999987553

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=1.9e-24  Score=223.91  Aligned_cols=191  Identities=24%  Similarity=0.358  Sum_probs=161.2

Q ss_pred             hhhhcCCCCcceEEEeeeeCC--CcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMG--SSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      ..++||+|.|++||++.+...  ..+.||+|.+...  .......+|+++|..+ -|.||+++.+++..++...+|+||+
T Consensus        40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~  117 (418)
T KOG1167|consen   40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF  117 (418)
T ss_pred             hhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence            346799999999999987653  5678999998763  3456799999999998 6999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc-CCCceEEecccccccccCCC----
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQ----  637 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~~~----  637 (762)
                      +.....+++.+   ++...+...+..+++||+++|.+   |||||||||+|+|.+ .-+.-.|.|||+|......+    
T Consensus       118 ~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~  191 (418)
T KOG1167|consen  118 EHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEH  191 (418)
T ss_pred             CccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhhh
Confidence            99988888744   56889999999999999999999   999999999999998 56788999999987221100    


Q ss_pred             ---------C------------------------------cccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHH
Q 004312          638 ---------S------------------------------HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEI  677 (762)
Q Consensus       638 ---------~------------------------------~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~el  677 (762)
                               .                              .......||++|.|||++.. ..-++++||||.|||++.+
T Consensus       192 s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsl  271 (418)
T KOG1167|consen  192 SRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSL  271 (418)
T ss_pred             hhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehh
Confidence                     0                              00113469999999999854 4688999999999999999


Q ss_pred             HhCCCCC
Q 004312          678 ICLRRTI  684 (762)
Q Consensus       678 ltg~~p~  684 (762)
                      ++++.||
T Consensus       272 ls~~~PF  278 (418)
T KOG1167|consen  272 LSRRYPF  278 (418)
T ss_pred             hcccccc
Confidence            9999996

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.2e-24  Score=211.76  Aligned_cols=248  Identities=21%  Similarity=0.361  Sum_probs=195.8

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccc--cccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      ++..+|.+...|..|+|+++.   ..+++|++.-  ......++|.+|.-.|+.+.||||+.++|.|.......++..||
T Consensus       193 nl~tkl~e~hsgelwrgrwqg---ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQG---NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhccCCCcccccccccC---cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            355678999999999999973   3577787753  33445578999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          563 SNGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       563 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +.|+|.+.|+...  ..+..+..+++.+||+|++|||+. .+-|.---|..+.|+||++.+++|+- +-.++     +..
T Consensus       270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf-----sfq  342 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SFQ  342 (448)
T ss_pred             cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee-----eee
Confidence            9999999998774  357888999999999999999997 33344446899999999999999852 11111     111


Q ss_pred             cccccccCcccCcccccCCCCC---CcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPIT---VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s---~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      .....-.|.||+||.++..+-+   +++|+|||.+++|||.|...||..-.+.+.-.     ++..++++...++..+..
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-----kialeglrv~ippgis~h  417 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-----KIALEGLRVHIPPGISRH  417 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-----hhhhccccccCCCCccHH
Confidence            1122346899999999876543   67999999999999999999984432222211     233345566667788889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      +.+|+.-|+..||.+||.+.+|+-.|+++.
T Consensus       418 m~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  418 MNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             HHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            999999999999999999999999999864

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.3e-22  Score=217.86  Aligned_cols=162  Identities=20%  Similarity=0.142  Sum_probs=125.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc-----ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-----FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLV  558 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV  558 (762)
                      +.+.+.||+|+||+||+|.....+++.+|||++...     .....+.|.+|++++++++|+|++..+..   ....+||
T Consensus        20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LV   96 (365)
T PRK09188         20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLV   96 (365)
T ss_pred             ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEE
Confidence            445678999999999999876545667899987532     12234579999999999999999853322   2457999


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCC-CCCceEEcCCCceEEecccccccccCCC
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDI-KPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      |||+++++|... ....      ...++.++++||.|||+.   +|+|||| ||+|||++.++.+||+|||+++.+....
T Consensus        97 mE~~~G~~L~~~-~~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~  166 (365)
T PRK09188         97 RGWTEGVPLHLA-RPHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRG  166 (365)
T ss_pred             EEccCCCCHHHh-Cccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecccCc
Confidence            999999999732 1111      246789999999999998   9999999 9999999999999999999999775432


Q ss_pred             Ccc-------cccccccCcccCcccccC
Q 004312          638 SHT-------NTAIRGTKGYVAPEWFRN  658 (762)
Q Consensus       638 ~~~-------~~~~~gt~~y~aPE~~~~  658 (762)
                      ...       -+...+++.|+|||.+..
T Consensus       167 ~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        167 ALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             chhhhhhhhhhhhhhccCccCCcccCCh
Confidence            111       134568889999999854

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=99.88  E-value=1.9e-22  Score=182.37  Aligned_cols=95  Identities=32%  Similarity=0.634  Sum_probs=83.8

Q ss_pred             ceeecCCCCcEeeCCCcEEEeeeccc------------------ccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEEEe
Q 004312           31 QLTAAESTEPWLSPSKDFALGFHQLD------------------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWK   92 (762)
Q Consensus        31 ~l~~~~~~~~lvS~~g~F~lgf~~~~------------------vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~ws   92 (762)
                      .|..++   +|+|++|.|++|||.+.                  ||.||++.|....+.|.|+.||+|+|+|.+|.+||+
T Consensus         3 ~l~~~~---~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~   79 (116)
T cd00028           3 PLSSGQ---TLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWS   79 (116)
T ss_pred             CcCCCC---EEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEE
Confidence            455443   78999999999998532                  899999999777889999999999999999999999


Q ss_pred             ecCCC-CceeEEEEecCCCEEEEecCCCccccccCCC
Q 004312           93 SEIST-GEAAFGVLYDTGNFLIVNTNSERLWQTFDHP  128 (762)
Q Consensus        93 ~~~~~-~~~~~~~l~d~GNlvl~~~~~~~~WqSFD~P  128 (762)
                      |+++. ....+|+|+|+|||||++.++.++|||||||
T Consensus        80 S~~~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P  116 (116)
T cd00028          80 SNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP  116 (116)
T ss_pred             ecccCCCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence            99876 4556899999999999999999999999999

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=99.86  E-value=1.4e-21  Score=176.31  Aligned_cols=94  Identities=34%  Similarity=0.635  Sum_probs=82.8

Q ss_pred             ceeecCCCCcEeeCCCcEEEeeeccc-----------------ccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEEEee
Q 004312           31 QLTAAESTEPWLSPSKDFALGFHQLD-----------------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKS   93 (762)
Q Consensus        31 ~l~~~~~~~~lvS~~g~F~lgf~~~~-----------------vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~ws~   93 (762)
                      .|..++   +|+|++|.|++|||.+.                 ||.||++.|+.+++.|.|+.||+|+|++.+|.+||+|
T Consensus         3 ~l~~~~---~l~s~~~~f~~G~~~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S   79 (114)
T smart00108        3 TLSSGQ---TLVSGNSLFELGFFTLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSS   79 (114)
T ss_pred             ccCCCC---EEecCCCcEeeeccccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEe
Confidence            454443   78999999999998642                 8999999998777899999999999999999999999


Q ss_pred             cCC-CCceeEEEEecCCCEEEEecCCCccccccCC
Q 004312           94 EIS-TGEAAFGVLYDTGNFLIVNTNSERLWQTFDH  127 (762)
Q Consensus        94 ~~~-~~~~~~~~l~d~GNlvl~~~~~~~~WqSFD~  127 (762)
                      ++. ..+..+|+|+|+|||||++.++.++||||||
T Consensus        80 ~t~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~  114 (114)
T smart00108       80 NTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY  114 (114)
T ss_pred             cccCCCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence            987 4455689999999999999999999999997

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.1e-21  Score=224.16  Aligned_cols=250  Identities=20%  Similarity=0.226  Sum_probs=188.2

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEccc---cccch---hHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDS---EKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~---~~~~~---~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      ...+|.|++|.|+....... .+..+.|....   .....   ...+..|+-+-..++|+|++..+..+.+.....-+||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~-~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSD-LKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             cceeeecccCceEEEEecCC-CccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            45799999997776643322 22233332210   11111   1236678888889999999999999888888777799


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC--
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS--  638 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~--  638 (762)
                      |+++ +|..++.....+....+..++.|+..|+.|+|+.   +|.|||+|++|+++..++.+||+|||.+..+..+..  
T Consensus       402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence            9999 9999998888899999999999999999999999   999999999999999999999999999988765544  


Q ss_pred             -cccccccccCcccCcccccCCCCCC-cchhHHHHHHHHHHHhCCCCCchhhHHHhh--hccccccccccccccCCCHHH
Q 004312          639 -HTNTAIRGTKGYVAPEWFRNMPITV-KVDVYSYGVLLLEIICLRRTILTDWAYDCY--QERTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       639 -~~~~~~~gt~~y~aPE~~~~~~~s~-~~DV~S~Gvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  714 (762)
                       .....++|...|+|||.+....|.+ ..||||.|+++..|++|+.|+......+..  ........-............
T Consensus       478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  557 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL  557 (601)
T ss_pred             hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence             3455678999999999999988875 599999999999999999996433222111  100000000000011112345


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          715 LQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +.+.+.++.++|+.+|.+|.|+++|++
T Consensus       558 p~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  558 PRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             hhhHHHHHHHHccCChhheecHHHHhh
Confidence            677899999999999999999999986

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=1.3e-20  Score=202.77  Aligned_cols=259  Identities=18%  Similarity=0.195  Sum_probs=189.8

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccccc----CCccchhcee-ccCCceeE
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHH----KNLVRLLGYC-DEGRNRLL  557 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~g~~-~~~~~~~L  557 (762)
                      .+.+.++||+|+||.||++.......+.+|+|............+..|+.++..+.+    +++.++++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            345668899999999999975543345788888765433333378888998888863    6888888888 57778899


Q ss_pred             EEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC-----CceEEeccccc
Q 004312          558 VYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY-----YNARISDFGLE  630 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-----~~~kl~Dfgla  630 (762)
                      ||+.. +.+|.++....  +.++..+.++|+.|++.+|.+||+.   |++||||||.|+++...     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 77999987543  6899999999999999999999999   99999999999999754     46999999999


Q ss_pred             c--cccCCCCc------c-cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccc
Q 004312          631 K--LLTLDQSH------T-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL  701 (762)
Q Consensus       631 ~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~  701 (762)
                      +  .+......      . ....+||..|.++..+.+.+.+++.|+||++.++.|++.|..|+..........  .....
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~--~~~~~  252 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS--KFEKD  252 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH--HHHHH
Confidence            9  43222211      1 223569999999999999999999999999999999999998862221110000  00000


Q ss_pred             cccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          702 VENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       702 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      .............+.++..+...+-..+..++|....+...|+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~  298 (322)
T KOG1164|consen  253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF  298 (322)
T ss_pred             hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence            0000000011123345566666666689999999999999887653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=4.6e-20  Score=197.06  Aligned_cols=249  Identities=27%  Similarity=0.336  Sum_probs=194.7

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc---hhHHHHHHhhhhcccccC-CccchhceeccCCceeEEEec
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD---SEKEFKAEVNGIGQTHHK-NLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.+.||.|+|+.||++...    ..+++|.+......   ....+.+|+.+++.+.|+ +|+++.+.+......++++|+
T Consensus         4 ~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           4 ILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             eEEeecCCCCeEEEEEEec----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            4467999999999999765    57999998765443   367899999999999888 799999999777778999999


Q ss_pred             cCCCchhhhccCCC---CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC-ceEEecccccccccCCC
Q 004312          562 MSNGALASFLFGDS---KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY-NARISDFGLEKLLTLDQ  637 (762)
Q Consensus       562 ~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~  637 (762)
                      +.+++|.+++....   .+.......++.|++.++.|+|..   +++|||+||+||+++... .+++.|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999998877664   789999999999999999999999   899999999999999988 79999999998665433


Q ss_pred             Cc-----ccccccccCcccCcccccC---CCCCCcchhHHHHHHHHHHHhCCCCCchhhH---HHhhhcccccccccccc
Q 004312          638 SH-----TNTAIRGTKGYVAPEWFRN---MPITVKVDVYSYGVLLLEIICLRRTILTDWA---YDCYQERTLGALVENDL  706 (762)
Q Consensus       638 ~~-----~~~~~~gt~~y~aPE~~~~---~~~s~~~DV~S~Gvil~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~  706 (762)
                      ..     ......|+..|+|||.+..   ...+...|+||+|++++++++|..|+.....   .....+. +.....+..
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~  235 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI-ILELPTPSL  235 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH-HHhcCCccc
Confidence            32     2356779999999999987   6889999999999999999999999544321   0111110 000000000


Q ss_pred             ccCCC----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          707 EAMDD----MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       707 ~~~~~----~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      .....    ......+.+++..++..+|..|.+..+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00001    1223578899999999999999998877653

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=1.4e-20  Score=213.76  Aligned_cols=249  Identities=24%  Similarity=0.263  Sum_probs=183.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhc--ccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIG--QTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~--~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||++.|=+|.+++.+.|   .|+||++-+.. .-..+.|.++++-++  .++|||.+.+.-.-......|||-+|
T Consensus        26 ~~~~~LGstRFlKv~r~k~~eG---~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   26 HYVENLGSTRFLKVARAKDREG---LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             eeecccCchhhhhhhhccCCCc---eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            4567899999999999987654   59999986544 334456665554444  45999999999888888888999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc--
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--  639 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~--  639 (762)
                      ..+ +|.++|..++-+...+.+.|+.|++.||..+|..   +|+|||||.+||||+.-.-+.|+||..-+-.......  
T Consensus       103 vkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  103 VKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             Hhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            965 8999998888889999999999999999999999   9999999999999999999999999887643222111  


Q ss_pred             ccc----cccccCcccCcccccC----------CC-CCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccc
Q 004312          640 TNT----AIRGTKGYVAPEWFRN----------MP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN  704 (762)
Q Consensus       640 ~~~----~~~gt~~y~aPE~~~~----------~~-~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  704 (762)
                      ...    +.+.-..|+|||.+-.          .. .+++.||||+||++.||++-+.|...-...-.++.+. ......
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~-~~~~e~  257 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN-ADDPEQ  257 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC-ccCHHH
Confidence            111    1122346999998743          12 7899999999999999999766632221111222211 111111


Q ss_pred             ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       705 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      .++...    ...++.++..|++.||++|.++++.++.-.+
T Consensus       258 ~Le~Ie----d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  258 LLEKIE----DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             HHHhCc----CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            111111    1367899999999999999999999987444

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=3.2e-20  Score=178.53  Aligned_cols=251  Identities=19%  Similarity=0.233  Sum_probs=190.4

Q ss_pred             HHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccccc-CCccchhceeccCCceeEEE
Q 004312          481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHH-KNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       481 ~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~LV~  559 (762)
                      ...+.+.++||.|+||.+|.|. ...++++||||.-+..  ....++..|.++...|+| ..|..+.-+..+...-.|||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~-~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGI-SITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             ccceEEEEeecCCchhheeeee-eccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            3445667889999999999995 5567889999986553  234578889999999976 77888888999999999999


Q ss_pred             eccCCCchhhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc---CCCceEEecccccccccC
Q 004312          560 EFMSNGALASFLF-GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTL  635 (762)
Q Consensus       560 E~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~~~  635 (762)
                      |.. +-+|++++. -.+.++.++.+-++-|++.-++|+|.+   ++|||||||+|+|..   ....+.++|||+++.+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            998 678888874 357789999999999999999999999   999999999999996   345699999999998865


Q ss_pred             CCCc------ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHH------hhhccccccccc
Q 004312          636 DQSH------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYD------CYQERTLGALVE  703 (762)
Q Consensus       636 ~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~------~~~~~~~~~~~~  703 (762)
                      ....      ......||.+|.+-..+.+...+.+.|+=|+|.+|.....|..|+.+-.+..      .+.+......+.
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie  246 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE  246 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence            4432      2334569999999998888888999999999999999999999974443322      222221111111


Q ss_pred             cccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 004312          704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQML  743 (762)
Q Consensus       704 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L  743 (762)
                      .     .-...+.++...+.-|-..--++-|....+.+.+
T Consensus       247 ~-----LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  247 V-----LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             H-----HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence            0     0112355666667777776667777665554443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=1.5e-19  Score=181.54  Aligned_cols=253  Identities=18%  Similarity=0.260  Sum_probs=194.3

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEec
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.++||+|.||.++.|+ ..-.+++||||.-..  .....++..|.+.++.| ..++|...+-|..++.+-.||+|.
T Consensus        29 hyrVGkKIGeGsFG~lf~G~-Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGK-NLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             cceeccccccCcceeeeccc-ccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            35567899999999999996 445678999997544  33445788899999988 569999999999999999999999


Q ss_pred             cCCCchhhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc-----CCCceEEecccccccccC
Q 004312          562 MSNGALASFLF-GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD-----DYYNARISDFGLEKLLTL  635 (762)
Q Consensus       562 ~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-----~~~~~kl~Dfgla~~~~~  635 (762)
                      + +-||+++.. ..++++.++...||.|++.-++|+|++   .+|.|||||+|+||.     +...+.|+|||+|+.+.+
T Consensus       106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            8 678888774 357899999999999999999999999   999999999999996     344689999999999876


Q ss_pred             CCCcc------cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhh------HHHhhhccccccccc
Q 004312          636 DQSHT------NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDW------AYDCYQERTLGALVE  703 (762)
Q Consensus       636 ~~~~~------~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~------~~~~~~~~~~~~~~~  703 (762)
                      .....      .....||.+||+-..+.+.+-+++.|+=|||-++...+.|..|+-+-.      .|+.+.+..-...+.
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~  261 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE  261 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence            65433      234569999999999999999999999999999999999999963321      122222211111110


Q ss_pred             cccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       704 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      .     .-...++++..-+.-.-..+-.+-|..+-+...+..++
T Consensus       262 ~-----Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl  300 (449)
T KOG1165|consen  262 V-----LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL  300 (449)
T ss_pred             H-----HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            0     01234566666666666677778888877666655543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.80  E-value=9.6e-20  Score=179.97  Aligned_cols=138  Identities=16%  Similarity=0.177  Sum_probs=108.9

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccc--h-------hHH-----------------HHHHhhhhcccccCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--S-------EKE-----------------FKAEVNGIGQTHHKN  541 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~n  541 (762)
                      ..||+|++|.||+|...  ++++||||+++.....  .       ...                 ..+|++.+.++.|++
T Consensus         3 ~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           3 GCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            57999999999999764  5789999999753211  1       112                 234999999998887


Q ss_pred             ccchhceeccCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHh-HhcCCCCeEeCCCCCCceEEcCCC
Q 004312          542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYL-HEECCTQIIHCDIKPQNILLDDYY  620 (762)
Q Consensus       542 Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dlkp~NILl~~~~  620 (762)
                      +.....+..  ...+|||||+++++|...+.....++......++.|++.+|.|+ |+.   +|+||||||+|||+++ +
T Consensus        81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~-~  154 (190)
T cd05147          81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD-G  154 (190)
T ss_pred             CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC-C
Confidence            754433322  23489999999988776644556789999999999999999999 677   9999999999999984 7


Q ss_pred             ceEEecccccccc
Q 004312          621 NARISDFGLEKLL  633 (762)
Q Consensus       621 ~~kl~Dfgla~~~  633 (762)
                      .++|+|||++...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=7.2e-19  Score=174.29  Aligned_cols=139  Identities=16%  Similarity=0.113  Sum_probs=110.6

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccch--------------------------hHHHHHHhhhhcccccCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS--------------------------EKEFKAEVNGIGQTHHKN  541 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~H~n  541 (762)
                      ..||+|++|.||+|...  +++.||||+++......                          ...+..|.+.+.++.|++
T Consensus         3 ~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           3 GCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             ceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            57999999999999765  57899999987542110                          112467899999999998


Q ss_pred             ccchhceeccCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEeCCCCCCceEEcCCC
Q 004312          542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE-ECCTQIIHCDIKPQNILLDDYY  620 (762)
Q Consensus       542 Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NILl~~~~  620 (762)
                      +.....+...  ..+|||||++++++.........++......++.|++.+|.++|+ .   +|+||||||+|||++ ++
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~  154 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DG  154 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CC
Confidence            7554443332  348999999988655443344567888999999999999999999 8   999999999999999 78


Q ss_pred             ceEEeccccccccc
Q 004312          621 NARISDFGLEKLLT  634 (762)
Q Consensus       621 ~~kl~Dfgla~~~~  634 (762)
                      .++|+|||+++...
T Consensus       155 ~~~liDFG~a~~~~  168 (190)
T cd05145         155 KPYIIDVSQAVELD  168 (190)
T ss_pred             CEEEEEcccceecC
Confidence            99999999998664

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=2.3e-19  Score=195.92  Aligned_cols=209  Identities=24%  Similarity=0.449  Sum_probs=162.2

Q ss_pred             hcccccCCccchhceeccCCceeEEEeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCe-EeCCCCC
Q 004312          534 IGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQI-IHCDIKP  611 (762)
Q Consensus       534 l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i-vH~Dlkp  611 (762)
                      |+.+.|.|+.+++|.+.++...++|.+||+.|+|.+.+... -.+++.....++++|++||+|||.-   +| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence            46789999999999999999999999999999999999874 5789999999999999999999997   54 9999999


Q ss_pred             CceEEcCCCceEEecccccccccCCC-CcccccccccCcccCcccccCC-------CCCCcchhHHHHHHHHHHHhCCCC
Q 004312          612 QNILLDDYYNARISDFGLEKLLTLDQ-SHTNTAIRGTKGYVAPEWFRNM-------PITVKVDVYSYGVLLLEIICLRRT  683 (762)
Q Consensus       612 ~NILl~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-------~~s~~~DV~S~Gvil~elltg~~p  683 (762)
                      .|.++|....+||+|||+..+..... ...........-|.|||.++..       ..+.+.||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99999999999999999998764311 1111222245579999998763       257889999999999999999999


Q ss_pred             CchhhHHHhhhccccccc-------cccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          684 ILTDWAYDCYQERTLGAL-------VENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       684 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      |......... ++.+..+       ..+....  ..+..+++..++..||..+|.+||++++|-..++.+..
T Consensus       158 ~~~~~~~~~~-~eii~~~~~~~~~~~rP~i~~--~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  158 FDLRNLVEDP-DEIILRVKKGGSNPFRPSIEL--LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             cccccccCCh-HHHHHHHHhcCCCCcCcchhh--hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            7432111111 1111111       1111111  11445579999999999999999999999999887644

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.78  E-value=1.5e-19  Score=180.77  Aligned_cols=173  Identities=11%  Similarity=0.082  Sum_probs=130.8

Q ss_pred             HHHHHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHH---------HHHHhhhhcccccCCccchhce
Q 004312          478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE---------FKAEVNGIGQTHHKNLVRLLGY  548 (762)
Q Consensus       478 el~~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~H~nIv~l~g~  548 (762)
                      ++.+..+...+.||.|+||.||....   +...+|||.++......++.         +.+|+..+.++.|++|..+..+
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~---~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~  103 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT---DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF  103 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec---CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence            34444455567899999999998643   24579999997654433332         6899999999999999999887


Q ss_pred             eccC--------CceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC
Q 004312          549 CDEG--------RNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY  620 (762)
Q Consensus       549 ~~~~--------~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~  620 (762)
                      ....        ...+|||||++|.+|.++..    ++.    ....+++.+|..+|+.   +++|||+||+||++++++
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence            5432        35789999999999988742    222    3456999999999999   999999999999999888


Q ss_pred             ceEEecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHH
Q 004312          621 NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII  678 (762)
Q Consensus       621 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ell  678 (762)
                       ++|+|||..+....+....             .+.....+..++|+|+||+.+..+.
T Consensus       173 -i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence             9999999987553211111             1333445667999999999887654

>PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation

Probab=99.78  E-value=4.9e-19  Score=158.30  Aligned_cols=109  Identities=28%  Similarity=0.423  Sum_probs=81.2

Q ss_pred             cccCCcceec-CCCCceeeeccCcceEEeecCceeEEeccccccCCccEEEEEEcCCCcEEEEEcCCCCCCCcceeeeec
Q 004312          185 FWSNTFDVNR-SNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSD  263 (762)
Q Consensus       185 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~~~~y~~~~~~~~~~~~w~~~~  263 (762)
                      |++|+|++.+ +|.+...  ...-..+.|+.+.+++++++ ...+.+.++|++||.+|++++|.|.+..+.    |...|
T Consensus         1 wrsG~WnG~~f~g~p~~~--~~~~~~~~fv~~~~e~~~t~-~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~----W~~~~   73 (110)
T PF00954_consen    1 WRSGPWNGQRFSGIPEMS--SNSLYNYSFVSNNEEVYYTY-SLSNSSVLSRLVLDSDGQLQRYIWNESTQS----WSVFW   73 (110)
T ss_pred             CCccccCCeEECCccccc--ccceeEEEEEECCCeEEEEE-ecCCCceEEEEEEeeeeEEEEEEEecCCCc----EEEEE
Confidence            6677777653 3322211  12223456677777777775 355778899999999999999999875554    66666


Q ss_pred             cCCccccccccccCCCCcCcCCCCcccccCCCCCCceecCCCCccCC
Q 004312          264 VLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLD  310 (762)
Q Consensus       264 ~~p~~~C~~~~~~~~~~~g~CG~~g~C~~~~~~~~~C~Cl~GF~~~~  310 (762)
                      .+|.|+||+        |+.||+||+|+.  +..|.|+||+||+|++
T Consensus        74 ~~p~d~Cd~--------y~~CG~~g~C~~--~~~~~C~Cl~GF~P~n  110 (110)
T PF00954_consen   74 SAPKDQCDV--------YGFCGPNGICNS--NNSPKCSCLPGFEPKN  110 (110)
T ss_pred             EecccCCCC--------ccccCCccEeCC--CCCCceECCCCcCCCc
Confidence            669999999        999999999985  3568899999999985

This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=5.2e-18  Score=165.92  Aligned_cols=182  Identities=16%  Similarity=0.100  Sum_probs=136.9

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc----hhHHHHHHhhhhcccc-cCCccchhceeccCCceeEEEec
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD----SEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      ...|++|+||+||.+.   ..+.+++.+.+.....-    ....|.+|+++|++++ |+++++++++    ...+++|||
T Consensus         7 ~~~l~~~~f~~v~~~~---~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          7 NEPLKSDTFGRILLVR---GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ceeecCCCcceEEEee---cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4579999999999653   34567887777643221    1235889999999994 5889999886    456999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCC-CCCceEEcCCCceEEecccccccccCCCCc-
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDI-KPQNILLDDYYNARISDFGLEKLLTLDQSH-  639 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kl~Dfgla~~~~~~~~~-  639 (762)
                      +++.+|...+..       ....++.|++++|.++|++   +|+|||| ||+|||+++++.++|+|||++......... 
T Consensus        80 I~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         80 LAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             ecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence            999998765421       1245788999999999999   9999999 799999999999999999999855432210 


Q ss_pred             ---c--------cccccccCcccCcccccCC-CCC-CcchhHHHHHHHHHHHhCCCCCc
Q 004312          640 ---T--------NTAIRGTKGYVAPEWFRNM-PIT-VKVDVYSYGVLLLEIICLRRTIL  685 (762)
Q Consensus       640 ---~--------~~~~~gt~~y~aPE~~~~~-~~s-~~~DV~S~Gvil~elltg~~p~~  685 (762)
                         .        ......++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+..
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence               0        0112357788888765322 333 66889999999999999998853

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.74  E-value=6.5e-18  Score=173.95  Aligned_cols=226  Identities=20%  Similarity=0.242  Sum_probs=143.8

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccc----------cCCccchhceec----
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTH----------HKNLVRLLGYCD----  550 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~----------H~nIv~l~g~~~----  550 (762)
                      +.||.|+++.||.++. ..+++++|||++...   .....+++++|.-.+..+.          |-.++-.++...    
T Consensus        18 ~~i~~g~~~~v~~v~d-~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   18 RIIGKGGFSIVFEVTD-VETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEETTEEEEEEEE-TTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             cccccCCceEEEEEEE-ccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            5699999999999975 456789999987532   2334467777776665542          222332232221    


Q ss_pred             -----cC---C-----ceeEEEeccCCCchhhhcc---CCC----CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCC
Q 004312          551 -----EG---R-----NRLLVYEFMSNGALASFLF---GDS----KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIK  610 (762)
Q Consensus       551 -----~~---~-----~~~LV~E~~~~gsL~~~l~---~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk  610 (762)
                           ..   .     ..+++|+-+ -++|.+++.   ...    .+....++.+..|+++.+++||+.   |++|+||+
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence                 11   1     235677777 557777753   211    234555667789999999999999   99999999


Q ss_pred             CCceEEcCCCceEEecccccccccCCCCcccccccccCcccCcccccC--------CCCCCcchhHHHHHHHHHHHhCCC
Q 004312          611 PQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN--------MPITVKVDVYSYGVLLLEIICLRR  682 (762)
Q Consensus       611 p~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DV~S~Gvil~elltg~~  682 (762)
                      |+|++++.+|.++|+||+........    ......+..|.+||....        -.++.+.|.|++|+++|.|.+++.
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999999999999887654321    111234578999997643        257899999999999999999999


Q ss_pred             CCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCC
Q 004312          683 TILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHR  733 (762)
Q Consensus       683 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R  733 (762)
                      |+...........         . -.... ..++.+..||..+|+.+|.+|
T Consensus       249 Pf~~~~~~~~~~~---------~-f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW---------D-FSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG---------G-GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc---------c-chhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9743311110000         1 11223 778999999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.73  E-value=6.9e-19  Score=191.75  Aligned_cols=227  Identities=22%  Similarity=0.205  Sum_probs=182.7

Q ss_pred             hcCCCCcceEEEeeeeC--CCcceEEEEEccccccch--hHHHHHHhhhhcccc-cCCccchhceeccCCceeEEEeccC
Q 004312          489 ELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVFQDS--EKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .+|+|.+|.|+...--.  ..+..+|.|.+++.....  ......|..++...+ ||.+|++.-.+......+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999998753211  123467888776432211  114556778888886 9999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +|.|...+.+...............++-+++++|+.   +|+|||+|++||+++.+|++|+.|||+++..-.....    
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----  153 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence            999999999888888888888999999999999999   9999999999999999999999999999876433222    


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                       +||..|||||++.  ....++|.||||++++||++|..||..+         ....++..  ....+.+....+.+++.
T Consensus       154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~---------~~~~Il~~--~~~~p~~l~~~a~~~~~  219 (612)
T KOG0603|consen  154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD---------TMKRILKA--ELEMPRELSAEARSLFR  219 (612)
T ss_pred             -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH---------HHHHHhhh--ccCCchhhhHHHHHHHH
Confidence             8999999999998  6789999999999999999999998551         11122221  23346677788889999


Q ss_pred             HhhccCCCCCCCH
Q 004312          724 WCIQEDPSHRPTM  736 (762)
Q Consensus       724 ~cl~~dp~~RPt~  736 (762)
                      .++..+|..|.-.
T Consensus       220 ~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  220 QLFKRNPENRLGA  232 (612)
T ss_pred             HHHhhCHHHHhcc
Confidence            9999999999644

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=1.6e-17  Score=193.36  Aligned_cols=252  Identities=19%  Similarity=0.174  Sum_probs=180.3

Q ss_pred             CHHHHHHHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc---cCCccchhceecc
Q 004312          475 TYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH---HKNLVRLLGYCDE  551 (762)
Q Consensus       475 ~~~el~~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~  551 (762)
                      +.-++......+.+.||+|+||+||+|....  ++.||+|.-+....=   +|.-=.+++.||+   -+.|..+.....-
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~--~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN--GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCC--CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHcc
Confidence            3344444555667889999999999997654  789999987643211   1222222333343   2445555555666


Q ss_pred             CCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc-------CCCceEE
Q 004312          552 GRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD-------DYYNARI  624 (762)
Q Consensus       552 ~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-------~~~~~kl  624 (762)
                      .+..+||+||.+-|+|.+++...+.++|.....++.|+++-+.+||..   +||||||||+|.||.       ++..++|
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence            778899999999999999999889999999999999999999999999   999999999999994       4557999


Q ss_pred             ecccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccc
Q 004312          625 SDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE  703 (762)
Q Consensus       625 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  703 (762)
                      +|||.+.-+..-.. ......++|-.+-.+|+..+.+++.++|.|.++.+++-||.|+.-      .  ...+... .+.
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~------q--~~~g~~~-~~~  913 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM------E--VKNGSSW-MVK  913 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH------H--hcCCcce-ecc
Confidence            99999976654333 355667889999999999999999999999999999999988642      1  1111111 111


Q ss_pred             cccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       704 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      ..+.....   -+..-++...+|+.|-..=|...++...|+++
T Consensus       914 ~~~~Ry~~---~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~  953 (974)
T KOG1166|consen  914 TNFPRYWK---RDMWNKFFDLLLNPDCDTLPNLQELRTELEEV  953 (974)
T ss_pred             ccchhhhh---HHHHHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence            11111111   12233455556665555557777777777664

>PRK10345 hypothetical protein; Provisional

Probab=99.72  E-value=2.7e-17  Score=164.06  Aligned_cols=134  Identities=19%  Similarity=0.222  Sum_probs=105.3

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-----ccCCccchhceeccCC---c-eeEE
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-----HHKNLVRLLGYCDEGR---N-RLLV  558 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~g~~~~~~---~-~~LV  558 (762)
                      +.||+|++|.||.  .. .... .+||++........+++.+|+++++++     .||||++++|++.++.   . ..+|
T Consensus         8 ~~LG~G~~~~Vy~--hp-~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          8 SPLGTGRHRKCYA--HP-EDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             ceecCCCceEEEE--CC-CCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            5799999999996  22 2232 468988765445567899999999999     5799999999998764   3 2378


Q ss_pred             Eec--cCCCchhhhccCCCCCCHHHHHHHHHHHHHHH-HHhHhcCCCCeEeCCCCCCceEEcC----CCceEEecccccc
Q 004312          559 YEF--MSNGALASFLFGDSKPNWKLRTEIVMGIARGL-FYLHEECCTQIIHCDIKPQNILLDD----YYNARISDFGLEK  631 (762)
Q Consensus       559 ~E~--~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~Dfgla~  631 (762)
                      +||  +++++|.+++.+. .+++.  ..++.+++.++ +|||++   +|+||||||+|||++.    +..++|+||+.+.
T Consensus        84 ~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             ecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence            999  6689999999664 45544  35678888777 999999   9999999999999973    3489999954443

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=8e-17  Score=164.67  Aligned_cols=141  Identities=21%  Similarity=0.223  Sum_probs=110.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc------------------------hhHHHHHHhhhhcccccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD------------------------SEKEFKAEVNGIGQTHHK  540 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H~  540 (762)
                      .+.+.||+|++|.||+|..+..+++.||||+++.....                        ....+..|++.+.++.+.
T Consensus        31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~  110 (237)
T smart00090       31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA  110 (237)
T ss_pred             HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence            35578999999999999733445789999998643210                        112357899999999763


Q ss_pred             C--ccchhceeccCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC-eEeCCCCCCceEEc
Q 004312          541 N--LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ-IIHCDIKPQNILLD  617 (762)
Q Consensus       541 n--Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH~Dlkp~NILl~  617 (762)
                      .  +.++++.    ...+|||||+++++|...+.....+.......++.||+.+|++||+.   + |+||||||+||+++
T Consensus       111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~  183 (237)
T smart00090      111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH  183 (237)
T ss_pred             CCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE
Confidence            3  3344433    23589999999999887765555566667789999999999999999   8 99999999999999


Q ss_pred             CCCceEEecccccccc
Q 004312          618 DYYNARISDFGLEKLL  633 (762)
Q Consensus       618 ~~~~~kl~Dfgla~~~  633 (762)
                       ++.++|+|||.+...
T Consensus       184 -~~~i~LiDFg~a~~~  198 (237)
T smart00090      184 -DGKVVIIDVSQSVEL  198 (237)
T ss_pred             -CCCEEEEEChhhhcc
Confidence             889999999998754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.69  E-value=1.4e-17  Score=178.34  Aligned_cols=169  Identities=22%  Similarity=0.322  Sum_probs=132.4

Q ss_pred             ceeEEEeccCCCchhhhccCC---CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccc
Q 004312          554 NRLLVYEFMSNGALASFLFGD---SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLE  630 (762)
Q Consensus       554 ~~~LV~E~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla  630 (762)
                      ..+|.|++|...+|.+||.+.   ...++...+.++.|++.|+.|   +   +.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999755   356888999999999999999   5   9999999999999999999999999998


Q ss_pred             ccccCCC-----CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcccccccccc
Q 004312          631 KLLTLDQ-----SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVEN  704 (762)
Q Consensus       631 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  704 (762)
                      .......     ....+...||..||+||.+.+..|+.|+||||||+||+||+. -..++........++++.+......
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~~  483 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFLQ  483 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHhh
Confidence            8766544     234455679999999999999999999999999999999997 3444333333333444333311111


Q ss_pred             ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 004312          705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMR  737 (762)
Q Consensus       705 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~  737 (762)
                               .-+.-..++.+++.+.|.+||++.
T Consensus       484 ---------d~p~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  484 ---------DYPEEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             ---------cCcHHHHHHHHhcCCCcccCchHH
Confidence                     112335789999999999999443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=2e-16  Score=159.70  Aligned_cols=134  Identities=20%  Similarity=0.244  Sum_probs=113.1

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccc--------hhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--------SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +.||+|++|.||+|..   .+..++||+.......        ....+.+|++++.+++|++|+....++......++||
T Consensus         2 ~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee---CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            4689999999999976   2457889976532211        1246889999999999999988888877778889999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                      ||+++++|.+++.....    .+..++.+++.+|.++|+.   +++|||++|+|||++ ++.++|+|||++..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999999865332    7889999999999999998   999999999999999 78999999999874

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.67  E-value=3e-16  Score=161.20  Aligned_cols=192  Identities=22%  Similarity=0.282  Sum_probs=136.6

Q ss_pred             ccCCccchhceecc---------------------------CCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHH
Q 004312          538 HHKNLVRLLGYCDE---------------------------GRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIA  590 (762)
Q Consensus       538 ~H~nIv~l~g~~~~---------------------------~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia  590 (762)
                      +|||||++.++|.+                           +...||||...+. +|..++..+. .+...+.-|+.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence            69999998887632                           3456888887744 8888886543 45566778899999


Q ss_pred             HHHHHhHhcCCCCeEeCCCCCCceEEc--CCC--ceEEecccccccccCC-----CCcccccccccCcccCcccccCCC-
Q 004312          591 RGLFYLHEECCTQIIHCDIKPQNILLD--DYY--NARISDFGLEKLLTLD-----QSHTNTAIRGTKGYVAPEWFRNMP-  660 (762)
Q Consensus       591 ~~L~yLH~~~~~~ivH~Dlkp~NILl~--~~~--~~kl~Dfgla~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~-  660 (762)
                      +|+.|||.+   +|.|||+|.+||||.  +|.  .+.|+|||++-.-...     -.......-|.-.-||||+....+ 
T Consensus       352 Eav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG  428 (598)
T KOG4158|consen  352 EAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG  428 (598)
T ss_pred             HHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence            999999999   999999999999993  444  4678999987432211     111122234677889999986532 


Q ss_pred             -----CCCcchhHHHHHHHHHHHhCCCCCchhhH----HHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCC
Q 004312          661 -----ITVKVDVYSYGVLLLEIICLRRTILTDWA----YDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPS  731 (762)
Q Consensus       661 -----~s~~~DV~S~Gvil~elltg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~  731 (762)
                           --.|+|.|+.|.+.||++....||+..-.    ...+++..+         ...+..++..+.+++...|+.||+
T Consensus       429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL---------Palp~~vpp~~rqlV~~lL~r~ps  499 (598)
T KOG4158|consen  429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL---------PALPSRVPPVARQLVFDLLKRDPS  499 (598)
T ss_pred             CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC---------CCCcccCChHHHHHHHHHhcCCcc
Confidence                 12689999999999999999999865211    111111111         122345677889999999999999


Q ss_pred             CCCCHHHHHHHh
Q 004312          732 HRPTMRRVTQML  743 (762)
Q Consensus       732 ~RPt~~evl~~L  743 (762)
                      +|++..-....|
T Consensus       500 kRvsp~iAANvl  511 (598)
T KOG4158|consen  500 KRVSPNIAANVL  511 (598)
T ss_pred             ccCCccHHHhHH
Confidence            999876544443

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=3.8e-16  Score=156.07  Aligned_cols=130  Identities=20%  Similarity=0.274  Sum_probs=106.8

Q ss_pred             hcCCCCcceEEEeeeeCCCcceEEEEEccccc-c-------chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-Q-------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~-------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .||+|++|.||+|.+.   +..+++|+..... .       .....+.+|++++.+++|+++.....++......++|||
T Consensus         1 ~ig~G~~~~vy~~~~~---~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL---GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeecC---CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEE
Confidence            3899999999999743   4679999864321 1       112567889999999999887666666666777899999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                      |+++++|.+++.....       .++.+++++|.+||+.   +++|||++|+||+++ ++.+++.|||+++.
T Consensus        78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999998754321       8899999999999998   999999999999999 78999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.64  E-value=6.7e-16  Score=177.51  Aligned_cols=132  Identities=20%  Similarity=0.271  Sum_probs=108.5

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEc-ccccc-------chhHHHHHHhhhhcccccCCccchhceeccCCceeEE
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKL-NRVFQ-------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLV  558 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV  558 (762)
                      .+.||+|+||.||+|.+...   .+++|+. .+...       .....+.+|++++.+++|++++....++......++|
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~---~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv  414 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGR---DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV  414 (535)
T ss_pred             cceeccCCcEEEEEEeecCc---cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence            56899999999999976432   3444432 21111       1234688999999999999999888888777788999


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccc
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL  633 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~  633 (762)
                      |||+++++|.+++.        .+..++.+++++|.|||+.   +++||||||+|||+ +++.++|+|||+++..
T Consensus       415 ~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        415 MEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            99999999999884        4678999999999999998   99999999999999 6779999999999753

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.63  E-value=1e-15  Score=152.85  Aligned_cols=136  Identities=18%  Similarity=0.177  Sum_probs=106.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc----------------------chhHHHHHHhhhhcccccCC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ----------------------DSEKEFKAEVNGIGQTHHKN  541 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~n  541 (762)
                      +.+.+.||+|+||.||++...  +++.||||++.....                      .....+..|+.++.+++|++
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            455678999999999999764  467899998653210                      01123678899999998874


Q ss_pred             --ccchhceeccCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC
Q 004312          542 --LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY  619 (762)
Q Consensus       542 --Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~  619 (762)
                        ++..++.    ...++||||+++++|......      .....++.+++.++.++|+.   +|+||||||+||+++++
T Consensus        95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~  161 (198)
T cd05144          95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCC
Confidence              4444432    345899999999999876531      34567899999999999998   99999999999999999


Q ss_pred             CceEEeccccccccc
Q 004312          620 YNARISDFGLEKLLT  634 (762)
Q Consensus       620 ~~~kl~Dfgla~~~~  634 (762)
                      +.++|+|||++....
T Consensus       162 ~~~~liDfg~~~~~~  176 (198)
T cd05144         162 EKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcEEEEECCccccCC
Confidence            999999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.58  E-value=2.2e-15  Score=172.04  Aligned_cols=202  Identities=20%  Similarity=0.277  Sum_probs=143.5

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCch
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGAL  567 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL  567 (762)
                      +.|..|++|.||..+.. .+.+++|+|+-++..      +.+-  ++.....|.+|                     |+-
T Consensus        89 klisngAygavylvrh~-~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv---------------------gDc  138 (1205)
T KOG0606|consen   89 KLISNGAYGAVYLVRHK-ETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV---------------------GDC  138 (1205)
T ss_pred             EeeccCCCCceeeeecc-ccccchhhcccccch------hhhc--cccccCCccee---------------------chh
Confidence            57899999999998654 345678885433211      1110  22222333333                     555


Q ss_pred             hhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC----------
Q 004312          568 ASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ----------  637 (762)
Q Consensus       568 ~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~----------  637 (762)
                      ...++..+.++...        +.+++|||+.   +|+|||+||+|.+|..-|++|+.|||+.+......          
T Consensus       139 ~tllk~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~  207 (1205)
T KOG0606|consen  139 ATLLKNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIE  207 (1205)
T ss_pred             hhhcccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchH
Confidence            66666655555333        7899999998   99999999999999999999999999987532110          


Q ss_pred             ----CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHH
Q 004312          638 ----SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMT  713 (762)
Q Consensus       638 ----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  713 (762)
                          .......+||+.|+|||++....|....|.|++|+|+||.+-|..||..+.+.+.+..-.-..+..    ...+..
T Consensus       208 k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w----pE~dea  283 (1205)
T KOG0606|consen  208 KDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW----PEEDEA  283 (1205)
T ss_pred             HHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc----cccCcC
Confidence                011223579999999999999999999999999999999999999998875555443322111111    112344


Q ss_pred             HHHHHHHHHHHhhccCCCCCC
Q 004312          714 VLQRFVMVAIWCIQEDPSHRP  734 (762)
Q Consensus       714 ~~~~~~~li~~cl~~dp~~RP  734 (762)
                      .+.++.+++.+.|+.+|.+|-
T Consensus       284 ~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  284 LPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             CCHHHHHHHHHHHHhChHhhc
Confidence            567889999999999999995

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.55  E-value=2.8e-14  Score=134.94  Aligned_cols=133  Identities=20%  Similarity=0.158  Sum_probs=114.7

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccccc--CCccchhceeccCCceeEEEeccCCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHH--KNLVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      +.||+|.++.||++....   ..++||.......  ...+.+|+.++..++|  .++++++++....+..++++||++++
T Consensus         4 ~~i~~g~~~~v~~~~~~~---~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD---EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             eecccccccceEEEEecC---CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            569999999999997642   5799999866433  5679999999999977  58999999888888899999999998


Q ss_pred             chhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          566 ALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       566 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                      .+..+       +......++.+++++|+++|.....+++|+|++|+||++++.+.+++.||+.+..
T Consensus        79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            88765       5677788999999999999997545799999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=8.8e-16  Score=175.93  Aligned_cols=251  Identities=22%  Similarity=0.276  Sum_probs=191.3

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccc-cCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +++.+.||+|+++.|-...........+|+|.+....  .........|..+-..+. |+|++++++...+.+..+++.|
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~  101 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS  101 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence            3455669999999998876554555678888776543  222334555777777776 9999999999999999999999


Q ss_pred             ccCCCchhhhc-cCCC-CCCHHHHHHHHHHHHHHHHHhH-hcCCCCeEeCCCCCCceEEcCCC-ceEEecccccccccC-
Q 004312          561 FMSNGALASFL-FGDS-KPNWKLRTEIVMGIARGLFYLH-EECCTQIIHCDIKPQNILLDDYY-NARISDFGLEKLLTL-  635 (762)
Q Consensus       561 ~~~~gsL~~~l-~~~~-~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~-  635 (762)
                      |..++++.+.+ +... ..+....-..+.|+..++.|+| ..   ++.|+|+||+|.+++..+ ..+++|||+|..+.. 
T Consensus       102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             cccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            99999999999 5554 6677788899999999999999 76   999999999999999999 999999999998876 


Q ss_pred             C-CCcccccccc-cCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccc--ccCC
Q 004312          636 D-QSHTNTAIRG-TKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL--EAMD  710 (762)
Q Consensus       636 ~-~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~  710 (762)
                      . ........+| ++.|+|||...+. -..+..|+||.|+++..+++|..|........    ...........  ....
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~  254 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD----GRYSSWKSNKGRFTQLP  254 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc----ccceeecccccccccCc
Confidence            2 2333445678 9999999999874 56788999999999999999999853321111    11111111110  1111


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          711 DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       711 ~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .........+++.+++..+|+.|.+.+++..
T Consensus       255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  255 WNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cccCChhhhhcccccccCCchhccccccccc
Confidence            2234566778888999999999999888754

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.53  E-value=2.6e-14  Score=141.29  Aligned_cols=137  Identities=19%  Similarity=0.221  Sum_probs=94.8

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchh--HHH----------------------HHHhhhhcccccCC-
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEF----------------------KAEVNGIGQTHHKN-  541 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~--~~~----------------------~~E~~~l~~l~H~n-  541 (762)
                      .+.||+|+||+||+|...  ++++||||+++.......  ..+                      ..|.+.+.++++.. 
T Consensus         2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            357999999999999765  567899998865322111  111                      23444444443332 


Q ss_pred             -ccchhceeccCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEeCCCCCCceEEcCC
Q 004312          542 -LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE-ECCTQIIHCDIKPQNILLDDY  619 (762)
Q Consensus       542 -Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NILl~~~  619 (762)
                       +.+.+++    ...++||||++++.+........... .....++.+++.++.++|. .   +|+|+||||+||+++ +
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C
Confidence             3333332    24589999999954432211111111 5678899999999999999 7   999999999999999 8


Q ss_pred             CceEEeccccccccc
Q 004312          620 YNARISDFGLEKLLT  634 (762)
Q Consensus       620 ~~~kl~Dfgla~~~~  634 (762)
                      +.++|+|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            899999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.51  E-value=6.3e-14  Score=143.60  Aligned_cols=135  Identities=18%  Similarity=0.119  Sum_probs=105.4

Q ss_pred             hhcC-CCCcceEEEeeeeCCCcceEEEEEccccc-------------cchhHHHHHHhhhhcccccCCc--cchhceecc
Q 004312          488 EELG-RGAFGTVYKGFVNMGSSDQVAVKKLNRVF-------------QDSEKEFKAEVNGIGQTHHKNL--VRLLGYCDE  551 (762)
Q Consensus       488 ~~iG-~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l~g~~~~  551 (762)
                      ..|| .|+.|+||+....   +..++||++....             ......+.+|++++.+++|++|  ++.+++...
T Consensus        37 ~~lg~~~g~gtv~~v~~~---~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP---GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             ceeecCCCCccEEEEEeC---CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            4687 8999999998654   4579999875311             1223568899999999998885  677776544


Q ss_pred             CCc----eeEEEeccCC-CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEec
Q 004312          552 GRN----RLLVYEFMSN-GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISD  626 (762)
Q Consensus       552 ~~~----~~LV~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  626 (762)
                      ...    .+||+|++++ .+|.+++... .++..    .+.+|+++|.+||+.   +|+||||||+|||++.++.++|+|
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEE
Confidence            322    2599999997 6899888553 34433    367899999999999   999999999999999988999999


Q ss_pred             ccccccc
Q 004312          627 FGLEKLL  633 (762)
Q Consensus       627 fgla~~~  633 (762)
                      ||.+...
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9998753

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.39  E-value=4.1e-13  Score=135.45  Aligned_cols=198  Identities=22%  Similarity=0.299  Sum_probs=139.5

Q ss_pred             hhhcccccCCccchhceeccC-----CceeEEEeccCCCchhhhccCC----CCCCHHHHHHHHHHHHHHHHHhHhcCCC
Q 004312          532 NGIGQTHHKNLVRLLGYCDEG-----RNRLLVYEFMSNGALASFLFGD----SKPNWKLRTEIVMGIARGLFYLHEECCT  602 (762)
Q Consensus       532 ~~l~~l~H~nIv~l~g~~~~~-----~~~~LV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~L~yLH~~~~~  602 (762)
                      ..|-++.|.|||+++.+..+.     .....+.|||..|+|..+|++.    ..+..+.-.++.-||+.||.|||+ |.|
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence            445667899999999988653     3568899999999999999754    467788888999999999999999 689


Q ss_pred             CeEeCCCCCCceEEcCCCceEEeccccccccc----CCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHH
Q 004312          603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLT----LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII  678 (762)
Q Consensus       603 ~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~----~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ell  678 (762)
                      +|+|+++..+.|++..++-+||.--.- ....    ...........+-++|.+||+-...+.+.++|||+||+..+||.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            999999999999999999888852111 1110    00111122234678999999988888899999999999999987


Q ss_pred             hCCCCC-chhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          679 CLRRTI-LTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       679 tg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      -+..-. ....  ....+..+...+-. +.       ...-+.++.+|++.+|..||+|++++-
T Consensus       277 ilEiq~tnseS--~~~~ee~ia~~i~~-le-------n~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQSTNSES--KVEVEENIANVIIG-LE-------NGLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccCCCcc--eeehhhhhhhheee-cc-------CccccCcCcccccCCCCCCcchhhhhc
Confidence            654321 1100  00111111111100 00       011245778899999999999998764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.36  E-value=1.9e-12  Score=144.24  Aligned_cols=138  Identities=21%  Similarity=0.242  Sum_probs=98.0

Q ss_pred             hcCCCCcceEEEeeeeCCCcceEEEEEccccccch----------------------------------------hHHHH
Q 004312          489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS----------------------------------------EKEFK  528 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~  528 (762)
                      .||.|++|.||+|++.+  ++.||||+.+......                                        +-+|.
T Consensus       124 plasaSigQVh~A~l~~--G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       124 PLAAASIAQVHRARLVD--GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             ceeeeehhheEEEEecC--CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            59999999999999864  5789999986432110                                        11355


Q ss_pred             HHhhhhcccc----cCCccchhcee-ccCCceeEEEeccCCCchhhhccCC-CCCCHHHHHHHHHHHHH-HHHHhHhcCC
Q 004312          529 AEVNGIGQTH----HKNLVRLLGYC-DEGRNRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIAR-GLFYLHEECC  601 (762)
Q Consensus       529 ~E~~~l~~l~----H~nIv~l~g~~-~~~~~~~LV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~-~L~yLH~~~~  601 (762)
                      +|++.+.+++    |.+-+.+-..+ ...+..+|||||+++++|.++.... ...   .+..++.++++ .+..+|..  
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~--  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD--  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC--
Confidence            5666666552    22222222222 2345579999999999998876422 112   34567777766 46788887  


Q ss_pred             CCeEeCCCCCCceEEcCCCceEEeccccccccc
Q 004312          602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLT  634 (762)
Q Consensus       602 ~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~  634 (762)
                       +++|+|+||+||++++++.++++|||++..+.
T Consensus       277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             -CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             99999999999999999999999999998664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.19  E-value=1.5e-10  Score=128.14  Aligned_cols=165  Identities=16%  Similarity=0.201  Sum_probs=123.6

Q ss_pred             CcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHH
Q 004312          507 SSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIV  586 (762)
Q Consensus       507 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~  586 (762)
                      ++.+|.|+..+...........+-++.|+.++||||++++....+.+..|||+|.+.  .|..+++..+   .......+
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~~Gl  110 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVCLGL  110 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHHHHH
Confidence            345788888766544444567788899999999999999999999999999999983  4555554333   55666788


Q ss_pred             HHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccccccCcccCcccccCCCCCCcch
Q 004312          587 MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD  666 (762)
Q Consensus       587 ~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~D  666 (762)
                      .||+.||.|||+.|  +++|++|..+.|++++.|..||++|-+......... .......-..|..|+.+....  -..|
T Consensus       111 ~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D  185 (690)
T KOG1243|consen  111 FQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSID  185 (690)
T ss_pred             HHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchh
Confidence            99999999999764  899999999999999999999999988764322111 111111223466666553222  4479


Q ss_pred             hHHHHHHHHHHHhCC
Q 004312          667 VYSYGVLLLEIICLR  681 (762)
Q Consensus       667 V~S~Gvil~elltg~  681 (762)
                      .|.||++++|++.|.
T Consensus       186 ~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  186 SWGLGCLIEELFNGS  200 (690)
T ss_pred             hhhHHHHHHHHhCcc
Confidence            999999999999983

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.19  E-value=4.9e-11  Score=115.67  Aligned_cols=129  Identities=19%  Similarity=0.132  Sum_probs=96.4

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCcc-chhceeccCCceeEEEeccCCCc
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLV-RLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      +.|+.|.++.||++...   ++.+++|....... ....+.+|++++..+.+.+++ +++.+..  ...++||||+++.+
T Consensus         4 ~~l~~G~~~~vy~~~~~---~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA---NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eecCCcccCceEEEEEC---CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            45889999999998753   45799998765422 234578899999998765544 4554432  34589999999988


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcC--CCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          567 LASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC--CTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       567 L~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                      +....        .....++.+++++|+.||+..  ..+++|+|++|.||+++ ++.++++||+.+.
T Consensus        78 l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          78 LLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            86541        112346789999999999983  22469999999999999 5689999999986

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.19  E-value=2e-11  Score=134.03  Aligned_cols=251  Identities=21%  Similarity=0.200  Sum_probs=182.8

Q ss_pred             HHHHHHhhhhhhcCC--CCcceEEEeeee-CCCcceEEEEEcccccc--chhHHHHHHhhhhccc-ccCCccchhceecc
Q 004312          478 ELVEVTRGFKEELGR--GAFGTVYKGFVN-MGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDE  551 (762)
Q Consensus       478 el~~~t~~~~~~iG~--G~~g~Vy~g~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~  551 (762)
                      +..+..-.+.+.+|.  |.+|.||++... ..+.+.+|+|+-+....  .....=.+|+....++ .|+|.++.......
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence            344444556678999  999999999762 12346799998544322  3333445677777777 59999998888999


Q ss_pred             CCceeEEEeccCCCchhhhccCCCC-CCHHHHHHHHHHHHH----HHHHhHhcCCCCeEeCCCCCCceEEcCC-CceEEe
Q 004312          552 GRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIAR----GLFYLHEECCTQIIHCDIKPQNILLDDY-YNARIS  625 (762)
Q Consensus       552 ~~~~~LV~E~~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~  625 (762)
                      ++..++-+|++. .+|.++.+.... ++......+..+..+    ||.++|..   .++|-|+||.||++.++ ...++.
T Consensus       190 ~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  190 SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence            999999999995 788888876644 777888888888888    99999998   99999999999999998 899999


Q ss_pred             cccccccccCCCCcc----cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchh--hHHHhhhccccc
Q 004312          626 DFGLEKLLTLDQSHT----NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTD--WAYDCYQERTLG  699 (762)
Q Consensus       626 Dfgla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~--~~~~~~~~~~~~  699 (762)
                      |||+...+.......    .....|...|++||..++ -++...|||++|.++.+..++-......  ..|...+...+.
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            999998776544211    122257889999999854 5689999999999999999887664332  122222221111


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          700 ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       700 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                              .........++...+..+++.+|..|++.+.+..
T Consensus       345 --------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  345 --------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             --------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                    0011112344555888999999999998766553

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.16  E-value=7.1e-11  Score=133.07  Aligned_cols=136  Identities=16%  Similarity=0.145  Sum_probs=87.7

Q ss_pred             hcCCCCcceEEEeeeeCCCcceEEEEEccccccch----------------------------------------hHHHH
Q 004312          489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS----------------------------------------EKEFK  528 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~  528 (762)
                      .||+|++|+||+|++.. +++.||||++++.....                                        +-+|.
T Consensus       126 PlasaSiaQVh~A~l~~-~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        126 PLASASIAQVHFARLKD-NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhcCCCccEEEEEEECC-CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            59999999999998864 36789999987532110                                        11244


Q ss_pred             HHhhhhcccc----cCCccchhceecc-CCceeEEEeccCCCchhhh--ccCCC----CCCHHHHHHHHHHHHHHHHHhH
Q 004312          529 AEVNGIGQTH----HKNLVRLLGYCDE-GRNRLLVYEFMSNGALASF--LFGDS----KPNWKLRTEIVMGIARGLFYLH  597 (762)
Q Consensus       529 ~E~~~l~~l~----H~nIv~l~g~~~~-~~~~~LV~E~~~~gsL~~~--l~~~~----~l~~~~~~~i~~~ia~~L~yLH  597 (762)
                      +|+..+.+++    +.+.+.+-..+.+ ....+|||||++|+.|.++  +...+    .+.......++.|+       +
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence            4554444442    3333332232222 3456799999999999874  22222    12222222233333       3


Q ss_pred             hcCCCCeEeCCCCCCceEEcCCC----ceEEecccccccccC
Q 004312          598 EECCTQIIHCDIKPQNILLDDYY----NARISDFGLEKLLTL  635 (762)
Q Consensus       598 ~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Dfgla~~~~~  635 (762)
                      ..   +++|+|+||+||+++.++    .+++.|||+...+..
T Consensus       278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            34   999999999999999888    999999999987643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.13  E-value=4.2e-10  Score=110.46  Aligned_cols=139  Identities=15%  Similarity=0.164  Sum_probs=99.4

Q ss_pred             hhcCCCCcceEEEeeeeCC-----CcceEEEEEcccc-------------c---------cchhHHHH----HHhhhhcc
Q 004312          488 EELGRGAFGTVYKGFVNMG-----SSDQVAVKKLNRV-------------F---------QDSEKEFK----AEVNGIGQ  536 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~-----~~~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~~  536 (762)
                      ..||.|.-+.||.|.-..+     .+..+|||+.+..             .         ....+.+.    +|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            3589999999999964422     2468999976411             0         01122333    89999999


Q ss_pred             ccc--CCccchhceeccCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHh-HhcCCCCeEeCCCCCCc
Q 004312          537 THH--KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYL-HEECCTQIIHCDIKPQN  613 (762)
Q Consensus       537 l~H--~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dlkp~N  613 (762)
                      +..  -++.+++++    ...+|||||+.++.+....-+...++......+..+++.+|..| |..   +|+||||++.|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~N  155 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYN  155 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence            854  456666654    56789999998754432222222345556678889999999999 777   99999999999


Q ss_pred             eEEcCCCceEEeccccccccc
Q 004312          614 ILLDDYYNARISDFGLEKLLT  634 (762)
Q Consensus       614 ILl~~~~~~kl~Dfgla~~~~  634 (762)
                      ||+++ +.+.|+|||.+....
T Consensus       156 IL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         156 MLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEEEC-CcEEEEECCCceeCC
Confidence            99974 689999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=99.11  E-value=9.3e-11  Score=99.52  Aligned_cols=72  Identities=18%  Similarity=0.360  Sum_probs=59.0

Q ss_pred             ceeeEeccCCCCCCCcccccCCCChhhHHhhhccCCCccccccc--cCcceecccCCccCccCCCCCCceEEeee
Q 004312          337 LYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLR--DDTCWKKKLPLSYGKTDRDETGTTFIKIR  409 (762)
Q Consensus       337 ~~~~~~~~~~~~p~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~--~~~C~~~~~~~~~~~~~~~~~~~~ylkv~  409 (762)
                      .+.|+.++++++|+..+.. .+.++++|++.|++||+|.||+|.  +++|++|..++.+..........+|+|++
T Consensus        11 ~~~f~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~   84 (84)
T cd01098          11 TDGFLKLPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA   84 (84)
T ss_pred             CCEEEEeCCeeCCCchhhh-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence            3468899999999876544 678999999999999999999996  48899998888876654444577898863

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.10  E-value=5.1e-11  Score=95.48  Aligned_cols=56  Identities=25%  Similarity=0.359  Sum_probs=47.2

Q ss_pred             eeeEeccCCCCCCCcccc-cCCCChhhHHhhhccCCCcccccccc----CcceecccCCcc
Q 004312          338 YYIEELRNTDWPTSDYEQ-ISPYGKDECVSSCLKDCQCSAAVLRD----DTCWKKKLPLSY  393 (762)
Q Consensus       338 ~~~~~~~~~~~p~~~~~~-~~~~s~~~C~~~Cl~nCsC~a~~~~~----~~C~~~~~~~~~  393 (762)
                      ..|+++++|++|+++... ..+.++++|+..||+||||+||+|..    ++|++|...+.+
T Consensus         5 d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d   65 (66)
T PF08276_consen    5 DGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD   65 (66)
T ss_pred             CEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence            369999999999986533 36699999999999999999999973    689999876654

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.07  E-value=7.4e-10  Score=104.83  Aligned_cols=131  Identities=21%  Similarity=0.305  Sum_probs=104.5

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEE-ccccccch-------hHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKK-LNRVFQDS-------EKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~-~~~~~~~~-------~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      ..+++|+-+.+|.+.+.   +.++++|. +.+.....       .....+|++++.+++--.|...+=+..+.....|+|
T Consensus         2 ~~i~~GAEa~i~~~~~~---g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL---GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeecc---CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEE
Confidence            35789999999998653   23455653 33322211       245778999999998878877777888888899999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                      ||+++..|.+.+...       +..++..+-.-+.-||..   +|+|+||.++||++..+. +.++||||+..
T Consensus        79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999999998654       367888888889999999   999999999999998775 99999999974

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.06  E-value=1e-09  Score=111.19  Aligned_cols=142  Identities=16%  Similarity=0.188  Sum_probs=111.3

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhccccc--CCccchhceeccCC---ceeEEEec
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHH--KNLVRLLGYCDEGR---NRLLVYEF  561 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~---~~~LV~E~  561 (762)
                      +.|+.|..+.||++....  ++.+++|....... ....++.+|+++++.+++  .++.+++.+..+..   ..++||||
T Consensus         4 ~~l~~G~~n~~~~v~~~~--g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG--GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             eecCCCccceEEEEEecC--CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            458999999999987643  36799999765332 134578999999999976  44677788776643   56899999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcC-----------------------------------------
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC-----------------------------------------  600 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----------------------------------------  600 (762)
                      +++.+|.+.+.. ..++...+..++.+++++|.+||+..                                         
T Consensus        82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            999999887643 45677888889999999999998531                                         


Q ss_pred             ------------CCCeEeCCCCCCceEEcC--CCceEEeccccccc
Q 004312          601 ------------CTQIIHCDIKPQNILLDD--YYNARISDFGLEKL  632 (762)
Q Consensus       601 ------------~~~ivH~Dlkp~NILl~~--~~~~kl~Dfgla~~  632 (762)
                                  ...++|+|++|+||++++  ++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        246899999999999998  66789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.03  E-value=1.8e-10  Score=126.60  Aligned_cols=242  Identities=19%  Similarity=0.180  Sum_probs=173.3

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHH--HHHHhhhhccc-ccCCccchhceeccCCceeEEEeccC
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE--FKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      ...||.|.|+.|++...+..++..+++|.+.+.......+  -..|+.+...+ .|.++++...-.......++=-||++
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~  349 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE  349 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence            3569999999999987664556789999887654443332  23566666655 68888888877777788889999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC-CceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY-YNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ++++...+.-...++...++++..|++.++.++|+.   .++|+|+||+||++..+ +.-++.|||++..+....   ..
T Consensus       350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~---~~  423 (524)
T KOG0601|consen  350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS---GV  423 (524)
T ss_pred             CcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceec---cc
Confidence            999888774445677888899999999999999988   99999999999999876 889999999987432111   11


Q ss_pred             cccccCcc-cCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          643 AIRGTKGY-VAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       643 ~~~gt~~y-~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ....+..| .+++..+...+-.+.|+||||.-+.|.+++..-......+.        .+.......  .....+.+..+
T Consensus       424 ~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~--------~i~~~~~p~--~~~~~~~~q~~  493 (524)
T KOG0601|consen  424 FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL--------TIRSGDTPN--LPGLKLQLQVL  493 (524)
T ss_pred             ccccccccccchhhccccccccccccccccccccccccCcccCcccccce--------eeecccccC--CCchHHhhhhh
Confidence            11123344 36666677789999999999999999998765421111111        111111111  11223666778


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhh
Q 004312          722 AIWCIQEDPSHRPTMRRVTQMLE  744 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~L~  744 (762)
                      .+.++..++..||.+.++..+.+
T Consensus       494 ~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  494 LKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             hhhhcCCccccchhhhhhcccch
Confidence            88899999999999887766543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.96  E-value=1.2e-08  Score=109.76  Aligned_cols=214  Identities=17%  Similarity=0.193  Sum_probs=148.9

Q ss_pred             cceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceec----cCCceeEEEeccCC-Cchhh
Q 004312          495 FGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCD----EGRNRLLVYEFMSN-GALAS  569 (762)
Q Consensus       495 ~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~----~~~~~~LV~E~~~~-gsL~~  569 (762)
                      ..+.||+.. .-++..|++|+++............-++.++++.|.|+|++...+.    .+..+++||+|.|+ ++|.+
T Consensus       289 ~~Ttyk~~s-~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATS-NVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeee-ccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            457888854 4456789999995432222223445678899999999999998876    34567899999986 57877


Q ss_pred             hccCC---------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccccc
Q 004312          570 FLFGD---------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT  634 (762)
Q Consensus       570 ~l~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~  634 (762)
                      +.+..               ...++..++.++.|+..||.++|+.   |+.-+-|.|++||++.+.+++|+..|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            76532               2357788999999999999999999   99999999999999999999999999887765


Q ss_pred             CCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHH
Q 004312          635 LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  714 (762)
                      .+....               ++   --.+-|.=.||.+++.|.||.......   +...+..+         .......
T Consensus       445 ~d~~~~---------------le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~---d~~~~s~~---------~~I~~~y  494 (655)
T KOG3741|consen  445 EDPTEP---------------LE---SQQQNDLRDLGLLLLALATGTENSNRT---DSTQSSHL---------TRITTTY  494 (655)
T ss_pred             CCCCcc---------------hh---HHhhhhHHHHHHHHHHHhhcccccccc---cchHHHHH---------HHhhhhh
Confidence            444111               11   124678899999999999996541000   00000000         0112245


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 004312          715 LQRFVMVAIWCIQEDPSHRPTMRRVTQML  743 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RPt~~evl~~L  743 (762)
                      +.++++++.-....++++ -++++++.++
T Consensus       495 S~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  495 STDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             hHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence            556666666666666665 4566665554

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.91  E-value=9.4e-10  Score=126.80  Aligned_cols=241  Identities=17%  Similarity=0.165  Sum_probs=163.7

Q ss_pred             hcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCC
Q 004312          489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      -+-+|.++.++... ..+.+...++|......   ....+....+-.++-..+||-+++..--+.......||++|..++
T Consensus       811 p~qS~sp~ss~p~~-pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~  889 (1205)
T KOG0606|consen  811 PSQSGSPSSSFPAS-PAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG  889 (1205)
T ss_pred             cccCCCCcccccCC-ccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence            46667777777653 22223233333322111   111112222222222234566665555555677889999999999


Q ss_pred             chhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC----------
Q 004312          566 ALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL----------  635 (762)
Q Consensus       566 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~----------  635 (762)
                      +|...|+..+..+..........+.++++|||..   .+.|+|++|.|+|+..++..+++||+.......          
T Consensus       890 ~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~  966 (1205)
T KOG0606|consen  890 DLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGP  966 (1205)
T ss_pred             CchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCcccc
Confidence            9999998887666666666777788999999997   799999999999999999999999984321100          


Q ss_pred             -----------CC---------CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc
Q 004312          636 -----------DQ---------SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE  695 (762)
Q Consensus       636 -----------~~---------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~  695 (762)
                                 ..         ........+|+.|.+||...+......+|.|++|++++|.++|..||........++.
T Consensus       967 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~n 1046 (1205)
T KOG0606|consen  967 SSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFEN 1046 (1205)
T ss_pred             cccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhc
Confidence                       00         0112345689999999999999999999999999999999999999877666555543


Q ss_pred             cccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 004312          696 RTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMR  737 (762)
Q Consensus       696 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~  737 (762)
                      ..-..+..+.    .+.+.+.++.+++...+..+|.+|..+.
T Consensus      1047 i~~~~~~~p~----g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1047 ILNRDIPWPE----GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             cccCCCCCCC----CccccChhhhhhhhhhhccCchhccCcc
Confidence            2222222111    1234456778888889999999997765

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.87  E-value=1e-08  Score=96.59  Aligned_cols=140  Identities=20%  Similarity=0.273  Sum_probs=105.5

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEE-cccccc-------chhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKK-LNRVFQ-------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~-~~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      ..|-+|+-+.|+++.+.   ++...||. +.+...       -..+...+|++.|.+++--.|.-..-++.+...-.|+|
T Consensus        13 ~likQGAEArv~~~~~~---Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS---GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             eeeeccceeeEeeeccC---CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            56889999999999764   55666663 333221       12357889999999987777766666677777788999


Q ss_pred             eccCC-CchhhhccCC-CCCCHHH-HHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC---ceEEecccccccc
Q 004312          560 EFMSN-GALASFLFGD-SKPNWKL-RTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY---NARISDFGLEKLL  633 (762)
Q Consensus       560 E~~~~-gsL~~~l~~~-~~l~~~~-~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Dfgla~~~  633 (762)
                      ||+++ -++.+++... ....... ...++.+|-+.+.-||..   +|+||||..+||+|..++   .+.++|||++...
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            99977 4788887654 2223333 378899999999999999   999999999999997544   4589999998643

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=98.87  E-value=4.9e-09  Score=94.76  Aligned_cols=79  Identities=25%  Similarity=0.423  Sum_probs=62.8

Q ss_pred             ceEEEEe-CCcEEEeCCC-CCEEEeecCCC--CceeEEEEecCCCEEEEecCCCccccccCCCccccCCCccccCccEEE
Q 004312           70 SKLRLTA-NGGLVLEDPE-AREIWKSEIST--GEAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVS  145 (762)
Q Consensus        70 ~~l~~~~-~g~l~l~~~~-~~~~ws~~~~~--~~~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~l~~~~~L~  145 (762)
                      ..+.++. ||+|++++.. +++||++++..  .....+.|+++|||||++.++.++|||=                    
T Consensus        22 ~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~--------------------   81 (116)
T cd00028          22 FKLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSN--------------------   81 (116)
T ss_pred             ccCCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEec--------------------
Confidence            3456676 9999999765 57999999864  3456789999999999999999999981                    


Q ss_pred             eecCCCCCCCcceEEEecCCCceeeEee
Q 004312          146 SRRKETDFSRGRFQFRLLEDGNAVLNTI  173 (762)
Q Consensus       146 S~~s~~dps~G~~~l~~~~~g~~~~~~~  173 (762)
                           +..+.+.+.+.|++||+++++..
T Consensus        82 -----~~~~~~~~~~~L~ddGnlvl~~~  104 (116)
T cd00028          82 -----TTRVNGNYVLVLLDDGNLVLYDS  104 (116)
T ss_pred             -----ccCCCCceEEEEeCCCCEEEECC
Confidence                 11135789999999999999753

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=98.87  E-value=6e-09  Score=93.87  Aligned_cols=78  Identities=21%  Similarity=0.416  Sum_probs=62.7

Q ss_pred             ceEEEEeCCcEEEeCCC-CCEEEeecCCCC--ceeEEEEecCCCEEEEecCCCccccccCCCccccCCCccccCccEEEe
Q 004312           70 SKLRLTANGGLVLEDPE-AREIWKSEISTG--EAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSS  146 (762)
Q Consensus        70 ~~l~~~~~g~l~l~~~~-~~~~ws~~~~~~--~~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~l~~~~~L~S  146 (762)
                      ..+.++.||+||+++.. +.+||++++...  ....++|+++|||||++.++.++|+|                      
T Consensus        22 ~~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S----------------------   79 (114)
T smart00108       22 FTLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSS----------------------   79 (114)
T ss_pred             cccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEe----------------------
Confidence            45677889999999765 589999998543  23688999999999999989999998                      


Q ss_pred             ecCCCCCCCcceEEEecCCCceeeEe
Q 004312          147 RRKETDFSRGRFQFRLLEDGNAVLNT  172 (762)
Q Consensus       147 ~~s~~dps~G~~~l~~~~~g~~~~~~  172 (762)
                         .+....|.+.+.|++||+++++.
T Consensus        80 ---~t~~~~~~~~~~L~ddGnlvl~~  102 (114)
T smart00108       80 ---NTTGANGNYVLVLLDDGNLVIYD  102 (114)
T ss_pred             ---cccCCCCceEEEEeCCCCEEEEC
Confidence               11123578999999999999864

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=98.77  E-value=6.8e-09  Score=85.98  Aligned_cols=64  Identities=17%  Similarity=0.145  Sum_probs=52.6

Q ss_pred             eeEeccCCCCCCCcccccCCCChhhHHhhhcc---CCCccccccc--cCcceecccCC-ccCccCCCCCCceEEe
Q 004312          339 YIEELRNTDWPTSDYEQISPYGKDECVSSCLK---DCQCSAAVLR--DDTCWKKKLPL-SYGKTDRDETGTTFIK  407 (762)
Q Consensus       339 ~~~~~~~~~~p~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~--~~~C~~~~~~~-~~~~~~~~~~~~~ylk  407 (762)
                      .|+++.++++|++..     .++++|++.|++   ||||+||+|.  +++|+.|...+ .+.+.....+..+|+|
T Consensus        10 ~fl~~~~~klpd~~~-----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r   79 (80)
T cd00129          10 TTLIKIALKIKTTKA-----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN   79 (80)
T ss_pred             eEEEeecccCCcccc-----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence            388888999998754     689999999999   9999999995  46899999888 6666655556778876

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.76  E-value=4.7e-08  Score=101.48  Aligned_cols=133  Identities=13%  Similarity=0.092  Sum_probs=98.4

Q ss_pred             CcceEEEeeeeCCCcceEEEEEccccccc-----------hhHHHHHHhhhhcccccCCcc--chhceecc-----CCce
Q 004312          494 AFGTVYKGFVNMGSSDQVAVKKLNRVFQD-----------SEKEFKAEVNGIGQTHHKNLV--RLLGYCDE-----GRNR  555 (762)
Q Consensus       494 ~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv--~l~g~~~~-----~~~~  555 (762)
                      ....|++..+.   ++.+.||+.......           ....+.+|.+.+.++...+|.  .++++...     ....
T Consensus        34 ~~rrvvr~~~~---g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s  110 (268)
T PRK15123         34 EGRRTLRFELA---GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTS  110 (268)
T ss_pred             CCceEEEEEEC---CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcccee
Confidence            33446676543   457999976432211           112478999999998655554  44556543     2346


Q ss_pred             eEEEeccCCC-chhhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC-------CCceEEe
Q 004312          556 LLVYEFMSNG-ALASFLFG--DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD-------YYNARIS  625 (762)
Q Consensus       556 ~LV~E~~~~g-sL~~~l~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-------~~~~kl~  625 (762)
                      +||+|++++. +|.+++..  ....+...+..++.++++.+.-||+.   +|+|+|++++|||++.       +..+.++
T Consensus       111 ~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI  187 (268)
T PRK15123        111 FIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVI  187 (268)
T ss_pred             EEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEE
Confidence            8999999986 89998853  24456677889999999999999999   9999999999999975       5789999


Q ss_pred             ccccccc
Q 004312          626 DFGLEKL  632 (762)
Q Consensus       626 Dfgla~~  632 (762)
                      ||+.++.
T Consensus       188 Dl~r~~~  194 (268)
T PRK15123        188 DLHRAQI  194 (268)
T ss_pred             ECCcccc
Confidence            9998863

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.68  E-value=8.9e-08  Score=93.75  Aligned_cols=126  Identities=22%  Similarity=0.255  Sum_probs=81.2

Q ss_pred             eEEEeeeeCCCcceEEEEEcccccc--------------------------chhHHHHHHhhhhcccccC--Cccchhce
Q 004312          497 TVYKGFVNMGSSDQVAVKKLNRVFQ--------------------------DSEKEFKAEVNGIGQTHHK--NLVRLLGY  548 (762)
Q Consensus       497 ~Vy~g~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~H~--nIv~l~g~  548 (762)
                      .||.|...  ++..+|||+.+....                          .......+|.+.|.++...  ++.+++++
T Consensus         1 ~Vy~~~~~--~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~   78 (188)
T PF01163_consen    1 DVYHAIDP--DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY   78 (188)
T ss_dssp             EEEEEEEC--TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred             CEEEEECC--CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence            38888643  346899997542100                          0113467899999999765  45666654


Q ss_pred             eccCCceeEEEeccC--CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHh-HhcCCCCeEeCCCCCCceEEcCCCceEEe
Q 004312          549 CDEGRNRLLVYEFMS--NGALASFLFGDSKPNWKLRTEIVMGIARGLFYL-HEECCTQIIHCDIKPQNILLDDYYNARIS  625 (762)
Q Consensus       549 ~~~~~~~~LV~E~~~--~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dlkp~NILl~~~~~~kl~  625 (762)
                      -    ...|||||++  +..+..+....  ++......++.+++..+..+ |..   +|+||||.+.|||++++ .+.|+
T Consensus        79 ~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   79 N----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             E----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred             e----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence            2    4579999998  65555443222  11345667888888866664 676   99999999999999988 99999


Q ss_pred             ccccccccc
Q 004312          626 DFGLEKLLT  634 (762)
Q Consensus       626 Dfgla~~~~  634 (762)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.64  E-value=4e-07  Score=102.23  Aligned_cols=136  Identities=18%  Similarity=0.270  Sum_probs=89.0

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccc----------------------------------------hhHHH
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD----------------------------------------SEKEF  527 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~~  527 (762)
                      +.|+.++-|.||+|++++  ++.||||+.+.....                                        .+-++
T Consensus       131 ~PiAsASIaQVH~A~L~s--G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy  208 (517)
T COG0661         131 EPIASASIAQVHRAVLKS--GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY  208 (517)
T ss_pred             CchhhhhHhhheeEEecC--CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence            358999999999999985  679999987643221                                        01134


Q ss_pred             HHHhhhhcccc-----cCCccchhcee-ccCCceeEEEeccCCCchhhhc--cCCCCCCHHHHHHHHHHHHHHH-HHhHh
Q 004312          528 KAEVNGIGQTH-----HKNLVRLLGYC-DEGRNRLLVYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGL-FYLHE  598 (762)
Q Consensus       528 ~~E~~~l~~l~-----H~nIv~l~g~~-~~~~~~~LV~E~~~~gsL~~~l--~~~~~l~~~~~~~i~~~ia~~L-~yLH~  598 (762)
                      .+|...+.+++     .+++ ++=..+ +-.....|+|||++|-.+.+..  +. ...+.   ..|+..++++. ..+-.
T Consensus       209 ~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~---k~ia~~~~~~f~~q~~~  283 (517)
T COG0661         209 RREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDR---KELAELLVRAFLRQLLR  283 (517)
T ss_pred             HHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCH---HHHHHHHHHHHHHHHHh
Confidence            45555554441     2222 222222 2346678999999999998884  33 33442   33333333322 11111


Q ss_pred             cCCCCeEeCCCCCCceEEcCCCceEEecccccccc
Q 004312          599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL  633 (762)
Q Consensus       599 ~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~  633 (762)
                      .   +++|.|.+|.||+++.++...+.|||+...+
T Consensus       284 d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         284 D---GFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             c---CccccCCCccceEEecCCcEEEEcCcceecC
Confidence            2   8999999999999999999999999998755

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.58  E-value=1.3e-06  Score=91.96  Aligned_cols=248  Identities=13%  Similarity=0.136  Sum_probs=153.6

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhce------eccCCc-eeEE
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGY------CDEGRN-RLLV  558 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~------~~~~~~-~~LV  558 (762)
                      ...||+|+-+.+|-.  .  .-...+.|+.+........+...|   |... .||-+-.-+.+      .-++.. .-+.
T Consensus        16 gr~LgqGgea~ly~l--~--e~~d~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          16 GRPLGQGGEADLYTL--G--EVRDQVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CccccCCccceeeec--c--hhhchhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            467999999999963  1  122355677776544443333333   3333 45543321111      112222 4466


Q ss_pred             EeccCCC-chhhhcc------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          559 YEFMSNG-ALASFLF------GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       559 ~E~~~~g-sL~~~l~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                      |..+++. ....++.      +-...+|...++.++.+|.+.+-||..   |.+-||+.++|+|+++++.+.|.|-..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence            7766553 2333332      124568999999999999999999999   99999999999999999999998744332


Q ss_pred             cccCCCCcccccccccCcccCccccc-----CCCCCCcchhHHHHHHHHHHHhC-CCCCchhh-------HHH-hhhccc
Q 004312          632 LLTLDQSHTNTAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICL-RRTILTDW-------AYD-CYQERT  697 (762)
Q Consensus       632 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvil~elltg-~~p~~~~~-------~~~-~~~~~~  697 (762)
                      +-  .......-.+|...|.+||.-.     +..-+...|-|.||+++++++.| +.||.+-.       +++ .+..+.
T Consensus       166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            22  1122222346889999999764     44667889999999999999988 77753221       111 111111


Q ss_pred             cccccccc--c---ccCCC-HHHHHHHHHHHHHhhccC--CCCCCCHHHHHHHhhcC
Q 004312          698 LGALVEND--L---EAMDD-MTVLQRFVMVAIWCIQED--PSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       698 ~~~~~~~~--~---~~~~~-~~~~~~~~~li~~cl~~d--p~~RPt~~evl~~L~~~  746 (762)
                      .....+..  +   ....+ .-.+..+..+..+|+...  +.-|||.+..+..|..+
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            11111110  0   01111 224566777888888653  56899999888877553

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.58  E-value=2.7e-07  Score=92.59  Aligned_cols=107  Identities=21%  Similarity=0.267  Sum_probs=88.2

Q ss_pred             hHHHHHHhhhhcccccCC--ccchhceeccCC----ceeEEEeccCCC-chhhhccCCCCCCHHHHHHHHHHHHHHHHHh
Q 004312          524 EKEFKAEVNGIGQTHHKN--LVRLLGYCDEGR----NRLLVYEFMSNG-ALASFLFGDSKPNWKLRTEIVMGIARGLFYL  596 (762)
Q Consensus       524 ~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~----~~~LV~E~~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~~L~yL  596 (762)
                      .....+|...+.++....  .++.+++.....    ..+||+|++++. +|.+++......+...+..++.++++.++-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            456888999988886544  456677765532    348999999984 8999998755577788899999999999999


Q ss_pred             HhcCCCCeEeCCCCCCceEEcCCC---ceEEecccccccc
Q 004312          597 HEECCTQIIHCDIKPQNILLDDYY---NARISDFGLEKLL  633 (762)
Q Consensus       597 H~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Dfgla~~~  633 (762)
                      |+.   +|+|+|++++|||++.+.   .+.++||+-++..
T Consensus       135 H~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999   999999999999999876   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.52  E-value=2.5e-08  Score=111.28  Aligned_cols=152  Identities=18%  Similarity=0.222  Sum_probs=106.4

Q ss_pred             HHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc--------cccccccCcccCccccc
Q 004312          586 VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT--------NTAIRGTKGYVAPEWFR  657 (762)
Q Consensus       586 ~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~  657 (762)
                      +.+++.||.|+|..  .++||++|.|++|.++.++..||+.|+............        ..-......|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34566999999997  699999999999999999999999999876543311111        11123456899999999


Q ss_pred             CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 004312          658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMR  737 (762)
Q Consensus       658 ~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~  737 (762)
                      +...+.++|+||+|+++|-+..|+++............  .....+..-......+++.++++=+.+++..++.-||++.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~  260 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--FSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD  260 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhh--hhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence            98899999999999999999977777422211111100  0011111111112346678888889999999999999877


Q ss_pred             HHHH
Q 004312          738 RVTQ  741 (762)
Q Consensus       738 evl~  741 (762)
                      ++..
T Consensus       261 ~l~~  264 (700)
T KOG2137|consen  261 LLLS  264 (700)
T ss_pred             hhhc
Confidence            6653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.48  E-value=8.1e-07  Score=89.41  Aligned_cols=135  Identities=17%  Similarity=0.165  Sum_probs=95.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc----------------------chhHHHHHHhhhhcccccC-
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ----------------------DSEKEFKAEVNGIGQTHHK-  540 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~-  540 (762)
                      +.+.+.||.|.-+.||.|...  .+.++|||.=+-...                      -.....++|.++|.+|.-. 
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~--~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP--KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HhhccccccCccceEEEEECC--CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            346678999999999999755  456899985221100                      0123467889999998655 


Q ss_pred             -CccchhceeccCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC
Q 004312          541 -NLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY  619 (762)
Q Consensus       541 -nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~  619 (762)
                       .+.+.+++    +...+||||+++-.|...-     ++......|+..|++-+..+-..   ||||||+++-||++++|
T Consensus       171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d  238 (304)
T COG0478         171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence             67777765    3457999999987665542     13334445555555555555555   99999999999999999


Q ss_pred             CceEEeccccccc
Q 004312          620 YNARISDFGLEKL  632 (762)
Q Consensus       620 ~~~kl~Dfgla~~  632 (762)
                      +.+.++||--+..
T Consensus       239 g~~~vIDwPQ~v~  251 (304)
T COG0478         239 GDIVVIDWPQAVP  251 (304)
T ss_pred             CCEEEEeCccccc
Confidence            9999999977653

>PRK09902 hypothetical protein; Provisional

Probab=98.45  E-value=1.8e-06  Score=85.12  Aligned_cols=135  Identities=16%  Similarity=0.142  Sum_probs=103.6

Q ss_pred             cCCCCcceEEEeeeeCCCcceEEEEEccccc------cchhHHHHHHhhhhcccccCC--ccchhceec-cC----Ccee
Q 004312          490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF------QDSEKEFKAEVNGIGQTHHKN--LVRLLGYCD-EG----RNRL  556 (762)
Q Consensus       490 iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~-~~----~~~~  556 (762)
                      -|+||-+-|++-.++   ++.+-+|+-....      +..+..|.+|...|.++...+  +.+++ ++. ..    -.-+
T Consensus        26 ~~rgG~SgV~r~~~~---g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~  101 (216)
T PRK09902         26 YRRNGMSGVQCVERN---GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL  101 (216)
T ss_pred             cCCCCcceEEEEEeC---CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence            577999999997654   2368889875211      335678999999999995433  45555 332 21    2357


Q ss_pred             EEEeccCC-CchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc--eEEecccccc
Q 004312          557 LVYEFMSN-GALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN--ARISDFGLEK  631 (762)
Q Consensus       557 LV~E~~~~-gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~Dfgla~  631 (762)
                      ||+|-+++ -+|.+++.+.  .+.+...+..++.+|++.+.-||+.   ++.|+|+.+.||+++.++.  ++++||--++
T Consensus       102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            99998764 5899998664  4568888899999999999999999   9999999999999986666  9999997665

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.25  E-value=5.6e-06  Score=92.73  Aligned_cols=157  Identities=19%  Similarity=0.270  Sum_probs=96.9

Q ss_pred             ccccCHHHHHHHHh------------hhh-hhcCCCCcceEEEeeeeCCCcceEEEEEccccccc---------------
Q 004312          471 LRCFTYKELVEVTR------------GFK-EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD---------------  522 (762)
Q Consensus       471 ~~~~~~~el~~~t~------------~~~-~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~---------------  522 (762)
                      .+.++++|+.+.-.            .|+ +.||.-..|.||+|+++.  ++.||||+.++..+.               
T Consensus       137 ~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~--G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~  214 (538)
T KOG1235|consen  137 APPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKN--GEDVAVKVQHPGLEKLIMLDLRNLRLLAKV  214 (538)
T ss_pred             CCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecC--CCEEEEEecCcChHHHHHHHHHHHHHHHHH
Confidence            34556666554433            344 459999999999999886  678999987643221               


Q ss_pred             ----------------------hhHHHHHHhhhhccc----ccCCccc---hhcee-ccCCceeEEEeccCCCchhhhcc
Q 004312          523 ----------------------SEKEFKAEVNGIGQT----HHKNLVR---LLGYC-DEGRNRLLVYEFMSNGALASFLF  572 (762)
Q Consensus       523 ----------------------~~~~~~~E~~~l~~l----~H~nIv~---l~g~~-~~~~~~~LV~E~~~~gsL~~~l~  572 (762)
                                            .+-+|.+|++...+.    .|-++..   +=..+ .-...+.|+||||+|..+.+.-.
T Consensus       215 l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~  294 (538)
T KOG1235|consen  215 LQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA  294 (538)
T ss_pred             HHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH
Confidence                                  112355665554443    4545111   11222 23456799999999988877642


Q ss_pred             C-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC----CCceEEeccccccccc
Q 004312          573 G-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD----YYNARISDFGLEKLLT  634 (762)
Q Consensus       573 ~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~Dfgla~~~~  634 (762)
                      - ...++..   .|+..+.++  |++.--..|++|+|-+|.||+++.    ++.+.+-|||+.....
T Consensus       295 i~~~gi~~~---~i~~~l~~~--~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  295 IDKRGISPH---DILNKLVEA--YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HHHcCCCHH---HHHHHHHHH--HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            1 1223333   233333222  222222238999999999999983    6789999999987553

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=98.20  E-value=5.8e-06  Score=74.16  Aligned_cols=70  Identities=26%  Similarity=0.415  Sum_probs=51.5

Q ss_pred             cccc-CCCCCCCCCceEEEEeCCcEEEeCCCCCEEEeecCCCCceeEEEEec--CCCEEEEecCCCccccccCCC
Q 004312           57 IWYA-SGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYD--TGNFLIVNTNSERLWQTFDHP  128 (762)
Q Consensus        57 vW~A-nr~~p~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~~l~d--~GNlvl~~~~~~~~WqSFD~P  128 (762)
                      ||.. +...+....+.+.|+.||||||+|..++++|+|. ..+..+.+..++  +||++ +.....+.|.|=+.|
T Consensus        41 iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf-~~ptdt~L~~q~l~~~~~~-~~~~~~~sw~s~~dp  113 (114)
T PF01453_consen   41 IWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSF-DYPTDTLLPGQKLGDGNVT-GKNDSLTSWSSNTDP  113 (114)
T ss_dssp             EEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEEST-TSSS-EEEEEET--TSEEE-EESTSSEEEESS---
T ss_pred             EEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeec-CCCccEEEeccCcccCCCc-cccceEEeECCCCCC
Confidence            8998 4343333578899999999999999999999994 345566788888  89999 777778999986666

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.16  E-value=1.6e-05  Score=80.92  Aligned_cols=132  Identities=17%  Similarity=0.196  Sum_probs=85.6

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCC--ccchhceeccCCceeEEEeccCCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN--LVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      +.||+|..+.||+..     +..+++|......  ......+|.++++.+..-.  +.+.++++...+...+|||+++|.
T Consensus         7 ~~i~~G~t~~~y~~~-----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTHK-----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEec-----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            468999999999841     2357788876532  3345789999999986544  467788887777788999999986


Q ss_pred             c-hhhhccCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHhHhc-CCCCe
Q 004312          566 A-LASFLFGDSKPNWKLRTEIVMGIARG---------------------------------------LFYLHEE-CCTQI  604 (762)
Q Consensus       566 s-L~~~l~~~~~l~~~~~~~i~~~ia~~---------------------------------------L~yLH~~-~~~~i  604 (762)
                      + +...+..    +...+..++..+++.                                       ..+|... ..+.+
T Consensus        80 ~~~~~~~~~----~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~  155 (226)
T TIGR02172        80 RSFSRIISD----NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC  155 (226)
T ss_pred             cchhhhhcC----CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence            3 2211110    000111111111111                                       1222211 12467


Q ss_pred             EeCCCCCCceEEcCCCceEEecccccc
Q 004312          605 IHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       605 vH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                      +|+|++|.||++++++ +.|+||+.+.
T Consensus       156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       156 LHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             EecCCCCCcEEEcCCC-cEEEechhcC
Confidence            9999999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.13  E-value=1.2e-05  Score=79.61  Aligned_cols=130  Identities=15%  Similarity=0.159  Sum_probs=82.9

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHH---------HHhhhhcccccCC---ccchhcee-----c
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK---------AEVNGIGQTHHKN---LVRLLGYC-----D  550 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~---------~E~~~l~~l~H~n---Iv~l~g~~-----~  550 (762)
                      +++-......|.+-..+   +..+++|..+......++.|+         +++..+.+++...   ...++...     .
T Consensus        37 kv~k~~~r~~ValIei~---~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~  113 (229)
T PF06176_consen   37 KVFKNTKRNYVALIEID---GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFR  113 (229)
T ss_pred             EeecCCCccEEEEEEEC---CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeecc
Confidence            34555555666664433   457888887654443333332         3344444443222   22222222     2


Q ss_pred             cCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccc
Q 004312          551 EGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLE  630 (762)
Q Consensus       551 ~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla  630 (762)
                      -....+|+|||++|..|.++..    ++.    .++..+++++.-||+.   |++|+|.+|+|++++++ .+++.||+..
T Consensus       114 ~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~k  181 (229)
T PF06176_consen  114 YTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQGK  181 (229)
T ss_pred             ceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECccc
Confidence            2344579999999988877642    221    3556778889999999   99999999999999966 4999999887


Q ss_pred             cc
Q 004312          631 KL  632 (762)
Q Consensus       631 ~~  632 (762)
                      +.
T Consensus       182 ~~  183 (229)
T PF06176_consen  182 RM  183 (229)
T ss_pred             cc
Confidence            63

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.08  E-value=3.1e-05  Score=77.50  Aligned_cols=137  Identities=18%  Similarity=0.218  Sum_probs=89.3

Q ss_pred             hcCCCCcceEEEeeeeCCCcceEEEEEccccccchh---------HH---------------HHHHhhhhcccc--cCCc
Q 004312          489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---------KE---------------FKAEVNGIGQTH--HKNL  542 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~---------~~---------------~~~E~~~l~~l~--H~nI  542 (762)
                      .|..|.-+.||+|.-  +++..+|||+.+......+         ..               ..+|.+.|.++.  +-.+
T Consensus        55 ~istGKEA~Vy~a~~--~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          55 CISTGKEANVYLAET--GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eecCCcceEEEeecc--CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            477888889999853  4567899999753211110         11               234555566552  3344


Q ss_pred             cchhceeccCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCce
Q 004312          543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNA  622 (762)
Q Consensus       543 v~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~  622 (762)
                      .+.+++.    .-.|||||+...-+..-.-+.-.+.......+..++++.+.-|-..  .++||+||+.-|||+. ++.+
T Consensus       133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             CCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeE
Confidence            4444443    3469999997542221111122223335677788888888877773  2999999999999999 7899


Q ss_pred             EEeccccccccc
Q 004312          623 RISDFGLEKLLT  634 (762)
Q Consensus       623 kl~Dfgla~~~~  634 (762)
                      .|+|||-+....
T Consensus       206 ~iID~~QaV~~~  217 (268)
T COG1718         206 YIIDVSQAVTID  217 (268)
T ss_pred             EEEECccccccC
Confidence            999999987654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.03  E-value=1.3e-05  Score=78.91  Aligned_cols=102  Identities=22%  Similarity=0.300  Sum_probs=84.0

Q ss_pred             HHHhhhhccccc-CCccchhceeccCCceeEEEeccCCCchhhh---ccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC
Q 004312          528 KAEVNGIGQTHH-KNLVRLLGYCDEGRNRLLVYEFMSNGALASF---LFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ  603 (762)
Q Consensus       528 ~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~---l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  603 (762)
                      .+|.-+++.+++ +++++++|.|    ..++|.||.+.+++...   +..--..+|..|.+||.++++.+.+|++.-...
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            457888888866 6999999999    45789999998766532   222235799999999999999999999965557


Q ss_pred             eEeCCCCCCceEEcCCCceEEecccccccc
Q 004312          604 IIHCDIKPQNILLDDYYNARISDFGLEKLL  633 (762)
Q Consensus       604 ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~  633 (762)
                      +.-.|++|+|+-+++++++|+.|.......
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999876544

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.02  E-value=3e-05  Score=79.98  Aligned_cols=136  Identities=14%  Similarity=0.046  Sum_probs=84.3

Q ss_pred             cCCCCc-ceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc-cCCccchhceeccCCceeEEEeccCCCch
Q 004312          490 LGRGAF-GTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLLVYEFMSNGAL  567 (762)
Q Consensus       490 iG~G~~-g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~~~~gsL  567 (762)
                      |..|.+ ..||+....   +..+.||+.....   ..++.+|+++++.+. +--+.+++++....+..++|||+++|.+|
T Consensus         6 ~~~g~~~~~v~~~~~~---~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           6 VTEGQSGATVYRLDGK---NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             cCCCCCcCeEEEEcCC---CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            445555 789997432   2578888876542   345778998888883 44466778877766678999999999887


Q ss_pred             hhhc-------------------cCCC----CCC--HHHHHHHHH--------------------HHHHHHHHhHhc---
Q 004312          568 ASFL-------------------FGDS----KPN--WKLRTEIVM--------------------GIARGLFYLHEE---  599 (762)
Q Consensus       568 ~~~l-------------------~~~~----~l~--~~~~~~i~~--------------------~ia~~L~yLH~~---  599 (762)
                      ....                   +...    ...  ...+.....                    .+...+..|-..   
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            6442                   1110    000  000000000                    011111222111   


Q ss_pred             -CCCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          600 -CCTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       600 -~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                       ..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence             13469999999999999998788999998875

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=97.96  E-value=1.1e-05  Score=66.99  Aligned_cols=57  Identities=26%  Similarity=0.443  Sum_probs=45.3

Q ss_pred             eeEeccCCCCCCCcccccCCCChhhHHhhhcc-CCCccccccc--cCcceecc-cCCccCc
Q 004312          339 YIEELRNTDWPTSDYEQISPYGKDECVSSCLK-DCQCSAAVLR--DDTCWKKK-LPLSYGK  395 (762)
Q Consensus       339 ~~~~~~~~~~p~~~~~~~~~~s~~~C~~~Cl~-nCsC~a~~~~--~~~C~~~~-~~~~~~~  395 (762)
                      .|+.++++.+++.........++++|++.|++ +|+|.|+.|.  ++.|++|. .++.+..
T Consensus         5 ~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~   65 (78)
T smart00473        5 CFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDAR   65 (78)
T ss_pred             eeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccce
Confidence            48889999998654433456799999999999 9999999997  57899988 5544443

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.90  E-value=4.2e-05  Score=77.89  Aligned_cols=140  Identities=20%  Similarity=0.176  Sum_probs=82.8

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCC--ccchhceecc---CCceeEEEecc
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN--LVRLLGYCDE---GRNRLLVYEFM  562 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~---~~~~~LV~E~~  562 (762)
                      +.|+.|..+.||+.....   ..+++|.....  .....+.+|..+++.+....  +.+++..+..   ....+++||++
T Consensus         3 ~~l~~G~~n~~~~v~~~~---~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD---GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEESSSSEEEEEEETT---SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC---cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            457889999999986542   48999987654  45567889999998885443  4566664422   23468999999


Q ss_pred             CCCchhh----------------hc---cCC----CCCCHHH---------HHHH------------HHHHHH-HHHHhH
Q 004312          563 SNGALAS----------------FL---FGD----SKPNWKL---------RTEI------------VMGIAR-GLFYLH  597 (762)
Q Consensus       563 ~~gsL~~----------------~l---~~~----~~l~~~~---------~~~i------------~~~ia~-~L~yLH  597 (762)
                      ++..+..                .+   +..    .......         ....            ...+.+ .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9988877                11   011    1111100         0000            111222 233333


Q ss_pred             hc----CCCCeEeCCCCCCceEEc-CCCceEEeccccccc
Q 004312          598 EE----CCTQIIHCDIKPQNILLD-DYYNARISDFGLEKL  632 (762)
Q Consensus       598 ~~----~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~  632 (762)
                      +.    ....++|+|+.|+|||++ +++.+.|.||+.+..
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            22    235799999999999999 666668999988753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.89  E-value=2.9e-06  Score=93.99  Aligned_cols=181  Identities=18%  Similarity=0.134  Sum_probs=130.9

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCC-ccchhceeccCCceeEEEeccCC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN-LVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      +-+.++++++++++|.+-.  ..+...++.+..     .....-++++|.+.+||| .++.++-+..++..+++++++..
T Consensus       246 ~fh~fvK~altknpKkRpt--aeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPT--AEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             HHHHHHHHHhcCCCccCCC--hhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            3356788999999997422  122333444433     245567889999999999 77777778888888999999988


Q ss_pred             C--chhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          565 G--ALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       565 g--sL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      +  +........-.+...+...+.+.-+++++++|+.   .=+|+|    ||+..+ ...|..||+....+....  ...
T Consensus       319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~  388 (829)
T KOG0576|consen  319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR  388 (829)
T ss_pred             CccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence            7  2222222223344555556667778899999986   457888    777766 589999999988665432  344


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCC
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRT  683 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p  683 (762)
                      ...+++.++|||......+..+-|+|++|+--.++--|-.|
T Consensus       389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence            56689999999999999999999999999876666655554

>PLN02876 acyl-CoA dehydrogenase

Probab=97.77  E-value=0.0002  Score=86.88  Aligned_cols=80  Identities=14%  Similarity=0.260  Sum_probs=57.1

Q ss_pred             hhcCCCCcceEEEeeeeCCCc-ceEEEEEccccc-cchhHHHHHHhhhhcccc-cCCc--cchhceeccC---CceeEEE
Q 004312          488 EELGRGAFGTVYKGFVNMGSS-DQVAVKKLNRVF-QDSEKEFKAEVNGIGQTH-HKNL--VRLLGYCDEG---RNRLLVY  559 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~-~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nI--v~l~g~~~~~---~~~~LV~  559 (762)
                      +.++.|.+..+|+.....+.. ..+++|+..... ......+.+|+++++.+. |.++  .+++++|.+.   +..++||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            458899999999876543221 367788765432 123457889999999995 6665  7888888764   4578999


Q ss_pred             eccCCCch
Q 004312          560 EFMSNGAL  567 (762)
Q Consensus       560 E~~~~gsL  567 (762)
                      ||+++..+
T Consensus       124 E~v~G~~~  131 (822)
T PLN02876        124 EYLEGRIF  131 (822)
T ss_pred             EecCCccc
Confidence            99998654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.69  E-value=0.00031  Score=69.46  Aligned_cols=127  Identities=16%  Similarity=0.223  Sum_probs=89.2

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc----------------cchhHHHHHHhhhhcccc------cCCccch
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF----------------QDSEKEFKAEVNGIGQTH------HKNLVRL  545 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~nIv~l  545 (762)
                      ..||+|+.-.||.=  ..  .....||+.....                ....++..+|+.-..++.      +.+|.++
T Consensus         7 ~~i~~G~~R~cy~H--P~--dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PD--DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             cccccCCCceEEEC--CC--CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            46999999999973  32  2357888876544                223466777777666665      8889999


Q ss_pred             hceeccCCceeEEEeccCC------CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC-
Q 004312          546 LGYCDEGRNRLLVYEFMSN------GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD-  618 (762)
Q Consensus       546 ~g~~~~~~~~~LV~E~~~~------gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-  618 (762)
                      +|+..+....-+|+|.+.+      -+|.+++.+.. ++. ...+   .+-+-..||-+.   .|+.+|++|+||++.. 
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~-~~~~---~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE-ELRQ---ALDEFKRYLLDH---HIVIRDLNPHNIVVQRR  154 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH-HHHH---HHHHHHHHHHHc---CCeecCCCcccEEEEec
Confidence            9999999999999999754      25778874433 443 2222   233334566666   8999999999999963 


Q ss_pred             -CC--ceEEec
Q 004312          619 -YY--NARISD  626 (762)
Q Consensus       619 -~~--~~kl~D  626 (762)
                       ++  .+.|+|
T Consensus       155 ~~~~~~lvlID  165 (199)
T PF10707_consen  155 DSGEFRLVLID  165 (199)
T ss_pred             CCCceEEEEEe
Confidence             22  467776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=97.64  E-value=0.00048  Score=73.16  Aligned_cols=75  Identities=7%  Similarity=0.068  Sum_probs=53.8

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccccc---CCccchhceeccC---CceeEEEec
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHH---KNLVRLLGYCDEG---RNRLLVYEF  561 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~g~~~~~---~~~~LV~E~  561 (762)
                      +.||.|..+.||+-...  ++ .+.+|..+.  ......|.+|.+.|+.+.-   ..+.++++.|..+   +..+||||+
T Consensus        20 ~~i~~G~~~~vy~~~~~--~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         20 ECISEQPYAALWALYDS--QG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eecCCccceeEEEEEcC--CC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            45999999999996432  22 466666432  1133588999999998843   4678888887543   568999999


Q ss_pred             cCCCch
Q 004312          562 MSNGAL  567 (762)
Q Consensus       562 ~~~gsL  567 (762)
                      ++++++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.64  E-value=0.00027  Score=72.46  Aligned_cols=74  Identities=14%  Similarity=0.220  Sum_probs=46.0

Q ss_pred             hhcCCCCcc-eEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccC---CccchhceeccCC---ceeEEEe
Q 004312          488 EELGRGAFG-TVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHK---NLVRLLGYCDEGR---NRLLVYE  560 (762)
Q Consensus       488 ~~iG~G~~g-~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~g~~~~~~---~~~LV~E  560 (762)
                      +.|+.|+.. .||+.  .    ..+++|..+.  ......+.+|++++..+...   -+.++++.....+   ..+++||
T Consensus         3 ~~~~~gG~~n~vy~~--~----~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~   74 (235)
T cd05155           3 EPVDSGGTDNATFRL--G----DDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR   74 (235)
T ss_pred             eeccCCCcccceEEc--C----CceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence            346766665 58974  1    2477776543  22345788999999887532   3444454443322   3478999


Q ss_pred             ccCCCchhh
Q 004312          561 FMSNGALAS  569 (762)
Q Consensus       561 ~~~~gsL~~  569 (762)
                      +++|.++.+
T Consensus        75 ~i~G~~l~~   83 (235)
T cd05155          75 WLEGETATA   83 (235)
T ss_pred             eecCCCCCc
Confidence            999977643

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.54  E-value=0.00042  Score=65.78  Aligned_cols=129  Identities=18%  Similarity=0.299  Sum_probs=87.7

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCcc-chhceeccCCceeEEEeccCC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLV-RLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      ..+.|++|.+|.||+|.+.   +.++|+|+-+.  ......+..|+++|..+.-.++- +++.+-    +..+.|||+.+
T Consensus        26 v~~~L~KG~~s~Vyl~~~~---~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G   96 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR---GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDG   96 (201)
T ss_pred             hhhhhhcccccEEEEeecc---CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcC
Confidence            3467999999999999876   34789998654  34457899999999998776654 333332    23456999998


Q ss_pred             CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCC-CCceEEcCCCceEEecccccccc
Q 004312          565 GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIK-PQNILLDDYYNARISDFGLEKLL  633 (762)
Q Consensus       565 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk-p~NILl~~~~~~kl~Dfgla~~~  633 (762)
                      -+|.+.-...   +    .+-...+++.---|...   ||-|+.|. |..++|..+..+.|+||.-|+..
T Consensus        97 ~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          97 RPLGKLEIGG---D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             cchhhhhhcc---c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            8887764322   1    22333444443334444   89999886 55555555559999999998743

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.45  E-value=0.00058  Score=67.03  Aligned_cols=135  Identities=27%  Similarity=0.374  Sum_probs=94.3

Q ss_pred             ccccccCHHHHHHHHhhhhhhcCCCCc-ceEEEeeeeCCCcceEEEEEccc-----------ccc----------chhHH
Q 004312          469 MNLRCFTYKELVEVTRGFKEELGRGAF-GTVYKGFVNMGSSDQVAVKKLNR-----------VFQ----------DSEKE  526 (762)
Q Consensus       469 ~~~~~~~~~el~~~t~~~~~~iG~G~~-g~Vy~g~~~~~~~~~vavK~~~~-----------~~~----------~~~~~  526 (762)
                      ..+..|+...   ....|.+.||.|.- |.|||+++.   ++.+|+|.+..           ...          .....
T Consensus        27 PKL~~F~~h~---~~I~flefLg~g~~~~~V~kv~I~---g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~P  100 (207)
T PF13095_consen   27 PKLEPFTHHG---DDIEFLEFLGHGSHDGYVFKVEID---GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADP  100 (207)
T ss_pred             CCcCCcCCCC---CcEeeeeecCCCCceeEEEEEEEC---CeEEEEEEeeccccCCCccccccccccccccchhhhhcCh
Confidence            4456666622   44567788999999 999999875   46899999321           000          11235


Q ss_pred             HHHHhhhhcccc---cCCc--cchhceeccC------------------CceeEEEeccCCCchhhhccCCCCCCHHHHH
Q 004312          527 FKAEVNGIGQTH---HKNL--VRLLGYCDEG------------------RNRLLVYEFMSNGALASFLFGDSKPNWKLRT  583 (762)
Q Consensus       527 ~~~E~~~l~~l~---H~nI--v~l~g~~~~~------------------~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~  583 (762)
                      |..|.+...+|+   +.++  |+.+|+..-.                  ....||.||++...             ....
T Consensus       101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~  167 (207)
T PF13095_consen  101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI  167 (207)
T ss_pred             HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch
Confidence            889999999984   4456  8999887221                  12357888776543             2233


Q ss_pred             HHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccc
Q 004312          584 EIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLE  630 (762)
Q Consensus       584 ~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla  630 (762)
                      +-+.+|.+-|..+|..   +|+-+|+++.|..     .-||+|||.+
T Consensus       168 ~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  168 RDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             hHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            4556777888899998   9999999999975     4589999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.42  E-value=0.00072  Score=70.27  Aligned_cols=134  Identities=11%  Similarity=0.076  Sum_probs=77.4

Q ss_pred             cCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCc-cchhceeccCCceeEEEeccCCCchh
Q 004312          490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGRNRLLVYEFMSNGALA  568 (762)
Q Consensus       490 iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~LV~E~~~~gsL~  568 (762)
                      +..|-...+|+...   +++.+++|..........-+..+|.++++.+....+ .++++.+.    ..+||||+++..+.
T Consensus         4 ~~~G~tn~~y~~~~---~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         4 LSGGLTNRSWRIEH---PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             CCCcCcCCeEEEEe---CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            56678889998752   345788887654322211246778888888854433 34444432    36899999987664


Q ss_pred             hh-----------------ccCCC----CCCHHHH-HHHHHH---------HHHHHHHhHhc-----CCCCeEeCCCCCC
Q 004312          569 SF-----------------LFGDS----KPNWKLR-TEIVMG---------IARGLFYLHEE-----CCTQIIHCDIKPQ  612 (762)
Q Consensus       569 ~~-----------------l~~~~----~l~~~~~-~~i~~~---------ia~~L~yLH~~-----~~~~ivH~Dlkp~  612 (762)
                      ..                 |+...    +++...+ .....+         +.+.+..+...     ....++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            32                 11111    1111111 111111         11112222111     1246899999999


Q ss_pred             ceEEcCCCceEEecccccc
Q 004312          613 NILLDDYYNARISDFGLEK  631 (762)
Q Consensus       613 NILl~~~~~~kl~Dfgla~  631 (762)
                      ||++++++ ++|+||..+.
T Consensus       157 Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             cEEEeCCC-CEEEeccccC
Confidence            99999876 7899998875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.35  E-value=0.00064  Score=80.84  Aligned_cols=196  Identities=19%  Similarity=0.145  Sum_probs=138.4

Q ss_pred             HHHHhhhhcccccCCccchhceeccCCce----eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCC
Q 004312          527 FKAEVNGIGQTHHKNLVRLLGYCDEGRNR----LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT  602 (762)
Q Consensus       527 ~~~E~~~l~~l~H~nIv~l~g~~~~~~~~----~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~  602 (762)
                      ..-|...+.++.|+|++.++++-.+....    .+.-|+++.-++...+..-...+..+.+.+..++.+||.|+|+.   
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~---  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL---  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence            34567778888999999999887665433    35568888889999998888899999999999999999999998   


Q ss_pred             CeEeCCCCCC---ceEEcCCCceEEe--cccccccccCCCCcccccccccCcccCcccccCCCCC--CcchhHHHHHHHH
Q 004312          603 QIIHCDIKPQ---NILLDDYYNARIS--DFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT--VKVDVYSYGVLLL  675 (762)
Q Consensus       603 ~ivH~Dlkp~---NILl~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s--~~~DV~S~Gvil~  675 (762)
                      ...|.-+..+   +.-.+.++.+.++  ||+..+.+......  .....+..+.+||.......+  ...|+|.+|..+.
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            5555444444   4445566777777  88888765432221  122345668888888766554  4489999999999


Q ss_pred             HHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 004312          676 EIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQML  743 (762)
Q Consensus       676 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L  743 (762)
                      .+..|..+....        .....+++.        ...........+|+..++++|++..+++...
T Consensus       384 ~~~~~~~i~~~~--------~~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  384 QLSQGEDISEKS--------AVPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhcCcccccc--------cchhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            999877652111        001111111        1111456778889999999999999998765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.34  E-value=0.00099  Score=68.17  Aligned_cols=139  Identities=16%  Similarity=0.199  Sum_probs=79.3

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCc-cchhceeccCCceeEEEeccCCCc
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      +.|..|-...+|+.....++.+.+++|+.... .....+..+|+.++..+...++ +++++...    ..+||||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~-~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK-TELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCC-ccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            34677888899987543212457888876543 2122234578888888854343 44444332    248999999876


Q ss_pred             hhhh-------c----------cCCC-----------CCC-HHHHHHHHH----------------------HHHHHHHH
Q 004312          567 LASF-------L----------FGDS-----------KPN-WKLRTEIVM----------------------GIARGLFY  595 (762)
Q Consensus       567 L~~~-------l----------~~~~-----------~l~-~~~~~~i~~----------------------~ia~~L~y  595 (762)
                      +...       +          +...           ... +..+..+..                      .+.+.+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6321       0          1110           011 112111111                      11111111


Q ss_pred             h----Hhc-CCCCeEeCCCCCCceEEcC-CCceEEecccccc
Q 004312          596 L----HEE-CCTQIIHCDIKPQNILLDD-YYNARISDFGLEK  631 (762)
Q Consensus       596 L----H~~-~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~  631 (762)
                      |    ... ....++|+|+.+.|||+++ +..+.|+||-.+.
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            1    111 2347999999999999998 5789999998875

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

Probab=97.24  E-value=0.00024  Score=58.26  Aligned_cols=49  Identities=20%  Similarity=0.428  Sum_probs=38.0

Q ss_pred             eccCCCCCCCcccccCCCChhhHHhhhccCCCccccccc--cCcceecccC
Q 004312          342 ELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLR--DDTCWKKKLP  390 (762)
Q Consensus       342 ~~~~~~~p~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~--~~~C~~~~~~  390 (762)
                      .++++++++.+.......+.++|+..|+.+|+|.|+.|.  .+.|+++...
T Consensus         8 ~~~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~~   58 (73)
T cd01100           8 QGSNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSSE   58 (73)
T ss_pred             ccCCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccCC
Confidence            335677776655444467899999999999999999995  4789988663

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.20  E-value=0.0012  Score=70.23  Aligned_cols=138  Identities=17%  Similarity=0.144  Sum_probs=84.5

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCC--ccchhcee------ccCCceeEEE
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN--LVRLLGYC------DEGRNRLLVY  559 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~------~~~~~~~LV~  559 (762)
                      +.|..|....+|+....   +..+++|+...   ....+...|++++..+++.+  +.+++...      ...+..++|+
T Consensus        20 ~~i~~G~~n~~y~v~~~---~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          20 EGISAGIENTNYFVTTD---SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             ecccCccccceEEEEeC---CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            34778888899997543   23688898764   23456777888888875433  44554422      2234568999


Q ss_pred             eccCCCchhhh----c----------cC------CC-----CCCHHHHH----------HHHHHHHHHHHHhHh----cC
Q 004312          560 EFMSNGALASF----L----------FG------DS-----KPNWKLRT----------EIVMGIARGLFYLHE----EC  600 (762)
Q Consensus       560 E~~~~gsL~~~----l----------~~------~~-----~l~~~~~~----------~i~~~ia~~L~yLH~----~~  600 (762)
                      |+++|..+...    +          +.      ..     ...|....          .....+..++.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            99998765330    0          10      00     01121111          011223344555553    12


Q ss_pred             CCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          601 CTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       601 ~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                      ..+++|+|+.|.|||++++....|.||..+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            3479999999999999998778999998875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.13  E-value=0.0028  Score=69.44  Aligned_cols=76  Identities=17%  Similarity=0.181  Sum_probs=51.8

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccc-------cchhHHHHHHhhhhcccc---cCCccchhceeccCCceeE
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-------QDSEKEFKAEVNGIGQTH---HKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~L  557 (762)
                      +.||.|.+..||++....+ .+.++||.-....       ......+..|.+.|..+.   ..++++++.+.  .+..++
T Consensus        32 ~elggGn~N~VyrV~~~~g-~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l  108 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEG-GKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT  108 (401)
T ss_pred             eEcCCCceEEEEEEEeCCC-CeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence            4689999999999976532 2479999854211       123456777888888762   24566777763  355789


Q ss_pred             EEeccCCCc
Q 004312          558 VYEFMSNGA  566 (762)
Q Consensus       558 V~E~~~~gs  566 (762)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.78  E-value=0.0051  Score=65.59  Aligned_cols=138  Identities=21%  Similarity=0.248  Sum_probs=81.4

Q ss_pred             hcCCCCcceEEEeeeeCC-----CcceEEEEEccccccchhHHHHHHhhhhcccccCCc-cchhceeccCCceeEEEecc
Q 004312          489 ELGRGAFGTVYKGFVNMG-----SSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+..|-...+|+.....+     .++.+++|+..... ....+..+|.+++..+....+ .++++++..    .+|+||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            355666778998765421     14678889865432 223456788888888754333 355555542    3589999


Q ss_pred             CCCchhhh-c----------------cCCC-C--------C--CHHHHHH--------------------------HHHH
Q 004312          563 SNGALASF-L----------------FGDS-K--------P--NWKLRTE--------------------------IVMG  588 (762)
Q Consensus       563 ~~gsL~~~-l----------------~~~~-~--------l--~~~~~~~--------------------------i~~~  588 (762)
                      +|..+... +                ++.. .        .  -+.....                          +...
T Consensus        80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (302)
T cd05156          80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED  159 (302)
T ss_pred             CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence            88776431 1                1110 0        0  0111111                          1112


Q ss_pred             HHHHHHHhHh------cCCCCeEeCCCCCCceEEcCC----CceEEecccccc
Q 004312          589 IARGLFYLHE------ECCTQIIHCDIKPQNILLDDY----YNARISDFGLEK  631 (762)
Q Consensus       589 ia~~L~yLH~------~~~~~ivH~Dlkp~NILl~~~----~~~kl~Dfgla~  631 (762)
                      +.+-+..+..      .....++|+|+.|.|||++++    +.++++||..+.
T Consensus       160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            2223334432      234579999999999999985    889999998885

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.59  E-value=0.00043  Score=83.89  Aligned_cols=157  Identities=11%  Similarity=-0.036  Sum_probs=111.7

Q ss_pred             HHHHhhhhcccccCCccchhceec--cCCceeEEEeccCCCchhhhccCC----CCCCHHHHHHHHHHHHHHHHHhHhcC
Q 004312          527 FKAEVNGIGQTHHKNLVRLLGYCD--EGRNRLLVYEFMSNGALASFLFGD----SKPNWKLRTEIVMGIARGLFYLHEEC  600 (762)
Q Consensus       527 ~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~LV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~L~yLH~~~  600 (762)
                      ...|...++...|+++.....-..  +..+.+.+++|+..|.+.+.|-+.    ..++.........+...+..-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            344555555668888877655442  345678999999999999988654    22333333333333244555555543


Q ss_pred             C--CCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHH
Q 004312          601 C--TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII  678 (762)
Q Consensus       601 ~--~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ell  678 (762)
                      .  .-.+|+++|+-|.+|..+.++|+.++|+.++..+. ........+++-|+.|+....-.++.++|+|..|+.+|+.-
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence            2  24789999999999999999999999999844322 22233445788899999998889999999999999999998


Q ss_pred             hCCCCC
Q 004312          679 CLRRTI  684 (762)
Q Consensus       679 tg~~p~  684 (762)
                      -|..++
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            777664

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.52  E-value=0.0081  Score=63.16  Aligned_cols=72  Identities=17%  Similarity=0.317  Sum_probs=46.2

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc---cCCccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH---HKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      +.++-|....+|+..   .+++.+.||.-.   ......|..|.+-|+.|.   --.+++++++....+..+||+||++.
T Consensus        23 ~~v~GG~i~~a~~~~---~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD---TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEE--SSSSEEEEEE---TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             EecCCCChhheEEEE---CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            358889999999865   345689999865   233457888888888873   34577888888777778999999987


Q ss_pred             C
Q 004312          565 G  565 (762)
Q Consensus       565 g  565 (762)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            6

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.50  E-value=0.029  Score=59.97  Aligned_cols=138  Identities=13%  Similarity=0.177  Sum_probs=80.2

Q ss_pred             hcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCC--ccchhcee------ccCCceeEEEe
Q 004312          489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN--LVRLLGYC------DEGRNRLLVYE  560 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~------~~~~~~~LV~E  560 (762)
                      .++.|....+|+....  + ..+++|+.+...  ...+...|++++..|....  +.+++...      ...+..++++|
T Consensus        29 ~~~~G~~n~~y~v~t~--~-~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        29 GIAEGVENSNYLLTTD--V-GRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccCCccccceEEEEeC--C-CcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            4677777899987532  2 357788765421  2344556677777664222  34444422      12345689999


Q ss_pred             ccCCCchhhh--------------ccCC------C------CCCHHHHH------------HHHHHHHHHHHHhHh----
Q 004312          561 FMSNGALASF--------------LFGD------S------KPNWKLRT------------EIVMGIARGLFYLHE----  598 (762)
Q Consensus       561 ~~~~gsL~~~--------------l~~~------~------~l~~~~~~------------~i~~~ia~~L~yLH~----  598 (762)
                      |++|..+...              ++..      .      ...|....            .....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9988654211              1110      0      01111110            011223345555543    


Q ss_pred             cCCCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       599 ~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                      ....+++|+|+++.||++++++...|.||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            234589999999999999988777899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.43  E-value=0.028  Score=59.65  Aligned_cols=119  Identities=21%  Similarity=0.268  Sum_probs=75.4

Q ss_pred             cceEEEEEccc--cccchhHHHHHHhhhhccccc--CCccchhceeccCC--ceeEEEeccCCCchhhhccCCCCCCHHH
Q 004312          508 SDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHH--KNLVRLLGYCDEGR--NRLLVYEFMSNGALASFLFGDSKPNWKL  581 (762)
Q Consensus       508 ~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~--~~~LV~E~~~~gsL~~~l~~~~~l~~~~  581 (762)
                      ++++++. ...  ..........+|.++|+.+.-  .-+.+.++.|.++.  ..+.||+|+++..+.+.+......    
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~----  122 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLG----  122 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccch----
Confidence            4567777 321  223334566778888887743  33456677887776  679999999985444333211100    


Q ss_pred             HHHHH-HHHHHHH--------------------------------------------------HHhHhcC-----CCCeE
Q 004312          582 RTEIV-MGIARGL--------------------------------------------------FYLHEEC-----CTQII  605 (762)
Q Consensus       582 ~~~i~-~~ia~~L--------------------------------------------------~yLH~~~-----~~~iv  605 (762)
                       .+.+ ..+++.|                                                  .+|++..     .+.++
T Consensus       123 -~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lv  201 (321)
T COG3173         123 -RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLV  201 (321)
T ss_pred             -HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceee
Confidence             1111 1333333                                                  3444432     25799


Q ss_pred             eCCCCCCceEEcCCCceEEeccccccc
Q 004312          606 HCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       606 H~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                      |||+++.||+++.+..+-|.||+++..
T Consensus       202 HGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         202 HGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             eCCcccCCEEEeCCCeeEEEecccccc
Confidence            999999999999988899999999875

>PRK05231 homoserine kinase; Provisional

Probab=96.38  E-value=0.027  Score=60.47  Aligned_cols=137  Identities=10%  Similarity=0.129  Sum_probs=74.6

Q ss_pred             hcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCC--ccchhce------eccCCceeEEEe
Q 004312          489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN--LVRLLGY------CDEGRNRLLVYE  560 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~------~~~~~~~~LV~E  560 (762)
                      .|+.|....+|+.....   ..+++|+....   .......|+.++..|...+  +.+.+..      ....+..++++|
T Consensus        29 ~l~~G~~n~~y~v~t~~---g~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         29 GIAEGIENSNFFLTTTQ---GEYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             hhccccccceEEEEeCC---CcEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            46777778999975432   26888987521   2234444555555553222  3333321      122445789999


Q ss_pred             ccCCCchhhh--------------ccCC---------C--CC-CHHHHHH------------HHHH-HHHHHHHhHh---
Q 004312          561 FMSNGALASF--------------LFGD---------S--KP-NWKLRTE------------IVMG-IARGLFYLHE---  598 (762)
Q Consensus       561 ~~~~gsL~~~--------------l~~~---------~--~l-~~~~~~~------------i~~~-ia~~L~yLH~---  598 (762)
                      |++|..+...              ++..         .  .+ .|.....            .+.+ +...+..+..   
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            9998754210              1110         0  01 1111111            1111 1122233321   


Q ss_pred             -cCCCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          599 -ECCTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       599 -~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                       ....+++|+|++|.||+++++...-|+||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             124589999999999999977666899999875

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.34  E-value=0.025  Score=59.35  Aligned_cols=31  Identities=29%  Similarity=0.542  Sum_probs=25.9

Q ss_pred             CCeEeCCCCCCceEEcCCCc-eEEeccccccc
Q 004312          602 TQIIHCDIKPQNILLDDYYN-ARISDFGLEKL  632 (762)
Q Consensus       602 ~~ivH~Dlkp~NILl~~~~~-~kl~Dfgla~~  632 (762)
                      +.++|+|++|.|||+++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 56999999864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=96.23  E-value=0.023  Score=61.72  Aligned_cols=138  Identities=17%  Similarity=0.182  Sum_probs=80.8

Q ss_pred             cCCCCcceEEEeeeeCC---CcceEEEEEccccccchhHHHHHHhhhhcccccCCcc-chhceeccCCceeEEEeccCCC
Q 004312          490 LGRGAFGTVYKGFVNMG---SSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLV-RLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       490 iG~G~~g~Vy~g~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      |-.|-...+|+..+..+   ..+.+++|+...... ..-+-.+|.+++..+...++- ++++.+..+    .|+||+++.
T Consensus        44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~  118 (344)
T PLN02236         44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR  118 (344)
T ss_pred             cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence            44577788998765432   235788898765432 222346788888888654443 556665433    589999877


Q ss_pred             chhhh-----------------ccCCC----C-C-CHHHHHHHHHH-----------------HHHHHHHhHh-----cC
Q 004312          566 ALASF-----------------LFGDS----K-P-NWKLRTEIVMG-----------------IARGLFYLHE-----EC  600 (762)
Q Consensus       566 sL~~~-----------------l~~~~----~-l-~~~~~~~i~~~-----------------ia~~L~yLH~-----~~  600 (762)
                      +|..-                 +|+..    . . .+.....+..+                 +...+..|..     ..
T Consensus       119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~  198 (344)
T PLN02236        119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ  198 (344)
T ss_pred             CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence            66421                 11111    0 1 12222222211                 1112222221     12


Q ss_pred             CCCeEeCCCCCCceEEcC-CCceEEeccccccc
Q 004312          601 CTQIIHCDIKPQNILLDD-YYNARISDFGLEKL  632 (762)
Q Consensus       601 ~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~  632 (762)
                      ...++|+|+++.|||+++ ++.++++||..+..
T Consensus       199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            347899999999999986 57899999988763

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.13  E-value=0.013  Score=57.68  Aligned_cols=152  Identities=18%  Similarity=0.210  Sum_probs=93.8

Q ss_pred             CcceEEEeeeeCCCcceEEEEEccccccc-hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCchhhhcc
Q 004312          494 AFGTVYKGFVNMGSSDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF  572 (762)
Q Consensus       494 ~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~  572 (762)
                      +.++.-.|+-+.+   +..+|++....-. ....|.++.+++++++  .|+++..  ..+-..-++.|+|..-       
T Consensus        74 gNsTl~~~kt~iG---~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~-------  139 (308)
T PF07387_consen   74 GNSTLLIGKTKIG---PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKI-------  139 (308)
T ss_pred             CceEEEEeccccc---hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCc-------
Confidence            3445555543332   4667776654333 4567888999998886  3555551  1333455889998431       


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccccccCcccC
Q 004312          573 GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVA  652 (762)
Q Consensus       573 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~a  652 (762)
                           .....-.|..+ +++|.-.|+. ..+.+|||-.|+||+-|..|.+||.|-+.-..-             +..|.-
T Consensus       140 -----~i~~~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~-------------~V~~vN  199 (308)
T PF07387_consen  140 -----KINFSNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN-------------QVNMVN  199 (308)
T ss_pred             -----ccchhHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhhh-------------eeeEEe
Confidence                 11111122222 4677888864 458999999999999999999999997654210             111222


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHhCCC
Q 004312          653 PEWFRNMPITVKVDVYSYGVLLLEIICLRR  682 (762)
Q Consensus       653 PE~~~~~~~s~~~DV~S~Gvil~elltg~~  682 (762)
                      -|   ....|+++.+=+|=.-+++++...+
T Consensus       200 ~~---Y~~lT~~aE~~~fv~s~l~~v~~~~  226 (308)
T PF07387_consen  200 IE---YESLTQEAEVKVFVKSCLKLVEKQR  226 (308)
T ss_pred             ee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence            11   2345788888888888888875443

The function of this family is unknown.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.04  E-value=0.05  Score=59.62  Aligned_cols=79  Identities=14%  Similarity=0.173  Sum_probs=50.6

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-------chhHHHHHHhhhhcccc---cCCccchhceeccCCceeE
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-------DSEKEFKAEVNGIGQTH---HKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~L  557 (762)
                      +.||-|....||+...  + +..++||+-.....       .....-..|++.|+.+.   ..++.+++.++.  +..++
T Consensus        38 ~eiggGn~N~VyrV~~--~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         38 KEVGDGNLNFVYIVVS--S-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             EEcCCCceeeEEEEEc--C-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            4689999999999753  2 34699998652111       12333444566665553   357888888887  44678


Q ss_pred             EEeccCC--Cchhhhc
Q 004312          558 VYEFMSN--GALASFL  571 (762)
Q Consensus       558 V~E~~~~--gsL~~~l  571 (762)
                      +||++++  ..+.+-+
T Consensus       113 vME~L~~~~~ilr~~L  128 (418)
T PLN02756        113 GMRYLEPPHIILRKGL  128 (418)
T ss_pred             EEeecCCcceehhhhh
Confidence            9999977  3444443

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.84  E-value=0.026  Score=60.50  Aligned_cols=60  Identities=18%  Similarity=0.222  Sum_probs=44.1

Q ss_pred             eeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc
Q 004312          555 RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD  617 (762)
Q Consensus       555 ~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~  617 (762)
                      ..|+-+|+++-++..++...+ .+++.+.+++.-.++|+.-+---  ...+|.|++|.||++.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEE
Confidence            457788888999999886544 34466777777777776433322  2799999999999995

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.46  E-value=0.05  Score=57.69  Aligned_cols=138  Identities=19%  Similarity=0.220  Sum_probs=91.4

Q ss_pred             hcCCCCcceEEEeeeeCCCcceEEEEEcccc---------ccchh-------------H----HHHHHhhhhcccccCCc
Q 004312          489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---------FQDSE-------------K----EFKAEVNGIGQTHHKNL  542 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---------~~~~~-------------~----~~~~E~~~l~~l~H~nI  542 (762)
                      .|..|.-+-||.+.-..  +..+|||+.+..         ...++             +    -...|++.|.+|+...|
T Consensus       151 CiSTGKEANVYHat~~d--G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  151 CISTGKEANVYHATEED--GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccCccceeEeeecCC--CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            47888999999986543  456999987521         01111             1    12356777777765543


Q ss_pred             cchhceeccCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCce
Q 004312          543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNA  622 (762)
Q Consensus       543 v~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~  622 (762)
                      ...--+.  -....|||+|+....-..-.-+.-.++...+..+-.++++-|.-|.+.|  ++||.||.--|+|+-+ |.+
T Consensus       229 P~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G~l  303 (520)
T KOG2270|consen  229 PCPEPIL--LKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-GKL  303 (520)
T ss_pred             CCCCcee--eecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-CEE
Confidence            3211111  1234699999965433333333445667778888889999998888886  8999999999999865 588


Q ss_pred             EEecccccccc
Q 004312          623 RISDFGLEKLL  633 (762)
Q Consensus       623 kl~Dfgla~~~  633 (762)
                      .|+|-+-+...
T Consensus       304 yiIDVSQSVE~  314 (520)
T KOG2270|consen  304 YIIDVSQSVEH  314 (520)
T ss_pred             EEEEccccccC
Confidence            99998776543

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.30  E-value=0.064  Score=57.94  Aligned_cols=139  Identities=17%  Similarity=0.232  Sum_probs=79.1

Q ss_pred             hcCCCCcceEEEeeeeCCC--cceEEEEEccccccchhHHHHHHhhhhcccccCCc-cchhceeccCCceeEEEeccCCC
Q 004312          489 ELGRGAFGTVYKGFVNMGS--SDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      .|..|-...+|+.......  ...|++|+...... ..-+-.+|..+++.+...++ .++++++..+    +|.||+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence            3555777788987544321  23788888765322 22344678888888866555 3566665322    589999776


Q ss_pred             chhhh-----------------ccCCC-----CC-CHHHHHHHHHH----------------------HHHHHHHhHh--
Q 004312          566 ALASF-----------------LFGDS-----KP-NWKLRTEIVMG----------------------IARGLFYLHE--  598 (762)
Q Consensus       566 sL~~~-----------------l~~~~-----~l-~~~~~~~i~~~----------------------ia~~L~yLH~--  598 (762)
                      .|..-                 +|+..     .. -|....++..+                      +.+-+..+..  
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            55321                 11111     01 12222222211                      1111222211  


Q ss_pred             ---cCCCCeEeCCCCCCceEEcC-CCceEEeccccccc
Q 004312          599 ---ECCTQIIHCDIKPQNILLDD-YYNARISDFGLEKL  632 (762)
Q Consensus       599 ---~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~  632 (762)
                         ....-+.|+|+.+.|||+++ ++.++++||..+..
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence               11235899999999999974 57899999988753

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.04  E-value=0.072  Score=53.01  Aligned_cols=73  Identities=18%  Similarity=0.306  Sum_probs=51.2

Q ss_pred             cCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc---cCCccchhceeccCCceeEEEeccCCCc
Q 004312          490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH---HKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       490 iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      +.-|.--..|+..   ....++-||.-.   ......|.+|+.-|..|.   .-++.+++..-.+..+.+||+||.+-+.
T Consensus        24 v~gG~inea~~v~---dg~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          24 VSGGDINEAWRLR---DGTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cCCccccceeEee---cCCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            4444444555532   234578888743   233467889988777774   3557788888899999999999999877


Q ss_pred             hh
Q 004312          567 LA  568 (762)
Q Consensus       567 L~  568 (762)
                      +.
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            65

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	762
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-53
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-52
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-40
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-39
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-37
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-36
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-36
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-33
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-21
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-20
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-18
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-18
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-18
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-18
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-18
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-18
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		9e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-18
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-17
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-17
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-17
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-17
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-17
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-17
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-17
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-17
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-16
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-16
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-16
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-16
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-16
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-16
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-16
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-16
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-16
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-16
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-16
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-16
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-15
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		8e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-14
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-14
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-14
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-14
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-13
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-13
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-13
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-13
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-13
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-13
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-13
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-13
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-13
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		8e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-11
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-11
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-11
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		9e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-10
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		9e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-09
3soa_A	444	Full-Length Human Camkii Length = 444		1e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		7e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		9e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		9e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-05
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-05
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		6e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-05
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		8e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  207 bits (526), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 124/309 (40%), Positives = 173/309 (55%), Gaps = 21/309 (6%)
Query: 456 FMRPHQEEQGVSYMNLRCFTYKELVEVTRGF--KEELGRGAFGTVYKGFVNMGSSDQVAV 513
           F  P +E+  V    L+ F+ +EL   +  F  K  LGRG FG VYKG +  G+   VAV
Sbjct: 10  FDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL--VAV 67
Query: 514 KKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF 572
           K+L     Q  E +F+ EV  I    H+NL+RL G+C     RLLVY +M+NG++AS L 
Sbjct: 68  KRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR 127
Query: 573 G--DSKP--NWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFG 628
              +S+P  +W  R  I +G ARGL YLH+ C  +IIH D+K  NILLD+ + A + DFG
Sbjct: 128 ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 187
Query: 629 LEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRT----- 683
           L KL+     H   A+RGT G++APE+      + K DV+ YGV+LLE+I  +R      
Sbjct: 188 LAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 247
Query: 684 -------ILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTM 736
                  +L DW     +E+ L ALV+ DL+       +++ + VA+ C Q  P  RP M
Sbjct: 248 LANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM 307
Query: 737 RRVTQMLEG 745
             V +MLEG
Sbjct: 308 SEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  204 bits (520), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 122/309 (39%), Positives = 170/309 (55%), Gaps = 21/309 (6%)
Query: 456 FMRPHQEEQGVSYMNLRCFTYKELVEVTRGF--KEELGRGAFGTVYKGFVNMGSSDQVAV 513
           F  P +E+  V    L+ F+ +EL   +  F  K  LGRG FG VYKG   +     VAV
Sbjct: 2   FDVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKG--RLADGXLVAV 59
Query: 514 KKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF 572
           K+L     Q  E +F+ EV  I    H+NL+RL G+C     RLLVY +M+NG++AS L 
Sbjct: 60  KRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR 119
Query: 573 G--DSKP--NWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFG 628
              +S+P  +W  R  I +G ARGL YLH+ C  +IIH D+K  NILLD+ + A + DFG
Sbjct: 120 ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179
Query: 629 LEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRT----- 683
           L KL+     H   A+RG  G++APE+      + K DV+ YGV+LLE+I  +R      
Sbjct: 180 LAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239
Query: 684 -------ILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTM 736
                  +L DW     +E+ L ALV+ DL+       +++ + VA+ C Q  P  RP M
Sbjct: 240 LANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM 299
Query: 737 RRVTQMLEG 745
             V +MLEG
Sbjct: 300 SEVVRMLEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  163 bits (412), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 104/284 (36%), Positives = 154/284 (54%), Gaps = 22/284 (7%)
Query: 478 ELVEVTRGFKEE--LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIG 535
           +L E T  F  +  +G G FG VYKG +  G+  +VA+K+         +EF+ E+  + 
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA--KVALKRRTPESSQGIEEFETEIETLS 90
Query: 536 QTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP----NWKLRTEIVMGIAR 591
              H +LV L+G+CDE    +L+Y++M NG L   L+G   P    +W+ R EI +G AR
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 592 GLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGY 650
           GL YLH      IIH D+K  NILLD+ +  +I+DFG+ K  T LDQ+H    ++GT GY
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGY 207
Query: 651 VAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTI----------LTDWAYDCYQERTLGA 700
           + PE+F    +T K DVYS+GV+L E++C R  I          L +WA + +    L  
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 701 LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           +V+ +L        L++F   A+ C+      RP+M  V   LE
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  160 bits (405), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 103/284 (36%), Positives = 153/284 (53%), Gaps = 22/284 (7%)
Query: 478 ELVEVTRGFKEE--LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIG 535
           +L E T  F  +  +G G FG VYKG +  G+  +VA+K+         +EF+ E+  + 
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA--KVALKRRTPESSQGIEEFETEIETLS 90
Query: 536 QTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP----NWKLRTEIVMGIAR 591
              H +LV L+G+CDE    +L+Y++M NG L   L+G   P    +W+ R EI +G AR
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 592 GLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGY 650
           GL YLH      IIH D+K  NILLD+ +  +I+DFG+ K  T L Q+H    ++GT GY
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGY 207
Query: 651 VAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTI----------LTDWAYDCYQERTLGA 700
           + PE+F    +T K DVYS+GV+L E++C R  I          L +WA + +    L  
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 701 LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           +V+ +L        L++F   A+ C+      RP+M  V   LE
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  152 bits (383), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 107/304 (35%), Positives = 160/304 (52%), Gaps = 33/304 (10%)
Query: 466 VSYMNLRCFTYKELVEVTRGFKE--------ELGRGAFGTVYKGFVNMGSSDQVAVKKLN 517
           VS      F++ EL  VT  F E        ++G G FG VYKG+VN   +  VAVKKL 
Sbjct: 7   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN---NTTVAVKKLA 63
Query: 518 RVF----QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGAL---ASF 570
            +     ++ +++F  E+  + +  H+NLV LLG+  +G +  LVY +M NG+L    S 
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 571 LFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLE 630
           L G    +W +R +I  G A G+ +LHE      IH DIK  NILLD+ + A+ISDFGL 
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 631 KLL-TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC---------L 680
           +      Q+   + I GT  Y+APE  R   IT K D+YS+GV+LLEII           
Sbjct: 181 RASEKFAQTVMXSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 681 RRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVT 740
            + +L        +E+T+   ++  +   D  +V +    VA  C+ E  + RP +++V 
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSV-EAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 741 QMLE 744
           Q+L+
Sbjct: 299 QLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  150 bits (380), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 107/304 (35%), Positives = 159/304 (52%), Gaps = 33/304 (10%)
Query: 466 VSYMNLRCFTYKELVEVTRGFKE--------ELGRGAFGTVYKGFVNMGSSDQVAVKKLN 517
           VS      F++ EL  VT  F E        ++G G FG VYKG+VN   +  VAVKKL 
Sbjct: 7   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN---NTTVAVKKLA 63
Query: 518 RVF----QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGAL---ASF 570
            +     ++ +++F  E+  + +  H+NLV LLG+  +G +  LVY +M NG+L    S 
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 571 LFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLE 630
           L G    +W +R +I  G A G+ +LHE      IH DIK  NILLD+ + A+ISDFGL 
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 631 KLL-TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC---------L 680
           +      Q+     I GT  Y+APE  R   IT K D+YS+GV+LLEII           
Sbjct: 181 RASEKFAQTVMXXRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 681 RRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVT 740
            + +L        +E+T+   ++  +   D  +V +    VA  C+ E  + RP +++V 
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSV-EAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 741 QMLE 744
           Q+L+
Sbjct: 299 QLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  150 bits (379), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 107/304 (35%), Positives = 158/304 (51%), Gaps = 33/304 (10%)
Query: 466 VSYMNLRCFTYKELVEVTRGFKE--------ELGRGAFGTVYKGFVNMGSSDQVAVKKLN 517
           VS      F++ EL  VT  F E        ++G G FG VYKG+VN   +  VAVKKL 
Sbjct: 1   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN---NTTVAVKKLA 57
Query: 518 RVF----QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGAL---ASF 570
            +     ++ +++F  E+  + +  H+NLV LLG+  +G +  LVY +M NG+L    S 
Sbjct: 58  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 117
Query: 571 LFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLE 630
           L G    +W +R +I  G A G+ +LHE      IH DIK  NILLD+ + A+ISDFGL 
Sbjct: 118 LDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLA 174
Query: 631 KLL-TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC---------L 680
           +      Q      I GT  Y+APE  R   IT K D+YS+GV+LLEII           
Sbjct: 175 RASEKFAQXVMXXRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 233
Query: 681 RRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVT 740
            + +L        +E+T+   ++  +   D  +V +    VA  C+ E  + RP +++V 
Sbjct: 234 PQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSV-EAMYSVASQCLHEKKNKRPDIKKVQ 292
Query: 741 QMLE 744
           Q+L+
Sbjct: 293 QLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  141 bits (356), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 108/304 (35%), Positives = 153/304 (50%), Gaps = 43/304 (14%)
Query: 471 LRCFTYKELVEVTRGFKE--------ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-- 520
              F++ EL  VT  F E        + G G FG VYKG+VN   +  VAVKKL  +   
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVN---NTTVAVKKLAAMVDI 59
Query: 521 --QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGAL---ASFLFGDS 575
             ++ +++F  E+    +  H+NLV LLG+  +G +  LVY +  NG+L    S L G  
Sbjct: 60  TTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTP 119
Query: 576 KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL-T 634
             +W  R +I  G A G+ +LHE      IH DIK  NILLD+ + A+ISDFGL +    
Sbjct: 120 PLSWHXRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEK 176
Query: 635 LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ 694
             Q    + I GT  Y APE  R   IT K D+YS+GV+LLEII    T L   A D ++
Sbjct: 177 FAQXVXXSRIVGTTAYXAPEALRG-EITPKSDIYSFGVVLLEII----TGLP--AVDEHR 229
Query: 695 ERTL--------GALVENDLEAMD------DMTVLQRFVMVAIWCIQEDPSHRPTMRRVT 740
           E  L            +   + +D      D T ++    VA  C+ E  + RP +++V 
Sbjct: 230 EPQLLLDIKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQ 289
Query: 741 QMLE 744
           Q+L+
Sbjct: 290 QLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 132/284 (46%), Gaps = 37/284 (13%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTHHKNLV 543
            KE++G G+FGTV++       SD VAVK L      +E+  EF  EV  + +  H N+V
Sbjct: 41  IKEKIGAGSFGTVHRA--EWHGSD-VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLF---GDSKPNWKLRTEIVMGIARGLFYLHEEC 600
             +G   +  N  +V E++S G+L   L       + + + R  +   +A+G+ YLH   
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              I+H D+K  N+L+D  Y  ++ DFGL +L       +  A  GT  ++APE  R+ P
Sbjct: 158 -PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA-GTPEWMAPEVLRDEP 215
Query: 661 ITVKVDVYSYGVLLLEIICLRRT--------ILTDWAYDCYQ---ERTLGALVENDLEAM 709
              K DVYS+GV+L E+  L++         ++    + C +    R L   V   +E  
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG- 274
Query: 710 DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPP 753
                          C   +P  RP+   +  +L  +++  +PP
Sbjct: 275 ---------------CWTNEPWKRPSFATIMDLLRPLIKSAVPP 303

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 133/284 (46%), Gaps = 37/284 (13%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTHHKNLV 543
            KE++G G+FGTV++       SD VAVK L      +E+  EF  EV  + +  H N+V
Sbjct: 41  IKEKIGAGSFGTVHRA--EWHGSD-VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLF---GDSKPNWKLRTEIVMGIARGLFYLHEEC 600
             +G   +  N  +V E++S G+L   L       + + + R  +   +A+G+ YLH   
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              I+H ++K  N+L+D  Y  ++ DFGL +L       + +A  GT  ++APE  R+ P
Sbjct: 158 -PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDEP 215
Query: 661 ITVKVDVYSYGVLLLEIICLRRT--------ILTDWAYDCYQ---ERTLGALVENDLEAM 709
              K DVYS+GV+L E+  L++         ++    + C +    R L   V   +E  
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG- 274
Query: 710 DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPP 753
                          C   +P  RP+   +  +L  +++  +PP
Sbjct: 275 ---------------CWTNEPWKRPSFATIMDLLRPLIKSAVPP 303

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 139/296 (46%), Gaps = 27/296 (9%)
Query: 474 FTYKELVEVTRGFKEEL-----------GRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVF 520
           FT+++  E  R F +E+           G G FG V  G + +    +  VA+K L   +
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 521 QDSEK-EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF-GDSKPN 578
            + ++ +F +E + +GQ  H N++ L G   +    +++ EFM NG+L SFL   D +  
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 579 WKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS 638
                 ++ GIA G+ YL +      +H D+  +NIL++     ++SDFGL + L  D S
Sbjct: 134 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 190
Query: 639 H-TNTAIRGTK---GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ 694
             T T+  G K    + APE  +    T   DV+SYG+++ E++           +D   
Sbjct: 191 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY----WDMTN 246
Query: 695 ERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
           +  + A +E D      M        + + C Q+D +HRP   ++   L+ ++  P
Sbjct: 247 QDVINA-IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 301

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 146/312 (46%), Gaps = 35/312 (11%)
Query: 454 KKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQ--V 511
           + F+ PH  E     ++      KEL        + +G G FG V  G + + S  +  V
Sbjct: 20  RTFVDPHTYEDPTQTVHEFA---KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 512 AVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASF 570
           A+K L   + + ++ +F  E + +GQ  H N++RL G   + +  ++V E+M NG+L SF
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 571 LFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
           L   D++        ++ GIA G+ YL +      +H D+  +NIL++     ++SDFGL
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 630 EKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILT 686
            ++L  D     T  RG K    + +PE       T   DV+SYG++L E++        
Sbjct: 194 SRVLEDDPEAAYTT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM-------- 244
Query: 687 DWAYDCYQERTLGALVEND-LEAMDD-------MTVLQRFVMVAIWCIQEDPSHRPTMRR 738
                 Y ER    +   D ++A+D+       M        + + C Q+D ++RP   +
Sbjct: 245 -----SYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 739 VTQMLEGVVEVP 750
           +  +L+ ++  P
Sbjct: 300 IVSILDKLIRNP 311

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 146/312 (46%), Gaps = 35/312 (11%)
Query: 454 KKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQ--V 511
           + F+ PH  E     ++      KEL        + +G G FG V  G + + S  +  V
Sbjct: 20  RTFVDPHTFEDPTQTVHEFA---KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 512 AVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASF 570
           A+K L   + + ++ +F  E + +GQ  H N++RL G   + +  ++V E+M NG+L SF
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 571 LFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
           L   D++        ++ GIA G+ YL +      +H D+  +NIL++     ++SDFGL
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGFVHRDLAARNILINSNLVCKVSDFGL 193
Query: 630 EKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILT 686
            ++L  D     T  RG K    + +PE       T   DV+SYG++L E++        
Sbjct: 194 SRVLEDDPEAAYTT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM-------- 244
Query: 687 DWAYDCYQERTLGALVEND-LEAMDD-------MTVLQRFVMVAIWCIQEDPSHRPTMRR 738
                 Y ER    +   D ++A+D+       M        + + C Q+D ++RP   +
Sbjct: 245 -----SYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 739 VTQMLEGVVEVP 750
           +  +L+ ++  P
Sbjct: 300 IVSILDKLIRNP 311

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 146/312 (46%), Gaps = 35/312 (11%)
Query: 454 KKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQ--V 511
           + F+ PH  E     ++      KEL        + +G G FG V  G + + S  +  V
Sbjct: 20  RTFVDPHTFEDPTQTVHEFA---KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 512 AVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASF 570
           A+K L   + + ++ +F  E + +GQ  H N++RL G   + +  ++V E+M NG+L SF
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 571 LFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
           L   D++        ++ GIA G+ YL +      +H D+  +NIL++     ++SDFGL
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 630 EKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILT 686
            ++L  D     T  RG K    + +PE       T   DV+SYG++L E++        
Sbjct: 194 SRVLEDDPEAAYTT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM-------- 244
Query: 687 DWAYDCYQERTLGALVEND-LEAMDD-------MTVLQRFVMVAIWCIQEDPSHRPTMRR 738
                 Y ER    +   D ++A+D+       M        + + C Q+D ++RP   +
Sbjct: 245 -----SYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 739 VTQMLEGVVEVP 750
           +  +L+ ++  P
Sbjct: 300 IVSILDKLIRNP 311

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 135/284 (47%), Gaps = 33/284 (11%)
Query: 482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQ---VAVKKLNRVFQDSEK-EFKAEVNGIGQT 537
           VTR  ++ +G G FG VYKG +   S  +   VA+K L   + + ++ +F  E   +GQ 
Sbjct: 46  VTR--QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF-GDSKPNWKLRTEIVMGIARGLFYL 596
            H N++RL G   + +  +++ E+M NGAL  FL   D + +      ++ GIA G+ YL
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPE 654
                   +H D+  +NIL++     ++SDFGL ++L  D   T T   G     + APE
Sbjct: 164 ---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 655 WFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND-LEAMDD-- 711
                  T   DV+S+G+++ E++              Y ER    L  ++ ++A++D  
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVM-------------TYGERPYWELSNHEVMKAINDGF 267
Query: 712 -----MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
                M        + + C Q++ + RP    +  +L+ ++  P
Sbjct: 268 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 146/312 (46%), Gaps = 35/312 (11%)
Query: 454 KKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQ--V 511
           + F+ PH  E     ++      KEL        + +G G FG V  G + + S  +  V
Sbjct: 20  RTFVDPHTFEDPTQTVHEFA---KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 512 AVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASF 570
           A+K L   + + ++ +F  E + +GQ  H N++RL G   + +  ++V E+M NG+L SF
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 571 LFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
           L   D++        ++ GIA G+ YL +      +H D+  +NIL++     ++SDFGL
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 630 EKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILT 686
            ++L  D     T  RG K    + +PE       T   DV+SYG++L E++        
Sbjct: 194 ARVLEDDPEAAYTT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM-------- 244
Query: 687 DWAYDCYQERTLGALVEND-LEAMDD-------MTVLQRFVMVAIWCIQEDPSHRPTMRR 738
                 Y ER    +   D ++A+D+       M        + + C Q+D ++RP   +
Sbjct: 245 -----SYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 739 VTQMLEGVVEVP 750
           +  +L+ ++  P
Sbjct: 300 IVSILDKLIRNP 311

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 138/289 (47%), Gaps = 32/289 (11%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSEK-EFKAEVNG 533
           KEL        + +G G FG V  G + + S  +  VA+K L   + + ++ +F  E + 
Sbjct: 28  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 87
Query: 534 IGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG-DSKPNWKLRTEIVMGIARG 592
           +GQ  H N++RL G   + +  ++V E+M NG+L SFL   D++        ++ GIA G
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 147
Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---G 649
           + YL +      +H D+  +NIL++     ++SDFGL ++L  D     T  RG K    
Sbjct: 148 MKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT-RGGKIPIR 203
Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND-LEA 708
           + +PE       T   DV+SYG++L E++              Y ER    +   D ++A
Sbjct: 204 WTSPEAIAYRKFTSASDVWSYGIVLWEVM-------------SYGERPYWEMSNQDVIKA 250
Query: 709 MDD-------MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
           +D+       M        + + C Q+D ++RP   ++  +L+ ++  P
Sbjct: 251 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 299

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 138/289 (47%), Gaps = 32/289 (11%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSEK-EFKAEVNG 533
           KEL        + +G G FG V  G + + S  +  VA+K L   + + ++ +F  E + 
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 534 IGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG-DSKPNWKLRTEIVMGIARG 592
           +GQ  H N++RL G   + +  ++V E+M NG+L SFL   D++        ++ GIA G
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---G 649
           + YL +      +H D+  +NIL++     ++SDFGL ++L  D     T  RG K    
Sbjct: 131 MKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT-RGGKIPIR 186
Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND-LEA 708
           + +PE       T   DV+SYG++L E++              Y ER    +   D ++A
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVM-------------SYGERPYWEMSNQDVIKA 233
Query: 709 MDD-------MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
           +D+       M        + + C Q+D ++RP   ++  +L+ ++  P
Sbjct: 234 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 282

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 146/312 (46%), Gaps = 35/312 (11%)
Query: 454 KKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQ--V 511
           + ++ PH  E     ++      KEL        + +G G FG V  G + + S  +  V
Sbjct: 20  RTYVDPHTYEDPTQTVHEFA---KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 512 AVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASF 570
           A+K L   + + ++ +F  E + +GQ  H N++RL G   + +  ++V E+M NG+L SF
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 571 LFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
           L   D++        ++ GIA G+ YL +      +H D+  +NIL++     ++SDFGL
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 630 EKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILT 686
            ++L  D     T  RG K    + +PE       T   DV+SYG++L E++        
Sbjct: 194 SRVLEDDPEAAYTT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM-------- 244
Query: 687 DWAYDCYQERTLGALVEND-LEAMDD-------MTVLQRFVMVAIWCIQEDPSHRPTMRR 738
                 Y ER    +   D ++A+D+       M        + + C Q+D ++RP   +
Sbjct: 245 -----SYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 739 VTQMLEGVVEVP 750
           +  +L+ ++  P
Sbjct: 300 IVSILDKLIRNP 311

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 138/289 (47%), Gaps = 32/289 (11%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSEK-EFKAEVNG 533
           KEL        + +G G FG V  G + + S  +  VA+K L   + + ++ +F  E + 
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 534 IGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG-DSKPNWKLRTEIVMGIARG 592
           +GQ  H N++RL G   + +  ++V E+M NG+L SFL   D++        ++ GIA G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---G 649
           + YL +      +H D+  +NIL++     ++SDFGL ++L  D     T  RG K    
Sbjct: 160 MKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT-RGGKIPIR 215
Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND-LEA 708
           + +PE       T   DV+SYG++L E++              Y ER    +   D ++A
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVM-------------SYGERPYWEMSNQDVIKA 262
Query: 709 MDD-------MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
           +D+       M        + + C Q+D ++RP   ++  +L+ ++  P
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 146/312 (46%), Gaps = 35/312 (11%)
Query: 454 KKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQ--V 511
           + F+ PH  E     ++      KEL        + +G G FG V  G + + S  +  V
Sbjct: 20  RTFVDPHTFEDPTQTVHEFA---KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 512 AVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASF 570
           A+K L   + + ++ +F  E + +GQ  H N++RL G   + +  ++V E+M NG+L SF
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 571 LFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
           L   D++        ++ GIA G+ YL +      +H D+  +NIL++     ++SDFGL
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 630 EKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILT 686
            ++L  D     T  RG K    + +PE       T   DV+SYG++L E++        
Sbjct: 194 GRVLEDDPEAAYTT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM-------- 244
Query: 687 DWAYDCYQERTLGALVEND-LEAMDD-------MTVLQRFVMVAIWCIQEDPSHRPTMRR 738
                 Y ER    +   D ++A+D+       M        + + C Q+D ++RP   +
Sbjct: 245 -----SYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 739 VTQMLEGVVEVP 750
           +  +L+ ++  P
Sbjct: 300 IVSILDKLIRNP 311

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 146/312 (46%), Gaps = 35/312 (11%)
Query: 454 KKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQ--V 511
           + ++ PH  E     ++      KEL        + +G G FG V  G + + S  +  V
Sbjct: 18  RTYVDPHTYEDPTQTVHEFA---KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV 74
Query: 512 AVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASF 570
           A+K L   + + ++ +F  E + +GQ  H N++RL G   + +  ++V E+M NG+L SF
Sbjct: 75  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 134
Query: 571 LFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
           L   D++        ++ GIA G+ YL +      +H D+  +NIL++     ++SDFGL
Sbjct: 135 LRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGL 191
Query: 630 EKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILT 686
            ++L  D     T  RG K    + +PE       T   DV+SYG++L E++        
Sbjct: 192 SRVLEDDPEAAYTT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM-------- 242
Query: 687 DWAYDCYQERTLGALVEND-LEAMDD-------MTVLQRFVMVAIWCIQEDPSHRPTMRR 738
                 Y ER    +   D ++A+D+       M        + + C Q+D ++RP   +
Sbjct: 243 -----SYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 297
Query: 739 VTQMLEGVVEVP 750
           +  +L+ ++  P
Sbjct: 298 IVSILDKLIRNP 309

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 145/312 (46%), Gaps = 35/312 (11%)
Query: 454 KKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQ--V 511
           + F+ PH  E     ++      KEL        + +G G FG V  G + + S  +  V
Sbjct: 20  RTFVDPHTFEDPTQTVHEFA---KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 512 AVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASF 570
           A+K L   + + ++ +F  E + +GQ  H N++RL G   + +  ++V E M NG+L SF
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 136
Query: 571 LFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
           L   D++        ++ GIA G+ YL +      +H D+  +NIL++     ++SDFGL
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSDMGA---VHRDLAARNILINSNLVCKVSDFGL 193
Query: 630 EKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILT 686
            ++L  D     T  RG K    + +PE       T   DV+SYG++L E++        
Sbjct: 194 SRVLEDDPEAAYTT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM-------- 244
Query: 687 DWAYDCYQERTLGALVEND-LEAMDD-------MTVLQRFVMVAIWCIQEDPSHRPTMRR 738
                 Y ER    +   D ++A+D+       M        + + C Q+D ++RP   +
Sbjct: 245 -----SYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 739 VTQMLEGVVEVP 750
           +  +L+ ++  P
Sbjct: 300 IVSILDKLIRNP 311

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 24/270 (8%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +E+G G FG V+ G+    + D+VA+K + R    SE++F  E   + +  H  LV+L
Sbjct: 14  FVQEIGSGQFGLVHLGY--WLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 70
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
            G C E     LV+EFM +G L+ +L            E ++G    +  G+ YL E C 
Sbjct: 71  YGVCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 126
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +IH D+  +N L+ +    ++SDFG+ + +  DQ  ++T  +    + +PE F     
Sbjct: 127 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 184
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN---DLEAMDDMTVLQRF 718
           + K DV+S+GVL+ E+    +          Y+ R+   +VE+                 
Sbjct: 185 SSKSDVWSFGVLMWEVFSEGKIP--------YENRSNSEVVEDISTGFRLYKPRLASTHV 236
Query: 719 VMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
             +   C +E P  RP   R+ + L  + E
Sbjct: 237 YQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 24/270 (8%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +E+G G FG V+ G+    + D+VA+K + R    SE++F  E   + +  H  LV+L
Sbjct: 9   FVQEIGSGQFGLVHLGY--WLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
            G C E     LV+EFM +G L+ +L            E ++G    +  G+ YL E C 
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +IH D+  +N L+ +    ++SDFG+ + +  DQ  ++T  +    + +PE F     
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN---DLEAMDDMTVLQRF 718
           + K DV+S+GVL+ E+    +          Y+ R+   +VE+                 
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIP--------YENRSNSEVVEDISTGFRLYKPRLASTHV 231
Query: 719 VMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
             +   C +E P  RP   R+ + L  + E
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 24/270 (8%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +E+G G FG V+ G+    + D+VA+K + R    SE++F  E   + +  H  LV+L
Sbjct: 11  FVQEIGSGQFGLVHLGY--WLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 67
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
            G C E     LV+EFM +G L+ +L            E ++G    +  G+ YL E C 
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 123
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +IH D+  +N L+ +    ++SDFG+ + +  DQ  ++T  +    + +PE F     
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 181
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN---DLEAMDDMTVLQRF 718
           + K DV+S+GVL+ E+    +          Y+ R+   +VE+                 
Sbjct: 182 SSKSDVWSFGVLMWEVFSEGKIP--------YENRSNSEVVEDISTGFRLYKPRLASTHV 233
Query: 719 VMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
             +   C +E P  RP   R+ + L  + E
Sbjct: 234 YQIMNHCWKERPEDRPAFSRLLRQLAEIAE 263

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 137/289 (47%), Gaps = 32/289 (11%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSEK-EFKAEVNG 533
           KEL        + +G G FG V  G + + S  +  VA+K L   + + ++ +F  E + 
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 534 IGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG-DSKPNWKLRTEIVMGIARG 592
           +GQ  H N++RL G   + +  ++V E M NG+L SFL   D++        ++ GIA G
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---G 649
           + YL +      +H D+  +NIL++     ++SDFGL ++L  D     T  RG K    
Sbjct: 131 MKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT-RGGKIPIR 186
Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND-LEA 708
           + +PE       T   DV+SYG++L E++              Y ER    +   D ++A
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVM-------------SYGERPYWEMSNQDVIKA 233
Query: 709 MDD-------MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
           +D+       M        + + C Q+D ++RP   ++  +L+ ++  P
Sbjct: 234 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 282

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 145/312 (46%), Gaps = 35/312 (11%)
Query: 454 KKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQ--V 511
           + ++ PH  E     ++      KEL        + +G G FG V  G + + S  +  V
Sbjct: 20  RTYVDPHTYEDPTQTVHEFA---KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 512 AVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASF 570
           A+K L   + + ++ +F  E + +GQ  H N++RL G   + +  ++V E M NG+L SF
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 136
Query: 571 LFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
           L   D++        ++ GIA G+ YL +      +H D+  +NIL++     ++SDFGL
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 630 EKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILT 686
            ++L  D     T  RG K    + +PE       T   DV+SYG++L E++        
Sbjct: 194 SRVLEDDPEAAYTT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM-------- 244
Query: 687 DWAYDCYQERTLGALVEND-LEAMDD-------MTVLQRFVMVAIWCIQEDPSHRPTMRR 738
                 Y ER    +   D ++A+D+       M        + + C Q+D ++RP   +
Sbjct: 245 -----SYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 739 VTQMLEGVVEVP 750
           +  +L+ ++  P
Sbjct: 300 IVSILDKLIRNP 311

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 119/269 (44%), Gaps = 14/269 (5%)
Query: 478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT 537
           E+   T    E LG G FG V+ G+ N     +VAVK L +    S   F AE N + Q 
Sbjct: 17  EVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSM-SPDAFLAEANLMKQL 73
Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFY 595
            H+ LVRL     +     ++ E+M NG+L  FL   S     +   + M   IA G+ +
Sbjct: 74  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 132
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           + E      IH D++  NIL+ D  + +I+DFGL +L+  ++       +    + APE 
Sbjct: 133 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 189
Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL 715
                 T+K DV+S+G+LL EI+   R       Y       +   +E     +      
Sbjct: 190 INYGTFTIKSDVWSFGILLTEIVTHGRI-----PYPGMTNPEVIQNLERGYRMVRPDNCP 244
Query: 716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           +    +   C +E P  RPT   +  +LE
Sbjct: 245 EELYQLMRLCWKERPEDRPTFDYLRSVLE 273

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 121/270 (44%), Gaps = 16/270 (5%)
Query: 478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT 537
           E+   T    E LG G FG V+ G+ N     +VAVK L +    S   F AE N + Q 
Sbjct: 11  EVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSM-SPDAFLAEANLMKQL 67
Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFY 595
            H+ LVRL     +     ++ E+M NG+L  FL   S     +   + M   IA G+ +
Sbjct: 68  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 126
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           + E      IH D++  NIL+ D  + +I+DFGL +L+  ++       +    + APE 
Sbjct: 127 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 183
Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQERTLGALVENDLEAMDDMTV 714
                 T+K DV+S+G+LL EI+   R         +  Q    G  +       +++  
Sbjct: 184 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 243
Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           L R       C +E P  RPT   +  +LE
Sbjct: 244 LMRL------CWKERPEDRPTFDYLRSVLE 267

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 124/270 (45%), Gaps = 24/270 (8%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +E+G G FG V+ G+    + D+VA+K + R    SE++F  E   + +  H  LV+L
Sbjct: 12  FVQEIGSGQFGLVHLGY--WLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 68
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
            G C E     LV EFM +G L+ +L            E ++G    +  G+ YL E C 
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 124
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +IH D+  +N L+ +    ++SDFG+ + +  DQ  ++T  +    + +PE F     
Sbjct: 125 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 182
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN---DLEAMDDMTVLQRF 718
           + K DV+S+GVL+ E+    +          Y+ R+   +VE+                 
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIP--------YENRSNSEVVEDISTGFRLYKPRLASTHV 234
Query: 719 VMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
             +   C +E P  RP   R+ + L  + E
Sbjct: 235 YQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 123/270 (45%), Gaps = 24/270 (8%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +E+G G FG V+ G+    + D+VA+K +      SE +F  E   + +  H  LV+L
Sbjct: 31  FVQEIGSGQFGLVHLGY--WLNKDKVAIKTIKEG-SMSEDDFIEEAEVMMKLSHPKLVQL 87
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
            G C E     LV+EFM +G L+ +L            E ++G    +  G+ YL E C 
Sbjct: 88  YGVCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 143
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +IH D+  +N L+ +    ++SDFG+ + +  DQ  ++T  +    + +PE F     
Sbjct: 144 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 201
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN---DLEAMDDMTVLQRF 718
           + K DV+S+GVL+ E+    +          Y+ R+   +VE+                 
Sbjct: 202 SSKSDVWSFGVLMWEVFSEGKIP--------YENRSNSEVVEDISTGFRLYKPRLASTHV 253
Query: 719 VMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
             +   C +E P  RP   R+ + L  + E
Sbjct: 254 YQIMNHCWKERPEDRPAFSRLLRQLAEIAE 283

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 121/270 (44%), Gaps = 16/270 (5%)
Query: 478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT 537
           E+   T    E LG G FG V+ G+ N     +VAVK L +    S   F AE N + Q 
Sbjct: 18  EVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSM-SPDAFLAEANLMKQL 74
Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFY 595
            H+ LVRL     +     ++ E+M NG+L  FL   S     +   + M   IA G+ +
Sbjct: 75  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 133
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           + E      IH D++  NIL+ D  + +I+DFGL +L+  ++       +    + APE 
Sbjct: 134 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 190
Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQERTLGALVENDLEAMDDMTV 714
                 T+K DV+S+G+LL EI+   R         +  Q    G  +       +++  
Sbjct: 191 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 250
Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           L R       C +E P  RPT   +  +LE
Sbjct: 251 LMRL------CWKERPEDRPTFDYLRSVLE 274

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 121/270 (44%), Gaps = 16/270 (5%)
Query: 478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT 537
           E+   T    E LG G FG V+ G+ N     +VAVK L +    S   F AE N + Q 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSM-SPDAFLAEANLMKQL 65
Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFY 595
            H+ LVRL     +     ++ E+M NG+L  FL   S     +   + M   IA G+ +
Sbjct: 66  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           + E      IH D++  NIL+ D  + +I+DFGL +L+  ++       +    + APE 
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 181
Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQERTLGALVENDLEAMDDMTV 714
                 T+K DV+S+G+LL EI+   R         +  Q    G  +       +++  
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241
Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           L R       C +E P  RPT   +  +LE
Sbjct: 242 LMRL------CWKERPEDRPTFDYLRSVLE 265

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 121/270 (44%), Gaps = 16/270 (5%)
Query: 478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT 537
           E+   T    E LG G FG V+ G+ N     +VAVK L +    S   F AE N + Q 
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSM-SPDAFLAEANLMKQL 71
Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFY 595
            H+ LVRL     +     ++ E+M NG+L  FL   S     +   + M   IA G+ +
Sbjct: 72  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 130
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           + E      IH D++  NIL+ D  + +I+DFGL +L+  ++       +    + APE 
Sbjct: 131 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 187
Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQERTLGALVENDLEAMDDMTV 714
                 T+K DV+S+G+LL EI+   R         +  Q    G  +       +++  
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 247
Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           L R       C +E P  RPT   +  +LE
Sbjct: 248 LMRL------CWKERPEDRPTFDYLRSVLE 271

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 121/270 (44%), Gaps = 16/270 (5%)
Query: 478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT 537
           E+   T    E LG G FG V+ G+ N     +VAVK L +    S   F AE N + Q 
Sbjct: 10  EVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSM-SPDAFLAEANLMKQL 66
Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFY 595
            H+ LVRL     +     ++ E+M NG+L  FL   S     +   + M   IA G+ +
Sbjct: 67  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 125
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           + E      IH D++  NIL+ D  + +I+DFGL +L+  ++       +    + APE 
Sbjct: 126 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 182
Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQERTLGALVENDLEAMDDMTV 714
                 T+K DV+S+G+LL EI+   R         +  Q    G  +       +++  
Sbjct: 183 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 242
Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           L R       C +E P  RPT   +  +LE
Sbjct: 243 LMRL------CWKERPEDRPTFDYLRSVLE 266

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 121/270 (44%), Gaps = 16/270 (5%)
Query: 478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT 537
           E+   T    E LG G FG V+ G+ N     +VAVK L +    S   F AE N + Q 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSM-SPDAFLAEANLMKQL 65
Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFY 595
            H+ LVRL     +     ++ E+M NG+L  FL   S     +   + M   IA G+ +
Sbjct: 66  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           + E      IH D++  NIL+ D  + +I+DFGL +L+  ++       +    + APE 
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 181
Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQERTLGALVENDLEAMDDMTV 714
                 T+K DV+S+G+LL EI+   R         +  Q    G  +       +++  
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241
Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           L R       C +E P  RPT   +  +LE
Sbjct: 242 LMRL------CWKERPEDRPTFDYLRSVLE 265

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 127/273 (46%), Gaps = 16/273 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNL 542
            +E +G G FG V +G +      +  VA+K L   + + ++ EF +E + +GQ  H N+
Sbjct: 20  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 79
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           +RL G        +++ EFM NGAL SFL   D +        ++ GIA G+ YL E   
Sbjct: 80  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAE--- 136
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-TNTAIRGTK---GYVAPEWFR 657
              +H D+  +NIL++     ++SDFGL + L  + S  T T+  G K    + APE   
Sbjct: 137 MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIA 196
Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR 717
               T   D +SYG+++ E++           +D   +  + A +E D            
Sbjct: 197 FRKFTSASDAWSYGIVMWEVMSFGERPY----WDMSNQDVINA-IEQDYRLPPPPDCPTS 251
Query: 718 FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
              + + C Q+D + RP   +V   L+ ++  P
Sbjct: 252 LHQLMLDCWQKDRNARPRFPQVVSALDKMIRNP 284

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 121/270 (44%), Gaps = 16/270 (5%)
Query: 478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT 537
           E+   T    E LG G FG V+ G+ N     +VAVK L +    S   F AE N + Q 
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSM-SPDAFLAEANLMKQL 71
Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFY 595
            H+ LVRL     +     ++ E+M NG+L  FL   S     +   + M   IA G+ +
Sbjct: 72  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 130
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           + E      IH D++  NIL+ D  + +I+DFGL +L+  ++       +    + APE 
Sbjct: 131 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 187
Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQERTLGALVENDLEAMDDMTV 714
                 T+K DV+S+G+LL EI+   R         +  Q    G  +       +++  
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 247
Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           L R       C +E P  RPT   +  +LE
Sbjct: 248 LMRL------CWKERPEDRPTFDYLRSVLE 271

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 121/270 (44%), Gaps = 16/270 (5%)
Query: 478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT 537
           E+   T    E LG G FG V+ G+ N     +VAVK L +    S   F AE N + Q 
Sbjct: 19  EVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSM-SPDAFLAEANLMKQL 75
Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFY 595
            H+ LVRL     +     ++ E+M NG+L  FL   S     +   + M   IA G+ +
Sbjct: 76  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 134
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           + E      IH D++  NIL+ D  + +I+DFGL +L+  ++       +    + APE 
Sbjct: 135 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 191
Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQERTLGALVENDLEAMDDMTV 714
                 T+K DV+S+G+LL EI+   R         +  Q    G  +       +++  
Sbjct: 192 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 251
Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           L R       C +E P  RPT   +  +LE
Sbjct: 252 LMRL------CWKERPEDRPTFDYLRSVLE 275

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 121/270 (44%), Gaps = 16/270 (5%)
Query: 478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT 537
           E+   T    E LG G FG V+ G+ N     +VAVK L +    S   F AE N + Q 
Sbjct: 14  EVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSM-SPDAFLAEANLMKQL 70
Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFY 595
            H+ LVRL     +     ++ E+M NG+L  FL   S     +   + M   IA G+ +
Sbjct: 71  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 129
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           + E      IH D++  NIL+ D  + +I+DFGL +L+  ++       +    + APE 
Sbjct: 130 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 186
Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQERTLGALVENDLEAMDDMTV 714
                 T+K DV+S+G+LL EI+   R         +  Q    G  +       +++  
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 246
Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           L R       C +E P  RPT   +  +LE
Sbjct: 247 LMRL------CWKERPEDRPTFDYLRSVLE 270

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 121/270 (44%), Gaps = 16/270 (5%)
Query: 478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT 537
           E+   T    E LG G FG V+ G+ N     +VAVK L +    S   F AE N + Q 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSM-SPDAFLAEANLMKQL 65
Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFY 595
            H+ LVRL     +     ++ E+M NG+L  FL   S     +   + M   IA G+ +
Sbjct: 66  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           + E      IH D++  NIL+ D  + +I+DFGL +L+  ++       +    + APE 
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQERTLGALVENDLEAMDDMTV 714
                 T+K DV+S+G+LL EI+   R         +  Q    G  +       +++  
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241
Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           L R       C +E P  RPT   +  +LE
Sbjct: 242 LMRL------CWKERPEDRPTFDYLRSVLE 265

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 121/270 (44%), Gaps = 16/270 (5%)
Query: 478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT 537
           E+   T    E LG G FG V+ G+ N     +VAVK L +    S   F AE N + Q 
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSM-SPDAFLAEANLMKQL 60
Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFY 595
            H+ LVRL     +     ++ E+M NG+L  FL   S     +   + M   IA G+ +
Sbjct: 61  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 119
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           + E      IH D++  NIL+ D  + +I+DFGL +L+  ++       +    + APE 
Sbjct: 120 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 176
Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQERTLGALVENDLEAMDDMTV 714
                 T+K DV+S+G+LL EI+   R         +  Q    G  +       +++  
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 236
Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           L R       C +E P  RPT   +  +LE
Sbjct: 237 LMRL------CWKERPEDRPTFDYLRSVLE 260

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 16/273 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNL 542
            ++ +G G FG V  G + +    +  VA+K L   + + ++ +F +E + +GQ  H N+
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLF-GDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           + L G   +    +++ EFM NG+L SFL   D +        ++ GIA G+ YL +   
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD--- 127
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-TNTAIRGTK---GYVAPEWFR 657
              +H  +  +NIL++     ++SDFGL + L  D S  T T+  G K    + APE  +
Sbjct: 128 MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR 717
               T   DV+SYG+++ E++           +D   +  + A +E D      M     
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMSYGERPY----WDMTNQDVINA-IEQDYRLPPPMDCPSA 242
Query: 718 FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
              + + C Q+D +HRP   ++   L+ ++  P
Sbjct: 243 LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 275

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 127/273 (46%), Gaps = 16/273 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNL 542
            +E +G G FG V +G +      +  VA+K L   + + ++ EF +E + +GQ  H N+
Sbjct: 18  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           +RL G        +++ EFM NGAL SFL   D +        ++ GIA G+ YL E   
Sbjct: 78  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAE--- 134
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-TNTAIRGTK---GYVAPEWFR 657
              +H D+  +NIL++     ++SDFGL + L  + S  T T+  G K    + APE   
Sbjct: 135 MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIA 194
Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR 717
               T   D +SYG+++ E++           +D   +  + A +E D            
Sbjct: 195 FRKFTSASDAWSYGIVMWEVMSFGERPY----WDMSNQDVINA-IEQDYRLPPPPDCPTS 249
Query: 718 FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
              + + C Q+D + RP   +V   L+ ++  P
Sbjct: 250 LHQLMLDCWQKDRNARPRFPQVVSALDKMIRNP 282

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 123/268 (45%), Gaps = 24/268 (8%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +E+G G FG V+ G+    + D+VA+K + R    SE++F  E   + +  H  LV+L
Sbjct: 11  FVQEIGSGQFGLVHLGY--WLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 67
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
            G C E     LV+EFM +G L+ +L            E ++G    +  G+ YL E   
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEE--- 121
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +IH D+  +N L+ +    ++SDFG+ + +  DQ  ++T  +    + +PE F     
Sbjct: 122 ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 181
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN---DLEAMDDMTVLQRF 718
           + K DV+S+GVL+ E+    +          Y+ R+   +VE+                 
Sbjct: 182 SSKSDVWSFGVLMWEVFSEGKI--------PYENRSNSEVVEDISTGFRLYKPRLASTHV 233
Query: 719 VMVAIWCIQEDPSHRPTMRRVTQMLEGV 746
             +   C +E P  RP   R+ + L  +
Sbjct: 234 YQIMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 121/270 (44%), Gaps = 16/270 (5%)
Query: 478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT 537
           E+   T    E LG G FG V+ G+ N     +VAVK L +    S   F AE N + Q 
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSM-SPDAFLAEANLMKQL 61
Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFY 595
            H+ LVRL     +     ++ E+M NG+L  FL   S     +   + M   IA G+ +
Sbjct: 62  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 120
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           + E      IH +++  NIL+ D  + +I+DFGL +L+  ++       +    + APE 
Sbjct: 121 IEER---NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 177
Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQERTLGALVENDLEAMDDMTV 714
                 T+K DV+S+G+LL EI+   R         +  Q    G  +       +++  
Sbjct: 178 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 237
Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           L R       C +E P  RPT   +  +LE
Sbjct: 238 LMRL------CWKERPEDRPTFDYLRSVLE 261

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G FG VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 15  MKHKLGGGQFGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 72
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++    
Sbjct: 73  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---N 129
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 190 KSDVWAFGVLLWEIATYGMS-----PYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMR 244
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 245 ACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ-------TH 538
            +E +G G FG VY+ F      D+VAVK       D +++    +  + Q         
Sbjct: 11  LEEIIGIGGFGKVYRAF---WIGDEVAVKAAR---HDPDEDISQTIENVRQEAKLFAMLK 64
Query: 539 HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-----NWKLRTEIVMGIARGL 593
           H N++ L G C +  N  LV EF   G L   L G   P     NW ++      IARG+
Sbjct: 65  HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGM 118
Query: 594 FYLHEECCTQIIHCDIKPQNILL------DDYYNA--RISDFGLEKLLTLDQSHTNTAIR 645
            YLH+E    IIH D+K  NIL+       D  N   +I+DFGL +        T  +  
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAA 175
Query: 646 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
           G   ++APE  R    +   DV+SYGVLL E++
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL 208

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 15  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 72
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++    
Sbjct: 73  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---N 129
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 190 KSDVWAFGVLLWEIATYGMS-----PYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMR 244
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 245 ACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 122/273 (44%), Gaps = 22/273 (8%)
Query: 478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT 537
           E+   T    E LG G  G V+ G+ N     +VAVK L +    S   F AE N + Q 
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYN--GHTKVAVKSLKQGSM-SPDAFLAEANLMKQL 65
Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFY 595
            H+ LVRL     +     ++ E+M NG+L  FL   S     +   + M   IA G+ +
Sbjct: 66  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVA 652
           + E      IH D++  NIL+ D  + +I+DFGL +L+   +    TA  G K    + A
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI---EDAEXTAREGAKFPIKWTA 178
Query: 653 PEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQERTLGALVENDLEAMDD 711
           PE       T+K DV+S+G+LL EI+   R         +  Q    G  +       ++
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           +  L R       C +E P  RPT   +  +LE
Sbjct: 239 LYQLMRL------CWKERPEDRPTFDYLRSVLE 265

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 144/303 (47%), Gaps = 21/303 (6%)
Query: 456 FMRPHQ-EEQGVSYMNLRCFTYKELVEVTRGFKEEL-GRGAFGTVYKGFVNM-GSSD-QV 511
           +  PH  EE G +    R FT +  +E +R   E++ G G  G V  G + + G  D  V
Sbjct: 26  YAEPHTYEEPGRAG---RSFTRE--IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPV 80
Query: 512 AVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASF 570
           A+K L   + + ++ +F +E + +GQ  H N++RL G    GR  ++V E+M NG+L +F
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 571 L-FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
           L   D +        ++ G+  G+ YL +      +H D+  +N+L+D     ++SDFGL
Sbjct: 141 LRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 630 EKLLT--LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTD 687
            ++L    D ++T T  +    + APE       +   DV+S+GV++ E++        +
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA-----YGE 252
Query: 688 WAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
             Y     R + + VE        M        + + C  +D + RP   ++  +L+ ++
Sbjct: 253 RPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312
Query: 748 EVP 750
             P
Sbjct: 313 RSP 315

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 139/296 (46%), Gaps = 29/296 (9%)
Query: 474 FTYKELVEVTRGFKEEL-----------GRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVF 520
           FT+++  +  R F +E+           G G FG V  G + +    +  VA+K L   +
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 521 QDSEK-EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF-GDSKPN 578
            D ++ +F +E + +GQ  H N++ L G   + +  +++ E+M NG+L +FL   D +  
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 579 WKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS 638
                 ++ GI  G+ YL +      +H D+  +NIL++     ++SDFG+ ++L  D  
Sbjct: 130 VIQLVGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE 186
Query: 639 HTNTAIRGTK---GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE 695
              T  RG K    + APE       T   DV+SYG+++ E++           +D   +
Sbjct: 187 AAYTT-RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY----WDMSNQ 241
Query: 696 RTLGALVEN-DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
             + A+ E   L    D  +    +M+  W  Q++ S RP   ++  ML+ ++  P
Sbjct: 242 DVIKAIEEGYRLPPPMDCPIALHQLMLDCW--QKERSDRPKFGQIVNMLDKLIRNP 295

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 91/319 (28%), Positives = 144/319 (45%), Gaps = 55/319 (17%)
Query: 462 EEQGVSYMNLRCFTYKELVEVTRG---FKEELGRGAFGTVYKGFV-NMGSSD---QVAVK 514
           E    ++++     Y E  E  R    F + LG GAFG V +     +G  D   +VAVK
Sbjct: 23  EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK 82
Query: 515 KLNRVFQDSEKE-FKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF 572
            L       EKE   +E+  +     H+N+V LLG C  G   L++ E+   G L +FL 
Sbjct: 83  MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 142
Query: 573 GDSK----------PNWKLRTEIVMG----IARGLFYLHEECCTQIIHCDIKPQNILLDD 618
             S+           N  L T  ++     +A+G+ +L  + C   IH D+  +N+LL +
Sbjct: 143 RKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVLLTN 199
Query: 619 YYNARISDFGLEKLLTLDQSHTNTAIRGTK----GYVAPEWFRNMPITVKVDVYSYGVLL 674
            + A+I DFGL + +  D   +N  ++G       ++APE   +   TV+ DV+SYG+LL
Sbjct: 200 GHVAKIGDFGLARDIMND---SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256
Query: 675 LEIICLRRT----ILTDWAY-----DCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWC 725
            EI  L       IL +  +     D YQ        +N              +M A W 
Sbjct: 257 WEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYS-----------IMQACWA 305
Query: 726 IQEDPSHRPTMRRVTQMLE 744
           +  +P+HRPT +++   L+
Sbjct: 306 L--EPTHRPTFQQICSFLQ 322

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 18  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 75
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++    
Sbjct: 76  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 132
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 192
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 193 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 247
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 248 ACWQWNPSDRPSFAEIHQAFETMFQ 272

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 131/268 (48%), Gaps = 16/268 (5%)
Query: 490 LGRGAFGTVYKGFVNM-GSSD-QVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLL 546
           +G G FG V  G + + G  D  VA+K L   + + ++ +F  E + +GQ  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
           G    G+  ++V EFM NGAL +FL   D +        ++ GIA G+ YL +      +
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLAD---MGYV 167
Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQS--HTNTAIRGTKGYVAPEWFRNMPITV 663
           H D+  +NIL++     ++SDFGL +++  D    +T T  +    + APE  +    T 
Sbjct: 168 HRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTS 227
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN-DLEAMDDMTVLQRFVMVA 722
             DV+SYG+++ E++           +D   +  + A+ E   L A  D       +M+ 
Sbjct: 228 ASDVWSYGIVMWEVMSYGERPY----WDMSNQDVIKAIEEGYRLPAPMDCPAGLHQLMLD 283
Query: 723 IWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
            W  Q++ + RP   ++  +L+ ++  P
Sbjct: 284 CW--QKERAERPKFEQIVGILDKMIRNP 309

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 543 VRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEE 599
           + LLG C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ +L   
Sbjct: 153 LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL--- 208
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL---TLDQSHTNTAIRGTKGYVAPEWF 656
              + +H D+  +N +LD+ +  +++DFGL + +     D  H  T  +    ++A E  
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +    T K DV+S+GVLL E++
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELM 290

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 22  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 79
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++    
Sbjct: 80  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 136
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 197 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 251
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 252 ACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 543 VRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEE 599
           + LLG C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ +L   
Sbjct: 94  LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL--- 149
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL---TLDQSHTNTAIRGTKGYVAPEWF 656
              + +H D+  +N +LD+ +  +++DFGL + +     D  H  T  +    ++A E  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +    T K DV+S+GVLL E++
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELM 231

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 543 VRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEE 599
           + LLG C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ +L   
Sbjct: 95  LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL--- 150
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL---TLDQSHTNTAIRGTKGYVAPEWF 656
              + +H D+  +N +LD+ +  +++DFGL + +     D  H  T  +    ++A E  
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +    T K DV+S+GVLL E++
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELM 232

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 15  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 72
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++    
Sbjct: 73  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---N 129
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 190 KSDVWAFGVLLWEIATYGMS-----PYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMR 244
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 245 ACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 22  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 79
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLF--GDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L      + N  +   +   I+  + YL ++    
Sbjct: 80  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 136
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 197 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 251
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 252 ACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 22  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 79
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLF--GDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L      + N  +   +   I+  + YL ++    
Sbjct: 80  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 136
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 197 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 251
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 252 ACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 132/288 (45%), Gaps = 40/288 (13%)
Query: 489 ELGRGAFGTVYKG----FVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY+G     +   +  +VAVK +N      E+ EF  E + +      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLF----------GDSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L+V E M++G L S+L           G   P  +   ++   IA G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++   +  +I DFG    +T D   T+   +G KG    
Sbjct: 141 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG----MTRDIXETDXXRKGGKGLLPV 193
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            ++APE  ++   T   D++S+GV+L EI  L        A   YQ    E+ L  +++ 
Sbjct: 194 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSL--------AEQPYQGLSNEQVLKFVMDG 245
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIP 752
                 D    +R   +   C Q +P  RPT   +  +L+  +    P
Sbjct: 246 GYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 292

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 39  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 543 VRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEE 599
           + LLG C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ +L   
Sbjct: 99  LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL--- 154
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL---TLDQSHTNTAIRGTKGYVAPEWF 656
              + +H D+  +N +LD+ +  +++DFGL + +     D  H  T  +    ++A E  
Sbjct: 155 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +    T K DV+S+GVLL E++
Sbjct: 215 QTQKFTTKSDVWSFGVLLWELM 236

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 543 VRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEE 599
           + LLG C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ +L   
Sbjct: 95  LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL--- 150
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT---LDQSHTNTAIRGTKGYVAPEWF 656
              + +H D+  +N +LD+ +  +++DFGL + +     D  H  T  +    ++A E  
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +    T K DV+S+GVLL E++
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELM 232

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 543 VRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEE 599
           + LLG C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ +L   
Sbjct: 94  LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL--- 149
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL---TLDQSHTNTAIRGTKGYVAPEWF 656
              + +H D+  +N +LD+ +  +++DFGL + +     D  H  T  +    ++A E  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +    T K DV+S+GVLL E++
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELM 231

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 131/280 (46%), Gaps = 40/280 (14%)
Query: 489 ELGRGAFGTVYKG----FVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY+G     +   +  +VAVK +N      E+ EF  E + +      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLF----------GDSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L+V E M++G L S+L           G   P  +   ++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++   +  +I DFG    +T D   T+   +G KG    
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG----MTRDIXETDXXRKGGKGLLPV 196
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            ++APE  ++   T   D++S+GV+L EI  L        A   YQ    E+ L  +++ 
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSL--------AEQPYQGLSNEQVLKFVMDG 248
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
                 D    +R   +   C Q +P+ RPT   +  +L+
Sbjct: 249 GYLDQPD-NCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 543 VRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEE 599
           + LLG C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ +L   
Sbjct: 92  LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL--- 147
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL---TLDQSHTNTAIRGTKGYVAPEWF 656
              + +H D+  +N +LD+ +  +++DFGL + +     D  H  T  +    ++A E  
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +    T K DV+S+GVLL E++
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELM 229

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 40/280 (14%)
Query: 489 ELGRGAFGTVYKG----FVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY+G     +   +  +VAVK +N      E+ EF  E + +      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLF----------GDSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L+V E M++G L S+L           G   P  +   ++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++   +  +I DFG    +T D   T+   +G KG    
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG----MTRDIXETDXXRKGGKGLLPV 196
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            ++APE  ++   T   D++S+GV+L EI  L        A   YQ    E+ L  +++ 
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSL--------AEQPYQGLSNEQVLKFVMDG 248
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
                 D    +R   +   C Q +P  RPT   +  +L+
Sbjct: 249 GYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 17  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 74
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++    
Sbjct: 75  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---N 131
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 192 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 246
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 247 ACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 21  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 78
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++    
Sbjct: 79  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 135
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 196 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 250
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 251 ACWQWNPSDRPSFAEIHQAFETMFQ 275

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 22  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 79
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++    
Sbjct: 80  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---N 136
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 197 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 251
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 252 ACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 22  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 79
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLF--GDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L      + N  +   +   I+  + YL ++    
Sbjct: 80  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 136
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 197 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 251
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 252 ACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 143/303 (47%), Gaps = 21/303 (6%)
Query: 456 FMRPHQ-EEQGVSYMNLRCFTYKELVEVTRGFKEEL-GRGAFGTVYKGFVNM-GSSD-QV 511
           +  PH  EE G +    R FT +  +E +R   E++ G G  G V  G + + G  D  V
Sbjct: 26  YAEPHTYEEPGRAG---RSFTRE--IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPV 80
Query: 512 AVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASF 570
           A+K L   + + ++ +F +E + +GQ  H N++RL G    GR  ++V E+M NG+L +F
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 571 L-FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
           L   D +        ++ G+  G+ YL +      +H D+  +N+L+D     ++SDFGL
Sbjct: 141 LRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 630 EKLLT--LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTD 687
            ++L    D + T T  +    + APE       +   DV+S+GV++ E++        +
Sbjct: 198 SRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA-----YGE 252
Query: 688 WAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
             Y     R + + VE        M        + + C  +D + RP   ++  +L+ ++
Sbjct: 253 RPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312
Query: 748 EVP 750
             P
Sbjct: 313 RSP 315

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 17  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 74
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++    
Sbjct: 75  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---N 131
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 192 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 246
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 247 ACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 91/316 (28%), Positives = 144/316 (45%), Gaps = 53/316 (16%)
Query: 462 EEQGVSYMNLRCFTYKELVEVTRG---FKEELGRGAFGTVYKGFV-NMGSSD---QVAVK 514
           E    ++++     Y E  E  R    F + LG GAFG V +     +G  D   +VAVK
Sbjct: 15  EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK 74
Query: 515 KLNRVFQDSEKE-FKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF 572
            L       EKE   +E+  +     H+N+V LLG C  G   L++ E+   G L +FL 
Sbjct: 75  MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 134
Query: 573 ---------GDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIHCDIKPQNILLDDYYN 621
                     D +P  +LR  +     +A+G+ +L  + C   IH D+  +N+LL + + 
Sbjct: 135 RKAEADLDKEDGRP-LELRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHV 190
Query: 622 ARISDFGLEKLLTLDQSHTNTAIRGTK----GYVAPEWFRNMPITVKVDVYSYGVLLLEI 677
           A+I DFGL + +  D   +N  ++G       ++APE   +   TV+ DV+SYG+LL EI
Sbjct: 191 AKIGDFGLARDIMND---SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 247
Query: 678 ICLRRT----ILTDWAY-----DCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQE 728
             L       IL +  +     D YQ        +N              +M A W +  
Sbjct: 248 FSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYS-----------IMQACWAL-- 294
Query: 729 DPSHRPTMRRVTQMLE 744
           +P+HRPT +++   L+
Sbjct: 295 EPTHRPTFQQICSFLQ 310

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 17  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 74
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++    
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---N 131
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 192 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 246
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 247 ACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 17  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 74
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++    
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---N 131
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 192 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 246
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 247 ACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 17  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 74
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++    
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 131
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 192 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 246
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 247 ACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 91/316 (28%), Positives = 144/316 (45%), Gaps = 53/316 (16%)
Query: 462 EEQGVSYMNLRCFTYKELVEVTRG---FKEELGRGAFGTVYKGFV-NMGSSD---QVAVK 514
           E    ++++     Y E  E  R    F + LG GAFG V +     +G  D   +VAVK
Sbjct: 23  EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK 82
Query: 515 KLNRVFQDSEKE-FKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF 572
            L       EKE   +E+  +     H+N+V LLG C  G   L++ E+   G L +FL 
Sbjct: 83  MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 142
Query: 573 ---------GDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIHCDIKPQNILLDDYYN 621
                     D +P  +LR  +     +A+G+ +L  + C   IH D+  +N+LL + + 
Sbjct: 143 RKAEADLDKEDGRP-LELRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHV 198
Query: 622 ARISDFGLEKLLTLDQSHTNTAIRGTK----GYVAPEWFRNMPITVKVDVYSYGVLLLEI 677
           A+I DFGL + +  D   +N  ++G       ++APE   +   TV+ DV+SYG+LL EI
Sbjct: 199 AKIGDFGLARDIMND---SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 255
Query: 678 ICLRRT----ILTDWAY-----DCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQE 728
             L       IL +  +     D YQ        +N              +M A W ++ 
Sbjct: 256 FSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYS-----------IMQACWALE- 303
Query: 729 DPSHRPTMRRVTQMLE 744
            P+HRPT +++   L+
Sbjct: 304 -PTHRPTFQQICSFLQ 318

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 19  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 76
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++    
Sbjct: 77  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 133
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 194 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 248
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 249 ACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 123/268 (45%), Gaps = 18/268 (6%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 19  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 76
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++    
Sbjct: 77  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 133
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMP 660
            IH D+  +N L+ + +  +++DFGL +L+T D   T TA  G K    + APE      
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAPAGAKFPIKWTAPESLAYNK 190
Query: 661 ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM 720
            ++K DV+++GVLL EI     +      Y       +  L+E D          ++   
Sbjct: 191 FSIKSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 245
Query: 721 VAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
           +   C Q +PS RP+   + Q  E + +
Sbjct: 246 LMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 12/261 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 17  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 74
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLF--GDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L      + N  +   +   I+  + YL ++    
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 131
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 192 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 246
Query: 724 WCIQEDPSHRPTMRRVTQMLE 744
            C Q +PS RP+   + Q  E
Sbjct: 247 ACWQWNPSDRPSFAEIHQAFE 267

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 19  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 76
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLF--GDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L      + N  +   +   I+  + YL ++    
Sbjct: 77  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 133
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 194 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 248
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 249 ACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 123/268 (45%), Gaps = 18/268 (6%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 18  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 75
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLF--GDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L      + N  +   +   I+  + YL ++    
Sbjct: 76  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 132
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMP 660
            IH D+  +N L+ + +  +++DFGL +L+T D   T TA  G K    + APE      
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAPAGAKFPIKWTAPESLAYNK 189
Query: 661 ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM 720
            ++K DV+++GVLL EI     +      Y       +  L+E D          ++   
Sbjct: 190 FSIKSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 244
Query: 721 VAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
           +   C Q +PS RP+   + Q  E + +
Sbjct: 245 LMRACWQWNPSDRPSFAEIHQAFETMFQ 272

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 129/286 (45%), Gaps = 40/286 (13%)
Query: 470 NLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA 529
           +L    YKE +EV    +E +GRGAFG V K       +  VA+K++    +   K F  
Sbjct: 2   SLHMIDYKE-IEV----EEVVGRGAFGVVCKA---KWRAKDVAIKQIES--ESERKAFIV 51
Query: 530 EVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIV--- 586
           E+  + + +H N+V+L G C       LV E+   G+L + L G     +      +   
Sbjct: 52  ELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 109
Query: 587 MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNA-RISDFGLEKLLTLDQSHTNTAIR 645
           +  ++G+ YLH      +IH D+KP N+LL       +I DFG       D     T  +
Sbjct: 110 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT----ACDIQTHMTNNK 165
Query: 646 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR--------TILTDWAYDCYQERT 697
           G+  ++APE F     + K DV+S+G++L E+I  R+             WA       T
Sbjct: 166 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA---VHNGT 222
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQML 743
              L++N  + ++ +            C  +DPS RP+M  + +++
Sbjct: 223 RPPLIKNLPKPIESLMTR---------CWSKDPSQRPSMEEIVKIM 259

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 89/319 (27%), Positives = 142/319 (44%), Gaps = 55/319 (17%)
Query: 462 EEQGVSYMNLRCFTYKELVEVTRG---FKEELGRGAFGTVYKGFV-NMGSSD---QVAVK 514
           E    ++++     Y E  E  R    F + LG GAFG V +     +G  D   +VAVK
Sbjct: 23  EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK 82
Query: 515 KLNRVFQDSEKE-FKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF 572
            L       EKE   +E+  +     H+N+V LLG C  G   L++ E+   G L +FL 
Sbjct: 83  MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 142
Query: 573 GDSK-----PNWKLRTEIV---------MGIARGLFYLHEECCTQIIHCDIKPQNILLDD 618
             S+     P + +                +A+G+ +L  + C   IH D+  +N+LL +
Sbjct: 143 RKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVLLTN 199
Query: 619 YYNARISDFGLEKLLTLDQSHTNTAIRGTK----GYVAPEWFRNMPITVKVDVYSYGVLL 674
            + A+I DFGL + +  D   +N  ++G       ++APE   +   TV+ DV+SYG+LL
Sbjct: 200 GHVAKIGDFGLARDIMND---SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256
Query: 675 LEIICLRRT----ILTDWAY-----DCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWC 725
            EI  L       IL +  +     D YQ        +N              +M A W 
Sbjct: 257 WEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYS-----------IMQACWA 305
Query: 726 IQEDPSHRPTMRRVTQMLE 744
           +  +P+HRPT +++   L+
Sbjct: 306 L--EPTHRPTFQQICSFLQ 322

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 30  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 87
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLF--GDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L      + N  +   +   I+  + YL ++    
Sbjct: 88  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 144
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 204
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 205 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 259
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 260 ACWQWNPSDRPSFAEIHQAFETMFQ 284

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 129/286 (45%), Gaps = 40/286 (13%)
Query: 470 NLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA 529
           +L    YKE +EV    +E +GRGAFG V K       +  VA+K++    +   K F  
Sbjct: 1   SLHMIDYKE-IEV----EEVVGRGAFGVVCKA---KWRAKDVAIKQIES--ESERKAFIV 50
Query: 530 EVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIV--- 586
           E+  + + +H N+V+L G C       LV E+   G+L + L G     +      +   
Sbjct: 51  ELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108
Query: 587 MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNA-RISDFGLEKLLTLDQSHTNTAIR 645
           +  ++G+ YLH      +IH D+KP N+LL       +I DFG       D     T  +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT----ACDIQTHMTNNK 164
Query: 646 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR--------TILTDWAYDCYQERT 697
           G+  ++APE F     + K DV+S+G++L E+I  R+             WA       T
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA---VHNGT 221
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQML 743
              L++N  + ++ +            C  +DPS RP+M  + +++
Sbjct: 222 RPPLIKNLPKPIESLMTR---------CWSKDPSQRPSMEEIVKIM 258

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 134/284 (47%), Gaps = 40/284 (14%)
Query: 489 ELGRGAFGTVY----KGFVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY    KG V      +VA+K +N      E+ EF  E + + + +  ++V
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFG----------DSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L++ E M+ G L S+L             + P+     ++   IA G+
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++ + +  +I DFG    +T D   T+   +G KG    
Sbjct: 146 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIXETDXXRKGGKGLLPV 198
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            +++PE  ++   T   DV+S+GV+L EI  L        A   YQ    E+ L  ++E 
Sbjct: 199 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATL--------AEQPYQGLSNEQVLRFVMEG 250
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            L    D      F ++ + C Q +P  RP+   +   ++  +E
Sbjct: 251 GLLDKPDNCPDMLFELMRM-CWQYNPKMRPSFLEIISSIKEEME 293

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 224 MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 281
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++    
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH ++  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 399 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 453
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 454 ACWQWNPSDRPSFAEIHQAFETMFQ 478

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 543 VRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEE 599
           + LLG C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ YL   
Sbjct: 93  LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 148
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL---TLDQSHTNTAIRGTKGYVAPEWF 656
              + +H D+  +N +LD+ +  +++DFGL + +        H  T  +    ++A E  
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +    T K DV+S+GVLL E++
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELM 230

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLL 546
           +G G FG V  G + +    +  VA+K L   + D ++ +F +E + +GQ  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLF-GDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
           G   + +  +++ E+M NG+L +FL   D +        ++ GI  G+ YL +      +
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSYV 132
Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPIT 662
           H D+  +NIL++     ++SDFG+ ++L  D     T  RG K    + APE       T
Sbjct: 133 HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT-RGGKIPIRWTAPEAIAYRKFT 191
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN-DLEAMDDMTVLQRFVMV 721
              DV+SYG+++ E++           +D   +  + A+ E   L    D  +    +M+
Sbjct: 192 SASDVWSYGIVMWEVMSYGERPY----WDMSNQDVIKAIEEGYRLPPPMDCPIALHQLML 247
Query: 722 AIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
             W  Q++ S RP   ++  ML+ ++  P
Sbjct: 248 DCW--QKERSDRPKFGQIVNMLDKLIRNP 274

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 90/321 (28%), Positives = 145/321 (45%), Gaps = 57/321 (17%)
Query: 462 EEQGVSYMNLRCFTYKELVEVTRG---FKEELGRGAFGTVYKGFV-NMGSSD---QVAVK 514
           E    ++++     Y E  E  R    F + LG GAFG V +     +G  D   +VAVK
Sbjct: 23  EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK 82
Query: 515 KLNRVFQDSEKE-FKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL- 571
            L       EKE   +E+  +     H+N+V LLG C  G   L++ E+   G L +FL 
Sbjct: 83  MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 142
Query: 572 ----------FGDSK-PNWKLRTEIVMG----IARGLFYLHEECCTQIIHCDIKPQNILL 616
                     +  S  P  +L +  ++     +A+G+ +L  + C   IH D+  +N+LL
Sbjct: 143 RKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVLL 199
Query: 617 DDYYNARISDFGLEKLLTLDQSHTNTAIRGTK----GYVAPEWFRNMPITVKVDVYSYGV 672
            + + A+I DFGL + +  D   +N  ++G       ++APE   +   TV+ DV+SYG+
Sbjct: 200 TNGHVAKIGDFGLARDIMND---SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 256
Query: 673 LLLEIICLRRT----ILTDWAY-----DCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           LL EI  L       IL +  +     D YQ        +N              +M A 
Sbjct: 257 LLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYS-----------IMQAC 305
Query: 724 WCIQEDPSHRPTMRRVTQMLE 744
           W +  +P+HRPT +++   L+
Sbjct: 306 WAL--EPTHRPTFQQICSFLQ 324

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 263 MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 320
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLF--GDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L      + N  +   +   I+  + YL ++    
Sbjct: 321 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 377
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH ++  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 378 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 437
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 438 KSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 492
Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 493 ACWQWNPSDRPSFAEIHQAFETMFQ 517

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLL 546
           +G G FG V  G + +    +  VA+K L   + D ++ +F +E + +GQ  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLF-GDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
           G   + +  +++ E+M NG+L +FL   D +        ++ GI  G+ YL +      +
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSYV 138
Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPIT 662
           H D+  +NIL++     ++SDFG+ ++L  D     T  RG K    + APE       T
Sbjct: 139 HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT-RGGKIPIRWTAPEAIAYRKFT 197
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN-DLEAMDDMTVLQRFVMV 721
              DV+SYG+++ E++           +D   +  + A+ E   L    D  +    +M+
Sbjct: 198 SASDVWSYGIVMWEVMSYGERPY----WDMSNQDVIKAIEEGYRLPPPMDCPIALHQLML 253
Query: 722 AIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
             W  Q++ S RP   ++  ML+ ++  P
Sbjct: 254 DCW--QKERSDRPKFGQIVNMLDKLIRNP 280

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 132/285 (46%), Gaps = 34/285 (11%)
Query: 489 ELGRGAFGTVYKG----FVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY+G     +   +  +VAVK +N      E+ EF  E + +      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLF----------GDSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L+V E M++G L S+L           G   P  +   ++   IA G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++   +  +I DFG    +T D   T+   +G KG    
Sbjct: 143 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 195
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYD-CYQERTLGALVENDLE 707
            ++APE  ++   T   D++S+GV+L EI     T L +  Y     E+ L  +++    
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEI-----TSLAEQPYQGLSNEQVLKFVMDGGYL 250
Query: 708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIP 752
              D    +R   +   C Q +P  RPT   +  +L+  +    P
Sbjct: 251 DQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 294

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 52  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 543 VRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEE 599
           + LLG C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ YL   
Sbjct: 112 LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 167
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ---SHTNTAIRGTKGYVAPEWF 656
              + +H D+  +N +LD+ +  +++DFGL + +   +    H  T  +    ++A E  
Sbjct: 168 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +    T K DV+S+GVLL E++
Sbjct: 228 QTQKFTTKSDVWSFGVLLWELM 249

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 40/280 (14%)
Query: 489 ELGRGAFGTVYKG----FVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY+G     +   +  +VAVK +N      E+ EF  E + +      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLF----------GDSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L+V E M++G L S+L           G   P  +   ++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++   +  +I DFG    +T D   T+   +G KG    
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 196
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            ++APE  ++   T   D++S+GV+L EI  L        A   YQ    E+ L  +++ 
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSL--------AEQPYQGLSNEQVLKFVMDG 248
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
                 D    +R   +   C Q +P  RPT   +  +L+
Sbjct: 249 GYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 120/273 (43%), Gaps = 26/273 (9%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E LG+G FG   K   +  + + + +K+L R  +++++ F  EV  +    H N+++ +G
Sbjct: 16  EVLGKGCFGQAIK-VTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
              + +    + E++  G L   +   DS+  W  R      IA G+ YLH      IIH
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-------------TNTAIRGTKGYVAP 653
            D+   N L+ +  N  ++DFGL +L+  +++                  + G   ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 654 EWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTL--GALVENDLEAMDD 711
           E         KVDV+S+G++L EII  R     D     Y  RT+  G  V   L+    
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIG-RVNADPD-----YLPRTMDFGLNVRGFLDRYCP 245
Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
                 F  + + C   DP  RP+  ++   LE
Sbjct: 246 PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 116/264 (43%), Gaps = 16/264 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           +ELG G FG V  G    G  D VAVK +      SE EF  E   + +  H  LV+  G
Sbjct: 14  KELGSGQFGVVKLGKWK-GQYD-VAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSK---PNWKLRTEIVMGIARGLFYLHEECCTQI 604
            C +     +V E++SNG L ++L    K   P+  L  E+   +  G+ +L      Q 
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL--EMCYDVCEGMAFLESH---QF 125
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           IH D+  +N L+D     ++SDFG+ + +  DQ  ++   +    + APE F     + K
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 665 VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW 724
            DV+++G+L+ E+  L +       YD Y    +   V                  +   
Sbjct: 186 SDVWAFGILMWEVFSLGKM-----PYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYS 240
Query: 725 CIQEDPSHRPTMRRVTQMLEGVVE 748
           C  E P  RPT +++   +E + E
Sbjct: 241 CWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 53  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 543 VRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEE 599
           + LLG C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ YL   
Sbjct: 113 LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 168
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ---SHTNTAIRGTKGYVAPEWF 656
              + +H D+  +N +LD+ +  +++DFGL + +   +    H  T  +    ++A E  
Sbjct: 169 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 228
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +    T K DV+S+GVLL E++
Sbjct: 229 QTQKFTTKSDVWSFGVLLWELM 250

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 543 VRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEE 599
           + LLG C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ YL   
Sbjct: 94  LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 149
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ---SHTNTAIRGTKGYVAPEWF 656
              + +H D+  +N +LD+ +  +++DFGL + +   +    H  T  +    ++A E  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +    T K DV+S+GVLL E++
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELM 231

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 26  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 543 VRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEE 599
           + LLG C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ YL   
Sbjct: 86  LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 141
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ---SHTNTAIRGTKGYVAPEWF 656
              + +H D+  +N +LD+ +  +++DFGL + +   +    H  T  +    ++A E  
Sbjct: 142 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +    T K DV+S+GVLL E++
Sbjct: 202 QTQKFTTKSDVWSFGVLLWELM 223

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 128/276 (46%), Gaps = 50/276 (18%)
Query: 489 ELGRGAFGTVY----KGFVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY    KG V      +VA+K +N      E+ EF  E + + + +  ++V
Sbjct: 17  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 76
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFG----------DSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L++ E M+ G L S+L             + P+     ++   IA G+
Sbjct: 77  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++ + +  +I DFG    +T D   T+   +G KG    
Sbjct: 137 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIXETDXXRKGGKGLLPV 189
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTL-----G 699
            +++PE  ++   T   DV+S+GV+L EI  L        A   YQ    E+ L     G
Sbjct: 190 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATL--------AEQPYQGLSNEQVLRFVMEG 241
Query: 700 ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPT 735
            L++      D +  L R       C Q +P  RP+
Sbjct: 242 GLLDKPDNCPDMLLELMRM------CWQYNPKMRPS 271

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 543 VRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEE 599
           + LLG C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ YL   
Sbjct: 92  LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 147
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ---SHTNTAIRGTKGYVAPEWF 656
              + +H D+  +N +LD+ +  +++DFGL + +   +    H  T  +    ++A E  
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 207
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +    T K DV+S+GVLL E++
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELM 229

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 543 VRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEE 599
           + LLG C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ YL   
Sbjct: 93  LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 148
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ---SHTNTAIRGTKGYVAPEWF 656
              + +H D+  +N +LD+ +  +++DFGL + +   +    H  T  +    ++A E  
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +    T K DV+S+GVLL E++
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELM 230

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 543 VRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEE 599
           + LLG C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ YL   
Sbjct: 91  LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 146
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ---SHTNTAIRGTKGYVAPEWF 656
              + +H D+  +N +LD+ +  +++DFGL + +   +    H  T  +    ++A E  
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 206
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +    T K DV+S+GVLL E++
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELM 228

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 543 VRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEE 599
           + LLG C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ YL   
Sbjct: 89  LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 144
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ---SHTNTAIRGTKGYVAPEWF 656
              + +H D+  +N +LD+ +  +++DFGL + +   +    H  T  +    ++A E  
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +    T K DV+S+GVLL E++
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELM 226

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 543 VRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEE 599
           + LLG C   EG + L+V  +M +G L +F+  ++  P  K      + +A+G+ YL   
Sbjct: 94  LSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 149
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ---SHTNTAIRGTKGYVAPEWF 656
              + +H D+  +N +LD+ +  +++DFGL + +   +    H  T  +    ++A E  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
           +    T K DV+S+GVLL E++
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELM 231

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 134/284 (47%), Gaps = 40/284 (14%)
Query: 489 ELGRGAFGTVY----KGFVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY    KG V      +VA+K +N      E+ EF  E + + + +  ++V
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFG----------DSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L++ E M+ G L S+L             + P+     ++   IA G+
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++ + +  +I DFG    +T D   T+   +G KG    
Sbjct: 139 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 191
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            +++PE  ++   T   DV+S+GV+L EI  L        A   YQ    E+ L  ++E 
Sbjct: 192 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATL--------AEQPYQGLSNEQVLRFVMEG 243
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            L    D      F ++ + C Q +P  RP+   +   ++  +E
Sbjct: 244 GLLDKPDNCPDMLFELMRM-CWQYNPKMRPSFLEIISSIKEEME 286

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 134/284 (47%), Gaps = 40/284 (14%)
Query: 489 ELGRGAFGTVY----KGFVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY    KG V      +VA+K +N      E+ EF  E + + + +  ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFG----------DSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L++ E M+ G L S+L             + P+     ++   IA G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++ + +  +I DFG    +T D   T+   +G KG    
Sbjct: 152 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 204
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            +++PE  ++   T   DV+S+GV+L EI  L        A   YQ    E+ L  ++E 
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATL--------AEQPYQGLSNEQVLRFVMEG 256
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            L    D      F ++ + C Q +P  RP+   +   ++  +E
Sbjct: 257 GLLDKPDNCPDMLFELMRM-CWQYNPKMRPSFLEIISSIKEEME 299

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 134/284 (47%), Gaps = 40/284 (14%)
Query: 489 ELGRGAFGTVY----KGFVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY    KG V      +VA+K +N      E+ EF  E + + + +  ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFG----------DSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L++ E M+ G L S+L             + P+     ++   IA G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 151
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++ + +  +I DFG    +T D   T+   +G KG    
Sbjct: 152 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 204
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            +++PE  ++   T   DV+S+GV+L EI  L        A   YQ    E+ L  ++E 
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATL--------AEQPYQGLSNEQVLRFVMEG 256
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            L    D      F ++ + C Q +P  RP+   +   ++  +E
Sbjct: 257 GLLDKPDNCPDMLFELMRM-CWQYNPKMRPSFLEIISSIKEEME 299

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 134/284 (47%), Gaps = 40/284 (14%)
Query: 489 ELGRGAFGTVY----KGFVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY    KG V      +VA+K +N      E+ EF  E + + + +  ++V
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFG----------DSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L++ E M+ G L S+L             + P+     ++   IA G+
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++ + +  +I DFG    +T D   T+   +G KG    
Sbjct: 146 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 198
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            +++PE  ++   T   DV+S+GV+L EI  L        A   YQ    E+ L  ++E 
Sbjct: 199 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATL--------AEQPYQGLSNEQVLRFVMEG 250
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            L    D      F ++ + C Q +P  RP+   +   ++  +E
Sbjct: 251 GLLDKPDNCPDMLFELMRM-CWQYNPKMRPSFLEIISSIKEEME 293

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 134/284 (47%), Gaps = 40/284 (14%)
Query: 489 ELGRGAFGTVY----KGFVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY    KG V      +VA+K +N      E+ EF  E + + + +  ++V
Sbjct: 23  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 82
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFG----------DSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L++ E M+ G L S+L             + P+     ++   IA G+
Sbjct: 83  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 142
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++ + +  +I DFG    +T D   T+   +G KG    
Sbjct: 143 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 195
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            +++PE  ++   T   DV+S+GV+L EI  L        A   YQ    E+ L  ++E 
Sbjct: 196 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATL--------AEQPYQGLSNEQVLRFVMEG 247
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            L    D      F ++ + C Q +P  RP+   +   ++  +E
Sbjct: 248 GLLDKPDNCPDMLFELMRM-CWQYNPKMRPSFLEIISSIKEEME 290

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 134/284 (47%), Gaps = 40/284 (14%)
Query: 489 ELGRGAFGTVY----KGFVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY    KG V      +VA+K +N      E+ EF  E + + + +  ++V
Sbjct: 22  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 81
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFG----------DSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L++ E M+ G L S+L             + P+     ++   IA G+
Sbjct: 82  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++ + +  +I DFG    +T D   T+   +G KG    
Sbjct: 142 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 194
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            +++PE  ++   T   DV+S+GV+L EI  L        A   YQ    E+ L  ++E 
Sbjct: 195 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATL--------AEQPYQGLSNEQVLRFVMEG 246
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            L    D      F ++ + C Q +P  RP+   +   ++  +E
Sbjct: 247 GLLDKPDNCPDMLFELMRM-CWQYNPKMRPSFLEIISSIKEEME 289

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 129/280 (46%), Gaps = 40/280 (14%)
Query: 489 ELGRGAFGTVYKG----FVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY+G     +   +  +VAVK +N      E+ EF  E + +      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLF----------GDSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L+V E M++G L S+L           G   P  +   ++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++   +  +I DFG    +T D   T    +G KG    
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG----MTRDIYETAYYRKGGKGLLPV 196
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            ++APE  ++   T   D++S+GV+L EI  L        A   YQ    E+ L  +++ 
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSL--------AEQPYQGLSNEQVLKFVMDG 248
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
                 D    +R   +   C Q +P  RPT   +  +L+
Sbjct: 249 GYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 129/271 (47%), Gaps = 40/271 (14%)
Query: 489 ELGRGAFGTVY----KGFVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY    KG V      +VA+K +N      E+ EF  E + + + +  ++V
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFG----------DSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L++ E M+ G L S+L             + P+     ++   IA G+
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++ + +  +I DFG    +T D   T+   +G KG    
Sbjct: 145 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 197
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            +++PE  ++   T   DV+S+GV+L EI  L        A   YQ    E+ L  ++E 
Sbjct: 198 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATL--------AEQPYQGLSNEQVLRFVMEG 249
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPT 735
            L    D      F ++ + C Q +P  RP+
Sbjct: 250 GLLDKPDNCPDMLFELMRM-CWQYNPKMRPS 279

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 129/271 (47%), Gaps = 40/271 (14%)
Query: 489 ELGRGAFGTVY----KGFVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY    KG V      +VA+K +N      E+ EF  E + + + +  ++V
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFG----------DSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L++ E M+ G L S+L             + P+     ++   IA G+
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++ + +  +I DFG    +T D   T+   +G KG    
Sbjct: 145 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 197
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            +++PE  ++   T   DV+S+GV+L EI  L        A   YQ    E+ L  ++E 
Sbjct: 198 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATL--------AEQPYQGLSNEQVLRFVMEG 249
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPT 735
            L    D      F ++ + C Q +P  RP+
Sbjct: 250 GLLDKPDNCPDMLFELMRM-CWQYNPKMRPS 279

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 133/288 (46%), Gaps = 40/288 (13%)
Query: 489 ELGRGAFGTVYKG----FVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY+G     +   +  +VAVK +N      E+ EF  E + +      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLF----------GDSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L+V E M++G L S+L           G   P  +   ++   IA G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H ++  +N ++   +  +I DFG    +T D   T+   +G KG    
Sbjct: 145 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 197
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            ++APE  ++   T   D++S+GV+L EI  L        A   YQ    E+ L  +++ 
Sbjct: 198 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSL--------AEQPYQGLSNEQVLKFVMDG 249
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIP 752
                 D    +R   +   C Q +P+ RPT   +  +L+  +    P
Sbjct: 250 GYLDQPD-NCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP 296

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 134/284 (47%), Gaps = 40/284 (14%)
Query: 489 ELGRGAFGTVY----KGFVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY    KG V      +VA+K +N      E+ EF  E + + + +  ++V
Sbjct: 54  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 113
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFG----------DSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L++ E M+ G L S+L             + P+     ++   IA G+
Sbjct: 114 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 173
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N ++ + +  +I DFG    +T D   T+   +G KG    
Sbjct: 174 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 226
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            +++PE  ++   T   DV+S+GV+L EI  L        A   YQ    E+ L  ++E 
Sbjct: 227 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATL--------AEQPYQGLSNEQVLRFVMEG 278
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            L    D      F ++ + C Q +P  RP+   +   ++  +E
Sbjct: 279 GLLDKPDNCPDMLFELMRM-CWQYNPKMRPSFLEIISSIKEEME 321

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 129/276 (46%), Gaps = 32/276 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLL 546
           +G G FG V  G + +    +  VA+K L   + + ++ +F  E + +GQ  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
           G   + +  ++V E+M NG+L +FL   D +        ++ GI+ G+ YL +      +
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSD---MGYV 146
Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPIT 662
           H D+  +NIL++     ++SDFGL ++L  D     T  RG K    + APE       T
Sbjct: 147 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT-RGGKIPIRWTAPEAIAFRKFT 205
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND-LEAMDD-------MTV 714
              DV+SYG+++ E++              Y ER    +   D ++A+++       M  
Sbjct: 206 SASDVWSYGIVMWEVV-------------SYGERPYWEMTNQDVIKAVEEGYRLPSPMDC 252
Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
                 + + C Q++ + RP    +  ML+ ++  P
Sbjct: 253 PAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIRNP 288

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 122/290 (42%), Gaps = 38/290 (13%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQ----VAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
            K ELG GAFG V+    +    +Q    VAVK L    + + ++F+ E   +    H++
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT----------------EI 585
           +VR  G C EGR  L+V+E+M +G L  FL     P+ KL                   +
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG-PDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 586 VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNTAI 644
              +A G+ YL        +H D+  +N L+      +I DFG+ + + + D        
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR----TILTDWAYDCYQERTLGA 700
                ++ PE       T + DV+S+GV+L EI    +     +    A DC    T G 
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI---TQGR 277
Query: 701 LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
            +E       ++  + R       C Q +P  R +++ V   L+ + + P
Sbjct: 278 ELERPRACPPEVYAIMR------GCWQREPQQRHSIKDVHARLQALAQAP 321

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 131/280 (46%), Gaps = 40/280 (14%)
Query: 489 ELGRGAFGTVYKG----FVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY+G     +   +  +VAVK +N      E+ EF  E + +      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLF----------GDSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L+V E M++G L S+L           G   P  +   ++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H ++  +N ++   +  +I DFG    +T D   T+   +G KG    
Sbjct: 144 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 196
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTLGALVEN 704
            ++APE  ++   T   D++S+GV+L EI  L        A   YQ    E+ L  +++ 
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSL--------AEQPYQGLSNEQVLKFVMDG 248
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
                 D    +R   +   C Q +P+ RPT   +  +L+
Sbjct: 249 GYLDQPD-NCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEK-EFKAEVNGIGQTHHKNLVR 544
           +ELG G FGTV KG+  M    +    K+  N     + K E  AE N + Q  +  +VR
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           ++G C E  + +LV E    G L  +L  +     K   E+V  ++ G+ YL E   +  
Sbjct: 91  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 146
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT--KGYVAPEWFRNMPIT 662
           +H D+  +N+LL   + A+ISDFGL K L  D+++      G     + APE       +
Sbjct: 147 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 206
Query: 663 VKVDVYSYGVLLLE 676
            K DV+S+GVL+ E
Sbjct: 207 SKSDVWSFGVLMWE 220

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEK-EFKAEVNGIGQTHHKNLVR 544
           +ELG G FGTV KG+  M    +    K+  N     + K E  AE N + Q  +  +VR
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           ++G C E  + +LV E    G L  +L  +     K   E+V  ++ G+ YL E   +  
Sbjct: 93  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 148
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT--KGYVAPEWFRNMPIT 662
           +H D+  +N+LL   + A+ISDFGL K L  D+++      G     + APE       +
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 663 VKVDVYSYGVLLLE 676
            K DV+S+GVL+ E
Sbjct: 209 SKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEK-EFKAEVNGIGQTHHKNLVR 544
           +ELG G FGTV KG+  M    +    K+  N     + K E  AE N + Q  +  +VR
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           ++G C E  + +LV E    G L  +L  +     K   E+V  ++ G+ YL E   +  
Sbjct: 93  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 148
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT--KGYVAPEWFRNMPIT 662
           +H D+  +N+LL   + A+ISDFGL K L  D+++      G     + APE       +
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 663 VKVDVYSYGVLLLE 676
            K DV+S+GVL+ E
Sbjct: 209 SKSDVWSFGVLMWE 222

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 122/290 (42%), Gaps = 38/290 (13%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQ----VAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
            K ELG GAFG V+    +    +Q    VAVK L    + + ++F+ E   +    H++
Sbjct: 16  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT----------------EI 585
           +VR  G C EGR  L+V+E+M +G L  FL     P+ KL                   +
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG-PDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 586 VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNTAI 644
              +A G+ YL        +H D+  +N L+      +I DFG+ + + + D        
Sbjct: 135 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 191
Query: 645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR----TILTDWAYDCYQERTLGA 700
                ++ PE       T + DV+S+GV+L EI    +     +    A DC    T G 
Sbjct: 192 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI---TQGR 248
Query: 701 LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
            +E       ++  + R       C Q +P  R +++ V   L+ + + P
Sbjct: 249 ELERPRACPPEVYAIMR------GCWQREPQQRHSIKDVHARLQALAQAP 292

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEK-EFKAEVNGIGQTHHKNLVR 544
           +ELG G FGTV KG+  M    +    K+  N     + K E  AE N + Q  +  +VR
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           ++G C E  + +LV E    G L  +L  +     K   E+V  ++ G+ YL E   +  
Sbjct: 436 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 491
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT--KGYVAPEWFRNMPIT 662
           +H D+  +N+LL   + A+ISDFGL K L  D+++      G     + APE       +
Sbjct: 492 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 551
Query: 663 VKVDVYSYGVLLLE 676
            K DV+S+GVL+ E
Sbjct: 552 SKSDVWSFGVLMWE 565

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEK-EFKAEVNGIGQTHHKNLVR 544
           +ELG G FGTV KG+  M    +    K+  N     + K E  AE N + Q  +  +VR
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           ++G C E  + +LV E    G L  +L  +     K   E+V  ++ G+ YL E   +  
Sbjct: 435 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 490
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT--KGYVAPEWFRNMPIT 662
           +H D+  +N+LL   + A+ISDFGL K L  D+++      G     + APE       +
Sbjct: 491 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 550
Query: 663 VKVDVYSYGVLLLE 676
            K DV+S+GVL+ E
Sbjct: 551 SKSDVWSFGVLMWE 564

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 122/290 (42%), Gaps = 38/290 (13%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQ----VAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
            K ELG GAFG V+    +    +Q    VAVK L    + + ++F+ E   +    H++
Sbjct: 22  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT----------------EI 585
           +VR  G C EGR  L+V+E+M +G L  FL     P+ KL                   +
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG-PDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 586 VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNTAI 644
              +A G+ YL        +H D+  +N L+      +I DFG+ + + + D        
Sbjct: 141 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 197
Query: 645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR----TILTDWAYDCYQERTLGA 700
                ++ PE       T + DV+S+GV+L EI    +     +    A DC    T G 
Sbjct: 198 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI---TQGR 254
Query: 701 LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
            +E       ++  + R       C Q +P  R +++ V   L+ + + P
Sbjct: 255 ELERPRACPPEVYAIMR------GCWQREPQQRHSIKDVHARLQALAQAP 298

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 92/329 (27%), Positives = 145/329 (44%), Gaps = 66/329 (20%)
Query: 462 EEQGVSYMNLRCFTYKELVEVTRG---FKEELGRGAFGTVYKGFV-NMGSSD---QVAVK 514
           E    ++++     Y E  E  R    F + LG GAFG V +     +G  D   +VAVK
Sbjct: 8   EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK 67
Query: 515 KLNRVFQDSEKE-FKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL- 571
            L       EKE   +E+  +     H+N+V LLG C  G   L++ E+   G L +FL 
Sbjct: 68  MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 127
Query: 572 ------FG---------------DSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIHCD 608
                  G               D +P  +LR  +     +A+G+ +L  + C   IH D
Sbjct: 128 RKAEAMLGPSLAPGQDPEGLDKEDGRP-LELRDLLHFSSQVAQGMAFLASKNC---IHRD 183
Query: 609 IKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK----GYVAPEWFRNMPITVK 664
           +  +N+LL + + A+I DFGL + +  D   +N  ++G       ++APE   +   TV+
Sbjct: 184 VAARNVLLTNGHVAKIGDFGLARDIMND---SNYIVKGNARLPVKWMAPESIFDCVYTVQ 240
Query: 665 VDVYSYGVLLLEIICLRRT----ILTDWAY-----DCYQERTLGALVENDLEAMDDMTVL 715
            DV+SYG+LL EI  L       IL +  +     D YQ        +N           
Sbjct: 241 SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYS-------- 292
Query: 716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
              +M A W +  +P+HRPT +++   L+
Sbjct: 293 ---IMQACWAL--EPTHRPTFQQICSFLQ 316

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEK-EFKAEVNGIGQTHHKNLVR 544
           +ELG G FGTV KG+  M    +    K+  N     + K E  AE N + Q  +  +VR
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           ++G C E  + +LV E    G L  +L  +     K   E+V  ++ G+ YL E   +  
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 128
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT--KGYVAPEWFRNMPIT 662
           +H D+  +N+LL   + A+ISDFGL K L  D+++      G     + APE       +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 663 VKVDVYSYGVLLLE 676
            K DV+S+GVL+ E
Sbjct: 189 SKSDVWSFGVLMWE 202

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEK-EFKAEVNGIGQTHHKNLVR 544
           +ELG G FGTV KG+  M    +    K+  N     + K E  AE N + Q  +  +VR
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           ++G C E  + +LV E    G L  +L  +     K   E+V  ++ G+ YL E   +  
Sbjct: 83  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 138
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT--KGYVAPEWFRNMPIT 662
           +H D+  +N+LL   + A+ISDFGL K L  D+++      G     + APE       +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 663 VKVDVYSYGVLLLE 676
            K DV+S+GVL+ E
Sbjct: 199 SKSDVWSFGVLMWE 212

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEK-EFKAEVNGIGQTHHKNLVR 544
           +ELG G FGTV KG+  M    +    K+  N     + K E  AE N + Q  +  +VR
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           ++G C E  + +LV E    G L  +L  +     K   E+V  ++ G+ YL E   +  
Sbjct: 77  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 132
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT--KGYVAPEWFRNMPIT 662
           +H D+  +N+LL   + A+ISDFGL K L  D+++      G     + APE       +
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 663 VKVDVYSYGVLLLE 676
            K DV+S+GVL+ E
Sbjct: 193 SKSDVWSFGVLMWE 206

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEK-EFKAEVNGIGQTHHKNLVR 544
           +ELG G FGTV KG+  M    +    K+  N     + K E  AE N + Q  +  +VR
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           ++G C E  + +LV E    G L  +L  +     K   E+V  ++ G+ YL E   +  
Sbjct: 71  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 126
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT--KGYVAPEWFRNMPIT 662
           +H D+  +N+LL   + A+ISDFGL K L  D+++      G     + APE       +
Sbjct: 127 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 186
Query: 663 VKVDVYSYGVLLLE 676
            K DV+S+GVL+ E
Sbjct: 187 SKSDVWSFGVLMWE 200

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 486 FKEELGRGAFGTVYKGFVNM-GSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQT-HHKNL 542
           F++ +G G FG V K  +   G     A+K++     +D  ++F  E+  + +  HH N+
Sbjct: 19  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFG----DSKPNWKLRT------------EIV 586
           + LLG C+      L  E+  +G L  FL      ++ P + +                 
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 587 MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG 646
             +ARG+ YL ++   Q IH D+  +NIL+ + Y A+I+DFGL +            ++ 
Sbjct: 139 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 188
Query: 647 TKGYVAPEWFR----NMPI-TVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQERTLGA 700
           T G +   W      N  + T   DV+SYGVLL EI+ L  T        + Y++   G 
Sbjct: 189 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 248
Query: 701 LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            +E  L   D++  L R       C +E P  RP+  ++   L  ++E
Sbjct: 249 RLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSLNRMLE 290

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 123/260 (47%), Gaps = 21/260 (8%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG +V  G + +  VA+K LN      +  EF  E   +    H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNW--KLRTEIVMGIARGLFYLHEECCTQ 603
           LG C     +L V + M +G L  ++  + K N   +L     + IA+G+ YL E    +
Sbjct: 106 LGVCLSPTIQL-VTQLMPHGCLLEYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEER---R 160
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT-AIRGTKGYVAPEWFRNMPIT 662
           ++H D+  +N+L+    + +I+DFGL +LL  D+   N    +    ++A E       T
Sbjct: 161 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 220
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQRFVM 720
            + DV+SYGV + E++           YD    R +  L+E    L      T+    VM
Sbjct: 221 HQSDVWSYGVTIWELMTFGGK-----PYDGIPTREIPDLLEKGERLPQPPICTIDVYMVM 275
Query: 721 VAIWCIQEDPSHRPTMRRVT 740
           V  W I  D   RP  + + 
Sbjct: 276 VKCWMIDAD--SRPKFKELA 293

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 486 FKEELGRGAFGTVYKGFVNM-GSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQT-HHKNL 542
           F++ +G G FG V K  +   G     A+K++     +D  ++F  E+  + +  HH N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFG----DSKPNWKLRT------------EIV 586
           + LLG C+      L  E+  +G L  FL      ++ P + +                 
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 587 MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG 646
             +ARG+ YL ++   Q IH D+  +NIL+ + Y A+I+DFGL +            ++ 
Sbjct: 149 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 198
Query: 647 TKGYVAPEWFR----NMPI-TVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQERTLGA 700
           T G +   W      N  + T   DV+SYGVLL EI+ L  T        + Y++   G 
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258
Query: 701 LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            +E  L   D++  L R       C +E P  RP+  ++   L  ++E
Sbjct: 259 RLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSLNRMLE 300

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 96/194 (49%), Gaps = 9/194 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEK-EFKAEVNGIGQTHHKNLVR 544
           +ELG G FGTV KG+  M    +    K+  N     + K E  AE N + Q  +  +VR
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           ++G C E  + +LV E    G L  +L  +     K   E+V  ++ G+ YL E   +  
Sbjct: 77  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 132
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT--KGYVAPEWFRNMPIT 662
           +H D+  +N+LL   + A+ISDFGL K L  D++       G     + APE       +
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 663 VKVDVYSYGVLLLE 676
            K DV+S+GVL+ E
Sbjct: 193 SKSDVWSFGVLMWE 206

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 123/260 (47%), Gaps = 21/260 (8%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG +V  G + +  VA+K LN      +  EF  E   +    H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNW--KLRTEIVMGIARGLFYLHEECCTQ 603
           LG C     +L V + M +G L  ++  + K N   +L     + IA+G+ YL E    +
Sbjct: 83  LGVCLSPTIQL-VTQLMPHGCLLEYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEER---R 137
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT-AIRGTKGYVAPEWFRNMPIT 662
           ++H D+  +N+L+    + +I+DFGL +LL  D+   N    +    ++A E       T
Sbjct: 138 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 197
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQRFVM 720
            + DV+SYGV + E++           YD    R +  L+E    L      T+    VM
Sbjct: 198 HQSDVWSYGVTIWELMTFGGK-----PYDGIPTREIPDLLEKGERLPQPPICTIDVYMVM 252
Query: 721 VAIWCIQEDPSHRPTMRRVT 740
           V  W I  D   RP  + + 
Sbjct: 253 VKCWMI--DADSRPKFKELA 270

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 127/276 (46%), Gaps = 50/276 (18%)
Query: 489 ELGRGAFGTVY----KGFVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLV 543
           ELG+G+FG VY    KG V      +VA+K +N      E+ EF  E + + + +  ++V
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFG----------DSKPNWKLRTEIVMGIARGL 593
           RLLG   +G+  L++ E M+ G L S+L             + P+     ++   IA G+
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG---- 649
            YL+     + +H D+  +N  + + +  +I DFG    +T D   T+   +G KG    
Sbjct: 139 AYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 191
Query: 650 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----ERTL-----G 699
            +++PE  ++   T   DV+S+GV+L EI  L        A   YQ    E+ L     G
Sbjct: 192 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATL--------AEQPYQGLSNEQVLRFVMEG 243
Query: 700 ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPT 735
            L++      D +  L R       C Q +P  RP+
Sbjct: 244 GLLDKPDNCPDMLLELMRM------CWQYNPKMRPS 273

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 486 FKEELGRGAFGTVYKGFVNM-GSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQT-HHKNL 542
           F++ +G G FG V K  +   G     A+K++     +D  ++F  E+  + +  HH N+
Sbjct: 26  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFG----DSKPNWKLRT------------EIV 586
           + LLG C+      L  E+  +G L  FL      ++ P + +                 
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 587 MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG 646
             +ARG+ YL ++   Q IH ++  +NIL+ + Y A+I+DFGL +            ++ 
Sbjct: 146 ADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 195
Query: 647 TKGYVAPEWFR----NMPI-TVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQERTLGA 700
           T G +   W      N  + T   DV+SYGVLL EI+ L  T        + Y++   G 
Sbjct: 196 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 255
Query: 701 LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            +E  L   D++  L R       C +E P  RP+  ++   L  ++E
Sbjct: 256 RLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSLNRMLE 297

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTHHKNLVRL 545
           + +G G+FGTVYKG  +      VAVK LN      ++   FK EV  + +T H N++  
Sbjct: 18  QRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 73
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           +GY  + +   +V ++    +L   L   ++K   K   +I    ARG+ YLH +    I
Sbjct: 74  MGYSTKPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---I 129
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGYVAPEWFR---NMP 660
           IH D+K  NI L +    +I DFGL  + +    SH    + G+  ++APE  R   + P
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 661 ITVKVDVYSYGVLLLEIIC 679
            + + DVY++G++L E++ 
Sbjct: 190 YSFQSDVYAFGIVLYELMT 208

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 8/193 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           ++LG G FG V+ G+ N  +S +VAVK L +    S + F  E N +    H  LVRL  
Sbjct: 18  KKLGAGQFGEVWMGYYN--NSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 74
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQII 605
              +     ++ EFM+ G+L  FL  D      L   I     IA G+ Y+  +     I
Sbjct: 75  VVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 131
Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 665
           H D++  N+L+ +    +I+DFGL +++  ++       +    + APE       T+K 
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 191
Query: 666 DVYSYGVLLLEII 678
           +V+S+G+LL EI+
Sbjct: 192 NVWSFGILLYEIV 204

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 94/193 (48%), Gaps = 8/193 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           + LG G FG V+ G+ N  +S +VAVK L +    S + F  E N +    H  LVRL  
Sbjct: 19  KRLGAGQFGEVWMGYYN--NSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 75
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQII 605
                    ++ E+M+ G+L  FL  D      L   I     IA G+ Y+  +     I
Sbjct: 76  VVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 132
Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 665
           H D++  N+L+ +    +I+DFGL +++  ++       +    + APE       T+K 
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 192
Query: 666 DVYSYGVLLLEII 678
           DV+S+G+LL EI+
Sbjct: 193 DVWSFGILLYEIV 205

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSD----QVAVKKLNRVFQDS-EKEFKAEVNGIGQTHHKNLVR 544
           LG GAFG VY+G V+   +D    QVAVK L  V+ +  E +F  E   I + +H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--------GIARGLFYL 596
            +G   +   R ++ E M+ G L SFL  +++P     + + M         IA G  YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 597 HEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYV 651
            E      IH DI  +N LL        A+I DFG+ + +     +     A+   K ++
Sbjct: 172 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WM 227
Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICL 680
            PE F     T K D +S+GVLL EI  L
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSL 256

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 15/199 (7%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTHHKNLVRL 545
           + +G G+FGTVYKG  +      VAVK LN      ++   FK EV  + +T H N++  
Sbjct: 30  QRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           +GY  + +   +V ++    +L   L   ++K   K   +I    ARG+ YLH +    I
Sbjct: 86  MGYSTKPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGYVAPEWFR---NMP 660
           IH D+K  NI L +    +I DFGL    +    SH    + G+  ++APE  R   + P
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 661 ITVKVDVYSYGVLLLEIIC 679
            + + DVY++G++L E++ 
Sbjct: 202 YSFQSDVYAFGIVLYELMT 220

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 20/261 (7%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 274 KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 330
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G+L  FL G++    +L   + M   IA G+ Y+        +H
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 386
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPITV 663
            D++  NIL+ +    +++DFGL +L+   + +  TA +G K    + APE       T+
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+S+G+LL E+    R       Y     R +   VE            +    +  
Sbjct: 444 KSDVWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 498
Query: 724 WCIQEDPSHRPTMRRVTQMLE 744
            C +++P  RPT   +   LE
Sbjct: 499 QCWRKEPEERPTFEYLQAFLE 519

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTHHKNLVRL 545
           + +G G+FGTVYKG  +      VAVK LN      ++   FK EV  + +T H N++  
Sbjct: 30  QRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           +GY        +V ++    +L   L   ++K   K   +I    ARG+ YLH +    I
Sbjct: 86  MGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGYVAPEWFR---NMP 660
           IH D+K  NI L +    +I DFGL    +    SH    + G+  ++APE  R   + P
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 661 ITVKVDVYSYGVLLLEIIC 679
            + + DVY++G++L E++ 
Sbjct: 202 YSFQSDVYAFGIVLYELMT 220

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 113/258 (43%), Gaps = 14/258 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 25  KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 81
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G+L  FL G+     +L   + M   IA G+ Y+        +H
Sbjct: 82  VSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D++  NIL+ +    +++DFGL +L+  ++       +    + APE       T+K D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           V+S+G+LL E+    R       Y     R +   VE            +    +   C 
Sbjct: 198 VWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 252
Query: 727 QEDPSHRPTMRRVTQMLE 744
           ++DP  RPT   +   LE
Sbjct: 253 RKDPEERPTFEYLQAFLE 270

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 119/261 (45%), Gaps = 20/261 (7%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L +    S + F  E   + +  H+ LV+L   
Sbjct: 192 KLGQGCFGEVWMGTWN--GTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAV 248
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G+L  FL G+     +L   + M   IA G+ Y+        +H
Sbjct: 249 VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 304
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPITV 663
            D++  NIL+ +    +++DFGL +L+   + +  TA +G K    + APE       T+
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 361
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+S+G+LL E+    R       Y     R +   VE            +    +  
Sbjct: 362 KSDVWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 416
Query: 724 WCIQEDPSHRPTMRRVTQMLE 744
            C ++DP  RPT   +   LE
Sbjct: 417 QCWRKDPEERPTFEYLQAFLE 437

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 114/258 (44%), Gaps = 14/258 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 15  KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 71
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G+L  FL G++    +L   + M   IA G+ Y+        +H
Sbjct: 72  VSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 127
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D++  NIL+ +    +++DFGL +L+  ++       +    + APE       T+K D
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           V+S+G+LL E+    R       Y     R +   VE            +    +   C 
Sbjct: 188 VWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 242
Query: 727 QEDPSHRPTMRRVTQMLE 744
           +++P  RPT   +   LE
Sbjct: 243 RKEPEERPTFEYLQAFLE 260

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 11/196 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSD-QVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNLVRLL 546
           ELG G FG+V +G   M      VA+K L +  + ++ +E   E   + Q  +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSK--PNWKLRTEIVMGIARGLFYLHEECCTQI 604
           G C +    +LV E    G L  FL G  +  P   +  E++  ++ G+ YL E+     
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYLEEK---NF 131
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--TNTAIRGTKGYVAPEWFRNMPIT 662
           +H D+  +N+LL + + A+ISDFGL K L  D S+    +A +    + APE       +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 663 VKVDVYSYGVLLLEII 678
            + DV+SYGV + E +
Sbjct: 192 SRSDVWSYGVTMWEAL 207

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 113/258 (43%), Gaps = 14/258 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 25  KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKIRHEKLVQLYAV 81
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G+L  FL G+     +L   + M   IA G+ Y+        +H
Sbjct: 82  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D++  NIL+ +    +++DFGL +L+  ++       +    + APE       T+K D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           V+S+G+LL E+    R       Y     R +   VE            +    +   C 
Sbjct: 198 VWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 252
Query: 727 QEDPSHRPTMRRVTQMLE 744
           ++DP  RPT   +   LE
Sbjct: 253 RKDPEERPTFEYLQAFLE 270

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 113/258 (43%), Gaps = 14/258 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 25  KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 81
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G+L  FL G+     +L   + M   IA G+ Y+        +H
Sbjct: 82  VSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D++  NIL+ +    +++DFGL +L+  ++       +    + APE       T+K D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           V+S+G+LL E+    R       Y     R +   VE            +    +   C 
Sbjct: 198 VWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 252
Query: 727 QEDPSHRPTMRRVTQMLE 744
           ++DP  RPT   +   LE
Sbjct: 253 RKDPEERPTFEYLQAFLE 270

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 95/194 (48%), Gaps = 7/194 (3%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 36  MKHKLGGGQYGEVYVG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 93
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQ 603
           LG C       +V E+M  G L  +L   ++        + M   I+  + YL ++    
Sbjct: 94  LGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKK---N 150
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 151 FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSI 210
Query: 664 KVDVYSYGVLLLEI 677
           K DV+++GVLL EI
Sbjct: 211 KSDVWAFGVLLWEI 224

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSD----QVAVKKLNRVFQDS-EKEFKAEVNGIGQTHHKNLVR 544
           LG GAFG VY+G V+   +D    QVAVK L  V  +  E +F  E   I + +H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--------GIARGLFYL 596
            +G   +   R ++ E M+ G L SFL  +++P     + + M         IA G  YL
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 597 HEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYV 651
            E      IH DI  +N LL        A+I DFG+ + +     +     A+   K ++
Sbjct: 158 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WM 213
Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICL 680
            PE F     T K D +S+GVLL EI  L
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFSL 242

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSD----QVAVKKLNRVFQDS-EKEFKAEVNGIGQTHHKNLVR 544
           LG GAFG VY+G V+   +D    QVAVK L  V  +  E +F  E   I + +H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--------GIARGLFYL 596
            +G   +   R ++ E M+ G L SFL  +++P     + + M         IA G  YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 597 HEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYV 651
            E      IH DI  +N LL        A+I DFG+ + +     +     A+   K ++
Sbjct: 172 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WM 227
Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICL 680
            PE F     T K D +S+GVLL EI  L
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSL 256

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 113/258 (43%), Gaps = 14/258 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 16  KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 72
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G+L  FL G+     +L   + M   IA G+ Y+        +H
Sbjct: 73  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 128
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D++  NIL+ +    +++DFGL +L+  ++       +    + APE       T+K D
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           V+S+G+LL E+    R       Y     R +   VE            +    +   C 
Sbjct: 189 VWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 243
Query: 727 QEDPSHRPTMRRVTQMLE 744
           ++DP  RPT   +   LE
Sbjct: 244 RKDPEERPTFEYLQAFLE 261

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 113/258 (43%), Gaps = 14/258 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 14  KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 70
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G+L  FL G+     +L   + M   IA G+ Y+        +H
Sbjct: 71  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 126
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D++  NIL+ +    +++DFGL +L+  ++       +    + APE       T+K D
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 186
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           V+S+G+LL E+    R       Y     R +   VE            +    +   C 
Sbjct: 187 VWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 241
Query: 727 QEDPSHRPTMRRVTQMLE 744
           ++DP  RPT   +   LE
Sbjct: 242 RKDPEERPTFEYLQAFLE 259

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSD----QVAVKKLNRVFQDS-EKEFKAEVNGIGQTHHKNLVR 544
           LG GAFG VY+G V+   +D    QVAVK L  V  +  E +F  E   I + +H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--------GIARGLFYL 596
            +G   +   R ++ E M+ G L SFL  +++P     + + M         IA G  YL
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 597 HEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYV 651
            E      IH DI  +N LL        A+I DFG+ + +     +     A+   K ++
Sbjct: 157 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WM 212
Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICL 680
            PE F     T K D +S+GVLL EI  L
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 113/258 (43%), Gaps = 14/258 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 25  KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 81
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G+L  FL G+     +L   + M   IA G+ Y+        +H
Sbjct: 82  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D++  NIL+ +    +++DFGL +L+  ++       +    + APE       T+K D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           V+S+G+LL E+    R       Y     R +   VE            +    +   C 
Sbjct: 198 VWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 252
Query: 727 QEDPSHRPTMRRVTQMLE 744
           ++DP  RPT   +   LE
Sbjct: 253 RKDPEERPTFEYLQAFLE 270

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSD----QVAVKKLNRVFQDS-EKEFKAEVNGIGQTHHKNLVR 544
           LG GAFG VY+G V+   +D    QVAVK L  V  +  E +F  E   I + +H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--------GIARGLFYL 596
            +G   +   R ++ E M+ G L SFL  +++P     + + M         IA G  YL
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 597 HEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYV 651
            E      IH DI  +N LL        A+I DFG+ + +     +     A+   K ++
Sbjct: 172 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WM 227
Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICL 680
            PE F     T K D +S+GVLL EI  L
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSL 256

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSD----QVAVKKLNRVFQDS-EKEFKAEVNGIGQTHHKNLVR 544
           LG GAFG VY+G V+   +D    QVAVK L  V  +  E +F  E   I + +H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--------GIARGLFYL 596
            +G   +   R ++ E M+ G L SFL  +++P     + + M         IA G  YL
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 597 HEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYV 651
            E      IH DI  +N LL        A+I DFG+ + +     +     A+   K ++
Sbjct: 157 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WM 212
Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICL 680
            PE F     T K D +S+GVLL EI  L
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSD----QVAVKKLNRVFQDS-EKEFKAEVNGIGQTHHKNLVR 544
           LG GAFG VY+G V+   +D    QVAVK L  V  +  E +F  E   I + +H+N+VR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--------GIARGLFYL 596
            +G   +   R ++ E M+ G L SFL  +++P     + + M         IA G  YL
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 597 HEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYV 651
            E      IH DI  +N LL        A+I DFG+ + +     +     A+   K ++
Sbjct: 149 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WM 204
Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICL 680
            PE F     T K D +S+GVLL EI  L
Sbjct: 205 PPEAFMEGIFTSKTDTWSFGVLLWEIFSL 233

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSD----QVAVKKLNRVFQDS-EKEFKAEVNGIGQTHHKNLVR 544
           LG GAFG VY+G V+   +D    QVAVK L  V  +  E +F  E   I + +H+N+VR
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--------GIARGLFYL 596
            +G   +   R ++ E M+ G L SFL  +++P     + + M         IA G  YL
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 597 HEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYV 651
            E      IH DI  +N LL        A+I DFG+ + +     +     A+   K ++
Sbjct: 174 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WM 229
Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICL 680
            PE F     T K D +S+GVLL EI  L
Sbjct: 230 PPEAFMEGIFTSKTDTWSFGVLLWEIFSL 258

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 113/258 (43%), Gaps = 14/258 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 25  KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 81
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G+L  FL G+     +L   + M   IA G+ Y+        +H
Sbjct: 82  VSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D++  NIL+ +    +++DFGL +L+  ++       +    + APE       T+K D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           V+S+G+LL E+    R       Y     R +   VE            +    +   C 
Sbjct: 198 VWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 252
Query: 727 QEDPSHRPTMRRVTQMLE 744
           ++DP  RPT   +   LE
Sbjct: 253 RKDPEERPTFEYLQAFLE 270

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 112/258 (43%), Gaps = 14/258 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 25  KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 81
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G L  FL G+     +L   + M   IA G+ Y+        +H
Sbjct: 82  VSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D++  NIL+ +    +++DFGL +L+  ++       +    + APE       T+K D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           V+S+G+LL E+    R       Y     R +   VE            +    +   C 
Sbjct: 198 VWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 252
Query: 727 QEDPSHRPTMRRVTQMLE 744
           ++DP  RPT   +   LE
Sbjct: 253 RKDPEERPTFEYLQAFLE 270

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSD----QVAVKKLNRVFQDS-EKEFKAEVNGIGQTHHKNLVR 544
           LG GAFG VY+G V+   +D    QVAVK L  V  +  E +F  E   I + +H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--------GIARGLFYL 596
            +G   +   R ++ E M+ G L SFL  +++P     + + M         IA G  YL
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 597 HEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYV 651
            E      IH DI  +N LL        A+I DFG+ + +     +     A+   K ++
Sbjct: 158 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WM 213
Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICL 680
            PE F     T K D +S+GVLL EI  L
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFSL 242

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 114/254 (44%), Gaps = 14/254 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +ELG G FG V  G    G  D VA+K +      SE EF  E   +    H+ LV+L
Sbjct: 28  FLKELGTGQFGVVKYGKWR-GQYD-VAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQL 84
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLFYLHEECCTQ 603
            G C + R   ++ E+M+NG L ++L  + +  ++ +   E+   +   + YL  +   Q
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 140
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            +H D+  +N L++D    ++SDFGL + +  D+  ++   +    +  PE       + 
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K D++++GVL+ EI  L +       Y+ +        +   L         ++   +  
Sbjct: 201 KSDIWAFGVLMWEIYSLGKM-----PYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 255
Query: 724 WCIQEDPSHRPTMR 737
            C  E    RPT +
Sbjct: 256 SCWHEKADERPTFK 269

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 124/257 (48%), Gaps = 17/257 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           E +G+G+FG V+KG  N  +   VA+K ++    +D  ++ + E+  + Q     + +  
Sbjct: 29  ERIGKGSFGEVFKGIDNR-TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYY 87
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           G   +G    ++ E++  G+    L       +++ T ++  I +GL YLH E   + IH
Sbjct: 88  GSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIAT-MLKEILKGLDYLHSE---KKIH 143
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIK  N+LL +  + +++DFG+   LT  Q   NT + GT  ++APE  +      K D
Sbjct: 144 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKAD 202
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM--DDMTVLQRFVMVAIW 724
           ++S G+  +E+             D +  R L  + +N+   +  D     + F+     
Sbjct: 203 IWSLGITAIELAKGEPP-----NSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDA--- 254
Query: 725 CIQEDPSHRPTMRRVTQ 741
           C+ +DPS RPT + + +
Sbjct: 255 CLNKDPSFRPTAKELLK 271

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSD----QVAVKKLNRVFQDS-EKEFKAEVNGIGQTHHKNLVR 544
           LG GAFG VY+G V+   +D    QVAVK L  V  +  E +F  E   I + +H+N+VR
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--------GIARGLFYL 596
            +G   +   R ++ E M+ G L SFL  +++P     + + M         IA G  YL
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 597 HEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYV 651
            E      IH DI  +N LL        A+I DFG+ + +     +     A+   K ++
Sbjct: 164 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WM 219
Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICL 680
            PE F     T K D +S+GVLL EI  L
Sbjct: 220 PPEAFMEGIFTSKTDTWSFGVLLWEIFSL 248

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 20/261 (7%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 191 KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 247
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G+L  FL G++    +L   + M   IA G+ Y+        +H
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 303
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPITV 663
            D++  NIL+ +    +++DFGL +L+   + +  TA +G K    + APE       T+
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+S+G+LL E+    R       Y     R +   VE            +    +  
Sbjct: 361 KSDVWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 415
Query: 724 WCIQEDPSHRPTMRRVTQMLE 744
            C +++P  RPT   +   LE
Sbjct: 416 QCWRKEPEERPTFEYLQAFLE 436

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSD-QVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNLV 543
           FK +LG GAFG V+   V   SS  +  +K +N+   Q   ++ +AE+  +    H N++
Sbjct: 26  FKRKLGSGAFGDVH--LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLR----TEIVMGIARGLFYLHEE 599
           ++    ++  N  +V E    G L   +         L      E++  +   L Y H +
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 600 CCTQIIHCDIKPQNILLDD---YYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
               ++H D+KP+NIL  D   +   +I DFGL +L   D+  TN A  GT  Y+APE F
Sbjct: 144 ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYMAPEVF 198
Query: 657 RNMPITVKVDVYSYGVLL 674
           +   +T K D++S GV++
Sbjct: 199 KR-DVTFKCDIWSAGVVM 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 114/258 (44%), Gaps = 14/258 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 18  KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 74
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G+L  FL G++    +L   + M   IA G+ Y+        +H
Sbjct: 75  VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 130
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D++  NIL+ +    +++DFGL +L+  ++       +    + APE       T+K D
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           V+S+G+LL E+    R       Y     R +   VE            +    +   C 
Sbjct: 191 VWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 245
Query: 727 QEDPSHRPTMRRVTQMLE 744
           +++P  RPT   +   LE
Sbjct: 246 RKEPEERPTFEYLQAFLE 263

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 20/261 (7%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 191 KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 247
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G+L  FL G++    +L   + M   IA G+ Y+        +H
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 303
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPITV 663
            D++  NIL+ +    +++DFGL +L+   + +  TA +G K    + APE       T+
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+S+G+LL E+    R       Y     R +   VE            +    +  
Sbjct: 361 KSDVWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 415
Query: 724 WCIQEDPSHRPTMRRVTQMLE 744
            C +++P  RPT   +   LE
Sbjct: 416 QCWRKEPEERPTFEYLQAFLE 436

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSD----QVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVR 544
           LG GAFG VY+G V+   +D    QVAVK L  V  +  E +F  E   I + +H+N+VR
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--------GIARGLFYL 596
            +G   +   R ++ E M+ G L SFL  +++P     + + M         IA G  YL
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 597 HEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYV 651
            E      IH DI  +N LL        A+I DFG+ + +     +     A+   K ++
Sbjct: 184 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WM 239
Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICL 680
            PE F     T K D +S+GVLL EI  L
Sbjct: 240 PPEAFMEGIFTSKTDTWSFGVLLWEIFSL 268

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 116/261 (44%), Gaps = 18/261 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           + LG G FG V+ G  N   + +VA+K L +    S + F  E   + +  H  LV+L  
Sbjct: 15  KRLGNGQFGEVWMGTWN--GNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLYA 71
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQII 605
              E     +V E+M+ G+L  FL        KL   + M   +A G+ Y+        I
Sbjct: 72  VVSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYI 127
Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 665
           H D++  NIL+ +    +I+DFGL +L+  ++       +    + APE       T+K 
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 666 DVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQRFVMVAI 723
           DV+S+G+LL E++   R       Y     R +   VE    +    D  +    +M+  
Sbjct: 188 DVWSFGILLTELVTKGRV-----PYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHC 242
Query: 724 WCIQEDPSHRPTMRRVTQMLE 744
           W  ++DP  RPT   +   LE
Sbjct: 243 W--KKDPEERPTFEYLQSFLE 261

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 112/258 (43%), Gaps = 14/258 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 25  KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 81
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G L  FL G+     +L   + M   IA G+ Y+        +H
Sbjct: 82  VSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D++  NIL+ +    +++DFGL +L+  ++       +    + APE       T+K D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           V+S+G+LL E+    R       Y     R +   VE            +    +   C 
Sbjct: 198 VWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 252
Query: 727 QEDPSHRPTMRRVTQMLE 744
           ++DP  RPT   +   LE
Sbjct: 253 RKDPEERPTFEYLQAFLE 270

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 98/194 (50%), Gaps = 10/194 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG G FG V  G   + +  +VAVK LNR      D   + + E+  +    H ++++L 
Sbjct: 24  LGVGTFGKVKVGKHEL-TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
                  +  +V E++S G L  ++  + + + K    +   I  G+ Y H      ++H
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVH 139
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR-NMPITVKV 665
            D+KP+N+LLD + NA+I+DFGL  +++  +    +   G+  Y APE     +    +V
Sbjct: 140 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC--GSPNYAAPEVISGRLYAGPEV 197
Query: 666 DVYSYGVLLLEIIC 679
           D++S GV+L  ++C
Sbjct: 198 DIWSSGVILYALLC 211

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 7/196 (3%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLL 546
           E++GRG FG V+ G +    +  VAVK        D + +F  E   + Q  H N+VRL+
Sbjct: 120 EQIGRGNFGEVFSGRLR-ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
           G C + +   +V E +  G   +FL  + ++   K   ++V   A G+ YL  +CC   I
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC---I 235
Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK-GYVAPEWFRNMPITVK 664
           H D+  +N L+ +    +ISDFG+ +         +  +R     + APE       + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 665 VDVYSYGVLLLEIICL 680
            DV+S+G+LL E   L
Sbjct: 296 SDVWSFGILLWETFSL 311

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSD----QVAVKKLNRVFQDS-EKEFKAEVNGIGQTHHKNLVR 544
           LG GAFG VY+G V+   +D    QVAVK L  V  +  E +F  E   I + +H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--------GIARGLFYL 596
            +G   +   R ++ E M+ G L SFL  +++P     + + M         IA G  YL
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 597 HEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYV 651
            E      IH DI  +N LL        A+I DFG+ + +     +     A+   K ++
Sbjct: 158 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK-WM 213
Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICL 680
            PE F     T K D +S+GVLL EI  L
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFSL 242

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 114/254 (44%), Gaps = 14/254 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +ELG G FG V  G    G  D VA+K +      SE EF  E   +    H+ LV+L
Sbjct: 28  FLKELGTGQFGVVKYGKWR-GQYD-VAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQL 84
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLFYLHEECCTQ 603
            G C + R   ++ E+M+NG L ++L  + +  ++ +   E+   +   + YL  +   Q
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 140
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            +H D+  +N L++D    ++SDFGL + +  D+  ++   +    +  PE       + 
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K D++++GVL+ EI  L +       Y+ +        +   L         ++   +  
Sbjct: 201 KSDIWAFGVLMWEIYSLGKM-----PYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 255
Query: 724 WCIQEDPSHRPTMR 737
            C  E    RPT +
Sbjct: 256 SCWHEKADERPTFK 269

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 20/261 (7%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 191 KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 247
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G+L  FL G++    +L   + M   IA G+ Y+        +H
Sbjct: 248 VSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 303
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPITV 663
            D++  NIL+ +    +++DFGL +L+   + +  TA +G K    + APE       T+
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+S+G+LL E+    R       Y     R +   VE            +    +  
Sbjct: 361 KSDVWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 415
Query: 724 WCIQEDPSHRPTMRRVTQMLE 744
            C +++P  RPT   +   LE
Sbjct: 416 QCWRKEPEERPTFEYLQAFLE 436

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSD----QVAVKKLNRVFQDS-EKEFKAEVNGIGQTHHKNLVR 544
           LG GAFG VY+G V+   +D    QVAVK L  V  +  E +F  E   I + +H+N+VR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--------GIARGLFYL 596
            +G   +   R ++ E M+ G L SFL  +++P     + + M         IA G  YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 597 HEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYV 651
            E      IH DI  +N LL        A+I DFG+ + +     +     A+   K ++
Sbjct: 198 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK-WM 253
Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICL 680
            PE F     T K D +S+GVLL EI  L
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFSL 282

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 125/293 (42%), Gaps = 50/293 (17%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQ----VAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
            K ELG GAFG V+         +Q    VAVK L     ++ K+F  E   +    H++
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASF---------LFGDSKPNWKLRT----EIVMG 588
           +V+  G C EG   ++V+E+M +G L  F         L  +  P  +L       I   
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQ----SHTNTA 643
           IA G+ YL  +     +H D+  +N L+ +    +I DFG+ + + + D      HT   
Sbjct: 137 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 193
Query: 644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
           IR    ++ PE       T + DV+S GV+L EI               Y ++    L  
Sbjct: 194 IR----WMPPESIMYRKFTTESDVWSLGVVLWEIF-------------TYGKQPWYQLSN 236
Query: 704 ND-LEAMDDMTVLQR-------FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
           N+ +E +    VLQR          + + C Q +P  R  ++ +  +L+ + +
Sbjct: 237 NEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           F ++LG+G FG+V    Y    +  + + VAVKKL    ++  ++F+ E+  +    H N
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 542 LVRLLGYCDEG--RNRLLVYEFMSNGALASFLFGDSKPNWKLRT-EIVMGIARGLFYLHE 598
           +V+  G C     RN  L+ E++  G+L  +L   ++    ++  +    I +G+ YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL-- 133
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPEWF 656
               + IH D+  +NIL+++    +I DFGL K+L  D+        G     + APE  
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
                +V  DV+S+GV+L E+ 
Sbjct: 193 TESKFSVASDVWSFGVVLYELF 214

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSD----QVAVKKLNRVFQDS-EKEFKAEVNGIGQTHHKNLVR 544
           LG GAFG VY+G V+   +D    QVAVK L  V  +  E +F  E   I + +H+N+VR
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--------GIARGLFYL 596
            +G   +   R ++ E M+ G L SFL  +++P     + + M         IA G  YL
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 597 HEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYV 651
            E      IH DI  +N LL        A+I DFG+ + +     +     A+   K ++
Sbjct: 175 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK-WM 230
Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICL 680
            PE F     T K D +S+GVLL EI  L
Sbjct: 231 PPEAFMEGIFTSKTDTWSFGVLLWEIFSL 259

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 100/196 (51%), Gaps = 11/196 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSD-QVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNLVRLL 546
           ELG G FG+V +G   M      VA+K L +  + ++ +E   E   + Q  +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSK--PNWKLRTEIVMGIARGLFYLHEECCTQI 604
           G C +    +LV E    G L  FL G  +  P   +  E++  ++ G+ YL E+     
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYLEEK---NF 457
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--TNTAIRGTKGYVAPEWFRNMPIT 662
           +H ++  +N+LL + + A+ISDFGL K L  D S+    +A +    + APE       +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 663 VKVDVYSYGVLLLEII 678
            + DV+SYGV + E +
Sbjct: 518 SRSDVWSYGVTMWEAL 533

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 119/257 (46%), Gaps = 20/257 (7%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +ELG G FG V  G    G  D VA+K +      SE EF  E   +    H+ LV+L
Sbjct: 13  FLKELGTGQFGVVKYGKWR-GQYD-VAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQL 69
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLFYLHEECCTQ 603
            G C + R   ++ E+M+NG L ++L  + +  ++ +   E+   +   + YL  +   Q
Sbjct: 70  YGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 125
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMP 660
            +H D+  +N L++D    ++SDFGL + + LD  +T++  RG+K    +  PE      
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSS--RGSKFPVRWSPPEVLMYSK 182
Query: 661 ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM 720
            + K D++++GVL+ EI  L +       Y+ +        +   L         ++   
Sbjct: 183 FSSKSDIWAFGVLMWEIYSLGKM-----PYERFTNSETAEHIAQGLRLYRPHLASEKVYT 237
Query: 721 VAIWCIQEDPSHRPTMR 737
           +   C  E    RPT +
Sbjct: 238 IMYSCWHEKADERPTFK 254

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 112/258 (43%), Gaps = 14/258 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 25  KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 81
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+MS G+L  FL G+     +L   + M   IA G+ Y+        +H
Sbjct: 82  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D+   NIL+ +    +++DFGL +L+  ++       +    + APE       T+K D
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           V+S+G+LL E+    R       Y     R +   VE            +    +   C 
Sbjct: 198 VWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 252
Query: 727 QEDPSHRPTMRRVTQMLE 744
           ++DP  RPT   +   LE
Sbjct: 253 RKDPEERPTFEYLQAFLE 270

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 7/196 (3%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLL 546
           E++GRG FG V+ G +    +  VAVK        D + +F  E   + Q  H N+VRL+
Sbjct: 120 EQIGRGNFGEVFSGRLR-ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
           G C + +   +V E +  G   +FL  + ++   K   ++V   A G+ YL  +CC   I
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC---I 235
Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK-GYVAPEWFRNMPITVK 664
           H D+  +N L+ +    +ISDFG+ +         +  +R     + APE       + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 665 VDVYSYGVLLLEIICL 680
            DV+S+G+LL E   L
Sbjct: 296 SDVWSFGILLWETFSL 311

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 12  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 124
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 114/254 (44%), Gaps = 14/254 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +ELG G FG V  G    G  D VA+K +      SE EF  E   +    H+ LV+L
Sbjct: 19  FLKELGTGQFGVVKYGKWR-GQYD-VAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQL 75
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLFYLHEECCTQ 603
            G C + R   ++ E+M+NG L ++L  + +  ++ +   E+   +   + YL  +   Q
Sbjct: 76  YGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 131
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            +H D+  +N L++D    ++SDFGL + +  D+  ++   +    +  PE       + 
Sbjct: 132 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 191
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K D++++GVL+ EI  L +       Y+ +        +   L         ++   +  
Sbjct: 192 KSDIWAFGVLMWEIYSLGKM-----PYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 246
Query: 724 WCIQEDPSHRPTMR 737
            C  E    RPT +
Sbjct: 247 SCWHEKADERPTFK 260

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 114/254 (44%), Gaps = 14/254 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +ELG G FG V  G    G  D VA+K +      SE EF  E   +    H+ LV+L
Sbjct: 12  FLKELGTGQFGVVKYGKWR-GQYD-VAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQL 68
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLFYLHEECCTQ 603
            G C + R   ++ E+M+NG L ++L  + +  ++ +   E+   +   + YL  +   Q
Sbjct: 69  YGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 124
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            +H D+  +N L++D    ++SDFGL + +  D+  ++   +    +  PE       + 
Sbjct: 125 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 184
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K D++++GVL+ EI  L +       Y+ +        +   L         ++   +  
Sbjct: 185 KSDIWAFGVLMWEIYSLGKM-----PYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 239
Query: 724 WCIQEDPSHRPTMR 737
            C  E    RPT +
Sbjct: 240 SCWHEKADERPTFK 253

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 38/287 (13%)
Query: 486 FKEELGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQT-HH 539
           F + LG GAFG V +    G +   ++  VAVK L      +E+E   +E+  +    +H
Sbjct: 50  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFL------FGDSKPNWKL------------ 581
            N+V LLG C  G   L++ E+   G L +FL      F  SK +  +            
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 582 RTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN 641
                  +A+G+ +L  + C   IH D+  +NILL      +I DFGL + +  D   +N
Sbjct: 170 LLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARHIKND---SN 223
Query: 642 TAIRGTK----GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
             ++G       ++APE   N   T + DV+SYG+ L E+  L  +       D      
Sbjct: 224 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----SK 279
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
              +++     +           +   C   DP  RPT +++ Q++E
Sbjct: 280 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 13  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 71
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 125
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 185
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 114/261 (43%), Gaps = 14/261 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            +++LG G FG V+    N  +  +VAVK + +    S + F AE N +    H  LV+L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHT--KVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL 248
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
                +     ++ EFM+ G+L  FL  D  SK       +    IA G+ ++ +     
Sbjct: 249 HAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---N 304
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D++  NIL+      +I+DFGL +++  ++       +    + APE       T+
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+S+G+LL+EI+   R       Y       +   +E            +    + +
Sbjct: 365 KSDVWSFGILLMEIVTYGRI-----PYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM 419
Query: 724 WCIQEDPSHRPTMRRVTQMLE 744
            C +  P  RPT   +  +L+
Sbjct: 420 RCWKNRPEERPTFEYIQSVLD 440

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           F  +LG+G FG+V    Y    +  + + VAVKKL    ++  ++F+ E+  +    H N
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 542 LVRLLGYCDEG--RNRLLVYEFMSNGALASFLFGDSKPNWKLRT-EIVMGIARGLFYLHE 598
           +V+  G C     RN  L+ EF+  G+L  +L    +    ++  +    I +G+ YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL-- 133
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPEWF 656
               + IH D+  +NIL+++    +I DFGL K+L  D+        G     + APE  
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
                +V  DV+S+GV+L E+ 
Sbjct: 193 TESKFSVASDVWSFGVVLYELF 214

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 114/254 (44%), Gaps = 14/254 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +ELG G FG V  G    G  D VA+K +      SE EF  E   +    H+ LV+L
Sbjct: 13  FLKELGTGQFGVVKYGKWR-GQYD-VAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQL 69
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLFYLHEECCTQ 603
            G C + R   ++ E+M+NG L ++L  + +  ++ +   E+   +   + YL  +   Q
Sbjct: 70  YGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 125
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            +H D+  +N L++D    ++SDFGL + +  D+  ++   +    +  PE       + 
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 185
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K D++++GVL+ EI  L +       Y+ +        +   L         ++   +  
Sbjct: 186 KSDIWAFGVLMWEIYSLGKM-----PYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 240
Query: 724 WCIQEDPSHRPTMR 737
            C  E    RPT +
Sbjct: 241 SCWHEKADERPTFK 254

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 114/254 (44%), Gaps = 14/254 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +ELG G FG V  G    G  D VA+K +      SE EF  E   +    H+ LV+L
Sbjct: 8   FLKELGTGQFGVVKYGKWR-GQYD-VAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQL 64
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLFYLHEECCTQ 603
            G C + R   ++ E+M+NG L ++L  + +  ++ +   E+   +   + YL  +   Q
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 120
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            +H D+  +N L++D    ++SDFGL + +  D+  ++   +    +  PE       + 
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K D++++GVL+ EI  L +       Y+ +        +   L         ++   +  
Sbjct: 181 KSDIWAFGVLMWEIYSLGKM-----PYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235
Query: 724 WCIQEDPSHRPTMR 737
            C  E    RPT +
Sbjct: 236 SCWHEKADERPTFK 249

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           F ++LG+G FG+V    Y    +  + + VAVKKL    ++  ++F+ E+  +    H N
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 79
Query: 542 LVRLLGYCDEG--RNRLLVYEFMSNGALASFLFGDSKPNWKLRT-EIVMGIARGLFYLHE 598
           +V+  G C     RN  L+ E++  G+L  +L    +    ++  +    I +G+ YL  
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 137
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPEWF 656
               + IH D+  +NIL+++    +I DFGL K+L  D+        G     + APE  
Sbjct: 138 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
                +V  DV+S+GV+L E+ 
Sbjct: 197 TESKFSVASDVWSFGVVLYELF 218

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAV-KKLNR-VFQDSEKE-FKAEVNGIGQTHHKNLVRLL 546
           +G G++G   K  +   S  ++ V K+L+     ++EK+   +EVN + +  H N+VR  
Sbjct: 14  IGTGSYGRCQK--IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 547 GYCDEGRNRLL--VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ- 603
               +  N  L  V E+   G LAS +   +K    L  E V+ +   L    +EC  + 
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 604 -----IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
                ++H D+KP N+ LD   N ++ DFGL ++L  D S   T + GT  Y++PE    
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190
Query: 659 MPITVKVDVYSYGVLLLEIICL 680
           M    K D++S G LL E+  L
Sbjct: 191 MSYNEKSDIWSLGCLLYELCAL 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           F ++LG+G FG+V    Y    +  + + VAVKKL    ++  ++F+ E+  +    H N
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 70
Query: 542 LVRLLGYCDEG--RNRLLVYEFMSNGALASFLFGDSKPNWKLRT-EIVMGIARGLFYLHE 598
           +V+  G C     RN  L+ E++  G+L  +L    +    ++  +    I +G+ YL  
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 128
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPEWF 656
               + IH D+  +NIL+++    +I DFGL K+L  D+        G     + APE  
Sbjct: 129 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 657 RNMPITVKVDVYSYGVLLLEI 677
                +V  DV+S+GV+L E+
Sbjct: 188 TESKFSVASDVWSFGVVLYEL 208

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 114/261 (43%), Gaps = 14/261 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            +++LG G FG V+    N  +  +VAVK + +    S + F AE N +    H  LV+L
Sbjct: 19  LEKKLGAGQFGEVWMATYNKHT--KVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL 75
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
                +     ++ EFM+ G+L  FL  D  SK       +    IA G+ ++ +     
Sbjct: 76  HAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---N 131
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D++  NIL+      +I+DFGL +++  ++       +    + APE       T+
Sbjct: 132 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 191
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+S+G+LL+EI+   R       Y       +   +E            +    + +
Sbjct: 192 KSDVWSFGILLMEIVTYGRI-----PYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM 246
Query: 724 WCIQEDPSHRPTMRRVTQMLE 744
            C +  P  RPT   +  +L+
Sbjct: 247 RCWKNRPEERPTFEYIQSVLD 267

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 114/258 (44%), Gaps = 14/258 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 22  KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 78
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+M+ G+L  FL G++    +L   + M   IA G+ Y+        +H
Sbjct: 79  VSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVH 134
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D++  NIL+ +    +++DFGL +L+  ++       +    + APE       T+K D
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           V+S+G+LL E+    R       Y     R +   VE            +    +   C 
Sbjct: 195 VWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 249
Query: 727 QEDPSHRPTMRRVTQMLE 744
           +++P  RPT   +   LE
Sbjct: 250 RKEPEERPTFEYLQAFLE 267

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 38/287 (13%)
Query: 486 FKEELGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQT-HH 539
           F + LG GAFG V +    G +   ++  VAVK L      +E+E   +E+  +    +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFL------FGDSKPNWKL------------ 581
            N+V LLG C  G   L++ E+   G L +FL      F  SK +  +            
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 582 RTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN 641
                  +A+G+ +L  + C   IH D+  +NILL      +I DFGL + +  D   +N
Sbjct: 147 LLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKND---SN 200
Query: 642 TAIRGTK----GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
             ++G       ++APE   N   T + DV+SYG+ L E+  L  +       D      
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----SK 256
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
              +++     +           +   C   DP  RPT +++ Q++E
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           F ++LG+G FG+V    Y    +  + + VAVKKL    ++  ++F+ E+  +    H N
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 542 LVRLLGYCDEG--RNRLLVYEFMSNGALASFLFGDSKPNWKLRT-EIVMGIARGLFYLHE 598
           +V+  G C     RN  L+ E++  G+L  +L    +    ++  +    I +G+ YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 133
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPEWF 656
               + IH D+  +NIL+++    +I DFGL K+L  D+        G     + APE  
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
                +V  DV+S+GV+L E+ 
Sbjct: 193 TESKFSVASDVWSFGVVLYELF 214

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           F ++LG+G FG+V    Y    +  + + VAVKKL    ++  ++F+ E+  +    H N
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 71
Query: 542 LVRLLGYCDEG--RNRLLVYEFMSNGALASFLFGDSKPNWKLRT-EIVMGIARGLFYLHE 598
           +V+  G C     RN  L+ E++  G+L  +L    +    ++  +    I +G+ YL  
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 129
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPEWF 656
               + IH D+  +NIL+++    +I DFGL K+L  D+        G     + APE  
Sbjct: 130 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 657 RNMPITVKVDVYSYGVLLLEI 677
                +V  DV+S+GV+L E+
Sbjct: 189 TESKFSVASDVWSFGVVLYEL 209

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           F ++LG+G FG+V    Y    +  + + VAVKKL    ++  ++F+ E+  +    H N
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 76
Query: 542 LVRLLGYCDEG--RNRLLVYEFMSNGALASFLFGDSKPNWKLRT-EIVMGIARGLFYLHE 598
           +V+  G C     RN  L+ E++  G+L  +L    +    ++  +    I +G+ YL  
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 134
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPEWF 656
               + IH D+  +NIL+++    +I DFGL K+L  D+        G     + APE  
Sbjct: 135 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
                +V  DV+S+GV+L E+ 
Sbjct: 194 TESKFSVASDVWSFGVVLYELF 215

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 38/287 (13%)
Query: 486 FKEELGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQT-HH 539
           F + LG GAFG V +    G +   ++  VAVK L      +E+E   +E+  +    +H
Sbjct: 43  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 102
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFL------FGDSKPNWKL------------ 581
            N+V LLG C  G   L++ E+   G L +FL      F  SK +  +            
Sbjct: 103 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 162
Query: 582 RTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN 641
                  +A+G+ +L  + C   IH D+  +NILL      +I DFGL + +  D   +N
Sbjct: 163 LLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKND---SN 216
Query: 642 TAIRGTK----GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
             ++G       ++APE   N   T + DV+SYG+ L E+  L  +       D      
Sbjct: 217 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----SK 272
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
              +++     +           +   C   DP  RPT +++ Q++E
Sbjct: 273 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           F ++LG+G FG+V    Y    +  + + VAVKKL    ++  ++F+ E+  +    H N
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 78
Query: 542 LVRLLGYCDEG--RNRLLVYEFMSNGALASFLFGDSKPNWKLRT-EIVMGIARGLFYLHE 598
           +V+  G C     RN  L+ E++  G+L  +L    +    ++  +    I +G+ YL  
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 136
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPEWF 656
               + IH D+  +NIL+++    +I DFGL K+L  D+        G     + APE  
Sbjct: 137 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
                +V  DV+S+GV+L E+ 
Sbjct: 196 TESKFSVASDVWSFGVVLYELF 217

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           F ++LG+G FG+V    Y    +  + + VAVKKL    ++  ++F+ E+  +    H N
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 542 LVRLLGYCDEG--RNRLLVYEFMSNGALASFLFGDSKPNWKLRT-EIVMGIARGLFYLHE 598
           +V+  G C     RN  L+ E++  G+L  +L    +    ++  +    I +G+ YL  
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 161
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPEWF 656
               + IH D+  +NIL+++    +I DFGL K+L  D+        G     + APE  
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
                +V  DV+S+GV+L E+ 
Sbjct: 221 TESKFSVASDVWSFGVVLYELF 242

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 38/287 (13%)
Query: 486 FKEELGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQT-HH 539
           F + LG GAFG V +    G +   ++  VAVK L      +E+E   +E+  +    +H
Sbjct: 50  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFL------FGDSKPNWKL------------ 581
            N+V LLG C  G   L++ E+   G L +FL      F  SK +  +            
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 582 RTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN 641
                  +A+G+ +L  + C   IH D+  +NILL      +I DFGL + +  D   +N
Sbjct: 170 LLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKND---SN 223
Query: 642 TAIRGTK----GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
             ++G       ++APE   N   T + DV+SYG+ L E+  L  +       D      
Sbjct: 224 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----SK 279
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
              +++     +           +   C   DP  RPT +++ Q++E
Sbjct: 280 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           F ++LG+G FG+V    Y    +  + + VAVKKL    ++  ++F+ E+  +    H N
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 77
Query: 542 LVRLLGYCDEG--RNRLLVYEFMSNGALASFLFGDSKPNWKLRT-EIVMGIARGLFYLHE 598
           +V+  G C     RN  L+ E++  G+L  +L    +    ++  +    I +G+ YL  
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 135
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPEWF 656
               + IH D+  +NIL+++    +I DFGL K+L  D+        G     + APE  
Sbjct: 136 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
                +V  DV+S+GV+L E+ 
Sbjct: 195 TESKFSVASDVWSFGVVLYELF 216

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 114/258 (44%), Gaps = 14/258 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L   
Sbjct: 22  KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 78
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEECCTQIIH 606
             E     +V E+M+ G+L  FL G++    +L   + M   IA G+ Y+        +H
Sbjct: 79  VSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVH 134
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D++  NIL+ +    +++DFGL +L+  ++       +    + APE       T+K D
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           V+S+G+LL E+    R       Y     R +   VE            +    +   C 
Sbjct: 195 VWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 249
Query: 727 QEDPSHRPTMRRVTQMLE 744
           +++P  RPT   +   LE
Sbjct: 250 RKEPEERPTFEYLQAFLE 267

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           F ++LG+G FG+V    Y    +  + + VAVKKL    ++  ++F+ E+  +    H N
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 542 LVRLLGYCDEG--RNRLLVYEFMSNGALASFLFGDSKPNWKLRT-EIVMGIARGLFYLHE 598
           +V+  G C     RN  L+ E++  G+L  +L    +    ++  +    I +G+ YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPEWF 656
               + IH D+  +NIL+++    +I DFGL K+L  D+        G     + APE  
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 657 RNMPITVKVDVYSYGVLLLEI 677
                +V  DV+S+GV+L E+
Sbjct: 190 TESKFSVASDVWSFGVVLYEL 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           F ++LG+G FG+V    Y    +  + + VAVKKL    ++  ++F+ E+  +    H N
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 542 LVRLLGYCDEG--RNRLLVYEFMSNGALASFLFGDSKPNWKLRT-EIVMGIARGLFYLHE 598
           +V+  G C     RN  L+ E++  G+L  +L    +    ++  +    I +G+ YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPEWF 656
               + IH D+  +NIL+++    +I DFGL K+L  D+        G     + APE  
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
                +V  DV+S+GV+L E+ 
Sbjct: 190 TESKFSVASDVWSFGVVLYELF 211

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 130/312 (41%), Gaps = 46/312 (14%)
Query: 468 YMNLRCFTYKELVEVTRG---FKEELGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVF 520
           Y++ R + Y    E  R    F + LG GAFG V      G    G S QVAVK L    
Sbjct: 28  YVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA 87
Query: 521 QDSEKE-FKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL------F 572
             SE+E   +E+  + Q   H+N+V LLG C       L++E+   G L ++L      F
Sbjct: 88  DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 147
Query: 573 GDSKPNW----KLRTE-------------IVMGIARGLFYLHEECCTQIIHCDIKPQNIL 615
            + +  +    +L  E                 +A+G+ +L  + C   +H D+  +N+L
Sbjct: 148 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC---VHRDLAARNVL 204
Query: 616 LDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK----GYVAPEWFRNMPITVKVDVYSYG 671
           +      +I DFGL + +  D   +N  +RG       ++APE       T+K DV+SYG
Sbjct: 205 VTHGKVVKICDFGLARDIMSD---SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 261
Query: 672 VLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPS 731
           +LL EI  L          D         L++N  +        +   ++   C   D  
Sbjct: 262 ILLWEIFSLGVNPYPGIPVDA----NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSR 317
Query: 732 HRPTMRRVTQML 743
            RP+   +T  L
Sbjct: 318 KRPSFPNLTSFL 329

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 12  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 124
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 108/255 (42%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 16  LGKGKFGNVYLA-REKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 75  GYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---KVIH 131
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S    A+ GT  Y+ PE         KVD
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVD 188
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +     +   D Y+  +       D        ++ R        +
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLISRL-------L 241
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 242 KHNPSQRPMLREVLE 256

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 12  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 124
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 21  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 80  GYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 136
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 193
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 194 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 246
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 247 KHNPSQRPMLREVLE 261

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 38/287 (13%)
Query: 486 FKEELGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQT-HH 539
           F + LG GAFG V +    G +   ++  VAVK L      +E+E   +E+  +    +H
Sbjct: 45  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 104
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFL------FGDSKPNWKL------------ 581
            N+V LLG C  G   L++ E+   G L +FL      F  SK +  +            
Sbjct: 105 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 164
Query: 582 RTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN 641
                  +A+G+ +L  + C   IH D+  +NILL      +I DFGL + +  D   +N
Sbjct: 165 LLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKND---SN 218
Query: 642 TAIRGTK----GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
             ++G       ++APE   N   T + DV+SYG+ L E+  L  +       D      
Sbjct: 219 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----SK 274
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
              +++     +           +   C   DP  RPT +++ Q++E
Sbjct: 275 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           F ++LG+G FG+V    Y    +  + + VAVKKL    ++  ++F+ E+  +    H N
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 542 LVRLLGYCDEG--RNRLLVYEFMSNGALASFLFGDSKPNWKLRT-EIVMGIARGLFYLHE 598
           +V+  G C     RN  L+ E++  G+L  +L    +    ++  +    I +G+ YL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 148
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPEWF 656
               + IH D+  +NIL+++    +I DFGL K+L  D+        G     + APE  
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 657 RNMPITVKVDVYSYGVLLLEI 677
                +V  DV+S+GV+L E+
Sbjct: 208 TESKFSVASDVWSFGVVLYEL 228

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           F ++LG+G FG+V    Y    +  + + VAVKKL    ++  ++F+ E+  +    H N
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 542 LVRLLGYCDEG--RNRLLVYEFMSNGALASFLFGDSKPNWKLRT-EIVMGIARGLFYLHE 598
           +V+  G C     RN  L+ E++  G+L  +L    +    ++  +    I +G+ YL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 148
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPEWF 656
               + IH D+  +NIL+++    +I DFGL K+L  D+        G     + APE  
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 657 RNMPITVKVDVYSYGVLLLEI 677
                +V  DV+S+GV+L E+
Sbjct: 208 TESKFSVASDVWSFGVVLYEL 228

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 12  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 124
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 13  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFY 71
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 125
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 12  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 124
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTH 538
           ++T G  + +G G+FGTVYKG  +      VAVK LN      ++   FK EV  + +T 
Sbjct: 14  QITVG--QRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 67
Query: 539 HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLH 597
           H N++  +GY  + +   +V ++    +L   L   ++K       +I    A+G+ YLH
Sbjct: 68  HVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 126
Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGYVAPEWF 656
            +    IIH D+K  NI L +    +I DFGL  + +    SH    + G+  ++APE  
Sbjct: 127 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183
Query: 657 RNM---PITVKVDVYSYGVLLLEIIC 679
           R     P + + DVY++G++L E++ 
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMT 209

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 17  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 132
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKVD 189
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 190 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 242
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 243 KHNPSQRPMLREVLE 257

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           F ++LG+G FG+V    Y    +  + + VAVKKL    ++  ++F+ E+  +    H N
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 542 LVRLLGYCDEG--RNRLLVYEFMSNGALASFLFGDSKPNWKLRT-EIVMGIARGLFYLHE 598
           +V+  G C     RN  L+ E++  G+L  +L    +    ++  +    I +G+ YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPEWF 656
               + IH D+  +NIL+++    +I DFGL K+L  D+        G     + APE  
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
                +V  DV+S+GV+L E+ 
Sbjct: 190 TESKFSVASDVWSFGVVLYELF 211

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTH 538
           ++T G  + +G G+FGTVYKG  +      VAVK LN      ++   FK EV  + +T 
Sbjct: 11  QITVG--QRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 64
Query: 539 HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLH 597
           H N++  +GY  + +   +V ++    +L   L   ++K       +I    A+G+ YLH
Sbjct: 65  HVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 123
Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGYVAPEWF 656
            +    IIH D+K  NI L +    +I DFGL  + +    SH    + G+  ++APE  
Sbjct: 124 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 180
Query: 657 RNM---PITVKVDVYSYGVLLLEIIC 679
           R     P + + DVY++G++L E++ 
Sbjct: 181 RMQDKNPYSFQSDVYAFGIVLYELMT 206

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 13  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 125
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 17/206 (8%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTH 538
           ++T G  + +G G+FGTVYKG         VAVK LN      ++   FK EV  + +T 
Sbjct: 9   QITVG--QRIGSGSFGTVYKG----KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 539 HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLH 597
           H N++  +GY  + +   +V ++    +L   L   ++K       +I    A+G+ YLH
Sbjct: 63  HVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGYVAPEWF 656
            +    IIH D+K  NI L +    +I DFGL  + +    SH    + G+  ++APE  
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 657 RNM---PITVKVDVYSYGVLLLEIIC 679
           R     P + + DVY++G++L E++ 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKG---FVNMGSSDQVAVKKL---NRVFQDSEKEFKAEVNGIGQTHHKN 541
           ++LG G   TVY      +N+    +VA+K +    R  +++ K F+ EV+   Q  H+N
Sbjct: 17  DKLGGGGMSTVYLAEDTILNI----KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           +V ++   +E     LV E++    L+ ++      +          I  G+ + H+   
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD--- 129
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
            +I+H DIKPQNIL+D     +I DFG+ K L+         + GT  Y +PE  +    
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 662 TVKVDVYSYGVLLLEIIC 679
               D+YS G++L E++ 
Sbjct: 190 DECTDIYSIGIVLYEMLV 207

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 12  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 124
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTHHKNLVRLLG 547
           +G G+FGTVYKG         VAVK L  V    E+   F+ EV  + +T H N++  +G
Sbjct: 44  IGSGSFGTVYKG----KWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 548 YCDEGRNRLLVYEFMSNGALASFLF-GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           Y  +  N  +V ++    +L   L   ++K       +I    A+G+ YLH      IIH
Sbjct: 100 YMTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIH 155
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGYVAPEWFR---NMPIT 662
            D+K  NI L +    +I DFGL  + +    S       G+  ++APE  R   N P +
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215
Query: 663 VKVDVYSYGVLLLEIIC 679
            + DVYSYG++L E++ 
Sbjct: 216 FQSDVYSYGIVLYELMT 232

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTH 538
           ++T G  + +G G+FGTVYKG  +      VAVK LN      ++   FK EV  + +T 
Sbjct: 14  QITVG--QRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 67
Query: 539 HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLH 597
           H N++  +GY  + +   +V ++    +L   L   ++K       +I    A+G+ YLH
Sbjct: 68  HVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 126
Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGYVAPEWF 656
            +    IIH D+K  NI L +    +I DFGL  + +    SH    + G+  ++APE  
Sbjct: 127 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183
Query: 657 RNM---PITVKVDVYSYGVLLLEIIC 679
           R     P + + DVY++G++L E++ 
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMT 209

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVR 544
            KE LG G FG V + +++  + +QVA+K+  +      +E +  E+  + + +H N+V 
Sbjct: 18  MKERLGTGGFGYVLR-WIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 545 LLGYCDEGRNRL-------LVYEFMSNGALASFL--FGD--SKPNWKLRTEIVMGIARGL 593
                D G  +L       L  E+   G L  +L  F +        +RT ++  I+  L
Sbjct: 77  AREVPD-GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT-LLSDISSAL 134
Query: 594 FYLHEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGY 650
            YLHE    +IIH D+KP+NI+L         +I D G  K   LDQ    T   GT  Y
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQY 189
Query: 651 VAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDW 688
           +APE       TV VD +S+G L  E I   R  L +W
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW 227

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 113/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 42  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 100
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H     ++IH
Sbjct: 101 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIH 157
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 214
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 215 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 267
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 268 KHNPSQRPMLREVLE 282

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 13  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 125
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 13  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 125
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVR 544
            KE LG G FG V + +++  + +QVA+K+  +      +E +  E+  + + +H N+V 
Sbjct: 19  MKERLGTGGFGYVLR-WIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 77
Query: 545 LLGYCDEGRNRL-------LVYEFMSNGALASFL--FGD--SKPNWKLRTEIVMGIARGL 593
                D G  +L       L  E+   G L  +L  F +        +RT ++  I+  L
Sbjct: 78  AREVPD-GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT-LLSDISSAL 135
Query: 594 FYLHEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGY 650
            YLHE    +IIH D+KP+NI+L         +I D G  K   LDQ    T   GT  Y
Sbjct: 136 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQY 190
Query: 651 VAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDW 688
           +APE       TV VD +S+G L  E I   R  L +W
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW 228

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 13  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 125
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTHHKNLVRL 545
           + +G G+FGTVYKG  +      VAVK LN      ++   FK EV  + +T H N++  
Sbjct: 42  QRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 97
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           +GY  + +   +V ++    +L   L   ++K       +I    A+G+ YLH +    I
Sbjct: 98  MGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGYVAPEWFRNM---P 660
           IH D+K  NI L +    +I DFGL  + +    SH    + G+  ++APE  R     P
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 661 ITVKVDVYSYGVLLLEIIC 679
            + + DVY++G++L E++ 
Sbjct: 214 YSFQSDVYAFGIVLYELMT 232

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTHHKNLVRL 545
           + +G G+FGTVYKG  +      VAVK LN      ++   FK EV  + +T H N++  
Sbjct: 41  QRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 96
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           +GY  + +   +V ++    +L   L   ++K       +I    A+G+ YLH +    I
Sbjct: 97  MGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 152
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGYVAPEWFRNM---P 660
           IH D+K  NI L +    +I DFGL  + +    SH    + G+  ++APE  R     P
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 661 ITVKVDVYSYGVLLLEIIC 679
            + + DVY++G++L E++ 
Sbjct: 213 YSFQSDVYAFGIVLYELMT 231

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 16  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 131
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 188
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 189 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 241
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 242 KHNPSQRPMLREVLE 256

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 21  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 80  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 136
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEXIEGRXHDEKVD 193
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 194 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 246
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 247 KHNPSQRPXLREVLE 261

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 12  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 124
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 12  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 124
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTH 538
           ++T G  + +G G+FGTVYKG         VAVK LN      ++   FK EV  + +T 
Sbjct: 9   QITVG--QRIGSGSFGTVYKG----KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 539 HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLH 597
           H N++  +GY        +V ++    +L   L   ++K       +I    A+G+ YLH
Sbjct: 63  HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGYVAPEWF 656
            +    IIH D+K  NI L +    +I DFGL  + +    SH    + G+  ++APE  
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 657 RNM---PITVKVDVYSYGVLLLEIIC 679
           R     P + + DVY++G++L E++ 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 12  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 124
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 12  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 124
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 113/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 33  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 91
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H     ++IH
Sbjct: 92  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIH 148
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 149 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 205
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 206 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 258
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 259 KHNPSQRPMLREVLE 273

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 11  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 70  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 123
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 184 AEPVDVWSCGIVLTAMLA 201

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 21  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 80  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 136
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 193
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 194 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 246
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 247 KHNPSQRPMLREVLE 261

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 12  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 124
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           F ++LG+G FG+V    Y    +  + + VAVKKL    ++  ++F+ E+  +    H N
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 73
Query: 542 LVRLLGYCDEG--RNRLLVYEFMSNGALASFLFGDSKPNWKLR-TEIVMGIARGLFYLHE 598
           +V+  G C     RN  L+ E++  G+L  +L    +    ++  +    I +G+ YL  
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 131
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAPEWF 656
               + IH ++  +NIL+++    +I DFGL K+L  D+ +      G     + APE  
Sbjct: 132 -GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 190
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
                +V  DV+S+GV+L E+ 
Sbjct: 191 TESKFSVASDVWSFGVVLYELF 212

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 112/255 (43%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 21  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H     ++IH
Sbjct: 80  GYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCH---SKRVIH 136
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S     + GT  Y+ PE         KVD
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKVD 193
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 194 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 246
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 247 KHNPSQRPMLREVLE 261

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 13  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 125
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 13  QTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 125
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 19  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 134
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 191
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 192 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 244
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 245 KHNPSQRPMLREVLE 259

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 19  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 134
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S    A+ GT  Y+ PE         KVD
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVD 191
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 192 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 244
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 245 KHNPSQRPMLREVLE 259

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAV-KKLNR-VFQDSEKE-FKAEVNGIGQTHHKNLVRLL 546
           +G G++G   K  +   S  ++ V K+L+     ++EK+   +EVN + +  H N+VR  
Sbjct: 14  IGTGSYGRCQK--IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 547 GYCDEGRNRLL--VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ- 603
               +  N  L  V E+   G LAS +   +K    L  E V+ +   L    +EC  + 
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 604 -----IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
                ++H D+KP N+ LD   N ++ DFGL ++L  D S    A  GT  Y++PE    
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK-AFVGTPYYMSPEQMNR 190
Query: 659 MPITVKVDVYSYGVLLLEIICL 680
           M    K D++S G LL E+  L
Sbjct: 191 MSYNEKSDIWSLGCLLYELCAL 212

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 120/264 (45%), Gaps = 24/264 (9%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           + +G+G FG V  G       ++VAVK +      + + F AE + + Q  H NLV+LLG
Sbjct: 199 QTIGKGEFGDVMLGDYR---GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 548 YCDEGRNRL-LVYEFMSNGALASFLF--GDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
              E +  L +V E+M+ G+L  +L   G S        +  + +   + YL        
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 310
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           +H D+  +N+L+ +   A++SDFGL K  +  Q      ++ T    APE  R    + K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 366
Query: 665 VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN--DLEAMDDMTVLQRFVMVA 722
            DV+S+G+LL EI    R       Y     + +   VE    ++A D        VM  
Sbjct: 367 SDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKN 421
Query: 723 IWCIQEDPSHRPTMRRVTQMLEGV 746
            W +  D + RPT  ++ + LE +
Sbjct: 422 CWHL--DAATRPTFLQLREQLEHI 443

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 16  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 131
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTELCGTLDYLPPEMIEGRMHDEKVD 188
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 189 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 241
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 242 KHNPSQRPMLREVLE 256

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 15  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 73
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 74  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 130
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 131 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 187
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 188 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 240
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 241 KHNPSQRPMLREVLE 255

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           + +G+G FG V  G       ++VAVK +      + + F AE + + Q  H NLV+LLG
Sbjct: 18  QTIGKGEFGDVMLGDYR---GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLG 72
Query: 548 YCDEGRNRL-LVYEFMSNGALASFLF--GDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
              E +  L +V E+M+ G+L  +L   G S        +  + +   + YL        
Sbjct: 73  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 129
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           +H D+  +N+L+ +   A++SDFGL K  +  Q      ++ T    APE  R    + K
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREAAFSTK 185
Query: 665 VDVYSYGVLLLEIICLRRT 683
            DV+S+G+LL EI    R 
Sbjct: 186 SDVWSFGILLWEIYSFGRV 204

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 16  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 131
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S    A+ GT  Y+ PE         KVD
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVD 188
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 189 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 241
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 242 KHNPSQRPMLREVLE 256

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 20  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 79  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 135
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 136 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 192
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 193 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 245
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 246 KHNPSQRPMLREVLE 260

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 19  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 134
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 191
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 192 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 244
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 245 KHNPSQRPMLREVLE 259

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 16  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 131
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTXLCGTLDYLPPEMIEGRMHDEKVD 188
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 189 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 241
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 242 KHNPSQRPMLREVLE 256

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 17  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 132
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVD 189
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 190 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 242
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 243 KHNPSQRPMLREVLE 257

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 16  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 131
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVD 188
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 189 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 241
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 242 KHNPSQRPMLREVLE 256

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 21  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 79
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 80  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 136
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVD 193
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 194 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 246
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 247 KHNPSQRPMLREVLE 261

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           + +G+G FG V  G       ++VAVK +      + + F AE + + Q  H NLV+LLG
Sbjct: 12  QTIGKGEFGDVMLGDYR---GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 548 YCDEGRNRL-LVYEFMSNGALASFLF--GDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
              E +  L +V E+M+ G+L  +L   G S        +  + +   + YL        
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 123
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           +H D+  +N+L+ +   A++SDFGL K  +  Q      ++ T    APE  R    + K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 179
Query: 665 VDVYSYGVLLLEIICLRRT 683
            DV+S+G+LL EI    R 
Sbjct: 180 SDVWSFGILLWEIYSFGRV 198

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           + +G+G FG V  G       ++VAVK +      + + F AE + + Q  H NLV+LLG
Sbjct: 27  QTIGKGEFGDVMLGDYR---GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 548 YCDEGRNRL-LVYEFMSNGALASFLF--GDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
              E +  L +V E+M+ G+L  +L   G S        +  + +   + YL        
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 138
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           +H D+  +N+L+ +   A++SDFGL K  +  Q      ++ T    APE  R    + K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 194
Query: 665 VDVYSYGVLLLEIICLRRT 683
            DV+S+G+LL EI    R 
Sbjct: 195 SDVWSFGILLWEIYSFGRV 213

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 16  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 131
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVD 188
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 189 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 241
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 242 KHNPSQRPMLREVLE 256

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTH 538
           ++T G  + +G G+FGTVYKG         VAVK LN      ++   FK EV  + +T 
Sbjct: 9   QITVG--QRIGSGSFGTVYKG----KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 539 HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLH 597
           H N++  +GY  + +   +V ++    +L   L   ++K       +I    A+G+ YLH
Sbjct: 63  HVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGYVAPEWF 656
            +    IIH D+K  NI L +    +I DFGL    +    SH    + G+  ++APE  
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 657 RNM---PITVKVDVYSYGVLLLEIIC 679
           R     P + + DVY++G++L E++ 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAV-KKLNR-VFQDSEKE-FKAEVNGIGQTHHKNLVRLL 546
           +G G++G   K  +   S  ++ V K+L+     ++EK+   +EVN + +  H N+VR  
Sbjct: 14  IGTGSYGRCQK--IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 547 GYCDEGRNRLL--VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ- 603
               +  N  L  V E+   G LAS +   +K    L  E V+ +   L    +EC  + 
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 604 -----IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
                ++H D+KP N+ LD   N ++ DFGL ++L  D+      + GT  Y++PE    
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV-GTPYYMSPEQMNR 190
Query: 659 MPITVKVDVYSYGVLLLEIICL 680
           M    K D++S G LL E+  L
Sbjct: 191 MSYNEKSDIWSLGCLLYELCAL 212

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 126/286 (44%), Gaps = 35/286 (12%)
Query: 490 LGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQT-HHKNLV 543
           LGRGAFG V +    G     +   VAVK L      SE +   +E+  +    HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 544 RLLGYCDE-GRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTEIV------------ 586
            LLG C + G   +++ EF   G L+++L   SK N    +K+  E +            
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 587 --MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA- 643
               +A+G+ +L    C   IH D+  +NILL +    +I DFGL + +  D  +     
Sbjct: 153 YSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            R    ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     L E
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKE 266
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
                  D T  + +    + C   +PS RPT   + + L  +++ 
Sbjct: 267 GTRMRAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 15/192 (7%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           EELG GAFG V++  V   +      K +N  +   +   K E++ + Q HH  L+ L  
Sbjct: 57  EELGSGAFGVVHRC-VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD 115
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----GLFYLHEECCTQ 603
             ++    +L+ EF+S G L   +  +   ++K+    V+   R    GL ++HE     
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHS--- 169
Query: 604 IIHCDIKPQNILLD--DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
           I+H DIKP+NI+ +     + +I DFGL   L  D+    T    T  + APE     P+
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPV 227
Query: 662 TVKVDVYSYGVL 673
               D+++ GVL
Sbjct: 228 GFYTDMWAIGVL 239

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTHHKNLVRL 545
           + +G G+FGTVYKG  +      VAVK LN      ++   FK EV  + +T H N++  
Sbjct: 42  QRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 97
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           +GY  + +   +V ++    +L   L   ++K       +I    A+G+ YLH +    I
Sbjct: 98  MGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGYVAPEWFRNM---P 660
           IH D+K  NI L +    +I DFGL    +    SH    + G+  ++APE  R     P
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 661 ITVKVDVYSYGVLLLEIIC 679
            + + DVY++G++L E++ 
Sbjct: 214 YSFQSDVYAFGIVLYELMT 232

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 126/286 (44%), Gaps = 35/286 (12%)
Query: 490 LGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQT-HHKNLV 543
           LGRGAFG V +    G     +   VAVK L      SE +   +E+  +    HH N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 544 RLLGYCDE-GRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTEIV------------ 586
            LLG C + G   +++ EF   G L+++L   SK N    +K+  E +            
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 587 --MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA- 643
               +A+G+ +L    C   IH D+  +NILL +    +I DFGL + +  D  +     
Sbjct: 190 YSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            R    ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     L E
Sbjct: 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKE 303
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
                  D T  + +    + C   +PS RPT   + + L  +++ 
Sbjct: 304 GTRMRAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK--EFKAEVNGIGQTHHKNLVRL 545
           + +G G+FGTVYKG  +      VAVK LN      ++   FK EV  + +T H N++  
Sbjct: 34  QRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 89
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           +GY  + +   +V ++    +L   L   ++K       +I    A+G+ YLH +    I
Sbjct: 90  MGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 145
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGYVAPEWFRNM---P 660
           IH D+K  NI L +    +I DFGL    +    SH    + G+  ++APE  R     P
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 205
Query: 661 ITVKVDVYSYGVLLLEIIC 679
            + + DVY++G++L E++ 
Sbjct: 206 YSFQSDVYAFGIVLYELMT 224

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVR 544
           + LG G FG V  G   + +  +VAVK LNR      D   + K E+  +    H ++++
Sbjct: 17  DTLGVGTFGKVKIGEHQL-TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L        +  +V E++S G L  ++    +        +   I   + Y H      +
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MV 132
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR-NMPITV 663
           +H D+KP+N+LLD + NA+I+DFGL  +++ D     T+  G+  Y APE     +    
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSC-GSPNYAAPEVISGRLYAGP 190
Query: 664 KVDVYSYGVLLLEIIC 679
           +VD++S GV+L  ++C
Sbjct: 191 EVDIWSCGVILYALLC 206

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + LG GA G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+  
Sbjct: 12  QTLGEGAAGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G+  EG  + L  E+ S G L   +    G  +P+ +     +M    G+ YLH      
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLH---GIG 124
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           I H DIKP+N+LLD+  N +ISDFGL  +    ++      + GT  YVAPE  +     
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 663 VK-VDVYSYGVLLLEIIC 679
            + VDV+S G++L  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 126/286 (44%), Gaps = 35/286 (12%)
Query: 490 LGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQT-HHKNLV 543
           LGRGAFG V +    G     +   VAVK L      SE +   +E+  +    HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 544 RLLGYCDE-GRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTEIV------------ 586
            LLG C + G   +++ EF   G L+++L   SK N    +K+  E +            
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 587 --MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA- 643
               +A+G+ +L    C   IH D+  +NILL +    +I DFGL + +  D  +     
Sbjct: 144 YSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            R    ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     L E
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKE 257
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
                  D T  + +    + C   +PS RPT   + + L  +++ 
Sbjct: 258 GTRMRAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 302

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 18  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 76
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 77  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 133
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I++FG         S   T + GT  Y+ PE         KVD
Sbjct: 134 RDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 190
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 191 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 243
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 244 KHNPSQRPMLREVLE 258

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 126/286 (44%), Gaps = 35/286 (12%)
Query: 490 LGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQT-HHKNLV 543
           LGRGAFG V +    G     +   VAVK L      SE +   +E+  +    HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 544 RLLGYCDE-GRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTEIV------------ 586
            LLG C + G   +++ EF   G L+++L   SK N    +K+  E +            
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 587 --MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA- 643
               +A+G+ +L    C   IH D+  +NILL +    +I DFGL + +  D  +     
Sbjct: 144 YSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            R    ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     L E
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKE 257
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
                  D T  + +    + C   +PS RPT   + + L  +++ 
Sbjct: 258 GTRMRAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 302

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK------EFKAEVNGIGQTHHKN 541
           EELG G F  V K      +  Q A K + +    S +      + + EV+ + +  H N
Sbjct: 17  EELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++ L    +   + +L+ E ++ G L  FL        +  TE +  I  G++YLH    
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---S 132
Query: 602 TQIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
            QI H D+KP+NI+L D        +I DFGL   +       N  I GT  +VAPE   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPAFVAPEIVN 190
Query: 658 NMPITVKVDVYSYGVL 673
             P+ ++ D++S GV+
Sbjct: 191 YEPLGLEADMWSIGVI 206

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 125/286 (43%), Gaps = 35/286 (12%)
Query: 490 LGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQT-HHKNLV 543
           LGRGAFG V +    G     +   VAVK L      SE +   +E+  +    HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 544 RLLGYCDE-GRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTEIV------------ 586
            LLG C + G   +++ EF   G L+++L   SK N    +K+  E +            
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 587 --MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA- 643
               +A+G+ +L    C   IH D+  +NILL +    +I DFGL + +  D        
Sbjct: 153 YSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            R    ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     L E
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKE 266
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
                  D T  + +    + C   +PS RPT   + + L  +++ 
Sbjct: 267 GTRMRAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 19/222 (8%)
Query: 470 NLRCFTYKELVEVTRGFKEE--------LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ 521
           NL   + K+   VTR    E        LG GAFG VYK   N  +S   A K ++   +
Sbjct: 17  NLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKA-QNKETSVLAAAKVIDTKSE 75
Query: 522 DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL 581
           +  +++  E++ +    H N+V+LL       N  ++ EF + GA+ + +    +P  + 
Sbjct: 76  EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTES 135
Query: 582 RTEIV-MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT 640
           + ++V       L YLH+    +IIH D+K  NIL     + +++DFG+    T      
Sbjct: 136 QIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRR 192
Query: 641 NTAIRGTKGYVAPEWF-----RNMPITVKVDVYSYGVLLLEI 677
           ++ I GT  ++APE       ++ P   K DV+S G+ L+E+
Sbjct: 193 DSFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 19/222 (8%)
Query: 470 NLRCFTYKELVEVTRGFKEE--------LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ 521
           NL   + K+   VTR    E        LG GAFG VYK   N  +S   A K ++   +
Sbjct: 17  NLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKA-QNKETSVLAAAKVIDTKSE 75
Query: 522 DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL 581
           +  +++  E++ +    H N+V+LL       N  ++ EF + GA+ + +    +P  + 
Sbjct: 76  EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTES 135
Query: 582 RTEIV-MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT 640
           + ++V       L YLH+    +IIH D+K  NIL     + +++DFG+    T      
Sbjct: 136 QIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 192
Query: 641 NTAIRGTKGYVAPEWF-----RNMPITVKVDVYSYGVLLLEI 677
           ++ I GT  ++APE       ++ P   K DV+S G+ L+E+
Sbjct: 193 DSFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 124/280 (44%), Gaps = 27/280 (9%)
Query: 490 LGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQT-HHKNLV 543
           LGRGAFG V +    G     +   VAVK L      SE +   +E+  +    HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 544 RLLGYCDE-GRNRLLVYEFMSNGALASFL---------FGDSKPNWKLRTEIV---MGIA 590
            LLG C + G   +++ EF   G L+++L         + D   ++     ++     +A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA-IRGTKG 649
           +G+ +L      + IH D+  +NILL +    +I DFGL + +  D  +      R    
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM 709
           ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     L E      
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFXRRLKEGTRMRA 268
Query: 710 DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
            D T  + +    + C   +PS RPT   + + L  +++ 
Sbjct: 269 PDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 307

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 99/191 (51%), Gaps = 6/191 (3%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E++G+GA GTVY    ++ +  +VA++++N   Q  ++    E+  + +  + N+V  L 
Sbjct: 26  EKIGQGASGTVYTAM-DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
               G    +V E+++ G+L   +        ++   +     + L +LH     Q+IH 
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-AAVCRECLQALEFLH---SNQVIHR 140
Query: 608 DIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDV 667
           DIK  NILL    + +++DFG    +T +QS  +T + GT  ++APE         KVD+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 668 YSYGVLLLEII 678
           +S G++ +E+I
Sbjct: 200 WSLGIMAIEMI 210

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 115/259 (44%), Gaps = 25/259 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQ----VAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNL 542
           LG+G FG VY     +    Q    +A+K L +   +    E + + EV       H N+
Sbjct: 13  LGKGKFGNVY-----LAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 67
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           +RL GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   
Sbjct: 68  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--- 124
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           ++IH DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE        
Sbjct: 125 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHD 181
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA 722
            KVD++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  
Sbjct: 182 EKVDLWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISR 236
Query: 723 IWCIQEDPSHRPTMRRVTQ 741
           +  ++ +PS RP +R V +
Sbjct: 237 L--LKHNPSQRPMLREVLE 253

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 123/282 (43%), Gaps = 29/282 (10%)
Query: 490 LGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQT-HHKNLV 543
           LGRGAFG V +    G     +   VAVK L      SE +   +E+  +    HH N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 544 RLLGYCDE-GRNRLLVYEFMSNGALASFL------FGDSKPNWKLRTEIVM--------G 588
            LLG C + G   +++ EF   G L+++L      F   KP    +  + +         
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA-IRGT 647
           +A+G+ +L      + IH D+  +NILL +    +I DFGL + +  D         R  
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE 707
             ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     L E    
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKEGTRM 270
Query: 708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
              D T  + +    + C   +PS RPT   + + L  +++ 
Sbjct: 271 RAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 122/283 (43%), Gaps = 30/283 (10%)
Query: 490 LGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQT-HHKNLV 543
           LGRGAFG V +    G     +   VAVK L      SE +   +E+  +    HH N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 544 RLLGYCDE-GRNRLLVYEFMSNGALASFL------FGDSKPNWKLRTEIV---------M 587
            LLG C + G   +++ EF   G L+++L      F   K    L  + +          
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA-IRG 646
            +A+G+ +L    C   IH D+  +NILL +    +I DFGL + +  D         R 
Sbjct: 156 QVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 647 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL 706
              ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     L E   
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKEGTR 269
Query: 707 EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
               D T  + +    + C   +PS RPT   + + L  +++ 
Sbjct: 270 MRAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 114/259 (44%), Gaps = 25/259 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 42  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 100
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H     ++IH
Sbjct: 101 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIH 157
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR----GTKGYVAPEWFRNMPIT 662
            DIKP+N+LL      +I+DFG          H  ++ R    GT  Y+ PE        
Sbjct: 158 RDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRDDLCGTLDYLPPEMIEGRMHD 210
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA 722
            KVD++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  
Sbjct: 211 EKVDLWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISR 265
Query: 723 IWCIQEDPSHRPTMRRVTQ 741
           +  ++ +PS RP +R V +
Sbjct: 266 L--LKHNPSQRPMLREVLE 282

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 125/286 (43%), Gaps = 35/286 (12%)
Query: 490 LGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQT-HHKNLV 543
           LGRGAFG V +    G     +   VAVK L      SE +   +E+  +    HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 544 RLLGYCDE-GRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTEIV------------ 586
            LLG C + G   +++ EF   G L+++L   SK N    +K+  E +            
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 587 --MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA- 643
               +A+G+ +L    C   IH D+  +NILL +    +I DFGL + +  D        
Sbjct: 144 YSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            R    ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     L E
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKE 257
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
                  D T  + +    + C   +PS RPT   + + L  +++ 
Sbjct: 258 GTRMRAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 302

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 89/189 (47%), Gaps = 9/189 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           EELG GAFG V++      + +  A K +    +  ++  + E+  +    H  LV L  
Sbjct: 163 EELGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 221
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
             ++    +++YEFMS G L   +  + +K +     E +  + +GL ++HE      +H
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVH 278
Query: 607 CDIKPQNILLDDYYNARIS--DFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
            D+KP+NI+     +  +   DFGL   L   QS   T   GT  + APE     P+   
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYY 336
Query: 665 VDVYSYGVL 673
            D++S GVL
Sbjct: 337 TDMWSVGVL 345

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 124/279 (44%), Gaps = 38/279 (13%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---------KEFKAEVNGIGQ 536
           +++++G+G FG V+KG + +     VA+K L  +  DSE         +EF+ EV  +  
Sbjct: 23  YEKQIGKGGFGLVHKGRL-VKDKSVVAIKSL--ILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFY 595
            +H N+V+L G         +V EF+  G L   L   + P  W ++  +++ IA G+ Y
Sbjct: 80  LNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYN-----ARISDFGLEKLLTLDQSHTNTAIRGTKGY 650
           +  +    I+H D++  NI L          A+++DFGL +       H+ + + G   +
Sbjct: 138 MQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQW 192
Query: 651 VAPEWF--RNMPITVKVDVYSYGVLLLEIICLRRTILT-DWAYDCY---QERTLGALVEN 704
           +APE         T K D YS+ ++L        TILT +  +D Y   + + +  + E 
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILY-------TILTGEGPFDEYSYGKIKFINMIREE 245
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQML 743
            L          R   V   C   DP  RP    + + L
Sbjct: 246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 124/280 (44%), Gaps = 27/280 (9%)
Query: 490 LGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQT-HHKNLV 543
           LGRGAFG V +    G     +   VAVK L      SE +   +E+  +    HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 544 RLLGYCDE-GRNRLLVYEFMSNGALASFL---------FGDSKPNWKLRTEIV---MGIA 590
            LLG C + G   +++ EF   G L+++L         + D   ++     ++     +A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA-IRGTKG 649
           +G+ +L      + IH D+  +NILL +    +I DFGL + +  D  +      R    
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM 709
           ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     L E      
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKEGTRMRA 268
Query: 710 DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
            D T  + +    + C   +PS RPT   + + L  +++ 
Sbjct: 269 PDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 307

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 113/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 18  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 76
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 77  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 133
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S     + GT  Y+ PE         KVD
Sbjct: 134 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVD 190
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 191 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 243
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 244 KHNPSQRPMLREVLE 258

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 125/286 (43%), Gaps = 35/286 (12%)
Query: 490 LGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQT-HHKNLV 543
           LGRGAFG V +    G     +   VAVK L      SE +   +E+  +    HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 544 RLLGYCDE-GRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTEIV------------ 586
            LLG C + G   +++ EF   G L+++L   SK N    +K+  E +            
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 587 --MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA- 643
               +A+G+ +L    C   IH D+  +NILL +    +I DFGL + +  D        
Sbjct: 153 YSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            R    ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     L E
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKE 266
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
                  D T  + +    + C   +PS RPT   + + L  +++ 
Sbjct: 267 GTRMRAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 113/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 17  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 132
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S     + GT  Y+ PE         KVD
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVD 189
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 190 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 242
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 243 KHNPSQRPMLREVLE 257

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVR 544
           + LG G FG V  G   + +  +VAVK LNR      D   + K E+  +    H ++++
Sbjct: 17  DTLGVGTFGKVKIGEHQL-TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L        +  +V E++S G L  ++    +        +   I   + Y H      +
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MV 132
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR-NMPITV 663
           +H D+KP+N+LLD + NA+I+DFGL  +++  +   ++   G+  Y APE     +    
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC--GSPNYAAPEVISGRLYAGP 190
Query: 664 KVDVYSYGVLLLEIIC 679
           +VD++S GV+L  ++C
Sbjct: 191 EVDIWSCGVILYALLC 206

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 106/222 (47%), Gaps = 19/222 (8%)
Query: 470 NLRCFTYKELVEVTRGFKEE--------LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ 521
           NL   + K+   VTR    E        LG GAFG VYK   N  +S   A K ++   +
Sbjct: 17  NLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKA-QNKETSVLAAAKVIDTKSE 75
Query: 522 DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL 581
           +  +++  E++ +    H N+V+LL       N  ++ EF + GA+ + +    +P  + 
Sbjct: 76  EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTES 135
Query: 582 RTEIV-MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT 640
           + ++V       L YLH+    +IIH D+K  NIL     + +++DFG+    T      
Sbjct: 136 QIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRR 192
Query: 641 NTAIRGTKGYVAPEWF-----RNMPITVKVDVYSYGVLLLEI 677
           +  I GT  ++APE       ++ P   K DV+S G+ L+E+
Sbjct: 193 DXFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 126/289 (43%), Gaps = 41/289 (14%)
Query: 490 LGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSEK-----EFKAEVNGIGQTHHK 540
           LGRGAFG V +    G     +   VAVK L      SE      E K  ++ IG  HH 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH-IG--HHL 82
Query: 541 NLVRLLGYCDE-GRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTEIV--------- 586
           N+V LLG C + G   +++ EF   G L+++L   SK N    +K+  E +         
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 587 -----MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN 641
                  +A+G+ +L    C   IH D+  +NILL +    +I DFGL + +  D     
Sbjct: 141 LICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 642 TA-IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGA 700
               R    ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRR 254
Query: 701 LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
           L E       D T  + +    + C   +PS RPT   + + L  +++ 
Sbjct: 255 LKEGTRMRAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 302

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 114/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 19  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 134
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I++FG         S   T + GT  Y+ PE         KVD
Sbjct: 135 RDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 191
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 192 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 244
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 245 KHNPSQRPMLREVLE 259

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK------EFKAEVNGIGQTHHKN 541
           EELG G F  V K      +  Q A K + +    S +      + + EV+ + +  H N
Sbjct: 17  EELGSGVFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++ L    +   + +L+ E ++ G L  FL        +  TE +  I  G++YLH    
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---S 132
Query: 602 TQIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
            QI H D+KP+NI+L D        +I DFGL   +       N  I GT  +VAPE   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVN 190
Query: 658 NMPITVKVDVYSYGVL 673
             P+ ++ D++S GV+
Sbjct: 191 YEPLGLEADMWSIGVI 206

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           +  +LG+G FG+V    Y    +  +   VAVK+L     D +++F+ E+  +   H   
Sbjct: 14  YISQLGKGNFGSVELCRYDPLGD-NTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 72
Query: 542 LVRLLGYC-DEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVM----GIARGLFY 595
           +V+  G     GR  L LV E++ +G L  FL    +   +L    ++     I +G+ Y
Sbjct: 73  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEY 129
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAP 653
           L    C   +H D+  +NIL++   + +I+DFGL KLL LD+ +      G     + AP
Sbjct: 130 LGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 186
Query: 654 EWFRNMPITVKVDVYSYGVLLLEII 678
           E   +   + + DV+S+GV+L E+ 
Sbjct: 187 ESLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           +  +LG+G FG+V    Y    +  +   VAVK+L     D +++F+ E+  +   H   
Sbjct: 15  YISQLGKGNFGSVELCRYDPLGD-NTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 73
Query: 542 LVRLLGYC-DEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVM----GIARGLFY 595
           +V+  G     GR  L LV E++ +G L  FL    +   +L    ++     I +G+ Y
Sbjct: 74  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEY 130
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAP 653
           L    C   +H D+  +NIL++   + +I+DFGL KLL LD+ +      G     + AP
Sbjct: 131 LGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 187
Query: 654 EWFRNMPITVKVDVYSYGVLLLEII 678
           E   +   + + DV+S+GV+L E+ 
Sbjct: 188 ESLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 476 YKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVFQD----SEKEFKA 529
           ++ +VE      EELG G F  V K     G+  + A K  K  R+       S +E + 
Sbjct: 20  FQSMVEDHYEMGEELGSGQFAIVRKC-RQKGTGKEYAAKFIKKRRLXSSRRGVSREEIER 78
Query: 530 EVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGI 589
           EVN + +  H N++ L    +   + +L+ E +S G L  FL           T+ +  I
Sbjct: 79  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 138
Query: 590 ARGLFYLHEECCTQIIHCDIKPQNILLDDYY--NARIS--DFGLEKLLTLDQSHTNTAIR 645
             G+ YLH     +I H D+KP+NI+L D    N RI   DFG+   +       N  I 
Sbjct: 139 LDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IF 193
Query: 646 GTKGYVAPEWFRNMPITVKVDVYSYGVL 673
           GT  +VAPE     P+ ++ D++S GV+
Sbjct: 194 GTPEFVAPEIVNYEPLGLEADMWSIGVI 221

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 119/257 (46%), Gaps = 17/257 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + +G+G+FG VYKG  N  + + VA+K ++    +D  ++ + E+  + Q     + R  
Sbjct: 25  DRIGKGSFGEVYKGIDNH-TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYF 83
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           G   +     ++ E++  G+    L         + T I+  I +GL YLH E   + IH
Sbjct: 84  GSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIAT-ILREILKGLDYLHSE---RKIH 139
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIK  N+LL +  + +++DFG+   LT  Q   N  + GT  ++APE  +      K D
Sbjct: 140 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDFKAD 198
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDM--TVLQRFVMVAIW 724
           ++S G+  +E+             D +  R L  + +N    ++       + FV     
Sbjct: 199 IWSLGITAIELAKGEPP-----NSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEA--- 250
Query: 725 CIQEDPSHRPTMRRVTQ 741
           C+ +DP  RPT + + +
Sbjct: 251 CLNKDPRFRPTAKELLK 267

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 125/286 (43%), Gaps = 35/286 (12%)
Query: 490 LGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQT-HHKNLV 543
           LGRGAFG V +    G     +   VAVK L      SE +   +E+  +    HH N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 544 RLLGYCDE-GRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTEIV------------ 586
            LLG C + G   +++ EF   G L+++L   SK N    +K   E +            
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 587 --MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA- 643
               +A+G+ +L    C   IH D+  +NILL +    +I DFGL + +  D  +     
Sbjct: 155 YSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            R    ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     L E
Sbjct: 212 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKE 268
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
                  D T  + +    + C   +PS RPT   + + L  +++ 
Sbjct: 269 GTRMRAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 313

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK------EFKAEVNGIGQTHHKN 541
           EELG G F  V K      +  Q A K + +    S +      + + EV+ + +  H N
Sbjct: 17  EELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++ L    +   + +L+ E ++ G L  FL        +  TE +  I  G++YLH    
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---S 132
Query: 602 TQIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
            QI H D+KP+NI+L D        +I DFGL   +       N  I GT  +VAPE   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVN 190
Query: 658 NMPITVKVDVYSYGVL 673
             P+ ++ D++S GV+
Sbjct: 191 YEPLGLEADMWSIGVI 206

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK------EFKAEVNGIGQTHHKN 541
           EELG G F  V K      +  Q A K + +    S +      + + EV+ + +  H N
Sbjct: 16  EELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++ L    +   + +L+ E ++ G L  FL        +  TE +  I  G++YLH    
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---S 131
Query: 602 TQIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
            QI H D+KP+NI+L D        +I DFGL   +       N  I GT  +VAPE   
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVN 189
Query: 658 NMPITVKVDVYSYGVL 673
             P+ ++ D++S GV+
Sbjct: 190 YEPLGLEADMWSIGVI 205

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 89/189 (47%), Gaps = 9/189 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           EELG GAFG V++      + +  A K +    +  ++  + E+  +    H  LV L  
Sbjct: 57  EELGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 115
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
             ++    +++YEFMS G L   +  + +K +     E +  + +GL ++HE      +H
Sbjct: 116 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVH 172
Query: 607 CDIKPQNILLDDYYNARIS--DFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
            D+KP+NI+     +  +   DFGL   L   QS   T   GT  + APE     P+   
Sbjct: 173 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYY 230
Query: 665 VDVYSYGVL 673
            D++S GVL
Sbjct: 231 TDMWSVGVL 239

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK------EFKAEVNGIGQTHHKN 541
           EELG G F  V K      +  Q A K + +    S +      + + EV+ + +  H N
Sbjct: 17  EELGSGKFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++ L    +   + +L+ E ++ G L  FL        +  TE +  I  G++YLH    
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---S 132
Query: 602 TQIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
            QI H D+KP+NI+L D        +I DFGL   +       N  I GT  +VAPE   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVN 190
Query: 658 NMPITVKVDVYSYGVL 673
             P+ ++ D++S GV+
Sbjct: 191 YEPLGLEADMWSIGVI 206

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           +  +LG+G FG+V    Y    +  +   VAVK+L     D +++F+ E+  +   H   
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGD-NTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85
Query: 542 LVRLLGYC-DEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVM----GIARGLFY 595
           +V+  G     GR  L LV E++ +G L  FL    +   +L    ++     I +G+ Y
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEY 142
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAP 653
           L    C   +H D+  +NIL++   + +I+DFGL KLL LD+ +      G     + AP
Sbjct: 143 LGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199
Query: 654 EWFRNMPITVKVDVYSYGVLLLEII 678
           E   +   + + DV+S+GV+L E+ 
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 113/255 (44%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 16  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 74
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 131
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S     + GT  Y+ PE         KVD
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVD 188
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 189 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 241
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 242 KHNPSQRPMLREVLE 256

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK------EFKAEVNGIGQTHHKN 541
           EELG G F  V K      +  Q A K + +    S +      + + EV+ + +  H N
Sbjct: 17  EELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++ L    +   + +L+ E ++ G L  FL        +  TE +  I  G++YLH    
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---S 132
Query: 602 TQIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
            QI H D+KP+NI+L D        +I DFGL   +       N  I GT  +VAPE   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVN 190
Query: 658 NMPITVKVDVYSYGVL 673
             P+ ++ D++S GV+
Sbjct: 191 YEPLGLEADMWSIGVI 206

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK------EFKAEVNGIGQTHHKN 541
           EELG G F  V K      +  Q A K + +    S +      + + EV+ + +  H N
Sbjct: 16  EELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++ L    +   + +L+ E ++ G L  FL        +  TE +  I  G++YLH    
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---S 131
Query: 602 TQIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
            QI H D+KP+NI+L D        +I DFGL   +       N  I GT  +VAPE   
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVN 189
Query: 658 NMPITVKVDVYSYGVL 673
             P+ ++ D++S GV+
Sbjct: 190 YEPLGLEADMWSIGVI 205

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 130/294 (44%), Gaps = 50/294 (17%)
Query: 490 LGRGAFGTVYKG----FVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNLVR 544
           LG G FG V K              VAVK L      SE ++  +E N + Q +H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSK--PNWKL--------------RTEIVMG 588
           L G C +    LL+ E+   G+L  FL    K  P +                   + MG
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 589 --------IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT 640
                   I++G+ YL E    +++H D+  +NIL+ +    +ISDFGL +    D    
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSR----DVYEE 203
Query: 641 NTAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE 695
           ++ ++ ++G +  +W       +   T + DV+S+GVLL EI+ L         Y     
Sbjct: 204 DSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN-----PYPGIPP 258
Query: 696 RTLGALVE--NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
             L  L++  + +E  D+ +  +    + + C +++P  RP    +++ LE ++
Sbjct: 259 ERLFNLLKTGHRMERPDNCS--EEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK------EFKAEVNGIGQTHHKN 541
           EELG G F  V K      +  Q A K + +    S +      + + EV+ + +  H N
Sbjct: 17  EELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++ L    +   + +L+ E ++ G L  FL        +  TE +  I  G++YLH    
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---S 132
Query: 602 TQIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
            QI H D+KP+NI+L D        +I DFGL   +       N  I GT  +VAPE   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVN 190
Query: 658 NMPITVKVDVYSYGVL 673
             P+ ++ D++S GV+
Sbjct: 191 YEPLGLEADMWSIGVI 206

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK------EFKAEVNGIGQTHHKN 541
           EELG G F  V K      +  Q A K + +    S +      + + EV+ + +  H N
Sbjct: 17  EELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++ L    +   + +L+ E ++ G L  FL        +  TE +  I  G++YLH    
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---S 132
Query: 602 TQIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
            QI H D+KP+NI+L D        +I DFGL   +       N  I GT  +VAPE   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVN 190
Query: 658 NMPITVKVDVYSYGVL 673
             P+ ++ D++S GV+
Sbjct: 191 YEPLGLEADMWSIGVI 206

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 34/293 (11%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFV---NMGSSDQ-VAVKKL-NRVFQDSEKEFKAEV 531
           KE+      F EELG   FG VYKG +     G   Q VA+K L ++      +EF+ E 
Sbjct: 4   KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63
Query: 532 NGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF--------GDSKPNWKLRT 583
               +  H N+V LLG   + +   +++ + S+G L  FL         G +  +  +++
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 584 --------EIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL-EKLLT 634
                    +V  IA G+ YL       ++H D+  +N+L+ D  N +ISD GL  ++  
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 635 LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ 694
            D             ++APE       ++  D++SYGV+L E+            Y  Y 
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ-----PYCGYS 235
Query: 695 ERTLGALVEND--LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG 745
            + +  ++ N   L   DD       +M+  W   E PS RP  + +   L  
Sbjct: 236 NQDVVEMIRNRQVLPCPDDCPAWVYALMIECW--NEFPSRRPRFKDIHSRLRA 286

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 115/259 (44%), Gaps = 25/259 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 19  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   ++IH
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIH 134
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR----GTKGYVAPEWFRNMPIT 662
            DIKP+N+LL      +I+DFG          H  ++ R    GT  Y+ PE        
Sbjct: 135 RDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRDDLCGTLDYLPPEMIEGRMHD 187
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA 722
            KVD++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  
Sbjct: 188 EKVDLWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISR 242
Query: 723 IWCIQEDPSHRPTMRRVTQ 741
           +  ++ +PS RP +R V +
Sbjct: 243 L--LKHNPSQRPMLREVLE 259

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK------EFKAEVNGIGQTHHKN 541
           EELG G F  V K      +  Q A K + +    S +      + + EV+ + +  H N
Sbjct: 17  EELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++ L    +   + +L+ E ++ G L  FL        +  TE +  I  G++YLH    
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---S 132
Query: 602 TQIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
            QI H D+KP+NI+L D        +I DFGL   +       N  I GT  +VAPE   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVN 190
Query: 658 NMPITVKVDVYSYGVL 673
             P+ ++ D++S GV+
Sbjct: 191 YEPLGLEADMWSIGVI 206

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK------EFKAEVNGIGQTHHKN 541
           EELG G F  V K      +  Q A K + +    S +      + + EV+ + +  H N
Sbjct: 17  EELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++ L    +   + +L+ E ++ G L  FL        +  TE +  I  G++YLH    
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---S 132
Query: 602 TQIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
            QI H D+KP+NI+L D        +I DFGL   +       N  I GT  +VAPE   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVN 190
Query: 658 NMPITVKVDVYSYGVL 673
             P+ ++ D++S GV+
Sbjct: 191 YEPLGLEADMWSIGVI 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 112/255 (43%), Gaps = 17/255 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 19  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 77
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H     ++IH
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIH 134
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S     + GT  Y+ PE         KVD
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVD 191
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCI 726
           ++S GVL  E +  +      +  + YQE T   +   +    D +T   R ++  +  +
Sbjct: 192 LWSLGVLCYEFLVGK----PPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRL--L 244
Query: 727 QEDPSHRPTMRRVTQ 741
           + +PS RP +R V +
Sbjct: 245 KHNPSQRPMLREVLE 259

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 486 FKEELGRGAFGTVYKG-FVNMGSSDQ---VAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
            K ELG GAFG V+     N+  +     VAVK L      + K+F+ E   +    H++
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFL---------FGDSKPN-------WKLRTEI 585
           +V+  G C +G   ++V+E+M +G L  FL           D +P              I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 586 VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQ----SHT 640
              IA G+ YL  +     +H D+  +N L+      +I DFG+ + + + D      HT
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 677
              IR    ++ PE       T + DV+S+GV+L EI
Sbjct: 196 MLPIR----WMPPESIMYRKFTTESDVWSFGVILWEI 228

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK------EFKAEVNGIGQTHHKN 541
           EELG G F  V K      +  Q A K + +    S +      + + EV+ + +  H N
Sbjct: 17  EELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++ L    +   + +L+ E ++ G L  FL        +  TE +  I  G++YLH    
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---S 132
Query: 602 TQIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
            QI H D+KP+NI+L D        +I DFGL   +       N  I GT  +VAPE   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVN 190
Query: 658 NMPITVKVDVYSYGVL 673
             P+ ++ D++S GV+
Sbjct: 191 YEPLGLEADMWSIGVI 206

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK------EFKAEVNGIGQTHHKN 541
           EELG G F  V K      +  Q A K + +    S +      + + EV+ + +  H N
Sbjct: 17  EELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++ L    +   + +L+ E ++ G L  FL        +  TE +  I  G++YLH    
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---S 132
Query: 602 TQIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
            QI H D+KP+NI+L D        +I DFGL   +       N  I GT  +VAPE   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVN 190
Query: 658 NMPITVKVDVYSYGVL 673
             P+ ++ D++S GV+
Sbjct: 191 YEPLGLEADMWSIGVI 206

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 118/260 (45%), Gaps = 13/260 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKL-NRVFQDSEKEFKAEVNGIGQTHHKNLVR 544
           F++ LG GAF  V     +  +   VA+K +  +  +  E   + E+  + +  H N+V 
Sbjct: 22  FRDVLGTGAFSEVILA-EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L    + G +  L+ + +S G L   +        +  + ++  +   + YLH+     I
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGI 137
Query: 605 IHCDIKPQNIL---LDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
           +H D+KP+N+L   LD+     ISDFGL K+   D     +   GT GYVAPE     P 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV 721
           +  VD +S GV+   ++C       +     + E+ L A  E D    DD++   +  + 
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLF-EQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 722 AIWCIQEDPSHRPTMRRVTQ 741
            +  +++DP  R T  +  Q
Sbjct: 255 HL--MEKDPEKRFTCEQALQ 272

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 130/272 (47%), Gaps = 28/272 (10%)
Query: 490 LGRGAFGTVYKG-FVNMGSSD-QVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVRLL 546
           +G+G FG VY G +++   +  Q A+K L+R+ +  + E F  E   +   +H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 547 GYC--DEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEECCTQ 603
           G     EG   +L+  +M +G L  F+    + P  K      + +ARG+ YL E+   +
Sbjct: 89  GIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---K 144
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMP 660
            +H D+  +N +LD+ +  +++DFGL + +   + ++    R  +    + A E  +   
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR 204
Query: 661 ITVKVDVYSYGVLLLEIIC-----LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL 715
            T K DV+S+GVLL E++       R     D  +   Q R L    + +        V+
Sbjct: 205 FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP---QPEYCPDSLYQVM 261
Query: 716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           Q+       C + DP+ RPT R +   +E +V
Sbjct: 262 QQ-------CWEADPAVRPTFRVLVGEVEQIV 286

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 124/257 (48%), Gaps = 17/257 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           E++G+G+FG V+KG  N  +   VA+K ++    +D  ++ + E+  + Q     + +  
Sbjct: 13  EKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           G   +     ++ E++  G+    L        ++ T I+  I +GL YLH E   + IH
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-ILREILKGLDYLHSE---KKIH 127
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIK  N+LL ++   +++DFG+   LT  Q   NT + GT  ++APE  +      K D
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKAD 186
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD--MTVLQRFVMVAIW 724
           ++S G+  +E+             + +  + L  + +N+   ++      L+ FV     
Sbjct: 187 IWSLGITAIELARGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA--- 238
Query: 725 CIQEDPSHRPTMRRVTQ 741
           C+ ++PS RPT + + +
Sbjct: 239 CLNKEPSFRPTAKELLK 255

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 129/294 (43%), Gaps = 50/294 (17%)
Query: 490 LGRGAFGTVYKG----FVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNLVR 544
           LG G FG V K              VAVK L      SE ++  +E N + Q +H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSK--PNWKL--------------RTEIVMG 588
           L G C +    LL+ E+   G+L  FL    K  P +                   + MG
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 589 --------IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT 640
                   I++G+ YL E     ++H D+  +NIL+ +    +ISDFGL +    D    
Sbjct: 151 DLISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFGLSR----DVYEE 203
Query: 641 NTAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE 695
           ++ ++ ++G +  +W       +   T + DV+S+GVLL EI+ L         Y     
Sbjct: 204 DSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN-----PYPGIPP 258
Query: 696 RTLGALVE--NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
             L  L++  + +E  D+ +  +    + + C +++P  RP    +++ LE ++
Sbjct: 259 ERLFNLLKTGHRMERPDNCS--EEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 127/276 (46%), Gaps = 26/276 (9%)
Query: 490 LGRGAFGTVYKGFVNM--GSSDQVAVK--KLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG G FG+V +G +    G+S +VAVK  KL+   Q   +EF +E   +    H N++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 546 LGYCDEGRNR-----LLVYEFMSNGALASFLF------GDSKPNWKLRTEIVMGIARGLF 594
           LG C E  ++     +++  FM  G L ++L       G      +   + ++ IA G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL-EKLLTLDQSHTNTAIRGTKGYVAP 653
           YL        +H D+  +N +L D     ++DFGL +K+ + D        +    ++A 
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 654 EWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQERTLGALVENDLEAMDDM 712
           E   +   T K DV+++GV + EI     T       ++ Y     G  ++   + +D++
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDEL 278
Query: 713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
                 +M + W  + DP  RPT   +   LE ++E
Sbjct: 279 YE----IMYSCW--RTDPLDRPTFSVLRLQLEKLLE 308

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 124/257 (48%), Gaps = 17/257 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           E++G+G+FG V+KG  N  +   VA+K ++    +D  ++ + E+  + Q     + +  
Sbjct: 33  EKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 91
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           G   +     ++ E++  G+    L        ++ T I+  I +GL YLH E   + IH
Sbjct: 92  GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-ILREILKGLDYLHSE---KKIH 147
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIK  N+LL ++   +++DFG+   LT  Q   NT + GT  ++APE  +      K D
Sbjct: 148 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKAD 206
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD--MTVLQRFVMVAIW 724
           ++S G+  +E+             + +  + L  + +N+   ++      L+ FV     
Sbjct: 207 IWSLGITAIELARGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA--- 258
Query: 725 CIQEDPSHRPTMRRVTQ 741
           C+ ++PS RPT + + +
Sbjct: 259 CLNKEPSFRPTAKELLK 275

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 486 FKEELGRGAFGTV----YKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           +  +LG+G FG+V    Y    +  +   VAVK+L     D +++F+ E+  +   H   
Sbjct: 11  YISQLGKGNFGSVELCRYDPLGD-NTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 69
Query: 542 LVRLLGYC-DEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVM----GIARGLFY 595
           +V+  G     GR  L LV E++ +G L  FL    +   +L    ++     I +G+ Y
Sbjct: 70  IVKYRGVSYGPGRPELRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEY 126
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG--YVAP 653
           L    C   +H D+  +NIL++   + +I+DFGL KLL LD+        G     + AP
Sbjct: 127 LGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAP 183
Query: 654 EWFRNMPITVKVDVYSYGVLLLEII 678
           E   +   + + DV+S+GV+L E+ 
Sbjct: 184 ESLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 130/294 (44%), Gaps = 50/294 (17%)
Query: 490 LGRGAFGTVYKG----FVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNLVR 544
           LG G FG V K              VAVK L      SE ++  +E N + Q +H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSK--PNWKL--------------RTEIVMG 588
           L G C +    LL+ E+   G+L  FL    K  P +                   + MG
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 589 --------IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT 640
                   I++G+ YL E    +++H D+  +NIL+ +    +ISDFGL +    D    
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSR----DVYEE 203
Query: 641 NTAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE 695
           ++ ++ ++G +  +W       +   T + DV+S+GVLL EI+ L         Y     
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN-----PYPGIPP 258
Query: 696 RTLGALVE--NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
             L  L++  + +E  D+ +  +    + + C +++P  RP    +++ LE ++
Sbjct: 259 ERLFNLLKTGHRMERPDNCS--EEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 34/293 (11%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFV---NMGSSDQ-VAVKKL-NRVFQDSEKEFKAEV 531
           KE+      F EELG   FG VYKG +     G   Q VA+K L ++      +EF+ E 
Sbjct: 21  KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 80
Query: 532 NGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF--------GDSKPNWKLRT 583
               +  H N+V LLG   + +   +++ + S+G L  FL         G +  +  +++
Sbjct: 81  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 140
Query: 584 --------EIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL-EKLLT 634
                    +V  IA G+ YL       ++H D+  +N+L+ D  N +ISD GL  ++  
Sbjct: 141 ALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 197
Query: 635 LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ 694
            D             ++APE       ++  D++SYGV+L E+            Y  Y 
Sbjct: 198 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ-----PYCGYS 252
Query: 695 ERTLGALVEND--LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG 745
            + +  ++ N   L   DD       +M+  W   E PS RP  + +   L  
Sbjct: 253 NQDVVEMIRNRQVLPCPDDCPAWVYALMIECW--NEFPSRRPRFKDIHSRLRA 303

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 125/280 (44%), Gaps = 40/280 (14%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---------KEFKAEVNGIGQ 536
           +++++G+G FG V+KG + +     VA+K L  +  DSE         +EF+ EV  +  
Sbjct: 23  YEKQIGKGGFGLVHKGRL-VKDKSVVAIKSL--ILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFY 595
            +H N+V+L G         +V EF+  G L   L   + P  W ++  +++ IA G+ Y
Sbjct: 80  LNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYN-----ARISDFGLEKLLTLDQS-HTNTAIRGTKG 649
           +  +    I+H D++  NI L          A+++DFG     T  QS H+ + + G   
Sbjct: 138 MQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG-----TSQQSVHSVSGLLGNFQ 191
Query: 650 YVAPEWF--RNMPITVKVDVYSYGVLLLEIICLRRTILT-DWAYDCY---QERTLGALVE 703
           ++APE         T K D YS+ ++L        TILT +  +D Y   + + +  + E
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILY-------TILTGEGPFDEYSYGKIKFINMIRE 244
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQML 743
             L          R   V   C   DP  RP    + + L
Sbjct: 245 EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 118/285 (41%), Gaps = 37/285 (12%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQ------VAVKKLNRVFQDSEKEFKAEVNGIGQTH----H 539
           LG GAFG V          D+      VAVK L      +EK+    V+ +        H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGKH 100
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI-------------- 585
           KN++ LLG C +     ++ E+ S G L  +L     P  +   +I              
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 586 --VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNT 642
                +ARG+ YL  + C   IH D+  +N+L+ +    RI+DFGL + +  +D     T
Sbjct: 161 SCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALV 702
             R    ++APE   +   T + DV+S+GVL+ EI  L  +      Y       L  L+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS-----PYPGIPVEELFKLL 272
Query: 703 ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           +                M+   C    PS RPT +++ + L+ ++
Sbjct: 273 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 6/190 (3%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           ++G G+ G V        +  QVAVKK++   Q   +    EV  +   HH N+V +   
Sbjct: 52  KIGEGSTGIVCIA-TEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCD 608
              G    +V EF+  GAL   +   ++ N +    + + + R L YLH +    +IH D
Sbjct: 111 YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRD 166
Query: 609 IKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVY 668
           IK  +ILL      ++SDFG    ++ +       + GT  ++APE    +P   +VD++
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV-GTPYWMAPEVISRLPYGTEVDIW 225
Query: 669 SYGVLLLEII 678
           S G++++E+I
Sbjct: 226 SLGIMVIEMI 235

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 10/198 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKL-NRVFQDSEKEFKAEVNGIGQTHHKNLVR 544
           FKE LG GAF  V        +    AVK +  +  +  E   + E+  + +  H+N+V 
Sbjct: 26  FKETLGTGAFSEVVLA-EEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVA 84
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L    +   +  LV + +S G L   +        K  + ++  +   ++YLH      I
Sbjct: 85  LEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHR---MGI 141
Query: 605 IHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
           +H D+KP+N+L    D+     ISDFGL K+    +    +   GT GYVAPE     P 
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSKMEG--KGDVMSTACGTPGYVAPEVLAQKPY 199
Query: 662 TVKVDVYSYGVLLLEIIC 679
           +  VD +S GV+   ++C
Sbjct: 200 SKAVDCWSIGVIAYILLC 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 118/260 (45%), Gaps = 13/260 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVR 544
           F++ LG GAF  V     +  +   VA+K + +   +  E   + E+  + +  H N+V 
Sbjct: 22  FRDVLGTGAFSEVILA-EDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L    + G +  L+ + +S G L   +        +  + ++  +   + YLH+     I
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGI 137
Query: 605 IHCDIKPQNIL---LDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
           +H D+KP+N+L   LD+     ISDFGL K+   D     +   GT GYVAPE     P 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV 721
           +  VD +S GV+   ++C       +     + E+ L A  E D    DD++   +  + 
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLF-EQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 722 AIWCIQEDPSHRPTMRRVTQ 741
            +  +++DP  R T  +  Q
Sbjct: 255 HL--MEKDPEKRFTCEQALQ 272

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK------EFKAEVNGIGQTHHKN 541
           EELG G F  V K      +  Q A K + +    S +      + + EV+ + +  H N
Sbjct: 17  EELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++ L    +   + +L+ E ++ G L  FL        +  TE +  I  G++YLH    
Sbjct: 76  VITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---S 132
Query: 602 TQIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
            QI H D+KP+NI+L D        +I DFGL   +       N  I GT  +VAPE   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVN 190
Query: 658 NMPITVKVDVYSYGVL 673
             P+ ++ D++S GV+
Sbjct: 191 YEPLGLEADMWSIGVI 206

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 131/278 (47%), Gaps = 37/278 (13%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVR 544
           ++LG+GA+G V+K  ++  + + VAVKK+   FQ   D+++ F+  +     + H+N+V 
Sbjct: 15  KKLGKGAYGIVWKS-IDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVN 73
Query: 545 LLGY--CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           LL     D  R+  LV+++M     A       +P  K    +V  + + + YLH     
Sbjct: 74  LLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHK--QYVVYQLIKVIKYLH---SG 128
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNTAIRGTKG------------ 649
            ++H D+KP NILL+   + +++DFGL +  + + +   N  +   +             
Sbjct: 129 GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
Query: 650 -YVAPEWFRNMPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
            YVA  W+R   I       T  +D++S G +L EI+C  + I    +     ER +G +
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC-GKPIFPGSSTMNQLERIIGVI 247
Query: 702 VENDLEAMDDMTVLQR-FVMVAIWCIQEDPSHRPTMRR 738
              D  + +D+  +Q  F    I  ++E    R + +R
Sbjct: 248 ---DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKR 282

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E++G+GA GTVY    ++ +  +VA++++N   Q  ++    E+  + +  + N+V  L 
Sbjct: 26  EKIGQGASGTVYTAM-DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
               G    +V E+++ G+L   +        ++   +     + L +LH     Q+IH 
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-AAVCRECLQALEFLH---SNQVIHR 140
Query: 608 DIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDV 667
           DIK  NILL    + +++DFG    +T +QS  +  + GT  ++APE         KVD+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 668 YSYGVLLLEII 678
           +S G++ +E+I
Sbjct: 200 WSLGIMAIEMI 210

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 479 LVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVFQD----SEKEFKAEVN 532
           +VE      EELG G F  V K     G+  + A K  K  R+       S +E + EVN
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKC-RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARG 592
            + +  H N++ L    +   + +L+ E +S G L  FL           T+ +  I  G
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYY--NARIS--DFGLEKLLTLDQSHTNTAIRGTK 648
           + YLH     +I H D+KP+NI+L D    N RI   DFG+   +       N  I GT 
Sbjct: 121 VHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTP 175
Query: 649 GYVAPEWFRNMPITVKVDVYSYGVL 673
            +VAPE     P+ ++ D++S GV+
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVI 200

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 92/196 (46%), Gaps = 16/196 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVFQD----SEKEFKAEVNGIGQTHHKN 541
           EELG G F  V K     G+  + A K  K  R+       S +E + EVN + +  H N
Sbjct: 18  EELGSGQFAIVRKC-RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 76
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++ L    +   + +L+ E +S G L  FL           T+ +  I  G+ YLH    
Sbjct: 77  IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH---S 133
Query: 602 TQIIHCDIKPQNILLDDYY--NARIS--DFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
            +I H D+KP+NI+L D    N RI   DFG+   +       N  I GT  +VAPE   
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIVN 191
Query: 658 NMPITVKVDVYSYGVL 673
             P+ ++ D++S GV+
Sbjct: 192 YEPLGLEADMWSIGVI 207

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 118/285 (41%), Gaps = 37/285 (12%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQ------VAVKKLNRVFQDSEKEFKAEVNGIGQTH----H 539
           LG GAFG V          D+      VAVK L      +EK+    V+ +        H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGKH 100
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI-------------- 585
           KN++ LLG C +     ++ E+ S G L  +L     P  +   +I              
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 586 --VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNT 642
                +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D     T
Sbjct: 161 SCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALV 702
             R    ++APE   +   T + DV+S+GVL+ EI  L  +      Y       L  L+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS-----PYPGIPVEELFKLL 272
Query: 703 ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           +                M+   C    PS RPT +++ + L+ ++
Sbjct: 273 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E++G+GA GTVY    ++ +  +VA++++N   Q  ++    E+  + +  + N+V  L 
Sbjct: 26  EKIGQGASGTVYTAM-DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
               G    +V E+++ G+L   +        ++   +     + L +LH     Q+IH 
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-AAVCRECLQALEFLH---SNQVIHR 140
Query: 608 DIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDV 667
           DIK  NILL    + +++DFG    +T +QS  +  + GT  ++APE         KVD+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 668 YSYGVLLLEII 678
           +S G++ +E+I
Sbjct: 200 WSLGIMAIEMI 210

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG G+FG V   + +  +  +VA+K +N+      D +   + E++ +    H ++++L 
Sbjct: 22  LGEGSFGKVKLAY-HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 80
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
                    ++V E+  N  L  ++    K + +        I   + Y H     +I+H
Sbjct: 81  DVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVH 136
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR-NMPITVKV 665
            D+KP+N+LLD++ N +I+DFGL  ++T D +   T+  G+  Y APE     +    +V
Sbjct: 137 RDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSC-GSPNYAAPEVISGKLYAGPEV 194
Query: 666 DVYSYGVLLLEIICLR 681
           DV+S GV+L  ++C R
Sbjct: 195 DVWSCGVILYVMLCRR 210

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 123/277 (44%), Gaps = 43/277 (15%)
Query: 488 EELGRGAFGTVYKG-FVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ-THHKNLVRL 545
           E +G G +G VYKG  V  G   Q+A  K+  V  D E+E K E+N + + +HH+N+   
Sbjct: 30  ELVGNGTYGQVYKGRHVKTG---QLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATY 86
Query: 546 LGYCDEGR------NRLLVYEFMSNGALASFLFGDSKPNWKLRTE----IVMGIARGLFY 595
            G   +           LV EF   G++   L  ++K N  L+ E    I   I RGL +
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGN-TLKEEWIAYICREILRGLSH 144
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           LH+    ++IH DIK QN+LL +    ++ DFG+   L       NT I GT  ++APE 
Sbjct: 145 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEV 200
Query: 656 FR-----NMPITVKVDVYSYGVLLLEI------ICLRRTILTDWAYDCYQERTLGALVEN 704
                  +     K D++S G+  +E+      +C           D +  R L  +  N
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC-----------DMHPMRALFLIPRN 249
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ 741
               +      ++F      C+ ++ S RP   ++ +
Sbjct: 250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 99/191 (51%), Gaps = 6/191 (3%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E++G+GA GTVY    ++ +  +VA++++N   Q  ++    E+  + +  + N+V  L 
Sbjct: 27  EKIGQGASGTVYTAM-DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
               G    +V E+++ G+L   +        ++   +     + L +LH     Q+IH 
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-AAVCRECLQALEFLH---SNQVIHR 141
Query: 608 DIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDV 667
           +IK  NILL    + +++DFG    +T +QS  +T + GT  ++APE         KVD+
Sbjct: 142 NIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 200
Query: 668 YSYGVLLLEII 678
           +S G++ +E+I
Sbjct: 201 WSLGIMAIEMI 211

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 118/260 (45%), Gaps = 13/260 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVR 544
           F++ LG GAF  V     +  +   VA+K + +   +  E   + E+  + +  H N+V 
Sbjct: 22  FRDVLGTGAFSEVILA-EDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L    + G +  L+ + +S G L   +        +  + ++  +   + YLH+     I
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGI 137
Query: 605 IHCDIKPQNIL---LDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
           +H D+KP+N+L   LD+     ISDFGL K+   D     +   GT GYVAPE     P 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV 721
           +  VD +S GV+   ++C       +     + E+ L A  E D    DD++   +  + 
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLF-EQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 722 AIWCIQEDPSHRPTMRRVTQ 741
            +  +++DP  R T  +  Q
Sbjct: 255 HL--MEKDPEKRFTCEQALQ 272

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E++G+GA GTVY    ++ +  +VA++++N   Q  ++    E+  + +  + N+V  L 
Sbjct: 27  EKIGQGASGTVYTAM-DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
               G    +V E+++ G+L   +        ++   +     + L +LH     Q+IH 
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLH---SNQVIHR 141
Query: 608 DIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDV 667
           DIK  NILL    + +++DFG    +T +QS  +  + GT  ++APE         KVD+
Sbjct: 142 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKVDI 200
Query: 668 YSYGVLLLEII 678
           +S G++ +E+I
Sbjct: 201 WSLGIMAIEMI 211

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG G+FG V   + +  +  +VA+K +N+      D +   + E++ +    H ++++L 
Sbjct: 21  LGEGSFGKVKLAY-HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 79
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
                    ++V E+  N  L  ++    K + +        I   + Y H     +I+H
Sbjct: 80  DVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVH 135
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR-NMPITVKV 665
            D+KP+N+LLD++ N +I+DFGL  ++T D +   T+  G+  Y APE     +    +V
Sbjct: 136 RDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSC-GSPNYAAPEVISGKLYAGPEV 193
Query: 666 DVYSYGVLLLEIICLR 681
           DV+S GV+L  ++C R
Sbjct: 194 DVWSCGVILYVMLCRR 209

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 118/285 (41%), Gaps = 37/285 (12%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQ------VAVKKLNRVFQDSEKEFKAEVNGIGQTH----H 539
           LG GAFG V          D+      VAVK L      +EK+    V+ +        H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGKH 100
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI-------------- 585
           KN++ LLG C +     ++ E+ S G L  +L     P  +   +I              
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 586 --VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNT 642
                +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D     T
Sbjct: 161 SCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALV 702
             R    ++APE   +   T + DV+S+GVL+ EI  L  +      Y       L  L+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS-----PYPGIPVEELFKLL 272
Query: 703 ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           +                M+   C    PS RPT +++ + L+ ++
Sbjct: 273 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG G+FG V   + +  +  +VA+K +N+      D +   + E++ +    H ++++L 
Sbjct: 16  LGEGSFGKVKLAY-HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 74
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
                    ++V E+  N  L  ++    K + +        I   + Y H     +I+H
Sbjct: 75  DVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVH 130
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR-NMPITVKV 665
            D+KP+N+LLD++ N +I+DFGL  ++T D +   T+  G+  Y APE     +    +V
Sbjct: 131 RDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSC-GSPNYAAPEVISGKLYAGPEV 188
Query: 666 DVYSYGVLLLEIICLR 681
           DV+S GV+L  ++C R
Sbjct: 189 DVWSCGVILYVMLCRR 204

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG G+FG V   + +  +  +VA+K +N+      D +   + E++ +    H ++++L 
Sbjct: 12  LGEGSFGKVKLAY-HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
                    ++V E+  N  L  ++    K + +        I   + Y H     +I+H
Sbjct: 71  DVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVH 126
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR-NMPITVKV 665
            D+KP+N+LLD++ N +I+DFGL  ++T D +   T+  G+  Y APE     +    +V
Sbjct: 127 RDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSC-GSPNYAAPEVISGKLYAGPEV 184
Query: 666 DVYSYGVLLLEIICLR 681
           DV+S GV+L  ++C R
Sbjct: 185 DVWSCGVILYVMLCRR 200

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVR 544
           F++ LG GAF  V     +  +   VA+K + +   +  E   + E+  + +  H N+V 
Sbjct: 22  FRDVLGTGAFSEVILA-EDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L    + G +  L+ + +S G L   +        +  + ++  +   + YLH+     I
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGI 137
Query: 605 IHCDIKPQNIL---LDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
           +H D+KP+N+L   LD+     ISDFGL K+   D     +   GT GYVAPE     P 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 662 TVKVDVYSYGVLLLEIIC 679
           +  VD +S GV+   ++C
Sbjct: 196 SKAVDCWSIGVIAYILLC 213

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 127/292 (43%), Gaps = 47/292 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAE---------------VNGI 534
           LG GAFG V      +  +  +   K NRV + + K  K++               +  I
Sbjct: 36  LGEGAFGQVV-----LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 535 GQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL-----------FGDSK-PNWKLR 582
           G+  HKN++ LLG C +     ++ E+ S G L  +L           F  S  P  +L 
Sbjct: 91  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLS 148
Query: 583 TEIVMG----IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQ 637
           ++ ++     +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D 
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDX 205
Query: 638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
               T  R    ++APE   +   T + DV+S+GVLL EI  L  +      Y       
Sbjct: 206 XKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----PYPGVPVEE 260
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
           L  L++                M+   C    PS RPT +++ + L+ +V +
Sbjct: 261 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 123/279 (44%), Gaps = 38/279 (13%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---------KEFKAEVNGIGQ 536
           +++++G+G FG V+KG + +     VA+K L  +  DSE         +EF+ EV  +  
Sbjct: 23  YEKQIGKGGFGLVHKGRL-VKDKSVVAIKSL--ILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFY 595
            +H N+V+L G         +V EF+  G L   L   + P  W ++  +++ IA G+ Y
Sbjct: 80  LNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYN-----ARISDFGLEKLLTLDQSHTNTAIRGTKGY 650
           +  +    I+H D++  NI L          A+++DF L +       H+ + + G   +
Sbjct: 138 MQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGLLGNFQW 192
Query: 651 VAPEWF--RNMPITVKVDVYSYGVLLLEIICLRRTILT-DWAYDCY---QERTLGALVEN 704
           +APE         T K D YS+ ++L        TILT +  +D Y   + + +  + E 
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILY-------TILTGEGPFDEYSYGKIKFINMIREE 245
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQML 743
            L          R   V   C   DP  RP    + + L
Sbjct: 246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 486 FKEELGRGAFGTVYKGFVNM-GSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVR 544
           F E LG GAF  V+     + G    +   K +  F+DS  E   E+  + +  H+N+V 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE--NEIAVLKKIKHENIVT 70
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L    +   +  LV + +S G L   +        K  + ++  +   + YLHE     I
Sbjct: 71  LEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE---NGI 127
Query: 605 IHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
           +H D+KP+N+L    ++     I+DFGL K+   +Q+   +   GT GYVAPE     P 
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYVAPEVLAQKPY 184
Query: 662 TVKVDVYSYGVLLLEIIC 679
           +  VD +S GV+   ++C
Sbjct: 185 SKAVDCWSIGVITYILLC 202

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 489 ELGRGAFGTVYKGFVNM---GSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNLVR 544
           +LG G FG V     +     + +QVAVK L      +   + K E+  +   +H+N+V+
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 545 LLGYCDE--GRNRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECC 601
             G C E  G    L+ EF+ +G+L  +L  + +K N K + +  + I +G+ YL     
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR-- 145
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGY-VAPEWFRNM 659
            Q +H D+  +N+L++  +  +I DFGL K +  D +  T    R +  +  APE     
Sbjct: 146 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 204
Query: 660 PITVKVDVYSYGVLLLEII 678
              +  DV+S+GV L E++
Sbjct: 205 KFYIASDVWSFGVTLHELL 223

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 118/285 (41%), Gaps = 37/285 (12%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQ------VAVKKLNRVFQDSEKEFKAEVNGIGQTH----H 539
           LG GAFG V          D+      VAVK L      +EK+    V+ +        H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGKH 100
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI-------------- 585
           KN++ LLG C +     ++ E+ S G L  +L     P  +   +I              
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 586 --VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNT 642
                +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D     T
Sbjct: 161 SCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALV 702
             R    ++APE   +   T + DV+S+GVL+ EI  L  +      Y       L  L+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS-----PYPGIPVEELFKLL 272
Query: 703 ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           +                M+   C    PS RPT +++ + L+ ++
Sbjct: 273 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 118/285 (41%), Gaps = 37/285 (12%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQ------VAVKKLNRVFQDSEKEFKAEVNGIGQTH----H 539
           LG GAFG V          D+      VAVK L      +EK+    V+ +        H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGKH 100
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI-------------- 585
           KN++ LLG C +     ++ E+ S G L  +L     P  +   +I              
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 586 --VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNT 642
                +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D     T
Sbjct: 161 SCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALV 702
             R    ++APE   +   T + DV+S+GVL+ EI  L  +      Y       L  L+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS-----PYPGIPVEELFKLL 272
Query: 703 ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           +                M+   C    PS RPT +++ + L+ ++
Sbjct: 273 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 111/261 (42%), Gaps = 24/261 (9%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            +++LG G FG V+    N  +  +VAVK + +    S + F AE N +    H  LV+L
Sbjct: 186 LEKKLGAGQFGEVWMATYNKHT--KVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL 242
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
                +     ++ EFM+ G+L  FL  D  SK       +    IA G+ ++ +     
Sbjct: 243 HAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---N 298
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D++  NIL+      +I+DFGL ++            +    + APE       T+
Sbjct: 299 YIHRDLRAANILVSASLVCKIADFGLARV----------GAKFPIKWTAPEAINFGSFTI 348
Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+S+G+LL+EI+   R       Y       +   +E            +    + +
Sbjct: 349 KSDVWSFGILLMEIVTYGRI-----PYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM 403
Query: 724 WCIQEDPSHRPTMRRVTQMLE 744
            C +  P  RPT   +  +L+
Sbjct: 404 RCWKNRPEERPTFEYIQSVLD 424

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 489 ELGRGAFGTVYKGFVNM---GSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNLVR 544
           +LG G FG V     +     + +QVAVK L      +   + K E+  +   +H+N+V+
Sbjct: 16  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 75
Query: 545 LLGYCDE--GRNRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECC 601
             G C E  G    L+ EF+ +G+L  +L  + +K N K + +  + I +G+ YL     
Sbjct: 76  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR-- 133
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGY-VAPEWFRNM 659
            Q +H D+  +N+L++  +  +I DFGL K +  D +  T    R +  +  APE     
Sbjct: 134 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 192
Query: 660 PITVKVDVYSYGVLLLEII 678
              +  DV+S+GV L E++
Sbjct: 193 KFYIASDVWSFGVTLHELL 211

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 119/283 (42%), Gaps = 33/283 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQ------VAVKKL-NRVFQDSEKEFKAEVNGIGQT-HHKN 541
           LG GAFG V          D+      VAVK L +   ++   +  +E+  +     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI---------------- 585
           ++ LLG C +     ++ E+ S G L  +L     P  +   +I                
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 586 VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNTAI 644
              +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D     T  
Sbjct: 163 TYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN 704
           R    ++APE   +   T + DV+S+GVL+ EI  L  +      Y       L  L++ 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS-----PYPGIPVEELFKLLKE 274
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
                          M+   C    PS RPT +++ + L+ ++
Sbjct: 275 GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 123/257 (47%), Gaps = 17/257 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           E++G+G+FG V+KG  N  +   VA+K ++    +D  ++ + E+  + Q     + +  
Sbjct: 28  EKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           G   +     ++ E++  G+    L        ++ T I+  I +GL YLH E   + IH
Sbjct: 87  GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-ILREILKGLDYLHSE---KKIH 142
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIK  N+LL ++   +++DFG+   LT  Q   N  + GT  ++APE  +      K D
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDSKAD 201
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD--MTVLQRFVMVAIW 724
           ++S G+  +E+             + +  + L  + +N+   ++      L+ FV     
Sbjct: 202 IWSLGITAIELARGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA--- 253
Query: 725 CIQEDPSHRPTMRRVTQ 741
           C+ ++PS RPT + + +
Sbjct: 254 CLNKEPSFRPTAKELLK 270

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 118/285 (41%), Gaps = 37/285 (12%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQ------VAVKKLNRVFQDSEKEFKAEVNGIGQTH----H 539
           LG GAFG V          D+      VAVK L      +EK+    V+ +        H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGKH 100
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI-------------- 585
           KN++ LLG C +     ++ E+ S G L  +L     P  +   +I              
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 586 --VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNT 642
                +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D     T
Sbjct: 161 SCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALV 702
             R    ++APE   +   T + DV+S+GVL+ EI  L  +      Y       L  L+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS-----PYPGIPVEELFKLL 272
Query: 703 ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           +                M+   C    PS RPT +++ + L+ ++
Sbjct: 273 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 123/257 (47%), Gaps = 17/257 (6%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           E++G+G+FG V+KG  N  +   VA+K ++    +D  ++ + E+  + Q     + +  
Sbjct: 13  EKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           G   +     ++ E++  G+    L        ++ T I+  I +GL YLH E   + IH
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-ILREILKGLDYLHSE---KKIH 127
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIK  N+LL ++   +++DFG+   LT  Q   N  + GT  ++APE  +      K D
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDSKAD 186
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD--MTVLQRFVMVAIW 724
           ++S G+  +E+             + +  + L  + +N+   ++      L+ FV     
Sbjct: 187 IWSLGITAIELARGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA--- 238
Query: 725 CIQEDPSHRPTMRRVTQ 741
           C+ ++PS RPT + + +
Sbjct: 239 CLNKEPSFRPTAKELLK 255

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 132/289 (45%), Gaps = 56/289 (19%)
Query: 482 VTRGFKEE-------LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS--EKEFKAEVN 532
           + R FKE        LG G FGTV+KG V +   + + +    +V +D    + F+A  +
Sbjct: 24  LARIFKETELRKLKVLGSGVFGTVHKG-VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD 82
Query: 533 ---GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF---GDSKP----NWKLR 582
               IG   H ++VRLLG C  G +  LV +++  G+L   +    G   P    NW ++
Sbjct: 83  HMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 141
Query: 583 TEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ----- 637
                 IA+G++YL E     ++H ++  +N+LL      +++DFG+  LL  D      
Sbjct: 142 ------IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 192
Query: 638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
           S   T I+    ++A E       T + DV+SYGV + E++         +  + Y    
Sbjct: 193 SEAKTPIK----WMALESIHFGKYTHQSDVWSYGVTVWELMT--------FGAEPYAGLR 240
Query: 698 LGALVENDLEAMDDM------TVLQRFVMVAIWCIQEDPSHRPTMRRVT 740
           L A V + LE  + +      T+    VMV  W I E+   RPT + + 
Sbjct: 241 L-AEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDEN--IRPTFKELA 286

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 125/292 (42%), Gaps = 47/292 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAE---------------VNGI 534
           LG GAFG V      +  +  +   K NRV + + K  K++               +  I
Sbjct: 77  LGEGAFGQVV-----LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 535 GQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG------------DSKPNWKLR 582
           G+  HKN++ LLG C +     ++ E+ S G L  +L                 P  +L 
Sbjct: 132 GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 583 TEIVMG----IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQ 637
           ++ ++     +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D 
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246
Query: 638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
               T  R    ++APE   +   T + DV+S+GVLL EI  L  +      Y       
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----PYPGVPVEE 301
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
           L  L++                M+   C    PS RPT +++ + L+ +V +
Sbjct: 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 124/290 (42%), Gaps = 47/290 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAE---------------VNGI 534
           LG GAFG V      +  +  +   K NRV + + K  K++               +  I
Sbjct: 25  LGEGAFGQVV-----LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 79
Query: 535 GQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG------------DSKPNWKLR 582
           G+  HKN++ LLG C +     ++ E+ S G L  +L                 P  +L 
Sbjct: 80  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 137
Query: 583 TEIVMG----IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQ 637
           ++ ++     +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D 
Sbjct: 138 SKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 194
Query: 638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
               T  R    ++APE   +   T + DV+S+GVLL EI  L  +      Y       
Sbjct: 195 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----PYPGVPVEE 249
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           L  L++                M+   C    PS RPT +++ + L+ +V
Sbjct: 250 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 299

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 124/290 (42%), Gaps = 47/290 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAE---------------VNGI 534
           LG GAFG V      +  +  +   K NRV + + K  K++               +  I
Sbjct: 28  LGEGAFGQVV-----LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 82
Query: 535 GQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG------------DSKPNWKLR 582
           G+  HKN++ LLG C +     ++ E+ S G L  +L                 P  +L 
Sbjct: 83  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 140
Query: 583 TEIVMG----IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQ 637
           ++ ++     +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D 
Sbjct: 141 SKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 197
Query: 638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
               T  R    ++APE   +   T + DV+S+GVLL EI  L  +      Y       
Sbjct: 198 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----PYPGVPVEE 252
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           L  L++                M+   C    PS RPT +++ + L+ +V
Sbjct: 253 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 302

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 125/292 (42%), Gaps = 47/292 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAE---------------VNGI 534
           LG GAFG V      +  +  +   K NRV + + K  K++               +  I
Sbjct: 21  LGEGAFGQVV-----LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 75
Query: 535 GQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG------------DSKPNWKLR 582
           G+  HKN++ LLG C +     ++ E+ S G L  +L                 P  +L 
Sbjct: 76  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLS 133
Query: 583 TEIVMG----IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQ 637
           ++ ++     +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D 
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
               T  R    ++APE   +   T + DV+S+GVLL EI  L  +      Y       
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----PYPGVPVEE 245
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
           L  L++                M+   C    PS RPT +++ + L+ +V +
Sbjct: 246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 133/295 (45%), Gaps = 42/295 (14%)
Query: 486 FKEELGRGAFGTVYK----GFVNMGSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHK 540
           +  ++G GAFG V++    G +       VAVK L      D + +F+ E   + +  + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGALASFL----------FGDSKPNWKLRTE------ 584
           N+V+LLG C  G+   L++E+M+ G L  FL             S  + + R        
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 585 --------IVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTL 635
                   I   +A G+ YL E    + +H D+  +N L+ +    +I+DFGL + + + 
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 636 D--QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCY 693
           D  ++  N AI     ++ PE       T + DV++YGV+L EI     +      Y   
Sbjct: 228 DYYKADGNDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIF----SYGLQPYYGMA 281
Query: 694 QERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            E  +  + + ++ A  +   L+ + ++ + C  + P+ RP+   + ++L+ + E
Sbjct: 282 HEEVIYYVRDGNILACPENCPLELYNLMRL-CWSKLPADRPSFCSIHRILQRMCE 335

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 132/289 (45%), Gaps = 56/289 (19%)
Query: 482 VTRGFKEE-------LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS--EKEFKAEVN 532
           + R FKE        LG G FGTV+KG V +   + + +    +V +D    + F+A  +
Sbjct: 6   LARIFKETELRKLKVLGSGVFGTVHKG-VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD 64
Query: 533 ---GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF---GDSKP----NWKLR 582
               IG   H ++VRLLG C  G +  LV +++  G+L   +    G   P    NW ++
Sbjct: 65  HMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 583 TEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ----- 637
                 IA+G++YL E     ++H ++  +N+LL      +++DFG+  LL  D      
Sbjct: 124 ------IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174
Query: 638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
           S   T I+    ++A E       T + DV+SYGV + E++         +  + Y    
Sbjct: 175 SEAKTPIK----WMALESIHFGKYTHQSDVWSYGVTVWELMT--------FGAEPYAGLR 222
Query: 698 LGALVENDLEAMDDM------TVLQRFVMVAIWCIQEDPSHRPTMRRVT 740
           L A V + LE  + +      T+    VMV  W I E+   RPT + + 
Sbjct: 223 L-AEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENI--RPTFKELA 268

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 124/290 (42%), Gaps = 47/290 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAE---------------VNGI 534
           LG GAFG V      +  +  +   K NRV + + K  K++               +  I
Sbjct: 29  LGEGAFGQVV-----LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 83
Query: 535 GQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG------------DSKPNWKLR 582
           G+  HKN++ LLG C +     ++ E+ S G L  +L                 P  +L 
Sbjct: 84  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 141
Query: 583 TEIVMG----IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQ 637
           ++ ++     +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D 
Sbjct: 142 SKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 198
Query: 638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
               T  R    ++APE   +   T + DV+S+GVLL EI  L  +      Y       
Sbjct: 199 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----PYPGVPVEE 253
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           L  L++                M+   C    PS RPT +++ + L+ +V
Sbjct: 254 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 303

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 124/290 (42%), Gaps = 47/290 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAE---------------VNGI 534
           LG GAFG V      +  +  +   K NRV + + K  K++               +  I
Sbjct: 36  LGEGAFGQVV-----LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 535 GQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG------------DSKPNWKLR 582
           G+  HKN++ LLG C +     ++ E+ S G L  +L                 P  +L 
Sbjct: 91  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLS 148
Query: 583 TEIVMG----IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQ 637
           ++ ++     +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D 
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 205
Query: 638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
               T  R    ++APE   +   T + DV+S+GVLL EI  L  +      Y       
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----PYPGVPVEE 260
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           L  L++                M+   C    PS RPT +++ + L+ +V
Sbjct: 261 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 124/290 (42%), Gaps = 47/290 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAE---------------VNGI 534
           LG GAFG V      +  +  +   K NRV + + K  K++               +  I
Sbjct: 36  LGEGAFGQVV-----LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 535 GQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG------------DSKPNWKLR 582
           G+  HKN++ LLG C +     ++ E+ S G L  +L                 P  +L 
Sbjct: 91  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 148
Query: 583 TEIVMG----IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQ 637
           ++ ++     +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D 
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 205
Query: 638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
               T  R    ++APE   +   T + DV+S+GVLL EI  L  +      Y       
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----PYPGVPVEE 260
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           L  L++                M+   C    PS RPT +++ + L+ +V
Sbjct: 261 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 125/292 (42%), Gaps = 47/292 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAE---------------VNGI 534
           LG GAFG V      +  +  +   K NRV + + K  K++               +  I
Sbjct: 36  LGEGAFGQVV-----LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 535 GQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG------------DSKPNWKLR 582
           G+  HKN++ LLG C +     ++ E+ S G L  +L                 P  +L 
Sbjct: 91  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLS 148
Query: 583 TEIVMG----IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQ 637
           ++ ++     +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D 
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 205
Query: 638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
               T  R    ++APE   +   T + DV+S+GVLL EI  L  +      Y       
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----PYPGVPVEE 260
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
           L  L++                M+   C    PS RPT +++ + L+ +V +
Sbjct: 261 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 92/194 (47%), Gaps = 11/194 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG+G +G VY G  ++ +  ++A+K++        +    E+       HKN+V+ LG  
Sbjct: 30  LGKGTYGIVYAG-RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 550 DEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
            E     +  E +  G+L++ L   +G  K N +        I  GL YLH+    QI+H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVH 145
Query: 607 CDIKPQNILLDDYYNA-RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP--ITV 663
            DIK  N+L++ Y    +ISDFG  K L      T T   GT  Y+APE     P     
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGK 204
Query: 664 KVDVYSYGVLLLEI 677
             D++S G  ++E+
Sbjct: 205 AADIWSLGCTIIEM 218

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 35  IGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 94  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 147
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 148 -SADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 196
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQ------VAVKKLNRVFQDSEKEFKAEVNGIGQTH----H 539
           LG G FG V          D+      VAVK L      +EK+    V+ +        H
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGKH 89
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI-------------- 585
           KN++ LLG C +     ++ E+ S G L  +L     P  +   +I              
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 586 --VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNT 642
                +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D     T
Sbjct: 150 SCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALV 702
             R    ++APE   +   T + DV+S+GVL+ EI  L  +      Y       L  L+
Sbjct: 207 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS-----PYPGIPVEELFKLL 261
Query: 703 ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           +                M+   C    PS RPT +++ + L+ ++
Sbjct: 262 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 306

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 108/246 (43%), Gaps = 37/246 (15%)
Query: 449 LVVNRKKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSS 508
           + +N   ++R  + + G SY  +R                +LG GA+G V       G S
Sbjct: 19  IAINPGMYVRKKEGKIGESYFKVR----------------KLGSGAYGEVLLCKEKNGHS 62
Query: 509 DQV--AVKKL----------NRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRL 556
           ++    +KK           N+  +   +E   E++ +    H N+++L    ++ +   
Sbjct: 63  EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY 122
Query: 557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL 616
           LV EF   G L   +    K +      I+  I  G+ YLH+     I+H DIKP+NILL
Sbjct: 123 LVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILL 179
Query: 617 DD---YYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVL 673
           ++     N +I DFGL    + D    +    GT  Y+APE  +      K DV+S GV+
Sbjct: 180 ENKNSLLNIKIVDFGLSSFFSKDYKLRDRL--GTAYYIAPEVLKK-KYNEKCDVWSCGVI 236
Query: 674 LLEIIC 679
           +  ++C
Sbjct: 237 MYILLC 242

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 49  VGSGAYGSVCAAF-DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 107
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 108 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 161
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 162 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 210
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQ------VAVKKLNRVFQDSEKEFKAEVNGIGQTH----H 539
           LG G FG V          D+      VAVK L      +EK+    V+ +        H
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGKH 92
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI-------------- 585
           KN++ LLG C +     ++ E+ S G L  +L     P  +   +I              
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 586 --VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNT 642
                +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D     T
Sbjct: 153 SCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALV 702
             R    ++APE   +   T + DV+S+GVL+ EI  L  +      Y       L  L+
Sbjct: 210 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS-----PYPGIPVEELFKLL 264
Query: 703 ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           +                M+   C    PS RPT +++ + L+ ++
Sbjct: 265 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 309

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 29/206 (14%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 50  VGSGAYGSVCAAF-DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 109 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 162
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG---TKGYVAPEWF 656
               IIH D+KP N+ +++    +I DFGL +       HT+  + G   T+ Y APE  
Sbjct: 163 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVATRWYRAPEIM 214
Query: 657 RN-MPITVKVDVYSYGVLLLEIICLR 681
            N M     VD++S G ++ E++  R
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 87/193 (45%), Gaps = 10/193 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 20  LGKGKFGNVYLA-RERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   S+ + +     +  +A  L Y H +   ++IH
Sbjct: 79  GYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK---RVIH 135
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S   T + GT  Y+ PE         KVD
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 192
Query: 667 VYSYGVLLLEIIC 679
           ++S GVL  E + 
Sbjct: 193 LWSLGVLCYEFLV 205

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 29/206 (14%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG---TKGYVAPEWF 656
               IIH D+KP N+ +++    +I DFGL +       HT+  + G   T+ Y APE  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPEIM 194
Query: 657 RN-MPITVKVDVYSYGVLLLEIICLR 681
            N M     VD++S G ++ E++  R
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 50  VGSGAYGSVCAAF-DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 109 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 162
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 163 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 211
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 40  VGSGAYGSVCAAF-DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 98
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 99  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 152
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 153 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 201
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 29/206 (14%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG---TKGYVAPEWF 656
               IIH D+KP N+ +++    +I DFGL +       HT+  + G   T+ Y APE  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPEIM 194
Query: 657 RN-MPITVKVDVYSYGVLLLEIICLR 681
            N M     VD++S G ++ E++  R
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 41  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 99
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 100 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 153
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 154 -SADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 202
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQ------VAVKKLNRVFQDSEKEFKAEVNGIGQTH----H 539
           LG G FG V          D+      VAVK L      +EK+    V+ +        H
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGKH 87
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI-------------- 585
           KN++ LLG C +     ++ E+ S G L  +L     P  +   +I              
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 586 --VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNT 642
                +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D     T
Sbjct: 148 SCTYQLARGMEYLASQKC---IHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALV 702
             R    ++APE   +   T + DV+S+GVL+ EI  L  +      Y       L  L+
Sbjct: 205 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS-----PYPGIPVEELFKLL 259
Query: 703 ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           +                M+   C    PS RPT +++ + L+ ++
Sbjct: 260 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 304

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 19/197 (9%)
Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLN------RVFQDSEKEFKAEVNGIGQTHHK 540
           KEELG+GAF  V +  V+  +  + A K +N      R FQ  E+E +       +  H 
Sbjct: 11  KEELGKGAFSVVRRC-VHKTTGLEFAAKIINTKKLSARDFQKLEREARI----CRKLQHP 65
Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
           N+VRL     E     LV++ ++ G L   +      +    +  +  I   + Y H   
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-- 123
Query: 601 CTQIIHCDIKPQNILLDDYYN---ARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
              I+H ++KP+N+LL         +++DFGL   + ++ S       GT GY++PE  +
Sbjct: 124 -NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 658 NMPITVKVDVYSYGVLL 674
             P +  VD+++ GV+L
Sbjct: 181 KDPYSKPVDIWACGVIL 197

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 35  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 94  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 147
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 148 -SADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 196
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 92/194 (47%), Gaps = 11/194 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG+G +G VY G  ++ +  ++A+K++        +    E+       HKN+V+ LG  
Sbjct: 16  LGKGTYGIVYAG-RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 550 DEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
            E     +  E +  G+L++ L   +G  K N +        I  GL YLH+    QI+H
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVH 131
Query: 607 CDIKPQNILLDDYYNA-RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP--ITV 663
            DIK  N+L++ Y    +ISDFG  K L      T T   GT  Y+APE     P     
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGK 190
Query: 664 KVDVYSYGVLLLEI 677
             D++S G  ++E+
Sbjct: 191 AADIWSLGCTIIEM 204

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 32  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 91  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 144
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 145 -SADIIHRDLKPSNLAVNEDSELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 193
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQ------VAVKKLNRVFQDSEKEFKAEVNGIGQTH----H 539
           LG G FG V          D+      VAVK L      +EK+    V+ +        H
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGKH 146
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI-------------- 585
           KN++ LLG C +     ++ E+ S G L  +L     P  +   +I              
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 586 --VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNT 642
                +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D     T
Sbjct: 207 SCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALV 702
             R    ++APE   +   T + DV+S+GVL+ EI  L  +      Y       L  L+
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS-----PYPGIPVEELFKLL 318
Query: 703 ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           +                M+   C    PS RPT +++ + L+ ++
Sbjct: 319 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 26  VGSGAYGSVCAAF-DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 85  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 138
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 139 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 187
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 36  VGSGAYGSVCAAF-DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 95  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 148
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 149 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 197
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 122/260 (46%), Gaps = 18/260 (6%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNL 542
            +E LG G+FG V K   +  +  +VA+K ++R      D     + E++ +    H ++
Sbjct: 13  IRETLGEGSFGKV-KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI 71
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           ++L        + ++V E+ + G L  ++    +            I   + Y H     
Sbjct: 72  IKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH--- 127
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR-NMPI 661
           +I+H D+KP+N+LLDD  N +I+DFGL  ++T D +   T+  G+  Y APE     +  
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSC-GSPNYAAPEVINGKLYA 185
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV 721
             +VDV+S G++L  ++  R     ++  + +++      V  D  +    ++++R ++ 
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVA 245
Query: 722 AIWCIQEDPSHRPTMRRVTQ 741
                  DP  R T++ + +
Sbjct: 246 -------DPMQRITIQEIRR 258

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 19/197 (9%)
Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLN------RVFQDSEKEFKAEVNGIGQTHHK 540
           KEELG+GAF  V +  V+  +  + A K +N      R FQ  E+E +       +  H 
Sbjct: 10  KEELGKGAFSVVRRC-VHKTTGLEFAAKIINTKKLSARDFQKLEREARI----CRKLQHP 64
Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
           N+VRL     E     LV++ ++ G L   +      +    +  +  I   + Y H   
Sbjct: 65  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-- 122
Query: 601 CTQIIHCDIKPQNILLDDYYN---ARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
              I+H ++KP+N+LL         +++DFGL   + ++ S       GT GY++PE  +
Sbjct: 123 -NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLK 179
Query: 658 NMPITVKVDVYSYGVLL 674
             P +  VD+++ GV+L
Sbjct: 180 KDPYSKPVDIWACGVIL 196

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 19/197 (9%)
Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLN------RVFQDSEKEFKAEVNGIGQTHHK 540
           KEELG+GAF  V +  V+  +  + A K +N      R FQ  E+E +       +  H 
Sbjct: 11  KEELGKGAFSVVRRC-VHKTTGLEFAAKIINTKKLSARDFQKLEREARI----CRKLQHP 65
Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
           N+VRL     E     LV++ ++ G L   +      +    +  +  I   + Y H   
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-- 123
Query: 601 CTQIIHCDIKPQNILLDDYYN---ARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
              I+H ++KP+N+LL         +++DFGL   + ++ S       GT GY++PE  +
Sbjct: 124 -NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 658 NMPITVKVDVYSYGVLL 674
             P +  VD+++ GV+L
Sbjct: 181 KDPYSKPVDIWACGVIL 197

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 29/206 (14%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 26  VGSGAYGSVCAAF-DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 85  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 138
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG---TKGYVAPEWF 656
               IIH D+KP N+ +++    +I DFGL +       HT+  + G   T+ Y APE  
Sbjct: 139 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPEIM 190
Query: 657 RN-MPITVKVDVYSYGVLLLEIICLR 681
            N M     VD++S G ++ E++  R
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 36  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 95  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 148
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 149 -SADIIHRDLKPSNLAVNEDSELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 197
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQ------VAVKKLNRVFQDSEKEFKAEVNGIGQTH----H 539
           LG GAFG V          D+      VAVK L      +EK+    V+ +        H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGKH 100
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI-------------- 585
           KN++ LLG C +     ++  + S G L  +L     P  +   +I              
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 586 --VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNT 642
                +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D     T
Sbjct: 161 SCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALV 702
             R    ++APE   +   T + DV+S+GVL+ EI  L  +      Y       L  L+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS-----PYPGIPVEELFKLL 272
Query: 703 ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           +                M+   C    PS RPT +++ + L+ ++
Sbjct: 273 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 26  VGSGAYGSVCAAF-DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNW----KLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 85  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIH-- 138
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 139 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 187
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 19/197 (9%)
Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLN------RVFQDSEKEFKAEVNGIGQTHHK 540
           KEELG+GAF  V +  V+  +  + A K +N      R FQ  E+E +       +  H 
Sbjct: 34  KEELGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKLEREARI----CRKLQHP 88
Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
           N+VRL     E     LV++ ++ G L   +      +    +  +  I   + Y H   
Sbjct: 89  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH--- 145
Query: 601 CTQIIHCDIKPQNILLDDYYNA---RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
              I+H ++KP+N+LL         +++DFGL   + ++ S       GT GY++PE  +
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLK 203
Query: 658 NMPITVKVDVYSYGVLL 674
             P +  VD+++ GV+L
Sbjct: 204 KDPYSKPVDIWACGVIL 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 20/203 (9%)
Query: 489 ELGRGAFGTVYKG-------FVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           E+G GA+GTVYK        FV + S               S     A +  +    H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 542 LVRLLGYCDEGRNR-----LLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLF 594
           +VRL+  C   R        LV+E +    L ++L     P     T  +++    RGL 
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           +LH  C   I+H D+KP+NIL+      +++DFGL ++ +   + T   +  T  Y APE
Sbjct: 135 FLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWYRAPE 189
Query: 655 WFRNMPITVKVDVYSYGVLLLEI 677
                     VD++S G +  E+
Sbjct: 190 VLLQSTYATPVDMWSVGCIFAEM 212

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 490 LGRGAFGTVYK------GFVNMGSSDQVAVKKLNRVFQDS--EKEFKAEVNGIGQTHHKN 541
           LGRG FG V+       G +           K  + +Q +  EK+  A+V       H  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HSR 245
Query: 542 LVRLLGYCDEGRNRL-LVYEFMSNGALASFLFG--DSKPNWKLRTEI--VMGIARGLFYL 596
            +  L Y  E +  L LV   M+ G +   ++   +  P ++    I     I  GL +L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
           H+     II+ D+KP+N+LLDD  N RISD GL   L   Q+ T     GT G++APE  
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK-GYAGTPGFMAPELL 361
Query: 657 RNMPITVKVDVYSYGVLLLEIICLR 681
                   VD ++ GV L E+I  R
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 490 LGRGAFGTVYK------GFVNMGSSDQVAVKKLNRVFQDS--EKEFKAEVNGIGQTHHKN 541
           LGRG FG V+       G +           K  + +Q +  EK+  A+V       H  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HSR 245
Query: 542 LVRLLGYCDEGRNRL-LVYEFMSNGALASFLFG--DSKPNWKLRTEI--VMGIARGLFYL 596
            +  L Y  E +  L LV   M+ G +   ++   +  P ++    I     I  GL +L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
           H+     II+ D+KP+N+LLDD  N RISD GL   L   Q+ T     GT G++APE  
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK-GYAGTPGFMAPELL 361
Query: 657 RNMPITVKVDVYSYGVLLLEIICLR 681
                   VD ++ GV L E+I  R
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 32  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 91  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 144
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 145 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 193
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 42  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 101 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 154
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 155 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 203
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 42  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 101 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 154
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 155 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 203
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 37  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 96  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 149
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 150 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 198
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 49  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 107
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 108 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 161
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 162 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 210
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 35  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 94  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 147
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 148 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 196
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 29  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 87
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 88  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 141
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 142 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 190
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 32  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 91  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 144
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 145 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 193
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 36  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 95  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 148
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 149 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 197
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 490 LGRGAFGTVYK------GFVNMGSSDQVAVKKLNRVFQDS--EKEFKAEVNGIGQTHHKN 541
           LGRG FG V+       G +           K  + +Q +  EK+  A+V       H  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HSR 245
Query: 542 LVRLLGYCDEGRNRL-LVYEFMSNGALASFLFG--DSKPNWKLRTEI--VMGIARGLFYL 596
            +  L Y  E +  L LV   M+ G +   ++   +  P ++    I     I  GL +L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
           H+     II+ D+KP+N+LLDD  N RISD GL   L   Q+ T     GT G++APE  
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK-GYAGTPGFMAPELL 361
Query: 657 RNMPITVKVDVYSYGVLLLEIICLR 681
                   VD ++ GV L E+I  R
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 490 LGRGAFGTVYK------GFVNMGSSDQVAVKKLNRVFQDS--EKEFKAEVNGIGQTHHKN 541
           LGRG FG V+       G +           K  + +Q +  EK+  A+V       H  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HSR 245
Query: 542 LVRLLGYCDEGRNRL-LVYEFMSNGALASFLFG--DSKPNWKLRTEI--VMGIARGLFYL 596
            +  L Y  E +  L LV   M+ G +   ++   +  P ++    I     I  GL +L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
           H+     II+ D+KP+N+LLDD  N RISD GL   L   Q+ T     GT G++APE  
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK-GYAGTPGFMAPELL 361
Query: 657 RNMPITVKVDVYSYGVLLLEIICLR 681
                   VD ++ GV L E+I  R
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQ------VAVKKLNRVFQDSEKEFKAEVNGIGQTH----H 539
           LG GAFG V          D+      VAVK L      +EK+    V+ +        H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGKH 100
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI-------------- 585
           KN++ LLG C +     ++  + S G L  +L     P  +   +I              
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 586 --VMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-LLTLDQSHTNT 642
                +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL + +  +D     T
Sbjct: 161 SCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALV 702
             R    ++APE   +   T + DV+S+GVL+ EI  L  +      Y       L  L+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS-----PYPGIPVEELFKLL 272
Query: 703 ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           +                M+   C    PS RPT +++ + L+ ++
Sbjct: 273 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 53  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 111
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 112 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 165
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 166 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---XGYVATRWYRAP 214
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 29/206 (14%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG---TKGYVAPEWF 656
               IIH D+KP N+ +++    +I DFGL +       HT+  + G   T+ Y APE  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGXVATRWYRAPEIM 194
Query: 657 RN-MPITVKVDVYSYGVLLLEIICLR 681
            N M     VD++S G ++ E++  R
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 32  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 91  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 144
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 145 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 193
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 50  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 109 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 162
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 163 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 211
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 53  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 111
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 112 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 165
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 166 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 214
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 27  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 85
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 86  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 139
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 140 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 188
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 28  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 86
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 87  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 140
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 141 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 189
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 27  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 85
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 86  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 139
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 140 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 188
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 41  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 99
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 100 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 153
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 154 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 202
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 26  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 85  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 138
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 139 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 187
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + ELGRGA   VY+     G+    A+K L +     +K  + E+  + +  H N+++L 
Sbjct: 58  ESELGRGATSIVYRC-KQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
              +      LV E ++ G L   +      + +   + V  I   + YLHE     I+H
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVH 171
Query: 607 CDIKPQNILLDDYYN---ARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            D+KP+N+L          +I+DFGL K++  +       + GT GY APE  R      
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTPGYCAPEILRGCAYGP 229
Query: 664 KVDVYSYGVLLLEIIC 679
           +VD++S G++   ++C
Sbjct: 230 EVDMWSVGIITYILLC 245

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 35  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 94  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 147
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 148 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 196
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 122/274 (44%), Gaps = 35/274 (12%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVR 544
            +E +G GA   V   +      ++VA+K++N    Q S  E   E+  + Q HH N+V 
Sbjct: 14  LQEVIGSGATAVVQAAYC-APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS 72
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLF-----GDSKP---NWKLRTEIVMGIARGLFYL 596
                       LV + +S G++   +      G+ K    +      I+  +  GL YL
Sbjct: 73  YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 132
Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR----GTKGYVA 652
           H+      IH D+K  NILL +  + +I+DFG+   L      T   +R    GT  ++A
Sbjct: 133 HKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 189
Query: 653 PEWFRNMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE-RTLGALVENDLEAMD 710
           PE    +     K D++S+G+  +E+            Y  Y   + L   ++ND  +++
Sbjct: 190 PEVMEQVRGYDFKADIWSFGITAIELAT------GAAPYHKYPPMKVLMLTLQNDPPSLE 243
Query: 711 ----DMTVLQRF-----VMVAIWCIQEDPSHRPT 735
               D  +L+++      M+++ C+Q+DP  RPT
Sbjct: 244 TGVQDKEMLKKYGKSFRKMISL-CLQKDPEKRPT 276

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 36  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 95  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 148
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 149 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 197
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 123/286 (43%), Gaps = 40/286 (13%)
Query: 471 LRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD-----SEK 525
           LR     EL +V     + LG GAFGTVYKG + +   + V +    +V ++     + K
Sbjct: 11  LRILKETELRKV-----KVLGSGAFGTVYKG-IWIPDGENVKIPVAIKVLRENTSPKANK 64
Query: 526 EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASF-------LFGDSKPN 578
           E   E   +       + RLLG C     +L V + M  G L          L      N
Sbjct: 65  EILDEAYVMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLN 123
Query: 579 WKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS 638
           W       M IA+G+ YL +    +++H D+  +N+L+    + +I+DFGL +LL +D++
Sbjct: 124 W------CMQIAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 174
Query: 639 --HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER 696
             H +      K ++A E       T + DV+SYGV + E++           YD    R
Sbjct: 175 EYHADGGKVPIK-WMALESILRRRFTHQSDVWSYGVTVWELMTFGAK-----PYDGIPAR 228
Query: 697 TLGALVEND--LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVT 740
            +  L+E    L      T+    +MV  W I  D   RP  R + 
Sbjct: 229 EIPDLLEKGERLPQPPICTIDVYMIMVKCWMI--DSECRPRFRELV 272

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 122/274 (44%), Gaps = 35/274 (12%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVR 544
            +E +G GA   V   +      ++VA+K++N    Q S  E   E+  + Q HH N+V 
Sbjct: 19  LQEVIGSGATAVVQAAYC-APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS 77
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLF-----GDSKP---NWKLRTEIVMGIARGLFYL 596
                       LV + +S G++   +      G+ K    +      I+  +  GL YL
Sbjct: 78  YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR----GTKGYVA 652
           H+      IH D+K  NILL +  + +I+DFG+   L      T   +R    GT  ++A
Sbjct: 138 HKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 653 PEWFRNMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE-RTLGALVENDLEAMD 710
           PE    +     K D++S+G+  +E+            Y  Y   + L   ++ND  +++
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELAT------GAAPYHKYPPMKVLMLTLQNDPPSLE 248
Query: 711 ----DMTVLQRF-----VMVAIWCIQEDPSHRPT 735
               D  +L+++      M+++ C+Q+DP  RPT
Sbjct: 249 TGVQDKEMLKKYGKSFRKMISL-CLQKDPEKRPT 281

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDSELKILDFGLCR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 34/271 (12%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQTHHKNLVRLLG 547
           LG+G+FG V K   +  +  + AVK +N+    ++       EV  + +  H N+++L  
Sbjct: 30  LGKGSFGEVLKC-KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
             ++  +  +V E  + G L   +    + +      I+  +  G+ Y+H+     I+H 
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHR 145
Query: 608 DIKPQNILLDDYY---NARISDFGLEKLLTLDQSHTNTAIR-GTKGYVAPEWFRNMPITV 663
           D+KP+NILL+      + +I DFGL    T  Q +T    R GT  Y+APE  R      
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPEVLRG-TYDE 201
Query: 664 KVDVYSYGVLLL-------------EIICLRRTILTDWAYDCYQERTLGALVENDLEAMD 710
           K DV+S GV+L              E   L+R     +A+D  Q RT+    ++ +  M 
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM- 260
Query: 711 DMTVLQRFVMVAIWC-----IQEDPSHRPTM 736
            +T      + A  C     IQ+  S  PT+
Sbjct: 261 -LTFHPSLRITATQCLEHPWIQKYSSETPTI 290

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 37  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 96  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 149
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT   +    GYVA  W+R  
Sbjct: 150 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEM---TGYVATRWYRAP 198
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 14/195 (7%)
Query: 488 EELGRGAFGTVYK---GFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNL 542
           EELG G F  V K       +  + +   K+ +R  +   S +E + EV+ + Q  H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           + L    +   + +L+ E +S G L  FL      + +  T  +  I  G+ YLH     
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 603 QIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
           +I H D+KP+NI+L D      + ++ DFGL   +       N  I GT  +VAPE    
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNY 192
Query: 659 MPITVKVDVYSYGVL 673
            P+ ++ D++S GV+
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 14/195 (7%)
Query: 488 EELGRGAFGTVYK---GFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNL 542
           EELG G F  V K       +  + +   K+ +R  +   S +E + EV+ + Q  H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           + L    +   + +L+ E +S G L  FL      + +  T  +  I  G+ YLH     
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 603 QIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
           +I H D+KP+NI+L D      + ++ DFGL   +       N  I GT  +VAPE    
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNY 192
Query: 659 MPITVKVDVYSYGVL 673
            P+ ++ D++S GV+
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 33/205 (16%)
Query: 490 LGRGAFGTVY--------KGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           LG+G FG V         K +       +   K+       +EK+   +VN         
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-------R 244
Query: 542 LVRLLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
            V  L Y  E ++ L LV   M+ G L   ++   +  +          AR +FY  E C
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE--------ARAVFYAAEIC 296
Query: 601 C-------TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAP 653
           C        +I++ D+KP+NILLDD+ + RISD GL   + + +  T     GT GY+AP
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL--AVHVPEGQTIKGRVGTVGYMAP 354
Query: 654 EWFRNMPITVKVDVYSYGVLLLEII 678
           E  +N   T   D ++ G LL E+I
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMI 379

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 37  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 96  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 149
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT   +    GYVA  W+R  
Sbjct: 150 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEM---TGYVATRWYRAP 198
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 14/195 (7%)
Query: 488 EELGRGAFGTVYK---GFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNL 542
           EELG G F  V K       +  + +   K+ +R  +   S +E + EV+ + Q  H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           + L    +   + +L+ E +S G L  FL      + +  T  +  I  G+ YLH     
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 603 QIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
           +I H D+KP+NI+L D      + ++ DFGL   +       N  I GT  +VAPE    
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNY 192
Query: 659 MPITVKVDVYSYGVL 673
            P+ ++ D++S GV+
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 14/195 (7%)
Query: 488 EELGRGAFGTVYK---GFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNL 542
           EELG G F  V K       +  + +   K+ +R  +   S +E + EV+ + Q  H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           + L    +   + +L+ E +S G L  FL      + +  T  +  I  G+ YLH     
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 603 QIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
           +I H D+KP+NI+L D      + ++ DFGL   +       N  I GT  +VAPE    
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNY 192
Query: 659 MPITVKVDVYSYGVL 673
            P+ ++ D++S GV+
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 125/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L++ + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 87  LGICLTSTVQLIM-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 140
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 141 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 197
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 198 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 252
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 253 YMIMVKCWMIDAD--SRPKFREL 273

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 14/195 (7%)
Query: 488 EELGRGAFGTVYK---GFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNL 542
           EELG G F  V K       +  + +   K+ +R  +   S +E + EV+ + Q  H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           + L    +   + +L+ E +S G L  FL      + +  T  +  I  G+ YLH     
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 603 QIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
           +I H D+KP+NI+L D      + ++ DFGL   +       N  I GT  +VAPE    
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNY 192
Query: 659 MPITVKVDVYSYGVL 673
            P+ ++ D++S GV+
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 33/205 (16%)
Query: 490 LGRGAFGTVY--------KGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN 541
           LG+G FG V         K +       +   K+       +EK+   +VN         
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-------R 244
Query: 542 LVRLLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
            V  L Y  E ++ L LV   M+ G L   ++   +  +          AR +FY  E C
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP--------EARAVFYAAEIC 296
Query: 601 C-------TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAP 653
           C        +I++ D+KP+NILLDD+ + RISD GL   + + +  T     GT GY+AP
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL--AVHVPEGQTIKGRVGTVGYMAP 354
Query: 654 EWFRNMPITVKVDVYSYGVLLLEII 678
           E  +N   T   D ++ G LL E+I
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMI 379

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 37  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 96  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 149
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT   +    GYVA  W+R  
Sbjct: 150 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEM---TGYVATRWYRAP 198
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 120/287 (41%), Gaps = 60/287 (20%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG+GAFG V K   N   S   A+KK+ R  ++      +EV  +   +H+ +VR     
Sbjct: 14  LGQGAFGQVVKA-RNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 550 DEGRN-------------RLLVYEFMSNGALASFLFGDS-----KPNWKLRTEIVMGIAR 591
            E RN               +  E+  NG L   +  ++        W+L  +I+     
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL----E 127
Query: 592 GLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-------LLTLD------QS 638
            L Y+H +    IIH D+KP NI +D+  N +I DFGL K       +L LD       S
Sbjct: 128 ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 639 HTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
              T+  GT  YVA E          K+D+YS G++  E+I         + +    ER 
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---------YPFSTGMERV 235
Query: 698 --LGALVENDLE---AMDD--MTVLQRFVMVAIWCIQEDPSHRPTMR 737
             L  L    +E     DD  M V ++ + +    I  DP+ RP  R
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRL---LIDHDPNKRPGAR 279

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 24/220 (10%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-------AEVNGIGQTHHKN 541
           E+G GA+G V+K          VA+K++    Q  E+          A +  +    H N
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 542 LVRLLGYC-----DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLF 594
           +VRL   C     D      LV+E +    L ++L    +P     T  +++  + RGL 
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           +LH     +++H D+KPQNIL+      +++DFGL ++ +   + T+  +  T  Y APE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPE 189
Query: 655 WFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ 694
                     VD++S G +  E+   RR  L   + D  Q
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEM--FRRKPLFRGSSDVDQ 227

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 125/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L++ + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 85  LGICLTSTVQLIM-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 138
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 139 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 195
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 250
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 251 YMIMVKCWMI--DADSRPKFREL 271

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 125/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L++ + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 84  LGICLTSTVQLIM-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 137
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 138 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 194
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 195 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 249
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 250 YMIMVKCWMIDAD--SRPKFREL 270

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 125/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L++ + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 86  LGICLTSTVQLIM-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 139
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 140 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 196
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 251
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 252 YMIMVKCWMI--DADSRPKFREL 272

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 125/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L++ + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 83  LGICLTSTVQLIM-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 193
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 248
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 249 YMIMVKCWMI--DADSRPKFREL 269

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I D+GL +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDYGLAR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 125/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L++ + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 84  LGICLTSTVQLIM-QLMPFGXLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 137
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 138 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 194
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN--DLEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 195 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 249
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 250 YMIMVKCWMI--DADSRPKFREL 270

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 24/220 (10%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-------AEVNGIGQTHHKN 541
           E+G GA+G V+K          VA+K++    Q  E+          A +  +    H N
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 542 LVRLLGYC-----DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLF 594
           +VRL   C     D      LV+E +    L ++L    +P     T  +++  + RGL 
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           +LH     +++H D+KPQNIL+      +++DFGL ++ +   + T+  +  T  Y APE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPE 189
Query: 655 WFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ 694
                     VD++S G +  E+   RR  L   + D  Q
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEM--FRRKPLFRGSSDVDQ 227

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL++ FQ     K    E+  +    H+N++ LL 
Sbjct: 42  VGSGAYGSVCAAF-DTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 101 VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 154
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DFGL +       HT+  +    GYVA  W+R  
Sbjct: 155 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRAP 203
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 491 GRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLLGYC 549
            RG FG V+K  +    ++ VAVK      QD +  + + EV  +    H+N+++ +G  
Sbjct: 33  ARGRFGCVWKAQL---LNEYVAVKIFP--IQDKQSWQNEYEVYSLPGMKHENILQFIGAE 87
Query: 550 DEGR----NRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC---- 601
             G     +  L+  F   G+L+ FL  +   +W     I   +ARGL YLHE+      
Sbjct: 88  KRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 602 ---TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR-GTKGYVAPEWFR 657
                I H DIK +N+LL +   A I+DFGL       +S  +T  + GT+ Y+APE   
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLE 206
Query: 658 NM-----PITVKVDVYSYGVLLLEI 677
                     +++D+Y+ G++L E+
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 86/193 (44%), Gaps = 10/193 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +   +    E + + EV       H N++RL 
Sbjct: 20  LGKGKFGNVYLA-RERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           GY  +     L+ E+   G +   L   S+ + +     +  +A  L Y H +   ++IH
Sbjct: 79  GYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK---RVIH 135
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S     + GT  Y+ PE         KVD
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWS---VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVD 192
Query: 667 VYSYGVLLLEIIC 679
           ++S GVL  E + 
Sbjct: 193 LWSLGVLCYEFLV 205

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 124/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 108 LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 161
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 162 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 218
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 219 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 273
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 274 YMIMVKCWMIDAD--SRPKFREL 294

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 124/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 86  LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 139
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 140 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 196
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 251
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 252 YMIMVKCWMI--DADSRPKFREL 272

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 23/201 (11%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG- 547
           ELG GAFG VYK   N  +    A K +    ++  +++  E+  +    H  +V+LLG 
Sbjct: 18  ELGDGAFGKVYKA-KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 76
Query: 548 YCDEGRNRLLVYEFMSNGALASFLF----GDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           Y  +G+  +++ EF   GA+ + +     G ++P  ++   +   +   L +LH +   +
Sbjct: 77  YYHDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV---VCRQMLEALNFLHSK---R 129
Query: 604 IIHCDIKPQNILLDDYYNARISDFGL--EKLLTLDQSHTNTAIRGTKGYVAP-----EWF 656
           IIH D+K  N+L+    + R++DFG+  + L TL +     +  GT  ++AP     E  
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK---RDSFIGTPYWMAPEVVMCETM 186
Query: 657 RNMPITVKVDVYSYGVLLLEI 677
           ++ P   K D++S G+ L+E+
Sbjct: 187 KDTPYDYKADIWSLGITLIEM 207

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 116/258 (44%), Gaps = 29/258 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQTHHKNLVRLLG 547
           LG+G+FG V K   +  +  + AVK +N+    ++       EV  + +  H N+++L  
Sbjct: 30  LGKGSFGEVLKC-KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
             ++  +  +V E  + G L   +    + +      I+  +  G+ Y+H+     I+H 
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHR 145
Query: 608 DIKPQNILLDDYY---NARISDFGLEKLLTLDQSHTNTAIR-GTKGYVAPEWFRNMPITV 663
           D+KP+NILL+      + +I DFGL    T  Q +T    R GT  Y+APE  R      
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPEVLRG-TYDE 201
Query: 664 KVDVYSYGVLLL-------------EIICLRRTILTDWAYDCYQERTLGALVENDLEAMD 710
           K DV+S GV+L              E   L+R     +A+D  Q RT+    ++ +  M 
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM- 260
Query: 711 DMTVLQRFVMVAIWCIQE 728
            +T      + A  C++ 
Sbjct: 261 -LTFHPSLRITATQCLEH 277

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 124/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 85  LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 138
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 139 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 195
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 250
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 251 YMIMVKCWMI--DADSRPKFREL 271

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 124/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 83  LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 193
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 248
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 249 YMIMVKCWMIDAD--SRPKFREL 269

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 107/225 (47%), Gaps = 12/225 (5%)
Query: 459 PHQEEQGVSYMNLRCFTYKELVEV--TRGFKE---ELGRGAFGTVYKGFVNMGSSDQVAV 513
           P +E Q VS+   R    + +V+    R + +   ++G G+ G V    V   S   VAV
Sbjct: 4   PQREPQRVSHEQFRA-ALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVR-SSGKLVAV 61
Query: 514 KKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG 573
           KK++   Q   +    EV  +    H+N+V +      G    +V EF+  GAL   +  
Sbjct: 62  KKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVT 120
Query: 574 DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL 633
            ++ N +    + + + + L  LH +    +IH DIK  +ILL      ++SDFG    +
Sbjct: 121 HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 177
Query: 634 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
           + +       + GT  ++APE    +P   +VD++S G++++E++
Sbjct: 178 SKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 221

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 24/220 (10%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-------AEVNGIGQTHHKN 541
           E+G GA+G V+K          VA+K++    Q  E+          A +  +    H N
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 542 LVRLLGYC-----DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLF 594
           +VRL   C     D      LV+E +    L ++L    +P     T  +++  + RGL 
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           +LH     +++H D+KPQNIL+      +++DFGL ++ +   + T+  +  T  Y APE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPE 189
Query: 655 WFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ 694
                     VD++S G +  E+   RR  L   + D  Q
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEM--FRRKPLFRGSSDVDQ 227

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVR 544
           F  E+GRG+F TVYKG     + +    +  +R    SE++ FK E   +    H N+VR
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVR 89
Query: 545 LLGYCD---EGRN-RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                +   +G+   +LV E  ++G L ++L        K+       I +GL +LH   
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTR- 148
Query: 601 CTQIIHCDIKPQNILLDDYYNA-RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
              IIH D+K  NI +     + +I D G   L TL ++    A+ GT  + APE +   
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLG---LATLKRASFAKAVIGTPEFXAPEXYEE- 204
Query: 660 PITVKVDVYSYGVLLLE 676
                VDVY++G   LE
Sbjct: 205 KYDESVDVYAFGXCXLE 221

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 107/225 (47%), Gaps = 12/225 (5%)
Query: 459 PHQEEQGVSYMNLRCFTYKELVEV--TRGFKE---ELGRGAFGTVYKGFVNMGSSDQVAV 513
           P +E Q VS+   R    + +V+    R + +   ++G G+ G V    V   S   VAV
Sbjct: 124 PQREPQRVSHEQFRA-ALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVR-SSGKLVAV 181
Query: 514 KKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG 573
           KK++   Q   +    EV  +    H+N+V +      G    +V EF+  GAL   +  
Sbjct: 182 KKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVT 240
Query: 574 DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL 633
            ++ N +    + + + + L  LH +    +IH DIK  +ILL      ++SDFG    +
Sbjct: 241 HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297
Query: 634 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
           + +       + GT  ++APE    +P   +VD++S G++++E++
Sbjct: 298 SKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 341

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 107/225 (47%), Gaps = 12/225 (5%)
Query: 459 PHQEEQGVSYMNLRCFTYKELVEV--TRGFKE---ELGRGAFGTVYKGFVNMGSSDQVAV 513
           P +E Q VS+   R    + +V+    R + +   ++G G+ G V    V   S   VAV
Sbjct: 2   PQREPQRVSHEQFRA-ALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVR-SSGKLVAV 59
Query: 514 KKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG 573
           KK++   Q   +    EV  +    H+N+V +      G    +V EF+  GAL   +  
Sbjct: 60  KKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVT 118
Query: 574 DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL 633
            ++ N +    + + + + L  LH +    +IH DIK  +ILL      ++SDFG    +
Sbjct: 119 HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 175
Query: 634 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
           + +       + GT  ++APE    +P   +VD++S G++++E++
Sbjct: 176 SKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 219

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIG------QTHHKNL 542
           E+G GA+GTVYK   +  S   VA+K + RV    E    + V  +          H N+
Sbjct: 11  EIGVGAYGTVYKA-RDPHSGHFVALKSV-RVPNGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 543 VRLLGYCDEGRNR-----LLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLFY 595
           VRL+  C   R        LV+E +    L ++L     P     T  +++    RGL +
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           LH  C   I+H D+KP+NIL+      +++DFGL ++ +   +     +  T  Y APE 
Sbjct: 128 LHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV--TLWYRAPEV 182
Query: 656 FRNMPITVKVDVYSYGVLLLEI 677
                    VD++S G +  E+
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEM 204

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 23/201 (11%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG- 547
           ELG GAFG VYK   N  +    A K +    ++  +++  E+  +    H  +V+LLG 
Sbjct: 26  ELGDGAFGKVYKA-KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 548 YCDEGRNRLLVYEFMSNGALASFLF----GDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           Y  +G+  +++ EF   GA+ + +     G ++P  ++   +   +   L +LH +   +
Sbjct: 85  YYHDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV---VCRQMLEALNFLHSK---R 137
Query: 604 IIHCDIKPQNILLDDYYNARISDFGL--EKLLTLDQSHTNTAIRGTKGYVAP-----EWF 656
           IIH D+K  N+L+    + R++DFG+  + L TL +     +  GT  ++AP     E  
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK---RDSFIGTPYWMAPEVVMCETM 194
Query: 657 RNMPITVKVDVYSYGVLLLEI 677
           ++ P   K D++S G+ L+E+
Sbjct: 195 KDTPYDYKADIWSLGITLIEM 215

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 124/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 86  LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 139
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 140 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 196
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 251
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 252 YMIMVKCWMI--DADSRPKFREL 272

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   + ++ S  ++AVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 59  VGSGAYGSVCSSY-DVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 117
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                 +     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 118 VFTPATS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 171
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG---TKGYVAPEWF 656
               IIH D+KP N+ +++    +I DFGL +       HT+  + G   T+ Y APE  
Sbjct: 172 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 223
Query: 657 RN-MPITVKVDVYSYGVLLLEIICLR 681
            N M   + VD++S G ++ E++  R
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 124/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 89  LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 142
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 143 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 199
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 200 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 254
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 255 YMIMVKCWMIDAD--SRPKFREL 275

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 124/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 83  LGICLTSTVQLIT-QLMPFGXLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 193
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN--DLEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 248
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 249 YMIMVKCWMI--DADSRPKFREL 269

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 124/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 90  LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 143
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 144 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 200
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 201 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 255
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 256 YMIMVKCWMIDAD--SRPKFREL 276

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 116/258 (44%), Gaps = 29/258 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQTHHKNLVRLLG 547
           LG+G+FG V K   +  +  + AVK +N+    ++       EV  + +  H N+++L  
Sbjct: 30  LGKGSFGEVLKC-KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
             ++  +  +V E  + G L   +    + +      I+  +  G+ Y+H+     I+H 
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHR 145
Query: 608 DIKPQNILLDDYY---NARISDFGLEKLLTLDQSHTNTAIR-GTKGYVAPEWFRNMPITV 663
           D+KP+NILL+      + +I DFGL    T  Q +T    R GT  Y+APE  R      
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPEVLRG-TYDE 201
Query: 664 KVDVYSYGVLLL-------------EIICLRRTILTDWAYDCYQERTLGALVENDLEAMD 710
           K DV+S GV+L              E   L+R     +A+D  Q RT+    ++ +  M 
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM- 260
Query: 711 DMTVLQRFVMVAIWCIQE 728
            +T      + A  C++ 
Sbjct: 261 -LTFHPSLRITATQCLEH 277

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 124/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 77  LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 130
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 131 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 187
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN--DLEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 242
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 243 YMIMVKCWMI--DADSRPKFREL 263

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 100/195 (51%), Gaps = 16/195 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E+LG G++G+VYK  ++  +   VA+K++    +   +E   E++ + Q    ++V+  G
Sbjct: 35  EKLGEGSYGSVYKA-IHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFYLHEECCT 602
              +  +  +V E+   G+++  +    +   K  TE     I+    +GL YLH     
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDII----RLRNKTLTEDEIATILQSTLKGLEYLH---FM 144
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           + IH DIK  NILL+   +A+++DFG+   LT   +  N  I GT  ++APE  + +   
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVI-GTPFWMAPEVIQEIGYN 203
Query: 663 VKVDVYSYGVLLLEI 677
              D++S G+  +E+
Sbjct: 204 CVADIWSLGITAIEM 218

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 14/195 (7%)
Query: 488 EELGRGAFGTVYK---GFVNMGSSDQVAVKKLNRVFQDS--EKEFKAEVNGIGQTHHKNL 542
           EELG G F  V K       +  + +   K+ +R  +     +E + EV+ + Q  H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           + L    +   + +L+ E +S G L  FL      + +  T  +  I  G+ YLH     
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 603 QIIHCDIKPQNILLDDYY----NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
           +I H D+KP+NI+L D      + ++ DFGL   +       N  I GT  +VAPE    
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNY 192
Query: 659 MPITVKVDVYSYGVL 673
            P+ ++ D++S GV+
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIG------QTHHKNL 542
           E+G GA+GTVYK   +  S   VA+K + RV    E    + V  +          H N+
Sbjct: 11  EIGVGAYGTVYKA-RDPHSGHFVALKSV-RVPNGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 543 VRLLGYCDEGRNR-----LLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLFY 595
           VRL+  C   R        LV+E +    L ++L     P     T  +++    RGL +
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           LH  C   I+H D+KP+NIL+      +++DFGL ++ +   +     +  T  Y APE 
Sbjct: 128 LHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV--TLWYRAPEV 182
Query: 656 FRNMPITVKVDVYSYGVLLLEI 677
                    VD++S G +  E+
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEM 204

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 11/194 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           +G+G F  V K   ++ +  +VAVK +++   +S   +K F+ EV  +   +H N+V+L 
Sbjct: 22  IGKGNFAKV-KLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
              +  +   LV E+ S G +  +L    +   K        I   + Y H++    I+H
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVH 136
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT-VKV 665
            D+K +N+LLD   N +I+DFG     T    +   A  G   Y APE F+       +V
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTF--GNKLDAFCGAPPYAAPELFQGKKYDGPEV 194
Query: 666 DVYSYGVLLLEIIC 679
           DV+S GV+L  ++ 
Sbjct: 195 DVWSLGVILYTLVS 208

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           ++G G+ G V    V   S   VAVKK++   Q   +    EV  +    H+N+V +   
Sbjct: 27  KIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCD 608
              G    +V EF+  GAL   +   ++ N +    + + + + L  LH +    +IH D
Sbjct: 86  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRD 141
Query: 609 IKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVY 668
           IK  +ILL      ++SDFG    ++ +       + GT  ++APE    +P   +VD++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIW 200
Query: 669 SYGVLLLEII 678
           S G++++E++
Sbjct: 201 SLGIMVIEMV 210

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I DF L +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFYLAR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           ++G G+ G V    V   S   VAVKK++   Q   +    EV  +    H+N+V +   
Sbjct: 31  KIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 89
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCD 608
              G    +V EF+  GAL   +   ++ N +    + + + + L  LH +    +IH D
Sbjct: 90  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRD 145
Query: 609 IKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVY 668
           IK  +ILL      ++SDFG    ++ +       + GT  ++APE    +P   +VD++
Sbjct: 146 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIW 204
Query: 669 SYGVLLLEII 678
           S G++++E++
Sbjct: 205 SLGIMVIEMV 214

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 107/225 (47%), Gaps = 12/225 (5%)
Query: 459 PHQEEQGVSYMNLRCFTYKELVEV--TRGFKE---ELGRGAFGTVYKGFVNMGSSDQVAV 513
           P +E Q VS+   R    + +V+    R + +   ++G G+ G V    V   S   VAV
Sbjct: 47  PQREPQRVSHEQFRA-ALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVR-SSGKLVAV 104
Query: 514 KKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG 573
           KK++   Q   +    EV  +    H+N+V +      G    +V EF+  GAL   +  
Sbjct: 105 KKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVT 163
Query: 574 DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL 633
            ++ N +    + + + + L  LH +    +IH DIK  +ILL      ++SDFG    +
Sbjct: 164 HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220
Query: 634 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
           + +       + GT  ++APE    +P   +VD++S G++++E++
Sbjct: 221 SKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 264

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIG--QTH------ 538
           K+ +GRG   +V +  V+  +  + AVK +    +    E   EV      +TH      
Sbjct: 99  KDVIGRGV-SSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 539 -HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLH 597
            H +++ L+   +      LV++ M  G L  +L      + K    I+  +   + +LH
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH 217
Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
                 I+H D+KP+NILLDD    R+SDFG      L+       + GT GY+APE  +
Sbjct: 218 ---ANNIVHRDLKPENILLDDNMQIRLSDFGFS--CHLEPGEKLRELCGTPGYLAPEILK 272
Query: 658 -NMPIT-----VKVDVYSYGVLLLEIIC 679
            +M  T      +VD+++ GV+L  ++ 
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLA 300

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIG------QTHHKNL 542
           E+G GA+GTVYK   +  S   VA+K + RV    E    + V  +          H N+
Sbjct: 11  EIGVGAYGTVYKA-RDPHSGHFVALKSV-RVPNGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 543 VRLLGYCDEGRNR-----LLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLFY 595
           VRL+  C   R        LV+E +    L ++L     P     T  +++    RGL +
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           LH  C   I+H D+KP+NIL+      +++DFGL ++ +   +     +  T  Y APE 
Sbjct: 128 LHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV--TLWYRAPEV 182
Query: 656 FRNMPITVKVDVYSYGVLLLEI 677
                    VD++S G +  E+
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEM 204

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 12/193 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA----EVNGIGQTHHKNLVRL 545
           +G G++G V K   N  +   VA+KK   +  D +K  K     E+  + Q  H+NLV L
Sbjct: 33  VGEGSYGMVMKC-RNKDTGRIVAIKKF--LESDDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
           L  C + +   LV+EF+ +  L       +  ++++  + +  I  G+ + H      II
Sbjct: 90  LEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NII 146
Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR-NMPITVK 664
           H DIKP+NIL+      ++ DFG  + L       +  +  T+ Y APE    ++     
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV-ATRWYRAPELLVGDVKYGKA 205
Query: 665 VDVYSYGVLLLEI 677
           VDV++ G L+ E+
Sbjct: 206 VDVWAIGCLVTEM 218

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 14/209 (6%)
Query: 476 YKELVEVTRGF--KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG 533
           ++  ++ T G+  KE++G G++ +V K  ++  ++ + AVK +++  +D  +E +  +  
Sbjct: 14  HRNSIQFTDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLR- 71
Query: 534 IGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGL 593
            GQ  H N++ L    D+G+   +V E M  G L   +      + +  + ++  I + +
Sbjct: 72  YGQ--HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTV 129
Query: 594 FYLHEECCTQIIHCDIKPQNIL-LDDYYNA---RISDFGLEKLLTLDQSHTNTAIRGTKG 649
            YLH +    ++H D+KP NIL +D+  N    RI DFG  K L  +     T    T  
Sbjct: 130 EYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY-TAN 185
Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEII 678
           +VAPE           D++S GVLL  ++
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTML 214

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 11/194 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           +G+G F  V K   ++ +  +VAVK +++   +S   +K F+ EV      +H N+V+L 
Sbjct: 22  IGKGNFAKV-KLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIVKLF 79
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
              +  +   LV E+ S G +  +L    +   K        I   + Y H++    I+H
Sbjct: 80  EVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF---IVH 136
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT-VKV 665
            D+K +N+LLD   N +I+DFG     T    +   A  G   Y APE F+       +V
Sbjct: 137 RDLKAENLLLDADXNIKIADFGFSNEFTF--GNKLDAFCGAPPYAAPELFQGKKYDGPEV 194
Query: 666 DVYSYGVLLLEIIC 679
           DV+S GV+L  ++ 
Sbjct: 195 DVWSLGVILYTLVS 208

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 116/258 (44%), Gaps = 24/258 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR-------VFQDSEKEFKAEVNGIGQTHHKNL 542
           LG+G+F  VY+   ++ +  +VA+K +++       + Q  + E K       Q  H ++
Sbjct: 19  LGKGSFAGVYRA-ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC----QLKHPSI 73
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEECC 601
           + L  Y ++     LV E   NG +  +L    KP  +      M  I  G+ YLH    
Sbjct: 74  LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH-- 131
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             I+H D+   N+LL    N +I+DFGL   L +      T + GT  Y++PE       
Sbjct: 132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAH 189
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV 721
            ++ DV+S G +   ++  R    TD       + TL  +V  D E    +++  + ++ 
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTV-----KNTLNKVVLADYEMPSFLSIEAKDLIH 244
Query: 722 AIWCIQEDPSHRPTMRRV 739
            +  ++ +P+ R ++  V
Sbjct: 245 QL--LRRNPADRLSLSSV 260

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I  FGL +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILGFGLAR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 104/230 (45%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 11  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 66
Query: 543 VRLLGYCDEGRNRLLVYEFMS----NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+S    +   AS L G   P   L    +  + +GL + H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 123
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KPQN+L++     +++DFGL +            +R     V   W+R 
Sbjct: 124 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 173
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 223

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 104/230 (45%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 12  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 67
Query: 543 VRLLGYCDEGRNRLLVYEFMS----NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+S    +   AS L G   P   L    +  + +GL + H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 124
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KPQN+L++     +++DFGL +            +R     V   W+R 
Sbjct: 125 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 174
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 123/263 (46%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA G+ YL +   
Sbjct: 80  LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAEGMNYLEDR-- 133
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 134 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 190
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 191 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 245
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 246 YMIMVKCWMI--DADSRPKFREL 266

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I D GL +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDAGLAR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA----EVNGIGQTHHKNLV 543
           E+LG G + TVYKG +N  +   VA+K+   V  DSE+   +    E++ + +  H+N+V
Sbjct: 11  EKLGNGTYATVYKG-LNKTTGVYVALKE---VKLDSEEGTPSTAIREISLMKELKHENIV 66
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM------GIARGLFYLH 597
           RL           LV+EFM N  L  ++   +  N     E+ +       + +GL + H
Sbjct: 67  RLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
           E    +I+H D+KPQN+L++     ++ DFGL +   +  +  ++ +  T  Y AP+   
Sbjct: 126 E---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLM 181
Query: 658 -NMPITVKVDVYSYGVLLLEIIC 679
            +   +  +D++S G +L E+I 
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMIT 204

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 93/194 (47%), Gaps = 11/194 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           +G+G F  V K   ++ +  +VAVK +++   +S   +K F+ EV  +   +H N+V+L 
Sbjct: 22  IGKGNFAKV-KLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
              +  +   LV E+ S G +  +L    +   K        I   + Y H++    I+H
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVH 136
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT-VKV 665
            D+K +N+LLD   N +I+DFG     T           G+  Y APE F+       +V
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPELFQGKKYDGPEV 194
Query: 666 DVYSYGVLLLEIIC 679
           DV+S GV+L  ++ 
Sbjct: 195 DVWSLGVILYTLVS 208

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK         Q  +  L R+  D+E E        E++ + + HH N+
Sbjct: 27  EKVGEGTYGVVYKA-----KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM-GIARGLFYLHEECC 601
           V L+      R   LV+EFM    L   L  +       + +I +  + RG+ + H+   
Sbjct: 82  VSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-- 138
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR-NM 659
            +I+H D+KPQN+L++     +++DFGL +   +  +S+T+  +  T  Y AP+    + 
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGSK 195
Query: 660 PITVKVDVYSYGVLLLEII 678
             +  VD++S G +  E+I
Sbjct: 196 KYSTSVDIWSIGCIFAEMI 214

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 22/198 (11%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           +ELGRG F  V +  ++  +  + A K  K  R  QD   E   E+  +     K+  R+
Sbjct: 35  KELGRGKFAVV-RQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELA--KSCPRV 91
Query: 546 LGYCDEGRNR---LLVYEFMSNGALASFLFGD----SKPNWKLRTEIVMGIARGLFYLHE 598
           +   +   N    +L+ E+ + G + S    +       N  +R  ++  I  G++YLH+
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR--LIKQILEGVYYLHQ 149
Query: 599 ECCTQIIHCDIKPQNILLDDYY---NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
                I+H D+KPQNILL   Y   + +I DFG+ +   +  +     I GT  Y+APE 
Sbjct: 150 ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR--KIGHACELREIMGTPEYLAPEI 204
Query: 656 FRNMPITVKVDVYSYGVL 673
               PIT   D+++ G++
Sbjct: 205 LNYDPITTATDMWNIGII 222

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 93/194 (47%), Gaps = 11/194 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           +G+G F  V K   ++ +  +VAVK +++   +S   +K F+ EV  +   +H N+V+L 
Sbjct: 22  IGKGNFAKV-KLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
              +  +   LV E+ S G +  +L    +   K        I   + Y H++    I+H
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVH 136
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT-VKV 665
            D+K +N+LLD   N +I+DFG     T           G+  Y APE F+       +V
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPELFQGKKYDGPEV 194
Query: 666 DVYSYGVLLLEIIC 679
           DV+S GV+L  ++ 
Sbjct: 195 DVWSLGVILYTLVS 208

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK         Q  +  L R+  D+E E        E++ + + HH N+
Sbjct: 27  EKVGEGTYGVVYKA-----KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM-GIARGLFYLHEECC 601
           V L+      R   LV+EFM    L   L  +       + +I +  + RG+ + H+   
Sbjct: 82  VSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-- 138
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR-NM 659
            +I+H D+KPQN+L++     +++DFGL +   +  +S+T+  +  T  Y AP+    + 
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGSK 195
Query: 660 PITVKVDVYSYGVLLLEII 678
             +  VD++S G +  E+I
Sbjct: 196 KYSTSVDIWSIGCIFAEMI 214

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 25/225 (11%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA-----EVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 16  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 71
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 128
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR 657
               +++H D+KPQN+L++     +++DFGL +   +  +++T+  +  T  Y APE   
Sbjct: 129 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 183
Query: 658 NMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
                +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 228

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I D GL +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDRGLAR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 25/225 (11%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 9   EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 64
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR 657
               +++H D+KPQN+L++     +++DFGL +   +  +++T+  +  T  Y APE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 658 NMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
                +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 91/194 (46%), Gaps = 9/194 (4%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKE-FKAEVNGIGQTHHKNLVRLL 546
           LG+G+FG V       G+ +  A+K L +  V QD + E    E   +        +  L
Sbjct: 27  LGKGSFGKVMLA-DRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 547 GYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
             C +  +RL  V E+++ G L   +    K            I+ GLF+LH+     II
Sbjct: 86  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRG---II 142
Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 665
           + D+K  N++LD   + +I+DFG+ K   +D   T     GT  Y+APE     P    V
Sbjct: 143 YRDLKLDNVMLDSEGHIKIADFGMCKEHMMD-GVTTREFCGTPDYIAPEIIAYQPYGKSV 201
Query: 666 DVYSYGVLLLEIIC 679
           D ++YGVLL E++ 
Sbjct: 202 DWWAYGVLLYEMLA 215

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 124/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L++ + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 85  LGICLTSTVQLIM-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 138
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFG  KLL  ++   +    G K    ++A E   +
Sbjct: 139 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA--EGGKVPIKWMALESILH 195
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 250
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 251 YMIMVKCWMI--DADSRPKFREL 271

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 35/209 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   F +  +  +VAVKKL+R FQ     K    E+  +    H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                R+     E  ++  L + L G    N     KL  +    ++  I RGL Y+H  
Sbjct: 89  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 142
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    +I D GL +       HT+  +    GYVA  W+R  
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDGGLAR-------HTDDEM---TGYVATRWYRAP 191
Query: 660 PITVK-------VDVYSYGVLLLEIICLR 681
            I +        VD++S G ++ E++  R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 124/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           L  GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L++ + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 90  LGICLTSTVQLIM-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 143
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 144 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 200
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 201 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 255
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 256 YMIMVKCWMIDAD--SRPKFREL 276

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 101/218 (46%), Gaps = 36/218 (16%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVN--GIGQTHHKNLVR 544
           E +GRG +G VYKG ++      VAVK    VF  + ++ F  E N   +    H N+ R
Sbjct: 19  ELIGRGRYGAVYKGSLD---ERPVAVK----VFSFANRQNFINEKNIYRVPLMEHDNIAR 71
Query: 545 LL----GYCDEGR-NRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
            +        +GR   LLV E+  NG+L  +L   +  +W     +   + RGL YLH E
Sbjct: 72  FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-DWVSSCRLAHSVTRGLAYLHTE 130
Query: 600 CCT------QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ-----SHTNTAIR--G 646
                     I H D+  +N+L+ +     ISDFGL   LT ++        N AI   G
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190
Query: 647 TKGYVAPEW------FRNMPITVK-VDVYSYGVLLLEI 677
           T  Y+APE        R+    +K VD+Y+ G++  EI
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 123/263 (46%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           L  GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 83  LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 193
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN--DLEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 248
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 249 YMIMVKCWMI--DADSRPKFREL 269

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 25/225 (11%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 16  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 71
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 128
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR 657
               +++H D+KPQN+L++     +++DFGL +   +  +++T+  +  T  Y APE   
Sbjct: 129 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 183
Query: 658 NMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
                +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 228

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 489 ELGRGAFGTVY---KGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVR 544
           +LG G FG V        N G+ + VAVK L        +  +K E++ +   +H+++++
Sbjct: 21  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 545 LLGYC-DEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
             G C D+G   L LV E++  G+L  +L   S    +L       I  G+ YLH +   
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL-FAQQICEGMAYLHSQ--- 136
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR----GTKGYVAPEWFRN 658
             IH ++  +N+LLD+    +I DFGL K   + + H    +R        + APE  + 
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 659 MPITVKVDVYSYGVLLLEII 678
                  DV+S+GV L E++
Sbjct: 195 YKFYYASDVWSFGVTLYELL 214

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 25/225 (11%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 10  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 65
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 122
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR 657
               +++H D+KPQN+L++     +++DFGL +   +  +++T+  +  T  Y APE   
Sbjct: 123 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 177
Query: 658 NMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
                +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 222

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 10/218 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           EELG+GAF  V +  V    + + A K +N  ++     ++ + E        H N+VRL
Sbjct: 37  EELGKGAFSVVRRC-VKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL 95
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
                E     LV++ ++ G L   +      +    +  +  I   + ++H+     I+
Sbjct: 96  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQH---DIV 152
Query: 606 HCDIKPQNILLDDYYNA---RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           H D+KP+N+LL         +++DFGL   +  +Q        GT GY++PE  R  P  
Sbjct: 153 HRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQ-AWFGFAGTPGYLSPEVLRKDPYG 211
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGA 700
             VD+++ GV+L  ++        +  +  YQ+   GA
Sbjct: 212 KPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGA 249

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 99/218 (45%), Gaps = 10/218 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           EELG+GAF  V +  V + +  + A K +N  ++     ++ + E        H N+VRL
Sbjct: 28  EELGKGAFSVVRR-CVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL 86
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
                E  +  L+++ ++ G L   +      +    +  +  I   + + H+     ++
Sbjct: 87  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVV 143
Query: 606 HCDIKPQNILLDDYYNA---RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           H D+KP+N+LL         +++DFGL   +  +Q        GT GY++PE  R  P  
Sbjct: 144 HRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYG 202
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGA 700
             VD+++ GV+L  ++        +  +  YQ+   GA
Sbjct: 203 KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 240

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 119/287 (41%), Gaps = 60/287 (20%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG+GAFG V K   N   S   A+KK+ R  ++      +EV  +   +H+ +VR     
Sbjct: 14  LGQGAFGQVVKA-RNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 550 DEGRN-------------RLLVYEFMSNGALASFLFGDS-----KPNWKLRTEIVMGIAR 591
            E RN               +  E+  N  L   +  ++        W+L  +I+     
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL----E 127
Query: 592 GLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-------LLTLD------QS 638
            L Y+H +    IIH D+KP NI +D+  N +I DFGL K       +L LD       S
Sbjct: 128 ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 639 HTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
              T+  GT  YVA E          K+D+YS G++  E+I         + +    ER 
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---------YPFSTGMERV 235
Query: 698 --LGALVENDLE---AMDD--MTVLQRFVMVAIWCIQEDPSHRPTMR 737
             L  L    +E     DD  M V ++ + +    I  DP+ RP  R
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRL---LIDHDPNKRPGAR 279

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 25/225 (11%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 9   EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 64
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR 657
               +++H D+KPQN+L++     +++DFGL +   +  +++T+  +  T  Y APE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 658 NMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
                +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 25/225 (11%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 9   EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 64
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR 657
               +++H D+KPQN+L++     +++DFGL +   +  +++T+  +  T  Y APE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 658 NMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
                +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 489 ELGRGAFGTVY---KGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVR 544
           +LG G FG V        N G+ + VAVK L        +  +K E++ +   +H+++++
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 545 LLGYC-DEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
             G C D G   L LV E++  G+L  +L   S    +L       I  G+ YLH +   
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL-FAQQICEGMAYLHAQ--- 153
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR----GTKGYVAPEWFRN 658
             IH D+  +N+LLD+    +I DFGL K   + + H    +R        + APE  + 
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEXYRVREDGDSPVFWYAPECLKE 211
Query: 659 MPITVKVDVYSYGVLLLEII 678
                  DV+S+GV L E++
Sbjct: 212 YKFYYASDVWSFGVTLYELL 231

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 25/225 (11%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 8   EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 63
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 120
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR 657
               +++H D+KPQN+L++     +++DFGL +   +  +++T+  +  T  Y APE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 658 NMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
                +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 25/225 (11%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 8   EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 63
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 120
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR 657
               +++H D+KPQN+L++     +++DFGL +   +  +++T+  +  T  Y APE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 658 NMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
                +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 123/263 (46%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 90  LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 143
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFG  KLL  ++   +    G K    ++A E   +
Sbjct: 144 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA--EGGKVPIKWMALESILH 200
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 201 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 255
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 256 YMIMVKCWMIDAD--SRPKFREL 276

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 124/263 (47%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L++ + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 87  LGICLTSTVQLIM-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 140
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFG  KLL  ++   +    G K    ++A E   +
Sbjct: 141 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA--EGGKVPIKWMALESILH 197
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN--DLEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 198 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 252
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 253 YMIMVKCWMI--DADSRPKFREL 273

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 489 ELGRGAFGTVY---KGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVR 544
           +LG G FG V        N G+ + VAVK L        +  +K E++ +   +H+++++
Sbjct: 21  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 545 LLGYC-DEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
             G C D+G   L LV E++  G+L  +L   S    +L       I  G+ YLH +   
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL-FAQQICEGMAYLHAQ--- 136
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR----GTKGYVAPEWFRN 658
             IH ++  +N+LLD+    +I DFGL K   + + H    +R        + APE  + 
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 659 MPITVKVDVYSYGVLLLEII 678
                  DV+S+GV L E++
Sbjct: 195 YKFYYASDVWSFGVTLYELL 214

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 123/263 (46%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 83  LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 193
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN--DLEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 248
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +M   W I  D   RP  R +
Sbjct: 249 YMIMRKCWMI--DADSRPKFREL 269

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 123/263 (46%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           L  GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 90  LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 143
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 144 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 200
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 201 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 255
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 256 YMIMVKCWMIDAD--SRPKFREL 276

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 123/263 (46%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 83  LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFG  KLL  ++   +    G K    ++A E   +
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA--EGGKVPIKWMALESILH 193
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN--DLEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 248
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +MV  W I  D   RP  R +
Sbjct: 249 YMIMVKCWMI--DADSRPKFREL 269

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 25/225 (11%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 13  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 68
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 125
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR 657
               +++H D+KPQN+L++     +++DFGL +   +  +++T+  +  T  Y APE   
Sbjct: 126 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 180
Query: 658 NMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
                +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 225

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 25/225 (11%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 9   EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 64
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLSFCHS 121
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR 657
               +++H D+KPQN+L++     +++DFGL +   +  +++T+  +  T  Y APE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 658 NMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
                +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 12  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 67
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 124
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KPQN+L++     +++DFGL +            +R     V   W+R 
Sbjct: 125 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 174
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 123/263 (46%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 86  LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 139
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 140 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 196
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 251
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +M   W I  D   RP  R +
Sbjct: 252 YMIMRKCWMI--DADSRPKFREL 272

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 19/197 (9%)
Query: 490 LGRGAFGTVY-------KGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNL 542
           LG G+FG V+         +  M    +  V +L +V   +++     +       H  +
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI-----VTHPFI 68
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           +R+ G   + +   ++ +++  G L S L    +    +       +   L YLH +   
Sbjct: 69  IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK--- 125
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            II+ D+KP+NILLD   + +I+DFG  K +          + GT  Y+APE     P  
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYXLCGTPDYIAPEVVSTKPYN 181
Query: 663 VKVDVYSYGVLLLEIIC 679
             +D +S+G+L+ E++ 
Sbjct: 182 KSIDWWSFGILIYEMLA 198

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 22/201 (10%)
Query: 490 LGRGAFGTVY----------KGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHH 539
           LG+G+FG V+          +    M    +  +K  +RV    E++   EVN      H
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN------H 85
Query: 540 KNLVRLLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
             +V+L  Y  +   +L L+ +F+  G L + L   SK       ++   +A     L  
Sbjct: 86  PFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDH 141
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
                II+ D+KP+NILLD+  + +++DFGL K  ++D      +  GT  Y+APE    
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 659 MPITVKVDVYSYGVLLLEIIC 679
              T   D +S+GVL+ E++ 
Sbjct: 201 RGHTQSADWWSFGVLMFEMLT 221

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 9   EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 64
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KPQN+L++     +++DFGL +            +R     V   W+R 
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 171
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 11/194 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           +G+G F  V K   ++ +  +VAV+ +++   +S   +K F+ EV  +   +H N+V+L 
Sbjct: 22  IGKGNFAKV-KLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
              +  +   LV E+ S G +  +L    +   K        I   + Y H++    I+H
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVH 136
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT-VKV 665
            D+K +N+LLD   N +I+DFG     T           G+  Y APE F+       +V
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPELFQGKKYDGPEV 194
Query: 666 DVYSYGVLLLEIIC 679
           DV+S GV+L  ++ 
Sbjct: 195 DVWSLGVILYTLVS 208

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 12  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 67
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 124
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KPQN+L++     +++DFGL +            +R     V   W+R 
Sbjct: 125 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 174
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 12  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 67
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 124
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KPQN+L++     +++DFGL +            +R     V   W+R 
Sbjct: 125 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 174
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 11  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 66
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 123
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KPQN+L++     +++DFGL +            +R     V   W+R 
Sbjct: 124 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 173
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 223

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 9   EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 64
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KPQN+L++     +++DFGL +            +R     V   W+R 
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 171
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 11/194 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           +G+G F  V K   ++ +  +VAV+ +++   +S   +K F+ EV  +   +H N+V+L 
Sbjct: 22  IGKGNFAKV-KLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
              +  +   LV E+ S G +  +L    +   K        I   + Y H++    I+H
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVH 136
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT-VKV 665
            D+K +N+LLD   N +I+DFG     T           G+  Y APE F+       +V
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC--GSPPYAAPELFQGKKYDGPEV 194
Query: 666 DVYSYGVLLLEIIC 679
           DV+S GV+L  ++ 
Sbjct: 195 DVWSLGVILYTLVS 208

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 14/205 (6%)
Query: 476 YKELVEVTRGF--KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG 533
           ++  ++ T G+  KE++G G++ +V K  ++  ++ + AVK +++  +D  +E +  +  
Sbjct: 14  HRNSIQFTDGYEVKEDIGVGSY-SVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLR- 71
Query: 534 IGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGL 593
            GQ  H N++ L    D+G+   +V E    G L   +      + +  + ++  I + +
Sbjct: 72  YGQ--HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTV 129
Query: 594 FYLHEECCTQIIHCDIKPQNIL-LDDYYNA---RISDFGLEKLLTLDQSHTNTAIRGTKG 649
            YLH +    ++H D+KP NIL +D+  N    RI DFG  K L  +     T    T  
Sbjct: 130 EYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY-TAN 185
Query: 650 YVAPEWFRNMPITVKVDVYSYGVLL 674
           +VAPE           D++S GVLL
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLL 210

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 118/265 (44%), Gaps = 15/265 (5%)
Query: 490 LGRGAFGTVYKGFV--NMGSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG G FG VY+G    + G    VAVK   +    D++++F +E   +    H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIV--MGIARGLFYLHEECCTQI 604
           G  +E     ++ E    G L  +L   +K + K+ T ++  + I + + YL    C   
Sbjct: 80  GIIEE-EPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESINC--- 134
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           +H DI  +NIL+      ++ DFGL + +  +  +  +  R    +++PE       T  
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA 194
Query: 665 VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW 724
            DV+ + V + EI+   +     W  +   +  +G L + D     D+     + ++   
Sbjct: 195 SDVWMFAVCMWEILSFGKQPFF-WLEN---KDVIGVLEKGDRLPKPDLCPPVLYTLMTR- 249
Query: 725 CIQEDPSHRPTMRRVTQMLEGVVEV 749
           C   DPS RP    +   L  V ++
Sbjct: 250 CWDYDPSDRPRFTELVCSLSDVYQM 274

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 8   EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 63
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 120
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KPQN+L++     +++DFGL +            +R     V   W+R 
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 170
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 10  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 65
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 122
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KPQN+L++     +++DFGL +            +R     V   W+R 
Sbjct: 123 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 172
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 222

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 8   EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 63
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 120
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KPQN+L++     +++DFGL +            +R     V   W+R 
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 170
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 9   EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 64
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KPQN+L++     +++DFGL +            +R     V   W+R 
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 171
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 123/263 (46%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 93  LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 146
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    G K    ++A E   +
Sbjct: 147 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILH 203
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN--DLEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 204 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 258
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +M   W I  D   RP  R +
Sbjct: 259 YMIMRKCWMI--DADSRPKFREL 279

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 22/201 (10%)
Query: 490 LGRGAFGTVY----------KGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHH 539
           LG+G+FG V+               M    +  +K  +RV    E++  A+VN      H
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVN------H 89
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
             +V+L   +  EG+   L+ +F+  G L + L  +     +     +  +A GL +LH 
Sbjct: 90  PFVVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLH- 147
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
                II+ D+KP+NILLD+  + +++DFGL K   +D      +  GT  Y+APE    
Sbjct: 148 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-EAIDHEKKAYSFCGTVEYMAPEVVNR 204
Query: 659 MPITVKVDVYSYGVLLLEIIC 679
              +   D +SYGVL+ E++ 
Sbjct: 205 QGHSHSADWWSYGVLMFEMLT 225

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 13  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 68
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 125
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KPQN+L++     +++DFGL +            +R     V   W+R 
Sbjct: 126 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 175
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 225

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 118/265 (44%), Gaps = 15/265 (5%)
Query: 490 LGRGAFGTVYKGFV--NMGSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG G FG VY+G    + G    VAVK   +    D++++F +E   +    H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIV--MGIARGLFYLHEECCTQI 604
           G  +E     ++ E    G L  +L   +K + K+ T ++  + I + + YL    C   
Sbjct: 92  GIIEE-EPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESINC--- 146
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           +H DI  +NIL+      ++ DFGL + +  +  +  +  R    +++PE       T  
Sbjct: 147 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA 206
Query: 665 VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW 724
            DV+ + V + EI+   +     W  +   +  +G L + D     D+     + ++   
Sbjct: 207 SDVWMFAVCMWEILSFGKQPFF-WLEN---KDVIGVLEKGDRLPKPDLCPPVLYTLMTR- 261
Query: 725 CIQEDPSHRPTMRRVTQMLEGVVEV 749
           C   DPS RP    +   L  V ++
Sbjct: 262 CWDYDPSDRPRFTELVCSLSDVYQM 286

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 11  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 66
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 123
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KPQN+L++     +++DFGL +            +R     V   W+R 
Sbjct: 124 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 173
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 223

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 10  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 65
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 122
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KPQN+L++     +++DFGL +            +R     V   W+R 
Sbjct: 123 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 172
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 222

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 9   EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 64
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KPQN+L++     +++DFGL +            +R     V   W+R 
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 171
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 22/201 (10%)
Query: 490 LGRGAFGTVY----------KGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHH 539
           LG+G+FG V+          +    M    +  +K  +RV    E++   EVN      H
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN------H 85
Query: 540 KNLVRLLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
             +V+L  Y  +   +L L+ +F+  G L + L   SK       ++   +A     L  
Sbjct: 86  PFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDH 141
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
                II+ D+KP+NILLD+  + +++DFGL K  ++D      +  GT  Y+APE    
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 659 MPITVKVDVYSYGVLLLEIIC 679
              T   D +S+GVL+ E++ 
Sbjct: 201 RGHTQSADWWSFGVLMFEMLT 221

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 22/201 (10%)
Query: 490 LGRGAFGTVY----------KGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHH 539
           LG+G+FG V+          +    M    +  +K  +RV    E++   EVN      H
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN------H 86
Query: 540 KNLVRLLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
             +V+L  Y  +   +L L+ +F+  G L + L   SK       ++   +A     L  
Sbjct: 87  PFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDH 142
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
                II+ D+KP+NILLD+  + +++DFGL K  ++D      +  GT  Y+APE    
Sbjct: 143 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNR 201
Query: 659 MPITVKVDVYSYGVLLLEIIC 679
              T   D +S+GVL+ E++ 
Sbjct: 202 RGHTQSADWWSFGVLMFEMLT 222

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 118/265 (44%), Gaps = 15/265 (5%)
Query: 490 LGRGAFGTVYKGFV--NMGSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG G FG VY+G    + G    VAVK   +    D++++F +E   +    H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIV--MGIARGLFYLHEECCTQI 604
           G  +E     ++ E    G L  +L   +K + K+ T ++  + I + + YL    C   
Sbjct: 76  GIIEE-EPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESINC--- 130
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           +H DI  +NIL+      ++ DFGL + +  +  +  +  R    +++PE       T  
Sbjct: 131 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA 190
Query: 665 VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW 724
            DV+ + V + EI+   +     W  +   +  +G L + D     D+     + ++   
Sbjct: 191 SDVWMFAVCMWEILSFGKQPFF-WLEN---KDVIGVLEKGDRLPKPDLCPPVLYTLMTR- 245
Query: 725 CIQEDPSHRPTMRRVTQMLEGVVEV 749
           C   DPS RP    +   L  V ++
Sbjct: 246 CWDYDPSDRPRFTELVCSLSDVYQM 270

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 115/254 (45%), Gaps = 22/254 (8%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK---AEVNGIGQTHHKNLVRL 545
           E+G G+FG VY    ++ +S+ VA+KK++   + S ++++    EV  + +  H N ++ 
Sbjct: 61  EIGHGSFGAVYFA-RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLR-TEIVMGIARGLFYLHEECCTQI 604
            G         LV E+   G+ +  L    KP  ++    +  G  +GL YLH      +
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 175
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM---PI 661
           IH D+K  NILL +    ++ DFG   ++            GT  ++APE    M     
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMAPEVILAMDEGQY 230
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV 721
             KVDV+S G+  +E +  R+  L    ++      L  + +N+  A+      + F   
Sbjct: 231 DGKVDVWSLGITCIE-LAERKPPL----FNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285
Query: 722 AIWCIQEDPSHRPT 735
              C+Q+ P  RPT
Sbjct: 286 VDSCLQKIPQDRPT 299

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 9/197 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLV 543
            ++ +G+G F  V K   ++ +  +VAVK +++   +  S ++   EV  +   +H N+V
Sbjct: 19  LQKTIGKGNFAKV-KLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +L    +  +   LV E+ S G +  +L    +   K        I   + Y H++    
Sbjct: 78  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY--- 134
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT- 662
           I+H D+K +N+LLD   N +I+DFG     T+          G+  Y APE F+      
Sbjct: 135 IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC--GSPPYAAPELFQGKKYDG 192
Query: 663 VKVDVYSYGVLLLEIIC 679
            +VDV+S GV+L  ++ 
Sbjct: 193 PEVDVWSLGVILYTLVS 209

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 10  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 65
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+S        AS L G   P   L    +  + +GL + H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 122
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KP+N+L++     +++DFGL +            +R     V   W+R 
Sbjct: 123 H---RVLHRDLKPENLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 172
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 222

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 12  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 67
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+S        AS L G   P   L    +  + +GL + H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 124
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KP+N+L++     +++DFGL +            +R     V   W+R 
Sbjct: 125 H---RVLHRDLKPENLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 174
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 121/265 (45%), Gaps = 33/265 (12%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+ +L       + KE   E   +    + ++ RL
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 117 LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 170
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +       G V  +W     I
Sbjct: 171 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH----AEGGKVPIKWMALESI 225
Query: 662 TVKV-----DVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN--DLEAMDDMTV 714
             ++     DV+SYGV + E++           YD      + +++E    L      T+
Sbjct: 226 LHRIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTI 280
Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRV 739
               +MV  W I  D   RP  R +
Sbjct: 281 DVYMIMVKCWMI--DADSRPKFREL 303

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 68/125 (54%), Gaps = 5/125 (4%)
Query: 560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY 619
           E M  G+L   L    +   ++  ++ + + RGL YL E+   QI+H D+KP NIL++  
Sbjct: 94  EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSR 151
Query: 620 YNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
              ++ DFG+   L    S  N+ + GT+ Y+APE  +    +V+ D++S G+ L+E+  
Sbjct: 152 GEIKLCDFGVSGQLI--DSMANSFV-GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAV 208
Query: 680 LRRTI 684
            R  I
Sbjct: 209 GRYPI 213

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 86/193 (44%), Gaps = 10/193 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---KEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   VA+K L +   + E    + + E+      HH N++RL 
Sbjct: 31  LGKGKFGNVYLA-REKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLY 89
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
            Y  + R   L+ E+   G L   L      + +    I+  +A  L Y H +   ++IH
Sbjct: 90  NYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGK---KVIH 146
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            DIKP+N+LL      +I+DFG         S     + GT  Y+ PE         KVD
Sbjct: 147 RDIKPENLLLGLKGELKIADFGWS---VHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVD 203
Query: 667 VYSYGVLLLEIIC 679
           ++  GVL  E++ 
Sbjct: 204 LWCIGVLCYELLV 216

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 124/276 (44%), Gaps = 27/276 (9%)
Query: 490 LGRGAFGTVYKGFVNM--GSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG+G FG+V +  +    GS  +VAVK L    +     +EF  E   + +  H ++ +L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 546 LGYCDEGRNR------LLVYEFMSNGALASFLF----GDSKPNWKLRTEI--VMGIARGL 593
           +G     R +      +++  FM +G L +FL     G++  N  L+T +  ++ IA G+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL-EKLLTLDQSHTNTAIRGTKGYVA 652
            YL        IH D+  +N +L +     ++DFGL  K+ + D      A +    ++A
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 653 PEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQERTLGALVENDLEAMDD 711
            E   +   TV  DV+++GV + EI+   +T        + Y     G  ++   E M++
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEE 267
Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV 747
           +  L         C   DP  RP+   +   LE ++
Sbjct: 268 VYDLM------YQCWSADPKQRPSFTCLRMELENIL 297

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 9/193 (4%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G+G F  V K   ++ +  +VA+K +++   +  S ++   EV  +   +H N+V+L  
Sbjct: 23  IGKGNFAKV-KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
             +  +   L+ E+ S G +  +L    +   K        I   + Y H++   +I+H 
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHR 138
Query: 608 DIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT-VKVD 666
           D+K +N+LLD   N +I+DFG     T+       A  G   Y APE F+       +VD
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFCGAPPYAAPELFQGKKYDGPEVD 196
Query: 667 VYSYGVLLLEIIC 679
           V+S GV+L  ++ 
Sbjct: 197 VWSLGVILYTLVS 209

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           KE +G G++    K  V+  ++ + AVK +++  +D  +E +  +   GQ  H N++ L 
Sbjct: 32  KETIGVGSYSEC-KRCVHKATNMEYAVKVIDKSKRDPSEEIEILLR-YGQ--HPNIITLK 87
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
              D+G++  LV E M  G L   +      + +  + ++  I + + YLH +    ++H
Sbjct: 88  DVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVH 144
Query: 607 CDIKPQNIL-LDDYYNA---RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            D+KP NIL +D+  N    RI DFG  K L  +     T    T  +VAPE  +     
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYD 203
Query: 663 VKVDVYSYGVLLLEIIC 679
              D++S G+LL  ++ 
Sbjct: 204 EGCDIWSLGILLYTMLA 220

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 115/254 (45%), Gaps = 22/254 (8%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK---AEVNGIGQTHHKNLVRL 545
           E+G G+FG VY    ++ +S+ VA+KK++   + S ++++    EV  + +  H N ++ 
Sbjct: 22  EIGHGSFGAVYFA-RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLR-TEIVMGIARGLFYLHEECCTQI 604
            G         LV E+   G+ +  L    KP  ++    +  G  +GL YLH      +
Sbjct: 81  RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 136
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM---PI 661
           IH D+K  NILL +    ++ DFG   ++            GT  ++APE    M     
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMAPEVILAMDEGQY 191
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV 721
             KVDV+S G+  +E +  R+  L    ++      L  + +N+  A+      + F   
Sbjct: 192 DGKVDVWSLGITCIE-LAERKPPL----FNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246
Query: 722 AIWCIQEDPSHRPT 735
              C+Q+ P  RPT
Sbjct: 247 VDSCLQKIPQDRPT 260

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           KE +G G++    K  V+  ++ + AVK +++  +D  +E +  +   GQ  H N++ L 
Sbjct: 32  KETIGVGSYSEC-KRCVHKATNMEYAVKVIDKSKRDPSEEIEILLR-YGQ--HPNIITLK 87
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
              D+G++  LV E M  G L   +      + +  + ++  I + + YLH +    ++H
Sbjct: 88  DVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVH 144
Query: 607 CDIKPQNIL-LDDYYNA---RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            D+KP NIL +D+  N    RI DFG  K L  +     T    T  +VAPE  +     
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYD 203
Query: 663 VKVDVYSYGVLLLEIIC 679
              D++S G+LL  ++ 
Sbjct: 204 EGCDIWSLGILLYTMLA 220

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 121/275 (44%), Gaps = 41/275 (14%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E +G G FG V+K    +     V    + RV  ++EK  + EV  + +  H N+V   G
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYV----IKRVKYNNEKA-EREVKALAKLDHVNIVHYNG 71
Query: 548 YCD------------EGRNR----LLVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGI 589
             D              R++     +  EF   G L  ++      K +  L  E+   I
Sbjct: 72  CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQI 131
Query: 590 ARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
            +G+ Y+H +   ++I+ D+KP NI L D    +I DFGL  + +L         +GT  
Sbjct: 132 TKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGL--VTSLKNDGKRXRSKGTLR 186
Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT-LGALVENDLEA 708
           Y++PE   +     +VD+Y+ G++L E++      + D A++  +  T L   + +D+  
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLH-----VCDTAFETSKFFTDLRDGIISDIFD 241
Query: 709 MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQML 743
             + T+LQ+        + + P  RP    + + L
Sbjct: 242 KKEKTLLQKL-------LSKKPEDRPNTSEILRTL 269

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 10/218 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           EELG+GAF  V +  + + +  + A K +N  ++     ++ + E        H N+VRL
Sbjct: 10  EELGKGAFSVVRR-CMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL 68
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
                E     LV++ ++ G L   +      +    +  +  I   + + H      I+
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCH---LNGIV 125
Query: 606 HCDIKPQNILLDDYYNA---RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           H D+KP+N+LL         +++DFGL   +  DQ        GT GY++PE  R  P  
Sbjct: 126 HRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGYLSPEVLRKDPYG 184
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGA 700
             VD+++ GV+L  ++        +  +  YQ+   GA
Sbjct: 185 KPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 222

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 122/288 (42%), Gaps = 54/288 (18%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E +G G FG V+K    +     V    + RV  ++EK  + EV  + +  H N+V   G
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYV----IRRVKYNNEKA-EREVKALAKLDHVNIVHYNG 72
Query: 548 YCD-------------------------EGRNR----LLVYEFMSNGALASFLFGD--SK 576
             D                           R++     +  EF   G L  ++      K
Sbjct: 73  CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 132
Query: 577 PNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD 636
            +  L  E+   I +G+ Y+H +   ++IH D+KP NI L D    +I DFGL  + +L 
Sbjct: 133 LDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGL--VTSLK 187
Query: 637 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER 696
                T  +GT  Y++PE   +     +VD+Y+ G++L E++      + D A++  +  
Sbjct: 188 NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH-----VCDTAFETSKFF 242
Query: 697 T-LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQML 743
           T L   + +D+    + T+LQ+        + + P  RP    + + L
Sbjct: 243 TDLRDGIISDIFDKKEKTLLQKL-------LSKKPEDRPNTSEILRTL 283

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 11/219 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           ELG G  G V+K  V+   S  V  +KL    +      +   E+  + + +   +V   
Sbjct: 75  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 132
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           G         +  E M  G+L   L    +   ++  ++ + + +GL YL E+   +I+H
Sbjct: 133 GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 190
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D+KP NIL++     ++ DFG+   L    S  N+ + GT+ Y++PE  +    +V+ D
Sbjct: 191 RDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGTHYSVQSD 247
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND 705
           ++S G+ L+E+   R  I    A +   E   G  VE D
Sbjct: 248 IWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGD 284

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 9   EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 64
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KP+N+L++     +++DFGL +            +R     V   W+R 
Sbjct: 122 H---RVLHRDLKPENLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 171
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 10  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 65
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 122
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KP+N+L++     +++DFGL +            +R     V   W+R 
Sbjct: 123 H---RVLHRDLKPENLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 172
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 222

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA-----EVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 11  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 66
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 123
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KP+N+L++     +++DFGL +            +R     V   W+R 
Sbjct: 124 H---RVLHRDLKPENLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 173
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 223

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 11/194 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 546
           +G+G F  V K   ++ +  +VAVK +++   +S   +K F+ EV  +   +H N+V+L 
Sbjct: 15  IGKGNFAKV-KLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 72
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
              +  +   LV E+ S G +  +L        K        I   + Y H++    I+H
Sbjct: 73  EVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF---IVH 129
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT-VKV 665
            D+K +N+LLD   N +I+DFG     T           G+  Y APE F+       +V
Sbjct: 130 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPELFQGKKYDGPEV 187
Query: 666 DVYSYGVLLLEIIC 679
           DV+S GV+L  ++ 
Sbjct: 188 DVWSLGVILYTLVS 201

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 491 GRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLLGYC 549
            RG FG V+K  +    +D VAVK      QD +  + + E+       H+NL++ +   
Sbjct: 24  ARGRFGCVWKAQL---MNDFVAVKIFP--LQDKQSWQSEREIFSTPGMKHENLLQFIAAE 78
Query: 550 DEGRNR----LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC--C-- 601
             G N      L+  F   G+L  +L G+    W     +   ++RGL YLHE+   C  
Sbjct: 79  KRGSNLEVELWLITAFHDKGSLTDYLKGNII-TWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 602 ----TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR-GTKGYVAPEWF 656
                 I H D K +N+LL     A ++DFGL       +   +T  + GT+ Y+APE  
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVL 197
Query: 657 R-----NMPITVKVDVYSYGVLLLEII 678
                      +++D+Y+ G++L E++
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 10/196 (5%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQ-VAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           ++LG GA+G V      +   ++ + + +   V   S  +   EV  +    H N+++L 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
            + ++ RN  LV E    G L   +    K N      I+  +  G+ YLH+     I+H
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVH 159
Query: 607 CDIKPQNILLDDYYN---ARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            D+KP+N+LL+        +I DFGL  +   +Q      + GT  Y+APE  R      
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERL-GTAYYIAPEVLRK-KYDE 216
Query: 664 KVDVYSYGVLLLEIIC 679
           K DV+S GV+L  ++ 
Sbjct: 217 KCDVWSIGVILFILLA 232

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 10/218 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           EELG+GAF  V +  + + +  + A K +N  ++     ++ + E        H N+VRL
Sbjct: 10  EELGKGAFSVVRRC-MKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL 68
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
                E     LV++ ++ G L   +      +    +  +  I   + + H      I+
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCH---LNGIV 125
Query: 606 HCDIKPQNILLDDYYNA---RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           H D+KP+N+LL         +++DFGL   +  DQ        GT GY++PE  R  P  
Sbjct: 126 HRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ-AWFGFAGTPGYLSPEVLRKDPYG 184
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGA 700
             VD+++ GV+L  ++        +  +  YQ+   GA
Sbjct: 185 KPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 222

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 11/219 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           ELG G  G V+K  V+   S  V  +KL    +      +   E+  + + +   +V   
Sbjct: 13  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           G         +  E M  G+L   L    +   ++  ++ + + +GL YL E+   +I+H
Sbjct: 71  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 128
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D+KP NIL++     ++ DFG+   L    S  N+ + GT+ Y++PE  +    +V+ D
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGTHYSVQSD 185
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND 705
           ++S G+ L+E+   R  I    A +   E   G  VE D
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGD 222

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 9/193 (4%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G+G F  V K   ++ +  +VA+K +++   +  S ++   EV  +   +H N+V+L  
Sbjct: 20  IGKGNFAKV-KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 78
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
             +  +   L+ E+ S G +  +L    +   K        I   + Y H++   +I+H 
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHR 135
Query: 608 DIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT-VKVD 666
           D+K +N+LLD   N +I+DFG     T+          G+  Y APE F+       +VD
Sbjct: 136 DLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC--GSPPYAAPELFQGKKYDGPEVD 193
Query: 667 VYSYGVLLLEIIC 679
           V+S GV+L  ++ 
Sbjct: 194 VWSLGVILYTLVS 206

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 85/203 (41%), Gaps = 30/203 (14%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH----------- 538
           LG+G FG VY           +A +K N+     +  FK+++   G  H           
Sbjct: 22  LGKGKFGNVY-----------LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 539 --HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYL 596
             H N++R+  Y  + +   L+ EF   G L   L    + + +     +  +A  L Y 
Sbjct: 71  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 130
Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
           HE    ++IH DIKP+N+L+      +I+DFG         S     + GT  Y+ PE  
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRXMCGTLDYLPPEMI 184
Query: 657 RNMPITVKVDVYSYGVLLLEIIC 679
                  KVD++  GVL  E + 
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLV 207

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 90/191 (47%), Gaps = 13/191 (6%)
Query: 490 LGRGAFGTVY--KGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVRLL 546
           LG+G+FG V   K  +  G    V V    +V Q ++KE    EV  + Q  H N+++L 
Sbjct: 34  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
            + ++     LV E  + G L   +    + +      I+  +  G+ Y+H+    +I+H
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVH 149
Query: 607 CDIKPQNILLDDY---YNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            D+KP+N+LL+      N RI DFGL       +   +    GT  Y+APE         
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEVLHG-TYDE 206
Query: 664 KVDVYSYGVLL 674
           K DV+S GV+L
Sbjct: 207 KCDVWSTGVIL 217

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 85/203 (41%), Gaps = 30/203 (14%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH----------- 538
           LG+G FG VY           +A +K N+     +  FK+++   G  H           
Sbjct: 23  LGKGKFGNVY-----------LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 71
Query: 539 --HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYL 596
             H N++R+  Y  + +   L+ EF   G L   L    + + +     +  +A  L Y 
Sbjct: 72  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 131
Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
           HE    ++IH DIKP+N+L+      +I+DFG         S     + GT  Y+ PE  
Sbjct: 132 HER---KVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRXMCGTLDYLPPEMI 185
Query: 657 RNMPITVKVDVYSYGVLLLEIIC 679
                  KVD++  GVL  E + 
Sbjct: 186 EGKTHDEKVDLWCAGVLCYEFLV 208

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 25/225 (11%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+ K+     D+E E        E++ + + +H N+
Sbjct: 9   EKIGEGTYGVVYKA-RNKLTGEVVALXKIR---LDTETEGVPSTAIREISLLKELNHPNI 64
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR 657
               +++H D+KPQN+L++     +++DFGL +   +  +++T+  +  T  Y APE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 658 NMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
                +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 25/225 (11%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+ K+     D+E E        E++ + + +H N+
Sbjct: 8   EKIGEGTYGVVYKA-RNKLTGEVVALXKIR---LDTETEGVPSTAIREISLLKELNHPNI 63
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+EF+         AS L G   P   L    +  + +GL + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 120
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR 657
               +++H D+KPQN+L++     +++DFGL +   +  +++T+  +  T  Y APE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 658 NMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
                +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNLVR 544
           LG G F TVYK   +  ++  VA+KK+    +   K+        E+  + +  H N++ 
Sbjct: 18  LGEGQFATVYKA-RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDS---KPNWKLRTEIVMGIARGLFYLHEECC 601
           LL       N  LV++FM    L   +  +S    P+  ++  ++M + +GL YLH+   
Sbjct: 77  LLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPS-HIKAYMLMTL-QGLEYLHQHW- 132
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLL-TLDQSHTNTAIRGTKGYVAPE-WFRNM 659
             I+H D+KP N+LLD+    +++DFGL K   + ++++ +  +  T+ Y APE  F   
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPELLFGAR 188
Query: 660 PITVKVDVYSYGVLLLEII 678
              V VD+++ G +L E++
Sbjct: 189 MYGVGVDMWAVGCILAELL 207

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 90/191 (47%), Gaps = 13/191 (6%)
Query: 490 LGRGAFGTVY--KGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVRLL 546
           LG+G+FG V   K  +  G    V V    +V Q ++KE    EV  + Q  H N+++L 
Sbjct: 58  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
            + ++     LV E  + G L   +    + +      I+  +  G+ Y+H+    +I+H
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVH 173
Query: 607 CDIKPQNILLDDY---YNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            D+KP+N+LL+      N RI DFGL       +   +    GT  Y+APE         
Sbjct: 174 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEVLHG-TYDE 230
Query: 664 KVDVYSYGVLL 674
           K DV+S GV+L
Sbjct: 231 KCDVWSTGVIL 241

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 118/274 (43%), Gaps = 27/274 (9%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           ELG G  G V+K  V+   S  V  +KL    +      +   E+  + + +   +V   
Sbjct: 40  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           G         +  E M  G+L   L    +   ++  ++ + + +GL YL E+   +I+H
Sbjct: 98  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 155
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D+KP NIL++     ++ DFG+   L    S  N+ + GT+ Y++PE  +    +V+ D
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGTHYSVQSD 212
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND-----LEAMDDMTVLQRFVMV 721
           ++S G+ L+E+   R  I    A +   E   G  VE D              L +F M 
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGDAAETPPRPRTPGRPLNKFGM- 269
Query: 722 AIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCP 755
                      RP M  + ++L+ +V  P P  P
Sbjct: 270 ---------DSRPPM-AIFELLDYIVNEPPPKLP 293

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 11/219 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           ELG G  G V+K  V+   S  V  +KL    +      +   E+  + + +   +V   
Sbjct: 13  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           G         +  E M  G+L   L    +   ++  ++ + + +GL YL E+   +I+H
Sbjct: 71  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 128
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D+KP NIL++     ++ DFG+   L    S  N+ + GT+ Y++PE  +    +V+ D
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGTHYSVQSD 185
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND 705
           ++S G+ L+E+   R  I    A +   E   G  VE D
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGD 222

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 123/263 (46%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L++ + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 85  LGICLTSTVQLIM-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 138
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFG  KLL  ++   +    G K    ++A E   +
Sbjct: 139 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA--EGGKVPIKWMALESILH 195
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 250
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +M   W I  D   RP  R +
Sbjct: 251 YMIMRKCWMI--DADSRPKFREL 271

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 90/191 (47%), Gaps = 13/191 (6%)
Query: 490 LGRGAFGTVY--KGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVRLL 546
           LG+G+FG V   K  +  G    V V    +V Q ++KE    EV  + Q  H N+++L 
Sbjct: 57  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
            + ++     LV E  + G L   +    + +      I+  +  G+ Y+H+    +I+H
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVH 172
Query: 607 CDIKPQNILLDDY---YNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            D+KP+N+LL+      N RI DFGL       +   +    GT  Y+APE         
Sbjct: 173 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEVLHG-TYDE 229
Query: 664 KVDVYSYGVLL 674
           K DV+S GV+L
Sbjct: 230 KCDVWSTGVIL 240

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 90/191 (47%), Gaps = 13/191 (6%)
Query: 490 LGRGAFGTVY--KGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVRLL 546
           LG+G+FG V   K  +  G    V V    +V Q ++KE    EV  + Q  H N+++L 
Sbjct: 40  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
            + ++     LV E  + G L   +    + +      I+  +  G+ Y+H+    +I+H
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVH 155
Query: 607 CDIKPQNILLDDY---YNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            D+KP+N+LL+      N RI DFGL       +   +    GT  Y+APE         
Sbjct: 156 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEVLHG-TYDE 212
Query: 664 KVDVYSYGVLL 674
           K DV+S GV+L
Sbjct: 213 KCDVWSTGVIL 223

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 37/207 (17%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   + +     +VAVKKL+R FQ     +    E+  +    H+N++ LL 
Sbjct: 36  VGSGAYGSVCSAY-DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLD 94
Query: 548 Y------CDEGRNRLLVYEFMS---NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
                   ++     LV   M    N  + S    D    +     +V  + RGL Y+H 
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-----LVYQLLRGLKYIH- 148
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
                IIH D+KP N+ +++    RI DFGL +    D+  T        GYVA  W+R 
Sbjct: 149 --SAGIIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMT--------GYVATRWYRA 196
Query: 659 MPITVK-------VDVYSYGVLLLEII 678
             I +        VD++S G ++ E++
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 11/219 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           ELG G  G V+K  V+   S  V  +KL    +      +   E+  + + +   +V   
Sbjct: 13  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           G         +  E M  G+L   L    +   ++  ++ + + +GL YL E+   +I+H
Sbjct: 71  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 128
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D+KP NIL++     ++ DFG+   L    S  N+ + GT+ Y++PE  +    +V+ D
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGTHYSVQSD 185
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND 705
           ++S G+ L+E+   R  I    A +   E   G  VE D
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGD 222

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 11/219 (5%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           ELG G  G V+K  V+   S  V  +KL    +      +   E+  + + +   +V   
Sbjct: 13  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           G         +  E M  G+L   L    +   ++  ++ + + +GL YL E+   +I+H
Sbjct: 71  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 128
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D+KP NIL++     ++ DFG+   L    S  N+ + GT+ Y++PE  +    +V+ D
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGTHYSVQSD 185
Query: 667 VYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND 705
           ++S G+ L+E+   R  I    A +   E   G  VE D
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGD 222

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 122/263 (46%), Gaps = 29/263 (11%)
Query: 490 LGRGAFGTVYKG-FVNMGSSDQ--VAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 545
           LG GAFGTVYKG ++  G   +  VA+K+L       + KE   E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEECC 601
           LG C     +L+  + M  G L  ++  + K N  + ++ ++     IA+G+ YL +   
Sbjct: 85  LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDN--IGSQYLLNWCVQIAKGMNYLEDR-- 138
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 658
            +++H D+  +N+L+    + +I+DFG  KLL  ++   +    G K    ++A E   +
Sbjct: 139 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA--EGGKVPIKWMALESILH 195
Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQ 716
              T + DV+SYGV + E++           YD      + +++E    L      T+  
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTIDV 250
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
             +M   W I  D   RP  R +
Sbjct: 251 YMIMRKCWMI--DADSRPKFREL 271

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVA--VKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           ++LG GA+G V      +  +++    +KK +     +      EV  + Q  H N+++L
Sbjct: 27  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
             + ++ RN  LV E    G L   +    K +      I+  +  G  YLH+     I+
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH---NIV 143
Query: 606 HCDIKPQNILLDDYYN---ARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           H D+KP+N+LL+        +I DFGL     +          GT  Y+APE  R     
Sbjct: 144 HRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL--GTAYYIAPEVLRK-KYD 200
Query: 663 VKVDVYSYGVLLLEIIC 679
            K DV+S GV+L  ++C
Sbjct: 201 EKCDVWSCGVILYILLC 217

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 35/206 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   + +     +VAVKKL+R FQ     +    E+  +    H+N++ LL 
Sbjct: 36  VGSGAYGSVCSAY-DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLD 94
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                 +     E  S   L + L G    N      L  E    +V  + RGL Y+H  
Sbjct: 95  VFTPATS----IEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH-- 148
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    RI DFGL +    D+  T        GYVA  W+R  
Sbjct: 149 -SAGIIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMT--------GYVATRWYRAP 197
Query: 660 PITVK-------VDVYSYGVLLLEII 678
            I +        VD++S G ++ E++
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKE-FKAEVNGIGQTHHKNL 542
           F   LG+G+FG V    V   + D  AVK L +  + QD + E    E   +    +   
Sbjct: 27  FIRVLGKGSFGKVMLARVK-ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 85
Query: 543 VRLLGYCDEGRNRLL-VYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEEC 600
           +  L  C +  +RL  V EF++ G L  F    S+   + R       I   L +LH++ 
Sbjct: 86  LTQLFCCFQTPDRLFFVMEFVNGGDLM-FHIQKSRRFDEARARFYAAEIISALMFLHDK- 143
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              II+ D+K  N+LLD   + +++DFG+ K    +   T T   GT  Y+APE  + M 
Sbjct: 144 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEILQEML 200
Query: 661 ITVKVDVYSYGVLLLEIIC 679
               VD ++ GVLL E++C
Sbjct: 201 YGPAVDWWAMGVLLYEMLC 219

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAV----KKLN-RVFQDSEKEFKAEVNGIGQTHHKNL 542
           EELG+GAF  V +    +   +  A+    KKL+ R  Q  E+E  A +  + +  H N+
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE--ARICRLLK--HPNI 72
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           VRL     E  +  L+++ ++ G L   +      +    +  +  I   + + H+    
Sbjct: 73  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---M 129
Query: 603 QIIHCDIKPQNILLDDYYNA---RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
            ++H ++KP+N+LL         +++DFGL   +  +Q        GT GY++PE  R  
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKD 188
Query: 660 PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGA 700
           P    VD+++ GV+L  ++        +  +  YQ+   GA
Sbjct: 189 PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 229

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 97/218 (44%), Gaps = 10/218 (4%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           E++G+GAF  V +  V + +  + A K +N  ++     ++ + E        H N+VRL
Sbjct: 10  EDIGKGAFSVVRR-CVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRL 68
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
                E     LV++ ++ G L   +      +    +  +  I   + + H+     ++
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVV 125
Query: 606 HCDIKPQNILLDDYYNA---RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           H D+KP+N+LL         +++DFGL   +  DQ        GT GY++PE  R     
Sbjct: 126 HRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQ-AWFGFAGTPGYLSPEVLRKEAYG 184
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGA 700
             VD+++ GV+L  ++        +  +  YQ+   GA
Sbjct: 185 KPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGA 222

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 118/275 (42%), Gaps = 33/275 (12%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           E +G+G FG VY G  +     +VA++ ++  R  +D  K FK EV    QT H+N+V  
Sbjct: 39  ELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLFYLHEECCTQ 603
           +G C    +  ++        L S +  D+K    +    +I   I +G+ YLH      
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYS-VVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLL-TLDQSHTNTAIRGTKGY---VAPEWFRN- 658
           I+H D+K +N+  D+     I+DFGL  +   L        +R   G+   +APE  R  
Sbjct: 151 ILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 659 --------MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEA-M 709
                   +P +   DV++ G +  E+         +W +       +   +   ++  +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHA------REWPFKTQPAEAIIWQMGTGMKPNL 263
Query: 710 DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
             + + +    + ++C   +   RPT  ++  MLE
Sbjct: 264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   +  +   + VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVVAAYDAILERN-VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN 90
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  +V E M +N +    +  D +    L  ++++GI     +LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIK----HLH--- 143
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 144 SAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 661 ITVKVDVYSYGVLLLEII 678
               VD++S GV++ E+I
Sbjct: 202 YKENVDIWSVGVIMGEMI 219

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 35  IGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYXQRTLREIKILLRFRHENII---GI 90
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 136
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 137 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 87/193 (45%), Gaps = 8/193 (4%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS--EKEFKAEVNGIGQTHHKNLVRLL 546
           ++G G++G V+K   N  +   VA+KK      D   +K    E+  + Q  H NLV LL
Sbjct: 10  KIGEGSYGVVFKC-RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
                 R   LV+E+  +  L             L   I     + + + H+  C   IH
Sbjct: 69  EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC---IH 125
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR-NMPITVKV 665
            D+KP+NIL+  +   ++ DFG  +LLT    + +  +  T+ Y +PE    +      V
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATRWYRSPELLVGDTQYGPPV 184
Query: 666 DVYSYGVLLLEII 678
           DV++ G +  E++
Sbjct: 185 DVWAIGCVFAELL 197

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 31/213 (14%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVK-----KLNRVFQDSEKEFKAEVNGIGQTHHKNL 542
           E +G+GAF  V +  +N  +  Q AVK     K       S ++ K E +      H ++
Sbjct: 30  EVIGKGAFSVVRRC-INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL---------ASFLFGDSKPNWKLRTEIVMGIARGL 593
           V LL          +V+EFM    L         A F++ ++  +  +R      I   L
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ-----ILEAL 143
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNA---RISDFGLEKLLTLDQSHTNTAIR-GTKG 649
            Y H+     IIH D+KP+N+LL    N+   ++ DFG+   + L +S      R GT  
Sbjct: 144 RYCHD---NNIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRVGTPH 198
Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEII--CL 680
           ++APE  +  P    VDV+  GV+L  ++  CL
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 11/190 (5%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E LG G FG V+K      +  ++A K +       ++E K E++ + Q  H NL++L  
Sbjct: 95  EILGGGRFGQVHKC-EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEECCTQIIH 606
             +   + +LV E++  G L   +  +S    +L T + M  I  G+ ++H+     I+H
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILH 210
Query: 607 CDIKPQNILL--DDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            D+KP+NIL    D    +I DFGL +     ++   N    GT  ++APE      ++ 
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLAPEVVNYDFVSF 267
Query: 664 KVDVYSYGVL 673
             D++S GV+
Sbjct: 268 PTDMWSVGVI 277

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 35/206 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G GA+G+V   + +     +VAVKKL+R FQ     +    E+  +    H+N++ LL 
Sbjct: 28  VGSGAYGSVCSAY-DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLD 86
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPN----WKLRTE----IVMGIARGLFYLHEE 599
                 +     E  S   L + L G    N      L  E    +V  + RGL Y+H  
Sbjct: 87  VFTPATS----IEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH-- 140
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH D+KP N+ +++    RI DFGL +    D+  T        GYVA  W+R  
Sbjct: 141 -SAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADEEMT--------GYVATRWYRAP 189
Query: 660 PITVK-------VDVYSYGVLLLEII 678
            I +        VD++S G ++ E++
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELL 215

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 25/225 (11%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 8   EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 63
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+E +         AS L G   P   L    +  + +GL + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 120
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR 657
               +++H D+KPQN+L++     +++DFGL +   +  +++T+  +  T  Y APE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 658 NMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
                +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 28/219 (12%)
Query: 483 TRGF------KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---------FQDSEKEF 527
           T GF      KE LGRG   +V +  ++  +  + AVK ++            Q+  +  
Sbjct: 12  THGFYENYEPKEILGRGV-SSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 528 KAEVNGIGQTH-HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIV 586
             EV+ + +   H N+++L    +      LV++ M  G L  +L      + K   +I+
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 587 MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG 646
             +   +  LH+     I+H D+KP+NILLDD  N +++DFG      LD      ++ G
Sbjct: 131 RALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPGEKLRSVCG 185
Query: 647 TKGYVAPEWFR-----NMPITVK-VDVYSYGVLLLEIIC 679
           T  Y+APE        N P   K VD++S GV++  ++ 
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 41/221 (18%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG+GAFG V K   N   S   A+KK+ R  ++      +EV  +   +H+ +VR     
Sbjct: 14  LGQGAFGQVVKA-RNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVVRYYAAW 71
Query: 550 DEGRN-------------RLLVYEFMSNGALASFLFGDS-----KPNWKLRTEIVMGIAR 591
            E RN               +  E+  N  L   +  ++        W+L  +I+  ++ 
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS- 130
Query: 592 GLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK-------LLTLD------QS 638
              Y+H +    IIH ++KP NI +D+  N +I DFGL K       +L LD       S
Sbjct: 131 ---YIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 639 HTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEII 678
              T+  GT  YVA E          K+D YS G++  E I
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVA--VKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           ++LG GA+G V      +  +++    +KK +     +      EV  + Q  H N+++L
Sbjct: 10  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
             + ++ RN  LV E    G L   +    K +      I+  +  G  YLH+     I+
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH---NIV 126
Query: 606 HCDIKPQNILLDDYYN---ARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           H D+KP+N+LL+        +I DFGL     +          GT  Y+APE  R     
Sbjct: 127 HRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL--GTAYYIAPEVLRK-KYD 183
Query: 663 VKVDVYSYGVLLLEIIC 679
            K DV+S GV+L  ++C
Sbjct: 184 EKCDVWSCGVILYILLC 200

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS--EKEFKAEVNGIGQTHHKNLVRL 545
           + +G GA+G V    V+  +  +VA+KKL R FQ     K    E+  +    H+N++ L
Sbjct: 31  QPVGSGAYGAVCSA-VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGL 89
Query: 546 LGY------CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
           L         D+  +  LV  FM  G     L    K        +V  + +GL Y+H  
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH-- 145
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG---TKGYVAPEWF 656
               IIH D+KP N+ +++    +I DFGL +         ++ + G   T+ Y APE  
Sbjct: 146 -AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QADSEMXGXVVTRWYRAPEVI 197
Query: 657 RN-MPITVKVDVYSYGVLLLEIIC 679
            N M  T  VD++S G ++ E+I 
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMIT 221

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 118/269 (43%), Gaps = 28/269 (10%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHH-KNLVRLL 546
           E+GRGA+G+V K  V+  S   +AVK++     + E K+   +++ + ++     +V+  
Sbjct: 29  EIGRGAYGSVNK-MVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 547 GYCDEGRNRLLVYEFMSNG-----ALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           G      +  +  E MS            +  D  P  ++  +I +   + L +L E   
Sbjct: 88  GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPE-EILGKITLATVKALNHLKENL- 145
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF----R 657
            +IIH DIKP NILLD   N ++ DFG+   L    + T  A  G + Y+APE       
Sbjct: 146 -KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERIDPSAS 202
Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDW--AYDCYQERTLGALVEND---LEAMDDM 712
                V+ DV+S G+ L E +   R     W   +D      L  +V+ D   L   ++ 
Sbjct: 203 RQGYDVRSDVWSLGITLYE-LATGRFPYPKWNSVFD-----QLTQVVKGDPPQLSNSEER 256
Query: 713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQ 741
                F+     C+ +D S RP  + + +
Sbjct: 257 EFSPSFINFVNLCLTKDESKRPKYKELLK 285

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---KEFKAEVNGIGQTHHKNLVR 544
           E++G G +GTV+K   N  + + VA+K++ R+  D E        E+  + +  HKN+VR
Sbjct: 8   EKIGEGTYGTVFKA-KNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVR 65
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L       +   LV+EF        F   +   + ++    +  + +GL + H      +
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NV 122
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           +H D+KPQN+L++     +++DFGL +   +        +R     V   W+R   +   
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAFGI-------PVRCYSAEVVTLWYRPPDVLFG 175
Query: 665 VDVYSYGVLLLEIICL 680
             +YS  + +    C+
Sbjct: 176 AKLYSTSIDMWSAGCI 191

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 51  IGEGAYGMVCSAYDNVNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 106
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE---------IVMGIARGLFYLHEE 599
            D  R   +  E M +  L + L G       L+T+          +  I RGL Y+H  
Sbjct: 107 NDIIRAPTI--EQMKDVYLVTHLMGADLYKL-LKTQHLSNDHICYFLYQILRGLKYIH-- 161
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYVAPEWFR 657
               ++H D+KP N+LL+   + +I DFGL ++   D  HT   T    T+ Y APE   
Sbjct: 162 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 658 NMP-ITVKVDVYSYGVLLLEIICLR 681
           N    T  +D++S G +L E++  R
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           ELG G  G V+K  V+   S  V  +KL    +      +   E+  + + +   +V   
Sbjct: 13  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           G         +  E M  G+L   L    +   ++  ++ + + +GL YL E+   +I+H
Sbjct: 71  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 128
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D+KP NIL++     ++ DFG+   L    S  N+ + GT+ Y++PE  +    +V+ D
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGTHYSVQSD 185
Query: 667 VYSYGVLLLEIICLRRTI 684
           ++S G+ L+E+   R  I
Sbjct: 186 IWSMGLSLVEMAVGRYPI 203

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 40/273 (14%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKL---------NRVFQDSEKEFKAEVNGIGQTHH 539
           ELGRGA+G V K   ++ S   +AVK++          R+  D +   +        T +
Sbjct: 58  ELGRGAYGVVEK-MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 116
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF-----GDSKPNWKLRTEIVMGIARGLF 594
             L R      EG +  +  E M + +L  F       G + P   +  +I + I + L 
Sbjct: 117 GALFR------EG-DVWICMELM-DTSLDKFYKQVIDKGQTIPE-DILGKIAVSIVKALE 167
Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           +LH +    +IH D+KP N+L++     ++ DFG+   L    S   T   G K Y+APE
Sbjct: 168 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DSVAKTIDAGCKPYMAPE 223
Query: 655 W----FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDLEA 708
                      +VK D++S G+ ++E+  LR      + YD +    + L  +VE     
Sbjct: 224 RINPELNQKGYSVKSDIWSLGITMIELAILR------FPYDSWGTPFQQLKQVVEEPSPQ 277
Query: 709 MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ 741
           +        FV     C++++   RPT   + Q
Sbjct: 278 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 310

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 35/230 (15%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA-----EVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+     D+E E        E++ + + +H N+
Sbjct: 12  EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 67
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V+LL          LV+E +         AS L G   P   L    +  + +GL + H 
Sbjct: 68  VKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 124
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +++H D+KPQN+L++     +++DFGL +            +R     V   W+R 
Sbjct: 125 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRA 174
Query: 659 MPI-------TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLG 699
             I       +  VD++S G +  E++  R     D   D      RTLG
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---------FQDSEKEFKAEVNGIGQT 537
           KE LGRG   +V +  ++  +  + AVK ++            Q+  +    EV+ + + 
Sbjct: 9   KEILGRGV-SSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 67
Query: 538 H-HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYL 596
             H N+++L    +      LV++ M  G L  +L      + K   +I+  +   +  L
Sbjct: 68  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICAL 127
Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
           H+     I+H D+KP+NILLDD  N +++DFG      LD       + GT  Y+APE  
Sbjct: 128 HK---LNIVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPGEKLREVCGTPSYLAPEII 182
Query: 657 R-----NMPITVK-VDVYSYGVLLLEIIC 679
                 N P   K VD++S GV++  ++ 
Sbjct: 183 ECSMNDNHPGYGKEVDMWSTGVIMYTLLA 211

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   +  +   + VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN 90
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  +V E M +N +    +  D +    L  ++++GI     +LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIK----HLH--- 143
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 144 SAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 661 ITVKVDVYSYGVLLLEII 678
               VD++S GV++ E+I
Sbjct: 202 YKENVDIWSVGVIMGEMI 219

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 115/263 (43%), Gaps = 19/263 (7%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA----EVNGIGQTHHKN 541
            ++++GRG F  VY+    +     VA+KK+ ++F   + + +A    E++ + Q +H N
Sbjct: 36  IEKKIGRGQFSEVYRAACLLDGVP-VALKKV-QIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFL--FGDSKPNWKLRT--EIVMGIARGLFYLH 597
           +++      E     +V E    G L+  +  F   K     RT  +  + +   L ++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
                +++H DIKP N+ +      ++ D GL +  +   +  ++ + GT  Y++PE   
Sbjct: 154 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 209
Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN-DLEAMDDMTVLQ 716
                 K D++S G LL E+  L+     D   + Y   +L   +E  D   +      +
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLY---SLCKKIEQCDYPPLPSDHYSE 265
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
               +   CI  DP  RP +  V
Sbjct: 266 ELRQLVNMCINPDPEKRPDVTYV 288

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 483 TRGF------KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---------FQDSEKEF 527
           T GF      KE LGRG   +V +  ++  +  + AVK ++            Q+  +  
Sbjct: 12  THGFYENYEPKEILGRGV-SSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 528 KAEVNGIGQTH-HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIV 586
             EV+ + +   H N+++L    +      LV++ M  G L  +L      + K   +I+
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 587 MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG 646
             +   +  LH+     I+H D+KP+NILLDD  N +++DFG      LD       + G
Sbjct: 131 RALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPGEKLREVCG 185
Query: 647 TKGYVAPEWFR-----NMPITVK-VDVYSYGVLLLEIIC 679
           T  Y+APE        N P   K VD++S GV++  ++ 
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 88/191 (46%), Gaps = 13/191 (6%)
Query: 490 LGRGAFGTVY--KGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVRLL 546
           LG+G+FG V   K  +  G    V V    +V Q ++KE    EV  + Q  H N+ +L 
Sbjct: 34  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
            + ++     LV E  + G L   +    + +      I+  +  G+ Y H+    +I+H
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHK---NKIVH 149
Query: 607 CDIKPQNILLDDY---YNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            D+KP+N+LL+      N RI DFGL       +   +    GT  Y+APE         
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI--GTAYYIAPEVLHGT-YDE 206
Query: 664 KVDVYSYGVLL 674
           K DV+S GV+L
Sbjct: 207 KCDVWSTGVIL 217

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR--VFQDSEKE---FKAEVNGIGQTHHKNLV 543
           LG+G+FG V+        ++Q  A+K L +  V  D + E    +  V  +   H   L 
Sbjct: 25  LGKGSFGKVF--LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH-PFLT 81
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
            +        N   V E+++ G L   +    K +    T     I  GL +LH +    
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--- 138
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
           I++ D+K  NILLD   + +I+DFG+ K   L  + TN    GT  Y+APE         
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC-GTPDYIAPEILLGQKYNH 197
Query: 664 KVDVYSYGVLLLEII 678
            VD +S+GVLL E++
Sbjct: 198 SVDWWSFGVLLYEML 212

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 89/194 (45%), Gaps = 9/194 (4%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKE-FKAEVNGIGQTHHKNLVRLL 546
           LG+G+FG V       G+ +  AVK L +  V QD + E    E   +        +  L
Sbjct: 349 LGKGSFGKVMLS-ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 547 GYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
             C +  +RL  V E+++ G L   +    +            IA GLF+L  +    II
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GII 464
Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 665
           + D+K  N++LD   + +I+DFG+ K    D   T     GT  Y+APE     P    V
Sbjct: 465 YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKXFCGTPDYIAPEIIAYQPYGKSV 523
Query: 666 DVYSYGVLLLEIIC 679
           D +++GVLL E++ 
Sbjct: 524 DWWAFGVLLYEMLA 537

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 35  IGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 90
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 136
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 137 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           +G+G+FG V     N  +    A+K +N+   V ++  +    E+  +    H  LV L 
Sbjct: 23  IGKGSFGKVCIVQKN-DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
               +  +  +V + +  G L   L  +     +     +  +   L YL  +   +IIH
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIH 138
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF---RNMPITV 663
            D+KP NILLD++ +  I+DF +  +L  +   T  A  GTK Y+APE F   +    + 
Sbjct: 139 RDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPEMFSSRKGAGYSF 196
Query: 664 KVDVYSYGVLLLEIICLRR 682
            VD +S GV   E++  RR
Sbjct: 197 AVDWWSLGVTAYELLRGRR 215

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR--VFQDSEKE---FKAEVNGIGQTHHKNLV 543
           LG+G+FG V+        ++Q  A+K L +  V  D + E    +  V  +    H  L 
Sbjct: 26  LGKGSFGKVF--LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLT 82
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
            +        N   V E+++ G L   +    K +    T     I  GL +LH +    
Sbjct: 83  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--- 139
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
           I++ D+K  NILLD   + +I+DFG+ K   L  + TN    GT  Y+APE         
Sbjct: 140 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC-GTPDYIAPEILLGQKYNH 198
Query: 664 KVDVYSYGVLLLEII 678
            VD +S+GVLL E++
Sbjct: 199 SVDWWSFGVLLYEML 213

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 36/208 (17%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS--EKEFKAEVNGIGQTHHKNLVRLL 546
            +G GA+G+V    ++  S ++VA+KKL+R FQ     K    E+  +    H+N++ LL
Sbjct: 31  HVGSGAYGSVCSA-IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 547 GYCDEG---RNRL---LVYEFMSNG--ALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
                    RN     LV  FM      +    F + K  +     +V  + +GL Y+H 
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-----LVYQMLKGLKYIH- 143
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
                ++H D+KP N+ +++    +I DFGL +       H +  +    GYV   W+R 
Sbjct: 144 --SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEM---TGYVVTRWYRA 191
Query: 659 -------MPITVKVDVYSYGVLLLEIIC 679
                  M     VD++S G ++ E++ 
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLT 219

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 31  IGEGAYGMVCSAYDNVNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 86
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 132
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 133 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYV 188
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           ELG G  G V+K  V+   S  V  +KL    +      +   E+  + + +   +V   
Sbjct: 32  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 89
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           G         +  E M  G+L   L    +   ++  ++ + + +GL YL E+   +I+H
Sbjct: 90  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 147
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D+KP NIL++     ++ DFG+   L    S  N+ + GT+ Y++PE  +    +V+ D
Sbjct: 148 RDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGTHYSVQSD 204
Query: 667 VYSYGVLLLEIICLRRTI 684
           ++S G+ L+E+   R  I
Sbjct: 205 IWSMGLSLVEMAVGRYPI 222

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 31  IGEGAYGMVCSAYDNVNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 86
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 132
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 133 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 40/273 (14%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKL---------NRVFQDSEKEFKAEVNGIGQTHH 539
           ELGRGA+G V K   ++ S   +AVK++          R+  D +   +        T +
Sbjct: 14  ELGRGAYGVVEK-MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF-----GDSKPNWKLRTEIVMGIARGLF 594
             L R      EG +  +  E M + +L  F       G + P   +  +I + I + L 
Sbjct: 73  GALFR------EG-DVWICMELM-DTSLDKFYKQVIDKGQTIPE-DILGKIAVSIVKALE 123
Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           +LH +    +IH D+KP N+L++     ++ DFG+   L  D +    A  G K Y+APE
Sbjct: 124 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--GCKPYMAPE 179
Query: 655 W----FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDLEA 708
                      +VK D++S G+ ++E+  LR      + YD +    + L  +VE     
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILR------FPYDSWGTPFQQLKQVVEEPSPQ 233
Query: 709 MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ 741
           +        FV     C++++   RPT   + Q
Sbjct: 234 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 488 EELGRGAFGTVYKGFVNMGSSD--QVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLV 543
           +++G G+FG   K  +   + D  Q  +K++N  R+     +E + EV  +    H N+V
Sbjct: 30  QKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIV 86
Query: 544 RLLGYCDEGRNRLLVYEFMSNG-------ALASFLFG-DSKPNWKLRTEIVMGIARGLFY 595
           +     +E  +  +V ++   G       A    LF  D   +W       + I   L +
Sbjct: 87  QYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKH 140
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           +H+    +I+H DIK QNI L      ++ DFG+ ++L          I GT  Y++PE 
Sbjct: 141 VHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEI 196
Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRT 683
             N P   K D+++ G +L E+  L+  
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHA 224

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   F  +   + VAVKKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAFDTVLGIN-VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 90
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  LV E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK----HLHS-- 144
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +    +   T   +  T+ Y APE    M 
Sbjct: 145 -AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILGMG 201
Query: 661 ITVKVDVYSYGVLLLEII 678
               VD++S G ++ E++
Sbjct: 202 YAANVDIWSVGCIMGELV 219

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 31  IGEGAYGMVCSAYDNVNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 86
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 132
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 133 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 36  IGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 91
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 137
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 138 -ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 193
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 37  IGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 92
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 93  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 138
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 139 -ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 194
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 195 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 28  IGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 83
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 84  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 129
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 130 -ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 185
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 186 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 89/194 (45%), Gaps = 9/194 (4%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKE-FKAEVNGIGQTHHKNLVRLL 546
           LG+G+FG V       G+ +  AVK L +  V QD + E    E   +        +  L
Sbjct: 28  LGKGSFGKVMLS-ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 547 GYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
             C +  +RL  V E+++ G L   +    +            IA GLF+L  +    II
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---II 143
Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 665
           + D+K  N++LD   + +I+DFG+ K    D   T     GT  Y+APE     P    V
Sbjct: 144 YRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVTTKXFCGTPDYIAPEIIAYQPYGKSV 202
Query: 666 DVYSYGVLLLEIIC 679
           D +++GVLL E++ 
Sbjct: 203 DWWAFGVLLYEMLA 216

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 35  IGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 90
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 136
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 137 -ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 14/197 (7%)
Query: 489 ELGRGAFGTVYK-GFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHH-KNLVRL 545
           E+G G  G V+K  F   G    +AVK++ R     E K    +++ + ++H    +V+ 
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHV--IAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
            G      +  +  E M   A             ++  ++ + I + L+YL E+    +I
Sbjct: 90  FGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVI 147
Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT--- 662
           H D+KP NILLD+    ++ DFG+   L  D++   +A  G   Y+APE       T   
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPTKPD 205
Query: 663 --VKVDVYSYGVLLLEI 677
             ++ DV+S G+ L+E+
Sbjct: 206 YDIRADVWSLGISLVEL 222

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 29  IGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 84
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 130
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 131 -ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 29  IGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 84
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 130
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 131 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   + +      VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAY-DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLN 90
Query: 548 Y------CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
                   +E ++  LV E M +  L   +    + + +  + ++  +  G+ +LH    
Sbjct: 91  VFTPQKTLEEFQDVYLVMELM-DANLXQVI--QMELDHERMSYLLYQMLXGIKHLH---S 144
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M  
Sbjct: 145 AGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 662 TVKVDVYSYGVLLLEIICLRRTIL 685
              VD++S G ++ E++  R  IL
Sbjct: 203 KENVDIWSVGCIMGEMV--RHKIL 224

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 36/208 (17%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS--EKEFKAEVNGIGQTHHKNLVRLL 546
            +G GA+G+V    ++  S ++VA+KKL+R FQ     K    E+  +    H+N++ LL
Sbjct: 49  HVGSGAYGSVCSA-IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 547 GYCDEG---RNRL---LVYEFMSNG--ALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
                    RN     LV  FM      +    F + K  +     +V  + +GL Y+H 
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQY-----LVYQMLKGLKYIH- 161
Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
                ++H D+KP N+ +++    +I DFGL +       H +  +    GYV   W+R 
Sbjct: 162 --SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEM---TGYVVTRWYRA 209
Query: 659 -------MPITVKVDVYSYGVLLLEIIC 679
                  M     VD++S G ++ E++ 
Sbjct: 210 PEVILSWMHYNQTVDIWSVGCIMAEMLT 237

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 35  IGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 90
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQ-------------- 136
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 137 -ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 87/190 (45%), Gaps = 6/190 (3%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           ++G G+ G V        S  QVAVK ++   Q   +    EV  +    H N+V +   
Sbjct: 52  KIGEGSTGIVCLAR-EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCD 608
              G    ++ EF+  GAL   +    + N +    +   + + L YLH +    +IH D
Sbjct: 111 YLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRD 166
Query: 609 IKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVY 668
           IK  +ILL      ++SDFG    ++ D       + GT  ++APE         +VD++
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV-GTPYWMAPEVISRSLYATEVDIW 225
Query: 669 SYGVLLLEII 678
           S G++++E++
Sbjct: 226 SLGIMVIEMV 235

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---KEFKAEVNGIGQTHHKNLVR 544
           E++G G +GTV+K   N  + + VA+K++ R+  D E        E+  + +  HKN+VR
Sbjct: 8   EKIGEGTYGTVFKA-KNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVR 65
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L       +   LV+EF        F   +   + ++    +  + +GL + H      +
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NV 122
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           +H D+KPQN+L++     ++++FGL +   +        +R     V   W+R   +   
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGI-------PVRCYSAEVVTLWYRPPDVLFG 175
Query: 665 VDVYSYGVLLLEIICL 680
             +YS  + +    C+
Sbjct: 176 AKLYSTSIDMWSAGCI 191

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   F  +   + VAVKKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 30  IGSGAQGIVCAAFDTVLGIN-VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 88
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  LV E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 89  VFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK----HLH--- 141
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   +   T    T+ Y APE    M 
Sbjct: 142 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TASTNFMMTPYVVTRYYRAPEVILGMG 199
Query: 661 ITVKVDVYSYGVLLLEII 678
               VD++S G ++ E++
Sbjct: 200 YKENVDIWSVGCIMGELV 217

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 39  IGEGAYGMVCSAYDNVNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 94
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 95  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 140
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 141 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 196
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 197 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 31  IGEGAYGMVCSAYDNVNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 86
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 132
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 133 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 33  IGEGAYGMVCSAYDNVNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 88
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 134
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 135 -ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 31  IGEGAYGMVCSAYDNVNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 86
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 132
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 133 -ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 51  IGEGAYGMVCSAYDNVNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 106
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 107 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 152
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 153 -ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 10/195 (5%)
Query: 490 LGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQTHHKNLV 543
           LG+G +G V++       N G    + V K   + ++++     KAE N + +  H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
            L+     G    L+ E++S G L   L  +           +  I+  L +LH++    
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--- 141
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
           II+ D+KP+NI+L+   + +++DFGL K    D + T+T   GT  Y+APE         
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEILMRSGHNR 200
Query: 664 KVDVYSYGVLLLEII 678
            VD +S G L+ +++
Sbjct: 201 AVDWWSLGALMYDML 215

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   + +      VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAY-DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLN 90
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  LV E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLH--- 143
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 661 ITVKVDVYSYGVLLLEIICLRRTIL 685
               VD++S G ++ E++  R  IL
Sbjct: 202 YKENVDIWSVGCIMGEMV--RHKIL 224

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 119/284 (41%), Gaps = 43/284 (15%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGY 548
           LG G+ GTV   F        VAVK++   F D       E+  + ++  H N++R   Y
Sbjct: 23  LGYGSSGTVV--FQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRY--Y 75
Query: 549 CDEGRNRLLVYEF-MSNGALASFLFGD--SKPNWKLRTE-----IVMGIARGLFYLHEEC 600
           C E  +R L     + N  L   +     S  N KL+ E     ++  IA G+ +LH   
Sbjct: 76  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 132
Query: 601 CTQIIHCDIKPQNILL--------DDYYNAR-----ISDFGLEKLLTLDQSHTNTAIR-- 645
             +IIH D+KPQNIL+        D    A      ISDFGL K L   QS   T +   
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 646 -GTKGYVAPEWFR-------NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
            GT G+ APE             +T  +D++S G +   I+   +    D  Y       
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD-KYSRESNII 251
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ 741
            G    ++++ + D +++     +    I  DP  RPT  +V +
Sbjct: 252 RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   + +      VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAY-DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLN 90
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  LV E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIK----HLH--- 143
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 661 ITVKVDVYSYGVLLLEIICLRRTIL 685
               VD++S G ++ E++  R  IL
Sbjct: 202 YKENVDIWSVGCIMGEMV--RHKIL 224

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA++K++    Q   +    E+  + +  H+N++   G 
Sbjct: 35  IGEGAYGMVCSAYDNLNKV-RVAIRKISPFEHQTYCQRTLREIKILLRFRHENII---GI 90
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 136
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 137 -ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   +  +   + VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 26  IGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 84
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  +V E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 85  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHS-- 138
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 139 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 661 ITVKVDVYSYGVLLLEIIC 679
               VD++S G ++ E++C
Sbjct: 196 YKENVDLWSVGCIMGEMVC 214

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  +    H+N++   G 
Sbjct: 33  IGEGAYGMVCSAYDNVNKV-RVAIKKISPFEHQTYCQRTLREIKILLAFRHENII---GI 88
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 134
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 135 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   +  +   + VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 37  IGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 95
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  +V E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 96  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHS-- 149
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 150 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 206
Query: 661 ITVKVDVYSYGVLLLEIIC 679
               VD++S G ++ E++C
Sbjct: 207 YKENVDLWSVGCIMGEMVC 225

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 9/195 (4%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           ELG G  G V+K  V+   S  V  +KL    +      +   E+  + + +   +V   
Sbjct: 16  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 73
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
           G         +  E M  G+L   L    +   ++  ++ + + +GL YL E+   +I+H
Sbjct: 74  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 131
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D+KP NIL++     ++ DFG+   L  + ++      GT+ Y++PE  +    +V+ D
Sbjct: 132 RDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV---GTRSYMSPERLQGTHYSVQSD 188
Query: 667 VYSYGVLLLEIICLR 681
           ++S G+ L+E+   R
Sbjct: 189 IWSMGLSLVEMAVGR 203

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 489 ELGRGAFGTVY---KGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVR 544
           +LG G FG V        N G+ + VAVK L        +  ++ E+  +   +H+++V+
Sbjct: 16  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 75
Query: 545 LLGYC-DEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
             G C D+G   + LV E++  G+L  +L        +L       I  G+ YLH +   
Sbjct: 76  YKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL-FAQQICEGMAYLHAQ--- 131
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR----GTKGYVAPEWFRN 658
             IH  +  +N+LLD+    +I DFGL K   + + H    +R        + APE  + 
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWYAPECLKE 189
Query: 659 MPITVKVDVYSYGVLLLEII 678
                  DV+S+GV L E++
Sbjct: 190 CKFYYASDVWSFGVTLYELL 209

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  +    H+N++   G 
Sbjct: 33  IGEGAYGMVCSAYDNVNKV-RVAIKKISPFEHQTYCQRTLREIKILLAFRHENII---GI 88
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 134
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIR 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT   T   
Sbjct: 135 -ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 489 ELGRGAFGTVY---KGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVR 544
           +LG G FG V        N G+ + VAVK L        +  ++ E+  +   +H+++V+
Sbjct: 15  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 74
Query: 545 LLGYC-DEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
             G C D+G   + LV E++  G+L  +L        +L       I  G+ YLH +   
Sbjct: 75  YKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL-FAQQICEGMAYLHAQ--- 130
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR----GTKGYVAPEWFRN 658
             IH  +  +N+LLD+    +I DFGL K   + + H    +R        + APE  + 
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWYAPECLKE 188
Query: 659 MPITVKVDVYSYGVLLLEII 678
                  DV+S+GV L E++
Sbjct: 189 CKFYYASDVWSFGVTLYELL 208

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 19/198 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   +  +   + VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN 90
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  +V E M +N +    +  D +    L  ++++GI     +LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIK----HLH--- 143
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 144 SAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 661 ITVKVDVYSYGVLLLEII 678
               VD++S G ++ E+I
Sbjct: 202 YKENVDIWSVGCIMGEMI 219

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 488 EELGRGAFGTVYKGFVNM--GSSDQVAVKKLN-RVFQDSEK--EFKAEVNGIGQTHHKNL 542
           E+LG G+FG V +G  +   G +  VAVK L   V    E   +F  EVN +    H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL--------ASFLFGDSKPNWKLRTEIVMGIARGLF 594
           +RL G       ++ V E    G+L          FL G         +   + +A G+ 
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 129
Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--TNTAIRGTKGYVA 652
           YL  +   + IH D+  +N+LL      +I DFGL + L  +  H       +    + A
Sbjct: 130 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 653 PEWFRNMPITVKVDVYSYGVLLLEII 678
           PE  +    +   D + +GV L E+ 
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMF 212

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 36  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N+ + GT  YV+PE      
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPELLTEKS 210
Query: 661 ITVKVDVYSYGVLLLEIIC 679
            +   D+++ G ++ +++ 
Sbjct: 211 ASKSSDLWALGCIIYQLVA 229

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   + +      VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAY-DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 90
Query: 548 Y------CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
                   +E ++  LV E M +  L   +    + + +  + ++  +  G+ +LH    
Sbjct: 91  VFTPQKTLEEFQDVYLVMELM-DANLXQVI--QMELDHERMSYLLYQMLXGIKHLH---S 144
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M  
Sbjct: 145 AGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 662 TVKVDVYSYGVLLLEIICLRRTIL 685
              VD++S G ++ E++  R  IL
Sbjct: 203 KENVDIWSVGCIMGEMV--RHKIL 224

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   +  +   + VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 128
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  LV E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 129 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHS-- 182
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 183 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 661 ITVKVDVYSYGVLLLEIICLRRTIL 685
               VD++S G ++ E++  R  IL
Sbjct: 240 YKENVDIWSVGCIMGEMV--RHKIL 262

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 488 EELGRGAFGTVYKGFVNM--GSSDQVAVKKLN-RVFQDSEK--EFKAEVNGIGQTHHKNL 542
           E+LG G+FG V +G  +   G +  VAVK L   V    E   +F  EVN +    H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL--------ASFLFGDSKPNWKLRTEIVMGIARGLF 594
           +RL G       ++ V E    G+L          FL G         +   + +A G+ 
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 125
Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--TNTAIRGTKGYVA 652
           YL  +   + IH D+  +N+LL      +I DFGL + L  +  H       +    + A
Sbjct: 126 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 182
Query: 653 PEWFRNMPITVKVDVYSYGVLLLEII 678
           PE  +    +   D + +GV L E+ 
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMF 208

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   + +      VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 25  IGSGAQGIVCAAY-DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 548 Y------CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
                   +E ++  LV E M +  L   +    + + +  + ++  +  G+ +LH    
Sbjct: 84  VFTPQKTLEEFQDVYLVMELM-DANLXQVI--QMELDHERMSYLLYQMLXGIKHLH---S 137
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M  
Sbjct: 138 AGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 662 TVKVDVYSYGVLLLEIICLRRTIL 685
              VD++S G ++ E++  R  IL
Sbjct: 196 KENVDIWSVGCIMGEMV--RHKIL 217

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 488 EELGRGAFGTVYKGFVNM--GSSDQVAVKKLN-RVFQDSEK--EFKAEVNGIGQTHHKNL 542
           E+LG G+FG V +G  +   G +  VAVK L   V    E   +F  EVN +    H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL--------ASFLFGDSKPNWKLRTEIVMGIARGLF 594
           +RL G       ++ V E    G+L          FL G         +   + +A G+ 
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 135
Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--TNTAIRGTKGYVA 652
           YL  +   + IH D+  +N+LL      +I DFGL + L  +  H       +    + A
Sbjct: 136 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 192
Query: 653 PEWFRNMPITVKVDVYSYGVLLLEII 678
           PE  +    +   D + +GV L E+ 
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMF 218

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 488 EELGRGAFGTVYKGFVNM--GSSDQVAVKKLN-RVFQDSEK--EFKAEVNGIGQTHHKNL 542
           E+LG G+FG V +G  +   G +  VAVK L   V    E   +F  EVN +    H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL--------ASFLFGDSKPNWKLRTEIVMGIARGLF 594
           +RL G       ++ V E    G+L          FL G         +   + +A G+ 
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 125
Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--TNTAIRGTKGYVA 652
           YL  +   + IH D+  +N+LL      +I DFGL + L  +  H       +    + A
Sbjct: 126 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 653 PEWFRNMPITVKVDVYSYGVLLLEII 678
           PE  +    +   D + +GV L E+ 
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMF 208

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 488 EELGRGAFGTVYKGFVNM--GSSDQVAVKKLN-RVFQDSEK--EFKAEVNGIGQTHHKNL 542
           E+LG G+FG V +G  +   G +  VAVK L   V    E   +F  EVN +    H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL--------ASFLFGDSKPNWKLRTEIVMGIARGLF 594
           +RL G       ++ V E    G+L          FL G         +   + +A G+ 
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 135
Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--TNTAIRGTKGYVA 652
           YL  +   + IH D+  +N+LL      +I DFGL + L  +  H       +    + A
Sbjct: 136 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192
Query: 653 PEWFRNMPITVKVDVYSYGVLLLEII 678
           PE  +    +   D + +GV L E+ 
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMF 218

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 24/201 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHHKNLVRLLGY 548
           +G G+FG V++    +  SD+VA+KK   V QD  K FK  E+  +    H N+V L  +
Sbjct: 48  IGNGSFGVVFQA--KLVESDEVAIKK---VLQD--KRFKNRELQIMRIVKHPNVVDLKAF 100
Query: 549 C-DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--------GIARGLFYLHEE 599
               G  +  V+  +    +   ++  S+   KL+  + M         + R L Y+H  
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-- 158
Query: 600 CCTQIIHCDIKPQNILLDDYYNA-RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW-FR 657
               I H DIKPQN+LLD      ++ DFG  K+L   +   N +   ++ Y APE  F 
Sbjct: 159 -SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSXICSRYYRAPELIFG 215
Query: 658 NMPITVKVDVYSYGVLLLEII 678
               T  +D++S G ++ E++
Sbjct: 216 ATNYTTNIDIWSTGCVMAELM 236

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR--VFQDSEKE-FKAEVNGIGQTHHKNLVRL 545
           +GRGAFG V    V + ++D+V A+K LN+  + + +E   F+ E + +     K +  L
Sbjct: 82  IGRGAFGEV--AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFL--FGDSKPNWKLR---TEIVMGIARGLFYLHEEC 600
                +  N  LV ++   G L + L  F D  P    R    E+V+ I   +  LH   
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID-SVHQLH--- 195
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
               +H DIKP NIL+D   + R++DFG    L  D +  ++   GT  Y++PE  + M 
Sbjct: 196 ---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 661 -----ITVKVDVYSYGVLLLEII 678
                   + D +S GV + E++
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEML 275

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 488 EELGRGAFGTVYKGFVNM--GSSDQVAVKKLN-RVFQDSEK--EFKAEVNGIGQTHHKNL 542
           E+LG G+FG V +G  +   G +  VAVK L   V    E   +F  EVN +    H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL--------ASFLFGDSKPNWKLRTEIVMGIARGLF 594
           +RL G       ++ V E    G+L          FL G         +   + +A G+ 
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 129
Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--TNTAIRGTKGYVA 652
           YL  +   + IH D+  +N+LL      +I DFGL + L  +  H       +    + A
Sbjct: 130 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 653 PEWFRNMPITVKVDVYSYGVLLLEII 678
           PE  +    +   D + +GV L E+ 
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMF 212

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 35  IGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 90
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 136
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR-- 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT       
Sbjct: 137 -ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 192
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 47/217 (21%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           +G GA+G V   + N+    +VA+KK++    Q   +    E+  + +  H+N++   G 
Sbjct: 36  IGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIKILLRFRHENII---GI 91
Query: 549 CDEGRN---------------------RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
            D  R                      +LL  + +SN  +  FL+               
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-------------- 137
Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR-- 645
            I RGL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  HT       
Sbjct: 138 -ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 193
Query: 646 GTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLR 681
            T+ Y APE   N    T  +D++S G +L E++  R
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 19/224 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-HKNLVRLL 546
           E LG GA+  V +G V++ +  + AVK + +    S      EV  + Q   +KN++ L+
Sbjct: 19  ELLGEGAYAKV-QGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIH 606
            + ++     LV+E +  G++ + +      N +  + +V  +A  L +LH +    I H
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTK---GIAH 134
Query: 607 CDIKPQNILLDD---YYNARISDFGLEKLLTLDQSHTN------TAIRGTKGYVAPEWFR 657
            D+KP+NIL +        +I DF L   + L+ S T       T   G+  Y+APE   
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 658 NMPITV-----KVDVYSYGVLLLEIICLRRTILTDWAYDCYQER 696
                      + D++S GV+L  ++      +     DC  +R
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDR 238

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 90/201 (44%), Gaps = 23/201 (11%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLL 546
           +LG G +G VYK  ++  +++ VA+K++    ++      A  EV+ + +  H+N++ L 
Sbjct: 41  KLGEGTYGEVYKA-IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLFYLHEECCTQI 604
                     L++E+  N  L  ++  D  P+  +R     +  +  G+ + H   C   
Sbjct: 100 SVIHHNHRLHLIFEYAEND-LKKYM--DKNPDVSMRVIKSFLYQLINGVNFCHSRRC--- 153
Query: 605 IHCDIKPQNILL-----DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
           +H D+KPQN+LL      +    +I DFGL +   +        IR     +   W+R  
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-------PIRQFTHEIITLWYRPP 206
Query: 660 PITVKVDVYSYGVLLLEIICL 680
            I +    YS  V +  I C+
Sbjct: 207 EILLGSRHYSTSVDIWSIACI 227

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 488 EELGRGAFGTVYKGFVNM--GSSDQVAVKKLN-RVFQDSEK--EFKAEVNGIGQTHHKNL 542
           E+LG G+FG V +G  +   G +  VAVK L   V    E   +F  EVN +    H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL--------ASFLFGDSKPNWKLRTEIVMGIARGLF 594
           +RL G       ++ V E    G+L          FL G         +   + +A G+ 
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 125
Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--TNTAIRGTKGYVA 652
           YL  +   + IH D+  +N+LL      +I DFGL + L  +  H       +    + A
Sbjct: 126 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 653 PEWFRNMPITVKVDVYSYGVLLLEII 678
           PE  +    +   D + +GV L E+ 
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMF 208

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   + +      VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAY-DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 90
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  LV E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLH--- 143
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 661 ITVKVDVYSYGVLLLEIICLRRTIL 685
               VD++S G ++ E++  R  IL
Sbjct: 202 YKENVDIWSVGCIMGEMV--RHKIL 224

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   + +      VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 70  IGSGAQGIVCAAY-DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 128
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  LV E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 129 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHS-- 182
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 183 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 661 ITVKVDVYSYGVLLLEIICLRRTIL 685
               VD++S G ++ E++  R  IL
Sbjct: 240 YKENVDIWSVGCIMGEMV--RHKIL 262

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/193 (21%), Positives = 90/193 (46%), Gaps = 7/193 (3%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E++G G +G VYK   N G +  +   +L +  +        E++ + +  H N+V+L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
                +  +LV+E +           +           ++ +  G+ Y H+    +++H 
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 608 DIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR-NMPITVKV 665
           D+KPQN+L++     +I+DFGL +   +  + +T+  +  T  Y AP+    +   +  +
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGSKKYSTTI 182
Query: 666 DVYSYGVLLLEII 678
           D++S G +  E++
Sbjct: 183 DIWSVGCIFAEMV 195

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   + +      VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 33  IGSGAQGIVCAAY-DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 91
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  LV E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 92  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLH--- 144
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 661 ITVKVDVYSYGVLLLEIICLRRTIL 685
               VD++S G ++ E++  R  IL
Sbjct: 203 YKENVDIWSVGCIMGEMV--RHKIL 225

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   + +      VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAY-DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 90
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  LV E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLH--- 143
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 661 ITVKVDVYSYGVLLLEIICLRRTIL 685
               VD++S G ++ E++  R  IL
Sbjct: 202 YKENVDIWSVGCIMGEMV--RHKIL 224

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 109/227 (48%), Gaps = 35/227 (15%)
Query: 476 YKELVEVTRGFKEE---------LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE 526
           Y+++V+  RG + +         +GRGAFG V    V   +S +V   KL   F+  ++ 
Sbjct: 60  YEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQ--LVRHKASQKVYAMKLLSKFEMIKRS 117
Query: 527 ----FKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG-DSKPNW-K 580
               F  E + +   +   +V+L     + +   +V E+M  G L + +   D    W K
Sbjct: 118 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK 177
Query: 581 LRT-EIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS- 638
             T E+V+ +      +H      +IH D+KP N+LLD + + +++DFG    + +D++ 
Sbjct: 178 FYTAEVVLALDA----IH---SMGLIHRDVKPDNMLLDKHGHLKLADFG--TCMKMDETG 228
Query: 639 --HTNTAIRGTKGYVAPEWFRNMP----ITVKVDVYSYGVLLLEIIC 679
             H +TA+ GT  Y++PE  ++         + D +S GV L E++ 
Sbjct: 229 MVHCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV 274

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   + +      VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 33  IGSGAQGIVCAAY-DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 91
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  LV E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 92  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLH--- 144
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 661 ITVKVDVYSYGVLLLEIICLRRTIL 685
               VD++S G ++ E++  R  IL
Sbjct: 203 YKENVDIWSVGCIMGEMV--RHKIL 225

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   +  +   + VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN 90
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  +V E M +N +    +  D +    L  +++ GI     +LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIK----HLH--- 143
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 144 SAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 661 ITVKVDVYSYGVLLLEII 678
               VD++S G ++ E+I
Sbjct: 202 YKENVDIWSVGCIMGEMI 219

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   + +      VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 31  IGSGAQGIVCAAY-DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 89
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  LV E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 90  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLH--- 142
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 143 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 200
Query: 661 ITVKVDVYSYGVLLLEIICLRRTIL 685
               VD++S G ++ E++  R  IL
Sbjct: 201 YKENVDIWSVGCIMGEMV--RHKIL 223

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/193 (21%), Positives = 90/193 (46%), Gaps = 7/193 (3%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E++G G +G VYK   N G +  +   +L +  +        E++ + +  H N+V+L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
                +  +LV+E +           +           ++ +  G+ Y H+    +++H 
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 608 DIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR-NMPITVKV 665
           D+KPQN+L++     +I+DFGL +   +  + +T+  +  T  Y AP+    +   +  +
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGSKKYSTTI 182
Query: 666 DVYSYGVLLLEII 678
           D++S G +  E++
Sbjct: 183 DIWSVGCIFAEMV 195

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   + +      VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 26  IGSGAQGIVCAAY-DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 84
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  LV E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 85  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHS-- 138
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 139 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 661 ITVKVDVYSYGVLLLEIICLRRTIL 685
               VD++S G ++ E++  R  IL
Sbjct: 196 YKENVDIWSVGCIMGEMV--RHKIL 218

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 87/198 (43%), Gaps = 8/198 (4%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 34  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 150
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT-AIRGTKGYVAPEWFRNMPI 661
            IIH D+KP+NILL++  + +I+DFG  K+L+ +       A  GT  YV+PE       
Sbjct: 151 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSA 209
Query: 662 TVKVDVYSYGVLLLEIIC 679
               D+++ G ++ +++ 
Sbjct: 210 CKSSDLWALGCIIYQLVA 227

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   + +      VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 26  IGSGAQGIVCAAY-DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 84
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  LV E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 85  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLH--- 137
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 138 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 661 ITVKVDVYSYGVLLLEIICLRRTIL 685
               VD++S G ++ E++  R  IL
Sbjct: 196 YKENVDIWSVGCIMGEMV--RHKIL 218

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   + +      VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 25  IGSGAQGIVCAAY-DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  LV E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHS-- 137
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 138 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 661 ITVKVDVYSYGVLLLEIICLRRTIL 685
               VD++S G ++ E++  R  IL
Sbjct: 195 YKENVDIWSVGCIMGEMV--RHKIL 217

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 37  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 153
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N+ + GT  YV+PE      
Sbjct: 154 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPELLTEKS 211
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 212 ACKSSDLWALGCIIYQLVA 230

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 111/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 72
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  + +VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 187
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 707 EAMD 710
             M+
Sbjct: 248 REMN 251

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRL--- 545
           +G GA+G V   + ++  + +VA+KK++    Q   +    E+  + +  H+N++ +   
Sbjct: 51  IGEGAYGMVSSAYDHVRKT-RVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDI 109
Query: 546 --LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
                 +  R+  +V + M    L   L      N  +    +  I RGL Y+H      
Sbjct: 110 LRASTLEAMRDVYIVQDLMETD-LYKLLKSQQLSNDHI-CYFLYQILRGLKYIH---SAN 164
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYVAPEWFRNMP- 660
           ++H D+KP N+L++   + +I DFGL ++   +  HT   T    T+ Y APE   N   
Sbjct: 165 VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKG 224
Query: 661 ITVKVDVYSYGVLLLEIICLR 681
            T  +D++S G +L E++  R
Sbjct: 225 YTKSIDIWSVGCILAEMLSNR 245

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 117/280 (41%), Gaps = 39/280 (13%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGY 548
           LG G+ GTV   F        VAVK++   F D       E+  + ++  H N++R   Y
Sbjct: 41  LGYGSSGTVV--FQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRY--Y 93
Query: 549 CDEGRNRLLVYEF-MSNGALASFLFGD--SKPNWKLRTE-----IVMGIARGLFYLHEEC 600
           C E  +R L     + N  L   +     S  N KL+ E     ++  IA G+ +LH   
Sbjct: 94  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 150
Query: 601 CTQIIHCDIKPQNILL--------DDYYNAR-----ISDFGLEKLLTLDQSHTNTAIR-- 645
             +IIH D+KPQNIL+        D    A      ISDFGL K L   Q      +   
Sbjct: 151 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 646 -GTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
            GT G+ APE         +T  +D++S G +   I+   +    D  Y        G  
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD-KYSRESNIIRGIF 269
Query: 702 VENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ 741
             ++++ + D +++     +    I  DP  RPT  +V +
Sbjct: 270 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 309

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 41  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 99
Query: 543 VRLLGYCDEGRNRLLV-YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           V+L  +C +   +L     +  NG L  ++      +          I   L YLH +  
Sbjct: 100 VKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG- 157
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNM 659
             IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N  + GT  YV+PE     
Sbjct: 158 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEK 214
Query: 660 PITVKVDVYSYGVLLLEIIC 679
                 D+++ G ++ +++ 
Sbjct: 215 SACKSSDLWALGCIIYQLVA 234

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 117/280 (41%), Gaps = 39/280 (13%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGY 548
           LG G+ GTV   F        VAVK++   F D       E+  + ++  H N++R   Y
Sbjct: 41  LGYGSSGTVV--FQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRY--Y 93
Query: 549 CDEGRNRLLVYEF-MSNGALASFLFGD--SKPNWKLRTE-----IVMGIARGLFYLHEEC 600
           C E  +R L     + N  L   +     S  N KL+ E     ++  IA G+ +LH   
Sbjct: 94  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 150
Query: 601 CTQIIHCDIKPQNILL--------DDYYNAR-----ISDFGLEKLLTLDQSHTNTAIR-- 645
             +IIH D+KPQNIL+        D    A      ISDFGL K L   Q      +   
Sbjct: 151 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 646 -GTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
            GT G+ APE         +T  +D++S G +   I+   +    D  Y        G  
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD-KYSRESNIIRGIF 269
Query: 702 VENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ 741
             ++++ + D +++     +    I  DP  RPT  +V +
Sbjct: 270 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 309

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/193 (21%), Positives = 90/193 (46%), Gaps = 7/193 (3%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E++G G +G VYK   N G +  +   +L +  +        E++ + +  H N+V+L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
                +  +LV+E +           +           ++ +  G+ Y H+    +++H 
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 608 DIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFR-NMPITVKV 665
           D+KPQN+L++     +I+DFGL +   +  + +T+  +  T  Y AP+    +   +  +
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMGSKKYSTTI 182
Query: 666 DVYSYGVLLLEII 678
           D++S G +  E++
Sbjct: 183 DIWSVGCIFAEMV 195

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 62/126 (49%), Gaps = 7/126 (5%)
Query: 557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL 616
           +V E++    L   +  +     K   E++    + L + H+     IIH D+KP NI++
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 149
Query: 617 DDYYNARISDFGLEKLLTLDQSHTNT---AIRGTKGYVAPEWFRNMPITVKVDVYSYGVL 673
                 ++ DFG+ + +  D  ++ T   A+ GT  Y++PE  R   +  + DVYS G +
Sbjct: 150 SATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 674 LLEIIC 679
           L E++ 
Sbjct: 209 LYEVLT 214

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRL 545
           E +G GA+G V      + +  QVA+KK+   F    + K    E+  +    H N++ +
Sbjct: 61  ETIGNGAYGVVSSARRRL-TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAI 119
Query: 546 LGYCD------EGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
                      E ++  +V + M +  L   +        +     +  + RGL Y+H  
Sbjct: 120 KDILRPTVPYGEFKSVYVVLDLMESD-LHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH-- 176
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL---TLDQSHTNTAIRGTKGYVAPEWF 656
              Q+IH D+KP N+L+++    +I DFG+ + L     +  +  T    T+ Y APE  
Sbjct: 177 -SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 235
Query: 657 RNM-PITVKVDVYSYGVLLLEIICLRR 682
            ++   T  +D++S G +  E++  R+
Sbjct: 236 LSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 62/126 (49%), Gaps = 7/126 (5%)
Query: 557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL 616
           +V E++    L   +  +     K   E++    + L + H+     IIH D+KP NI++
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 149
Query: 617 DDYYNARISDFGLEKLLTLDQSHTNT---AIRGTKGYVAPEWFRNMPITVKVDVYSYGVL 673
                 ++ DFG+ + +  D  ++ T   A+ GT  Y++PE  R   +  + DVYS G +
Sbjct: 150 SATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 674 LLEIIC 679
           L E++ 
Sbjct: 209 LYEVLT 214

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 60/125 (48%), Gaps = 5/125 (4%)
Query: 557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL 616
           +V E++    L   +  +     K   E++    + L + H+     IIH D+KP NIL+
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANILI 149
Query: 617 DDYYNARISDFGLEKLL--TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLL 674
                 ++ DFG+ + +  + +      A+ GT  Y++PE  R   +  + DVYS G +L
Sbjct: 150 SATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209
Query: 675 LEIIC 679
            E++ 
Sbjct: 210 YEVLT 214

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   +  +   + VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  +V E M +N +    +  D +    L  +++ GI     +LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIK----HLH--- 143
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 144 SAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 661 ITVKVDVYSYGVLLLEII 678
               VD++S G ++ E+I
Sbjct: 202 YKENVDIWSVGCIMGEMI 219

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 11/160 (6%)
Query: 527 FKAEVNGIGQTHHKNLVRLLGYCDE----GRNRLLVYEFMSNGALASFLFGDSKPNWKLR 582
           F+ E       +H  +V +    +     G    +V E++    L   +  +     K  
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 583 TEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT 642
            E++    + L + H+     IIH D+KP NI++      ++ DFG+ + +  D  ++ T
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVT 174
Query: 643 ---AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
              A+ GT  Y++PE  R   +  + DVYS G +L E++ 
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 62/126 (49%), Gaps = 7/126 (5%)
Query: 557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL 616
           +V E++    L   +  +     K   E++    + L + H+     IIH D+KP NI++
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 149
Query: 617 DDYYNARISDFGLEKLLTLDQSHTNT---AIRGTKGYVAPEWFRNMPITVKVDVYSYGVL 673
                 ++ DFG+ + +  D  ++ T   A+ GT  Y++PE  R   +  + DVYS G +
Sbjct: 150 SATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 674 LLEIIC 679
           L E++ 
Sbjct: 209 LYEVLT 214

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 490 LGRGAFGTVYK----GFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQTHHKNLV 543
           LG+G +G V++       N G    + V K   + ++++     KAE N + +  H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
            L+     G    L+ E++S G L   L  +           +  I+  L +LH++    
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--- 141
Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
           II+ D+KP+NI+L+   + +++DFGL K    D + T+    GT  Y+APE         
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC-GTIEYMAPEILMRSGHNR 200
Query: 664 KVDVYSYGVLLLEII 678
            VD +S G L+ +++
Sbjct: 201 AVDWWSLGALMYDML 215

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 36  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N  + GT  YV+PE      
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 210
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 211 AXKSSDLWALGCIIYQLVA 229

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 14  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 72
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 73  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 130
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N  + GT  YV+PE      
Sbjct: 131 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 188
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 189 ACKSSDLWALGCIIYQLVA 207

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 140/323 (43%), Gaps = 56/323 (17%)
Query: 397 DRDETGTTFIKIRKVPSGGKKKVDVLIPVVSVLFGSSALIN--LLLVSACCLGFLVVNRK 454
           D+D  G   +KI    +G  + + V  P +++    + LI+    LV+     F++  +K
Sbjct: 279 DKDRKGMLQLKI----AGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQK 334
Query: 455 KFMRP--------HQEEQGVSYMNLRCFTYKELVEV-----------TRGF-----KEEL 490
           +  R         + E+QGV    +      +  E+           TR +     + EL
Sbjct: 335 EGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIEL 394
Query: 491 GR----GAFGTVYKGFVNMGSSD---QVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNL 542
           GR    G FG V++G + M   +    VA+K       DS +E F  E   + Q  H ++
Sbjct: 395 GRCIGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEEC 600
           V+L+G   E     ++ E  + G L SFL    K +  L + I+    ++  L YL  + 
Sbjct: 454 VKLIGVITEN-PVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLESK- 510
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG-----YVAPEW 655
             + +H DI  +N+L+      ++ DFGL + +       +T  + +KG     ++APE 
Sbjct: 511 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPES 563
Query: 656 FRNMPITVKVDVYSYGVLLLEII 678
                 T   DV+ +GV + EI+
Sbjct: 564 INFRRFTSASDVWMFGVCMWEIL 586

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   +  +   + VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  +V E M +N +    +  D +    L  +++ GI     +LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIK----HLH--- 143
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 661 ITVKVDVYSYGVLLLEII 678
               VD++S G ++ E+I
Sbjct: 202 YKENVDIWSVGCIMGEMI 219

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 33  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 149
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N+ + GT  YV+PE      
Sbjct: 150 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPELLTEKS 207
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 208 ACKSSDLWALGCIIYQLVA 226

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 16/164 (9%)
Query: 584 EIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA 643
           +I + I + L +LH +    +IH D+KP N+L++     +  DFG+   L  D +    A
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 644 IRGTKGYVAPEW----FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RT 697
             G K Y APE           +VK D++S G+  +E+  LR      + YD +    + 
Sbjct: 198 --GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILR------FPYDSWGTPFQQ 249
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ 741
           L  +VE     +        FV     C++++   RPT   + Q
Sbjct: 250 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQ 293

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSD---QVAVKKLNRVFQDSEKE-FKAEVN 532
           +E +E+ R     +G G FG V++G + M   +    VA+K       DS +E F  E  
Sbjct: 9   RERIELGRC----IGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IA 590
            + Q  H ++V+L+G   E     ++ E  + G L SFL    K +  L + I+    ++
Sbjct: 64  TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLS 121
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG- 649
             L YL  +   + +H DI  +N+L+      ++ DFGL + +       +T  + +KG 
Sbjct: 122 TALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTXXKASKGK 173
Query: 650 ----YVAPEWFRNMPITVKVDVYSYGVLLLEII 678
               ++APE       T   DV+ +GV + EI+
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 39  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 97
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 98  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 155
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N  + GT  YV+PE      
Sbjct: 156 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 213
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 214 ACKSSDLWALGCIIYQLVA 232

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQV--AVKKLNR---VFQDSEKEFKAEVNGI-GQTHH 539
           F + +G+G+FG V    +    +++V  AVK L +   + +  EK   +E N +     H
Sbjct: 42  FLKVIGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDS---KPNWKLRTEIVMGIARGLFYL 596
             LV L            V ++++ G L   L  +    +P  +        IA  L YL
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF---YAAEIASALGYL 155
Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
           H      I++ D+KP+NILLD   +  ++DFGL K   ++ + T +   GT  Y+APE  
Sbjct: 156 H---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 657 RNMPITVKVDVYSYGVLLLEII 678
              P    VD +  G +L E++
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEML 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 37  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 153
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N  + GT  YV+PE      
Sbjct: 154 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 211
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 212 ACKSSDLWALGCIIYQLVA 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 36  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N  + GT  YV+PE      
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 210
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 211 ACKSSDLWALGCIIYQLVA 229

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 34  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 150
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N  + GT  YV+PE      
Sbjct: 151 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 208
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 209 ACKSSDLWALGCIIYQLVA 227

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 36  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N  + GT  YV+PE      
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 210
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 211 ACKSSDLWALGCIIYQLVA 229

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 34  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 150
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N  + GT  YV+PE      
Sbjct: 151 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 208
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 209 ACKSSDLWALGCIIYQLVA 227

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 13  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 71
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 72  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 129
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N  + GT  YV+PE      
Sbjct: 130 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 187
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 188 ACKSSDLWALGCIIYQLVA 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 11  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 69
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 70  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 127
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N  + GT  YV+PE      
Sbjct: 128 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 185
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 186 ACKSSDLWALGCIIYQLVA 204

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 36  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N  + GT  YV+PE      
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 210
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 211 ACKSSDLWALGCIIYQLVA 229

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 57  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 110
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 111 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 170
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 171 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 225
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 226 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 285
Query: 707 EAMD 710
             M+
Sbjct: 286 REMN 289

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 116/278 (41%), Gaps = 37/278 (13%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVF-----QDS-----E 524
           +E  E        LG+G FGTV+ G   +    QVA+K +  NRV       DS     E
Sbjct: 26  REAFEAEYRLGPLLGKGGFGTVFAGH-RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLE 84
Query: 525 KEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE 584
                +V   G   H  ++RLL + +     +LV E             +  P  +  + 
Sbjct: 85  VALLWKVGAGGG--HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR 142
Query: 585 IVMG-IARGLFYLHEECCTQIIHCDIKPQNILLDDYYN-ARISDFGLEKLLTLDQSHTNT 642
              G +   + + H      ++H DIK +NIL+D     A++ DFG   LL  D+ +T+ 
Sbjct: 143 CFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTD- 197
Query: 643 AIRGTKGYVAPEWF-RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
              GT+ Y  PEW  R+    +   V+S G+LL +++C       D  ++  QE  L A 
Sbjct: 198 -FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC------GDIPFERDQE-ILEAE 249
Query: 702 VENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
           +        D   L R       C+   PS RP++  +
Sbjct: 250 LHFPAHVSPDCCALIRR------CLAPKPSSRPSLEEI 281

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 62/126 (49%), Gaps = 7/126 (5%)
Query: 557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL 616
           +V E++    L   +  +     K   E++    + L + H+     IIH D+KP NI++
Sbjct: 110 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 166
Query: 617 DDYYNARISDFGLEKLLTLDQSHTNT---AIRGTKGYVAPEWFRNMPITVKVDVYSYGVL 673
                 ++ DFG+ + +  D  ++ T   A+ GT  Y++PE  R   +  + DVYS G +
Sbjct: 167 SATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 225
Query: 674 LLEIIC 679
           L E++ 
Sbjct: 226 LYEVLT 231

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 12  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 128
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N  + GT  YV+PE      
Sbjct: 129 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 186
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 187 ACKSSDLWALGCIIYQLVA 205

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   +  +   + VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  +V E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLH--- 143
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S        T+ Y APE    M 
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEVVTRYYRAPEVILGMG 201
Query: 661 ITVKVDVYSYGVLLLEIIC 679
               VD++S G ++ E++C
Sbjct: 202 YKENVDIWSVGCIMGEMVC 220

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 140/323 (43%), Gaps = 56/323 (17%)
Query: 397 DRDETGTTFIKIRKVPSGGKKKVDVLIPVVSVLFGSSALIN--LLLVSACCLGFLVVNRK 454
           D+D  G   +KI    +G  + + V  P +++    + LI+    LV+     F++  +K
Sbjct: 279 DKDRKGMLQLKI----AGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQK 334
Query: 455 KFMRP--------HQEEQGVSYMNLRCFTYKELVEV-----------TRGF-----KEEL 490
           +  R         + E+QGV    +      +  E+           TR +     + EL
Sbjct: 335 EGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIEL 394
Query: 491 GR----GAFGTVYKGFVNMGSSD---QVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNL 542
           GR    G FG V++G + M   +    VA+K       DS +E F  E   + Q  H ++
Sbjct: 395 GRCIGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEEC 600
           V+L+G   E     ++ E  + G L SFL    K +  L + I+    ++  L YL  + 
Sbjct: 454 VKLIGVITEN-PVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLESK- 510
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG-----YVAPEW 655
             + +H DI  +N+L+      ++ DFGL + +       +T  + +KG     ++APE 
Sbjct: 511 --RFVHRDIAARNVLVSATDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPES 563
Query: 656 FRNMPITVKVDVYSYGVLLLEII 678
                 T   DV+ +GV + EI+
Sbjct: 564 INFRRFTSASDVWMFGVCMWEIL 586

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   +  +   + VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  +V E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLH--- 143
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 661 ITVKVDVYSYGVLLLEII 678
               VD++S G ++ E+I
Sbjct: 202 YKENVDIWSVGCIMGEMI 219

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 106
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 221
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 707 EAMD 710
             M+
Sbjct: 282 REMN 285

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 47  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 100
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 101 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 160
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 161 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 215
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 275
Query: 707 EAMD 710
             M+
Sbjct: 276 REMN 279

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 106
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 221
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 707 EAMD 710
             M+
Sbjct: 282 REMN 285

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 36  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N  + GT  YV+PE      
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 210
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 211 ACKSSDLWALGCIIYQLVA 229

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 55  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 108
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 109 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 168
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 169 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 223
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 224 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 283
Query: 707 EAMD 710
             M+
Sbjct: 284 REMN 287

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRL 545
           E +G GA+G V      + +  QVA+KK+   F    + K    E+  +    H N++ +
Sbjct: 60  ETIGNGAYGVVSSARRRL-TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAI 118
Query: 546 LGYCD------EGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
                      E ++  +V + M +  L   +        +     +  + RGL Y+H  
Sbjct: 119 KDILRPTVPYGEFKSVYVVLDLMESD-LHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH-- 175
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL---TLDQSHTNTAIRGTKGYVAPEWF 656
              Q+IH D+KP N+L+++    +I DFG+ + L     +  +  T    T+ Y APE  
Sbjct: 176 -SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 234
Query: 657 RNM-PITVKVDVYSYGVLLLEIICLRR 682
            ++   T  +D++S G +  E++  R+
Sbjct: 235 LSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   +  +   + VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 33  IGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 91
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  +V E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 92  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLH--- 144
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 661 ITVKVDVYSYGVLLLEII 678
               VD++S G ++ E+I
Sbjct: 203 YKENVDIWSVGCIMGEMI 220

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSD---QVAVKKLNRVFQDSEKE-FKAEVN 532
           +E +E+ R     +G G FG V++G + M   +    VA+K       DS +E F  E  
Sbjct: 9   RERIELGRC----IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IA 590
            + Q  H ++V+L+G   E     ++ E  + G L SFL    K +  L + I+    ++
Sbjct: 64  TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLS 121
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG- 649
             L YL  +   + +H DI  +N+L+      ++ DFGL + +       +T  + +KG 
Sbjct: 122 TALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGK 173
Query: 650 ----YVAPEWFRNMPITVKVDVYSYGVLLLEII 678
               ++APE       T   DV+ +GV + EI+
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSD---QVAVKKLNRVFQDSEKE-FKAEVN 532
           +E +E+ R     +G G FG V++G + M   +    VA+K       DS +E F  E  
Sbjct: 14  RERIELGRC----IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IA 590
            + Q  H ++V+L+G   E     ++ E  + G L SFL    K +  L + I+    ++
Sbjct: 69  TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLS 126
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG- 649
             L YL  +   + +H DI  +N+L+      ++ DFGL + +       +T  + +KG 
Sbjct: 127 TALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGK 178
Query: 650 ----YVAPEWFRNMPITVKVDVYSYGVLLLEII 678
               ++APE       T   DV+ +GV + EI+
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 474 FTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVN 532
           + Y+E V      +  LGRG+FG V++   +  +  Q AVKK+   VF+  E    A ++
Sbjct: 65  YEYREEVHWMT-HQPRLGRGSFGEVHR-MKDKQTGFQCAVKKVRLEVFRVEELVACAGLS 122
Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIA 590
                    +V L G   EG    +  E +  G+L   +   G    +   R    +G A
Sbjct: 123 S------PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED---RALYYLGQA 173
Query: 591 -RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLD----QSHTNTAI 644
             GL YLH     +I+H D+K  N+LL  D   A + DFG    L  D       T   I
Sbjct: 174 LEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 230
Query: 645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
            GT+ ++APE     P   KVD++S   ++L ++
Sbjct: 231 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 264

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSD---QVAVKKLNRVFQDSEKE-FKAEVN 532
           +E +E+ R     +G G FG V++G + M   +    VA+K       DS +E F  E  
Sbjct: 9   RERIELGRC----IGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IA 590
            + Q  H ++V+L+G   E     ++ E  + G L SFL    K +  L + I+    ++
Sbjct: 64  TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLS 121
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG- 649
             L YL  +   + +H DI  +N+L+      ++ DFGL + +       +T  + +KG 
Sbjct: 122 TALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGK 173
Query: 650 ----YVAPEWFRNMPITVKVDVYSYGVLLLEII 678
               ++APE       T   DV+ +GV + EI+
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 98  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 151
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 152 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 212 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 266
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 267 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 326
Query: 707 EAMD 710
             M+
Sbjct: 327 REMN 330

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 31  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 84
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 145 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 199
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 259
Query: 707 EAMD 710
             M+
Sbjct: 260 REMN 263

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 18  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 76
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 77  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 134
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N  + GT  YV+PE      
Sbjct: 135 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 192
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 193 ACKSSDLWALGCIIYQLVA 211

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSD---QVAVKKLNRVFQDSEKE-FKAEVN 532
           +E +E+ R     +G G FG V++G + M   +    VA+K       DS +E F  E  
Sbjct: 11  RERIELGRC----IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 65
Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IA 590
            + Q  H ++V+L+G   E     ++ E  + G L SFL    K +  L + I+    ++
Sbjct: 66  TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLS 123
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG- 649
             L YL  +   + +H DI  +N+L+      ++ DFGL + +       +T  + +KG 
Sbjct: 124 TALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGK 175
Query: 650 ----YVAPEWFRNMPITVKVDVYSYGVLLLEII 678
               ++APE       T   DV+ +GV + EI+
Sbjct: 176 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   +  +   + VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  +V E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLH--- 143
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 661 ITVKVDVYSYGVLLLEII 678
               VD++S G ++ E+I
Sbjct: 202 YKENVDIWSVGCIMGEMI 219

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNRVFQDSEKEF---KAEVNGIGQTHHKNLVRL 545
           +GRG++  V    V +  +D++ A+K + +   + +++    + E +   Q  +   +  
Sbjct: 28  IGRGSYAKVL--LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 546 LGYCDEGRNRLL-VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L  C +  +RL  V E+++ G L   +    K   +        I+  L YLHE     I
Sbjct: 86  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---I 142
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           I+ D+K  N+LLD   + +++D+G+ K   L    T +   GT  Y+APE  R       
Sbjct: 143 IYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSXFCGTPNYIAPEILRGEDYGFS 201
Query: 665 VDVYSYGVLLLEIICLR 681
           VD ++ GVL+ E++  R
Sbjct: 202 VDWWALGVLMFEMMAGR 218

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSD---QVAVKKLNRVFQDSEKE-FKAEVN 532
           +E +E+ R     +G G FG V++G + M   +    VA+K       DS +E F  E  
Sbjct: 37  RERIELGRC----IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 91
Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IA 590
            + Q  H ++V+L+G   E     ++ E  + G L SFL    K +  L + I+    ++
Sbjct: 92  TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLS 149
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG- 649
             L YL  +   + +H DI  +N+L+      ++ DFGL + +       +T  + +KG 
Sbjct: 150 TALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGK 201
Query: 650 ----YVAPEWFRNMPITVKVDVYSYGVLLLEII 678
               ++APE       T   DV+ +GV + EI+
Sbjct: 202 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSD---QVAVKKLNRVFQDSEKE-FKAEVN 532
           +E +E+ R     +G G FG V++G + M   +    VA+K       DS +E F  E  
Sbjct: 6   RERIELGRC----IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IA 590
            + Q  H ++V+L+G   E     ++ E  + G L SFL    K +  L + I+    ++
Sbjct: 61  TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLS 118
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG- 649
             L YL  +   + +H DI  +N+L+      ++ DFGL + +       +T  + +KG 
Sbjct: 119 TALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGK 170
Query: 650 ----YVAPEWFRNMPITVKVDVYSYGVLLLEII 678
               ++APE       T   DV+ +GV + EI+
Sbjct: 171 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 10/193 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           +GRG++G V K  V  G+  + A KK+ + F +    FK E+  +    H N++RL    
Sbjct: 17  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 550 DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDI 609
           ++  +  LV E  + G L   +             I+  +   + Y H+     + H D+
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDL 132
Query: 610 KPQNIL-LDDYYNA--RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
           KP+N L L D  ++  ++ DFGL       +        GT  YV+P+    +    + D
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLEGL-YGPECD 189
Query: 667 VYSYGVLLLEIIC 679
            +S GV++  ++C
Sbjct: 190 EWSAGVMMYVLLC 202

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 27  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 80
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 81  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 140
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 141 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 195
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 255
Query: 707 EAMD 710
             M+
Sbjct: 256 REMN 259

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSD---QVAVKKLNRVFQDSEKE-FKAEVN 532
           +E +E+ R     +G G FG V++G + M   +    VA+K       DS +E F  E  
Sbjct: 12  RERIELGRC----IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 66
Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IA 590
            + Q  H ++V+L+G   E     ++ E  + G L SFL    K +  L + I+    ++
Sbjct: 67  TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLS 124
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG- 649
             L YL  +   + +H DI  +N+L+      ++ DFGL + +       +T  + +KG 
Sbjct: 125 TALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGK 176
Query: 650 ----YVAPEWFRNMPITVKVDVYSYGVLLLEII 678
               ++APE       T   DV+ +GV + EI+
Sbjct: 177 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 31  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 84
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 145 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 199
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 259
Query: 707 EAMD 710
             M+
Sbjct: 260 REMN 263

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 24  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 77
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 78  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 138 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 192
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 252
Query: 707 EAMD 710
             M+
Sbjct: 253 REMN 256

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +   + ++       E + + +  H   
Sbjct: 33  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 149
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N  + GT  YV+PE      
Sbjct: 150 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 207
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 208 ACKSSDLWALGCIIYQLVA 226

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 38  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 91
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 92  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 151
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 152 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 206
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 266
Query: 707 EAMD 710
             M+
Sbjct: 267 REMN 270

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   +  +   + VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  +V E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLH--- 143
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M 
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTRYYRAPEVILGMG 201
Query: 661 ITVKVDVYSYGVLLLEII 678
               VD++S G ++ E+I
Sbjct: 202 YKENVDIWSVGCIMGEMI 219

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 32  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 85
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 86  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 145
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 146 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 200
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 260
Query: 707 EAMD 710
             M+
Sbjct: 261 REMN 264

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 23  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 76
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 77  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 136
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 137 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 191
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 251
Query: 707 EAMD 710
             M+
Sbjct: 252 REMN 255

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNRVFQDSEKEF---KAEVNGIGQTHHKNLVRL 545
           +GRG++  V    V +  +D++ A+K + +   + +++    + E +   Q  +   +  
Sbjct: 17  IGRGSYAKVL--LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 546 LGYCDEGRNRLL-VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L  C +  +RL  V E+++ G L   +    K   +        I+  L YLHE     I
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---I 131
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           I+ D+K  N+LLD   + +++D+G+ K   L    T +   GT  Y+APE  R       
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSXFCGTPNYIAPEILRGEDYGFS 190
Query: 665 VDVYSYGVLLLEIICLR 681
           VD ++ GVL+ E++  R
Sbjct: 191 VDWWALGVLMFEMMAGR 207

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 72
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 187
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 707 EAMD 710
             M+
Sbjct: 248 REMN 251

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSD---QVAVKKLNRVFQDSEKE-FKAEVN 532
           +E +E+ R     +G G FG V++G + M   +    VA+K       DS +E F  E  
Sbjct: 9   RERIELGRC----IGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IA 590
            + Q  H ++V+L+G   E     ++ E  + G L SFL    K +  L + I+    ++
Sbjct: 64  TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLS 121
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG- 649
             L YL  +   + +H DI  +N+L+      ++ DFGL + +       +T  + +KG 
Sbjct: 122 TALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYM-----EDSTYYKASKGK 173
Query: 650 ----YVAPEWFRNMPITVKVDVYSYGVLLLEII 678
               ++APE       T   DV+ +GV + EI+
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 10/193 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           +GRG++G V K  V  G+  + A KK+ + F +    FK E+  +    H N++RL    
Sbjct: 34  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 92
Query: 550 DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDI 609
           ++  +  LV E  + G L   +             I+  +   + Y H+     + H D+
Sbjct: 93  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDL 149
Query: 610 KPQNIL-LDDYYNA--RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
           KP+N L L D  ++  ++ DFGL       +        GT  YV+P+    +    + D
Sbjct: 150 KPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLEGL-YGPECD 206
Query: 667 VYSYGVLLLEIIC 679
            +S GV++  ++C
Sbjct: 207 EWSAGVMMYVLLC 219

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNRVFQDSEKEF---KAEVNGIGQTHHKNLVRL 545
           +GRG++  V    V +  +D++ A+K + +   + +++    + E +   Q  +   +  
Sbjct: 13  IGRGSYAKVL--LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 546 LGYCDEGRNRLL-VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L  C +  +RL  V E+++ G L   +    K   +        I+  L YLHE     I
Sbjct: 71  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---I 127
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           I+ D+K  N+LLD   + +++D+G+ K   L    T +   GT  Y+APE  R       
Sbjct: 128 IYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSXFCGTPNYIAPEILRGEDYGFS 186
Query: 665 VDVYSYGVLLLEIICLR 681
           VD ++ GVL+ E++  R
Sbjct: 187 VDWWALGVLMFEMMAGR 203

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   +  +   + VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  +V E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLH--- 143
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S        T+ Y APE    M 
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEVVTRYYRAPEVILGMG 201
Query: 661 ITVKVDVYSYGVLLLEIIC 679
               VD++S G ++ E++C
Sbjct: 202 YKENVDLWSVGCIMGEMVC 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 20  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 73
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 74  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 133
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 134 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 188
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 248
Query: 707 EAMD 710
             M+
Sbjct: 249 REMN 252

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 72
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY 187
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 707 EAMD 710
             M+
Sbjct: 248 REMN 251

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 25/244 (10%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHH 539
           EV+    + +G G+FG VY+  +   S + VA+KK   V QD  K FK  E+  + +  H
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDH 72
Query: 540 KNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGIA 590
            N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++ 
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 187
Query: 650 YVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 707 EAMD 710
             M+
Sbjct: 248 REMN 251

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNRVFQDSEKEF---KAEVNGIGQTHHKNLVRL 545
           +GRG++  V    V +  +D++ A++ + +   + +++    + E +   Q  +   +  
Sbjct: 60  IGRGSYAKVL--LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 546 LGYCDEGRNRLL-VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L  C +  +RL  V E+++ G L   +    K   +        I+  L YLHE     I
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---I 174
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           I+ D+K  N+LLD   + +++D+G+ K   L    T +   GT  Y+APE  R       
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 233
Query: 665 VDVYSYGVLLLEIICLR 681
           VD ++ GVL+ E++  R
Sbjct: 234 VDWWALGVLMFEMMAGR 250

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 120/287 (41%), Gaps = 37/287 (12%)
Query: 486 FKEELGRGAFGTVYKGFV-NMGSSDQ-----VAVKKLNRVFQDSEKEFKAEVNGIGQTHH 539
           F E LG+G F  ++KG    +G   Q     V +K L++  ++  + F    + + +  H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDS---KPNWKLRTEIVMGIARGLFYL 596
           K+LV   G C  G   +LV EF+  G+L ++L  +       WKL  E+   +A  + +L
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAAAMHFL 129
Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT---NTAIRGTKGYVAP 653
            E     +IH ++  +NILL    + +  +    KL     S T      ++    +V P
Sbjct: 130 EE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPP 186
Query: 654 EWFRNMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL-VENDLEAMDD 711
           E   N   + +  D +S+G  L EI                 ++ L AL  +  L+  +D
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEIC-------------SGGDKPLSALDSQRKLQFYED 233
Query: 712 MTVL-----QRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPP 753
              L          +   C+  +P HRP+ R + + L  +    + P
Sbjct: 234 RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 474 FTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVN 532
           + Y+E V      +  +GRG+FG V++   +  +  Q AVKK+   VF+  E    A ++
Sbjct: 51  YEYREEVHWMT-HQPRVGRGSFGEVHR-MKDKQTGFQCAVKKVRLEVFRVEELVACAGLS 108
Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIA 590
                    +V L G   EG    +  E +  G+L   +   G    +   R    +G A
Sbjct: 109 S------PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED---RALYYLGQA 159
Query: 591 -RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLD----QSHTNTAI 644
             GL YLH     +I+H D+K  N+LL  D   A + DFG    L  D       T   I
Sbjct: 160 LEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
            GT+ ++APE     P   KVD++S   ++L ++
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 19/198 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 547
           +G GA G V   +  +   + VA+KKL+R FQ+     +A  E+  +   +HKN++ LL 
Sbjct: 34  IGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 92
Query: 548 Y------CDEGRNRLLVYEFM-SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
                   +E ++  +V E M +N      +  D +    L  +++ GI     +LH   
Sbjct: 93  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLH--- 145
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IIH D+KP NI++      +I DFGL +  T   S        T+ Y APE    M 
Sbjct: 146 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMVPFVVTRYYRAPEVILGMG 203
Query: 661 ITVKVDVYSYGVLLLEII 678
               VD++S G ++ E+I
Sbjct: 204 YKENVDIWSVGCIMGEMI 221

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 33/208 (15%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR--VFQDSEKE-FKAE----VNGIGQTHHKN 541
           +GRGAFG V    V M +++++ A+K LN+  + + +E   F+ E    VNG  Q     
Sbjct: 82  IGRGAFGEV--AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ----- 134
Query: 542 LVRLLGYCDEGRNRL-LVYEFMSNGALASFL--FGDSKPNWKLR---TEIVMGIARGLFY 595
            +  L Y  +  N L LV ++   G L + L  F D  P    R    E+V+ I   +  
Sbjct: 135 WITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAID-SIHQ 193
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           LH       +H DIKP N+LLD   + R++DFG    +  D +  ++   GT  Y++PE 
Sbjct: 194 LH------YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEI 247
Query: 656 FRNMPITV-----KVDVYSYGVLLLEII 678
            + M   +     + D +S GV + E++
Sbjct: 248 LQAMEDGMGKYGPECDWWSLGVCMYEML 275

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 33/208 (15%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR--VFQDSEKE-FKAE----VNGIGQTHHKN 541
           +GRGAFG V    V M +++++ A+K LN+  + + +E   F+ E    VNG  Q     
Sbjct: 98  IGRGAFGEV--AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ----- 150
Query: 542 LVRLLGYCDEGRNRL-LVYEFMSNGALASFL--FGDSKPNWKLR---TEIVMGIARGLFY 595
            +  L Y  +  N L LV ++   G L + L  F D  P    R    E+V+ I   +  
Sbjct: 151 WITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAID-SIHQ 209
Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           LH       +H DIKP N+LLD   + R++DFG    +  D +  ++   GT  Y++PE 
Sbjct: 210 LH------YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEI 263
Query: 656 FRNMPITV-----KVDVYSYGVLLLEII 678
            + M   +     + D +S GV + E++
Sbjct: 264 LQAMEDGMGKYGPECDWWSLGVCMYEML 291

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 474 FTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVN 532
           + Y+E V      +  LGRG+FG V++   +  +  Q AVKK+   VF+  E    A + 
Sbjct: 86  YEYREEVHWAT-HQLRLGRGSFGEVHR-MEDKQTGFQCAVKKVRLEVFRAEELMACAGLT 143
Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIA-R 591
                    +V L G   EG    +  E +  G+L   L  +     + R    +G A  
Sbjct: 144 S------PRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQGCLPEDRALYYLGQALE 196
Query: 592 GLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLD----QSHTNTAIRG 646
           GL YLH     +I+H D+K  N+LL  D  +A + DFG    L  D       T   I G
Sbjct: 197 GLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPG 253
Query: 647 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
           T+ ++APE         KVDV+S   ++L ++
Sbjct: 254 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHML 285

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 117/284 (41%), Gaps = 43/284 (15%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGY 548
           LG G+ GTV   F        VAVK++   F D       E+  + ++  H N++R   Y
Sbjct: 23  LGYGSSGTVV--FQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRY--Y 75
Query: 549 CDEGRNRLLVYEF-MSNGALASFLFGD--SKPNWKLRTE-----IVMGIARGLFYLHEEC 600
           C E  +R L     + N  L   +     S  N KL+ E     ++  IA G+ +LH   
Sbjct: 76  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 132
Query: 601 CTQIIHCDIKPQNILL--------DDYYNAR-----ISDFGLEKLLTLDQSHTNTAIR-- 645
             +IIH D+KPQNIL+        D    A      ISDFGL K L   Q      +   
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 192
Query: 646 -GTKGYVAPEWFR-------NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
            GT G+ APE             +T  +D++S G +   I+   +    D  Y       
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD-KYSRESNII 251
Query: 698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ 741
            G    ++++ + D +++     +    I  DP  RPT  +V +
Sbjct: 252 RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 33/210 (15%)
Query: 487 KEELGRGAFGT-VYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           K+ LG GA GT VY+G   M  +  VAVK++      F D E +   E +      H N+
Sbjct: 29  KDVLGHGAEGTIVYRG---MFDNRDVAVKRILPECFSFADREVQLLRESD-----EHPNV 80
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE---IVMGIARGLFYLHEE 599
           +R   +C E ++R   Y  +   A     + + K    L  E   ++     GL +LH  
Sbjct: 81  IRY--FCTE-KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 600 CCTQIIHCDIKPQNILLD-----DYYNARISDFGLEKLLTLDQS--HTNTAIRGTKGYVA 652
               I+H D+KP NIL+          A ISDFGL K L + +      + + GT+G++A
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 653 PEWF----RNMPITVKVDVYSYGVLLLEII 678
           PE      +  P T  VD++S G +   +I
Sbjct: 195 PEMLSEDCKENP-TYTVDIFSAGCVFYYVI 223

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 89/199 (44%), Gaps = 10/199 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
           F + LG G+F T       + +S + A+K L +   + ++       E + + +  H   
Sbjct: 34  FGKILGEGSFSTTVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 150
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD--QSHTNTAIRGTKGYVAPEWFRNMP 660
            IIH D+KP+NILL++  + +I+DFG  K+L+ +  Q+  N  + GT  YV+PE      
Sbjct: 151 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 208
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D+++ G ++ +++ 
Sbjct: 209 ACKSSDLWALGCIIYQLVA 227

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 118/281 (41%), Gaps = 25/281 (8%)
Query: 486 FKEELGRGAFGTVYKGFV-NMGSSDQ-----VAVKKLNRVFQDSEKEFKAEVNGIGQTHH 539
           F E LG+G F  ++KG    +G   Q     V +K L++  ++  + F    + + +  H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDS---KPNWKLRTEIVMGIARGLFYL 596
           K+LV   G C  G   +LV EF+  G+L ++L  +       WKL  E+   +A  + +L
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAWAMHFL 129
Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT---NTAIRGTKGYVAP 653
            E     +IH ++  +NILL    + +  +    KL     S T      ++    +V P
Sbjct: 130 EE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPP 186
Query: 654 EWFRNMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDM 712
           E   N   + +  D +S+G  L EI       L+  A D   +R L    +         
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS--ALD--SQRKLQFYEDRHQLPAPKA 242
Query: 713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPP 753
             L   +     C+  +P HRP+ R + + L  +    + P
Sbjct: 243 AELANLINN---CMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 474 FTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVN 532
           + Y+E V      +  +GRG+FG V++   +  +  Q AVKK+   VF+  E    A ++
Sbjct: 67  YEYREEVHWMT-HQPRVGRGSFGEVHR-MKDKQTGFQCAVKKVRLEVFRVEELVACAGLS 124
Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIA 590
                    +V L G   EG    +  E +  G+L   +   G    +   R    +G A
Sbjct: 125 S------PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED---RALYYLGQA 175
Query: 591 -RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLD----QSHTNTAI 644
             GL YLH     +I+H D+K  N+LL  D   A + DFG    L  D       T   I
Sbjct: 176 LEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 232
Query: 645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
            GT+ ++APE     P   KVD++S   ++L ++
Sbjct: 233 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 266

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHHKNLVRLL 546
           E +G+G +G V++G   +   + VAVK  +   +D +  F+  E+       H N++  +
Sbjct: 14  ECVGKGRYGEVWRG---LWHGESVAVKIFSS--RDEQSWFRETEIYNTVLLRHDNILGFI 68
Query: 547 GYCDEGRNR----LLVYEFMSNGALASFLFGDS-KPNWKLRTEIVMGIARGLFYLHEECC 601
                 RN      L+  +  +G+L  FL   + +P+  LR  + +  A GL +LH E  
Sbjct: 69  ASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALR--LAVSAACGLAHLHVEIF 126
Query: 602 -TQ----IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT---NTAIRGTKGYVAP 653
            TQ    I H D K +N+L+       I+D GL  + +    +    N    GTK Y+AP
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 654 EWFRNMPIT------VKVDVYSYGVLLLEIICLRRTIL 685
           E       T         D++++G++L EI   RRTI+
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEIA--RRTIV 222

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 8/162 (4%)
Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA-IRGT 647
           +A+G+ +L    C   IH D+  +NILL +    +I DFGL + +  D  +      R  
Sbjct: 202 VAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE 707
             ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     L E    
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKEGTRM 315
Query: 708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
              D T  + +    + C   +PS RPT   + + L  +++ 
Sbjct: 316 RAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 8/162 (4%)
Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA-IRGT 647
           +A+G+ +L    C   IH D+  +NILL +    +I DFGL + +  D  +      R  
Sbjct: 200 VAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE 707
             ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     L E    
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKEGTRM 313
Query: 708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
              D T  + +    + C   +PS RPT   + + L  +++ 
Sbjct: 314 RAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 354

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 8/162 (4%)
Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA-IRGT 647
           +A+G+ +L    C   IH D+  +NILL +    +I DFGL + +  D  +      R  
Sbjct: 209 VAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE 707
             ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     L E    
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKEGTRM 322
Query: 708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
              D T  + +    + C   +PS RPT   + + L  +++ 
Sbjct: 323 RAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 363

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 474 FTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVN 532
           + Y+E V      +  LGRG+FG V++   +  +  Q AVKK+   VF+  E    A + 
Sbjct: 67  YEYREEVHWAT-HQLRLGRGSFGEVHR-MEDKQTGFQCAVKKVRLEVFRAEELMACAGLT 124
Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIA-R 591
                    +V L G   EG    +  E +  G+L   L  +     + R    +G A  
Sbjct: 125 S------PRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQGCLPEDRALYYLGQALE 177
Query: 592 GLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLD----QSHTNTAIRG 646
           GL YLH     +I+H D+K  N+LL  D  +A + DFG    L  D       T   I G
Sbjct: 178 GLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPG 234
Query: 647 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
           T+ ++APE         KVDV+S   ++L ++
Sbjct: 235 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHML 266

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 8/162 (4%)
Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA-IRGT 647
           +A+G+ +L    C   IH D+  +NILL +    +I DFGL + +  D  +      R  
Sbjct: 207 VAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE 707
             ++APE   +   T++ DV+S+GVLL EI  L  +       D   E     L E    
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKEGTRM 320
Query: 708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
              D T  + +    + C   +PS RPT   + + L  +++ 
Sbjct: 321 RAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 361

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQ-------DSEKEFKAEVNGIGQTHHKN 541
           LG GA G V   F    +  +VA+K ++ R F        D     + E+  + + +H  
Sbjct: 17  LGSGACGEVKLAF-ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 75
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++++  + D   +  +V E M  G L   + G+ +            +   + YLHE   
Sbjct: 76  IIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE--- 131
Query: 602 TQIIHCDIKPQNILLDDYYN---ARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
             IIH D+KP+N+LL         +I+DFG  K+  L ++     + GT  Y+APE   +
Sbjct: 132 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVLVS 189
Query: 659 MPIT---VKVDVYSYGVLLLEIICL 680
           +        VD +S GV+L   ICL
Sbjct: 190 VGTAGYNRAVDCWSLGVILF--ICL 212

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQ-------DSEKEFKAEVNGIGQTHHKN 541
           LG GA G V   F    +  +VA+K ++ R F        D     + E+  + + +H  
Sbjct: 18  LGSGACGEVKLAF-ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++++  + D   +  +V E M  G L   + G+ +            +   + YLHE   
Sbjct: 77  IIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE--- 132
Query: 602 TQIIHCDIKPQNILLDDYYN---ARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
             IIH D+KP+N+LL         +I+DFG  K+  L ++     + GT  Y+APE   +
Sbjct: 133 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVLVS 190
Query: 659 MPIT---VKVDVYSYGVLLLEIICL 680
           +        VD +S GV+L   ICL
Sbjct: 191 VGTAGYNRAVDCWSLGVILF--ICL 213

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQ-------DSEKEFKAEVNGIGQTHHKN 541
           LG GA G V   F    +  +VA+K ++ R F        D     + E+  + + +H  
Sbjct: 18  LGSGACGEVKLAF-ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++++  + D   +  +V E M  G L   + G+ +            +   + YLHE   
Sbjct: 77  IIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE--- 132
Query: 602 TQIIHCDIKPQNILLDDYYN---ARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
             IIH D+KP+N+LL         +I+DFG  K+  L ++     + GT  Y+APE   +
Sbjct: 133 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVLVS 190
Query: 659 MPIT---VKVDVYSYGVLLLEIICL 680
           +        VD +S GV+L   ICL
Sbjct: 191 VGTAGYNRAVDCWSLGVILF--ICL 213

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQ-------DSEKEFKAEVNGIGQTHHKN 541
           LG GA G V   F    +  +VA+K ++ R F        D     + E+  + + +H  
Sbjct: 18  LGSGACGEVKLAF-ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++++  + D   +  +V E M  G L   + G+ +            +   + YLHE   
Sbjct: 77  IIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE--- 132
Query: 602 TQIIHCDIKPQNILLDDYYN---ARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
             IIH D+KP+N+LL         +I+DFG  K+  L ++     + GT  Y+APE   +
Sbjct: 133 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVLVS 190
Query: 659 MPIT---VKVDVYSYGVLLLEIICL 680
           +        VD +S GV+L   ICL
Sbjct: 191 VGTAGYNRAVDCWSLGVILF--ICL 213

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQ-------DSEKEFKAEVNGIGQTHHKN 541
           LG GA G V   F    +  +VA+K ++ R F        D     + E+  + + +H  
Sbjct: 24  LGSGACGEVKLAF-ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 82
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++++  + D   +  +V E M  G L   + G+ +            +   + YLHE   
Sbjct: 83  IIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE--- 138
Query: 602 TQIIHCDIKPQNILLDDYYN---ARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
             IIH D+KP+N+LL         +I+DFG  K+  L ++     + GT  Y+APE   +
Sbjct: 139 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVLVS 196
Query: 659 MPIT---VKVDVYSYGVLLLEIICL 680
           +        VD +S GV+L   ICL
Sbjct: 197 VGTAGYNRAVDCWSLGVILF--ICL 219

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVK-----KLNRVFQDSEKEFKAEVNGIGQTHHKNL 542
           E +G+G F  V +  +N  +  Q AVK     K       S ++ K E +      H ++
Sbjct: 32  EVIGKGPFSVVRR-CINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 90
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL---------ASFLFGDSKPNWKLRTEIVMGIARGL 593
           V LL          +V+EFM    L         A F++ ++  +  +R      I   L
Sbjct: 91  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ-----ILEAL 145
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNA---RISDFGLEKLLTLDQSHTNTAIR-GTKG 649
            Y H+     IIH D+KP  +LL    N+   ++  FG+   + L +S      R GT  
Sbjct: 146 RYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVGTPH 200
Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEII--CL 680
           ++APE  +  P    VDV+  GV+L  ++  CL
Sbjct: 201 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 233

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 111/245 (45%), Gaps = 27/245 (11%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEKEFKAEVNGIGQTH 538
           EV+    + +G G+FG VY+  +   S + VA+KK+   + F++ E +   +++      
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKKVLQGKAFKNRELQIMRKLD------ 71
Query: 539 HKNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGI 589
           H N+VRL   +   G  +  VY  +    + + ++  ++   + +  +        +  +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 590 ARGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTK 648
            R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSR 186
Query: 649 GYVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVEND 705
            Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 706 LEAMD 710
           +  M+
Sbjct: 247 IREMN 251

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVK-----KLNRVFQDSEKEFKAEVNGIGQTHHKNL 542
           E +G+G F  V +  +N  +  Q AVK     K       S ++ K E +      H ++
Sbjct: 30  EVIGKGPFSVVRRC-INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 543 VRLLGYCDEGRNRLLVYEFMSNGAL---------ASFLFGDSKPNWKLRTEIVMGIARGL 593
           V LL          +V+EFM    L         A F++ ++  +  +R      I   L
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ-----ILEAL 143
Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNA---RISDFGLEKLLTLDQSHTNTAIR-GTKG 649
            Y H+     IIH D+KP  +LL    N+   ++  FG+   + L +S      R GT  
Sbjct: 144 RYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVGTPH 198
Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEII--CL 680
           ++APE  +  P    VDV+  GV+L  ++  CL
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 35/218 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVRLL-G 547
           LGRG FG V++   N       A+K++    ++  +E    EV  + +  H  +VR    
Sbjct: 13  LGRGGFGVVFEA-KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 548 YCDEGRNRLL------VYEFMS-----NGALASFLFGDSKPNWKLRT---EIVMGIARGL 593
           + ++     L      VY ++         L  ++ G      + R+    I + IA  +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 594 FYLHEECCTQIIHCDIKPQNIL--LDDYYNARISDFGLEKLLTLDQSHT----------- 640
            +LH +    ++H D+KP NI   +DD    ++ DFGL   +  D+              
Sbjct: 132 EFLHSKG---LMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
           +T   GTK Y++PE       + KVD++S G++L E++
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 81/150 (54%), Gaps = 15/150 (10%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRL 545
           ++LG G + TVYKG   + + + VA+K++ R+  +      A  EV+ +    H N+V L
Sbjct: 8   DKLGEGTYATVYKGKSKL-TDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTL 65
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFL--FGD--SKPNWKLRTEIVMGIARGLFYLHEECC 601
                  ++  LV+E++    L  +L   G+  +  N KL    +  + RGL Y H +  
Sbjct: 66  HDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNIINMHNVKL---FLFQLLRGLAYCHRQ-- 119
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEK 631
            +++H D+KPQN+L+++    +++DFGL +
Sbjct: 120 -KVLHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 110/245 (44%), Gaps = 27/245 (11%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEKEFKAEVNGIGQTH 538
           EV+    + +G G+FG VY+  +   S + VA+KK+   + F++ E +   +++      
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKKVLQGKAFKNRELQIMRKLD------ 71
Query: 539 HKNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGI 589
           H N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 590 ARGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTK 648
            R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSR 186
Query: 649 GYVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVEND 705
            Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 706 LEAMD 710
           +  M+
Sbjct: 247 IREMN 251

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQ-------DSEKEFKAEVNGIGQTHHKN 541
           LG GA G V   F    +  +VA++ ++ R F        D     + E+  + + +H  
Sbjct: 143 LGSGACGEVKLAF-ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++++  + D   +  +V E M  G L   + G+ +            +   + YLHE   
Sbjct: 202 IIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE--- 257
Query: 602 TQIIHCDIKPQNILLDDYYN---ARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
             IIH D+KP+N+LL         +I+DFG  K+  L ++     + GT  Y+APE   +
Sbjct: 258 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVLVS 315
Query: 659 MPIT---VKVDVYSYGVLLLEIICL 680
           +        VD +S GV+L   ICL
Sbjct: 316 VGTAGYNRAVDCWSLGVILF--ICL 338

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 110/245 (44%), Gaps = 27/245 (11%)
Query: 481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKL--NRVFQDSEKEFKAEVNGIGQTH 538
           EV+    + +G G+FG VY+  +   S + VA+KK+   + F++ E +   +++      
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKKVLQGKAFKNRELQIMRKLD------ 71
Query: 539 HKNLVRL-LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI--------VMGI 589
           H N+VRL   +   G  +  VY  +    +   ++  ++   + +  +        +  +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 590 ARGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTK 648
            R L Y+H      I H DIKPQN+LLD D    ++ DFG  K L   +   N +   ++
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSR 186
Query: 649 GYVAPEW-FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVEND 705
            Y APE  F     T  +DV+S G +L E++  +     D   D   E  + LG      
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 706 LEAMD 710
           +  M+
Sbjct: 247 IREMN 251

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQ-------DSEKEFKAEVNGIGQTHHKN 541
           LG GA G V   F    +  +VA++ ++ R F        D     + E+  + + +H  
Sbjct: 157 LGSGACGEVKLAF-ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 215
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++++  + D   +  +V E M  G L   + G+ +            +   + YLHE   
Sbjct: 216 IIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE--- 271
Query: 602 TQIIHCDIKPQNILLDDYYN---ARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
             IIH D+KP+N+LL         +I+DFG  K+  L ++     + GT  Y+APE   +
Sbjct: 272 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVLVS 329
Query: 659 MPIT---VKVDVYSYGVLLLEIICL 680
           +        VD +S GV+L   ICL
Sbjct: 330 VGTAGYNRAVDCWSLGVILF--ICL 352

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 115/281 (40%), Gaps = 45/281 (16%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIG- 535
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 3   KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 58
Query: 536 ----------QTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI 585
                      +    ++RLL + +   + +L+ E M        LF        L+ E+
Sbjct: 59  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEP---VQDLFDFITERGALQEEL 115
Query: 586 VMGIARGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSH 639
               AR  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +  
Sbjct: 116 ----ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT 168
Query: 640 TNTAIRGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTL 698
             T   GT+ Y  PEW R      +   V+S G+LL +++C       D  ++  +E   
Sbjct: 169 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIR 222
Query: 699 GALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
           G +      + +   +++       WC+   PS RPT   +
Sbjct: 223 GQVFFRQRVSSECQHLIR-------WCLALRPSDRPTFEEI 256

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/265 (21%), Positives = 112/265 (42%), Gaps = 45/265 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKL---NRVFQDSEKE-FKAEVNGIGQTHHKNLVRL 545
           LG+G F   ++  ++   + +V   K+   + + +  ++E    E++      H+++V  
Sbjct: 25  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 546 LGYCDEGRNRLLVYEFMSNGALASF-----LFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
            G+ ++     +V E     +L           + +  + LR +IV+G      YLH   
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHR-- 135
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
             ++IH D+K  N+ L++    +I DFGL   +  D     T + GT  Y+APE      
Sbjct: 136 -NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKG 193
Query: 661 ITVKVDVYSYGVLL---------LEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD 711
            + +VDV+S G ++          E  CL+ T L     +    + +  +  + ++ M  
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 251
Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTM 736
                         +Q DP+ RPT+
Sbjct: 252 --------------LQTDPTARPTI 262

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/265 (21%), Positives = 112/265 (42%), Gaps = 45/265 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKL---NRVFQDSEKE-FKAEVNGIGQTHHKNLVRL 545
           LG+G F   ++  ++   + +V   K+   + + +  ++E    E++      H+++V  
Sbjct: 29  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 546 LGYCDEGRNRLLVYEFMSNGALASF-----LFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
            G+ ++     +V E     +L           + +  + LR +IV+G      YLH   
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHR-- 139
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
             ++IH D+K  N+ L++    +I DFGL   +  D     T + GT  Y+APE      
Sbjct: 140 -NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKG 197
Query: 661 ITVKVDVYSYGVLL---------LEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD 711
            + +VDV+S G ++          E  CL+ T L     +    + +  +  + ++ M  
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 255
Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTM 736
                         +Q DP+ RPT+
Sbjct: 256 --------------LQTDPTARPTI 266

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/265 (21%), Positives = 112/265 (42%), Gaps = 45/265 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKL---NRVFQDSEKE-FKAEVNGIGQTHHKNLVRL 545
           LG+G F   ++  ++   + +V   K+   + + +  ++E    E++      H+++V  
Sbjct: 25  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 546 LGYCDEGRNRLLVYEFMSNGALASF-----LFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
            G+ ++     +V E     +L           + +  + LR +IV+G      YLH   
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHR-- 135
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
             ++IH D+K  N+ L++    +I DFGL   +  D     T + GT  Y+APE      
Sbjct: 136 -NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKG 193
Query: 661 ITVKVDVYSYGVLL---------LEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD 711
            + +VDV+S G ++          E  CL+ T L     +    + +  +  + ++ M  
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 251
Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTM 736
                         +Q DP+ RPT+
Sbjct: 252 --------------LQTDPTARPTI 262

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 79/174 (45%), Gaps = 18/174 (10%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           +GRGAF  V    V M  + QV A+K +N+  + +  E     E   +     +  +  L
Sbjct: 69  IGRGAFSEV--AVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 547 GYCDEGRNRL-LVYEFMSNGALASFL--FGDSKPNWKLR---TEIVMGIARGLFYLHEEC 600
            +  +  N L LV E+   G L + L  FG+  P    R    EIVM I      +H   
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS----VHR-- 180
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
               +H DIKP NILLD   + R++DFG    L  D +  +    GT  Y++PE
Sbjct: 181 -LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 111/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 32  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 87
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 145
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 146 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 202
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++ + E  +G  V 
Sbjct: 203 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFE-HDEEIIGGQVF 255
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
                  +   L R      WC+   PS RPT   +
Sbjct: 256 FRQRVSSECQHLIR------WCLALRPSDRPTFEEI 285

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 111/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 32  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 87
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 145
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 146 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 202
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++ + E  +G  V 
Sbjct: 203 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFE-HDEEIIGGQVF 255
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
                  +   L R      WC+   PS RPT   +
Sbjct: 256 FRQRVSSECQHLIR------WCLALRPSDRPTFEEI 285

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/236 (22%), Positives = 99/236 (41%), Gaps = 49/236 (20%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLV 543
            K  +GRG++G VY  + +  ++  VA+KK+NR+F+D    K    E+  + +     ++
Sbjct: 32  IKHLIGRGSYGYVYLAY-DKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYII 90
Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVM----------GIARG 592
           RL        + ++  + +    L   L   DS      +T I +           +  G
Sbjct: 91  RL-------HDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLG 143
Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-------------- 638
             ++HE   + IIH D+KP N LL+   + +I DFGL + +  D+               
Sbjct: 144 EKFIHE---SGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENE 200
Query: 639 ----HTNTAIRGTKGYVAPEWFRNMPI-------TVKVDVYSYGVLLLEIICLRRT 683
               H     +    +V   W+R   +       T  +D++S G +  E++ + ++
Sbjct: 201 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKS 256

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 111/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 31  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 86
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 144
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 145 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 201
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++ + E  +G  V 
Sbjct: 202 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFE-HDEEIIGGQVF 254
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
                  +   L R      WC+   PS RPT   +
Sbjct: 255 FRQRVSSECQHLIR------WCLALRPSDRPTFEEI 284

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 111/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 31  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 86
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 144
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 145 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 201
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++ + E  +G  V 
Sbjct: 202 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFE-HDEEIIGGQVF 254
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
                  +   L R      WC+   PS RPT   +
Sbjct: 255 FRQRVSSECQHLIR------WCLALRPSDRPTFEEI 284

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 111/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 32  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 87
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 145
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 146 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 202
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++ + E  +G  V 
Sbjct: 203 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFE-HDEEIIGGQVF 255
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
                  +   L R      WC+   PS RPT   +
Sbjct: 256 FRQRVSXECQHLIR------WCLALRPSDRPTFEEI 285

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 111/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 32  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 87
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 145
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 146 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 202
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++ + E  +G  V 
Sbjct: 203 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFE-HDEEIIGGQVF 255
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
                  +   L R      WC+   PS RPT   +
Sbjct: 256 FRQRVSXECQHLIR------WCLALRPSDRPTFEEI 285

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 63/128 (49%), Gaps = 15/128 (11%)
Query: 557 LVYEFMSNGALASF--LFGDSKPNW------KLRTEIVMGIARGLFYLHEECCTQIIHCD 608
           ++YE+M N ++  F   F     N+      ++   I+  +     Y+H E    I H D
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRD 177
Query: 609 IKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT--VKVD 666
           +KP NIL+D     ++SDFG E    +D+    +  RGT  ++ PE+F N       KVD
Sbjct: 178 VKPSNILMDKNGRVKLSDFG-ESEYMVDKKIKGS--RGTYEFMPPEFFSNESSYNGAKVD 234
Query: 667 VYSYGVLL 674
           ++S G+ L
Sbjct: 235 IWSLGICL 242

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 111/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 31  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 86
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 144
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 145 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 201
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++ + E  +G  V 
Sbjct: 202 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFE-HDEEIIGGQVF 254
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
                  +   L R      WC+   PS RPT   +
Sbjct: 255 FRQRVSXECQHLIR------WCLALRPSDRPTFEEI 284

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 85/190 (44%), Gaps = 10/190 (5%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           +++G G FG V +   +  +++ VAVK + R  +  ++  K E+       H N+VR   
Sbjct: 25  KDIGAGNFG-VARLMRDKQANELVAVKYIER-GEKIDENVKREIINHRSLRHPNIVRFKE 82
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
                 +  +V E+ S G L   +    + +          +  G+ Y H     Q+ H 
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAH---AMQVAHR 139
Query: 608 DIKPQNILLDDYYNAR--ISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 665
           D+K +N LLD     R  I+DFG  K   L  S   +A+ GT  Y+APE         KV
Sbjct: 140 DLKLENTLLDGSPAPRLKIADFGYSKASVL-HSQPKSAV-GTPAYIAPEVLLKKEYDGKV 197
Query: 666 -DVYSYGVLL 674
            DV+S GV L
Sbjct: 198 ADVWSCGVTL 207

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA-IRGT 647
           +ARG+ +L    C   IH D+  +NILL +    +I DFGL + +  +  +      R  
Sbjct: 208 VARGMEFLSSRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICL 680
             ++APE   +   + K DV+SYGVLL EI  L
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSL 297

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 107/263 (40%), Gaps = 35/263 (13%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG G FG+VY G + +  +  VA+K + +   D   ++    NG        L++ +   
Sbjct: 12  LGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 550 DEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIARGLFYLHEECCTQ 603
             G  RLL  ++         +    +P   L      R  +   +AR  F+   E    
Sbjct: 68  FSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 604 -----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
                ++H DIK +NIL+D +    ++ DFG   LL   +    T   GT+ Y  PEW R
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 182
Query: 658 NMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ 716
                 +   V+S G+LL +++C       D  ++ + E  +G  V        +   L 
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVC------GDIPFE-HDEEIIGGQVFFRQRVSSECQHLI 235
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
           R      WC+   PS RPT   +
Sbjct: 236 R------WCLALRPSDRPTFEEI 252

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 24/200 (12%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK--AEVNG---IGQTHHKNLVR 544
           LG G++G V+K   +       AVK+    F+  +   +  AEV     +GQ  H   VR
Sbjct: 65  LGHGSYGEVFK-VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ--HPCCVR 121
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASF--LFGDSKPN---WKLRTEIVMGIARGLFYLHEE 599
           L    +EG    L  E +   +L      +G S P    W    + ++ +A    +LH +
Sbjct: 122 LEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA----HLHSQ 176
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               ++H D+KP NI L      ++ DFGL  L+ L  +       G   Y+APE  +  
Sbjct: 177 G---LVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMAPELLQGS 231
Query: 660 PITVKVDVYSYGVLLLEIIC 679
             T   DV+S G+ +LE+ C
Sbjct: 232 YGTA-ADVFSLGLTILEVAC 250

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVFQDSEKE------FKAEVNGIGQTHHKN 541
           LG GAFG V+   V+   + +V VK  K  +V +D   E         E+  + +  H N
Sbjct: 32  LGSGAFGFVWTA-VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP--NWKLRTEIVMGIARGLFYLHEE 599
           ++++L   +      LV E   +G L  F F D  P  +  L + I   +   + YL   
Sbjct: 91  IIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR-- 147
Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               IIH DIK +NI++ + +  ++ DFG      L++        GT  Y APE     
Sbjct: 148 -LKDIIHRDIKDENIVIAEDFTIKLIDFG--SAAYLERGKLFYTFCGTIEYCAPEVLMGN 204
Query: 660 PIT-VKVDVYSYGVLLLEII 678
           P    +++++S GV L  ++
Sbjct: 205 PYRGPELEMWSLGVTLYTLV 224

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 103/238 (43%), Gaps = 30/238 (12%)
Query: 478 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ- 536
           EL E+    +  L  G F  VY+   ++GS  + A+K+L    ++  +    EV  + + 
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEA-QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKL 82
Query: 537 THHKNLVRLLGYC-------DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGI 589
           + H N+V+            D G+   L+   +  G L  FL    +    L  + V+ I
Sbjct: 83  SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL-KKMESRGPLSCDTVLKI 141
Query: 590 ----ARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR 645
                R + ++H +    IIH D+K +N+LL +    ++ DFG    ++    ++ +A R
Sbjct: 142 FYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 646 -----------GTKGYVAPE---WFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA 689
                       T  Y  PE    + N PI  K D+++ G +L  ++C R+    D A
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY-LLCFRQHPFEDGA 257

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 19  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 74
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 75  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 132
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 133 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 189
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++  +E   G +  
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFF 243
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
               + +   +++       WC+   PS RPT   +
Sbjct: 244 RQRVSXECQHLIR-------WCLALRPSDRPTFEEI 272

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 100/233 (42%), Gaps = 40/233 (17%)
Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVR 544
           K  +GRG++G VY  + +  +   VA+KK+NR+F+D    K    E+  + +     ++R
Sbjct: 31  KHLIGRGSYGYVYLAY-DKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIR 89
Query: 545 L--------LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYL 596
           L        L   DE     +V E   +     F          ++T I+  +  G  ++
Sbjct: 90  LYDLIIPDDLLKFDE---LYIVLEIADSDLKKLFKTPIFLTEEHIKT-ILYNLLLGENFI 145
Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS---------------HTN 641
           HE   + IIH D+KP N LL+   + ++ DFGL + +  ++                H  
Sbjct: 146 HE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 642 TAIRGTKGYVAPEWFRNMPI-------TVKVDVYSYGVLLLEIICLRRTILTD 687
              +    +V   W+R   +       T  +D++S G +  E++ + ++ + D
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/265 (21%), Positives = 111/265 (41%), Gaps = 45/265 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKL---NRVFQDSEKE-FKAEVNGIGQTHHKNLVRL 545
           LG+G F   ++  ++   + +V   K+   + + +  ++E    E++      H+++V  
Sbjct: 49  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 546 LGYCDEGRNRLLVYEFMSNGALASF-----LFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
            G+ ++     +V E     +L           + +  + LR +IV+G      YLH   
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHR-- 159
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
             ++IH D+K  N+ L++    +I DFGL   +  D       + GT  Y+APE      
Sbjct: 160 -NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKG 217
Query: 661 ITVKVDVYSYGVLL---------LEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD 711
            + +VDV+S G ++          E  CL+ T L     +    + +  +  + ++ M  
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 275
Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTM 736
                         +Q DP+ RPT+
Sbjct: 276 --------------LQTDPTARPTI 286

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 89/193 (46%), Gaps = 12/193 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           LG G+F ++ +  V+  S+   AVK ++ R+  +++KE  A     G   H N+V+L   
Sbjct: 19  LGEGSF-SICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG---HPNIVKLHEV 74
Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCD 608
             +  +  LV E ++ G L   +      +    + I+  +   + ++H+     ++H D
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRD 131
Query: 609 IKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 665
           +KP+N+L    +D    +I DFG  +L   D     T    T  Y APE           
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNGYDESC 190
Query: 666 DVYSYGVLLLEII 678
           D++S GV+L  ++
Sbjct: 191 DLWSLGVILYTML 203

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 18  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 73
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 74  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 131
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 132 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 188
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++  +E   G +  
Sbjct: 189 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFF 242
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
               + +   +++       WC+   PS RPT   +
Sbjct: 243 RQRVSXECQHLIR-------WCLALRPSDRPTFEEI 271

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 7/195 (3%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           LG+G FG V        +    A+K L +  +    E       N + Q      +  L 
Sbjct: 156 LGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEECCTQIIH 606
           Y  +  +RL      +NG    F     +   + R       I   L YLH E    +++
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVY 272
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D+K +N++LD   + +I+DFGL K    D +   T   GT  Y+APE   +      VD
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGRAVD 331
Query: 667 VYSYGVLLLEIICLR 681
            +  GV++ E++C R
Sbjct: 332 WWGLGVVMYEMMCGR 346

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 100/258 (38%), Gaps = 41/258 (15%)
Query: 522 DSEKEFKAEVNGIGQTHHKNLVRLLG--YCDEGRNRLLVYEFMSNGALASFLFGDSKPNW 579
           + E   K E+  + +  HKN+++L+   Y +E +   +V E+   G        DS P  
Sbjct: 48  NGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEK 104
Query: 580 KLRTEIVMG----IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL-EKLLT 634
           +       G    +  GL YLH +    I+H DIKP N+LL      +IS  G+ E L  
Sbjct: 105 RFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161
Query: 635 LDQSHTNTAIRGTKGYVAPEWFRNMPI--TVKVDVYSYGVLLLEIICLRRTILTDWAYDC 692
                T    +G+  +  PE    +      KVD++S GV L  I         D  Y  
Sbjct: 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL 221
Query: 693 YQERTLGAL---------VENDLEAMDDMTVLQRFVMVAI----WCIQEDPSHRPTMRRV 739
           ++    G+          + + L+ M +    +RF +  I    W  ++ P         
Sbjct: 222 FENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE------ 275
Query: 740 TQMLEGVVEVPIPPCPWT 757
                    VPIPP P T
Sbjct: 276 -------APVPIPPSPDT 286

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 7/195 (3%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           LG+G FG V        +    A+K L +  +    E       N + Q      +  L 
Sbjct: 159 LGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 217
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEECCTQIIH 606
           Y  +  +RL      +NG    F     +   + R       I   L YLH E    +++
Sbjct: 218 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVY 275
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D+K +N++LD   + +I+DFGL K    D +   T   GT  Y+APE   +      VD
Sbjct: 276 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGRAVD 334
Query: 667 VYSYGVLLLEIICLR 681
            +  GV++ E++C R
Sbjct: 335 WWGLGVVMYEMMCGR 349

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 46  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 101
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 102 PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 159
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 160 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 216
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++  +E   G +  
Sbjct: 217 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFF 270
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
               + +   +++       WC+   PS RPT   +
Sbjct: 271 RQRVSXECQHLIR-------WCLALRPSDRPTFEEI 299

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 51  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 106
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 107 PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 164
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 165 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 221
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++  +E   G +  
Sbjct: 222 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFF 275
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
               + +   +++       WC+   PS RPT   +
Sbjct: 276 RQRVSXECQHLIR-------WCLALRPSDRPTFEEI 304

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 26  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 81
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 82  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 139
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 140 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 196
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++  +E   G +  
Sbjct: 197 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFF 250
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
               + +   +++       WC+   PS RPT   +
Sbjct: 251 RQRVSXECQHLIR-------WCLALRPSDRPTFEEI 279

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 4   KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 59
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 60  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 117
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 118 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 174
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++  +E   G +  
Sbjct: 175 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFF 228
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
               + +   +++       WC+   PS RPT   +
Sbjct: 229 RQRVSSECQHLIR-------WCLALRPSDRPTFEEI 257

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 82/190 (43%), Gaps = 10/190 (5%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           +++G G FG V +   +  S++ VAVK + R  +  ++  K E+       H N+VR   
Sbjct: 24  KDIGSGNFG-VARLMRDKQSNELVAVKYIER-GEKIDENVKREIINHRSLRHPNIVRFKE 81
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
                 +  +V E+ S G L   +    + +          +  G+ Y H     Q+ H 
Sbjct: 82  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH---AMQVCHR 138
Query: 608 DIKPQNILLDDYYNAR--ISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 665
           D+K +N LLD     R  I DFG  K   L     +T   GT  Y+APE         KV
Sbjct: 139 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLKKEYDGKV 196
Query: 666 -DVYSYGVLL 674
            DV+S GV L
Sbjct: 197 ADVWSCGVTL 206

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/265 (21%), Positives = 111/265 (41%), Gaps = 45/265 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKL---NRVFQDSEKE-FKAEVNGIGQTHHKNLVRL 545
           LG+G F   ++  ++   + +V   K+   + + +  ++E    E++      H+++V  
Sbjct: 47  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 104
Query: 546 LGYCDEGRNRLLVYEFMSNGALASF-----LFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
            G+ ++     +V E     +L           + +  + LR +IV+G      YLH   
Sbjct: 105 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHR-- 157
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
             ++IH D+K  N+ L++    +I DFGL   +  D       + GT  Y+APE      
Sbjct: 158 -NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKG 215
Query: 661 ITVKVDVYSYGVLL---------LEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD 711
            + +VDV+S G ++          E  CL+ T L     +    + +  +  + ++ M  
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 273
Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTM 736
                         +Q DP+ RPT+
Sbjct: 274 --------------LQTDPTARPTI 284

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 7/91 (7%)
Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK 648
           I  GL ++H      +++ D+KP NILLD++ + RISD GL    +  + H +    GT 
Sbjct: 300 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTH 353
Query: 649 GYVAPEWF-RNMPITVKVDVYSYGVLLLEII 678
           GY+APE   + +      D +S G +L +++
Sbjct: 354 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/265 (21%), Positives = 111/265 (41%), Gaps = 45/265 (16%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKL---NRVFQDSEKE-FKAEVNGIGQTHHKNLVRL 545
           LG+G F   ++  ++   + +V   K+   + + +  ++E    E++      H+++V  
Sbjct: 23  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 546 LGYCDEGRNRLLVYEFMSNGALASF-----LFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
            G+ ++     +V E     +L           + +  + LR +IV+G      YLH   
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHR-- 133
Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
             ++IH D+K  N+ L++    +I DFGL   +  D       + GT  Y+APE      
Sbjct: 134 -NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKG 191
Query: 661 ITVKVDVYSYGVLL---------LEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD 711
            + +VDV+S G ++          E  CL+ T L     +    + +  +  + ++ M  
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 249
Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTM 736
                         +Q DP+ RPT+
Sbjct: 250 --------------LQTDPTARPTI 260

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 7/91 (7%)
Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK 648
           I  GL ++H      +++ D+KP NILLD++ + RISD GL    +  + H +    GT 
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTH 354
Query: 649 GYVAPEWF-RNMPITVKVDVYSYGVLLLEII 678
           GY+APE   + +      D +S G +L +++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 19  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 74
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 75  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 132
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 133 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 189
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++  +E   G +  
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFF 243
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
               + +   +++       WC+   PS RPT   +
Sbjct: 244 RQRVSSECQHLIR-------WCLALRPSDRPTFEEI 272

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 38  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 93
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 94  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 151
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 152 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 208
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++  +E   G +  
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFF 262
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
               + +   +++       WC+   PS RPT   +
Sbjct: 263 RQRVSSECQHLIR-------WCLALRPSDRPTFEEI 291

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 18  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 73
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 74  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 131
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 132 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 188
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++  +E   G +  
Sbjct: 189 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFF 242
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
               + +   +++       WC+   PS RPT   +
Sbjct: 243 RQRVSSECQHLIR-------WCLALRPSDRPTFEEI 271

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 84/197 (42%), Gaps = 12/197 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR----VFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG+G FG V    V   ++ +    K+ R    + +D       E   +  T H  L   
Sbjct: 13  LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 69
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEECCTQI 604
           L Y  +  +RL      +NG    F     +   + R       I   L YLH      +
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 126
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           ++ DIK +N++LD   + +I+DFGL K    D +   T   GT  Y+APE   +      
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRA 185
Query: 665 VDVYSYGVLLLEIICLR 681
           VD +  GV++ E++C R
Sbjct: 186 VDWWGLGVVMYEMMCGR 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 84/197 (42%), Gaps = 12/197 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR----VFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG+G FG V    V   ++ +    K+ R    + +D       E   +  T H  L   
Sbjct: 13  LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 69
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEECCTQI 604
           L Y  +  +RL      +NG    F     +   + R       I   L YLH      +
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 126
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           ++ DIK +N++LD   + +I+DFGL K    D +   T   GT  Y+APE   +      
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRA 185
Query: 665 VDVYSYGVLLLEIICLR 681
           VD +  GV++ E++C R
Sbjct: 186 VDWWGLGVVMYEMMCGR 202

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 7/91 (7%)
Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK 648
           I  GL ++H      +++ D+KP NILLD++ + RISD GL    +  + H +    GT 
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTH 354
Query: 649 GYVAPEWF-RNMPITVKVDVYSYGVLLLEII 678
           GY+APE   + +      D +S G +L +++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 7/91 (7%)
Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK 648
           I  GL ++H      +++ D+KP NILLD++ + RISD GL    +  + H +    GT 
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTH 354
Query: 649 GYVAPEWF-RNMPITVKVDVYSYGVLLLEII 678
           GY+APE   + +      D +S G +L +++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 3   KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 58
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 59  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 116
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 117 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 173
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++  +E   G +  
Sbjct: 174 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFF 227
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
               + +   +++       WC+   PS RPT   +
Sbjct: 228 RQRVSSECQHLIR-------WCLALRPSDRPTFEEI 256

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 4   KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 59
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 60  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 117
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 118 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 174
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++  +E   G +  
Sbjct: 175 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFF 228
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
               + +   +++       WC+   PS RPT   +
Sbjct: 229 RQRVSSECQHLIR-------WCLALRPSDRPTFEEI 257

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 31  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 86
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 144
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 145 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 201
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++  +E   G +  
Sbjct: 202 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFF 255
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
               + +   +++       WC+   PS RPT   +
Sbjct: 256 RQRVSSECQHLIR-------WCLALRPSDRPTFEEI 284

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 84/197 (42%), Gaps = 12/197 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR----VFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG+G FG V    V   ++ +    K+ R    + +D       E   +  T H  L   
Sbjct: 16  LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 72
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEECCTQI 604
           L Y  +  +RL      +NG    F     +   + R       I   L YLH      +
Sbjct: 73  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 129
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           ++ DIK +N++LD   + +I+DFGL K    D +   T   GT  Y+APE   +      
Sbjct: 130 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRA 188
Query: 665 VDVYSYGVLLLEIICLR 681
           VD +  GV++ E++C R
Sbjct: 189 VDWWGLGVVMYEMMCGR 205

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           LG+G FG V        +    A+K L +  +    E       N + Q      +  L 
Sbjct: 18  LGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 76
Query: 548 YCDEGRNRL-LVYEFMSNGALASFL-----FGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           Y  +  +RL  V E+ + G L   L     F + +  +    EIV      L YLH E  
Sbjct: 77  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIV----SALDYLHSE-- 129
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +++ D+K +N++LD   + +I+DFGL K    D + T     GT  Y+APE   +   
Sbjct: 130 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFCGTPEYLAPEVLEDNDY 188
Query: 662 TVKVDVYSYGVLLLEIICLR 681
              VD +  GV++ E++C R
Sbjct: 189 GRAVDWWGLGVVMYEMMCGR 208

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 46  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 101
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 102 PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 159
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 160 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 216
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++  +E   G +  
Sbjct: 217 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFF 270
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
               + +   +++       WC+   PS RPT   +
Sbjct: 271 RQRVSSECQHLIR-------WCLALRPSDRPTFEEI 299

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           LG+G FG V        +    A+K L +  +    E       N + Q      +  L 
Sbjct: 17  LGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 75
Query: 548 YCDEGRNRL-LVYEFMSNGALASFL-----FGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           Y  +  +RL  V E+ + G L   L     F + +  +    EIV      L YLH E  
Sbjct: 76  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIV----SALDYLHSE-- 128
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +++ D+K +N++LD   + +I+DFGL K    D + T     GT  Y+APE   +   
Sbjct: 129 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFCGTPEYLAPEVLEDNDY 187
Query: 662 TVKVDVYSYGVLLLEIICLR 681
              VD +  GV++ E++C R
Sbjct: 188 GRAVDWWGLGVVMYEMMCGR 207

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 84/197 (42%), Gaps = 12/197 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR----VFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG+G FG V    V   ++ +    K+ R    + +D       E   +  T H  L   
Sbjct: 18  LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 74
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEECCTQI 604
           L Y  +  +RL      +NG    F     +   + R       I   L YLH      +
Sbjct: 75  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 131
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           ++ DIK +N++LD   + +I+DFGL K    D + T     GT  Y+APE   +      
Sbjct: 132 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEYLAPEVLEDNDYGRA 190
Query: 665 VDVYSYGVLLLEIICLR 681
           VD +  GV++ E++C R
Sbjct: 191 VDWWGLGVVMYEMMCGR 207

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 84/197 (42%), Gaps = 12/197 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR----VFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG+G FG V    V   ++ +    K+ R    + +D       E   +  T H  L   
Sbjct: 13  LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 69
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEECCTQI 604
           L Y  +  +RL      +NG    F     +   + R       I   L YLH      +
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 126
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           ++ DIK +N++LD   + +I+DFGL K    D + T     GT  Y+APE   +      
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEYLAPEVLEDNDYGRA 185
Query: 665 VDVYSYGVLLLEIICLR 681
           VD +  GV++ E++C R
Sbjct: 186 VDWWGLGVVMYEMMCGR 202

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 7/195 (3%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           LG+G FG V        +    A+K L +  +    E       N + Q      +  L 
Sbjct: 16  LGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 74
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEECCTQIIH 606
           Y  +  +RL      +NG    F     +   + R       I   L YLH E    +++
Sbjct: 75  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVY 132
Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 666
            D+K +N++LD   + +I+DFGL K    D + T     GT  Y+APE   +      VD
Sbjct: 133 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFCGTPEYLAPEVLEDNDYGRAVD 191
Query: 667 VYSYGVLLLEIICLR 681
            +  GV++ E++C R
Sbjct: 192 WWGLGVVMYEMMCGR 206

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 4   KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 59
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 60  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 117
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 118 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 174
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++  +E   G +  
Sbjct: 175 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFF 228
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
               + +   +++       WC+   PS RPT   +
Sbjct: 229 RQRVSSECQHLIR-------WCLALRPSDRPTFEEI 257

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 108/263 (41%), Gaps = 35/263 (13%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG G FG+VY G + +  +  VA+K + +   D   ++    NG        L++ +   
Sbjct: 12  LGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 550 DEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIARGLFYLHEECCTQ 603
             G  RLL  ++         +    +P   L      R  +   +AR  F+   E    
Sbjct: 68  FSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 604 -----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
                ++H DIK +NIL+D +    ++ DFG   LL   +    T   GT+ Y  PEW R
Sbjct: 126 CHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 182
Query: 658 NMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ 716
                 +   V+S G+LL +++C       D  ++  +E   G +      + +   +++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFFRQRVSXECQHLIR 236
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
                  WC+   PS RPT   +
Sbjct: 237 -------WCLALRPSDRPTFEEI 252

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE----FKAEVNGIGQTHHKNLVRL 545
           +GRGAFG V    V   S+ +V   KL   F+  ++     F  E + +   +   +V+L
Sbjct: 77  IGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLR---TEIVMGIARGLFYLHEECCT 602
                + R   +V E+M  G L + +     P    R    E+V+ +      +H     
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA----IH---SM 187
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGL-EKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP- 660
             IH D+KP N+LLD   + +++DFG   K+        +TA+ GT  Y++PE  ++   
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 246
Query: 661 ---ITVKVDVYSYGVLLLEIIC 679
                 + D +S GV L E++ 
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLV 268

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE----FKAEVNGIGQTHHKNLVRL 545
           +GRGAFG V    V   S+ +V   KL   F+  ++     F  E + +   +   +V+L
Sbjct: 82  IGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLR---TEIVMGIARGLFYLHEECCT 602
                + R   +V E+M  G L + +     P    R    E+V+ +      +H     
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA----IH---SM 192
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGL-EKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP- 660
             IH D+KP N+LLD   + +++DFG   K+        +TA+ GT  Y++PE  ++   
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 251
Query: 661 ---ITVKVDVYSYGVLLLEIIC 679
                 + D +S GV L E++ 
Sbjct: 252 DGYYGRECDWWSVGVFLYEMLV 273

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 84/197 (42%), Gaps = 12/197 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR----VFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG+G FG V    V   ++ +    K+ R    + +D       E   +  T H  L   
Sbjct: 13  LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 69
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEECCTQI 604
           L Y  +  +RL      +NG    F     +   + R       I   L YLH      +
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 126
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           ++ DIK +N++LD   + +I+DFGL K    D + T     GT  Y+APE   +      
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEYLAPEVLEDNDYGRA 185
Query: 665 VDVYSYGVLLLEIICLR 681
           VD +  GV++ E++C R
Sbjct: 186 VDWWGLGVVMYEMMCGR 202

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +M + +  A+K L++      KE +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+   G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+++D     +++DFGL K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLMIDQQGYIKVTDFGLAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE----FKAEVNGIGQTHHKNLVRL 545
           +GRGAFG V    V   S+ +V   KL   F+  ++     F  E + +   +   +V+L
Sbjct: 82  IGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLR---TEIVMGIARGLFYLHEECCT 602
                + R   +V E+M  G L + +     P    R    E+V+ +      +H     
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA----IH---SM 192
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGL-EKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP- 660
             IH D+KP N+LLD   + +++DFG   K+        +TA+ GT  Y++PE  ++   
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 251
Query: 661 ---ITVKVDVYSYGVLLLEIIC 679
                 + D +S GV L E++ 
Sbjct: 252 DGYYGRECDWWSVGVFLYEMLV 273

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 2   KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 57
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 58  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 115
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 116 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 172
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++  +E   G +  
Sbjct: 173 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFF 226
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
               + +   +++       WC+   PS RPT   +
Sbjct: 227 RQRVSSECQHLIR-------WCLALRPSDRPTFEEI 255

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 13/104 (12%)
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGY 650
           +G+ YLH     ++IH D+K  N+ L+D  + +I DFGL   +  D     T + GT  Y
Sbjct: 153 QGVQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNY 208
Query: 651 VAPEWFRNMPITVKVDVYSYGVLL---------LEIICLRRTIL 685
           +APE       + +VD++S G +L          E  CL+ T +
Sbjct: 209 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYI 252

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 108/263 (41%), Gaps = 35/263 (13%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG G FG+VY G + +  +  VA+K + +   D   ++    NG        L++ +   
Sbjct: 12  LGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 550 DEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIARGLFYLHEECCTQ 603
             G  RLL  ++         +    +P   L      R  +   +AR  F+   E    
Sbjct: 68  FSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 604 -----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
                ++H DIK +NIL+D +    ++ DFG   LL   +    T   GT+ Y  PEW R
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 182
Query: 658 NMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ 716
                 +   V+S G+LL +++C       D  ++  +E   G +      + +   +++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFFRQRVSSECQHLIR 236
Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
                  WC+   PS RPT   +
Sbjct: 237 -------WCLALRPSDRPTFEEI 252

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 84/197 (42%), Gaps = 12/197 (6%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR----VFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG+G FG V    V   ++ +    K+ R    + +D       E   +  T H  L   
Sbjct: 13  LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 69
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEECCTQI 604
           L Y  +  +RL      +NG    F     +   + R       I   L YLH      +
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 126
Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           ++ DIK +N++LD   + +I+DFGL K    D + T     GT  Y+APE   +      
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEYLAPEVLEDNDYGRA 185
Query: 665 VDVYSYGVLLLEIICLR 681
           VD +  GV++ E++C R
Sbjct: 186 VDWWGLGVVMYEMMCGR 202

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 41/217 (18%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHHKNLVRLL 546
           E +G+G +G V++G       + VAVK  +   +D +  F+  E+       H+N++  +
Sbjct: 43  ECVGKGRYGEVWRG---SWQGENVAVKIFSS--RDEKSWFRETELYNTVMLRHENILGFI 97
Query: 547 GYCDEGRNR----LLVYEFMSNGALASFLFGDSKPNWKLRT-------EIVMGIARGLFY 595
                 R+      L+  +   G+L  +L        +L T        IV+ IA GL +
Sbjct: 98  ASDMTSRHSSTQLWLITHYHEMGSLYDYL--------QLTTLDTVSCLRIVLSIASGLAH 149
Query: 596 LHEECC-TQ----IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT---NTAIRGT 647
           LH E   TQ    I H D+K +NIL+       I+D GL  + +   +     N    GT
Sbjct: 150 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 209
Query: 648 KGYVAPEWFRNMPITV-------KVDVYSYGVLLLEI 677
           K Y+APE   +  I V       +VD++++G++L E+
Sbjct: 210 KRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 41/217 (18%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHHKNLVRLL 546
           E +G+G +G V++G       + VAVK  +   +D +  F+  E+       H+N++  +
Sbjct: 14  ECVGKGRYGEVWRG---SWQGENVAVKIFSS--RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 547 GYCDEGRNR----LLVYEFMSNGALASFLFGDSKPNWKLRT-------EIVMGIARGLFY 595
                 R+      L+  +   G+L  +L        +L T        IV+ IA GL +
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL--------QLTTLDTVSCLRIVLSIASGLAH 120
Query: 596 LHEECC-TQ----IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT---NTAIRGT 647
           LH E   TQ    I H D+K +NIL+       I+D GL  + +   +     N    GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 648 KGYVAPEWFRNMPITV-------KVDVYSYGVLLLEI 677
           K Y+APE   +  I V       +VD++++G++L E+
Sbjct: 181 KRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 37/215 (17%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT---HHKNLVR 544
           +++G+G +G V+ G       ++VAVK    VF  +E+        I QT    H+N++ 
Sbjct: 43  KQIGKGRYGEVWMG---KWRGEKVAVK----VFFTTEEASWFRETEIYQTVLMRHENILG 95
Query: 545 LLGYCDEGRNR----LLVYEFMSNGALASFLFG---DSKPNWKLRTEIVMGIARGLFYLH 597
            +    +G        L+ ++  NG+L  +L     D+K   KL    V     GL +LH
Sbjct: 96  FIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSV----SGLCHLH 151
Query: 598 EEC-CTQ----IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT----NTAIRGTK 648
            E   TQ    I H D+K +NIL+       I+D GL      D +      NT + GTK
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTK 210
Query: 649 GYVAPEWF-----RN-MPITVKVDVYSYGVLLLEI 677
            Y+ PE       RN     +  D+YS+G++L E+
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 37/228 (16%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA-----EVNGIGQTHHK 540
            K  LG GA+G V     +  + + VA+KK+    +  +K   A     E+  +    H+
Sbjct: 15  LKSLLGEGAYGVVCSA-THKPTGEIVAIKKI----EPFDKPLFALRTLREIKILKHFKHE 69
Query: 541 NLVRLLGY--CDEGRNRLLVY---EFMS---NGALASFLFGDSKPNWKLRTEIVMGIARG 592
           N++ +      D   N   VY   E M    +  +++ +  D    +      +    R 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLRA 124
Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL---TLDQSHTNTAIRGTKG 649
           +  LH    + +IH D+KP N+L++   + ++ DFGL +++     D S       G   
Sbjct: 125 VKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 650 YVAPEWFRNMPITV-------KVDVYSYGVLLLEIICLRRTILTDWAY 690
           YVA  W+R   + +        +DV+S G +L E+  LRR I     Y
Sbjct: 182 YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFPGRDY 228

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 80/192 (41%), Gaps = 10/192 (5%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +++G G FG V +   +  + + VAVK + R     E   + E+       H N+VR 
Sbjct: 24  FVKDIGSGNFG-VARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRF 81
Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
                   +  ++ E+ S G L   +    + +          +  G+ Y H     QI 
Sbjct: 82  KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS---MQIC 138
Query: 606 HCDIKPQNILLDDYYNAR--ISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
           H D+K +N LLD     R  I DFG  K   L     +T   GT  Y+APE         
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLRQEYDG 196
Query: 664 KV-DVYSYGVLL 674
           K+ DV+S GV L
Sbjct: 197 KIADVWSCGVTL 208

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 41/217 (18%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-AEVNGIGQTHHKNLVRLL 546
           E +G+G +G V++G       + VAVK  +   +D +  F+  E+       H+N++  +
Sbjct: 14  ECVGKGRYGEVWRG---SWQGENVAVKIFSS--RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 547 GYCDEGRNR----LLVYEFMSNGALASFLFGDSKPNWKLRT-------EIVMGIARGLFY 595
                 R+      L+  +   G+L  +L        +L T        IV+ IA GL +
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL--------QLTTLDTVSCLRIVLSIASGLAH 120
Query: 596 LHEECC-TQ----IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT---NTAIRGT 647
           LH E   TQ    I H D+K +NIL+       I+D GL  + +   +     N    GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 648 KGYVAPEWFRNMPITV-------KVDVYSYGVLLLEI 677
           K Y+APE   +  I V       +VD++++G++L E+
Sbjct: 181 KRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +M + +  A+K L++      KE +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+   G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+++D     +++DFGL K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLMIDQQGYIQVTDFGLAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           +G G+FG V     +M + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  IGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+M  G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           +G G+FG V     +M + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  IGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+M  G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 80/190 (42%), Gaps = 10/190 (5%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           +++G G FG V +   +  S++ VAVK + R  +      K E+       H N+VR   
Sbjct: 25  KDIGSGNFG-VARLMRDKQSNELVAVKYIER-GEKIAANVKREIINHRSLRHPNIVRFKE 82
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
                 +  +V E+ S G L   +    + +          +  G+ Y H     Q+ H 
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH---AMQVCHR 139
Query: 608 DIKPQNILLDDYYNAR--ISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 665
           D+K +N LLD     R  I DFG  K   L     +T   GT  Y+APE         KV
Sbjct: 140 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLKKEYDGKV 197
Query: 666 -DVYSYGVLL 674
            DV+S GV L
Sbjct: 198 ADVWSCGVTL 207

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 35/276 (12%)
Query: 477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ 536
           KE +E        LG G FG+VY G + +  +  VA+K + +   D   ++    NG   
Sbjct: 19  KEPLESQYQVGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEK---DRISDWGELPNGTRV 74
Query: 537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKL------RTEIVMGIA 590
                L++ +     G  RLL  ++         +    +P   L      R  +   +A
Sbjct: 75  PMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 132
Query: 591 RGLFYLHEECCTQ-----IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAI 644
           R  F+   E         ++H DIK +NIL+D +    ++ DFG   LL   +    T  
Sbjct: 133 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 189
Query: 645 RGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
            GT+ Y  PEW R      +   V+S G+LL +++C       D  ++  +E   G +  
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC------GDIPFEHDEEIIRGQVFF 243
Query: 704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
               + +   +++       WC+   P  RPT   +
Sbjct: 244 RQRVSXECQHLIR-------WCLALRPXDRPTFEEI 272

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +M + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 50  LGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E++  G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 161
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +   +  T T + GT  Y+APE   +    
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRTWT-LCGTPEYLAPEIILSKGYN 217
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +M + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 35  LGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 93
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E++  G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 94  FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 146
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +   +  T T + GT  Y+APE   +    
Sbjct: 147 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRTWT-LCGTPEYLAPEIILSKGYN 202
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 203 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 241

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +M + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+++ G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 491 GRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCD 550
           G+G FGTV  G     +   VA+KK+ +  +   +E +  +  +   HH N+V+L  Y  
Sbjct: 32  GQGTFGTVQLG-KEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNIVQLQSYFY 89
Query: 551 E--GRNRLLVY-----EFMSNG---ALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
               R+R  +Y     E++ +       ++      P   L    +  + R +  LH   
Sbjct: 90  TLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS 149
Query: 601 CTQIIHCDIKPQNILLDDYYNA-RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW-FRN 658
              + H DIKP N+L+++     ++ DFG  K   L  S  N A   ++ Y APE  F N
Sbjct: 150 -VNVCHRDIKPHNVLVNEADGTLKLCDFGSAK--KLSPSEPNVAYICSRYYRAPELIFGN 206
Query: 659 MPITVKVDVYSYGVLLLEII 678
              T  VD++S G +  E++
Sbjct: 207 QHYTTAVDIWSVGCIFAEMM 226

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  S +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+++ G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLXGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG G  G V + F N  + ++ A+K L    QD  K  +        +   ++VR++   
Sbjct: 25  LGLGINGKVLQIF-NKRTQEKFALKML----QDCPKARREVELHWRASQCPHIVRIVDVY 79
Query: 550 DE---GRNRLL-VYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +    GR  LL V E +  G L S +   GD     +  +EI+  I   + YLH      
Sbjct: 80  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 136
Query: 604 IIHCDIKPQNILLDDYY-NA--RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
           I H D+KP+N+L      NA  +++DFG  K  T   S T      T  YVAPE      
Sbjct: 137 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEK 194
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D++S GV++  ++C
Sbjct: 195 YDKSCDMWSLGVIMYILLC 213

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG G  G V + F N  + ++ A+K L    QD  K  +        +   ++VR++   
Sbjct: 32  LGLGINGKVLQIF-NKRTQEKFALKML----QDCPKARREVELHWRASQCPHIVRIVDVY 86
Query: 550 DE---GRNRLL-VYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +    GR  LL V E +  G L S +   GD     +  +EI+  I   + YLH      
Sbjct: 87  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 143
Query: 604 IIHCDIKPQNILLDDYY-NA--RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
           I H D+KP+N+L      NA  +++DFG  K  T   S T      T  YVAPE      
Sbjct: 144 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEK 201
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D++S GV++  ++C
Sbjct: 202 YDKSCDMWSLGVIMYILLC 220

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG G  G V + F N  + ++ A+K L    QD  K  +        +   ++VR++   
Sbjct: 30  LGLGINGKVLQIF-NKRTQEKFALKML----QDCPKARREVELHWRASQCPHIVRIVDVY 84
Query: 550 DE---GRNRLL-VYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +    GR  LL V E +  G L S +   GD     +  +EI+  I   + YLH      
Sbjct: 85  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 141
Query: 604 IIHCDIKPQNILLDDYY-NA--RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
           I H D+KP+N+L      NA  +++DFG  K  T   S T      T  YVAPE      
Sbjct: 142 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEK 199
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D++S GV++  ++C
Sbjct: 200 YDKSCDMWSLGVIMYILLC 218

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG G  G V + F N  + ++ A+K L    QD  K  +        +   ++VR++   
Sbjct: 24  LGLGINGKVLQIF-NKRTQEKFALKML----QDCPKARREVELHWRASQCPHIVRIVDVY 78
Query: 550 DE---GRNRLL-VYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +    GR  LL V E +  G L S +   GD     +  +EI+  I   + YLH      
Sbjct: 79  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 135
Query: 604 IIHCDIKPQNILLDDYY-NA--RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
           I H D+KP+N+L      NA  +++DFG  K  T   S T      T  YVAPE      
Sbjct: 136 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEK 193
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D++S GV++  ++C
Sbjct: 194 YDKSCDMWSLGVIMYILLC 212

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  S +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+++ G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLAGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG G  G V + F N  + ++ A+K L    QD  K  +        +   ++VR++   
Sbjct: 24  LGLGINGKVLQIF-NKRTQEKFALKML----QDCPKARREVELHWRASQCPHIVRIVDVY 78
Query: 550 DE---GRNRLL-VYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +    GR  LL V E +  G L S +   GD     +  +EI+  I   + YLH      
Sbjct: 79  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 135
Query: 604 IIHCDIKPQNILLDDYY-NA--RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
           I H D+KP+N+L      NA  +++DFG  K  T   S T      T  YVAPE      
Sbjct: 136 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCY--TPYYVAPEVLGPEK 193
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D++S GV++  ++C
Sbjct: 194 YDKSCDMWSLGVIMYILLC 212

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG G  G V + F N  + ++ A+K L    QD  K  +        +   ++VR++   
Sbjct: 70  LGLGINGKVLQIF-NKRTQEKFALKML----QDCPKARREVELHWRASQCPHIVRIVDVY 124
Query: 550 DE---GRNRLL-VYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +    GR  LL V E +  G L S +   GD     +  +EI+  I   + YLH      
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 181
Query: 604 IIHCDIKPQNILLDDYY-NA--RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
           I H D+KP+N+L      NA  +++DFG  K  T   S T      T  YVAPE      
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEK 239
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D++S GV++  ++C
Sbjct: 240 YDKSCDMWSLGVIMYILLC 258

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG G  G V + F N  + ++ A+K L    QD  K  +        +   ++VR++   
Sbjct: 31  LGLGINGKVLQIF-NKRTQEKFALKML----QDCPKARREVELHWRASQCPHIVRIVDVY 85
Query: 550 DE---GRNRLL-VYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +    GR  LL V E +  G L S +   GD     +  +EI+  I   + YLH      
Sbjct: 86  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 142
Query: 604 IIHCDIKPQNILLDDYY-NA--RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
           I H D+KP+N+L      NA  +++DFG  K  T   S T      T  YVAPE      
Sbjct: 143 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEK 200
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D++S GV++  ++C
Sbjct: 201 YDKSCDMWSLGVIMYILLC 219

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 101/249 (40%), Gaps = 56/249 (22%)
Query: 479 LVEVTRGF--KEELGRGAFGTVYKGFVNMGSSDQ-VAVKKLNRVFQDSEKE---FKAEVN 532
           L+E+ + +  K  +G+G++G V     N   + + + +   N++ Q + K+    K EV 
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL--FGDSKP------------- 577
            + + HH N+ RL    ++ +   LV E    G L   L  F D                
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 578 ---------------------NWKLRTEIVMGIARGLF----YLHEECCTQIIHCDIKPQ 612
                                ++  R +++  I R +F    YLH +    I H DIKP+
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPE 197
Query: 613 NILL--DDYYNARISDFGLEK---LLTLDQSHTNTAIRGTKGYVAPEWFR--NMPITVKV 665
           N L   +  +  ++ DFGL K    L   + +  T   GT  +VAPE     N     K 
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 666 DVYSYGVLL 674
           D +S GVLL
Sbjct: 258 DAWSAGVLL 266

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG G  G V + F N  + ++ A+K L    QD  K  +        +   ++VR++   
Sbjct: 40  LGLGINGKVLQIF-NKRTQEKFALKML----QDCPKARREVELHWRASQCPHIVRIVDVY 94
Query: 550 DE---GRNRLL-VYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +    GR  LL V E +  G L S +   GD     +  +EI+  I   + YLH      
Sbjct: 95  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 151
Query: 604 IIHCDIKPQNILLDDYY-NA--RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
           I H D+KP+N+L      NA  +++DFG  K  T   S T      T  YVAPE      
Sbjct: 152 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEK 209
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D++S GV++  ++C
Sbjct: 210 YDKSCDMWSLGVIMYILLC 228

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG G  G V + F N  + ++ A+K L    QD  K  +        +   ++VR++   
Sbjct: 26  LGLGINGKVLQIF-NKRTQEKFALKML----QDCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 550 DE---GRNRLL-VYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +    GR  LL V E +  G L S +   GD     +  +EI+  I   + YLH      
Sbjct: 81  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 137
Query: 604 IIHCDIKPQNILLDDYY-NA--RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
           I H D+KP+N+L      NA  +++DFG  K  T   S T      T  YVAPE      
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEK 195
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D++S GV++  ++C
Sbjct: 196 YDKSCDMWSLGVIMYILLC 214

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +M + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 50  LGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E++  G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 161
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +M + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E++  G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +M + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E++  G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +M + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E++  G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG G  G V + F N  + ++ A+K L    QD  K  +        +   ++VR++   
Sbjct: 26  LGLGINGKVLQIF-NKRTQEKFALKML----QDCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 550 DE---GRNRLL-VYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +    GR  LL V E +  G L S +   GD     +  +EI+  I   + YLH      
Sbjct: 81  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 137
Query: 604 IIHCDIKPQNILLDDYY-NA--RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
           I H D+KP+N+L      NA  +++DFG  K  T   S T      T  YVAPE      
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEK 195
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D++S GV++  ++C
Sbjct: 196 YDKSCDMWSLGVIMYILLC 214

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEF---KAEVNGIGQTHHKNL 542
            +E +G+G FG V++G       ++VAVK    +F   E+     +AE+       H+N+
Sbjct: 46  LQESIGKGRFGEVWRG---KWRGEEVAVK----IFSSREERSWFREAEIYQTVMLRHENI 98
Query: 543 VRLLGYCDEGRNRL----LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           +  +   ++         LV ++  +G+L  +L        +   ++ +  A GL +LH 
Sbjct: 99  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 599 ECC-TQ----IIHCDIKPQNILLDDYYNARISDFGL-----EKLLTLDQSHTNTAIRGTK 648
           E   TQ    I H D+K +NIL+       I+D GL         T+D +  +    GTK
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTK 215
Query: 649 GYVAPEWF------RNMPITVKVDVYSYGVLLLEI 677
            Y+APE        ++     + D+Y+ G++  EI
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 490 LGRGAFGTVY--KGFVNMGSSDQVAVKKLNR--VFQDSE--KEFKAEVNGIGQTHHKNLV 543
           LG GA+G V+  +      +    A+K L +  + Q ++  +  + E   +        +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 544 RLLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMG-IARGLFYLHEECC 601
             L Y  +   +L L+ ++++ G L + L    +   +   +I +G I   L +LH+   
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT-EHEVQIYVGEIVLALEHLHK--- 177
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR--NM 659
             II+ DIK +NILLD   +  ++DFGL K    D++       GT  Y+AP+  R  + 
Sbjct: 178 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 237
Query: 660 PITVKVDVYSYGVLLLEIIC 679
                VD +S GVL+ E++ 
Sbjct: 238 GHDKAVDWWSLGVLMYELLT 257

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG G  G V + F N  + ++ A+K L    QD  K  +        +   ++VR++   
Sbjct: 76  LGLGINGKVLQIF-NKRTQEKFALKML----QDCPKARREVELHWRASQCPHIVRIVDVY 130
Query: 550 DE---GRNRLL-VYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +    GR  LL V E +  G L S +   GD     +  +EI+  I   + YLH      
Sbjct: 131 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 187
Query: 604 IIHCDIKPQNILLDDYY-NA--RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
           I H D+KP+N+L      NA  +++DFG  K  T   S T      T  YVAPE      
Sbjct: 188 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEK 245
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D++S GV++  ++C
Sbjct: 246 YDKSCDMWSLGVIMYILLC 264

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  S +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 36  LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 94
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+++ G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 95  FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 147
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D+    +++DFG  K +          + GT  Y+APE   +    
Sbjct: 148 DLIYRDLKPENLLIDEQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 203
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 204 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 242

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 22/156 (14%)
Query: 530 EVNGIGQTHHKNLVRLLGYCDEGR--NRLLVYEFMSNGALASFLFGDSKPNWKLRTE--- 584
           E+  + +  H N+V+L+   D+    +  +V+E ++ G +         P  K  +E   
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV------PTLKPLSEDQA 139
Query: 585 --IVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLE-KLLTLDQSHTN 641
                 + +G+ YLH +   +IIH DIKP N+L+ +  + +I+DFG+  +    D   +N
Sbjct: 140 RFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN 196
Query: 642 TAIRGTKGYVAPEWF---RNMPITVKVDVYSYGVLL 674
           T   GT  ++APE     R +     +DV++ GV L
Sbjct: 197 TV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEF---KAEVNGIGQTHHKNL 542
            +E +G+G FG V++G       ++VAVK    +F   E+     +AE+       H+N+
Sbjct: 33  LQESIGKGRFGEVWRG---KWRGEEVAVK----IFSSREERSWFREAEIYQTVMLRHENI 85
Query: 543 VRLLGYCDEGRNRL----LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           +  +   ++         LV ++  +G+L  +L        +   ++ +  A GL +LH 
Sbjct: 86  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 144
Query: 599 ECC-TQ----IIHCDIKPQNILLDDYYNARISDFGL-----EKLLTLDQSHTNTAIRGTK 648
           E   TQ    I H D+K +NIL+       I+D GL         T+D +  +    GTK
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTK 202
Query: 649 GYVAPEWF------RNMPITVKVDVYSYGVLLLEI 677
            Y+APE        ++     + D+Y+ G++  EI
Sbjct: 203 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 13/104 (12%)
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGY 650
           +G+ YLH     ++IH D+K  N+ L+D  + +I DFGL   +  D       + GT  Y
Sbjct: 153 QGVQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKXLCGTPNY 208
Query: 651 VAPEWFRNMPITVKVDVYSYGVLL---------LEIICLRRTIL 685
           +APE       + +VD++S G +L          E  CL+ T +
Sbjct: 209 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYI 252

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  S +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 70  LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+++ G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 181
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 182 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGATWTLCGTPEYLAPEIILSKGYN 237
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 238 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 276

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 81/190 (42%), Gaps = 10/190 (5%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           +++G G FG V +   +  S++ VAVK + R  +  ++  K E+       H N+VR   
Sbjct: 25  KDIGSGNFG-VARLMRDKQSNELVAVKYIER-GEKIDENVKREIINHRSLRHPNIVRFKE 82
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
                 +  +V E+ S G L   +    + +          +  G+ Y H     Q+ H 
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH---AMQVCHR 139
Query: 608 DIKPQNILLDDYYNAR--ISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 665
           D+K +N LLD     R  I  FG  K   L     +T   GT  Y+APE         KV
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV--GTPAYIAPEVLLKKEYDGKV 197
Query: 666 -DVYSYGVLL 674
            DV+S GV L
Sbjct: 198 ADVWSCGVTL 207

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEF---KAEVNGIGQTHHKNL 542
            +E +G+G FG V++G       ++VAVK    +F   E+     +AE+       H+N+
Sbjct: 8   LQESIGKGRFGEVWRG---KWRGEEVAVK----IFSSREERSWFREAEIYQTVMLRHENI 60
Query: 543 VRLLGYCDEGRNRL----LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           +  +   ++         LV ++  +G+L  +L        +   ++ +  A GL +LH 
Sbjct: 61  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 119
Query: 599 ECC-TQ----IIHCDIKPQNILLDDYYNARISDFGL-----EKLLTLDQSHTNTAIRGTK 648
           E   TQ    I H D+K +NIL+       I+D GL         T+D +  +    GTK
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTK 177
Query: 649 GYVAPEWF------RNMPITVKVDVYSYGVLLLEI 677
            Y+APE        ++     + D+Y+ G++  EI
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKL--------NRVFQDSEKEFKAEVNGIGQTHHKN 541
           LG GA   V +  +N+ +S + AVK +        +RVF++ E  ++ +        H+N
Sbjct: 21  LGEGAHARV-QTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ-------GHRN 72
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++ L+ + +E     LV+E M  G++ S +      N    + +V  +A  L +LH +  
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK-- 130
Query: 602 TQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTNTAIR------GTKGYVA 652
             I H D+KP+NIL +        +I DFGL   + L+   +  +        G+  Y+A
Sbjct: 131 -GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 653 PEWFRNMPITVKV-----DVYSYGVLL 674
           PE          +     D++S GV+L
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 36/212 (16%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNLV 543
           ++G+G FG V+K   +  +  +VA+KK   V  ++EKE        E+  +    H+N+V
Sbjct: 25  KIGQGTFGEVFKA-RHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENVV 80
Query: 544 RLLGYCDEGR---NR-----LLVYEFMSN---GALASFLFGDSKPNWKLRTEIVMGIARG 592
            L+  C       NR      LV++F  +   G L++ L   +    K   ++++    G
Sbjct: 81  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN---G 137
Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVA 652
           L+Y+H     +I+H D+K  N+L+      +++DFGL +  +L +   N+        V 
Sbjct: 138 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK---NSQPNRYXNRVV 191
Query: 653 PEWFRNMPITV-------KVDVYSYGVLLLEI 677
             W+R   + +        +D++  G ++ E+
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEF---KAEVNGIGQTHHKNL 542
            +E +G+G FG V++G       ++VAVK    +F   E+     +AE+       H+N+
Sbjct: 7   LQESIGKGRFGEVWRG---KWRGEEVAVK----IFSSREERSWFREAEIYQTVMLRHENI 59
Query: 543 VRLLGYCDEGRNRL----LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           +  +   ++         LV ++  +G+L  +L        +   ++ +  A GL +LH 
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 599 ECC-TQ----IIHCDIKPQNILLDDYYNARISDFGL-----EKLLTLDQSHTNTAIRGTK 648
           E   TQ    I H D+K +NIL+       I+D GL         T+D +  +    GTK
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTK 176
Query: 649 GYVAPEWF------RNMPITVKVDVYSYGVLLLEI 677
            Y+APE        ++     + D+Y+ G++  EI
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEF---KAEVNGIGQTHHKNL 542
            +E +G+G FG V++G       ++VAVK    +F   E+     +AE+       H+N+
Sbjct: 13  LQESIGKGRFGEVWRG---KWRGEEVAVK----IFSSREERSWFREAEIYQTVMLRHENI 65
Query: 543 VRLLGYCDEGRNRL----LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           +  +   ++         LV ++  +G+L  +L        +   ++ +  A GL +LH 
Sbjct: 66  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 124
Query: 599 ECC-TQ----IIHCDIKPQNILLDDYYNARISDFGL-----EKLLTLDQSHTNTAIRGTK 648
           E   TQ    I H D+K +NIL+       I+D GL         T+D +  +    GTK
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTK 182
Query: 649 GYVAPEWF------RNMPITVKVDVYSYGVLLLEI 677
            Y+APE        ++     + D+Y+ G++  EI
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 88/185 (47%), Gaps = 29/185 (15%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNLV 543
           ++G+G FG V+K   +  +  +VA+KK   V  ++EKE        E+  +    H+N+V
Sbjct: 24  KIGQGTFGEVFKA-RHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENVV 79
Query: 544 RLLGYCDEGR---NR-----LLVYEFMSN---GALASFLFGDSKPNWKLRTEIVMGIARG 592
            L+  C       NR      LV++F  +   G L++ L   +    K   ++++    G
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN---G 136
Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVA 652
           L+Y+H     +I+H D+K  N+L+      +++DFGL +  +L +   N+        V 
Sbjct: 137 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK---NSQPNRYXNRVV 190
Query: 653 PEWFR 657
             W+R
Sbjct: 191 TLWYR 195

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 30/213 (14%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVFQDS-EKEFK--AEVNGIGQTHH---- 539
           +LG G F TV+    +M ++  VA+K  + ++V+ ++ E E K    VN    T      
Sbjct: 26  KLGWGHFSTVWLA-KDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 540 -KNLVRLLGYCDE----GRNRLLVYEFMSNGALASFLFGDSK--PNWKLRTEIVMGIARG 592
             ++++LL + +     G + ++V+E +    LA     + +  P   ++ +I   +  G
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK-QISKQLLLG 143
Query: 593 LFYLHEECCTQIIHCDIKPQNILL------DDYYNARISDFGLEKLLTLDQSHTNTAIRG 646
           L Y+H  C   IIH DIKP+N+L+      ++    +I+D G       D+ +TN+    
Sbjct: 144 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNSI--Q 197
Query: 647 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
           T+ Y +PE     P     D++S   L+ E+I 
Sbjct: 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           +G G+FG V     +M + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  IGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E++  G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEF---KAEVNGIGQTHHKNL 542
            +E +G+G FG V++G       ++VAVK    +F   E+     +AE+       H+N+
Sbjct: 10  LQESIGKGRFGEVWRG---KWRGEEVAVK----IFSSREERSWFREAEIYQTVMLRHENI 62
Query: 543 VRLLGYCDEGRNRL----LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           +  +   ++         LV ++  +G+L  +L        +   ++ +  A GL +LH 
Sbjct: 63  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 121
Query: 599 ECC-TQ----IIHCDIKPQNILLDDYYNARISDFGL-----EKLLTLDQSHTNTAIRGTK 648
           E   TQ    I H D+K +NIL+       I+D GL         T+D +  +    GTK
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTK 179
Query: 649 GYVAPEWF------RNMPITVKVDVYSYGVLLLEI 677
            Y+APE        ++     + D+Y+ G++  EI
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 37/228 (16%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA-----EVNGIGQTHHK 540
            K  LG GA+G V     +  + + VA+KK+    +  +K   A     E+  +    H+
Sbjct: 15  LKSLLGEGAYGVVCSA-THKPTGEIVAIKKI----EPFDKPLFALRTLREIKILKHFKHE 69
Query: 541 NLVRLLGY--CDEGRNRLLVY---EFMS---NGALASFLFGDSKPNWKLRTEIVMGIARG 592
           N++ +      D   N   VY   E M    +  +++ +  D    +      +    R 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLRA 124
Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL---TLDQSHTNTAIRGTKG 649
           +  LH    + +IH D+KP N+L++   + ++ DFGL +++     D S       G   
Sbjct: 125 VKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 650 YVAPEWFRNMPITV-------KVDVYSYGVLLLEIICLRRTILTDWAY 690
           +VA  W+R   + +        +DV+S G +L E+  LRR I     Y
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFPGRDY 228

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 30/213 (14%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVFQDS-EKEFK--AEVNGIGQTHH---- 539
           +LG G F TV+    +M ++  VA+K  + ++V+ ++ E E K    VN    T      
Sbjct: 26  KLGWGHFSTVWLA-KDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 540 -KNLVRLLGYCDE----GRNRLLVYEFMSNGALASFLFGDSK--PNWKLRTEIVMGIARG 592
             ++++LL + +     G + ++V+E +    LA     + +  P   ++ +I   +  G
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK-QISKQLLLG 143
Query: 593 LFYLHEECCTQIIHCDIKPQNILL------DDYYNARISDFGLEKLLTLDQSHTNTAIRG 646
           L Y+H  C   IIH DIKP+N+L+      ++    +I+D G       D+ +TN+    
Sbjct: 144 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNSI--Q 197
Query: 647 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
           T+ Y +PE     P     D++S   L+ E+I 
Sbjct: 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 88/185 (47%), Gaps = 29/185 (15%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNLV 543
           ++G+G FG V+K   +  +  +VA+KK   V  ++EKE        E+  +    H+N+V
Sbjct: 25  KIGQGTFGEVFKA-RHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENVV 80
Query: 544 RLLGYCDEGR---NR-----LLVYEFMSN---GALASFLFGDSKPNWKLRTEIVMGIARG 592
            L+  C       NR      LV++F  +   G L++ L   +    K   ++++    G
Sbjct: 81  NLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN---G 137
Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVA 652
           L+Y+H     +I+H D+K  N+L+      +++DFGL +  +L +   N+        V 
Sbjct: 138 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK---NSQPNRYXNRVV 191
Query: 653 PEWFR 657
             W+R
Sbjct: 192 TLWYR 196

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 81/190 (42%), Gaps = 10/190 (5%)
Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           +++G G FG V +   +  S++ VAVK + R  +  ++  K E+       H N+VR   
Sbjct: 25  KDIGSGNFG-VARLMRDKQSNELVAVKYIER-GEKIDENVKREIINHRSLRHPNIVRFKE 82
Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
                 +  +V E+ S G L   +    + +          +  G+ Y H     Q+ H 
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH---AMQVCHR 139
Query: 608 DIKPQNILLDDYYNAR--ISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 665
           D+K +N LLD     R  I  FG  K   L     +T   GT  Y+APE         KV
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLKKEYDGKV 197
Query: 666 -DVYSYGVLL 674
            DV+S GV L
Sbjct: 198 ADVWSCGVTL 207

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 13/104 (12%)
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGY 650
           +G+ YLH     ++IH D+K  N+ L+D  + +I DFGL   +  D       + GT  Y
Sbjct: 153 QGVQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD-LCGTPNY 208
Query: 651 VAPEWFRNMPITVKVDVYSYGVLL---------LEIICLRRTIL 685
           +APE       + +VD++S G +L          E  CL+ T +
Sbjct: 209 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYI 252

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  S +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+++ G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 18/107 (16%)
Query: 585 IVMGIARGLFYLHEECCTQIIHCDIKPQNIL--LDDYYNARISDFGLEKLLTLDQSH--- 639
           I + IA  + +LH +    ++H D+KP NI   +DD    ++ DFGL   +  D+     
Sbjct: 169 IFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTV 223
Query: 640 --------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
                   T+    GTK Y++PE       + KVD++S G++L E++
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 88/185 (47%), Gaps = 29/185 (15%)
Query: 489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNLV 543
           ++G+G FG V+K   +  +  +VA+KK   V  ++EKE        E+  +    H+N+V
Sbjct: 25  KIGQGTFGEVFKA-RHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENVV 80
Query: 544 RLLGYCDEGR---NR-----LLVYEFMSN---GALASFLFGDSKPNWKLRTEIVMGIARG 592
            L+  C       NR      LV++F  +   G L++ L   +    K   ++++    G
Sbjct: 81  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN---G 137
Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVA 652
           L+Y+H     +I+H D+K  N+L+      +++DFGL +  +L +   N+        V 
Sbjct: 138 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK---NSQPNRYXNRVV 191
Query: 653 PEWFR 657
             W+R
Sbjct: 192 TLWYR 196

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 13/104 (12%)
Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGY 650
           +G+ YLH     ++IH D+K  N+ L+D  + +I DFGL   +  D       + GT  Y
Sbjct: 137 QGVQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKDLCGTPNY 192
Query: 651 VAPEWFRNMPITVKVDVYSYGVLL---------LEIICLRRTIL 685
           +APE       + +VD++S G +L          E  CL+ T +
Sbjct: 193 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYI 236

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 114/291 (39%), Gaps = 35/291 (12%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F ++LG G F  V      +      A+K++    Q   +E + E +     +H N++RL
Sbjct: 33  FIQKLGEGGFSYV-DLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRL 91
Query: 546 LGYCDEGR----NRLLVYEFMSNGALASFLFG-DSKPNWKLRTEIV---MGIARGLFYLH 597
           + YC   R       L+  F   G L + +     K N+    +I+   +GI RGL  +H
Sbjct: 92  VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI--------RGTKG 649
            +      H D+KP NILL D     + D G      +    +  A+        R T  
Sbjct: 152 AKGYA---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 650 YVAPEWF---RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER--TLGALVEN 704
           Y APE F    +  I  + DV+S G +L  +      +  +  YD   ++  ++   V+N
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAM------MFGEGPYDMVFQKGDSVALAVQN 262
Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCP 755
            L              +    +  DP  RP +  +   LE +     PP P
Sbjct: 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ----PPAP 309

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  S +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+++ G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +M + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+   G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+++D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  S +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+++ G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  S +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+++ G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 83/200 (41%), Gaps = 30/200 (15%)
Query: 488 EELGRGAFGTVYK------------GFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIG 535
           E+LGRG FG V++             FV +  +DQV VKK              E++ + 
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK--------------EISILN 56
Query: 536 QTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDS-KPNWKLRTEIVMGIARGLF 594
              H+N++ L    +     ++++EF+S   +   +   + + N +     V  +   L 
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           +LH      I H DI+P+NI+     ++ I      +   L        +     Y APE
Sbjct: 117 FLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173
Query: 655 WFRNMPITVKVDVYSYGVLL 674
             ++  ++   D++S G L+
Sbjct: 174 VHQHDVVSTATDMWSLGTLV 193

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  S +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 50  LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+++ G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 109 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 161
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  S +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+++ G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKV 255

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 29/224 (12%)
Query: 490 LGRGAFGTV----YKGFVN---MGSSDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKN 541
           LG G+FG V    +K   N   M   D+  V KL ++    +EK  +  VN         
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVN------FPF 103
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLH 597
           LV+L     +  N  +V E+   G + S L   G  S+P+ +    +IV+       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH 159
Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
                 +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   
Sbjct: 160 ---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIIL 212
Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
           +      VD ++ GVL+ E+         D     Y++   G +
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +M + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+   G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+++D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLMIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +M + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL-----FGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
               +  N  +V E++  G + S L     F +    +    +IV+       YLH    
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFE----YLH---S 159
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
              VD ++ GVL+ E+         D     Y++   G +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +M + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL-----FGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
               +  N  +V E++  G + S L     F +    +    +IV+       YLH    
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFE----YLH---S 159
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
              VD ++ GVL+ E+         D     Y++   G +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +M + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 50  LGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL-----FGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
               +  N  +V E++  G + S L     F +    +    +IV+       YLH    
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFE----YLH---S 160
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +   
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 216
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
              VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 37/228 (16%)
Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA-----EVNGIGQTHHK 540
            K  LG GA+G V     +  + + VA+KK+    +  +K   A     E+  +    H+
Sbjct: 15  LKSLLGEGAYGVVCSA-THKPTGEIVAIKKI----EPFDKPLFALRTLREIKILKHFKHE 69
Query: 541 NLVRLLGY--CDEGRNRLLVY---EFMS---NGALASFLFGDSKPNWKLRTEIVMGIARG 592
           N++ +      D   N   VY   E M    +  +++ +  D    +      +    R 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLRA 124
Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL---TLDQSHTNTAIRGTKG 649
           +  LH    + +IH D+KP N+L++   + ++ DFGL +++     D S       G   
Sbjct: 125 VKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 650 YVAPEWFRNMPITV-------KVDVYSYGVLLLEIICLRRTILTDWAY 690
            VA  W+R   + +        +DV+S G +L E+  LRR I     Y
Sbjct: 182 XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFPGRDY 228

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  S +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL-----FGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
               +  N  +V E+++ G + S L     F +    +    +IV+       YLH    
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFE----YLH---S 159
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
              VD ++ GVL+ E+         D     Y++   G +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL---- 545
           LG G  G V+   V+     +VA+KK+      S K    E+  I +  H N+V++    
Sbjct: 19  LGCGGNGLVFSA-VDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77
Query: 546 ----------LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM-GIARGLF 594
                     +G   E  +  +V E+M    LA+ L  +  P  +    + M  + RGL 
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVL--EQGPLLEEHARLFMYQLLRGLK 134
Query: 595 YLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRG--TKGYV 651
           Y+H      ++H D+KP N+ ++ +    +I DFGL +++    SH      G  TK Y 
Sbjct: 135 YIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191
Query: 652 APEWFRNMP--ITVKVDVYSYGVLLLEIIC 679
           +P    + P   T  +D+++ G +  E++ 
Sbjct: 192 SPRLLLS-PNNYTKAIDMWAAGCIFAEMLT 220

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 86/199 (43%), Gaps = 19/199 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG G  G V + F N  + ++ A+K L    QD  K  +        +   ++VR++   
Sbjct: 70  LGLGINGKVLQIF-NKRTQEKFALKXL----QDCPKARREVELHWRASQCPHIVRIVDVY 124
Query: 550 DE---GRNRLL-VYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +    GR  LL V E +  G L S +   GD     +  +EI   I   + YLH      
Sbjct: 125 ENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLH---SIN 181
Query: 604 IIHCDIKPQNILLDDYY-NA--RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
           I H D+KP+N+L      NA  +++DFG  K  T   S T      T  YVAPE      
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEK 239
Query: 661 ITVKVDVYSYGVLLLEIIC 679
                D +S GV+   ++C
Sbjct: 240 YDKSCDXWSLGVIXYILLC 258

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  S +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+++ G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ ++         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  S +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E+++ G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+++D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLIIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIISKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  S +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 70  LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL-----FGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
               +  N  +V E+++ G + S L     F +    +    +IV+       YLH    
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFE----YLH---S 180
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +   
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 236
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
              VD ++ GVL+ E+         D     Y++   G +
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 276

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  S +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL-----FGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
               +  N  +V E+++ G + S L     F +    +    +IV+       YLH    
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFE----YLH---S 159
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
              VD ++ GVL+ E+         D     Y++   G +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 38/215 (17%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-----DSEKEFKAEVNGIGQTHHKNLVR 544
           LG GAFG V +   +      VAVK +  V +      SE +    +N          V+
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81
Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIA----RGLFYLHEEC 600
           +L + +   +  +V+E +    L+++ F         R + +  +A    + + +LH   
Sbjct: 82  MLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS-- 136
Query: 601 CTQIIHCDIKPQNILL--DDY---YNARIS--------------DFGLEKLLTLDQSHTN 641
             ++ H D+KP+NIL    DY   YN +I               DFG     T D  H +
Sbjct: 137 -NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA---TYDDEHHS 192
Query: 642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLE 676
           T +  T+ Y APE    +  +   DV+S G +L+E
Sbjct: 193 TLV-STRHYRAPEVILALGWSQPCDVWSIGCILIE 226

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  S +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL-----FGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
               +  N  +V E+++ G + S L     F +    +    +IV+       YLH    
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFE----YLH---S 159
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
              VD ++ GVL+ E+         D     Y++   G +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 29/224 (12%)
Query: 490 LGRGAFGTV----YKGFVN---MGSSDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKN 541
           LG G+FG V    +K   N   M   D+  V KL ++    +EK     VN         
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN------FPF 103
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLH 597
           LV+L     +  N  +V E++  G + S L   G  S+P+ +    +IV+       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH 159
Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
                 +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   
Sbjct: 160 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 212
Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
           +      VD ++ GVL+ E+         D     Y++   G +
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/225 (21%), Positives = 96/225 (42%), Gaps = 39/225 (17%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 547
           +G G++G V + +  +     VA+KK+ RVF+D    K    E+  + + +H ++V++L 
Sbjct: 61  IGTGSYGHVCEAYDKL-EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 548 YC-----DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
                  ++     +V E   +     F          ++T ++  +  G+ Y+H     
Sbjct: 120 IVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH---SA 175
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS--------------------HTNT 642
            I+H D+KP N L++   + ++ DFGL + +   ++                    HT  
Sbjct: 176 GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKN 235
Query: 643 AIRGTKGYVAPEWFRNMPI-------TVKVDVYSYGVLLLEIICL 680
             R   G+V   W+R   +       T  +DV+S G +  E++ +
Sbjct: 236 LKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E++  G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 29/224 (12%)
Query: 490 LGRGAFGTV----YKGFVN---MGSSDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKN 541
           LG G+FG V    +K   N   M   D+  V KL ++    +EK     VN         
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN------FPF 123
Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLH 597
           LV+L     +  N  +V E++  G + S L   G  S+P+ +    +IV+       YLH
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH 179
Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
                 +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   
Sbjct: 180 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 232
Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
           +      VD ++ GVL+ E+         D     Y++   G +
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 276

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 19/219 (8%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +  + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL--FGD-SKPNWKL-RTEIVMGIARGLFYLHEECCT 602
               +  N  +V E++  G + S L   G  S+P+ +    +IV+       YLH     
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----YLH---SL 160
Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +I+ D+KP+N+L+D     +++DFG  K +          + GT  Y+APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
             VD ++ GVL+ E+         D     Y++   G +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 21/220 (9%)
Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNG---IGQTHHKNLVRLL 546
           LG G+FG V     +M + +  A+K L++      K+ +  +N    +   +   LV+L 
Sbjct: 49  LGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 547 GYCDEGRNRLLVYEFMSNGALASFL-----FGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
               +  N  +V E+   G + S L     F +    +    +IV+       YLH    
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFE----YLH---S 159
Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +I+ D+KP+N+++D     +++DFG  K +          + GT  Y+APE   +   
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGY 215
Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
              VD ++ GVL+ E+         D     Y++   G +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	762
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-121
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-113
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-111
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-66
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-58
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-56
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-54
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-54
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-53
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-53
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-53
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-52
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-49
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-47
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-46
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-46
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-44
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-41
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-39
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-39
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	9e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-36
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-36
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-36
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-36
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-36
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-35
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-35
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-35
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-35
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-34
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-34
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-34
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-33
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-33
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-32
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-31
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-31
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-31
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-31
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-31
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-30
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-30
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-30
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-30
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-28
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-27
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-27
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-27
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-27
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-27
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-26
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-26
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-26
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-26
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-25
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-25
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-25
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-25
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-25
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-24
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-24
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-23
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-19
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-19
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-18
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-16
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-16
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-15
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-15
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	9e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-15
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-14
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-14
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-14
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-12
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-12
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	3e-11
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	4e-04
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	4e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-09
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	5e-09
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	1e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-09
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	6e-08
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	6e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-06
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	6e-06
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	2e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-06
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	3e-05
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	3e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-05
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	3e-05
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	1e-04
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	2e-04
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	2e-04
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	2e-04
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	6e-04
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  364 bits (938), Expect = e-121
 Identities = 121/306 (39%), Positives = 170/306 (55%), Gaps = 21/306 (6%)

Query: 459 PHQEEQGVSYMNLRCFTYKELVEVTRGFKEE--LGRGAFGTVYKGFVNMGSSDQVAVKKL 516
           P +E+  V    L+ F+ +EL   +  F  +  LGRG FG VYKG +  G+   VAVK+L
Sbjct: 5   PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGT--LVAVKRL 62

Query: 517 NR-VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDS 575
                Q  E +F+ EV  I    H+NL+RL G+C     RLLVY +M+NG++AS L    
Sbjct: 63  KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122

Query: 576 KP----NWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK 631
           +     +W  R  I +G ARGL YLH+ C  +IIH D+K  NILLD+ + A + DFGL K
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182

Query: 632 LLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTI------- 684
           L+    +H  TA+RGT G++APE+      + K DV+ YGV+LLE+I  +R         
Sbjct: 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242

Query: 685 -----LTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
                L DW     +E+ L ALV+ DL+       +++ + VA+ C Q  P  RP M  V
Sbjct: 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

Query: 740 TQMLEG 745
            +MLEG
Sbjct: 303 VRMLEG 308

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  344 bits (886), Expect = e-113
 Identities = 104/305 (34%), Positives = 158/305 (51%), Gaps = 22/305 (7%)

Query: 462 EEQGVSYMNLRCFTYKELVEVTRGFKEE--LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV 519
               +           +L E T  F  +  +G G FG VYKG +  G+  +VA+K+    
Sbjct: 17  SSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA--KVALKRRTPE 74

Query: 520 FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-- 577
                +EF+ E+  +    H +LV L+G+CDE    +L+Y++M NG L   L+G   P  
Sbjct: 75  SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM 134

Query: 578 --NWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL-LT 634
             +W+ R EI +G ARGL YLH      IIH D+K  NILLD+ +  +I+DFG+ K    
Sbjct: 135 SMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE 191

Query: 635 LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTI---------- 684
           LDQ+H +T ++GT GY+ PE+F    +T K DVYS+GV+L E++C R  I          
Sbjct: 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251

Query: 685 LTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           L +WA + +    L  +V+ +L        L++F   A+ C+      RP+M  V   LE
Sbjct: 252 LAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

Query: 745 GVVEV 749
             + +
Sbjct: 312 YALRL 316

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  338 bits (869), Expect = e-111
 Identities = 106/312 (33%), Positives = 158/312 (50%), Gaps = 33/312 (10%)

Query: 461 QEEQGVSYMNLRCFTYKELVEVTRGFKEE--------LGRGAFGTVYKGFVNMGSSDQVA 512
            +   VS      F++ EL  VT  F E         +G G FG VYKG+VN   +  VA
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN---NTTVA 58

Query: 513 VKKLNRVFQDS----EKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALA 568
           VKKL  +   +    +++F  E+  + +  H+NLV LLG+  +G +  LVY +M NG+L 
Sbjct: 59  VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLL 118

Query: 569 SFLFGDSKP---NWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARIS 625
             L         +W +R +I  G A G+ +LHE      IH DIK  NILLD+ + A+IS
Sbjct: 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKIS 175

Query: 626 DFGLEKLL-TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTI 684
           DFGL +      Q+   + I GT  Y+APE  R   IT K D+YS+GV+LLEII     +
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAV 234

Query: 685 --------LTDWAYDCYQE-RTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPT 735
                   L D   +   E +T+   ++  +    D T ++    VA  C+ E  + RP 
Sbjct: 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPD 293

Query: 736 MRRVTQMLEGVV 747
           +++V Q+L+ + 
Sbjct: 294 IKKVQQLLQEMT 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  221 bits (565), Expect = 3e-66
 Identities = 74/325 (22%), Positives = 123/325 (37%), Gaps = 48/325 (14%)

Query: 457 MRPHQEEQGVSYMNLRCFTYKELVEVTRGFK--EELGRGAFGTVYKGFVNMGSSDQVAVK 514
           M  H         +      + L   +   +  E   RG FG V+K  +    ++ VAVK
Sbjct: 1   MGHHHHHH----SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL---NEYVAVK 53

Query: 515 KLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRN----RLLVYEFMSNGALASF 570
                      + + EV  +    H+N+++ +G    G +      L+  F   G+L+ F
Sbjct: 54  IFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF 112

Query: 571 LFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ-------IIHCDIKPQNILLDDYYNAR 623
           L   +  +W     I   +ARGL YLHE+           I H DIK +N+LL +   A 
Sbjct: 113 LKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171

Query: 624 ISDFGLEKLLTLDQSHTNT-AIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEI 677
           I+DFGL       +S  +T    GT+ Y+APE             +++D+Y+ G++L E+
Sbjct: 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

Query: 678 ICLRRTILTDWAYDCYQERTLGALVEND-LEAMDDM-----------------TVLQRFV 719
               R    D   D Y       + ++  LE M ++                   +    
Sbjct: 232 AS--RCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLC 289

Query: 720 MVAIWCIQEDPSHRPTMRRVTQMLE 744
                C   D   R +   V + + 
Sbjct: 290 ETIEECWDHDAEARLSAGCVGERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  199 bits (509), Expect = 3e-58
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 27/279 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLV 543
            KE++G G+FGTV++   +      VAVK L       +   EF  EV  + +  H N+V
Sbjct: 41  IKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
             +G   +  N  +V E++S G+L   L       + + + R  +   +A+G+ YLH   
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-R 156

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              I+H ++K  N+L+D  Y  ++ DFGL +L       ++ +  GT  ++APE  R+ P
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRDEP 215

Query: 661 ITVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQERTLGALVENDL-----EAMDDMTV 714
              K DVYS+GV+L E+  L+      W   +  Q   + A+            ++    
Sbjct: 216 SNEKSDVYSFGVILWELATLQ----QPWGNLNPAQ--VVAAVGFKCKRLEIPRNLN---- 265

Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPP 753
             +   +   C   +P  RP+   +  +L  +++  +PP
Sbjct: 266 -PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  192 bits (491), Expect = 7e-56
 Identities = 72/273 (26%), Positives = 119/273 (43%), Gaps = 24/273 (8%)

Query: 476 YKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIG 535
           YKE+       +E +GRGAFG V K       +  VA+K++    +   K F  E+  + 
Sbjct: 7   YKEIE-----VEEVVGRGAFGVVCKAKWR---AKDVAIKQIES--ESERKAFIVELRQLS 56

Query: 536 QTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP---NWKLRTEIVMGIARG 592
           + +H N+V+L G C       LV E+   G+L + L G                +  ++G
Sbjct: 57  RVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114

Query: 593 LFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV 651
           + YLH      +IH D+KP N+LL       +I DFG       D     T  +G+  ++
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWM 170

Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD 711
           APE F     + K DV+S+G++L E+I  R+     +         +   V N       
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAVHNGTRPPLI 226

Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
             + +    +   C  +DPS RP+M  + +++ 
Sbjct: 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  191 bits (487), Expect = 3e-55
 Identities = 64/273 (23%), Positives = 111/273 (40%), Gaps = 22/273 (8%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
             E LG+G FG   K      + + + +K+L R  +++++ F  EV  +    H N+++ 
Sbjct: 14  HGEVLGKGCFGQAIKVTHR-ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYLHEECCTQI 604
           +G   + +    + E++  G L   +        W  R      IA G+ YLH      I
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NI 129

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN-------------TAIRGTKGYV 651
           IH D+   N L+ +  N  ++DFGL +L+  +++                  + G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD 711
           APE         KVDV+S+G++L EII               +    G  V   L+    
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYLPRTMDFGLNVRGFLDRYCP 245

Query: 712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
                 F  + + C   DP  RP+  ++   LE
Sbjct: 246 PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  189 bits (481), Expect = 3e-54
 Identities = 62/276 (22%), Positives = 113/276 (40%), Gaps = 31/276 (11%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLV 543
             E +G+G FG VY G  +     +VA++ ++  R  +D  K FK EV    QT H+N+V
Sbjct: 37  IGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCT 602
             +G C    +  ++        L S +       +     +I   I +G+ YLH +   
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK--- 149

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTL----DQSHTNTAIRGTKGYVAPEWFRN 658
            I+H D+K +N+  D+     I+DFGL  +  +     +        G   ++APE  R 
Sbjct: 150 GILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208

Query: 659 M---------PITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQERTLGALVENDLEA 708
           +         P +   DV++ G +  E+          W +     E  +  +       
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHARE------WPFKTQPAEAIIWQMGTGMKPN 262

Query: 709 MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           +  + + +    + ++C   +   RPT  ++  MLE
Sbjct: 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  186 bits (475), Expect = 8e-54
 Identities = 71/271 (26%), Positives = 125/271 (46%), Gaps = 26/271 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLV 543
             + +G G+FGTVYKG  +      VAVK LN         + FK EV  + +T H N++
Sbjct: 28  VGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
             +GY        +V ++    +L   L   ++K   K   +I    ARG+ YLH +   
Sbjct: 84  LFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK--- 139

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ-SHTNTAIRGTKGYVAPEWFRN--- 658
            IIH D+K  NI L +    +I DFGL    +    SH    + G+  ++APE  R    
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199

Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL--- 715
            P + + DVY++G++L E++  +      ++    +++ +  +    L    D++ +   
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQIIEMVGRGSL--SPDLSKVRSN 253

Query: 716 --QRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
             +R   +   C+++    RP+  R+   +E
Sbjct: 254 CPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  184 bits (470), Expect = 3e-53
 Identities = 68/285 (23%), Positives = 118/285 (41%), Gaps = 33/285 (11%)

Query: 476 YKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKL-------NRVFQDSEKEFK 528
             E+      +++++G+G FG V+KG +    S  VA+K L            +  +EF+
Sbjct: 18  DNEIE-----YEKQIGKGGFGLVHKGRLVKDKSV-VAIKSLILGDSEGETEMIEKFQEFQ 71

Query: 529 AEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVM 587
            EV  +   +H N+V+L G         +V EF+  G L   L   + P  W ++  +++
Sbjct: 72  REVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML 129

Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDY-----YNARISDFGLEKLLTLDQSHTNT 642
            IA G+ Y+       I+H D++  NI L          A+++DFGL +       H+ +
Sbjct: 130 DIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVS 184

Query: 643 AIRGTKGYVAPEWF--RNMPITVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQERTLG 699
            + G   ++APE         T K D YS+ ++L  I+         +  Y   + + + 
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSYGKIKFIN 240

Query: 700 ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
            + E  L          R   V   C   DP  RP    + + L 
Sbjct: 241 MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  184 bits (468), Expect = 4e-53
 Identities = 74/274 (27%), Positives = 105/274 (38%), Gaps = 30/274 (10%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN----RVFQDSEKEFKAEVNGIGQTHHKN 541
            +E +G G FG VY+ F      D+VAVK            + +  + E        H N
Sbjct: 11  LEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           ++ L G C +  N  LV EF   G L   L G  +    +     + IARG+ YLH+E  
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 602 TQIIHCDIKPQNILLDDYYNAR--------ISDFGLEKLLTLDQSHTNTAIRGTKGYVAP 653
             IIH D+K  NIL+               I+DFGL +        T  +  G   ++AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAGAYAWMAP 183

Query: 654 EWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQERTLGALVEND--LEAMD 710
           E  R    +   DV+SYGVLL E++         +   D         +  N   L    
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE----VPFRGIDGLA--VAYGVAMNKLALPIPS 237

Query: 711 DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
                   +M   W    DP  RP+   +   L 
Sbjct: 238 TCPEPFAKLMEDCW--NPDPHSRPSFTNILDQLT 269

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  185 bits (471), Expect = 8e-53
 Identities = 69/307 (22%), Positives = 110/307 (35%), Gaps = 57/307 (18%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT---HHKNL 542
             E +GRG +G VYKG ++      VAVK        + + F  E N I +     H N+
Sbjct: 17  LLELIGRGRYGAVYKGSLD---ERPVAVKVF---SFANRQNFINEKN-IYRVPLMEHDNI 69

Query: 543 VRLLGYCDEG-----RNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLH 597
            R +   +          LLV E+  NG+L  +L      +W     +   + RGL YLH
Sbjct: 70  ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-LHTSDWVSSCRLAHSVTRGLAYLH 128

Query: 598 EECCT------QIIHCDIKPQNILLDDYYNARISDFGL-------EKLLTLDQSHTNTAI 644
            E          I H D+  +N+L+ +     ISDFGL         +   ++ +   + 
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188

Query: 645 RGTKGYVAPEWFRN-------MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
            GT  Y+APE                +VD+Y+ G++  EI      +    +   YQ   
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ-MA 247

Query: 698 LGALVEND--LEAMDDMTVLQR------------------FVMVAIWCIQEDPSHRPTMR 737
               V N    E M  +   ++                         C  +D   R T +
Sbjct: 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQ 307

Query: 738 RVTQMLE 744
              + + 
Sbjct: 308 XAEERMA 314

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  174 bits (444), Expect = 1e-49
 Identities = 54/288 (18%), Positives = 105/288 (36%), Gaps = 64/288 (22%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLV 543
           F  +L     G ++KG       + + VK L          ++F  E   +    H N++
Sbjct: 14  FLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70

Query: 544 RLLGYCDE--GRNRLLVYEFMSNGALASFLFGDSKP--NWKLRTEIVMGIARGLFYLHEE 599
            +LG C      +  L+  +M  G+L + L   +    +     +  + +ARG+ +LH  
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT- 129

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               I    +  +++++D+   ARIS   ++       S  +        +VAPE  +  
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKK 183

Query: 660 P---ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ 716
           P        D++S+ VLL E++           +                    D++ ++
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREV------PF-------------------ADLSNME 218

Query: 717 RFVMVAI--------------------WCIQEDPSHRPTMRRVTQMLE 744
             + VA+                     C+ EDP+ RP    +  +LE
Sbjct: 219 IGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  169 bits (430), Expect = 5e-47
 Identities = 59/294 (20%), Positives = 112/294 (38%), Gaps = 42/294 (14%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
             +++G+G +G V+ G         VAVK      +++    + E+       H+N++  
Sbjct: 41  MVKQIGKGRYGEVWMG--KWRGEK-VAVKVFFTT-EEASWFRETEIYQTVLMRHENILGF 96

Query: 546 LGYCDEGRNR----LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           +    +G        L+ ++  NG+L  +L   +  + K   ++      GL +LH E  
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 602 TQ-----IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT---NTAIRGTKGYVAP 653
           +      I H D+K +NIL+       I+D GL      D +          GTK Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

Query: 654 E------WFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE 707
           E         +    +  D+YS+G++L E+   RR +      +           +   E
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEEYQLPYHDLVPSDPSYE 273

Query: 708 AMDDMTVLQRF------------VMVAIW-----CIQEDPSHRPTMRRVTQMLE 744
            M ++  +++              +  +      C   +P+ R T  RV + L 
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  165 bits (419), Expect = 7e-46
 Identities = 66/298 (22%), Positives = 116/298 (38%), Gaps = 50/298 (16%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT---HHKNL 542
             E +G+G +G V++G       + VAVK  +      EK +  E   +  T    H+N+
Sbjct: 12  LLECVGKGRYGEVWRGSWQ---GENVAVKIFS---SRDEKSWFRETE-LYNTVMLRHENI 64

Query: 543 VRLLGYCDEGRNR----LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           +  +      R+      L+  +   G+L  +L   +  +      IV+ IA GL +LH 
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 599 ECCTQ-----IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH---TNTAIRGTKGY 650
           E         I H D+K +NIL+       I+D GL  + +   +     N    GTK Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 651 VAPEWFRNMPITV------KVDVYSYGVLLLEIICLRRTILTDWAYDCYQ---------- 694
           +APE               +VD++++G++L E+   RR + ++   + Y+          
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV-SNGIVEDYKPPFYDVVPND 240

Query: 695 ---ERTLGALVENDL-----EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
              E     +  +               L     +   C  ++PS R T  R+ + L 
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  163 bits (413), Expect = 1e-44
 Identities = 62/297 (20%), Positives = 109/297 (36%), Gaps = 48/297 (16%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAE--VNGIGQTHHKNLV 543
            +E +G+G FG V++G       + VAVK  +      E+ +  E  +       H+N++
Sbjct: 46  LQESIGKGRFGEVWRG--KWRGEE-VAVKIFS---SREERSWFREAEIYQTVMLRHENIL 99

Query: 544 RLLGYCDEGRNR----LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
             +   ++         LV ++  +G+L  +L        +   ++ +  A GL +LH E
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHME 158

Query: 600 CCTQ-----IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT---NTAIRGTKGYV 651
                    I H D+K +NIL+       I+D GL                   GTK Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 652 APE------WFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ----------- 694
           APE        ++     + D+Y+ G++  EI   RR       ++ YQ           
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCS-IGGIHEDYQLPYYDLVPSDP 275

Query: 695 --ERTLGALVENDL-----EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
             E     + E  L             L+    +   C   + + R T  R+ + L 
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  154 bits (391), Expect = 3e-41
 Identities = 70/276 (25%), Positives = 112/276 (40%), Gaps = 28/276 (10%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVR 544
             E++GRG FG V+ G +    +  VAVK          K +F  E   + Q  H N+VR
Sbjct: 118 LGEQIGRGNFGEVFSGRLR-ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           L+G C + +   +V E +  G   +FL    ++   K   ++V   A G+ YL  +CC  
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC-- 234

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGY----VAPEWFRNM 659
            IH D+  +N L+ +    +ISDFG+ +           A  G +       APE     
Sbjct: 235 -IHRDLAARNCLVTEKNVLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALNYG 290

Query: 660 PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLG---ALVEND--LEAMDDMTV 714
             + + DV+S+G+LL E   L            Y   +       VE    L   +    
Sbjct: 291 RYSSESDVWSFGILLWETFSL--------GASPYPNLSNQQTREFVEKGGRLPCPELCPD 342

Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
               +M   W    +P  RP+   + Q L+ + +  
Sbjct: 343 AVFRLMEQCW--AYEPGQRPSFSTIYQELQSIRKRH 376

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  146 bits (370), Expect = 3e-39
 Identities = 62/261 (23%), Positives = 116/261 (44%), Gaps = 25/261 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVFQDSEKEFKAEVNGIGQTHHKNLV 543
           F  E+GRG+F TVYKG  +  ++ +VA    +  ++ +   + FK E   +    H N+V
Sbjct: 30  FDIEIGRGSFKTVYKGL-DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88

Query: 544 RLLGYC---DEGRNRLLVY-EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
           R         +G+  +++  E M++G L ++L        K+       I +GL +LH  
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-T 147

Query: 600 CCTQIIHCDIKPQNILLDDYY-NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               IIH D+K  NI +     + +I D GL  L     +     + GT  ++APE +  
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYEE 204

Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL--EAMDDMT--V 714
                 VDVY++G+ +LE+          ++ +C     +   V + +   + D +    
Sbjct: 205 -KYDESVDVYAFGMCMLEMATSEYP----YS-ECQNAAQIYRRVTSGVKPASFDKVAIPE 258

Query: 715 LQRFVMVAIWCIQEDPSHRPT 735
           ++  +     CI+++   R +
Sbjct: 259 VKEIIE---GCIRQNKDERYS 276

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  150 bits (381), Expect = 4e-39
 Identities = 76/267 (28%), Positives = 121/267 (45%), Gaps = 24/267 (8%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G      S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 224 MKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 281

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++    
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-- 339

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ----SHTNTAIRGTKGYVAPEWFRNM 659
            IH ++  +N L+ + +  +++DFGL +L+T D     +     I+ T    APE     
Sbjct: 340 -IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 394

Query: 660 PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQR 717
             ++K DV+++GVLL EI     +      Y       +  L+E D  +E  +       
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVY 449

Query: 718 FVMVAIWCIQEDPSHRPTMRRVTQMLE 744
            +M A W  Q +PS RP+   + Q  E
Sbjct: 450 ELMRACW--QWNPSDRPSFAEIHQAFE 474

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  141 bits (358), Expect = 2e-37
 Identities = 66/280 (23%), Positives = 114/280 (40%), Gaps = 28/280 (10%)

Query: 486 FKEELGRGAFGTVYKGFVNM---GSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNL 542
           +  +LG+G FG+V     +     +   VAVK+L     D +++F+ E+  +   H   +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 543 VRLLGYCDEGRNR--LLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHE 598
           V+  G       +   LV E++ +G L  FL    +        ++    I +G+ YL  
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLGS 145

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEW 655
             C   +H D+  +NIL++   + +I+DFGL KLL LD+ +        +  +   APE 
Sbjct: 146 RRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY-VVREPGQSPIFWYAPES 201

Query: 656 FRNMPITVKVDVYSYGVLLLEII------CLRRTILTDWAYDCYQERTLGALVEND---- 705
             +   + + DV+S+GV+L E+       C                  L  L+E      
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261

Query: 706 -LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
            L A          +M   W     P  RP+   +   L+
Sbjct: 262 RLPAPPACPAEVHELMKLCW--APSPQDRPSFSALGPQLD 299

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  138 bits (350), Expect = 7e-37
 Identities = 77/273 (28%), Positives = 125/273 (45%), Gaps = 24/273 (8%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +E+G G FG V+ G+    + D+VA+K + R    SE++F  E   + +  H  LV+L
Sbjct: 12  FVQEIGSGQFGLVHLGYWL--NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 68

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEECCTQ 603
            G C E     LV EFM +G L+ +L    +  +   T + M   +  G+ YL E C   
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEACV-- 125

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWFRNMP 660
            IH D+  +N L+ +    ++SDFG+ + +  DQ    T+  GTK  V   +PE F    
Sbjct: 126 -IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSR 181

Query: 661 ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQRF 718
            + K DV+S+GVL+ E+    +       Y+      +   +     L      +     
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKI-----PYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 236

Query: 719 VMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPI 751
           +M   W  +E P  RP   R+ + L  + E  +
Sbjct: 237 IMNHCW--RERPEDRPAFSRLLRQLAEIAESGL 267

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  140 bits (354), Expect = 9e-37
 Identities = 69/289 (23%), Positives = 111/289 (38%), Gaps = 51/289 (17%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQ---VAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKN 541
             + LG GAFGTVYKG            VA+K+L          E   E   +    + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEE 599
           + RLLG C       L+ + M  G L  ++  + K N   +  +     IA+G+ YL + 
Sbjct: 79  VCRLLGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWF 656
                +H D+  +N+L+    + +I+DFGL KLL  ++   +    G K  +   A E  
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESI 191

Query: 657 RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGA-------------LVE 703
            +   T + DV+SYGV + E++                  T G+             ++E
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELM------------------TFGSKPYDGIPASEISSILE 233

Query: 704 ND--LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
               L      T+    +M   W    D   RP  R +      +   P
Sbjct: 234 KGERLPQPPICTIDVYMIMRKCW--MIDADSRPKFRELIIEFSKMARDP 280

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  138 bits (351), Expect = 1e-36
 Identities = 58/269 (21%), Positives = 107/269 (39%), Gaps = 29/269 (10%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA---EVNGIGQTHHKNLVR 544
           +++GRG F  VY+    +     VA+KK+        K       E++ + Q +H N+++
Sbjct: 38  KKIGRGQFSEVYRAA-CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEEC 600
                 E     +V E    G L+  +    K    +    V      +   L ++H   
Sbjct: 97  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR- 155

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
             +++H DIKP N+ +      ++ D GL +  +   +  ++ + GT  Y++PE      
Sbjct: 156 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENG 212

Query: 661 ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL----VENDLEAMDDMTV-- 714
              K D++S G LL E+  L+        +    +  L +L     + D   +       
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQS------PFYG-DKMNLYSLCKKIEQCDYPPLPSDHYSE 265

Query: 715 -LQRFVMVAIWCIQEDPSHRPTMRRVTQM 742
            L++ V     CI  DP  RP +  V  +
Sbjct: 266 ELRQLVN---MCINPDPEKRPDVTYVYDV 291

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  139 bits (353), Expect = 1e-36
 Identities = 72/276 (26%), Positives = 127/276 (46%), Gaps = 23/276 (8%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQ---VAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKN 541
            ++ +G G FG VYKG +   S  +   VA+K L   + + ++ +F  E   +GQ  H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEE 599
           ++RL G   + +  +++ E+M NGAL  FL  +    + +   + M  GIA G+ YL   
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYLANM 166

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWF 656
                +H D+  +NIL++     ++SDFGL ++L  D   T T   G K  +   APE  
Sbjct: 167 NY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT-SGGKIPIRWTAPEAI 222

Query: 657 RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTV 714
                T   DV+S+G+++ E++           Y       +   + +   L    D   
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGER-----PYWELSNHEVMKAINDGFRLPTPMDCPS 277

Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
               +M+  W  Q++ + RP    +  +L+ ++  P
Sbjct: 278 AIYQLMMQCW--QQERARRPKFADIVSILDKLIRAP 311

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  142 bits (359), Expect = 2e-36
 Identities = 72/267 (26%), Positives = 118/267 (44%), Gaps = 26/267 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            + +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL 244

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEECCTQ 603
                E     +V E+MS G+L  FL G++    +L   + M   IA G+ Y+       
Sbjct: 245 YAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-- 301

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ----SHTNTAIRGTKGYVAPEWFRNM 659
            +H D++  NIL+ +    +++DFGL +L+  ++          I+ T    APE     
Sbjct: 302 -VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYG 356

Query: 660 PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQR 717
             T+K DV+S+G+LL E+    R       Y     R +   VE    +    +      
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESLH 411

Query: 718 FVMVAIWCIQEDPSHRPTMRRVTQMLE 744
            +M   W  +++P  RPT   +   LE
Sbjct: 412 DLMCQCW--RKEPEERPTFEYLQAFLE 436

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  143 bits (362), Expect = 2e-36
 Identities = 70/268 (26%), Positives = 116/268 (43%), Gaps = 28/268 (10%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            + +LG+G FG V+ G  N   + +VA+K L       E  F  E   + +  H+ LV+L
Sbjct: 271 LEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL 327

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEECCTQ 603
                E     +V E+MS G+L  FL G++    +L   + M   IA G+ Y+       
Sbjct: 328 YAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-- 384

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ----SHTNTAIRGTKGYVAPEWFRNM 659
            +H D++  NIL+ +    +++DFGL +L+  ++          I+ T    APE     
Sbjct: 385 -VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYG 439

Query: 660 PITVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQERTLGALVEND--LEAMDDMTVLQ 716
             T+K DV+S+G+LL E+    R         +          VE    +    +     
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD------QVERGYRMPCPPECPESL 493

Query: 717 RFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
             +M   W  +++P  RPT   +   LE
Sbjct: 494 HDLMCQCW--RKEPEERPTFEYLQAFLE 519

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  141 bits (357), Expect = 3e-36
 Identities = 72/264 (27%), Positives = 116/264 (43%), Gaps = 24/264 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
             + +G+G FG V  G       ++VAVK +      + + F AE + + Q  H NLV+L
Sbjct: 197 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 251

Query: 546 LGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEECCT 602
           LG   E +  L +V E+M+ G+L  +L    +        +     +   + YL      
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 310

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
             +H D+  +N+L+ +   A++SDFGL K  +  Q      ++ T    APE  R    +
Sbjct: 311 --VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 364

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQRFVM 720
            K DV+S+G+LL EI    R       Y     + +   VE    ++A D        VM
Sbjct: 365 TKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM 419

Query: 721 VAIWCIQEDPSHRPTMRRVTQMLE 744
              W    D + RPT  ++ + LE
Sbjct: 420 KNCW--HLDAATRPTFLQLREQLE 441

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  138 bits (349), Expect = 4e-36
 Identities = 69/278 (24%), Positives = 125/278 (44%), Gaps = 28/278 (10%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSD--QVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNL 542
            ++ +G G  G V  G + +       VA+K L   + + ++ +F +E + +GQ  H N+
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEEC 600
           +RL G    GR  ++V E+M NG+L +FL       + +   + M  G+  G+ YL +  
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWFR 657
               +H D+  +N+L+D     ++SDFGL ++L  D         G K  +   APE   
Sbjct: 172 Y---VHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWA-YDCYQERTLGALVEND--LEAMDD--M 712
               +   DV+S+GV++ E++        +    D          VE    L A      
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS------SVEEGYRLPAPMGCPH 281

Query: 713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
            + Q  +M+  W   +D + RP   ++  +L+ ++  P
Sbjct: 282 ALHQ--LMLDCW--HKDRAQRPRFSQIVSVLDALIRSP 315

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  137 bits (348), Expect = 4e-36
 Identities = 67/276 (24%), Positives = 110/276 (39%), Gaps = 25/276 (9%)

Query: 486 FKEELGRGAFGTVYKGF---VNMGSSDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKN 541
             + LG G FGTV+KG            V +K +       S +     +  IG   H +
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEE 599
           +VRLLG C  G +  LV +++  G+L   +    +     +  +     IA+G++YL E 
Sbjct: 77  IVRLLGLC-PGSSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEEH 134

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWF 656
                +H ++  +N+LL      +++DFG+  LL  D           K  +   A E  
Sbjct: 135 GM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMALESI 189

Query: 657 RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTV 714
                T + DV+SYGV + E++           Y   +   +  L+E    L      T+
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAE-----PYAGLRLAEVPDLLEKGERLAQPQICTI 244

Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
               VMV  W    D + RPT + +      +   P
Sbjct: 245 DVYMVMVKCW--MIDENIRPTFKELANEFTRMARDP 278

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  137 bits (346), Expect = 5e-36
 Identities = 64/284 (22%), Positives = 118/284 (41%), Gaps = 35/284 (12%)

Query: 486 FKEELGRGAFGTVYKGFVNM---GSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNL 542
           F ++LG+G FG+V     +     + + VAVKKL    ++  ++F+ E+  +    H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 543 VRLLGYCDEGRNR--LLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHE 598
           V+  G C     R   L+ E++  G+L  +L    K        +     I +G+ YL  
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT 132

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEW 655
           +     IH D+  +NIL+++    +I DFGL K+L  D+          +  +   APE 
Sbjct: 133 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF-KVKEPGESPIFWYAPES 188

Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL 715
                 +V  DV+S+GV+L E+           +      R +G   +  +     + +L
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIE---KSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245

Query: 716 QR---------------FVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           +                 +M   W    + + RP+ R +   ++
Sbjct: 246 KNNGRLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 287

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  139 bits (351), Expect = 6e-36
 Identities = 74/277 (26%), Positives = 130/277 (46%), Gaps = 26/277 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSD--QVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNL 542
             + +G G FG V  G + + S     VA+K L   + + ++ +F  E + +GQ  H N+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEEC 600
           +RL G   + +  ++V E+M NG+L SFL       + +   + M  GIA G+ YL +  
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWFR 657
               +H D+  +NIL++     ++SDFGL ++L  D        RG K  +   +PE   
Sbjct: 168 Y---VHRDLAARNILINSNLVCKVSDFGLGRVLE-DDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDD--MT 713
               T   DV+SYG++L E++           Y     + +   V+    L    D    
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGER-----PYWEMSNQDVIKAVDEGYRLPPPMDCPAA 278

Query: 714 VLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
           + Q  +M+  W  Q+D ++RP   ++  +L+ ++  P
Sbjct: 279 LYQ--LMLDCW--QKDRNNRPKFEQIVSILDKLIRNP 311

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  136 bits (344), Expect = 7e-36
 Identities = 62/292 (21%), Positives = 111/292 (38%), Gaps = 65/292 (22%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSD------QVAVKKLNRVFQDSEKEFKAEVNGIGQTHH 539
           F E LG+G F  ++KG              +V +K L++  ++  + F    + + +  H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71

Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLH 597
           K+LV   G C  G   +LV EF+  G+L ++L   +K    +  ++ +   +A  + +L 
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLE 130

Query: 598 EECCTQIIHCDIKPQNILLDDYYNAR--------ISDFGLEKLLTLDQSHTNTAIRGTKG 649
           E      IH ++  +NILL    + +        +SD G+   + L +      I     
Sbjct: 131 ENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV-- 184

Query: 650 YVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEA 708
              PE   N     +  D +S+G  L EI                   + G   +  L A
Sbjct: 185 --PPECIENPKNLNLATDKWSFGTTLWEIC------------------SGG---DKPLSA 221

Query: 709 MDDMTVLQRF----------------VMVAIWCIQEDPSHRPTMRRVTQMLE 744
           +D    LQ +                ++        +P HRP+ R + + L 
Sbjct: 222 LDSQRKLQFYEDRHQLPAPKAAELANLINNCM--DYEPDHRPSFRAIIRDLN 271

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  137 bits (346), Expect = 8e-36
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 35/284 (12%)

Query: 486 FKEELGRGAFGTVYKGFVNM---GSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNL 542
           F ++LG+G FG+V     +     + + VAVKKL    ++  ++F+ E+  +    H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 543 VRLLGYCDEGRNR--LLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHE 598
           V+  G C     R   L+ E++  G+L  +L    K        +     I +G+ YL  
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT 163

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEW 655
           +     IH D+  +NIL+++    +I DFGL K+L  D+ +        +  +   APE 
Sbjct: 164 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY-KVKEPGESPIFWYAPES 219

Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL 715
                 +V  DV+S+GV+L E+        +  A      R +G   +  +     + +L
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMIGNDKQGQMIVFHLIELL 276

Query: 716 QR---------------FVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           +                 +M   W    + + RP+ R +   ++
Sbjct: 277 KNNGRLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 318

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  136 bits (344), Expect = 8e-36
 Identities = 79/272 (29%), Positives = 124/272 (45%), Gaps = 22/272 (8%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G      S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 17  MKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 74

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L   ++        + M   I+  + YL ++    
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-- 132

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWFRNMP 660
            IH D+  +N L+ + +  +++DFGL +L+T D     TA  G K  +   APE      
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNK 188

Query: 661 ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQRF 718
            ++K DV+++GVLL EI     +      Y       +  L+E D  +E  +        
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 243

Query: 719 VMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
           +M A W  Q +PS RP+   + Q  E + +  
Sbjct: 244 LMRACW--QWNPSDRPSFAEIHQAFETMFQES 273

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  136 bits (344), Expect = 1e-35
 Identities = 66/285 (23%), Positives = 120/285 (42%), Gaps = 29/285 (10%)

Query: 486 FKEELGRGAFGTVYKGFVNM---GSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKN 541
              +LG G FG V     +     + +QVAVK L      +   + K E+  +   +H+N
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 542 LVRLLGYC--DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLH 597
           +V+  G C  D G    L+ EF+ +G+L  +L   +K    L+ ++     I +G+ YL 
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLG 143

Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APE 654
                  +H D+  +N+L++  +  +I DFGL K +  D+ +  T        V   APE
Sbjct: 144 SRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY-TVKDDRDSPVFWYAPE 199

Query: 655 WFRNMPITVKVDVYSYGVLLLEII------CLRRTILTDWAYDCYQERTLGALVEND--- 705
                   +  DV+S+GV L E++           +        + + T+  LV      
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259

Query: 706 --LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
             L    +       +M   W  +  PS+R + + + +  E +++
Sbjct: 260 KRLPCPPNCPDEVYQLMRKCW--EFQPSNRTSFQNLIEGFEALLK 302

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  139 bits (353), Expect = 1e-35
 Identities = 71/269 (26%), Positives = 118/269 (43%), Gaps = 30/269 (11%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            +++LG G FG V+    N     +VAVK + +    S + F AE N +    H  LV+L
Sbjct: 192 LEKKLGAGQFGEVWMATYN--KHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL 248

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEECCTQ 603
                +     ++ EFM+ G+L  FL  D      L   I     IA G+ ++ +     
Sbjct: 249 HAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY-- 305

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWFRNMP 660
            IH D++  NIL+      +I+DFGL +++  ++    TA  G K  +   APE      
Sbjct: 306 -IHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 361

Query: 661 ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLG---ALVEND--LEAMDDMTVL 715
            T+K DV+S+G+LL+EI+   R          Y   +       +E    +   ++    
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIP--------YPGMSNPEVIRALERGYRMPRPENCPEE 413

Query: 716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
              +M+  W  +  P  RPT   +  +L+
Sbjct: 414 LYNIMMRCW--KNRPEERPTFEYIQSVLD 440

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  135 bits (341), Expect = 2e-35
 Identities = 68/273 (24%), Positives = 120/273 (43%), Gaps = 30/273 (10%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +ELG G FG V  G         VA+K + +    SE EF  E   +    H+ LV+L
Sbjct: 28  FLKELGTGQFGVVKYGKWR--GQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQL 84

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEECCTQ 603
            G C + R   ++ E+M+NG L ++L  + +  ++ +  + M   +   + YL  +    
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQF-- 141

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWFRNMP 660
            +H D+  +N L++D    ++SDFGL + +  D+    T+  G+K  V    PE      
Sbjct: 142 -LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSK 197

Query: 661 ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLG---ALVEND--LEAMDDMTVL 715
            + K D++++GVL+ EI  L +          Y+  T       +     L      +  
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMP--------YERFTNSETAEHIAQGLRLYRPHLASEK 249

Query: 716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
              +M + W   E    RPT + +   +  V++
Sbjct: 250 VYTIMYSCW--HEKADERPTFKILLSNILDVMD 280

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  134 bits (340), Expect = 2e-35
 Identities = 62/271 (22%), Positives = 103/271 (38%), Gaps = 30/271 (11%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQTHHKNLVRL 545
             +G G++G   K          +  K+L+         +   +EVN + +  H N+VR 
Sbjct: 12  YTIGTGSYGRCQKI-RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70

Query: 546 LG-YCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHE- 598
                D     L +V E+   G LAS +   +K    L  E V+     +   L   H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130

Query: 599 -ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
            +    ++H D+KP N+ LD   N ++ DFGL ++L  D S   T + GT  Y++PE   
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMN 189

Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN----DLEAMDDM- 712
            M    K D++S G LL E+  L            +   +   L           +    
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPP---------FTAFSQKELAGKIREGKFRRIPYRY 240

Query: 713 -TVLQRFVMVAIWCIQEDPSHRPTMRRVTQM 742
              L   +      +     HRP++  + + 
Sbjct: 241 SDELNEIIT---RMLNLKDYHRPSVEEILEN 268

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  136 bits (345), Expect = 2e-35
 Identities = 62/301 (20%), Positives = 122/301 (40%), Gaps = 38/301 (12%)

Query: 457 MRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKL 516
           M  H        +      ++ + +  R   +++G G+FG       +     Q  +K++
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMEKYVRL--QKIGEGSFGKAILVK-STEDGRQYVIKEI 57

Query: 517 NRVFQDSEKEFKA---EVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG 573
           N + + S KE +    EV  +    H N+V+     +E  +  +V ++   G L   +  
Sbjct: 58  N-ISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-- 114

Query: 574 DSKPNWKLRTEIVMG----IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
           +++     + + ++     I   L ++H+    +I+H DIK QNI L      ++ DFG+
Sbjct: 115 NAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI 171

Query: 630 EKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA 689
            ++L          I GT  Y++PE   N P   K D+++ G +L E+  L+        
Sbjct: 172 ARVLNSTVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA------ 224

Query: 690 YDCYQERTLGALV----ENDLEAMDDM--TVLQRFVMVAIWCIQEDPSHRPTMRRVTQML 743
              ++  ++  LV          +       L+  V       + +P  RP+   V  +L
Sbjct: 225 ---FEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS---QLFKRNPRDRPS---VNSIL 275

Query: 744 E 744
           E
Sbjct: 276 E 276

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  134 bits (340), Expect = 3e-35
 Identities = 71/267 (26%), Positives = 111/267 (41%), Gaps = 22/267 (8%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSD-QVAVKKL-NRVFQDSEKEFKAEVNGIGQTHHKNLVR 544
             ELG G FG+V +G   M      VA+K L     +   +E   E   + Q  +  +VR
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEECCT 602
           L+G C +    +LV E    G L  FL    +    +     +   ++ G+ YL E+   
Sbjct: 75  LIGVC-QAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNF- 131

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWFRNM 659
             +H D+  +N+LL + + A+ISDFGL K L  D S+  TA    K  +   APE     
Sbjct: 132 --VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFR 188

Query: 660 PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQR 717
             + + DV+SYGV + E +   +       Y   +   + A +E    +E   +      
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQK-----PYKKMKGPEVMAFIEQGKRMECPPECPPELY 243

Query: 718 FVMVAIWCIQEDPSHRPTMRRVTQMLE 744
            +M   W        RP    V Q + 
Sbjct: 244 ALMSDCW--IYKWEDRPDFLTVEQRMR 268

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  133 bits (338), Expect = 3e-35
 Identities = 69/269 (25%), Positives = 110/269 (40%), Gaps = 30/269 (11%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
             +ELG G FG V  G         VAVK +       + EF  E   + +  H  LV+ 
Sbjct: 12  LLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKF 68

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEECCTQ 603
            G C +     +V E++SNG L ++L        +    + M   +  G+ +L       
Sbjct: 69  YGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLESHQF-- 125

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWFRNMP 660
            IH D+  +N L+D     ++SDFG+ + +  DQ     +  GTK  V   APE F    
Sbjct: 126 -IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFHYFK 181

Query: 661 ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLG---ALVEND--LEAMDDMTVL 715
            + K DV+++G+L+ E+  L +          Y   T       V     L      +  
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMP--------YDLYTNSEVVLKVSQGHRLYRPHLASDT 233

Query: 716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
              +M + W   E P  RPT +++   +E
Sbjct: 234 IYQIMYSCW--HELPEKRPTFQQLLSSIE 260

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  134 bits (339), Expect = 3e-35
 Identities = 78/264 (29%), Positives = 114/264 (43%), Gaps = 20/264 (7%)

Query: 489 ELGRGAFGTVYKGFVNMGSSD-QVAVK--KLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           ELG G FGTV KG+  M      VAVK  K        + E  AE N + Q  +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
           +G C E  + +LV E    G L  +L  +     K   E+V  ++ G+ YL E      +
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF---V 139

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWFRNMPIT 662
           H D+  +N+LL   + A+ISDFGL K L  D+++   A    K  V   APE       +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINYYKFS 198

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQRFVM 720
            K DV+S+GVL+ E     +       Y   +   + A++E    +            +M
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQK-----PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM 253

Query: 721 VAIWCIQEDPSHRPTMRRVTQMLE 744
              W    D  +RP    V   L 
Sbjct: 254 NLCW--TYDVENRPGFAAVELRLR 275

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  133 bits (337), Expect = 6e-35
 Identities = 71/264 (26%), Positives = 116/264 (43%), Gaps = 24/264 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
             + +G+G FG V  G       ++VAVK +      + + F AE + + Q  H NLV+L
Sbjct: 25  LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 79

Query: 546 LGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEECCT 602
           LG   E +  L +V E+M+ G+L  +L    +        +     +   + YL      
Sbjct: 80  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 138

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
             +H D+  +N+L+ +   A++SDFGL K  +  Q      ++ T    APE  R    +
Sbjct: 139 --VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 192

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVLQRFVM 720
            K DV+S+G+LL EI    R       Y     + +   VE    ++A D        VM
Sbjct: 193 TKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 247

Query: 721 VAIWCIQEDPSHRPTMRRVTQMLE 744
              W    D + RP+  ++ + LE
Sbjct: 248 KNCW--HLDAAMRPSFLQLREQLE 269

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  134 bits (339), Expect = 8e-35
 Identities = 70/276 (25%), Positives = 113/276 (40%), Gaps = 25/276 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQ---VAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKN 541
             + LG GAFGTVYKG            VA+K+L          E   E   +    + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEE 599
           + RLLG C       L+ + M  G L  ++  + K N   +  +     IA+G+ YL + 
Sbjct: 79  VCRLLGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWF 656
                +H D+  +N+L+    + +I+DFGL KLL  ++   +    G K  +   A E  
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESI 191

Query: 657 RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTV 714
            +   T + DV+SYGV + E++           YD      + +++E    L      T+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLPQPPICTI 246

Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
               +MV  W    D   RP  R +      +   P
Sbjct: 247 DVYMIMVKCW--MIDADSRPKFRELIIEFSKMARDP 280

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  133 bits (337), Expect = 1e-34
 Identities = 67/279 (24%), Positives = 111/279 (39%), Gaps = 27/279 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNM---GSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKN 541
              +LG G FG V     +    G+ + VAVK L           +K E++ +   +H++
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 542 LVRLLGYCDEGRNR--LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
           +++  G C++       LV E++  G+L  +L   S    +L       I  G+ YLH +
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-LLFAQQICEGMAYLHAQ 153

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWF 656
                IH D+  +N+LLD+    +I DFGL K +     +           V   APE  
Sbjct: 154 HY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY-RVREDGDSPVFWYAPECL 209

Query: 657 RNMPITVKVDVYSYGVLLLEII------CLRRTILTDWAYDCYQERTLGALVEND----- 705
           +        DV+S+GV L E++          T   +       + T+  L E       
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269

Query: 706 LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           L   D        +M   W  + + S RPT   +  +L+
Sbjct: 270 LPRPDKCPAEVYHLMKNCW--ETEASFRPTFENLIPILK 306

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  133 bits (337), Expect = 1e-34
 Identities = 86/326 (26%), Positives = 122/326 (37%), Gaps = 53/326 (16%)

Query: 457 MRPHQEEQGVSYMNLRCFTYKELVEVTRG---FKEELGRGAFGTVYKGFVN----MGSSD 509
              H           +  +  +L EV R        LG GAFG VY+G V+      S  
Sbjct: 2   AHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPL 61

Query: 510 QVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALA 568
           QVAVK L  V  + ++ +F  E   I + +H+N+VR +G   +   R ++ E M+ G L 
Sbjct: 62  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLK 121

Query: 569 SFL-------FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN 621
           SFL          S         +   IA G  YL E      IH DI  +N LL     
Sbjct: 122 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGP 178

Query: 622 AR---ISDFGLEKLLTLDQSHTNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVL 673
            R   I DFG    +  D    +   +G    +      PE F     T K D +S+GVL
Sbjct: 179 GRVAKIGDFG----MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 234

Query: 674 LLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR---------FVMVAIW 724
           L EI  L         Y  Y  ++     +  LE +     +            +M   W
Sbjct: 235 LWEIFSL--------GYMPYPSKS----NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCW 282

Query: 725 CIQEDPSHRPTMRRVTQMLEGVVEVP 750
             Q  P  RP    + + +E   + P
Sbjct: 283 --QHQPEDRPNFAIILERIEYCTQDP 306

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  132 bits (334), Expect = 2e-34
 Identities = 68/272 (25%), Positives = 105/272 (38%), Gaps = 26/272 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVFQDSEK---EFKAEVNGIGQTHHK 540
             E+LG G+FG V +G  +   G +  VAVK L        +   +F  EVN +    H+
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81

Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHE 598
           NL+RL G         +V E    G+L   L    + ++ L T       +A G+ YL  
Sbjct: 82  NLIRLYGVV-LTPPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLES 139

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEW 655
           +     IH D+  +N+LL      +I DFGL + L  +  H        K      APE 
Sbjct: 140 KRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY-VMQEHRKVPFAWCAPES 195

Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND---LEAMDDM 712
            +    +   D + +GV L E+    +       +       +   ++ +   L   +D 
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLPRPEDC 250

Query: 713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
                 VMV  W     P  RPT   +   L 
Sbjct: 251 PQDIYNVMVQCW--AHKPEDRPTFVALRDFLL 280

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  132 bits (335), Expect = 5e-34
 Identities = 83/302 (27%), Positives = 119/302 (39%), Gaps = 53/302 (17%)

Query: 481 EVTRG---FKEELGRGAFGTVYKGFVNMGSSD----QVAVKKLNRVFQDSEK-EFKAEVN 532
           EV R        LG GAFG VY+G V+   +D    QVAVK L  V  + ++ +F  E  
Sbjct: 67  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126

Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL-----FGDSKPNWKLRTEIVM 587
            I + +H+N+VR +G   +   R ++ E M+ G L SFL           +  +   + +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186

Query: 588 --GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNAR---ISDFGLEKLLTLDQSHTNT 642
              IA G  YL E      IH DI  +N LL      R   I DFG    +  D      
Sbjct: 187 ARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRAGY 239

Query: 643 AIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT 697
             +G    +      PE F     T K D +S+GVLL EI  L         Y  Y  ++
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL--------GYMPYPSKS 291

Query: 698 LGALVENDLEAMDDMTVLQR---------FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
                +  LE +     +            +M   W  Q  P  RP    + + +E   +
Sbjct: 292 ----NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCW--QHQPEDRPNFAIILERIEYCTQ 345

Query: 749 VP 750
            P
Sbjct: 346 DP 347

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  132 bits (333), Expect = 5e-34
 Identities = 75/323 (23%), Positives = 133/323 (41%), Gaps = 65/323 (20%)

Query: 468 YMNLRCFTYKELVEVTRG---FKEELGRGAFGTVYKGFVN----MGSSDQVAVKKLNRVF 520
           Y +       +  EV R       ELG+G+FG VY+G            +VA+K +N   
Sbjct: 8   YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 67

Query: 521 QDSEK-EFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL------FG 573
              E+ EF  E + + + +  ++VRLLG   +G+  L++ E M+ G L S+L        
Sbjct: 68  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 127

Query: 574 DSKPNWKLR----TEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
           ++            ++   IA G+ YL+       +H D+  +N ++ + +  +I DFG 
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFG- 183

Query: 630 EKLLTLDQSHTNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRTI 684
              +T D   T+   +G KG +     +PE  ++   T   DV+S+GV+L EI       
Sbjct: 184 ---MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA------ 234

Query: 685 LTDWAYDCYQERTLGAL----VEND--LEAMDDMTVLQR---------FVMVAIWCIQED 729
                       TL       + N+  L  + +  +L +          +M   W  Q +
Sbjct: 235 ------------TLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCW--QYN 280

Query: 730 PSHRPTMRRVTQMLEGVVEVPIP 752
           P  RP+   +   ++  +E    
Sbjct: 281 PKMRPSFLEIISSIKEEMEPGFR 303

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  132 bits (333), Expect = 5e-34
 Identities = 70/306 (22%), Positives = 119/306 (38%), Gaps = 57/306 (18%)

Query: 481 EVTRG---FKEELGRGAFGTVYKGFVNMGSSDQ----VAVKKLNRVFQDSEKEFKAEVNG 533
            + R     K ELG GAFG V+    +    +Q    VAVK L    + + ++F+ E   
Sbjct: 37  HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96

Query: 534 IGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL---------------FGDSKPN 578
           +    H+++VR  G C EGR  L+V+E+M +G L  FL                      
Sbjct: 97  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 579 WKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS 638
                 +   +A G+ YL        +H D+  +N L+      +I DFG    ++ D  
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFG----MSRDIY 209

Query: 639 HTNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCY 693
            T+    G +  +      PE       T + DV+S+GV+L EI               +
Sbjct: 210 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTY--------GKQPW 261

Query: 694 QERTLGALVENDLEAMDDMTVLQR---------FVMVAIWCIQEDPSHRPTMRRVTQMLE 744
            + +        ++ +     L+R          +M   W  Q +P  R +++ V   L+
Sbjct: 262 YQLS----NTEAIDCITQGRELERPRACPPEVYAIMRGCW--QREPQQRHSIKDVHARLQ 315

Query: 745 GVVEVP 750
            + + P
Sbjct: 316 ALAQAP 321

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  130 bits (330), Expect = 7e-34
 Identities = 74/313 (23%), Positives = 119/313 (38%), Gaps = 70/313 (22%)

Query: 481 EVTRG---FKEELGRGAFGTVYKGFVNMGSSDQ----VAVKKLNRVFQDSEKEFKAEVNG 533
            + R     K ELG GAFG V+       S  +    VAVK L      + K+F+ E   
Sbjct: 11  HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70

Query: 534 IGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLR----------- 582
           +    H+++V+  G C +G   ++V+E+M +G L  FL         L            
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 583 -----TEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ 637
                  I   IA G+ YL  +     +H D+  +N L+      +I DFG+ + +    
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187

Query: 638 ---SHTNTA--IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDC 692
                 +T   IR       PE       T + DV+S+GV+L EI               
Sbjct: 188 YYRVGGHTMLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIF-------------- 229

Query: 693 YQERTLGAL----VEND--LEAMDDMTVLQR---------FVMVAIWCIQEDPSHRPTMR 737
               T G      + N   +E +    VL+R          VM+  W  Q +P  R  ++
Sbjct: 230 ----TYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCW--QREPQQRLNIK 283

Query: 738 RVTQMLEGVVEVP 750
            + ++L  + +  
Sbjct: 284 EIYKILHALGKAT 296

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  130 bits (329), Expect = 7e-34
 Identities = 81/269 (30%), Positives = 121/269 (44%), Gaps = 30/269 (11%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
             E LG G FG V+ G+ N     +VAVK L +     +  F AE N + Q  H+ LVRL
Sbjct: 17  LVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL 73

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEECCTQ 603
                +     ++ E+M NG+L  FL   S     +   + M   IA G+ ++ E     
Sbjct: 74  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY-- 130

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWFRNMP 660
            IH D++  NIL+ D  + +I+DFGL +L+  ++    TA  G K  +   APE      
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGT 186

Query: 661 ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLG---ALVEND--LEAMDDMTVL 715
            T+K DV+S+G+LL EI+   R          Y   T       +E    +   D+    
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP--------YPGMTNPEVIQNLERGYRMVRPDNCPEE 238

Query: 716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
              +M   W  +E P  RPT   +  +LE
Sbjct: 239 LYQLMRLCW--KERPEDRPTFDYLRSVLE 265

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  130 bits (328), Expect = 1e-33
 Identities = 64/275 (23%), Positives = 108/275 (39%), Gaps = 25/275 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNL 542
               +G G FG V++G        +  VA+K       DS + +F  E   + Q  H ++
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEEC 600
           V+L+G   E     ++ E  + G L SFL    K +  L + I+    ++  L YL  + 
Sbjct: 79  VKLIGVITENPV-WIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKR 136

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWFR 657
               +H DI  +N+L+      ++ DFGL + +   +  T       K  +   APE   
Sbjct: 137 F---VHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESIN 190

Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTVL 715
               T   DV+ +GV + EI+           +   +   +   +EN   L    +    
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVK-----PFQGVKNNDVIGRIENGERLPMPPNCPPT 245

Query: 716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
              +M   W    DPS RP    +   L  ++E  
Sbjct: 246 LYSLMTKCW--AYDPSRRPRFTELKAQLSTILEEE 278

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  131 bits (332), Expect = 2e-33
 Identities = 70/287 (24%), Positives = 116/287 (40%), Gaps = 48/287 (16%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSD--QVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +          AVK LNR+    E  +F  E   +    H N+
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152

Query: 543 VRLLGYC-DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEE 599
           + LLG C     + L+V  +M +G L +F+  +   N  ++  I     +A+G+ +L  +
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLASK 211

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWF 656
                +H D+  +N +LD+ +  +++DFGL + +   +  +     G K  V   A E  
Sbjct: 212 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 657 RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL----VEND--LEAMD 710
           +    T K DV+S+GVLL E++                  T GA     V        + 
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELM------------------TRGAPPYPDVNTFDITVYLL 310

Query: 711 DMTVLQR---------FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
               L +          VM+  W        RP+   +   +  +  
Sbjct: 311 QGRRLLQPEYCPDPLYEVMLKCW--HPKAEMRPSFSELVSRISAIFS 355

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  129 bits (327), Expect = 2e-33
 Identities = 72/287 (25%), Positives = 118/287 (41%), Gaps = 48/287 (16%)

Query: 486 FKEELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +    G     AVK LNR+    E  +F  E   +    H N+
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88

Query: 543 VRLLGYC-DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEE 599
           + LLG C     + L+V  +M +G L +F+  +   N  ++  I     +A+G+ YL  +
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLASK 147

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWF 656
                +H D+  +N +LD+ +  +++DFGL + +   + ++     G K  V   A E  
Sbjct: 148 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 657 RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL----VEND--LEAMD 710
           +    T K DV+S+GVLL E++                  T GA     V        + 
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELM------------------TRGAPPYPDVNTFDITVYLL 246

Query: 711 DMTVLQR---------FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
               L +          VM+  W        RP+   +   +  +  
Sbjct: 247 QGRRLLQPEYCPDPLYEVMLKCW--HPKAEMRPSFSELVSRISAIFS 291

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  129 bits (326), Expect = 2e-33
 Identities = 63/272 (23%), Positives = 109/272 (40%), Gaps = 31/272 (11%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSD--QVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNL 542
               LG G FG VY+G       +   VAVK   +    D++++F +E   +    H ++
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEEC 600
           V+L+G  +E     ++ E    G L  +L   +K + K+ T ++    I + + YL    
Sbjct: 76  VKLIGIIEEEP-TWIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESIN 133

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWFR 657
           C   +H DI  +NIL+      ++ DFGL + +   +         T+  +   +PE   
Sbjct: 134 C---VHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLPIKWMSPESIN 187

Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT----LGALVEND-LEAMDDM 712
               T   DV+ + V + EI+   +          +        +G L + D L   D  
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQP--------FFWLENKDVIGVLEKGDRLPKPDLC 239

Query: 713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
             +   +M   W    DPS RP    +   L 
Sbjct: 240 PPVLYTLMTRCW--DYDPSDRPRFTELVCSLS 269

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  128 bits (325), Expect = 3e-33
 Identities = 68/274 (24%), Positives = 120/274 (43%), Gaps = 22/274 (8%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSD--QVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNL 542
               +G+G FG VY G     + +  Q A+K L+R+ +  +   F  E   +   +H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 543 VRLLGYC-DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG--IARGLFYLHEE 599
           + L+G          ++  +M +G L  F+    + N  ++  I  G  +ARG+ YL E+
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLAEQ 143

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWF 656
                +H D+  +N +LD+ +  +++DFGL + +   + ++    R  +  V   A E  
Sbjct: 144 KF---VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200

Query: 657 RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTV 714
           +    T K DV+S+GVLL E++           Y       L   +     L   +    
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAP-----PYRHIDPFDLTHFLAQGRRLPQPEYCPD 255

Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
               VM   W  + DP+ RPT R +   +E +V 
Sbjct: 256 SLYQVMQQCW--EADPAVRPTFRVLVGEVEQIVS 287

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  129 bits (326), Expect = 5e-33
 Identities = 56/263 (21%), Positives = 101/263 (38%), Gaps = 36/263 (13%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           +  +GRG+FG V++   +  +  Q AVKK+    +    E   E+          +V L 
Sbjct: 63  QPRVGRGSFGEVHRMK-DKQTGFQCAVKKVR--LEVFRVE---ELVACAGLSSPRIVPLY 116

Query: 547 GYCDEGRNRLLVY-EFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----GLFYLHEECC 601
           G        + ++ E +  G+L   +    K    L  +  +        GL YLH    
Sbjct: 117 G-AVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR-- 169

Query: 602 TQIIHCDIKPQNILLDDY-YNARISDFGLEKLLTLDQSHTNTA----IRGTKGYVAPEWF 656
            +I+H D+K  N+LL      A + DFG    L  D    +      I GT+ ++APE  
Sbjct: 170 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228

Query: 657 RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND---LEAMDDMT 713
              P   KVD++S   ++L ++         W    ++      +        E      
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHP----WT-QYFRGPLCLKIASEPPPIREIPPSCA 283

Query: 714 -VLQRFVMVAIWCIQEDPSHRPT 735
            +  + +      ++++P HR +
Sbjct: 284 PLTAQAIQ---EGLRKEPVHRAS 303

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  134 bits (338), Expect = 6e-33
 Identities = 70/269 (26%), Positives = 114/269 (42%), Gaps = 26/269 (9%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSD-QVAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNLVR 544
             ELG G FG+V +G   M      VA+K L +  + ++  E   E   + Q  +  +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEECCT 602
           L+G C +    +LV E    G L  FL    +    +     +   ++ G+ YL E+   
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNF- 457

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV---APEWFRNM 659
             +H ++  +N+LL + + A+ISDFGL K L  D S+  TA    K  +   APE     
Sbjct: 458 --VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFR 514

Query: 660 PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDD--MTVL 715
             + + DV+SYGV + E +   +       Y   +   + A +E    +E   +    + 
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQK-----PYKKMKGPEVMAFIEQGKRMECPPECPPELY 569

Query: 716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
              +M   W        RP    V Q + 
Sbjct: 570 A--LMSDCW--IYKWEDRPDFLTVEQRMR 594

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  127 bits (321), Expect = 1e-32
 Identities = 57/286 (19%), Positives = 104/286 (36%), Gaps = 46/286 (16%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVRLL 546
           + LGRG FG V++   N       A+K++    ++  +E    EV  + +  H  +VR  
Sbjct: 11  QCLGRGGFGVVFEA-KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 69

Query: 547 GYCDEGRN---------RLLVY---EFMSNGALASFLF---GDSKPNWKLRTEIVMGIAR 591
               E            ++ +Y   +      L  ++       +    +   I + IA 
Sbjct: 70  NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129

Query: 592 GLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR------ 645
            + +LH +    ++H D+KP NI        ++ DFGL   +  D+              
Sbjct: 130 AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186

Query: 646 -----GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGA 700
                GTK Y++PE       + KVD++S G++L E++    T +        + RTL  
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQME-------RVRTLTD 239

Query: 701 LVENDLEAMDDM--TVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           +       +           V      +   P  RP       ++E
Sbjct: 240 VRNLKFPPLFTQKYPCEYVMVQ---DMLSPSPMERPE---AINIIE 279

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  127 bits (321), Expect = 1e-32
 Identities = 58/194 (29%), Positives = 92/194 (47%), Gaps = 13/194 (6%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           LG+G +G VY G  ++ +  ++A+K++        +    E+       HKN+V+ LG  
Sbjct: 30  LGKGTYGIVYAGR-DLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-S 87

Query: 550 DEGRNRLLVY-EFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
                 + ++ E +  G+L++ L   +G  K N +        I  GL YLH+    QI+
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIV 144

Query: 606 HCDIKPQNILLDDYY-NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI--T 662
           H DIK  N+L++ Y    +ISDFG  K L      T T   GT  Y+APE     P    
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYG 203

Query: 663 VKVDVYSYGVLLLE 676
              D++S G  ++E
Sbjct: 204 KAADIWSLGCTIIE 217

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  127 bits (322), Expect = 1e-32
 Identities = 67/293 (22%), Positives = 109/293 (37%), Gaps = 32/293 (10%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F ++LG G F  V      +      A+K++    Q   +E + E +     +H N++RL
Sbjct: 33  FIQKLGEGGFSYVDLV-EGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRL 91

Query: 546 LGYCDEGRNR----LLVYEFMSNGALASFLFGDSKPNWKLRTEIVM----GIARGLFYLH 597
           + YC   R       L+  F   G L + +         L  + ++    GI RGL  +H
Sbjct: 92  VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151

Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR--------GTKG 649
                   H D+KP NILL D     + D G      +    +  A+          T  
Sbjct: 152 A---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208

Query: 650 YVAPEWF---RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER--TLGALVEN 704
           Y APE F    +  I  + DV+S G +L  ++           YD   ++  ++   V+N
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG------PYDMVFQKGDSVALAVQN 262

Query: 705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCPWT 757
            L              +    +  DP  RP +  +   LE  ++ P P    T
Sbjct: 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE-ALQPPAPGQHTT 314

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  133 bits (335), Expect = 2e-32
 Identities = 64/276 (23%), Positives = 107/276 (38%), Gaps = 27/276 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSEK-EFKAEVNGIGQTHHKNL 542
               +G G FG V++G      +    VA+K       DS + +F  E   + Q  H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM--GIARGLFYLHEEC 600
           V+L+G   E     ++ E  + G L SFL    K +  L + I+    ++  L YL  + 
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLESKR 511

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD----QSHTNTAIRGTKGYVAPEWF 656
               +H DI  +N+L+      ++ DFGL + +        S     I+      APE  
Sbjct: 512 F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 564

Query: 657 RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--LEAMDDMTV 714
                T   DV+ +GV + EI+           +   +   +   +EN   L    +   
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVK-----PFQGVKNNDVIGRIENGERLPMPPNCPP 619

Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
               +M   W    DPS RP    +   L  ++E  
Sbjct: 620 TLYSLMTKCW--AYDPSRRPRFTELKAQLSTILEEE 653

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (326), Expect = 3e-32
 Identities = 65/270 (24%), Positives = 109/270 (40%), Gaps = 32/270 (11%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKA--EVNGIGQTHHKNL 542
            K+ LG GA GT+   +  M  +  VAVK++       +++E +   E +      H N+
Sbjct: 28  PKDVLGHGAEGTIV--YRGMFDNRDVAVKRILPECFSFADREVQLLRESDE-----HPNV 80

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
           +R      + + + +  E  +   L  ++     +    +  T ++     GL +LH   
Sbjct: 81  IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPIT-LLQQTTSGLAHLHSL- 137

Query: 601 CTQIIHCDIKPQNILL-----DDYYNARISDFGLEKLLTLDQS--HTNTAIRGTKGYVAP 653
              I+H D+KP NIL+          A ISDFGL K L + +      + + GT+G++AP
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 654 EWFR---NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMD 710
           E          T  VD++S G +   +I                   LGA   + L    
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS-LQRQANILLGACSLDCLHPEK 254

Query: 711 DMTVLQR-FVMVAIWCIQEDPSHRPTMRRV 739
              V+ R  +      I  DP  RP+ + V
Sbjct: 255 HEDVIARELIE---KMIAMDPQKRPSAKHV 281

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  125 bits (317), Expect = 5e-32
 Identities = 73/298 (24%), Positives = 121/298 (40%), Gaps = 62/298 (20%)

Query: 486 FKEELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKN 541
             + LG G FG+V +G +    G+S +VAVK +      Q   +EF +E   +    H N
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 542 LVRLLGYCDEGRNR-----LLVYEFMSNGALASFL----FGDSKPNWKLRTEIVMG--IA 590
           ++RLLG C E  ++     +++  FM  G L ++L          +  L+T +     IA
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGY 650
            G+ YL        +H D+  +N +L D     ++DFGL K         +   +G    
Sbjct: 158 LGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQGRIAK 210

Query: 651 V-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL---- 701
           +     A E   +   T K DV+++GV + EI                   T G      
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA------------------TRGMTPYPG 252

Query: 702 VEND--LEAMDDMTVLQR---------FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
           V+N    + +     L++          +M + W  + DP  RPT   +   LE ++E
Sbjct: 253 VQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCW--RTDPLDRPTFSVLRLQLEKLLE 308

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  125 bits (315), Expect = 8e-32
 Identities = 59/258 (22%), Positives = 89/258 (34%), Gaps = 32/258 (12%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS--EKEFKAEVNGIGQ-THHKNLVR 544
             LG G++G V+K   +       AVK+    F+         AEV    +   H   VR
Sbjct: 63  SRLGHGSYGEVFKVR-SKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEEC 600
           L    +EG    L  E     +L             L    V G        L +LH + 
Sbjct: 122 LEQAWEEGGILYLQTEL-CGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLHSQ- 176

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              ++H D+KP NI L      ++ DFGL   L            G   Y+APE  +   
Sbjct: 177 --GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQE-GDPRYMAPELLQG-S 231

Query: 661 ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV---LQR 717
                DV+S G+ +LE+ C             +       L +  L       +   L+ 
Sbjct: 232 YGTAADVFSLGLTILEVACNMELP--------HGGEGWQQLRQGYLPPEFTAGLSSELRS 283

Query: 718 FVMVAIWCIQEDPSHRPT 735
            ++     ++ DP  R T
Sbjct: 284 VLV---MMLEPDPKLRAT 298

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  124 bits (313), Expect = 1e-31
 Identities = 51/278 (18%), Positives = 95/278 (34%), Gaps = 51/278 (18%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQ-THHKNLVR 544
           E++G G FG+V+K  V        A+K+  +    S  E  A  EV        H ++VR
Sbjct: 17  EKIGSGEFGSVFKC-VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75

Query: 545 LLGYCDEGRNRLLVY-EFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLHEE 599
                    + +L+  E+ + G+LA  +  + +     +   +      + RGL Y+H  
Sbjct: 76  YFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134

Query: 600 CCTQIIHCDIKPQNILLD-------------------DYYNARISDFGLEKLLTLDQSHT 640
               ++H DIKP NI +                    +    +I D G    ++  Q   
Sbjct: 135 ---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191

Query: 641 NTAIRGTKGYVAPE-WFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLG 699
                G   ++A E    N     K D+++  + ++                   +    
Sbjct: 192 -----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP------LPRNGDQ--WH 238

Query: 700 ALVENDLEAMDDM--TVLQRFVMVAIWCIQEDPSHRPT 735
            + +  L  +  +        +      I  DP  RP+
Sbjct: 239 EIRQGRLPRIPQVLSQEFTELLK---VMIHPDPERRPS 273

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  124 bits (314), Expect = 1e-31
 Identities = 73/304 (24%), Positives = 118/304 (38%), Gaps = 64/304 (21%)

Query: 486 FKEELGRGAFGTVYKG----FVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVN---GIGQT 537
           F + LG GAFG V +      +   ++  VAVK L      +E+    +E+     +G  
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 85

Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL----------------FGDSKPNWKL 581
            H N+V LLG C  G   L++ E+   G L +FL                  D +    L
Sbjct: 86  -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 582 RTEIVMG--IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH 639
              +     +A+G+ +L        IH D+  +NILL      +I DFG    L  D  +
Sbjct: 145 EDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFG----LARDIKN 197

Query: 640 TNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ 694
            +  +      +     APE   N   T + DV+SYG+ L E+  L  +         Y 
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP--------YP 249

Query: 695 ERTLGALVENDLEA---M-------DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
              + +     ++    M        +M  +    M   W    DP  RPT +++ Q++E
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDI----MKTCW--DADPLKRPTFKQIVQLIE 303

Query: 745 GVVE 748
             + 
Sbjct: 304 KQIS 307

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  123 bits (312), Expect = 1e-31
 Identities = 71/302 (23%), Positives = 118/302 (39%), Gaps = 59/302 (19%)

Query: 481 EVTRG---FKEELGRGAFGTVYKGFVNMGSSDQ----VAVKKLNRVFQDSEK-EFKAEVN 532
           E++     F EELG   FG VYKG +   +  +    VA+K L    +   + EF+ E  
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64

Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-------- 584
              +  H N+V LLG   + +   +++ + S+G L  FL   S  +    T+        
Sbjct: 65  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124

Query: 585 --------IVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD 636
                   +V  IA G+ YL        +H D+  +N+L+ D  N +ISD G    L  +
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHV---VHKDLATRNVLVYDKLNVKISDLG----LFRE 177

Query: 637 QSHTNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYD 691
               +         +     APE       ++  D++SYGV+L E+              
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY--------GLQ 229

Query: 692 CYQERTLGALVENDLEAMDDMTVLQR---------FVMVAIWCIQEDPSHRPTMRRVTQM 742
            Y   +     ++ +E + +  VL            +M+  W   E PS RP  + +   
Sbjct: 230 PYCGYS----NQDVVEMIRNRQVLPCPDDCPAWVYALMIECW--NEFPSRRPRFKDIHSR 283

Query: 743 LE 744
           L 
Sbjct: 284 LR 285

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  124 bits (313), Expect = 1e-31
 Identities = 66/283 (23%), Positives = 111/283 (39%), Gaps = 48/283 (16%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
               LG+GAFG V K   N   S   A+KK+    ++      +EV  +   +H+ +VR 
Sbjct: 10  EIAVLGQGAFGQVVKA-RNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRY 67

Query: 546 LG-YCDEGRNRL------------LVYEFMSNGALASFL-----FGDSKPNWKLRTEIVM 587
              + +                  +  E+  NG L   +            W+L  +I+ 
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127

Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD----------- 636
            ++    Y+H +    IIH D+KP NI +D+  N +I DFGL K +              
Sbjct: 128 ALS----YIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 637 ---QSHTNTAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRTILTDWAYDC 692
                +  +AI GT  YVA E          K+D+YS G++  E+I    T +     + 
Sbjct: 181 PGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMER--VNI 237

Query: 693 YQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPT 735
            ++    ++        + M V ++ +      I  DP+ RP 
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIR---LLIDHDPNKRPG 277

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  125 bits (315), Expect = 2e-31
 Identities = 77/295 (26%), Positives = 124/295 (42%), Gaps = 50/295 (16%)

Query: 486 FKEELGRGAFGTVYKG----FVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVN---GIGQT 537
           F + LG GAFG V +          +  +VAVK L       EK    +E+     +GQ 
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ- 108

Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL--------------FGDSKPNWKLRT 583
            H+N+V LLG C  G   L++ E+   G L +FL                +S  + +   
Sbjct: 109 -HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 584 EIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA 643
                +A+G+ +L  + C   IH D+  +N+LL + + A+I DFG    L  D  + +  
Sbjct: 168 HFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFG----LARDIMNDSNY 220

Query: 644 IRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRT----ILTDWAYDCYQ 694
           I      +     APE   +   TV+ DV+SYG+LL EI  L       IL +       
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN------- 273

Query: 695 ERTLGALVE-NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            +    + +   +            +M A W    +P+HRPT +++   L+   +
Sbjct: 274 SKFYKLVKDGYQMAQPAFAPKNIYSIMQACW--ALEPTHRPTFQQICSFLQEQAQ 326

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  124 bits (313), Expect = 2e-31
 Identities = 78/303 (25%), Positives = 115/303 (37%), Gaps = 63/303 (20%)

Query: 486 FKEELGRGAFGTVYKGFVN----MGSSDQVAVKKLNRVFQDSEK-EFKAEVN---GIGQT 537
             + LGRGAFG V +          +   VAVK L      SE     +E+     IG  
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH- 89

Query: 538 HHKNLVRLLGYC-DEGRNRLLVYEFMSNGALASFL--------------FGDSKPNWKLR 582
            H N+V LLG C   G   +++ EF   G L+++L                  K    L 
Sbjct: 90  -HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 583 TEIVMG--IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT 640
             I     +A+G+ +L    C   IH D+  +NILL +    +I DFG    L  D    
Sbjct: 149 HLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFG----LARDIYKD 201

Query: 641 NTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE 695
              +R     +     APE   +   T++ DV+S+GVLL EI  L            Y  
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL--------GASPYPG 253

Query: 696 RTLGALVENDLEA---M-------DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG 745
             +       L+    M        +M       M+  W    +PS RPT   + + L  
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQT----MLDCW--HGEPSQRPTFSELVEHLGN 307

Query: 746 VVE 748
           +++
Sbjct: 308 LLQ 310

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  123 bits (312), Expect = 3e-31
 Identities = 69/301 (22%), Positives = 118/301 (39%), Gaps = 63/301 (20%)

Query: 486 FKEELGRGAFGTVYKGFVN--MGSSDQVAVKKLNR-VFQDSEKE-FKAEVNGIGQTHHKN 541
               LG+G FG+V +  +    GS  +VAVK L   +   S+ E F  E   + +  H +
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86

Query: 542 LVRLLGYCDEGRNR------LLVYEFMSNGALASFL----FGDSKPNWKLRTEIVMG--I 589
           + +L+G     R +      +++  FM +G L +FL     G++  N  L+T +     I
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 590 ARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           A G+ YL        IH D+  +N +L +     ++DFGL +         +   +G   
Sbjct: 147 ACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQGCAS 199

Query: 650 YV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL--- 701
            +     A E   +   TV  DV+++GV + EI+                  T G     
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM------------------TRGQTPYA 241

Query: 702 -VEND--LEAMDDMTVLQR---------FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
            +EN      +     L++          +M   W    DP  RP+   +   LE ++  
Sbjct: 242 GIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCW--SADPKQRPSFTCLRMELENILGH 299

Query: 750 P 750
            
Sbjct: 300 L 300

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  125 bits (315), Expect = 3e-31
 Identities = 74/317 (23%), Positives = 125/317 (39%), Gaps = 78/317 (24%)

Query: 481 EVTRG---FKEELGRGAFGTVYKGFVN------MGSSDQVAVKKLNRVFQDSEK-EFKAE 530
           E  R      + LG G FG V               +  VAVK L     + +  +  +E
Sbjct: 77  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136

Query: 531 VN---GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVM 587
           +     IG+  HKN++ LLG C +     ++ E+ S G L  +L     P  +   +I  
Sbjct: 137 MEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194

Query: 588 G----------------IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK 631
                            +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL +
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLAR 251

Query: 632 LLTLDQSHTNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILT 686
               D ++ +   + T G +     APE   +   T + DV+S+GVL+ EI         
Sbjct: 252 ----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF-------- 299

Query: 687 DWAYDCYQERTLGAL------VENDLEAMDDMTVLQR---------FVMVAIWCIQEDPS 731
                     TLG        VE   + + +   + +          +M   W     PS
Sbjct: 300 ----------TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCW--HAVPS 347

Query: 732 HRPTMRRVTQMLEGVVE 748
            RPT +++ + L+ ++ 
Sbjct: 348 QRPTFKQLVEDLDRILT 364

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  123 bits (312), Expect = 3e-31
 Identities = 73/314 (23%), Positives = 125/314 (39%), Gaps = 75/314 (23%)

Query: 486 FKEELGRGAFGTVYKGFVN------MGSSDQVAVKKLNRVFQDSEK-EFKAEVN---GIG 535
             + LG GAFG V               +  VAVK L     + +  +  +E+     IG
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98

Query: 536 QTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG------- 588
           +  HKN++ LLG C +     ++ E+ S G L  +L     P  +   +I          
Sbjct: 99  K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156

Query: 589 ---------IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH 639
                    +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFGL +    D ++
Sbjct: 157 KDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLAR----DINN 209

Query: 640 TNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ 694
            +   + T G +     APE   +   T + DV+S+GVL+ EI                 
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF---------------- 253

Query: 695 ERTLGAL------VENDLEAMDDMTVLQR---------FVMVAIWCIQEDPSHRPTMRRV 739
             TLG        VE   + + +   + +          +M   W     PS RPT +++
Sbjct: 254 --TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCW--HAVPSQRPTFKQL 309

Query: 740 TQMLEGVVEVPIPP 753
            + L+ ++ +    
Sbjct: 310 VEDLDRILTLTTNE 323

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  123 bits (310), Expect = 5e-31
 Identities = 52/214 (24%), Positives = 88/214 (41%), Gaps = 28/214 (13%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVR 544
             + LG+GA   V++G  +  + D  A+K  N + F         E   + + +HKN+V+
Sbjct: 13  LSDILGQGATANVFRG-RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 545 LLGYCDEGRNRL--LVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFYLH 597
           L    +E   R   L+ EF   G+L + L  +   N     E     ++  +  G+ +L 
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMNHLR 129

Query: 598 EECCTQIIHCDIKPQNILL----DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAP 653
           E     I+H +IKP NI+     D     +++DFG  + L  D     +   GT+ Y+ P
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHP 184

Query: 654 E--------WFRNMPITVKVDVYSYGVLLLEIIC 679
           +                  VD++S GV       
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  122 bits (307), Expect = 6e-31
 Identities = 59/272 (21%), Positives = 108/272 (39%), Gaps = 43/272 (15%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E +G G FG V+K   +        +K++     ++EK  + EV  + +  H N+V   G
Sbjct: 17  ELIGSGGFGQVFKA-KHRIDGKTYVIKRVK---YNNEKAER-EVKALAKLDHVNIVHYNG 71

Query: 548 YCDEGRNRLLVYEFMSNGALASFLF--------GD-----SKPNWKLRTE-----IVMGI 589
             D            S+ +    LF        G       K   +   +     +   I
Sbjct: 72  CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQI 131

Query: 590 ARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
            +G+ Y+H +   ++I+ D+KP NI L D    +I DFGL   L  D   T +   GT  
Sbjct: 132 TKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GTLR 186

Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM 709
           Y++PE   +     +VD+Y+ G++L E++ +  T     A++    +    L +  +  +
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFE--TSKFFTDLRDGIISDI 239

Query: 710 --DDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
                   +  +      + + P  RP    +
Sbjct: 240 FDKK---EKTLLQ---KLLSKKPEDRPNTSEI 265

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  124 bits (312), Expect = 1e-30
 Identities = 76/298 (25%), Positives = 126/298 (42%), Gaps = 49/298 (16%)

Query: 486 FKEELGRGAFGTVYKGFVN------MGSSDQVAVKKLNRVFQDSEK-EFKAEVN---GIG 535
             + LG GAFG V                 +VAVK L     + +  +  +E+     IG
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132

Query: 536 QTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL------------FGDSKPNWKLRT 583
           +  HKN++ LLG C +     ++ E+ S G L  +L                 P  +L +
Sbjct: 133 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190

Query: 584 E--IVMG--IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH 639
           +  +     +ARG+ YL  + C   IH D+  +N+L+ +    +I+DFG    L  D  H
Sbjct: 191 KDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFG----LARDIHH 243

Query: 640 TNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ 694
            +   + T G +     APE   +   T + DV+S+GVLL EI  L  +      Y    
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----PYPGVP 298

Query: 695 ERTLGALVEND--LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
              L  L++    ++   + T     +M   W     PS RPT +++ + L+ +V + 
Sbjct: 299 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCW--HAVPSQRPTFKQLVEDLDRIVALT 354

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  122 bits (307), Expect = 2e-30
 Identities = 70/317 (22%), Positives = 110/317 (34%), Gaps = 81/317 (25%)

Query: 486 FKEELGRGAFGTVYKG----FVNMGSSDQVAVKKLNRVFQDSEK-EFKAEVN---GIGQT 537
           F + LG GAFG V           G S QVAVK L      SE+    +E+     +G  
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS- 107

Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL---------------------FGDSK 576
            H+N+V LLG C       L++E+   G L ++L                       +  
Sbjct: 108 -HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 577 PNWKLRTEIVMG--IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT 634
                   +     +A+G+ +L  + C   +H D+  +N+L+      +I DFG    L 
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKICDFG----LA 219

Query: 635 LDQSHTNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA 689
            D    +  +      +     APE       T+K DV+SYG+LL EI            
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF----------- 268

Query: 690 YDCYQERTLGAL----VENDLEAMDDMTVLQR------------FVMVAIWCIQEDPSHR 733
                  +LG      +  D      +    +             +M + W    D   R
Sbjct: 269 -------SLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCW--AFDSRKR 319

Query: 734 PTMRRVTQMLEGVVEVP 750
           P+   +T  L   +   
Sbjct: 320 PSFPNLTSFLGCQLADA 336

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  121 bits (305), Expect = 2e-30
 Identities = 73/312 (23%), Positives = 123/312 (39%), Gaps = 76/312 (24%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQ----VAVKKLNRVFQDSEK-EFKAEVNGIGQTHHK 540
             + LG G FG V K              VAVK L      SE  +  +E N + Q +H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGALASFL----------------FGDSKPNWKLRTE 584
           ++++L G C +    LL+ E+   G+L  FL                   S  +      
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 585 IVMG--------IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD 636
           + MG        I++G+ YL E      +H D+  +NIL+ +    +ISDFG    L+ D
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKL---VHRDLAARNILVAEGRKMKISDFG----LSRD 199

Query: 637 QSHTNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYD 691
               ++ ++ ++G +     A E   +   T + DV+S+GVLL EI+             
Sbjct: 200 VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV------------- 246

Query: 692 CYQERTLGAL------VENDLEAMDDMTVLQR---------FVMVAIWCIQEDPSHRPTM 736
                TLG         E     +     ++R          +M+  W  +++P  RP  
Sbjct: 247 -----TLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCW--KQEPDKRPVF 299

Query: 737 RRVTQMLEGVVE 748
             +++ LE ++ 
Sbjct: 300 ADISKDLEKMMV 311

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  123 bits (309), Expect = 2e-30
 Identities = 52/214 (24%), Positives = 88/214 (41%), Gaps = 28/214 (13%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVR 544
             + LG+GA   V++G  +  + D  A+K  N + F         E   + + +HKN+V+
Sbjct: 13  LSDILGQGATANVFRG-RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 545 LLGYCDEGRNRL--LVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFYLH 597
           L    +E   R   L+ EF   G+L + L  +   N     E     ++  +  G+ +L 
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMNHLR 129

Query: 598 EECCTQIIHCDIKPQNILL----DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAP 653
           E     I+H +IKP NI+     D     +++DFG  + L  D     +   GT+ Y+ P
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHP 184

Query: 654 E--------WFRNMPITVKVDVYSYGVLLLEIIC 679
           +                  VD++S GV       
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  125 bits (315), Expect = 5e-30
 Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 23/209 (11%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVR 544
            KE LG G FG V +  ++  + +QVA+K+  +      +E +  E+  + + +H N+V 
Sbjct: 18  MKERLGTGGFGYVLRW-IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76

Query: 545 LL------GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGL 593
                            LL  E+   G L  +L  +   N     E     ++  I+  L
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL--NQFENCCGLKEGPIRTLLSDISSAL 134

Query: 594 FYLHEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGY 650
            YLHE    +IIH D+KP+NI+L         +I D G  K L          + GT  Y
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-GTLQY 189

Query: 651 VAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
           +APE       TV VD +S+G L  E I 
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECIT 218

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  120 bits (304), Expect = 5e-30
 Identities = 67/322 (20%), Positives = 117/322 (36%), Gaps = 79/322 (24%)

Query: 481 EVTRG---FKEELGRGAFGTVYKGFVN----MGSSDQVAVKKLNRVFQDSEK-EFKAEVN 532
           E  R    +  ++G GAFG V++              VAVK L        + +F+ E  
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102

Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFL--------------------- 571
            + +  + N+V+LLG C  G+   L++E+M+ G L  FL                     
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162

Query: 572 ---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFG 628
               G    +   +  I   +A G+ YL E      +H D+  +N L+ +    +I+DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFG 219

Query: 629 LEKLLTLDQSHTNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRT 683
           L +    +    +         +      PE       T + DV++YGV+L EI      
Sbjct: 220 LSR----NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF----- 270

Query: 684 ILTDWAYDCYQERTLGAL------VENDLEAMDDMTVLQR---------FVMVAIWCIQE 728
                        + G         E  +  + D  +L            +M   W   +
Sbjct: 271 -------------SYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCW--SK 315

Query: 729 DPSHRPTMRRVTQMLEGVVEVP 750
            P+ RP+   + ++L+ + E  
Sbjct: 316 LPADRPSFCSIHRILQRMCERA 337

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  120 bits (303), Expect = 9e-30
 Identities = 39/218 (17%), Positives = 73/218 (33%), Gaps = 30/218 (13%)

Query: 486 FKEELGRGAFGTVYKG----FVNMGSSDQVAVKKLNRVFQDSEKEF---KAEVNGIGQTH 538
               LG GAF  VY+       +  +  +  +K        +  EF      +  +  + 
Sbjct: 69  VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK---PANPWEFYIGTQLMERLKPSM 125

Query: 539 HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGL 593
               ++           +LV E  S G L + +        K+  +       M +   +
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNA-----------RISDFGLEKLLTL-DQSHTN 641
             +H+    +IIH DIKP N +L + +              + D G    + L  +    
Sbjct: 186 EQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242

Query: 642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
           TA   T G+   E   N P   ++D +     +  ++ 
Sbjct: 243 TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  122 bits (307), Expect = 9e-30
 Identities = 68/288 (23%), Positives = 107/288 (37%), Gaps = 47/288 (16%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVR 544
            ++ LG G+ GTV   F        VAVK++     D       E+  + ++  H N++R
Sbjct: 19  SEKILGYGSSGTVV--FQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIR 73

Query: 545 LLGYCDEGRNRLLVYEFMSNGALA-------SFLFGDSKPNWKLRTEIVMGIARGLFYLH 597
                   R   +  E   N  L                        ++  IA G+ +LH
Sbjct: 74  YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 598 EECCTQIIHCDIKPQNILLD-------------DYYNARISDFGLEKLLTLDQSHTNTAI 644
                +IIH D+KPQNIL+              +     ISDFGL K L   QS   T +
Sbjct: 133 SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 645 R---GTKGYVAPE-------WFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ 694
               GT G+ APE             +T  +D++S G +   I+   +    D  Y    
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK-YSRES 248

Query: 695 ERTLGALVENDLEAMDDMTVLQR---FVMVAIWCIQEDPSHRPTMRRV 739
               G    ++++ + D +++      +      I  DP  RPT  +V
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEATDLIS---QMIDHDPLKRPTAMKV 293

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  118 bits (298), Expect = 2e-29
 Identities = 71/304 (23%), Positives = 117/304 (38%), Gaps = 69/304 (22%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQ-VAVKKLNRVFQDSEK-EFKAEVNGIGQ-THHKNL 542
           F++ +G G FG V K  +         A+K++       +  +F  E+  + +  HH N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFL----------------FGDSKPNWKLRTEIV 586
           + LLG C+      L  E+  +G L  FL                   S  + +      
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 587 MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG 646
             +ARG+ YL ++   Q IH D+  +NIL+ + Y A+I+DFGL +            ++ 
Sbjct: 149 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 198

Query: 647 TKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
           T G +     A E       T   DV+SYGVLL EI+                  +LG  
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV------------------SLGGT 240

Query: 702 ------VENDLEAMDDMTVLQR---------FVMVAIWCIQEDPSHRPTMRRVTQMLEGV 746
                      E +     L++          +M   W  +E P  RP+  ++   L  +
Sbjct: 241 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCW--REKPYERPSFAQILVSLNRM 298

Query: 747 VEVP 750
           +E  
Sbjct: 299 LEER 302

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  119 bits (299), Expect = 3e-29
 Identities = 44/336 (13%), Positives = 95/336 (28%), Gaps = 77/336 (22%)

Query: 454 KKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAV 513
                  Q  +  S +  R  T        RG    LG+       +   +  + +   V
Sbjct: 53  TSLWNTGQPFRVESELGERPRTLV------RG--TVLGQEDPYAYLEA-TDQETGESFEV 103

Query: 514 K---KLNRVFQDSEKEFKAEVNGIGQ-------------------------THHKNLVRL 545
                  R   ++ K+ K EV  +                              K ++R+
Sbjct: 104 HVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV 163

Query: 546 LGYCDEG--RNRLLVYEFMSN------GALASFLFGDSKPNWKLRTEIVMGIARGLFYLH 597
                +    +R  +Y  M +        L S            R ++ + + R L  LH
Sbjct: 164 RLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 223

Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF- 656
                 ++H  ++P +I+LD      ++ F       L +         ++G+  PE   
Sbjct: 224 HYG---LVHTYLRPVDIVLDQRGGVFLTGFEH-----LVRDGARVVSSVSRGFEPPELEA 275

Query: 657 ----------RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL 706
                     R   +T   D ++ G+++  I C               +       E   
Sbjct: 276 RRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP---------ITKDAALGGSEWIF 326

Query: 707 EAMDDMTV-LQRFVMVAIWCIQEDPSHRPTMRRVTQ 741
            +  ++   ++  +      ++     R    +  +
Sbjct: 327 RSCKNIPQPVRALLE---GFLRYPKEDRLLPLQAME 359

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  118 bits (297), Expect = 5e-29
 Identities = 35/331 (10%), Positives = 77/331 (23%), Gaps = 61/331 (18%)

Query: 453 RKKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVA 512
                  + E    S ++      K          E L  G    V+    ++   +  A
Sbjct: 41  TATVWPQNAETTVDSLLSQGERKLK--------LVEPLRVGDRSVVFLV-RDVERLEDFA 91

Query: 513 VKKLNRVFQDSEKE---FKAEVNGIGQTHHKNLVRLLGYC------DEGR---------- 553
           +K      ++S  E            +   ++              D             
Sbjct: 92  LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151

Query: 554 ----------NRLLVYEFMS------NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLH 597
                     N LL+    S         L                 +   + R    L 
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211

Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF- 656
            +    ++H    P N+ +       + D      +         A      Y   E+  
Sbjct: 212 SKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKV----GTRGPASSVPVTYAPREFLN 264

Query: 657 -RNMPITVKVDVYSYGVLLLEIICLRR--TILTDWAYDCYQERTLGALVENDLEAMDDMT 713
                 T  ++ +  G+ +  + CL     ++T      ++  +L     + L       
Sbjct: 265 ASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTP 324

Query: 714 V---LQRFVMVAIWCIQEDPSHRPTMRRVTQ 741
           +   ++  +      +  D   R       +
Sbjct: 325 LPDFVKTLIG---RFLNFDRRRRLLPLEAME 352

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  116 bits (293), Expect = 9e-29
 Identities = 52/195 (26%), Positives = 87/195 (44%), Gaps = 14/195 (7%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
            ++G G+ G V        S  QVAVK ++   Q   +    EV  +    H N+V +  
Sbjct: 51  VKIGEGSTGIVCLA-REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----GLFYLHEECCTQ 603
               G    ++ EF+  GAL      D     +L  E +  +       L YLH +    
Sbjct: 110 SYLVGEELWVLMEFLQGGALT-----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ---G 161

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
           +IH DIK  +ILL      ++SDFG    ++ D     + + GT  ++APE         
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYAT 220

Query: 664 KVDVYSYGVLLLEII 678
           +VD++S G++++E++
Sbjct: 221 EVDIWSLGIMVIEMV 235

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  114 bits (288), Expect = 2e-28
 Identities = 54/196 (27%), Positives = 99/196 (50%), Gaps = 16/196 (8%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E++G+GA GTVY   +++ +  +VA++++N   Q  ++    E+  + +  + N+V  L 
Sbjct: 26  EKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFYLHEECCT 602
               G    +V E+++ G+L   +            E     +     + L +LH     
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVV--TETC----MDEGQIAAVCRECLQALEFLHSN--- 135

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           Q+IH DIK  NILL    + +++DFG    +T +QS  +T + GT  ++APE        
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194

Query: 663 VKVDVYSYGVLLLEII 678
            KVD++S G++ +E+I
Sbjct: 195 PKVDIWSLGIMAIEMI 210

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  115 bits (289), Expect = 5e-28
 Identities = 51/202 (25%), Positives = 82/202 (40%), Gaps = 19/202 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVK-----KLNRVFQDSEKEFKAEVNGIGQTHHK 540
             E +G+G F  V +  +N  +  Q AVK     K       S ++ K E +      H 
Sbjct: 28  LCEVIGKGPFSVVRRC-INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86

Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFY 595
           ++V LL          +V+EFM    L   +   +   +   +E      +  I   L Y
Sbjct: 87  HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY-SEAVASHYMRQILEALRY 145

Query: 596 LHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVA 652
            H+     IIH D+KP  +LL   ++    ++  FG+   L          + GT  ++A
Sbjct: 146 CHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMA 201

Query: 653 PEWFRNMPITVKVDVYSYGVLL 674
           PE  +  P    VDV+  GV+L
Sbjct: 202 PEVVKREPYGKPVDVWGCGVIL 223

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  113 bits (284), Expect = 1e-27
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 16/199 (8%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVK-----KLNRVFQDSEKE-FKAEVNGIGQTHH 539
             EELG G F  V K      +  + A K     +     +   +E  + EV+ + Q  H
Sbjct: 16  IGEELGSGQFAIVKKC-REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74

Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
            N++ L    +   + +L+ E +S G L  FL      + +  T  +  I  G+ YLH +
Sbjct: 75  HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 600 CCTQIIHCDIKPQNILL----DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
              +I H D+KP+NI+L        + ++ DFGL   +       N    GT  +VAPE 
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEI 189

Query: 656 FRNMPITVKVDVYSYGVLL 674
               P+ ++ D++S GV+ 
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  113 bits (284), Expect = 2e-27
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 20/199 (10%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQ-THHKNLV 543
            +ELGRG F  V +  ++  +  + A K L   R  QD   E   E+  +        ++
Sbjct: 34  SKELGRGKFAVVRQC-ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFYLHE 598
            L    +     +L+ E+ + G +  F     +    + +E     ++  I  G++YLH+
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEI--FSLCLPELAEMV-SENDVIRLIKQILEGVYYLHQ 149

Query: 599 ECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
                I+H D+KPQNILL       + +I DFG+ + +            GT  Y+APE 
Sbjct: 150 N---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLAPEI 204

Query: 656 FRNMPITVKVDVYSYGVLL 674
               PIT   D+++ G++ 
Sbjct: 205 LNYDPITTATDMWNIGIIA 223

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  112 bits (283), Expect = 3e-27
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 16/199 (8%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVK-----KLNRVFQDSEKE-FKAEVNGIGQTHH 539
             EELG G F  V K      +  + A K     +     +   +E  + EV+ + Q  H
Sbjct: 16  IGEELGSGQFAIVKKC-REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74

Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
            N++ L    +   + +L+ E +S G L  FL      + +  T  +  I  G+ YLH +
Sbjct: 75  PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 600 CCTQIIHCDIKPQNILL----DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
              +I H D+KP+NI+L        + ++ DFGL   +       N    GT  +VAPE 
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEI 189

Query: 656 FRNMPITVKVDVYSYGVLL 674
               P+ ++ D++S GV+ 
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  113 bits (285), Expect = 3e-27
 Identities = 63/242 (26%), Positives = 100/242 (41%), Gaps = 36/242 (14%)

Query: 453 RKKFMRPHQEEQGVSYMNLRCFTYKELVEVTRG-------FKEELGRGAFGTVYKGFVNM 505
           R K+  P   +    Y ++      + VEV +G         EELG GAFG V++  V  
Sbjct: 15  RGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRC-VEK 73

Query: 506 GSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNG 565
            +      K +N  +   +   K E++ + Q HH  L+ L    ++    +L+ EF+S G
Sbjct: 74  ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133

Query: 566 AL------ASFLFGDSKPNWKLRTE-----IVMGIARGLFYLHEECCTQIIHCDIKPQNI 614
            L        +            +E      +     GL ++HE     I+H DIKP+NI
Sbjct: 134 ELFDRIAAEDYKM----------SEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENI 180

Query: 615 LLDDYYNAR--ISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGV 672
           + +    +   I DFGL   L  D+    T    T  + APE     P+    D+++ GV
Sbjct: 181 MCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTDMWAIGV 238

Query: 673 LL 674
           L 
Sbjct: 239 LG 240

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  111 bits (279), Expect = 4e-27
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 19/200 (9%)

Query: 488 EELGRGAFGTVYKGFVNMGSSD-----QVAVKKLNRVFQDSE---KEFKAEVNGIGQTHH 539
           ++LG G   TVY         D     +VA+K +    ++ E   K F+ EV+   Q  H
Sbjct: 17  DKLGGGGMSTVYLAE------DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70

Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
           +N+V ++   +E     LV E++    L+ ++      +          I  G+ + H+ 
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT-AIRGTKGYVAPEWFRN 658
              +I+H DIKPQNIL+D     +I DFG+ K L+ + S T T  + GT  Y +PE  + 
Sbjct: 131 ---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKG 186

Query: 659 MPITVKVDVYSYGVLLLEII 678
                  D+YS G++L E++
Sbjct: 187 EATDECTDIYSIGIVLYEML 206

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  111 bits (281), Expect = 4e-27
 Identities = 45/196 (22%), Positives = 83/196 (42%), Gaps = 18/196 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
             E+LGRG FG V++  V   S      K +     D     K E++ +    H+N++ L
Sbjct: 9   IAEDLGRGEFGIVHRC-VETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHL 66

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFYLHEEC 600
               +     ++++EF+S   +   +       ++L  E      V  +   L +LH   
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTS---AFEL-NEREIVSYVHQVCEALQFLHSH- 121

Query: 601 CTQIIHCDIKPQNILLDDYYNA--RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
              I H DI+P+NI+     ++  +I +FG  + L    +           Y APE  ++
Sbjct: 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQH 177

Query: 659 MPITVKVDVYSYGVLL 674
             ++   D++S G L+
Sbjct: 178 DVVSTATDMWSLGTLV 193

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  110 bits (278), Expect = 4e-27
 Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 12/194 (6%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       +   +A+K L +     +  E + + E+       H N++R+ 
Sbjct: 22  LGKGKFGNVYLA-REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEECCTQII 605
            Y  + +   L+ EF   G L   L    +    +  T +   +A  L Y HE    ++I
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-LADALHYCHER---KVI 136

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 665
           H DIKP+N+L+      +I+DFG        +  T   + GT  Y+ PE         KV
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT---MCGTLDYLPPEMIEGKTHDEKV 193

Query: 666 DVYSYGVLLLEIIC 679
           D++  GVL  E + 
Sbjct: 194 DLWCAGVLCYEFLV 207

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  112 bits (281), Expect = 5e-27
 Identities = 56/296 (18%), Positives = 108/296 (36%), Gaps = 40/296 (13%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ-THHKNLVRL 545
           +  L  G F  VY+   ++GS  + A+K+L    ++  +    EV  + + + H N+V+ 
Sbjct: 33  RRVLAEGGFAFVYEA-QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91

Query: 546 LGYC-------DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGL 593
                      D G+   L+   +  G L  FL      +    +      I     R +
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFL--KKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI--------- 644
            ++H      IIH D+K +N+LL +    ++ DFG    ++    ++ +A          
Sbjct: 150 QHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 645 --RGTKGYVAPE---WFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLG 699
               T  Y  PE    + N PI  K D+++ G +L  +   +           +++    
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP---------FEDGAKL 259

Query: 700 ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCP 755
            +V          T    F  +    +Q +P  R ++  V   L+ +         
Sbjct: 260 RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  110 bits (277), Expect = 6e-27
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 16/199 (8%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVK-----KLNRVFQDSEKE-FKAEVNGIGQTHH 539
             EELG G F  V K     G+  + A K     +L+   +   +E  + EVN + +  H
Sbjct: 9   MGEELGSGQFAIVRKC-RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
            N++ L    +   + +L+ E +S G L  FL           T+ +  I  G+ YLH +
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK 127

Query: 600 CCTQIIHCDIKPQNILL----DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
              +I H D+KP+NI+L          ++ DFG+   +       N    GT  +VAPE 
Sbjct: 128 ---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--GTPEFVAPEI 182

Query: 656 FRNMPITVKVDVYSYGVLL 674
               P+ ++ D++S GV+ 
Sbjct: 183 VNYEPLGLEADMWSIGVIT 201

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  110 bits (277), Expect = 7e-27
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 19/201 (9%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
            ELG GAFG VYK   N  +    A K +    ++  +++  E+  +    H  +V+LLG
Sbjct: 25  GELGDGAFGKVYKA-KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 83

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFYLHEECCT 602
                    ++ EF   GA+ + +    +      TE     +   +   L +LH +   
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLHSK--- 136

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE-----WFR 657
           +IIH D+K  N+L+    + R++DFG+           ++ I GT  ++APE       +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMK 195

Query: 658 NMPITVKVDVYSYGVLLLEII 678
           + P   K D++S G+ L+E+ 
Sbjct: 196 DTPYDYKADIWSLGITLIEMA 216

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  109 bits (276), Expect = 8e-27
 Identities = 57/194 (29%), Positives = 85/194 (43%), Gaps = 12/194 (6%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G FG VY       S   +A+K L +        E + + EV       H N++RL 
Sbjct: 17  LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEECCTQII 605
           GY  +     L+ E+   G +   L   SK    +  T  +  +A  L Y H +   ++I
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-YITELANALSYCHSK---RVI 131

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 665
           H DIKP+N+LL      +I+DFG        +      + GT  Y+ PE         KV
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD---LCGTLDYLPPEMIEGRMHDEKV 188

Query: 666 DVYSYGVLLLEIIC 679
           D++S GVL  E + 
Sbjct: 189 DLWSLGVLCYEFLV 202

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  110 bits (277), Expect = 1e-26
 Identities = 55/196 (28%), Positives = 100/196 (51%), Gaps = 16/196 (8%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E+LG G++G+VYK   +  +   VA+K++    +   +E   E++ + Q    ++V+  G
Sbjct: 35  EKLGEGSYGSVYKAI-HKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYG 91

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFYLHEECCT 602
              +  +  +V E+   G+++  +   +K      TE     I+    +GL YLH     
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIRLRNKT----LTEDEIATILQSTLKGLEYLHFM--- 144

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           + IH DIK  NILL+   +A+++DFG+   LT   +  NT I GT  ++APE  + +   
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYN 203

Query: 663 VKVDVYSYGVLLLEII 678
              D++S G+  +E+ 
Sbjct: 204 CVADIWSLGITAIEMA 219

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  111 bits (279), Expect = 1e-26
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 42/208 (20%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ-THHKNLVR 544
            KE++G G++    +  ++  ++ + AVK +++    S+++   E+  + +   H N++ 
Sbjct: 26  VKEDIGVGSYSVCKRC-IHKATNMEFAVKIIDK----SKRDPTEEIEILLRYGQHPNIIT 80

Query: 545 LLGYCDEGRNRLLVYEFMSNGAL--------------ASFLFGDSKPNWKLRTEIVMGIA 590
           L    D+G+   +V E M  G L              AS +           T     I 
Sbjct: 81  LKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL---------FT-----IT 126

Query: 591 RGLFYLHEECCTQIIHCDIKPQNILL----DDYYNARISDFGLEKLLTLDQSHTNTAIRG 646
           + + YLH +    ++H D+KP NIL      +  + RI DFG  K L  +     T    
Sbjct: 127 KTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-Y 182

Query: 647 TKGYVAPEWFRNMPITVKVDVYSYGVLL 674
           T  +VAPE           D++S GVLL
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLL 210

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  110 bits (276), Expect = 1e-26
 Identities = 56/277 (20%), Positives = 106/277 (38%), Gaps = 49/277 (17%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQT---HHKNL 542
           +++G G    V++           A+K +N    D++    ++ E+         H   +
Sbjct: 34  KQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIA-YLNKLQQHSDKI 90

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           +RL  Y    +   +V E   N  L S+L      +   R      +   +  +H+    
Sbjct: 91  IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH--- 146

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN-TAIRGTKGYVAPEWFRNMP- 660
            I+H D+KP N L+ D    ++ DFG+   +  D +     +  GT  Y+ PE  ++M  
Sbjct: 147 GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205

Query: 661 ----------ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL---- 706
                     I+ K DV+S G +L  +   +    T +     Q   L A+++ +     
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK----TPFQQIINQISKLHAIIDPNHEIEF 261

Query: 707 ------EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMR 737
                 +  D   VL+        C++ DP  R ++ 
Sbjct: 262 PDIPEKDLQD---VLKC-------CLKRDPKQRISIP 288

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  110 bits (278), Expect = 1e-26
 Identities = 56/277 (20%), Positives = 106/277 (38%), Gaps = 49/277 (17%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQT---HHKNL 542
           +++G G    V++           A+K +N    D++    ++ E+         H   +
Sbjct: 15  KQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIA-YLNKLQQHSDKI 71

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           +RL  Y    +   +V E   N  L S+L      +   R      +   +  +H+    
Sbjct: 72  IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH--- 127

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN-TAIRGTKGYVAPEWFRNMP- 660
            I+H D+KP N L+ D    ++ DFG+   +  D +     +  GT  Y+ PE  ++M  
Sbjct: 128 GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 661 ----------ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL---- 706
                     I+ K DV+S G +L  +   +    T +     Q   L A+++ +     
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK----TPFQQIINQISKLHAIIDPNHEIEF 242

Query: 707 ------EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMR 737
                 +  D   VL+        C++ DP  R ++ 
Sbjct: 243 PDIPEKDLQD---VLKC-------CLKRDPKQRISIP 269

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  109 bits (275), Expect = 1e-26
 Identities = 51/219 (23%), Positives = 87/219 (39%), Gaps = 50/219 (22%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---------VFQDSEKEFKAEVNGIGQ 536
            KE LGRG    V +  ++  +  + AVK ++            Q+  +    EV+ + +
Sbjct: 21  PKEILGRGVSSVVRRC-IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79

Query: 537 -THHKNLVRLLGYCDEGRNRLLVYEFMSNGAL--------------ASFLFGDSKPNWKL 581
            + H N+++L    +      LV++ M  G L                 +          
Sbjct: 80  VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM--------- 130

Query: 582 RTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN 641
           R      +   +  LH+     I+H D+KP+NILLDD  N +++DFG    L   +    
Sbjct: 131 RA-----LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 182

Query: 642 TAIRGTKGYVAPEWFRNMPITV------KVDVYSYGVLL 674
               GT  Y+APE               +VD++S GV++
Sbjct: 183 VC--GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  109 bits (275), Expect = 2e-26
 Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 16/199 (8%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVK-----KLNRVFQDSEKE-FKAEVNGIGQTHH 539
             EELG G F  V K      +  Q A K     +     +   +E  + EV+ + +  H
Sbjct: 15  TGEELGSGQFAVVKKC-REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73

Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
            N++ L    +   + +L+ E ++ G L  FL        +  TE +  I  G++YLH  
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133

Query: 600 CCTQIIHCDIKPQNILL----DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
              QI H D+KP+NI+L          +I DFGL   +       N    GT  +VAPE 
Sbjct: 134 ---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEI 188

Query: 656 FRNMPITVKVDVYSYGVLL 674
               P+ ++ D++S GV+ 
Sbjct: 189 VNYEPLGLEADMWSIGVIT 207

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  108 bits (273), Expect = 2e-26
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 11/194 (5%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLV 543
            KEELG+GAF  V +  V+  +  + A K +N  ++     ++ + E     +  H N+V
Sbjct: 10  VKEELGKGAFSVVRRC-VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           RL     E     LV++ ++ G L   +      +    +  +  I   + Y H      
Sbjct: 69  RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---G 125

Query: 604 IIHCDIKPQNILLDDYYNA---RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
           I+H ++KP+N+LL         +++DFGL   +   ++    A  GT GY++PE  +  P
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVLKKDP 183

Query: 661 ITVKVDVYSYGVLL 674
            +  VD+++ GV+L
Sbjct: 184 YSKPVDIWACGVIL 197

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  110 bits (277), Expect = 2e-26
 Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 29/203 (14%)

Query: 485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVR 544
              E LG G FG V+K      +  ++A K +       ++E K E++ + Q  H NL++
Sbjct: 92  SKTEILGGGRFGQVHKC-EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 545 LLGYCDEGRNRLLVYEFMSNGAL------ASFLFGDSKPNWKLRTE-----IVMGIARGL 593
           L    +   + +LV E++  G L       S+            TE      +  I  G+
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNL----------TELDTILFMKQICEGI 200

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARI--SDFGLEKLLTLDQSHTNTAIRGTKGYV 651
            ++H+     I+H D+KP+NIL  +    +I   DFGL +     +        GT  ++
Sbjct: 201 RHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--GTPEFL 255

Query: 652 APEWFRNMPITVKVDVYSYGVLL 674
           APE      ++   D++S GV+ 
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIA 278

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  108 bits (272), Expect = 5e-26
 Identities = 53/324 (16%), Positives = 96/324 (29%), Gaps = 92/324 (28%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           + +GRG FG V++   N       A+K++     + + ++   EV  + +  H  +VR  
Sbjct: 12  QCMGRGGFGVVFEA-KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 70

Query: 547 G---YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE------------------- 584
                    + +  + E         +      P      +                   
Sbjct: 71  NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130

Query: 585 -------IVMG-------------------------------IARGLFYLHEECCTQIIH 606
                  I M                                IA  + +LH +    ++H
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMH 187

Query: 607 CDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR-----------GTKGYVAPEW 655
            D+KP NI        ++ DFGL   +  D+                   GTK Y++PE 
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247

Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER--TLGALVENDLEAM--DD 711
                 + KVD++S G++L E++    T           ER   +  +       +    
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLYSFST---------QMERVRIITDVRNLKFPLLFTQK 298

Query: 712 MTVLQRFVMVAIWCIQEDPSHRPT 735
                  V      +   P+ RP 
Sbjct: 299 YPQEHMMVQ---DMLSPSPTERPE 319

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  109 bits (273), Expect = 5e-26
 Identities = 56/273 (20%), Positives = 109/273 (39%), Gaps = 23/273 (8%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTHHKNLVRLL 546
            ELG G  G V+K   +  S   +A K ++   + +   +   E+  + + +   +V   
Sbjct: 39  SELGAGNGGVVFKV-SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 97

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----GLFYLHEECCT 602
           G         +  E M  G+L   L    K   ++  +I+  ++     GL YL E+   
Sbjct: 98  GAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKH-- 151

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           +I+H D+KP NIL++     ++ DFG+   L    +++     GT+ Y++PE  +    +
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYS 208

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA 722
           V+ D++S G+ L+E+   R        Y           +    +   D           
Sbjct: 209 VQSDIWSMGLSLVEMAVGR--------YPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260

Query: 723 IWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCP 755
              + +          + ++L+ +V  P P  P
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP 293

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  109 bits (275), Expect = 6e-26
 Identities = 54/276 (19%), Positives = 106/276 (38%), Gaps = 47/276 (17%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQTHHKNL--V 543
           +++G G    V++           A+K +N    D++    ++ E+  + +    +   +
Sbjct: 62  KQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           RL  Y    +   +V E   N  L S+L      +   R      +   +  +H+     
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---G 175

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN-TAIRGTKGYVAPEWFRNMP-- 660
           I+H D+KP N L+ D    ++ DFG+   +  D +     +  G   Y+ PE  ++M   
Sbjct: 176 IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 661 ---------ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL----- 706
                    I+ K DV+S G +L  +   +    T +     Q   L A+++ +      
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK----TPFQQIINQISKLHAIIDPNHEIEFP 290

Query: 707 -----EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMR 737
                +  D   VL+        C++ DP  R ++ 
Sbjct: 291 DIPEKDLQD---VLKC-------CLKRDPKQRISIP 316

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  107 bits (270), Expect = 6e-26
 Identities = 54/196 (27%), Positives = 98/196 (50%), Gaps = 15/196 (7%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           E++G+G+FG V+KG ++  +   VA+K ++    +D  ++ + E+  + Q     + +  
Sbjct: 28  EKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----GLFYLHEECCT 602
           G   +     ++ E++  G+    L    +P   L    +  I R    GL YLH E   
Sbjct: 87  GSYLKDTKLWIIMEYLGGGSALDLL----EPG-PLDETQIATILREILKGLDYLHSE--- 138

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           + IH DIK  N+LL ++   +++DFG+   LT  Q   NT + GT  ++APE  +     
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYD 197

Query: 663 VKVDVYSYGVLLLEII 678
            K D++S G+  +E+ 
Sbjct: 198 SKADIWSLGITAIELA 213

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  111 bits (279), Expect = 9e-26
 Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 17/196 (8%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
             EELG GAFG V++      + +  A K +    +  ++  + E+  +    H  LV L
Sbjct: 161 IHEELGTGAFGVVHRV-TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFYLHEEC 600
               ++    +++YEFMS G L   +  +   + K+ +E      +  + +GL ++HE  
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADE---HNKM-SEDEAVEYMRQVCKGLCHMHEN- 274

Query: 601 CTQIIHCDIKPQNILLDDYYNARI--SDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +H D+KP+NI+     +  +   DFGL   L   QS   T   GT  + APE    
Sbjct: 275 --NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEG 330

Query: 659 MPITVKVDVYSYGVLL 674
            P+    D++S GVL 
Sbjct: 331 KPVGYYTDMWSVGVLS 346

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  106 bits (268), Expect = 2e-25
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 34/204 (16%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F E LG GAF  V+       +    A+K + +     +   + E+  + +  H+N+V L
Sbjct: 13  FMEVLGSGAFSEVFLV-KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71

Query: 546 LGYCDEGRNRLLVYEFMSNGAL-------ASFLFGDSKPNWKLRTE-----IVMGIARGL 593
               +   +  LV + +S G L         +            TE     ++  +   +
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRILERGVY------------TEKDASLVIQQVLSAV 119

Query: 594 FYLHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGY 650
            YLHE     I+H D+KP+N+L    ++     I+DFGL K+        +TA  GT GY
Sbjct: 120 KYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTAC-GTPGY 173

Query: 651 VAPEWFRNMPITVKVDVYSYGVLL 674
           VAPE     P +  VD +S GV+ 
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVIT 197

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  107 bits (268), Expect = 2e-25
 Identities = 69/277 (24%), Positives = 117/277 (42%), Gaps = 39/277 (14%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVN-GIGQTHHKNLVRL 545
            E+GRGA+G+V K  V+  S   +AVK++     + E K+   +++  +  +    +V+ 
Sbjct: 28  GEIGRGAYGSVNKM-VHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFYLHEEC 600
            G      +  +  E M + +   F          +  E     I +   + L +L E  
Sbjct: 87  YGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN- 144

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE----WF 656
             +IIH DIKP NILLD   N ++ DFG+   L    + T  A  G + Y+APE      
Sbjct: 145 -LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERIDPSA 201

Query: 657 RNMPITVKVDVYSYGVLLLEIICLR---RTILTDWAYDCYQERTLGALVEND---LEAMD 710
                 V+ DV+S G+ L E+   R       + +         L  +V+ D   L   +
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-------DQLTQVVKGDPPQLSNSE 254

Query: 711 DMT---VLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           +         FV +   C+ +D S RP  +   ++L+
Sbjct: 255 EREFSPSFINFVNL---CLTKDESKRPKYK---ELLK 285

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  109 bits (275), Expect = 2e-25
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNL 542
            +  LG+G+FG V     +  +  + AVK +++     +  ++    EV  + Q  H N+
Sbjct: 30  GQRVLGKGSFGEVILC-KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           ++L  + ++     LV E  + G L   +    + +      I+  +  G+ Y+H+    
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN--- 145

Query: 603 QIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
           +I+H D+KP+N+LL       N RI DFGL       +   +    GT  Y+APE     
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEVLHG- 202

Query: 660 PITVKVDVYSYGVLLLEIIC 679
               K DV+S GV+L  ++ 
Sbjct: 203 TYDEKCDVWSTGVILYILLS 222

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  107 bits (270), Expect = 2e-25
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 11/194 (5%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLV 543
            KEELG+GAF  V +  V+  +  + A K +N  ++     ++ + E     +  H N+V
Sbjct: 33  VKEELGKGAFSVVRRC-VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           RL     E     LV++ ++ G L   +      +    +  +  I   + Y H      
Sbjct: 92  RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---G 148

Query: 604 IIHCDIKPQNILLDDYYNA---RISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
           I+H ++KP+N+LL         +++DFGL   +   ++    A  GT GY++PE  +  P
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVLKKDP 206

Query: 661 ITVKVDVYSYGVLL 674
            +  VD+++ GV+L
Sbjct: 207 YSKPVDIWACGVIL 220

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  108 bits (272), Expect = 2e-25
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 23/209 (11%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--------VFQDSEKEFKAEVNGIGQT 537
             + LG GA G V        +  +VA++ +++           D     + E+  + + 
Sbjct: 139 MSKTLGSGACGEVKLA-FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197

Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLH 597
           +H  ++++  + D   +  +V E M  G L   + G+ +            +   + YLH
Sbjct: 198 NHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 256

Query: 598 EECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           E     IIH D+KP+N+LL   ++    +I+DFG  K+L  + S   T   GT  Y+APE
Sbjct: 257 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPTYLAPE 311

Query: 655 WFRNM---PITVKVDVYSYGVLLLEIICL 680
              ++        VD +S GV+L   ICL
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILF--ICL 338

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  109 bits (275), Expect = 2e-25
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 12/199 (6%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLV 543
             ++LG GA+G V     +  +  + A+K +    V   S  +   EV  +    H N++
Sbjct: 41  RVKKLGSGAYGEVLLC-RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +L  + ++ RN  LV E    G L   +    K N      I+  +  G+ YLH+     
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---N 156

Query: 604 IIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
           I+H D+KP+N+LL   +     +I DFGL  +    +        GT  Y+APE  R   
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVLRK-K 213

Query: 661 ITVKVDVYSYGVLLLEIIC 679
              K DV+S GV+L  ++ 
Sbjct: 214 YDEKCDVWSIGVILFILLA 232

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  105 bits (265), Expect = 2e-25
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G+F  VY+   ++ +  +VA+K +++         +  + EV    Q  H +++ L 
Sbjct: 19  LGKGSFAGVYRA-ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFYLHEECC 601
            Y ++     LV E   NG +  +L    K   K  +E      +  I  G+ YLH    
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYL----KNRVKPFSENEARHFMHQIITGMLYLHSH-- 131

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             I+H D+   N+LL    N +I+DFGL   L +      T + GT  Y++PE       
Sbjct: 132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAH 189

Query: 662 TVKVDVYSYGVLLLEIIC 679
            ++ DV+S G +   ++ 
Sbjct: 190 GLESDVWSLGCMFYTLLI 207

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  105 bits (265), Expect = 3e-25
 Identities = 63/270 (23%), Positives = 112/270 (41%), Gaps = 29/270 (10%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVN-GIGQTHHKNLVRL 545
            ELGRGA+G V K   ++ S   +AVK++       E K    +++  +        V  
Sbjct: 13  MELGRGAYGVVEKM-RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----GLFYLHEECC 601
            G      +  +  E M + +L  F          +  +I+  IA      L +LH +  
Sbjct: 72  YGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK-- 128

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE----WFR 657
             +IH D+KP N+L++     ++ DFG+   L  D    +    G K Y+APE       
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDA-GCKPYMAPERINPELN 186

Query: 658 NMPITVKVDVYSYGVLLLEIICLR---RTILTDWAYDCYQERTLGALVENDLEAMDDMTV 714
               +VK D++S G+ ++E+  LR    +  T +       + L  +VE     +     
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-------QQLKQVVEEPSPQLPADKF 239

Query: 715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
              FV     C++++   RPT     ++++
Sbjct: 240 SAEFVDFTSQCLKKNSKERPT---YPELMQ 266

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  105 bits (264), Expect = 3e-25
 Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 10/192 (5%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            +  +GRG++G V    V  G+  + A KK+ + F +    FK E+  +    H N++RL
Sbjct: 13  LENTIGRGSWGEVKIA-VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
               ++  +  LV E  + G L   +             I+  +   + Y H+     + 
Sbjct: 72  YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVA 128

Query: 606 HCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           H D+KP+N L          ++ DFGL       +        GT  YV+P+        
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLEG-LYG 185

Query: 663 VKVDVYSYGVLL 674
            + D +S GV++
Sbjct: 186 PECDEWSAGVMM 197

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  105 bits (263), Expect = 4e-25
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 17/198 (8%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVR 544
           FK +LG GAFG V+       S  +  +K +N    Q   ++ +AE+  +    H N+++
Sbjct: 26  FKRKLGSGAFGDVHLV-EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFYLHEE 599
           +    ++  N  +V E    G L   +         L +E     ++  +   L Y H +
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKAL-SEGYVAELMKQMMNALAYFHSQ 143

Query: 600 CCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
               ++H D+KP+NIL      +   +I DFGL +L   D+  TN A  GT  Y+APE F
Sbjct: 144 ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYMAPEVF 198

Query: 657 RNMPITVKVDVYSYGVLL 674
           +   +T K D++S GV++
Sbjct: 199 KR-DVTFKCDIWSAGVVM 215

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  106 bits (267), Expect = 4e-25
 Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 51/219 (23%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--------VFQDSEKEFKAEVNGIGQ- 536
            K+ +GRG    V +  V+  +  + AVK +            ++  +  + E + I + 
Sbjct: 98  PKDVIGRGVSSVVRRC-VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH-ILRQ 155

Query: 537 -THHKNLVRLLGYCDEGRNRLLVYEFMSNGAL--------------ASFLFGDSKPNWKL 581
              H +++ L+   +      LV++ M  G L                 +          
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM--------- 206

Query: 582 RTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN 641
           R+     +   + +LH      I+H D+KP+NILLDD    R+SDFG    L   +    
Sbjct: 207 RS-----LLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE 258

Query: 642 TAIRGTKGYVAPEWFRNMPITV------KVDVYSYGVLL 674
               GT GY+APE  +            +VD+++ GV+L
Sbjct: 259 LC--GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  108 bits (271), Expect = 4e-25
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 34/206 (16%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--VFQDSEKEFKAEVNGIGQTHHKNLV 543
             EELG+GAF  V +  V + +  + A   +N   +     ++ + E        H N+V
Sbjct: 15  LFEELGKGAFSVVRRC-VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73

Query: 544 RLLGYCDEGRNRLLVYEFMSNGAL-------ASFLFGDSKPNWKLRTE-----IVMGIAR 591
           RL     E  +  L+++ ++ G L         +            +E      +  I  
Sbjct: 74  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYY------------SEADASHCIQQILE 121

Query: 592 GLFYLHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTK 648
            + + H+     ++H ++KP+N+LL         +++DFGL   +  +Q        GT 
Sbjct: 122 AVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTP 177

Query: 649 GYVAPEWFRNMPITVKVDVYSYGVLL 674
           GY++PE  R  P    VD+++ GV+L
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVIL 203

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  106 bits (265), Expect = 5e-25
 Identities = 55/246 (22%), Positives = 89/246 (36%), Gaps = 56/246 (22%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVK-----KLNRVFQDSEKEFKAEVNGIGQTHHK 540
            K  +G+G++G V    +   +    A+K     K+ ++     +  K EV  + + HH 
Sbjct: 30  LKGAIGQGSYGVVRVA-IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88

Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGAL--------------------------------- 567
           N+ RL    ++ +   LV E    G L                                 
Sbjct: 89  NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 568 --ASFLFGDSKPNWKLRTE-----IVMGIARGLFYLHEECCTQIIHCDIKPQNILL--DD 618
                + G  +    ++ E     I+  I   L YLH +    I H DIKP+N L   + 
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205

Query: 619 YYNARISDFGLEKLLTLDQSHTNTAIR---GTKGYVAPEWFRNM--PITVKVDVYSYGVL 673
            +  ++ DFGL K      +     +    GT  +VAPE           K D +S GVL
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 674 LLEIIC 679
           L  ++ 
Sbjct: 266 LHLLLM 271

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  105 bits (263), Expect = 6e-25
 Identities = 47/198 (23%), Positives = 74/198 (37%), Gaps = 19/198 (9%)

Query: 488 EELGRGAFGTVYKGFVNMGSSD-----QVAVKKLNRVFQDSE---KEFKAEVNGIGQTHH 539
             +GRG  G VY+        D      VA+K ++             + E    G+   
Sbjct: 40  RLVGRGGMGDVYEAE------DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE 93

Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
            ++V +  + +      +    ++   LA+ L             IV  I   L   H  
Sbjct: 94  PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT-AIRGTKGYVAPEWFRN 658
                 H D+KP+NIL+     A + DFG+    T D+  T      GT  Y+APE F  
Sbjct: 154 ---GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSE 209

Query: 659 MPITVKVDVYSYGVLLLE 676
              T + D+Y+   +L E
Sbjct: 210 SHATYRADIYALTCVLYE 227

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  105 bits (264), Expect = 6e-25
 Identities = 55/223 (24%), Positives = 90/223 (40%), Gaps = 51/223 (22%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--------VFQDSEKEFKAEVNGIGQT 537
             + LG GA G V        +  +VA+K +++           D     + E+  + + 
Sbjct: 14  MSKTLGSGACGEVKLA-FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72

Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGAL--------------ASFLFGDSKPNWKLRT 583
           +H  ++++  + D   +  +V E M  G L                  F           
Sbjct: 73  NHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---------YQ 122

Query: 584 EIVMGIARGLFYLHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHT 640
                +   + YLHE     IIH D+KP+N+LL   ++    +I+DFG  K+L  + S  
Sbjct: 123 -----MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLM 173

Query: 641 NTAIRGTKGYVAPEWFRNM---PITVKVDVYSYGVLLLEIICL 680
            T   GT  Y+APE   ++        VD +S GV+L   ICL
Sbjct: 174 RTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF--ICL 213

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  104 bits (262), Expect = 7e-25
 Identities = 52/194 (26%), Positives = 87/194 (44%), Gaps = 12/194 (6%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLV 543
               LG+G+FG V K   +  +  + AVK +N              EV  + +  H N++
Sbjct: 26  IVCMLGKGSFGEVLKC-KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +L    ++  +  +V E  + G L   +    + +      I+  +  G+ Y+H+     
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141

Query: 604 IIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
           I+H D+KP+NILL   +   + +I DFGL      +    +    GT  Y+APE  R   
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLRG-T 198

Query: 661 ITVKVDVYSYGVLL 674
              K DV+S GV+L
Sbjct: 199 YDEKCDVWSAGVIL 212

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  105 bits (264), Expect = 7e-25
 Identities = 45/198 (22%), Positives = 84/198 (42%), Gaps = 18/198 (9%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G F   ++   +  + +  A K + +   +     ++   E++      H+++V   
Sbjct: 49  LGKGGFAKCFEI-SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFYLHEECC 601
           G+ ++     +V E     +L        K    L TE      +  I  G  YLH    
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH----KRRKAL-TEPEARYYLRQIVLGCQYLHRN-- 160

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
            ++IH D+K  N+ L++    +I DFGL   +  D       + GT  Y+APE       
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 218

Query: 662 TVKVDVYSYGVLLLEIIC 679
           + +VDV+S G ++  ++ 
Sbjct: 219 SFEVDVWSIGCIMYTLLV 236

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  105 bits (263), Expect = 7e-25
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLL 546
           E +G G +G VYKG  ++ +    A+K ++ V  D E+E K E+N + +  HH+N+    
Sbjct: 30  ELVGNGTYGQVYKG-RHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYY 87

Query: 547 G-----YCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTE----IVMGIARGLFYL 596
           G           ++L LV EF   G++   +   +     L+ E    I   I RGL +L
Sbjct: 88  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHL 145

Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE-- 654
           H+    ++IH DIK QN+LL +    ++ DFG+   L       NT I GT  ++APE  
Sbjct: 146 HQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 201

Query: 655 ---WFRNMPITVKVDVYSYGVLLLEII 678
                 +     K D++S G+  +E+ 
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMA 228

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  104 bits (261), Expect = 9e-25
 Identities = 45/198 (22%), Positives = 84/198 (42%), Gaps = 18/198 (9%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG+G F   ++   +  + +  A K + +   +     ++   E++      H+++V   
Sbjct: 23  LGKGGFAKCFEI-SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFYLHEECC 601
           G+ ++     +V E     +L        K    L TE      +  I  G  YLH    
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELH----KRRKAL-TEPEARYYLRQIVLGCQYLHRN-- 134

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
            ++IH D+K  N+ L++    +I DFGL   +  D       + GT  Y+APE       
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 192

Query: 662 TVKVDVYSYGVLLLEIIC 679
           + +VDV+S G ++  ++ 
Sbjct: 193 SFEVDVWSIGCIMYTLLV 210

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  104 bits (261), Expect = 1e-24
 Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 23/209 (11%)

Query: 488 EELGRGAFGTVYKGFVNMGSSD-----QVAVKKLNRVFQDSE---KEFKAEVNGIGQTHH 539
           E LG G    V+         D      VAVK L             F+ E       +H
Sbjct: 18  EILGFGGMSEVHLA------RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71

Query: 540 KNLVRLLGY-CDEGRNRLLVY---EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFY 595
             +V +      E     L Y   E++    L   +  +     K   E++    + L +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131

Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-TNT-AIRGTKGYVAP 653
            H+     IIH D+KP NI++      ++ DFG+ + +    +  T T A+ GT  Y++P
Sbjct: 132 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 654 EWFRNMPITVKVDVYSYGVLLLEIICLRR 682
           E  R   +  + DVYS G +L E++    
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  104 bits (261), Expect = 2e-24
 Identities = 49/204 (24%), Positives = 83/204 (40%), Gaps = 36/204 (17%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ-THHKNLVRL 545
            + LG G+F    K  V+  S+   AVK +++     E   + E+  +     H N+V+L
Sbjct: 16  DKPLGEGSFSICRKC-VHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKL 71

Query: 546 LGYCDEGRNRLLVYEFMSNGAL-------ASFLFGDSKPNWKLRTE-----IVMGIARGL 593
                +  +  LV E ++ G L         F            +E     I+  +   +
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKHF------------SETEASYIMRKLVSAV 119

Query: 594 FYLHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGY 650
            ++H+     ++H D+KP+N+L    +D    +I DFG  +L   D     T    T  Y
Sbjct: 120 SHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHY 175

Query: 651 VAPEWFRNMPITVKVDVYSYGVLL 674
            APE           D++S GV+L
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVIL 199

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  106 bits (266), Expect = 3e-24
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 12/199 (6%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLV 543
               LG+G+FG V K   +  +  + AVK +N              EV  + +  H N++
Sbjct: 26  IVCMLGKGSFGEVLKC-KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           +L    ++  +  +V E  + G L   +    + +      I+  +  G+ Y+H+     
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141

Query: 604 IIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
           I+H D+KP+NILL   +   + +I DFGL      +    +    GT  Y+APE  R   
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLRG-T 198

Query: 661 ITVKVDVYSYGVLLLEIIC 679
              K DV+S GV+L  ++ 
Sbjct: 199 YDEKCDVWSAGVILYILLS 217

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  104 bits (260), Expect = 3e-24
 Identities = 46/221 (20%), Positives = 80/221 (36%), Gaps = 43/221 (19%)

Query: 490 LGRGAFGTVY----KGFVNMGSSDQVAVKKLNR-----------------VFQDSEKEFK 528
           L +G F  +                 A+KK  +                   +    +FK
Sbjct: 39  LNQGKFNKIILCEKDNK-------FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK 91

Query: 529 AEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG 588
            E+  I    ++  +   G         ++YE+M N ++  F       +      I + 
Sbjct: 92  NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151

Query: 589 IAR--------GLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT 640
           + +           Y+H E    I H D+KP NIL+D     ++SDFG  + +   +   
Sbjct: 152 VIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209

Query: 641 NTAIRGTKGYVAPEWFRNMPITV--KVDVYSYGVLLLEIIC 679
               RGT  ++ PE+F N       KVD++S G+ L  +  
Sbjct: 210 ---SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  103 bits (260), Expect = 3e-24
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 35/204 (17%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            + ELGRGA   VY+     G+    A+K L +     +K  + E+  + +  H N+++L
Sbjct: 57  VESELGRGATSIVYRC-KQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKL 113

Query: 546 LGYCDEGRNRLLVYEFMSNGAL-------ASFLFGDSKPNWKLRTE-----IVMGIARGL 593
               +      LV E ++ G L         +            +E      V  I   +
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYY------------SERDAADAVKQILEAV 161

Query: 594 FYLHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGY 650
            YLHE     I+H D+KP+N+L          +I+DFGL K++            GT GY
Sbjct: 162 AYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGY 216

Query: 651 VAPEWFRNMPITVKVDVYSYGVLL 674
            APE  R      +VD++S G++ 
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIIT 240

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  105 bits (265), Expect = 4e-24
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 23/210 (10%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR-------------VFQDSEKEFKAEVN 532
              +LG GA+G V           + A+K + +               +   +E   E++
Sbjct: 40  KVRKLGSGAYGEVLLC-KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98

Query: 533 GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARG 592
            +    H N+++L    ++ +   LV EF   G L   +    K +      I+  I  G
Sbjct: 99  LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG 158

Query: 593 LFYLHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           + YLH+     I+H DIKP+NILL   +   N +I DFGL    + D    +    GT  
Sbjct: 159 ICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL--GTAY 213

Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
           Y+APE  +      K DV+S GV++  ++C
Sbjct: 214 YIAPEVLKK-KYNEKCDVWSCGVIMYILLC 242

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  101 bits (254), Expect = 1e-23
 Identities = 62/271 (22%), Positives = 114/271 (42%), Gaps = 32/271 (11%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE-KEFKAEVNGIGQTH-HKNLVRL 545
            E+G G  G V+K      +   +AVK++ R     E K    +++ + ++H    +V+ 
Sbjct: 31  GEMGSGTCGQVWKMR-FRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
            G      +  +  E M   A             ++  ++ + I + L+YL E+    +I
Sbjct: 90  FGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVI 147

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE-----WFRNMP 660
           H D+KP NILLD+    ++ DFG+   L  D++   +A  G   Y+APE           
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPTKPD 205

Query: 661 ITVKVDVYSYGVLLLEIICLR---RTILTDWAYDCYQERTLGALVENDLEAMDDMTV--- 714
             ++ DV+S G+ L+E+   +   +   TD+         L  +++ +   +        
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTDF-------EVLTKVLQEEPPLLPGHMGFSG 258

Query: 715 -LQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
             Q FV     C+ +D   RP      ++LE
Sbjct: 259 DFQSFVKD---CLTKDHRKRPKYN---KLLE 283

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  103 bits (257), Expect = 1e-23
 Identities = 41/331 (12%), Positives = 85/331 (25%), Gaps = 66/331 (19%)

Query: 453 RKKFMRPHQEEQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVA 512
                   Q  +  S +  R  T        RG    LG+       +   +  + +   
Sbjct: 57  STSLWNTGQPFRVESELGERPRTLV------RG--TVLGQEDPYAYLEA-TDQETGESFE 107

Query: 513 VK---KLNRVFQDSEKEFKAEVNGIGQTHH----------------KNLVRLLGYCDEGR 553
           V       R   ++ K+ K EV  +                      +LV+        R
Sbjct: 108 VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIR 167

Query: 554 -----------NRLLVYEFMSN------GALASFLFGDSKPNWKLRTEIVMGIARGLFYL 596
                      +R  +Y  M +        L S            R ++ + + R L  L
Sbjct: 168 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227

Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
           H      ++H  ++P +I+LD      ++ F                        A    
Sbjct: 228 HHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERML 284

Query: 657 RNMP-----ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD 711
                    +T   D ++ G+ +  I C               +       E    +  +
Sbjct: 285 PFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---------NTDDAALGGSEWIFRSCKN 335

Query: 712 MTV-LQRFVMVAIWCIQEDPSHRPTMRRVTQ 741
           +   ++  +      ++     R    +  +
Sbjct: 336 IPQPVRALLE---GFLRYPKEDRLLPLQAME 363

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  103 bits (258), Expect = 4e-23
 Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 24/203 (11%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLN--RVFQDSEKEF-KAEVNGIGQTHHKNLVRL 545
           LGRG FG V+     M ++ ++ A KKLN  R+ +    +    E   + + H + +V L
Sbjct: 193 LGRGGFGEVFA--CQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250

Query: 546 LGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLR--------TEIVMGIARGLFYL 596
             Y  E +  L LV   M+ G +   ++   + N   +         +IV G    L +L
Sbjct: 251 A-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHL 305

Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
           H+     II+ D+KP+N+LLDD  N RISD GL   L   Q+ T     GT G++APE  
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELL 361

Query: 657 RNMPITVKVDVYSYGVLLLEIIC 679
                   VD ++ GV L E+I 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIA 384

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 98.9 bits (247), Expect = 6e-23
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 18/205 (8%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           E +G GA   V          ++VA+K++N    Q S  E   E+  + Q HH N+V   
Sbjct: 21  EVIGSGATAVVQAA-YCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79

Query: 547 GYCDEGRNRLLVYEFMSNGALASFL---FGDSKPNWKLRTE-----IVMGIARGLFYLHE 598
                     LV + +S G++   +       +    +  E     I+  +  GL YLH+
Sbjct: 80  TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR----GTKGYVAPE 654
                 IH D+K  NILL +  + +I+DFG+   L      T   +R    GT  ++APE
Sbjct: 140 N---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196

Query: 655 WF-RNMPITVKVDVYSYGVLLLEII 678
              +      K D++S+G+  +E+ 
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELA 221

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  103 bits (257), Expect = 8e-23
 Identities = 52/273 (19%), Positives = 94/273 (34%), Gaps = 32/273 (11%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNLVRLL 546
             +  G  G +Y       +   V +K L        +    AE   + +  H ++V++ 
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 547 GYCDEGRNRL-----LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
            + +           +V E++   +L             +    ++ I   L YLH    
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--YLLEILPALSYLHSI-- 201

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +++ D+KP+NI+L +    ++ D G    +            GT G+ APE  R  P 
Sbjct: 202 -GLVYNDLKPENIMLTE-EQLKLIDLGAVSRIN----SFGYLY-GTPGFQAPEIVRTGP- 253

Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV 721
           TV  D+Y+ G  L  +     T    +      E        +         +L+R    
Sbjct: 254 TVATDIYTVGRTLAALTLDLPTRNGRYVDG-LPEDDPVLKTYDSYGR-----LLRR---- 303

Query: 722 AIWCIQEDPSHRP-TMRRVTQMLEGVVEVPIPP 753
               I  DP  R  T   ++  L GV+   +  
Sbjct: 304 ---AIDPDPRQRFTTAEEMSAQLTGVLREVVAQ 333

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 98.9 bits (247), Expect = 8e-23
 Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 47/217 (21%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ-THHKNLVRL 545
           ++ LG GA   V    +N+ +S + AVK + +           EV  + Q   H+N++ L
Sbjct: 18  EDVLGEGAHARVQTC-INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76

Query: 546 LGYCDEGRNRLLVYEFMSNGAL--------------ASFLFGDSKPNWKLRTEIVMGIAR 591
           + + +E     LV+E M  G++              AS               +V  +A 
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS--------------VVVQDVAS 122

Query: 592 GLFYLHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIR--- 645
            L +LH +    I H D+KP+NIL    +     +I DF L   + L+   +  +     
Sbjct: 123 ALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179

Query: 646 ---GTKGYVAPEWFRNMPITVK-----VDVYSYGVLL 674
              G+  Y+APE                D++S GV+L
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 97.1 bits (242), Expect = 7e-22
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 25/202 (12%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---KEFKAEVNGIGQTHHKNLVR 544
            E+G G+FG VY    ++ +S+ VA+KK++   + S    ++   EV  + +  H N ++
Sbjct: 60  REIGHGSFGAVYFA-RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIARGLFYLHEE 599
             G         LV E+    A         + + K   E     +  G  +GL YLH  
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASD-----LLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE---WF 656
               +IH D+K  NILL +    ++ DFG   ++       N+ + GT  ++APE     
Sbjct: 174 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----PANSFV-GTPYWMAPEVILAM 225

Query: 657 RNMPITVKVDVYSYGVLLLEII 678
                  KVDV+S G+  +E+ 
Sbjct: 226 DEGQYDGKVDVWSLGITCIELA 247

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 99.1 bits (247), Expect = 1e-21
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 23/201 (11%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLN--RVFQDSEKEF-KAEVNGIGQTHHKNLVRL 545
           LG+G FG V      + ++ ++ A KKL   R+ +   +     E   + + + + +V L
Sbjct: 192 LGKGGFGEVC--ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249

Query: 546 LGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRT------EIVMGIARGLFYLHE 598
             Y  E ++ L LV   M+ G L   ++   +  +          EI  G    L  LH 
Sbjct: 250 -AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG----LEDLHR 304

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
           E   +I++ D+KP+NILLDD+ + RISD GL   +   Q+     + GT GY+APE  +N
Sbjct: 305 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKN 359

Query: 659 MPITVKVDVYSYGVLLLEIIC 679
              T   D ++ G LL E+I 
Sbjct: 360 ERYTFSPDWWALGCLLYEMIA 380

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 95.7 bits (238), Expect = 3e-21
 Identities = 34/207 (16%), Positives = 67/207 (32%), Gaps = 22/207 (10%)

Query: 488 EELGRGA--FGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLV 543
             +G+G     TV        + + V V+++N      +     + E++     +H N+V
Sbjct: 31  TVIGKGFEDLMTVNLA-RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----GLFYLHEE 599
                        +V  FM+ G+    +   +     +    +  I +     L Y+H  
Sbjct: 90  PYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYILQGVLKALDYIHHM 147

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV------AP 653
                +H  +K  +IL+       +S       +              K  V      +P
Sbjct: 148 ---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

Query: 654 EWFRNMPI--TVKVDVYSYGVLLLEII 678
           E  +        K D+YS G+   E+ 
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELA 231

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 49/203 (24%), Positives = 83/203 (40%), Gaps = 32/203 (15%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ-THHKNLVRL 545
           K+ LG G  G V +   +  +  + A+K L         + + EV+   Q +   ++V +
Sbjct: 34  KQVLGLGVNGKVLEC-FHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCI 87

Query: 546 LGYCDEGRNR----LLVYEFMSNGALASFLFGD--SKPNWKLRTE-----IVMGIARGLF 594
           L   +   +     L++ E M  G     LF     + +    TE     I+  I   + 
Sbjct: 88  LDVYENMHHGKRCLLIIMECMEGGE----LFSRIQERGDQAF-TEREAAEIMRDIGTAIQ 142

Query: 595 YLHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV 651
           +LH      I H D+KP+N+L    +     +++DFG  K  T +   T      T  YV
Sbjct: 143 FLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT---PCYTPYYV 196

Query: 652 APEWFRNMPITVKVDVYSYGVLL 674
           APE           D++S GV++
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIM 219

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 92.7 bits (231), Expect = 9e-21
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 40/213 (18%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR----VFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG G++G V +  ++  +  + AVK L +       + E   K E+  + +  HKN+++L
Sbjct: 13  LGEGSYGKVKEV-LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 546 LG-YCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLF--------Y 595
           +    +E + ++ +V E+   G     +  DS P  +         A G F        Y
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQE--ML-DSVPEKRFPVCQ----AHGYFCQLIDGLEY 124

Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS----HTNTAIRGTKGYV 651
           LH +    I+H DIKP N+LL      +IS  G+ + L    +     T+   +G+  + 
Sbjct: 125 LHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS---QGSPAFQ 178

Query: 652 APEWFRNM-----PITVKVDVYSYGVLLLEIIC 679
            PE    +         KVD++S GV L  I  
Sbjct: 179 PPEIANGLDTFSGF---KVDIWSAGVTLYNITT 208

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 93.6 bits (233), Expect = 2e-20
 Identities = 54/204 (26%), Positives = 84/204 (41%), Gaps = 31/204 (15%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ-THHKNLVR 544
             + LG G  G V +   N  + ++ A+K L     D  K  + EV    + +   ++VR
Sbjct: 66  TSQVLGLGINGKVLQI-FNKRTQEKFALKMLQ----DCPKARR-EVELHWRASQCPHIVR 119

Query: 545 LLG-YCDEGRNR---LLVYEFMSNGALASFLFGD--SKPNWKLRTE-----IVMGIARGL 593
           ++  Y +    R   L+V E +  G     LF     + +    TE     I+  I   +
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAF-TEREASEIMKSIGEAI 174

Query: 594 FYLHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGY 650
            YLH      I H D+KP+N+L          +++DFG  K  T   S T      T  Y
Sbjct: 175 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYY 229

Query: 651 VAPEWFRNMPITVKVDVYSYGVLL 674
           VAPE           D++S GV++
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIM 253

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 89.6 bits (223), Expect = 6e-20
 Identities = 63/204 (30%), Positives = 94/204 (46%), Gaps = 29/204 (14%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           LG GA+G V    VN  + + VAVK ++     D  +  K E+      +H+N+V+  G+
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLF--------YLHEEC 600
             EG  + L  E+ S G L    F   +P+  +        A+  F        YLH   
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPD----AQRFFHQLMAGVVYLHGI- 124

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS----HTNTAIRGTKGYVAPEWF 656
              I H DIKP+N+LLD+  N +ISDFGL  +   +      +      GT  YVAPE  
Sbjct: 125 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAPELL 179

Query: 657 RNMPIT-VKVDVYSYGVLLLEIIC 679
           +        VDV+S G++L  ++ 
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLA 203

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 90.4 bits (225), Expect = 7e-20
 Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 9/195 (4%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRL 545
           + +G+G F  V     ++ +  +VA+K +++   +     K   EV  +   +H N+V+L
Sbjct: 21  KTIGKGNFAKVKLA-RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
               +  +   L+ E+ S G +  +L    +   K        I   + Y H++    I+
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IV 136

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT-VK 664
           H D+K +N+LLD   N +I+DFG     T+     +    G   Y APE F+       +
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYAAPELFQGKKYDGPE 194

Query: 665 VDVYSYGVLLLEIIC 679
           VDV+S GV+L  ++ 
Sbjct: 195 VDVWSLGVILYTLVS 209

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 91.9 bits (228), Expect = 2e-19
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 26/203 (12%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLN--RVFQDSEKEF-KAEVN---GIGQTHHKNL 542
           +GRG FG VY        + ++ A+K L+  R+     +     E      +       +
Sbjct: 197 IGRGGFGEVYG--CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 543 VRLLGYCDEGRNRL-LVYEFMSNGALASFLFGDSK-PNWKLR---TEIVMGIARGLFYLH 597
           V +  Y     ++L  + + M+ G L   L          +R    EI++G    L ++H
Sbjct: 255 VCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG----LEHMH 309

Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE-WF 656
                 +++ D+KP NILLD++ + RISD GL    +  + H      GT GY+APE   
Sbjct: 310 NR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SVGTHGYMAPEVLQ 363

Query: 657 RNMPITVKVDVYSYGVLLLEIIC 679
           + +      D +S G +L +++ 
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLR 386

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 90.2 bits (224), Expect = 3e-19
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 29/208 (13%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR--VFQDSEKE-FKAEVNGIGQTHHKNLVRL 545
           +GRGAF  V    V M  + QV A+K +N+  + +  E   F+ E + +     + + +L
Sbjct: 69  IGRGAFSEVA--VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 546 LGYCDEGRNRL-LVYEFMSNGALASFL--FGDSKPNWKLR---TEIVMGIARGLFYLHEE 599
             +  +  N L LV E+   G L + L  FG+  P    R    EIVM     +  +H  
Sbjct: 127 H-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA----IDSVHRL 181

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRN 658
                +H DIKP NILLD   + R++DFG    L  D +  +  A+ GT  Y++PE  + 
Sbjct: 182 ---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQA 237

Query: 659 MPITVKVDVY-------SYGVLLLEIIC 679
           +        Y       + GV   E+  
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFY 265

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 63/204 (30%), Positives = 94/204 (46%), Gaps = 29/204 (14%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGY 548
           LG GA+G V    VN  + + VAVK ++     D  +  K E+      +H+N+V+  G+
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLF--------YLHEEC 600
             EG  + L  E+ S G L    F   +P+  +        A+  F        YLH   
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPD----AQRFFHQLMAGVVYLHGI- 124

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS----HTNTAIRGTKGYVAPEWF 656
              I H DIKP+N+LLD+  N +ISDFGL  +   +      +      GT  YVAPE  
Sbjct: 125 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAPELL 179

Query: 657 RNMPIT-VKVDVYSYGVLLLEIIC 679
           +        VDV+S G++L  ++ 
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLA 203

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 88.2 bits (219), Expect = 4e-19
 Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 34/211 (16%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNR--------VFQDSEKEFKAEVNGIGQTHH 539
             LG GAFG V+   V+   + +V VK + +        +      +   E+  + +  H
Sbjct: 30  SPLGSGAFGFVWTA-VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88

Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGA-LASFLFGDSKPNWKLRTEIVMGIARGLF---- 594
            N++++L   +      LV E   +G  L  F F D  P            A  +F    
Sbjct: 89  ANIIKVLDIFENQGFFQLVMEKHGSGLDL--FAFIDRHPRLDEPL------ASYIFRQLV 140

Query: 595 ----YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-HTNTAIRGTKG 649
               YL  +    IIH DIK +NI++ + +  ++ DFG    L   +  +T     GT  
Sbjct: 141 SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIE 194

Query: 650 YVAPEWFRNMP-ITVKVDVYSYGVLLLEIIC 679
           Y APE     P    +++++S GV L  ++ 
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 87.7 bits (218), Expect = 5e-19
 Identities = 66/302 (21%), Positives = 107/302 (35%), Gaps = 76/302 (25%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNR------VFQDSEKEFKAEVNGI----GQT 537
             LG+G FGTV+ G   +    QVA+K + R                 EV  +       
Sbjct: 37  PLLGKGGFGTVFAG-HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95

Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGA-LASFLFGDSKPNWKLRTEIVMGIARGLF-- 594
            H  ++RLL + +     +LV E       L  ++          +  +  G +R  F  
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI--------TEKGPLGEGPSRCFFGQ 147

Query: 595 ------YLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGL------EKLLTLDQSHTN 641
                 + H      ++H DIK +NIL+D     A++ DFG       E     D     
Sbjct: 148 VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----- 199

Query: 642 TAIRGTKGYVAPEWFRNMPIT-VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGA 700
               GT+ Y  PEW        +   V+S G+LL +++C                   G 
Sbjct: 200 ----GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC-------------------GD 236

Query: 701 L-VENDLEAMD-DMTVLQRFVMVAI----WCIQEDPSHRPTMRRVTQ---MLEGVVEVPI 751
           +  E D E ++ ++                C+   PS RP++  +     M     +VP+
Sbjct: 237 IPFERDQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPL 296

Query: 752 PP 753
            P
Sbjct: 297 NP 298

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 87.3 bits (217), Expect = 5e-19
 Identities = 53/239 (22%), Positives = 89/239 (37%), Gaps = 67/239 (28%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVK-----KLNRVFQDSEKEFKAEVNGIGQT---- 537
           K+E+G+G++G V     N   +   A+K     KL R      +                
Sbjct: 18  KDEIGKGSYGVVKLA-YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76

Query: 538 -----------------HHKNLVRLLGYC---DEGRNRL-LVYEFMSNGAL--------- 567
                             H N+V+L       D   + L +V+E ++ G +         
Sbjct: 77  RGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPL 134

Query: 568 ----ASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNAR 623
               A F F D          ++ GI     YLH +   +IIH DIKP N+L+ +  + +
Sbjct: 135 SEDQARFYFQD----------LIKGIE----YLHYQ---KIIHRDIKPSNLLVGEDGHIK 177

Query: 624 ISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV---KVDVYSYGVLLLEIIC 679
           I+DFG+        +  +  + GT  ++APE             +DV++ GV L   + 
Sbjct: 178 IADFGVSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 89.0 bits (221), Expect = 7e-19
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 33/209 (15%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLN--RVFQDSEKE-FKAEVNGIGQTHHKNLVRL 545
           +GRGAFG V    V + ++D+V A+K LN   + + +E   F+ E + +     K +  L
Sbjct: 82  IGRGAFGEVA--VVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 546 LGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLR--------TEIVMGIARGLFYL 596
             Y  +  N L LV ++   G L + L   SK   +L          E+V+     +  +
Sbjct: 140 H-YAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLAEMVIA----IDSV 191

Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEW 655
           H+      +H DIKP NIL+D   + R++DFG    L  D +  ++ A+ GT  Y++PE 
Sbjct: 192 HQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEI 247

Query: 656 FRNMPITVK-----VDVYSYGVLLLEIIC 679
            + M           D +S GV + E++ 
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 88.6 bits (220), Expect = 8e-19
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 23/206 (11%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           + +G G+FG VY+      S + VA+KK   V QD   + + E+  + +  H N+VRL  
Sbjct: 60  KVIGNGSFGVVYQA-KLCDSGELVAIKK---VLQDKRFKNR-ELQIMRKLDHCNIVRLRY 114

Query: 548 Y---CDEGRNRL---LVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYLH 597
           +     E ++ +   LV +++    +       S+    L    V      + R L Y+H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173

Query: 598 EECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW- 655
                 I H DIKPQN+LLD D    ++ DFG  K   L +   N +   ++ Y APE  
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRYYRAPELI 228

Query: 656 FRNMPITVKVDVYSYGVLLLEIICLR 681
           F     T  +DV+S G +L E++  +
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQ 254

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 52/211 (24%), Positives = 86/211 (40%), Gaps = 34/211 (16%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNR------VFQDSEKEFKAEVNGIGQTHHK- 540
             LG G FG+VY G + +  +  VA+K + +          +      EV  + +     
Sbjct: 49  PLLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107

Query: 541 -NLVRLLGYCDEGRNRLLVYEFMSN-GALASFLFGDSKPNWKLRTEIVMGIARGLF---- 594
             ++RLL + +   + +L+ E       L  F+         L+ E+    AR  F    
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFI----TERGALQEEL----ARSFFWQVL 159

Query: 595 ----YLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
               + H      ++H DIK +NIL+D +    ++ DFG   LL            GT+ 
Sbjct: 160 EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRV 213

Query: 650 YVAPEWFRNMPIT-VKVDVYSYGVLLLEIIC 679
           Y  PEW R          V+S G+LL +++C
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.4 bits (217), Expect = 2e-18
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 24/203 (11%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLN--RVFQDSEKE-FKAEVNGIGQTHHKNLVRL 545
           +GRGAFG V    V   S+ +V A+K L+   + + S+   F  E + +   +   +V+L
Sbjct: 77  IGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 546 LGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLR---TEIVMGIARGLFYLHEECC 601
             Y  +    L +V E+M  G L + +     P    R    E+V+     L  +H    
Sbjct: 135 F-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA----LDAIHS--- 186

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGL-EKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
              IH D+KP N+LLD   + +++DFG   K+        +TA+ GT  Y++PE  ++  
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 245

Query: 661 ITVK----VDVYSYGVLLLEIIC 679
                    D +S GV L E++ 
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLV 268

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 20/204 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQV-AVKKLN--RVFQDSEKEF-KAEVNGIGQTHHKN 541
           F + LG G+F TV        ++ +  A+K L    + ++++  +   E + + +  H  
Sbjct: 34  FGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLR---TEIVMGIARGLFYLH 597
            V+L     +         +  NG L  ++           R    EIV  +     YLH
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE----YLH 147

Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT--LDQSHTNTAIRGTKGYVAPEW 655
            +    IIH D+KP+NILL++  + +I+DFG  K+L+    Q+  N+   GT  YV+PE 
Sbjct: 148 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVSPEL 203

Query: 656 FRNMPITVKVDVYSYGVLLLEIIC 679
                     D+++ G ++ +++ 
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVA 227

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 86.6 bits (215), Expect = 3e-18
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 26/207 (12%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA-EVNGIGQTHHKNLVRLL 546
           + +G G+FG V++  +    SD+VA+KK   V QD  K FK  E+  +    H N+V L 
Sbjct: 46  KVIGNGSFGVVFQAKLV--ESDEVAIKK---VLQD--KRFKNRELQIMRIVKHPNVVDLK 98

Query: 547 GY-----CDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARGLFYL 596
            +       +    L LV E++    +       +K    +   ++      + R L Y+
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157

Query: 597 HEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           H      I H DIKPQN+LLD      ++ DFG  K   L     N +   ++ Y APE 
Sbjct: 158 H---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK--ILIAGEPNVSYICSRYYRAPEL 212

Query: 656 -FRNMPITVKVDVYSYGVLLLEIICLR 681
            F     T  +D++S G ++ E++  +
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 85.8 bits (213), Expect = 4e-18
 Identities = 48/214 (22%), Positives = 86/214 (40%), Gaps = 39/214 (18%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK----AEVNGIGQTHHKNLV 543
              G+G FGTV  G     +   VA+KK   V QD    F+      +  +   HH N+V
Sbjct: 29  RMAGQGTFGTVQLG-KEKSTGMSVAIKK---VIQD--PRFRNRELQIMQDLAVLHHPNIV 82

Query: 544 RLLGY----CDEGRNRL---LVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----IARG 592
           +L  Y     +  R  +   +V E++ +  L        +        ++      + R 
Sbjct: 83  QLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRS 141

Query: 593 LFYLHEECCTQIIHCDIKPQNILLDDYYNA-RISDFGLEKLLTLDQSHTNTAIRGTKGYV 651
           +  LH      + H DIKP N+L+++     ++ DFG  K L+  + +          Y+
Sbjct: 142 IGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV--------AYI 192

Query: 652 APEWFRNMPI-------TVKVDVYSYGVLLLEII 678
              ++R   +       T  VD++S G +  E++
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 84.5 bits (210), Expect = 6e-18
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 30/205 (14%)

Query: 490 LGRGAFGTVY--KGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           LG+G+FG V+  K      +    A+K L    +        K E + + + +H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 546 LGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----------IARGLF 594
             Y  +   +L L+ +F+  G L  F         +L  E++            +A  L 
Sbjct: 92  H-YAFQTEGKLYLILDFLRGGDL--F--------TRLSKEVMFTEEDVKFYLAELALALD 140

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           +LH      II+ D+KP+NILLD+  + +++DFGL K     +    +   GT  Y+APE
Sbjct: 141 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPE 196

Query: 655 WFRNMPITVKVDVYSYGVLLLEIIC 679
                  T   D +S+GVL+ E++ 
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLT 221

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 82.6 bits (205), Expect = 1e-17
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 28/203 (13%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG G FG V  G  +  +  +VAVK LNR      D   + K E+  +    H ++++L 
Sbjct: 19  LGVGTFGKVKIG-EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLF--------YLHE 598
                  +  +V E++S G L  ++    +       E+    AR LF        Y H 
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKHGRVE-----EME---ARRLFQQILSAVDYCHR 129

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFR 657
                ++H D+KP+N+LLD + NA+I+DFGL  +++  +   T+    G+  Y APE   
Sbjct: 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVIS 183

Query: 658 NMPIT-VKVDVYSYGVLLLEIIC 679
                  +VD++S GV+L  ++C
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLC 206

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 84.4 bits (209), Expect = 1e-17
 Identities = 57/229 (24%), Positives = 91/229 (39%), Gaps = 55/229 (24%)

Query: 481 EVTRGFK--EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE------------KE 526
            V + ++  + +G GA G V     +      VA+KKL+R FQ+              K 
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAA-YDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 80

Query: 527 FKAEVNGIGQTHHKNLVRLL------GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWK 580
                       HKN++ LL         +E ++  +V E M           D+     
Sbjct: 81  VN----------HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----------DANLCQV 119

Query: 581 LRTE--------IVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL 632
           ++ E        ++  +  G+ +LH      IIH D+KP NI++      +I DFGL + 
Sbjct: 120 IQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR- 175

Query: 633 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR 681
            T   S   T    T+ Y APE    M     VD++S G ++ E+I   
Sbjct: 176 -TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 21/198 (10%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLN--RVFQDSEKE-FKAEVNGIGQTHHKNLVRL 545
           LG G+FG V    V    S    A+K L+  +V +  + E    E   +   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLR---TEIVMGIARGLFYLHEECC 601
                +  N  +V E+++ G + S L    +      R    +IV+       YLH    
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHSL-- 160

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             +I+ D+KP+N+L+D     +++DFG  K     +  T T + GT   +APE   +   
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWT-LCGTPEALAPEIILSKGY 215

Query: 662 TVKVDVYSYGVLLLEIIC 679
              VD ++ GVL+ E+  
Sbjct: 216 NKAVDWWALGVLIYEMAA 233

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 82.2 bits (204), Expect = 3e-17
 Identities = 44/151 (29%), Positives = 79/151 (52%), Gaps = 19/151 (12%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE---FKA--EVNGIGQTHHKNL 542
           E++G G +G VYK   N  + + VA+KK+ R+  D+E E     A  E++ + + +H N+
Sbjct: 9   EKIGEGTYGVVYKA-RNKLTGEVVALKKI-RL--DTETEGVPSTAIREISLLKELNHPNI 64

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIA----RGLFYLHE 598
           V+LL          LV+EF+    L  F+  D+     +   ++        +GL + H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQD-LKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHS 121

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
               +++H D+KPQN+L++     +++DFGL
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGL 149

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 82.2 bits (204), Expect = 3e-17
 Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 32/187 (17%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVN-----------GIGQ 536
            E+G GA+GTVYK   +  S   VA+K + RV   +       +             +  
Sbjct: 15  AEIGVGAYGTVYKA-RDPHSGHFVALKSV-RV--PNGGGGGGGLPISTVREVALLRRLEA 70

Query: 537 THHKNLVRLL----GYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIA- 590
             H N+VRL+        +   ++ LV+E +    L ++L  D  P   L  E +  +  
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL--DKAPPPGLPAETIKDLMR 127

Query: 591 ---RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT 647
              RGL +LH      I+H D+KP+NIL+      +++DFGL ++ +   + T   +  T
Sbjct: 128 QFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--T 182

Query: 648 KGYVAPE 654
             Y APE
Sbjct: 183 LWYRAPE 189

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 82.6 bits (205), Expect = 3e-17
 Identities = 53/184 (28%), Positives = 86/184 (46%), Gaps = 28/184 (15%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE---FKA--EVN---GIGQTHH 539
            E+G GA+G V+K          VA+K++ RV   + +E        EV     +    H
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRV-RV--QTGEEGMPLSTIREVAVLRHLETFEH 73

Query: 540 KNLVRLL----GYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIA---- 590
            N+VRL         +   +L LV+E +    L ++L  D  P   + TE +  +     
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL--DKVPEPGVPTETIKDMMFQLL 130

Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGY 650
           RGL +LH      ++H D+KPQNIL+      +++DFGL ++ +   + T+  +  T  Y
Sbjct: 131 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWY 185

Query: 651 VAPE 654
            APE
Sbjct: 186 RAPE 189

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 84.1 bits (208), Expect = 4e-17
 Identities = 60/233 (25%), Positives = 94/233 (40%), Gaps = 57/233 (24%)

Query: 481 EVTRGFK--EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE------------KE 526
            V + ++  + +G GA G V     +      VA+KKL+R FQ+              K 
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAA-YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 117

Query: 527 FKAEVNGIGQTHHKNLVRLL------GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWK 580
                       HKN++ LL         +E ++  LV E M           D+     
Sbjct: 118 VN----------HKNIISLLNVFTPQKTLEEFQDVYLVMELM-----------DANLCQV 156

Query: 581 LRTE--------IVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL 632
           ++ E        ++  +  G+ +LH      IIH D+KP NI++      +I DFGL + 
Sbjct: 157 IQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR- 212

Query: 633 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTIL 685
            T   S   T    T+ Y APE    M     VD++S G ++ E+  +R  IL
Sbjct: 213 -TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM--VRHKIL 262

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 83.2 bits (206), Expect = 5e-17
 Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 31/205 (15%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKL--NRVFQDSEKEF-KAEVNGIGQTHHKNLVRL 545
           LG+G FG V    V   ++ +  A+K L    +    E      E   +  + H  L  L
Sbjct: 156 LGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213

Query: 546 LGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----------GLF 594
             Y  +  +RL  V E+ + G L    F      + L  E V    R           L 
Sbjct: 214 K-YSFQTHDRLCFVMEYANGGEL----F------FHLSRERVFSEDRARFYGAEIVSALD 262

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE 654
           YLH E    +++ D+K +N++LD   + +I+DFGL K    D +   T   GT  Y+APE
Sbjct: 263 YLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPE 319

Query: 655 WFRNMPITVKVDVYSYGVLLLEIIC 679
              +      VD +  GV++ E++C
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMC 344

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 82.0 bits (203), Expect = 7e-17
 Identities = 54/229 (23%), Positives = 98/229 (42%), Gaps = 51/229 (22%)

Query: 481 EVTRGFK--EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQ 536
           E+ + +     +G GA+G+V    ++  S ++VA+KKL+R FQ      +A  E+  +  
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSA-IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH 79

Query: 537 THHKNLVRLL------GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE------ 584
             H+N++ LL             +  LV  FM            +     +  +      
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----------QTDLQKIMGLKFSEEKI 128

Query: 585 --IVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT 642
             +V  + +GL Y+H      ++H D+KP N+ +++    +I DFGL +    D   T  
Sbjct: 129 QYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMT-- 181

Query: 643 AIRGTKGYVAPEWFR-------NMPITVKVDVYSYGVLLLEIICLRRTI 684
                 GYV   W+R        M     VD++S G ++ E++   +T+
Sbjct: 182 ------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML-TGKTL 223

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 82.4 bits (204), Expect = 8e-17
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 24/205 (11%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           +G+G+FG V    V    + ++ A+K +N+   V ++  +    E+  +    H  LV L
Sbjct: 23  IGKGSFGKVCI--VQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 546 LGYCDEGRNRL-LVYEFMSNGALASFLFGDSK-PNWKLR---TEIVMGIARGLFYLHEEC 600
             Y  +    + +V + +  G L   L  +       ++    E+VM     L YL  + 
Sbjct: 81  W-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM----ALDYLQNQ- 134

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 660
             +IIH D+KP NILLD++ +  I+DF +  +L  +   T  A  GTK Y+APE F +  
Sbjct: 135 --RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPEMFSSRK 190

Query: 661 I---TVKVDVYSYGVLLLEIICLRR 682
               +  VD +S GV   E++  RR
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRR 215

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 80.6 bits (200), Expect = 9e-17
 Identities = 50/208 (24%), Positives = 98/208 (47%), Gaps = 22/208 (10%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE---FKA--EVNGIGQTHHKNL 542
           E++G G +GTV+K   N  + + VA+K++ R+  D + E     A  E+  + +  HKN+
Sbjct: 8   EKIGEGTYGTVFKA-KNRETHEIVALKRV-RL--DDDDEGVPSSALREICLLKELKHKNI 63

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI---VMGIARGLFYLHEE 599
           VRL       +   LV+EF     L  +   DS         +   +  + +GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQD-LKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL-DQSHTNTAIRGTKGYVAPEWFRN 658
               ++H D+KPQN+L++     ++++FGL +   +  + ++   +  T  Y  P+    
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFG 175

Query: 659 MPI-TVKVDVYSYGVLLLEIICLRRTIL 685
             + +  +D++S G +  E+    R + 
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLF 203

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 82.5 bits (204), Expect = 1e-16
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 28/203 (13%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG G FG V  G  +  +  +VAVK LNR      D   + + E+  +    H ++++L 
Sbjct: 24  LGVGTFGKVKVG-KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLF--------YLHE 598
                  +  +V E++S G L  ++      N +L  +     +R LF        Y H 
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICK----NGRLDEKE----SRRLFQQILSGVDYCH- 133

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFR 657
                ++H D+KP+N+LLD + NA+I+DFGL  +++  +   T+    G+  Y APE   
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVIS 188

Query: 658 NMP-ITVKVDVYSYGVLLLEIIC 679
                  +VD++S GV+L  ++C
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLC 211

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 38/147 (25%), Positives = 63/147 (42%), Gaps = 12/147 (8%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQTHHKNLVRL 545
            ++G G++G V+K   N  +   VA+KK      D   +  A  E+  + Q  H NLV L
Sbjct: 9   GKIGEGSYGVVFKC-RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI---VMGIARGLFYLHEECCT 602
           L      R   LV+E+  +  +   L  D          +        + + + H+    
Sbjct: 68  LEVFRRKRRLHLVFEYCDHT-VLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKH--- 121

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGL 629
             IH D+KP+NIL+  +   ++ DFG 
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGF 148

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 81.3 bits (201), Expect = 1e-16
 Identities = 52/201 (25%), Positives = 76/201 (37%), Gaps = 26/201 (12%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 549
           +G G FG       +  + + VAVK + R     E   + E+       H N+VR     
Sbjct: 28  IGSGNFGVARLM-RDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVI 85

Query: 550 DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLF--------YLHEECC 601
               +  ++ E+ S G L    +       +   +     AR  F        Y H    
Sbjct: 86  LTPTHLAIIMEYASGGEL----YERICNAGRFSEDE----ARFFFQQLLSGVSYCHSM-- 135

Query: 602 TQIIHCDIKPQNILLDD--YYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
            QI H D+K +N LLD       +I DFG  K   L  S   + + GT  Y+APE     
Sbjct: 136 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPEVLLRQ 192

Query: 660 PIT-VKVDVYSYGVLLLEIIC 679
                  DV+S GV L  ++ 
Sbjct: 193 EYDGKIADVWSCGVTLYVMLV 213

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 58/209 (27%), Positives = 86/209 (41%), Gaps = 40/209 (19%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLN--RVFQDSEKEF-KAEVNGIGQTHHKNLVRL 545
           LG+G FG V    V   ++ +  A+K L    +    E      E   +  T H  L  L
Sbjct: 13  LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 546 LGYCDEGRNRL-LVYEFMSNGAL--------------ASFLFGDSKPNWKLRTEIVMGIA 590
             Y  +  +RL  V E+ + G L              A F             EIV    
Sbjct: 71  K-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA----------EIVSA-- 117

Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGY 650
             L YLH      +++ DIK +N++LD   + +I+DFGL K    D +   T   GT  Y
Sbjct: 118 --LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEY 171

Query: 651 VAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
           +APE   +      VD +  GV++ E++C
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 78.8 bits (195), Expect = 5e-16
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 18/150 (12%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-FKA----EVNGIGQTHHKNL 542
             +G G++G V K   N  +   VA+KK        + +  K     E+  + Q  H+NL
Sbjct: 31  GLVGEGSYGMVMKC-RNKDTGRIVAIKKFLE---SDDDKMVKKIAMREIKLLKQLRHENL 86

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI---VMGIARGLFYLHEE 599
           V LL  C + +   LV+EF+ +  +   L  +  PN      +   +  I  G+ + H  
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDHT-ILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSH 143

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGL 629
               IIH DIKP+NIL+      ++ DFG 
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGF 170

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.7 bits (195), Expect = 6e-16
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 21/198 (10%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLN--RVFQDSEKE-FKAEVNGIGQTHHKNLVRL 545
           LG G+FG V+   +    + +  A+K L    V +  + E    E   +    H  ++R+
Sbjct: 14  LGTGSFGRVH--LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSK-PNWKLR---TEIVMGIARGLFYLHEECC 601
            G   + +   ++ +++  G L S L    + PN   +    E+ +     L YLH +  
Sbjct: 72  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA----LEYLHSK-- 125

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             II+ D+KP+NILLD   + +I+DFG  K        T T + GT  Y+APE     P 
Sbjct: 126 -DIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYT-LCGTPDYIAPEVVSTKPY 180

Query: 662 TVKVDVYSYGVLLLEIIC 679
              +D +S+G+L+ E++ 
Sbjct: 181 NKSIDWWSFGILIYEMLA 198

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 78.4 bits (194), Expect = 9e-16
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 34/208 (16%)

Query: 490 LGRGAFGTVY--KGFVNMGSSDQVAVKKLN--RVFQDSEKEF---KAEVNGIGQTHHKNL 542
           LG+G +G V+  +      +    A+K L    + ++  K+    KAE N + +  H  +
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN-AKDTAHTKAERNILEEVKHPFI 83

Query: 543 VRLLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR---------- 591
           V L+ Y  +   +L L+ E++S G L  F         +L  E +               
Sbjct: 84  VDLI-YAFQTGGKLYLILEYLSGGEL--F--------MQLEREGIFMEDTACFYLAEISM 132

Query: 592 GLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYV 651
            L +LH++    II+ D+KP+NI+L+   + +++DFGL K    D + T+T   GT  Y+
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYM 188

Query: 652 APEWFRNMPITVKVDVYSYGVLLLEIIC 679
           APE          VD +S G L+ +++ 
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLT 216

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 22/154 (14%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE---FKA--EVNGIGQTHHKNL 542
            +LG G +G VYK  ++  +++ VA+K++     + E+E     A  EV+ + +  H+N+
Sbjct: 40  TKLGEGTYGEVYKA-IDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKELQHRNI 95

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRT--EIVMGIARGLFYLHEEC 600
           + L           L++E+  N  L  ++  D  P+  +R     +  +  G+ + H   
Sbjct: 96  IELKSVIHHNHRLHLIFEYAEND-LKKYM--DKNPDVSMRVIKSFLYQLINGVNFCHSR- 151

Query: 601 CTQIIHCDIKPQNILLDDYYNAR-----ISDFGL 629
             + +H D+KPQN+LL     +      I DFGL
Sbjct: 152 --RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 52/230 (22%)

Query: 481 EVTRGFK--EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQ 536
           EV   ++  + +G GA+G V    V+  +  +VA+KKL R FQ      +A  E+  +  
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSA-VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH 80

Query: 537 THHKNLVRLL------GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE------ 584
             H+N++ LL         D+  +  LV  FM            +     ++ E      
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----------GTDLGKLMKHEKLGEDR 129

Query: 585 ---IVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN 641
              +V  + +GL Y+H      IIH D+KP N+ +++    +I DFGL +    D   T 
Sbjct: 130 IQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMT- 183

Query: 642 TAIRGTKGYVAPEWFR-------NMPITVKVDVYSYGVLLLEIICLRRTI 684
                  GYV   W+R        M  T  VD++S G ++ E+I   +T+
Sbjct: 184 -------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTL 225

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 52/202 (25%), Positives = 95/202 (47%), Gaps = 27/202 (13%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           LG G+FG V     +  +  +VA+K ++R      D     + E++ +    H ++++L 
Sbjct: 17  LGEGSFGKVKLA-THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLF--------YLHE 598
                  + ++V E+ + G L  ++        ++  +      R  F        Y H 
Sbjct: 76  DVITTPTDIVMVIEY-AGGELFDYIVE----KKRMTEDE----GRRFFQQIICAIEYCH- 125

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               +I+H D+KP+N+LLDD  N +I+DFGL  ++T D +   T+  G+  Y APE    
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSC-GSPNYAAPEVING 181

Query: 659 MPIT-VKVDVYSYGVLLLEIIC 679
                 +VDV+S G++L  ++ 
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLV 203

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 76.4 bits (189), Expect = 2e-15
 Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 19/150 (12%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE---FKA--EVNGIGQTHHKNL 542
           E++G G +G VYK   N G  +  A+KK   +  + E E        E++ + +  H N+
Sbjct: 8   EKIGEGTYGVVYKAQNNYG--ETFALKK---IRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI---VMGIARGLFYLHEE 599
           V+L       +  +LV+E +    L   L  D              ++ +  G+ Y H+ 
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQD-LKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGL 629
              +++H D+KPQN+L++     +I+DFGL
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGL 146

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 76.4 bits (189), Expect = 3e-15
 Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 19/150 (12%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE---FKA--EVNGIGQTHHKNL 542
           E++G G +G VYK   + G    VA+K+   +  D+E E     A  E++ + + HH N+
Sbjct: 27  EKVGEGTYGVVYKAKDSQG--RIVALKR---IRLDAEDEGIPSTAIREISLLKELHHPNI 81

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI---VMGIARGLFYLHEE 599
           V L+      R   LV+EFM    L   L  D        ++I   +  + RG+ + H+ 
Sbjct: 82  VSLIDVIHSERCLTLVFEFMEKD-LKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQH 138

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGL 629
              +I+H D+KPQN+L++     +++DFGL
Sbjct: 139 ---RILHRDLKPQNLLINSDGALKLADFGL 165

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 77.9 bits (192), Expect = 3e-15
 Identities = 54/270 (20%), Positives = 91/270 (33%), Gaps = 76/270 (28%)

Query: 460 HQEEQGVSYMNLRCFTYKELVEVTRGFK--EELGRGAFGTVYKGFVNMGSSDQVAVKKLN 517
           H      S      F   + V V   +     +GRG++G VY    +  +   VA+KK+N
Sbjct: 2   HHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLA-YDKNTEKNVAIKKVN 60

Query: 518 RVFQDSE------------KEFKAEVNGIGQTHHKNLVRLL-----GYCDEGRNRLLVYE 560
           R+F+D                 K             ++RL          +     +V E
Sbjct: 61  RMFEDLIDCKRILREITILNRLK----------SDYIIRLYDLIIPDDLLKFDELYIVLE 110

Query: 561 FMSNGALASFLFGDS------KPNWKLRTE----IVMGIARGLFYLHEECCTQIIHCDIK 610
                        DS      K    L  E    I+  +  G  ++HE   + IIH D+K
Sbjct: 111 IA-----------DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLK 156

Query: 611 PQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK---------------GYVAPEW 655
           P N LL+   + ++ DFGL + +  ++                           +V   W
Sbjct: 157 PANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRW 216

Query: 656 FR-------NMPITVKVDVYSYGVLLLEII 678
           +R           T  +D++S G +  E++
Sbjct: 217 YRAPELILLQENYTKSIDIWSTGCIFAELL 246

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 76.5 bits (189), Expect = 4e-15
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 41/210 (19%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKL--NRVFQDSEKEF-KAEVNGIGQ-THHKNLVR 544
           +GRG++  V    V +  +D++ A+K +    V  D + ++ + E +   Q ++H  LV 
Sbjct: 17  IGRGSYAKVL--LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74

Query: 545 LLGYCDEGRNRL-LVYEFMSNGAL--------------ASFLFGDSKPNWKLRTEIVMGI 589
           L   C +  +RL  V E+++ G L              A F             EI +  
Sbjct: 75  LH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA----------EISL-- 121

Query: 590 ARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
              L YLHE     II+ D+K  N+LLD   + +++D+G+ K        T+T   GT  
Sbjct: 122 --ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPN 175

Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
           Y+APE  R       VD ++ GVL+ E++ 
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMA 205

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 76.1 bits (188), Expect = 4e-15
 Identities = 47/154 (30%), Positives = 81/154 (52%), Gaps = 22/154 (14%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA----EVNGIGQTHHKNLV 543
           E+LG G + TVYKG +N  +   VA+K++ ++  DSE+   +    E++ + +  H+N+V
Sbjct: 11  EKLGNGTYATVYKG-LNKTTGVYVALKEV-KL--DSEEGTPSTAIREISLMKELKHENIV 66

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIA--------RGLFY 595
           RL           LV+EFM N  L  ++  DS+        + + +         +GL +
Sbjct: 67  RLYDVIHTENKLTLVFEFMDND-LKKYM--DSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
            HE    +I+H D+KPQN+L++     ++ DFGL
Sbjct: 124 CHEN---KILHRDLKPQNLLINKRGQLKLGDFGL 154

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 76.1 bits (188), Expect = 6e-15
 Identities = 50/246 (20%), Positives = 92/246 (37%), Gaps = 73/246 (29%)

Query: 481 EVTRGFK--EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE------------KE 526
            ++  F+    LG GA+G V     +  + + VA+KK+   F                K 
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSA-THKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKH 65

Query: 527 FKAEVNGIGQTHHKNLVRLL-----GYCDEGRNRLLVYEFM--------SNGALA----- 568
           FK          H+N++ +         +      ++ E M        S   L+     
Sbjct: 66  FK----------HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115

Query: 569 SFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFG 628
            F++                  R +  LH    + +IH D+KP N+L++   + ++ DFG
Sbjct: 116 YFIYQ---------------TLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFG 157

Query: 629 LEKLLTLDQSHTNTAIRGTK---GYVAPEWFR-------NMPITVKVDVYSYGVLLLEII 678
           L +++    +  +           +VA  W+R       +   +  +DV+S G +L E+ 
Sbjct: 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

Query: 679 CLRRTI 684
            LRR I
Sbjct: 218 -LRRPI 222

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 76.1 bits (188), Expect = 6e-15
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 41/210 (19%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKL--NRVFQDSEKEF-KAEVNGIGQ-THHKNLVR 544
           LG+G+FG V         +D++ AVK L  + V QD + E    E   +        L +
Sbjct: 28  LGKGSFGKVM--LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85

Query: 545 LLGYCDEGRNRL-LVYEFMSNGAL--------------ASFLFGDSKPNWKLRTEIVMGI 589
           L   C +  +RL  V E+++ G L              A F             EI +  
Sbjct: 86  LH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA----------EIAI-- 132

Query: 590 ARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
             GLF+L  +    II+ D+K  N++LD   + +I+DFG+ K    D   T T   GT  
Sbjct: 133 --GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPD 186

Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
           Y+APE     P    VD +++GVLL E++ 
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 76.1 bits (188), Expect = 6e-15
 Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 27/156 (17%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT---------- 537
           + LG G F TVYK   +  ++  VA+KK+    +   K+      GI +T          
Sbjct: 16  DFLGEGQFATVYKA-RDKNTNQIVAIKKIKLGHRSEAKD------GINRTALREIKLLQE 68

Query: 538 -HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI---VMGIARGL 593
             H N++ LL       N  LV++FM    L   +           + I   ++   +GL
Sbjct: 69  LSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVII--KDNSLVLTPSHIKAYMLMTLQGL 125

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
            YLH+     I+H D+KP N+LLD+    +++DFGL
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL 158

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 76.2 bits (188), Expect = 7e-15
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 41/210 (19%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKL--NRVFQDSEKEF-KAEVNGIGQ-THHKNLVR 544
           +GRG++  V    V +  +D++ A++ +    V  D + ++ + E +   Q ++H  LV 
Sbjct: 60  IGRGSYAKVL--LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117

Query: 545 LLGYCDEGRNRL-LVYEFMSNGAL--------------ASFLFGDSKPNWKLRTEIVMGI 589
           L   C +  +RL  V E+++ G L              A F             EI +  
Sbjct: 118 LH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA----------EISL-- 164

Query: 590 ARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
              L YLHE     II+ D+K  N+LLD   + +++D+G+ K        T+T   GT  
Sbjct: 165 --ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPN 218

Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
           Y+APE  R       VD ++ GVL+ E++ 
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMA 248

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.8 bits (187), Expect = 8e-15
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 40/224 (17%)

Query: 481 EVTRGFK--EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA--EVNGIGQ 536
           EV   ++    +G GA+G+V     +  +  +VAVKKL+R FQ      +   E+  +  
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 84

Query: 537 THHKNLVRLL------GYCDEGRNRLLVYEFMS---NGALASFLFGDSKPNWKLRTEIVM 587
             H+N++ LL         +E  +  LV   M    N  +      D    +     ++ 
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIY 139

Query: 588 GIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGT 647
            I RGL Y+H      IIH D+KP N+ +++    +I DFGL +        T       
Sbjct: 140 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMT------- 187

Query: 648 KGYVAPEWFR-------NMPITVKVDVYSYGVLLLEIICLRRTI 684
            GYVA  W+R        M     VD++S G ++ E++   RT+
Sbjct: 188 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTL 229

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 75.4 bits (186), Expect = 8e-15
 Identities = 47/203 (23%), Positives = 90/203 (44%), Gaps = 31/203 (15%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ--THHKNLVRL 545
            +LGRG +  V++  +N+ ++++V VK L  V    +K+ K E+  I +      N++ L
Sbjct: 42  RKLGRGKYSEVFEA-INITNNEKVVVKILKPV---KKKKIKREIK-ILENLRGGPNIITL 96

Query: 546 LG--YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
                    R   LV+E ++N          +  ++ +R   +  I + L Y H      
Sbjct: 97  ADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRF-YMYEILKALDYCHSM---G 150

Query: 604 IIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR----- 657
           I+H D+KP N+++D ++   R+ D+GL +     Q +           VA  +F+     
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN--------VRVASRYFKGPELL 202

Query: 658 --NMPITVKVDVYSYGVLLLEII 678
                    +D++S G +L  +I
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMI 225

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 37/290 (12%), Positives = 74/290 (25%), Gaps = 73/290 (25%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQ-----VAVKKLNRVFQDSE---KEFKAEVNGIGQTHH 539
              G       ++        D      VA+  ++      +   +E  +    + +   
Sbjct: 37  IFHGGVPPLQFWQAL------DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90

Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
             + R+L         L+V E++  G+L      D+ P+       +  +A      H  
Sbjct: 91  PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA 148

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
               +      P  +         +S  G   L                  +        
Sbjct: 149 ---GVALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPDA----- 179

Query: 660 PITVKVDVYSYGVLLLEIICLR--------RTILTDWAYDCYQE----RTLGALVENDLE 707
               + D+   G  L  ++  R        R+ L     D   +      +   +   + 
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237

Query: 708 AMDDMTVLQRFVMVAIWCIQEDPSHRP--TMRRVTQMLEGVVEVPIPPCP 755
           A            VA   +Q D   R   T+  + Q    V +      P
Sbjct: 238 A------------VAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGP 275

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 75.8 bits (187), Expect = 9e-15
 Identities = 55/238 (23%), Positives = 86/238 (36%), Gaps = 47/238 (19%)

Query: 476 YKELVEVTRGFK--EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS------EKEF 527
             EL  +   +     +  G++G V  G  + G    VA+K++     D          F
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEG--IPVAIKRVFNTVSDGRTVNILSDSF 71

Query: 528 KA-----EVNGIGQTHHKNLVRLL-----GYCDEGRNRLLVYEFMSNGALASFLFGDSKP 577
                  E+  +   HH N++ L                LV E M    LA  +      
Sbjct: 72  LCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVI---HDQ 127

Query: 578 NWKLRTE----IVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL 633
              +  +     +  I  GL  LHE     ++H D+ P NILL D  +  I DF L +  
Sbjct: 128 RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLARED 184

Query: 634 TLDQSHTNTAIRGTKGYVAPEWFR-------NMPITVKVDVYSYGVLLLEIICLRRTI 684
           T D + T         YV   W+R           T  VD++S G ++ E+   R+ +
Sbjct: 185 TADANKT--------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKAL 233

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 75.9 bits (187), Expect = 9e-15
 Identities = 60/250 (24%), Positives = 105/250 (42%), Gaps = 71/250 (28%)

Query: 481 EVTRGFK--EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE------------KE 526
            V R ++  ++LG+GA+G V+K  ++  + + VAVKK+   FQ+S              E
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKS-IDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTE 64

Query: 527 FKAEVNGIGQTHHKNLVRLLG--YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE 584
                       H+N+V LL     D  R+  LV+++M           ++  +  +R  
Sbjct: 65  LS---------GHENIVNLLNVLRADNDRDVYLVFDYM-----------ETDLHAVIRAN 104

Query: 585 ---------IVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL 635
                    +V  + + + YLH      ++H D+KP NILL+   + +++DFGL +    
Sbjct: 105 ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161

Query: 636 DQSHTNTAIRGTK--------------GYVAPEWFR-------NMPITVKVDVYSYGVLL 674
            +  TN                      YVA  W+R       +   T  +D++S G +L
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221

Query: 675 LEIICLRRTI 684
            EI+   + I
Sbjct: 222 GEIL-CGKPI 230

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 75.9 bits (187), Expect = 9e-15
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 36/216 (16%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVFQD-SEKEFK--AEVNGIGQTHH--- 539
            +LG G F TV+    +M ++  VA+K  + ++V+ + +E E K    VN    T     
Sbjct: 25  RKLGWGHFSTVWLAK-DMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 540 --KNLVRLLGYCD-EGRNRL---LVYEFMS-NGALASFLFGDSKPNWKLRTEIVMGIAR- 591
              ++++LL + + +G N +   +V+E +  N  L + +      +  +    V  I++ 
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGEN--LLALI--KKYEHRGIPLIYVKQISKQ 139

Query: 592 ---GLFYLHEECCTQIIHCDIKPQNILLDD------YYNARISDFGLEKLLTLDQSHTNT 642
              GL Y+H  C   IIH DIKP+N+L++           +I+D G             T
Sbjct: 140 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLG----NACWYDEHYT 193

Query: 643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 678
               T+ Y +PE     P     D++S   L+ E+I
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI 229

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 33/206 (16%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKLN--RVFQDSEKEF-KAEVNGIGQ-THHKNLVR 544
           +G+G+FG V        + +   AVK L    + +  E++   +E N + +   H  LV 
Sbjct: 46  IGKGSFGKVL--LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103

Query: 545 LLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMG----------IARGL 593
           L  +  +  ++L  V ++++ G L  F        + L+ E              IA  L
Sbjct: 104 LH-FSFQTADKLYFVLDYINGGEL--F--------YHLQRERCFLEPRARFYAAEIASAL 152

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAP 653
            YLH      I++ D+KP+NILLD   +  ++DFGL K      S T+T   GT  Y+AP
Sbjct: 153 GYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAP 208

Query: 654 EWFRNMPITVKVDVYSYGVLLLEIIC 679
           E     P    VD +  G +L E++ 
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLY 234

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 76.0 bits (187), Expect = 1e-14
 Identities = 46/258 (17%), Positives = 88/258 (34%), Gaps = 89/258 (34%)

Query: 481 EVTRGFK--EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE------------KE 526
           ++   ++    +G G++G V +   +      VA+KK+ RVF+D                
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEA-YDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNR 108

Query: 527 FKAEVNGIGQTHHKNLVRLL-----GYCDEGRNRLLVYEFM---------SNGALA---- 568
                       H ++V++L        ++     +V E           +   L     
Sbjct: 109 LN----------HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHI 158

Query: 569 -SFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDF 627
            + L+                +  G+ Y+H      I+H D+KP N L++   + ++ DF
Sbjct: 159 KTLLYN---------------LLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDF 200

Query: 628 GL--------------------EKLLTLDQSHTNTAIRGTKGYVAPEWFR-------NMP 660
           GL                    + +  +   HT    R   G+V   W+R          
Sbjct: 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN 260

Query: 661 ITVKVDVYSYGVLLLEII 678
            T  +DV+S G +  E++
Sbjct: 261 YTEAIDVWSIGCIFAELL 278

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 76.6 bits (188), Expect = 1e-14
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 41/210 (19%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKL--NRVFQDSEKEF-KAEVNGIGQ-THHKNLVR 544
           LG+G+FG V         +D++ AVK L  + V QD + E    E   +        L +
Sbjct: 349 LGKGSFGKVM--LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406

Query: 545 LLGYCDEGRNRL-LVYEFMSNGAL--------------ASFLFGDSKPNWKLRTEIVMGI 589
           L   C +  +RL  V E+++ G L              A F             EI +  
Sbjct: 407 LH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA----------EIAI-- 453

Query: 590 ARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
             GLF+L  +    II+ D+K  N++LD   + +I+DFG+ K    D   T T   GT  
Sbjct: 454 --GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPD 507

Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
           Y+APE     P    VD +++GVLL E++ 
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 33/206 (16%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKL--NRVFQDSEKE-FKAEVNGIGQ-THHKNLVR 544
           LG+G+FG V+        ++Q  A+K L  + V  D + E    E   +     H  L  
Sbjct: 25  LGKGSFGKVF--LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82

Query: 545 LLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----------GL 593
           +     + +  L  V E+++ G L           + +++     ++R          GL
Sbjct: 83  MF-CTFQTKENLFFVMEYLNGGDL----M------YHIQSCHKFDLSRATFYAAEIILGL 131

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAP 653
            +LH +    I++ D+K  NILLD   + +I+DFG+ K   L  + TNT   GT  Y+AP
Sbjct: 132 QFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAP 187

Query: 654 EWFRNMPITVKVDVYSYGVLLLEIIC 679
           E          VD +S+GVLL E++ 
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLI 213

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 75.0 bits (185), Expect = 2e-14
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 33/206 (16%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQV-AVKKL--NRVFQDSEKEF-KAEVNGIGQ-THHKNLVR 544
           LG+G+FG V      +  +  + AVK L  + + QD + E    E   +    +H  L +
Sbjct: 31  LGKGSFGKVM--LARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88

Query: 545 LLGYCDEGRNRL-LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIAR----------GL 593
           L   C +  +RL  V EF++ G L           + ++       AR           L
Sbjct: 89  LF-CCFQTPDRLFFVMEFVNGGDL--M--------FHIQKSRRFDEARARFYAAEIISAL 137

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAP 653
            +LH++    II+ D+K  N+LLD   + +++DFG+ K    +   T T   GT  Y+AP
Sbjct: 138 MFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAP 193

Query: 654 EWFRNMPITVKVDVYSYGVLLLEIIC 679
           E  + M     VD ++ GVLL E++C
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLC 219

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 28/159 (17%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE---FKA--EVNGIGQTHHKNL 542
            ++G+G FG V+K   +  +  +VA+KK+  +  ++EKE     A  E+  +    H+N+
Sbjct: 23  AKIGQGTFGEVFKA-RHRKTGQKVALKKV-LM--ENEKEGFPITALREIKILQLLKHENV 78

Query: 543 VRLLGYCDEGRNRL--------LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIA---- 590
           V L+  C    +          LV++F  +  LA  L   S    K     +  +     
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL---SNVLVKFTLSEIKRVMQMLL 134

Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL 629
            GL+Y+H     +I+H D+K  N+L+      +++DFGL
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 42/149 (28%), Positives = 78/149 (52%), Gaps = 17/149 (11%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA----EVNGIGQTHHKNLV 543
           ++LG G + TVYKG  +  + + VA+K++ R+  + E+        EV+ +    H N+V
Sbjct: 8   DKLGEGTYATVYKGK-SKLTDNLVALKEI-RL--EHEEGAPCTAIREVSLLKDLKHANIV 63

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEI---VMGIARGLFYLHEEC 600
            L       ++  LV+E++    L  +L  D   N      +   +  + RGL Y H + 
Sbjct: 64  TLHDIIHTEKSLTLVFEYLDKD-LKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCHRQ- 119

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGL 629
             +++H D+KPQN+L+++    +++DFGL
Sbjct: 120 --KVLHRDLKPQNLLINERGELKLADFGL 146

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 42/205 (20%), Positives = 73/205 (35%), Gaps = 54/205 (26%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ-THHKNLVR 544
             + LG G  G V +   N  + ++ A+K L         + + EV    + +   ++VR
Sbjct: 22  TSQVLGLGINGKVLQI-FNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVR 75

Query: 545 LLG-YCDEGRNRLLVY---EFMSNGALASFLFGD---SKPNWKLRTE-----IVMGIARG 592
           ++  Y +    R  +    E +  G L  F        + +    TE     I+  I   
Sbjct: 76  IVDVYENLYAGRKCLLIVMECLDGGEL--F---SRIQDRGDQAF-TEREASEIMKSIGEA 129

Query: 593 LFYLHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKG 649
           + YLH      I H D+KP+N+L          +++DFG                     
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------- 166

Query: 650 YVAPEWFRNMPITVKVDVYSYGVLL 674
             A E           D++S GV++
Sbjct: 167 --AKE-TTGEKYDKSCDMWSLGVIM 188

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 73.6 bits (181), Expect = 5e-14
 Identities = 46/247 (18%), Positives = 88/247 (35%), Gaps = 68/247 (27%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKA-EVNGIGQTHHKNLVRLL 546
           + LG G+FG V +   ++ S  + A+KK   V QD    +K  E++ +    H N+++L+
Sbjct: 13  KTLGTGSFGIVCEV-FDIESGKRFALKK---VLQD--PRYKNRELDIMKVLDHVNIIKLV 66

Query: 547 GY---CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-------IVMG-------- 588
            Y     +   +        N         ++     +          ++M         
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 589 -----------------------IARGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARI 624
                                  + R + ++H      I H DIKPQN+L++      ++
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKL 183

Query: 625 SDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR-------NMPITVKVDVYSYGVLLLEI 677
            DFG  K L   +            Y+   ++R           T  +D++S G +  E+
Sbjct: 184 CDFGSAKKLIPSEPSV--------AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235

Query: 678 ICLRRTI 684
           I L + +
Sbjct: 236 I-LGKPL 241

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 73.2 bits (180), Expect = 8e-14
 Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 40/210 (19%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVFQD-SEKEFK--AEVNGIGQTHHKNL 542
           + +G+G+FG V K + +      VA+K  +  + F   + +E +    +    + +  N+
Sbjct: 103 KVIGKGSFGQVVKAY-DHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 543 VRLLGYCDEGRNRL-LVYEFMS-NGALASFL-FGDSKPNWKLRTEIVMGIAR----GLFY 595
           + +L      RN + + +E +S N  L   +     +        +V   A      L  
Sbjct: 162 IHMLENFTF-RNHICMTFELLSMN--LYELIKKNKFQG---FSLPLVRKFAHSILQCLDA 215

Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNA--RISDFGL-----EKLLTLDQS-HTNTAIRGT 647
           LH+    +IIHCD+KP+NILL     +  ++ DFG      +++ T  QS          
Sbjct: 216 LHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-------- 264

Query: 648 KGYVAPEWFRNMPITVKVDVYSYGVLLLEI 677
             Y APE        + +D++S G +L E+
Sbjct: 265 --YRAPEVILGARYGMPIDMWSLGCILAEL 292

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 28/204 (13%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVFQD-SEKEFK--AEVNGIGQTHHKNL 542
             +G+G+FG V K + +    + VA+K  K  + F + ++ E +    +N         +
Sbjct: 60  SLIGKGSFGQVVKAY-DRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118

Query: 543 VRLLGYCDEGRNRL-LVYEFMS-NGALASFLFGDSKPNWK--LRTEIVMGIAR----GLF 594
           V L  +    RN L LV+E +S N  L   L    +      +   +    A+     L 
Sbjct: 119 VHLKRHFMF-RNHLCLVFEMLSYN--LYDLL----RNTNFRGVSLNLTRKFAQQMCTALL 171

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNA--RISDFGLEKLLTLDQSHTNTAIRGTKGYVA 652
           +L       IIHCD+KP+NILL +   +  +I DFG               I+ ++ Y +
Sbjct: 172 FLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQYIQ-SRFYRS 226

Query: 653 PEWFRNMPITVKVDVYSYGVLLLE 676
           PE    MP  + +D++S G +L+E
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVE 250

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 54/263 (20%), Positives = 102/263 (38%), Gaps = 70/263 (26%)

Query: 459 PHQEEQGVSYMNLRCFTYKELVEVTRGFK--EELGRGAFGTVYKGFVNMGSSDQVAVKKL 516
            H      +          ++ +V   +     +G GA+G V     +  +  +VA+KK+
Sbjct: 2   HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSA-YDNLNKVRVAIKKI 60

Query: 517 NRVFQDSE------------KEFKAEVNGIGQTHHKNLVRLL-----GYCDEGRNRLLVY 559
           +  F+                 F+          H+N++ +         ++ ++  +V 
Sbjct: 61  S-PFEHQTYCQRTLREIKILLRFR----------HENIIGINDIIRAPTIEQMKDVYIVQ 109

Query: 560 EFMSNGALASFLFGDSKPNWKLRTE---------IVMGIARGLFYLHEECCTQIIHCDIK 610
           + M           ++     L+T+          +  I RGL Y+H      ++H D+K
Sbjct: 110 DLM-----------ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLK 155

Query: 611 PQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYVAPEWFR-------NMPI 661
           P N+LL+   + +I DFGL ++   D  HT   T       YVA  W+R       +   
Sbjct: 156 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT------EYVATRWYRAPEIMLNSKGY 209

Query: 662 TVKVDVYSYGVLLLEIICLRRTI 684
           T  +D++S G +L E++   R I
Sbjct: 210 TKSIDIWSVGCILAEML-SNRPI 231

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 70.8 bits (174), Expect = 3e-13
 Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 44/215 (20%)

Query: 490 LGRGAFGTVY--KGFVNMGSSDQVAVKKLN--RVFQD--------SEKEFKAEVNGIGQT 537
           LG GA+G V+  +      +    A+K L    + Q         +E++    +      
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR----- 116

Query: 538 HHKNLVRLLGYCDEGRNRL-LVYEFMSNGALASFL-----FGDSKPNWKLRT-----EIV 586
               LV L  Y  +   +L L+ ++++ G L + L     F +              EIV
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH------EVQIYVGEIV 169

Query: 587 MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG 646
           +     L +LH+     II+ DIK +NILLD   +  ++DFGL K    D++       G
Sbjct: 170 L----ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222

Query: 647 TKGYVAPEWFRNMPI--TVKVDVYSYGVLLLEIIC 679
           T  Y+AP+  R         VD +S GVL+ E++ 
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 69.6 bits (171), Expect = 6e-13
 Identities = 45/251 (17%), Positives = 90/251 (35%), Gaps = 81/251 (32%)

Query: 481 EVTRGFK--EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE------------KE 526
           ++   +   + LG G  G V+   V+     +VA+KK+  V  D +            + 
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSA-VDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRR 64

Query: 527 FKAEVNGIGQTHHKNLVRLL--------------GYCDEGRNRLLVYEFMSNGALASFLF 572
                       H N+V++               G   E  +  +V E+M          
Sbjct: 65  LD----------HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM---------- 104

Query: 573 GDSKPNWKLRTE---------IVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY-YNA 622
            ++     L             +  + RGL Y+H      ++H D+KP N+ ++      
Sbjct: 105 -ETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVL 160

Query: 623 RISDFGLEKLLTLDQSHTN--TAIRGTKGYVAPEWFR-------NMPITVKVDVYSYGVL 673
           +I DFGL +++    SH    +        +  +W+R           T  +D+++ G +
Sbjct: 161 KIGDFGLARIMDPHYSHKGHLS------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCI 214

Query: 674 LLEIICLRRTI 684
             E++   +T+
Sbjct: 215 FAEML-TGKTL 224

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 44/171 (25%), Positives = 69/171 (40%), Gaps = 28/171 (16%)

Query: 589 IARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTK 648
           +A+G+ +L    C   IH D+  +NILL +    +I DFGL +    D       +R   
Sbjct: 202 VAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGD 254

Query: 649 GYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVE 703
             +     APE   +   T++ DV+S+GVLL EI  L            Y    +     
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL--------GASPYPGVKIDEEFC 306

Query: 704 NDLEA---MD---DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
             L+    M      T      M+  W    +PS RPT   + + L  +++
Sbjct: 307 RRLKEGTRMRAPDYTTPEMYQTMLDCW--HGEPSQRPTFSELVEHLGNLLQ 355

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.9 bits (163), Expect = 5e-12
 Identities = 43/155 (27%), Positives = 64/155 (41%), Gaps = 18/155 (11%)

Query: 486 FKEELGRGAFGTVYKGFVN----MGSSDQVAVKKLNRVFQDSE-KEFKAEVN---GIGQT 537
             + LGRGAFG V +          +   VAVK L      SE +   +E+     IG  
Sbjct: 26  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-- 83

Query: 538 HHKNLVRLLGYC-DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYL 596
           HH N+V LLG C   G   +++ EF   G L+++L          R E V    +G  + 
Sbjct: 84  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-------RSKRNEFVPYKTKGARFR 136

Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK 631
             +     I  D+K +   +    ++  S F  EK
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 33/165 (20%), Positives = 63/165 (38%), Gaps = 34/165 (20%)

Query: 487 KEELGRGAFGTVYKG-FVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT------HH 539
             ++GRG +G VYK    +       A+K++        +     ++   +        H
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLRELKH 77

Query: 540 KNLVRLLGYCDEGRNRL--LVYEFMSNGALASFL-----FGDSKPNWKLRTEIVMGIA-- 590
            N++ L        +R   L++++  +  L   +        +K   +L   +V  +   
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136

Query: 591 --RGLFYLHEECCTQIIHCDIKPQNILLDDYYNAR----ISDFGL 629
              G+ YLH      ++H D+KP NIL+      R    I+D G 
Sbjct: 137 ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 178

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 63.9 bits (154), Expect = 3e-11
 Identities = 46/273 (16%), Positives = 77/273 (28%), Gaps = 51/273 (18%)

Query: 18  TAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD-----------IWYASGDDPG 66
                   +   Q L+A +     LSP++ F L   Q D           +W A+   P 
Sbjct: 9   FNGVGTSVLPAYQTLSAGQY---LLSPNQRFKLLL-QGDGNLVIQDNGATVWVANEQQPF 64

Query: 67  PG-------GSKLRLTANGGLVLEDPEAREIWKSEIST------GEAAFGVLYDTGNFLI 113
                     + L      G  L+D   R +W ++ ST            VL D GN ++
Sbjct: 65  SSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVL 124

Query: 114 VNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTI 173
           V++ +              + +  +  G  +           G  +     DGN V    
Sbjct: 125 VDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGA---GASKLVFQGDGNLVA--- 178

Query: 174 NLESGFAYDAFFWSNTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYL 233
               G    A + + T          R VF   G L V      ++     + +      
Sbjct: 179 ---YGPNGAATWNAGTQ----GKGAVRAVFQGDGNLVVYGAGNAVLW---HSHTGGHASA 228

Query: 234 RATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLP 266
              L  +G                +W+     P
Sbjct: 229 VLRLQANGSIAILD-------EKPVWARFGFQP 254

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 42.3 bits (98), Expect = 4e-04
 Identities = 13/77 (16%), Positives = 23/77 (29%), Gaps = 2/77 (2%)

Query: 66  GPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQTF 125
           G G  +     +G LV+       +W S      +A   L   G+  I++     +W  F
Sbjct: 193 GKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDEKP--VWARF 250

Query: 126 DHPTDTLLPTQTMERGG 142
                     +      
Sbjct: 251 GFQPTYRHIRKINPDQK 267

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 59.9 bits (144), Expect = 4e-10
 Identities = 43/253 (16%), Positives = 70/253 (27%), Gaps = 41/253 (16%)

Query: 23  NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD---IWYASG------DDPGPGGSKLR 73
           +   S  Q L AA+S E        F     Q D   + + S       +  G  G +  
Sbjct: 8   SHEGSHPQTLHAAQSLE-----LSSFRFTM-QSDCNLVLFDSDVRVWASNTAGATGCRAV 61

Query: 74  LTANGGLVLEDPEAREIWKSEISTGEAAF-GVLYDTGNFLIVN-----TNSERLWQTFDH 127
           L ++G LV+   +    W S        +  VL       I       + +         
Sbjct: 62  LQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVA 121

Query: 128 PTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWS 187
                +   T        +           ++  +  D N VL          +D     
Sbjct: 122 NNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVL----------FDRDDRV 171

Query: 188 NTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYS 247
            + +      G R V   +G++ VL      V  T     +   Y    L  D     Y 
Sbjct: 172 WSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAV-WTSGNSRSAGRY-VFVLQPDRNLAIY- 228

Query: 248 HPKNNSTGDAIWS 260
                  G A+W+
Sbjct: 229 -------GGALWT 234

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.9 bits (144), Expect = 1e-09
 Identities = 29/204 (14%), Positives = 58/204 (28%), Gaps = 51/204 (25%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKL--------NRVFQDSEKEFKAEV-------- 531
           E++G G FG V++   +      VA+K +        N   Q + +E   E+        
Sbjct: 26  EKIGEGVFGEVFQTIADHT---PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSL 82

Query: 532 -NGIGQTHHKNLVRLLG-YCDEGR----------------------------NRLLVYEF 561
            +G      +  + L   +C +G                             ++L +   
Sbjct: 83  LSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLE 142

Query: 562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN 621
              G +          +      I+  +   L         +  H D+   N+LL     
Sbjct: 143 FEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSL 200

Query: 622 ARISDFGLEKLLTLDQSHTNTAIR 645
            ++      K  T+       +I 
Sbjct: 201 KKLHYTLNGKSSTIPSCGLQVSII 224

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 45/221 (20%), Positives = 82/221 (37%), Gaps = 46/221 (20%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVFQD-SEKEFK--AEVNGIGQTHHKNL 542
             LG G FG V +   +     QVA+K  +    +++ +  E     ++    + +    
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84

Query: 543 VRLLGYCDEGRNRL-LV--------YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGL 593
           V +  + +     + +         +EF+       +      P   +R  +   +   L
Sbjct: 85  VLMSDWFNF-HGHMCIAFELLGKNTFEFLKENNFQPY------PLPHVR-HMAYQLCHAL 136

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIR----G--- 646
            +LHE    Q+ H D+KP+NIL  +     + +   E     ++S  NT+IR    G   
Sbjct: 137 RFLHEN---QLTHTDLKPENILFVNSEFETLYN---EHKSCEEKSVKNTSIRVADFGSAT 190

Query: 647 -----------TKGYVAPEWFRNMPITVKVDVYSYGVLLLE 676
                      T+ Y  PE    +      DV+S G +L E
Sbjct: 191 FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 58.4 bits (142), Expect = 3e-09
 Identities = 49/227 (21%), Positives = 84/227 (37%), Gaps = 58/227 (25%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVFQD-SEKEFK--AEVNGIGQTHHKNL 542
           + LG GAFG V +   +      VAVK  K    + + +  E +    +N          
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79

Query: 543 VRLLGYCDEGRNRL-LVYEFMS-NGALASFLFGDSKPNWK--LRTEIVMGIARGLF---- 594
           V++L + +     + +V+E +  +     F+    K N     R + +  +A  +     
Sbjct: 80  VQMLEWFEH-HGHICIVFELLGLS--TYDFI----KENGFLPFRLDHIRKMAYQICKSVN 132

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNA-------------------RISDFG-----LE 630
           +LH     ++ H D+KP+NIL                          ++ DFG      E
Sbjct: 133 FLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189

Query: 631 KLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLE 676
              TL  + H          Y APE    +  +   DV+S G +L+E
Sbjct: 190 HHSTLVSTRH----------YRAPEVILALGWSQPCDVWSIGCILIE 226

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 53.4 bits (128), Expect = 5e-09
 Identities = 26/132 (19%), Positives = 46/132 (34%), Gaps = 27/132 (20%)

Query: 129 TDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSN 188
           +D L     ++ GG ++          G + F +  D N VL   N           W++
Sbjct: 1   SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDNN--------RAVWAS 43

Query: 189 TFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSH 248
               N   +G  +     G L +   ++ I      T     NY    L  D   + Y  
Sbjct: 44  --GTNGKASGCVLKMQNDGNLVIYSGSRAI--WASNTNRQNGNY-YLILQRDRNVVIY-- 96

Query: 249 PKNNSTGDAIWS 260
              +++ +AIW+
Sbjct: 97  ---DNSNNAIWA 105

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 43.8 bits (103), Expect = 1e-05
 Identities = 23/111 (20%), Positives = 41/111 (36%), Gaps = 18/111 (16%)

Query: 25  TISIGQQLTAAESTEPWLSPSKDFALGFHQLD----------IWYASGDDPGPGGSKLRL 74
            ++ G QL    S          +     Q D            +ASG +    G  L++
Sbjct: 3   RLNSGHQLDTGGS-----LAEGGYLFII-QNDCNLVLYDNNRAVWASGTNGKASGCVLKM 56

Query: 75  TANGGLVLEDPEAREIWKSEISTGEAAFG-VLYDTGNFLIVNTNSERLWQT 124
             +G LV+    +R IW S  +     +  +L    N +I + ++  +W T
Sbjct: 57  QNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWAT 106

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 57.6 bits (139), Expect = 7e-09
 Identities = 48/250 (19%), Positives = 80/250 (32%), Gaps = 68/250 (27%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVFQDS---EKEFKAEVNGIGQTH--HKNL 542
           LG G F TV+  + ++     VA+K  K    + ++   E      V          + +
Sbjct: 45  LGWGHFSTVWLSW-DIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103

Query: 543 VRLLGYCD----EGRNRLLVYEFMSNGALASFL-FGDSKPNWKLRTEIVMGIAR----GL 593
           V+LL         G +  +V+E +        L +        L    V  I +    GL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLG----HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159

Query: 594 FYLHEECCTQIIHCDIKPQNILL------------------------------------- 616
            YLH +C  +IIH DIKP+NILL                                     
Sbjct: 160 DYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217

Query: 617 ----DDYYNARISDFGLEKLLTLDQS----HTNTAIRGTKGYVAPEWFRNMPITVKVDVY 668
                +    + ++    K+  L  +       T    T+ Y + E           D++
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIW 277

Query: 669 SYGVLLLEII 678
           S   +  E+ 
Sbjct: 278 STACMAFELA 287

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 57.3 bits (139), Expect = 8e-09
 Identities = 48/226 (21%), Positives = 84/226 (37%), Gaps = 52/226 (23%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVFQDSEKEFKAEVNGIGQT------HH 539
            ++G G FG V     ++ +    AVK  +  + +  S K    E + I +       ++
Sbjct: 41  RKMGDGTFGRVLLCQ-HIDNKKYYAVKVVRNIKKYTRSAKI---EAD-ILKKIQNDDINN 95

Query: 540 KNLVRLLGYCDEGRNRL-LVYEFMS-NGALASFLFGDSKPNWK--LRTEIVMGIARGLF- 594
            N+V+  G      + + L++E +  +  L   +      N       E +      +  
Sbjct: 96  NNIVKYHGKFMY-YDHMCLIFEPLGPS--LYEII----TRNNYNGFHIEDIKLYCIEILK 148

Query: 595 ---YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT---NTAIR--- 645
              YL +     + H D+KP+NILLDD Y  +                    +T I+   
Sbjct: 149 ALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 646 -G--------------TKGYVAPEWFRNMPITVKVDVYSYGVLLLE 676
            G              T+ Y APE   N+   V  D++S+G +L E
Sbjct: 206 FGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 50.6 bits (121), Expect = 6e-08
 Identities = 26/115 (22%), Positives = 47/115 (40%), Gaps = 21/115 (18%)

Query: 25  TISIGQQLTAAESTEPWLSPSKDFALGFHQLD-----------IWYASGDDPGPGGSKLR 73
            ++ G+ L A +S +      + +     Q D           +W ++    G  G K  
Sbjct: 3   LLTNGEGLYAGQSLD-----VEPYHFIM-QEDCNLVLYDHSTSVWASNTGILGKKGCKAV 56

Query: 74  LTANGGLVLEDPEAREIWKSEISTGEAAFG-VLYDTGNFLIVNTNSERLWQTFDH 127
           L ++G  V+ D E R +W S    G   +  VL + GN +I  ++   +W T  +
Sbjct: 57  LQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD---IWSTGTY 108

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 39.1 bits (91), Expect = 6e-04
 Identities = 24/134 (17%), Positives = 40/134 (29%), Gaps = 39/134 (29%)

Query: 60  ASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEIST--GEAAFGVLYDTGNFLIVNTN 117
            +G           +  +  LVL D  +  +W S       +    VL   GNF++ +  
Sbjct: 11  YAGQSLDVEPYHFIMQEDCNLVLYDH-STSVWASNTGILGKKGCKAVLQSDGNFVVYDAE 69

Query: 118 SERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLES 177
              LW +                          +    G +   L EDGN V+       
Sbjct: 70  GRSLWAS-------------------------HSVRGNGNYVLVLQEDGNVVI------- 97

Query: 178 GFAYDAFFW-SNTF 190
              Y +  W + T+
Sbjct: 98  ---YGSDIWSTGTY 108

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.1 bits (129), Expect = 1e-07
 Identities = 74/485 (15%), Positives = 127/485 (26%), Gaps = 159/485 (32%)

Query: 315 YGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSS------C 368
           Y      F    E+    +  D   ++++  +     + + I      + VS        
Sbjct: 18  YKDILSVF----EDAFVDN-FDCKDVQDMPKSILSKEEIDHI--IMSKDAVSGTLRLFWT 70

Query: 369 LKDCQCSAA------VLRDDTCWKKKLPLSYGKTDRDETGTTFI--KIRKVPSGGKKKVD 420
           L   Q          VLR +          Y           F+   I+           
Sbjct: 71  LLSKQEEMVQKFVEEVLRIN----------YK----------FLMSPIKTEQRQPSMMTR 110

Query: 421 VLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEEQGVSYMNLRCFTYKELV 480
           + I     L+  + +     VS               R         Y+ LR    + L 
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVS---------------RLQP------YLKLR----QAL- 144

Query: 481 EVTRGFKEELGRGAFGTVYKGFVNM-GSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHH 539
                   EL       +  G   + GS           V    + + K +   I     
Sbjct: 145 -------LELRPAKNVLID-G---VLGSGKTWVALD---VCLSYKVQCKMD-FKI---FW 186

Query: 540 KNLVRLLGYCDEGRNRL-----LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLF 594
            NL      C+     L     L+Y+   N    S    D   N KLR   +    R L 
Sbjct: 187 LNL----KNCNSPETVLEMLQKLLYQIDPNWTSRS----DHSSNIKLRIHSIQAELRRLL 238

Query: 595 YL--HEECCTQIIHCDIKPQNILLDDYYNARISD-FGLE-KLL--TLDQSHTNTAIRGT- 647
               +E C             ++L +  NA+  + F L  K+L  T  +  T+     T 
Sbjct: 239 KSKPYENCL------------LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT 286

Query: 648 ---------KGYVAPE-------WFRNMPITVKVDVYSYGVLLLEII--CLRRTILTDWA 689
                          E       +    P  +  +V +     L II   +R  + T W 
Sbjct: 287 THISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT-WD 345

Query: 690 -YDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            +       L  ++E+ L  ++     + F  +++                         
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV--FPPS------------------- 384

Query: 749 VPIPP 753
             IP 
Sbjct: 385 AHIPT 389

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 43/180 (23%), Positives = 71/180 (39%), Gaps = 30/180 (16%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVFQDSEKEFKA--EVNGIGQTHHKNLV 543
            ++G G+FG +Y G  ++ + ++VA+K   +         E K    + G        + 
Sbjct: 15  RKIGSGSFGDIYLG-TDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG-----VGIP 68

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIA----RGLFYLHEE 599
            +     EG   ++V E +  G     LF      + L+T  V+ +A      + Y+H  
Sbjct: 69  TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKT--VLLLADQMISRIEYIHS- 123

Query: 600 CCTQIIHCDIKPQNILLDDYYNA---RISDFGLEKLLTLDQSHT------NTAIRGTKGY 650
                IH D+KP N L+          I DFGL K     ++H       N  + GT  Y
Sbjct: 124 --KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 36/155 (23%), Positives = 64/155 (41%), Gaps = 22/155 (14%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVK--KLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           +++G G FG +  G  N+ +++ VA+K   +         E++             + ++
Sbjct: 15  KKIGCGNFGELRLG-KNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IPQV 70

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLF----YLHEECC 601
             +   G+   +V E +  G     LF      + L+T  V+ IA  L     Y+H +  
Sbjct: 71  YYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKT--VLMIAIQLISRMEYVHSKNL 126

Query: 602 TQIIHCDIKPQNILLDDYYNAR-----ISDFGLEK 631
              I+ D+KP+N L+    N       I DF L K
Sbjct: 127 ---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 34/157 (21%), Positives = 65/157 (41%), Gaps = 26/157 (16%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS----EKEFKAEVNGIGQTHHKNLV 543
             +G G+FG +++G  N+ ++ QVA+K   R         E      + G        + 
Sbjct: 16  RRIGEGSFGVIFEG-TNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC-----TGIP 69

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLF----YLHEE 599
            +  +  EG + +LV + +  G     L       + ++T  V   A+ +      +HE+
Sbjct: 70  NVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKT--VAMAAKQMLARVQSIHEK 125

Query: 600 CCTQIIHCDIKPQNILLDDYYNAR-----ISDFGLEK 631
               +++ DIKP N L+    +       + DFG+ K
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 44/179 (24%), Positives = 75/179 (41%), Gaps = 28/179 (15%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS----EKEFKAEVNGIGQTHHKNLV 543
            ++G G+FG +Y G  N+ ++++VA+K  N   +      E +    + G        + 
Sbjct: 13  RKIGSGSFGEIYLG-TNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGG-----TGIP 66

Query: 544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMG---IARGLFYLHEEC 600
            +  +  EG   +LV + +  G     LF        L+T +++    I R + ++H + 
Sbjct: 67  NVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINR-VEFVHSKS 123

Query: 601 CTQIIHCDIKPQNILLDDYYNAR---ISDFGLEKLLTLDQSHT------NTAIRGTKGY 650
               +H DIKP N L+     A    I DFGL K      +H       N  + GT  Y
Sbjct: 124 ---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110

 Score = 44.8 bits (106), Expect = 6e-06
 Identities = 27/111 (24%), Positives = 40/111 (36%), Gaps = 19/111 (17%)

Query: 25  TISIGQQLTAAESTEPWLSPSKDFALGFHQLD----------IWYASGDDPGPGGSKLRL 74
           ++S    L    S    L     + L   Q D            +AS       G +L L
Sbjct: 3   SLSSPNSLFTGHS----LEVGPSYRLIM-QGDCNFVLYDSGKPVWASNTGGLGSGCRLTL 57

Query: 75  TANGGLVLEDPEAREIWKSEISTGEAAFG-VLYDTGNFLIVNTNSERLWQT 124
             NG LV+ D   R IW+++ +  E  +  VL    N +I       +W T
Sbjct: 58  HNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWAT 105

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110

 Score = 43.6 bits (103), Expect = 2e-05
 Identities = 21/124 (16%), Positives = 40/124 (32%), Gaps = 38/124 (30%)

Query: 68  GGSKLRLTANGGLVLEDPEAREIWKSE-ISTGEAAFGVLYDTGNFLIVNTNSERLWQTFD 126
              +L +  +   VL D   + +W S     G      L++ GN +I + ++  +WQT  
Sbjct: 20  PSYRLIMQGDCNFVLYDS-GKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQT-- 76

Query: 127 HPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFW 186
                                  +T+     +   L +D N V+          Y    W
Sbjct: 77  -----------------------KTNGKEDHYVLVLQQDRNVVI----------YGPVVW 103

Query: 187 -SNT 189
            + +
Sbjct: 104 ATGS 107

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.8 bits (114), Expect = 7e-06
 Identities = 38/194 (19%), Positives = 63/194 (32%), Gaps = 51/194 (26%)

Query: 490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS---EKEFK-----AEVNGIGQTHHKN 541
           +G G FG +Y         ++ A   +   +Q++     E K     A+ + I +   + 
Sbjct: 45  IGSGGFGLIYLA-FPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 542 LVRLLG-----YC-----DEGRNRLLVYEFMSNGALASFLFGDS-----KPNWKLRTEIV 586
            +  LG                 R +V E            G         N   +   V
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVME----------RLGIDLQKISGQNGTFKKSTV 153

Query: 587 MGIA----RGLFYLHEECCTQIIHCDIKPQNILLDDYYNAR---ISDFGLEKLLTLDQSH 639
           + +       L Y+HE      +H DIK  N+LL  Y N     ++D+GL      + +H
Sbjct: 154 LQLGIRMLDVLEYIHENE---YVHGDIKAANLLL-GYKNPDQVYLADYGLSYRYCPNGNH 209

Query: 640 ------TNTAIRGT 647
                       GT
Sbjct: 210 KQYQENPRKGHNGT 223

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109

 Score = 42.9 bits (101), Expect = 3e-05
 Identities = 26/132 (19%), Positives = 50/132 (37%), Gaps = 32/132 (24%)

Query: 129 TDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSN 188
           T+ LL  QT++  G + +         G F   + +D N VL          Y+  + SN
Sbjct: 3   TNYLLSGQTLDTEGHLKN---------GDFDLVMQDDCNLVL----------YNGNWQSN 43

Query: 189 TFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSH 248
           T +   +    ++   + G+L +   +   V       S K NY  A ++ DG  + +  
Sbjct: 44  TAN---NGRDCKLTLTDYGELVIKNGDGSTV-WKSGAQSVKGNY-AAVVHPDGRLVVFGP 98

Query: 249 PKNNSTGDAIWS 260
                   +++ 
Sbjct: 99  --------SVFK 102

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109

 Score = 39.8 bits (93), Expect = 3e-04
 Identities = 22/112 (19%), Positives = 43/112 (38%), Gaps = 19/112 (16%)

Query: 22  SNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD--------IWYASGDDPGPGGSKLR 73
               +  GQ L            + DF L   Q D         W ++  + G    KL 
Sbjct: 2   GTNYLLSGQTLDTEGH-----LKNGDFDLVM-QDDCNLVLYNGNWQSNTANNGRD-CKLT 54

Query: 74  LTANGGLVLEDPEAREIWKSEISTGEAAFG-VLYDTGNFLIVNTNSERLWQT 124
           LT  G LV+++ +   +WKS   + +  +  V++  G  ++   +   +++ 
Sbjct: 55  LTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPS---VFKI 103

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 28/192 (14%), Positives = 60/192 (31%), Gaps = 44/192 (22%)

Query: 490 LGRGAFGTVYKGF-------VNMGSSDQVAVK-------------KLNRVFQDSEKEFKA 529
             R   G +Y+          +     + ++K                R  +  +     
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 530 EVNGIGQTHHKNLVRLLGY-CDEGRNRLLVYEFMSNGA-LASFLFGDSKPNWKLRTEIVM 587
           ++          +   +G+   + + R LV   +  G  L S L    K     R+  V+
Sbjct: 110 KLYSTP---LLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERS--VL 162

Query: 588 GIARGLF----YLHEECCTQIIHCDIKPQNILLDDYYNARI--SDFGLEKLLTLDQSH-- 639
            +A  L     +LHE      +H ++  +NI +D    +++  + +G          H  
Sbjct: 163 QVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219

Query: 640 ----TNTAIRGT 647
               + +   G 
Sbjct: 220 YVEGSRSPHEGD 231

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119

 Score = 43.0 bits (101), Expect = 3e-05
 Identities = 26/115 (22%), Positives = 39/115 (33%), Gaps = 18/115 (15%)

Query: 22  SNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD-----------IWYASGDDPGPGGS 70
                +  Q L A ES E     +  +     Q D           IW  +    G G  
Sbjct: 7   KQPDDNHPQILHATESLEIL-FGTHVYRFIM-QTDCNLVLYDNNNPIWATNTGGLGNG-C 63

Query: 71  KLRLTANGGLVLEDPEAREIWKSEISTGEAAFG-VLYDTGNFLIVNTNSERLWQT 124
           +  L  +G LV+   E   +W+S ++     +  VL    N +I       LW T
Sbjct: 64  RAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD---ALWAT 115

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 41.0 bits (96), Expect = 1e-04
 Identities = 25/114 (21%), Positives = 44/114 (38%), Gaps = 21/114 (18%)

Query: 22  SNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD----------IWYASGDDPGPGGSK 71
           +N  +  GQ L            +K+  L   Q D           W ++    G     
Sbjct: 5   TNNLLFSGQVLYGDGRLT-----AKNHQLVM-QGDCNLVLYGGKYGWQSNTHGNGEH-CF 57

Query: 72  LRLTANGGLVLEDPEAREIWKSEISTGEAAFG-VLYDTGNFLIVNTNSERLWQT 124
           LRL   G L+++D + + IW S  S+ +  +  +L D G  +I       +++T
Sbjct: 58  LRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGP---AIFET 108

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 40.6 bits (95), Expect = 2e-04
 Identities = 19/124 (15%), Positives = 39/124 (31%), Gaps = 39/124 (31%)

Query: 68  GGSKLRLTANGGLVLEDPEAREIWKSEIS-TGEAAFGVLYDTGNFLIVNTNSERLWQTFD 126
              +L +  +  LVL     +  W+S     GE  F  L   G  +I + + + +W +  
Sbjct: 24  KNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSS-- 79

Query: 127 HPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFW 186
                                   +   +G +   L +DG  V+          Y    +
Sbjct: 80  -----------------------RSSSKQGEYVLILQDDGFGVI----------YGPAIF 106

Query: 187 -SNT 189
            +++
Sbjct: 107 ETSS 110

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109

 Score = 40.6 bits (95), Expect = 2e-04
 Identities = 24/131 (18%), Positives = 42/131 (32%), Gaps = 29/131 (22%)

Query: 130 DTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNT 189
           + L   +T+  G  +++         GR+ F + ED N VL  ++           W+  
Sbjct: 2   NILYSGETLSPGEFLNN---------GRYVFIMQEDCNLVLYDVD--------KPIWAT- 43

Query: 190 FDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSHP 249
            +    +    +     G L V+   +        T     NY    L  D   + Y   
Sbjct: 44  -NTGGLDRRCHLSMQSDGNL-VVYSPRNNPIWASNTGGENGNY-VCVLQKDRNVVIY--- 97

Query: 250 KNNSTGDAIWS 260
                G A W+
Sbjct: 98  -----GTARWA 103

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109

 Score = 40.2 bits (94), Expect = 2e-04
 Identities = 21/113 (18%), Positives = 35/113 (30%), Gaps = 20/113 (17%)

Query: 23  NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD----------IWYASGDDPGPGGSKL 72
           +  +  G+ L+  E        +  +     Q D            +A+          L
Sbjct: 1   DNILYSGETLSPGEF-----LNNGRYVFIM-QEDCNLVLYDVDKPIWATNTGGLDRRCHL 54

Query: 73  RLTANGGLVLEDPEAREIWKSEISTGEAAFG-VLYDTGNFLIVNTNSERLWQT 124
            + ++G LV+  P    IW S        +  VL    N +I  T     W T
Sbjct: 55  SMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA---RWAT 104

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113

 Score = 39.1 bits (91), Expect = 6e-04
 Identities = 17/118 (14%), Positives = 37/118 (31%), Gaps = 24/118 (20%)

Query: 21  QSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD-------------IWYASGDDPGP 67
           +    +   Q +            ++D++L   + D             +W +     G 
Sbjct: 4   RVRNVLFSSQVMYDNAQ-----LATRDYSLVM-RDDCNLVLTKGSKTNIVWESGTSGRGQ 57

Query: 68  GGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFG-VLYDTGNFLIVNTNSERLWQT 124
               +RL  +G L + D     ++ S     E  +  +L   G  ++       +W T
Sbjct: 58  H-CFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYGP---AVWST 111

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113

 Score = 39.1 bits (91), Expect = 7e-04
 Identities = 22/137 (16%), Positives = 43/137 (31%), Gaps = 29/137 (21%)

Query: 126 DHP--TDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDA 183
           + P   + L  +Q M     +++           +   + +D N VL   +         
Sbjct: 1   NIPRVRNVLFSSQVMYDNAQLAT---------RDYSLVMRDDCNLVLTKGS------KTN 45

Query: 184 FFWSNTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVF 243
             W +    +       +    SG+L +  +    V     TV  + +Y    L  +G  
Sbjct: 46  IVWESGT--SGRGQHCFMRLGHSGELDITDDRLNTV-FVSNTVGQEGDY-VLILQINGQA 101

Query: 244 IFYSHPKNNSTGDAIWS 260
           + Y          A+WS
Sbjct: 102 VVYGP--------AVWS 110

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	762
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.83
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	99.82
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.79
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.76
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.74
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	99.71
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.71
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	99.66
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	99.66
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.64
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.62
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.61
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.59
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.57
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.57
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.44
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.41
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	99.39
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	99.33
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.3
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	99.24
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	99.24
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	99.23
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	99.22
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.17
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.96
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.94
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.77
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.37
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.31
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.23
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.19
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.07
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.05
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.77
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.65
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.55
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.38
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.26
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.98
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.97
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.9
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.89
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.57
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.52
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.47
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.42
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.35
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.86
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.54
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.22
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.67
2ll3_A	82	Micronemal protein 4; cell adhesion; NMR {Toxoplas	84.0
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	81.94
3no2_A	276	Uncharacterized protein; six-bladed beta-propeller	80.74
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	80.57

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.1e-53  Score=452.42  Aligned_cols=255  Identities=24%  Similarity=0.390  Sum_probs=208.3

Q ss_pred             hhhhcCCCCcceEEEeeeeC----CCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          486 FKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.++||+|+||+||+|++..    .+++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..+|||||
T Consensus        45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey  124 (329)
T 4aoj_A           45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY  124 (329)
T ss_dssp             EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            45789999999999998642    34678999999877667778999999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEec
Q 004312          562 MSNGALASFLFGD---------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISD  626 (762)
Q Consensus       562 ~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  626 (762)
                      |++|+|.++|++.               .+++|.+++.|+.|||+||+|||++   +||||||||+||||++++.+||+|
T Consensus       125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~D  201 (329)
T 4aoj_A          125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGD  201 (329)
T ss_dssp             CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECC
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcc
Confidence            9999999999753               3589999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcccccccccc
Q 004312          627 FGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVEN  704 (762)
Q Consensus       627 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  704 (762)
                      ||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+....      +..
T Consensus       202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~------i~~  275 (329)
T 4aoj_A          202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC------ITQ  275 (329)
T ss_dssp             CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH------HHH
T ss_pred             cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH------HHc
Confidence            999997654332 23345679999999999999999999999999999999999 8999855433322211      111


Q ss_pred             ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       705 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      ......+..+++++.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus       276 g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            222233445678899999999999999999999999999998765

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.5e-53  Score=450.64  Aligned_cols=256  Identities=26%  Similarity=0.341  Sum_probs=212.8

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeC----CCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeE
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L  557 (762)
                      +..|.++||+|+||+||+|.+..    .+++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            34677899999999999998742    345689999997543 3345789999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc
Q 004312          558 VYEFMSNGALASFLFGD----------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN  621 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~  621 (762)
                      |||||++|+|.++|...                ..++|..+++|+.|||+||+|||++   +||||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence            99999999999999643                3589999999999999999999998   9999999999999999999


Q ss_pred             eEEecccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccc
Q 004312          622 ARISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLG  699 (762)
Q Consensus       622 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~  699 (762)
                      +||+|||+++....... .......||+.|||||++.++.++.++|||||||+||||+| |+.||......+...     
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~-----  258 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE-----  258 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH-----
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH-----
Confidence            99999999987654332 33445679999999999999999999999999999999998 788875443322221     


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          700 ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       700 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                       .+........+..+++++.+|+.+||+.||++||||+||++.|+...
T Consensus       259 -~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          259 -MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             -HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             -HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence             12222223334567788999999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.4e-53  Score=447.70  Aligned_cols=255  Identities=24%  Similarity=0.387  Sum_probs=213.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeC----CCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .+.++||+|+||+||+|++..    .+++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..+||||
T Consensus        16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E   95 (299)
T 4asz_A           16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE   95 (299)
T ss_dssp             EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence            356789999999999998643    3456899999987766677899999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCC-------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecc
Q 004312          561 FMSNGALASFLFGD-------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDF  627 (762)
Q Consensus       561 ~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  627 (762)
                      ||++|+|.++|+..             ..++|.+++.|+.|||+||+|||++   +|+||||||+||||++++.+||+||
T Consensus        96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DF  172 (299)
T 4asz_A           96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDF  172 (299)
T ss_dssp             CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCc
Confidence            99999999999643             4689999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccc
Q 004312          628 GLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVEND  705 (762)
Q Consensus       628 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  705 (762)
                      |+++........ ......||+.|||||.+.+..++.++|||||||+||||+| |+.||......+....      +...
T Consensus       173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~------i~~~  246 (299)
T 4asz_A          173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC------ITQG  246 (299)
T ss_dssp             SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH------HHHT
T ss_pred             ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH------HHcC
Confidence            999876543332 2334568999999999999999999999999999999998 8999855433322211      1111


Q ss_pred             cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          706 LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       706 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      .....+..+++++.+|+.+||+.||++||||+||++.|+++.+
T Consensus       247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          247 RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            2222344567889999999999999999999999999998754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.9e-52  Score=437.85  Aligned_cols=260  Identities=27%  Similarity=0.375  Sum_probs=203.3

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.++||+|+||+||+|++.    ..||||+++...  ....++|.+|++++++++|||||+++|+|.+ +..+||||||
T Consensus        39 ~l~~~iG~G~fG~Vy~~~~~----~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~  113 (307)
T 3omv_A           39 MLSTRIGSGSFGTVYKGKWH----GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC  113 (307)
T ss_dssp             CEEEECCCCSSSEEEEEESS----SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             EEeeEEeeCCCcEEEEEEEC----CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence            35678999999999999864    369999987432  3345689999999999999999999999865 5689999999


Q ss_pred             CCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC-Ccc
Q 004312          563 SNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ-SHT  640 (762)
Q Consensus       563 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-~~~  640 (762)
                      ++|+|.++|+.. ..+++.++..|+.|||+||+|||++   +||||||||+||||++++.+||+|||+|+...... ...
T Consensus       114 ~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~  190 (307)
T 3omv_A          114 EGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ  190 (307)
T ss_dssp             SSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence            999999999765 6799999999999999999999998   99999999999999999999999999998765433 233


Q ss_pred             cccccccCcccCcccccC---CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRN---MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~---~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      ....+||+.|||||++..   +.++.++|||||||+||||+||+.||...................+... ..+..++++
T Consensus       191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~-~~~~~~~~~  269 (307)
T 3omv_A          191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLS-KLYKNCPKA  269 (307)
T ss_dssp             ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCST-TSCTTSCHH
T ss_pred             ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcc-cccccchHH
Confidence            445689999999999863   4699999999999999999999999854322211111111111111111 123356788


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCCCCCC
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPC  754 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~p~~  754 (762)
                      +.+|+.+||+.||++||||+||++.|+.+ +.+.|+.
T Consensus       270 l~~li~~cl~~dP~~RPs~~ei~~~Le~l-~~~lpk~  305 (307)
T 3omv_A          270 MKRLVADCVKKVKEERPLFPQILSSIELL-QHSLPKI  305 (307)
T ss_dssp             HHHHHHHHTCSSSTTSCCHHHHHHHHHHH-HTTCCC-
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHH-hccCCCC
Confidence            99999999999999999999999999764 3444543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9e-50  Score=425.71  Aligned_cols=259  Identities=22%  Similarity=0.230  Sum_probs=210.5

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      +.++||+|+||.||+|+.. .+++.||||+++...     ...+|++++++++|||||++++++.+.+..+||||||++|
T Consensus        62 ~~~~lG~G~fG~Vy~a~~~-~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           62 HQPRVGRGSFGEVHRMKDK-QTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG  135 (336)
T ss_dssp             EEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             eCcEeccCCCeEEEEEEEC-CCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            4467999999999999754 567899999997532     2347999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC-ceEEecccccccccCCCCc----c
Q 004312          566 ALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY-NARISDFGLEKLLTLDQSH----T  640 (762)
Q Consensus       566 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~----~  640 (762)
                      +|.++|.+.+.+++..+..++.||+.||+|||++   +||||||||+||||+.++ .+||+|||+++.+..+...    .
T Consensus       136 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence            9999998888999999999999999999999999   999999999999999887 6999999999987543321    1


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccc-ccCCCHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL-EAMDDMTVLQRFV  719 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  719 (762)
                      ....+||+.|||||++.+..++.++|||||||+||||++|+.||.........     ..+..... ....+..+++++.
T Consensus       213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-----~~i~~~~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-----LKIASEPPPIREIPPSCAPLTA  287 (336)
T ss_dssp             -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH-----HHHHHSCCGGGGSCTTSCHHHH
T ss_pred             CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-----HHHHcCCCCchhcCccCCHHHH
Confidence            23467999999999999999999999999999999999999998543221111     11111111 1112345678899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHhhcC-cCCCCCCCCCCC
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQMLEGV-VEVPIPPCPWTL  758 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~~L~~~-~~~~~p~~p~~~  758 (762)
                      +++.+||+.||++|||+.|+++.|... .+...-.+||..
T Consensus       288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~  327 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKG  327 (336)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSS
T ss_pred             HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcC
Confidence            999999999999999999999988773 344556677753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=9.3e-50  Score=426.86  Aligned_cols=247  Identities=23%  Similarity=0.314  Sum_probs=208.9

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      .+.++||+|+||+||+|+.. .+++.||||+++.......+.+.+|+++|++++|||||++++++.+.+..+||||||++
T Consensus        77 ~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g  155 (346)
T 4fih_A           77 DNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  155 (346)
T ss_dssp             EEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             EEeEEeecCcCeEEEEEEEC-CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence            34567999999999999754 56789999999876566667899999999999999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccc
Q 004312          565 GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI  644 (762)
Q Consensus       565 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  644 (762)
                      |+|.+++.+ ..+++..+..++.||+.||+|||++   +|+||||||+||||++++.+||+|||+++.+.... ......
T Consensus       156 g~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~  230 (346)
T 4fih_A          156 GALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL  230 (346)
T ss_dssp             EEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCC
T ss_pred             CcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cccccc
Confidence            999999965 5699999999999999999999999   99999999999999999999999999998765432 234557


Q ss_pred             cccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHH
Q 004312          645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW  724 (762)
Q Consensus       645 ~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  724 (762)
                      +||+.|||||++.+..++.++|||||||++|||++|+.||......+.+....  ....+  .......+++++.+|+.+
T Consensus       231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~--~~~~~--~~~~~~~~s~~~~dli~~  306 (346)
T 4fih_A          231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR--DNLPP--RLKNLHKVSPSLKGFLDR  306 (346)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--HSSCC--CCSCGGGSCHHHHHHHHH
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH--cCCCC--CCCccccCCHHHHHHHHH
Confidence            89999999999999999999999999999999999999986654333322110  00111  111223467889999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 004312          725 CIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       725 cl~~dp~~RPt~~evl~  741 (762)
                      ||+.||++|||++|+++
T Consensus       307 ~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          307 LLVRDPAQRATAAELLK  323 (346)
T ss_dssp             HSCSSTTTSCCHHHHTT
T ss_pred             HcCCChhHCcCHHHHhc
Confidence            99999999999999876

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.6e-49  Score=415.14  Aligned_cols=245  Identities=27%  Similarity=0.386  Sum_probs=198.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceecc----CCceeEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE----GRNRLLV  558 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~LV  558 (762)
                      .|.++||+|+||+||+|... .+++.||||++...  .....+.|.+|++++++++|||||++++++.+    ....+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            35567999999999999754 56789999999653  23345679999999999999999999999864    3457999


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEeCCCCCCceEEc-CCCceEEecccccccccC
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ--IIHCDIKPQNILLD-DYYNARISDFGLEKLLTL  635 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~  635 (762)
                      ||||++|+|.++|.+...+++..+..|+.||+.||+|||++   +  |+||||||+||||+ +++.+||+|||+|+....
T Consensus       108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999999888999999999999999999999998   6  99999999999998 489999999999986432


Q ss_pred             CCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                         ......+||+.|||||++.+ .++.++|||||||+||||+||+.||..............    ........+...+
T Consensus       185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~----~~~~~~~~~~~~~  256 (290)
T 3fpq_A          185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT----SGVKPASFDKVAI  256 (290)
T ss_dssp             ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT----TTCCCGGGGGCCC
T ss_pred             ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH----cCCCCCCCCccCC
Confidence               23445789999999999865 699999999999999999999999854321111111111    1101111122234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+|+.+||+.||++|||++|+++
T Consensus       257 ~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          257 PEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            67899999999999999999999986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.1e-49  Score=423.45  Aligned_cols=247  Identities=20%  Similarity=0.299  Sum_probs=201.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      |.+.+.||+|+||+||+|+.. .+++.||||+++...  ....+.|.+|++++++++|||||++++++.+.+..+|||||
T Consensus        26 Y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy  104 (350)
T 4b9d_A           26 YVRLQKIGEGSFGKAILVKST-EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY  104 (350)
T ss_dssp             EEEEEEC------CEEEEEET-TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            456678999999999999754 567899999997542  33456799999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          562 MSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       562 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |++|+|.++|...  ..+++..++.|+.||+.||+|||++   +|+||||||+||||++++.+||+|||+++.+... ..
T Consensus       105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~  180 (350)
T 4b9d_A          105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VE  180 (350)
T ss_dssp             CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-HH
T ss_pred             CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC-cc
Confidence            9999999999644  4578999999999999999999999   9999999999999999999999999999876422 12


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      .....+||+.|||||++.+..++.++|||||||+||||++|+.||......+.+...     ..... ...+..+++++.
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-----~~~~~-~~~~~~~s~~~~  254 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI-----ISGSF-PPVSLHYSYDLR  254 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-----HHTCC-CCCCTTSCHHHH
T ss_pred             cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-----HcCCC-CCCCccCCHHHH
Confidence            234567999999999999999999999999999999999999999665443333221     11111 122335678899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +|+.+||+.||++|||++|+++
T Consensus       255 ~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          255 SLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.7e-49  Score=417.06  Aligned_cols=246  Identities=20%  Similarity=0.271  Sum_probs=210.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||+||+|+. ..+++.||||++.+.   .....+.+.+|++++++++|||||++++++.+.+..+||||
T Consensus        34 y~i~~~lG~G~fg~V~~a~~-~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE  112 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARE-LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS  112 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cEEEEEEecccCeEEEEEEE-CCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            55678999999999999974 456789999999753   23345689999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC-c
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-H  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~  639 (762)
                      |+++|+|.++|.+.+.+++.....++.||+.||+|||++   +|+||||||+||||++++.+||+|||+++.+..... .
T Consensus       113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence            999999999999888999999999999999999999999   999999999999999999999999999998754433 3


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      .....+||+.|||||++.+..++.++||||+||+||||++|+.||......+.+...     .....  ..+..+++++.
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-----~~~~~--~~p~~~s~~~~  262 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI-----IKLEY--DFPEKFFPKAR  262 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHTCC--CCCTTCCHHHH
T ss_pred             cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----HcCCC--CCCcccCHHHH
Confidence            345678999999999999999999999999999999999999999665433333221     11111  12334567899


Q ss_pred             HHHHHhhccCCCCCCCHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVT  740 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl  740 (762)
                      +|+.+||+.||++|||++|++
T Consensus       263 dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          263 DLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHHHHHSCSSGGGSTTSGGGT
T ss_pred             HHHHHHccCCHhHCcChHHHc
Confidence            999999999999999999863

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4e-49  Score=418.93  Aligned_cols=258  Identities=22%  Similarity=0.289  Sum_probs=197.7

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCC----ceeEEEec
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR----NRLLVYEF  561 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~LV~E~  561 (762)
                      +.++||+|+||+||+|++.   ++.||||+++... .....+.+|+..+.+++|||||+++|+|.+.+    ..+|||||
T Consensus         7 L~~~iG~G~fG~Vy~~~~~---g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey   82 (303)
T 3hmm_A            7 LQESIGKGRFGEVWRGKWR---GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             EEEEEEECSSSEEEEEEET---TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEeeCCCeEEEEEEEC---CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence            4578999999999999873   5789999997542 22334456778888999999999999997654    57999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcC-----CCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC-----CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      |++|+|.++|+. ..+++..+.+|+.|+++||+|||+++     .++|+||||||+||||++++.+||+|||+++.....
T Consensus        83 ~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  161 (303)
T 3hmm_A           83 HEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             CTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             CCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence            999999999975 45899999999999999999999863     458999999999999999999999999999877543


Q ss_pred             CCc---ccccccccCcccCcccccCC------CCCCcchhHHHHHHHHHHHhCCCCCchhh----HHH----------hh
Q 004312          637 QSH---TNTAIRGTKGYVAPEWFRNM------PITVKVDVYSYGVLLLEIICLRRTILTDW----AYD----------CY  693 (762)
Q Consensus       637 ~~~---~~~~~~gt~~y~aPE~~~~~------~~s~~~DV~S~Gvil~elltg~~p~~~~~----~~~----------~~  693 (762)
                      ...   .....+||+.|||||++.+.      .++.++|||||||+||||+||+.|+....    ++.          ..
T Consensus       162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~  241 (303)
T 3hmm_A          162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM  241 (303)
T ss_dssp             TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred             CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence            322   22345799999999999754      46789999999999999999977642111    010          01


Q ss_pred             hcccccccccccccc-CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          694 QERTLGALVENDLEA-MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       694 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ..........+.... ....+.++.+.+|+.+||+.||++||||+||+++|+++.+
T Consensus       242 ~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            110111111111111 1123567789999999999999999999999999988654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.4e-50  Score=431.43  Aligned_cols=257  Identities=25%  Similarity=0.332  Sum_probs=209.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCC----CcceEEEEEcccccc-chhHHHHHHhhhhcccc-cCCccchhceeccC-Ccee
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMG----SSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEG-RNRL  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~-~~~~  556 (762)
                      +.+.+.||+|+||+||+|.+...    ..+.||||+++.... ...++|.+|+++|.+++ |||||+++|+|.+. +..+
T Consensus        66 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~  145 (353)
T 4ase_A           66 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  145 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred             eEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEE
Confidence            44567899999999999986532    235799999976433 33567999999999995 59999999999764 5689


Q ss_pred             EEEeccCCCchhhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC
Q 004312          557 LVYEFMSNGALASFLFGD----------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY  620 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~  620 (762)
                      ||||||++|+|.++|++.                ..+++..+..|+.|||+||+|||++   +||||||||+||||++++
T Consensus       146 iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~  222 (353)
T 4ase_A          146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN  222 (353)
T ss_dssp             EEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCC
Confidence            999999999999999642                3479999999999999999999999   999999999999999999


Q ss_pred             ceEEecccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcccc
Q 004312          621 NARISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTL  698 (762)
Q Consensus       621 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~  698 (762)
                      .+||+|||+|+.+..+... .....+||+.|||||++.+..++.++|||||||+||||+| |+.||........     +
T Consensus       223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~-----~  297 (353)
T 4ase_A          223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----F  297 (353)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-----H
T ss_pred             CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-----H
Confidence            9999999999977554433 3345679999999999999999999999999999999998 8999744221111     1


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          699 GALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       699 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ...+........+..+++++.+++.+||+.||++||||+||++.|+++++
T Consensus       298 ~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          298 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            11222222333344567889999999999999999999999999988754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.8e-48  Score=424.43  Aligned_cols=248  Identities=23%  Similarity=0.309  Sum_probs=209.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.++||+|+||.||+|... .+++.||||++........+.+.+|+++|++++|||||++++++.+.+..+||||||+
T Consensus       153 y~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~  231 (423)
T 4fie_A          153 LDNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  231 (423)
T ss_dssp             EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             cEeeeEeccCcCcEEEEEEEC-CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence            345578999999999999754 5678999999987656666789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +|+|.+++.. ..+++..+..|+.||+.||+|||++   +||||||||+||||+.++.+||+|||+++.+.... .....
T Consensus       232 gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~  306 (423)
T 4fie_A          232 GGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS  306 (423)
T ss_dssp             TEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCBCC
T ss_pred             CCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccccc
Confidence            9999999964 5699999999999999999999999   99999999999999999999999999998765432 23455


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      .+||+.|||||++.+..++.++|||||||++|||++|+.||......+.+...  .....+  .......+++++.+|+.
T Consensus       307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i--~~~~~~--~~~~~~~~s~~~~dli~  382 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--RDNLPP--RLKNLHKVSPSLKGFLD  382 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HHSCCC--CCSCTTSSCHHHHHHHH
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--HcCCCC--CCcccccCCHHHHHHHH
Confidence            78999999999999999999999999999999999999998665433332211  000111  11122345678999999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 004312          724 WCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       724 ~cl~~dp~~RPt~~evl~  741 (762)
                      +||+.||++|||++|+++
T Consensus       383 ~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          383 RLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             HHSCSSTTTSCCHHHHTT
T ss_pred             HHcCCChhHCcCHHHHhc
Confidence            999999999999999876

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-48  Score=412.11  Aligned_cols=247  Identities=22%  Similarity=0.237  Sum_probs=200.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC--CCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +.+.+.||+|+||+||+|+...  .+++.||||++++..  ......+.+|++++++++|||||++++++.+.+..+|||
T Consensus        26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm  105 (304)
T 3ubd_A           26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL  105 (304)
T ss_dssp             EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred             cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5567899999999999997532  346789999997532  223457899999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |||++|+|.++|.+.+.+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+...... .
T Consensus       106 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~  181 (304)
T 3ubd_A          106 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K  181 (304)
T ss_dssp             CCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC------C
T ss_pred             EcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC-c
Confidence            9999999999999888999999999999999999999999   99999999999999999999999999998654322 2


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      .....+||+.|||||++.+..++.++|||||||++|||++|+.||......+.....     .....  ..+..+++++.
T Consensus       182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-----~~~~~--~~p~~~s~~~~  254 (304)
T 3ubd_A          182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI-----LKAKL--GMPQFLSPEAQ  254 (304)
T ss_dssp             CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHCCC--CCCTTSCHHHH
T ss_pred             cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH-----HcCCC--CCCCcCCHHHH
Confidence            334567999999999999999999999999999999999999999665443333221     11111  12334677899


Q ss_pred             HHHHHhhccCCCCCCC-----HHHHHH
Q 004312          720 MVAIWCIQEDPSHRPT-----MRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt-----~~evl~  741 (762)
                      +|+.+||+.||++|||     ++|+++
T Consensus       255 ~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             HHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            9999999999999998     567764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.8e-48  Score=401.36  Aligned_cols=244  Identities=22%  Similarity=0.354  Sum_probs=193.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||+||+|.. ..+++.||||++++..   ......+.+|++++++++|||||++++++.+.+..+||||
T Consensus        15 Y~i~~~lG~G~fg~V~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           15 YQIVKTLGEGSFGKVKLAYH-TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CEEEEEEEC---CCEEEEEC-TTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEecCcCeEEEEEEE-CCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            45668899999999999964 4567899999997532   2334679999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+ +|+|.+++.+.+.+++..+..++.||+.||+|||++   +|+||||||+||||++++.+||+|||+|+....  ...
T Consensus        94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--~~~  167 (275)
T 3hyh_A           94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNF  167 (275)
T ss_dssp             CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC--CCc
Confidence            99 689999998888999999999999999999999999   999999999999999999999999999986543  223


Q ss_pred             cccccccCcccCcccccCCCC-CCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ....+||+.|||||++.+..+ +.++||||+||++|||++|+.||............     .....  ..+...++++.
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i-----~~~~~--~~p~~~s~~~~  240 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI-----SNGVY--TLPKFLSPGAA  240 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHTCC--CCCTTSCHHHH
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----HcCCC--CCCCCCCHHHH
Confidence            345689999999999998876 58999999999999999999998654333322211     11111  12234567899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +|+.+||+.||++|||++|+++
T Consensus       241 ~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          241 GLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHc
Confidence            9999999999999999999987

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.3e-46  Score=394.80  Aligned_cols=246  Identities=21%  Similarity=0.307  Sum_probs=185.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCC---------
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR---------  553 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~---------  553 (762)
                      +.+.+.||+|+||+||+|+.. .+++.||||+++.... ...+.+.+|++++++++|||||++++++.+.+         
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEET-TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             CEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            345678999999999999754 4578999999975433 33467999999999999999999999986544         


Q ss_pred             ---ceeEEEeccCCCchhhhccCCCC---CCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecc
Q 004312          554 ---NRLLVYEFMSNGALASFLFGDSK---PNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDF  627 (762)
Q Consensus       554 ---~~~LV~E~~~~gsL~~~l~~~~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  627 (762)
                         ..+||||||++|+|.+++.....   ..+..++.|+.||++||+|||++   +|+||||||+||||+.++.+||+||
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccC
Confidence               36899999999999999987654   45667889999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCc-----------ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc
Q 004312          628 GLEKLLTLDQSH-----------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER  696 (762)
Q Consensus       628 gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~  696 (762)
                      |+++.+......           ..+..+||+.|||||++.+..++.++|||||||++|||++   ||.........   
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~---  236 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT---  236 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH---
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH---
Confidence            999977543321           1234579999999999999999999999999999999996   66443211110   


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          697 TLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       697 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                       +........ ........+.+.+|+.+||+.||++|||+.|+++
T Consensus       237 -~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          237 -LTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -HHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             111111110 0111234456788999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.1e-44  Score=391.29  Aligned_cols=253  Identities=21%  Similarity=0.296  Sum_probs=200.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceecc------CCce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDE------GRNR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~~  555 (762)
                      +.+.+.||+|+||+||+|.. ..+++.||||++++...  ...+.+.+|+++|++++|||||++++++..      .+..
T Consensus        56 Y~~~~~lG~G~fG~V~~a~~-~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~  134 (398)
T 4b99_A           56 YEIIETIGNGAYGVVSSARR-RLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV  134 (398)
T ss_dssp             EEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred             eEEEEEEecccCeEEEEEEE-CCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence            45667899999999999975 45678999999975432  334678899999999999999999998753      4678


Q ss_pred             eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          556 LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      +||||||+ |+|.+++.+.+.+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus       135 ~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          135 YVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCT  210 (398)
T ss_dssp             EEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred             EEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence            99999996 78999999989999999999999999999999999   999999999999999999999999999987643


Q ss_pred             CC---CcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccc-----c-c-----
Q 004312          636 DQ---SHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTL-----G-A-----  700 (762)
Q Consensus       636 ~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~-----~-~-----  700 (762)
                      ..   .......+||+.|||||++.+. .++.++||||+||++|||++|+.||......+.......     . .     
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~  290 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV  290 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred             CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence            32   2234457899999999998775 579999999999999999999999865433322211000     0 0     


Q ss_pred             -------ccccc-cccCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          701 -------LVEND-LEAMDD-----MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       701 -------~~~~~-~~~~~~-----~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                             .+... .....+     ...++++.+|+.+||+.||++|||++|+++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                   00000 000001     123567899999999999999999999886

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-43  Score=385.43  Aligned_cols=250  Identities=18%  Similarity=0.278  Sum_probs=194.5

Q ss_pred             hhhhhhcCCCCcceEEEeeee--CCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVN--MGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.++||+|+||+||+|+.+  .++++.||||++.+.  ....++.+|+++|+++ +|||||++++++.+.+..+||||
T Consensus        23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE  100 (361)
T 4f9c_A           23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP  100 (361)
T ss_dssp             CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred             EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence            455678999999999999754  345678999998653  3456788999999998 79999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC-CceEEecccccccccCCCC-
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY-YNARISDFGLEKLLTLDQS-  638 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~~~~~-  638 (762)
                      |+++|+|.+++.   .+++.++..++.||+.||+|||++   +|+||||||+|||++.+ +.+||+|||+|+....... 
T Consensus       101 ~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~  174 (361)
T 4f9c_A          101 YLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE  174 (361)
T ss_dssp             CCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred             CCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence            999999999994   589999999999999999999999   99999999999999876 7999999999986543221 


Q ss_pred             --------------------------cccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHH-
Q 004312          639 --------------------------HTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAY-  690 (762)
Q Consensus       639 --------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~-  690 (762)
                                                ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...... 
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~  254 (361)
T 4f9c_A          175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL  254 (361)
T ss_dssp             GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHH
Confidence                                      112345799999999999775 5899999999999999999999998432110 


Q ss_pred             Hhhhc-------------------ccc----------cccc------c---cc---------cccCCCHHHHHHHHHHHH
Q 004312          691 DCYQE-------------------RTL----------GALV------E---ND---------LEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       691 ~~~~~-------------------~~~----------~~~~------~---~~---------~~~~~~~~~~~~~~~li~  723 (762)
                      +....                   ...          ....      +   +.         .........++++.+|+.
T Consensus       255 ~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~  334 (361)
T 4f9c_A          255 TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLD  334 (361)
T ss_dssp             HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHH
T ss_pred             HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHH
Confidence            00000                   000          0000      0   00         000001124567899999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 004312          724 WCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       724 ~cl~~dp~~RPt~~evl~  741 (762)
                      +||+.||++|||++|+++
T Consensus       335 ~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          335 KLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHTCSCTTTSCCHHHHHT
T ss_pred             HHCcCChhHCcCHHHHhc
Confidence            999999999999999887

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-42  Score=374.08  Aligned_cols=279  Identities=41%  Similarity=0.669  Sum_probs=232.9

Q ss_pred             ccccccccCHHHHHHHHhhhh--hhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCcc
Q 004312          467 SYMNLRCFTYKELVEVTRGFK--EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLV  543 (762)
Q Consensus       467 ~~~~~~~~~~~el~~~t~~~~--~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv  543 (762)
                      .....+.+++.++.....+|.  +.||+|+||.||+|...  +++.||||++..... .....+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv   90 (326)
T 3uim_A           13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL   90 (326)
T ss_dssp             --CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS--SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBC
T ss_pred             ccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEec--CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCcc
Confidence            344567789999988887764  67999999999999754  467899999975432 2334799999999999999999


Q ss_pred             chhceeccCCceeEEEeccCCCchhhhccCCC----CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC
Q 004312          544 RLLGYCDEGRNRLLVYEFMSNGALASFLFGDS----KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY  619 (762)
Q Consensus       544 ~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~  619 (762)
                      ++++++.+.+..++||||+++|+|.+++....    .+++..+..|+.|++.||+|||+++.++|+||||||+|||++++
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~  170 (326)
T 3uim_A           91 RLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE  170 (326)
T ss_dssp             CCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT
T ss_pred             ceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC
Confidence            99999999999999999999999999997653    48999999999999999999999877799999999999999999


Q ss_pred             CceEEecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhH----------
Q 004312          620 YNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA----------  689 (762)
Q Consensus       620 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~----------  689 (762)
                      +.+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||.....          
T Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  250 (326)
T 3uim_A          171 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD  250 (326)
T ss_dssp             CCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred             CCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence            9999999999998765555555566799999999999988999999999999999999999999843211          


Q ss_pred             --HHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          690 --YDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       690 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                        .............+...........++.+.+++.+||+.||++|||++||+++|++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence              1112223334444555555667788999999999999999999999999999998753

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.6e-43  Score=402.07  Aligned_cols=249  Identities=22%  Similarity=0.326  Sum_probs=209.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||++.. ..+++.||||++........+.+.+|+++|++++|||||++++++.+....+||||||+
T Consensus       159 Y~i~~~lG~G~fg~V~~~~~-~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~  237 (573)
T 3uto_A          159 YDIHEELGTGAFGVVHRVTE-RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  237 (573)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             cEEEEEEeeccCeEEEEEEE-CCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence            45668899999999999975 45678999999987666666789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC--CceEEecccccccccCCCCcc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY--YNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~--~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +|+|.++|... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+++.+..  ...
T Consensus       238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~--~~~  312 (573)
T 3uto_A          238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQS  312 (573)
T ss_dssp             CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--TSE
T ss_pred             CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC--CCc
Confidence            99999999654 6799999999999999999999999   99999999999999854  8999999999997753  233


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....+||+.|||||++.+..++.++|||||||++|||++|+.||......+.+........   .........+++++.+
T Consensus       313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~s~~~~d  389 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW---NMDDSAFSGISEDGKD  389 (573)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC---CCCSGGGTTSCHHHHH
T ss_pred             eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC---CCCcccccCCCHHHHH
Confidence            4456899999999999999999999999999999999999999866544333322111100   0111112235678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~  741 (762)
                      |+.+||+.||++|||++|+++
T Consensus       390 li~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          390 FIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=9e-42  Score=366.29  Aligned_cols=261  Identities=36%  Similarity=0.649  Sum_probs=221.2

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      +.+.||+|+||.||+|...  +++.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus        43 ~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  120 (321)
T 2qkw_B           43 HKFLIGHGVFGKVYKGVLR--DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG  120 (321)
T ss_dssp             CCCCSCBCSSSEEEEEECT--TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred             ccceeecCCCeeEEEEEEC--CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence            3467999999999999854  46789999998776667788999999999999999999999999999999999999999


Q ss_pred             chhhhccCCC----CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC-Ccc
Q 004312          566 ALASFLFGDS----KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ-SHT  640 (762)
Q Consensus       566 sL~~~l~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-~~~  640 (762)
                      +|.+++....    .+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus       121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  197 (321)
T 2qkw_B          121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL  197 (321)
T ss_dssp             BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred             cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            9999997653    589999999999999999999998   99999999999999999999999999998654322 223


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhH----------HHhhhccccccccccccccCC
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA----------YDCYQERTLGALVENDLEAMD  710 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~----------~~~~~~~~~~~~~~~~~~~~~  710 (762)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....          ........+...+++......
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (321)
T 2qkw_B          198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI  277 (321)
T ss_dssp             BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCS
T ss_pred             ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcccc
Confidence            3445689999999999999999999999999999999999999743321          112222334444555555556


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCCC
Q 004312          711 DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPI  751 (762)
Q Consensus       711 ~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~  751 (762)
                      ....+..+.+++.+||+.||++|||++||++.|+.++++..
T Consensus       278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~  318 (321)
T 2qkw_B          278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE  318 (321)
T ss_dssp             CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred             CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence            77889999999999999999999999999999998766543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.7e-42  Score=394.53  Aligned_cols=246  Identities=21%  Similarity=0.215  Sum_probs=199.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHH---HhhhhcccccCCccchhceeccCCceeEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKA---EVNGIGQTHHKNLVRLLGYCDEGRNRLLV  558 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~nIv~l~g~~~~~~~~~LV  558 (762)
                      .+.+.||+|+||+||+++.. .+++.||||++++..   ......+.+   ++.+++.++|||||++++.+.+.+..+||
T Consensus       192 ~i~k~LG~G~fG~V~la~~~-~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV  270 (689)
T 3v5w_A          192 SVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI  270 (689)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEEecccCeEEEEEEEC-CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence            45578999999999999754 567899999997532   122233333   46677788999999999999999999999


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      ||||++|+|.++|.+.+.+++..+..++.||+.||+|||++   +||||||||+||||++++.+||+|||+|+.+...  
T Consensus       271 mEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~--  345 (689)
T 3v5w_A          271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--  345 (689)
T ss_dssp             ECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCC--
Confidence            99999999999999888999999999999999999999999   9999999999999999999999999999876533  


Q ss_pred             cccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          639 HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                       .....+||+.|||||++.. ..++.++|||||||+||||++|+.||.........  ..........  ...+..++++
T Consensus       346 -~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~--~i~~~i~~~~--~~~p~~~S~~  420 (689)
T 3v5w_A          346 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTMA--VELPDSFSPE  420 (689)
T ss_dssp             -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH--HHHHHHHHCC--CCCCTTSCHH
T ss_pred             -CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHhhcCCC--CCCCccCCHH
Confidence             2345689999999999975 57999999999999999999999998543211110  0011111111  1223456788


Q ss_pred             HHHHHHHhhccCCCCCCC-----HHHHHH
Q 004312          718 FVMVAIWCIQEDPSHRPT-----MRRVTQ  741 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt-----~~evl~  741 (762)
                      +.+|+.+||+.||++|++     ++||++
T Consensus       421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             HHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            999999999999999998     677764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.6e-42  Score=366.60  Aligned_cols=260  Identities=27%  Similarity=0.426  Sum_probs=201.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.+.+.||+|+||+||+|+..   ++.||||++....  ....+++.+|++++++++||||+++++++.+....++||||
T Consensus        39 y~i~~~lG~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  115 (309)
T 3p86_A           39 LNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY  115 (309)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred             ceeeeEeecCCCeEEEEEEEC---CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence            345578999999999999753   5689999987543  23346799999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCC---CCHHHHHHHHHHHHHHHHHhHhcCCCC--eEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          562 MSNGALASFLFGDSK---PNWKLRTEIVMGIARGLFYLHEECCTQ--IIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      +++|+|.+++.....   +++..+..++.||++||+|||++   +  |+||||||+|||+++++.+||+|||+++.....
T Consensus       116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            999999999987653   89999999999999999999998   8  999999999999999999999999999864332


Q ss_pred             CCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          637 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                       ........||+.|+|||.+.+..++.++||||||+++|||++|+.||............     .........+...+.
T Consensus       193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  266 (309)
T 3p86_A          193 -FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV-----GFKCKRLEIPRNLNP  266 (309)
T ss_dssp             ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH-----HHSCCCCCCCTTSCH
T ss_pred             -ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----HhcCCCCCCCccCCH
Confidence             22233456999999999999999999999999999999999999998544322222111     001111222334567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCCCCCCC
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCP  755 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~p~~p  755 (762)
                      ++.+++.+||+.||++|||++|+++.|+.+.+-..||.+
T Consensus       267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~  305 (309)
T 3p86_A          267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN  305 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence            899999999999999999999999999998766555443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4e-42  Score=367.07  Aligned_cols=256  Identities=25%  Similarity=0.423  Sum_probs=209.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      .+.+.||+|+||+||+|... .+++.||+|++........+.|.+|++++++++||||+++++++.+.+..++||||+++
T Consensus        13 ~~~~~lG~G~~g~V~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   91 (310)
T 3s95_A           13 IHGEVLGKGCFGQAIKVTHR-ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG   91 (310)
T ss_dssp             EEEEEEECCSSEEEEEEEET-TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eccceecCCCCEEEEEEEEC-CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCC
Confidence            34578999999999999754 45679999999776667778899999999999999999999999999999999999999


Q ss_pred             CchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc---
Q 004312          565 GALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT---  640 (762)
Q Consensus       565 gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~---  640 (762)
                      ++|.+++.. ...+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+++.........   
T Consensus        92 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  168 (310)
T 3s95_A           92 GTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL  168 (310)
T ss_dssp             CBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred             CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence            999999986 46799999999999999999999999   99999999999999999999999999998764332211   


Q ss_pred             ----------cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCC
Q 004312          641 ----------NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMD  710 (762)
Q Consensus       641 ----------~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  710 (762)
                                .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.................    .....
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~----~~~~~  244 (310)
T 3s95_A          169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF----LDRYC  244 (310)
T ss_dssp             -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH----HHHTC
T ss_pred             ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc----ccccC
Confidence                      1245699999999999999999999999999999999999988633211110000001111    11112


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          711 DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       711 ~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      +..+++.+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus       245 ~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            23445678999999999999999999999999988753

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.2e-41  Score=367.67  Aligned_cols=256  Identities=25%  Similarity=0.358  Sum_probs=208.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC------CCcceEEEEEcccccc-chhHHHHHHhhhhccc-ccCCccchhceeccCCce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM------GSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  555 (762)
                      +.+.+.||+|+||.||+|....      ..+..||||+++.... ...+++.+|+++++++ +||||+++++++.+.+..
T Consensus        83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  162 (370)
T 2psq_A           83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL  162 (370)
T ss_dssp             EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSC
T ss_pred             CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCE
Confidence            3456789999999999997632      2345799999976432 3446799999999999 899999999999999999


Q ss_pred             eEEEeccCCCchhhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC
Q 004312          556 LLVYEFMSNGALASFLFGD----------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY  619 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~  619 (762)
                      ++||||+++|+|.+++...                ..+++..+..++.||++||+|||++   +|+||||||+|||++++
T Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~  239 (370)
T 2psq_A          163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN  239 (370)
T ss_dssp             EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred             EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCC
Confidence            9999999999999999754                2478999999999999999999999   99999999999999999


Q ss_pred             CceEEecccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccc
Q 004312          620 YNARISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERT  697 (762)
Q Consensus       620 ~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~  697 (762)
                      +.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+..    
T Consensus       240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~----  315 (370)
T 2psq_A          240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF----  315 (370)
T ss_dssp             CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH----
T ss_pred             CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH----
Confidence            9999999999986654332 22334457889999999999999999999999999999999 88887433211111    


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       698 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                        ..+........+..++.++.+++.+||+.||++||+++|+++.|+.+..
T Consensus       316 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          316 --KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             --HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              1111222222344566789999999999999999999999999998653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=362.67  Aligned_cols=258  Identities=26%  Similarity=0.423  Sum_probs=209.6

Q ss_pred             hhhhhcCCCCcceEEEeeeeCC--CcceEEEEEcccc-ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMG--SSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||+|.....  .+..||||+++.. .....+.|.+|++++++++||||+++++++.+.+..++||||
T Consensus        52 ~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  131 (325)
T 3kul_A           52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEY  131 (325)
T ss_dssp             EEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEEC
T ss_pred             EEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeC
Confidence            3456799999999999987532  2346999999764 334456899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc-
Q 004312          562 MSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-  639 (762)
Q Consensus       562 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-  639 (762)
                      +++++|.+++... ..+++..+..|+.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++........ 
T Consensus       132 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  208 (325)
T 3kul_A          132 MENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA  208 (325)
T ss_dssp             CTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CC
T ss_pred             CCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccce
Confidence            9999999999765 6799999999999999999999999   9999999999999999999999999999877543322 


Q ss_pred             -ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          640 -TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       640 -~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                       ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........      +........+..+++.
T Consensus       209 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~  282 (325)
T 3kul_A          209 YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS------VEEGYRLPAPMGCPHA  282 (325)
T ss_dssp             EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH------HHTTCCCCCCTTCCHH
T ss_pred             eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH------HHcCCCCCCCCCcCHH
Confidence             2223346778999999998999999999999999999999 9999754332222211      1111222233456678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCCC
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPI  751 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~  751 (762)
                      +.+++.+||+.||++|||++||+++|+.+.+.+.
T Consensus       283 l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          283 LHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence            9999999999999999999999999999876543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.2e-41  Score=354.30  Aligned_cols=262  Identities=23%  Similarity=0.319  Sum_probs=208.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||++... .+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   91 (294)
T 4eqm_A           13 YKIVDKLGGGGMSTVYLAEDT-ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME   91 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred             EEEEEEEccCCCEEEEEEEEC-CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence            445678999999999999744 456799999985432   2334678999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++++|.+++.....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.........
T Consensus        92 ~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           92 YIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence            999999999998888899999999999999999999999   99999999999999999999999999998765444444


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.................  +..........++.+.+
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~  246 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV--PNVTTDVRKDIPQSLSN  246 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC--CCHHHHSCTTSCHHHHH
T ss_pred             cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC--CCcchhcccCCCHHHHH
Confidence            4456799999999999999999999999999999999999999865433222111111100  00011112235678999


Q ss_pred             HHHHhhccCCCCCC-CHHHHHHHhhcCcCCCC
Q 004312          721 VAIWCIQEDPSHRP-TMRRVTQMLEGVVEVPI  751 (762)
Q Consensus       721 li~~cl~~dp~~RP-t~~evl~~L~~~~~~~~  751 (762)
                      ++.+||+.||++|| +++++.+.|+.+..-..
T Consensus       247 li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          247 VILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             HHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             HHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence            99999999999998 99999999999765443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1e-40  Score=354.09  Aligned_cols=247  Identities=24%  Similarity=0.332  Sum_probs=206.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      .+.+.||+|+||+||+|.. ..+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus        23 ~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  101 (297)
T 3fxz_A           23 TRFEKIGQGASGTVYTAMD-VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (297)
T ss_dssp             CCCEEEEEETTEEEEEEEB-TTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eeeeeeccCCCeEEEEEEE-CCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence            3457899999999999964 345789999999876666677899999999999999999999999999999999999999


Q ss_pred             CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccc
Q 004312          565 GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAI  644 (762)
Q Consensus       565 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  644 (762)
                      |+|.+++... .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++........ .....
T Consensus       102 ~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~  176 (297)
T 3fxz_A          102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM  176 (297)
T ss_dssp             CBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCC
T ss_pred             CCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccCCc
Confidence            9999999654 589999999999999999999999   999999999999999999999999999987654332 23446


Q ss_pred             cccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHH
Q 004312          645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW  724 (762)
Q Consensus       645 ~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  724 (762)
                      .||+.|+|||.+.+..++.++||||||+++|||++|+.||..............    ........+...+..+.+++.+
T Consensus       177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~  252 (297)
T 3fxz_A          177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT----NGTPELQNPEKLSAIFRDFLNR  252 (297)
T ss_dssp             CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----HCSCCCSCGGGSCHHHHHHHHH
T ss_pred             cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCCCccccCHHHHHHHHH
Confidence            799999999999999999999999999999999999999855433222211100    0011112233456788999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 004312          725 CIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       725 cl~~dp~~RPt~~evl~  741 (762)
                      ||+.||++|||++|+++
T Consensus       253 ~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          253 CLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HSCSSTTTSCCHHHHTT
T ss_pred             HccCChhHCcCHHHHhh
Confidence            99999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.6e-41  Score=370.44  Aligned_cols=256  Identities=26%  Similarity=0.436  Sum_probs=198.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC--CCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|+...  ..+..||||+++... ....++|.+|++++++++||||+++++++.+....+||||
T Consensus        47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (373)
T 2qol_A           47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE  126 (373)
T ss_dssp             CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEe
Confidence            3455789999999999997652  345679999997643 3345689999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          561 FMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |+++|+|.+++... ..+++..+..|+.||++||+|||++   +|+||||||+|||++.++.+||+|||+++........
T Consensus       127 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  203 (373)
T 2qol_A          127 YMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA  203 (373)
T ss_dssp             CCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence            99999999999876 4689999999999999999999998   9999999999999999999999999999876543322


Q ss_pred             cc--ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          640 TN--TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       640 ~~--~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      ..  ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..........      .+........+..++.
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~------~i~~~~~~~~~~~~~~  277 (373)
T 2qol_A          204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK------AVDEGYRLPPPMDCPA  277 (373)
T ss_dssp             ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHH------HHHTTEECCCCTTCBH
T ss_pred             ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHcCCCCCCCccccH
Confidence            21  22235778999999999999999999999999999998 999975432222111      1122222223345667


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ++.+++.+||+.||++||+++||+++|+++.+
T Consensus       278 ~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          278 ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence            89999999999999999999999999988654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2e-41  Score=358.85  Aligned_cols=261  Identities=25%  Similarity=0.392  Sum_probs=207.3

Q ss_pred             hhhhhhcCCCCcceEEEeee---eCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccC--CceeEE
Q 004312          484 RGFKEELGRGAFGTVYKGFV---NMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--RNRLLV  558 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~---~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~LV  558 (762)
                      +.+.+.||+|+||.||++++   +..+++.||||++........+.+.+|++++++++||||+++++++...  ...++|
T Consensus        12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   91 (295)
T 3ugc_A           12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI   91 (295)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEE
T ss_pred             hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEE
Confidence            45667899999999999975   3445678999999876666667899999999999999999999998553  458999


Q ss_pred             EeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          559 YEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      |||+++++|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (295)
T 3ugc_A           92 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  168 (295)
T ss_dssp             EECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred             EEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence            9999999999999765 4589999999999999999999998   99999999999999999999999999998765433


Q ss_pred             C--cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHh--hhcc--------ccccccccc
Q 004312          638 S--HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDC--YQER--------TLGALVEND  705 (762)
Q Consensus       638 ~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~--~~~~--------~~~~~~~~~  705 (762)
                      .  .......++..|+|||.+.+..++.++||||||+++|||++|..|+........  ....        .....+...
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (295)
T 3ugc_A          169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN  248 (295)
T ss_dssp             -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred             ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence            2  122334577889999999999999999999999999999999998754322110  0000        111112222


Q ss_pred             cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          706 LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       706 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      .....+..+++++.+++.+||+.||++|||++|++++|+.+.
T Consensus       249 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            223334456788999999999999999999999999998864

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=100.00  E-value=6.3e-41  Score=347.22  Aligned_cols=219  Identities=22%  Similarity=0.319  Sum_probs=181.3

Q ss_pred             ccccCcccCCCceeecCCCCcEeeCCCcEEEeeeccc----------ccccCCCCCCCC-----CceEEEEeCCcEEE--
Q 004312           20 AQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD----------IWYASGDDPGPG-----GSKLRLTANGGLVL--   82 (762)
Q Consensus        20 ~~~~~~~~~~~~l~~~~~~~~lvS~~g~F~lgf~~~~----------vW~Anr~~p~~~-----~~~l~~~~~g~l~l--   82 (762)
                      +++.|+|.+||+|++++   +|||++|+|+||||..+          ||+|||++|+.+     ++.|+|+.||+|+|  
T Consensus        11 ~~~~~~l~~g~~l~~~~---~l~S~~g~F~lgf~~~~~~~ly~~~~vvW~Anr~~p~~~~~~~~~~~l~l~~~G~Lvl~~   87 (276)
T 3m7h_A           11 GVGTSVLPAYQTLSAGQ---YLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFSSTIPLRNKKAPLAFYVQYGAFL   87 (276)
T ss_dssp             CTTSSEECTTEEBCTTC---EEECTTSSEEEEECTTSCEEEEETTEEEEECSTTSTTEEEEECCCTTCCSEEEESSSEEE
T ss_pred             cccCCEecCCCEecCCC---EEEcCCCcEEEEEECCCCeEEECCCCeEEECCCCCCcCCcccccceEEEEeCCCcEEEEE
Confidence            45679999999999765   89999999999999654          999999999976     67899999999999  


Q ss_pred             eCCCCCEEEeecCCC------CceeEEEEecCCCEEEEecCCCccccccCCCccccCCCcc----ccCccEEEeecCCCC
Q 004312           83 EDPEAREIWKSEIST------GEAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQT----MERGGVVSSRRKETD  152 (762)
Q Consensus        83 ~~~~~~~~ws~~~~~------~~~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~----l~~~~~L~S~~s~~d  152 (762)
                      .|++|++||+|+++.      .++.+|+|+|+|||||+|  +.+||||  ||||||||||+    |..++.|   ++.+|
T Consensus        88 ~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~~L---~S~~d  160 (276)
T 3m7h_A           88 DDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGSEL---VQGVV  160 (276)
T ss_dssp             EEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSEEE---CTTCE
T ss_pred             eCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCccc---ccCCC
Confidence            788899999999865      345789999999999998  7899999  99999999999    7778888   56789


Q ss_pred             CCCcceEEEecCCCceeeEeeccCCCcccccccccCCcceecCCCCceeeeccCcceEEeecCceeEEeccccccCCccE
Q 004312          153 FSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENY  232 (762)
Q Consensus       153 ps~G~~~l~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (762)
                      |++|.|+++++++|+++++  +..    ...||.++++..   +. ..+.++.+|.+.+++.++..++.+...   ....
T Consensus       161 ps~G~fsl~l~~dGnlvLy--~~~----~~~yW~Sgt~~~---~~-~~l~l~~dGnLvl~d~~~~~vWsS~t~---~~~~  227 (276)
T 3m7h_A          161 YGAGASKLVFQGDGNLVAY--GPN----GAATWNAGTQGK---GA-VRAVFQGDGNLVVYGAGNAVLWHSHTG---GHAS  227 (276)
T ss_dssp             EEETTEEEEECTTSCEEEE--CTT----SSEEEECCCTTT---TC-CEEEECTTSCEEEECTTSCEEEECSCT---TCTT
T ss_pred             CCCceEEEeecCCceEEEE--eCC----CeEEEECCCCCC---cc-EEEEEcCCCeEEEEeCCCcEEEEecCC---CCCC
Confidence            9999999999999987664  221    257999988753   22 567888999999888877777776422   2234


Q ss_pred             EEEEEcCCCcEEEEEcCCCCCCCcceeeeeccCCcc
Q 004312          233 LRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPEN  268 (762)
Q Consensus       233 ~~~~l~~dG~~~~y~~~~~~~~~~~~w~~~~~~p~~  268 (762)
                      .|++|+.||++++|.|.       ..|+..+.+|..
T Consensus       228 ~rl~Ld~dGnLvly~~~-------~~Wqsf~~~P~~  256 (276)
T 3m7h_A          228 AVLRLQANGSIAILDEK-------PVWARFGFQPTY  256 (276)
T ss_dssp             CEEEECTTSCEEEEEEE-------EEEESSSCCTTS
T ss_pred             EEEEEcCCccEEEEcCC-------CeEEccCccCCc
Confidence            79999999999999981       238876666653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.2e-40  Score=348.05  Aligned_cols=271  Identities=37%  Similarity=0.645  Sum_probs=221.3

Q ss_pred             ccccccCHHHHHHHHhhhhh--------hcCCCCcceEEEeeeeCCCcceEEEEEccccc----cchhHHHHHHhhhhcc
Q 004312          469 MNLRCFTYKELVEVTRGFKE--------ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF----QDSEKEFKAEVNGIGQ  536 (762)
Q Consensus       469 ~~~~~~~~~el~~~t~~~~~--------~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~  536 (762)
                      .....|++.++.+++.+|.+        .||+|+||.||+|..   .++.||||++....    ....+.+.+|++++++
T Consensus        10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~   86 (307)
T 2nru_A           10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK   86 (307)
T ss_dssp             -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES---SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHH
T ss_pred             CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE---CCceEEEEEEecccCcchHHHHHHHHHHHHHHHh
Confidence            34577999999999999874        499999999999975   35689999986532    2345689999999999


Q ss_pred             cccCCccchhceeccCCceeEEEeccCCCchhhhccC---CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCc
Q 004312          537 THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG---DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQN  613 (762)
Q Consensus       537 l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N  613 (762)
                      ++||||+++++++.+.+..++||||+++++|.+++..   ...+++..+..++.||+.||+|||++   +|+||||||+|
T Consensus        87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~N  163 (307)
T 2nru_A           87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSAN  163 (307)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred             cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence            9999999999999999999999999999999999864   35689999999999999999999998   99999999999


Q ss_pred             eEEcCCCceEEecccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHh
Q 004312          614 ILLDDYYNARISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDC  692 (762)
Q Consensus       614 ILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~  692 (762)
                      |++++++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.|+........
T Consensus       164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  242 (307)
T 2nru_A          164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL  242 (307)
T ss_dssp             EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred             EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence            99999999999999999876543322 2334568999999998865 589999999999999999999999744321110


Q ss_pred             -------hh--ccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          693 -------YQ--ERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       693 -------~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                             ..  ...+...++... ...+...++.+.+++.+||+.+|++|||+++|++.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence                   00  011112222222 2235677889999999999999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.3e-40  Score=358.23  Aligned_cols=246  Identities=22%  Similarity=0.325  Sum_probs=205.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++....  ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus        17 y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~   95 (328)
T 3fe3_A           17 YRLLKTIGKGNFAKVKLARHI-LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY   95 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence            345578999999999999753 456799999997542  23456788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|+|.+++...+.+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        96 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~  170 (328)
T 3fe3_A           96 ASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKL  170 (328)
T ss_dssp             CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--CGG
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--Ccc
Confidence            99999999998888899999999999999999999999   9999999999999999999999999999866432  234


Q ss_pred             ccccccCcccCcccccCCCCC-CcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPIT-VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s-~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ...+||+.|+|||.+.+..+. .++||||||+++|||++|+.||...........     +.....  ..+...+.++.+
T Consensus       171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-----i~~~~~--~~p~~~s~~~~~  243 (328)
T 3fe3_A          171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER-----VLRGKY--RIPFYMSTDCEN  243 (328)
T ss_dssp             GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHCCC--CCCTTSCHHHHH
T ss_pred             ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhCCC--CCCCCCCHHHHH
Confidence            456799999999999888765 899999999999999999999865433222211     111111  112235678899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ++.+||+.||.+|||++|+++.
T Consensus       244 li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          244 LLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             HHHHHCCSSTTTSCCHHHHTTC
T ss_pred             HHHHHCCCChhHCcCHHHHhcC
Confidence            9999999999999999999863

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7.3e-40  Score=351.53  Aligned_cols=261  Identities=22%  Similarity=0.278  Sum_probs=214.7

Q ss_pred             ccccCHHHHHHHHhh------------hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc
Q 004312          471 LRCFTYKELVEVTRG------------FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH  538 (762)
Q Consensus       471 ~~~~~~~el~~~t~~------------~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  538 (762)
                      ...++++++++++..            +.+.||+|+||.||+|... .+++.||||++........+.+.+|+.++++++
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  100 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ  100 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC-CCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence            356889999888864            2346999999999999754 456799999998766666778999999999999


Q ss_pred             cCCccchhceeccCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC
Q 004312          539 HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD  618 (762)
Q Consensus       539 H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~  618 (762)
                      ||||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||++||+|||+.   +|+||||||+|||++.
T Consensus       101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL  176 (321)
T ss_dssp             CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred             CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence            99999999999999999999999999999999864 4689999999999999999999998   9999999999999999


Q ss_pred             CCceEEecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccc
Q 004312          619 YYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTL  698 (762)
Q Consensus       619 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~  698 (762)
                      ++.+||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||............  
T Consensus       177 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~--  253 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--  253 (321)
T ss_dssp             TCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--
T ss_pred             CCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--
Confidence            99999999999987654322 234457999999999999999999999999999999999999998554332222111  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          699 GALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       699 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .....+  ........+..+.+++.+||+.||++|||++|+++
T Consensus       254 ~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          254 RDSPPP--KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HHSSCC--CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcCCCC--CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000001  11112234678899999999999999999999987

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.3e-41  Score=350.71  Aligned_cols=253  Identities=26%  Similarity=0.423  Sum_probs=209.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+|...  +++.||||++.... ...+++.+|++++++++||||+++++++.+....++||||++
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           12 LTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             EEEEEEEEECSSCEEEEEEET--TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             ceeeheecCCCccEEEEEEec--CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            345578999999999999765  35679999997643 345689999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      +++|.+++... ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  165 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  165 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence            99999999764 5689999999999999999999999   9999999999999999999999999999876543333334


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++ |+.||............      ........+...++.+.++
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l  239 (269)
T 4hcu_A          166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI------STGFRLYKPRLASTHVYQI  239 (269)
T ss_dssp             STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HTTCCCCCCTTSCHHHHHH
T ss_pred             CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH------hcCccCCCCCcCCHHHHHH
Confidence            4557788999999999999999999999999999999 88887543322222111      1111222233346789999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          722 AIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      +.+||+.||++|||++|+++.|+++.+
T Consensus       240 i~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          240 MNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            999999999999999999999998754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.8e-41  Score=351.44  Aligned_cols=254  Identities=25%  Similarity=0.364  Sum_probs=209.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+|...  ++..||||+++... ...+++.+|++++.+++||||+++++++.+....++||||++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A           10 ITLLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             EEEEEEEEEETTEEEEEEEET--TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             eeeeeeeccCCCceEEEEEec--CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            445678999999999999765  35679999997643 345679999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      +++|.+++... ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  163 (268)
T 3sxs_A           87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV  163 (268)
T ss_dssp             TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred             CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence            99999999765 4589999999999999999999999   9999999999999999999999999999876554443344


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ...+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+............      ........+...++.+.++
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~l  237 (268)
T 3sxs_A          164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV------SQGHRLYRPHLASDTIYQI  237 (268)
T ss_dssp             SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH------HTTCCCCCCTTSCHHHHHH
T ss_pred             CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH------HcCCCCCCCCcChHHHHHH
Confidence            4556788999999998899999999999999999999 88887443222221111      1111111223345688999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          722 AIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      +.+||+.+|++|||++|+++.|+.+.+.
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          238 MYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            9999999999999999999999998654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.4e-40  Score=357.80  Aligned_cols=249  Identities=24%  Similarity=0.318  Sum_probs=205.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc------hhHHHHHHhhhhcccccCCccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD------SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L  557 (762)
                      +.+.+.||+|+||.||++... .+++.||||++++....      ..+.+.+|+.++++++||||+++++++.+....++
T Consensus        14 y~~~~~LG~G~fg~V~~~~~~-~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   92 (361)
T 2yab_A           14 YDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL   92 (361)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eEEeeEEeeCcCEEEEEEEEC-CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence            445678999999999999754 45679999999754322      34689999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC----ceEEecccccccc
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY----NARISDFGLEKLL  633 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Dfgla~~~  633 (762)
                      ||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||+++++    .+||+|||+++..
T Consensus        93 v~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           93 ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             EEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            999999999999998888899999999999999999999999   999999999999998776    7999999999876


Q ss_pred             cCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHH
Q 004312          634 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMT  713 (762)
Q Consensus       634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  713 (762)
                      ...  .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+..........   .........
T Consensus       170 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~  244 (361)
T 2yab_A          170 EDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY---DFDEEFFSQ  244 (361)
T ss_dssp             CTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC---CCCHHHHTT
T ss_pred             CCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---CCCchhccC
Confidence            532  233456799999999999999999999999999999999999999865433332221110000   000000112


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          714 VLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       714 ~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .++.+.+++.+||+.||++|||++|+++
T Consensus       245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          245 TSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            4577899999999999999999999886

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-40  Score=374.92  Aligned_cols=253  Identities=26%  Similarity=0.405  Sum_probs=208.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+|.+.  .+..||||+++... ...++|.+|++++++++||||+++++++. .+..+|||||++
T Consensus       190 ~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~  265 (454)
T 1qcf_A          190 LKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA  265 (454)
T ss_dssp             EEEEEEEECCSSEEEEEEEET--TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             eEEEEEcccCCceEEEEEEEC--CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence            345678999999999999875  34679999997643 45678999999999999999999999986 567899999999


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +|+|.+++...  ..+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++..........
T Consensus       266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~  342 (454)
T 1qcf_A          266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR  342 (454)
T ss_dssp             TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence            99999999865  3688999999999999999999999   999999999999999999999999999987643322222


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....+++.|+|||.+....++.++||||||+++|||++ |+.||......+....      +........+..+++++.+
T Consensus       343 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~------i~~~~~~~~~~~~~~~l~~  416 (454)
T 1qcf_A          343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA------LERGYRMPRPENCPEELYN  416 (454)
T ss_dssp             CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH------HHHTCCCCCCTTSCHHHHH
T ss_pred             CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH------HHcCCCCCCCCCCCHHHHH
Confidence            33446789999999999999999999999999999999 8988754322222211      1111222233456788999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      ++.+||+.||++|||+++|+++|+.+...
T Consensus       417 li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          417 IMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             HHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999999997543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.6e-40  Score=377.77  Aligned_cols=254  Identities=27%  Similarity=0.379  Sum_probs=211.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+|.+.. .++.||||+++... ...++|.+|++++++++||||++++++|.+....+|||||++
T Consensus       222 ~~~~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~  299 (495)
T 1opk_A          222 ITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT  299 (495)
T ss_dssp             EEEEEESGGGTTSSEEEEEEGG-GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             ceeeeEecCCCCeEEEEEEEcC-CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence            3456789999999999998653 45789999997643 346789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +|+|.+++...  ..+++..++.|+.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++..........
T Consensus       300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  376 (495)
T 1opk_A          300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  376 (495)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence            99999999753  5689999999999999999999999   999999999999999999999999999987654333333


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....+++.|+|||.+....++.++||||||+++|||++ |+.|+.......      +...+........+..+++++.+
T Consensus       377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~  450 (495)
T 1opk_A          377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE  450 (495)
T ss_dssp             TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------HHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCCCCCHHHHH
Confidence            33456789999999999999999999999999999999 888874322111      11222222233334456788999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      |+.+||+.||++|||+++|+++|+.+.+
T Consensus       451 li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          451 LMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             HHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999998754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.3e-40  Score=350.29  Aligned_cols=252  Identities=24%  Similarity=0.376  Sum_probs=205.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||++...  ++..||||+++... ...+++.+|++++.+++||||+++++++.+.+..++||||++
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  102 (283)
T 3gen_A           26 LTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA  102 (283)
T ss_dssp             EEEEEECC---CEEEEEEEET--TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred             HHhHhhcCCCCCceEEEEEEc--CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence            345678999999999999765  45679999997643 345789999999999999999999999999999999999999


Q ss_pred             CCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      +++|.+++.. ...+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++...........
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  179 (283)
T 3gen_A          103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  179 (283)
T ss_dssp             TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence            9999999987 46799999999999999999999999   9999999999999999999999999999876543333333


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........      +........+...++.+.++
T Consensus       180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~l  253 (283)
T 3gen_A          180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH------IAQGLRLYRPHLASEKVYTI  253 (283)
T ss_dssp             STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH------HHTTCCCCCCTTCCHHHHHH
T ss_pred             CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH------HhcccCCCCCCcCCHHHHHH
Confidence            4457788999999998999999999999999999998 8888754322221111      11111222233345789999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          722 AIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      +.+||+.+|++|||++|+++.|+++.
T Consensus       254 i~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          254 MYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHHHHHHHHh
Confidence            99999999999999999999998764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=8.8e-41  Score=364.11  Aligned_cols=256  Identities=25%  Similarity=0.361  Sum_probs=206.0

Q ss_pred             hhhhhhcCCCCcceEEEeeee----CCCcceEEEEEcccccc-chhHHHHHHhhhhccc-ccCCccchhceeccCCc-ee
Q 004312          484 RGFKEELGRGAFGTVYKGFVN----MGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRN-RL  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~-~~  556 (762)
                      +.+.+.||+|+||.||+|.+.    ..+++.||||+++.... ...+.+.+|++++.++ +||||+++++++.+.+. .+
T Consensus        24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~  103 (359)
T 3vhe_A           24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  103 (359)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred             eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence            345578999999999999753    34457899999976433 3346799999999999 89999999999887654 89


Q ss_pred             EEEeccCCCchhhhccCCCC------------------------------------------------------------
Q 004312          557 LVYEFMSNGALASFLFGDSK------------------------------------------------------------  576 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~~------------------------------------------------------------  576 (762)
                      +||||+++|+|.+++.....                                                            
T Consensus       104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (359)
T 3vhe_A          104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE  183 (359)
T ss_dssp             EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence            99999999999999976532                                                            


Q ss_pred             ------CCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC-cccccccccCc
Q 004312          577 ------PNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-HTNTAIRGTKG  649 (762)
Q Consensus       577 ------l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~  649 (762)
                            +++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus       184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~  260 (359)
T 3vhe_A          184 DLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK  260 (359)
T ss_dssp             CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred             chhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence                  88999999999999999999999   999999999999999999999999999986644332 23334568899


Q ss_pred             ccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhcc
Q 004312          650 YVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQE  728 (762)
Q Consensus       650 y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  728 (762)
                      |+|||.+.+..++.++||||||+++|||++ |+.||.........     ...+........+...++++.+++.+||+.
T Consensus       261 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  335 (359)
T 3vhe_A          261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----CRRLKEGTRMRAPDYTTPEMYQTMLDCWHG  335 (359)
T ss_dssp             GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-----HHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             eEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH-----HHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence            999999999999999999999999999998 99887432211111     111111112222334567899999999999


Q ss_pred             CCCCCCCHHHHHHHhhcCc
Q 004312          729 DPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       729 dp~~RPt~~evl~~L~~~~  747 (762)
                      ||++|||++|+++.|++++
T Consensus       336 dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          336 EPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             SGGGSCCHHHHHHHHHHHH
T ss_pred             ChhhCCCHHHHHHHHHHHH
Confidence            9999999999999998865

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2e-40  Score=356.05  Aligned_cols=259  Identities=25%  Similarity=0.358  Sum_probs=201.8

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCC----ceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR----NRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~LV~E  560 (762)
                      .+.+.||+|+||+||+|+..   ++.||||++... ......+.+|+.++++++||||+++++++.+..    ..++|||
T Consensus        27 ~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e  102 (322)
T 3soc_A           27 QLLEVKARGRFGCVWKAQLL---NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA  102 (322)
T ss_dssp             EEEEEEECSTTCEEEEEEET---TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             hhhheecccCceEEEEEEEC---CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence            35678999999999999764   578999999654 233456677999999999999999999998754    3699999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcC-------CCCeEeCCCCCCceEEcCCCceEEecccccccc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC-------CTQIIHCDIKPQNILLDDYYNARISDFGLEKLL  633 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~  633 (762)
                      |+++|+|.+++... .+++..+..++.||++||+|||+.+       .++|+||||||+|||+++++.+||+|||+++..
T Consensus       103 ~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~  181 (322)
T 3soc_A          103 FHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF  181 (322)
T ss_dssp             CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEE
T ss_pred             cCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccc
Confidence            99999999999654 5899999999999999999999852       238999999999999999999999999999876


Q ss_pred             cCCCCc-ccccccccCcccCcccccCC-----CCCCcchhHHHHHHHHHHHhCCCCCchhhH-------H--------Hh
Q 004312          634 TLDQSH-TNTAIRGTKGYVAPEWFRNM-----PITVKVDVYSYGVLLLEIICLRRTILTDWA-------Y--------DC  692 (762)
Q Consensus       634 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~s~~~DV~S~Gvil~elltg~~p~~~~~~-------~--------~~  692 (762)
                      ...... ......||+.|+|||.+.+.     .++.++||||||+++|||++|+.||.....       .        ..
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (322)
T 3soc_A          182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED  261 (322)
T ss_dssp             CTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHH
T ss_pred             ccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhh
Confidence            544332 23346799999999999763     456789999999999999999998743211       0        00


Q ss_pred             hhccccccccccccc-cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          693 YQERTLGALVENDLE-AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       693 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ..+........+... .......++++.+++.+||+.||++|||++||+++|+.+.+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          262 MQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            000000000111111 01123567789999999999999999999999999988654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2e-40  Score=358.90  Aligned_cols=255  Identities=24%  Similarity=0.359  Sum_probs=208.9

Q ss_pred             hhhhhcCCCCcceEEEeeeeC----CCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      .+.+.||+|+||.||+|....    .+++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        50 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  129 (343)
T 1luf_A           50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF  129 (343)
T ss_dssp             EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEE
Confidence            455789999999999998763    334789999997643 334568999999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCC------------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceE
Q 004312          560 EFMSNGALASFLFGD------------------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNIL  615 (762)
Q Consensus       560 E~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIL  615 (762)
                      ||+++|+|.+++...                        ..+++..++.++.||++||+|||++   +|+||||||+|||
T Consensus       130 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl  206 (343)
T 1luf_A          130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL  206 (343)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             ecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEE
Confidence            999999999999653                        5689999999999999999999999   9999999999999


Q ss_pred             EcCCCceEEecccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhh
Q 004312          616 LDDYYNARISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCY  693 (762)
Q Consensus       616 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~  693 (762)
                      +++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+..
T Consensus       207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  286 (343)
T 1luf_A          207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI  286 (343)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHH
Confidence            99999999999999987643322 22334567899999999999999999999999999999999 88887544322222


Q ss_pred             hccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          694 QERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ..     +... .....+..++.++.+++.+||+.||++|||++++++.|+++.+
T Consensus       287 ~~-----~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          287 YY-----VRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             HH-----HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HH-----HhCC-CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            11     1111 1112233456789999999999999999999999999999765

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.9e-41  Score=369.76  Aligned_cols=253  Identities=25%  Similarity=0.350  Sum_probs=206.3

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .+.+.||+|+||.||+|... .+++.||||+++.... ....+|.+|++++++++||||+++++++.+.+..++||||++
T Consensus       117 ~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  195 (377)
T 3cbl_A          117 VLGEQIGRGNFGEVFSGRLR-ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ  195 (377)
T ss_dssp             EEEEEEEEETTEEEEEEEET-TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             EEeeEeccCCCCeEEEEEEe-cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCC
Confidence            35578999999999999865 3467899999875432 234578999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc-
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN-  641 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~-  641 (762)
                      +|+|.+++... ..+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.......... 
T Consensus       196 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~  272 (377)
T 3cbl_A          196 GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG  272 (377)
T ss_dssp             TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence            99999999765 4689999999999999999999999   999999999999999999999999999986433221111 


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....+++.|+|||.+....++.++||||||+++|||++ |+.|+.........      ..+........+..+++++.+
T Consensus       273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~  346 (377)
T 3cbl_A          273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR------EFVEKGGRLPCPELCPDAVFR  346 (377)
T ss_dssp             SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH------HHHHTTCCCCCCTTCCHHHHH
T ss_pred             CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHcCCCCCCCCCCCHHHHH
Confidence            12235778999999998899999999999999999998 88887443222111      112222222233445678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      ++.+||+.||++|||+++|++.|+.+.
T Consensus       347 li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          347 LMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            999999999999999999999998864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.5e-39  Score=351.06  Aligned_cols=246  Identities=23%  Similarity=0.270  Sum_probs=206.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||++... .+++.||||++++.   .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~   86 (337)
T 1o6l_A            8 DYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence            44578999999999999754 45789999999753   233456789999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|+|..++.....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus        87 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~  162 (337)
T 1o6l_A           87 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATM  162 (337)
T ss_dssp             CTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCCB
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC-CCcc
Confidence            99999999998888899999999999999999999999   9999999999999999999999999999864322 2234


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ...+||+.|+|||.+.+..++.++||||||+++|||++|+.||...........     +.....  ..+...+.++.++
T Consensus       163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-----i~~~~~--~~p~~~s~~~~~l  235 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-----ILMEEI--RFPRTLSPEAKSL  235 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHCCC--CCCTTSCHHHHHH
T ss_pred             cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH-----HHcCCC--CCCCCCCHHHHHH
Confidence            456799999999999999999999999999999999999999865433222211     111111  1223456789999


Q ss_pred             HHHhhccCCCCCC-----CHHHHHHH
Q 004312          722 AIWCIQEDPSHRP-----TMRRVTQM  742 (762)
Q Consensus       722 i~~cl~~dp~~RP-----t~~evl~~  742 (762)
                      +.+||+.||++||     +++|+++.
T Consensus       236 i~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          236 LAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            9999999999999     89999753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2e-40  Score=356.79  Aligned_cols=255  Identities=24%  Similarity=0.349  Sum_probs=201.5

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCc---ceEEEEEcccc-ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSS---DQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +.+.+.||+|+||+||+|.......   .+||+|++... .....++|.+|+.++++++||||+++++++.+.. .++|+
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~   95 (327)
T 3poz_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT   95 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEE
T ss_pred             cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence            3455789999999999998643222   24788988643 2345578999999999999999999999998754 78999


Q ss_pred             eccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          560 EFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       560 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      ||+++|+|.+++... ..+++..++.|+.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.......
T Consensus        96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  172 (327)
T 3poz_A           96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             ECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred             EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence            999999999999764 6789999999999999999999999   999999999999999999999999999987754333


Q ss_pred             c-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          639 H-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       639 ~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      . ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......      .+...+........+...+.
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~  246 (327)
T 3poz_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------EISSILEKGERLPQPPICTI  246 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------GHHHHHHTTCCCCCCTTBCH
T ss_pred             cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH------HHHHHHHcCCCCCCCccCCH
Confidence            2 2233456889999999999999999999999999999999 89887432211      12222222222233445667


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ++.+++.+||+.+|++||+++|+++.|+.+.+
T Consensus       247 ~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            89999999999999999999999999987643

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.8e-40  Score=369.87  Aligned_cols=251  Identities=20%  Similarity=0.241  Sum_probs=204.0

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.++||+|+||+||+|+.. .+++.||||++++...   .....+.+|+.++.+++||||+++++++.+.+..+|||||+
T Consensus        78 ~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~  156 (437)
T 4aw2_A           78 ILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY  156 (437)
T ss_dssp             EEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeCCCEEEEEEEEc-CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecC
Confidence            3467999999999999865 4567899999975321   22334889999999999999999999999999999999999


Q ss_pred             CCCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          563 SNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       563 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      ++|+|.+++.. ...+++..+..++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++..........
T Consensus       157 ~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~  233 (437)
T 4aw2_A          157 VGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  233 (437)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred             CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence            99999999987 47899999999999999999999998   999999999999999999999999999987765544444


Q ss_pred             ccccccCcccCccccc-----CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          642 TAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      ...+||+.|+|||++.     ...++.++|||||||++|||++|+.||......+......... ..... .......++
T Consensus       234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~-p~~~~~~s~  311 (437)
T 4aw2_A          234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-ERFQF-PTQVTDVSE  311 (437)
T ss_dssp             CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-HHCCC-CSSCCCSCH
T ss_pred             ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc-ccccC-CcccccCCH
Confidence            5578999999999997     5678999999999999999999999986554333322211000 00000 001123567


Q ss_pred             HHHHHHHHhhccCCCC--CCCHHHHHHH
Q 004312          717 RFVMVAIWCIQEDPSH--RPTMRRVTQM  742 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~--RPt~~evl~~  742 (762)
                      ++.+|+.+||..+|++  ||+++|+++.
T Consensus       312 ~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          312 NAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             HHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            8899999999888888  9999999863

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=364.12  Aligned_cols=256  Identities=29%  Similarity=0.345  Sum_probs=207.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC----CCcceEEEEEcccc-ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLV  558 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV  558 (762)
                      +.+.+.||+|+||.||+|.+..    .+++.||||+++.. ......++.+|+.++++++||||+++++++.+....++|
T Consensus        73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  152 (367)
T 3l9p_A           73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL  152 (367)
T ss_dssp             EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEE
Confidence            4456789999999999998642    34568999999753 334456799999999999999999999999999999999


Q ss_pred             EeccCCCchhhhccCC-------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC---ceEEeccc
Q 004312          559 YEFMSNGALASFLFGD-------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY---NARISDFG  628 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Dfg  628 (762)
                      |||+++|+|.+++...       ..+++..++.++.||++||+|||++   +|+||||||+|||++.++   .+||+|||
T Consensus       153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG  229 (367)
T 3l9p_A          153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG  229 (367)
T ss_dssp             EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred             EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCc
Confidence            9999999999999643       3589999999999999999999999   999999999999999554   59999999


Q ss_pred             ccccccCCC-CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcccccccccccc
Q 004312          629 LEKLLTLDQ-SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDL  706 (762)
Q Consensus       629 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  706 (762)
                      +++...... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........      +....
T Consensus       230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~------i~~~~  303 (367)
T 3l9p_A          230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF------VTSGG  303 (367)
T ss_dssp             HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH------HHTTC
T ss_pred             cccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------HHcCC
Confidence            998653322 222334568899999999999999999999999999999998 8888754432222211      11111


Q ss_pred             ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          707 EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       707 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ....+..++..+.+++.+||+.||++|||++||++.|+.+.+
T Consensus       304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            222233456789999999999999999999999999987654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-40  Score=362.77  Aligned_cols=259  Identities=25%  Similarity=0.357  Sum_probs=210.9

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeC------CCcceEEEEEccccc-cchhHHHHHHhhhhccc-ccCCccchhceeccCCc
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNM------GSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRN  554 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  554 (762)
                      .+.+.+.||+|+||.||+|....      .....||||+++... ....+++.+|+++++++ +||||+++++++.+.+.
T Consensus        70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  149 (382)
T 3tt0_A           70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP  149 (382)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCc
Confidence            34456789999999999997642      223579999997643 33346899999999999 99999999999999999


Q ss_pred             eeEEEeccCCCchhhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC
Q 004312          555 RLLVYEFMSNGALASFLFGD----------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD  618 (762)
Q Consensus       555 ~~LV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~  618 (762)
                      .++||||+++|+|.+++...                ..+++..++.|+.||+.||+|||++   +|+||||||+|||+++
T Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~  226 (382)
T 3tt0_A          150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE  226 (382)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred             eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcC
Confidence            99999999999999999754                3489999999999999999999999   9999999999999999


Q ss_pred             CCceEEecccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcc
Q 004312          619 YYNARISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQER  696 (762)
Q Consensus       619 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~  696 (762)
                      ++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+......+...  
T Consensus       227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~--  304 (382)
T 3tt0_A          227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--  304 (382)
T ss_dssp             TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH--
T ss_pred             CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--
Confidence            99999999999987654332 22334557889999999999999999999999999999999 888875432222111  


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCC
Q 004312          697 TLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP  750 (762)
Q Consensus       697 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  750 (762)
                          .+........+..++.++.+++.+||+.||++|||++||++.|+++....
T Consensus       305 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          305 ----LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             ----HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             ----HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence                11111122223345678999999999999999999999999999876443

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.4e-40  Score=348.10  Aligned_cols=254  Identities=21%  Similarity=0.290  Sum_probs=194.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCC--CcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMG--SSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|.....  ....||||++.... ....+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus        17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e   95 (281)
T 1mp8_A           17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME   95 (281)
T ss_dssp             EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEe
Confidence            44567899999999999986532  23569999987543 334567999999999999999999999984 467899999


Q ss_pred             ccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          561 FMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |+++++|.+++... ..+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++........
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (281)
T 1mp8_A           96 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  172 (281)
T ss_dssp             CCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccccc
Confidence            99999999999755 4689999999999999999999998   9999999999999999999999999999876544433


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      ......+++.|+|||.+....++.++||||||+++|||++ |+.||......+...      .+........+...++.+
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~------~i~~~~~~~~~~~~~~~l  246 (281)
T 1mp8_A          173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG------RIENGERLPMPPNCPPTL  246 (281)
T ss_dssp             ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH------HHHTTCCCCCCTTCCHHH
T ss_pred             ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHH------HHHcCCCCCCCCCCCHHH
Confidence            3344557889999999998999999999999999999997 888874332211111      111111122234566789


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      .+++.+||+.||++|||++|+++.|+.+.
T Consensus       247 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          247 YSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            99999999999999999999999998864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.9e-40  Score=352.44  Aligned_cols=261  Identities=24%  Similarity=0.342  Sum_probs=208.0

Q ss_pred             hhhhhhcCCCCcceEEEeee---eCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccC--CceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFV---NMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--RNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~---~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~L  557 (762)
                      +.+.+.||+|+||.||++.+   +..+++.||||+++... ....+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l  102 (302)
T 4e5w_A           23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL  102 (302)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred             hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence            45567899999999999975   23456789999997532 33457899999999999999999999999876  66899


Q ss_pred             EEeccCCCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          558 VYEFMSNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      ||||+++++|.+++.. ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       103 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  179 (302)
T 4e5w_A          103 IMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  179 (302)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             EEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence            9999999999999954 46799999999999999999999999   9999999999999999999999999999877544


Q ss_pred             CC--cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhh---------hccccccccccc
Q 004312          637 QS--HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCY---------QERTLGALVEND  705 (762)
Q Consensus       637 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~---------~~~~~~~~~~~~  705 (762)
                      ..  .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.........         ........+...
T Consensus       180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (302)
T 4e5w_A          180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG  259 (302)
T ss_dssp             CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred             CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence            32  2233456888899999999999999999999999999999999885433221100         001111112222


Q ss_pred             cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          706 LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       706 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      .....+..+++++.+++.+||+.||++|||++|++++|+.++
T Consensus       260 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            222334456788999999999999999999999999998764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=349.90  Aligned_cols=250  Identities=26%  Similarity=0.348  Sum_probs=205.9

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc------hhHHHHHHhhhhcccccCCccchhceeccCCcee
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD------SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRL  556 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  556 (762)
                      .+.+.+.||+|+||.||++... .+++.||||++......      ..+.+.+|++++++++||||+++++++.+....+
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ceEeceEEeeCCCeEEEEEEEC-CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            4556788999999999999754 45679999998754322      3568999999999999999999999999999999


Q ss_pred             EEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC----ceEEeccccccc
Q 004312          557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY----NARISDFGLEKL  632 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Dfgla~~  632 (762)
                      +||||+++++|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||+++++    .+||+|||+++.
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            9999999999999998888899999999999999999999998   999999999999999877    899999999987


Q ss_pred             ccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCH
Q 004312          633 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDM  712 (762)
Q Consensus       633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (762)
                      .....  ......||+.|+|||.+....++.++||||||+++|+|++|+.||......+..........   ........
T Consensus       168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~  242 (326)
T 2y0a_A          168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY---EFEDEYFS  242 (326)
T ss_dssp             CCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC---CCCHHHHT
T ss_pred             CCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC---CcCccccc
Confidence            64322  23345699999999999999999999999999999999999999865433322221110000   00000011


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       713 ~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ..+..+.+++.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            23567899999999999999999999987

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.9e-40  Score=348.90  Aligned_cols=253  Identities=23%  Similarity=0.333  Sum_probs=195.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcc--cccCCccchhceecc----CCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ--THHKNLVRLLGYCDE----GRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~----~~~~~L  557 (762)
                      +.+.+.||+|+||+||+|+.   +++.||||++...   ....+.+|.+++..  ++||||+++++++..    ....++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A           10 ITLLECVGKGRYGEVWRGSW---QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             CEEEEEEEECSSEEEEEEEE---TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEEEEeeccCCCcEEEEEEE---CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            34567899999999999976   3578999998653   34556666666655  799999999998654    345789


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhH--------hcCCCCeEeCCCCCCceEEcCCCceEEecccc
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLH--------EECCTQIIHCDIKPQNILLDDYYNARISDFGL  629 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl  629 (762)
                      ||||+++|+|.+++.. ..+++..+..++.||+.||+|||        +.   +|+||||||+|||++.++.+||+|||+
T Consensus        84 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~  159 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGL  159 (301)
T ss_dssp             EECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             ehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCC
Confidence            9999999999999954 56899999999999999999999        66   999999999999999999999999999


Q ss_pred             cccccCCCCcc---cccccccCcccCcccccCC------CCCCcchhHHHHHHHHHHHhC----------CCCCchhhHH
Q 004312          630 EKLLTLDQSHT---NTAIRGTKGYVAPEWFRNM------PITVKVDVYSYGVLLLEIICL----------RRTILTDWAY  690 (762)
Q Consensus       630 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~~~DV~S~Gvil~elltg----------~~p~~~~~~~  690 (762)
                      ++.........   .....||+.|+|||.+.+.      .++.++||||||+++|||++|          +.||......
T Consensus       160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~  239 (301)
T 3q4u_A          160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN  239 (301)
T ss_dssp             CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence            98765433321   2334799999999999876      455799999999999999999          6776332111


Q ss_pred             ----Hhhhcccccccccccc-ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          691 ----DCYQERTLGALVENDL-EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       691 ----~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                          .............+.. ....+...+.++.+++.+||+.||++|||++||+++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence                1111100000000100 1111235788999999999999999999999999999864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.5e-40  Score=369.93  Aligned_cols=253  Identities=26%  Similarity=0.392  Sum_probs=202.9

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      .+.+.||+|+||.||+|....  ...||||+++... ...++|.+|++++++++||||+++++++.+ +..+|||||+++
T Consensus       187 ~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~  262 (452)
T 1fmk_A          187 RLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK  262 (452)
T ss_dssp             EEEEEEEECSSCEEEEEEETT--TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred             eeeeeecCCCCeEEEEEEECC--CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcC
Confidence            456789999999999998753  3579999998643 345689999999999999999999999976 678999999999


Q ss_pred             CchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          565 GALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       565 gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      |+|.+++...  ..+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++...........
T Consensus       263 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  339 (452)
T 1fmk_A          263 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ  339 (452)
T ss_dssp             CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceeccc
Confidence            9999999753  5689999999999999999999999   9999999999999999999999999999876543333333


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ...+++.|+|||.+....++.++||||||+++|||++ |+.|+......+....      +........+..+++.+.++
T Consensus       340 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~------i~~~~~~~~~~~~~~~l~~l  413 (452)
T 1fmk_A          340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ------VERGYRMPCPPECPESLHDL  413 (452)
T ss_dssp             ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH------HHTTCCCCCCTTSCHHHHHH
T ss_pred             CCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH------HHcCCCCCCCCCCCHHHHHH
Confidence            4457889999999999999999999999999999999 8888754322222111      11122222344567889999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhhcCcCCC
Q 004312          722 AIWCIQEDPSHRPTMRRVTQMLEGVVEVP  750 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~L~~~~~~~  750 (762)
                      +.+||+.||++|||+++|+++|+.+....
T Consensus       414 i~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          414 MCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence            99999999999999999999999975543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.3e-40  Score=351.41  Aligned_cols=252  Identities=23%  Similarity=0.380  Sum_probs=204.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCc------ceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSS------DQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L  557 (762)
                      +.+.+.||+|+||.||+|.......      ..||+|++........+.+.+|++++++++||||+++++++.+.+..++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (289)
T 4fvq_A           10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL   89 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred             eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence            4456789999999999997654321      4699999987766777889999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhccCCCC-CCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc--------eEEeccc
Q 004312          558 VYEFMSNGALASFLFGDSK-PNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN--------ARISDFG  628 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~kl~Dfg  628 (762)
                      ||||+++++|.+++..... +++..+..++.||+.||+|||++   +|+||||||+|||++.++.        +||+|||
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg  166 (289)
T 4fvq_A           90 VQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG  166 (289)
T ss_dssp             EEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred             EEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence            9999999999999987654 89999999999999999999999   9999999999999998887        9999999


Q ss_pred             ccccccCCCCcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccc
Q 004312          629 LEKLLTLDQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE  707 (762)
Q Consensus       629 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  707 (762)
                      ++.....     .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+...........     .....  
T Consensus       167 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-----~~~~~--  234 (289)
T 4fvq_A          167 ISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-----FYEDR--  234 (289)
T ss_dssp             SCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-----HHHTT--
T ss_pred             ccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-----Hhhcc--
Confidence            9875432     223457899999999987 6799999999999999999997766533321111111     00000  


Q ss_pred             cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCC
Q 004312          708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP  750 (762)
Q Consensus       708 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  750 (762)
                      ...+...+.++.+++.+||+.||++|||++|+++.|+++....
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            0011122456889999999999999999999999999986543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.7e-40  Score=368.90  Aligned_cols=246  Identities=27%  Similarity=0.370  Sum_probs=202.8

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCC-ceeEEEeccCC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR-NRLLVYEFMSN  564 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~LV~E~~~~  564 (762)
                      +.+.||+|+||.||+|...   ++.||||+++...  ..+.|.+|++++++++||||+++++++.+.. ..+|||||+++
T Consensus       197 ~~~~lG~G~fg~V~~~~~~---~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~  271 (450)
T 1k9a_A          197 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK  271 (450)
T ss_dssp             EEEEEEECSSEEEEEEEET---TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred             EEeeecCcCCeeEEEEEec---CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence            4568999999999999764   4689999997643  5678999999999999999999999987665 78999999999


Q ss_pred             CchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          565 GALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       565 gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      |+|.+++....  .+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+++.....    ..
T Consensus       272 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~  344 (450)
T 1k9a_A          272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QD  344 (450)
T ss_dssp             CBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----cc
Confidence            99999997653  379999999999999999999999   9999999999999999999999999999854321    12


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ...+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+..      ..+........+..++.++.++
T Consensus       345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~------~~i~~~~~~~~p~~~~~~l~~l  418 (450)
T 1k9a_A          345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------PRVEKGYKMDAPDGCPPAVYDV  418 (450)
T ss_dssp             --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH------HHHHTTCCCCCCTTCCHHHHHH
T ss_pred             CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHcCCCCCCCCcCCHHHHHH
Confidence            2357889999999999999999999999999999998 88887432211111      1112222223344567889999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          722 AIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      +.+||+.||++|||++++++.|+.+...
T Consensus       419 i~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          419 MKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999999886543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-40  Score=356.17  Aligned_cols=257  Identities=26%  Similarity=0.362  Sum_probs=207.3

Q ss_pred             hhhhhhcCCCCcceEEEeeee----CCCcceEEEEEcccc-ccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVN----MGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~L  557 (762)
                      +.+.+.||+|+||.||+|...    .+.++.||||++... .....+.+.+|++++.++ +||||+++++++...+..++
T Consensus        47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  126 (344)
T 1rjb_A           47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL  126 (344)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEE
Confidence            445678999999999999863    344568999999754 233457899999999999 99999999999999999999


Q ss_pred             EEeccCCCchhhhccCCC-----------------------CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCce
Q 004312          558 VYEFMSNGALASFLFGDS-----------------------KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNI  614 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  614 (762)
                      ||||+++|+|.+++....                       .+++..+..++.||+.||+|||++   +|+||||||+||
T Consensus       127 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NI  203 (344)
T 1rjb_A          127 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNV  203 (344)
T ss_dssp             EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGE
T ss_pred             EEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhE
Confidence            999999999999997653                       278999999999999999999999   999999999999


Q ss_pred             EEcCCCceEEecccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHh
Q 004312          615 LLDDYYNARISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDC  692 (762)
Q Consensus       615 Ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~  692 (762)
                      |++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus       204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  283 (344)
T 1rjb_A          204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN  283 (344)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH
Confidence            9999999999999999876543332 2234557889999999999999999999999999999998 8888744321111


Q ss_pred             hhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          693 YQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      .     ...+........+...++++.+++.+||+.||.+|||++|+++.|+.+.+
T Consensus       284 ~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          284 F-----YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             H-----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             H-----HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            1     11111222222233456789999999999999999999999999998654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.4e-40  Score=350.78  Aligned_cols=256  Identities=25%  Similarity=0.357  Sum_probs=208.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC----CCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLV  558 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV  558 (762)
                      +.+.+.||+|+||.||++....    .+++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  104 (314)
T 2ivs_A           25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI  104 (314)
T ss_dssp             EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence            3455789999999999997632    234689999997543 33456899999999999999999999999999999999


Q ss_pred             EeccCCCchhhhccCCC------------------------CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCce
Q 004312          559 YEFMSNGALASFLFGDS------------------------KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNI  614 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  614 (762)
                      |||+++++|.+++....                        .+++..+..++.||++||+|||++   +|+||||||+||
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NI  181 (314)
T 2ivs_A          105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNI  181 (314)
T ss_dssp             EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheE
Confidence            99999999999997543                        378999999999999999999999   999999999999


Q ss_pred             EEcCCCceEEecccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHh
Q 004312          615 LLDDYYNARISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDC  692 (762)
Q Consensus       615 Ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~  692 (762)
                      |+++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+........
T Consensus       182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  261 (314)
T 2ivs_A          182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL  261 (314)
T ss_dssp             EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999999876543322 2233457889999999999899999999999999999999 8888744322111


Q ss_pred             hhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          693 YQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      .      ..+........+...++++.+++.+||+.||++|||++|+++.|+++.+
T Consensus       262 ~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          262 F------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             H------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H------HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1      1111112222334566789999999999999999999999999988643

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.9e-40  Score=351.65  Aligned_cols=256  Identities=25%  Similarity=0.391  Sum_probs=209.3

Q ss_pred             hhhhhhcCCCCcceEEEeee----eCCCcceEEEEEcccccc-chhHHHHHHhhhhccc-ccCCccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFV----NMGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~L  557 (762)
                      +.+.+.||+|+||.||+|..    +..+++.||||+++.... ...+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  104 (313)
T 1t46_A           25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV  104 (313)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEE
Confidence            44567899999999999975    334567899999975433 3456899999999999 99999999999999999999


Q ss_pred             EEeccCCCchhhhccCCC------------------CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC
Q 004312          558 VYEFMSNGALASFLFGDS------------------KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY  619 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~  619 (762)
                      ||||+++|+|.+++....                  .+++..+..++.||++||+|||++   +|+||||||+|||++++
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~  181 (313)
T 1t46_A          105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG  181 (313)
T ss_dssp             EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETT
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCC
Confidence            999999999999997543                  489999999999999999999999   99999999999999999


Q ss_pred             CceEEecccccccccCCCCcc-cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccc
Q 004312          620 YNARISDFGLEKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERT  697 (762)
Q Consensus       620 ~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~  697 (762)
                      +.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.........    
T Consensus       182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----  257 (313)
T 1t46_A          182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF----  257 (313)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH----
T ss_pred             CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH----
Confidence            999999999998765443322 233457889999999999999999999999999999999 88887433211111    


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       698 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                       ...+........+...+.++.+++.+||+.||.+|||++|++++|+++.
T Consensus       258 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          258 -YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             -HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence             1111111122223345678999999999999999999999999998854

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=361.08  Aligned_cols=251  Identities=22%  Similarity=0.298  Sum_probs=204.9

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .+.+.+.||+|+||.||++.. ..+++.+|+|++....  ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        12 ~Y~i~~~LG~G~fg~V~~~~~-~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           12 EYQLFEELGKGAFSVVRRCVK-VLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HEEEEEEEEEC--CEEEEEEE-TTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CeEEEEEeccCCCeEEEEEEE-CCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            355668899999999999964 3456799999987543  2334678999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc---CCCceEEecccccccccCCC
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~~~~~  637 (762)
                      |+++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||++   +++.+||+|||+++......
T Consensus        91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~  167 (444)
T 3soa_A           91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ  167 (444)
T ss_dssp             CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence            999999999998888899999999999999999999999   999999999999998   56789999999998765332


Q ss_pred             CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                       .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..................   .........+++
T Consensus       168 -~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~s~~  243 (444)
T 3soa_A          168 -QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD---FPSPEWDTVTPE  243 (444)
T ss_dssp             -CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCTTTTTTSCHH
T ss_pred             -ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC---CCccccccCCHH
Confidence             2234467999999999999999999999999999999999999998554333222221111100   011111245678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +.+++.+||+.||++|||++|+++
T Consensus       244 ~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          244 AKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCCCHHHHhc
Confidence            999999999999999999999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.1e-40  Score=345.79  Aligned_cols=251  Identities=30%  Similarity=0.453  Sum_probs=206.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+|...  +++.||||++.... ...+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus        15 y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   90 (279)
T 1qpc_A           15 LKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (279)
T ss_dssp             EEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             hhheeeecCCCCeEEEEEEEc--CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence            345678999999999999754  34689999987543 345789999999999999999999999864 46899999999


Q ss_pred             CCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|.+++....  .+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||++...........
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  167 (279)
T 1qpc_A           91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR  167 (279)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred             CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence            999999997653  689999999999999999999999   999999999999999999999999999987754433333


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......+....      +........+...++++.+
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~  241 (279)
T 1qpc_A          168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN------LERGYRMVRPDNCPEELYQ  241 (279)
T ss_dssp             TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH------HHTTCCCCCCTTCCHHHHH
T ss_pred             cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH------HhcccCCCCcccccHHHHH
Confidence            34557889999999998899999999999999999999 8888744322221111      1111112223345678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      ++.+||+.||++|||++++++.|+++.
T Consensus       242 li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          242 LMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhccChhhCCCHHHHHHHHHHHH
Confidence            999999999999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-39  Score=357.43  Aligned_cols=255  Identities=24%  Similarity=0.415  Sum_probs=194.2

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCC--cceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceecc-CCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGS--SDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-GRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~LV~E  560 (762)
                      .+.+.||+|+||.||+|.+...+  ...||||.++... ....++|.+|+.++++++||||+++++++.+ .+..++|||
T Consensus        92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e  171 (373)
T 3c1x_A           92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  171 (373)
T ss_dssp             EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred             ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence            34578999999999999875433  3468999987543 3445789999999999999999999998754 557899999


Q ss_pred             ccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          561 FMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |+++|+|.+++... ..+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+++........
T Consensus       172 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence            99999999999865 4688999999999999999999999   9999999999999999999999999999866433221


Q ss_pred             ---ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCC-CCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          640 ---TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR-TILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       640 ---~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                         ......+++.|+|||.+.+..++.++||||||+++|||++|+. |+......+      ....+........+..++
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~------~~~~~~~~~~~~~p~~~~  322 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGRRLLQPEYCP  322 (373)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC------HHHHHHTTCCCCCCTTCC
T ss_pred             cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH------HHHHHHcCCCCCCCCCCC
Confidence               2233457889999999999999999999999999999999554 442211111      111111111222233456


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus       323 ~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          323 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            789999999999999999999999999988654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.6e-40  Score=353.14  Aligned_cols=258  Identities=22%  Similarity=0.343  Sum_probs=195.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCc--ceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccCCce----
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSS--DQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNR----  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~----  555 (762)
                      +.+.+.||+|+||.||+|......+  ..||||+++..  .....+.+.+|++++++++||||+++++++......    
T Consensus        25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (323)
T 3qup_A           25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP  104 (323)
T ss_dssp             CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred             eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence            4566789999999999997654322  37999999754  344567899999999999999999999999877655    


Q ss_pred             --eEEEeccCCCchhhhccCC------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecc
Q 004312          556 --LLVYEFMSNGALASFLFGD------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDF  627 (762)
Q Consensus       556 --~LV~E~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  627 (762)
                        ++||||+++|+|.+++...      ..+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+||
T Consensus       105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Df  181 (323)
T 3qup_A          105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADF  181 (323)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeec
Confidence              9999999999999998543      2589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccc
Q 004312          628 GLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVEND  705 (762)
Q Consensus       628 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  705 (762)
                      |+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..........      .+...
T Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~------~~~~~  255 (323)
T 3qup_A          182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN------YLIGG  255 (323)
T ss_dssp             CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH------HHHTT
T ss_pred             cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH------HHhcC
Confidence            99987644332 22233456789999999999999999999999999999999 888874432211111      11111


Q ss_pred             cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCC
Q 004312          706 LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP  750 (762)
Q Consensus       706 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  750 (762)
                      .....+...++++.+++.+||+.||++|||++++++.|+++++.+
T Consensus       256 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            112223455678999999999999999999999999999987654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=7.5e-40  Score=351.74  Aligned_cols=251  Identities=26%  Similarity=0.308  Sum_probs=201.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         9 y~i~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   87 (323)
T 3tki_A            9 WDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   87 (323)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             ceeeeEEecCCCEEEEEEEEC-CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence            345578999999999999754 456799999986432 233467899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC-Cccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ-SHTN  641 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-~~~~  641 (762)
                      ++++|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.... ....
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           88 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence            9999999999888899999999999999999999998   99999999999999999999999999998764332 2223


Q ss_pred             ccccccCcccCcccccCCCC-CCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.........    .................+..+.+
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  240 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE----YSDWKEKKTYLNPWKKIDSAPLA  240 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH----HHHHHTTCTTSTTGGGSCHHHHH
T ss_pred             CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH----HHHHhcccccCCccccCCHHHHH
Confidence            45679999999999987765 78999999999999999999998533211000    00011111111112345678889


Q ss_pred             HHHHhhccCCCCCCCHHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ++.+||+.||++|||++|+++.
T Consensus       241 li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          241 LLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHccCChhhCcCHHHHhhC
Confidence            9999999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.1e-40  Score=349.92  Aligned_cols=266  Identities=20%  Similarity=0.284  Sum_probs=200.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhcccccCCccchhceeccCCce----e
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNR----L  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~----~  556 (762)
                      +.+.+.||+|+||.||++... .+++.||||+++....   .....+.+|++++++++||||+++++++......    +
T Consensus        14 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   92 (311)
T 3ork_A           14 YELGEILGFGGMSEVHLARDL-RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   92 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             EEEEEEEccCCCEEEEEEEEC-CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence            445678999999999999753 4567999999976432   2345789999999999999999999998765543    9


Q ss_pred             EEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      +||||+++++|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        93 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence            9999999999999998888899999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CC--cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHH
Q 004312          637 QS--HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       637 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  714 (762)
                      ..  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....................   .......
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~  246 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---SARHEGL  246 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH---HHHSTTC
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc---ccccCCC
Confidence            22  222345689999999999999999999999999999999999999865433322211111100000   0001124


Q ss_pred             HHHHHHHHHHhhccCCCCCCCH-HHHHHHhhcCcCCCCCCCCC
Q 004312          715 LQRFVMVAIWCIQEDPSHRPTM-RRVTQMLEGVVEVPIPPCPW  756 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RPt~-~evl~~L~~~~~~~~p~~p~  756 (762)
                      +.++.+++.+||+.||++||+. +++...|..+.....|..|.
T Consensus       247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~  289 (311)
T 3ork_A          247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK  289 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCC
T ss_pred             CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCc
Confidence            6788999999999999999954 55556676655444444443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.1e-39  Score=347.36  Aligned_cols=246  Identities=21%  Similarity=0.303  Sum_probs=194.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCc--------
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRN--------  554 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~--------  554 (762)
                      +.+.+.||+|+||.||+|+.. .+++.||||+++... ....+.+.+|++++++++||||+++++++.+...        
T Consensus         8 y~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~   86 (332)
T 3qd2_B            8 FEPIQCMGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD   86 (332)
T ss_dssp             EEEEEEEECC-CSEEEEEEET-TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred             CceeeEecCCCCeEEEEEEEc-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence            345578999999999999754 456799999997533 3345789999999999999999999998855432        


Q ss_pred             -------------------------------------------------eeEEEeccCCCchhhhccCCC---CCCHHHH
Q 004312          555 -------------------------------------------------RLLVYEFMSNGALASFLFGDS---KPNWKLR  582 (762)
Q Consensus       555 -------------------------------------------------~~LV~E~~~~gsL~~~l~~~~---~l~~~~~  582 (762)
                                                                       .++||||+++++|.+++....   ...+..+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~  166 (332)
T 3qd2_B           87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC  166 (332)
T ss_dssp             C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred             hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence                                                             789999999999999998764   3466678


Q ss_pred             HHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC-----------cccccccccCccc
Q 004312          583 TEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-----------HTNTAIRGTKGYV  651 (762)
Q Consensus       583 ~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~~y~  651 (762)
                      ..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......           .......||+.|+
T Consensus       167 ~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          167 LHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            99999999999999998   999999999999999999999999999987754322           1223456999999


Q ss_pred             CcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCC
Q 004312          652 APEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPS  731 (762)
Q Consensus       652 aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~  731 (762)
                      |||.+.+..++.++||||||+++|||++|..|+.....  ....     .... ...........++.+++.+||+.||+
T Consensus       244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~--~~~~-----~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~  315 (332)
T 3qd2_B          244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR--IITD-----VRNL-KFPLLFTQKYPQEHMMVQDMLSPSPT  315 (332)
T ss_dssp             CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH--HHHH-----HHTT-CCCHHHHHHCHHHHHHHHHHHCSSGG
T ss_pred             ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH--HHHH-----hhcc-CCCcccccCChhHHHHHHHHccCCCC
Confidence            99999999999999999999999999999877422211  1100     0000 01111234456779999999999999


Q ss_pred             CCCCHHHHHH
Q 004312          732 HRPTMRRVTQ  741 (762)
Q Consensus       732 ~RPt~~evl~  741 (762)
                      +|||++|+++
T Consensus       316 ~Rps~~~~l~  325 (332)
T 3qd2_B          316 ERPEATDIIE  325 (332)
T ss_dssp             GSCCHHHHHH
T ss_pred             cCCCHHHHhh
Confidence            9999999997

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.6e-39  Score=353.02  Aligned_cols=251  Identities=23%  Similarity=0.309  Sum_probs=205.3

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      ..+.+.+.||+|+||.||++... .+++.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            34556788999999999999754 456799999997532  233467899999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC---CceEEecccccccccCC
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY---YNARISDFGLEKLLTLD  636 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~Dfgla~~~~~~  636 (762)
                      ||+++|+|.+++.....+++..+..++.||++||+|||++   +|+||||||+|||++.+   +.+||+|||++......
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            9999999999998888899999999999999999999999   99999999999999864   45999999999876532


Q ss_pred             CCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          637 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                        .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..................   ........+++
T Consensus       185 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~  259 (362)
T 2bdw_A          185 --EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD---YPSPEWDTVTP  259 (362)
T ss_dssp             --CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---CCTTGGGGSCH
T ss_pred             --cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC---CCcccccCCCH
Confidence              2233467999999999999999999999999999999999999998554332222211110000   01111123567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ++.+++.+||+.||++|||++|+++
T Consensus       260 ~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          260 EAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhc
Confidence            8999999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.9e-40  Score=352.10  Aligned_cols=261  Identities=24%  Similarity=0.328  Sum_probs=212.4

Q ss_pred             hhhhhhcCCCCcceEEEeee---eCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceec--cCCceeEE
Q 004312          484 RGFKEELGRGAFGTVYKGFV---NMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCD--EGRNRLLV  558 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~---~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~LV  558 (762)
                      +.+.+.||+|+||.||++.+   +..+++.||||++........+.+.+|++++++++||||+++++++.  +....++|
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv  104 (327)
T 3lxl_A           25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV  104 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred             hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEE
Confidence            34567899999999999985   34456789999998766666778999999999999999999999886  45668899


Q ss_pred             EeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          559 YEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      |||+++++|.+++... ..+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++......
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~  181 (327)
T 3lxl_A          105 MEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK  181 (327)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred             EeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence            9999999999999763 5689999999999999999999998   99999999999999999999999999998765433


Q ss_pred             Cc--ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc---------ccccccccccc
Q 004312          638 SH--TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE---------RTLGALVENDL  706 (762)
Q Consensus       638 ~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~---------~~~~~~~~~~~  706 (762)
                      ..  ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.|+...........         ......+....
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (327)
T 3lxl_A          182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ  261 (327)
T ss_dssp             SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC
T ss_pred             ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc
Confidence            22  22334578889999999998999999999999999999999999754432211000         01111222222


Q ss_pred             ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          707 EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       707 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      ....+..+++.+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       262 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          262 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            33334456788999999999999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2e-39  Score=356.75  Aligned_cols=250  Identities=22%  Similarity=0.279  Sum_probs=201.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .+.+.||+|+||.||+++.. .+++.||||++++...   .....+.+|..++.++ +||||+++++++.+.+..+||||
T Consensus        55 ~~~~~LG~G~fG~V~~~~~~-~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E  133 (396)
T 4dc2_A           55 DLLRVIGRGSYAKVLLVRLK-KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE  133 (396)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             EEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence            45578999999999999765 4567899999976432   2234688999999887 89999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++|+|..++.....+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++.... ....
T Consensus       134 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~-~~~~  209 (396)
T 4dc2_A          134 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDT  209 (396)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-TTCC
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc-CCCc
Confidence            999999999998888899999999999999999999999   999999999999999999999999999985332 2233


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhh----hccccccccccccccCCCHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCY----QERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      ....+||+.|+|||++.+..++.++||||||+++|||++|+.||.........    .+.....+.....  ..+...+.
T Consensus       210 ~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~s~  287 (396)
T 4dc2_A          210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSV  287 (396)
T ss_dssp             BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--CCCTTSCH
T ss_pred             cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--CCCCcCCH
Confidence            45577999999999999999999999999999999999999998432111000    0001111111111  12334567


Q ss_pred             HHHHHHHHhhccCCCCCCCH------HHHHH
Q 004312          717 RFVMVAIWCIQEDPSHRPTM------RRVTQ  741 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~------~evl~  741 (762)
                      ++.+|+.+||+.||++||++      +||++
T Consensus       288 ~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          288 KAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence            89999999999999999985      56654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.5e-39  Score=339.41  Aligned_cols=247  Identities=21%  Similarity=0.348  Sum_probs=202.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccC--CceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--RNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~LV~E  560 (762)
                      .+.+.||+|+||.||+|+..   ++.||||+++...  ....+.+.+|++++++++||||+++++++.+.  ...++|||
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (271)
T 3kmu_A           13 NFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH   89 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEET---TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred             HHHHHhcCCCcceEEEEEEC---CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence            45578999999999999864   5689999987542  33456799999999999999999999999877  77899999


Q ss_pred             ccCCCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          561 FMSNGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQ--IIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      |+++|+|.+++....  .+++..+..++.||+.||+|||+.   +  |+||||||+|||+++++.++|+|||++....  
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--  164 (271)
T 3kmu_A           90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--  164 (271)
T ss_dssp             CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred             ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence            999999999998765  489999999999999999999998   7  9999999999999999999999999876432  


Q ss_pred             CCcccccccccCcccCcccccCCCCCC---cchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHH
Q 004312          637 QSHTNTAIRGTKGYVAPEWFRNMPITV---KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMT  713 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~---~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  713 (762)
                          .....+|+.|+|||.+.+...+.   ++||||||+++|||++|+.||...........     ..........+..
T Consensus       165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~  235 (271)
T 3kmu_A          165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK-----VALEGLRPTIPPG  235 (271)
T ss_dssp             ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH-----HHHSCCCCCCCTT
T ss_pred             ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH-----HHhcCCCCCCCCC
Confidence                22345899999999998765444   89999999999999999999854332222111     1111122223344


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          714 VLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       714 ~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      .+.++.+++.+||+.||++|||++|+++.|+.+.+
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          236 ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            56789999999999999999999999999988653

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=344.99  Aligned_cols=246  Identities=28%  Similarity=0.444  Sum_probs=193.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      .+.+.||+|+||.||+|+..   ++.||||++..  ....+.|.+|++++++++||||+++++++.+  ..++||||+++
T Consensus        11 ~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~   83 (307)
T 2eva_A           11 EVEEVVGRGAFGVVCKAKWR---AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG   83 (307)
T ss_dssp             EEEEEEECCSSSEEEEEEET---TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred             eeeeEeecCCCceEEEEEEC---CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence            35578999999999999764   46899999864  3445789999999999999999999999874  47999999999


Q ss_pred             CchhhhccCCC---CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc-eEEecccccccccCCCCcc
Q 004312          565 GALASFLFGDS---KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN-ARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       565 gsL~~~l~~~~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~-~kl~Dfgla~~~~~~~~~~  640 (762)
                      ++|.+++....   .+++..++.++.||++||+|||+....+|+||||||+|||+++++. +||+|||++......    
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----  159 (307)
T 2eva_A           84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----  159 (307)
T ss_dssp             CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred             CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence            99999998764   4688999999999999999999932239999999999999998876 799999999755322    


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhH--HHhhhccccccccccccccCCCHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA--YDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....  .....      ..............+..+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l  233 (307)
T 2eva_A          160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW------AVHNGTRPPLIKNLPKPI  233 (307)
T ss_dssp             -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH------HHHTTCCCCCBTTCCHHH
T ss_pred             cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH------HHhcCCCCCcccccCHHH
Confidence            2234589999999999999999999999999999999999999743210  00000      000111111223456788


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      .+++.+||+.||++|||++|++++|+.+.
T Consensus       234 ~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            99999999999999999999999998864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.3e-39  Score=340.28  Aligned_cols=250  Identities=29%  Similarity=0.407  Sum_probs=193.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc----chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ----DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .+.+.||+|+||.||+|...   ++.||||+++....    ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        10 ~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (271)
T 3dtc_A           10 TLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME   86 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEET---TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred             eeeeeeccCCCeEEEEEEEc---CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence            45578999999999999753   56899999875322    224678999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC--------CCceEEeccccccc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD--------YYNARISDFGLEKL  632 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~--------~~~~kl~Dfgla~~  632 (762)
                      |+++++|.+++. ...+++..+..++.|+++||+|||++...+|+||||||+|||++.        ++.+||+|||+++.
T Consensus        87 ~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~  165 (271)
T 3dtc_A           87 FARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE  165 (271)
T ss_dssp             CCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred             cCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence            999999999985 457899999999999999999999982223999999999999986        77899999999986


Q ss_pred             ccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCH
Q 004312          633 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDM  712 (762)
Q Consensus       633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (762)
                      .....   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........     ..........+.
T Consensus       166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~  237 (271)
T 3dtc_A          166 WHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG-----VAMNKLALPIPS  237 (271)
T ss_dssp             -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH-----HHTSCCCCCCCT
T ss_pred             ccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh-----hhcCCCCCCCCc
Confidence            54322   2245689999999999999999999999999999999999999854322222111     111111222234


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       713 ~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      ..++.+.+++.+||+.||++|||++|+++.|+++
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            4567899999999999999999999999999864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-39  Score=343.97  Aligned_cols=253  Identities=27%  Similarity=0.384  Sum_probs=211.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+|... ..++.||||++... ....+.+.+|++++++++||||+++++++.+....++||||++
T Consensus        15 ~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   92 (288)
T 3kfa_A           15 ITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   92 (288)
T ss_dssp             EEEEEESGGGTTCSEEEEEEG-GGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             eeEEeecCCCCceeEEEeEec-CCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence            345678999999999999765 34678999998753 3456789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|.+++...  ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++...........
T Consensus        93 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  169 (288)
T 3kfa_A           93 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  169 (288)
T ss_dssp             TEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEE
T ss_pred             CCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccc
Confidence            99999999753  4589999999999999999999999   999999999999999999999999999987765544444


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++ |..|+.......      ....+........+...++++.+
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~  243 (288)
T 3kfa_A          170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE  243 (288)
T ss_dssp             TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------HHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHhccCCCCCCCCCCHHHHH
Confidence            45567889999999999999999999999999999999 888864322111      11112222222233455678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      ++.+||+.||.+|||++|++++|+.+.
T Consensus       244 li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          244 LMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999999998753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-39  Score=348.73  Aligned_cols=246  Identities=19%  Similarity=0.252  Sum_probs=203.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||++... .+++.+|+|.+... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         7 y~~~~~lG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~   84 (321)
T 1tki_A            7 YMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             eEeeeEEecCCCeEEEEEEEC-CCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence            345678999999999999754 45678999998753 3345678999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC--CCceEEecccccccccCCCCcc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD--YYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +++|.+++... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.  ++.+||+|||+++.....  ..
T Consensus        85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~--~~  159 (321)
T 1tki_A           85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DN  159 (321)
T ss_dssp             CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--CE
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--Cc
Confidence            99999999765 4799999999999999999999999   9999999999999987  789999999999876532  23


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccC--CCHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM--DDMTVLQRF  718 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  718 (762)
                      .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........     +........  .....+.++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-----i~~~~~~~~~~~~~~~s~~~  234 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN-----IMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----HHHTCCCCCHHHHTTSCHHH
T ss_pred             cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH-----HHcCCCCCChhhhccCCHHH
Confidence            3446699999999999988899999999999999999999999865433322221     111111100  011346788


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+++.+||+.||++|||++|+++
T Consensus       235 ~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          235 MDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHhc
Confidence            99999999999999999999987

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=350.76  Aligned_cols=261  Identities=16%  Similarity=0.173  Sum_probs=198.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC--CCcceEEEEEccccccc-----------hhHHHHHHhhhhcccccCCccchhceec
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVFQD-----------SEKEFKAEVNGIGQTHHKNLVRLLGYCD  550 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~g~~~  550 (762)
                      +.+.+.||+|+||.||+|....  ...+.+|||++......           ....+.+|+..+..++||||+++++++.
T Consensus        39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~  118 (345)
T 2v62_A           39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL  118 (345)
T ss_dssp             EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEE
T ss_pred             EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccc
Confidence            4566789999999999998653  14578999998754321           1234678888999999999999999998


Q ss_pred             c----CCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC--ceEE
Q 004312          551 E----GRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY--NARI  624 (762)
Q Consensus       551 ~----~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~--~~kl  624 (762)
                      .    ....++||||+ +++|.+++...+.+++..+..|+.||+.||+|||++   +|+||||||+|||++.++  .+||
T Consensus       119 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kL  194 (345)
T 2v62_A          119 TEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYL  194 (345)
T ss_dssp             EESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEEE
T ss_pred             cccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEEE
Confidence            7    67889999999 999999998878899999999999999999999999   999999999999999877  9999


Q ss_pred             ecccccccccCCCC------cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHh----hh
Q 004312          625 SDFGLEKLLTLDQS------HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDC----YQ  694 (762)
Q Consensus       625 ~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~----~~  694 (762)
                      +|||+++.+.....      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........    ..
T Consensus       195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  274 (345)
T 2v62_A          195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK  274 (345)
T ss_dssp             CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred             EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence            99999987643321      112445799999999999999999999999999999999999999843211110    00


Q ss_pred             ccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          695 ERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ......+.............++++.+++.+||+.||++||++++|++.|+++..
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          275 TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            000000000000000011345689999999999999999999999999988543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.2e-40  Score=350.62  Aligned_cols=261  Identities=24%  Similarity=0.335  Sum_probs=208.8

Q ss_pred             hhhhhcCCCCcceEEEeeee---CCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceecc--CCceeEE
Q 004312          485 GFKEELGRGAFGTVYKGFVN---MGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GRNRLLV  558 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~---~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~LV  558 (762)
                      .+.+.||+|+||.||++.+.   ..+++.||||+++... ....+.+.+|++++++++||||+++++++.+  ....++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            45678999999999888653   2356789999997643 2345679999999999999999999999977  4567999


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      |||+++++|.+++... .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       114 ~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  189 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  189 (318)
T ss_dssp             ECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred             EecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence            9999999999999765 489999999999999999999999   999999999999999999999999999987754332


Q ss_pred             --cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHH---------hhhccccccccccccc
Q 004312          639 --HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYD---------CYQERTLGALVENDLE  707 (762)
Q Consensus       639 --~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~---------~~~~~~~~~~~~~~~~  707 (762)
                        .......+++.|+|||.+.+..++.++||||||+++|||++|+.|+.......         ..........+.....
T Consensus       190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (318)
T 3lxp_A          190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER  269 (318)
T ss_dssp             EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC
T ss_pred             ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC
Confidence              12234457888999999999899999999999999999999999975432110         0111112222223333


Q ss_pred             cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       708 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      ...+..++.++.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus       270 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          270 LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            333455678899999999999999999999999999987543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=8.3e-40  Score=355.34  Aligned_cols=246  Identities=24%  Similarity=0.326  Sum_probs=200.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +.+.+.||+|+||.||+++.. .+++.||||++++.   .......+.+|++++.++ +||||+++++++.+.+..+|||
T Consensus        25 y~~~~~lG~G~fg~V~~~~~~-~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~  103 (353)
T 3txo_A           25 FEFIRVLGKGSFGKVMLARVK-ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM  103 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             eEEEEEEeeCCCEEEEEEEEc-CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence            345678999999999999754 45679999999753   223445688999999988 7999999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      ||+++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++.... ...
T Consensus       104 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~-~~~  179 (353)
T 3txo_A          104 EFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC-NGV  179 (353)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc-CCc
Confidence            9999999999998888899999999999999999999999   999999999999999999999999999985432 223


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      .....+||+.|+|||++.+..++.++||||||+++|||++|+.||......+.....     .....  ..+...++++.
T Consensus       180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i-----~~~~~--~~p~~~~~~~~  252 (353)
T 3txo_A          180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI-----LNDEV--VYPTWLHEDAT  252 (353)
T ss_dssp             ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHCCC--CCCTTSCHHHH
T ss_pred             cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH-----HcCCC--CCCCCCCHHHH
Confidence            344567999999999999889999999999999999999999998655433322221     11111  12233567889


Q ss_pred             HHHHHhhccCCCCCCCH------HHHHH
Q 004312          720 MVAIWCIQEDPSHRPTM------RRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~------~evl~  741 (762)
                      +++.+||+.||++||++      +|+++
T Consensus       253 ~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          253 GILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            99999999999999998      67764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-39  Score=350.89  Aligned_cols=254  Identities=24%  Similarity=0.356  Sum_probs=201.1

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCc---ceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSS---DQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .+.+.||+|+||.||+|.......   ..||+|.+.... ......+.+|+.++++++||||+++++++. .+..++|||
T Consensus        16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   94 (325)
T 3kex_A           16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ   94 (325)
T ss_dssp             EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred             eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence            345789999999999998653322   138888875432 233457889999999999999999999986 566899999


Q ss_pred             ccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          561 FMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |+++|+|.+++... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........
T Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  171 (325)
T 3kex_A           95 YLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ  171 (325)
T ss_dssp             CCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred             eCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence            99999999999875 5789999999999999999999999   9999999999999999999999999999987544332


Q ss_pred             -ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          640 -TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       640 -~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                       ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........      ...+........+...+.+
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~  245 (325)
T 3kex_A          172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV------PDLLEKGERLAQPQICTID  245 (325)
T ss_dssp             CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH------HHHHHTTCBCCCCTTBCTT
T ss_pred             ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH------HHHHHcCCCCCCCCcCcHH
Confidence             2344567889999999999999999999999999999999 9999754321111      1111111122222334557


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      +.+++.+||+.||++|||++|+++.|+.+..
T Consensus       246 ~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          246 VYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             TTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            8899999999999999999999999988643

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.3e-39  Score=338.72  Aligned_cols=250  Identities=26%  Similarity=0.418  Sum_probs=199.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccch-------hHHHHHHhhhhcccccCCccchhceeccCCcee
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS-------EKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRL  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  556 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++.......       .+.+.+|++++++++||||+++++++.+..  +
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~   97 (287)
T 4f0f_A           21 IEYEKQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--R   97 (287)
T ss_dssp             EEEEEECCCCSSSCEEEEEET-TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--E
T ss_pred             ceehhccccCCceeEEEEEEc-CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--e
Confidence            345678999999999999764 456799999986433221       167999999999999999999999997665  6


Q ss_pred             EEEeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEeCCCCCCceEEcCCCc-----eEEeccc
Q 004312          557 LVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQ--IIHCDIKPQNILLDDYYN-----ARISDFG  628 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NILl~~~~~-----~kl~Dfg  628 (762)
                      +||||+++++|.+++... ..+++..+..++.|++.||+|||++   +  |+||||||+|||++.++.     +||+|||
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A           98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence            999999999999888665 5789999999999999999999998   8  999999999999988776     9999999


Q ss_pred             ccccccCCCCcccccccccCcccCcccc--cCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccc
Q 004312          629 LEKLLTLDQSHTNTAIRGTKGYVAPEWF--RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL  706 (762)
Q Consensus       629 la~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  706 (762)
                      +++...    .......||+.|+|||.+  ....++.++||||||+++|||++|+.||.........   ..........
T Consensus       175 ~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~  247 (287)
T 4f0f_A          175 LSQQSV----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK---FINMIREEGL  247 (287)
T ss_dssp             TCBCCS----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH---HHHHHHHSCC
T ss_pred             cccccc----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH---HHHHHhccCC
Confidence            997433    233446799999999998  4456789999999999999999999997432111100   0011111122


Q ss_pred             ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          707 EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       707 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      ....+..+++++.+++.+||+.||++|||++|+++.|+++
T Consensus       248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            2223345567899999999999999999999999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-39  Score=344.58  Aligned_cols=242  Identities=23%  Similarity=0.336  Sum_probs=204.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||+++.. .+++.||+|++++..   ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus         9 ~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~   87 (318)
T 1fot_A            9 QILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   87 (318)
T ss_dssp             EEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence            45578999999999999754 456799999997532   23346788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....    ..
T Consensus        88 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----~~  160 (318)
T 1fot_A           88 IEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VT  160 (318)
T ss_dssp             CCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS----CB
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC----cc
Confidence            99999999998888899999999999999999999998   999999999999999999999999999986532    23


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ...+||+.|+|||.+.+..++.++||||||+++|||++|+.||...........     ++....  ..+...++++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-----i~~~~~--~~p~~~~~~~~~l  233 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK-----ILNAEL--RFPPFFNEDVKDL  233 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----HHHCCC--CCCTTSCHHHHHH
T ss_pred             ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhCCC--CCCCCCCHHHHHH
Confidence            346799999999999999999999999999999999999999865433322221     111111  1223456789999


Q ss_pred             HHHhhccCCCCCC-----CHHHHHH
Q 004312          722 AIWCIQEDPSHRP-----TMRRVTQ  741 (762)
Q Consensus       722 i~~cl~~dp~~RP-----t~~evl~  741 (762)
                      +.+||+.||++||     +++|+++
T Consensus       234 i~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          234 LSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHhccCHHHcCCCcCCCHHHHhc
Confidence            9999999999999     8899884

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.7e-39  Score=344.97  Aligned_cols=257  Identities=24%  Similarity=0.271  Sum_probs=203.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceec----cCCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCD----EGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~----~~~~~~LV~  559 (762)
                      +.+.+.||+|+||.||++... .+++.||||++........+.+.+|++++++++||||+++++++.    .....++||
T Consensus        31 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~  109 (317)
T 2buj_A           31 YLFIQKLGEGGFSYVDLVEGL-HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL  109 (317)
T ss_dssp             EEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred             EEEEEEecCCCCeEEEEEEec-CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence            445678999999999999753 456799999997765666778999999999999999999999986    345778999


Q ss_pred             eccCCCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          560 EFMSNGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       560 E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ||+++|+|.+++..    ...+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI  186 (317)
T ss_dssp             ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred             EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence            99999999999864    46789999999999999999999999   999999999999999999999999999876532


Q ss_pred             CCCc--------ccccccccCcccCcccccCCC---CCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccc
Q 004312          636 DQSH--------TNTAIRGTKGYVAPEWFRNMP---ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN  704 (762)
Q Consensus       636 ~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  704 (762)
                      ....        ......||+.|+|||.+....   ++.++||||||+++|||++|+.||......    ..........
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~  262 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK----GDSVALAVQN  262 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT----TSCHHHHHHC
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc----cchhhHHhhc
Confidence            2111        112345799999999987554   789999999999999999999997432111    0111111111


Q ss_pred             ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       705 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ..........+.++.+++.+||+.||++|||++|+++.|+.+..
T Consensus       263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            11222233456789999999999999999999999999998754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.1e-39  Score=342.93  Aligned_cols=254  Identities=22%  Similarity=0.319  Sum_probs=202.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCC--cceEEEEEcccc-ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGS--SDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||+|......  ...||||++... .....+.+.+|++++++++||||+++++++.+. ..++||||
T Consensus        15 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~   93 (281)
T 3cc6_A           15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMEL   93 (281)
T ss_dssp             EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEEC
T ss_pred             EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEec
Confidence            35578999999999999865432  346999999764 234457899999999999999999999998654 56899999


Q ss_pred             cCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          562 MSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       562 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +++++|.+++... ..+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||++..........
T Consensus        94 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  170 (281)
T 3cc6_A           94 YPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK  170 (281)
T ss_dssp             CTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-------
T ss_pred             CCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccccccc
Confidence            9999999999764 4689999999999999999999998   99999999999999999999999999998765444333


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..........      .+........+...++.+.
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~  244 (281)
T 3cc6_A          171 ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG------VLEKGDRLPKPDLCPPVLY  244 (281)
T ss_dssp             --CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH------HHHHTCCCCCCTTCCHHHH
T ss_pred             cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH------HHhcCCCCCCCCCCCHHHH
Confidence            444567889999999998999999999999999999998 999974322111111      1111111122334567899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      +++.+||+.||++|||++|+++.|+.+.+
T Consensus       245 ~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          245 TLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence            99999999999999999999999987643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-39  Score=353.46  Aligned_cols=250  Identities=24%  Similarity=0.317  Sum_probs=206.3

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+|... .+++.||+|++..........+.+|++++++++||||+++++++.+....++||||++
T Consensus        53 y~i~~~LG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  131 (387)
T 1kob_A           53 YDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS  131 (387)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             eEEEEEEecCCCEEEEEEEEC-CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence            445678999999999999754 4567999999987655566789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC--CCceEEecccccccccCCCCcc
Q 004312          564 NGALASFLFGDS-KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD--YYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       564 ~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +|+|.+++.... .+++..+..++.||+.||+|||++   +|+||||||+|||++.  ++.+||+|||+++......  .
T Consensus       132 gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~  206 (387)
T 1kob_A          132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--I  206 (387)
T ss_dssp             CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--C
T ss_pred             CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc--c
Confidence            999999997654 789999999999999999999999   9999999999999974  5789999999998765332  2


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.................   ..........+.++.+
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~s~~~~~  283 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW---EFDEDAFSSVSPEAKD  283 (387)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC---CCCSSTTTTSCHHHHH
T ss_pred             eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCccccccCCHHHHH
Confidence            3345699999999999999999999999999999999999999865433322221111000   0111112245678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ++.+||+.||++|||++|+++.
T Consensus       284 li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          284 FIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHcCCChhHCcCHHHHhhC
Confidence            9999999999999999999873

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-39  Score=342.75  Aligned_cols=254  Identities=25%  Similarity=0.376  Sum_probs=205.0

Q ss_pred             hhhcCCCCcceEEEeeeeCC--CcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCce-eEEEecc
Q 004312          487 KEELGRGAFGTVYKGFVNMG--SSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNR-LLVYEFM  562 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~-~LV~E~~  562 (762)
                      .+.||+|+||.||+|.....  ....+|+|++..... ...+.+.+|++++++++||||+++++++.+.+.. ++||||+
T Consensus        26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  105 (298)
T 3pls_A           26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM  105 (298)
T ss_dssp             EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred             CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence            46799999999999986433  223799999876433 3456899999999999999999999999876665 9999999


Q ss_pred             CCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC---C
Q 004312          563 SNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ---S  638 (762)
Q Consensus       563 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~---~  638 (762)
                      .+++|.+++... ..+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++......   .
T Consensus       106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  182 (298)
T 3pls_A          106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV  182 (298)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred             cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence            999999999874 5689999999999999999999999   99999999999999999999999999998654322   1


Q ss_pred             cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          639 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++|+.|+.......     .....+........+...++.+
T Consensus       183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l  257 (298)
T 3pls_A          183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-----DLTHFLAQGRRLPQPEYCPDSL  257 (298)
T ss_dssp             CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-----GHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-----HHHHHhhcCCCCCCCccchHHH
Confidence            22334567899999999999999999999999999999999877753321111     1111111111222233456789


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      .+++.+||+.||.+|||++|++++|+++.+
T Consensus       258 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          258 YQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            999999999999999999999999988643

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.7e-40  Score=341.10  Aligned_cols=252  Identities=26%  Similarity=0.428  Sum_probs=207.9

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      .+.+.||+|+||.||++...  +++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus        11 ~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   87 (267)
T 3t9t_A           11 TFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH   87 (267)
T ss_dssp             EEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred             eeeeEecCCCceeEEEEEec--CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence            35578999999999999765  346899999976433 346899999999999999999999999999999999999999


Q ss_pred             CchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          565 GALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       565 gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      ++|.+++... ..+++..+..++.|+++||+|||++   +|+||||||+||++++++.+||+|||+++............
T Consensus        88 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  164 (267)
T 3t9t_A           88 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  164 (267)
T ss_dssp             CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred             CcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence            9999999765 5689999999999999999999999   99999999999999999999999999998764332222334


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ..+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...........      +........+...+..+.+++
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~------i~~~~~~~~~~~~~~~l~~li  238 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED------ISTGFRLYKPRLASTHVYQIM  238 (267)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH------HHTTCCCCCCTTSCHHHHHHH
T ss_pred             ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH------HhcCCcCCCCccCcHHHHHHH
Confidence            457789999999998899999999999999999999 7888754322222211      111111122333467889999


Q ss_pred             HHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          723 IWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       723 ~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      .+||+.||++|||++|+++.|+++.+
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          239 NHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999988654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.8e-39  Score=340.14  Aligned_cols=252  Identities=20%  Similarity=0.272  Sum_probs=198.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|+||+||+|... .+++.||||++....  ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         5 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   83 (292)
T 3o0g_A            5 EKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eeeeEecCCCCeEEEEEEEC-CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence            45578999999999999754 456799999997533  233467899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      +++.+..+......+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~  159 (292)
T 3o0g_A           84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYS  159 (292)
T ss_dssp             SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CSCCC
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc-ccccc
Confidence            8755555555567899999999999999999999999   9999999999999999999999999999876432 22234


Q ss_pred             cccccCcccCcccccCCC-CCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccc--------------cccc----
Q 004312          643 AIRGTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLG--------------ALVE----  703 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~-~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~--------------~~~~----  703 (762)
                      ...||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+...............              ...+    
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence            456899999999997765 899999999999999999999986332211111000000              0000    


Q ss_pred             -----cccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          704 -----NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       704 -----~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                           ...........++++.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                 00000111235678899999999999999999999987

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.7e-39  Score=341.27  Aligned_cols=247  Identities=20%  Similarity=0.322  Sum_probs=194.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc--------------------------hhHHHHHHhhhhccc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--------------------------SEKEFKAEVNGIGQT  537 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l  537 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++......                          ..+.+.+|+++++++
T Consensus        15 y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           15 YTLKDEIGKGSYGVVKLAYNE-NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             EEEEEEEEC--CCEEEEEEET-TTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             eEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            345678999999999999754 45679999998653211                          134688999999999


Q ss_pred             ccCCccchhceecc--CCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceE
Q 004312          538 HHKNLVRLLGYCDE--GRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNIL  615 (762)
Q Consensus       538 ~H~nIv~l~g~~~~--~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIL  615 (762)
                      +||||+++++++.+  ....++||||+++++|.+++. ...+++..+..++.||++||+|||++   +|+||||||+|||
T Consensus        94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLL  169 (298)
T ss_dssp             CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred             CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEE
Confidence            99999999999976  567899999999999998764 45789999999999999999999999   9999999999999


Q ss_pred             EcCCCceEEecccccccccCCCCcccccccccCcccCcccccCCC---CCCcchhHHHHHHHHHHHhCCCCCchhhHHHh
Q 004312          616 LDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP---ITVKVDVYSYGVLLLEIICLRRTILTDWAYDC  692 (762)
Q Consensus       616 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~  692 (762)
                      ++.++.+||+|||+++....... ......||+.|+|||.+.+..   .+.++||||||+++|||++|+.||........
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            99999999999999987653322 233457999999999997765   47889999999999999999999855432221


Q ss_pred             hhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          693 YQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ...     +.............++++.+++.+||+.||++|||++|+++
T Consensus       249 ~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          249 HSK-----IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHH-----HHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHH-----HhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            111     11111111112235678999999999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.7e-39  Score=340.55  Aligned_cols=257  Identities=28%  Similarity=0.423  Sum_probs=193.6

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .+.+.+.||+|+||.||+|+..    ..||||+++...  ....+.|.+|++++++++||||+++++++ .....++|||
T Consensus        25 ~y~~~~~lG~G~~g~Vy~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           25 QITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             SCEEEEEEEECSSEEEEEEESS----SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ceeeeeEecCCCCeEEEEEEEc----CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            3456678999999999999753    359999987543  33446799999999999999999999976 4556899999


Q ss_pred             ccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC-C
Q 004312          561 FMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ-S  638 (762)
Q Consensus       561 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-~  638 (762)
                      |+++++|.+++... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...... .
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccccc
Confidence            99999999999654 5789999999999999999999999   99999999999999999999999999998654322 2


Q ss_pred             cccccccccCcccCccccc---CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          639 HTNTAIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                      .......||+.|+|||.+.   ...++.++||||||+++|||++|+.||..........+........+... .....++
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  255 (289)
T 3og7_A          177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS-KVRSNCP  255 (289)
T ss_dssp             -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTT-SSCTTSC
T ss_pred             ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchh-hccccCC
Confidence            2233456899999999986   56789999999999999999999999854322211111111111111111 1123456


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      +++.+++.+||+.+|++|||++|++++|+++.+
T Consensus       256 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          256 KRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            789999999999999999999999999998753

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-39  Score=349.07  Aligned_cols=253  Identities=26%  Similarity=0.449  Sum_probs=199.9

Q ss_pred             hhhhcCCCCcceEEEeeeeCCC---cceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          486 FKEELGRGAFGTVYKGFVNMGS---SDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.+.||+|+||.||+|......   ...||||+++... ......+.+|++++++++||||+++++++.+.+..+|||||
T Consensus        48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  127 (333)
T 1mqb_A           48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY  127 (333)
T ss_dssp             EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeC
Confidence            3467999999999999876432   2469999997543 23456799999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          562 MSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       562 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +++++|.+++... ..+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+++.........
T Consensus       128 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  204 (333)
T 1mqb_A          128 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT  204 (333)
T ss_dssp             CTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred             CCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccccccc
Confidence            9999999999754 6789999999999999999999999   99999999999999999999999999998765433221


Q ss_pred             --cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          641 --NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       641 --~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                        .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....      +........+...+.+
T Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~------~~~~~~~~~~~~~~~~  278 (333)
T 1mqb_A          205 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA------INDGFRLPTPMDCPSA  278 (333)
T ss_dssp             ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH------HHTTCCCCCCTTCBHH
T ss_pred             cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH------HHCCCcCCCcccCCHH
Confidence              222346788999999999999999999999999999999 9999754322222111      1111112223345678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      +.+++.+||+.+|++||++.|+++.|+++.
T Consensus       279 l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          279 IYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999999999998754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=342.21  Aligned_cols=258  Identities=20%  Similarity=0.250  Sum_probs=205.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCC--ceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR--NRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~LV~E  560 (762)
                      +.+.+.||+|+||+||+|... .+++.||||++.... ....+.+.+|++++++++||||+++++++....  ..+||||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (319)
T 4euu_A           11 WLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME   89 (319)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             EEEEEEecCCCCeEEEEEEEC-CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence            345678999999999999764 456799999997543 334567889999999999999999999987655  6799999


Q ss_pred             ccCCCchhhhccCCC---CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE----cCCCceEEecccccccc
Q 004312          561 FMSNGALASFLFGDS---KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL----DDYYNARISDFGLEKLL  633 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~Dfgla~~~  633 (762)
                      |+++++|.+++....   .+++..+..++.||++||+|||++   +|+||||||+|||+    +.++.+||+|||+++..
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~  166 (319)
T 4euu_A           90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (319)
T ss_dssp             CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred             CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence            999999999998653   389999999999999999999999   99999999999999    78888999999999876


Q ss_pred             cCCCCcccccccccCcccCccccc--------CCCCCCcchhHHHHHHHHHHHhCCCCCchhhH----HHhhhc---ccc
Q 004312          634 TLDQSHTNTAIRGTKGYVAPEWFR--------NMPITVKVDVYSYGVLLLEIICLRRTILTDWA----YDCYQE---RTL  698 (762)
Q Consensus       634 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~----~~~~~~---~~~  698 (762)
                      ....  ......||+.|+|||.+.        +..++.++||||||+++|||++|+.||.....    ......   ...
T Consensus       167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             CCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            5432  233456999999999986        57889999999999999999999999742111    111100   000


Q ss_pred             ----ccc---c--------ccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          699 ----GAL---V--------ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       699 ----~~~---~--------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                          ...   .        .-.............+.+++.+||+.||++|||++|+++..++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence                000   0        000111234677889999999999999999999999999887643

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.2e-39  Score=351.97  Aligned_cols=245  Identities=22%  Similarity=0.278  Sum_probs=197.8

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCch
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGAL  567 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL  567 (762)
                      +.||+|+||.||+|... .+++.||||+++.......+.+.+|++++++++||||+++++++.+.+..+|||||+++++|
T Consensus        95 ~~lG~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           95 EILGGGRFGQVHKCEET-ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EECC-----CEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             eEEecCcCEEEEEEEEc-CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56999999999999754 45679999999876556677899999999999999999999999999999999999999999


Q ss_pred             hhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE--cCCCceEEecccccccccCCCCcccccc
Q 004312          568 ASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL--DDYYNARISDFGLEKLLTLDQSHTNTAI  644 (762)
Q Consensus       568 ~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl--~~~~~~kl~Dfgla~~~~~~~~~~~~~~  644 (762)
                      .+++... ..+++..+..++.||++||+|||+.   +|+||||||+|||+  ++++.+||+|||+++......  .....
T Consensus       174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~~  248 (373)
T 2x4f_A          174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVN  248 (373)
T ss_dssp             HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCCC
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccccc
Confidence            9988654 4689999999999999999999999   99999999999999  577899999999998765332  23345


Q ss_pred             cccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHH
Q 004312          645 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW  724 (762)
Q Consensus       645 ~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  724 (762)
                      .||+.|+|||.+....++.++||||||+++|||++|+.||......+.......... .  .........++++.+++.+
T Consensus       249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~-~--~~~~~~~~~~~~~~~li~~  325 (373)
T 2x4f_A          249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW-D--LEDEEFQDISEEAKEFISK  325 (373)
T ss_dssp             CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-C--SCSGGGTTSCHHHHHHHHT
T ss_pred             cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-C--CChhhhccCCHHHHHHHHH
Confidence            699999999999988999999999999999999999999865433322221110000 0  0001112346789999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 004312          725 CIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       725 cl~~dp~~RPt~~evl~  741 (762)
                      ||+.||++|||++|+++
T Consensus       326 ~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          326 LLIKEKSWRISASEALK  342 (373)
T ss_dssp             TSCSSGGGSCCHHHHHH
T ss_pred             HcCCChhhCCCHHHHhc
Confidence            99999999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.5e-39  Score=347.51  Aligned_cols=253  Identities=16%  Similarity=0.160  Sum_probs=202.2

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .+.+.||+|+||.||+|.. ..+++.||||++....  ....+.+|+++++++ +||||+++++++...+..++||||+ 
T Consensus        12 ~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-   87 (330)
T 2izr_A           12 RVGKKIGCGNFGELRLGKN-LYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-   87 (330)
T ss_dssp             EEEEECCC-CTTSEEEEEE-TTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEeeccCCceEEEEEE-CCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence            3557899999999999974 3456899999986532  234688999999999 9999999999999999999999999 


Q ss_pred             CCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc-----eEEecccccccccCCC
Q 004312          564 NGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN-----ARISDFGLEKLLTLDQ  637 (762)
Q Consensus       564 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~Dfgla~~~~~~~  637 (762)
                      +++|.+++.. ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.     +||+|||+++.+....
T Consensus        88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~  164 (330)
T 2izr_A           88 GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE  164 (330)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence            9999999976 36799999999999999999999999   9999999999999998887     9999999998765433


Q ss_pred             Cc------ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhH---HHhhhcccccccccccccc
Q 004312          638 SH------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA---YDCYQERTLGALVENDLEA  708 (762)
Q Consensus       638 ~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~  708 (762)
                      ..      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....   .+.+..........+... 
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-  243 (330)
T 2izr_A          165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV-  243 (330)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH-
T ss_pred             CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH-
Confidence            22      12456799999999999999999999999999999999999999854211   111110000000000000 


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          709 MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       709 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                       .....+ ++.+++.+||+.+|.+||++++|++.|+++.
T Consensus       244 -~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          244 -LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             -HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             -HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence             000123 8999999999999999999999999997653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.2e-39  Score=349.71  Aligned_cols=246  Identities=25%  Similarity=0.335  Sum_probs=188.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+|... .+++.||||+++...  ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        55 y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  131 (349)
T 2w4o_A           55 FEVESELGRGATSIVYRCKQK-GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT  131 (349)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEeeEEeeCCCEEEEEEEEC-CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence            345578999999999999754 456789999997642  34678899999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC---CCceEEecccccccccCCCCcc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD---YYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +++|.+++.....+++..+..++.||++||.|||+.   +|+||||||+|||++.   ++.+||+|||+++.....  ..
T Consensus       132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~  206 (349)
T 2w4o_A          132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VL  206 (349)
T ss_dssp             SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc--cc
Confidence            999999998888899999999999999999999999   9999999999999975   889999999999865432  22


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccc--ccCCCHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL--EAMDDMTVLQRF  718 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  718 (762)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...........    .+.....  ........+.++
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----~i~~~~~~~~~~~~~~~~~~~  282 (349)
T 2w4o_A          207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR----RILNCEYYFISPWWDEVSLNA  282 (349)
T ss_dssp             ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHH----HHHTTCCCCCTTTTTTSCHHH
T ss_pred             cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHH----HHHhCCCccCCchhhhCCHHH
Confidence            3345689999999999999999999999999999999999999854322221111    1111111  111123456789


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+++.+||+.||++|||++|+++
T Consensus       283 ~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          283 KDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHhc
Confidence            99999999999999999999987

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.9e-39  Score=342.66  Aligned_cols=256  Identities=25%  Similarity=0.414  Sum_probs=200.9

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCC--cceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceec-cCCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGS--SDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCD-EGRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~LV~E  560 (762)
                      .+.+.||+|+||.||+|......  ...+|||++..... ...+.+.+|++++++++||||+++++++. ..+..++|||
T Consensus        28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e  107 (298)
T 3f66_A           28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  107 (298)
T ss_dssp             EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred             hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence            45578999999999999864332  33689999876433 34467999999999999999999999864 4567899999


Q ss_pred             ccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC-
Q 004312          561 FMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-  638 (762)
Q Consensus       561 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-  638 (762)
                      |+++|+|.+++... ..+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+|||+++....... 
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  184 (298)
T 3f66_A          108 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY  184 (298)
T ss_dssp             CCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred             CCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence            99999999999764 5689999999999999999999999   999999999999999999999999999987643322 


Q ss_pred             --cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          639 --HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       639 --~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                        .......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+........     ....+........+...+.
T Consensus       185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  259 (298)
T 3f66_A          185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVYLLQGRRLLQPEYCPD  259 (298)
T ss_dssp             BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-----HHHHHHTTCCCCCCTTCCH
T ss_pred             ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-----HHHHHhcCCCCCCCccCCH
Confidence              222334578899999999999999999999999999999996665432211111     1111111111222333467


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      .+.+++.+||+.||++|||++|++++|+++..
T Consensus       260 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          260 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            89999999999999999999999999998654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-39  Score=351.62  Aligned_cols=244  Identities=23%  Similarity=0.311  Sum_probs=203.3

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .+.+.||+|+||.||+|+.. .+++.||||++++..   ......+..|.+++.++ +||||+++++++.+.+..++|||
T Consensus        20 ~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E   98 (345)
T 1xjd_A           20 ILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   98 (345)
T ss_dssp             EEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             EEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            45578999999999999764 456799999997542   23456788899999887 99999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        99 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~  174 (345)
T 1xjd_A           99 YLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAK  174 (345)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCC
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccC-CCc
Confidence            999999999998878899999999999999999999999   9999999999999999999999999999864322 223


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....+||+.|+|||.+.+..++.++||||||+++|||++|+.||............     ....  ...+...+.++.+
T Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i-----~~~~--~~~p~~~s~~~~~  247 (345)
T 1xjd_A          175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-----RMDN--PFYPRWLEKEAKD  247 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHCC--CCCCTTSCHHHHH
T ss_pred             ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-----HhCC--CCCCcccCHHHHH
Confidence            34567999999999999999999999999999999999999998654333322211     1111  1122335678999


Q ss_pred             HHHHhhccCCCCCCCHH-HHH
Q 004312          721 VAIWCIQEDPSHRPTMR-RVT  740 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~-evl  740 (762)
                      ++.+||+.||++||++. |++
T Consensus       248 li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          248 LLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGG
T ss_pred             HHHHHhcCCHhHcCCChHHHH
Confidence            99999999999999997 665

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.8e-39  Score=359.01  Aligned_cols=249  Identities=21%  Similarity=0.267  Sum_probs=203.2

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.||+|+||+||+++.. .+++.||+|++++..   ......+.+|+.++++++|||||++++++.+....+|||||+
T Consensus        73 ~~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~  151 (410)
T 3v8s_A           73 VVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM  151 (410)
T ss_dssp             EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEcCCCEEEEEEEEC-CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            3467999999999999754 456799999987522   223346889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ++|+|.+++.. ..+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++...........
T Consensus       152 ~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~  227 (410)
T 3v8s_A          152 PGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD  227 (410)
T ss_dssp             TTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECC
T ss_pred             CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccccc
Confidence            99999999965 4689999999999999999999999   9999999999999999999999999999876544433444


Q ss_pred             cccccCcccCcccccCCC----CCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMP----ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~----~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      ..+||+.|+|||++....    ++.++||||||+++|||++|+.||................   ...........+.++
T Consensus       228 ~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---~~~~~p~~~~~s~~~  304 (410)
T 3v8s_A          228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK---NSLTFPDDNDISKEA  304 (410)
T ss_dssp             SCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH---HHCCCCTTCCCCHHH
T ss_pred             CCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc---ccccCCCcccccHHH
Confidence            678999999999997665    7899999999999999999999986554333222211100   001111122356789


Q ss_pred             HHHHHHhhccCCCC--CCCHHHHHHH
Q 004312          719 VMVAIWCIQEDPSH--RPTMRRVTQM  742 (762)
Q Consensus       719 ~~li~~cl~~dp~~--RPt~~evl~~  742 (762)
                      .+|+.+||+.+|.+  ||+++||++.
T Consensus       305 ~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          305 KNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             HHHHHHHccChhhhCCCCCHHHHhcC
Confidence            99999999999988  9999999964

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-38  Score=339.98  Aligned_cols=260  Identities=20%  Similarity=0.219  Sum_probs=200.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc---hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD---SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||++... .+++.||||++......   ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        36 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 2h34_A           36 YRLRRLVGRGGMGDVYEAEDT-VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR  114 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEET-TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EEEEEEEcCCCCeeEEEEEEc-CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence            345678999999999999754 45678999999754322   24678999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++++|.+++.....+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||++..........
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          115 LINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence            999999999998878899999999999999999999999   99999999999999999999999999998765444333


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ...........   ....+...+.++.+
T Consensus       192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~l~~  267 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-MGAHINQAIPR---PSTVRPGIPVAFDA  267 (309)
T ss_dssp             -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-HHHHHHSCCCC---GGGTSTTCCTHHHH
T ss_pred             ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-HHHHhccCCCC---ccccCCCCCHHHHH
Confidence            445668999999999999999999999999999999999999986543221 11110000000   11112345678899


Q ss_pred             HHHHhhccCCCCCC-CHHHHHHHhhcCcCCCC
Q 004312          721 VAIWCIQEDPSHRP-TMRRVTQMLEGVVEVPI  751 (762)
Q Consensus       721 li~~cl~~dp~~RP-t~~evl~~L~~~~~~~~  751 (762)
                      ++.+||+.||++|| +++++++.|+...+...
T Consensus       268 li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          268 VIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             HHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             HHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            99999999999999 99999999998765543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.3e-39  Score=349.28  Aligned_cols=244  Identities=23%  Similarity=0.357  Sum_probs=202.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++.+..   ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus        11 Y~i~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (336)
T 3h4j_B           11 YIIRETLGEGSFGKVKLATHY-KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE   89 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence            345678999999999999753 456799999986532   2234679999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+ +|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||++......  ..
T Consensus        90 ~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--~~  163 (336)
T 3h4j_B           90 YA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NF  163 (336)
T ss_dssp             CC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--BT
T ss_pred             CC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC--cc
Confidence            99 789999998888899999999999999999999999   9999999999999999999999999999876432  22


Q ss_pred             cccccccCcccCcccccCCCC-CCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ....+||+.|+|||.+.+..+ ++++||||||+++|+|++|+.||.........     ..+ ... ....+...+.++.
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----~~i-~~~-~~~~p~~~s~~~~  236 (336)
T 3h4j_B          164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-----KKV-NSC-VYVMPDFLSPGAQ  236 (336)
T ss_dssp             TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----CCC-CSS-CCCCCTTSCHHHH
T ss_pred             cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----HHH-HcC-CCCCcccCCHHHH
Confidence            344579999999999988775 78999999999999999999998543211111     111 111 1112334567889


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+||+.||.+|||++|+++
T Consensus       237 ~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          237 SLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHcCCChhHCcCHHHHHh
Confidence            9999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.3e-39  Score=377.93  Aligned_cols=249  Identities=29%  Similarity=0.404  Sum_probs=203.1

Q ss_pred             hhcCCCCcceEEEeeeeCC-CcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNMG-SSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      ++||+|+||.||+|.+... .++.||||+++....  ...+++.+|++++++++|||||++++++.. +..+|||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4699999999999976533 357899999976433  335789999999999999999999999964 568899999999


Q ss_pred             CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC--cccc
Q 004312          565 GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS--HTNT  642 (762)
Q Consensus       565 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~--~~~~  642 (762)
                      |+|.+++.....+++..+..|+.||+.||+|||++   +|+||||||+||||++++.+||+|||+++.+.....  ....
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  530 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  530 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence            99999998888899999999999999999999999   999999999999999999999999999987754432  2223


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ...+|+.|+|||.+....++.++||||||+++|||++ |+.||......+..      ..+........+..+++++.++
T Consensus       531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~------~~i~~~~~~~~p~~~~~~l~~l  604 (635)
T 4fl3_A          531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT------AMLEKGERMGCPAGCPREMYDL  604 (635)
T ss_dssp             ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH------HHHHTTCCCCCCTTCCHHHHHH
T ss_pred             CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHcCCCCCCCCCCCHHHHHH
Confidence            3456789999999999999999999999999999998 99998544322211      1122222222344567889999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          722 AIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      +.+||+.||++||++++|+++|+++
T Consensus       605 i~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          605 MNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            9999999999999999999999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.9e-39  Score=354.69  Aligned_cols=258  Identities=15%  Similarity=0.173  Sum_probs=200.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCC----CcceEEEEEccccccch-----------hHHHHHHhhhhcccccCCccchhce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMG----SSDQVAVKKLNRVFQDS-----------EKEFKAEVNGIGQTHHKNLVRLLGY  548 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~l~g~  548 (762)
                      +.+.+.||+|+||.||+|....+    .++.||||++.......           ...+..|+..+.+++||||++++++
T Consensus        37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~  116 (364)
T 3op5_A           37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS  116 (364)
T ss_dssp             EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred             EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence            45667899999999999987643    24689999986543211           1234456667788899999999999


Q ss_pred             eccC----CceeEEEeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc--CCCc
Q 004312          549 CDEG----RNRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD--DYYN  621 (762)
Q Consensus       549 ~~~~----~~~~LV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~--~~~~  621 (762)
                      +.+.    ...+|||||+ +++|.+++... ..+++..++.|+.||+.||+|||++   +|+||||||+|||++  +++.
T Consensus       117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~~  192 (364)
T 3op5_A          117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQ  192 (364)
T ss_dssp             EEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTTC
T ss_pred             eeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCCe
Confidence            8765    4479999999 99999999765 6799999999999999999999999   999999999999999  8899


Q ss_pred             eEEecccccccccCCCCc------ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhh-
Q 004312          622 ARISDFGLEKLLTLDQSH------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ-  694 (762)
Q Consensus       622 ~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~-  694 (762)
                      +||+|||+++.+......      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... 
T Consensus       193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~  272 (364)
T 3op5_A          193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR  272 (364)
T ss_dssp             EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred             EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence            999999999876543221      1233559999999999999999999999999999999999999985421111110 


Q ss_pred             ------ccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          695 ------ERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       695 ------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                            ...+..+++..+.   ....++++.+++.+||+.+|++||++++|++.|+++.+
T Consensus       273 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          273 DSKIRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             HHHHHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence                  0011111111110   12235788999999999999999999999999988643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7.8e-39  Score=341.95  Aligned_cols=251  Identities=23%  Similarity=0.266  Sum_probs=194.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.+.+.||+|+||+||+|...  +++.||||++....  ......+.+|++++++++||||+++++++.+....++||||
T Consensus        23 y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  100 (311)
T 3niz_A           23 YQKLEKVGEGTYGVVYKAKDS--QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF  100 (311)
T ss_dssp             EEEEEEEEECSSCEEEEEEET--TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred             hHhhhhccCCCCeEEEEEEEC--CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence            345578999999999999764  36789999987532  22346789999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          562 MSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       562 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +++ +|.+++... ..+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus       101 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~  175 (311)
T 3niz_A          101 MEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RS  175 (311)
T ss_dssp             CSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C-
T ss_pred             CCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc-cc
Confidence            985 777777654 5689999999999999999999999   99999999999999999999999999998764322 22


Q ss_pred             cccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------cccc---------
Q 004312          641 NTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------TLGA---------  700 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~~~~---------  700 (762)
                      .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.....          ....         
T Consensus       176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  255 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ  255 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence            334568999999999876 56899999999999999999999997433211111100          0000         


Q ss_pred             ----ccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          701 ----LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       701 ----~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                          ..............++++.+++.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                00000000001123467899999999999999999999987

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=373.65  Aligned_cols=254  Identities=26%  Similarity=0.387  Sum_probs=208.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+|.+..  ...||||+++... ...++|.+|++++++++||||+++++++.+ +..+|||||++
T Consensus       269 ~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~  344 (535)
T 2h8h_A          269 LRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  344 (535)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hhhheecccCCCeEEEEEEECC--CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence            3456789999999999998753  3579999997643 345689999999999999999999999976 67899999999


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +|+|.++|...  ..+++..+..|+.||++||+|||++   +|+||||||+||||++++.+||+|||+++..........
T Consensus       345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  421 (535)
T 2h8h_A          345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  421 (535)
T ss_dssp             TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence            99999999753  5689999999999999999999999   999999999999999999999999999987643222222


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....++..|+|||.+....++.++||||||++||||++ |+.||......+....      +........+..+++++.+
T Consensus       422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~------i~~~~~~~~~~~~~~~l~~  495 (535)
T 2h8h_A          422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ------VERGYRMPCPPECPESLHD  495 (535)
T ss_dssp             CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH------HHTTCCCCCCTTCCHHHHH
T ss_pred             cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------HHcCCCCCCCCCCCHHHHH
Confidence            23446789999999999999999999999999999999 8888754322222211      1112222233456778999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHhhcCcCCC
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQMLEGVVEVP  750 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~L~~~~~~~  750 (762)
                      |+.+||+.||++|||+++|+++|+.+....
T Consensus       496 li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          496 LMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             HHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence            999999999999999999999999976543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.4e-39  Score=348.28  Aligned_cols=258  Identities=25%  Similarity=0.364  Sum_probs=208.5

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeC------CCcceEEEEEccccc-cchhHHHHHHhhhhccc-ccCCccchhceeccCCc
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNM------GSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRN  554 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  554 (762)
                      .+.+.+.||+|+||.||+|....      .+++.||||+++... ....+.+.+|+++++++ +||||+++++++.+.+.
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  115 (334)
T 2pvf_A           36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP  115 (334)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred             HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCc
Confidence            34566789999999999997632      245689999997543 23456799999999999 99999999999999999


Q ss_pred             eeEEEeccCCCchhhhccCCC----------------CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC
Q 004312          555 RLLVYEFMSNGALASFLFGDS----------------KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD  618 (762)
Q Consensus       555 ~~LV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~  618 (762)
                      .++||||+++|+|.+++....                .+++..+..++.||++||+|||+.   +|+||||||+|||++.
T Consensus       116 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~  192 (334)
T 2pvf_A          116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTE  192 (334)
T ss_dssp             CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred             eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcC
Confidence            999999999999999997653                388999999999999999999999   9999999999999999


Q ss_pred             CCceEEecccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcc
Q 004312          619 YYNARISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQER  696 (762)
Q Consensus       619 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~  696 (762)
                      ++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......+...  
T Consensus       193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~--  270 (334)
T 2pvf_A          193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK--  270 (334)
T ss_dssp             TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH--
T ss_pred             CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH--
Confidence            99999999999987654332 12233457889999999998899999999999999999999 888875432222111  


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          697 TLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       697 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                          .+........+..++.++.+++.+||+.+|++|||++|+++.|+++...
T Consensus       271 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          271 ----LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             ----HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                1111111122334567899999999999999999999999999987543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.9e-39  Score=347.75  Aligned_cols=250  Identities=22%  Similarity=0.280  Sum_probs=201.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .+.+.||+|+||.||+++.. .+++.||||++++...   ...+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e   90 (345)
T 3a8x_A           12 DLLRVIGRGSYAKVLLVRLK-KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE   90 (345)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence            45578999999999999764 4567999999976432   2345688999999987 89999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        91 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-~~~  166 (345)
T 3a8x_A           91 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT  166 (345)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-TCC
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC-CCc
Confidence            999999999998878899999999999999999999999   9999999999999999999999999999854322 223


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHH----hhhccccccccccccccCCCHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYD----CYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      ....+||+.|+|||.+.+..++.++||||||+++|||++|+.||.......    .........+.....  ..+...+.
T Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~s~  244 (345)
T 3a8x_A          167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSV  244 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--CCCTTSCH
T ss_pred             ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--CCCCCCCH
Confidence            445679999999999999999999999999999999999999984311000    000000111111111  12334567


Q ss_pred             HHHHHHHHhhccCCCCCCCH------HHHHH
Q 004312          717 RFVMVAIWCIQEDPSHRPTM------RRVTQ  741 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~------~evl~  741 (762)
                      ++.+++.+||+.||++||++      +|+++
T Consensus       245 ~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          245 KAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             HHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             HHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence            89999999999999999995      56654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=8.8e-39  Score=335.24  Aligned_cols=249  Identities=20%  Similarity=0.309  Sum_probs=205.4

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.+.||+|+||.||+|... .+++.+|+|++........+.+.+|++++++++||||+++++++.+....++||||+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A           10 YYTLENTIGRGSWGEVKIAVQK-GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hEEeeeEEeecCCEEEEEEEeC-CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            3455678999999999999754 456789999998776667789999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE---cCCCceEEecccccccccCCCCc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      ++++|.+++.....+++..+..++.|++.||+|||++   +|+||||||+|||+   +.++.+||+|||++.......  
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--  163 (277)
T 3f3z_A           89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--  163 (277)
T ss_dssp             CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--
Confidence            9999999998888899999999999999999999999   99999999999999   788999999999998765332  


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+............+..   .....++.+.
T Consensus       164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  239 (277)
T 3f3z_A          164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK---DWLNVSPQAE  239 (277)
T ss_dssp             CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH---HHTTSCHHHH
T ss_pred             chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch---hhhcCCHHHH
Confidence            33445699999999998654 8999999999999999999999985543322222111000000000   0012457889


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+||+.||++|||+.|+++
T Consensus       240 ~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999999999985

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.1e-38  Score=346.83  Aligned_cols=249  Identities=21%  Similarity=0.276  Sum_probs=201.3

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-----cchhHHHHHHhhhhcccccCCccchhceeccCCcee
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-----QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRL  556 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  556 (762)
                      ..+.+.+.||+|+||.||++... .+++.||||++....     ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINR-ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            44667788999999999999654 456899999986421     123578999999999999999999999999999999


Q ss_pred             EEEeccCCCchhhhccCC----CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc---eEEecccc
Q 004312          557 LVYEFMSNGALASFLFGD----SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN---ARISDFGL  629 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~Dfgl  629 (762)
                      |||||+++++|.+++...    ..+++..+..++.||++||+|||++   +|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998887543    3589999999999999999999999   9999999999999986554   99999999


Q ss_pred             cccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccC
Q 004312          630 EKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM  709 (762)
Q Consensus       630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  709 (762)
                      ++...... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ....     .+........
T Consensus       180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~-----~i~~~~~~~~  252 (351)
T 3c0i_A          180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFE-----GIIKGKYKMN  252 (351)
T ss_dssp             CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHH-----HHHHTCCCCC
T ss_pred             eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHH-----HHHcCCCCCC
Confidence            98765422 223345799999999999999999999999999999999999999865321 1111     1111111100


Q ss_pred             C--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          710 D--DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       710 ~--~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .  ....++++.+++.+||+.||++|||+.|+++
T Consensus       253 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          253 PRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0  0124578899999999999999999999985

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.7e-39  Score=359.99  Aligned_cols=246  Identities=22%  Similarity=0.252  Sum_probs=195.3

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||++... .+++.||||+++..   .......+.+|++++++++||||+++++++.+.+..+||||
T Consensus       150 y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  228 (446)
T 4ejn_A          150 FEYLKLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME  228 (446)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred             cEEeEEEeeCcCEEEEEEEEc-CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence            345578999999999999754 55789999999753   23334578899999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE-ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |+++|+|.+++.....+++..+..++.||+.||+|||+ .   +|+||||||+||||+.++.+||+|||+++..... ..
T Consensus       229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~  304 (446)
T 4ejn_A          229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GA  304 (446)
T ss_dssp             CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred             eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCC-Cc
Confidence            99999999999888889999999999999999999998 7   9999999999999999999999999999864322 22


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||............     .....  ..+...+.++.
T Consensus       305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i-----~~~~~--~~p~~~~~~~~  377 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-----LMEEI--RFPRTLGPEAK  377 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHCCC--CCCTTSCHHHH
T ss_pred             ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH-----HhCCC--CCCccCCHHHH
Confidence            334567999999999999999999999999999999999999998554332222211     11111  12234567899


Q ss_pred             HHHHHhhccCCCCCC-----CHHHHHH
Q 004312          720 MVAIWCIQEDPSHRP-----TMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RP-----t~~evl~  741 (762)
                      +++.+||+.||++||     +++|+++
T Consensus       378 ~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          378 SLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            999999999999999     9999985

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=339.02  Aligned_cols=249  Identities=22%  Similarity=0.259  Sum_probs=197.5

Q ss_pred             HHHHHHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhccc-ccCCccchhceeccCC
Q 004312          477 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGR  553 (762)
Q Consensus       477 ~el~~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  553 (762)
                      .++....+.+.++||+|+||+||+|... .+++.||||++.....  .....+..|+..+.++ +||||+++++++.+++
T Consensus        52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~  130 (311)
T 3p1a_A           52 ESFFQQSFQRLSRLGHGSYGEVFKVRSK-EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG  130 (311)
T ss_dssp             SCHHHHHEEEEEEEEEETTEEEEEEEET-TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cchhhhheeeeheeccCCCeEEEEEEEC-CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence            3444555666788999999999999764 4567999999865332  2334556666666655 9999999999999999


Q ss_pred             ceeEEEeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          554 NRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       554 ~~~LV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                      ..+|||||+ +++|.+++... ..+++..+..|+.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~  206 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred             EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeee
Confidence            999999999 66888888654 5699999999999999999999998   999999999999999999999999999986


Q ss_pred             ccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCH
Q 004312          633 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDM  712 (762)
Q Consensus       633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (762)
                      ....  .......||+.|+|||.+.+ .++.++||||||+++|||++|+.++.................        .+.
T Consensus       207 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~--------~~~  275 (311)
T 3p1a_A          207 LGTA--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPE--------FTA  275 (311)
T ss_dssp             CC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHH--------HHT
T ss_pred             cccC--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcc--------ccc
Confidence            6432  22334569999999999876 799999999999999999999887655444433332221111        112


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       713 ~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ..++++.+++.+||+.||++|||++|+++
T Consensus       276 ~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          276 GLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            34578999999999999999999999987

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3e-39  Score=341.59  Aligned_cols=252  Identities=29%  Similarity=0.394  Sum_probs=204.6

Q ss_pred             hhh-hcCCCCcceEEEeeeeC-CCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          486 FKE-ELGRGAFGTVYKGFVNM-GSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       486 ~~~-~iG~G~~g~Vy~g~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.+ .||+|+||.||+|.... ..++.||||+++...  ....+++.+|++++++++||||+++++++ +.+..++||||
T Consensus        20 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~   98 (291)
T 1xbb_A           20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEM   98 (291)
T ss_dssp             EEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred             hccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEe
Confidence            445 79999999999996543 345789999997543  22356899999999999999999999999 56778999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc-
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT-  640 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~-  640 (762)
                      +++++|.+++.....+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++......... 
T Consensus        99 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  175 (291)
T 1xbb_A           99 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  175 (291)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCccc
Confidence            99999999998888899999999999999999999999   99999999999999999999999999998765443322 


Q ss_pred             -cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          641 -NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       641 -~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                       .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..........      .+........+...++++
T Consensus       176 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l  249 (291)
T 1xbb_A          176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA------MLEKGERMGCPAGCPREM  249 (291)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH------HHHTTCCCCCCTTCCHHH
T ss_pred             ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH------HHHcCCCCCCCCCCCHHH
Confidence             222346789999999998889999999999999999999 999975432222111      111111222234556789


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      .+++.+||+.||++||+++++++.|+++.
T Consensus       250 ~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          250 YDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            99999999999999999999999998864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=347.12  Aligned_cols=256  Identities=24%  Similarity=0.339  Sum_probs=199.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcc---eEEEEEcccc-ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSD---QVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +.+.+.||+|+||.||+|........   .||+|.+... .....+.+.+|+.++++++||||+++++++.... .++|+
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~   95 (327)
T 3lzb_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT   95 (327)
T ss_dssp             EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred             ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence            34557899999999999976433221   3678877543 3345678999999999999999999999998765 78999


Q ss_pred             eccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          560 EFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       560 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      ||+++|+|.+++... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        96 ~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~  172 (327)
T 3lzb_A           96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             CCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred             EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence            999999999999764 5789999999999999999999999   999999999999999999999999999987643332


Q ss_pred             -cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          639 -HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       639 -~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                       .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......      .+...+........+...+.
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~  246 (327)
T 3lzb_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------EISSILEKGERLPQPPICTI  246 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------GHHHHHHTTCCCCCCTTBCH
T ss_pred             cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH------HHHHHHHcCCCCCCCccCCH
Confidence             22223456889999999999999999999999999999999 88887433211      11122222222233444667


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      ++.+++.+||+.||.+||+++|+++.|+++.+.
T Consensus       247 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            899999999999999999999999999987643

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=347.58  Aligned_cols=261  Identities=25%  Similarity=0.387  Sum_probs=209.7

Q ss_pred             hhhhhhcCCCCcceEEEeee---eCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCC--ceeEE
Q 004312          484 RGFKEELGRGAFGTVYKGFV---NMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR--NRLLV  558 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~---~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~LV  558 (762)
                      +.+.+.||+|+||.||++.+   ...+++.||||++........+.+.+|++++++++||||+++++++...+  ..++|
T Consensus        43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  122 (326)
T 2w1i_A           43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI  122 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred             ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence            34567899999999999975   33456789999998766666778999999999999999999999987654  67999


Q ss_pred             EeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          559 YEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      |||+++++|.+++... ..+++..+..++.||++||+|||+.   +|+||||||+|||+++++.+||+|||+++......
T Consensus       123 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~  199 (326)
T 2w1i_A          123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  199 (326)
T ss_dssp             ECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred             EECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence            9999999999999765 4689999999999999999999998   99999999999999999999999999998775443


Q ss_pred             Cc--ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHH--Hhhhcc--------ccccccccc
Q 004312          638 SH--TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY--DCYQER--------TLGALVEND  705 (762)
Q Consensus       638 ~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~--~~~~~~--------~~~~~~~~~  705 (762)
                      ..  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......  ......        .+...+...
T Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (326)
T 2w1i_A          200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN  279 (326)
T ss_dssp             SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred             cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence            22  122345678899999999888999999999999999999999886433111  000000        111122222


Q ss_pred             cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          706 LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       706 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      .....+..++.++.+++.+||+.||++|||++||++.|+.+.
T Consensus       280 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          280 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            222234456788999999999999999999999999998764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8.3e-39  Score=349.85  Aligned_cols=244  Identities=25%  Similarity=0.286  Sum_probs=194.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhh-hcccccCCccchhceeccCCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNG-IGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +.+.+.||+|+||.||+++.. .+++.||||++++...   .....+.+|..+ ++.++||||+++++++.+.+..++||
T Consensus        40 y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~  118 (373)
T 2r5t_A           40 FHFLKVIGKGSFGKVLLARHK-AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL  118 (373)
T ss_dssp             EEEEEEEECCTTCEEEEEEET-TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence            445678999999999999754 4567899999976432   233456777776 57789999999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      ||+++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus       119 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-~~  194 (373)
T 2r5t_A          119 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NS  194 (373)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-CC
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC-CC
Confidence            9999999999998888899999999999999999999999   9999999999999999999999999999864322 22


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      .....+||+.|+|||++.+..++.++||||||+++|||++|+.||......+....     ++.....  .+...+..+.
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~-----i~~~~~~--~~~~~~~~~~  267 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN-----ILNKPLQ--LKPNITNSAR  267 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH-----HHHSCCC--CCSSSCHHHH
T ss_pred             ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH-----HHhcccC--CCCCCCHHHH
Confidence            34456799999999999999999999999999999999999999865433332221     1111111  1233567889


Q ss_pred             HHHHHhhccCCCCCCCHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRV  739 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~ev  739 (762)
                      +++.+||+.||.+||++.+.
T Consensus       268 ~li~~lL~~dp~~R~~~~~~  287 (373)
T 2r5t_A          268 HLLEGLLQKDRTKRLGAKDD  287 (373)
T ss_dssp             HHHHHHTCSSGGGSTTTTTT
T ss_pred             HHHHHHcccCHHhCCCCCCC
Confidence            99999999999999998543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8e-39  Score=347.32  Aligned_cols=242  Identities=21%  Similarity=0.237  Sum_probs=204.3

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||+++.. .+++.||||++.+..   ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus        44 ~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  122 (350)
T 1rdq_E           44 DRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY  122 (350)
T ss_dssp             EEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence            34578999999999999754 456799999986532   23446788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.....    .
T Consensus       123 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~  195 (350)
T 1rdq_E          123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----T  195 (350)
T ss_dssp             CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----B
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC----c
Confidence            99999999998878899999999999999999999999   9999999999999999999999999999866432    2


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ...+||+.|+|||.+.+..++.++||||||+++|||++|+.||...........     +.....  ..+...+.++.++
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-----i~~~~~--~~p~~~~~~~~~l  268 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK-----IVSGKV--RFPSHFSSDLKDL  268 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHCCC--CCCTTCCHHHHHH
T ss_pred             ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHH-----HHcCCC--CCCCCCCHHHHHH
Confidence            345799999999999999999999999999999999999999865433322221     111111  1223456789999


Q ss_pred             HHHhhccCCCCCCC-----HHHHHH
Q 004312          722 AIWCIQEDPSHRPT-----MRRVTQ  741 (762)
Q Consensus       722 i~~cl~~dp~~RPt-----~~evl~  741 (762)
                      +.+||+.||++||+     ++||++
T Consensus       269 i~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          269 LRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHhhcCHHhccCCccCCHHHHHh
Confidence            99999999999998     888875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-39  Score=338.62  Aligned_cols=250  Identities=26%  Similarity=0.363  Sum_probs=204.4

Q ss_pred             hhcCCCCcceEEEeeee-CCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCC
Q 004312          488 EELGRGAFGTVYKGFVN-MGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      +.||+|+||.||+|... ...++.||||+++... ....+.+.+|++++++++||||+++++++ +.+..++||||++++
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~   94 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG   94 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence            37999999999999754 2345789999997643 33456899999999999999999999999 556789999999999


Q ss_pred             chhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc--cc
Q 004312          566 ALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT--NT  642 (762)
Q Consensus       566 sL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~--~~  642 (762)
                      +|.+++... ..+++..+..++.||++||.|||+.   +|+||||||+||++++++.+||+|||+++.........  ..
T Consensus        95 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  171 (287)
T 1u59_A           95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  171 (287)
T ss_dssp             EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred             CHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence            999999754 5689999999999999999999999   99999999999999999999999999998775433221  22


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+...      .+........+...++++.++
T Consensus       172 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------~i~~~~~~~~~~~~~~~l~~l  245 (287)
T 1u59_A          172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA------FIEQGKRMECPPECPPELYAL  245 (287)
T ss_dssp             SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH------HHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH------HHhcCCcCCCCCCcCHHHHHH
Confidence            3446889999999998889999999999999999998 999974432222111      111111222334567889999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          722 AIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      +.+||+.+|++||+++|+++.|+.+.
T Consensus       246 i~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          246 MSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            99999999999999999999998863

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-38  Score=344.20  Aligned_cols=265  Identities=23%  Similarity=0.317  Sum_probs=199.2

Q ss_pred             HHHHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhc--ccccCCccchhceeccC----
Q 004312          479 LVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIG--QTHHKNLVRLLGYCDEG----  552 (762)
Q Consensus       479 l~~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~H~nIv~l~g~~~~~----  552 (762)
                      .....+.+.+.||+|+||.||+|+..   ++.||||++...   ....+.+|.+++.  .++||||+++++++.+.    
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR---GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC---CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            33445666788999999999999764   578999998643   2334444554444  45999999999999877    


Q ss_pred             CceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcC-----CCCeEeCCCCCCceEEcCCCceEEecc
Q 004312          553 RNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC-----CTQIIHCDIKPQNILLDDYYNARISDF  627 (762)
Q Consensus       553 ~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~~kl~Df  627 (762)
                      ...++||||+++|+|.+++... .+++..+..++.|++.||+|||+++     .++|+||||||+|||++.++.+||+||
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence            6789999999999999999654 6899999999999999999999862     348999999999999999999999999


Q ss_pred             cccccccCCCCcc---cccccccCcccCcccccCCCCCCc------chhHHHHHHHHHHHhC----------CCCCchhh
Q 004312          628 GLEKLLTLDQSHT---NTAIRGTKGYVAPEWFRNMPITVK------VDVYSYGVLLLEIICL----------RRTILTDW  688 (762)
Q Consensus       628 gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~------~DV~S~Gvil~elltg----------~~p~~~~~  688 (762)
                      |+++.+.......   .....||+.|+|||.+.+...+.+      +||||||+++|||++|          +.|+....
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~  266 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV  266 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence            9998765433221   224569999999999988766665      9999999999999999          55542211


Q ss_pred             H----HHhhhccccccccccccc-cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCC
Q 004312          689 A----YDCYQERTLGALVENDLE-AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP  750 (762)
Q Consensus       689 ~----~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  750 (762)
                      .    ..............+... ......+++++.+++.+||+.||++|||++||++.|+++.+-.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            0    111111100011111111 1112367889999999999999999999999999999876654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7e-39  Score=372.88  Aligned_cols=248  Identities=27%  Similarity=0.378  Sum_probs=201.6

Q ss_pred             hcCCCCcceEEEeeeeC-CCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCc
Q 004312          489 ELGRGAFGTVYKGFVNM-GSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      .||+|+||.||+|.+.. +.+..||||+++... ....++|.+|++++++++|||||++++++.. +..+|||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            69999999999998753 244679999998643 3356789999999999999999999999976 56899999999999


Q ss_pred             hhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc--cc
Q 004312          567 LASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TA  643 (762)
Q Consensus       567 L~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~--~~  643 (762)
                      |.+++... ..+++..+..|+.||+.||+|||++   +|+||||||+||||++++.+||+|||+++..........  ..
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            99999765 5689999999999999999999999   999999999999999999999999999987654332221  22


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ..+++.|+|||++....++.++||||||+++|||++ |+.||......+..      ..+........+..++.++.+|+
T Consensus       499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~------~~i~~~~~~~~p~~~~~~l~~li  572 (613)
T 2ozo_A          499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------AFIEQGKRMECPPECPPELYALM  572 (613)
T ss_dssp             ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH------HHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH------HHHHcCCCCCCCCcCCHHHHHHH
Confidence            335689999999999999999999999999999998 99997543222211      11222222233445678899999


Q ss_pred             HHhhccCCCCCCCHHHHHHHhhcC
Q 004312          723 IWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       723 ~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      .+||+.+|++||++++|++.|+.+
T Consensus       573 ~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          573 SDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             HHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHH
Confidence            999999999999999999999885

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.6e-39  Score=345.01  Aligned_cols=247  Identities=22%  Similarity=0.259  Sum_probs=195.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC--CCcceEEEEEccccc----cchhHHHHHHhhhhcccccCCccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVF----QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L  557 (762)
                      +.+.+.||+|+||.||+++...  .+++.||||++++..    ......+.+|++++++++||||+++++++.+.+..++
T Consensus        19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   98 (327)
T 3a62_A           19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL   98 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred             eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence            4456789999999999997642  456799999997642    2234568899999999999999999999999999999


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ||||+++++|.+++.....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  175 (327)
T 3a62_A           99 ILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG  175 (327)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccCC
Confidence            999999999999998878899999999999999999999999   99999999999999999999999999997543222


Q ss_pred             CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                       .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........     +.....  ..+...+.+
T Consensus       176 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-----i~~~~~--~~p~~~~~~  247 (327)
T 3a62_A          176 -TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK-----ILKCKL--NLPPYLTQE  247 (327)
T ss_dssp             ----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-----HHHTCC--CCCTTSCHH
T ss_pred             -ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH-----HHhCCC--CCCCCCCHH
Confidence             223345799999999999999999999999999999999999999865433222211     111111  122345678


Q ss_pred             HHHHHHHhhccCCCCCC-----CHHHHHH
Q 004312          718 FVMVAIWCIQEDPSHRP-----TMRRVTQ  741 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RP-----t~~evl~  741 (762)
                      +.+++.+||+.||++||     +++|+++
T Consensus       248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          248 ARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            99999999999999999     7788875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.7e-39  Score=350.91  Aligned_cols=251  Identities=23%  Similarity=0.285  Sum_probs=194.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+++.. .+++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        22 y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           22 YDFVKDIGSGNFGVARLMRDK-LTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             EEEEEEESSSTTSSEEEEEET-TTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            456678999999999999754 456799999997542 334678999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc--eEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN--ARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +|+|.+++...+.+++..+..++.||+.||+|||++   +|+||||||+|||++.++.  +||+|||+++.....  ...
T Consensus       100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~~~  174 (361)
T 3uc3_A          100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQP  174 (361)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--CCC
Confidence            999999998878899999999999999999999998   9999999999999987765  999999999753322  223


Q ss_pred             ccccccCcccCcccccCCCCCCc-chhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~-~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....||+.|+|||.+.+..++.+ +||||||+++|+|++|+.||........... .+..+.............+.++.+
T Consensus       175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~  253 (361)
T 3uc3_A          175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK-TIQRILSVKYSIPDDIRISPECCH  253 (361)
T ss_dssp             ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH-HHHHHHTTCCCCCTTSCCCHHHHH
T ss_pred             CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH-HHHHHhcCCCCCCCcCCCCHHHHH
Confidence            34569999999999988877655 8999999999999999999854322111110 111111111122222234678899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~  742 (762)
                      |+.+||+.||++|||++|+++.
T Consensus       254 li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          254 LISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHccCChhHCcCHHHHHhC
Confidence            9999999999999999999863

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.6e-39  Score=345.08  Aligned_cols=256  Identities=23%  Similarity=0.374  Sum_probs=207.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC----CCcceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLV  558 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV  558 (762)
                      +.+.+.||+|+||.||+|....    .+++.||||++..... .....+.+|++++++++||||+++++++.+.+..++|
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  106 (322)
T 1p4o_A           27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI  106 (322)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEE
Confidence            4456789999999999997652    2356899999975432 3345799999999999999999999999999999999


Q ss_pred             EeccCCCchhhhccCC----------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccc
Q 004312          559 YEFMSNGALASFLFGD----------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFG  628 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  628 (762)
                      |||+++|+|.+++...          ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg  183 (322)
T 1p4o_A          107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG  183 (322)
T ss_dssp             EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCc
Confidence            9999999999999642          4568999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcccccccccccc
Q 004312          629 LEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDL  706 (762)
Q Consensus       629 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  706 (762)
                      +++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...........     +.. ..
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-----~~~-~~  257 (322)
T 1p4o_A          184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF-----VME-GG  257 (322)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH-----HHT-TC
T ss_pred             cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH-----HHc-CC
Confidence            99866433221 2223456889999999999999999999999999999999 7777644322221111     111 11


Q ss_pred             ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          707 EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       707 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ....+...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          258 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            111233456789999999999999999999999999988654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.8e-38  Score=340.58  Aligned_cols=251  Identities=25%  Similarity=0.309  Sum_probs=206.1

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc------hhHHHHHHhhhhcccccCCccchhceeccCCce
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD------SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNR  555 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  555 (762)
                      ..+.+.+.||+|+||.||++... .+++.||||++......      ..+++.+|+.++++++||||+++++++.+....
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEEC-CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            34566788999999999999754 45679999998754322      356899999999999999999999999999999


Q ss_pred             eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC----ceEEecccccc
Q 004312          556 LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY----NARISDFGLEK  631 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Dfgla~  631 (762)
                      ++||||+++++|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||+++++    .+||+|||+++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            99999999999999999888899999999999999999999999   999999999999999887    79999999998


Q ss_pred             cccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCC
Q 004312          632 LLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD  711 (762)
Q Consensus       632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  711 (762)
                      ......  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+......... .  .......
T Consensus       168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~--~~~~~~~  242 (321)
T 2a2a_A          168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS-Y--DFDEEFF  242 (321)
T ss_dssp             ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC-C--CCCHHHH
T ss_pred             ecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc-c--ccChhhh
Confidence            765322  2334568999999999999999999999999999999999999986543332222110000 0  0000001


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       712 ~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ...++.+.+++.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          243 SHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            123567899999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.7e-39  Score=341.99  Aligned_cols=254  Identities=26%  Similarity=0.384  Sum_probs=193.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCC--CcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCc-----e
Q 004312          485 GFKEELGRGAFGTVYKGFVNMG--SSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRN-----R  555 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-----~  555 (762)
                      .+.+.||+|+||.||+|.....  .++.||||+++...  ....+.+.+|++++++++||||+++++++.+...     .
T Consensus        37 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  116 (313)
T 3brb_A           37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKP  116 (313)
T ss_dssp             EEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CE
T ss_pred             eeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCccc
Confidence            3456799999999999977543  34589999987542  3334679999999999999999999999977653     4


Q ss_pred             eEEEeccCCCchhhhcc------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccc
Q 004312          556 LLVYEFMSNGALASFLF------GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL  629 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl  629 (762)
                      ++||||+++++|.+++.      ....+++..+..++.||++||.|||++   +|+||||||+|||+++++.+||+|||+
T Consensus       117 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~  193 (313)
T 3brb_A          117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGL  193 (313)
T ss_dssp             EEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred             EEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecCc
Confidence            99999999999999983      345789999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccc
Q 004312          630 EKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLE  707 (762)
Q Consensus       630 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  707 (762)
                      ++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..........      .+.....
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~------~~~~~~~  267 (313)
T 3brb_A          194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD------YLLHGHR  267 (313)
T ss_dssp             C----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH------HHHTTCC
T ss_pred             ceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH------HHHcCCC
Confidence            987644332 22233457889999999999999999999999999999999 777764332211111      1111111


Q ss_pred             cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       708 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      ...+...++++.+++.+||+.||++|||++++++.|+++.
T Consensus       268 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          268 LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            2223345678999999999999999999999999998864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.1e-39  Score=347.42  Aligned_cols=246  Identities=24%  Similarity=0.329  Sum_probs=204.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +.+.+.||+|+||.||+++.. .+++.||||++++..   ......+.+|.+++.++ +||||+++++++.+.+..++||
T Consensus        22 y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~  100 (353)
T 2i0e_A           22 FNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM  100 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence            345578999999999999754 456789999997542   23456788999999988 8999999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      ||+++|+|.+++...+.+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus       101 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~  176 (353)
T 2i0e_A          101 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GV  176 (353)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TC
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC-Cc
Confidence            9999999999998878899999999999999999999999   9999999999999999999999999999854322 22


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      .....+||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....     +.....  ..+...+.++.
T Consensus       177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~-----i~~~~~--~~p~~~s~~~~  249 (353)
T 2i0e_A          177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS-----IMEHNV--AYPKSMSKEAV  249 (353)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHCCC--CCCTTSCHHHH
T ss_pred             ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH-----HHhCCC--CCCCCCCHHHH
Confidence            34456799999999999999999999999999999999999999865433322221     111111  12334567899


Q ss_pred             HHHHHhhccCCCCCCC-----HHHHHH
Q 004312          720 MVAIWCIQEDPSHRPT-----MRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt-----~~evl~  741 (762)
                      +++.+||+.||++||+     ++|+++
T Consensus       250 ~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          250 AICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            9999999999999995     577764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.4e-39  Score=345.99  Aligned_cols=257  Identities=25%  Similarity=0.360  Sum_probs=206.2

Q ss_pred             hhhhhhcCCCCcceEEEeeee----CCCcceEEEEEcccccc-chhHHHHHHhhhhccc-ccCCccchhceeccCC-cee
Q 004312          484 RGFKEELGRGAFGTVYKGFVN----MGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGR-NRL  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~-~~~  556 (762)
                      +.+.+.||+|+||.||+|...    ..+++.||||+++.... ...+.+.+|++++.++ +||||+++++++.+.+ ..+
T Consensus        29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~  108 (316)
T 2xir_A           29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  108 (316)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred             eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceE
Confidence            345678999999999999753    23457899999976433 3346799999999999 7999999999987755 489


Q ss_pred             EEEeccCCCchhhhccCCCC----------------CCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC
Q 004312          557 LVYEFMSNGALASFLFGDSK----------------PNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY  620 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~  620 (762)
                      +||||+++++|.+++.....                +++..+..++.||++||.|||++   +|+||||||+||+++.++
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~  185 (316)
T 2xir_A          109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN  185 (316)
T ss_dssp             EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCC
Confidence            99999999999999987543                78999999999999999999999   999999999999999999


Q ss_pred             ceEEecccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhcccc
Q 004312          621 NARISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTL  698 (762)
Q Consensus       621 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~  698 (762)
                      .+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..........    
T Consensus       186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~----  261 (316)
T 2xir_A          186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC----  261 (316)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH----
T ss_pred             CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH----
Confidence            9999999999876543332 2334567899999999999999999999999999999998 888874321111111    


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          699 GALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       699 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                       ..+........+...+.++.+++.+||+.||.+|||++|+++.|+.+.+
T Consensus       262 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          262 -RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             -HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence             1111111111223356789999999999999999999999999988653

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.6e-38  Score=346.74  Aligned_cols=248  Identities=23%  Similarity=0.318  Sum_probs=202.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||++... .+++.||+|++.+..   ....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus        17 y~i~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   95 (384)
T 4fr4_A           17 FEILRAIGKGSFGKVCIVQKN-DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD   95 (384)
T ss_dssp             EEEEEEEECCTTCCEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            345678999999999999754 556789999986532   3345678999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++|+|..++.....+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+++....  ...
T Consensus        96 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~  170 (384)
T 4fr4_A           96 LLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQ  170 (384)
T ss_dssp             CCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT--TCC
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC--CCc
Confidence            999999999999888999999999999999999999999   999999999999999999999999999987643  233


Q ss_pred             cccccccCcccCcccccC---CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRN---MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~---~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      .....||+.|+|||++..   ..++.++||||||+++|||++|+.||........  ......+...  ....+...+..
T Consensus       171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~~~~~--~~~~p~~~s~~  246 (384)
T 4fr4_A          171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KEIVHTFETT--VVTYPSAWSQE  246 (384)
T ss_dssp             BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HHHHHHHHHC--CCCCCTTSCHH
T ss_pred             eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--HHHHHHHhhc--ccCCCCcCCHH
Confidence            445679999999999964   4589999999999999999999999853211100  0000001111  11123345678


Q ss_pred             HHHHHHHhhccCCCCCCC-HHHHHH
Q 004312          718 FVMVAIWCIQEDPSHRPT-MRRVTQ  741 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt-~~evl~  741 (762)
                      +.+++.+||+.||++||+ +++|++
T Consensus       247 ~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          247 MVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHHHHHHHhcCCHhHhcccHHHHHc
Confidence            999999999999999998 777764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.3e-38  Score=336.13  Aligned_cols=250  Identities=20%  Similarity=0.264  Sum_probs=195.1

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|+||.||+|..  .+++.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         5 ~~~~~lg~G~~g~V~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (288)
T 1ob3_A            5 HGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEE--TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             hhhhhcccCCCEEEEEEEc--CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence            4557899999999999975  346789999986532  223468899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          563 SNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       563 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      ++ +|.+++... ..+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  157 (288)
T 1ob3_A           83 DQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY  157 (288)
T ss_dssp             SE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             CC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-ccc
Confidence            85 899988764 6789999999999999999999999   99999999999999999999999999998764322 222


Q ss_pred             ccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc----------cc---c--ccccc
Q 004312          642 TAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT----------LG---A--LVEND  705 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~----------~~---~--~~~~~  705 (762)
                      ....+|+.|+|||.+.+. .++.++||||||+++|||++|+.||......+......          ..   .  ..++.
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            345689999999999764 58999999999999999999999985432222111100          00   0  00000


Q ss_pred             cc-------cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          706 LE-------AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       706 ~~-------~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ..       .......++++.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00       0001234678899999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.2e-39  Score=340.46  Aligned_cols=256  Identities=16%  Similarity=0.178  Sum_probs=205.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||.||+|.. ..+++.||||++...  .....+.+|+++++++ +|+|++++++++.+....++||||+
T Consensus        12 y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A           12 YKVGRRIGEGSFGVIFEGTN-LLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             EEEEEEEEECSSCEEEEEEE-TTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             eEEEEEEeecCCEEEEEEEE-CCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            34567899999999999974 345679999998653  2345688999999999 8999999999999999999999999


Q ss_pred             CCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc-----eEEecccccccccCC
Q 004312          563 SNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN-----ARISDFGLEKLLTLD  636 (762)
Q Consensus       563 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~Dfgla~~~~~~  636 (762)
                       +++|.+++... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.     +||+|||+++.....
T Consensus        89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A           89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence             99999999865 4699999999999999999999998   9999999999999987776     999999999877544


Q ss_pred             CCc------ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhH---HHhhhccccccccccccc
Q 004312          637 QSH------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA---YDCYQERTLGALVENDLE  707 (762)
Q Consensus       637 ~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~  707 (762)
                      ...      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....   ....... ........ .
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~-~  242 (298)
T 1csn_A          165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI-GEKKQSTP-L  242 (298)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH-HHHHHHSC-H
T ss_pred             cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH-HhhccCcc-H
Confidence            331      23446699999999999999999999999999999999999999854211   1111000 00000000 0


Q ss_pred             cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       708 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ......+++++.+++.+||+.||++||++++|++.|+++.+
T Consensus       243 ~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          243 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            00011345789999999999999999999999999998654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-38  Score=344.67  Aligned_cols=250  Identities=25%  Similarity=0.268  Sum_probs=196.9

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc-----ccchhHHHHHHhhhhcccccCCccchhceeccCCceeE
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-----FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L  557 (762)
                      .+.+.+.||+|+||.||+|... .+++.||||++...     .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        27 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           27 KYHLKGAIGQGSYGVVRVAIEN-QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             heeecceeeecCCeEEEEEEEC-CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            3556688999999999999753 55678999998653     23455789999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhccCC----------------------------------------CCCCHHHHHHHHHHHHHHHHHhH
Q 004312          558 VYEFMSNGALASFLFGD----------------------------------------SKPNWKLRTEIVMGIARGLFYLH  597 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~----------------------------------------~~l~~~~~~~i~~~ia~~L~yLH  597 (762)
                      ||||+++|+|.+++...                                        ..+++..+..|+.||++||+|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            99999999999998521                                        12356778889999999999999


Q ss_pred             hcCCCCeEeCCCCCCceEEcCCC--ceEEecccccccccCCCC---cccccccccCcccCcccccC--CCCCCcchhHHH
Q 004312          598 EECCTQIIHCDIKPQNILLDDYY--NARISDFGLEKLLTLDQS---HTNTAIRGTKGYVAPEWFRN--MPITVKVDVYSY  670 (762)
Q Consensus       598 ~~~~~~ivH~Dlkp~NILl~~~~--~~kl~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~  670 (762)
                      ++   +|+||||||+|||++.++  .+||+|||+++.+.....   .......||+.|+|||.+..  ..++.++|||||
T Consensus       186 ~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  262 (345)
T 3hko_A          186 NQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA  262 (345)
T ss_dssp             HT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred             HC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence            99   999999999999998776  899999999987643222   22345679999999999965  678999999999


Q ss_pred             HHHHHHHHhCCCCCchhhHHHhhhcccccccccccccc--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          671 GVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEA--MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       671 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      |+++|||++|+.||......+....     +.......  ......++.+.+++.+||+.||.+|||+.|+++
T Consensus       263 G~il~el~~g~~pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          263 GVLLHLLLMGAVPFPGVNDADTISQ-----VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHH-----HHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCCChHHHHHH-----HHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            9999999999999854433222221     11111111  111234678999999999999999999999987

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-39  Score=356.75  Aligned_cols=249  Identities=21%  Similarity=0.235  Sum_probs=201.3

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.||+|+||.||+++.. .+++.||||++++..   ......+.+|+.++.+++||||+++++++.+.+..+|||||+
T Consensus        65 ~~~~lG~G~fG~V~~~~~~-~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~  143 (412)
T 2vd5_A           65 ILKVIGRGAFSEVAVVKMK-QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYY  143 (412)
T ss_dssp             EEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCC
Confidence            3467999999999999764 456899999997532   222345889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          563 SNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       563 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      ++|+|.+++.+. ..+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++..........
T Consensus       144 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~  220 (412)
T 2vd5_A          144 VGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS  220 (412)
T ss_dssp             CSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCcccc
Confidence            999999999764 4799999999999999999999998   999999999999999999999999999987755444344


Q ss_pred             ccccccCcccCccccc-------CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccc-cCCCHH
Q 004312          642 TAIRGTKGYVAPEWFR-------NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE-AMDDMT  713 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~-------~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  713 (762)
                      ...+||+.|+|||++.       ...++.++|||||||++|||++|+.||......+.+.......   .... ...+..
T Consensus       221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~~~p~~~~~  297 (412)
T 2vd5_A          221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK---EHLSLPLVDEG  297 (412)
T ss_dssp             SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH---HHCCCC----C
T ss_pred             ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---cCcCCCccccC
Confidence            4568999999999997       3578999999999999999999999986554333222211000   0000 011223


Q ss_pred             HHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 004312          714 VLQRFVMVAIWCIQEDPSHR---PTMRRVTQM  742 (762)
Q Consensus       714 ~~~~~~~li~~cl~~dp~~R---Pt~~evl~~  742 (762)
                      .+.++.+++.+||. +|.+|   |+++|+++.
T Consensus       298 ~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          298 VPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            56789999999999 99998   689998853

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.8e-39  Score=348.53  Aligned_cols=256  Identities=27%  Similarity=0.401  Sum_probs=205.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCC----cceEEEEEcccccc-chhHHHHHHhhhhccc-ccCCccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGS----SDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~L  557 (762)
                      +.+.+.||+|+||.||+|......    ...||||++..... ...+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus        48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  127 (333)
T 2i1m_A           48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV  127 (333)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence            345678999999999999764322    24799999976432 3456799999999999 89999999999999999999


Q ss_pred             EEeccCCCchhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceE
Q 004312          558 VYEFMSNGALASFLFG--------------DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNAR  623 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k  623 (762)
                      ||||+++|+|.+++..              ...+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+|
T Consensus       128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~k  204 (333)
T 2i1m_A          128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAK  204 (333)
T ss_dssp             EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEE
T ss_pred             EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEE
Confidence            9999999999999864              23579999999999999999999999   999999999999999999999


Q ss_pred             EecccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccc
Q 004312          624 ISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGAL  701 (762)
Q Consensus       624 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  701 (762)
                      |+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..|+.........     ...
T Consensus       205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-----~~~  279 (333)
T 2i1m_A          205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF-----YKL  279 (333)
T ss_dssp             BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-----HHH
T ss_pred             ECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-----HHH
Confidence            9999999866443322 2233457889999999999999999999999999999998 88887432111111     111


Q ss_pred             cccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          702 VENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       702 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      +........+...++.+.+++.+||+.||.+|||++||++.|+.+.
T Consensus       280 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            1111112222334678899999999999999999999999998753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=343.56  Aligned_cols=240  Identities=23%  Similarity=0.313  Sum_probs=201.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--------chhHHHHHHhhhhcccccCCccchhceeccCCce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  555 (762)
                      +.+.+.||+|+||.||+|... .+++.||||+++....        .....+.+|++++++++||||+++++++.+.+..
T Consensus        26 y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  104 (335)
T 3dls_A           26 YSTMSPLGSGAFGFVWTAVDK-EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF  104 (335)
T ss_dssp             EEEEEECSSSSSCSEEEEEET-TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eEEEeEEEecCCEEEEEEEEC-CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence            445578999999999999744 4567999999875421        1334678899999999999999999999999999


Q ss_pred             eEEEeccCCC-chhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccccc
Q 004312          556 LLVYEFMSNG-ALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT  634 (762)
Q Consensus       556 ~LV~E~~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~  634 (762)
                      ++||||+..| +|.+++.....+++..+..|+.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++...
T Consensus       105 ~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          105 QLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            9999999877 9999999888999999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccccCcccCcccccCCCC-CCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHH
Q 004312          635 LDQSHTNTAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMT  713 (762)
Q Consensus       635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  713 (762)
                      ..  .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....           .......  ..+..
T Consensus       182 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----------~~~~~~~--~~~~~  246 (335)
T 3dls_A          182 RG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE-----------ETVEAAI--HPPYL  246 (335)
T ss_dssp             TT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG-----------GGTTTCC--CCSSC
T ss_pred             CC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH-----------HHHhhcc--CCCcc
Confidence            33  22334669999999999988776 889999999999999999999984321           0111111  11223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          714 VLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       714 ~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      .++++.+++.+||+.||++|||++|+++.
T Consensus       247 ~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          247 VSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            46789999999999999999999999984

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-38  Score=337.13  Aligned_cols=254  Identities=24%  Similarity=0.293  Sum_probs=197.7

Q ss_pred             HHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-----chhHHHHHHhhhhcccc---cCCccchhceeccC
Q 004312          481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-----DSEKEFKAEVNGIGQTH---HKNLVRLLGYCDEG  552 (762)
Q Consensus       481 ~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~  552 (762)
                      ...+.+.+.||+|+||+||+|... .+++.||||++.....     .....+.+|++++++++   ||||+++++++...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECT-TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            334566788999999999999743 4567999999874321     22357778888887775   99999999999765


Q ss_pred             C-----ceeEEEeccCCCchhhhccCCCC--CCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEe
Q 004312          553 R-----NRLLVYEFMSNGALASFLFGDSK--PNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARIS  625 (762)
Q Consensus       553 ~-----~~~LV~E~~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~  625 (762)
                      .     ..++||||++ ++|.+++.....  +++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence            5     4789999997 599999987644  89999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc--ccccc-
Q 004312          626 DFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT--LGALV-  702 (762)
Q Consensus       626 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~--~~~~~-  702 (762)
                      |||+++....  ........||+.|+|||.+.+..++.++||||||+++|||++|+.||.............  ..... 
T Consensus       163 Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          163 DFGLARIYSY--QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             SCSCTTTSTT--CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eCccccccCC--CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9999986643  223345678999999999999999999999999999999999999985543322221100  00000 


Q ss_pred             ----------ccccc--cC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          703 ----------ENDLE--AM-----DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       703 ----------~~~~~--~~-----~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                                .....  ..     .....++++.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence                      00000  00     01134578899999999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.6e-38  Score=350.40  Aligned_cols=255  Identities=17%  Similarity=0.195  Sum_probs=199.9

Q ss_pred             hhhhhhcCCC--CcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          484 RGFKEELGRG--AFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G--~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +.+.+.||+|  +||.||++... .+++.||||+++...  ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus        27 y~~~~~lG~G~~~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  105 (389)
T 3gni_B           27 YELLTVIGKGFEDLMTVNLARYK-PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT  105 (389)
T ss_dssp             EEEEEEEEEETTTTEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEEecccCCcCCceEEEEEEEc-CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence            4456789999  99999999754 457899999997543  233467889999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          560 EFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       560 E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ||+++|+|.+++...  ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||.+.......
T Consensus       106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~  182 (389)
T 3gni_B          106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG  182 (389)
T ss_dssp             ECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred             EccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence            999999999999765  6789999999999999999999999   99999999999999999999999999987543221


Q ss_pred             C------cccccccccCcccCcccccC--CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc---cccccccc-
Q 004312          638 S------HTNTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT---LGALVEND-  705 (762)
Q Consensus       638 ~------~~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~-  705 (762)
                      .      .......||+.|+|||.+.+  ..++.++||||||+++|||++|+.||.............   .....+.. 
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (389)
T 3gni_B          183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST  262 (389)
T ss_dssp             EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred             ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence            1      11223468999999999987  579999999999999999999999984432111111100   00000000 


Q ss_pred             -----------------------------------cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          706 -----------------------------------LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       706 -----------------------------------~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                                                         .........++++.+|+.+||+.||++|||++|+++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                                               0001122345779999999999999999999999854

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.6e-38  Score=356.01  Aligned_cols=245  Identities=25%  Similarity=0.414  Sum_probs=204.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++....   ......+.+|++++++++||||+++++++.+.+..+||||
T Consensus        18 Y~l~~~LG~G~fg~V~~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E   96 (476)
T 2y94_A           18 YILGDTLGVGTFGKVKVGKHE-LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME   96 (476)
T ss_dssp             EEEEEEEECCSSSCEEEEEET-TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            345678999999999999754 456899999997532   2234678999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++|+|.+++...+.+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--~~  171 (476)
T 2y94_A           97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EF  171 (476)
T ss_dssp             CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--CC
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc--cc
Confidence            999999999999888899999999999999999999998   9999999999999999999999999999876432  22


Q ss_pred             cccccccCcccCcccccCCCC-CCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ....+||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...........     +.....  ..+...+.++.
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~-----i~~~~~--~~p~~~s~~~~  244 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK-----ICDGIF--YTPQYLNPSVI  244 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH-----HHTTCC--CCCTTCCHHHH
T ss_pred             ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH-----HhcCCc--CCCccCCHHHH
Confidence            344579999999999988765 7899999999999999999999865432222211     111111  11223457889


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+||+.||++|||++|+++
T Consensus       245 ~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          245 SLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHcCCCchhCcCHHHHHh
Confidence            9999999999999999999996

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.3e-38  Score=339.22  Aligned_cols=252  Identities=22%  Similarity=0.322  Sum_probs=188.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||.||+|... .+++.||||+++... ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   85 (317)
T 2pmi_A            7 FKQLEKLGNGTYATVYKGLNK-TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM   85 (317)
T ss_dssp             ------------CEEEEEECS-SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred             eeEeeEECCCCCEEEEEEEEC-CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence            445678999999999999754 456799999987543 234468899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCC------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          563 SNGALASFLFGD------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       563 ~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      + ++|.+++...      ..+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            8 5999988542      4589999999999999999999998   9999999999999999999999999999876432


Q ss_pred             CCcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------cccc---c-
Q 004312          637 QSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------TLGA---L-  701 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~~~~---~-  701 (762)
                      . .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.....          ....   . 
T Consensus       162 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          162 V-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             C-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred             c-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence            2 22334568999999999976 46899999999999999999999998544322211100          0000   0 


Q ss_pred             -ccccc------------ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          702 -VENDL------------EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       702 -~~~~~------------~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                       ..+..            ........+.++.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence             00000            00011124568999999999999999999999886

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.9e-39  Score=343.26  Aligned_cols=250  Identities=24%  Similarity=0.284  Sum_probs=194.9

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEeccCCCc
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      +.||+|+||.||++... .+++.||||++..........+.+|++++.++ +||||+++++++.+.+..++||||+++++
T Consensus        19 ~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   97 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINL-ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS   97 (316)
T ss_dssp             CCCCCCSSEEEEEEECS-SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             ceecCCceEEEEEEEEc-CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence            57999999999999743 45679999999876666677899999999985 79999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc---eEEecccccccccCCCC-----
Q 004312          567 LASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN---ARISDFGLEKLLTLDQS-----  638 (762)
Q Consensus       567 L~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~Dfgla~~~~~~~~-----  638 (762)
                      |.+++.....+++..+..++.||++||+|||++   +|+||||||+|||++.++.   +||+|||+++.......     
T Consensus        98 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  174 (316)
T 2ac3_A           98 ILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS  174 (316)
T ss_dssp             HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------------
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccc
Confidence            999998888899999999999999999999999   9999999999999998766   99999999986543221     


Q ss_pred             -cccccccccCcccCcccccC-----CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHH----h------hhcccccccc
Q 004312          639 -HTNTAIRGTKGYVAPEWFRN-----MPITVKVDVYSYGVLLLEIICLRRTILTDWAYD----C------YQERTLGALV  702 (762)
Q Consensus       639 -~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~----~------~~~~~~~~~~  702 (762)
                       .......||+.|+|||.+..     ..++.++||||||+++|||++|+.||......+    .      ........+.
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  254 (316)
T 2ac3_A          175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ  254 (316)
T ss_dssp             -------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHH
T ss_pred             ccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHh
Confidence             12223469999999999875     468899999999999999999999985431100    0      0000000111


Q ss_pred             ccccccCC--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          703 ENDLEAMD--DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       703 ~~~~~~~~--~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ........  ....+.++.+++.+||+.||++|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          255 EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            11111000  0124578899999999999999999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.5e-38  Score=342.01  Aligned_cols=246  Identities=21%  Similarity=0.273  Sum_probs=181.1

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc-cCCccchhceeccCCceeEEEeccCCCc
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      +.||+|+||.||++... .+++.||||++.+.   ....+.+|++++.++. ||||+++++++.+....++||||+++|+
T Consensus        17 ~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHK-KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             CCSEEETTEEEEEEEET-TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CccccCCCeEEEEEEEC-CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            57999999999999754 45679999998643   4567889999999996 9999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC---ceEEecccccccccCCCCccccc
Q 004312          567 LASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY---NARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       567 L~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      |.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||++.++   .+||+|||+++..... ......
T Consensus        93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~  168 (325)
T 3kn6_A           93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKT  168 (325)
T ss_dssp             HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CCcccc
Confidence            999999888899999999999999999999999   999999999999997665   8999999999865432 222344


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhh--ccccccccccccccCC--CHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ--ERTLGALVENDLEAMD--DMTVLQRFV  719 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~--~~~~~~~~~  719 (762)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||..........  ......+.........  ...+++++.
T Consensus       169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  248 (325)
T 3kn6_A          169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAK  248 (325)
T ss_dssp             ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHH
T ss_pred             cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHH
Confidence            568999999999999999999999999999999999999985432110000  0001111111111110  123567899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+||+.||++|||++|+++
T Consensus       249 ~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          249 DLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHHHHHCCCTTTCCCTTTSTT
T ss_pred             HHHHHHCCCChhHCCCHHHHhc
Confidence            9999999999999999999875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5e-38  Score=331.91  Aligned_cols=245  Identities=27%  Similarity=0.388  Sum_probs=196.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceecc----CCceeEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE----GRNRLLV  558 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~LV  558 (762)
                      .+.+.||+|+||.||+|... .+++.||+|++....  ....+.+.+|++++++++||||+++++++..    ....++|
T Consensus        29 ~~~~~lg~G~~g~Vy~~~~~-~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           29 KFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EeeeeccCCCCeEEEEeEec-CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            34567999999999999654 556789999987532  3345679999999999999999999998764    4567999


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEeCCCCCCceEEc-CCCceEEecccccccccC
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ--IIHCDIKPQNILLD-DYYNARISDFGLEKLLTL  635 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~  635 (762)
                      |||+++++|.+++.....+++..+..++.||+.||.|||+.   +  |+||||||+|||++ +++.+||+|||++.....
T Consensus       108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence            99999999999998878899999999999999999999998   7  99999999999998 889999999999975432


Q ss_pred             CCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                         .......||+.|+|||.+. +.++.++||||||+++|+|++|+.||..................    ....+...+
T Consensus       185 ---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~  256 (290)
T 1t4h_A          185 ---SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----PASFDKVAI  256 (290)
T ss_dssp             ---TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----CGGGGGCCC
T ss_pred             ---cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC----ccccCCCCC
Confidence               2233456899999999886 45899999999999999999999998542222111111111111    111122234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+++.+||+.||++|||++|+++
T Consensus       257 ~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          257 PEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhh
Confidence            67899999999999999999999987

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1e-38  Score=335.52  Aligned_cols=256  Identities=23%  Similarity=0.352  Sum_probs=204.0

Q ss_pred             HHHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceecc--------
Q 004312          480 VEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--------  551 (762)
Q Consensus       480 ~~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--------  551 (762)
                      ....+.+.+.||+|+||.||+|... .+++.||||++....    ..+.+|++++++++||||+++++++..        
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHR-IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEET-TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hccccceeeeeccCCceEEEEEEEc-CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            3444556678999999999999754 356799999987542    357789999999999999999998854        


Q ss_pred             --------CCceeEEEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc
Q 004312          552 --------GRNRLLVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN  621 (762)
Q Consensus       552 --------~~~~~LV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~  621 (762)
                              ....++||||+++++|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||+++++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence                    44579999999999999999654  5789999999999999999999999   9999999999999999999


Q ss_pred             eEEecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccc
Q 004312          622 ARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL  701 (762)
Q Consensus       622 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~  701 (762)
                      +||+|||++.......  ......|++.|+|||.+.+..++.++||||||+++|||++|..|+......  ..     .+
T Consensus       161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--~~-----~~  231 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF--FT-----DL  231 (284)
T ss_dssp             EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH--HH-----HH
T ss_pred             EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH--HH-----Hh
Confidence            9999999998765432  233456899999999999999999999999999999999999986432111  10     01


Q ss_pred             cccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCCCCCCCC
Q 004312          702 VENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCPW  756 (762)
Q Consensus       702 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~p~~p~  756 (762)
                      ....    .+...+..+.+++.+||+.||++|||++|+++.|+.+...+...+..
T Consensus       232 ~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~~~  282 (284)
T 2a19_B          232 RDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERH  282 (284)
T ss_dssp             HTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--------
T ss_pred             hccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccccc
Confidence            1111    11234467889999999999999999999999999887665544443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=332.63  Aligned_cols=245  Identities=23%  Similarity=0.347  Sum_probs=180.9

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||+|... .+++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        14 ~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   92 (278)
T 3cok_A           14 KVGNLLGKGSFAGVYRAESI-HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM   92 (278)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eeeeeecCCCceEEEEEEEc-cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence            34578999999999999753 456799999986532   22346799999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          562 MSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       562 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +++++|.+++... ..+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||++........ .
T Consensus        93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~  168 (278)
T 3cok_A           93 CHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-K  168 (278)
T ss_dssp             CTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             CCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-c
Confidence            9999999999876 6789999999999999999999999   999999999999999999999999999987643222 2


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.|+..........     .......  ..+...+.++.+
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~--~~~~~~~~~~~~  241 (278)
T 3cok_A          169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-----KVVLADY--EMPSFLSIEAKD  241 (278)
T ss_dssp             -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CCSSCC--CCCTTSCHHHHH
T ss_pred             ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-----HHhhccc--CCccccCHHHHH
Confidence            234568999999999999899999999999999999999999975432111111     1111111  122335678899


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~  741 (762)
                      ++.+||+.||++|||++|+++
T Consensus       242 li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          242 LIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHcccCHhhCCCHHHHhc
Confidence            999999999999999999886

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.5e-38  Score=343.86  Aligned_cols=265  Identities=21%  Similarity=0.306  Sum_probs=206.7

Q ss_pred             cCHHHHHHHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcc--cccCCccchhceecc
Q 004312          474 FTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ--THHKNLVRLLGYCDE  551 (762)
Q Consensus       474 ~~~~el~~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~  551 (762)
                      +...+.....+.+.+.||+|+||.||+|+..   ++.||||++...   ....+.+|++++..  ++||||+++++++..
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEEc---CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            3344555566677789999999999999763   578999998643   34677888888877  799999999999987


Q ss_pred             CC----ceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhH--------hcCCCCeEeCCCCCCceEEcCC
Q 004312          552 GR----NRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLH--------EECCTQIIHCDIKPQNILLDDY  619 (762)
Q Consensus       552 ~~----~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dlkp~NILl~~~  619 (762)
                      ..    ..++||||+++|+|.+++.+ ..+++..+..++.|++.||+|||        +.   +|+||||||+|||++.+
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~  183 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN  183 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC
Confidence            76    78999999999999999965 46899999999999999999999        66   99999999999999999


Q ss_pred             CceEEecccccccccCCCCc---ccccccccCcccCcccccCC------CCCCcchhHHHHHHHHHHHhC----------
Q 004312          620 YNARISDFGLEKLLTLDQSH---TNTAIRGTKGYVAPEWFRNM------PITVKVDVYSYGVLLLEIICL----------  680 (762)
Q Consensus       620 ~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~~~DV~S~Gvil~elltg----------  680 (762)
                      +.+||+|||+++........   ......||+.|+|||.+.+.      .++.++||||||+++|||++|          
T Consensus       184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~  263 (342)
T 1b6c_B          184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  263 (342)
T ss_dssp             SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence            99999999999876543322   22345699999999999765      234789999999999999999          


Q ss_pred             CCCCchhhH----HHhhhcccccccccccccc-CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          681 RRTILTDWA----YDCYQERTLGALVENDLEA-MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       681 ~~p~~~~~~----~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      +.||.....    ..............+.... ......++.+.+++.+||+.||++|||++||++.|+.+.+
T Consensus       264 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            667633211    0111111111111111110 1123677889999999999999999999999999998654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3e-38  Score=330.75  Aligned_cols=250  Identities=26%  Similarity=0.313  Sum_probs=203.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (276)
T 2yex_A            9 WDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   87 (276)
T ss_dssp             EEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eEEEEEeecCCCcEEEEEEEC-CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence            445678999999999999754 456799999986433 344578999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC-ccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-HTN  641 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~  641 (762)
                      ++++|.+++.....+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++........ ...
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           88 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence            9999999998888899999999999999999999998   999999999999999999999999999986643322 223


Q ss_pred             ccccccCcccCcccccCCCC-CCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||.........    .................+..+.+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  240 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE----YSDWKEKKTYLNPWKKIDSAPLA  240 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH----HHHHHTTCTTSTTGGGSCHHHHH
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH----HHHhhhcccccCchhhcCHHHHH
Confidence            34568999999999987765 78999999999999999999998543211000    00001111111112245678899


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~  741 (762)
                      ++.+||+.||++|||++|+++
T Consensus       241 li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          241 LLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHCCCCchhCCCHHHHhc
Confidence            999999999999999999886

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.1e-38  Score=332.78  Aligned_cols=244  Identities=27%  Similarity=0.374  Sum_probs=200.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||+|... .+++.||||++....   ......+.+|++++++++||||+++++++.+....++||||
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (279)
T 3fdn_A           12 EIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   90 (279)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEeeEEecCCCeEEEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence            34578999999999999754 456789999986532   22346789999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++++|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.....   ...
T Consensus        91 ~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~---~~~  164 (279)
T 3fdn_A           91 APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRR  164 (279)
T ss_dssp             CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc---ccc
Confidence            99999999998878899999999999999999999998   999999999999999999999999999865432   222


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.............     .  .....+...++.+.++
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~--~~~~~~~~~~~~~~~l  237 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-----R--VEFTFPDFVTEGARDL  237 (279)
T ss_dssp             ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----H--TCCCCCTTSCHHHHHH
T ss_pred             cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH-----h--CCCCCCCcCCHHHHHH
Confidence            34568999999999999999999999999999999999999985443222221110     0  0111223356788999


Q ss_pred             HHHhhccCCCCCCCHHHHHHH
Q 004312          722 AIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~  742 (762)
                      +.+||+.||++|||++|+++.
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHC
T ss_pred             HHHHhccChhhCCCHHHHhhC
Confidence            999999999999999999963

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1e-38  Score=343.48  Aligned_cols=255  Identities=26%  Similarity=0.419  Sum_probs=203.3

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCc-ceEEEEEcccc-ccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSS-DQVAVKKLNRV-FQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~-~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|....... ..+|||+++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e  106 (327)
T 1fvr_A           27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE  106 (327)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence            3456789999999999998654322 24599998753 233456799999999999 99999999999999999999999


Q ss_pred             ccCCCchhhhccCCC----------------CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEE
Q 004312          561 FMSNGALASFLFGDS----------------KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARI  624 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl  624 (762)
                      |+++++|.+++....                .+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL  183 (327)
T 1fvr_A          107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI  183 (327)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred             cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEE
Confidence            999999999997654                689999999999999999999998   9999999999999999999999


Q ss_pred             ecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccc
Q 004312          625 SDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVE  703 (762)
Q Consensus       625 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  703 (762)
                      +|||+++....  ........+++.|+|||.+....++.++||||||+++|||++ |+.||...........      +.
T Consensus       184 ~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~------~~  255 (327)
T 1fvr_A          184 ADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------LP  255 (327)
T ss_dssp             CCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH------GG
T ss_pred             cccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH------hh
Confidence            99999974322  112233457889999999998889999999999999999998 9999754433222211      11


Q ss_pred             cccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          704 NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       704 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      .......+...++++.+++.+||+.||++|||++|+++.|+.+.+-
T Consensus       256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            1111222334567899999999999999999999999999886543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=345.48  Aligned_cols=248  Identities=20%  Similarity=0.287  Sum_probs=194.3

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhccccc--CCccchhceeccCCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHH--KNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +.+.+.||+|+||.||++...  +++.||||++....  ....+.+.+|++++.+++|  +||+++++++.+....+|||
T Consensus        11 y~i~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A           11 YSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             EEEEEEESCCSSEEEEEEECT--TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEEEEecCCCeEEEEEEeC--CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            345678999999999999753  46789999986532  3334679999999999976  99999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      | +.+++|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||++ ++.+||+|||+++........
T Consensus        89 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           89 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             C-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred             e-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence            9 56889999999888899999999999999999999999   999999999999997 578999999999876543322


Q ss_pred             -ccccccccCcccCcccccC-----------CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccc
Q 004312          640 -TNTAIRGTKGYVAPEWFRN-----------MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE  707 (762)
Q Consensus       640 -~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  707 (762)
                       ......||+.|+|||.+.+           ..++.++||||||+++|||++|+.||.......    ......++....
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~~~~~  239 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SKLHAIIDPNHE  239 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH----HHHHHHHCTTSC
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH----HHHHHHhcCCcc
Confidence             2335679999999999865           678999999999999999999999984321110    011112222222


Q ss_pred             cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       708 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ...+...+.++.+++.+||+.||++|||++|+++.
T Consensus       240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            22233335678999999999999999999999863

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.3e-38  Score=339.81  Aligned_cols=260  Identities=20%  Similarity=0.314  Sum_probs=197.3

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++...   .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus        34 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  112 (310)
T 2wqm_A           34 FRIEKKIGRGQFSEVYRAACL-LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE  112 (310)
T ss_dssp             EEEEEEEECC--CEEEEEEET-TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEeecCCCCceEEEEEEc-CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence            455678999999999999754 45679999998752   23345678999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          561 FMSNGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       561 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      |+++++|.+++..    ...+++..+..++.||++||.|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred             cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence            9999999999863    46689999999999999999999999   9999999999999999999999999999866432


Q ss_pred             CCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          637 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      .. ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.........   ....+.............++
T Consensus       190 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          190 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS---LCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH---HHHHHHTTCSCCCCTTTSCH
T ss_pred             Cc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH---HHHHhhcccCCCCcccccCH
Confidence            22 223456899999999999999999999999999999999999998543110000   00001111111111234567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCCC
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVPI  751 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~  751 (762)
                      ++.+++.+||+.||++|||+++|++.|+++.+...
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence            89999999999999999999999999999765443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.5e-38  Score=331.80  Aligned_cols=249  Identities=23%  Similarity=0.316  Sum_probs=203.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.+.+.||+|+||.||+|... .+++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   86 (284)
T 3kk8_A            8 YDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL   86 (284)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hhhhhhhcCcCCeEEEEEEEc-CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence            345578999999999999754 456799999986543  23346788999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc---eEEecccccccccCCCC
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN---ARISDFGLEKLLTLDQS  638 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~Dfgla~~~~~~~~  638 (762)
                      +++++|.+++.....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.   +||+|||++......  
T Consensus        87 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~--  161 (284)
T 3kk8_A           87 VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--  161 (284)
T ss_dssp             CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS--
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC--
Confidence            99999999998888899999999999999999999999   9999999999999986655   999999999866432  


Q ss_pred             cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          639 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..................   .........++++
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  238 (284)
T 3kk8_A          162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD---YPSPEWDTVTPEA  238 (284)
T ss_dssp             CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---CCTTTTTTSCHHH
T ss_pred             ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc---CCchhhcccCHHH
Confidence            2233456899999999999999999999999999999999999998554332222211111000   0111112346788


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+++.+||+.||++|||++|+++
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHcccChhhCCCHHHHhc
Confidence            99999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.2e-39  Score=349.45  Aligned_cols=255  Identities=13%  Similarity=0.140  Sum_probs=200.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCC-------CcceEEEEEccccccchhHHHHHHhhhhcccccCCccch-----------
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMG-------SSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL-----------  545 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l-----------  545 (762)
                      +.+.+.||+|+||.||+|.....       .++.||||++...     ..+.+|++++++++||||+++           
T Consensus        44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  118 (352)
T 2jii_A           44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA  118 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred             EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence            44567899999999999986542       3678999998653     468899999999999999984           


Q ss_pred             ----hceecc-CCceeEEEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC
Q 004312          546 ----LGYCDE-GRNRLLVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD  618 (762)
Q Consensus       546 ----~g~~~~-~~~~~LV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~  618 (762)
                          ++++.. ....+|||||+ +++|.+++...  ..+++..+..|+.||+.||+|||++   +|+||||||+|||++.
T Consensus       119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~  194 (352)
T 2jii_A          119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP  194 (352)
T ss_dssp             CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEET
T ss_pred             ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcC
Confidence                455554 67789999999 99999999876  7899999999999999999999999   9999999999999999


Q ss_pred             CC--ceEEecccccccccCCCCc------ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhh-H
Q 004312          619 YY--NARISDFGLEKLLTLDQSH------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDW-A  689 (762)
Q Consensus       619 ~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~-~  689 (762)
                      ++  .+||+|||+++.+......      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .
T Consensus       195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  274 (352)
T 2jii_A          195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN  274 (352)
T ss_dssp             TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence            98  9999999999876543221      1234579999999999999999999999999999999999999985432 1


Q ss_pred             HHhhhcccccccccccc--c--cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          690 YDCYQERTLGALVENDL--E--AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       690 ~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ....... .........  .  .......++++.+++.+||+.||++|||+++|+++|+++.+
T Consensus       275 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  336 (352)
T 2jii_A          275 TEDIMKQ-KQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ  336 (352)
T ss_dssp             HHHHHHH-HHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHH-HHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence            1111100 000000000  0  00011235789999999999999999999999999988653

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.3e-38  Score=335.71  Aligned_cols=249  Identities=24%  Similarity=0.334  Sum_probs=202.6

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.+.||+|+||.||++... .+++.||||+++.........+.+|++++++++||||+++++++.+....++||||+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A           10 TFIFMEVLGSGAFSEVFLVKQR-LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             cceeeeeccCCCCceEEEEEEC-CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            4556678999999999999754 456799999998655555678999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE---cCCCceEEecccccccccCCCCc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      ++++|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+||++   ++++.+||+|||+++....   .
T Consensus        89 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~---~  162 (304)
T 2jam_A           89 SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---G  162 (304)
T ss_dssp             CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC---B
T ss_pred             CCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC---C
Confidence            9999999998778899999999999999999999999   99999999999999   7889999999999975432   2


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||............. ....  ..........++++.
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~-~~~~--~~~~~~~~~~~~~~~  239 (304)
T 2jam_A          163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK-EGYY--EFESPFWDDISESAK  239 (304)
T ss_dssp             TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HCCC--CCCTTTTTTSCHHHH
T ss_pred             ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-cCCC--CCCccccccCCHHHH
Confidence            2334568999999999999999999999999999999999999985543222211110 0000  001111234567899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+||+.||++|||++|+++
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          240 DFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHHHcCCChhHCcCHHHHhc
Confidence            9999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.7e-38  Score=329.83  Aligned_cols=248  Identities=25%  Similarity=0.356  Sum_probs=196.3

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.+.||+|+||.||++... .+++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEER-SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             heeecceeccCCCeEEEEEEEc-cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            3556788999999999999754 456789999987643 33457899999999999999999999999999999999999


Q ss_pred             cCCCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE---cCCCceEEeccccccccc
Q 004312          562 MSNGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLT  634 (762)
Q Consensus       562 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~  634 (762)
                      +++++|.+++..    ...+++..+..|+.||+.||+|||++   +|+||||||+|||+   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            999999999854    36789999999999999999999999   99999999999999   456889999999998664


Q ss_pred             CCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHH
Q 004312          635 LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  714 (762)
                      ..  .......||+.|+|||.+. ..++.++||||||+++|||++|+.||..................   .. ......
T Consensus       179 ~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---~~-~~~~~~  251 (285)
T 3is5_A          179 SD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN---YA-VECRPL  251 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CC-C--CCC
T ss_pred             Cc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc---cc-cccCcC
Confidence            32  2234456899999999985 57899999999999999999999998554332222211111100   00 001123


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          715 LQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ++++.+++.+||+.||++|||++|+++
T Consensus       252 ~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          252 TPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            567889999999999999999999986

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3e-38  Score=336.97  Aligned_cols=252  Identities=25%  Similarity=0.298  Sum_probs=196.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc--hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|+||.||+|... .+++.||||++......  ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         6 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (311)
T 4agu_A            6 EKIGKIGEGSYGVVFKCRNR-DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC   84 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eEeeEEeecCCeEEEEEEeC-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence            44578999999999999754 45679999998654332  3467889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ++++|.+++.....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        85 ~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  160 (311)
T 4agu_A           85 DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYD  160 (311)
T ss_dssp             SEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             CCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-ccC
Confidence            9999999998888899999999999999999999999   999999999999999999999999999987653222 223


Q ss_pred             cccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc--ccc-----------------ccc
Q 004312          643 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER--TLG-----------------ALV  702 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~--~~~-----------------~~~  702 (762)
                      ...||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+.....  ...                 ...
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            4568999999999976 67899999999999999999999997543222111100  000                 000


Q ss_pred             ccccccCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          703 ENDLEAMDD-----MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       703 ~~~~~~~~~-----~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+......+     ...+..+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000000     234567899999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.3e-38  Score=342.62  Aligned_cols=257  Identities=29%  Similarity=0.348  Sum_probs=202.7

Q ss_pred             HhhhhhhcCCCCcceEEEeeee----CCCcceEEEEEcccc-ccchhHHHHHHhhhhcccccCCccchhceeccCCceeE
Q 004312          483 TRGFKEELGRGAFGTVYKGFVN----MGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L  557 (762)
                      .+.+.+.||+|+||.||+|...    ..+++.||||++... ......++.+|+.++++++||||+++++++.+....++
T Consensus        31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (327)
T 2yfx_A           31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI  110 (327)
T ss_dssp             GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEE
Confidence            3456678999999999999753    234568999999753 33445689999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhccCC-------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC---CCceEEecc
Q 004312          558 VYEFMSNGALASFLFGD-------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD---YYNARISDF  627 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Df  627 (762)
                      ||||+++++|.+++...       ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.   +..+||+||
T Consensus       111 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Df  187 (327)
T 2yfx_A          111 LMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDF  187 (327)
T ss_dssp             EEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             EEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECcc
Confidence            99999999999999754       3488999999999999999999999   9999999999999984   456999999


Q ss_pred             cccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccc
Q 004312          628 GLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVEND  705 (762)
Q Consensus       628 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  705 (762)
                      |+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...........      +...
T Consensus       188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~------~~~~  261 (327)
T 2yfx_A          188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF------VTSG  261 (327)
T ss_dssp             HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH------HHTT
T ss_pred             ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH------HhcC
Confidence            99986543322 22234557899999999999999999999999999999998 8888754322221111      1111


Q ss_pred             cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          706 LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       706 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      .....+..++..+.+++.+||+.||++||+++|+++.|+.+..
T Consensus       262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            1112233456789999999999999999999999999987654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.1e-38  Score=334.74  Aligned_cols=247  Identities=26%  Similarity=0.362  Sum_probs=195.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccC-CceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-RNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||.||++...   ++.||||+++..  ...+.+.+|++++++++||||+++++++.+. +..++||||+
T Consensus        23 y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           23 LKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             EEEEEEEEECSSCEEEEEEET---TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             ceEEeEEecCCCceEEEEEEc---CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            345678999999999999753   568999999753  3457899999999999999999999987554 4789999999


Q ss_pred             CCCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          563 SNGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       563 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      ++++|.+++....  .+++..+..++.|+++||+|||++   +|+||||||+||++++++.+||+|||+++.....    
T Consensus        98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----  170 (278)
T 1byg_A           98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  170 (278)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc----
Confidence            9999999997653  378999999999999999999999   9999999999999999999999999998755322    


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      .....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..........      .+........+...++.+.
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~  244 (278)
T 1byg_A          171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP------RVEKGYKMDAPDGCPPAVY  244 (278)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH------HHTTTCCCCCCTTCCHHHH
T ss_pred             ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHhcCCCCCCcccCCHHHH
Confidence            223357889999999999999999999999999999998 888874332111111      1111112222344567899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      +++.+||+.||++|||++|+++.|+.+..
T Consensus       245 ~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          245 EVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            99999999999999999999999988643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.7e-38  Score=350.11  Aligned_cols=248  Identities=19%  Similarity=0.283  Sum_probs=195.3

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccc--cCCccchhceeccCCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTH--HKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +.+.+.||+|+||.||++...  .++.||||++....  ....+.+.+|++++.+++  ||||+++++++...+..+|||
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             eEEEEEEccCCCeEEEEEEcC--CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            445678999999999999754  36789999986532  334568999999999995  599999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      | +.+++|.+++.....+++..+..++.||+.||.|||++   +|+||||||+|||++ ++.+||+|||+++.+......
T Consensus       136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            9 67889999998888899999999999999999999998   999999999999995 579999999999876543322


Q ss_pred             -ccccccccCcccCcccccC-----------CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccc
Q 004312          640 -TNTAIRGTKGYVAPEWFRN-----------MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE  707 (762)
Q Consensus       640 -~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  707 (762)
                       ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......    ..+..++.....
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~~~~~~~~~~~~  286 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SKLHAIIDPNHE  286 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHCTTSC
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH----HHHHHHhCcccc
Confidence             2344679999999999865           368999999999999999999999984321110    011122222222


Q ss_pred             cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       708 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ...+...+.++.+++.+||+.||++|||++|+++.
T Consensus       287 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            22222235678999999999999999999999853

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.3e-38  Score=341.12  Aligned_cols=252  Identities=19%  Similarity=0.284  Sum_probs=191.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc--hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.+.+.||+|+||+||+|... .+++.||||+++.....  ..+.+.+|++++++++||||+++++++.+....+|||||
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  114 (329)
T 3gbz_A           36 YRRITKLGEGTYGEVYKAIDT-VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY  114 (329)
T ss_dssp             EEEEEEEEECSSSEEEEEEET-TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEEecCCeEEEEEEEC-CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence            345578999999999999643 45779999999754322  245688999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc-----CCCceEEecccccccccCC
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD-----DYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-----~~~~~kl~Dfgla~~~~~~  636 (762)
                      ++ |+|.+++.....+++..+..|+.||+.||+|||++   +|+||||||+|||++     +++.+||+|||+++.....
T Consensus       115 ~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~  190 (329)
T 3gbz_A          115 AE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP  190 (329)
T ss_dssp             CS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred             CC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence            98 59999998888899999999999999999999999   999999999999994     5556999999999876432


Q ss_pred             CCcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccc-cc-------------
Q 004312          637 QSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLG-AL-------------  701 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~-~~-------------  701 (762)
                      . .......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||......+........ ..             
T Consensus       191 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (329)
T 3gbz_A          191 I-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP  269 (329)
T ss_dssp             ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             c-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence            2 223345689999999999874 5899999999999999999999998554332221110000 00             


Q ss_pred             ---------cccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          702 ---------VENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       702 ---------~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                               .............++++.+|+.+||+.||++|||++|+++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                     0000000001114577899999999999999999999987

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.1e-38  Score=344.12  Aligned_cols=248  Identities=19%  Similarity=0.207  Sum_probs=200.2

Q ss_pred             hhhhhhcCCCCcceEEEeee----eCCCcceEEEEEccccccchhHHHHHHhhhhcccc---cCCccchhceeccCCcee
Q 004312          484 RGFKEELGRGAFGTVYKGFV----NMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH---HKNLVRLLGYCDEGRNRL  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~  556 (762)
                      +.+.+.||+|+||.||+|..    +...++.||||+++..   ...++.+|++++.+++   |+||+++++++...+..+
T Consensus        67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~  143 (365)
T 3e7e_A           67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV  143 (365)
T ss_dssp             EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred             EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence            34557899999999999953    2345678999999754   3456777777777775   999999999999999999


Q ss_pred             EEEeccCCCchhhhcc-----CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC-----------CC
Q 004312          557 LVYEFMSNGALASFLF-----GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD-----------YY  620 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-----------~~  620 (762)
                      |||||+++|+|.+++.     ....+++..+..|+.||++||+|||++   +|+||||||+||||+.           ++
T Consensus       144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~  220 (365)
T 3e7e_A          144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSA  220 (365)
T ss_dssp             EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CT
T ss_pred             EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccC
Confidence            9999999999999997     356799999999999999999999998   9999999999999998           89


Q ss_pred             ceEEecccccccccCC-CCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccc
Q 004312          621 NARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLG  699 (762)
Q Consensus       621 ~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~  699 (762)
                      .+||+|||+++.+... .........||+.|+|||++.+..++.++||||||+++|||++|+.||......    ...  
T Consensus       221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~--  294 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG----ECK--  294 (365)
T ss_dssp             TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT----EEE--
T ss_pred             CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC----cee--
Confidence            9999999999765422 233345567999999999999999999999999999999999999997433110    000  


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHhhcCcC
Q 004312          700 ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHR-PTMRRVTQMLEGVVE  748 (762)
Q Consensus       700 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R-Pt~~evl~~L~~~~~  748 (762)
                        +.......   ...+.+.+++..|++.+|.+| |+++++.+.|++..+
T Consensus       295 --~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          295 --PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             --ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             --echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence              11111111   235677889999999999998 689999888887543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.6e-38  Score=331.49  Aligned_cols=251  Identities=25%  Similarity=0.344  Sum_probs=202.1

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc------chhHHHHHHhhhhcccccCCccchhceeccCCce
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNR  555 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  555 (762)
                      ..+.+.+.||+|+||.||++... .+++.||||+++....      ...+.+.+|++++++++||||+++++++.+....
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQK-GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEc-CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            34556788999999999999754 4567999999875322      1357899999999999999999999999999999


Q ss_pred             eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC----ceEEecccccc
Q 004312          556 LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY----NARISDFGLEK  631 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Dfgla~  631 (762)
                      ++||||+++++|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+||++++++    .+||+|||++.
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            99999999999999998778899999999999999999999998   999999999999998877    89999999998


Q ss_pred             cccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCC
Q 004312          632 LLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD  711 (762)
Q Consensus       632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  711 (762)
                      ......  ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||................   ........
T Consensus       161 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~  235 (283)
T 3bhy_A          161 KIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN---YDFDEEYF  235 (283)
T ss_dssp             ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---CCCCHHHH
T ss_pred             eccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcc---cCCcchhc
Confidence            664322  2234568999999999999999999999999999999999999986543322222110000   00000001


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       712 ~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ...++.+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             TTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            123567899999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.2e-38  Score=336.41  Aligned_cols=256  Identities=24%  Similarity=0.323  Sum_probs=198.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCc--ceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSS--DQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLV  558 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV  558 (762)
                      +.+.+.||+|+||.||+|.+...++  ..||||+++..   .....+.+.+|++++++++||||+++++++.+.. .++|
T Consensus        20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v   98 (291)
T 1u46_A           20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV   98 (291)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred             eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence            4456789999999999998654433  36999998753   2334578999999999999999999999998765 8899


Q ss_pred             EeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          559 YEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      +||+++++|.+++... ..+++..+..++.||++||.|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  175 (291)
T 1u46_A           99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  175 (291)
T ss_dssp             EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             EecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence            9999999999999764 5689999999999999999999999   99999999999999999999999999998765433


Q ss_pred             Cc--ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHH
Q 004312          638 SH--TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       638 ~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  714 (762)
                      ..  ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...........     +.........+...
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~  250 (291)
T 1u46_A          176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK-----IDKEGERLPRPEDC  250 (291)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-----HHTSCCCCCCCTTC
T ss_pred             cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHH-----HHccCCCCCCCcCc
Confidence            22  1223457889999999998889999999999999999999 9999754432222211     11111112223345


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          715 LQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ++++.+++.+||+.||++|||++++++.|+++..
T Consensus       251 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            6789999999999999999999999999988643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.4e-38  Score=344.05  Aligned_cols=251  Identities=22%  Similarity=0.315  Sum_probs=200.6

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .+.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        36 ~~~~~lg~G~~g~V~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  114 (360)
T 3eqc_A           36 EKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD  114 (360)
T ss_dssp             EEEEEEEECSSCEEEEEEET-TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             eeeeeecCCCCeEEEEEEEC-CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCC
Confidence            34567999999999999754 456799999987542 3345689999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +++|.+++.....+++..+..++.|++.||+|||++  .+|+||||||+|||++.++.+||+|||++......   ....
T Consensus       115 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~  189 (360)
T 3eqc_A          115 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS  189 (360)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C---
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---cccC
Confidence            999999998888899999999999999999999983  17999999999999999999999999999765322   2234


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc---------------------------
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER---------------------------  696 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~---------------------------  696 (762)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||............                           
T Consensus       190 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (360)
T 3eqc_A          190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM  269 (360)
T ss_dssp             -CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------------
T ss_pred             CCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccccc
Confidence            56899999999999999999999999999999999999998543221110000                           


Q ss_pred             ----------ccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          697 ----------TLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       697 ----------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                                ....+.............+.++.+++.+||+.||++|||++|+++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          270 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                      000000000111111234668999999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=341.72  Aligned_cols=251  Identities=22%  Similarity=0.295  Sum_probs=187.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc-cCCccchhcee--------ccCCc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYC--------DEGRN  554 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~--------~~~~~  554 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++........+.+.+|+.++.++. ||||+++++++        .....
T Consensus        30 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~  108 (337)
T 3ll6_A           30 LRVRRVLAEGGFAFVYEAQDV-GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE  108 (337)
T ss_dssp             EEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred             EEEEEEEccCCceEEEEEEEC-CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence            445678999999999999754 456799999997666666778999999999996 99999999998        34455


Q ss_pred             eeEEEeccCCCchhhhccC---CCCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEeCCCCCCceEEcCCCceEEecccc
Q 004312          555 RLLVYEFMSNGALASFLFG---DSKPNWKLRTEIVMGIARGLFYLHEECCTQ--IIHCDIKPQNILLDDYYNARISDFGL  629 (762)
Q Consensus       555 ~~LV~E~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NILl~~~~~~kl~Dfgl  629 (762)
                      .++||||++ |+|.+++..   ...+++..+..|+.||+.||+|||++   +  |+||||||+|||+++++.+||+|||+
T Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence            799999996 799988864   46799999999999999999999998   7  99999999999999999999999999


Q ss_pred             cccccCCCCc-----------ccccccccCcccCcccc---cCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc
Q 004312          630 EKLLTLDQSH-----------TNTAIRGTKGYVAPEWF---RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE  695 (762)
Q Consensus       630 a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~  695 (762)
                      ++........           ......||+.|+|||.+   .+..++.++||||||+++|||++|+.||........   
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---  261 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI---  261 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh---
Confidence            9876543221           11234589999999998   566789999999999999999999999844322111   


Q ss_pred             cccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          696 RTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       696 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                            .............+..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus       262 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          262 ------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             ----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                  11111111122234567899999999999999999999999988754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.2e-38  Score=341.60  Aligned_cols=244  Identities=25%  Similarity=0.336  Sum_probs=198.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +...+.||+|+||.||+|... .+++.||||++.....   ...+++.+|++++++++||||+++++++.+.+..+||||
T Consensus        56 y~~~~~lG~G~~g~Vy~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           56 FSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeeeeEEccCCCEEEEEEEEc-cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            444578999999999999743 4567999999875322   234578999999999999999999999999999999999


Q ss_pred             ccCCCchhhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          561 FMSNGALASFLF-GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       561 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |++ |+|.+++. ....+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+|||+++.....   
T Consensus       135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---  207 (348)
T 1u5q_A          135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  207 (348)
T ss_dssp             CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence            997 68888775 346789999999999999999999999   9999999999999999999999999999865422   


Q ss_pred             ccccccccCcccCccccc---CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                        ....||+.|+|||.+.   ...++.++||||||+++|||++|+.|+...........     +.............++
T Consensus       208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  280 (348)
T 1u5q_A          208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-----IAQNESPALQSGHWSE  280 (348)
T ss_dssp             --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----HHHSCCCCCCCTTSCH
T ss_pred             --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-----HHhcCCCCCCCCCCCH
Confidence              2356899999999984   56789999999999999999999999754432222111     1111111112233467


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      .+.+++.+||+.||++|||++++++.
T Consensus       281 ~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          281 YFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhhC
Confidence            78999999999999999999998863

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.2e-38  Score=329.21  Aligned_cols=244  Identities=23%  Similarity=0.315  Sum_probs=203.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++....   ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus        16 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   94 (284)
T 2vgo_A           16 FDIGRPLGKGKFGNVYLAREK-QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE   94 (284)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceeeheecCCCCeEEEEEEEc-CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence            345678999999999999754 456789999986532   2234679999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++++|.+++.....+++..+..++.||++||.|||+.   +|+||||||+||+++.++.+||+|||++......   .
T Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---~  168 (284)
T 2vgo_A           95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---R  168 (284)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---C
T ss_pred             eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc---c
Confidence            999999999998878899999999999999999999998   9999999999999999999999999998765422   2


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........     +....  ...+...+..+.+
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~~~  241 (284)
T 2vgo_A          169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR-----IVNVD--LKFPPFLSDGSKD  241 (284)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----HHTTC--CCCCTTSCHHHHH
T ss_pred             cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH-----Hhccc--cCCCCcCCHHHHH
Confidence            2345689999999999999999999999999999999999999854432222111     11111  1122345678899


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~  741 (762)
                      ++.+||+.||++|||++|+++
T Consensus       242 li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          242 LISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhcCHhhCCCHHHHhh
Confidence            999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.4e-38  Score=342.51  Aligned_cols=247  Identities=23%  Similarity=0.305  Sum_probs=197.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||.||++... .+++.||||++.+...    .+.+|++++.++ +||||+++++++.+....++||||+
T Consensus        24 y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   98 (342)
T 2qr7_A           24 YEVKEDIGVGSYSVCKRCIHK-ATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM   98 (342)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence            455678999999999999754 4568999999975432    345788888887 7999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC----CceEEecccccccccCCCC
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY----YNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~Dfgla~~~~~~~~  638 (762)
                      ++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||+.++    +.+||+|||+++.......
T Consensus        99 ~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~  175 (342)
T 2qr7_A           99 KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG  175 (342)
T ss_dssp             CSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence            9999999999888899999999999999999999999   99999999999998543    3599999999987654322


Q ss_pred             cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccc--ccCCCHHHHH
Q 004312          639 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL--EAMDDMTVLQ  716 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  716 (762)
                       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......  ........+.....  ........++
T Consensus       176 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~  252 (342)
T 2qr7_A          176 -LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARIGSGKFSLSGGYWNSVSD  252 (342)
T ss_dssp             -CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred             -ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHHHccCCcccCccccccCCH
Confidence             234467899999999998888999999999999999999999998532100  00000111111111  1111234567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ++.+++.+||+.||++|||++|+++
T Consensus       253 ~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          253 TAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhc
Confidence            8999999999999999999999885

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.9e-38  Score=328.74  Aligned_cols=240  Identities=21%  Similarity=0.285  Sum_probs=198.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++...  ......++.+|+..+.++ +||||+++++++.+.+..++|||
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e   91 (289)
T 1x8b_A           13 FHELEKIGSGEFGSVFKCVKR-LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE   91 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhhhhhcCCCceEEEEEEEc-CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence            445678999999999999754 45679999998753  233456888999999999 99999999999999999999999


Q ss_pred             ccCCCchhhhccCC----CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC------------------
Q 004312          561 FMSNGALASFLFGD----SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD------------------  618 (762)
Q Consensus       561 ~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~------------------  618 (762)
                      |+++++|.+++...    ..+++..+..|+.||++||+|||++   +|+||||||+|||++.                  
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-------------------
T ss_pred             ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            99999999999764    6689999999999999999999999   9999999999999984                  


Q ss_pred             -CCceEEecccccccccCCCCcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc
Q 004312          619 -YYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER  696 (762)
Q Consensus       619 -~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~  696 (762)
                       ...+||+|||++.......     ...||+.|+|||.+.+. .++.++||||||+++|+|++|..++............
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~  243 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQG  243 (289)
T ss_dssp             -CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHTT
T ss_pred             CceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHcC
Confidence             4479999999998764322     23489999999999766 6778999999999999999998876444333332222


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          697 TLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       697 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ...         ..+...++++.+++.+||+.||++|||++|+++
T Consensus       244 ~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          244 RLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             CCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            111         112234578899999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1e-38  Score=350.45  Aligned_cols=235  Identities=15%  Similarity=0.152  Sum_probs=185.1

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHh---hhhcccccCCccchh-------ceeccC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEV---NGIGQTHHKNLVRLL-------GYCDEG  552 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~nIv~l~-------g~~~~~  552 (762)
                      +.+.||+|+||.||+|... .+++.||||++...   .....+.+.+|+   +++++++|||||+++       +++.+.
T Consensus        77 ~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~  155 (377)
T 3byv_A           77 RGTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP  155 (377)
T ss_dssp             EEEEEEEETTEEEEEEEC--CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECT
T ss_pred             EcceeecCCCEEEEEEEEC-CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhcc
Confidence            3578999999999999754 34679999999742   334457899999   666677899999999       444433


Q ss_pred             C-----------------ceeEEEeccCCCchhhhccCCCCCC-------HHHHHHHHHHHHHHHHHhHhcCCCCeEeCC
Q 004312          553 R-----------------NRLLVYEFMSNGALASFLFGDSKPN-------WKLRTEIVMGIARGLFYLHEECCTQIIHCD  608 (762)
Q Consensus       553 ~-----------------~~~LV~E~~~~gsL~~~l~~~~~l~-------~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D  608 (762)
                      +                 ..+|||||+ +|+|.+++.....++       +..+..|+.||++||+|||++   +|+|||
T Consensus       156 ~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrD  231 (377)
T 3byv_A          156 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTY  231 (377)
T ss_dssp             TSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             CCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            2                 278999999 689999997644343       488889999999999999999   999999


Q ss_pred             CCCCceEEcCCCceEEecccccccccCCCCcccccccccCcccCcccccCC-----------CCCCcchhHHHHHHHHHH
Q 004312          609 IKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM-----------PITVKVDVYSYGVLLLEI  677 (762)
Q Consensus       609 lkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~DV~S~Gvil~el  677 (762)
                      |||+||||+.++.+||+|||+++...    .......| +.|+|||.+.+.           .++.++||||||+++|||
T Consensus       232 ikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          232 LRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            99999999999999999999998532    23344567 999999999887           899999999999999999


Q ss_pred             HhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          678 ICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       678 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ++|+.||.......     ....+.. .     ....++++.+++.+||+.||++|||++|+++
T Consensus       307 ltg~~Pf~~~~~~~-----~~~~~~~-~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          307 WCADLPITKDAALG-----GSEWIFR-S-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHSSCCC------C-----CSGGGGS-S-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHCCCCCccccccc-----chhhhhh-h-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999984432111     1111111 1     1234578899999999999999999999985

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.3e-38  Score=351.19  Aligned_cols=247  Identities=23%  Similarity=0.322  Sum_probs=189.8

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--------chhHHHHHHhhhhcccccCCccchhceeccCCc
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRN  554 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  554 (762)
                      .+.+.+.||+|+||.||+|... .+++.||||++.....        .....+.+|++++++++||||+++++++.. +.
T Consensus       136 ~y~~~~~LG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~  213 (419)
T 3i6u_A          136 EYIMSKTLGSGACGEVKLAFER-KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED  213 (419)
T ss_dssp             TEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred             cEEEEeEEeeCCCeEEEEEEEC-CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence            3556678999999999999754 4567999999875321        112358899999999999999999999854 45


Q ss_pred             eeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC---CceEEecccccc
Q 004312          555 RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY---YNARISDFGLEK  631 (762)
Q Consensus       555 ~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~Dfgla~  631 (762)
                      .++||||+++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||++.+   ..+||+|||+++
T Consensus       214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccce
Confidence            799999999999999999888999999999999999999999998   99999999999999754   459999999998


Q ss_pred             cccCCCCcccccccccCcccCcccccC---CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccccc
Q 004312          632 LLTLDQSHTNTAIRGTKGYVAPEWFRN---MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEA  708 (762)
Q Consensus       632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  708 (762)
                      ....  ........||+.|+|||.+.+   ..++.++||||||+++|+|++|+.||.......     .+...+......
T Consensus       291 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-----~~~~~i~~~~~~  363 (419)
T 3i6u_A          291 ILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-----SLKDQITSGKYN  363 (419)
T ss_dssp             SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-----CHHHHHHTTCCC
T ss_pred             ecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-----HHHHHHhcCCCC
Confidence            7643  223345679999999999853   578899999999999999999999984321110     011111111111


Q ss_pred             CCC---HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          709 MDD---MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       709 ~~~---~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ..+   ...++.+.+++.+||+.||++|||++|+++
T Consensus       364 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          364 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            111   124678999999999999999999999987

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-37  Score=335.22  Aligned_cols=260  Identities=23%  Similarity=0.341  Sum_probs=204.9

Q ss_pred             cCHHHHHHHHhhhh-hhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhccc-ccCCccchhcee
Q 004312          474 FTYKELVEVTRGFK-EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQT-HHKNLVRLLGYC  549 (762)
Q Consensus       474 ~~~~el~~~t~~~~-~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~  549 (762)
                      |...+.....+.+. +.||+|+||.||+|... .+++.||||++....  ......+.+|+.++.++ +||||+++++++
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISK-STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            33334444444454 78999999999999754 456799999987543  23357899999999999 579999999999


Q ss_pred             ccCCceeEEEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC---CCceEE
Q 004312          550 DEGRNRLLVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD---YYNARI  624 (762)
Q Consensus       550 ~~~~~~~LV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl  624 (762)
                      .+....++||||+++|+|.+++...  ..+++..+..++.||+.||+|||++   +|+||||||+|||++.   ++.+||
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEE
Confidence            9999999999999999999999654  6789999999999999999999999   9999999999999997   789999


Q ss_pred             ecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccc
Q 004312          625 SDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN  704 (762)
Q Consensus       625 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  704 (762)
                      +|||+++.....  .......||+.|+|||.+....++.++||||||+++|||++|+.||...............   ..
T Consensus       176 ~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---~~  250 (327)
T 3lm5_A          176 VDFGMSRKIGHA--CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV---NV  250 (327)
T ss_dssp             CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---CC
T ss_pred             eeCccccccCCc--cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc---cc
Confidence            999999876432  2233456999999999999999999999999999999999999998554332222111000   01


Q ss_pred             ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          705 DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       705 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ..........++.+.+++.+||+.||++|||++|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          251 DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            11111123456788999999999999999999999864

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=341.43  Aligned_cols=257  Identities=25%  Similarity=0.376  Sum_probs=192.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHH--HHhhhhcccccCCccchhceec-----cCCceeE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK--AEVNGIGQTHHKNLVRLLGYCD-----EGRNRLL  557 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~H~nIv~l~g~~~-----~~~~~~L  557 (762)
                      .+.+.||+|+||.||+|+.   +++.||||++....   ...+.  .|+..+..++||||+++++.+.     .....+|
T Consensus        16 ~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           16 KLLELIGRGRYGAVYKGSL---DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             EEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             heeeecccCCCeEEEEEEE---CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            3457899999999999975   35789999986432   23344  4455566689999999998542     3345689


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcC------CCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC------CTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                      ||||+++|+|.+++.... .++..+..++.||++||+|||+.+      .++|+||||||+|||++.++.+||+|||+++
T Consensus        90 v~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~  168 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM  168 (336)
T ss_dssp             EECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecccee
Confidence            999999999999996544 488999999999999999999863      2389999999999999999999999999998


Q ss_pred             cccCCCC-------cccccccccCcccCcccccC-------CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc-
Q 004312          632 LLTLDQS-------HTNTAIRGTKGYVAPEWFRN-------MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER-  696 (762)
Q Consensus       632 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~-  696 (762)
                      .+.....       .......||+.|+|||.+.+       ..++.++||||||+++|||++|+.|+............ 
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~  248 (336)
T 3g2f_A          169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF  248 (336)
T ss_dssp             ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTT
T ss_pred             ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhh
Confidence            7654321       12234569999999999976       45678999999999999999998875332111000000 


Q ss_pred             ----------------cccccccccc--ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          697 ----------------TLGALVENDL--EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       697 ----------------~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                                      .......+..  ........++++.+++.+||+.||++|||++|+++.|+++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             HHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence                            0000000000  011123467789999999999999999999999999998653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-37  Score=350.64  Aligned_cols=192  Identities=23%  Similarity=0.362  Sum_probs=153.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceecc-----CCcee
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-----GRNRL  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-----~~~~~  556 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++....  ....+.+.+|++++++++|||||++++++..     ....+
T Consensus        55 y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  133 (458)
T 3rp9_A           55 YEIRHLIGTGSYGHVCEAYDK-LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY  133 (458)
T ss_dssp             EEECCC-------CEEEEEEC-C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             eEEeeEeeecCCeEEEEEEEC-CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence            445678999999999999754 456799999986532  2344679999999999999999999999843     35789


Q ss_pred             EEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      +||||+ +++|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++.....
T Consensus       134 lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          134 VVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             EEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             EEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            999998 579999998888899999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CC--------------------------cccccccccCcccCcccc-cCCCCCCcchhHHHHHHHHHHHhC
Q 004312          637 QS--------------------------HTNTAIRGTKGYVAPEWF-RNMPITVKVDVYSYGVLLLEIICL  680 (762)
Q Consensus       637 ~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~DV~S~Gvil~elltg  680 (762)
                      ..                          ......+||+.|+|||++ ....++.++|||||||+||||++|
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            21                          123345789999999986 566799999999999999999995

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.8e-38  Score=331.55  Aligned_cols=246  Identities=20%  Similarity=0.303  Sum_probs=204.6

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||++... .+++.+|+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        18 ~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   96 (294)
T 2rku_A           18 VRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL   96 (294)
T ss_dssp             EEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeecCCEEEEEEEEC-CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence            34578999999999999754 456789999986542   23456789999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++++|.+++.....+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||++....... ...
T Consensus        97 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~  172 (294)
T 2rku_A           97 CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERK  172 (294)
T ss_dssp             CTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc-ccc
Confidence            99999999998778899999999999999999999999   99999999999999999999999999998764322 223


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+.....     ....  ...+...+..+.++
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~~--~~~~~~~~~~~~~l  245 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-----KKNE--YSIPKHINPVAASL  245 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-----HTTC--CCCCTTSCHHHHHH
T ss_pred             ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----hhcc--CCCccccCHHHHHH
Confidence            3456899999999999989999999999999999999999998554322222111     1111  11122345678999


Q ss_pred             HHHhhccCCCCCCCHHHHHHH
Q 004312          722 AIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~  742 (762)
                      +.+||+.||++|||++|+++.
T Consensus       246 i~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          246 IQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             HHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHHcccChhhCcCHHHHhhC
Confidence            999999999999999999963

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=346.44  Aligned_cols=254  Identities=22%  Similarity=0.244  Sum_probs=203.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC--CCcceEEEEEccccc----cchhHHHHHHhhhhccc-ccCCccchhceeccCCcee
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVF----QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRL  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  556 (762)
                      +.+.+.||+|+||.||+++...  .+++.||||+++...    ......+.+|++++.++ +||||+++++++......+
T Consensus        56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  135 (355)
T 1vzo_A           56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  135 (355)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence            4456789999999999997642  356799999987532    23345678899999999 6999999999999999999


Q ss_pred             EEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      |||||+++++|.+++.....+++..+..++.||++||.|||++   +|+||||||+|||++.++.+||+|||+++.+...
T Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  212 (355)
T 1vzo_A          136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD  212 (355)
T ss_dssp             EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred             EEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence            9999999999999998878899999999999999999999998   9999999999999999999999999999876544


Q ss_pred             CCcccccccccCcccCcccccC--CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHH
Q 004312          637 QSHTNTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  714 (762)
                      .........||+.|+|||.+.+  ..++.++||||||+++|||++|+.||.......... .........  ....+...
T Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~--~~~~~~~~  289 (355)
T 1vzo_A          213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA-EISRRILKS--EPPYPQEM  289 (355)
T ss_dssp             GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH-HHHHHHHHC--CCCCCTTS
T ss_pred             CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH-HHHHHHhcc--CCCCCccc
Confidence            4444455679999999999985  357899999999999999999999985321110000 000011111  11123345


Q ss_pred             HHHHHHHHHHhhccCCCCCC-----CHHHHHHHh
Q 004312          715 LQRFVMVAIWCIQEDPSHRP-----TMRRVTQML  743 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RP-----t~~evl~~L  743 (762)
                      +..+.+++.+||+.||++||     +++|+++..
T Consensus       290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            67889999999999999999     999998653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.5e-37  Score=348.15  Aligned_cols=250  Identities=25%  Similarity=0.283  Sum_probs=190.3

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccC------Cce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------RNR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~  555 (762)
                      +.+.+.||+|+||.||+|.. ..+++.||||++...  .....+.+.+|++++++++||||+++++++...      ...
T Consensus        64 y~~~~~lG~G~~g~V~~a~~-~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  142 (464)
T 3ttj_A           64 YQNLKPIGSGAQGIVCAAYD-AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV  142 (464)
T ss_dssp             EEEEEEEEECSSCEEEEEEE-TTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             eEEEEEeecCCCeEEEEEEE-CCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence            34557899999999999964 445678999999754  233456789999999999999999999998654      456


Q ss_pred             eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          556 LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      +|||||++++ |.+.+..  .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       143 ~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          143 YLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             EEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             EEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            9999999865 6565543  489999999999999999999999   999999999999999999999999999986643


Q ss_pred             CCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc-----------------c
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT-----------------L  698 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~-----------------~  698 (762)
                        ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.+....                 .
T Consensus       217 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~  294 (464)
T 3ttj_A          217 --SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  294 (464)
T ss_dssp             --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred             --CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence              223445679999999999999999999999999999999999999985543222111100                 0


Q ss_pred             cccccc---------------ccccCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          699 GALVEN---------------DLEAMD---DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       699 ~~~~~~---------------~~~~~~---~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ...+..               ......   ....+.++.+|+.+||+.||++|||++|+++.
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000               000000   11236789999999999999999999999873

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.4e-38  Score=347.05  Aligned_cols=260  Identities=20%  Similarity=0.240  Sum_probs=206.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCC--ceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR--NRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~LV~E  560 (762)
                      +.+.+.||+|+||+||+|... .+++.||||++.... ....+.+.+|++++++++||||+++++++.+..  ..++|||
T Consensus        11 y~i~~~LG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e   89 (396)
T 4eut_A           11 WLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME   89 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred             eEEEEEEEcCCCeEEEEEEEC-CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence            345678999999999999754 456799999997543 334567889999999999999999999987655  6799999


Q ss_pred             ccCCCchhhhccCCC---CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE----cCCCceEEecccccccc
Q 004312          561 FMSNGALASFLFGDS---KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL----DDYYNARISDFGLEKLL  633 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~Dfgla~~~  633 (762)
                      |+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||+    +.++.+||+|||+++..
T Consensus        90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~  166 (396)
T 4eut_A           90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (396)
T ss_dssp             CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred             cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence            999999999997653   389999999999999999999999   99999999999999    77888999999999876


Q ss_pred             cCCCCcccccccccCcccCcccccC--------CCCCCcchhHHHHHHHHHHHhCCCCCchhhH----HHhhh---cccc
Q 004312          634 TLDQSHTNTAIRGTKGYVAPEWFRN--------MPITVKVDVYSYGVLLLEIICLRRTILTDWA----YDCYQ---ERTL  698 (762)
Q Consensus       634 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DV~S~Gvil~elltg~~p~~~~~~----~~~~~---~~~~  698 (762)
                      ....  ......||+.|+|||.+..        ..++.++||||||+++|||++|+.||.....    .+.+.   ....
T Consensus       167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             CCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             cCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            4322  2334569999999999865        4678899999999999999999999742110    11110   0000


Q ss_pred             ccc-------c--------ccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          699 GAL-------V--------ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       699 ~~~-------~--------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      ...       .        ...............+.+++.+||+.||++||+++|+++.++.+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            000       0        00011122357788999999999999999999999999999887654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7e-38  Score=338.19  Aligned_cols=246  Identities=20%  Similarity=0.308  Sum_probs=204.5

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||++... .+++.+|+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        43 y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  121 (335)
T 2owb_A           43 YVRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE  121 (335)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence            334578999999999999754 456789999986542   2345678999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++++|.+++.....+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus       122 ~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~  197 (335)
T 2owb_A          122 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ER  197 (335)
T ss_dssp             CCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred             cCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc-cc
Confidence            999999999998778899999999999999999999999   99999999999999999999999999998764322 22


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.....     .....  ..+...+..+.+
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~~  270 (335)
T 2owb_A          198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-----KKNEY--SIPKHINPVAAS  270 (335)
T ss_dssp             BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-----HHTCC--CCCTTSCHHHHH
T ss_pred             ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH-----hcCCC--CCCccCCHHHHH
Confidence            33456899999999999999999999999999999999999998544322221111     11111  112234567889


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~  741 (762)
                      ++.+||+.||++|||++|+++
T Consensus       271 li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          271 LIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.2e-38  Score=337.97  Aligned_cols=252  Identities=24%  Similarity=0.347  Sum_probs=197.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc--hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD--SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|+||.||++... .+++.||||++......  ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        28 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  106 (331)
T 4aaa_A           28 ENLGLVGEGSYGMVMKCRNK-DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV  106 (331)
T ss_dssp             EEEEEGGGGTTSSEEEEEET-TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eeeeEEeecCCEEEEEEEEC-CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecC
Confidence            34578999999999999754 45679999998654332  3456889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      ++++|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus       107 ~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  182 (331)
T 4aaa_A          107 DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYD  182 (331)
T ss_dssp             SEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred             CcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-cccC
Confidence            9999999988888899999999999999999999999   99999999999999999999999999998654322 2223


Q ss_pred             cccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc-------------------cccccc
Q 004312          643 AIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER-------------------TLGALV  702 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~-------------------~~~~~~  702 (762)
                      ...||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+.....                   ......
T Consensus       183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (331)
T 4aaa_A          183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR  262 (331)
T ss_dssp             -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC
T ss_pred             CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccccc
Confidence            45689999999999775 7899999999999999999999998544322211100                   000000


Q ss_pred             ccccccCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          703 ENDLEAMD-----DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       703 ~~~~~~~~-----~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+......     ....++++.+++.+||+.||++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00001001     1134678999999999999999999998875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.6e-38  Score=333.47  Aligned_cols=256  Identities=19%  Similarity=0.238  Sum_probs=200.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhcee-ccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC-DEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++....  ....+.+|++++++++|++++..++.+ .+.+..++||||+
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A           11 YRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             CEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             eEEeeeecCCCCeEEEEEEEc-CCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            456678999999999999743 456799999865432  234688999999999988877777766 5667789999999


Q ss_pred             CCCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE---cCCCceEEecccccccccCCCC
Q 004312          563 SNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       563 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                       +++|.+++.. ...+++..+..++.||+.||+|||++   +|+||||||+|||+   ++++.+||+|||+++.......
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             -CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence             9999999974 46799999999999999999999999   99999999999999   7899999999999987654433


Q ss_pred             c------ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccC---
Q 004312          639 H------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM---  709 (762)
Q Consensus       639 ~------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  709 (762)
                      .      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  ..............   
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~  241 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYERISEKKMSTPIEV  241 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SHHHHHHHHHHHSCHHH
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh--hhhhhhhcccccchhhh
Confidence            1      223457999999999999999999999999999999999999997432110000  00000000000000   


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          710 DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       710 ~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      .....++++.+++.+||+.||++|||+++|++.|+++.+
T Consensus       242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            001235789999999999999999999999999988643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.5e-38  Score=333.77  Aligned_cols=250  Identities=21%  Similarity=0.284  Sum_probs=199.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceec--cCCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCD--EGRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~LV~E  560 (762)
                      .+.+.||+|+||.||++... .+++.||+|++....  ....+.+.+|++++++++||||+++++++.  .....++|||
T Consensus         9 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   87 (279)
T 2w5a_A            9 EVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME   87 (279)
T ss_dssp             EEEEEEEECSSSEEEEEEET-TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred             eeehhccCCCCcEEEEEEEC-CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence            34578999999999999754 456799999987532  334567999999999999999999999874  4667899999


Q ss_pred             ccCCCchhhhccCC----CCCCHHHHHHHHHHHHHHHHHhHhcCCCC-----eEeCCCCCCceEEcCCCceEEecccccc
Q 004312          561 FMSNGALASFLFGD----SKPNWKLRTEIVMGIARGLFYLHEECCTQ-----IIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       561 ~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-----ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                      |+++++|.+++...    ..+++..+..++.|++.||+|||+.   +     |+||||||+|||+++++.+||+|||+++
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999643    3589999999999999999999998   7     9999999999999999999999999998


Q ss_pred             cccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCC
Q 004312          632 LLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDD  711 (762)
Q Consensus       632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  711 (762)
                      ...... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........     +... .....+
T Consensus       165 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----i~~~-~~~~~~  237 (279)
T 2w5a_A          165 ILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK-----IREG-KFRRIP  237 (279)
T ss_dssp             HC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHT-CCCCCC
T ss_pred             eecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH-----Hhhc-ccccCC
Confidence            764322 122335689999999999999999999999999999999999999754422221111     1111 111122


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       712 ~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      ...+.++.+++.+||+.||++|||++||++.+..
T Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            3456789999999999999999999999986644

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=8.1e-38  Score=332.07  Aligned_cols=249  Identities=21%  Similarity=0.326  Sum_probs=197.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+|... .+++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        21 y~i~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   99 (302)
T 2j7t_A           21 WEIVGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP   99 (302)
T ss_dssp             EEEEEEEECSTTCCEEEEEET-TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred             eeecceeccCCCeEEEEEEEc-CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence            345578999999999999754 4567999999987666667889999999999999999999999999999999999999


Q ss_pred             CCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      +++|.+++.. ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++...... .....
T Consensus       100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~  175 (302)
T 2j7t_A          100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQKRD  175 (302)
T ss_dssp             TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC--
T ss_pred             CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-ccccc
Confidence            9999999865 46789999999999999999999999   9999999999999999999999999997643211 11122


Q ss_pred             cccccCcccCcccc-----cCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          643 AIRGTKGYVAPEWF-----RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       643 ~~~gt~~y~aPE~~-----~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      ...||+.|+|||.+     ....++.++||||||+++|+|++|+.|+...............    .......+...+..
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~  251 (302)
T 2j7t_A          176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS----DPPTLLTPSKWSVE  251 (302)
T ss_dssp             ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----CCCCCSSGGGSCHH
T ss_pred             cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc----CCcccCCccccCHH
Confidence            34689999999998     4667899999999999999999999997543322221111000    00011123345678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +.+++.+||+.||++|||++|+++
T Consensus       252 l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          252 FRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHcccChhhCCCHHHHhc
Confidence            999999999999999999999876

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.9e-38  Score=344.82  Aligned_cols=252  Identities=23%  Similarity=0.347  Sum_probs=186.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccc-cCCccchhceeccC--CceeEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEG--RNRLLV  558 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~LV  558 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++....  ....+.+.+|+.++.++. ||||+++++++...  ...++|
T Consensus        11 y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv   89 (388)
T 3oz6_A           11 YELVKKLGKGAYGIVWKSIDR-RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV   89 (388)
T ss_dssp             EEEEEC-------CEEEEEET-TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred             eEEEEEeeeCCCeEEEEEEEC-CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence            445678999999999999644 457899999986532  334467889999999997 99999999998654  368999


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC-
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ-  637 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-  637 (762)
                      ||||+ ++|..++.. ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.... 
T Consensus        90 ~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           90 FDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             EECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             ecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            99998 689998865 4789999999999999999999999   99999999999999999999999999998754211 


Q ss_pred             -------------------CcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc
Q 004312          638 -------------------SHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT  697 (762)
Q Consensus       638 -------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~  697 (762)
                                         .......+||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.............
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  244 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII  244 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                               112334579999999999976 679999999999999999999999985443222211100


Q ss_pred             ccccc-----------------------------cccccc------------CCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 004312          698 LGALV-----------------------------ENDLEA------------MDDMTVLQRFVMVAIWCIQEDPSHRPTM  736 (762)
Q Consensus       698 ~~~~~-----------------------------~~~~~~------------~~~~~~~~~~~~li~~cl~~dp~~RPt~  736 (762)
                       ..+-                             ......            ......++++.+|+.+||+.||++|||+
T Consensus       245 -~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          245 -GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             -HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             -HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence             0000                             000000            0001235678999999999999999999


Q ss_pred             HHHHHH
Q 004312          737 RRVTQM  742 (762)
Q Consensus       737 ~evl~~  742 (762)
                      +|+++.
T Consensus       324 ~e~l~H  329 (388)
T 3oz6_A          324 NDALKH  329 (388)
T ss_dssp             HHHTTS
T ss_pred             HHHhCC
Confidence            999875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.3e-38  Score=345.73  Aligned_cols=243  Identities=22%  Similarity=0.291  Sum_probs=188.2

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcc-cccCCccchhceecc----CCceeEEEecc
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ-THHKNLVRLLGYCDE----GRNRLLVYEFM  562 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~----~~~~~LV~E~~  562 (762)
                      +.||+|+||+||++.. ..+++.||||+++.     ...+.+|++++.+ .+||||+++++++..    ....+|||||+
T Consensus        68 ~~LG~G~~g~V~~~~~-~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~  141 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFN-KRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL  141 (400)
T ss_dssp             EEEEEETTEEEEEEEE-TTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             ceeeeccCeEEEEEEE-CCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence            5799999999999975 45578999999863     2467788888755 489999999998865    56789999999


Q ss_pred             CCCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC---CCceEEecccccccccCCC
Q 004312          563 SNGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD---YYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       563 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~  637 (762)
                      ++|+|.+++....  .+++..+..|+.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++..... 
T Consensus       142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~-  217 (400)
T 1nxk_A          142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-  217 (400)
T ss_dssp             CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred             CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCC-
Confidence            9999999998753  589999999999999999999998   9999999999999997   789999999999865432 


Q ss_pred             CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccc--ccCCCHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL--EAMDDMTVL  715 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  715 (762)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+.....  .......++
T Consensus       218 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~s  295 (400)
T 1nxk_A          218 -NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKTRIRMGQYEFPNPEWSEVS  295 (400)
T ss_dssp             ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-CSHHHHHHHTCCCCCTTTTTTSC
T ss_pred             -CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-HHHHHHHHcCcccCCCcccccCC
Confidence             2234567899999999999999999999999999999999999998543211100 000001111111  111112456


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      +++.+|+.+||+.||++|||++|+++.
T Consensus       296 ~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          296 EEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            789999999999999999999999874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.1e-37  Score=352.33  Aligned_cols=249  Identities=24%  Similarity=0.304  Sum_probs=199.7

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .+.+.+.||+|+||+||+|... .+++.||||++.+..  ......+.+|+.++++++||||+++++++.+....++|||
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDK-VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEET-TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEeeEEecCCCEEEEEEEEC-CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            4566788999999999999754 456789999987542  3345789999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC---CCceEEecccccccccCCC
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD---YYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~  637 (762)
                      |+++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||++.   ++.+||+|||+++..... 
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-  192 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-  192 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence            999999999998888899999999999999999999999   9999999999999976   455999999999876533 


Q ss_pred             CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                       .......||+.|+|||.+. ..++.++||||||+++|+|++|+.||......+............   ........++.
T Consensus       193 -~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~s~~  267 (494)
T 3lij_A          193 -KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF---DSPEWKNVSEG  267 (494)
T ss_dssp             -BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---CSGGGTTSCHH
T ss_pred             -ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---CchhcccCCHH
Confidence             2334467999999999986 569999999999999999999999986544333222211111000   00011234678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +.+++.+||+.||++|||++|+++
T Consensus       268 ~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          268 AKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHCCCChhhCccHHHHhc
Confidence            999999999999999999999884

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.2e-38  Score=358.55  Aligned_cols=247  Identities=26%  Similarity=0.292  Sum_probs=201.8

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.||+|+||.||++... .+++.||||++.+..   ......+.+|++++++++||||+++++++.+.+..+|||||+
T Consensus       188 ~~~~LG~G~fG~Vy~a~~~-~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~  266 (576)
T 2acx_A          188 QYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM  266 (576)
T ss_dssp             EEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcC
Confidence            4568999999999999754 457899999997532   234567899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          563 SNGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       563 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      ++|+|.+++....  .+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++.....  ..
T Consensus       267 ~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~--~~  341 (576)
T 2acx_A          267 NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QT  341 (576)
T ss_dssp             CSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT--CC
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC--cc
Confidence            9999999997654  489999999999999999999999   9999999999999999999999999999876432  22


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ....+...+.. .....+...+.++.+
T Consensus       342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--~~~~i~~~i~~-~~~~~p~~~s~~~~d  418 (576)
T 2acx_A          342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKE-VPEEYSERFSPQARS  418 (576)
T ss_dssp             EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--CHHHHHHHHHH-CCCCCCTTSCHHHHH
T ss_pred             ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--hHHHHHHHhhc-ccccCCccCCHHHHH
Confidence            344579999999999999899999999999999999999999985431100  00000111110 011123345678999


Q ss_pred             HHHHhhccCCCCCC-----CHHHHHH
Q 004312          721 VAIWCIQEDPSHRP-----TMRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RP-----t~~evl~  741 (762)
                      |+.+||+.||++||     +++||++
T Consensus       419 LI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          419 LCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             HHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            99999999999999     7888875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.3e-37  Score=330.87  Aligned_cols=246  Identities=23%  Similarity=0.353  Sum_probs=202.8

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus        25 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  103 (303)
T 3a7i_A           25 TKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG  103 (303)
T ss_dssp             EEEEEEEECSSSEEEEEEET-TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             HHhhhhcccCCeEEEEEEEC-CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence            34578999999999999643 456799999987543 3445789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +++|.+++.. ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........ ....
T Consensus       104 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~  178 (303)
T 3a7i_A          104 GGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNT  178 (303)
T ss_dssp             TEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBCC
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-ccCc
Confidence            9999999964 5689999999999999999999999   999999999999999999999999999987653322 2234


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..|++.|+|||.+.+..++.++||||||+++|+|++|+.|+...........      +........+...+..+.+++.
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~  252 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL------IPKNNPPTLEGNYSKPLKEFVE  252 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHHSCCCCCCSSCCHHHHHHHH
T ss_pred             cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH------hhcCCCCCCccccCHHHHHHHH
Confidence            5689999999999999999999999999999999999999754322221111      0001111122234577899999


Q ss_pred             HhhccCCCCCCCHHHHHHH
Q 004312          724 WCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       724 ~cl~~dp~~RPt~~evl~~  742 (762)
                      +||+.||++|||++|+++.
T Consensus       253 ~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          253 ACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             HHCCSSGGGSCCHHHHTTC
T ss_pred             HHcCCChhhCcCHHHHhhC
Confidence            9999999999999999863

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.1e-37  Score=351.64  Aligned_cols=251  Identities=24%  Similarity=0.329  Sum_probs=204.5

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      ..+.+.+.||+|+||+||++... .+++.||||++....  ......+.+|++++++++||||+++++++.+....++||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEET-TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            44667789999999999999754 456799999986432  334578999999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc---CCCceEEecccccccccCC
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~~~~  636 (762)
                      ||+++|+|.+++.....+++..+..++.||+.||.|||++   +|+||||||+|||++   .++.+||+|||+++.....
T Consensus       101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            9999999999998888899999999999999999999999   999999999999995   5567999999999866432


Q ss_pred             CCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          637 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                        .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+...........   .........++
T Consensus       178 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~s~  251 (486)
T 3mwu_A          178 --TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA---FDLPQWRTISD  251 (486)
T ss_dssp             ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---SCSGGGGGSCH
T ss_pred             --CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCCcccCCCCH
Confidence              22344569999999999975 5999999999999999999999998655433332221111100   01111124567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ++.+++.+||+.||++|||+.|+++.
T Consensus       252 ~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          252 DAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            89999999999999999999999873

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.8e-37  Score=364.44  Aligned_cols=245  Identities=24%  Similarity=0.333  Sum_probs=205.6

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      .+.+.||+|+||.||+|... .+++.||||++++.   .......+..|.+++.++ +||||+++++++.+.+..+||||
T Consensus       344 ~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E  422 (674)
T 3pfq_A          344 NFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME  422 (674)
T ss_dssp             EEEEESSBTTTBCEEEEEES-SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred             EEEEEEccCCCEEEEEEEEC-CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence            34567999999999999754 45678999999753   233456788999999987 79999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++|+|.+++...+.+++..+..++.||+.||+|||++   +|+||||||+||||++++.+||+|||+++..... ...
T Consensus       423 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~~~  498 (674)
T 3pfq_A          423 YVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVT  498 (674)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT-TCC
T ss_pred             CcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccC-Ccc
Confidence            999999999998888899999999999999999999999   9999999999999999999999999999864322 233


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....+||+.|+|||++.+..++.++||||||++||||++|+.||......+.+..     ++....  ..+...+.++.+
T Consensus       499 ~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~-----i~~~~~--~~p~~~s~~~~~  571 (674)
T 3pfq_A          499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS-----IMEHNV--AYPKSMSKEAVA  571 (674)
T ss_dssp             BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHSSCC--CCCTTSCHHHHH
T ss_pred             cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHH-----HHhCCC--CCCccCCHHHHH
Confidence            4557799999999999999999999999999999999999999865533332222     121111  123346788999


Q ss_pred             HHHHhhccCCCCCCCH-----HHHHH
Q 004312          721 VAIWCIQEDPSHRPTM-----RRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt~-----~evl~  741 (762)
                      |+.+||+.||++||++     +||++
T Consensus       572 li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          572 ICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             HHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            9999999999999997     77764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.7e-38  Score=335.43  Aligned_cols=258  Identities=24%  Similarity=0.360  Sum_probs=197.3

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|+||.||+|...    ..+|+|+++...  ....+.+.+|++++++++||||+++++++.+....++||||+
T Consensus        36 ~~~~~lg~G~~g~V~~~~~~----~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~  111 (319)
T 2y4i_B           36 EIGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC  111 (319)
T ss_dssp             ECCCBCCCSSSSEEEEEEES----SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred             EEeeEeccCCceEEEEEEEc----CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence            45678999999999999764    259999987532  233457889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC----
Q 004312          563 SNGALASFLFGDS-KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ----  637 (762)
Q Consensus       563 ~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~----  637 (762)
                      ++++|.+++.... .+++..+..++.||++||+|||++   +|+||||||+|||++ ++.+||+|||+++......    
T Consensus       112 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~  187 (319)
T 2y4i_B          112 KGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR  187 (319)
T ss_dssp             CSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred             cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence            9999999998764 789999999999999999999999   999999999999998 6799999999987653221    


Q ss_pred             CcccccccccCcccCcccccC---------CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccccc
Q 004312          638 SHTNTAIRGTKGYVAPEWFRN---------MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEA  708 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~---------~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  708 (762)
                      ........|++.|+|||.+..         ..++.++||||||+++|||++|+.||............     .......
T Consensus       188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-----~~~~~~~  262 (319)
T 2y4i_B          188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM-----GTGMKPN  262 (319)
T ss_dssp             CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH-----HTTCCCC
T ss_pred             ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh-----ccCCCCC
Confidence            122233458999999999864         45789999999999999999999998544322222111     0000111


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCC-CCCCC
Q 004312          709 MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP-IPPCP  755 (762)
Q Consensus       709 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~-~p~~p  755 (762)
                      ......+.++.+++.+||+.||++|||+++++++|+.+.+.. ..+.|
T Consensus       263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~  310 (319)
T 2y4i_B          263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP  310 (319)
T ss_dssp             CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------
T ss_pred             CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCC
Confidence            111234567899999999999999999999999999976543 33444

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.8e-38  Score=331.54  Aligned_cols=256  Identities=19%  Similarity=0.245  Sum_probs=201.1

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhcee-ccCCceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC-DEGRNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~LV~E~~~  563 (762)
                      .+.+.||+|+||.||+|... .+++.||||++....  ...++.+|++++++++|++++..+..+ .+....++||||+ 
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 3uzp_A           12 RLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             EEEEEEEEETTEEEEEEEET-TTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEccCCCeEEEEEEEc-CCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence            45578999999999999753 456799999986532  334789999999999998877766665 5566779999999 


Q ss_pred             CCchhhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE---cCCCceEEecccccccccCCCCc
Q 004312          564 NGALASFLF-GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       564 ~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      +++|.+++. ....+++..+..++.||+.||+|||++   +|+||||||+|||+   ++++.+||+|||+++........
T Consensus        88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~  164 (296)
T 3uzp_A           88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence            999999997 346799999999999999999999999   99999999999999   48889999999999876544331


Q ss_pred             ------ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccC---C
Q 004312          640 ------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM---D  710 (762)
Q Consensus       640 ------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~  710 (762)
                            ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........  ......+........   .
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~  242 (296)
T 3uzp_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--RQKYERISEKKMSTPIEVL  242 (296)
T ss_dssp             CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--SSHHHHHHHHHHHSCHHHH
T ss_pred             cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh--hhhhhhhcccccCCchHHH
Confidence                  22445799999999999999999999999999999999999999753211000  000000000000000   0


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          711 DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       711 ~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      ....++++.+++.+||+.||++|||+++|++.|+++.+-
T Consensus       243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence            123457899999999999999999999999999986543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=328.78  Aligned_cols=245  Identities=24%  Similarity=0.307  Sum_probs=195.7

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCch
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGAL  567 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL  567 (762)
                      ..||+|+||.||+|... .+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus        28 ~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  106 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDL-SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL  106 (295)
T ss_dssp             CEEEECSSSEEEEEEET-TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred             EEEeecCcEEEEEEEEC-CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence            37999999999999754 45679999999876666677899999999999999999999999999999999999999999


Q ss_pred             hhhccCC---CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC-CCceEEecccccccccCCCCccccc
Q 004312          568 ASFLFGD---SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD-YYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       568 ~~~l~~~---~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      .+++...   ..+++..+..++.||++||+|||++   +|+||||||+||+++. ++.+||+|||+++...... .....
T Consensus       107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~  182 (295)
T 2clq_A          107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTET  182 (295)
T ss_dssp             HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred             HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Ccccc
Confidence            9999754   3467889999999999999999999   9999999999999987 8999999999998764322 22234


Q ss_pred             ccccCcccCcccccCCC--CCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMP--ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~--~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ..|++.|+|||.+.+..  ++.++||||||+++|+|++|+.||...........    ...........+...+.++.++
T Consensus       183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l  258 (295)
T 2clq_A          183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF----KVGMFKVHPEIPESMSAEAKAF  258 (295)
T ss_dssp             CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH----HHHHHCCCCCCCTTSCHHHHHH
T ss_pred             cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH----hhccccccccccccCCHHHHHH
Confidence            56899999999997653  88999999999999999999999743211110000    0000011112233456788999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 004312          722 AIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~  741 (762)
                      +.+||+.||++||+++|+++
T Consensus       259 i~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          259 ILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHTTCSSTTTSCCHHHHHT
T ss_pred             HHHHccCChhhCCCHHHHhc
Confidence            99999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.5e-37  Score=352.85  Aligned_cols=250  Identities=24%  Similarity=0.309  Sum_probs=206.5

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEE
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLV  558 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV  558 (762)
                      ..+.+.+.||+|+||.||++... .+++.||||++....   ......+.+|++++++++||||+++++++.+....++|
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDK-ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEEC-CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            44666788999999999999754 456799999986432   33467899999999999999999999999999999999


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE---cCCCceEEecccccccccC
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~~  635 (762)
                      |||+++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||+   +.++.+||+|||+++.+..
T Consensus       105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            99999999999999888999999999999999999999999   99999999999999   5678999999999987643


Q ss_pred             CCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                      .  .......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||......+...........   .........+
T Consensus       182 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~s  255 (484)
T 3nyv_A          182 S--KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT---FELPQWKKVS  255 (484)
T ss_dssp             C--CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCSGGGGGSC
T ss_pred             c--cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC---CCCcccccCC
Confidence            3  23344569999999999876 6999999999999999999999998655433332221111000   0111112456


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+++.+||+.+|++|||++|+++
T Consensus       256 ~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          256 ESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            78999999999999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.6e-37  Score=334.71  Aligned_cols=253  Identities=20%  Similarity=0.259  Sum_probs=194.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceecc--------CC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--------GR  553 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--------~~  553 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++....  ......+.+|++++++++||||+++++++..        .+
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (351)
T 3mi9_A           19 YEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   97 (351)
T ss_dssp             EEEEEECSSCSTTSEEEEEET-TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred             eeEEEEEecCCCcEEEEEEEC-CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence            445678999999999999754 456799999986533  2334678899999999999999999999876        34


Q ss_pred             ceeEEEeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          554 NRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       554 ~~~LV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                      ..++||||+++ +|.+.+... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        98 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  173 (351)
T 3mi9_A           98 SIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA  173 (351)
T ss_dssp             EEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence            68999999986 666666544 6799999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCC---CcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc-----ccccccc
Q 004312          633 LTLDQ---SHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER-----TLGALVE  703 (762)
Q Consensus       633 ~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~-----~~~~~~~  703 (762)
                      +....   ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||............     .......
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  253 (351)
T 3mi9_A          174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  253 (351)
T ss_dssp             CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            65322   222344568999999999876 46899999999999999999999998554322211100     0000000


Q ss_pred             cc---------c----ccCCC--H-----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          704 ND---------L----EAMDD--M-----TVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       704 ~~---------~----~~~~~--~-----~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +.         .    .....  .     ..++.+.+|+.+||+.||++|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            00         0    00000  0     11456889999999999999999999987

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.7e-37  Score=335.01  Aligned_cols=249  Identities=20%  Similarity=0.320  Sum_probs=199.5

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccch-----------------hHHHHHHhhhhcccccCCccchh
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS-----------------EKEFKAEVNGIGQTHHKNLVRLL  546 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~nIv~l~  546 (762)
                      +.+.+.||+|+||.||+|..   +++.||||++.......                 .+.+.+|++++++++||||++++
T Consensus        33 y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           33 YRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             EEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             eEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            34567899999999999976   56799999987532221                 17899999999999999999999


Q ss_pred             ceeccCCceeEEEeccCCCchhhh------ccC--CCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEeCCCCCCceEEc
Q 004312          547 GYCDEGRNRLLVYEFMSNGALASF------LFG--DSKPNWKLRTEIVMGIARGLFYLHE-ECCTQIIHCDIKPQNILLD  617 (762)
Q Consensus       547 g~~~~~~~~~LV~E~~~~gsL~~~------l~~--~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NILl~  617 (762)
                      +++.+.+..++||||+++++|.++      +..  ...+++..+..++.||+.||+|||+ .   +|+||||||+||+++
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMD  186 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEEC
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEc
Confidence            999999999999999999999999      766  5678999999999999999999999 7   999999999999999


Q ss_pred             CCCceEEecccccccccCCCCcccccccccCcccCcccccCC-CCCC-cchhHHHHHHHHHHHhCCCCCchhhH-HHh--
Q 004312          618 DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM-PITV-KVDVYSYGVLLLEIICLRRTILTDWA-YDC--  692 (762)
Q Consensus       618 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~~DV~S~Gvil~elltg~~p~~~~~~-~~~--  692 (762)
                      .++.+||+|||++......   ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||..... .+.  
T Consensus       187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  263 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN  263 (348)
T ss_dssp             TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred             CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            9999999999999876432   33445689999999999887 6666 99999999999999999999854322 111  


Q ss_pred             -hhccccccccccc--c-------ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          693 -YQERTLGALVEND--L-------EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       693 -~~~~~~~~~~~~~--~-------~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                       .............  .       ........+.++.+++.+||+.||++|||++|+++
T Consensus       264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             1111110000000  0       00001335678999999999999999999999987

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.9e-37  Score=324.76  Aligned_cols=244  Identities=24%  Similarity=0.381  Sum_probs=194.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      .+.+.||+|+||.||+|... .+++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        14 ~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   92 (276)
T 2h6d_A           14 VLGDTLGVGTFGKVKIGEHQ-LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY   92 (276)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEeeecCCCCeEEEEEEEC-CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence            45578999999999999754 356799999986532   23346789999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +++++|.+++.....+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++.......  ..
T Consensus        93 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~  167 (276)
T 2h6d_A           93 VSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FL  167 (276)
T ss_dssp             CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------
T ss_pred             cCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc--ce
Confidence            99999999998878899999999999999999999999   99999999999999999999999999998764322  22


Q ss_pred             ccccccCcccCcccccCCCC-CCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.............     ...  ...+...+..+.+
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-----~~~--~~~~~~~~~~l~~  240 (276)
T 2h6d_A          168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR-----GGV--FYIPEYLNRSVAT  240 (276)
T ss_dssp             ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HCC--CCCCTTSCHHHHH
T ss_pred             ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh-----cCc--ccCchhcCHHHHH
Confidence            34568999999999987765 689999999999999999999985443222221110     000  0112234567899


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~  741 (762)
                      ++.+||+.||++|||++|+++
T Consensus       241 li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          241 LLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhhCCCHHHHHh
Confidence            999999999999999999987

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.8e-37  Score=346.74  Aligned_cols=196  Identities=25%  Similarity=0.389  Sum_probs=165.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccC-----Ccee
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-----RNRL  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~  556 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++....  ....+.+.+|++++++++||||+++++++...     ...+
T Consensus        28 y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  106 (432)
T 3n9x_A           28 YIIKHLIGRGSYGYVYLAYDK-NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY  106 (432)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             EEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence            445678999999999999754 556789999997542  23456899999999999999999999999766     5789


Q ss_pred             EEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      |||||++ ++|.+++.....+++..+..++.||++||+|||+.   +|+||||||+||||+.++.+||+|||+++.....
T Consensus       107 lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          107 IVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             EEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            9999997 59999999888899999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CC---------------------cccccccccCcccCcccc-cCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 004312          637 QS---------------------HTNTAIRGTKGYVAPEWF-RNMPITVKVDVYSYGVLLLEIICLRRTI  684 (762)
Q Consensus       637 ~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~DV~S~Gvil~elltg~~p~  684 (762)
                      ..                     ......+||+.|+|||.+ ....++.++|||||||++|||++|..|+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            21                     123456799999999986 5667999999999999999999865443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-37  Score=330.40  Aligned_cols=254  Identities=24%  Similarity=0.332  Sum_probs=181.5

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++.... ....+++.+|++++++++||||+++++++...+..++||||+
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   95 (303)
T 2vwi_A           17 YELQEVIGSGATAVVQAAYCA-PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL   95 (303)
T ss_dssp             CEEEEECC---CCCEEEEEC-----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECC
T ss_pred             hhhhheeccccceEEEEEEEC-CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhc
Confidence            345678999999999999754 346789999986532 334567899999999999999999999999999999999999


Q ss_pred             CCCchhhhccC--------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccccc
Q 004312          563 SNGALASFLFG--------DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT  634 (762)
Q Consensus       563 ~~gsL~~~l~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~  634 (762)
                      ++++|.+++..        ...+++..+..++.||+.||+|||++   +|+||||||+||++++++.+||+|||++....
T Consensus        96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  172 (303)
T 2vwi_A           96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA  172 (303)
T ss_dssp             TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred             cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence            99999999863        45689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCC----cccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc---ccccccccccc
Q 004312          635 LDQS----HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE---RTLGALVENDL  706 (762)
Q Consensus       635 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~  706 (762)
                      ....    .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||...........   ...........
T Consensus       173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  252 (303)
T 2vwi_A          173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ  252 (303)
T ss_dssp             ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC---
T ss_pred             cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccc
Confidence            3221    12234568999999999876 5689999999999999999999999754322111110   00000000000


Q ss_pred             ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          707 EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       707 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ........+.++.+++.+||+.||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             --CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00111234567899999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.6e-38  Score=366.45  Aligned_cols=254  Identities=22%  Similarity=0.299  Sum_probs=202.5

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCC--CcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMG--SSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|.....  ....||||+++... ....+.|.+|+.++++++||||+++++++.+ +..++|||
T Consensus       392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E  470 (656)
T 2j0j_A          392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIME  470 (656)
T ss_dssp             EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEE
Confidence            44567899999999999987532  24579999987543 2334689999999999999999999999854 56899999


Q ss_pred             ccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          561 FMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |+++|+|.+++... ..+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++........
T Consensus       471 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~  547 (656)
T 2j0j_A          471 LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  547 (656)
T ss_dssp             CCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred             cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCcce
Confidence            99999999999755 4689999999999999999999999   9999999999999999999999999999876544433


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      ......+|+.|+|||.+....++.++||||||+++|||++ |..||......+....      +........+..++..+
T Consensus       548 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~------i~~~~~~~~~~~~~~~l  621 (656)
T 2j0j_A          548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR------IENGERLPMPPNCPPTL  621 (656)
T ss_dssp             ------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH------HHHTCCCCCCTTCCHHH
T ss_pred             eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH------HHcCCCCCCCccccHHH
Confidence            3344557889999999999999999999999999999997 8888754322222111      11111122234556789


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      .+++.+||+.||++|||+.|+++.|+.+.
T Consensus       622 ~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          622 YSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            99999999999999999999999998764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.4e-37  Score=326.24  Aligned_cols=247  Identities=22%  Similarity=0.313  Sum_probs=198.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++...  ...+.+.+|++++++++||||+++++++.+....++||||++
T Consensus        31 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  107 (314)
T 3com_A           31 FDVLEKLGEGSYGSVYKAIHK-ETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG  107 (314)
T ss_dssp             EEEEEECC----CEEEEEEET-TTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             hhhheeeccCCCeEEEEEEEC-CCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence            445678999999999999754 45679999998753  345689999999999999999999999999999999999999


Q ss_pred             CCchhhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLF-GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      +++|.+++. ....+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++........ ...
T Consensus       108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~  183 (314)
T 3com_A          108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRN  183 (314)
T ss_dssp             TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CBC
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-ccC
Confidence            999999996 356789999999999999999999998   999999999999999999999999999987643322 233


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ...|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........  ....  .......+...+..+.+++
T Consensus       184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~l~~li  259 (314)
T 3com_A          184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM--IPTN--PPPTFRKPELWSDNFTDFV  259 (314)
T ss_dssp             CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHHS--CCCCCSSGGGSCHHHHHHH
T ss_pred             ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HhcC--CCcccCCcccCCHHHHHHH
Confidence            45689999999999999999999999999999999999999854322211110  0000  0001111233467899999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 004312          723 IWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       723 ~~cl~~dp~~RPt~~evl~  741 (762)
                      .+||+.||++|||++++++
T Consensus       260 ~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          260 KQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHHTCSCTTTSCCHHHHTT
T ss_pred             HHHccCChhhCcCHHHHHh
Confidence            9999999999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.5e-37  Score=335.14  Aligned_cols=247  Identities=23%  Similarity=0.346  Sum_probs=200.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--------chhHHHHHHhhhhccc-ccCCccchhceeccCCc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--------DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRN  554 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  554 (762)
                      +.+.+.||+|+||.||+|... .+++.||||+++....        ...+.+.+|+.++.++ +||||+++++++.....
T Consensus        96 y~~~~~lg~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  174 (365)
T 2y7j_A           96 YDPKDVIGRGVSSVVRRCVHR-ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF  174 (365)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred             cccceEEecCCCEEEEEEEEC-CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence            334478999999999999764 3467999999865331        1135688999999999 89999999999999999


Q ss_pred             eeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccccc
Q 004312          555 RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT  634 (762)
Q Consensus       555 ~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~  634 (762)
                      .+|||||+++++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||++..+.
T Consensus       175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence            999999999999999998778899999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCcccccccccCcccCcccccC------CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccccc
Q 004312          635 LDQSHTNTAIRGTKGYVAPEWFRN------MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEA  708 (762)
Q Consensus       635 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  708 (762)
                      ..  .......||+.|+|||++.+      ..++.++||||||+++|||++|+.||...........     +.......
T Consensus       252 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~-----i~~~~~~~  324 (365)
T 2y7j_A          252 PG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM-----IMEGQYQF  324 (365)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHTCCCC
T ss_pred             CC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH-----HHhCCCCC
Confidence            32  22344679999999999863      3688999999999999999999999854322221111     11110000


Q ss_pred             CC--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          709 MD--DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       709 ~~--~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ..  ....+..+.+++.+||+.||++|||++|+++
T Consensus       325 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          325 SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00  0123467899999999999999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.9e-37  Score=329.82  Aligned_cols=246  Identities=20%  Similarity=0.292  Sum_probs=195.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc-cCCccchhceecc--CCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDE--GRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~--~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|... .+++.||||+++.   ...+.+.+|++++++++ ||||+++++++.+  ....++|||
T Consensus        38 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e  113 (330)
T 3nsz_A           38 YQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  113 (330)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             eEEEEEecccCCeEEEEEEEC-CCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence            345678999999999999754 4567999999874   33568999999999996 9999999999987  667899999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC-ceEEecccccccccCCCCc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY-NARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~  639 (762)
                      |+++++|.+++.   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+++......  
T Consensus       114 ~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--  185 (330)
T 3nsz_A          114 HVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--  185 (330)
T ss_dssp             CCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--
T ss_pred             ccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--
Confidence            999999999984   488999999999999999999999   999999999999999766 89999999998765332  


Q ss_pred             ccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHH-Hhhh-------cccccccc--------
Q 004312          640 TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQ-------ERTLGALV--------  702 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~-~~~~-------~~~~~~~~--------  702 (762)
                      ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... +...       .......+        
T Consensus       186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  265 (330)
T 3nsz_A          186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  265 (330)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence            2334568999999999977 67999999999999999999999998332110 0000       00000000        


Q ss_pred             ---------------ccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          703 ---------------ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       703 ---------------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                                     ............++++.+++.+||+.||++|||++|+++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                           000011112225678999999999999999999999987

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.4e-37  Score=333.87  Aligned_cols=249  Identities=22%  Similarity=0.286  Sum_probs=196.1

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc-----cCCccchhceeccCCceeE
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-----HKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~l~g~~~~~~~~~L  557 (762)
                      .+.+.++||+|+||.||+|... .+++.||||+++.. ......+..|++++++++     ||||+++++++...+..+|
T Consensus        36 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l  113 (360)
T 3llt_A           36 AFLVIRKMGDGTFGRVLLCQHI-DNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL  113 (360)
T ss_dssp             TEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred             EEEEEEEEcccCCeEEEEEEEC-CCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence            3455678999999999999754 45679999998743 334567788999988886     9999999999999999999


Q ss_pred             EEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC-----------------
Q 004312          558 VYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD-----------------  618 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-----------------  618 (762)
                      ||||+ +++|.+++...  ..+++..+..++.||+.||+|||++   +|+||||||+|||+++                 
T Consensus       114 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~  189 (360)
T 3llt_A          114 IFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGK  189 (360)
T ss_dssp             EECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred             EEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccccc
Confidence            99999 99999999765  3589999999999999999999998   9999999999999975                 


Q ss_pred             --------CCceEEecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHH
Q 004312          619 --------YYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAY  690 (762)
Q Consensus       619 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~  690 (762)
                              ++.+||+|||+++....    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus       190 ~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  265 (360)
T 3llt_A          190 KIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM  265 (360)
T ss_dssp             EEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHH
Confidence                    78999999999986432    223456899999999999999999999999999999999999998543221


Q ss_pred             Hhhhcc------------------ccccccccc-ccc-----CCC---------------HHHHHHHHHHHHHhhccCCC
Q 004312          691 DCYQER------------------TLGALVEND-LEA-----MDD---------------MTVLQRFVMVAIWCIQEDPS  731 (762)
Q Consensus       691 ~~~~~~------------------~~~~~~~~~-~~~-----~~~---------------~~~~~~~~~li~~cl~~dp~  731 (762)
                      +.....                  .....+... ...     ...               ....+.+.+|+.+||+.||+
T Consensus       266 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  345 (360)
T 3llt_A          266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPT  345 (360)
T ss_dssp             HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChh
Confidence            111100                  000000000 000     000               00126678999999999999


Q ss_pred             CCCCHHHHHH
Q 004312          732 HRPTMRRVTQ  741 (762)
Q Consensus       732 ~RPt~~evl~  741 (762)
                      +|||++|+++
T Consensus       346 ~Rpta~elL~  355 (360)
T 3llt_A          346 LRPSPAELLK  355 (360)
T ss_dssp             GSCCHHHHTT
T ss_pred             hCCCHHHHhc
Confidence            9999999875

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.3e-38  Score=343.44  Aligned_cols=248  Identities=12%  Similarity=0.029  Sum_probs=178.6

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhccc--ccCCccchhc-------eeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQT--HHKNLVRLLG-------YCDEG  552 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~H~nIv~l~g-------~~~~~  552 (762)
                      .+.+.||+|+||.||+|... .+++.||||++.....   ...+.+.+|+++++.+  +||||++++.       .+...
T Consensus        65 ~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~  143 (371)
T 3q60_A           65 KLVEPLRVGDRSVVFLVRDV-ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ  143 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred             eeeeeccCCCCEEEEEEEEC-CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence            35578999999999999754 4567999999986432   3345677886555555  6999888553       33221


Q ss_pred             -----------------CceeEEEeccCCCchhhhccCC-CCCCHHHH------HHHHHHHHHHHHHhHhcCCCCeEeCC
Q 004312          553 -----------------RNRLLVYEFMSNGALASFLFGD-SKPNWKLR------TEIVMGIARGLFYLHEECCTQIIHCD  608 (762)
Q Consensus       553 -----------------~~~~LV~E~~~~gsL~~~l~~~-~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~ivH~D  608 (762)
                                       ...+|||||++ |+|.+++... ..+.+..+      ..++.||++||+|||++   +|+|||
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrD  219 (371)
T 3q60_A          144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGH  219 (371)
T ss_dssp             TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCc
Confidence                             34799999999 8999999763 34456666      78889999999999999   999999


Q ss_pred             CCCCceEEcCCCceEEecccccccccCCCCcccccccccCcccCcccccC--CCCCCcchhHHHHHHHHHHHhCCCCCch
Q 004312          609 IKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRTILT  686 (762)
Q Consensus       609 lkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvil~elltg~~p~~~  686 (762)
                      |||+||||+.++.+||+|||+++....    ......+|+.|+|||.+.+  ..++.++||||||+++|||++|+.||..
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999986532    2224457799999999987  6799999999999999999999999854


Q ss_pred             hhHHHh--hhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          687 DWAYDC--YQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       687 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ......  +.....................++.+.+++.+||+.||++|||++|+++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            422111  1110001111111111112345788999999999999999999999874

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.8e-37  Score=332.96  Aligned_cols=249  Identities=23%  Similarity=0.304  Sum_probs=195.3

Q ss_pred             HHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--------chhHHHHHHhhhhcccccCCccchhceeccC
Q 004312          481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG  552 (762)
Q Consensus       481 ~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  552 (762)
                      ...+.+.+.||+|+||.||+|... .+++.||||++.....        .....+.+|++++++++||||+++++++...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFER-KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEc-CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            344566788999999999999754 4567999999865321        1234588999999999999999999998765


Q ss_pred             CceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc---eEEecccc
Q 004312          553 RNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN---ARISDFGL  629 (762)
Q Consensus       553 ~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~Dfgl  629 (762)
                      . .++||||+++++|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.   +||+|||+
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence            5 899999999999999999888999999999999999999999999   9999999999999987654   99999999


Q ss_pred             cccccCCCCcccccccccCcccCccccc---CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccc
Q 004312          630 EKLLTLDQSHTNTAIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL  706 (762)
Q Consensus       630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  706 (762)
                      ++.....  .......||+.|+|||.+.   ...++.++||||||+++|+|++|+.||........     +...+....
T Consensus       164 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~  236 (322)
T 2ycf_A          164 SKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-----LKDQITSGK  236 (322)
T ss_dssp             CEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-----HHHHHHHTC
T ss_pred             ceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-----HHHHHHhCc
Confidence            9876422  2223456899999999974   56789999999999999999999999743211100     000010000


Q ss_pred             ccCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          707 EAMD---DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       707 ~~~~---~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ....   ....++++.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            0000   1124578899999999999999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-37  Score=334.60  Aligned_cols=253  Identities=26%  Similarity=0.290  Sum_probs=193.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCC------ce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR------NR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~  555 (762)
                      +.+.+.||+|+||.||+|.. ..+++.||||++....  ....+.+.+|++++++++||||+++++++....      ..
T Consensus        27 y~~~~~lG~G~~g~V~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  105 (367)
T 1cm8_A           27 YRDLQPVGSGAYGAVCSAVD-GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF  105 (367)
T ss_dssp             EEEEEEC------CEEEEEE-TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             EEEeEEeeecCCeEEEEEEE-CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence            34557899999999999975 3457899999996532  233467899999999999999999999987653      45


Q ss_pred             eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          556 LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       106 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          106 YLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             EEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            9999999 8899999875 5689999999999999999999999   999999999999999999999999999987542


Q ss_pred             CCCcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc-----c-----------
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT-----L-----------  698 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~-----~-----------  698 (762)
                          ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+......     .           
T Consensus       181 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  256 (367)
T 1cm8_A          181 ----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  256 (367)
T ss_dssp             ----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             ----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence                2334568999999999877 689999999999999999999999985443222111100     0           


Q ss_pred             ---------ccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hhcCc
Q 004312          699 ---------GALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM--LEGVV  747 (762)
Q Consensus       699 ---------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~~~  747 (762)
                               ......... ......+..+.+|+.+||+.||++|||++|+++.  ++++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          257 EAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             HHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                     000000000 0112346788999999999999999999999873  45443

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.6e-37  Score=351.35  Aligned_cols=248  Identities=25%  Similarity=0.327  Sum_probs=199.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-------------chhHHHHHHhhhhcccccCCccchhceec
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-------------DSEKEFKAEVNGIGQTHHKNLVRLLGYCD  550 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~  550 (762)
                      +.+.++||+|+||+||+|... .+++.||||++.....             ...+.+.+|++++++++||||+++++++.
T Consensus        38 Y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  116 (504)
T 3q5i_A           38 YFKVRKLGSGAYGEVLLCKEK-NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE  116 (504)
T ss_dssp             EEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             eEEEeEecccCCeEEEEEEEC-CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            445678999999999999754 4567999999875321             23467999999999999999999999999


Q ss_pred             cCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC---ceEEecc
Q 004312          551 EGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY---NARISDF  627 (762)
Q Consensus       551 ~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Df  627 (762)
                      +....+|||||+++|+|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++   .+||+||
T Consensus       117 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          117 DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            9999999999999999999998888899999999999999999999999   999999999999998765   6999999


Q ss_pred             cccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccc
Q 004312          628 GLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE  707 (762)
Q Consensus       628 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  707 (762)
                      |+++.....  .......||+.|+|||.+. +.++.++||||||+++|+|++|+.||......+............   .
T Consensus       194 g~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---~  267 (504)
T 3q5i_A          194 GLSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF---D  267 (504)
T ss_dssp             TTCEECCTT--SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---C
T ss_pred             CCCEEcCCC--CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC---C
Confidence            999876533  2334456999999999987 468999999999999999999999986543333222111110000   0


Q ss_pred             cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       708 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ......+++++.+++.+||+.||.+|||++|+++
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0000124578999999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-37  Score=334.14  Aligned_cols=253  Identities=24%  Similarity=0.265  Sum_probs=196.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc-----hhHHHHHHhhhhcccccCCccchhceeccCCceeEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD-----SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLV  558 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV  558 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++......     ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        12 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   90 (346)
T 1ua2_A           12 YEKLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV   90 (346)
T ss_dssp             -CEEEEEEEETTEEEEEEECS-SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred             cEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence            445678999999999999754 45679999998753221     134688999999999999999999999999999999


Q ss_pred             EeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          559 YEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      |||+++ +|.+++... ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        91 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           91 FDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             EEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            999986 888888765 4689999999999999999999999   99999999999999999999999999998764322


Q ss_pred             CcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccc----------cc------
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTL----------GA------  700 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~----------~~------  700 (762)
                       .......+|+.|+|||.+.+. .++.++||||||+++|||++|..|+......+.......          ..      
T Consensus       167 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  245 (346)
T 1ua2_A          167 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  245 (346)
T ss_dssp             -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             -ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence             233445689999999999764 589999999999999999999988755433222111000          00      


Q ss_pred             ccccccccCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          701 LVENDLEAMDD-----MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       701 ~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      .+........+     ...+.++.+++.+||+.||++|||++|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00000000001     2235789999999999999999999999874

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5.5e-37  Score=349.27  Aligned_cols=247  Identities=26%  Similarity=0.304  Sum_probs=200.0

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .+.||+|+||.||+++.. .+++.||||++.+..   ......+.+|++++++++||||+++++++.+....++||||++
T Consensus       190 ~~~LG~G~fG~Vy~a~~~-~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~  268 (543)
T 3c4z_A          190 FRVLGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN  268 (543)
T ss_dssp             EEEEEECSSSEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEeeCCCeEEEEEEEC-CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence            357999999999999754 456899999997532   2334678999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC----CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          564 NGALASFLFGD----SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       564 ~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      +|+|.+++...    ..+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+++....... 
T Consensus       269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~-  344 (543)
T 3c4z_A          269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-  344 (543)
T ss_dssp             TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred             CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc-
Confidence            99999998753    4689999999999999999999999   999999999999999999999999999987653322 


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......+....  ...+...+..+.
T Consensus       345 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i~~~~--~~~p~~~s~~~~  421 (543)
T 3c4z_A          345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRVLEQA--VTYPDKFSPASK  421 (543)
T ss_dssp             CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHHHHCC--CCCCTTSCHHHH
T ss_pred             ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHHhhcc--cCCCcccCHHHH
Confidence            23345799999999999999999999999999999999999999854311000 000011111111  112334567899


Q ss_pred             HHHHHhhccCCCCCCCH-----HHHHH
Q 004312          720 MVAIWCIQEDPSHRPTM-----RRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~-----~evl~  741 (762)
                      +++.+||+.||++||++     ++|++
T Consensus       422 ~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          422 DFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             HHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             HHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            99999999999999975     56653

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-36  Score=322.54  Aligned_cols=247  Identities=23%  Similarity=0.296  Sum_probs=195.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc----cchhHHHHHHhhhhcccccCCccchhcee--ccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF----QDSEKEFKAEVNGIGQTHHKNLVRLLGYC--DEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~--~~~~~~~L  557 (762)
                      +.+.+.||+|+||.||++.. ..+++.||||+++...    ......+.+|++++++++||||+++++++  .+....++
T Consensus         7 y~i~~~lg~G~~g~V~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (305)
T 2wtk_C            7 YLMGDLLGEGSYGKVKEVLD-SETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM   85 (305)
T ss_dssp             BCCCCEEEECSSCEEEEEEB-TTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred             eeEeeEEecCCCeEEEEEEE-CCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence            34567899999999999974 3456799999997532    23457899999999999999999999998  45567899


Q ss_pred             EEeccCCCchhhhccC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          558 VYEFMSNGALASFLFG--DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ||||++++ |.+++..  ...+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            99999877 6666653  35789999999999999999999999   999999999999999999999999999987653


Q ss_pred             CC-CcccccccccCcccCcccccCCC--CCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCH
Q 004312          636 DQ-SHTNTAIRGTKGYVAPEWFRNMP--ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDM  712 (762)
Q Consensus       636 ~~-~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (762)
                      .. ........||+.|+|||.+.+..  .+.++||||||+++|||++|+.||............     ....  ...+.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i-----~~~~--~~~~~  234 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI-----GKGS--YAIPG  234 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-----HHCC--CCCCS
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH-----hcCC--CCCCC
Confidence            22 22233456899999999997654  478999999999999999999998654332222111     0010  01122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       713 ~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ..+..+.+++.+||+.||++|||++|+++.
T Consensus       235 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            345788899999999999999999999964

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.8e-37  Score=325.50  Aligned_cols=248  Identities=23%  Similarity=0.296  Sum_probs=201.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---------cchhHHHHHHhhhhcccc-cCCccchhceeccCCc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---------QDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRN  554 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~  554 (762)
                      .+.+.||+|+||.||+|... .+++.||||++....         ....+.+.+|+++++++. ||||+++++++.+...
T Consensus        20 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   98 (298)
T 1phk_A           20 EPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF   98 (298)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             ceeeeecCCCceEEEEEEEc-CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence            34578999999999999754 456799999986432         122456889999999995 9999999999999999


Q ss_pred             eeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccccc
Q 004312          555 RLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT  634 (762)
Q Consensus       555 ~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~  634 (762)
                      .++||||+++++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        99 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  175 (298)
T 1phk_A           99 FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  175 (298)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence            999999999999999998878899999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcccccccccCcccCccccc------CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccccc
Q 004312          635 LDQSHTNTAIRGTKGYVAPEWFR------NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEA  708 (762)
Q Consensus       635 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  708 (762)
                      ...  ......+++.|+|||.+.      ...++.++||||||+++|||++|+.|+................ .  ....
T Consensus       176 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~--~~~~  250 (298)
T 1phk_A          176 PGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN-Y--QFGS  250 (298)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-C--CCCT
T ss_pred             CCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC-c--ccCc
Confidence            322  233456899999999985      4568999999999999999999999985433222211100000 0  0011


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          709 MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       709 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ......+..+.+++.+||+.||++|||++|+++
T Consensus       251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            111345678999999999999999999999886

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=333.91  Aligned_cols=251  Identities=20%  Similarity=0.284  Sum_probs=190.2

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc-hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      .+.+.||+|+||.||+|... .+++.||||++...... ....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         5 ~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (324)
T 3mtl_A            5 IKLDKLGEGTYATVYKGKSK-LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD   83 (324)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred             EEEEEEcCCCCEEEEEEEEC-CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence            34578999999999999754 45679999998653322 22256689999999999999999999999999999999998


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                       |+|.+++... ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~  158 (324)
T 3mtl_A           84 -KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYD  158 (324)
T ss_dssp             -EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             -cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC-ccccc
Confidence             5888888754 5689999999999999999999999   9999999999999999999999999999865432 22233


Q ss_pred             cccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------cccccccc-------
Q 004312          643 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------TLGALVEN-------  704 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~~~~~~~~-------  704 (762)
                      ...+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.....          ........       
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
T 3mtl_A          159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN  238 (324)
T ss_dssp             ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred             cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence            4568999999999876 57899999999999999999999998554322211110          00000000       


Q ss_pred             --ccc----cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          705 --DLE----AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       705 --~~~----~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                        ...    .......+.++.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence              000    0001124567899999999999999999999987

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.3e-37  Score=337.00  Aligned_cols=247  Identities=21%  Similarity=0.269  Sum_probs=190.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceecc------------
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE------------  551 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------------  551 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++....    ....+|++++++++||||+++++++..            
T Consensus         9 y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            9 YSLGKTLGTGSFGIVCEVFDI-ESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             EEEEEEEECC-CEEEEEEEET-TTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             EEEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            445678999999999999754 456899999986532    223479999999999999999999843            


Q ss_pred             --------------------------CCceeEEEeccCCCchhhhcc----CCCCCCHHHHHHHHHHHHHHHHHhHhcCC
Q 004312          552 --------------------------GRNRLLVYEFMSNGALASFLF----GDSKPNWKLRTEIVMGIARGLFYLHEECC  601 (762)
Q Consensus       552 --------------------------~~~~~LV~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~  601 (762)
                                                ....++||||+++ +|.+.+.    ....+++..+..++.||++||+|||+.  
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--  160 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--  160 (383)
T ss_dssp             --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence                                      2337899999984 7666554    467899999999999999999999998  


Q ss_pred             CCeEeCCCCCCceEEc-CCCceEEecccccccccCCCCcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHh
Q 004312          602 TQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIIC  679 (762)
Q Consensus       602 ~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~ellt  679 (762)
                       +|+||||||+|||++ +++.+||+|||+++......  ......+|+.|+|||.+.+. .++.++||||||+++|||++
T Consensus       161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  237 (383)
T 3eb0_A          161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL  237 (383)
T ss_dssp             -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred             -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence             999999999999998 68899999999998764332  33345689999999998765 59999999999999999999


Q ss_pred             CCCCCchhhHHHhhhccc----------------------cccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 004312          680 LRRTILTDWAYDCYQERT----------------------LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMR  737 (762)
Q Consensus       680 g~~p~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~  737 (762)
                      |+.||......+......                      .............+...+.++.+|+.+||+.||++|||+.
T Consensus       238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  317 (383)
T 3eb0_A          238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY  317 (383)
T ss_dssp             SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence            999986543322221110                      0000000001111223567799999999999999999999


Q ss_pred             HHHH
Q 004312          738 RVTQ  741 (762)
Q Consensus       738 evl~  741 (762)
                      |+++
T Consensus       318 e~l~  321 (383)
T 3eb0_A          318 EAMA  321 (383)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9984

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.4e-36  Score=327.56  Aligned_cols=249  Identities=21%  Similarity=0.314  Sum_probs=199.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCC------ccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN------LVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~~~~~~~~L  557 (762)
                      +.+.+.||+|+||.||++.....+++.||||+++.. ....+.+.+|++++++++|++      ++++++++.+.+..++
T Consensus        16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l   94 (339)
T 1z57_A           16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI   94 (339)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred             eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence            456678999999999999764556789999999754 234567889999999987765      9999999999999999


Q ss_pred             EEeccCCCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC-----------------
Q 004312          558 VYEFMSNGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD-----------------  618 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-----------------  618 (762)
                      ||||+ +++|.+++....  .+++..+..++.||++||+|||++   +|+||||||+|||++.                 
T Consensus        95 v~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~  170 (339)
T 1z57_A           95 VFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERT  170 (339)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred             EEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence            99999 889999997654  688999999999999999999999   9999999999999987                 


Q ss_pred             --CCceEEecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc-
Q 004312          619 --YYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE-  695 (762)
Q Consensus       619 --~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~-  695 (762)
                        ++.+||+|||+++....    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.... 
T Consensus       171 ~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  246 (339)
T 1z57_A          171 LINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM  246 (339)
T ss_dssp             ESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH
T ss_pred             ccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence              67899999999986432    22345689999999999999999999999999999999999999854322111100 


Q ss_pred             -cccc-------------ccc---------------------cc-ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 004312          696 -RTLG-------------ALV---------------------EN-DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV  739 (762)
Q Consensus       696 -~~~~-------------~~~---------------------~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~ev  739 (762)
                       ....             ...                     .+ ..........++++.+++.+||+.||++|||++|+
T Consensus       247 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el  326 (339)
T 1z57_A          247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA  326 (339)
T ss_dssp             HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence             0000             000                     00 00011234567889999999999999999999999


Q ss_pred             HH
Q 004312          740 TQ  741 (762)
Q Consensus       740 l~  741 (762)
                      ++
T Consensus       327 l~  328 (339)
T 1z57_A          327 LK  328 (339)
T ss_dssp             TT
T ss_pred             hc
Confidence            86

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.8e-36  Score=321.30  Aligned_cols=248  Identities=27%  Similarity=0.348  Sum_probs=189.5

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceecc------------
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE------------  551 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------------  551 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++... ....+.+.+|++++++++||||+++++++.+            
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            8 FEEIAVLGQGAFGQVVKARNA-LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             chhhheeccCCcEEEEEEEEc-CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            345578999999999999754 45679999999653 3445689999999999999999999998754            


Q ss_pred             -CCceeEEEeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccc
Q 004312          552 -GRNRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL  629 (762)
Q Consensus       552 -~~~~~LV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl  629 (762)
                       ....++||||+++++|.+++... ..+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcc
Confidence             45678999999999999999754 4678899999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCC-------------CcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc
Q 004312          630 EKLLTLDQ-------------SHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE  695 (762)
Q Consensus       630 a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~  695 (762)
                      ++......             ........|++.|+|||.+.+. .++.++||||||+++|||++   |+...........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~  239 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK  239 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence            98664321             1122345689999999999764 78999999999999999998   4432211111111


Q ss_pred             cccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          696 RTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       696 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ....  .........+...+..+.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          240 KLRS--VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHS--TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccc--cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            0000  0111112223345677899999999999999999999997

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.7e-36  Score=332.03  Aligned_cols=250  Identities=24%  Similarity=0.268  Sum_probs=187.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCC------ce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR------NR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~  555 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++....  ....+.+.+|+.++++++||||+++++++....      ..
T Consensus        27 y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  105 (371)
T 2xrw_A           27 YQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  105 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred             eeEeeeeEecCCEEEEEEEEC-CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence            345578999999999999643 456789999987532  233467889999999999999999999987654      67


Q ss_pred             eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          556 LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ++||||+++ +|.+++.  ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       106 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          106 YIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             EEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             EEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            999999974 7888875  3588999999999999999999999   999999999999999999999999999986542


Q ss_pred             CCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccc-----------------
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTL-----------------  698 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~-----------------  698 (762)
                      .  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........+.....                 
T Consensus       180 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  257 (371)
T 2xrw_A          180 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  257 (371)
T ss_dssp             ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred             c--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence            2  223345789999999999999999999999999999999999999854432221111000                 


Q ss_pred             ccccc--------------cccc-cC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          699 GALVE--------------NDLE-AM---DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       699 ~~~~~--------------~~~~-~~---~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      .....              +... ..   .....+.++.+|+.+||+.||++|||++|+++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            00000              0000 00   012346789999999999999999999999863

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.2e-36  Score=339.69  Aligned_cols=194  Identities=22%  Similarity=0.332  Sum_probs=166.5

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc------ccCCccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT------HHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~g~~~~~~~~~L  557 (762)
                      +.+.+.||+|+||.||+|... .+++.||||+++.. .....++.+|+++++.+      +|+||+++++.+......++
T Consensus        99 y~~~~~LG~G~fg~V~~a~~~-~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  176 (429)
T 3kvw_A           99 YEVLKVIGKGSFGQVVKAYDH-KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM  176 (429)
T ss_dssp             EEEEEEEEESSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             EEEEEEcccCccEEEEEEEEC-CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence            445678999999999999754 45679999999753 23345677888887776      57799999999999999999


Q ss_pred             EEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc--eEEecccccccc
Q 004312          558 VYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN--ARISDFGLEKLL  633 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~Dfgla~~~  633 (762)
                      ||||+. ++|.+++...  ..+++..+..|+.||+.||+|||++   +|+||||||+||||+.++.  +||+|||++...
T Consensus       177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~  252 (429)
T 3kvw_A          177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE  252 (429)
T ss_dssp             EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence            999996 6899988755  3589999999999999999999999   9999999999999999887  999999999754


Q ss_pred             cCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchh
Q 004312          634 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTD  687 (762)
Q Consensus       634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~  687 (762)
                      ..    ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       253 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          253 HQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             TC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            32    233457899999999999999999999999999999999999997543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.6e-37  Score=324.18  Aligned_cols=247  Identities=24%  Similarity=0.329  Sum_probs=183.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc-h-hHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD-S-EKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.+.+.||+|+||.||++... .+++.||||+++..... . .+.+.++...++.++||||+++++++.+.+..++||||
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~   87 (290)
T 3fme_A            9 LEPIMELGRGAYGVVEKMRHV-PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL   87 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred             hhhHHhcCCCCCeEEEEEEec-CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence            345578999999999999753 45679999999754222 2 23445555668889999999999999999999999999


Q ss_pred             cCCCchhhhcc----CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          562 MSNGALASFLF----GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       562 ~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ++ |+|.+++.    ....+++..+..++.|++.||+|||++  .+|+||||||+|||++.++.+||+|||+++......
T Consensus        88 ~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  164 (290)
T 3fme_A           88 MD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV  164 (290)
T ss_dssp             CS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred             hc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence            97 58877764    356799999999999999999999985  389999999999999999999999999998664322


Q ss_pred             CcccccccccCcccCcccc----cCCCCCCcchhHHHHHHHHHHHhCCCCCchh-hHHHhhhccccccccccccccCCCH
Q 004312          638 SHTNTAIRGTKGYVAPEWF----RNMPITVKVDVYSYGVLLLEIICLRRTILTD-WAYDCYQERTLGALVENDLEAMDDM  712 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DV~S~Gvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  712 (762)
                        ......||+.|+|||.+    ....++.++||||||+++|||++|+.|+... .......     .............
T Consensus       165 --~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~  237 (290)
T 3fme_A          165 --AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK-----QVVEEPSPQLPAD  237 (290)
T ss_dssp             -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH-----HHHHSCCCCCCTT
T ss_pred             --cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH-----HHhccCCCCcccc
Confidence              22334689999999996    5567899999999999999999999998531 1111111     1111111122223


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       713 ~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ..+.++.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          238 KFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            45678999999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.7e-36  Score=319.70  Aligned_cols=251  Identities=24%  Similarity=0.325  Sum_probs=202.3

Q ss_pred             HHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEE
Q 004312          481 EVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLV  558 (762)
Q Consensus       481 ~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV  558 (762)
                      ...+.+.+.||+|+||.||+|... .+++.||||++....  ......+.+|++++++++||||+++++++.+....++|
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEc-CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            344566788999999999999754 456799999986532  23457899999999999999999999999999999999


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC---CceEEecccccccccC
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY---YNARISDFGLEKLLTL  635 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~Dfgla~~~~~  635 (762)
                      +||+++++|.+++.....+++..+..++.||+.||.|||++   +|+||||||+||+++.+   +.+||+|||++.....
T Consensus       100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            99999999999998777899999999999999999999999   99999999999999754   4799999999987643


Q ss_pred             CCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                      ..  ......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||................. ..  ........+
T Consensus       177 ~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~  250 (287)
T 2wei_A          177 NT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY-AF--DLPQWRTIS  250 (287)
T ss_dssp             CS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CC--CSGGGTTSC
T ss_pred             CC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CC--CchhhhhcC
Confidence            32  2233458899999999875 489999999999999999999999865433322211100000 00  000112346


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .++.+++.+||+.||++|||++|+++
T Consensus       251 ~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          251 DDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHhc
Confidence            78899999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.2e-36  Score=332.35  Aligned_cols=249  Identities=25%  Similarity=0.298  Sum_probs=178.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccC------Cce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------RNR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~  555 (762)
                      +.+.+.||+|+||.||+|.. ..+++.||||++....  ....+.+.+|++++++++||||+++++++...      ...
T Consensus        31 y~~~~~lG~G~~g~V~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  109 (367)
T 2fst_X           31 YQNLSPVGSGAYGSVCAAFD-TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV  109 (367)
T ss_dssp             EEEEEECC----CCEEEEEE-TTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             eEEeeEEeecCCeEEEEEEE-CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence            34557899999999999964 4557899999997532  23456788999999999999999999998654      567


Q ss_pred             eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          556 LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       110 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          110 YLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             EEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             EEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            9999999 7899999865 5789999999999999999999998   999999999999999999999999999986532


Q ss_pred             CCCcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc----------c------
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT----------L------  698 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~----------~------  698 (762)
                          ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.............          .      
T Consensus       185 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  260 (367)
T 2fst_X          185 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  260 (367)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred             ----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence                2334578999999999877 689999999999999999999999985443222111100          0      


Q ss_pred             --ccccccccc-cCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          699 --GALVENDLE-AMDD-----MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       699 --~~~~~~~~~-~~~~-----~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                        ...+..... ....     ...++.+.+|+.+||+.||++|||++|+++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence              000000000 0000     1234678999999999999999999999863

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-36  Score=337.00  Aligned_cols=249  Identities=19%  Similarity=0.285  Sum_probs=178.1

Q ss_pred             hhcCCCCcceEEEeeeeC-CCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhcee--ccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNM-GSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC--DEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~--~~~~~~~LV~E~~~~  564 (762)
                      ++||+|+||.||+|.... .+++.||||++...  .....+.+|++++++++||||+++++++  ......+|||||++ 
T Consensus        27 ~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-  103 (405)
T 3rgf_A           27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-  103 (405)
T ss_dssp             CCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred             cEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence            479999999999998653 34678999999753  2345788999999999999999999999  45778899999997 


Q ss_pred             CchhhhccCC---------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE----cCCCceEEecccccc
Q 004312          565 GALASFLFGD---------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL----DDYYNARISDFGLEK  631 (762)
Q Consensus       565 gsL~~~l~~~---------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~Dfgla~  631 (762)
                      ++|.+++...         ..+++..+..|+.||+.||+|||++   +|+||||||+||||    ++++.+||+|||+++
T Consensus       104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  180 (405)
T 3rgf_A          104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  180 (405)
T ss_dssp             EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred             CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence            4787777421         2489999999999999999999999   99999999999999    678999999999998


Q ss_pred             cccCCCC--cccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHH---------Hhhhc----
Q 004312          632 LLTLDQS--HTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAY---------DCYQE----  695 (762)
Q Consensus       632 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~---------~~~~~----  695 (762)
                      .......  .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......         +....    
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~  260 (405)
T 3rgf_A          181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  260 (405)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHH
T ss_pred             ecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHh
Confidence            7653322  223446789999999999874 5999999999999999999999998432110         00000    


Q ss_pred             ------cccccc-------------cccccccC--------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          696 ------RTLGAL-------------VENDLEAM--------DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       696 ------~~~~~~-------------~~~~~~~~--------~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                            .....+             ........        .....+.++.+|+.+||+.||++|||++|+++.
T Consensus       261 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                  000000             00000000        000114578899999999999999999999873

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=325.88  Aligned_cols=251  Identities=22%  Similarity=0.272  Sum_probs=190.2

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceec--------------
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCD--------------  550 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--------------  550 (762)
                      .+.+.||+|+||.||+|... .+++.||||++........+.+.+|++++++++||||+++++++.              
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~   92 (320)
T 2i6l_A           14 MDLKPLGCGGNGLVFSAVDN-DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT   92 (320)
T ss_dssp             EEEEECC-----CEEEEEET-TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred             eEEEEeccCCCeEEEEEEEC-CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence            34578999999999999754 456799999998766666678999999999999999999998873              


Q ss_pred             cCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc-CCCceEEecccc
Q 004312          551 EGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGL  629 (762)
Q Consensus       551 ~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgl  629 (762)
                      +....++||||++ |+|.+++.. ..+++..+..++.||++||+|||++   +|+||||||+|||++ +++.+||+|||+
T Consensus        93 ~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~  167 (320)
T 2i6l_A           93 ELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGL  167 (320)
T ss_dssp             SCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence            4467899999998 699999964 5689999999999999999999999   999999999999997 677999999999


Q ss_pred             cccccCCCC--cccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc---------
Q 004312          630 EKLLTLDQS--HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT---------  697 (762)
Q Consensus       630 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~---------  697 (762)
                      ++.......  .......+++.|+|||.+.. ..++.++||||||+++|||++|+.||.............         
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (320)
T 2i6l_A          168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE  247 (320)
T ss_dssp             CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHH
T ss_pred             ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence            987643222  12233457899999998865 679999999999999999999999985543322211100         


Q ss_pred             --------cccccccccc-cCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          698 --------LGALVENDLE-AMD-----DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       698 --------~~~~~~~~~~-~~~-----~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                              +...+..... ...     ....+.++.+++.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          248 DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence                    0000000000 000     1124678999999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.4e-37  Score=328.49  Aligned_cols=246  Identities=25%  Similarity=0.379  Sum_probs=192.0

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceecc------CCceeE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDE------GRNRLL  557 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~------~~~~~L  557 (762)
                      .+.+.||+|+||.||+|... .+++.||||++... ......+.+|+.+++++ +||||+++++++..      ....++
T Consensus        27 ~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l  104 (326)
T 2x7f_A           27 ELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL  104 (326)
T ss_dssp             EEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred             EEEEEeccCCCEEEEEEEEC-CCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence            34578999999999999754 45679999998654 33457899999999999 89999999999976      467899


Q ss_pred             EEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          558 VYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ||||+++++|.+++...  ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  181 (326)
T 2x7f_A          105 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  181 (326)
T ss_dssp             EEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred             EEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence            99999999999999764  5689999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCcccccccccCcccCccccc-----CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCC
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMD  710 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  710 (762)
                      .. .......|++.|+|||.+.     ...++.++||||||+++|+|++|+.||...........     +.........
T Consensus       182 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~  255 (326)
T 2x7f_A          182 TV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-----IPRNPAPRLK  255 (326)
T ss_dssp             ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----HHHSCCCCCS
T ss_pred             Cc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-----hhcCccccCC
Confidence            22 1223456899999999986     56789999999999999999999999854322221111     1111111111


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          711 DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       711 ~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ....+..+.+++.+||+.||++||+++|+++
T Consensus       256 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            2234578899999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.1e-36  Score=332.15  Aligned_cols=248  Identities=23%  Similarity=0.266  Sum_probs=186.0

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc-----------hhHHHHHHhhhhcccccCCccchhceecc---
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD-----------SEKEFKAEVNGIGQTHHKNLVRLLGYCDE---  551 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~---  551 (762)
                      +.+.||+|+||.||+|...  .++.||||++......           ..+.+.+|++++++++||||+++++++..   
T Consensus        26 ~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (362)
T 3pg1_A           26 VQRFISSGSYGAVCAGVDS--EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE  103 (362)
T ss_dssp             EEEEEEEETTEEEEEEECT--TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCT
T ss_pred             EeEEeccCCCEEEEEEECC--CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccC
Confidence            3478999999999999754  3678999998653221           12689999999999999999999999843   


Q ss_pred             --CCceeEEEeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccc
Q 004312          552 --GRNRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFG  628 (762)
Q Consensus       552 --~~~~~LV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  628 (762)
                        ....++||||++ |+|.+++... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  179 (362)
T 3pg1_A          104 PAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFN  179 (362)
T ss_dssp             TTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred             CCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEecC
Confidence              346799999998 6788777655 4789999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc----------
Q 004312          629 LEKLLTLDQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT----------  697 (762)
Q Consensus       629 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~----------  697 (762)
                      +++.....  .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.............          
T Consensus       180 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (362)
T 3pg1_A          180 LAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED  257 (362)
T ss_dssp             C-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence            99754322  22334568999999999877 679999999999999999999999985543222211100          


Q ss_pred             --------ccccccccccc-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          698 --------LGALVENDLEA-------MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       698 --------~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                              ....+......       ......++.+.+++.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence                    00000000000       001123567899999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.5e-36  Score=325.95  Aligned_cols=252  Identities=22%  Similarity=0.294  Sum_probs=196.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhccc---ccCCccchhceec-----cCC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQT---HHKNLVRLLGYCD-----EGR  553 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~-----~~~  553 (762)
                      +.+.+.||+|+||.||+|.....+++.||||+++....  .....+.+|+.+++++   +||||+++++++.     ...
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   92 (326)
T 1blx_A           13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   92 (326)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred             eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence            34567899999999999986445567899999875332  2234677888877776   8999999999987     567


Q ss_pred             ceeEEEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          554 NRLLVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       554 ~~~LV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                      ..++||||++ |+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        93 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           93 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             EEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             eEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            7899999998 6999998754  3589999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc----------ccc-
Q 004312          632 LLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT----------LGA-  700 (762)
Q Consensus       632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~----------~~~-  700 (762)
                      .....  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.............          ... 
T Consensus       169 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (326)
T 1blx_A          169 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  246 (326)
T ss_dssp             CCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             cccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence            65422  22334568999999999999999999999999999999999999985543222111100          000 


Q ss_pred             ------cccc---ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          701 ------LVEN---DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       701 ------~~~~---~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                            ....   ..........++.+.+++.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                  0000   0000111235678899999999999999999999995

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.1e-36  Score=330.51  Aligned_cols=252  Identities=23%  Similarity=0.286  Sum_probs=196.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccC-----CceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-----RNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~L  557 (762)
                      +.+.+.||+|+||.||++... .+++.||||++.... ....+.+.+|++++.+++||||+++++++...     ...++
T Consensus        29 y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           29 YTNLSYIGEGAYGMVCSAYDN-LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             EEEEEEeecCCCeEEEEEEEC-CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            445678999999999999744 456789999997533 23346789999999999999999999998654     46899


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ||||++ ++|.+++.. ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       108 v~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          108 VQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            999997 599998864 4689999999999999999999999   99999999999999999999999999998765433


Q ss_pred             Ccc--cccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc----------cc-----
Q 004312          638 SHT--NTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT----------LG-----  699 (762)
Q Consensus       638 ~~~--~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~----------~~-----  699 (762)
                      ...  .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+......          ..     
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            222  244579999999998754 458999999999999999999999985432222111100          00     


Q ss_pred             ---cccccc-cccCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          700 ---ALVEND-LEAMD-----DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       700 ---~~~~~~-~~~~~-----~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                         ...... .....     ....+.++.+|+.+||+.||++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               000000 00000     0123567899999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.8e-36  Score=340.06  Aligned_cols=251  Identities=19%  Similarity=0.254  Sum_probs=199.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccccc-CCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHH-KNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++....  ...++.+|++++.+++| ++|..+..++.+.+..+|||||+
T Consensus         9 y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            9 FRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             EECCCCCEECSSCEEEEEEET-TTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEEEEeeCCCEEEEEEEEC-CCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            345678999999999999753 456799999876532  23468899999999976 55666666777888889999999


Q ss_pred             CCCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE---cCCCceEEecccccccccCCCC
Q 004312          563 SNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL---DDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       563 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                       +++|.+++.. ...+++..++.|+.||+.||+|||++   +|+||||||+||||   ++++.+||+|||+++.+.....
T Consensus        86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence             9999999974 46799999999999999999999999   99999999999999   6889999999999987754433


Q ss_pred             c------ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhH------HHhhhcccccccccccc
Q 004312          639 H------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWA------YDCYQERTLGALVENDL  706 (762)
Q Consensus       639 ~------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~------~~~~~~~~~~~~~~~~~  706 (762)
                      .      ......||+.|+|||.+.+..++.++||||||++||||++|+.||.....      +...........+..  
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~--  239 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA--  239 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH--
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH--
Confidence            2      12356799999999999999999999999999999999999999854211      111111111100000  


Q ss_pred             ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          707 EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       707 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                         ....+++++.+++.+||+.+|++||++++|+++|+.+
T Consensus       240 ---l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          240 ---LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             ---HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             ---HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence               0012357899999999999999999999999999876

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.2e-36  Score=325.03  Aligned_cols=247  Identities=20%  Similarity=0.299  Sum_probs=192.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccc--cCCccchhceeccCCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTH--HKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +.+.+.||+|+||.||++...  +++.||||++....  ......+.+|++++.+++  |+||+++++++.+.+..++||
T Consensus        30 y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  107 (313)
T 3cek_A           30 YSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  107 (313)
T ss_dssp             EEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEEEecCCCCEEEEEEEcC--CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence            345578999999999999754  36789999986432  334568999999999996  599999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      | +.+++|.+++.....+++..+..++.||++||.|||++   +|+||||||+|||+++ +.+||+|||+++........
T Consensus       108 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          108 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             C-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred             e-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence            9 67889999998888899999999999999999999999   9999999999999965 79999999999876543322


Q ss_pred             -ccccccccCcccCcccccC-----------CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccc
Q 004312          640 -TNTAIRGTKGYVAPEWFRN-----------MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE  707 (762)
Q Consensus       640 -~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  707 (762)
                       ......|++.|+|||.+.+           ..++.++||||||+++|||++|+.||........    ...........
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~  258 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----KLHAIIDPNHE  258 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH----HHHHHHCTTSC
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH----HHHHHHhcccc
Confidence             2234568999999999875           4788999999999999999999999743211100    11111222222


Q ss_pred             cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          708 AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       708 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ...+...+.++.+++.+||+.||++||+++|+++
T Consensus       259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            2222233568899999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.1e-36  Score=336.68  Aligned_cols=247  Identities=23%  Similarity=0.262  Sum_probs=188.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccC------CceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------RNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~L  557 (762)
                      +.+.+.||+|+||.||+|+.. .+++.||||++....    ..+.+|++++++++|||||++++++...      ...++
T Consensus        56 y~~~~~lG~G~fg~Vy~~~~~-~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           56 YTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             EEeeeEEeeCCCEEEEEEEEC-CCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            345578999999999999764 456799999986532    2344799999999999999999988432      23579


Q ss_pred             EEeccCCCchhhhcc----CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC-CceEEeccccccc
Q 004312          558 VYEFMSNGALASFLF----GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY-YNARISDFGLEKL  632 (762)
Q Consensus       558 V~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~  632 (762)
                      ||||+++ +|.+.+.    ....+++..+..++.||++||+|||++   +|+||||||+||||+.+ +.+||+|||+++.
T Consensus       131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            9999986 5555443    457799999999999999999999998   99999999999999954 6789999999987


Q ss_pred             ccCCCCcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc----------c---
Q 004312          633 LTLDQSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT----------L---  698 (762)
Q Consensus       633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~----------~---  698 (762)
                      +....  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.+.+..          +   
T Consensus       207 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~  284 (420)
T 1j1b_A          207 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  284 (420)
T ss_dssp             CCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             cccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            64322  23345689999999998765 79999999999999999999999986543222211100          0   


Q ss_pred             ----cccccccccc-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          699 ----GALVENDLEA-----MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       699 ----~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                          .....+....     ..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                0000000000     011234578999999999999999999999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.6e-36  Score=328.91  Aligned_cols=251  Identities=21%  Similarity=0.237  Sum_probs=182.3

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCc-------eeE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRN-------RLL  557 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-------~~L  557 (762)
                      .+.+.||+|+||.||+|... .+++.||||++... ......+.+|++.+++++||||+++++++.....       .++
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l  103 (360)
T 3e3p_A           26 QVERMAGQGTFGTVQLGKEK-STGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV  103 (360)
T ss_dssp             EEC----------CEEEEET-TTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred             EEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence            44578999999999999754 45679999998653 2233467788888899999999999999865433       789


Q ss_pred             EEeccCCCch---hhhccCCCCCCHHHHHHHHHHHHHHHHHhH--hcCCCCeEeCCCCCCceEEcC-CCceEEecccccc
Q 004312          558 VYEFMSNGAL---ASFLFGDSKPNWKLRTEIVMGIARGLFYLH--EECCTQIIHCDIKPQNILLDD-YYNARISDFGLEK  631 (762)
Q Consensus       558 V~E~~~~gsL---~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~  631 (762)
                      ||||++++.+   ..++.....+++..+..++.|++.||.|||  +.   +|+||||||+|||++. ++.+||+|||+++
T Consensus       104 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~  180 (360)
T 3e3p_A          104 VMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAK  180 (360)
T ss_dssp             EEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred             EeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence            9999997633   334446678899999999999999999999  77   9999999999999996 8999999999998


Q ss_pred             cccCCCCcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccc------cc---c
Q 004312          632 LLTLDQSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTL------GA---L  701 (762)
Q Consensus       632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~------~~---~  701 (762)
                      ......  ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||..............      ..   .
T Consensus       181 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3e3p_A          181 KLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK  258 (360)
T ss_dssp             CCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence            765332  23345689999999998665 489999999999999999999999855432222111000      00   0


Q ss_pred             ccc----------------ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          702 VEN----------------DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       702 ~~~----------------~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      +.+                ..........++++.+|+.+||+.||++|||++|+++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            000                00001112256789999999999999999999999863

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.8e-36  Score=328.51  Aligned_cols=248  Identities=23%  Similarity=0.268  Sum_probs=192.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccCCce------
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNR------  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~------  555 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++.....  ...+.+.+|+.++++++||||+++++++...+..      
T Consensus        44 y~~~~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  122 (371)
T 4exu_A           44 YVSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  122 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred             EEEEeEEecCCCeEEEEEEEC-CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence            334578999999999999754 4567999999975432  2346789999999999999999999999877665      


Q ss_pred             eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          556 LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ++||||++ ++|.+++.  ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       123 ~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          123 YLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             EEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             EEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence            99999997 68988884  3489999999999999999999999   999999999999999999999999999986532


Q ss_pred             CCCcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccc----------------
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTL----------------  698 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~----------------  698 (762)
                          ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+.......                
T Consensus       197 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          197 ----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             ----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence                2334568999999999987 6899999999999999999999999854432221111000                


Q ss_pred             --ccccc---ccccc---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          699 --GALVE---NDLEA---MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       699 --~~~~~---~~~~~---~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                        .....   .....   ......++++.+|+.+||+.||++|||++|+++.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence              00000   00000   0011236789999999999999999999999864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.9e-36  Score=334.03  Aligned_cols=243  Identities=25%  Similarity=0.312  Sum_probs=184.0

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEeccCCC
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      .+.||+|+||+||.+..  .+++.||||++...   ..+.+.+|++++.++ +||||+++++++.+.+..+|||||++ |
T Consensus        20 ~~~LG~G~~g~V~~~~~--~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g   93 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGS--FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L   93 (434)
T ss_dssp             EEEEEECSTTCEEEEEE--SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred             cCeEeeCCCeEEEEEEE--ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence            36799999999976533  34679999998643   345678999999886 89999999999999999999999996 6


Q ss_pred             chhhhccCCCCC-------CHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC-------------CceEEe
Q 004312          566 ALASFLFGDSKP-------NWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY-------------YNARIS  625 (762)
Q Consensus       566 sL~~~l~~~~~l-------~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-------------~~~kl~  625 (762)
                      +|.+++......       .+..+..++.||+.||+|||++   +|+||||||+|||++.+             +.+||+
T Consensus        94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~  170 (434)
T 2rio_A           94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS  170 (434)
T ss_dssp             EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred             CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence            999999866432       2334578999999999999999   99999999999999754             589999


Q ss_pred             cccccccccCCCCc---ccccccccCcccCcccccC-------CCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHh-h
Q 004312          626 DFGLEKLLTLDQSH---TNTAIRGTKGYVAPEWFRN-------MPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDC-Y  693 (762)
Q Consensus       626 Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~-~  693 (762)
                      |||+++........   ......||+.|+|||.+.+       ..++.++|||||||++|||++ |+.||........ .
T Consensus       171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i  250 (434)
T 2rio_A          171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI  250 (434)
T ss_dssp             CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHH
T ss_pred             ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHH
Confidence            99999977544322   1234579999999999965       678999999999999999999 8888754322111 1


Q ss_pred             hccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          694 QERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ....   ...+......+...+.++.+++.+||+.||++|||+.||++
T Consensus       251 ~~~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          251 IRGI---FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHTC---CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hcCC---CCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            0100   01111122234567889999999999999999999999985

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.5e-36  Score=333.22  Aligned_cols=251  Identities=20%  Similarity=0.232  Sum_probs=194.6

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc--------cCCccchhceec---
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH--------HKNLVRLLGYCD---  550 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~g~~~---  550 (762)
                      ..+.+.+.||+|+||+||+|... .+++.||||+++.. ....+.+.+|++++++++        |+||+++++.+.   
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDI-QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEec-CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            34556678999999999999654 45679999999753 334567899999999985        788999999987   


Q ss_pred             -cCCceeEEEeccCCCchhhhc-cCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC-------
Q 004312          551 -EGRNRLLVYEFMSNGALASFL-FGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY-------  620 (762)
Q Consensus       551 -~~~~~~LV~E~~~~gsL~~~l-~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-------  620 (762)
                       +....+|||||+.+ +|.+++ ... ..+++..+..|+.||+.||+|||+++  +|+||||||+||||+.++       
T Consensus       115 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          115 VNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence             66788999999954 555554 433 56899999999999999999999952  899999999999999775       


Q ss_pred             ------------------------------------------ceEEecccccccccCCCCcccccccccCcccCcccccC
Q 004312          621 ------------------------------------------NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN  658 (762)
Q Consensus       621 ------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~  658 (762)
                                                                .+||+|||+++.....    .....||+.|+|||.+.+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence                                                      7999999999876432    234568999999999999


Q ss_pred             CCCCCcchhHHHHHHHHHHHhCCCCCchhhHH---------Hhhhc------------cc-cccccccc-----------
Q 004312          659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAY---------DCYQE------------RT-LGALVEND-----------  705 (762)
Q Consensus       659 ~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~---------~~~~~------------~~-~~~~~~~~-----------  705 (762)
                      ..++.++||||||+++|||++|+.||......         ....+            .. ........           
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence            99999999999999999999999998432110         00000            00 00000000           


Q ss_pred             --------cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          706 --------LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       706 --------~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                              .....+...+..+.+|+.+||+.||++|||++|+++
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                    001124567788999999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.7e-36  Score=323.55  Aligned_cols=250  Identities=22%  Similarity=0.294  Sum_probs=195.8

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCC------ccchhceeccCCcee
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN------LVRLLGYCDEGRNRL  556 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~~~~~~~~  556 (762)
                      .+.+.+.||+|+||.||++......++.||||+++.. ......+.+|++++++++|++      ++.+++++......+
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~   98 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC   98 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence            3456678999999999999765444478999999753 334567889999999998776      889999999999999


Q ss_pred             EEEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE------------------
Q 004312          557 LVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL------------------  616 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl------------------  616 (762)
                      |||||+ +++|.+++...  ..+++..+..++.||+.||+|||++   +|+||||||+|||+                  
T Consensus        99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~  174 (355)
T 2eu9_A           99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEK  174 (355)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred             EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccccc
Confidence            999999 55666666543  4689999999999999999999998   99999999999999                  


Q ss_pred             -cCCCceEEecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc
Q 004312          617 -DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE  695 (762)
Q Consensus       617 -~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~  695 (762)
                       +.++.+||+|||+++....    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........
T Consensus       175 ~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  250 (355)
T 2eu9_A          175 SVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM  250 (355)
T ss_dssp             EESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence             5688999999999986432    22345689999999999999999999999999999999999999854322111100


Q ss_pred             --ccccc-------------cc-cc---------------------ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 004312          696 --RTLGA-------------LV-EN---------------------DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRR  738 (762)
Q Consensus       696 --~~~~~-------------~~-~~---------------------~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~e  738 (762)
                        .....             .. ..                     ..........+.++.+|+.+||+.||++|||++|
T Consensus       251 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e  330 (355)
T 2eu9_A          251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE  330 (355)
T ss_dssp             HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHH
Confidence              00000             00 00                     0001122345678999999999999999999999


Q ss_pred             HHH
Q 004312          739 VTQ  741 (762)
Q Consensus       739 vl~  741 (762)
                      +++
T Consensus       331 ~l~  333 (355)
T 2eu9_A          331 ALL  333 (355)
T ss_dssp             HTT
T ss_pred             Hhc
Confidence            985

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1e-35  Score=323.52  Aligned_cols=247  Identities=23%  Similarity=0.278  Sum_probs=192.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceeccCCc------e
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRN------R  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------~  555 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++.....  ...+.+.+|+.++++++||||+++++++.....      .
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  104 (353)
T 3coi_A           26 YVSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  104 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             EEEeeeEecCCCeEEEEEEEC-CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence            334578999999999999754 4567999999975432  234678999999999999999999999987654      4


Q ss_pred             eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          556 LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      ++||||++ ++|.+++..  .+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++....
T Consensus       105 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          105 YLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             EEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             EEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence            99999997 699988853  489999999999999999999999   999999999999999999999999999986532


Q ss_pred             CCCcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccc----------------
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTL----------------  698 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~----------------  698 (762)
                          ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.......                
T Consensus       179 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  254 (353)
T 3coi_A          179 ----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  254 (353)
T ss_dssp             ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred             ----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence                2234568999999999877 6789999999999999999999999854432221111000                


Q ss_pred             --cccc-------ccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          699 --GALV-------ENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       699 --~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                        ...+       .... .......+.++.+++.+||+.||++|||++|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          255 AAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence              0000       0000 01112456789999999999999999999999863

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.3e-36  Score=332.39  Aligned_cols=248  Identities=23%  Similarity=0.247  Sum_probs=188.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCc------eeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRN------RLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------~~L  557 (762)
                      +.+.+.||+|+||.||+|+....  ..+|+|++.....    ...+|++++++++||||+++++++.....      .++
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~~~--~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLVES--DEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTT--EEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCC--CeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            44567899999999999976532  3599998854322    22379999999999999999999854433      789


Q ss_pred             EEeccCCCchhhhc---cCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc-CCCceEEecccccccc
Q 004312          558 VYEFMSNGALASFL---FGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLL  633 (762)
Q Consensus       558 V~E~~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~  633 (762)
                      ||||++++.+....   .....+++..+..++.||++||+|||++   +|+||||||+|||++ +++.+||+|||+++..
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            99999876544333   3456789999999999999999999999   999999999999999 7999999999999876


Q ss_pred             cCCCCcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccc--------------
Q 004312          634 TLDQSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTL--------------  698 (762)
Q Consensus       634 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~--------------  698 (762)
                      ....  ......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||......+.......              
T Consensus       193 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  270 (394)
T 4e7w_A          193 IAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN  270 (394)
T ss_dssp             CTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            4332  23345689999999998765 599999999999999999999999865432221111000              


Q ss_pred             cccccccc--------ccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          699 GALVENDL--------EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       699 ~~~~~~~~--------~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                      ........        ........++++.+|+.+||+.||++|||+.|+++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            00000000        000112245789999999999999999999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-36  Score=322.52  Aligned_cols=243  Identities=24%  Similarity=0.353  Sum_probs=192.9

Q ss_pred             HHHHHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc------hhHHHHHHhhhhccc----ccCCccchhce
Q 004312          479 LVEVTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD------SEKEFKAEVNGIGQT----HHKNLVRLLGY  548 (762)
Q Consensus       479 l~~~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~nIv~l~g~  548 (762)
                      .....+.+.+.||+|+||.||+|... .+++.||||++......      ....+.+|++++.++    +|+||++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRL-TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECT-TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEc-cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            33445667788999999999999653 45679999999754322      223466788988888    89999999999


Q ss_pred             eccCCceeEEEec-cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc-CCCceEEec
Q 004312          549 CDEGRNRLLVYEF-MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISD  626 (762)
Q Consensus       549 ~~~~~~~~LV~E~-~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~D  626 (762)
                      +.+.+..++|+|| +++++|.+++.....+++..+..++.||++||+|||+.   +|+||||||+||+++ +++.+||+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~d  183 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLID  183 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEE
Confidence            9999999999999 79999999998878899999999999999999999999   999999999999999 899999999


Q ss_pred             ccccccccCCCCcccccccccCcccCcccccCCCCC-CcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccc
Q 004312          627 FGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT-VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND  705 (762)
Q Consensus       627 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  705 (762)
                      ||+++.....   ......|++.|+|||.+.+..+. .++||||||+++|||++|+.||......  ..         ..
T Consensus       184 fg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~---------~~  249 (312)
T 2iwi_A          184 FGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI--LE---------AE  249 (312)
T ss_dssp             CSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--HH---------TC
T ss_pred             cchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH--hh---------hc
Confidence            9999876532   23345689999999999876654 5899999999999999999998543211  10         00


Q ss_pred             cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          706 LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       706 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                        ...+...+.++.+++.+||+.||++|||++|+++
T Consensus       250 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          250 --LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0112234577899999999999999999999997

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.6e-36  Score=325.41  Aligned_cols=238  Identities=24%  Similarity=0.382  Sum_probs=197.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc------hhHHHHHHhhhhcccc--cCCccchhceeccCCce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD------SEKEFKAEVNGIGQTH--HKNLVRLLGYCDEGRNR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~  555 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++......      ....+.+|+.++++++  |+||+++++++.+.+..
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~  123 (320)
T 3a99_A           45 YQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF  123 (320)
T ss_dssp             EEEEEECSSSSSCEEEEEEET-TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcE
Confidence            445678999999999999754 45689999998754322      2346778999999995  59999999999999999


Q ss_pred             eEEEeccCC-CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc-CCCceEEecccccccc
Q 004312          556 LLVYEFMSN-GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLL  633 (762)
Q Consensus       556 ~LV~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~  633 (762)
                      ++|+|++.+ ++|.+++.....+++..+..++.||++||+|||+.   +|+||||||+|||++ +++.+||+|||+++..
T Consensus       124 ~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~  200 (320)
T 3a99_A          124 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL  200 (320)
T ss_dssp             EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence            999999986 89999998888899999999999999999999998   999999999999999 7899999999999876


Q ss_pred             cCCCCcccccccccCcccCcccccCCCC-CCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCH
Q 004312          634 TLDQSHTNTAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDM  712 (762)
Q Consensus       634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (762)
                      ...   ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......  ... .          ...+.
T Consensus       201 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~-~----------~~~~~  264 (320)
T 3a99_A          201 KDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--IRG-Q----------VFFRQ  264 (320)
T ss_dssp             CSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--HHC-C----------CCCSS
T ss_pred             ccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh--hcc-c----------ccccc
Confidence            532   2234568999999999987665 78899999999999999999998543211  110 0          01122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       713 ~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ..++++.+++.+||+.||++|||++|+++
T Consensus       265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          265 RVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            34578899999999999999999999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.5e-36  Score=324.86  Aligned_cols=251  Identities=20%  Similarity=0.237  Sum_probs=193.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccC-----CceeEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-----RNRLLV  558 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~LV  558 (762)
                      .+.+.||+|+||.||+|... .+++.||||++.... ......+.+|++++++++||||+++++++...     ...++|
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   92 (353)
T 2b9h_A           14 QLKSLLGEGAYGVVCSATHK-PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII   92 (353)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred             EEeeEEcCCCCeEEEEEEEC-CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence            35578999999999999754 456789999997533 23346788999999999999999999988654     678999


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      |||++ ++|.+++.. ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        93 ~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (353)
T 2b9h_A           93 QELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA  167 (353)
T ss_dssp             ECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             EeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence            99997 689998865 4689999999999999999999999   999999999999999999999999999987653221


Q ss_pred             c---------ccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc-----------c
Q 004312          639 H---------TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER-----------T  697 (762)
Q Consensus       639 ~---------~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~-----------~  697 (762)
                      .         ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||............           .
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T 2b9h_A          168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND  247 (353)
T ss_dssp             ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred             cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence            1         1223468999999998764 67999999999999999999999998543221111000           0


Q ss_pred             c--------cccccccc-ccC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          698 L--------GALVENDL-EAM-----DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       698 ~--------~~~~~~~~-~~~-----~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .        ...+.... ...     .....+.++.+++.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0        00000000 000     01134578899999999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.1e-36  Score=323.12  Aligned_cols=247  Identities=21%  Similarity=0.260  Sum_probs=170.4

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceecc----CCceeEEEeccC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE----GRNRLLVYEFMS  563 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~LV~E~~~  563 (762)
                      +.||+|+||.||+|... .+++.||||++...    .....+....++.++||||+++++++..    ....++||||++
T Consensus        35 ~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~  109 (336)
T 3fhr_A           35 QVLGLGVNGKVLECFHR-RTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME  109 (336)
T ss_dssp             EEEEEETTEEEEEEEET-TTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred             eeeeeCCCeEEEEEEEC-CCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence            46999999999999754 45679999998653    1222222334566799999999999876    445799999999


Q ss_pred             CCchhhhccCCC--CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC---CCceEEecccccccccCCCC
Q 004312          564 NGALASFLFGDS--KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD---YYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       564 ~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~~  638 (762)
                      +|+|.+++....  .+++..+..++.||+.||+|||++   +|+||||||+|||++.   ++.+||+|||+++.....  
T Consensus       110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~--  184 (336)
T 3fhr_A          110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--  184 (336)
T ss_dssp             TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc--
Confidence            999999998763  689999999999999999999999   9999999999999986   455999999999865422  


Q ss_pred             cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccc--ccccCCCHHHHH
Q 004312          639 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN--DLEAMDDMTVLQ  716 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  716 (762)
                       ......+|+.|+|||.+....++.++||||||+++|+|++|+.||........... ....+...  ..........++
T Consensus       185 -~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  262 (336)
T 3fhr_A          185 -ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-MKRRIRLGQYGFPNPEWSEVSE  262 (336)
T ss_dssp             --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------CCCTTTSTTCCH
T ss_pred             -ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-HHHhhhccccccCchhhccCCH
Confidence             22345689999999999888899999999999999999999999854432211110 00111111  111111234567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH--HhhcC
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQ--MLEGV  746 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~--~L~~~  746 (762)
                      ++.+++.+||+.||++|||++|+++  .+.+.
T Consensus       263 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          263 DAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            8999999999999999999999997  34443

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.2e-36  Score=321.07  Aligned_cols=246  Identities=26%  Similarity=0.368  Sum_probs=174.7

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhh-hhcccccCCccchhceeccCCceeEEEeccC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVN-GIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.||+|+||.||+|... .+++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||||++
T Consensus        26 ~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~  104 (327)
T 3aln_A           26 DLGEIGRGAYGSVNKMVHK-PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS  104 (327)
T ss_dssp             C-CEEEECSSEEEEEEEET-TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             ehheeccCCCEEEEEEEEc-CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence            4568999999999999754 456799999997643 233445666665 7778899999999999999999999999998


Q ss_pred             CCchhhhccC-----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          564 NGALASFLFG-----DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       564 ~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      + +|.+++..     ...+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       105 ~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  180 (327)
T 3aln_A          105 T-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-  180 (327)
T ss_dssp             E-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred             C-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc-
Confidence            5 88777752     56789999999999999999999994  389999999999999999999999999998664322 


Q ss_pred             cccccccccCcccCcccc----cCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccc---ccccCCC
Q 004312          639 HTNTAIRGTKGYVAPEWF----RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEN---DLEAMDD  711 (762)
Q Consensus       639 ~~~~~~~gt~~y~aPE~~----~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  711 (762)
                       ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||........    ........   .......
T Consensus       181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~  255 (327)
T 3aln_A          181 -AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----QLTQVVKGDPPQLSNSEE  255 (327)
T ss_dssp             --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCSCCCCCCCCSS
T ss_pred             -ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----HHHHHhcCCCCCCCCccc
Confidence             22334689999999998    456789999999999999999999999854211100    11111111   1111112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       712 ~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ...+..+.+++.+||+.||++|||++|+++
T Consensus       256 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          256 REFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            235678999999999999999999999864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.2e-35  Score=325.26  Aligned_cols=255  Identities=20%  Similarity=0.258  Sum_probs=196.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc-----------cCCccchhceeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-----------HKNLVRLLGYCDEG  552 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~g~~~~~  552 (762)
                      +.+.+.||+|+||.||+|+.. .+++.||||++... ......+.+|++++++++           |+||+++++++...
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~   98 (373)
T 1q8y_A           21 YILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   98 (373)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             EEEEEeeeecCCeEEEEEEec-CCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence            456688999999999999753 45679999998753 234567889999999886           89999999998765


Q ss_pred             C----ceeEEEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc------CCC
Q 004312          553 R----NRLLVYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD------DYY  620 (762)
Q Consensus       553 ~----~~~LV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~------~~~  620 (762)
                      .    ..++||||+ +++|.+++...  ..+++..+..++.||+.||+|||++  .+|+||||||+|||++      ..+
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~~~  175 (373)
T 1q8y_A           99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLI  175 (373)
T ss_dssp             ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcCcc
Confidence            4    789999999 89999999753  4589999999999999999999994  2899999999999994      445


Q ss_pred             ceEEecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc-cccc
Q 004312          621 NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE-RTLG  699 (762)
Q Consensus       621 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~-~~~~  699 (762)
                      .+||+|||+++.....    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........... ..+.
T Consensus       176 ~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  251 (373)
T 1q8y_A          176 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  251 (373)
T ss_dssp             EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence            8999999999866432    2334689999999999999999999999999999999999999854321100000 0000


Q ss_pred             ccc---------------------------cc-------------ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 004312          700 ALV---------------------------EN-------------DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV  739 (762)
Q Consensus       700 ~~~---------------------------~~-------------~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~ev  739 (762)
                      .++                           ..             ......+...++++.+|+.+||+.||++|||++|+
T Consensus       252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  331 (373)
T 1q8y_A          252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  331 (373)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHH
Confidence            000                           00             00112345678899999999999999999999999


Q ss_pred             HH--HhhcCc
Q 004312          740 TQ--MLEGVV  747 (762)
Q Consensus       740 l~--~L~~~~  747 (762)
                      ++  .+.+..
T Consensus       332 l~hp~f~~~~  341 (373)
T 1q8y_A          332 VNHPWLKDTL  341 (373)
T ss_dssp             HTCGGGTTCT
T ss_pred             hhChhhhccc
Confidence            97  345443

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.8e-35  Score=325.34  Aligned_cols=196  Identities=25%  Similarity=0.346  Sum_probs=165.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc-cC-----CccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-HK-----NLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~g~~~~~~~~~L  557 (762)
                      +.+.+.||+|+||+||+|... .+++.||||+++.. .....++.+|+++++.++ |+     +|+++++++...+..+|
T Consensus        56 y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  133 (382)
T 2vx3_A           56 YEIDSLIGKGSFGQVVKAYDR-VEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL  133 (382)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred             EEEEEEEeecCCEEEEEEEEc-CCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence            445678999999999999754 45678999999753 233567788898888874 44     48999999999999999


Q ss_pred             EEeccCCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc--CCCceEEecccccccc
Q 004312          558 VYEFMSNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD--DYYNARISDFGLEKLL  633 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~Dfgla~~~  633 (762)
                      ||||++ ++|.+++...  ..+++..+..++.||+.||.|||++ ..+|+||||||+|||++  .++.+||+|||+++..
T Consensus       134 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~  211 (382)
T 2vx3_A          134 VFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL  211 (382)
T ss_dssp             EEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence            999996 5999998765  4689999999999999999999952 23899999999999995  5788999999999876


Q ss_pred             cCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchh
Q 004312          634 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTD  687 (762)
Q Consensus       634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~  687 (762)
                      ..    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       212 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          212 GQ----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             TC----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cc----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            42    223456899999999999999999999999999999999999998643

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.4e-35  Score=338.52  Aligned_cols=260  Identities=25%  Similarity=0.328  Sum_probs=201.0

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc-ccchhHHHHHHhhhhcccccCCccchhceecc------CCce
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE------GRNR  555 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~~  555 (762)
                      .+.+.+.||+|+||.||+|... .+++.||||+++.. .....+.+.+|++++++++||||+++++++..      .+..
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~-~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQ-DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCT-TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CeEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            3566789999999999999754 45678999998754 33445679999999999999999999998765      6778


Q ss_pred             eEEEeccCCCchhhhccCCC---CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCc---eEEecccc
Q 004312          556 LLVYEFMSNGALASFLFGDS---KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYN---ARISDFGL  629 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~Dfgl  629 (762)
                      ++||||+++|+|.+++....   .+++..+..|+.|++.||+|||+.   +|+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            99999999999999997653   689999999999999999999998   9999999999999997665   99999999


Q ss_pred             cccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc---------cccc
Q 004312          630 EKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER---------TLGA  700 (762)
Q Consensus       630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~---------~~~~  700 (762)
                      +.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........+...         ....
T Consensus       171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  248 (676)
T 3qa8_A          171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD  248 (676)
T ss_dssp             CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred             cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence            98764332  234467999999999999999999999999999999999999998654222211100         0000


Q ss_pred             ccccc--------cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHH-----HHHHhhcCcC
Q 004312          701 LVEND--------LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRR-----VTQMLEGVVE  748 (762)
Q Consensus       701 ~~~~~--------~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~e-----vl~~L~~~~~  748 (762)
                      .....        .........++.+.+++.+||+.||++|||++|     ..+.++.+.+
T Consensus       249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            00000        011123457889999999999999999999977     4455554433

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.8e-35  Score=346.48  Aligned_cols=238  Identities=22%  Similarity=0.300  Sum_probs=191.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCc-----eeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRN-----RLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-----~~L  557 (762)
                      +.+.+.||+|+||.||+|.....+++.||||++.... ......+.+|++++++++||||+++++++.+.+.     .+|
T Consensus        82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l  161 (681)
T 2pzi_A           82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI  161 (681)
T ss_dssp             EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence            4556789999999999998765456789999986532 3345678999999999999999999999987665     699


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ||||+++++|.+++..  .+++..+..|+.||+.||.|||++   +|+||||||+|||++++ .+||+|||+++..... 
T Consensus       162 v~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-  234 (681)
T 2pzi_A          162 VMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-  234 (681)
T ss_dssp             EEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred             EEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence            9999999999998865  789999999999999999999999   99999999999999986 9999999999876432 


Q ss_pred             CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                          ....||+.|+|||.+.+.. +.++||||||+++|+|++|..|+....         ...+.    ........++.
T Consensus       235 ----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~---------~~~~~----~~~~~~~~~~~  296 (681)
T 2pzi_A          235 ----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRY---------VDGLP----EDDPVLKTYDS  296 (681)
T ss_dssp             ----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEE---------CSSCC----TTCHHHHHCHH
T ss_pred             ----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccc---------ccccc----ccccccccCHH
Confidence                3456999999999987654 899999999999999999987753211         00000    11111234578


Q ss_pred             HHHHHHHhhccCCCCCC-CHHHHHHHhhcC
Q 004312          718 FVMVAIWCIQEDPSHRP-TMRRVTQMLEGV  746 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RP-t~~evl~~L~~~  746 (762)
                      +.+++.+||+.||++|| +++++.+.|.++
T Consensus       297 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            89999999999999999 577777776654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.5e-35  Score=313.16  Aligned_cols=245  Identities=21%  Similarity=0.337  Sum_probs=174.8

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc-h-hHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD-S-EKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|+||.||+|... .+++.||||++...... . .+.+.++..+++.++||||+++++++.+.+..++||||+
T Consensus        28 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~  106 (318)
T 2dyl_A           28 ENLGEMGSGTCGQVWKMRFR-KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM  106 (318)
T ss_dssp             EEEEEC------CEEEEEET-TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             cccceeeecCCeeEEEEEEe-cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc
Confidence            34568999999999999764 35679999999754322 2 234455556788889999999999999999999999999


Q ss_pred             CCCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          563 SNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHE-ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       563 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                       ++.+..++.. ...+++..+..++.||++||.|||+ .   +|+||||||+|||++.++.+||+|||++.......  .
T Consensus       107 -~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~  180 (318)
T 2dyl_A          107 -GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--A  180 (318)
T ss_dssp             -SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             -CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--c
Confidence             4555555433 4678999999999999999999998 5   89999999999999999999999999997654322  2


Q ss_pred             cccccccCcccCccccc-----CCCCCCcchhHHHHHHHHHHHhCCCCCchhh-HHHhhhcccccccccccc-ccCCCHH
Q 004312          641 NTAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRTILTDW-AYDCYQERTLGALVENDL-EAMDDMT  713 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~  713 (762)
                      .....+++.|+|||.+.     ...++.++||||||+++|||++|+.||.... .......     ...... .......
T Consensus       181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-----~~~~~~~~~~~~~~  255 (318)
T 2dyl_A          181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK-----VLQEEPPLLPGHMG  255 (318)
T ss_dssp             ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH-----HHHSCCCCCCSSSC
T ss_pred             ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHH-----HhccCCCCCCccCC
Confidence            23456899999999994     4578899999999999999999999975421 1111111     111100 0111123


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          714 VLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       714 ~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+.++.+++.+||+.||.+||+++|+++
T Consensus       256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          256 FSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            4578899999999999999999999875

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.4e-35  Score=326.81  Aligned_cols=243  Identities=25%  Similarity=0.286  Sum_probs=181.2

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEeccCC
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      ..+.||+|+||+|+....  .+++.||||++.....   ..+.+|+++++++ +|||||++++++.+....+|||||++ 
T Consensus        28 ~~~~LG~G~~G~V~~~~~--~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-  101 (432)
T 3p23_A           28 PKDVLGHGAEGTIVYRGM--FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-  101 (432)
T ss_dssp             EEEEEEECGGGCEEEEEE--SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             cCCeeecCcCEEEEEEEE--eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence            446799999999654322  2467899999865322   2356899999998 89999999999999999999999996 


Q ss_pred             CchhhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC-----CCceEEecccccccccCCCC
Q 004312          565 GALASFLFGDS-KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD-----YYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       565 gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~Dfgla~~~~~~~~  638 (762)
                      |+|.+++.... ...+..+..++.||++||+|||++   +|+||||||+|||++.     ...+||+|||+++.......
T Consensus       102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~  178 (432)
T 3p23_A          102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH  178 (432)
T ss_dssp             EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred             CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence            69999997653 455566789999999999999999   9999999999999953     34688999999987654322


Q ss_pred             --cccccccccCcccCccccc---CCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCH
Q 004312          639 --HTNTAIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDM  712 (762)
Q Consensus       639 --~~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (762)
                        .......||+.|+|||.+.   ...++.++|||||||++|||++ |..||..........  .......  .......
T Consensus       179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--~~~~~~~--~~~~~~~  254 (432)
T 3p23_A          179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--LLGACSL--DCLHPEK  254 (432)
T ss_dssp             -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--HTTCCCC--TTSCTTC
T ss_pred             ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--HhccCCc--cccCccc
Confidence              2234467999999999997   4577889999999999999999 888874322111100  0000000  0111223


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       713 ~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .....+.+|+.+||+.||++|||++||++
T Consensus       255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          255 HEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            45677899999999999999999999984

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.8e-35  Score=307.98  Aligned_cols=229  Identities=12%  Similarity=0.051  Sum_probs=181.3

Q ss_pred             HhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          483 TRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       483 t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      .+.+.+.||+|+||.||+|... .+++.||||++.....   ...+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        32 ~y~i~~~lg~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           32 RYRLLIFHGGVPPLQFWQALDT-ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TEEEEEEEEBSTTCEEEEEEET-TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cEEEEEEEcccCCeEEEEEEec-CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            3556678999999999999754 4567999999976433   23368999999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      ||+++++|.+++...  .......+|+.||+.||+|||++   +|+||||||+|||+++++.+||++++           
T Consensus       111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            999999999999543  45667889999999999999999   99999999999999999999997443           


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccc--cCCCHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLE--AMDDMTVLQR  717 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  717 (762)
                                |++|       ++.++||||||+++|||++|+.||...........  ....+.....  .......+++
T Consensus       175 ----------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T 3uqc_A          175 ----------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--AERDTAGQPIEPADIDRDIPFQ  235 (286)
T ss_dssp             ----------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--CCBCTTSCBCCHHHHCTTSCHH
T ss_pred             ----------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--HHHHhccCCCChhhcccCCCHH
Confidence                      3433       68999999999999999999999854321111100  0000111000  0011235678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      +.+++.+||+.||++| |++|+++.|+.+..
T Consensus       236 l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          236 ISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             HHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            9999999999999999 99999999988543

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=100.00  E-value=7.5e-34  Score=289.62  Aligned_cols=202  Identities=19%  Similarity=0.238  Sum_probs=160.3

Q ss_pred             cccCcccCCCceeecCCCCcEeeCCCcEEEeeeccc----------ccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEE
Q 004312           21 QSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD----------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREI   90 (762)
Q Consensus        21 ~~~~~~~~~~~l~~~~~~~~lvS~~g~F~lgf~~~~----------vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~   90 (762)
                      ++.|+|.+||+|++++   +|  ++|.|+|||+.++          ||+|||+.|  ..+.|+|+.||||||+|++|++|
T Consensus         6 ~~~~~i~~g~~L~~g~---~l--~~g~f~l~f~~~gnl~ly~~~~~vW~an~~~~--~~~~l~l~~dGnLvl~d~~~~~v   78 (236)
T 1dlp_A            6 GLSHEGSHPQTLHAAQ---SL--ELSSFRFTMQSDCNLVLFDSDVRVWASNTAGA--TGCRAVLQSDGLLVILTAQNTIR   78 (236)
T ss_dssp             CSSSSSCSCSCCCTTC---EE--CSTTEEEEECTTSCEEEEESSSEEECCCCCSC--SCCBCCBCSSSCBCCBCTTTCCS
T ss_pred             eccceeCCCCEECCCC---EE--EcCCEEEEECCCCcEEEEECCEEEEECCCCCC--CCeEEEEcCCCcEEEEcCCCcEE
Confidence            4458999999999876   56  5999999998765          999999998  67899999999999999999999


Q ss_pred             EeecCCCC-ceeEEEEecCCCEEEEecCCCccccccCCCcccc----------CCCccccCc-cEEEeecCCCCCCCcce
Q 004312           91 WKSEISTG-EAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTL----------LPTQTMERG-GVVSSRRKETDFSRGRF  158 (762)
Q Consensus        91 ws~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTl----------Lpgq~l~~~-~~L~S~~s~~dps~G~~  158 (762)
                      |+|++... +..+|+|+|+|||||+++   ++||||||||||+          +|||+++.+ ++|+|   .+||++|.|
T Consensus        79 W~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s---~~d~s~G~~  152 (236)
T 1dlp_A           79 WSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHA---TQSLQLSPY  152 (236)
T ss_dssp             CCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECS---SCCCBCSSC
T ss_pred             EeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEEc---CcEeecCcE
Confidence            99998643 345899999999999954   8999999998655          777766554 46764   789999999


Q ss_pred             EEEecCCCceeeEeeccCCCcccccccccCCcceecCCCCceeeeccCcceEEeecCceeEEeccccccCCccEEEEEEc
Q 004312          159 QFRLLEDGNAVLNTINLESGFAYDAFFWSNTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLN  238 (762)
Q Consensus       159 ~l~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  238 (762)
                      +|+++++|+++++  +..     ..||.++++...   ....+.+..+|.+++++.++++++.++. ... ...+|++|+
T Consensus       153 ~l~l~~dG~LvL~--~~~-----~~~W~s~~~~~~---~~~~~~L~~~Gnl~ly~~~~~~vw~s~~-~~~-~~~~rl~Ld  220 (236)
T 1dlp_A          153 RLSMETDCNLVLF--DRD-----DRVWSTNTAGKG---TGCRAVLQPNGRMDVLTNQNIAVWTSGN-SRS-AGRYVFVLQ  220 (236)
T ss_dssp             EEEEETTTEEEEE--BTT-----BCCSCCCCCSSC---SSCEEEEETTTEEEEEETTTEEEEECCC-CCS-SSCCEEEEC
T ss_pred             EEEECCCCcEEEE--cCC-----EeEEeCCCcCCC---CceEEEECCCCcEEEEeCCCcEEEEeCC-CCC-CCCEEEEEc
Confidence            9999999976553  333     468998887431   2345667788888888877777777642 222 246899999


Q ss_pred             CCCcEEEEE
Q 004312          239 FDGVFIFYS  247 (762)
Q Consensus       239 ~dG~~~~y~  247 (762)
                      +||++++|.
T Consensus       221 ~dG~l~ly~  229 (236)
T 1dlp_A          221 PDRNLAIYG  229 (236)
T ss_dssp             SSSCEEEEC
T ss_pred             CCCcEEEeC
Confidence            999999995

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.1e-34  Score=309.63  Aligned_cols=241  Identities=14%  Similarity=0.093  Sum_probs=184.4

Q ss_pred             HHhhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--------cchhHHHHHHhhhhcccc---------------
Q 004312          482 VTRGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--------QDSEKEFKAEVNGIGQTH---------------  538 (762)
Q Consensus       482 ~t~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------------  538 (762)
                      ..+.+.+.||+|+||+||+|+.   +++.||||++....        ....+.+.+|++++++++               
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             ccchheeeecccCceEEEEEEe---CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            4456678899999999999975   35799999997542        222378899999988886               


Q ss_pred             -----------cCCccchhceecc-------------CCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHH
Q 004312          539 -----------HKNLVRLLGYCDE-------------GRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLF  594 (762)
Q Consensus       539 -----------H~nIv~l~g~~~~-------------~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~  594 (762)
                                 ||||+++++++.+             ....+|||||+++|++.+.+.+ ..+++..+..|+.||+.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence                       6777777777665             7789999999999987777744 56899999999999999999


Q ss_pred             HhH-hcCCCCeEeCCCCCCceEEcCCC--------------------ceEEecccccccccCCCCcccccccccCcccCc
Q 004312          595 YLH-EECCTQIIHCDIKPQNILLDDYY--------------------NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAP  653 (762)
Q Consensus       595 yLH-~~~~~~ivH~Dlkp~NILl~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aP  653 (762)
                      ||| +.   +|+||||||+||||+.++                    .+||+|||+++....      ....||+.|+||
T Consensus       176 ~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aP  246 (336)
T 2vuw_A          176 VAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCS
T ss_pred             HHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccCh
Confidence            999 88   999999999999999887                    899999999987643      234699999999


Q ss_pred             ccccCCCCCCcchhHHHHHH-HHHHHhCCCCCchhhHHHhhhccccccc-cccccccCCCHHHHHHHHHHHHHhhccCCC
Q 004312          654 EWFRNMPITVKVDVYSYGVL-LLEIICLRRTILTDWAYDCYQERTLGAL-VENDLEAMDDMTVLQRFVMVAIWCIQEDPS  731 (762)
Q Consensus       654 E~~~~~~~s~~~DV~S~Gvi-l~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~dp~  731 (762)
                      |.+.+.. +.++|||||+++ .+++++|..|+..........+...... .............++++.+|+.+||+.|  
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--  323 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--  323 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence            9998766 899999998776 7788889988633210011111111010 0111111123467889999999999976  


Q ss_pred             CCCCHHHHH-H
Q 004312          732 HRPTMRRVT-Q  741 (762)
Q Consensus       732 ~RPt~~evl-~  741 (762)
                         |++|++ +
T Consensus       324 ---sa~e~l~~  331 (336)
T 2vuw_A          324 ---SATDLLCQ  331 (336)
T ss_dssp             ---SHHHHHHH
T ss_pred             ---CHHHHHhc
Confidence               899888 5

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.8e-34  Score=301.32  Aligned_cols=230  Identities=22%  Similarity=0.314  Sum_probs=178.3

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhh-cccccCCccchhceecc----CCceeEEEecc
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGI-GQTHHKNLVRLLGYCDE----GRNRLLVYEFM  562 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~g~~~~----~~~~~LV~E~~  562 (762)
                      +.||+|+||.||++... .+++.||||+++.     ...+.+|++++ +.++||||+++++++..    ....++||||+
T Consensus        24 ~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~   97 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNK-RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL   97 (299)
T ss_dssp             EEEEEETTEEEEEEEET-TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred             cccccCCCeEEEEEEEc-CCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence            56999999999999754 4567999999864     34677888888 55699999999999876    67789999999


Q ss_pred             CCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC---CCceEEecccccccccCCC
Q 004312          563 SNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD---YYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       563 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~  637 (762)
                      ++|+|.+++...  ..+++..+..++.||+.||+|||++   +|+||||||+|||++.   ++.+||+|||++....   
T Consensus        98 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---  171 (299)
T 3m2w_A           98 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---  171 (299)
T ss_dssp             CSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence            999999999765  3689999999999999999999999   9999999999999997   7899999999987542   


Q ss_pred             CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCC--CHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMD--DMTVL  715 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  715 (762)
                                          +..++.++||||||+++|||++|+.||........... ..............  ....+
T Consensus       172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  230 (299)
T 3m2w_A          172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVS  230 (299)
T ss_dssp             --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-SCCSSCTTCCSSCHHHHTTSC
T ss_pred             --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-HHHHHhhccccCCchhcccCC
Confidence                                23467899999999999999999999854432221111 11111111111000  02346


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH--HhhcCcCCC
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQ--MLEGVVEVP  750 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~--~L~~~~~~~  750 (762)
                      +++.+++.+||+.||++|||++|+++  .+.+....+
T Consensus       231 ~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~  267 (299)
T 3m2w_A          231 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP  267 (299)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence            78999999999999999999999997  344444333

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.9e-34  Score=316.27  Aligned_cols=233  Identities=16%  Similarity=0.132  Sum_probs=175.1

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhccccc-CCccchhce--------------
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHH-KNLVRLLGY--------------  548 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~nIv~l~g~--------------  548 (762)
                      .+.||+|+||.||+|... .+++.||||++.....   ...+.|.+|+.+++.++| +|...+..+              
T Consensus        83 ~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (413)
T 3dzo_A           83 GTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ  161 (413)
T ss_dssp             EEEEEEETTEEEEEEEET-TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred             ecccccCCCEEEEEEEec-CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence            467999999999999754 4567999999874322   235789999999999977 433322222              


Q ss_pred             -------ecc-----CCceeEEEeccCCCchhhhcc------C-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCC
Q 004312          549 -------CDE-----GRNRLLVYEFMSNGALASFLF------G-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDI  609 (762)
Q Consensus       549 -------~~~-----~~~~~LV~E~~~~gsL~~~l~------~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl  609 (762)
                             ...     ....+++|+++ +++|.+++.      . ...+++..++.|+.||++||+|||++   +|+||||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDi  237 (413)
T 3dzo_A          162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL  237 (413)
T ss_dssp             ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCc
Confidence                   111     12346666665 689998884      2 23577889999999999999999999   9999999


Q ss_pred             CCCceEEcCCCceEEecccccccccCCCCcccccccccCcccCcccc----------cCCCCCCcchhHHHHHHHHHHHh
Q 004312          610 KPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF----------RNMPITVKVDVYSYGVLLLEIIC  679 (762)
Q Consensus       610 kp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~~DV~S~Gvil~ellt  679 (762)
                      ||+||||+.++.+||+|||+++.....    .....| +.|+|||.+          ....++.++|||||||++|||++
T Consensus       238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            999999999999999999998865322    344567 999999999          55568899999999999999999


Q ss_pred             CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 004312          680 LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVT  740 (762)
Q Consensus       680 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl  740 (762)
                      |+.||.......     .....+..      ....++++.+|+.+||+.||++||++.|++
T Consensus       313 g~~Pf~~~~~~~-----~~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          313 ADLPNTDDAALG-----GSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             SSCCCCTTGGGS-----CSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             CCCCCCCcchhh-----hHHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999985432211     11111111      112357899999999999999999965553

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=8.2e-29  Score=284.77  Aligned_cols=186  Identities=18%  Similarity=0.115  Sum_probs=131.8

Q ss_pred             hcCCCCcceEEEeeeeCCCcceEEEEEccccc----------cchhHHHHHHhhhhccc-ccCCccchhceeccCCceeE
Q 004312          489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF----------QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~L  557 (762)
                      .++.|++|.+..+. +...++.++||.+.+..          +...++|.+|+++|+++ +|+||++++++++++...||
T Consensus       241 ~~~~~~~~~h~~~r-r~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          241 QPYAGAGLAHKRSR-RYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             C-C--------CCE-EEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             ccccCCcccccccc-cccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            35666666555432 22234679999986431          22345799999999999 79999999999999999999


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ||||++|++|.++|...+.++..   +|+.||+.||+|+|++   +||||||||+||||++++.+||+|||+++....+.
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            99999999999999988888764   5899999999999999   99999999999999999999999999998765433


Q ss_pred             CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCC
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRT  683 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p  683 (762)
                      . .....+||+.|||||.+.+ ....++|+||+|++++++.++..+
T Consensus       394 ~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          394 S-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             c-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            2 3345679999999999975 467889999999999888765444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=4.9e-25  Score=251.91  Aligned_cols=182  Identities=16%  Similarity=0.180  Sum_probs=146.1

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--------chhHHHHHHhhhhcccccCCccchhceeccCCceeEE
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLV  558 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV  558 (762)
                      .+.||+|+||.||+|...   ++.+++|+......        ...+.+.+|++++++++||||+++..++...+..+||
T Consensus       341 ~~~LG~G~fg~Vy~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSYL---DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             -------CCEEEEEEECS---SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCEEeeCCCEEEEEEEEC---CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            457999999999999543   46789988643211        1134589999999999999999877777788888999


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      |||+++++|.+++..        +..++.||++||+|||++   +|+||||||+|||+++  .+||+|||+++.......
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~  484 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED  484 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence            999999999999975        568999999999999999   9999999999999999  999999999997754322


Q ss_pred             cc------cccccccCcccCcccccC--CCCCCcchhHHHHHHHHHHHhCCCCC
Q 004312          639 HT------NTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRTI  684 (762)
Q Consensus       639 ~~------~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvil~elltg~~p~  684 (762)
                      ..      .....||+.|||||++..  ..|+...|+|+..+-..+-+.++.++
T Consensus       485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            21      235679999999999987  56888899999999988888777664

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=6.7e-22  Score=207.26  Aligned_cols=140  Identities=14%  Similarity=0.104  Sum_probs=114.9

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc------------------chhHHHHHHhhhhcccccCCccchhce
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ------------------DSEKEFKAEVNGIGQTHHKNLVRLLGY  548 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~g~  548 (762)
                      .+.||+|+||.||+|..  .+++.||||+++....                  .....+.+|++++++++  | +++.++
T Consensus        95 ~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~  169 (282)
T 1zar_A           95 GKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV  169 (282)
T ss_dssp             EEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred             cCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence            37899999999999986  4567999999864321                  13457899999999999  5 777776


Q ss_pred             eccCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccc
Q 004312          549 CDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFG  628 (762)
Q Consensus       549 ~~~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  628 (762)
                      +.. +..++||||+++++|.+ +..      .....++.||++||.|||+.   +|+||||||+|||++ ++.+||+|||
T Consensus       170 ~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          170 YAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             EEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             Eec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECC
Confidence            543 56799999999999999 522      23457999999999999998   999999999999999 9999999999


Q ss_pred             ccccccCCCCcccccccccCcccCccccc
Q 004312          629 LEKLLTLDQSHTNTAIRGTKGYVAPEWFR  657 (762)
Q Consensus       629 la~~~~~~~~~~~~~~~gt~~y~aPE~~~  657 (762)
                      +++.              +..++|||++.
T Consensus       238 ~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          238 QSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             TCEE--------------TTSTTHHHHHH
T ss_pred             CCeE--------------CCCCCHHHHHH
Confidence            9973              34578899874

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.83  E-value=1.8e-20  Score=168.47  Aligned_cols=109  Identities=21%  Similarity=0.288  Sum_probs=91.5

Q ss_pred             cccCcccCCCceeecCCCCcEe--eCCCcEEEeeecccccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEEEeecCCCC
Q 004312           21 QSNGTISIGQQLTAAESTEPWL--SPSKDFALGFHQLDIWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTG   98 (762)
Q Consensus        21 ~~~~~~~~~~~l~~~~~~~~lv--S~~g~F~lgf~~~~vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~   98 (762)
                      ++.++|.+||+|.+++   +|+  |++|.|+|+|+                      .||||+|++. +++||++++...
T Consensus         6 ~~~~~l~~g~~L~~g~---~l~~~S~~g~~~L~~~----------------------~dgnlvly~~-~~~vW~sn~~~~   59 (119)
T 1b2p_A            6 SKQPDDNHPQILHATE---SLEILFGTHVYRFIMQ----------------------TDCNLVLYDN-NNPIWATNTGGL   59 (119)
T ss_dssp             CSCSSSCCCCEEETTC---EEEEEETTEEEEEEEC----------------------TTSCEEEEET-TEEEEECCCTTS
T ss_pred             ecCcccCCCCEEcCCC---EEEEeCCCCCEEEEEe----------------------cCCCEEEEEC-CEEEEeCCCccC
Confidence            3458999999999887   799  99999998887                      3688999987 789999998654


Q ss_pred             c-eeEEEEecCCCEEEEecCCCccccccCCCccccCCCccccCccEEEeecCCCCCCCcceEEEecCCCceeeEeeccCC
Q 004312           99 E-AAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLES  177 (762)
Q Consensus        99 ~-~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~l~~~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~  177 (762)
                      . ..+|+|+|+|||||+|.++.++||||                         ++|++|.|++.++++|+++++.     
T Consensus        60 ~~~~~l~l~~dGNLVl~d~~~~~lW~S~-------------------------~~~~~g~~~l~l~~~Gnlvl~~-----  109 (119)
T 1b2p_A           60 GNGCRAVLQPDGVLVVITNENVTVWQSP-------------------------VAGKAGHYVLVLQPDRNVVIYG-----  109 (119)
T ss_dssp             CSSCEEEECTTSCEEEECTTCCEEEECS-------------------------CCCCSSCEEEEECTTSCEEEEE-----
T ss_pred             CCceEEEEccCCEEEEEeCCCcEEEcCC-------------------------CCCCCCCEEEEEECCCcEEEEC-----
Confidence            3 46899999999999998899999998                         4556899999999999977752     


Q ss_pred             CcccccccccCC
Q 004312          178 GFAYDAFFWSNT  189 (762)
Q Consensus       178 ~~~~~~~~~~~~  189 (762)
                          ..||.+++
T Consensus       110 ----~~~W~Sg~  117 (119)
T 1b2p_A          110 ----DALWATQT  117 (119)
T ss_dssp             ----SEEEECCC
T ss_pred             ----ccEeCCCC
Confidence                14887765

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=99.82  E-value=2.6e-20  Score=163.44  Aligned_cols=94  Identities=21%  Similarity=0.417  Sum_probs=83.3

Q ss_pred             cCcccCCCceeecCCCCcEeeCCCcEEEeeeccc----------ccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEEEe
Q 004312           23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD----------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWK   92 (762)
Q Consensus        23 ~~~~~~~~~l~~~~~~~~lvS~~g~F~lgf~~~~----------vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~ws   92 (762)
                      .|+|.+||.|.+|+   +|.|  |.|.|.|...|          ||+|||+.|....+.|+|+.||||||+|+++++||+
T Consensus         1 kn~L~~g~~L~~g~---~L~s--g~y~l~~q~DgNLvly~~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWs   75 (105)
T 4h3o_A            1 RNILDNNEGLYAGQ---SLDV--EPYHFIMQDDCNLVLYDHSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWA   75 (105)
T ss_dssp             CCEECTTEEECTTC---EEEE--TTEEEEECTTSCEEEEETTEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEE
T ss_pred             CCCcCCCCEEcCCC---EEEE--CCEEEEECCCCeEEEEECCEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEE
Confidence            37899999999887   6877  88999997765          999999999888899999999999999999999999


Q ss_pred             ecCCCC-ceeEEEEecCCCEEEEecCCCccccc
Q 004312           93 SEISTG-EAAFGVLYDTGNFLIVNTNSERLWQT  124 (762)
Q Consensus        93 ~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqS  124 (762)
                      |+++.. ...+|+|+|+|||||++.   .||||
T Consensus        76 s~t~~~~~~~~l~L~ddGNlVly~~---~~W~S  105 (105)
T 4h3o_A           76 SHSTRGSGNYILILQDDGNVIIYGS---DIWST  105 (105)
T ss_dssp             CCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred             ecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence            998754 346899999999999964   69998

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.79  E-value=2.7e-19  Score=158.71  Aligned_cols=99  Identities=23%  Similarity=0.352  Sum_probs=86.1

Q ss_pred             cCcccCCCceeecCCCCcEeeCCCcEEEeeeccc----------ccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEEEe
Q 004312           23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD----------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWK   92 (762)
Q Consensus        23 ~~~~~~~~~l~~~~~~~~lvS~~g~F~lgf~~~~----------vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~ws   92 (762)
                      +|+|.+||+|.+++   +|+ ++|.|+|+|+..|          ||.||++.| ..++.+.|+.||||||+|.+|++||+
T Consensus         1 ~d~l~~g~~L~~g~---~l~-~~~~~~l~~~~dGnlvl~~~~~~vW~sn~~~~-~~~~~l~l~~dGNLVl~~~~~~~~W~   75 (110)
T 3a0c_A            1 VNSLSSPNSLFTGH---SLE-VGPSYRLIMQGDCNFVLYDSGKPVWASNTGGL-GSGCRLTLHNNGNLVIYDQSNRVIWQ   75 (110)
T ss_dssp             CCEEETTCEECTTC---EEE-ETTTEEEEECTTSCEEEEETTEEEEECCCTTS-CSSCEEEECTTSCEEEECTTCCEEEE
T ss_pred             CCEeCCCCEECCCC---EEE-ECCCEEEEEcCCCcEEEEECCEEEEECCCCCC-CCcEEEEEeCCCCEEEECCCCcEEEe
Confidence            37899999999877   789 9999999998766          999999877 34678999999999999999999999


Q ss_pred             ecCCCCc-eeEEEEecCCCEEEEecCCCccccccCCCc
Q 004312           93 SEISTGE-AAFGVLYDTGNFLIVNTNSERLWQTFDHPT  129 (762)
Q Consensus        93 ~~~~~~~-~~~~~l~d~GNlvl~~~~~~~~WqSFD~PT  129 (762)
                      |++.... ..+++|+|+|||||++.   .+||||+||.
T Consensus        76 S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~  110 (110)
T 3a0c_A           76 TKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA  110 (110)
T ss_dssp             CCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred             cCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence            9987543 44899999999999974   7999999984

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.76  E-value=1e-18  Score=156.44  Aligned_cols=99  Identities=25%  Similarity=0.424  Sum_probs=85.9

Q ss_pred             cCcccCCCceeecCCCCcEeeCCCcEEEeeeccc----------ccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEEEe
Q 004312           23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD----------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWK   92 (762)
Q Consensus        23 ~~~~~~~~~l~~~~~~~~lvS~~g~F~lgf~~~~----------vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~ws   92 (762)
                      .|||.+||+|.+++   +|+  +|.|+|+|+..|          ||.||++.|. .++.|.|+.||||||+|.++++||+
T Consensus         2 ~dtl~~gq~L~~g~---~L~--~g~~~L~~~~dgnlvly~~~~~vW~sn~~~~~-~~~~l~l~~~GnLvl~d~~~~~vW~   75 (115)
T 2dpf_A            2 DNVLLSGQTLHADH---SLQ--AGAYTLTIQNKCNLVKYQNGRQIWASNTDRRG-SGCRLTLLSDGNLVIYDHNNNDVWG   75 (115)
T ss_dssp             CCEEETTCEEETTE---EEE--ETTEEEEECTTSCEEEEETTEEEEECSCTTSC-SSCEEEECTTSCEEEECTTCCEEEE
T ss_pred             CCEeCCCCEECCCC---EEE--CCCEEEEEcCCCcEEEEeCCEEEEeCCCCCCC-CceEEEECCCCcEEEECCCceEEEE
Confidence            48999999999876   687  899999998766          9999999883 4678999999999999998999999


Q ss_pred             ecCCCC-ceeEEEEecCCCEEEEecCCCccccccCCCcc
Q 004312           93 SEISTG-EAAFGVLYDTGNFLIVNTNSERLWQTFDHPTD  130 (762)
Q Consensus        93 ~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTD  130 (762)
                      |++..+ +..+++|+|+|||||++.   ++||||.+++.
T Consensus        76 S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~  111 (115)
T 2dpf_A           76 SACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR  111 (115)
T ss_dssp             CCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred             cCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence            998643 345899999999999964   89999998765

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.74  E-value=3e-18  Score=152.65  Aligned_cols=99  Identities=18%  Similarity=0.416  Sum_probs=85.0

Q ss_pred             cCcccCCCceeecCCCCcEeeCCCcEEEeeeccc----------ccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEEEe
Q 004312           23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD----------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWK   92 (762)
Q Consensus        23 ~~~~~~~~~l~~~~~~~~lvS~~g~F~lgf~~~~----------vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~ws   92 (762)
                      +|||.+||+|.+++   +|  ++|.|+|+|+.+|          ||.||++.+ ..++.|.|+.||||||+| +++++|+
T Consensus         1 tdtl~~gq~L~~g~---~L--~~~~~~L~~~~dgnlvl~~~~~~vW~sn~~~~-~~~~~l~l~~~GNLvl~d-~~~~~W~   73 (112)
T 1xd5_A            1 SDRLNSGHQLDTGG---SL--AEGGYLFIIQNDCNLVLYDNNRAVWASGTNGK-ASGCVLKMQNDGNLVIYS-GSRAIWA   73 (112)
T ss_dssp             CCEEETTEEECTTC---EE--EETTEEEEECTTSCEEEEETTEEEEECCCTTS-CSSEEEEECTTSCEEEEE-TTEEEEE
T ss_pred             CCCCCCCCEECCCC---EE--eCCCEEEEEcCCCcEEEEECCEEEEeCCCcCC-CCCEEEEEeCCCCEEEEc-CCEEEEE
Confidence            48999999999887   56  5899999998776          999999864 345789999999999999 7889999


Q ss_pred             ecCCCCc-eeEEEEecCCCEEEEecCCCccccccCCC
Q 004312           93 SEISTGE-AAFGVLYDTGNFLIVNTNSERLWQTFDHP  128 (762)
Q Consensus        93 ~~~~~~~-~~~~~l~d~GNlvl~~~~~~~~WqSFD~P  128 (762)
                      |.+.... ..+++|+++|||||++..+.++||||+|.
T Consensus        74 S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~  110 (112)
T 1xd5_A           74 SNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV  110 (112)
T ss_dssp             CCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred             CCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence            9876433 45899999999999987788999999985

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=99.71  E-value=1.6e-17  Score=147.13  Aligned_cols=92  Identities=22%  Similarity=0.358  Sum_probs=79.8

Q ss_pred             CcccCCCceeecCCCCcEeeCCCcEEEeeeccc----------ccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEEEee
Q 004312           24 GTISIGQQLTAAESTEPWLSPSKDFALGFHQLD----------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKS   93 (762)
Q Consensus        24 ~~~~~~~~l~~~~~~~~lvS~~g~F~lgf~~~~----------vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~ws~   93 (762)
                      +||.+||+|.+++   +|+  +|.|+|+|+..|          ||.+|++.+ +.++.|.|+.||||||+|.+++++|+|
T Consensus         2 ntL~~gq~L~~g~---~L~--~g~~~L~~q~dGnLvly~~~~~vW~snt~~~-~~~~~l~l~~dGNLvl~~~~~~~~W~S   75 (109)
T 3dzw_A            2 NILYSGETLSPGE---FLN--NGRYVFIMQEDCNLVLYDVDKPIWATNTGGL-DRRCHLSMQSDGNLVVYSPRNNPIWAS   75 (109)
T ss_dssp             CEEETTEEECTTC---EEE--ETTEEEEECTTSCEEEEETTEEEEECCCTTS-SSSCEEEECTTSCEEEECTTSCEEEEC
T ss_pred             CCcCCCCEeCCCC---EEE--CCCEEEEEcCCCcEEEEeCCEEEEECCcccC-CCCEEEEEeCCCCEEEECCCCCEEEEC
Confidence            6899999999876   565  799999998765          999999876 346789999999999999999999999


Q ss_pred             cCCCCc-eeEEEEecCCCEEEEecCCCccccc
Q 004312           94 EISTGE-AAFGVLYDTGNFLIVNTNSERLWQT  124 (762)
Q Consensus        94 ~~~~~~-~~~~~l~d~GNlvl~~~~~~~~WqS  124 (762)
                      +++... ..+|+|+|+|||||+++   ++|||
T Consensus        76 ~t~~~~~~~~~~L~ddGNlvly~~---~~W~s  104 (109)
T 3dzw_A           76 NTGGENGNYVCVLQKDRNVVIYGT---ARWAT  104 (109)
T ss_dssp             CCCCSSSCEEEEECTTSCEEEEES---CCCCC
T ss_pred             CCCCCCCCEEEEEeCCCEEEEECC---CEEeC
Confidence            986544 35899999999999984   89998

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.71  E-value=7.8e-18  Score=174.04  Aligned_cols=135  Identities=16%  Similarity=0.147  Sum_probs=103.3

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcce--EEEEEccccccc------------------------hhHHHHHHhhhhccccc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQD------------------------SEKEFKAEVNGIGQTHH  539 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H  539 (762)
                      +.+.||+|+||.||+|... .+++.  ||||+++.....                        ....+.+|++++.+++|
T Consensus        51 i~~~ig~G~~g~Vy~a~~~-~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~  129 (258)
T 1zth_A           51 MGGVISTGKEANVFYADGV-FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE  129 (258)
T ss_dssp             EEEEEEECSSEEEEEEEEE-ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred             hCCEEeecceEEEEEEEEc-CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence            4467999999999999762 23457  999986532111                        12368899999999998


Q ss_pred             CCc--cchhceeccCCceeEEEeccCC-C----chhhhccCCCCCCHHHHHHHHHHHHHHHHHhH-hcCCCCeEeCCCCC
Q 004312          540 KNL--VRLLGYCDEGRNRLLVYEFMSN-G----ALASFLFGDSKPNWKLRTEIVMGIARGLFYLH-EECCTQIIHCDIKP  611 (762)
Q Consensus       540 ~nI--v~l~g~~~~~~~~~LV~E~~~~-g----sL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~Dlkp  611 (762)
                      +++  +.++++    ...+|||||+.+ |    +|.++...   .++.....++.|++.||.||| +.   +|+||||||
T Consensus       130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp  199 (258)
T 1zth_A          130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADLSE  199 (258)
T ss_dssp             TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCST
T ss_pred             CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCH
Confidence            864  333332    467899999942 4    66665432   234567899999999999999 87   999999999


Q ss_pred             CceEEcCCCceEEecccccccc
Q 004312          612 QNILLDDYYNARISDFGLEKLL  633 (762)
Q Consensus       612 ~NILl~~~~~~kl~Dfgla~~~  633 (762)
                      +|||+++  .++|+|||++...
T Consensus       200 ~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEET
T ss_pred             HHEEEcC--cEEEEECcccccC
Confidence            9999998  9999999999754

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.66  E-value=1.7e-16  Score=140.17  Aligned_cols=100  Identities=20%  Similarity=0.340  Sum_probs=84.4

Q ss_pred             ccCcccCCCceeecCCCCcEeeCCCcEEEeeeccc-------ccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEEEeec
Q 004312           22 SNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD-------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSE   94 (762)
Q Consensus        22 ~~~~~~~~~~l~~~~~~~~lvS~~g~F~lgf~~~~-------vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~ws~~   94 (762)
                      +.|||.+||.|..++   +|  .+|.|.|.|...|       +|.+|+..+ +.++.|+|+.||||||+|.+++++|+|+
T Consensus         2 ~~dtL~~gq~L~~g~---~L--~~g~~~L~~q~dGNLvl~~~~Wssnt~~~-~~~~~l~l~~dGnLvl~d~~~~~vWss~   75 (109)
T 3r0e_A            2 GTNYLLSGQTLDTEG---HL--KNGDFDLVMQDDCNLVLYNGNWQSNTANN-GRDCKLTLTDYGELVIKNGDGSTVWKSG   75 (109)
T ss_dssp             CCSEEETTCEECTTC---EE--EETTEEEEECTTSCEEEETTTEECCCTTS-CSSCEEEECTTSCEEEECTTSCEEEECC
T ss_pred             ccCCcCCCCCcCCCC---Ee--ECCCEEEEEecCCeEEEEeCeEEcCCCCC-CCcEEEEEcCCCeEEEEeCCCCEEEcCC
Confidence            579999999999876   56  5799999997655       999998865 3468899999999999999999999999


Q ss_pred             CCCCc-eeEEEEecCCCEEEEecCCCccccccCCCccccCCC
Q 004312           95 ISTGE-AAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPT  135 (762)
Q Consensus        95 ~~~~~-~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpg  135 (762)
                      +.... ..+|+|+|||||||++   ..+|+|     .|.+||
T Consensus        76 t~~~~~~~~~~L~~dGNlvly~---~~~W~s-----~t~~~~  109 (109)
T 3r0e_A           76 AQSVKGNYAAVVHPDGRLVVFG---PSVFKI-----DPWVRG  109 (109)
T ss_dssp             CCCSSSCCEEEEETTTEEEEEC---SEEEEE-----CTTSCC
T ss_pred             CcCCCcCEEEEEcCCCeEEEEe---cCEECC-----CCccCC
Confidence            86443 4589999999999997   689997     666664

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.66  E-value=1.8e-16  Score=140.30  Aligned_cols=95  Identities=23%  Similarity=0.305  Sum_probs=79.4

Q ss_pred             cccCcccCCCceeecCCCCcEeeCCCcEEEeeeccc---------ccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEEE
Q 004312           21 QSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD---------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIW   91 (762)
Q Consensus        21 ~~~~~~~~~~~l~~~~~~~~lvS~~g~F~lgf~~~~---------vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~w   91 (762)
                      ++.|||.+||+|..++   +|+|  |.|.|-|...|         ||.+|++.. +.++.|.|+.||||||+|.+++++|
T Consensus         4 ~~~dtL~~gq~L~~g~---~L~s--g~~~L~~q~dGnLvl~~~~~vW~snt~~~-~~~~~l~l~~dGNLvl~d~~~~~iW   77 (110)
T 3r0e_B            4 FTNNLLFSGQVLYGDG---RLTA--KNHQLVMQGDCNLVLYGGKYGWQSNTHGN-GEHCFLRLNHKGELIIKDDDFKTIW   77 (110)
T ss_dssp             CBTTEEETTCEEETTE---EEEC--SSCEEEECTTSCEEEECSSSCEECCCTTS-SSSCEEEECTTSCEEEECTTCCEEE
T ss_pred             cccCEECCCCEecCCC---EEEe--CCEEEEEcCCCeEEEECCeEEEECCCcCC-CcCEEEEEeCCCcEEEEeCCCCEEE
Confidence            5679999999999876   6887  55888776544         999999863 3357899999999999999999999


Q ss_pred             eecCCCCc-eeEEEEecCCCEEEEecCCCccccc
Q 004312           92 KSEISTGE-AAFGVLYDTGNFLIVNTNSERLWQT  124 (762)
Q Consensus        92 s~~~~~~~-~~~~~l~d~GNlvl~~~~~~~~WqS  124 (762)
                      +|++.... ..+|+|+||||||||+   ..+|+|
T Consensus        78 ~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t  108 (110)
T 3r0e_B           78 SSRSSSKQGEYVLILQDDGFGVIYG---PAIFET  108 (110)
T ss_dssp             ECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred             EcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence            99986433 3689999999999997   489997

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.64  E-value=2.2e-16  Score=139.81  Aligned_cols=89  Identities=19%  Similarity=0.305  Sum_probs=74.3

Q ss_pred             CCCceEEEEeCCcEEEeCCCCCEEEeecCCCCc-eeEEEEecCCCEEEEecCCCccccccCCCccccCCCccccCccEEE
Q 004312           67 PGGSKLRLTANGGLVLEDPEAREIWKSEISTGE-AAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVS  145 (762)
Q Consensus        67 ~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~-~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~l~~~~~L~  145 (762)
                      +....|.|+.||||+|++ .+++||++++.... ..+++|+|+|||||+|.++.++||||.                   
T Consensus        19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~t-------------------   78 (110)
T 3a0c_A           19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKT-------------------   78 (110)
T ss_dssp             TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCC-------------------
T ss_pred             CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecCC-------------------
Confidence            456889999999999998 47899999986443 468999999999999998999999983                   


Q ss_pred             eecCCCCCCCcceEEEecCCCceeeEeeccCCCcccccccccCCc
Q 004312          146 SRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTF  190 (762)
Q Consensus       146 S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~  190 (762)
                            ++++|.|++.++++|+++++.  .       .||.++++
T Consensus        79 ------~~~~g~~~l~l~~dGnlvl~~--~-------~~W~S~~~  108 (110)
T 3a0c_A           79 ------NGKEDHYVLVLQQDRNVVIYG--P-------VVWATGSG  108 (110)
T ss_dssp             ------CCSSSCCEEEECTTSCEEEEC--S-------EEEECSCC
T ss_pred             ------CCCCCCEEEEEeCCccEEEEC--C-------CEecCCCc
Confidence                  456799999999999987752  1       48887765

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.62  E-value=1.3e-15  Score=135.56  Aligned_cols=95  Identities=16%  Similarity=0.254  Sum_probs=79.0

Q ss_pred             cccCcccCCCceeecCCCCcEeeCCCcEEEeeeccc------------ccccCCCCCCCCCceEEEEeCCcEEEeCCCCC
Q 004312           21 QSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD------------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAR   88 (762)
Q Consensus        21 ~~~~~~~~~~~l~~~~~~~~lvS~~g~F~lgf~~~~------------vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~   88 (762)
                      .+.|+|.+||.|.+++   +|.  +|.|.|-|...|            ||.+|+..+ ..++.|.|+.||||||+|.+++
T Consensus         4 ~~~~tL~~gq~L~~g~---~L~--~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~-~~~~~l~l~~dGNLVl~d~~~~   77 (113)
T 3mez_B            4 RVRNVLFSSQVMYDNA---QLA--TRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGR-GQHCFMRLGHSGELDITDDRLN   77 (113)
T ss_dssp             CCSSEEETTCEEETTC---EEE--ETTEEEEECTTSCEEEEETTTTEEEEECCCTTS-CSSCEEEECTTSCEEEECTTSC
T ss_pred             ccCCEeCCCCEECCCC---EeE--cCCEEEEEcCCCEEEEEECCCCEEEEECCcccC-CcCEEEEEeCCCcEEEECCCCC
Confidence            3568999999999876   565  488888885433            899999876 3457899999999999999999


Q ss_pred             EEEeecCCCCc-eeEEEEecCCCEEEEecCCCccccc
Q 004312           89 EIWKSEISTGE-AAFGVLYDTGNFLIVNTNSERLWQT  124 (762)
Q Consensus        89 ~~ws~~~~~~~-~~~~~l~d~GNlvl~~~~~~~~WqS  124 (762)
                      ++|+|++.... ..+|+|+|+||||||+   ..+|+|
T Consensus        78 ~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s  111 (113)
T 3mez_B           78 TVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST  111 (113)
T ss_dssp             EEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred             EEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence            99999986433 3689999999999997   689997

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.61  E-value=1.4e-15  Score=135.34  Aligned_cols=92  Identities=23%  Similarity=0.368  Sum_probs=75.2

Q ss_pred             CCceEEEEeCCcEEEeCCCCCEEEeecCCCC-ceeEEEEecCCCEEEEecCCCccccccCCCccccCCCccccCccEEEe
Q 004312           68 GGSKLRLTANGGLVLEDPEAREIWKSEISTG-EAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSS  146 (762)
Q Consensus        68 ~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~l~~~~~L~S  146 (762)
                      ....|.|+.||||+|++. +++||++++... ...+|+|+++|||||+| ++.++||||+                    
T Consensus        19 ~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~--------------------   76 (112)
T 1xd5_A           19 GGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNT--------------------   76 (112)
T ss_dssp             TTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCC--------------------
T ss_pred             CCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCc--------------------
Confidence            457899999999999987 789999998643 34689999999999999 7889999994                    


Q ss_pred             ecCCCCCCCcceEEEecCCCceeeEeeccCCCcccccccccCCcce
Q 004312          147 RRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTFDV  192 (762)
Q Consensus       147 ~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (762)
                           +|++|.|++.+++||+++++.  ..    ...||.+++|.+
T Consensus        77 -----~~~~g~~~l~l~~dGnlvl~~--~~----~~~~W~S~~~~g  111 (112)
T 1xd5_A           77 -----NRQNGNYYLILQRDRNVVIYD--NS----NNAIWATHTNVG  111 (112)
T ss_dssp             -----CCSCCCCEEEECTTSCEEEEC--TT----SCEEEECCCCCC
T ss_pred             -----cCCCCCEEEEEeCCCcEEEEC--CC----CceEEECCCccC
Confidence                 445789999999999977753  11    146898888753

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.59  E-value=3.4e-15  Score=132.27  Aligned_cols=106  Identities=16%  Similarity=0.214  Sum_probs=81.9

Q ss_pred             cCcccCCCceeecCCCCcEeeCCCcEEEeeecccccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEEEeecCCCCc-ee
Q 004312           23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDIWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGE-AA  101 (762)
Q Consensus        23 ~~~~~~~~~l~~~~~~~~lvS~~g~F~lgf~~~~vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~-~~  101 (762)
                      +|+|.+||.|.+|+   .|  .+|.|                      .|.|+.||||||++.++  +|++++...+ ..
T Consensus         2 ~~~l~~gq~L~~g~---~L--~~g~~----------------------~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~   52 (111)
T 3mez_A            2 NNVLLTGDVIHTDN---QL--SYESA----------------------AFVMQGDCNLVLYNEAG--GFQSNTHGRGVDC   52 (111)
T ss_dssp             TTEEETTCEECTTC---EE--EETTE----------------------EEEECTTSCEEEECSSC--CEECCCTTSCSSC
T ss_pred             cCEeCCCCEeCCCC---EE--ecCCE----------------------EEEEccCCeEEEECCCC--EEECCcccCCcCE
Confidence            57899999999876   34  23444                      47888999999999876  9999986543 36


Q ss_pred             EEEEecCCCEEEEecCCC-ccccccCCCccccCCCccccCccEEEeecCCCCCCCcceEEEecCCCceeeEeeccCCCcc
Q 004312          102 FGVLYDTGNFLIVNTNSE-RLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFA  180 (762)
Q Consensus       102 ~~~l~d~GNlvl~~~~~~-~~WqSFD~PTDTlLpgq~l~~~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~  180 (762)
                      .++|+++|||||++.++. ++|||.-+                       .....|.|.+.++.||++++|.        
T Consensus        53 ~l~l~~dGNLVl~~~~~~~~vW~S~t~-----------------------~~~~~~~~~l~Lq~dGNlvly~--------  101 (111)
T 3mez_A           53 TLRLNNRGQLEIHSANSNTPVWVYPRS-----------------------VNTVRGNYAATLGPDQHVTIYG--------  101 (111)
T ss_dssp             EEEECTTSCEEEECSSCSSCSEEESSS-----------------------CCCCSSCCEEEECTTSCEEEEC--------
T ss_pred             EEEEcCCCcEEEEeCCCCEEEEEeccc-----------------------cCCCCcCEEEEECCCCeEEEec--------
Confidence            899999999999998765 59998521                       1123578999999999999973        


Q ss_pred             cccccccCC
Q 004312          181 YDAFFWSNT  189 (762)
Q Consensus       181 ~~~~~~~~~  189 (762)
                       ..+|.+++
T Consensus       102 -~~~W~s~t  109 (111)
T 3mez_A          102 -PAIWSTPA  109 (111)
T ss_dssp             -SEEEECCC
T ss_pred             -cCEEccCC
Confidence             34787765

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.57  E-value=4.3e-15  Score=132.78  Aligned_cols=91  Identities=21%  Similarity=0.364  Sum_probs=75.8

Q ss_pred             CCCceEEEEeCCcEEEeCCCCCEEEeecCCCCc-eeEEEEecCCCEEEEecCCCccccccCCCccccCCCccccCccEEE
Q 004312           67 PGGSKLRLTANGGLVLEDPEAREIWKSEISTGE-AAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVS  145 (762)
Q Consensus        67 ~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~-~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~l~~~~~L~  145 (762)
                      +....|.|+.||||+|++ .+++||++++.... ..+++|+++|||||+|.++.++|||||+|                 
T Consensus        19 ~g~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~-----------------   80 (115)
T 2dpf_A           19 AGAYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWG-----------------   80 (115)
T ss_dssp             ETTEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCC-----------------
T ss_pred             CCCEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCCC-----------------
Confidence            346789999999999998 47899999986543 46899999999999998889999999983                 


Q ss_pred             eecCCCCCCCcceEEEecCCCceeeEeeccCCCcccccccccCCcce
Q 004312          146 SRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTFDV  192 (762)
Q Consensus       146 S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (762)
                              ++|.|++.++++|+++++.  .       .||.+++|..
T Consensus        81 --------~~g~~~l~l~~dGnlvl~~--~-------~~W~S~~~~~  110 (115)
T 2dpf_A           81 --------DNGKYALVLQKDGRFVIYG--P-------VLWSLGPNGC  110 (115)
T ss_dssp             --------SSSCCEEEECTTSCEEEEC--S-------EEECSSTTCB
T ss_pred             --------CCCCEEEEEeCCCeEEEEC--C-------CEEECCCCCC
Confidence                    4688999999999987752  1       5899988843

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.57  E-value=1.6e-15  Score=163.27  Aligned_cols=138  Identities=12%  Similarity=0.009  Sum_probs=97.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--------------chhHHHHHHhhhhcccccCCccchhceec
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--------------DSEKEFKAEVNGIGQTHHKNLVRLLGYCD  550 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~  550 (762)
                      .+...||+|++|.||+|...  +++.||||+++....              ........++++.+...|+|+++++....
T Consensus        98 ~I~~~IG~Gk~a~VY~a~d~--~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           98 SVGSRIGVGKESDIMIVADE--KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             EEEEEEEECSSEEEEEEECT--TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EecCEeeeCCceEEEEEECC--CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            45567999999999999754  467899998753211              01122333333434444555555543322


Q ss_pred             cC------CceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC----
Q 004312          551 EG------RNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY----  620 (762)
Q Consensus       551 ~~------~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----  620 (762)
                      ..      ...+|||||+++++|..+...      +....++.||+.+|.|||+.   +||||||||.|||+++++    
T Consensus       176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          176 PVPEPIAQSRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             SCCCEEEEETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSC
T ss_pred             CCCeeeeccCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCccc
Confidence            11      233699999999999876532      23457889999999999998   999999999999998776    


Q ss_pred             ------ceEEecccccccc
Q 004312          621 ------NARISDFGLEKLL  633 (762)
Q Consensus       621 ------~~kl~Dfgla~~~  633 (762)
                            .+.|+||+-+...
T Consensus       247 ~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TTSEEEEEEECCCTTCEET
T ss_pred             ccccccceEEEEeCCcccC
Confidence                  3899999987654

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.44  E-value=1.8e-13  Score=121.66  Aligned_cols=84  Identities=19%  Similarity=0.245  Sum_probs=68.0

Q ss_pred             CCCCC-CCceEEEEeCCcEEEeCC-CCCEEEeecCCCCc-eeEEEEecCCCEEEEecCCCccccccCCCccccCCCcccc
Q 004312           63 DDPGP-GGSKLRLTANGGLVLEDP-EAREIWKSEISTGE-AAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTME  139 (762)
Q Consensus        63 ~~p~~-~~~~l~~~~~g~l~l~~~-~~~~~ws~~~~~~~-~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~l~  139 (762)
                      +.|+. ....|.|+.||||||++. .++++|++++.... ...++|+++|||||+|.++.++|||=.             
T Consensus        18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t-------------   84 (113)
T 3mez_B           18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNT-------------   84 (113)
T ss_dssp             TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSC-------------
T ss_pred             CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCC-------------
Confidence            44444 457899999999999998 48899999986433 468999999999999988899999811             


Q ss_pred             CccEEEeecCCCCCCCcceEEEecCCCceeeE
Q 004312          140 RGGVVSSRRKETDFSRGRFQFRLLEDGNAVLN  171 (762)
Q Consensus       140 ~~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~  171 (762)
                                  ....|.|.+.+++||++++|
T Consensus        85 ------------~~~~~~~~~~L~~dGnlvly  104 (113)
T 3mez_B           85 ------------VGQEGDYVLILQINGQAVVY  104 (113)
T ss_dssp             ------------CCSSSCCEEEECTTSCEEEE
T ss_pred             ------------cCCCCCEEEEEcCCceEEEe
Confidence                        11135699999999999997

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.41  E-value=4.9e-13  Score=119.83  Aligned_cols=98  Identities=19%  Similarity=0.326  Sum_probs=77.3

Q ss_pred             cccCcccCCCcee--ecCCCCcE-eeCCCcEEEeeeccc--ccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEEEeecC
Q 004312           21 QSNGTISIGQQLT--AAESTEPW-LSPSKDFALGFHQLD--IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEI   95 (762)
Q Consensus        21 ~~~~~~~~~~~l~--~~~~~~~l-vS~~g~F~lgf~~~~--vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~   95 (762)
                      ....+|.+|++|.  ...+.-.| +.++|.+.+  |..+  ||.||++.| ..++.|.|+.||||||+|.++++||+|++
T Consensus        12 ~~g~~L~~g~~l~~~S~~g~~~L~~~~dgnlvl--y~~~~~vW~sn~~~~-~~~~~l~l~~dGNLVl~d~~~~~lW~S~~   88 (119)
T 1b2p_A           12 NHPQILHATESLEILFGTHVYRFIMQTDCNLVL--YDNNNPIWATNTGGL-GNGCRAVLQPDGVLVVITNENVTVWQSPV   88 (119)
T ss_dssp             CCCCEEETTCEEEEEETTEEEEEEECTTSCEEE--EETTEEEEECCCTTS-CSSCEEEECTTSCEEEECTTCCEEEECSC
T ss_pred             CCCCEEcCCCEEEEeCCCCCEEEEEecCCCEEE--EECCEEEEeCCCccC-CCceEEEEccCCEEEEEeCCCcEEEcCCC
Confidence            3457899999997  32322234 577888765  4434  999999977 44688999999999999999999999997


Q ss_pred             CCC-ceeEEEEecCCCEEEEecCCCccccc
Q 004312           96 STG-EAAFGVLYDTGNFLIVNTNSERLWQT  124 (762)
Q Consensus        96 ~~~-~~~~~~l~d~GNlvl~~~~~~~~WqS  124 (762)
                      ... +..+++|+|+|||||++   .++|||
T Consensus        89 ~~~~g~~~l~l~~~Gnlvl~~---~~~W~S  115 (119)
T 1b2p_A           89 AGKAGHYVLVLQPDRNVVIYG---DALWAT  115 (119)
T ss_dssp             CCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred             CCCCCCEEEEEECCCcEEEEC---ccEeCC
Confidence            643 34589999999999998   389998

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=99.39  E-value=1e-12  Score=116.08  Aligned_cols=88  Identities=19%  Similarity=0.313  Sum_probs=70.8

Q ss_pred             CCceEEEEeCCcEEEeCCCCCEEEeecCCCCc-eeEEEEecCCCEEEEecCCCccccccCCCccccCCCccccCccEEEe
Q 004312           68 GGSKLRLTANGGLVLEDPEAREIWKSEISTGE-AAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSS  146 (762)
Q Consensus        68 ~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~-~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~l~~~~~L~S  146 (762)
                      ....|.|+.||||+|++. ++++|++++...+ ...++|+++|||||+|.++.++|||..+                   
T Consensus        19 g~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~-------------------   78 (109)
T 3dzw_A           19 GRYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTG-------------------   78 (109)
T ss_dssp             TTEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCC-------------------
T ss_pred             CCEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCC-------------------
Confidence            467899999999999987 6899999986543 4689999999999999888999998321                   


Q ss_pred             ecCCCCCCCcceEEEecCCCceeeEeeccCCCcccccccccCCc
Q 004312          147 RRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTF  190 (762)
Q Consensus       147 ~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~  190 (762)
                            ...+.|.+.+++||++++|.         ...|.+++.
T Consensus        79 ------~~~~~~~~~L~ddGNlvly~---------~~~W~s~t~  107 (109)
T 3dzw_A           79 ------GENGNYVCVLQKDRNVVIYG---------TARWATGTN  107 (109)
T ss_dssp             ------CSSSCEEEEECTTSCEEEEE---------SCCCCCCCC
T ss_pred             ------CCCCCEEEEEeCCCEEEEEC---------CCEEeCCCc
Confidence                  12357899999999999974         246777653

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.33  E-value=2.6e-12  Score=113.41  Aligned_cols=79  Identities=20%  Similarity=0.376  Sum_probs=64.8

Q ss_pred             CCCceEEEEeCCcEEEeCCCCCEEEeecCCCCc-eeEEEEecCCCEEEEecCCCccccccCCCccccCCCccccCccEEE
Q 004312           67 PGGSKLRLTANGGLVLEDPEAREIWKSEISTGE-AAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVS  145 (762)
Q Consensus        67 ~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~-~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~l~~~~~L~  145 (762)
                      +....|.|+.||||+|++.  +++|++++...+ ...++|+++|||||+|.++.++|||-.+                  
T Consensus        23 sg~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~------------------   82 (110)
T 3r0e_B           23 AKNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSS------------------   82 (110)
T ss_dssp             CSSCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCC------------------
T ss_pred             eCCEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCc------------------
Confidence            3467899999999999986  589999986543 3589999999999999988999998321                  


Q ss_pred             eecCCCCCCCcceEEEecCCCceeeEe
Q 004312          146 SRRKETDFSRGRFQFRLLEDGNAVLNT  172 (762)
Q Consensus       146 S~~s~~dps~G~~~l~~~~~g~~~~~~  172 (762)
                             ...|.|.+.+++||++++|.
T Consensus        83 -------~~~~~~~~~L~~dGNlvly~  102 (110)
T 3r0e_B           83 -------SKQGEYVLILQDDGFGVIYG  102 (110)
T ss_dssp             -------CSSSCCEEEECTTSCEEEEC
T ss_pred             -------CCCCCEEEEEcCCccEEEec
Confidence                   12456999999999999973

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.30  E-value=4.5e-12  Score=112.08  Aligned_cols=96  Identities=16%  Similarity=0.173  Sum_probs=75.7

Q ss_pred             cCcccCCCceeecCCCCcEeeCCCcEEEeeecccccccCCCCCCCCCceEEEEeCCcEEEeCCCCC-EEEeecCCC---C
Q 004312           23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDIWYASGDDPGPGGSKLRLTANGGLVLEDPEAR-EIWKSEIST---G   98 (762)
Q Consensus        23 ~~~~~~~~~l~~~~~~~~lvS~~g~F~lgf~~~~vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~-~~ws~~~~~---~   98 (762)
                      ..+|.+|++|+.+... -.+..+|.+.|=-... ||.+|+..+ ...+.|.|+.||||||+|.++. ++|+|++..   .
T Consensus         8 gq~L~~g~~L~~g~~~-L~~q~dGnLvl~~~~~-vW~snt~~~-~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~~~~~~   84 (111)
T 3mez_A            8 GDVIHTDNQLSYESAA-FVMQGDCNLVLYNEAG-GFQSNTHGR-GVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVR   84 (111)
T ss_dssp             TCEECTTCEEEETTEE-EEECTTSCEEEECSSC-CEECCCTTS-CSSCEEEECTTSCEEEECSSCSSCSEEESSSCCCCS
T ss_pred             CCEeCCCCEEecCCEE-EEEccCCeEEEECCCC-EEECCcccC-CcCEEEEEcCCCcEEEEeCCCCEEEEEeccccCCCC
Confidence            4689999999876532 3468889998822223 999999876 3468999999999999998876 599999632   2


Q ss_pred             ceeEEEEecCCCEEEEecCCCccccc
Q 004312           99 EAAFGVLYDTGNFLIVNTNSERLWQT  124 (762)
Q Consensus        99 ~~~~~~l~d~GNlvl~~~~~~~~WqS  124 (762)
                      ...+++|+++||||||+   ..+|+|
T Consensus        85 ~~~~l~Lq~dGNlvly~---~~~W~s  107 (111)
T 3mez_A           85 GNYAATLGPDQHVTIYG---PAIWST  107 (111)
T ss_dssp             SCCEEEECTTSCEEEEC---SEEEEC
T ss_pred             cCEEEEECCCCeEEEec---cCEEcc
Confidence            34689999999999997   689997

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=99.24  E-value=1.4e-11  Score=124.83  Aligned_cols=144  Identities=19%  Similarity=0.285  Sum_probs=99.1

Q ss_pred             CCCceEEEEeCCcEEEeCCCCCEEEeecCCCCceeEEEEecCCCEEEEecCCCccccccCCCccccCCCccccCccEEEe
Q 004312           67 PGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSS  146 (762)
Q Consensus        67 ~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~l~~~~~L~S  146 (762)
                      +....|.|+.||||+|++. +++||++|+......+++|+++|||||+|.++.++|+|+++                   
T Consensus        25 ~g~f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~-------------------   84 (236)
T 1dlp_A           25 LSSFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTK-------------------   84 (236)
T ss_dssp             STTEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCC-------------------
T ss_pred             cCCEEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCcc-------------------
Confidence            4567899999999999986 68999999865555689999999999999999999999865                   


Q ss_pred             ecCCCCCCCcceEEEecCCCceeeEeeccCCCcccccccccCCcce----------e--cCC------------------
Q 004312          147 RRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTFDV----------N--RSN------------------  196 (762)
Q Consensus       147 ~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~----------~--~~~------------------  196 (762)
                            ...|.|.+.++++|+++++.         ..+|.+..++.          .  .+|                  
T Consensus        85 ------~~~~~~~~~l~d~Gnlvl~~---------~~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s~~d~s~  149 (236)
T 1dlp_A           85 ------GSIGNYVLVLQPDRTVTIYG---------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQL  149 (236)
T ss_dssp             ------CCSSCCEEEECSSSCEEEEC---------SEEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECSSCCCBC
T ss_pred             ------ccCCcEEEEEeCCCCEEEec---------CCEEECCCCCCcccccCCccceEEecCCcCCCccceEEcCcEeec
Confidence                  12467899999999999862         14676554431          0  111                  


Q ss_pred             CCceeeeccCcceEEeecCceeEEeccccccCCccEEEEEEcCCCcEEEEEc
Q 004312          197 AGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSH  248 (762)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~~~~y~~  248 (762)
                      ..+.+.++.+|.++++..+ ..+ +...+ .+.....++.|+.+|++++|..
T Consensus       150 G~~~l~l~~dG~LvL~~~~-~~~-W~s~~-~~~~~~~~~~L~~~Gnl~ly~~  198 (236)
T 1dlp_A          150 SPYRLSMETDCNLVLFDRD-DRV-WSTNT-AGKGTGCRAVLQPNGRMDVLTN  198 (236)
T ss_dssp             SSCEEEEETTTEEEEEBTT-BCC-SCCCC-CSSCSSCEEEEETTTEEEEEET
T ss_pred             CcEEEEECCCCcEEEEcCC-EeE-EeCCC-cCCCCceEEEECCCCcEEEEeC
Confidence            1234556666666555432 222 22111 1112235788999999998863

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=99.24  E-value=1.1e-11  Score=127.84  Aligned_cols=100  Identities=18%  Similarity=0.311  Sum_probs=77.3

Q ss_pred             cccCcccCCCc----eeecCCCCcEeeCC----CcEEEeeeccc-----------ccccCCCCCCCCCceEEEEeCCcEE
Q 004312           21 QSNGTISIGQQ----LTAAESTEPWLSPS----KDFALGFHQLD-----------IWYASGDDPGPGGSKLRLTANGGLV   81 (762)
Q Consensus        21 ~~~~~~~~~~~----l~~~~~~~~lvS~~----g~F~lgf~~~~-----------vW~Anr~~p~~~~~~l~~~~~g~l~   81 (762)
                      ..+||+.||+.    |..++   .|+|+.    |.|.|.+-..|           +|.+++..+-  ...|.|+.+|+|+
T Consensus       134 ~ptdtlLpg~~~~~~l~~g~---~L~S~~dps~G~fsl~l~~dGnlvLy~~~~~~yW~Sgt~~~~--~~~l~l~~dGnLv  208 (276)
T 3m7h_A          134 TPAIPLVPGAIDSLLLAPGS---ELVQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGKG--AVRAVFQGDGNLV  208 (276)
T ss_dssp             CTTSCCCCSCTTCEEECSSE---EECTTCEEEETTEEEEECTTSCEEEECTTSSEEEECCCTTTT--CCEEEECTTSCEE
T ss_pred             ccccccccccccccccccCc---ccccCCCCCCceEEEeecCCceEEEEeCCCeEEEECCCCCCc--cEEEEEcCCCeEE
Confidence            34689999999    77654   465432    44444442211           7998888763  3789999999999


Q ss_pred             EeCCCCCEEEeecCCCCceeEEEEecCCCEEEEecCCCccccccCC
Q 004312           82 LEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQTFDH  127 (762)
Q Consensus        82 l~~~~~~~~ws~~~~~~~~~~~~l~d~GNlvl~~~~~~~~WqSFD~  127 (762)
                      ++|.++.++|++++......+|+|+++|||||++.  +++||||||
T Consensus       209 l~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~  252 (276)
T 3m7h_A          209 VYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF  252 (276)
T ss_dssp             EECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred             EEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence            99998899999998755557999999999999986  689999997

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=99.23  E-value=2.5e-11  Score=106.07  Aligned_cols=78  Identities=24%  Similarity=0.508  Sum_probs=64.8

Q ss_pred             CCceEEEEeCCcEEEeCCCCCEEEeecCCCC--ceeEEEEecCCCEEEEecCCCccccccCCCccccCCCccccCccEEE
Q 004312           68 GGSKLRLTANGGLVLEDPEAREIWKSEISTG--EAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVS  145 (762)
Q Consensus        68 ~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~--~~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~l~~~~~L~  145 (762)
                      ...+|.|+.||||||++. +++||++++..+  ....++|+++|||||+|.+++++|+|                     
T Consensus        19 g~y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss---------------------   76 (105)
T 4h3o_A           19 EPYHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWAS---------------------   76 (105)
T ss_dssp             TTEEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEEC---------------------
T ss_pred             CCEEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEe---------------------
Confidence            356899999999999985 489999998643  34689999999999999999999997                     


Q ss_pred             eecCCCCCCCcceEEEecCCCceeeE
Q 004312          146 SRRKETDFSRGRFQFRLLEDGNAVLN  171 (762)
Q Consensus       146 S~~s~~dps~G~~~l~~~~~g~~~~~  171 (762)
                          .+....+.+.+.+++||++++|
T Consensus        77 ----~t~~~~~~~~l~L~ddGNlVly   98 (105)
T 4h3o_A           77 ----HSTRGSGNYILILQDDGNVIIY   98 (105)
T ss_dssp             ----CCCCCSSCEEEEECTTSCEEEE
T ss_pred             ----cCCCCCCCEEEEEeCCCeEEEE
Confidence                1222357799999999999986

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.22  E-value=1.6e-11  Score=108.19  Aligned_cols=90  Identities=20%  Similarity=0.331  Sum_probs=70.1

Q ss_pred             CCCCC-CCceEEEEeCCcEEEeCCCCCEEEeecCCCCc-eeEEEEecCCCEEEEecCCCccccccCCCccccCCCccccC
Q 004312           63 DDPGP-GGSKLRLTANGGLVLEDPEAREIWKSEISTGE-AAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMER  140 (762)
Q Consensus        63 ~~p~~-~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~-~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~l~~  140 (762)
                      +.|+. ....|.|+.||||||+++    +|+|++...+ ...++|+++|||||+|.++.++|+|-     |         
T Consensus        15 g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~-----t---------   76 (109)
T 3r0e_A           15 EGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSG-----A---------   76 (109)
T ss_dssp             TCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECC-----C---------
T ss_pred             CCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCC-----C---------
Confidence            34443 357899999999999985    7999987543 46899999999999998889999871     1         


Q ss_pred             ccEEEeecCCCCCCCcceEEEecCCCceeeEeeccCCCcccccccccCCc
Q 004312          141 GGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTF  190 (762)
Q Consensus       141 ~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~  190 (762)
                                 ....+.|.+.+++||++++|.         ...|.++++
T Consensus        77 -----------~~~~~~~~~~L~~dGNlvly~---------~~~W~s~t~  106 (109)
T 3r0e_A           77 -----------QSVKGNYAAVVHPDGRLVVFG---------PSVFKIDPW  106 (109)
T ss_dssp             -----------CCSSSCCEEEEETTTEEEEEC---------SEEEEECTT
T ss_pred             -----------cCCCcCEEEEEcCCCeEEEEe---------cCEECCCCc
Confidence                       112467899999999999973         347877765

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.17  E-value=3.9e-11  Score=123.73  Aligned_cols=137  Identities=12%  Similarity=0.056  Sum_probs=108.3

Q ss_pred             hhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc-cCCccchhceeccCCceeEEEeccCCC
Q 004312          487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLLVYEFMSNG  565 (762)
Q Consensus       487 ~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~~~~g  565 (762)
                      ...++.|+.+.||+....   ++.+++|+...........+.+|+++++.+. |..+.++++++.+.+..++||||++|.
T Consensus        19 ~~~~~g~s~~~v~~~~~~---~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   95 (263)
T 3tm0_A           19 VKDTEGMSPAKVYKLVGE---NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGV   95 (263)
T ss_dssp             EECCSCCSSSEEEEEECS---SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred             EeeccCCCCCeEEEEECC---CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCe
Confidence            456778888999998532   4689999987543233456899999999884 677889999998888899999999999


Q ss_pred             chhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcC---------------------------------------------
Q 004312          566 ALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC---------------------------------------------  600 (762)
Q Consensus       566 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------------  600 (762)
                      +|.+.+.     +......++.+++++|..||+..                                             
T Consensus        96 ~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  170 (263)
T 3tm0_A           96 LCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL  170 (263)
T ss_dssp             EHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred             ehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence            9988742     12334578899999999999810                                             


Q ss_pred             -----------CCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          601 -----------CTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       601 -----------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                                 ...++|+|++|.|||++++..+.|+||+.+.
T Consensus       171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                       1359999999999999877667799999875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.96  E-value=1.5e-09  Score=111.22  Aligned_cols=130  Identities=15%  Similarity=0.042  Sum_probs=97.9

Q ss_pred             cC-CCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCC--ccchhceeccCCceeEEEeccCCCc
Q 004312          490 LG-RGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN--LVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       490 iG-~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      ++ .|..+.||+...  .+++.+++|+....   ....+.+|+++++.+++.+  +.+++++...++..++||||+++.+
T Consensus        27 ~~~gg~~~~v~~~~~--~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~  101 (264)
T 1nd4_A           27 QTIGCSDAAVFRLSA--QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD  101 (264)
T ss_dssp             CSCTTSSCEEEEEEC--TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             cccCCCCceEEEEec--CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcc
Confidence            44 555699999854  33457999987643   2346889999999986544  5568888888888899999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcC----------------------------------------------
Q 004312          567 LASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC----------------------------------------------  600 (762)
Q Consensus       567 L~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------------------  600 (762)
                      |.  ...   .+   ...++.++++.|..||+..                                              
T Consensus       102 l~--~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (264)
T 1nd4_A          102 LL--SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  173 (264)
T ss_dssp             TT--TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cC--cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence            85  211   11   3467888888888888742                                              


Q ss_pred             ---------CCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          601 ---------CTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       601 ---------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                               ...++|+|++|+|||++++..++|+||+.+..
T Consensus       174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                     11399999999999998876678999999763

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.94  E-value=2.3e-09  Score=115.94  Aligned_cols=140  Identities=16%  Similarity=0.204  Sum_probs=105.6

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEcc--ccc-cchhHHHHHHhhhhcccc--cCCccchhceeccC---CceeEEE
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVF-QDSEKEFKAEVNGIGQTH--HKNLVRLLGYCDEG---RNRLLVY  559 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~---~~~~LV~  559 (762)
                      +.|+.|.++.||+....   +..+++|+..  ... ......+.+|+++++.++  +..++++++++.+.   +..++||
T Consensus        44 ~~l~~G~sn~~y~v~~~---~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP---GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EECCC-CCSCEEEEECS---SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             EEcCCcccceEEEEEEC---CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            45899999999997643   3578888876  322 123457889999999986  45678899988776   4479999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcC---------------------------------------
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC---------------------------------------  600 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------  600 (762)
                      ||+++..+.+..  ...++...+..++.++++.|+.||+..                                       
T Consensus       121 e~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          121 EFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             ECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             EecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            999998885422  134678889999999999999999831                                       


Q ss_pred             ----------------CCCeEeCCCCCCceEEcCCCc--eEEeccccccc
Q 004312          601 ----------------CTQIIHCDIKPQNILLDDYYN--ARISDFGLEKL  632 (762)
Q Consensus       601 ----------------~~~ivH~Dlkp~NILl~~~~~--~kl~Dfgla~~  632 (762)
                                      ...++|||++|+|||+++++.  +.|.||+.+..
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                            257999999999999997653  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.77  E-value=3.1e-09  Score=112.10  Aligned_cols=184  Identities=16%  Similarity=0.117  Sum_probs=121.6

Q ss_pred             hcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCC--ccchhceeccCC---ceeEEEecc
Q 004312          489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKN--LVRLLGYCDEGR---NRLLVYEFM  562 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~n--Iv~l~g~~~~~~---~~~LV~E~~  562 (762)
                      .++.|....||+..      ..+++|+....  .....+.+|+++++.+ .+..  +.+++.......   ..++|||++
T Consensus        27 ~~~~G~~n~v~~v~------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           27 ISGEGNDCIAYEIN------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             EEEECSSEEEEEST------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             ecCCCCcceEEEEC------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            47899999999863      36889986532  3456789999999887 3333  345555544333   347899999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhc-------------------------------------------
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE-------------------------------------------  599 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------------------------------------------  599 (762)
                      +|.+|.+...  ..++..++..++.++++.|+.||+.                                           
T Consensus        99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  176 (304)
T 3sg8_A           99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF  176 (304)
T ss_dssp             CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred             CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence            9998875432  3467778888999999999999861                                           


Q ss_pred             ------------CCCCeEeCCCCCCceEEcC--CCceEEecccccccccCCCCccccc-------------ccccCcccC
Q 004312          600 ------------CCTQIIHCDIKPQNILLDD--YYNARISDFGLEKLLTLDQSHTNTA-------------IRGTKGYVA  652 (762)
Q Consensus       600 ------------~~~~ivH~Dlkp~NILl~~--~~~~kl~Dfgla~~~~~~~~~~~~~-------------~~gt~~y~a  652 (762)
                                  ..+.++|+|++|.||++++  +..+.|+||+.+..-.....-....             .....+...
T Consensus       177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~  256 (304)
T 3sg8_A          177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD  256 (304)
T ss_dssp             HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred             HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence                        1146899999999999998  5668899999886532110000000             000001111


Q ss_pred             -cccccCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 004312          653 -PEWFRNMPITVKVDVYSYGVLLLEIICLRRTI  684 (762)
Q Consensus       653 -PE~~~~~~~s~~~DV~S~Gvil~elltg~~p~  684 (762)
                       |+....  .....+.|+++.++|++.+|..++
T Consensus       257 ~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          257 IPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence             222111  112268999999999999998775

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.23  E-value=3.1e-06  Score=87.05  Aligned_cols=136  Identities=15%  Similarity=0.111  Sum_probs=98.1

Q ss_pred             hcCCCCcc-eEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc-cCCccchhceeccCCceeEEEeccCCCc
Q 004312          489 ELGRGAFG-TVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       489 ~iG~G~~g-~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      .+..|..+ .||+..... .+..+++|+-...   ...++.+|.+.|+.+. +--+.++++++.+.+..++|||++++.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~-~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKP-NAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCT-TCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecC-CCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            35556555 689865432 3457888886532   3457888999988873 3346788999988889999999999988


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcC----------------------------------------------
Q 004312          567 LASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC----------------------------------------------  600 (762)
Q Consensus       567 L~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------------------  600 (762)
                      +.+....    .......++.++++.|..||...                                              
T Consensus       107 ~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          107 AFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             ccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            8776432    12334456677777777777531                                              


Q ss_pred             ---------CCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          601 ---------CTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       601 ---------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                               .+.++|+|+++.|||+++++.+-|+||+.+..
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                     12489999999999999887778999998863

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.19  E-value=5.6e-06  Score=87.05  Aligned_cols=134  Identities=16%  Similarity=0.139  Sum_probs=94.8

Q ss_pred             hcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccC---Cccchhceec-cCCceeEEEeccCC
Q 004312          489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHK---NLVRLLGYCD-EGRNRLLVYEFMSN  564 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~g~~~-~~~~~~LV~E~~~~  564 (762)
                      .++.|....||+.      +..++||+-..  ......+.+|+++|+.+.+.   .+.+++.++. ..+..++|||+++|
T Consensus        26 ~l~~G~~n~v~~v------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           26 SLGEGFRNYAILV------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEECSSEEEEEE------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             ecCCCcceeEEEE------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            4778888899986      24688888432  23456789999999999652   3556666663 45567899999999


Q ss_pred             CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhc---------------------------------------------
Q 004312          565 GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE---------------------------------------------  599 (762)
Q Consensus       565 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------------------  599 (762)
                      .+|.+...  ..++...+..++.++++.|+.||+.                                             
T Consensus        98 ~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  175 (306)
T 3tdw_A           98 QILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR  175 (306)
T ss_dssp             EECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred             eECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence            98876321  2234555666666666666666653                                             


Q ss_pred             ------------CCCCeEeCCCCCCceEEcC---CCc-eEEeccccccc
Q 004312          600 ------------CCTQIIHCDIKPQNILLDD---YYN-ARISDFGLEKL  632 (762)
Q Consensus       600 ------------~~~~ivH~Dlkp~NILl~~---~~~-~kl~Dfgla~~  632 (762)
                                  ..+.++|+|++|.|||+++   ++. ..|+||+.+..
T Consensus       176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                        2235799999999999987   455 58999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.07  E-value=7.6e-06  Score=87.92  Aligned_cols=145  Identities=11%  Similarity=0.119  Sum_probs=91.1

Q ss_pred             hhc-CCCCcceEEEeeee---CC--CcceEEEEEccccc---cchhHHHHHHhhhhccccc---CCccchhceeccC---
Q 004312          488 EEL-GRGAFGTVYKGFVN---MG--SSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHH---KNLVRLLGYCDEG---  552 (762)
Q Consensus       488 ~~i-G~G~~g~Vy~g~~~---~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H---~nIv~l~g~~~~~---  552 (762)
                      +.| +.|....+|+....   .+  .++.+++|+.....   ......+.+|+++++.+..   ..+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            346 78889999987643   11  14578888765432   1112467889999988843   3567788887665   


Q ss_pred             CceeEEEeccCCCchhhhcc---CC---CCCCHHHHHHHHHHHHHHHHHhH-----------------------------
Q 004312          553 RNRLLVYEFMSNGALASFLF---GD---SKPNWKLRTEIVMGIARGLFYLH-----------------------------  597 (762)
Q Consensus       553 ~~~~LV~E~~~~gsL~~~l~---~~---~~l~~~~~~~i~~~ia~~L~yLH-----------------------------  597 (762)
                      ...++||||+++..+.+.+.   ..   ..++..++..++.++++.|+-||                             
T Consensus       106 g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  185 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNWV  185 (357)
T ss_dssp             SSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHHH
T ss_pred             CCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHHH
Confidence            35689999999987764320   00   01222222333333333333333                             


Q ss_pred             -------------------------hcC-------CCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          598 -------------------------EEC-------CTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       598 -------------------------~~~-------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                                               +..       ...++|+|++|+|||++++..+.|+||..+..
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          186 RSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             HHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             HHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence                                     211       35799999999999999755579999998763

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.77  E-value=4.5e-05  Score=83.15  Aligned_cols=75  Identities=13%  Similarity=0.154  Sum_probs=48.1

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEcccccc-------chhHHHHHHhhhhccccc--CC-ccchhceeccCCceeE
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ-------DSEKEFKAEVNGIGQTHH--KN-LVRLLGYCDEGRNRLL  557 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~n-Iv~l~g~~~~~~~~~L  557 (762)
                      +.||.|..+.||++.... +++.++||.......       .....+..|.++++.+.+  +. +.+++.+  +.+..++
T Consensus        36 ~~lg~G~~n~vyrv~~~~-~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQE-HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EECCSSSSEEEEEEEC-----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EECCCCceEEEEEEEECC-CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            468999999999986543 246799998653211       123456788888887742  33 3455544  3345689


Q ss_pred             EEeccCCC
Q 004312          558 VYEFMSNG  565 (762)
Q Consensus       558 V~E~~~~g  565 (762)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.65  E-value=0.00015  Score=75.98  Aligned_cols=134  Identities=17%  Similarity=0.127  Sum_probs=89.3

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc---cCCccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH---HKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      +.|+.|....+|+...   ++..++||+....   ....+..|++.|+.|.   ...++++++++...+..++||||+++
T Consensus        42 ~~l~gG~~n~~y~v~~---~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND---EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEECCSSSSEEEEEES---SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             EEeCCccceeeeEEEE---CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            3588999999999753   2457889886542   3567889999999884   25688889888888889999999998


Q ss_pred             Cchhh-----------hccCCC----------------------CCCHHHHH---HHHH----------------HHHHH
Q 004312          565 GALAS-----------FLFGDS----------------------KPNWKLRT---EIVM----------------GIARG  592 (762)
Q Consensus       565 gsL~~-----------~l~~~~----------------------~l~~~~~~---~i~~----------------~ia~~  592 (762)
                      ..+..           .|+...                      .-+|..-.   ++..                .+.+.
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            76521           111110                      01343221   1111                11111


Q ss_pred             -HHHhHh-cCCCCeEeCCCCCCceEEcCCCceEEeccc
Q 004312          593 -LFYLHE-ECCTQIIHCDIKPQNILLDDYYNARISDFG  628 (762)
Q Consensus       593 -L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  628 (762)
                       ...|.. ...+.++|+|+.+.||+++.++ +.|.|+.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             123432 2356899999999999999887 8899974

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.55  E-value=0.00032  Score=74.29  Aligned_cols=136  Identities=16%  Similarity=0.178  Sum_probs=78.5

Q ss_pred             hcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccccc--CCccchhce------eccCCceeEEEe
Q 004312          489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHH--KNLVRLLGY------CDEGRNRLLVYE  560 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~------~~~~~~~~LV~E  560 (762)
                      .|+.|..+.||+....  + ..+++|+....    ..++..|++++..+..  -.+.+++..      ....+..++|||
T Consensus        39 ~l~gG~~n~~~~v~~~--~-~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           39 VIQGNQMALVWKVHTD--S-GAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             ECC----CEEEEEEET--T-EEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eccccccCcEEEEEeC--C-CCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            3556678899997543  2 35899988652    2344456666665532  123444431      123556789999


Q ss_pred             ccCCCchh--------------hhccC----C--C--------CCCHHHHH-----------------------------
Q 004312          561 FMSNGALA--------------SFLFG----D--S--------KPNWKLRT-----------------------------  583 (762)
Q Consensus       561 ~~~~gsL~--------------~~l~~----~--~--------~l~~~~~~-----------------------------  583 (762)
                      |+++..+.              ..++.    .  .        ...|....                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542              11110    0  0        01232110                             


Q ss_pred             --HHHHHHHHHHHHhHh----------cCCCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          584 --EIVMGIARGLFYLHE----------ECCTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       584 --~i~~~ia~~L~yLH~----------~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                        .+...+.+++.+|++          .....++|+|++++|||++.++.+.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence              111223446667763          124589999999999999888899999999875

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.38  E-value=0.00039  Score=76.30  Aligned_cols=80  Identities=9%  Similarity=-0.005  Sum_probs=48.2

Q ss_pred             CCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccccccccCcccCcccccCC---CCCCcchhHHHHHHHHHH
Q 004312          601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM---PITVKVDVYSYGVLLLEI  677 (762)
Q Consensus       601 ~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DV~S~Gvil~el  677 (762)
                      ...++|||++|.|||+++++ ++|+||+.+..-.....-......-...|.+|+.....   ......++......+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            35899999999999999876 99999988864321000000000011345666655311   112235666888888888


Q ss_pred             HhCC
Q 004312          678 ICLR  681 (762)
Q Consensus       678 ltg~  681 (762)
                      ++++
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.26  E-value=0.00054  Score=70.99  Aligned_cols=73  Identities=19%  Similarity=0.243  Sum_probs=51.8

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccC---CccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHK---NLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      +.+|.|..+.||+..+.  +++.+.||+-..........|..|++.|+.|.-.   -++++++..    ..++||||++.
T Consensus        21 ~~~g~G~~~~vyrv~l~--DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~   94 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELA--DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDE   94 (288)
T ss_dssp             EEEEEETTEEEEEEEET--TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCC
T ss_pred             EecCCCCCeEEEEEEEC--CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecc
Confidence            35899999999998765  4568999987654444455788999988887422   244555442    34789999987


Q ss_pred             Cc
Q 004312          565 GA  566 (762)
Q Consensus       565 gs  566 (762)
                      +.
T Consensus        95 ~~   96 (288)
T 3f7w_A           95 RP   96 (288)
T ss_dssp             CC
T ss_pred             cC
Confidence            64

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.98  E-value=0.0011  Score=72.79  Aligned_cols=74  Identities=14%  Similarity=0.164  Sum_probs=49.8

Q ss_pred             hhcCCCCcceEEEeeeeCC------CcceEEEEEccccccchhHHHHHHhhhhcccccCCc-cchhceeccCCceeEEEe
Q 004312          488 EELGRGAFGTVYKGFVNMG------SSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~LV~E  560 (762)
                      +.|+.|....||+.....+      .++.+++|+....  .....+.+|..+++.+...++ .++++.+.+    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            3578888899999875421      2357888887432  112456689999988854444 567776653    28999


Q ss_pred             ccCCCch
Q 004312          561 FMSNGAL  567 (762)
Q Consensus       561 ~~~~gsL  567 (762)
                      |+++.+|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9987554

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.97  E-value=0.002  Score=69.42  Aligned_cols=139  Identities=15%  Similarity=0.188  Sum_probs=82.8

Q ss_pred             hcCCCCcceEEEeeeeC------CCcceEEEEEccccccchhHHHHHHhhhhcccccCC-ccchhceeccCCceeEEEec
Q 004312          489 ELGRGAFGTVYKGFVNM------GSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN-LVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~LV~E~  561 (762)
                      .|..|-...+|+.....      +..+.+++|+.... ......+.+|.++++.+.-.+ ..++++.+.++    +||||
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~  131 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY  131 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence            46678888999986532      12357889886432 223456778999998884333 35677776643    99999


Q ss_pred             cCCCchhhh-----------------ccCC-----CCCC--HHHHHHHHHHHH-------------------HHHHHhHh
Q 004312          562 MSNGALASF-----------------LFGD-----SKPN--WKLRTEIVMGIA-------------------RGLFYLHE  598 (762)
Q Consensus       562 ~~~gsL~~~-----------------l~~~-----~~l~--~~~~~~i~~~ia-------------------~~L~yLH~  598 (762)
                      +++.+|..-                 |+..     +...  +.++.++..++.                   +.+..|..
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            998765421                 1111     1122  344444444332                   12333322


Q ss_pred             ----c-CCCCeEeCCCCCCceEEcCC----CceEEeccccccc
Q 004312          599 ----E-CCTQIIHCDIKPQNILLDDY----YNARISDFGLEKL  632 (762)
Q Consensus       599 ----~-~~~~ivH~Dlkp~NILl~~~----~~~kl~Dfgla~~  632 (762)
                          . ....++|+|+.+.|||++++    +.+.|+||..+..
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                1 23479999999999999876    7899999988753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.90  E-value=0.0015  Score=68.05  Aligned_cols=127  Identities=14%  Similarity=0.131  Sum_probs=74.3

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCc-cchhceeccCCceeEEEecc-CCC
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGRNRLLVYEFM-SNG  565 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~LV~E~~-~~g  565 (762)
                      +.|+.|....+|+.       +.+++|+...... ...+..+|+.+++.+....+ .++++++  .+..++|+||+ ++.
T Consensus        24 ~~l~gG~tN~~~~~-------~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-------GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             EEEESCSSEEEEEE-------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eEcCCcccccccee-------eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            45888999999997       3588888764311 11233568877777743333 4555544  33457899999 665


Q ss_pred             chhhhccCCCCCCHHHHHHHHHHHHHHHHHhHh-----------------------------------------------
Q 004312          566 ALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE-----------------------------------------------  598 (762)
Q Consensus       566 sL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~-----------------------------------------------  598 (762)
                      +|......       .+..++.++++.|+-||+                                               
T Consensus        94 ~l~~~~~~-------~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l  166 (301)
T 3dxq_A           94 TMSPEKFK-------TRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSAL  166 (301)
T ss_dssp             ECCHHHHH-------HSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHH
T ss_pred             cCCHhhHh-------hhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHH
Confidence            55321000       000112222222222222                                               


Q ss_pred             ---cCCCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          599 ---ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       599 ---~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                         .....++|+|+.|.||+ .+++.+.|+||..+..
T Consensus       167 ~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          167 AAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence               12345899999999999 5666789999988753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.89  E-value=0.0016  Score=68.33  Aligned_cols=138  Identities=13%  Similarity=0.125  Sum_probs=78.2

Q ss_pred             hcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCC--ccchhcee------ccCCceeEEEe
Q 004312          489 ELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN--LVRLLGYC------DEGRNRLLVYE  560 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~------~~~~~~~LV~E  560 (762)
                      .|+.|....+|+.....   ..+++|+....  ....++..|++++..+....  +.+++...      ...+..++++|
T Consensus        29 ~i~~G~~n~~~~v~~~~---g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           29 GIAEGVENSNFLLHTTK---DPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EECC---EEEEEEEESS---CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             ccCCCcccceEEEEeCC---ccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            46778888999976542   26889987652  12335667777777764322  33444221      12345689999


Q ss_pred             ccCCCchhhh--------------cc----C--CCC---C---CHHHHHH------------HHHHHHHHHHHhHhc---
Q 004312          561 FMSNGALASF--------------LF----G--DSK---P---NWKLRTE------------IVMGIARGLFYLHEE---  599 (762)
Q Consensus       561 ~~~~gsL~~~--------------l~----~--~~~---l---~~~~~~~------------i~~~ia~~L~yLH~~---  599 (762)
                      |+++..+...              ++    .  ...   .   .|.....            +...+.+.++.++..   
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            9998654210              11    1  010   1   1222110            111244455566542   


Q ss_pred             -CCCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          600 -CCTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       600 -~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                       ....++|+|++++|||++++..+.|+||+.+.
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             13479999999999999987666899998875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.57  E-value=0.01  Score=62.28  Aligned_cols=137  Identities=10%  Similarity=0.030  Sum_probs=78.5

Q ss_pred             cCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCC--ccchhce-----eccCCceeEEEecc
Q 004312          490 LGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKN--LVRLLGY-----CDEGRNRLLVYEFM  562 (762)
Q Consensus       490 iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~-----~~~~~~~~LV~E~~  562 (762)
                      ++ |....||+....  +++.+++|+..... .....+..|..++..+....  +++++..     ....+..+++||++
T Consensus        34 l~-g~~n~~y~v~~~--~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           34 LN-SYENRVYQFQDE--DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EC-CSSSEEEEECCT--TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             ec-CcccceEEEEcC--CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            55 777899986543  34579999986331 23456777888888774322  4455543     11234557899999


Q ss_pred             CCCchhh----h----------cc----CC-----CCCCHHHH----HHH---------------HHHHHHHHHHhHhc-
Q 004312          563 SNGALAS----F----------LF----GD-----SKPNWKLR----TEI---------------VMGIARGLFYLHEE-  599 (762)
Q Consensus       563 ~~gsL~~----~----------l~----~~-----~~l~~~~~----~~i---------------~~~ia~~L~yLH~~-  599 (762)
                      ++..+..    .          ++    ..     ...++...    ..+               ...+.+.++.+... 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            9865431    0          11    00     11122110    001               11111223333321 


Q ss_pred             ---CCCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          600 ---CCTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       600 ---~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                         ....++|||++++|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               234689999999999999 4 899999988753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.52  E-value=0.0057  Score=67.57  Aligned_cols=75  Identities=15%  Similarity=0.053  Sum_probs=46.5

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCc-cchhceeccCCceeEEEeccCCCc
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      +.|+.|-...+|+..... .+..+++|+..... ...-+..+|..++..|...++ .++++.+..    .+||||+++.+
T Consensus       114 ~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMS-KQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEECC--CEEEEEEEETT-TTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEcCCCeEeEEEEEEECC-CCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            357888889999986542 13578888764322 111123578888888865444 567777642    25999999866


Q ss_pred             hh
Q 004312          567 LA  568 (762)
Q Consensus       567 L~  568 (762)
                      |.
T Consensus       188 l~  189 (458)
T 2qg7_A          188 LS  189 (458)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.47  E-value=0.009  Score=58.10  Aligned_cols=144  Identities=10%  Similarity=-0.052  Sum_probs=90.7

Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      .-+|.+.|... .++++.+++.++.|.+++|.-+-.+..+  ..+=+.|..|+|..+|.+.+.+ ..+.           
T Consensus        32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence            34788888754 6899999999999999998776321111  1222446899999999998864 1110           


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                        .....+.|||... ...+.+.=|||+|+++|..+--..|-                        ..+.+.++.+-+|+
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e------------------------~eE~eLS~~LE~LL  150 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE------------------------NEERELSPPLEQLI  150 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT------------------------TEEECCCHHHHHHH
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc------------------------ccchhhCHHHHHHH
Confidence              1123467888763 35578899999999999987433331                        01112334555566


Q ss_pred             HHhhcc-------------------------CCCCCCCHHHHHHHhhcCcC
Q 004312          723 IWCIQE-------------------------DPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       723 ~~cl~~-------------------------dp~~RPt~~evl~~L~~~~~  748 (762)
                      ..|...                         .+..|+++++|++.-+.-+.
T Consensus       151 ~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~  201 (229)
T 2yle_A          151 DHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLP  201 (229)
T ss_dssp             HHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTSS
T ss_pred             HHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhcc
Confidence            666544                         35688999999998877543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.42  E-value=0.0073  Score=63.71  Aligned_cols=32  Identities=28%  Similarity=0.281  Sum_probs=27.6

Q ss_pred             CCCeEeCCCCCCceEEcCC----CceEEeccccccc
Q 004312          601 CTQIIHCDIKPQNILLDDY----YNARISDFGLEKL  632 (762)
Q Consensus       601 ~~~ivH~Dlkp~NILl~~~----~~~kl~Dfgla~~  632 (762)
                      ...++|||++++||+++++    ..+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3579999999999999874    6899999998764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.35  E-value=0.0049  Score=66.12  Aligned_cols=74  Identities=9%  Similarity=0.068  Sum_probs=43.2

Q ss_pred             hcCCCCcceEEEeeeeCC-------CcceEEEEEccccccchhHHHHHHhhhhcccccCCc-cchhceeccCCceeEEEe
Q 004312          489 ELGRGAFGTVYKGFVNMG-------SSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~LV~E  560 (762)
                      .|+.|....+|+.....+       ..+.+++|+...... ...+...|.++++.+...++ .++++...    -.+|||
T Consensus        40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~e  114 (369)
T 3c5i_A           40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIEE  114 (369)
T ss_dssp             EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEEE
Confidence            477888889999865421       125788888654321 11234678888888754343 45665442    368999


Q ss_pred             ccCCCch
Q 004312          561 FMSNGAL  567 (762)
Q Consensus       561 ~~~~gsL  567 (762)
                      |+++..+
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9998654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.86  E-value=0.079  Score=55.92  Aligned_cols=31  Identities=26%  Similarity=0.333  Sum_probs=27.6

Q ss_pred             CCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          602 TQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       602 ~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                      ..++|+|+.+.||++++++.+.|.||..+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999987753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.22  E-value=0.072  Score=58.01  Aligned_cols=138  Identities=14%  Similarity=0.125  Sum_probs=81.6

Q ss_pred             hcCCCCcceEEEeeeeCCC------cceEEEEEccccccchhHHHHHHhhhhcccccCCc-cchhceeccCCceeEEEec
Q 004312          489 ELGRGAFGTVYKGFVNMGS------SDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~~------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~LV~E~  561 (762)
                      .|..|-...+|+.......      .+.+++|+..... ...-+..+|.++++.+...++ .++++.+.    -++||||
T Consensus        77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef  151 (424)
T 3mes_A           77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF  151 (424)
T ss_dssp             EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred             EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence            4677888899998764211      3678888864432 122234678888888753333 45555432    3789999


Q ss_pred             cCCCchhhh-----------------ccC------------CC-CCCHHHHHHHHHHH-------------------HHH
Q 004312          562 MSNGALASF-----------------LFG------------DS-KPNWKLRTEIVMGI-------------------ARG  592 (762)
Q Consensus       562 ~~~gsL~~~-----------------l~~------------~~-~l~~~~~~~i~~~i-------------------a~~  592 (762)
                      +++..|..-                 |+.            .. +.-+.++.++..++                   .+.
T Consensus       152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e  231 (424)
T 3mes_A          152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE  231 (424)
T ss_dssp             CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred             eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence            998765311                 010            11 11233333333222                   222


Q ss_pred             HHHhHh---------------------cCCCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          593 LFYLHE---------------------ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       593 L~yLH~---------------------~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                      +..|.+                     .....++|+|+.+.||+ ++++.+.|+||..+..
T Consensus       232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            333321                     11246899999999999 8888999999988763

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.67  E-value=0.83  Score=49.20  Aligned_cols=30  Identities=27%  Similarity=0.351  Sum_probs=25.1

Q ss_pred             CeEeCCCCCCceEE------cCCCceEEeccccccc
Q 004312          603 QIIHCDIKPQNILL------DDYYNARISDFGLEKL  632 (762)
Q Consensus       603 ~ivH~Dlkp~NILl------~~~~~~kl~Dfgla~~  632 (762)
                      .++|+|+.+.|||+      +++..++++||-++..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567899999988753

>2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M*

Probab=84.00  E-value=0.36  Score=38.89  Aligned_cols=33  Identities=21%  Similarity=0.495  Sum_probs=28.6

Q ss_pred             CCCChhhHHhhhccCCCccccccc--cCcceeccc
Q 004312          357 SPYGKDECVSSCLKDCQCSAAVLR--DDTCWKKKL  389 (762)
Q Consensus       357 ~~~s~~~C~~~Cl~nCsC~a~~~~--~~~C~~~~~  389 (762)
                      ..+++++|+..|+.+=.|.||.|+  ...|+++..
T Consensus        28 ~~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~   62 (82)
T 2ll3_A           28 RASSLSECRARCQAEKECSHYTYNVKSGLCYPKRG   62 (82)
T ss_dssp             ECSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEES
T ss_pred             cCCCHHHHHHHhhccCCCCeEEeccCCCceEcccC
Confidence            347899999999999999999997  467998865

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=81.94  E-value=1.8  Score=41.88  Aligned_cols=114  Identities=10%  Similarity=0.130  Sum_probs=78.6

Q ss_pred             ccCCccchhceeccCCceeEEEeccCCC-chhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE
Q 004312          538 HHKNLVRLLGYCDEGRNRLLVYEFMSNG-ALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL  616 (762)
Q Consensus       538 ~H~nIv~l~g~~~~~~~~~LV~E~~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl  616 (762)
                      .||+.+.. .+-.+.+...+.|+.-+.+ ++.. +   ...+...+++++..|+....+++.+     +|-=|+|+||++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEE
Confidence            67877765 4555666666666665432 3333 2   3568899999999999988776654     788999999999


Q ss_pred             cCCCceEEecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 004312          617 DDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTI  684 (762)
Q Consensus       617 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~  684 (762)
                      +.++.+++.--|+-..+.                  |.     ..++..=.-.+=+++..+++++..|
T Consensus       113 ~~~~~p~i~~RGik~~l~------------------P~-----~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNVVD------------------PL-----PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             CTTSCEEESCCEETTTBS------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             cCCCCEEEEEccCccCCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            999999998777754332                  21     1122222335678888899888775

>3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae}

Probab=80.74  E-value=5.2  Score=40.25  Aligned_cols=48  Identities=15%  Similarity=0.185  Sum_probs=30.7

Q ss_pred             EeCCcEEEeCCCCCEEEeecCCCCceeEEEEecCCCEEEE----------ecC-CCcccc
Q 004312           75 TANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIV----------NTN-SERLWQ  123 (762)
Q Consensus        75 ~~~g~l~l~~~~~~~~ws~~~~~~~~~~~~l~d~GNlvl~----------~~~-~~~~Wq  123 (762)
                      ..+|.++.+|.+|+.+|+-..... ...+..+.+||+++-          |.. ++.+|+
T Consensus       143 ~~~~~v~~~d~~G~~~w~~~~~~~-~~~~~~~~~g~~~v~~~~~~~v~~~d~~tG~~~w~  201 (276)
T 3no2_A          143 FATSEVREIAPNGQLLNSVKLSGT-PFSSAFLDNGDCLVACGDAHCFVQLNLESNRIVRR  201 (276)
T ss_dssp             TTTTEEEEECTTSCEEEEEECSSC-CCEEEECTTSCEEEECBTTSEEEEECTTTCCEEEE
T ss_pred             cCCCEEEEECCCCCEEEEEECCCC-ccceeEcCCCCEEEEeCCCCeEEEEeCcCCcEEEE
Confidence            356788888888899998875422 122344566665553          333 678888

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=80.57  E-value=2.6  Score=40.89  Aligned_cols=113  Identities=10%  Similarity=0.049  Sum_probs=75.8

Q ss_pred             ccCCccchhceeccCCceeEEEeccCCC-chhhhccCCCCCCHHHHHHHHHHHHHHHH-HhHhcCCCCeEeCCCCCCceE
Q 004312          538 HHKNLVRLLGYCDEGRNRLLVYEFMSNG-ALASFLFGDSKPNWKLRTEIVMGIARGLF-YLHEECCTQIIHCDIKPQNIL  615 (762)
Q Consensus       538 ~H~nIv~l~g~~~~~~~~~LV~E~~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~~L~-yLH~~~~~~ivH~Dlkp~NIL  615 (762)
                      .||++  --..-.+.+...+.|+.-+++ +.. .+   ...+...+++++..|+.... +++..     +|-=|+|+||+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i---~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI---RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH---HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH---HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCceEE
Confidence            57776  333446667777777765443 333 22   45788999999999988777 66654     78889999999


Q ss_pred             EcCCCceEEecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 004312          616 LDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTI  684 (762)
Q Consensus       616 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~  684 (762)
                      ++.++.++|.-.|+-..+                  +|..+     ++.-=.-.+=+++..++.++..|
T Consensus       117 f~~~~~p~i~hRGi~~~l------------------pP~e~-----~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          117 FNRALEPFFLHVGVKESL------------------PPDEW-----DDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             ECTTCCEEESCCEETTTB------------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             EeCCCcEEEEEcCCcccC------------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCH
Confidence            999999999877765433                  23221     11111234667788888877775

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	762
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-64
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-64
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-64
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-60
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-58
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-57
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-56
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-55
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-55
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-54
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-53
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-53
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-53
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-49
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-42
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-41
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-41
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-39
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-37
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-36
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-36
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-33
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-30
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-17
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	6e-12
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	9e-06
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	1e-09
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	8e-09
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	2e-09
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	0.002
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	5e-08
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	9e-07
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	0.001
d1jpca_	108	b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan	3e-06
d1jpca_	108	b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan	5e-06

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 3e-65
 Identities = 74/261 (28%), Positives = 116/261 (44%), Gaps = 14/261 (5%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
             E LG G FG V+ G+ N  +  +VAVK L +    S   F AE N + Q  H+ LVRL
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHT--KVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRL 73

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLF--GDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
                +     ++ E+M NG+L  FL      K       ++   IA G+ ++ E     
Sbjct: 74  YAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D++  NIL+ D  + +I+DFGL +L+  ++       +    + APE       T+
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189

Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+S+G+LL EI+   R       Y       +   +E     +      +    +  
Sbjct: 190 KSDVWSFGILLTEIVTHGR-----IPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244

Query: 724 WCIQEDPSHRPTMRRVTQMLE 744
            C +E P  RPT   +  +LE
Sbjct: 245 LCWKERPEDRPTFDYLRSVLE 265

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  215 bits (547), Expect = 2e-64
 Identities = 74/296 (25%), Positives = 131/296 (44%), Gaps = 27/296 (9%)

Query: 474 FTYKELVEVTRGFKEE-----------LGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVF 520
           FT+++  E  R F +E           +G G FG V  G + +    +  VA+K L   +
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 521 -QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-N 578
            +   ++F +E + +GQ  H N++ L G   +    +++ EFM NG+L SFL  +     
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 579 WKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS 638
                 ++ GIA G+ YL +      +H D+  +NIL++     ++SDFGL + L  D S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 639 HTNT----AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ 694
                     +    + APE  +    T   DV+SYG+++ E++           Y    
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-----PYWDMT 238

Query: 695 ERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
            + +   +E D      M        + + C Q+D +HRP   ++   L+ ++  P
Sbjct: 239 NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 2e-64
 Identities = 68/264 (25%), Positives = 118/264 (44%), Gaps = 12/264 (4%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +E+G G FG V+ G+      D+VA+K +      SE++F  E   + +  H  LV+L
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNK--DKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQL 65

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYLHEECCTQI 604
            G C E     LV+EFM +G L+ +L         +    + + +  G+ YL E C   +
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           IH D+  +N L+ +    ++SDFG+ + +  DQ  ++T  +    + +PE F     + K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182

Query: 665 VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW 724
            DV+S+GVL+ E+    +       Y+      +   +                  +   
Sbjct: 183 SDVWSFGVLMWEVFSEGKIP-----YENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237

Query: 725 CIQEDPSHRPTMRRVTQMLEGVVE 748
           C +E P  RP   R+ + L  + E
Sbjct: 238 CWKERPEDRPAFSRLLRQLAEIAE 261

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 6e-64
 Identities = 70/274 (25%), Positives = 120/274 (43%), Gaps = 19/274 (6%)

Query: 481 EVTRG---FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIG 535
           E+  G     + +G G+FGTVYKG  +      VAVK LN      +  + FK EV  + 
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59

Query: 536 QTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG-DSKPNWKLRTEIVMGIARGLF 594
           +T H N++  +GY        +V ++    +L   L   ++K       +I    A+G+ 
Sbjct: 60  KTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118

Query: 595 YLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKGYVAP 653
           YLH +    IIH D+K  NI L +    +I DFGL  + +    SH    + G+  ++AP
Sbjct: 119 YLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

Query: 654 EWFRNM---PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMD 710
           E  R     P + + DVY++G++L E++  +         D          +  DL  + 
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235

Query: 711 DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
                +    +   C+++    RP   ++   +E
Sbjct: 236 S-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 1e-62
 Identities = 62/260 (23%), Positives = 109/260 (41%), Gaps = 12/260 (4%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
           F +ELG G FG V  G         VA+K +      SE EF  E   +    H+ LV+L
Sbjct: 8   FLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQL 64

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYLHEECCTQI 604
            G C + R   ++ E+M+NG L ++L         +   E+   +   + YL      Q 
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 121

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           +H D+  +N L++D    ++SDFGL + +  D+  ++   +    +  PE       + K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181

Query: 665 VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW 724
            D++++GVL+ EI  L +       Y+ +        +   L         ++   +   
Sbjct: 182 SDIWAFGVLMWEIYSLGK-----MPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236

Query: 725 CIQEDPSHRPTMRRVTQMLE 744
           C  E    RPT + +   + 
Sbjct: 237 CWHEKADERPTFKILLSNIL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 2e-61
 Identities = 67/270 (24%), Positives = 114/270 (42%), Gaps = 14/270 (5%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            + +LG+G FG V+ G  N   + +VA+K L        + F  E   + +  H+ LV+L
Sbjct: 21  LEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQL 77

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKP--NWKLRTEIVMGIARGLFYLHEECCTQ 603
                E     +V E+MS G+L  FL G++          ++   IA G+ Y+       
Sbjct: 78  YAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMN 133

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            +H D++  NIL+ +    +++DFGL +L+  ++       +    + APE       T+
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193

Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+S+G+LL E+    R       Y     R +   VE            +    +  
Sbjct: 194 KSDVWSFGILLTELTTKGRVP-----YPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248

Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVEVPIPP 753
            C +++P  RPT   +   LE       P 
Sbjct: 249 QCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 1e-60
 Identities = 75/261 (28%), Positives = 114/261 (43%), Gaps = 14/261 (5%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQ-VAVKKLNRVFQDSE--KEFKAEVNGIGQTHHKNLVRL 545
           ELG G FGTV KG+  M    + VAVK L     D     E  AE N + Q  +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
           +G C E  + +LV E    G L  +L  +     K   E+V  ++ G+ YL     +  +
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 129

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--TNTAIRGTKGYVAPEWFRNMPITV 663
           H D+  +N+LL   + A+ISDFGL K L  D+++    T  +    + APE       + 
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189

Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+S+GVL+ E     +       Y   +   + A++E            +    +  
Sbjct: 190 KSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 244

Query: 724 WCIQEDPSHRPTMRRVTQMLE 744
            C   D  +RP    V   L 
Sbjct: 245 LCWTYDVENRPGFAAVELRLR 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (516), Expect = 3e-60
 Identities = 68/261 (26%), Positives = 108/261 (41%), Gaps = 14/261 (5%)

Query: 489 ELGRGAFGTVYKGFVNMGSSDQ-VAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
           ELG G FG+V +G   M      VA+K L +   +   +E   E   + Q  +  +VRL+
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75

Query: 547 GYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYLHEECCTQII 605
           G C +    +LV E    G L  FL G  +        E++  ++ G+ YL        +
Sbjct: 76  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 131

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--TNTAIRGTKGYVAPEWFRNMPITV 663
           H D+  +N+LL + + A+ISDFGL K L  D S+    +A +    + APE       + 
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191

Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           + DV+SYGV + E +   +       Y   +   + A +E                 +  
Sbjct: 192 RSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMS 246

Query: 724 WCIQEDPSHRPTMRRVTQMLE 744
            C       RP    V Q + 
Sbjct: 247 DCWIYKWEDRPDFLTVEQRMR 267

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  201 bits (512), Expect = 1e-59
 Identities = 72/265 (27%), Positives = 120/265 (45%), Gaps = 12/265 (4%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            K +LG G +G VY+G V    S  VAVK L     + E EF  E   + +  H NLV+L
Sbjct: 21  MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 78

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLF--GDSKPNWKLRTEIVMGIARGLFYLHEECCTQ 603
           LG C       ++ EFM+ G L  +L      + +  +   +   I+  + YL ++    
Sbjct: 79  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--- 135

Query: 604 IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 663
            IH D+  +N L+ + +  +++DFGL +L+T D    +   +    + APE       ++
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195

Query: 664 KVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI 723
           K DV+++GVLL EI     +      Y       +  L+E D          ++   +  
Sbjct: 196 KSDVWAFGVLLWEIATYGMSP-----YPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 250

Query: 724 WCIQEDPSHRPTMRRVTQMLEGVVE 748
            C Q +PS RP+   + Q  E + +
Sbjct: 251 ACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 6e-59
 Identities = 65/271 (23%), Positives = 111/271 (40%), Gaps = 16/271 (5%)

Query: 486 FKEELGRGAFGTVYKGFV--NMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNL 542
           F E +GRG FG VY G +  N G     AVK LNR+       +F  E   +    H N+
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90

Query: 543 VRLLGYCDEGRNR-LLVYEFMSNGALASFLFGDS-KPNWKLRTEIVMGIARGLFYLHEEC 600
           + LLG C       L+V  +M +G L +F+  ++  P  K      + +A+G+       
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLA 147

Query: 601 CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT---LDQSHTNTAIRGTKGYVAPEWFR 657
             + +H D+  +N +LD+ +  +++DFGL + +     D  H  T  +    ++A E  +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR 717
               T K DV+S+GVLL E++           Y       +   +      +        
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDITVYLLQGRRLLQPEYCPDP 262

Query: 718 FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
              V + C       RP+   +   +  +  
Sbjct: 263 LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 2e-58
 Identities = 70/264 (26%), Positives = 114/264 (43%), Gaps = 20/264 (7%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
             + +G+G FG V  G       ++VAVK +      + + F AE + + Q  H NLV+L
Sbjct: 11  LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 65

Query: 546 LGYCDEGRNRL-LVYEFMSNGALASFLF--GDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           LG   E +  L +V E+M+ G+L  +L   G S        +  + +   + YL      
Sbjct: 66  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-- 123

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
             +H D+  +N+L+ +   A++SDFGL K      S T    +    + APE  R    +
Sbjct: 124 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFS 178

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA 722
            K DV+S+G+LL EI    R       Y     + +   VE   +             V 
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVP-----YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 233

Query: 723 IWCIQEDPSHRPTMRRVTQMLEGV 746
             C   D + RP+  ++ + LE +
Sbjct: 234 KNCWHLDAAMRPSFLQLREQLEHI 257

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 2e-57
 Identities = 70/309 (22%), Positives = 120/309 (38%), Gaps = 35/309 (11%)

Query: 468 YMNLRCFTYKELVEVTRG---FKEELGRGAFGTVYKG----FVNMGSSDQVAVKKLNR-V 519
           Y++     Y    E  R    F + LG GAFG V +      +   ++  VAVK L    
Sbjct: 6   YIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA 65

Query: 520 FQDSEKEFKAEVNGIGQ-THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP- 577
                +   +E+  +    +H N+V LLG C  G   L++ E+   G L +FL       
Sbjct: 66  HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 125

Query: 578 -----------------NWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY 620
                            + +        +A+G+ +L  +     IH D+  +NILL    
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGR 182

Query: 621 NARISDFGLEKLLTLDQSHTN-TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 679
             +I DFGL + +  D ++      R    ++APE   N   T + DV+SYG+ L E+  
Sbjct: 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

Query: 680 LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
           L  +           +     +++     +           +   C   DP  RPT +++
Sbjct: 243 LGSS----PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298

Query: 740 TQMLEGVVE 748
            Q++E  + 
Sbjct: 299 VQLIEKQIS 307

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 2e-57
 Identities = 75/316 (23%), Positives = 123/316 (38%), Gaps = 40/316 (12%)

Query: 462 EEQGVSYMNLRCFTYKELVEVTRG---FKEELGRGAFGTVYKGFV----NMGSSDQVAVK 514
            +    Y++ R + Y    E  R    F + LG GAFG V           G S QVAVK
Sbjct: 14  SDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK 73

Query: 515 KLNRVFQDSEKE-FKAEVNGIGQ-THHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF 572
            L      SE+E   +E+  + Q   H+N+V LLG C       L++E+   G L ++L 
Sbjct: 74  MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133

Query: 573 GDSKP-----------------------NWKLRTEIVMGIARGLFYLHEECCTQIIHCDI 609
              +                         ++        +A+G+ +L  +     +H D+
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190

Query: 610 KPQNILLDDYYNARISDFGLEKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVY 668
             +N+L+      +I DFGL + +  D ++      R    ++APE       T+K DV+
Sbjct: 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250

Query: 669 SYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQE 728
           SYG+LL EI  L              +     L++N  +        +   ++   C   
Sbjct: 251 SYGILLWEIFSLGVNPYPGIP----VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 306

Query: 729 DPSHRPTMRRVTQMLE 744
           D   RP+   +T  L 
Sbjct: 307 DSRKRPSFPNLTSFLG 322

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 4e-57
 Identities = 66/274 (24%), Positives = 121/274 (44%), Gaps = 17/274 (6%)

Query: 486 FKEE--LGRGAFGTVYKGFVNMGSSDQ---VAVKKLNRVF-QDSEKEFKAEVNGIGQTHH 539
              +  +G G FG VYKG +   S  +   VA+K L   + +    +F  E   +GQ  H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYLHE 598
            N++RL G   + +  +++ E+M NGAL  FL       +      ++ GIA G+ YL  
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ--SHTNTAIRGTKGYVAPEWF 656
                 +H D+  +NIL++     ++SDFGL ++L  D   ++T +  +    + APE  
Sbjct: 129 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 657 RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ 716
                T   DV+S+G+++ E++           Y       +   + +       M    
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGE-----RPYWELSNHEVMKAINDGFRLPTPMDCPS 240

Query: 717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
               + + C Q++ + RP    +  +L+ ++  P
Sbjct: 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 7e-57
 Identities = 64/261 (24%), Positives = 115/261 (44%), Gaps = 17/261 (6%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN--RVFQDSEKEFKAEVNGIGQTHHKNLV 543
           F  E+GRG+F TVYKG ++  ++ +VA  +L   ++ +   + FK E   +    H N+V
Sbjct: 13  FDIEIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 71

Query: 544 RLLGYC----DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
           R            +  +LV E M++G L ++L        K+       I +GL +LH  
Sbjct: 72  RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 600 CCTQIIHCDIKPQNILLDD-YYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
               IIH D+K  NI +     + +I D GL  L    ++    A+ GT  ++APE +  
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYEE 187

Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF 718
                 VDVY++G+ +LE+          ++      +    +      A  D   +   
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEY----PYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242

Query: 719 VMVAIWCIQEDPSHRPTMRRV 739
             +   CI+++   R +++ +
Sbjct: 243 KEIIEGCIRQNKDERYSIKDL 263

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  193 bits (492), Expect = 1e-56
 Identities = 65/293 (22%), Positives = 120/293 (40%), Gaps = 38/293 (12%)

Query: 486 FKEELGRGAFGTVYKG----FVNMGSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHK 540
           +  ++G GAFG V++      +       VAVK L      D + +F+ E   + +  + 
Sbjct: 17  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76

Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGALASFLF------------------------GDSK 576
           N+V+LLG C  G+   L++E+M+ G L  FL                         G   
Sbjct: 77  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136

Query: 577 PNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL-TL 635
            +   +  I   +A G+ YL E      +H D+  +N L+ +    +I+DFGL + + + 
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193

Query: 636 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE 695
           D    +        ++ PE       T + DV++YGV+L EI            Y    E
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ----PYYGMAHE 249

Query: 696 RTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
             +  + + ++ A  +         +   C  + P+ RP+   + ++L+ + E
Sbjct: 250 EVIYYVRDGNILACPE-NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 7e-56
 Identities = 57/296 (19%), Positives = 115/296 (38%), Gaps = 38/296 (12%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
            +E +G+G FG V++G       ++VAVK  +   ++     +AE+       H+N++  
Sbjct: 7   LQESIGKGRFGEVWRGKWR---GEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGF 62

Query: 546 LGYCDEGRNRL----LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           +   ++         LV ++  +G+L  +L        +   ++ +  A GL +LH E  
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 602 TQ-----IIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA---IRGTKGYVAP 653
                  I H D+K +NIL+       I+D GL           + A     GTK Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 654 EWF------RNMPITVKVDVYSYGVLLLEIICLRRT--------------ILTDWAYDCY 693
           E        ++     + D+Y+ G++  EI                    + +D + +  
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 694 QERTLGALVENDL-EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
           ++      +  ++         L+    +   C   + + R T  R+ + L  + +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (484), Expect = 2e-55
 Identities = 62/258 (24%), Positives = 106/258 (41%), Gaps = 20/258 (7%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---KEFKAEVNGIGQTHHKNLVR 544
            E+G G+FG VY    ++ +S+ VA+KK++   + S    ++   EV  + +  H N ++
Sbjct: 21  REIGHGSFGAVYFA-RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
             G         LV E+    A                  +  G  +GL YLH      +
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 136

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM---PI 661
           IH D+K  NILL +    ++ DFG   ++         +  GT  ++APE    M     
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVILAMDEGQY 191

Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV 721
             KVDV+S G+  +E+   +        ++      L  + +N+  A+      + F   
Sbjct: 192 DGKVDVWSLGITCIELAERKP-----PLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246

Query: 722 AIWCIQEDPSHRPTMRRV 739
              C+Q+ P  RPT   +
Sbjct: 247 VDSCLQKIPQDRPTSEVL 264

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 4e-55
 Identities = 59/272 (21%), Positives = 113/272 (41%), Gaps = 15/272 (5%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS-EKEFKAEVNGIGQTHHKNLVR 544
              ELG G  G V+K   +  S   +A K ++   + +   +   E+  + + +   +V 
Sbjct: 10  KISELGAGNGGVVFKV-SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
             G         +  E M  G+L   L    +   ++  ++ + + +GL YL E+   +I
Sbjct: 69  FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KI 126

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           +H D+KP NIL++     ++ DFG+   L    +++     GT+ Y++PE  +    +V+
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQ 183

Query: 665 VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW 724
            D++S G+ L+E+   R              + L  +    +E     T   R       
Sbjct: 184 SDIWSMGLSLVEMAVGRY------PIPPPDAKELELMFGCQVEGDAAETP-PRPRTPGRP 236

Query: 725 CIQEDPSHRPTMRRVTQMLEGVVEVPIPPCPW 756
                   RP M  + ++L+ +V  P P  P 
Sbjct: 237 LSSYGMDSRPPM-AIFELLDYIVNEPPPKLPS 267

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 6e-54
 Identities = 72/282 (25%), Positives = 116/282 (41%), Gaps = 29/282 (10%)

Query: 486 FKEELGRGAFGTVYKG-FVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQ-THHKNL 542
           F++ +G G FG V K      G     A+K++     +D  ++F  E+  + +  HH N+
Sbjct: 14  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGD----------------SKPNWKLRTEIV 586
           + LLG C+      L  E+  +G L  FL                   S  + +      
Sbjct: 74  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133

Query: 587 MGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRG 646
             +ARG+ YL ++   Q IH D+  +NIL+ + Y A+I+DFGL +    +     T  R 
Sbjct: 134 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTMGRL 188

Query: 647 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDL 706
              ++A E       T   DV+SYGVLL EI+ L  T      Y       L   +    
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEKLPQGY 243

Query: 707 EAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
                +        +   C +E P  RP+  ++   L  ++E
Sbjct: 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 7e-54
 Identities = 58/267 (21%), Positives = 100/267 (37%), Gaps = 13/267 (4%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQ--VAVKKLNRVFQDSEKE-FKAEVNGIGQTHHKNL 542
               +G G FG V++G      +    VA+K       DS +E F  E   + Q  H ++
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYLHEECC 601
           V+L+G   E     ++ E  + G L SFL       +          ++  L YL  +  
Sbjct: 71  VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
              +H DI  +N+L+      ++ DFGL + +     +  +  +    ++APE       
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186

Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV 721
           T   DV+ +GV + EI+                   +G +   +   M           +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVK----PFQGVKNNDVIGRIENGERLPMPP-NCPPTLYSL 241

Query: 722 AIWCIQEDPSHRPTMRRVTQMLEGVVE 748
              C   DPS RP    +   L  ++E
Sbjct: 242 MTKCWAYDPSRRPRFTELKAQLSTILE 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 8e-54
 Identities = 66/259 (25%), Positives = 109/259 (42%), Gaps = 17/259 (6%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIGQTHHKNL 542
               LG+G FG VY       S   +A+K L +        E + + EV       H N+
Sbjct: 10  IGRPLGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           +RL GY  +     L+ E+   G +   L   SK + +     +  +A  L Y H +   
Sbjct: 69  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--- 125

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           ++IH DIKP+N+LL      +I+DFG        +  T   + GT  Y+ PE        
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRMHD 182

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA 722
            KVD++S GVL  E +  +     +   + Y+      +   +    D +T  +    + 
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-----RISRVEFTFPDFVT--EGARDLI 235

Query: 723 IWCIQEDPSHRPTMRRVTQ 741
              ++ +PS RP +R V +
Sbjct: 236 SRLLKHNPSQRPMLREVLE 254

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-53
 Identities = 62/270 (22%), Positives = 106/270 (39%), Gaps = 13/270 (4%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSD---QVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKN 541
             + LG GAFGTVYKG            VA+K+L       + KE   E   +    + +
Sbjct: 13  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           + RLLG C     +L+         L            +      + IA+G+ YL     
Sbjct: 73  VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---ED 129

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT-AIRGTKGYVAPEWFRNMP 660
            +++H D+  +N+L+    + +I+DFGL KLL  ++   +    +    ++A E   +  
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189

Query: 661 ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM 720
            T + DV+SYGV + E++           YD      + +++E                M
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGS-----KPYDGIPASEISSILEKGERLPQPPICTIDVYM 244

Query: 721 VAIWCIQEDPSHRPTMRRVTQMLEGVVEVP 750
           + + C   D   RP  R +      +   P
Sbjct: 245 IMVKCWMIDADSRPKFRELIIEFSKMARDP 274

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 2e-53
 Identities = 59/266 (22%), Positives = 102/266 (38%), Gaps = 18/266 (6%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQTHHKNLV 543
               +G G++G   K          +  K+L+         +   +EVN + +  H N+V
Sbjct: 8   VLYTIGTGSYGRCQKI-RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66

Query: 544 RLLGYCDEGRNRLL--VYEFMSNGALASFLFGDSKP----NWKLRTEIVMGIARGLFYLH 597
           R      +  N  L  V E+   G LAS +   +K     + +    ++  +   L   H
Sbjct: 67  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126

Query: 598 E--ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
              +    ++H D+KP N+ LD   N ++ DFGL ++L  D S       GT  Y++PE 
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQ 185

Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL 715
              M    K D++S G LL E+  L             Q+   G + E     +      
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPF-----TAFSQKELAGKIREGKFRRIPY-RYS 239

Query: 716 QRFVMVAIWCIQEDPSHRPTMRRVTQ 741
                +    +     HRP++  + +
Sbjct: 240 DELNEIITRMLNLKDYHRPSVEEILE 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 4e-53
 Identities = 62/263 (23%), Positives = 116/263 (44%), Gaps = 17/263 (6%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
              ELG GAFG VYK   N  +S   A K ++   ++  +++  E++ +    H N+V+L
Sbjct: 16  IIGELGDGAFGKVYKA-QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 74

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYLHEECCTQI 604
           L       N  ++ EF + GA+ + +    +P        +       L YLH+    +I
Sbjct: 75  LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KI 131

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF-----RNM 659
           IH D+K  NIL     + +++DFG+    T      ++   GT  ++APE       ++ 
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDR 190

Query: 660 PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL-QRF 718
           P   K DV+S G+ L+E+  +         ++    R L  + +++   +   +     F
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEP-----PHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245

Query: 719 VMVAIWCIQEDPSHRPTMRRVTQ 741
                 C++++   R T  ++ Q
Sbjct: 246 KDFLKKCLEKNVDARWTTSQLLQ 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 4e-53
 Identities = 63/267 (23%), Positives = 99/267 (37%), Gaps = 16/267 (5%)

Query: 486 FKEELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVFQDSE---KEFKAEVNGIGQTHHK 540
             E+LG G+FG V +G  +   G +  VAVK L            +F  EVN +    H+
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71

Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYLHEE 599
           NL+RL G       + +V E    G+L   L            +   + +A G+ YL  +
Sbjct: 72  NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--TNTAIRGTKGYVAPEWFR 657
                IH D+  +N+LL      +I DFGL + L  +  H       +    + APE  +
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187

Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR 717
               +   D + +GV L E+    +             + L  + +            Q 
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN----GSQILHKIDKEGERLPRPEDCPQD 243

Query: 718 FVMVAIWCIQEDPSHRPTMRRVTQMLE 744
              V + C    P  RPT   +   L 
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 6e-53
 Identities = 68/257 (26%), Positives = 109/257 (42%), Gaps = 11/257 (4%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN-RVFQDSEKEFKAEVNGIGQTHHKNLVR 544
             + LG GA+G V    VN  + + VAVK ++ +   D  +  K E+      +H+N+V+
Sbjct: 9   LVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
             G+  EG  + L  E+ S G L   +  D              +  G+ YLH      I
Sbjct: 68  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 124

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLD-QSHTNTAIRGTKGYVAPEWFRNMPI-T 662
            H DIKP+N+LLD+  N +ISDFGL  +   + +      + GT  YVAPE  +      
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA 722
             VDV+S G++L  ++         W       +      E          +    + + 
Sbjct: 185 EPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240

Query: 723 IWCIQEDPSHRPTMRRV 739
              + E+PS R T+  +
Sbjct: 241 HKILVENPSARITIPDI 257

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 2e-51
 Identities = 61/255 (23%), Positives = 121/255 (47%), Gaps = 12/255 (4%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           E++G+GA GTVY   +++ +  +VA++++N   Q  ++    E+  + +  + N+V  L 
Sbjct: 26  EKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHC 607
               G    +V E+++ G+L   +  ++  +      +     + L +LH     Q+IH 
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 140

Query: 608 DIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDV 667
           DIK  NILL    + +++DFG    +T +QS  +T + GT  ++APE         KVD+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDI 199

Query: 668 YSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMT-VLQRFVMVAIWCI 726
           +S G++ +E+I      L +               E  L+  + ++ + + F+     C+
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE--LQNPEKLSAIFRDFLN---RCL 254

Query: 727 QEDPSHRPTMRRVTQ 741
             D   R + + + Q
Sbjct: 255 DMDVEKRGSAKELLQ 269

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 5e-51
 Identities = 67/279 (24%), Positives = 122/279 (43%), Gaps = 24/279 (8%)

Query: 486 FKEELGRGAFGTVYKGF----VNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHK 540
              ELG+G+FG VY+G     V      +VA+K +N         EF  E + + + +  
Sbjct: 24  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83

Query: 541 NLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGD----------SKPNWKLRTEIVMGIA 590
           ++VRLLG   +G+  L++ E M+ G L S+L             + P+     ++   IA
Sbjct: 84  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143

Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLT-LDQSHTNTAIRGTKG 649
            G+ YL+     + +H D+  +N ++ + +  +I DFG+ + +   D             
Sbjct: 144 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200

Query: 650 YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM 709
           +++PE  ++   T   DV+S+GV+L EI  L        +     E+ L  ++E  L   
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----NEQVLRFVMEGGLLDK 256

Query: 710 DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
            D         +   C Q +P  RP+   +   ++  +E
Sbjct: 257 PD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 5e-49
 Identities = 70/289 (24%), Positives = 116/289 (40%), Gaps = 33/289 (11%)

Query: 486 FKEELGRGAFGTVYKGF------VNMGSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQ-T 537
             + LG GAFG V                 +VAVK L     +    +  +E+  +    
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP----------------NWKL 581
            HKN++ LLG C +     ++ E+ S G L  +L     P                + K 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 582 RTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN 641
                  +ARG+ YL  +   + IH D+  +N+L+ +    +I+DFGL + +     +  
Sbjct: 137 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 642 T-AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGA 700
           T   R    ++APE   +   T + DV+S+GVLL EI  L  +      Y       L  
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-----YPGVPVEELFK 248

Query: 701 LVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV 749
           L++                M+   C    PS RPT +++ + L+ +V +
Sbjct: 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 7e-48
 Identities = 66/287 (22%), Positives = 111/287 (38%), Gaps = 31/287 (10%)

Query: 486 FKEELGRGAFGTVYKGFV----NMGSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQT-HH 539
             + LGRGAFG V +          +   VAVK L         +   +E+  +    HH
Sbjct: 17  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76

Query: 540 KNLVRLLGYC-DEGRNRLLVYEFMSNGALASFLFGDSKP----------------NWKLR 582
            N+V LLG C   G   +++ EF   G L+++L                        +  
Sbjct: 77  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136

Query: 583 TEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT 642
                 +A+G+ +L      + IH D+  +NILL +    +I DFGL + +  D  +   
Sbjct: 137 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193

Query: 643 A-IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGAL 701
              R    ++APE   +   T++ DV+S+GVLL EI  L  +           +      
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS----PYPGVKIDEEFCRR 249

Query: 702 VENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE 748
           ++                   + C   +PS RPT   + + L  +++
Sbjct: 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  171 bits (433), Expect = 8e-48
 Identities = 57/257 (22%), Positives = 104/257 (40%), Gaps = 12/257 (4%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
             EELG GAFG V++      + +  A K +    +  ++  + E+  +    H  LV L
Sbjct: 30  IHEELGTGAFGVVHRV-TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 88

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYLHEECCTQI 604
               ++    +++YEFMS G L   +  +    +     E +  + +GL ++HE      
Sbjct: 89  HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---Y 145

Query: 605 IHCDIKPQNILLDDYYNARI--SDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           +H D+KP+NI+     +  +   DFGL     LD   +     GT  + APE     P+ 
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTTGTAEFAAPEVAEGKPVG 203

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA 722
              D++S GVL   ++        +   +  +         +D          + F+   
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR-- 261

Query: 723 IWCIQEDPSHRPTMRRV 739
              +  DP+ R T+ + 
Sbjct: 262 -KLLLADPNTRMTIHQA 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 1e-46
 Identities = 51/264 (19%), Positives = 99/264 (37%), Gaps = 17/264 (6%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---KEFKAEVNGIGQTHHKNL 542
           F + LG G+F TV      + +S + A+K L +     E        E + + +  H   
Sbjct: 12  FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           V+L     +         +  NG L  ++      +          I   L YLH +   
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 128

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN-TAIRGTKGYVAPEWFRNMPI 661
            IIH D+KP+NILL++  + +I+DFG  K+L+ +       +  GT  YV+PE       
Sbjct: 129 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187

Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMT-VLQRFVM 720
               D+++ G ++ +++               +      +++ + +  +      +  V 
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE 242

Query: 721 VAIWCIQEDPSHRPTMRRVTQMLE 744
                +  D + R     +     
Sbjct: 243 ---KLLVLDATKRLGCEEMEGYGP 263

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (417), Expect = 5e-46
 Identities = 62/258 (24%), Positives = 107/258 (41%), Gaps = 9/258 (3%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR-VFQDSEKEFKAEVNGIGQTHHKNLVR 544
           F++ LG GAF  V     +  +   VA+K + +   +  E   + E+  + +  H N+V 
Sbjct: 13  FRDVLGTGAFSEVILA-EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L    + G +  L+ + +S G L   +        +  + ++  +   + YLH+      
Sbjct: 72  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
                      LD+     ISDFGL K+   D     +   GT GYVAPE     P +  
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189

Query: 665 VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMT-VLQRFVMVAI 723
           VD +S GV+   ++C       +     + E+ L A  E D    DD++   + F+    
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKLF-EQILKAEYEFDSPYWDDISDSAKDFIR--- 245

Query: 724 WCIQEDPSHRPTMRRVTQ 741
             +++DP  R T  +  Q
Sbjct: 246 HLMEKDPEKRFTCEQALQ 263

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  165 bits (418), Expect = 9e-46
 Identities = 59/259 (22%), Positives = 105/259 (40%), Gaps = 12/259 (4%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
             EELG GAFG V++  V   +      K +N  +   +   K E++ + Q HH  L+ L
Sbjct: 33  ILEELGSGAFGVVHRC-VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 91

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYLHEECCTQI 604
               ++    +L+ EF+S G L   +  +    +       +     GL ++HE     I
Sbjct: 92  HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SI 148

Query: 605 IHCDIKPQNILLDDYYNARI--SDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
           +H DIKP+NI+ +    + +   DFGL   L  D+    T    T  + APE     P+ 
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREPVG 206

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA 722
              D+++ GVL   ++        +   +  Q         ++          + F+   
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK-- 264

Query: 723 IWCIQEDPSHRPTMRRVTQ 741
              +Q++P  R T+    +
Sbjct: 265 -NLLQKEPRKRLTVHDALE 282

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 5e-44
 Identities = 55/260 (21%), Positives = 103/260 (39%), Gaps = 15/260 (5%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
             E+LGRG FG V++  V   S      K +     D +   K E++ +    H+N++ L
Sbjct: 9   IAEDLGRGEFGIVHRC-VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHL 66

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYLHEECCTQI 604
               +     ++++EF+S   +   +   +   N +     V  +   L +LH      I
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NI 123

Query: 605 IHCDIKPQNILLD--DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            H DI+P+NI+         +I +FG  + L    +           Y APE  ++  ++
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVS 181

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV-LQRFVMV 721
              D++S G L+  ++      L +       E  + A    D EA  ++++    FV  
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQII-ENIMNAEYTFDEEAFKEISIEAMDFVD- 239

Query: 722 AIWCIQEDPSHRPTMRRVTQ 741
               + ++   R T     Q
Sbjct: 240 --RLLVKERKSRMTASEALQ 257

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  155 bits (393), Expect = 3e-43
 Identities = 55/271 (20%), Positives = 97/271 (35%), Gaps = 17/271 (6%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE---KEFKAEVNGIGQTHHKNL 542
             E LG G    V+    ++     VAVK L             F+ E       +H  +
Sbjct: 11  LGEILGFGGMSEVHLA-RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69

Query: 543 VRLLGYC----DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
           V +          G    +V E++    L   +  +     K   E++    + L + H+
Sbjct: 70  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 129

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN--TAIRGTKGYVAPEWF 656
                IIH D+KP NI++      ++ DFG+ + +    +      A+ GT  Y++PE  
Sbjct: 130 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 657 RNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ 716
           R   +  + DVYS G +L E++        D       +      +            L 
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246

Query: 717 RFVMVAIWCIQEDPSHRP-TMRRVTQMLEGV 746
             V+     + ++P +R  T   +   L  V
Sbjct: 247 AVVL---KALAKNPENRYQTAAEMRADLVRV 274

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  154 bits (391), Expect = 6e-43
 Identities = 61/270 (22%), Positives = 106/270 (39%), Gaps = 25/270 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLN---------RVFQDSEKEFKAEVNGIGQ 536
            KE LGRG    V +  ++  +  + AVK ++            Q+  +    EV+ + +
Sbjct: 7   PKEILGRGVSSVVRRC-IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65

Query: 537 TH-HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFY 595
              H N+++L    +      LV++ M  G L  +L      + K   +I+  +   +  
Sbjct: 66  VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA 125

Query: 596 LHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           LH+     I+H D+KP+NILLDD  N +++DFG      LD       + GT  Y+APE 
Sbjct: 126 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVCGTPSYLAPEI 180

Query: 656 FR------NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM 709
                   +     +VD++S GV++  ++               +    G       E  
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240

Query: 710 DDMTVLQRFVMVAIWCIQEDPSHRPTMRRV 739
           D    ++  V      +   P  R T    
Sbjct: 241 DYSDTVKDLVS---RFLVVQPQKRYTAEEA 267

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  154 bits (390), Expect = 2e-42
 Identities = 57/259 (22%), Positives = 103/259 (39%), Gaps = 20/259 (7%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE---FKAEVNGIGQTHHKNL 542
               LG G+FG V+    +  +    A+K L +      K+      E   +    H  +
Sbjct: 8   ILRTLGTGSFGRVHLI-RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           +R+ G   + +   ++ +++  G L S L    +    +       +   L YLH +   
Sbjct: 67  IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD-- 124

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            II+ D+KP+NILLD   + +I+DFG  K +          + GT  Y+APE     P  
Sbjct: 125 -IIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPYN 179

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMT-VLQRFVMV 721
             +D +S+G+L+ E++           YD    +T   ++  +L         ++  +  
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPF-----YDSNTMKTYEKILNAELRFPPFFNEDVKDLLS- 233

Query: 722 AIWCIQEDPSHRPTMRRVT 740
               I  D S R    +  
Sbjct: 234 --RLITRDLSQRLGNLQNG 250

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  155 bits (392), Expect = 4e-42
 Identities = 51/264 (19%), Positives = 94/264 (35%), Gaps = 22/264 (8%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGI---GQTHH 539
               +GRG FG VY       +    A+K L++     +  E     E   +        
Sbjct: 8   VHRIIGRGGFGEVYGC-RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66

Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
             +V +            + + M+ G L   L      +          I  GL ++H  
Sbjct: 67  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 126

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF-RN 658
               +++ D+KP NILLD++ + RISD GL    +  + H      GT GY+APE   + 
Sbjct: 127 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SVGTHGYMAPEVLQKG 180

Query: 659 MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDM--TVLQ 716
           +      D +S G +L +++           +  ++ +    +    L    ++  +   
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGH------SPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234

Query: 717 RFVMVAIWCIQEDPSHRPTMRRVT 740
               +    +Q D + R       
Sbjct: 235 ELRSLLEGLLQRDVNRRLGCLGRG 258

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 1e-41
 Identities = 60/256 (23%), Positives = 101/256 (39%), Gaps = 16/256 (6%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFKAEVNGIGQT-HHKN 541
             + LG+G+FG V+       ++   A+K L +   +  D  +    E   +     H  
Sbjct: 6   LHKMLGKGSFGKVFLA-EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64

Query: 542 LVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECC 601
           L  +        N   V E+++ G L   +    K +    T     I  GL +LH +  
Sbjct: 65  LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG- 123

Query: 602 TQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 661
             I++ D+K  NILLD   + +I+DFG+ K   L  + TNT   GT  Y+APE       
Sbjct: 124 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQKY 180

Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV 721
              VD +S+GVLL E++  +         + +    +           +   +L +    
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK---- 236

Query: 722 AIWCIQEDPSHRPTMR 737
                  +P  R  +R
Sbjct: 237 ---LFVREPEKRLGVR 249

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  151 bits (381), Expect = 2e-41
 Identities = 52/271 (19%), Positives = 94/271 (34%), Gaps = 19/271 (7%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL 545
              ++G G+FG +Y G  ++ + ++VA+K      +    +   E            +  
Sbjct: 11  LGRKIGSGSFGDIYLG-TDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPT 67

Query: 546 LGYC-DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           + +C  EG   ++V E +       F F   K + K    +   +   + Y+H +     
Sbjct: 68  IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NF 124

Query: 605 IHCDIKPQNIL---LDDYYNARISDFGLEKLLTLDQSHT------NTAIRGTKGYVAPEW 655
           IH D+KP N L           I DFGL K     ++H       N  + GT  Y +   
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ--ERTLGALVENDLEAMDDMT 713
              +  + + D+ S G +L+             A    Q  ER     +   +E +    
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK-G 243

Query: 714 VLQRFVMVAIWCIQEDPSHRPTMRRVTQMLE 744
               F     +C       +P    + Q+  
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 3e-41
 Identities = 65/264 (24%), Positives = 111/264 (42%), Gaps = 19/264 (7%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE------KEFKAEVNGIGQTHH 539
             EELG G F  V K      +  Q A K + +    S       ++ + EV+ + +  H
Sbjct: 14  TGEELGSGQFAVVKKC-REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72

Query: 540 KNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
            N++ L    +   + +L+ E ++ G L  FL        +  TE +  I  G++YLH  
Sbjct: 73  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 132

Query: 600 CCTQIIHCDIKPQNILLDDY----YNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
               I H D+KP+NI+L D        +I DFGL     +D  +    I GT  +VAPE 
Sbjct: 133 Q---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIFGTPEFVAPEI 187

Query: 656 FRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL 715
               P+ ++ D++S GV+   ++      L D   +     +       D    +   + 
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 247

Query: 716 QRFVMVAIWCIQEDPSHRPTMRRV 739
           + F+      + +DP  R T++  
Sbjct: 248 KDFIR---RLLVKDPKKRMTIQDS 268

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 2e-39
 Identities = 67/282 (23%), Positives = 106/282 (37%), Gaps = 32/282 (11%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE-----FKAEVNGIGQTHHKNL 542
           + LG G F TVYK   +  ++  VA+KK+    +   K+        E+  + +  H N+
Sbjct: 4   DFLGEGQFATVYKA-RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           + LL       N  LV++FM                       ++   +GL YLH+    
Sbjct: 63  IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE-WFRNMPI 661
            I+H D+KP N+LLD+    +++DFGL K      +   T    T+ Y APE  F     
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 662 TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDLEAMDDMTVLQRFV 719
            V VD+++ G +L E++     +  D   D       TLG   E     M  +     F 
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 720 MVAI-------------------WCIQEDPSHRPTMRRVTQM 742
                                       +P  R T  +  +M
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 2e-39
 Identities = 57/263 (21%), Positives = 106/263 (40%), Gaps = 20/263 (7%)

Query: 487 KEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLL 546
            + LG G  G V +   N  + ++ A+K L      + +E +        +   ++VR++
Sbjct: 17  SQVLGLGINGKVLQI-FNKRTQEKFALKMLQDC-PKARREVELHWR---ASQCPHIVRIV 71

Query: 547 GYCD----EGRNRLLVYEFMSNGALASFL--FGDSKPNWKLRTEIVMGIARGLFYLHEEC 600
              +      +  L+V E +  G L S +   GD     +  +EI+  I   + YLH   
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI- 130

Query: 601 CTQIIHCDIKPQNILLDDYYN---ARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
              I H D+KP+N+L          +++DFG  K  T   S T      T  YVAPE   
Sbjct: 131 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLG 186

Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE-RTLGALVENDLEAMDDMTVLQ 716
                   D++S GV++  ++C      ++         +T   + + +    +   V +
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246

Query: 717 RFVMVAIWCIQEDPSHRPTMRRV 739
              M+    ++ +P+ R T+   
Sbjct: 247 EVKMLIRNLLKTEPTQRMTITEF 269

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-37
 Identities = 56/285 (19%), Positives = 99/285 (34%), Gaps = 36/285 (12%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFK-----AEVNGIGQTHHKNL 542
            E+G GA+G V+K          VA+K++     +           A +  +    H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 543 VRLLGYCDEGRNR-----LLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYL 596
           VRL   C   R        LV+E +                  +   +++  + RGL +L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 597 HEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWF 656
           H      ++H D+KPQNIL+      +++DFGL ++         T++  T  Y APE  
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVL 187

Query: 657 RNMPITVKVDVYSYGVLLLEIICLR----------------RTILTDWAYDCYQERTLGA 700
                   VD++S G +  E+   +                  I      D  ++  L  
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247

Query: 701 LVENDLEAMDDMTVLQRFVMVAI----WCIQEDPSHRPTMRRVTQ 741
              +   A      +     +       C+  +P+ R +      
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  139 bits (351), Expect = 2e-37
 Identities = 50/277 (18%), Positives = 102/277 (36%), Gaps = 31/277 (11%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS--EKEFKAEVNGIGQTHHKNLVRL 545
           E++G G +G VYK   N G  +  A+KK+    +D         E++ + +  H N+V+L
Sbjct: 8   EKIGEGTYGVVYKAQNNYG--ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
                  +  +LV+E +           +           ++ +  G+ Y H+     ++
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VL 122

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 665
           H D+KPQN+L++     +I+DFGL +   +        I             +   +  +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182

Query: 666 DVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI-- 723
           D++S G +  E++            D    R    L   + +   ++T L ++       
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLM-RIFRILGTPNSKNWPNVTELPKYDPNFTVY 241

Query: 724 ---------------------WCIQEDPSHRPTMRRV 739
                                  ++ DP+ R T ++ 
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  139 bits (350), Expect = 3e-37
 Identities = 40/278 (14%), Positives = 90/278 (32%), Gaps = 31/278 (11%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ-THHKNLVR 544
               +G G+FG +++G  N+ ++ QVA+K   R  +    + + E            +  
Sbjct: 9   VGRRIGEGSFGVIFEG-TNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPN 65

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           +  +  EG + +LV + +             K + K        +   +  +HE+    +
Sbjct: 66  VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---L 122

Query: 605 IHCDIKPQNILLDDYYN-----ARISDFGLEKLLTLDQSHTN------TAIRGTKGYVAP 653
           ++ DIKP N L+    +       + DFG+ K      +  +        + GT  Y++ 
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

Query: 654 EWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMT 713
                   + + D+ + G + +  +           +   +  T     E   E      
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGS------LPWQGLKAATNKQKYERIGEKKQSTP 236

Query: 714 VLQR-------FVMVAIWCIQEDPSHRPTMRRVTQMLE 744
           + +        F     +         P    +  +  
Sbjct: 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 4e-37
 Identities = 56/266 (21%), Positives = 104/266 (39%), Gaps = 33/266 (12%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR------VFQDSEKEFKAEVNGIGQ--T 537
               LG G FG+VY G + +  +  VA+K + +          +      EV  + +  +
Sbjct: 8   VGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66

Query: 538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYL 596
               ++RLL + +   + +L+ E             +      +L       +   + + 
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126

Query: 597 HEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEW 655
           H      ++H DIK +NIL+D +    ++ DFG   LL   +    T   GT+ Y  PEW
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEW 180

Query: 656 FRNMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMT- 713
            R          V+S G+LL +++C          ++  +E     ++   +     ++ 
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDI------PFEHDEE-----IIRGQVFFRQRVSS 229

Query: 714 VLQRFVMVAIWCIQEDPSHRPTMRRV 739
             Q  +    WC+   PS RPT   +
Sbjct: 230 ECQHLIR---WCLALRPSDRPTFEEI 252

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 6e-37
 Identities = 52/277 (18%), Positives = 104/277 (37%), Gaps = 29/277 (10%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQTHHKNLVRL 545
           E++G G +GTV+K   N  + + VA+K++     D         E+  + +  HKN+VRL
Sbjct: 8   EKIGEGTYGTVFKA-KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQII 605
                  +   LV+EF        F   +   + ++    +  + +GL + H      ++
Sbjct: 67  HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVL 123

Query: 606 HCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 665
           H D+KPQN+L++     ++++FGL +   +     +  +           F     +  +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183

Query: 666 DVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW- 724
           D++S G +  E+    R +      D   +R    L     E    MT L  +    ++ 
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243

Query: 725 ----------------------CIQEDPSHRPTMRRV 739
                                  ++ +P  R +    
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 1e-36
 Identities = 56/295 (18%), Positives = 112/295 (37%), Gaps = 37/295 (12%)

Query: 478 ELVEVTRGFK--EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGI 534
           ++ +V   +     +G GA+G V     +  +  +VA+KK++    Q   +    E+  +
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 60

Query: 535 GQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFG---DSKPNWKLRTEIVMGIAR 591
            +  H+N++ +           +   ++    + + L+        +       +  I R
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 120

Query: 592 GLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--TNTAIRGTKG 649
           GL Y+H      ++H D+KP N+LL+   + +I DFGL ++   D  H    T    T+ 
Sbjct: 121 GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 650 YVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDL 706
           Y APE   N    T  +D++S G +L E++  R         D        LG+  + DL
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

Query: 707 EAMDDMTVLQRFVMVAIW----------------------CIQEDPSHRPTMRRV 739
             + ++      + +                          +  +P  R  + + 
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 5e-36
 Identities = 54/277 (19%), Positives = 101/277 (36%), Gaps = 29/277 (10%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQTHHKNLVRL 545
           E++G G +G VYK   N  + + VA+KK+    +          E++ + + +H N+V+L
Sbjct: 8   EKIGEGTYGVVYKA-RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66

Query: 546 LGYCDEGRNRLLVYEFMSNGALASFLFGDSKP-NWKLRTEIVMGIARGLFYLHEECCTQI 604
           L          LV+EF+                   L    +  + +GL + H      +
Sbjct: 67  LDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 123

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           +H D+KPQN+L++     +++DFGL +   +        +                 +  
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183

Query: 665 VDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDLEAMDDM---------- 712
           VD++S G +  E++  R     D   D      RTLG   E     +  M          
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243

Query: 713 ----------TVLQRFVMVAIWCIQEDPSHRPTMRRV 739
                      + +    +    +  DP+ R + +  
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 5e-36
 Identities = 58/259 (22%), Positives = 100/259 (38%), Gaps = 17/259 (6%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE---FKAEVNGIGQTHHKNL 542
           + + LG+G FG V        +    A+K L +    ++ E      E   +  T H  L
Sbjct: 9   YLKLLGKGTFGKVILV-REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67

Query: 543 VRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
             L            V E+ + G L   L  +     +        I   L YLH     
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--- 124

Query: 603 QIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 662
            +++ DIK +N++LD   + +I+DFGL K    D +   T   GT  Y+APE   +    
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYG 183

Query: 663 VKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMT-VLQRFVMV 721
             VD +  GV++ E++C R        Y+   ER    ++  ++     ++   +  +  
Sbjct: 184 RAVDWWGLGVVMYEMMCGRL-----PFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA- 237

Query: 722 AIWCIQEDPSHRPTMRRVT 740
               +++DP  R       
Sbjct: 238 --GLLKKDPKQRLGGGPSD 254

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  132 bits (333), Expect = 2e-34
 Identities = 53/256 (20%), Positives = 95/256 (37%), Gaps = 18/256 (7%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKE---FKAEVNGIGQTHHKNLVR 544
           + LG G+FG V     +  S +  A+K L++      K+      E   +   +   LV+
Sbjct: 47  KTLGTGSFGRVMLV-KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105

Query: 545 LLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQI 604
           L     +  N  +V E+++ G + S L    + +          I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DL 162

Query: 605 IHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 664
           I+ D+KP+N+L+D     +++DFG  K            + GT   +APE   +      
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKA 218

Query: 665 VDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAIW 724
           VD ++ GVL+ E+         D     Y++   G +                   +   
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS-------HFSSDLKDLLRN 271

Query: 725 CIQEDPSHRPTMRRVT 740
            +Q D + R    +  
Sbjct: 272 LLQVDLTKRFGNLKNG 287

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-33
 Identities = 49/291 (16%), Positives = 104/291 (35%), Gaps = 43/291 (14%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDS--EKEFKAEVNGIGQTHHKNLVRL 545
            ++G+G FG V+K   +  +  +VA+KK+    +          E+  +    H+N+V L
Sbjct: 16  AKIGQGTFGEVFKA-RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 74

Query: 546 LGYCDEGRNR--------LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLH 597
           +  C    +          LV++F  +           K        ++  +  GL+Y+H
Sbjct: 75  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 134

Query: 598 EECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS---HTNTAIRGTKGYVAPE 654
                 I+H D+K  N+L+      +++DFGL +  +L ++   +  T    T  Y  PE
Sbjct: 135 RNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 655 WFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ--ERTLGALVENDLEAMDD 711
                      +D++  G ++ E+      +  +          +  G++       +D+
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 712 MTVLQRFVMVAI-----------------------WCIQEDPSHRPTMRRV 739
             + ++  +V                           +  DP+ R      
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 3e-33
 Identities = 59/282 (20%), Positives = 99/282 (35%), Gaps = 41/282 (14%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 547
           + +G G+FG VY+      S + VA+KK+ +     ++    E+  + +  H N+VRL  
Sbjct: 26  KVIGNGSFGVVYQA-KLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRY 80

Query: 548 YCDEGRNR------LLVYEFMSNGALASFLFGDSKP---NWKLRTEIVMGIARGLFYLHE 598
           +      +       LV +++                          +  + R L Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140

Query: 599 ECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFR 657
                I H DIKPQN+LLD D    ++ DFG  K L        + I           F 
Sbjct: 141 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYYRAPELIFG 196

Query: 658 NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE--RTLGALVENDLEAMDDMTVL 715
               T  +DV+S G +L E++  +     D   D   E  + LG      +  M+     
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256

Query: 716 QRFVMVAI--------------------WCIQEDPSHRPTMR 737
            +F  +                        ++  P+ R T  
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 1e-31
 Identities = 57/264 (21%), Positives = 97/264 (36%), Gaps = 15/264 (5%)

Query: 486 FKEELGRGAFGTVYKGF--VNMGSSDQVAVKKLNRVF----QDSEKEFKAEVNGIGQ-TH 538
             + LG GA+G V+         +    A+K L +        + +  + E   +     
Sbjct: 28  LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87

Query: 539 HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE 598
              LV L           L+ ++++ G L + L    +         V  I   L +LH+
Sbjct: 88  SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 147

Query: 599 ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRN 658
                II+ DIK +NILLD   +  ++DFGL K    D++       GT  Y+AP+  R 
Sbjct: 148 L---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204

Query: 659 MP--ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ 716
                   VD +S GVL+ E++        D   +   E +   L        +   + +
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 264

Query: 717 RFVMVAIWCIQEDPSHRPTMRRVT 740
             +      + +DP  R       
Sbjct: 265 DLIQ---RLLMKDPKKRLGCGPRD 285

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 2e-30
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 25/223 (11%)

Query: 474 FTYKELVEVTRGFK------EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--K 525
           F  +E+ +     +      + +G GA+G V    V+  +  +VA+KKL R FQ     K
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSA-VDGRTGAKVAIKKLYRPFQSELFAK 62

Query: 526 EFKAEVNGIGQTHHKNLVRLLGYCDEGRNR------LLVYEFMSNGALASFLFGDSKPNW 579
               E+  +    H+N++ LL                LV  FM  G     L    K   
Sbjct: 63  RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGE 120

Query: 580 KLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH 639
                +V  + +GL Y+H       IH D+KP N+ +++    +I DFGL +        
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQA----DS 173

Query: 640 TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLR 681
             T    T+ Y APE   N M  T  VD++S G ++ E+I  +
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 3e-30
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 17/216 (7%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--KEFKAEVNGIGQTHHKNLVRL 545
           + +G GA G V     +      VA+KKL+R FQ+    K    E+  +   +HKN++ L
Sbjct: 23  KPIGSGAQGIVCAA-YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81

Query: 546 LGYC------DEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEE 599
           L         +E ++  LV E M             + + +  + ++  +  G+ +LH  
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA 138

Query: 600 CCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 659
                IH D+KP NI++      +I DFGL +  T   S   T    T+ Y APE    M
Sbjct: 139 GI---IHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 193

Query: 660 PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE 695
                VD++S G ++ E++  +         D + +
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  113 bits (284), Expect = 3e-28
 Identities = 56/288 (19%), Positives = 108/288 (37%), Gaps = 48/288 (16%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQ-THHKNLVR 544
              +LGRG +  V++  +N+ ++++V VK L  V    +K+ K E+  +       N++ 
Sbjct: 39  LVRKLGRGKYSEVFEA-INITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIIT 94

Query: 545 LLGYCDEGRNRL--LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCT 602
           L     +  +R   LV+E ++N                     +  I + L Y H     
Sbjct: 95  LADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG-- 149

Query: 603 QIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPE-WFRNMP 660
            I+H D+KP N+++D ++   R+ D+GL +     Q +       ++ +  PE       
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDYQM 206

Query: 661 ITVKVDVYSYGVLLLEIICLR-----------------RTILTDWAYDCYQERTLGALVE 703
               +D++S G +L  +I  +                 + + T+  YD   +  +     
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 704 -NDLEAMDDMTVLQRFVMVAIW-------------CIQEDPSHRPTMR 737
            ND+         +RFV                   ++ D   R T R
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 2e-27
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 21/221 (9%)

Query: 474 FTYKEL----VEVTRGFK--EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSE--K 525
           F  +EL     EV   ++    +G GA+G+V     +  +  +VAVKKL+R FQ     K
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAK 62

Query: 526 EFKAEVNGIGQTHHKNLVRLLGYCDEGR----NRLLVYEFMSNGALASFLFGDSKPNWKL 581
               E+  +    H+N++ LL      R       +       GA  + +    K     
Sbjct: 63  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 122

Query: 582 RTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN 641
              ++  I RGL Y+H       IH D+KP N+ +++    +I DFG    L        
Sbjct: 123 VQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFG----LARHTDDEM 175

Query: 642 TAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLR 681
           T    T+ Y APE   N M     VD++S G ++ E++  R
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  101 bits (252), Expect = 7e-24
 Identities = 44/213 (20%), Positives = 79/213 (37%), Gaps = 20/213 (9%)

Query: 486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNR---VFQDSEKEFK-------AEVNGIG 535
              +LG G F TV+    +M ++  VA+K +       + +E E K       A+     
Sbjct: 17  LVRKLGWGHFSTVWLA-KDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 75

Query: 536 QTHHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTE-----IVMGIA 590
                ++++LL + +      +    +      + L    K   +         I   + 
Sbjct: 76  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135

Query: 591 RGLFYLHEECCTQIIHCDIKPQNILLD-DYYNARISDFGLEKLLTLDQSHTNTA-IRGTK 648
            GL Y+H  C   IIH DIKP+N+L++       +    +  L        +      T+
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 649 GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR 681
            Y +PE     P     D++S   L+ E+I   
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 77.1 bits (189), Expect = 8e-17
 Identities = 25/203 (12%), Positives = 58/203 (28%), Gaps = 31/203 (15%)

Query: 488 EELGRGAFGTVYKGFVNMGSSDQVAVK----------KLNRVFQDSEKEFKAEVNGIGQT 537
           + +G G    V+  +       +  VK          K+       +  F        + 
Sbjct: 6   KLMGEGKESAVFNCYSEKF--GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 538 HHKNLVRLLGYCD----EGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGL 593
             + L +L G             ++ E +             +   +   E++  I   +
Sbjct: 64  EFRALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMILEEV 116

Query: 594 FYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTAIRGTKGYVAP 653
              +      I+H D+   N+L+ +     I DF       + +      +      +  
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSV--EVGEEGWREILERDVRNII- 169

Query: 654 EWFRNMPITVKVDVYSYGVLLLE 676
            +F       + D+ S    +L+
Sbjct: 170 TYFSR-TYRTEKDINSAIDRILQ 191

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 60.7 bits (147), Expect = 6e-12
 Identities = 24/114 (21%), Positives = 45/114 (39%), Gaps = 19/114 (16%)

Query: 25  TISIGQQLTAAESTEPWLSPSKDFALGFH----------QLDIWYASGDDPGPGGSKLRL 74
            ++ G+ L A +S +      + +                  +W ++    G  G K  L
Sbjct: 3   LLTNGEGLYAGQSLD-----VEPYHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVL 57

Query: 75  TANGGLVLEDPEAREIWKSEISTGEAAFG-VLYDTGNFLIVNTNSERLWQTFDH 127
            ++G  V+ D E R +W S    G   +  VL + GN +I  ++   +W T  +
Sbjct: 58  QSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD---IWSTGTY 108

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 43.0 bits (101), Expect = 9e-06
 Identities = 22/120 (18%), Positives = 37/120 (30%), Gaps = 20/120 (16%)

Query: 130 DTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNT 189
           + L   + +  G  +             + F + ED N VL   +        + + SNT
Sbjct: 2   NLLTNGEGLYAGQSLDV---------EPYHFIMQEDCNLVLYDHS-------TSVWASNT 45

Query: 190 FDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSHP 249
                   G + V    G   V     + +  +  +V    NY    L  DG  + Y   
Sbjct: 46  G--ILGKKGCKAVLQSDGNFVVYDAEGRSLWASH-SVRGNGNY-VLVLQEDGNVVIYGSD 101

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 54.0 bits (129), Expect = 1e-09
 Identities = 21/132 (15%), Positives = 46/132 (34%), Gaps = 27/132 (20%)

Query: 129 TDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSN 188
           +D L     ++ GG ++          G + F +  D N VL        +  +   W++
Sbjct: 1   SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVL--------YDNNRAVWAS 43

Query: 189 TFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSH 248
             +   S     +     G L +   ++ I +      + +       L  D   + Y  
Sbjct: 44  GTNGKASGC--VLKMQNDGNLVIYSGSRAIWA---SNTNRQNGNYYLILQRDRNVVIY-- 96

Query: 249 PKNNSTGDAIWS 260
              +++ +AIW+
Sbjct: 97  ---DNSNNAIWA 105

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 51.7 bits (123), Expect = 8e-09
 Identities = 15/116 (12%), Positives = 36/116 (31%), Gaps = 16/116 (13%)

Query: 25  TISIGQQLTAAESTEPWLSPSKDFALGF----------HQLDIWYASGDDPGPGGSKLRL 74
            ++ G QL    S          +              +   +W +  +    G   L++
Sbjct: 3   RLNSGHQLDTGGS-----LAEGGYLFIIQNDCNLVLYDNNRAVWASGTNGKASG-CVLKM 56

Query: 75  TANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQTFDHPTD 130
             +G LV+          +        + +L    N +I + ++  +W T  +  +
Sbjct: 57  QNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 53.9 bits (129), Expect = 2e-09
 Identities = 28/139 (20%), Positives = 44/139 (31%), Gaps = 31/139 (22%)

Query: 122 WQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAY 181
            Q  D+    L  T+++E             F    ++F +  D N VL        +  
Sbjct: 7   KQPDDNHPQILHATESLE-----------ILFGTHVYRFIMQTDCNLVL--------YDN 47

Query: 182 DAFFWSNTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDG 241
           +   W+          G R V    G L V+      V  +P    A   +    L  D 
Sbjct: 48  NNPIWATN--TGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKA--GHYVLVLQPDR 103

Query: 242 VFIFYSHPKNNSTGDAIWS 260
             + Y        GDA+W+
Sbjct: 104 NVVIY--------GDALWA 114

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 36.5 bits (84), Expect = 0.002
 Identities = 18/124 (14%), Positives = 31/124 (25%), Gaps = 36/124 (29%)

Query: 68  GGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQTFDH 127
              +  +  +  LVL D        +    G     VL   G  +++   +  +WQ+   
Sbjct: 30  HVYRFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP-- 87

Query: 128 PTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFW- 186
                                       G +   L  D N V+          Y    W 
Sbjct: 88  -----------------------VAGKAGHYVLVLQPDRNVVI----------YGDALWA 114

Query: 187 SNTF 190
           + T 
Sbjct: 115 TQTV 118

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 49.9 bits (119), Expect = 5e-08
 Identities = 20/131 (15%), Positives = 33/131 (25%), Gaps = 36/131 (27%)

Query: 58  WYASGDDP-GPGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNT 116
                         +L +  +  LVL D + R    +    G     VL   G   ++  
Sbjct: 24  QTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTN 83

Query: 117 NSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLE 176
            +  +W +                             S GR+ F L  D N  +      
Sbjct: 84  QNIAVWTSG-------------------------NSRSAGRYVFVLQPDRNLAI------ 112

Query: 177 SGFAYDAFFWS 187
               Y    W+
Sbjct: 113 ----YGGALWT 119

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 46.1 bits (109), Expect = 9e-07
 Identities = 21/141 (14%), Positives = 34/141 (24%), Gaps = 37/141 (26%)

Query: 48  FALGFHQLDIWYASGDDPGPGGS-KLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLY 106
           F L                   S +  + ++  LVL D +   +W S  +       VL 
Sbjct: 5   FGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSD-VRVWASNTAGATGCRAVLQ 63

Query: 107 DTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDG 166
             G  +I+   +   W +                          T  S G +   L  D 
Sbjct: 64  SDGLLVILTAQNTIRWSSG-------------------------TKGSIGNYVLVLQPDR 98

Query: 167 NAVLNTINLESGFAYDAFFWS 187
              +          Y    W 
Sbjct: 99  TVTI----------YGPGLWD 109

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 37.2 bits (86), Expect = 0.001
 Identities = 23/119 (19%), Positives = 39/119 (32%), Gaps = 11/119 (9%)

Query: 7   SLLFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDIWYASGDDPG 66
           ++LF L     +  Q   T+   Q L  +       +   D  L     D+   + +  G
Sbjct: 2   NILFGLS-HEGSHPQ---TLHAAQSLELSSFR---FTMQSDCNLVLFDSDVRVWASNTAG 54

Query: 67  PGGSKLRLTANGGLVLEDPEAREIWKSEISTGEAAF-GVLYDTGNFLIVNTNSERLWQT 124
             G +  L ++G LV+   +    W S        +  VL       I       LW +
Sbjct: 55  ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPG---LWDS 110

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

 Score = 44.2 bits (104), Expect = 3e-06
 Identities = 22/124 (17%), Positives = 36/124 (29%), Gaps = 21/124 (16%)

Query: 130 DTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNT 189
           + L   +T+  G  ++          G F F + ED N VL        +  D   W+  
Sbjct: 2   NILYSGETLSTGEFLNY---------GSFVFIMQEDCNLVL--------YDVDKPIWATN 44

Query: 190 FDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYSHP 249
                 +    +     G L V+            T     NY    L  D   + Y   
Sbjct: 45  TGGLSRSC--FLSMQTDGNL-VVYNPSNKPIWASNTGGQNGNY-VCILQKDRNVVIYGTD 100

Query: 250 KNNS 253
           +  +
Sbjct: 101 RWAT 104

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

 Score = 43.9 bits (103), Expect = 5e-06
 Identities = 24/108 (22%), Positives = 40/108 (37%), Gaps = 8/108 (7%)

Query: 22  SNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDIWYASGDDPGPG-GSKLRLTANGGL 80
           S  T+S G+ L             +D  L  + +D    + +  G      L +  +G L
Sbjct: 6   SGETLSTGEFLNYGSFV---FIMQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNL 62

Query: 81  VLEDPEAREIWKSEISTGEAAFG-VLYDTGNFLIVNTNSERLWQTFDH 127
           V+ +P  + IW S        +  +L    N +I  T+    W T  H
Sbjct: 63  VVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD---RWATGTH 107

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	762
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.83
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	99.8
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.8
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.78
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.65
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.64
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.55
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.29
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.25
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.24
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.18
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	99.07
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	98.95
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.24
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.87
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.39
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.59
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.86
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.64
d1emoa2	39	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	91.49
d2vj3a1	42	Neurogenic locus notch homolog protein 1, Notch1 {	90.82
d1emoa1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	88.83
d1lmja2	42	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	88.5
d1xkba1	39	Factor X, N-terminal module {Human (Homo sapiens)	87.6
d2vj3a2	39	Neurogenic locus notch homolog protein 1, Notch1 {	86.53
d1q4ga2	42	Prostaglandin H2 synthase-1, EGF-like module {Shee	85.41
d1uzka1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	85.35
d1lmja1	44	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	85.1
d1i0ua2	41	Low density lipoprotein (LDL) receptor, different	83.93
d2vj3a3	35	Neurogenic locus notch homolog protein 1, Notch1 {	83.71
d1uzka2	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	83.09
d1edmb_	39	Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606	82.75

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-50  Score=426.13  Aligned_cols=269  Identities=27%  Similarity=0.446  Sum_probs=210.7

Q ss_pred             cccCHHHHHHHHhhhh-----------hhcCCCCcceEEEeeeeCCC--cceEEEEEcccc-ccchhHHHHHHhhhhccc
Q 004312          472 RCFTYKELVEVTRGFK-----------EELGRGAFGTVYKGFVNMGS--SDQVAVKKLNRV-FQDSEKEFKAEVNGIGQT  537 (762)
Q Consensus       472 ~~~~~~el~~~t~~~~-----------~~iG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l  537 (762)
                      ..++++++.+++.+|.           +.||+|+||+||+|.+....  ...||||++... .....++|.+|+++++++
T Consensus         5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l   84 (299)
T d1jpaa_           5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF   84 (299)
T ss_dssp             CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred             CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence            3467777888877763           46999999999999875432  236899998754 334456899999999999


Q ss_pred             ccCCccchhceeccCCceeEEEeccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEE
Q 004312          538 HHKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILL  616 (762)
Q Consensus       538 ~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl  616 (762)
                      +|||||+++|+|.+.+..++|||||++|+|.+++... +.+++.+++.|+.||++||+|||++   +|+||||||+||||
T Consensus        85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl  161 (299)
T d1jpaa_          85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV  161 (299)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence            9999999999999999999999999999999998775 5789999999999999999999998   99999999999999


Q ss_pred             cCCCceEEecccccccccCCCCcc----cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHH
Q 004312          617 DDYYNARISDFGLEKLLTLDQSHT----NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYD  691 (762)
Q Consensus       617 ~~~~~~kl~Dfgla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~  691 (762)
                      ++++.+||+|||+++.+.......    .....||+.|||||.+.++.++.++|||||||++|||+| |+.||......+
T Consensus       162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~  241 (299)
T d1jpaa_         162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD  241 (299)
T ss_dssp             CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999775443322    222457899999999999999999999999999999998 788875443322


Q ss_pred             hhhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCC
Q 004312          692 CYQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEV  749 (762)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~  749 (762)
                      ...      .+........+..+++++.+|+.+||+.||++||||+||++.|+++++.
T Consensus       242 ~~~------~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         242 VIN------AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             HHH------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHH------HHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            221      1222223334455678899999999999999999999999999987664

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=417.88  Aligned_cols=253  Identities=26%  Similarity=0.432  Sum_probs=199.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      .+.+.||+|+||+||+|.+.  +++.||||+++.. ....++|.+|++++++++|||||+++|+|.+.+..+|||||+++
T Consensus         8 ~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~   84 (263)
T d1sm2a_           8 TFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   84 (263)
T ss_dssp             EEEEEEECCSSCCEEEEEET--TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             EEEEEEeeCCCeEEEEEEEC--CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence            35678999999999999875  3457999999764 34457899999999999999999999999999999999999999


Q ss_pred             CchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          565 GALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       565 gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      |+|.+++... ..+++..++.|+.|||+||+|||++   +|+||||||+|||+++++.+||+|||+++............
T Consensus        85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~  161 (263)
T d1sm2a_          85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  161 (263)
T ss_dssp             CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred             CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence            9999998765 5689999999999999999999998   99999999999999999999999999998776554444455


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..||+.|+|||.+.+..++.++|||||||++|||+|++.|+...........     .+........+..+++++.+++.
T Consensus       162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~-----~i~~~~~~~~p~~~~~~l~~li~  236 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-----DISTGFRLYKPRLASTHVYQIMN  236 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHH-----HHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHH-----HHHhcCCCCCccccCHHHHHHHH
Confidence            6799999999999999999999999999999999997666433221111111     11112222233445678999999


Q ss_pred             HhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          724 WCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       724 ~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      +||+.||++||||+||++.|+++.+
T Consensus       237 ~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         237 HCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHHHHHHHh
Confidence            9999999999999999999998754

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-49  Score=415.22  Aligned_cols=255  Identities=27%  Similarity=0.398  Sum_probs=215.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||+||+|.+. .+++.||||+++.. ....++|.+|++++++++|||||+++|+|.+++..+|||||++
T Consensus        19 ~~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~   96 (287)
T d1opja_          19 ITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   96 (287)
T ss_dssp             EEEEEETTTTTTSSEEEEEEG-GGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             eEEeeEEeeCCCeEEEEEEEC-CCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence            345678999999999999865 34678999999754 3345689999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +|+|.+++...  ..+++..++.|+.||++||+|||++   +|+||||||+||||++++.+||+|||+++..........
T Consensus        97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~  173 (287)
T d1opja_          97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  173 (287)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred             CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence            99999999643  6789999999999999999999998   999999999999999999999999999998765555555


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ....|++.|+|||.+.+..++.++|||||||++|||++|+.|+.........     ...+........+..+++++.+|
T Consensus       174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~-----~~~i~~~~~~~~~~~~~~~l~~l  248 (287)
T d1opja_         174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----YELLEKDYRMERPEGCPEKVYEL  248 (287)
T ss_dssp             TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-----HHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH-----HHHHhcCCCCCCCccchHHHHHH
Confidence            5566899999999999999999999999999999999988886443222211     12222333333444567889999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          722 AIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      +.+||+.||++|||++||++.|+.+.+
T Consensus       249 i~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         249 MRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             HHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            999999999999999999999988643

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-49  Score=410.83  Aligned_cols=255  Identities=26%  Similarity=0.383  Sum_probs=201.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|+||+||+|++.    ..||||+++..  .....+.|.+|++++++++|||||+++|++.+ +..+|||||+
T Consensus        11 ~~~~~lG~G~fg~Vy~~~~~----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~   85 (276)
T d1uwha_          11 TVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC   85 (276)
T ss_dssp             CCCSEEEECSSCEEEEEESS----SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             EEEEEEeeCCCcEEEEEEEC----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence            35578999999999999754    35999998643  34455789999999999999999999999865 5689999999


Q ss_pred             CCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC-cc
Q 004312          563 SNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-HT  640 (762)
Q Consensus       563 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~  640 (762)
                      ++|+|.++|... ..+++..+..|+.||++||+|||++   +|+||||||+||||++++.+||+|||+++....... ..
T Consensus        86 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~  162 (276)
T d1uwha_          86 EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ  162 (276)
T ss_dssp             CEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred             CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence            999999999754 6799999999999999999999998   999999999999999999999999999987654332 33


Q ss_pred             cccccccCcccCcccccC---CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRN---MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~---~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      .....||+.|||||++..   ..++.++|||||||+||||+||+.||...................+.. ...+..++++
T Consensus       163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~-~~~~~~~~~~  241 (276)
T d1uwha_         163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL-SKVRSNCPKA  241 (276)
T ss_dssp             ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG-GGSCTTCCHH
T ss_pred             ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc-hhccccchHH
Confidence            445679999999999864   358999999999999999999999985432222111111111111111 1123345678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      +.+|+.+||+.||++|||++||++.|+.+.+
T Consensus       242 l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         242 MKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            9999999999999999999999999998754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=414.43  Aligned_cols=251  Identities=29%  Similarity=0.449  Sum_probs=208.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||+||+|.++  +++.||||+++.. ....++|.+|++++++++|||||+++|++.+ +..+|||||++
T Consensus        15 ~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          15 LKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             EEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             eEEeEEEecCCCcEEEEEEEC--CCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            345678999999999999865  3468999999764 3445689999999999999999999998865 56799999999


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +|+|.+++...  ..+++..++.|+.||++||+|||++   +|+||||||+||||++++.+||+|||+++..........
T Consensus        91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~  167 (272)
T d1qpca_          91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR  167 (272)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence            99999988655  3689999999999999999999998   999999999999999999999999999998765554455


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ....||+.|+|||.+.++.++.++|||||||++|||+||+.|+..........     ..+........+..+++++.+|
T Consensus       168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~-----~~i~~~~~~~~p~~~~~~l~~l  242 (272)
T d1qpca_         168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-----QNLERGYRMVRPDNCPEELYQL  242 (272)
T ss_dssp             TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-----HHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH-----HHHHhcCCCCCcccChHHHHHH
Confidence            56679999999999999999999999999999999999877754332211111     1112222333344567889999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          722 AIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      +.+||+.||++||||+||+++|+++
T Consensus       243 i~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         243 MRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            9999999999999999999999863

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-49  Score=409.57  Aligned_cols=248  Identities=29%  Similarity=0.399  Sum_probs=204.5

Q ss_pred             hhcCCCCcceEEEeeeeC-CCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          488 EELGRGAFGTVYKGFVNM-GSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      ++||+|+||+||+|.+.. +.++.||||+++...  ....++|.+|++++++++|||||+++|+|.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            469999999999998754 345689999996532  3335689999999999999999999999864 567899999999


Q ss_pred             CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc--cc
Q 004312          565 GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT--NT  642 (762)
Q Consensus       565 gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~--~~  642 (762)
                      |+|.+++.....+++..+..|+.||++||+|||++   +|+||||||+||||+.++.+||+|||+++.+.......  ..
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            99999999888999999999999999999999998   99999999999999999999999999999775443322  23


Q ss_pred             cccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          643 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ...||+.|+|||.+.+..++.++|||||||++|||++ |+.||......+..      ..+........+..+++++.+|
T Consensus       169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~------~~i~~~~~~~~p~~~~~~~~~l  242 (277)
T d1xbba_         169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT------AMLEKGERMGCPAGCPREMYDL  242 (277)
T ss_dssp             --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH------HHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH------HHHHcCCCCCCCcccCHHHHHH
Confidence            4568999999999999999999999999999999998 88887543222211      1222222333344567889999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhhc
Q 004312          722 AIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      +.+||+.||++|||+++|+++|+.
T Consensus       243 i~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         243 MNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhC
Confidence            999999999999999999998876

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=408.48  Aligned_cols=264  Identities=25%  Similarity=0.374  Sum_probs=209.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||+||+|.+..  .+.||||+++.. ....++|.+|+.++++++|||||+++|+|.+ +..++||||++
T Consensus        19 ~~i~~~iG~G~fg~Vy~~~~~~--~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          19 LRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             EEEEEEEEECSSCEEEEEEETT--TEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             EEEeeEEeeCCCeEEEEEEECC--CCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            4566789999999999998653  357999999754 3455789999999999999999999999855 56899999999


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +|+|..++...  ..+++.+++.|+.||++||+|||++   +|+||||||+||||++++.+||+|||+++..........
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  171 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  171 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence            99999998754  5789999999999999999999998   999999999999999999999999999987765554455


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMV  721 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  721 (762)
                      ....||+.|+|||.+.++.++.++||||||+++|||++|+.|+...........     .+........+..+++++.++
T Consensus       172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~-----~i~~~~~~~~~~~~~~~l~~l  246 (285)
T d1fmka3         172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-----QVERGYRMPCPPECPESLHDL  246 (285)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-----HHHTTCCCCCCTTSCHHHHHH
T ss_pred             ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHH-----HHHhcCCCCCCcccCHHHHHH
Confidence            556799999999999999999999999999999999998887644322221111     111222233345567889999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhhcCcCCCCCCCCCCCC
Q 004312          722 AIWCIQEDPSHRPTMRRVTQMLEGVVEVPIPPCPWTLN  759 (762)
Q Consensus       722 i~~cl~~dp~~RPt~~evl~~L~~~~~~~~p~~p~~~~  759 (762)
                      +.+||+.||++||||++|+++|++......|+.++.-|
T Consensus       247 i~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~~~  284 (285)
T d1fmka3         247 MCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN  284 (285)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSCC
T ss_pred             HHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCCCC
Confidence            99999999999999999999999966555555554433

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=401.52  Aligned_cols=250  Identities=24%  Similarity=0.374  Sum_probs=212.6

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSN  564 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~  564 (762)
                      .|.++||+|+||+||+|+++  +++.||||+++.. ....++|.+|++++++++|||||+++|+|.+.+..++||||+++
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~   83 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN   83 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEET--TTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred             EEeEEEecCCCeEEEEEEEC--CCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence            35688999999999999874  4568999999864 33457899999999999999999999999999999999999999


Q ss_pred             CchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          565 GALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       565 gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      |+|..++... ..+++..+.+|+.||++||.|||+.   +|+||||||+|||+++++.+||+|||+++............
T Consensus        84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (258)
T d1k2pa_          84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG  160 (258)
T ss_dssp             EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred             CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence            9999997654 6789999999999999999999998   99999999999999999999999999998776555555555


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ..+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+..      ..+........+...++++.+++
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~------~~i~~~~~~~~p~~~~~~l~~li  234 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EHIAQGLRLYRPHLASEKVYTIM  234 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH------HHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH------HHHHhCCCCCCcccccHHHHHHH
Confidence            679999999999999999999999999999999998 78787543322221      11222223334445668899999


Q ss_pred             HHhhccCCCCCCCHHHHHHHhhcC
Q 004312          723 IWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       723 ~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      .+||+.||++|||++||++.|.++
T Consensus       235 ~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         235 YSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             HHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             HHHccCCHhHCcCHHHHHHHhhCC
Confidence            999999999999999999998653

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=405.85  Aligned_cols=250  Identities=26%  Similarity=0.313  Sum_probs=203.3

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||+||+|+.. .+++.||||+++... .+..+++.+|++++++++|||||++++++.+.+..+|||||+
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~   85 (271)
T d1nvra_           7 WDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   85 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence            345678999999999999754 456899999987532 233467999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC-ccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-HTN  641 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~  641 (762)
                      ++|+|.++|.....+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++....... ...
T Consensus        86 ~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          86 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             CCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence            9999999999888999999999999999999999999   999999999999999999999999999997754332 334


Q ss_pred             ccccccCcccCcccccCCCC-CCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ...+||+.|||||++.+..+ +.++|||||||++|||++|+.||.........    ................+++++.+
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~s~~~~~  238 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE----YSDWKEKKTYLNPWKKIDSAPLA  238 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH----HHHHHTTCTTSTTGGGSCHHHHH
T ss_pred             cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH----HHHHhcCCCCCCccccCCHHHHH
Confidence            45789999999999988776 67899999999999999999998443211100    00111111111122345678899


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~  741 (762)
                      |+.+||+.||++|||++|+++
T Consensus       239 li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         239 LLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHhc
Confidence            999999999999999999865

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=408.77  Aligned_cols=257  Identities=25%  Similarity=0.441  Sum_probs=204.3

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCc---ceEEEEEcccccc-chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEec
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSS---DQVAVKKLNRVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEF  561 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~  561 (762)
                      +.+.||+|+||.||+|.+.....   ..||||+++.... ....+|.+|++++++++|||||+++|++.+.+..++||||
T Consensus        11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~   90 (283)
T d1mqba_          11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY   90 (283)
T ss_dssp             EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence            45679999999999998775432   4699999975433 3345799999999999999999999999999999999999


Q ss_pred             cCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc-
Q 004312          562 MSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH-  639 (762)
Q Consensus       562 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-  639 (762)
                      +.+++|.+++... ..+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++.+...... 
T Consensus        91 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~  167 (283)
T d1mqba_          91 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT  167 (283)
T ss_dssp             CTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred             cccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCccc
Confidence            9999999988654 6799999999999999999999998   9999999999999999999999999999977543322 


Q ss_pred             -ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          640 -TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       640 -~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                       ......||+.|+|||.+.++.++.++|||||||++|||++++.|+.........     ...+........+..++.++
T Consensus       168 ~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~-----~~~i~~~~~~~~~~~~~~~l  242 (283)
T d1mqba_         168 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-----MKAINDGFRLPTPMDCPSAI  242 (283)
T ss_dssp             ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----HHHHHTTCCCCCCTTCBHHH
T ss_pred             eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH-----HHHHhccCCCCCchhhHHHH
Confidence             233456899999999999999999999999999999999987775433222111     11222233333444567889


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHhhcCcCCC
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP  750 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  750 (762)
                      .+|+.+||+.||++||||+||+++|+++.+.|
T Consensus       243 ~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         243 YQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             HHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence            99999999999999999999999999877654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=401.71  Aligned_cols=248  Identities=23%  Similarity=0.321  Sum_probs=208.3

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||+||+|... .+++.||||+++.......+.+.+|++++++++|||||++++++.+.+..+|||||++
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~  100 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBT-TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             cEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence            445678999999999999743 4578999999987666667789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccccc
Q 004312          564 NGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNTA  643 (762)
Q Consensus       564 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  643 (762)
                      +|+|.+++.+ ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.+.... .....
T Consensus       101 gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~  175 (293)
T d1yhwa1         101 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRST  175 (293)
T ss_dssp             TCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCC
T ss_pred             CCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccccc
Confidence            9999998864 4689999999999999999999999   99999999999999999999999999998765433 23345


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVAI  723 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  723 (762)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...............    .......+..+++++.+++.
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~~li~  251 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN----GTPELQNPEKLSAIFRDFLN  251 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH----CSCCCSSGGGSCHHHHHHHH
T ss_pred             cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC----CCCCCCCcccCCHHHHHHHH
Confidence            67999999999999999999999999999999999999998554332222211100    11111223456788999999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 004312          724 WCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       724 ~cl~~dp~~RPt~~evl~  741 (762)
                      +||+.||++|||++|+++
T Consensus       252 ~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         252 RCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             HHTCSSTTTSCCHHHHTT
T ss_pred             HHccCChhHCcCHHHHhc
Confidence            999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-48  Score=398.65  Aligned_cols=244  Identities=27%  Similarity=0.362  Sum_probs=207.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||+||+|+.. .+++.||||++.+.   .....+.+.+|++++++++|||||++++++.+.+..+||||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEecCCCcEEEEEEEC-CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence            456678999999999999754 45789999998643   23345689999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++|+|.+++.....+++..+..++.||++||+|||++   +|+||||||+||||++++.+||+|||+++....   ..
T Consensus        87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---~~  160 (263)
T d2j4za1          87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SR  160 (263)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---CC
T ss_pred             ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC---Cc
Confidence            999999999998888899999999999999999999998   999999999999999999999999999986542   22


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.....     ....  ...+...++++.+
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i-----~~~~--~~~p~~~s~~~~~  233 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-----SRVE--FTFPDFVTEGARD  233 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-----HTTC--CCCCTTSCHHHHH
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH-----HcCC--CCCCccCCHHHHH
Confidence            34567999999999999999999999999999999999999998654333322221     1111  1123345678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~  741 (762)
                      |+.+||+.||++|||++|+++
T Consensus       234 li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         234 LISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCCHhHCcCHHHHHc
Confidence            999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-48  Score=403.50  Aligned_cols=248  Identities=27%  Similarity=0.385  Sum_probs=204.6

Q ss_pred             hcCCCCcceEEEeeeeCC-CcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccCCCc
Q 004312          489 ELGRGAFGTVYKGFVNMG-SSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       489 ~iG~G~~g~Vy~g~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      +||+|+||+||+|.+... ++..||||+++... ....++|.+|++++++++|||||+++|+|.+ +..+|||||+++|+
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~   94 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP   94 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence            499999999999976532 34579999997543 3345789999999999999999999999865 56899999999999


Q ss_pred             hhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc--cccc
Q 004312          567 LASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH--TNTA  643 (762)
Q Consensus       567 L~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~--~~~~  643 (762)
                      |.+++... ..+++..++.|+.||++||+|||++   +|+||||||+||||++++.+||+|||+++.+......  ....
T Consensus        95 L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  171 (285)
T d1u59a_          95 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  171 (285)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred             HHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccccc
Confidence            99998654 6799999999999999999999998   9999999999999999999999999999987544332  2234


Q ss_pred             ccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHHHH
Q 004312          644 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVMVA  722 (762)
Q Consensus       644 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  722 (762)
                      ..||+.|+|||.+.++.++.++|||||||++|||+| |+.||......+..      ..+........+..+++++.+|+
T Consensus       172 ~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~------~~i~~~~~~~~p~~~~~~l~~li  245 (285)
T d1u59a_         172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------AFIEQGKRMECPPECPPELYALM  245 (285)
T ss_dssp             SCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH------HHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             cccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH------HHHHcCCCCCCCCcCCHHHHHHH
Confidence            568999999999999999999999999999999998 89997543222111      11222223333455678899999


Q ss_pred             HHhhccCCCCCCCHHHHHHHhhcC
Q 004312          723 IWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       723 ~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      .+||+.||++||||.+|++.|+..
T Consensus       246 ~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         246 SDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             HHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHHHHH
Confidence            999999999999999999998753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-47  Score=394.96  Aligned_cols=245  Identities=27%  Similarity=0.384  Sum_probs=197.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceecc----CCceeEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE----GRNRLLV  558 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~LV  558 (762)
                      .|.++||+|+||+||+|... .+++.||+|++....  ....+.|.+|++++++++|||||++++++.+    ....+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~-~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            35568999999999999754 556799999987542  3345679999999999999999999999854    3457899


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEeCCCCCCceEEc-CCCceEEecccccccccC
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQ--IIHCDIKPQNILLD-DYYNARISDFGLEKLLTL  635 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~  635 (762)
                      |||+++|+|.+++.+...+++..+..++.||++||+|||++   +  |+||||||+||||+ +++.+||+|||+++....
T Consensus        91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999998888899999999999999999999998   6  99999999999996 588999999999986432


Q ss_pred             CCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                         .......||+.|||||.+.+ .++.++|||||||++|||++|+.||...............    .......+...+
T Consensus       168 ---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~----~~~~~~~~~~~~  239 (270)
T d1t4ha_         168 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS----GVKPASFDKVAI  239 (270)
T ss_dssp             ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT----TCCCGGGGGCCC
T ss_pred             ---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc----CCCCcccCccCC
Confidence               23345679999999999865 6999999999999999999999998533221111111111    101111122345


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+|+.+||+.||++|||++|+++
T Consensus       240 ~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         240 PEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            67899999999999999999999976

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-48  Score=399.87  Aligned_cols=250  Identities=22%  Similarity=0.315  Sum_probs=192.3

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceecc--CCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~LV~  559 (762)
                      +.+.+.||+|+||+||+|+.. .+++.||||+++...  ....+.+.+|++++++++|||||++++++.+  ....+|||
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm   84 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   84 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred             CEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence            345678999999999999754 456799999987543  3334678999999999999999999998865  45679999


Q ss_pred             eccCCCchhhhccC----CCCCCHHHHHHHHHHHHHHHHHhHhcC--CCCeEeCCCCCCceEEcCCCceEEecccccccc
Q 004312          560 EFMSNGALASFLFG----DSKPNWKLRTEIVMGIARGLFYLHEEC--CTQIIHCDIKPQNILLDDYYNARISDFGLEKLL  633 (762)
Q Consensus       560 E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~  633 (762)
                      ||+++|+|.+++.+    ...+++..++.++.||+.||+|||++.  ..+|+||||||+||||++++.+||+|||+++.+
T Consensus        85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~  164 (269)
T d2java1          85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  164 (269)
T ss_dssp             ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred             ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence            99999999999864    367999999999999999999999972  124999999999999999999999999999987


Q ss_pred             cCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHH
Q 004312          634 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMT  713 (762)
Q Consensus       634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  713 (762)
                      ..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....     +..... ...+..
T Consensus       165 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~-----i~~~~~-~~~~~~  237 (269)
T d2java1         165 NHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK-----IREGKF-RRIPYR  237 (269)
T ss_dssp             ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-----HHHTCC-CCCCTT
T ss_pred             ccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHH-----HHcCCC-CCCCcc
Confidence            54322 23456799999999999999999999999999999999999999865433322211     111111 122334


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          714 VLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       714 ~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .++++.+|+.+||+.||++|||++|+++
T Consensus       238 ~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         238 YSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            6678999999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=408.61  Aligned_cols=254  Identities=26%  Similarity=0.352  Sum_probs=206.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCC----cceEEEEEcccc-ccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGS----SDQVAVKKLNRV-FQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~L  557 (762)
                      ..+.+.||+|+||+||+|+.....    ...||||++... .......+.+|+.++.++ +|||||++++++.+.+..+|
T Consensus        39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l  118 (325)
T d1rjba_          39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL  118 (325)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEE
Confidence            345678999999999999875432    236999998653 334456899999999998 89999999999999999999


Q ss_pred             EEeccCCCchhhhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCce
Q 004312          558 VYEFMSNGALASFLFGD-----------------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNI  614 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~-----------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  614 (762)
                      ||||+++|+|.++|+..                       ..+++..++.|+.||++||+|||++   +|+||||||+||
T Consensus       119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Ni  195 (325)
T d1rjba_         119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNV  195 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGE
T ss_pred             EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhcc
Confidence            99999999999999754                       2478999999999999999999998   999999999999


Q ss_pred             EEcCCCceEEecccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHh
Q 004312          615 LLDDYYNARISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDC  692 (762)
Q Consensus       615 Ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~  692 (762)
                      |++.++.+||+|||+++........ ......||+.|||||.+.++.++.++|||||||++|||+| |+.||....... 
T Consensus       196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~-  274 (325)
T d1rjba_         196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA-  274 (325)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred             ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH-
Confidence            9999999999999999876544433 2334568999999999999999999999999999999998 788874321111 


Q ss_pred             hhccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          693 YQERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                          .+..++........+..+++++.+|+.+||+.||++|||++||+++|..
T Consensus       275 ----~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         275 ----NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             ----HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence                1122233333333445567889999999999999999999999999963

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=400.98  Aligned_cols=246  Identities=21%  Similarity=0.280  Sum_probs=205.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||+||+|+.. .+++.||||++++.   .....+.+.+|++++++++|||||++++++.+.+..+||||
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence            456688999999999999754 45689999998753   23344679999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC-c
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS-H  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~  639 (762)
                      |+++|+|.+++...+.+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++.+..... .
T Consensus        89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            999999999998888999999999999999999999999   999999999999999999999999999997754332 2


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||............     ....  ...+...++++.
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i-----~~~~--~~~p~~~s~~~~  238 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI-----IKLE--YDFPEKFFPKAR  238 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HTTC--CCCCTTCCHHHH
T ss_pred             ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH-----HcCC--CCCCccCCHHHH
Confidence            334567999999999999999999999999999999999999998655433332221     1111  112334567899


Q ss_pred             HHHHHhhccCCCCCCCHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVT  740 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl  740 (762)
                      +|+.+||+.||++|||++|++
T Consensus       239 ~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         239 DLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             HHHHTTSCSSGGGSTTSGGGT
T ss_pred             HHHHHHccCCHhHCcCHHHHc
Confidence            999999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=408.98  Aligned_cols=251  Identities=22%  Similarity=0.302  Sum_probs=202.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc-ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||+||+|.. ..+++.||||+++.. .......+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus         8 y~~~~~iG~G~fg~V~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~   86 (322)
T d1s9ja_           8 FEKISELGAGNGGVVFKVSH-KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM   86 (322)
T ss_dssp             EEEEEEEECCSSCCEEEEEE-TTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CEEEEEEecCCCeEEEEEEE-CCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            44557899999999999975 355789999999754 2344568999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHE-ECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      ++|+|.+++.+.+.+++..+..++.||++||.|||+ .   +|+||||||+||||++++.+||+|||+|+.....   ..
T Consensus        87 ~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~~  160 (322)
T d1s9ja_          87 DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA  160 (322)
T ss_dssp             TTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---TC
T ss_pred             CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC---cc
Confidence            999999999888889999999999999999999997 5   8999999999999999999999999999876432   22


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhh--ccccc--------------------
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ--ERTLG--------------------  699 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~--~~~~~--------------------  699 (762)
                      ...+||+.|+|||++.+..++.++||||+||++|||++|+.||..........  .....                    
T Consensus       161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY  240 (322)
T ss_dssp             ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred             ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence            34679999999999999999999999999999999999999985432111000  00000                    


Q ss_pred             ---------------cccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          700 ---------------ALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       700 ---------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                                     ...............+.++.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                           000000000011123567899999999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-47  Score=399.98  Aligned_cols=248  Identities=23%  Similarity=0.324  Sum_probs=205.5

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||+||+|... .+++.||||+++.......+.|.+|++++++++|||||++++++.+.+..+|||||++
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~   92 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNK-ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             eEEeEEEeeCCCcEEEEEEEC-CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence            345678999999999999754 5567999999987666667889999999999999999999999999999999999999


Q ss_pred             CCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          564 NGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       564 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      +|+|.+++.+ ...+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~  168 (288)
T d2jfla1          93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD  168 (288)
T ss_dssp             TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHT
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-cccc
Confidence            9999999765 46799999999999999999999999   99999999999999999999999999997653221 1223


Q ss_pred             cccccCcccCccccc-----CCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccc-cccCCCHHHHH
Q 004312          643 AIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND-LEAMDDMTVLQ  716 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  716 (762)
                      ...||+.|+|||++.     ...++.++|||||||++|||++|+.||......+....     +.... .....+...++
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~-----i~~~~~~~~~~~~~~s~  243 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK-----IAKSEPPTLAQPSRWSS  243 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-----HHHSCCCCCSSGGGSCH
T ss_pred             ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH-----HHcCCCCCCCccccCCH
Confidence            467999999999984     45689999999999999999999999854332222211     11111 11122345678


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ++.+|+.+||+.||++|||++|+++
T Consensus       244 ~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         244 NFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhc
Confidence            8999999999999999999999876

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.4e-47  Score=399.29  Aligned_cols=249  Identities=23%  Similarity=0.347  Sum_probs=192.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||+||+|... .+++.||||++.+.. ....+.+.+|++++++++|||||++++++.+.+..+|||||+
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~   89 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDK-RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV   89 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEET-TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            456788999999999999754 557899999997543 233457889999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc---CCCceEEecccccccccCCCCc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      ++|+|.++|...+.+++..+..++.||+.||+|||++   +|+||||||+|||+.   +++.+||+|||+++.....  .
T Consensus        90 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~--~  164 (307)
T d1a06a_          90 SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--S  164 (307)
T ss_dssp             CSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             CCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC--C
Confidence            9999999999888999999999999999999999998   999999999999995   5789999999999865432  2


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      .....+||+.|||||.+.+..++.++|||||||++|||++|+.||......+..........   .........+++++.
T Consensus       165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY---EFDSPYWDDISDSAK  241 (307)
T ss_dssp             --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC---CCCTTTTTTSCHHHH
T ss_pred             eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC---CCCCccccCCCHHHH
Confidence            33456799999999999999999999999999999999999999865443332221111100   111112234567899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 004312          720 MVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +|+.+||+.||++|||++|+++
T Consensus       242 ~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         242 DFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHhc
Confidence            9999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.8e-47  Score=400.72  Aligned_cols=255  Identities=24%  Similarity=0.359  Sum_probs=208.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeC----CCcceEEEEEccccccc-hhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      .+.+.||+|+||+||+|+...    .+++.||||+++..... ..++|.+|++++++++||||++++++|.+....++||
T Consensus        16 ~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~   95 (301)
T d1lufa_          16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF   95 (301)
T ss_dssp             EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEE
Confidence            456789999999999998753    34568999999754333 3568999999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCC------------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceE
Q 004312          560 EFMSNGALASFLFGD------------------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNIL  615 (762)
Q Consensus       560 E~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIL  615 (762)
                      ||+++|+|.++|...                        ..+++..++.|+.||+.||+|||++   +|+||||||+|||
T Consensus        96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NIL  172 (301)
T d1lufa_          96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL  172 (301)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceE
Confidence            999999999998532                        2478999999999999999999998   9999999999999


Q ss_pred             EcCCCceEEecccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCC-CCchhhHHHhh
Q 004312          616 LDDYYNARISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR-TILTDWAYDCY  693 (762)
Q Consensus       616 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~-p~~~~~~~~~~  693 (762)
                      |+.++.+||+|||+++.+..... .......+++.|+|||.+.+..++.++|||||||++|||++|.. |+......+..
T Consensus       173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~  252 (301)
T d1lufa_         173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI  252 (301)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHH
Confidence            99999999999999987654332 23345668999999999999999999999999999999999975 45433222222


Q ss_pred             hccccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          694 QERTLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ..      +........+..+++++.+|+.+||+.+|++||||+||+++|+++.+
T Consensus       253 ~~------v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         253 YY------VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             HH------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HH------HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            11      11111222344566789999999999999999999999999998764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=397.94  Aligned_cols=256  Identities=24%  Similarity=0.392  Sum_probs=207.1

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCc--ceEEEEEcccc-ccchhHHHHHHhhhhcccccCCccchhceecc-CCceeEEEe
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSS--DQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-GRNRLLVYE  560 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~LV~E  560 (762)
                      +|.++||+|+||+||+|.+...++  ..||||++++. .....++|.+|++++++++|||||+++|++.+ ....++|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            456789999999999998765432  36899999753 33445789999999999999999999999875 457899999


Q ss_pred             ccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          561 FMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      ||++|+|.+++... ..+++..+++++.|+++||.|||+.   +|+||||||+||||++++.+||+|||+++........
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999999865 4678899999999999999999998   9999999999999999999999999999977544332


Q ss_pred             ---ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          640 ---TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       640 ---~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                         ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.........     ...+........+..+++
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~-----~~~i~~g~~~~~p~~~~~  261 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----TVYLLQGRRLLQPEYCPD  261 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C-----HHHHHTTCCCCCCTTCCH
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH-----HHHHHcCCCCCCcccCcH
Confidence               223356899999999999999999999999999999999999887543221111     111111222223344567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ++.+|+.+||+.||++||+|+||++.|+++..
T Consensus       262 ~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         262 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            89999999999999999999999999988753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-46  Score=397.37  Aligned_cols=244  Identities=25%  Similarity=0.319  Sum_probs=203.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +...+.||+|+||+||+|+.. .+++.||||+++....   ...+++.+|++++++++|||||++++++.+.+..+||||
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEeeEEEecCCCeEEEEEEEC-CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            445578999999999999754 4577899999875432   233578999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      ||++|+|..++.....+++..+..++.||+.||.|||++   +|+||||||+||||++++.+||+|||+++....     
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----  167 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence            999999998887788899999999999999999999999   999999999999999999999999999986532     


Q ss_pred             cccccccCcccCcccccC---CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRN---MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQR  717 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~---~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  717 (762)
                      .....||+.|||||++.+   +.++.++|||||||++|||++|+.||......+....     +.........+...+++
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~-----i~~~~~~~~~~~~~s~~  242 (309)
T d1u5ra_         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-----IAQNESPALQSGHWSEY  242 (309)
T ss_dssp             BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----HHHSCCCCCSCTTSCHH
T ss_pred             CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH-----HHhCCCCCCCCCCCCHH
Confidence            234569999999999863   4689999999999999999999999865433332221     11111122223345678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 004312          718 FVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       718 ~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +.+|+.+||+.||++|||++|+++
T Consensus       243 ~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         243 FRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHCcCChhHCcCHHHHHh
Confidence            999999999999999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-47  Score=392.95  Aligned_cols=254  Identities=22%  Similarity=0.300  Sum_probs=196.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCC--cceEEEEEccccccc-hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGS--SDQVAVKKLNRVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|......  ...||||+++..... ..+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus         9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E   87 (273)
T d1mp8a_           9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIME   87 (273)
T ss_dssp             EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEEE
Confidence            445678999999999999865432  346899998754333 34679999999999999999999999964 67899999


Q ss_pred             ccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          561 FMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |+++|+|.+++... ..+++..++.++.||++||.|||++   +|+||||||+||++++++.+||+|||+++........
T Consensus        88 ~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~  164 (273)
T d1mp8a_          88 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  164 (273)
T ss_dssp             CCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred             eccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence            99999999987654 5789999999999999999999999   9999999999999999999999999999977655555


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRF  718 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  718 (762)
                      ......||+.|+|||.+.+..++.++|||||||++|||++ |+.|+......+...      .+........+..+++++
T Consensus       165 ~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~------~i~~~~~~~~~~~~~~~~  238 (273)
T d1mp8a_         165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG------RIENGERLPMPPNCPPTL  238 (273)
T ss_dssp             ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH------HHHTTCCCCCCTTCCHHH
T ss_pred             eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH------HHHcCCCCCCCCCCCHHH
Confidence            5556678999999999999999999999999999999998 677764432222111      111222223345667889


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      .+|+.+||+.||++|||++||++.|+.++
T Consensus       239 ~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         239 YSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            99999999999999999999999998764

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.8e-46  Score=399.84  Aligned_cols=250  Identities=22%  Similarity=0.323  Sum_probs=208.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+|+.. .+++.||||++........+.+.+|++++++++|||||++++++.+.+..+||||||+
T Consensus        28 Y~i~~~lG~G~fg~Vy~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  106 (350)
T d1koaa2          28 YDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  106 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             eEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            556788999999999999754 4578999999987666667789999999999999999999999999999999999999


Q ss_pred             CCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc--CCCceEEecccccccccCCCCcc
Q 004312          564 NGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD--DYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       564 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +|+|.+++.. ...+++..+..|+.||+.||+|||++   +|+||||||+|||++  .++.+||+|||+++.+...  ..
T Consensus       107 gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--~~  181 (350)
T d1koaa2         107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QS  181 (350)
T ss_dssp             SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--SC
T ss_pred             CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc--cc
Confidence            9999999964 46799999999999999999999999   999999999999996  4678999999999876532  33


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....||+.|||||++.+..++.++|||||||++|||++|+.||......+.+........   .........+++++.+
T Consensus       182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~s~~~~~  258 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW---NMDDSAFSGISEDGKD  258 (350)
T ss_dssp             EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---CSCCGGGGGCCHHHHH
T ss_pred             cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCcccccCCCHHHHH
Confidence            4456799999999999999999999999999999999999999865543333322111100   0111112345678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~  742 (762)
                      |+.+||+.||++|||++|+++.
T Consensus       259 li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         259 FIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHHS
T ss_pred             HHHHHccCChhHCcCHHHHhcC
Confidence            9999999999999999999873

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=389.03  Aligned_cols=246  Identities=27%  Similarity=0.381  Sum_probs=196.1

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccC-CceeEEEeccC
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-RNRLLVYEFMS  563 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~LV~E~~~  563 (762)
                      .+.+.||+|+||.||+|.+.   ++.||||+++..  ...++|.+|++++++++|||||+++|+|.+. +..+|||||++
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_          10 KLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             EEEEEEEECSSCEEEEEEET---TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             EEeEEEecCCCeEEEEEEEC---CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence            35678999999999999874   468999999753  3457899999999999999999999998654 56799999999


Q ss_pred             CCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          564 NGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       564 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      +|+|.++|...  ..+++..++.|+.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....    ..
T Consensus        85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----~~  157 (262)
T d1byga_          85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----TQ  157 (262)
T ss_dssp             TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC----CC
Confidence            99999999764  3589999999999999999999998   999999999999999999999999999986532    22


Q ss_pred             ccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhC-CCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          642 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICL-RRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....+++.|+|||++.++.++.++||||||+++|||+|+ +.|+......+      +...+........+...++++.+
T Consensus       158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~------~~~~i~~~~~~~~~~~~~~~~~~  231 (262)
T d1byga_         158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPDGCPPAVYE  231 (262)
T ss_dssp             ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------HHHHHTTTCCCCCCTTCCHHHHH
T ss_pred             ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCCCCCCccCCHHHHH
Confidence            334578999999999999999999999999999999985 55543221111      11112222333344456688999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      |+.+||+.||++||||.||+++|+.+..
T Consensus       232 li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         232 VMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999988653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=396.66  Aligned_cols=254  Identities=28%  Similarity=0.435  Sum_probs=204.7

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCc-ceEEEEEcccc-ccchhHHHHHHhhhhccc-ccCCccchhceeccCCceeEEEecc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSS-DQVAVKKLNRV-FQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~-~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.||+|+||+||+|++..... ..||||+++.. .....++|.+|+++++++ +|||||+++|+|.+.+..++||||+
T Consensus        14 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~   93 (309)
T d1fvra_          14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   93 (309)
T ss_dssp             EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             EEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEec
Confidence            55789999999999998764332 36889988643 333456899999999998 7999999999999999999999999


Q ss_pred             CCCchhhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEec
Q 004312          563 SNGALASFLFGD----------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISD  626 (762)
Q Consensus       563 ~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  626 (762)
                      ++|+|.++|+..                ..+++..+.+++.|||+||.|||++   +|+||||||+|||++.++.+||+|
T Consensus        94 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~D  170 (309)
T d1fvra_          94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD  170 (309)
T ss_dssp             TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECC
T ss_pred             CCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEcc
Confidence            999999999754                5689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCC-CchhhHHHhhhccccccccccc
Q 004312          627 FGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRT-ILTDWAYDCYQERTLGALVEND  705 (762)
Q Consensus       627 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~  705 (762)
                      ||+++.....  .......||..|+|||.+.+..++.++||||||+++|||++|..| +......+...      .+...
T Consensus       171 fG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~------~i~~~  242 (309)
T d1fvra_         171 FGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------KLPQG  242 (309)
T ss_dssp             TTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HGGGT
T ss_pred             cccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH------HHHhc
Confidence            9999865422  222345689999999999999999999999999999999998765 43322222111      11122


Q ss_pred             cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcCCC
Q 004312          706 LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVEVP  750 (762)
Q Consensus       706 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~  750 (762)
                      .....+..+++++.+|+.+||+.||++||||+||++.|+++.+-.
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            223334456789999999999999999999999999999876433

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.6e-45  Score=396.03  Aligned_cols=249  Identities=24%  Similarity=0.316  Sum_probs=208.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      +.+.+.||+|+||.||+|... .+++.||||+++.......+.+.+|++++++++|||||++++++.+.+..+|||||++
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  109 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS  109 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             eEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            556688999999999999743 4578999999987655666789999999999999999999999999999999999999


Q ss_pred             CCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc--CCCceEEecccccccccCCCCcc
Q 004312          564 NGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD--DYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       564 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +|+|.+++... .++++..+..|+.||+.||+|||++   +|+||||||+||||+  +++.+||+|||+++.+...  ..
T Consensus       110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--~~  184 (352)
T d1koba_         110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EI  184 (352)
T ss_dssp             CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--SC
T ss_pred             CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC--Cc
Confidence            99999887665 4699999999999999999999998   999999999999998  6789999999999877543  33


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.................   .........+++++.+
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~s~~~~~  261 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW---EFDEDAFSSVSPEAKD  261 (352)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC---CCCSSTTTTSCHHHHH
T ss_pred             eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCcccccCCCHHHHH
Confidence            4456799999999999999999999999999999999999999865433333222111100   1111122345678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 004312          721 VAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt~~evl~  741 (762)
                      |+.+||+.||.+|||++|+++
T Consensus       262 li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         262 FIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999986

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=388.71  Aligned_cols=249  Identities=26%  Similarity=0.348  Sum_probs=206.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc------chhHHHHHHhhhhcccccCCccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L  557 (762)
                      +.+.+.||+|+||+||+|... .+++.||||++++...      ...+.+.+|++++++++|||||++++++.+.+..+|
T Consensus        12 Y~~~~~lG~G~fg~Vy~~~~~-~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (293)
T d1jksa_          12 YDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   90 (293)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             EEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            456688999999999999754 5678999999864321      235789999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC----ceEEecccccccc
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY----NARISDFGLEKLL  633 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Dfgla~~~  633 (762)
                      |||||++|+|.++|...+.+++..++.++.||+.||+|||++   +|+||||||+|||++.++    .+||+|||+++..
T Consensus        91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          91 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            999999999999998888899999999999999999999999   999999999999998766    5999999999876


Q ss_pred             cCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHH
Q 004312          634 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMT  713 (762)
Q Consensus       634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  713 (762)
                      ...  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+..........   .........
T Consensus       168 ~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~  242 (293)
T d1jksa_         168 DFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY---EFEDEYFSN  242 (293)
T ss_dssp             TTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC---CCCHHHHTT
T ss_pred             CCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---CCCchhcCC
Confidence            432  233455789999999999999999999999999999999999999865543333222111000   000001123


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          714 VLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       714 ~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+.++.+|+.+||+.||++|||++|+++
T Consensus       243 ~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         243 TSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            4578899999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=388.43  Aligned_cols=252  Identities=25%  Similarity=0.332  Sum_probs=197.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCc--ceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSS--DQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      .+.+.||+|+||.||+|++...++  ..||||++++.   .....++|.+|++++++++|||||+++|+|.+ ...++||
T Consensus        11 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~   89 (273)
T d1u46a_          11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVT   89 (273)
T ss_dssp             EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             EEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheee
Confidence            456789999999999998764433  47999998753   23345689999999999999999999999976 4678999


Q ss_pred             eccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          560 EFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       560 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      ||+++|+|.+++... ..+++..++.++.||++||.|||++   +|+||||||+||||+.++.+||+|||+++.......
T Consensus        90 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~  166 (273)
T d1u46a_          90 ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD  166 (273)
T ss_dssp             ECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred             eeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence            999999999887654 5699999999999999999999998   999999999999999999999999999998754433


Q ss_pred             c--ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHH
Q 004312          639 H--TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVL  715 (762)
Q Consensus       639 ~--~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  715 (762)
                      .  ......++..|+|||.+.+..++.++||||||+++|||+| |+.||......+...     .+.........+..++
T Consensus       167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~-----~i~~~~~~~~~~~~~~  241 (273)
T d1u46a_         167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-----KIDKEGERLPRPEDCP  241 (273)
T ss_dssp             EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-----HHHTSCCCCCCCTTCC
T ss_pred             cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH-----HHHhCCCCCCCccccc
Confidence            2  2234567889999999999999999999999999999998 788875443332221     1222222223344566


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHhhc
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQMLEG  745 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~~L~~  745 (762)
                      .++.+|+.+||+.||++||||+||++.|++
T Consensus       242 ~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         242 QDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            789999999999999999999999999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-45  Score=389.38  Aligned_cols=246  Identities=23%  Similarity=0.250  Sum_probs=208.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|+.. .+++.||||++++.   .....+.+.+|+.+|++++|||||++++.+.+.+..++|||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e   85 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence            445678999999999999743 56789999999753   23345678999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      ||++|+|.+++.....+++..++.++.||+.||+|||++   +|+||||||+||||++++.+||+|||+++..... ...
T Consensus        86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~~~  161 (337)
T d1o6la_          86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GAT  161 (337)
T ss_dssp             CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCC
T ss_pred             ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC-Ccc
Confidence            999999999999889999999999999999999999999   9999999999999999999999999999865432 233


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+......     ...  ...+...++++.+
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~-----~~~--~~~p~~~s~~~~d  234 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-----MEE--IRFPRTLSPEAKS  234 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HCC--CCCCTTSCHHHHH
T ss_pred             cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh-----cCC--CCCCccCCHHHHH
Confidence            445779999999999999999999999999999999999999986654433332211     111  1123346678999


Q ss_pred             HHHHhhccCCCCCCC-----HHHHHH
Q 004312          721 VAIWCIQEDPSHRPT-----MRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RPt-----~~evl~  741 (762)
                      |+.+||+.||++||+     ++|+++
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         235 LLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHhhccCCchhhcccccccHHHHHc
Confidence            999999999999995     788875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-46  Score=393.60  Aligned_cols=257  Identities=25%  Similarity=0.353  Sum_probs=197.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCC----CcceEEEEEccccc-cchhHHHHHHhhhhccc-ccCCccchhceeccC-Ccee
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMG----SSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEG-RNRL  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~~~~  556 (762)
                      +.+.++||+|+||.||+|.....    +.+.||||+++... ....+.+.+|+..+.++ +|+|||++++++.+. ...+
T Consensus        15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~   94 (299)
T d1ywna1          15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM   94 (299)
T ss_dssp             EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred             EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence            44567899999999999986532    34679999997543 33456788888888887 789999999988664 4689


Q ss_pred             EEEeccCCCchhhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC
Q 004312          557 LVYEFMSNGALASFLFGD----------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY  620 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~  620 (762)
                      +|||||++|+|.++|+..                ..+++..++.++.||++||+|||++   +|+||||||+||||++++
T Consensus        95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~  171 (299)
T d1ywna1          95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN  171 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCC
Confidence            999999999999999643                3478999999999999999999998   999999999999999999


Q ss_pred             ceEEecccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCC-CCchhhHHHhhhcccc
Q 004312          621 NARISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR-TILTDWAYDCYQERTL  698 (762)
Q Consensus       621 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~-p~~~~~~~~~~~~~~~  698 (762)
                      .+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+. |+........     +
T Consensus       172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~-----~  246 (299)
T d1ywna1         172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----F  246 (299)
T ss_dssp             CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-----H
T ss_pred             cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-----H
Confidence            9999999999876544332 3345679999999999999999999999999999999999865 4422211111     1


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          699 GALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       699 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ...+........+...++++.+++.+||+.||++|||++||+++|+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11122222223334456789999999999999999999999999998754

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-46  Score=394.50  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=201.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCc---ceEEEEEcccc-ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSS---DQVAVKKLNRV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +.+.+.||+|+||+||+|.+.....   .+||||+++.. .....++|.+|++++++++|||||+++|+|.++ ..++++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence            3456789999999999998653321   25999998653 344567899999999999999999999999875 567889


Q ss_pred             eccCCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          560 EFMSNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       560 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      ||+.+|+|.+++... ..+++..++.++.||++||+|||++   +|+||||||+||||+.++.+||+|||+++.......
T Consensus        90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~  166 (317)
T d1xkka_          90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  166 (317)
T ss_dssp             ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred             EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence            999999999887654 6789999999999999999999998   999999999999999999999999999998765443


Q ss_pred             cc-cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          639 HT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       639 ~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                      .. .....||+.|+|||.+.++.++.++|||||||++|||+| |+.|+.....      ..+...+........+..+++
T Consensus       167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~------~~~~~~i~~~~~~~~p~~~~~  240 (317)
T d1xkka_         167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SEISSILEKGERLPQPPICTI  240 (317)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG------GGHHHHHHHTCCCCCCTTBCH
T ss_pred             cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH------HHHHHHHHcCCCCCCCcccCH
Confidence            32 334568999999999999999999999999999999999 5666533211      112222323333334455678


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          717 RFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      ++.+|+.+||+.||++|||++||++.|+.+
T Consensus       241 ~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         241 DVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            899999999999999999999999988765

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.2e-45  Score=386.67  Aligned_cols=243  Identities=22%  Similarity=0.310  Sum_probs=207.0

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||+||+|+.. .+++.||||++++.   .....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   84 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   84 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence            345678999999999999754 45789999999753   23345689999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+++|+|..++.....+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++....    .
T Consensus        85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~----~  157 (316)
T d1fota_          85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----V  157 (316)
T ss_dssp             CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS----C
T ss_pred             ecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc----c
Confidence            999999999999989999999999999999999999999   999999999999999999999999999987642    2


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      ....+||+.|||||++.+..++.++|||||||++|||++|+.||......+.....     ....  ...+...++++.+
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i-----~~~~--~~~p~~~s~~~~~  230 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-----LNAE--LRFPPFFNEDVKD  230 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-----HHCC--CCCCTTSCHHHHH
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH-----HcCC--CCCCCCCCHHHHH
Confidence            34567999999999999999999999999999999999999998665443333221     1111  1123345678999


Q ss_pred             HHHHhhccCCCCCC-----CHHHHHH
Q 004312          721 VAIWCIQEDPSHRP-----TMRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RP-----t~~evl~  741 (762)
                      ++.+||+.||.+||     |++|+++
T Consensus       231 li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         231 LLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHHhhhCHHhccccchhhHHHHHc
Confidence            99999999999996     8999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=392.19  Aligned_cols=256  Identities=26%  Similarity=0.410  Sum_probs=211.0

Q ss_pred             hhhhhhcCCCCcceEEEeeee----CCCcceEEEEEcccccc-chhHHHHHHhhhhccc-ccCCccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVN----MGSSDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~L  557 (762)
                      +.+.+.||+|+||.||+|++.    ...++.||||+++.... ....+|.+|+.+++++ +|||||+++|+|.+....+|
T Consensus        25 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~l  104 (311)
T d1t46a_          25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV  104 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             eEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEE
Confidence            446688999999999999864    24456899999976433 3445799999999999 79999999999999999999


Q ss_pred             EEeccCCCchhhhccCC------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC
Q 004312          558 VYEFMSNGALASFLFGD------------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY  619 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~  619 (762)
                      |||||++|+|.++|+..                  ..+++..+..++.||++||+|||++   +|+||||||+|||++.+
T Consensus       105 vmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~  181 (311)
T d1t46a_         105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG  181 (311)
T ss_dssp             EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETT
T ss_pred             EEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccccc
Confidence            99999999999998643                  2589999999999999999999999   99999999999999999


Q ss_pred             CceEEecccccccccCCCC-cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccc
Q 004312          620 YNARISDFGLEKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTL  698 (762)
Q Consensus       620 ~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~  698 (762)
                      +.+||+|||+++....... .......||+.|+|||.+.++.++.++||||||+++|||+|++.|+......    ...+
T Consensus       182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~----~~~~  257 (311)
T d1t46a_         182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV----DSKF  257 (311)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS----SHHH
T ss_pred             CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH----HHHH
Confidence            9999999999997754433 2334467899999999999999999999999999999999976664322111    1112


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          699 GALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       699 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      ..++........+...++++.+|+.+||+.||++||||+||+++|+++
T Consensus       258 ~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            223333333344445678899999999999999999999999999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-45  Score=387.10  Aligned_cols=256  Identities=24%  Similarity=0.395  Sum_probs=207.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeC----CCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNM----GSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      .+.+.||+|+||+||+|.+..    ..++.||||+++... ......|.+|++++++++|||||+++|+|...+..++||
T Consensus        23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~  102 (308)
T d1p4oa_          23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM  102 (308)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence            355789999999999997642    224679999997543 333457999999999999999999999999999999999


Q ss_pred             eccCCCchhhhccCC----------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccc
Q 004312          560 EFMSNGALASFLFGD----------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGL  629 (762)
Q Consensus       560 E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl  629 (762)
                      ||+++|+|.+++...          ..+++..+..++.|+|+||.|||++   +|+||||||+||||++++.+||+|||+
T Consensus       103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGl  179 (308)
T d1p4oa_         103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM  179 (308)
T ss_dssp             ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeeccc
Confidence            999999999998632          3468999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccccccccccccc
Q 004312          630 EKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEA  708 (762)
Q Consensus       630 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  708 (762)
                      ++.+...... ......+|+.|+|||.+.+..++.++||||||+++|||+||+.|+.........    ...+.+ ....
T Consensus       180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~----~~~i~~-~~~~  254 (308)
T d1p4oa_         180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----LRFVME-GGLL  254 (308)
T ss_dssp             CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH----HHHHHT-TCCC
T ss_pred             ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHh-CCCC
Confidence            9877544332 233346899999999999999999999999999999999997553322111111    111111 1122


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          709 MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       709 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                      ..+..+++.+.+++.+||+.+|++||||+||+++|++.++
T Consensus       255 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            2334566789999999999999999999999999998754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-45  Score=385.92  Aligned_cols=256  Identities=26%  Similarity=0.345  Sum_probs=205.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCC------cceEEEEEcccccc-chhHHHHHHhhhhccc-ccCCccchhceeccCCce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGS------SDQVAVKKLNRVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGRNR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  555 (762)
                      +.+.+.||+|+||.||+|+....+      ...||||+++.... ....++.+|+..+.++ +|||||+++++|.+....
T Consensus        15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~   94 (299)
T d1fgka_          15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL   94 (299)
T ss_dssp             EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeE
Confidence            345678999999999999764322      24799999976443 3347899999999988 899999999999999999


Q ss_pred             eEEEeccCCCchhhhccCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC
Q 004312          556 LLVYEFMSNGALASFLFGD----------------SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY  619 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~  619 (762)
                      ++||||+++|+|.++|...                ..+++.+++.++.||+.||+|||+.   +|+||||||+|||++.+
T Consensus        95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~  171 (299)
T d1fgka_          95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED  171 (299)
T ss_dssp             EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred             EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCC
Confidence            9999999999999999654                3589999999999999999999999   99999999999999999


Q ss_pred             CceEEecccccccccCCCCc-ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHh-CCCCCchhhHHHhhhccc
Q 004312          620 YNARISDFGLEKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRTILTDWAYDCYQERT  697 (762)
Q Consensus       620 ~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~  697 (762)
                      +.+||+|||+++........ ......+++.|+|||.+.++.+++++||||||+++|||++ |+.|+.........    
T Consensus       172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~----  247 (299)
T d1fgka_         172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF----  247 (299)
T ss_dssp             CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH----
T ss_pred             CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH----
Confidence            99999999999977654432 3344678999999999999999999999999999999998 56665433222221    


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCcC
Q 004312          698 LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVVE  748 (762)
Q Consensus       698 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~~  748 (762)
                        ..+........+..+++++.+|+.+||+.||++|||++||+++|++++.
T Consensus       248 --~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         248 --KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             --HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence              1222233333444567889999999999999999999999999998753

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.2e-45  Score=379.90  Aligned_cols=256  Identities=21%  Similarity=0.287  Sum_probs=201.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc---chhHHHHHHhhhhcccccCCccchhceeccCC----cee
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR----NRL  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~  556 (762)
                      +.+.+.||+|+||+||+|... .+++.||||+++....   ...+.|.+|++++++++|||||++++++...+    ..+
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~   87 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDL-RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   87 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             eEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence            456688999999999999743 4578999999975432   23457999999999999999999999987644    378


Q ss_pred             EEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      |||||+++++|.+++...+.+++.+++.++.||+.||+|||++   +|+||||||+|||++.++..+|+|||.+......
T Consensus        88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS  164 (277)
T ss_dssp             EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred             EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhccc
Confidence            9999999999999998888999999999999999999999998   9999999999999999999999999998765433


Q ss_pred             CC--cccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHH
Q 004312          637 QS--HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       637 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  714 (762)
                      ..  .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......+............   .......+
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~  241 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP---PSARHEGL  241 (277)
T ss_dssp             --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC---GGGTSSSC
T ss_pred             cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC---CchhccCC
Confidence            22  23445679999999999999999999999999999999999999986543333222111111110   11112345


Q ss_pred             HHHHHHHHHHhhccCCCCCC-CHHHHHHHhhcC
Q 004312          715 LQRFVMVAIWCIQEDPSHRP-TMRRVTQMLEGV  746 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RP-t~~evl~~L~~~  746 (762)
                      ++++.+++.+||+.||++|| |++++++.|.++
T Consensus       242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            67899999999999999999 899999988764

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-45  Score=383.13  Aligned_cols=257  Identities=22%  Similarity=0.297  Sum_probs=195.7

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCC----ceeEEEec
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR----NRLLVYEF  561 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~LV~E~  561 (762)
                      +.+.||+|+||.||+|+++   ++.||||+++.. ......+..|+..+.+++|||||+++|+|.+.+    ..+|||||
T Consensus         7 l~~~iG~G~fg~Vy~~~~~---g~~vAvK~~~~~-~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey   82 (303)
T d1vjya_           7 LQESIGKGRFGEVWRGKWR---GEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             EEEEEECCSSSEEEEEEET---TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEeeCCCeEEEEEEEC---CEEEEEEEECcc-chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence            4578999999999999863   578999998643 222233455677778899999999999997654    57899999


Q ss_pred             cCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcC-----CCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          562 MSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC-----CTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       562 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      |++|+|.++|++. .++|..+..++.|+|.||+|||+..     ..+|+||||||+||||++++.+||+|||+++.....
T Consensus        83 ~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~  161 (303)
T d1vjya_          83 HEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             CTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             ccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence            9999999999754 6899999999999999999999742     259999999999999999999999999999977544


Q ss_pred             CCc---ccccccccCcccCcccccCCC------CCCcchhHHHHHHHHHHHhCCCCCchhhH----H----------Hhh
Q 004312          637 QSH---TNTAIRGTKGYVAPEWFRNMP------ITVKVDVYSYGVLLLEIICLRRTILTDWA----Y----------DCY  693 (762)
Q Consensus       637 ~~~---~~~~~~gt~~y~aPE~~~~~~------~s~~~DV~S~Gvil~elltg~~p~~~~~~----~----------~~~  693 (762)
                      ...   ......||+.|+|||++.+..      ++.++|||||||+||||+||..|+.....    +          ...
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T d1vjya_         162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM  241 (303)
T ss_dssp             TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred             CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence            322   233467999999999987643      57789999999999999999876422110    0          000


Q ss_pred             hccccccccccccc-cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          694 QERTLGALVENDLE-AMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       694 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      ..........+... ...+.+....+.+|+.+||+.||++|||++||+++|+++.
T Consensus       242 ~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             HHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            00111111111111 1112346678999999999999999999999999998764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.6e-44  Score=375.62  Aligned_cols=247  Identities=22%  Similarity=0.289  Sum_probs=204.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc---------hhHHHHHHhhhhcccc-cCCccchhceeccCC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD---------SEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGR  553 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~  553 (762)
                      +.+.+.||+|+||+||+|+.. .+++.||||++++....         ..+.+.+|+.++++++ |||||++++++.+.+
T Consensus         5 y~~~~~iG~G~~g~V~~~~~~-~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~   83 (277)
T d1phka_           5 YEPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   83 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CEEceEEecCcCeEEEEEEEC-CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence            345678999999999999753 45789999998653211         2246889999999996 999999999999999


Q ss_pred             ceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccc
Q 004312          554 NRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL  633 (762)
Q Consensus       554 ~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~  633 (762)
                      ..+|||||+++|+|.++|.....+++.+++.++.||++||+|||++   +|+||||||+|||+++++.+||+|||+++..
T Consensus        84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEc
Confidence            9999999999999999998888999999999999999999999998   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccCcccCcccccC------CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccc--
Q 004312          634 TLDQSHTNTAIRGTKGYVAPEWFRN------MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVEND--  705 (762)
Q Consensus       634 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  705 (762)
                      ...  .......||+.|+|||++.+      ..++.++||||+||++|||++|+.||...........     +....  
T Consensus       161 ~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~-----i~~~~~~  233 (277)
T d1phka_         161 DPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-----IMSGNYQ  233 (277)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHTCCC
T ss_pred             cCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH-----HHhCCCC
Confidence            542  23345679999999999853      3578999999999999999999999866543332211     11111  


Q ss_pred             cccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          706 LEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       706 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .........++++.+++.+||+.||++|||++||++
T Consensus       234 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            111222356788999999999999999999999876

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-44  Score=383.58  Aligned_cols=246  Identities=23%  Similarity=0.309  Sum_probs=205.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHHHhhhhc-ccccCCccchhceeccCCceeEEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKAEVNGIG-QTHHKNLVRLLGYCDEGRNRLLVY  559 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~LV~  559 (762)
                      +.+.+.||+|+||+||+|+.. .+++.||||++++..   ....+.+..|+.++. .++|||||++++++.+++..+|||
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~-~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm   82 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   82 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEEC-CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence            346688999999999999754 567899999997532   233456777777765 589999999999999999999999


Q ss_pred             eccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCc
Q 004312          560 EFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       560 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      ||+++|+|.+++.....+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++...... .
T Consensus        83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~  158 (320)
T d1xjda_          83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A  158 (320)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred             eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc-c
Confidence            9999999999999888999999999999999999999999   99999999999999999999999999998654332 3


Q ss_pred             ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHH
Q 004312          640 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFV  719 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  719 (762)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...............       ....+..+++++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-------~~~~p~~~s~~~~  231 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-------NPFYPRWLEKEAK  231 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------CCCCCTTSCHHHH
T ss_pred             cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------CCCCCccCCHHHH
Confidence            334467999999999999999999999999999999999999999665444333222111       1112334567899


Q ss_pred             HHHHHhhccCCCCCCCHH-HHHH
Q 004312          720 MVAIWCIQEDPSHRPTMR-RVTQ  741 (762)
Q Consensus       720 ~li~~cl~~dp~~RPt~~-evl~  741 (762)
                      +|+.+||+.||++|||++ |+++
T Consensus       232 dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         232 DLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             HHHHHhcccCCCCCcCHHHHHHh
Confidence            999999999999999996 6753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.4e-44  Score=382.57  Aligned_cols=243  Identities=21%  Similarity=0.222  Sum_probs=205.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc---ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E  560 (762)
                      +.+.+.||+|+||.||+|+.. .+++.||||++.+.   .....+.+.+|++++++++|||||++++++.+....++|||
T Consensus        43 y~i~~~lG~G~fg~Vy~a~~~-~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          43 FDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence            345678999999999999754 45789999998643   22334678999999999999999999999999999999999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      |+.+|+|..++...+.+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+++....    .
T Consensus       122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~----~  194 (350)
T d1rdqe_         122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----R  194 (350)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS----C
T ss_pred             cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc----c
Confidence            999999999998888999999999999999999999999   999999999999999999999999999987642    2


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQRFVM  720 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  720 (762)
                      .....||+.|||||++.+..++.++|||||||++|||++|+.||............     ....  ...+..+++++.+
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i-----~~~~--~~~p~~~s~~~~~  267 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-----VSGK--VRFPSHFSSDLKD  267 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHCC--CCCCTTCCHHHHH
T ss_pred             cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH-----hcCC--CCCCccCCHHHHH
Confidence            33467999999999999999999999999999999999999998655333322221     1111  1123345678999


Q ss_pred             HHHHhhccCCCCCC-----CHHHHHH
Q 004312          721 VAIWCIQEDPSHRP-----TMRRVTQ  741 (762)
Q Consensus       721 li~~cl~~dp~~RP-----t~~evl~  741 (762)
                      ++.+||+.||.+|+     |++|+++
T Consensus       268 li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         268 LLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHHhhhCHHhccccccccHHHHHc
Confidence            99999999999994     8999985

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-44  Score=375.79  Aligned_cols=249  Identities=23%  Similarity=0.257  Sum_probs=197.2

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccc-----hhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD-----SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      ++||+|+||+||+|+.. .+++.||||+++.....     ..+.+.+|+.++++++|||||++++++.+.+..+|||||+
T Consensus         4 ~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEETTEEEEEEECS-SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             eEeccCcCeEEEEEEEC-CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            57999999999999754 45789999998653222     1346899999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      +++++..++.....+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++....... ...
T Consensus        83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~  158 (299)
T d1ua2a_          83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYT  158 (299)
T ss_dssp             SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCC
T ss_pred             cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-ccc
Confidence            9999988887788899999999999999999999999   999999999999999999999999999987654322 233


Q ss_pred             cccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------cccccc------ccc
Q 004312          643 AIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------TLGALV------END  705 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~~~~~~------~~~  705 (762)
                      ...||+.|+|||.+... .++.++|||||||++|||++|+.||......+.....          ......      ...
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK  238 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred             ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence            45799999999998654 6799999999999999999999988554333222110          000000      000


Q ss_pred             cccCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          706 LEAMDD-----MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       706 ~~~~~~-----~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .....+     ...++++.+|+.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            000001     123578999999999999999999999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2e-43  Score=381.74  Aligned_cols=247  Identities=21%  Similarity=0.219  Sum_probs=198.1

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc---cchhHHHHH---HhhhhcccccCCccchhceeccCCceeE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF---QDSEKEFKA---EVNGIGQTHHKNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~nIv~l~g~~~~~~~~~L  557 (762)
                      +.+.+.||+|+||.||+|+.. .+++.||||++.+..   ......+.+   |+++++.++|||||++++++.+.+..+|
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~-~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i   84 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   84 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             CeeeeEEecCCCeEEEEEEEC-CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence            345678999999999999754 457899999986422   122333444   4677788899999999999999999999


Q ss_pred             EEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCC
Q 004312          558 VYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       558 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~  637 (762)
                      ||||+++|+|.++|.....+++..+..++.||+.||+|||++   +|+||||||+||||++++.+||+|||+++.+... 
T Consensus        85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-  160 (364)
T d1omwa3          85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  160 (364)
T ss_dssp             EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred             EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence            999999999999998888899999999999999999999999   9999999999999999999999999999876533 


Q ss_pred             CcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTVLQ  716 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  716 (762)
                        ......||+.|+|||++.. ..++.++|||||||+||||++|+.||..........  .......  .....+..+++
T Consensus       161 --~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~~~~~~~--~~~~~~~~~s~  234 (364)
T d1omwa3         161 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLT--MAVELPDSFSP  234 (364)
T ss_dssp             --CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH--HHHHSSS--CCCCCCSSSCH
T ss_pred             --cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccc--CCCCCCCCCCH
Confidence              2334579999999999975 568999999999999999999999985432111000  0000111  11112334567


Q ss_pred             HHHHHHHHhhccCCCCCCC-----HHHHHH
Q 004312          717 RFVMVAIWCIQEDPSHRPT-----MRRVTQ  741 (762)
Q Consensus       717 ~~~~li~~cl~~dp~~RPt-----~~evl~  741 (762)
                      ++.+|+.+||+.||++|||     ++|+++
T Consensus       235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             HHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            8999999999999999999     688874

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-44  Score=377.99  Aligned_cols=246  Identities=19%  Similarity=0.245  Sum_probs=204.2

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFMS  563 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~  563 (762)
                      |.+.+.||+|+||+||+|... .+++.||||+++... .....+.+|+++|++++|||||++++++.+.+..+||||||+
T Consensus         7 Y~i~~~lG~G~fg~Vy~~~~~-~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~   84 (321)
T d1tkia_           7 YMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             eEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence            445678999999999999644 457899999997643 334578899999999999999999999999999999999999


Q ss_pred             CCchhhhccCCC-CCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC--CCceEEecccccccccCCCCcc
Q 004312          564 NGALASFLFGDS-KPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD--YYNARISDFGLEKLLTLDQSHT  640 (762)
Q Consensus       564 ~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~Dfgla~~~~~~~~~~  640 (762)
                      +|+|.++|...+ .+++.++..|+.||++||+|||++   +|+||||||+|||++.  ...+||+|||+++....  ...
T Consensus        85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--~~~  159 (321)
T d1tkia_          85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDN  159 (321)
T ss_dssp             CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--TCE
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc--CCc
Confidence            999999998765 799999999999999999999998   9999999999999984  45899999999987643  233


Q ss_pred             cccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccC--CCHHHHHHH
Q 004312          641 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM--DDMTVLQRF  718 (762)
Q Consensus       641 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  718 (762)
                      .....+|+.|+|||.+.+..++.++|||||||++|+|++|+.||......+.+...     ........  ....+++++
T Consensus       160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i-----~~~~~~~~~~~~~~~s~~~  234 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-----MNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-----HHTCCCCCHHHHTTSCHHH
T ss_pred             ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH-----HhCCCCCChhhccCCCHHH
Confidence            44567899999999999999999999999999999999999998665443332221     11111100  011245778


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 004312          719 VMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       719 ~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      .+|+.+||+.||++|||++|+++
T Consensus       235 ~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         235 MDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhHCcCHHHHhc
Confidence            99999999999999999999987

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=378.18  Aligned_cols=242  Identities=23%  Similarity=0.299  Sum_probs=194.3

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccc-ccCCccchhceecc----CCceeEEEecc
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDE----GRNRLLVYEFM  562 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~----~~~~~LV~E~~  562 (762)
                      +.||+|+||+||+|+.. .+++.||||++++     ...+.+|++++.++ +|||||++++++.+    ....+||||||
T Consensus        18 ~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~   91 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNK-RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL   91 (335)
T ss_dssp             EEEEECSSCEEEEEEET-TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             EEeeeccCeEEEEEEEC-CCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence            46999999999999754 4578999999864     35678899987665 89999999998864    46689999999


Q ss_pred             CCCchhhhccCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC---CCceEEecccccccccCCC
Q 004312          563 SNGALASFLFGD--SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD---YYNARISDFGLEKLLTLDQ  637 (762)
Q Consensus       563 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~  637 (762)
                      ++|+|.++|...  ..+++.++..|+.||+.||+|||++   +|+||||||+|||+++   ++.+||+|||+++......
T Consensus        92 ~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~  168 (335)
T d2ozaa1          92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  168 (335)
T ss_dssp             CSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred             CCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCC
Confidence            999999999764  4689999999999999999999999   9999999999999985   5679999999998765432


Q ss_pred             CcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccC--CCHHHH
Q 004312          638 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAM--DDMTVL  715 (762)
Q Consensus       638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  715 (762)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... ....+........  ....++
T Consensus       169 --~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~s  245 (335)
T d2ozaa1         169 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVS  245 (335)
T ss_dssp             --CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCSCSSSCCTTHHHHSC
T ss_pred             --ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-HHHHHhcCCCCCCCcccccCC
Confidence              33456799999999999999999999999999999999999999854422111110 0111111111111  113457


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          716 QRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       716 ~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      +++.+|+.+||+.||++|||++|+++
T Consensus       246 ~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         246 EEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHc
Confidence            88999999999999999999999987

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-43  Score=367.27  Aligned_cols=238  Identities=24%  Similarity=0.373  Sum_probs=196.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccc------hhHHHHHHhhhhcccc--cCCccchhceeccCCce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQD------SEKEFKAEVNGIGQTH--HKNLVRLLGYCDEGRNR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~  555 (762)
                      +.+.+.||+|+||+||+|+.. .+++.||||++++....      ...++.+|+.++++++  |||||++++++.+.+..
T Consensus         6 Y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~   84 (273)
T d1xwsa_           6 YQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF   84 (273)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             EEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence            456688999999999999754 45789999998653211      2234778999999986  89999999999999999


Q ss_pred             eEEEeccCC-CchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC-CCceEEecccccccc
Q 004312          556 LLVYEFMSN-GALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD-YYNARISDFGLEKLL  633 (762)
Q Consensus       556 ~LV~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~  633 (762)
                      ++||||+.+ +++.+++.....+++..+..++.||++||+|||++   +|+||||||+|||++. ++.+||+|||+++..
T Consensus        85 ~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          85 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceec
Confidence            999999976 68888888888899999999999999999999999   9999999999999985 579999999999865


Q ss_pred             cCCCCcccccccccCcccCcccccCCCC-CCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCH
Q 004312          634 TLDQSHTNTAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDM  712 (762)
Q Consensus       634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (762)
                      ..   .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....  ... .        .  ...+.
T Consensus       162 ~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--i~~-~--------~--~~~~~  225 (273)
T d1xwsa_         162 KD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--IIR-G--------Q--VFFRQ  225 (273)
T ss_dssp             CS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HHH-C--------C--CCCSS
T ss_pred             cc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--Hhh-c--------c--cCCCC
Confidence            42   23345679999999999987765 6779999999999999999999854321  111 0        0  01122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          713 TVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       713 ~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ..++++.+++.+||+.||++|||++|+++
T Consensus       226 ~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         226 RVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            34678999999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-42  Score=363.71  Aligned_cols=253  Identities=22%  Similarity=0.289  Sum_probs=196.1

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.+.||+|+||+||+|+.. .+++.||||+++...  ....+++.+|++++++++|||||++++++.+....++||||+
T Consensus         5 ~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~   83 (298)
T d1gz8a_           5 QKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   83 (298)
T ss_dssp             EEEEEEEECSSSEEEEEEET-TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EeccEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence            34578999999999999754 456799999996532  233578999999999999999999999999999999999999


Q ss_pred             CCCchhhhccC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCccc
Q 004312          563 SNGALASFLFG-DSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTN  641 (762)
Q Consensus       563 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  641 (762)
                      .++.+...... ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus        84 ~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-~~~~  159 (298)
T d1gz8a_          84 HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTY  159 (298)
T ss_dssp             SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-SBCT
T ss_pred             CCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC-cccc
Confidence            86655544443 46799999999999999999999999   9999999999999999999999999999876432 2334


Q ss_pred             ccccccCcccCcccccCCC-CCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------cccccc-ccccc--
Q 004312          642 TAIRGTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------TLGALV-ENDLE--  707 (762)
Q Consensus       642 ~~~~gt~~y~aPE~~~~~~-~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~~~~~~-~~~~~--  707 (762)
                      ....||+.|+|||.+.... .+.++|||||||++|+|++|+.||......+.....          ...... .....  
T Consensus       160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS  239 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence            4457999999999987665 589999999999999999999998544322211110          000000 00000  


Q ss_pred             ----cCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          708 ----AMD-----DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       708 ----~~~-----~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                          ...     ....++++.+|+.+||+.||++|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                000     11335788999999999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.4e-42  Score=360.05  Aligned_cols=251  Identities=20%  Similarity=0.254  Sum_probs=198.4

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.++||+|+||+||+|+..  +++.||||+++..  .....+.+.+|+.++++++|||||++++.+.+.+..++++||+
T Consensus         5 ~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~   82 (286)
T d1ob3a_           5 HGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (286)
T ss_dssp             EEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             eeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence            34578999999999999764  5578999999653  2333578999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      .++.+..+......+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++....... ....
T Consensus        83 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~  158 (286)
T d1ob3a_          83 DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYT  158 (286)
T ss_dssp             SEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             hhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc-cccc
Confidence            9998888888888999999999999999999999998   99999999999999999999999999998765332 2233


Q ss_pred             cccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------c---ccccc--cc--
Q 004312          643 AIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------T---LGALV--EN--  704 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~---~~~~~--~~--  704 (762)
                      ...+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+.....          .   .....  ..  
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence            44689999999998754 5799999999999999999999998544222211110          0   00000  00  


Q ss_pred             -----ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          705 -----DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       705 -----~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                           ..........++++.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0000111234578899999999999999999999975

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-42  Score=364.21  Aligned_cols=253  Identities=21%  Similarity=0.275  Sum_probs=195.5

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhccc---ccCCccchhceec-----cCC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQT---HHKNLVRLLGYCD-----EGR  553 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~-----~~~  553 (762)
                      +.+.++||+|+||+||+|.....+++.||||+++....  .....+.+|+.+++.+   +||||+++++++.     ...
T Consensus         9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~   88 (305)
T d1blxa_           9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   88 (305)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred             EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence            44567899999999999976444466899999865322  2234577888877766   7999999999985     335


Q ss_pred             ceeEEEeccCCCchhhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          554 NRLLVYEFMSNGALASFLF-GDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       554 ~~~LV~E~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                      ..+++|||++++++..... ....+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.
T Consensus        89 ~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             EEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             eEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence            6799999999988865554 346789999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc----------cc----
Q 004312          633 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER----------TL----  698 (762)
Q Consensus       633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~~----  698 (762)
                      ...  ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+.....          ..    
T Consensus       166 ~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (305)
T d1blxa_         166 YSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  243 (305)
T ss_dssp             CCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             hcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence            532  23344567999999999999999999999999999999999999998654322221110          00    


Q ss_pred             --cccc-c---cccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          699 --GALV-E---NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       699 --~~~~-~---~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                        .... .   ...........++.+.+|+.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence              0000 0   00000111234577899999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-41  Score=360.57  Aligned_cols=269  Identities=23%  Similarity=0.251  Sum_probs=212.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeC--CCcceEEEEEccccc----cchhHHHHHHhhhhccccc-CCccchhceeccCCcee
Q 004312          484 RGFKEELGRGAFGTVYKGFVNM--GSSDQVAVKKLNRVF----QDSEKEFKAEVNGIGQTHH-KNLVRLLGYCDEGRNRL  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~  556 (762)
                      +.+.++||+|+||+||+|+...  .+++.||||++++..    ....+.+.+|++++++++| |||+++++++.+....+
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            5567899999999999997532  356799999986532    2234678899999999966 89999999999999999


Q ss_pred             EEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      +||||+++|+|.+++.....+.+.....++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++.+...
T Consensus       106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~  182 (322)
T d1vzoa_         106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD  182 (322)
T ss_dssp             EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred             eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence            9999999999999998888889999999999999999999998   9999999999999999999999999999887655


Q ss_pred             CCcccccccccCcccCcccccCC--CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccccccccccccccCCCHHH
Q 004312          637 QSHTNTAIRGTKGYVAPEWFRNM--PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTLGALVENDLEAMDDMTV  714 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  714 (762)
                      .........|++.|+|||.+...  .++.++|||||||+||||++|+.||........... ........  ....+...
T Consensus       183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~-i~~~~~~~--~~~~~~~~  259 (322)
T d1vzoa_         183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE-ISRRILKS--EPPYPQEM  259 (322)
T ss_dssp             GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH-HHHHHHHC--CCCCCTTS
T ss_pred             ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcccC--CCCCcccC
Confidence            55555567799999999999764  478899999999999999999999854422111111 00011111  11223356


Q ss_pred             HHHHHHHHHHhhccCCCCCC-----CHHHHHHH--hhcC-------cCCCCCCCCCCC
Q 004312          715 LQRFVMVAIWCIQEDPSHRP-----TMRRVTQM--LEGV-------VEVPIPPCPWTL  758 (762)
Q Consensus       715 ~~~~~~li~~cl~~dp~~RP-----t~~evl~~--L~~~-------~~~~~p~~p~~~  758 (762)
                      ++++.+++.+||+.||++||     |++|+++.  ++++       .++|.|-.|..-
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~  317 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIR  317 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCC
Confidence            78999999999999999999     47888762  3221       245556566543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-40  Score=352.74  Aligned_cols=254  Identities=19%  Similarity=0.230  Sum_probs=194.5

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccc--ccchhHHHHHHhhhhcccccCCccchhceecc--------CC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--------GR  553 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--------~~  553 (762)
                      +.+.++||+|+||+||+|+.. .+++.||||++...  .....+++.+|+++|++++||||+++++.+..        ..
T Consensus        12 Y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~   90 (318)
T d3blha1          12 YEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   90 (318)
T ss_dssp             EEEEEEEEECSSSEEEEEEET-TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred             EEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence            345578999999999999754 55789999998643  23345789999999999999999999998855        34


Q ss_pred             ceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccc
Q 004312          554 NRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLL  633 (762)
Q Consensus       554 ~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~  633 (762)
                      ..++||||++++.+..+......++...+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          91 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             eEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeec
Confidence            5789999999998888877778899999999999999999999998   9999999999999999999999999999876


Q ss_pred             cCCCC---cccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc--ccc--------
Q 004312          634 TLDQS---HTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER--TLG--------  699 (762)
Q Consensus       634 ~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~--~~~--------  699 (762)
                      .....   .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||............  ...        
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            54332   222335699999999998765 6899999999999999999999998543322211100  000        


Q ss_pred             cc--------cccccccCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          700 AL--------VENDLEAMDD-------MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       700 ~~--------~~~~~~~~~~-------~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                      ..        ..........       ....+.+++|+.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            00        0000000000       112456788999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.8e-41  Score=353.23  Aligned_cols=256  Identities=19%  Similarity=0.207  Sum_probs=194.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccch-hceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRL-LGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l-~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||.||+|... .+++.||||++....  ...++..|++++++++|+|++.. .++..+.+..++||||+
T Consensus         9 Y~l~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~   85 (299)
T d1ckia_           9 YRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   85 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             EEEeEEEeeCCCcEEEEEEEC-CCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence            456788999999999999754 456799999886532  33468899999999987765555 55557778889999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEc---CCCceEEecccccccccCCCCc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLD---DYYNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~~~~~~~  639 (762)
                      .++.+..+......+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|||+++.+......
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          86 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            6554444445567899999999999999999999999   999999999999986   4567999999999987544322


Q ss_pred             ------ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc-ccc-cccccccccCCC
Q 004312          640 ------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER-TLG-ALVENDLEAMDD  711 (762)
Q Consensus       640 ------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~  711 (762)
                            ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............ ... ....... ....
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  241 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-EVLC  241 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-HHHT
T ss_pred             cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-hHhc
Confidence                  233467999999999999999999999999999999999999998443211111100 000 0000000 0001


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcC
Q 004312          712 MTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGV  746 (762)
Q Consensus       712 ~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~  746 (762)
                      ..+++++.+++.+||+.+|++||+++++.+.|+.+
T Consensus       242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            23457889999999999999999999999988775

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-40  Score=345.76  Aligned_cols=252  Identities=19%  Similarity=0.264  Sum_probs=201.5

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCCceeEEEecc
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      .+.++||+|+||+||+|+.. .+++.||||+++...  ......+.+|+.++++++||||+++++++.+....++|+|++
T Consensus         5 ~~i~~LG~G~fg~V~~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~   83 (292)
T d1unla_           5 EKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EeeeEEecCcCeEEEEEEEC-CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence            44578999999999999754 567899999986432  334578999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCCcccc
Q 004312          563 SNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQSHTNT  642 (762)
Q Consensus       563 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  642 (762)
                      .+++|..++...+.+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||.++....... ...
T Consensus        84 ~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~~  159 (292)
T d1unla_          84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYS  159 (292)
T ss_dssp             SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CCC
T ss_pred             cccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc-cce
Confidence            9999999998888999999999999999999999998   999999999999999999999999999987654332 233


Q ss_pred             cccccCcccCcccccCCC-CCCcchhHHHHHHHHHHHhCCCCCchhhHH-Hhhhc----------ccc---ccc------
Q 004312          643 AIRGTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLRRTILTDWAY-DCYQE----------RTL---GAL------  701 (762)
Q Consensus       643 ~~~gt~~y~aPE~~~~~~-~s~~~DV~S~Gvil~elltg~~p~~~~~~~-~~~~~----------~~~---~~~------  701 (762)
                      ...+++.|+|||.+.... ++.++|||||||++|||++|+.|+...... +....          ...   ...      
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence            345788999999987654 799999999999999999999996432111 10000          000   000      


Q ss_pred             ---cccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          702 ---VENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       702 ---~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                         .............++.+.+|+.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0000011112334577899999999999999999999876

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-40  Score=354.55  Aligned_cols=254  Identities=20%  Similarity=0.246  Sum_probs=192.6

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc-cchhHHHHHHhhhhcccccCCccchhceeccCC----ceeEE
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR----NRLLV  558 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~LV  558 (762)
                      +.+.++||+|+||+||+|.. ..+++.||||++++.. ....+.+++|+++|++++||||+++++++....    ..+++
T Consensus        10 Y~~~~~LG~G~fg~Vy~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l   88 (345)
T d1pmea_          10 YTNLSYIGEGAYGMVCSAYD-NVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL   88 (345)
T ss_dssp             EEEEEECC---CCCEEEEEE-TTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             eEEEEEEeeccCeEEEEEEE-CCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence            34557899999999999974 4567899999997543 233567899999999999999999999986653    23556


Q ss_pred             EeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCCCC
Q 004312          559 YEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLDQS  638 (762)
Q Consensus       559 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~  638 (762)
                      +||+.+|+|.+++.. ..+++..++.++.||++||+|||++   +|+||||||+||||++++.+||+|||+++.......
T Consensus        89 ~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          89 VTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            667789999999964 4689999999999999999999999   999999999999999999999999999987654332


Q ss_pred             --cccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcccc--c--------------
Q 004312          639 --HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERTL--G--------------  699 (762)
Q Consensus       639 --~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~--~--------------  699 (762)
                        .......||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+.......  .              
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence              22344679999999999854 5678999999999999999999999854332211111000  0              


Q ss_pred             --ccc-ccccccCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 004312          700 --ALV-ENDLEAMD-----DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM  742 (762)
Q Consensus       700 --~~~-~~~~~~~~-----~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~  742 (762)
                        ... ........     ....+.++++|+.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              000 00000000     01234578999999999999999999999974

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-40  Score=355.56  Aligned_cols=247  Identities=23%  Similarity=0.251  Sum_probs=189.6

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCccchhceeccC------CceeEE
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------RNRLLV  558 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~LV  558 (762)
                      ...++||+|+||+||+|+.. .+++.||||++.....    .+.+|+++|++++||||+++++++...      ...+||
T Consensus        23 ~~~k~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          23 TDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             EeeeEEeeCcCeEEEEEEEC-CCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            34568999999999999754 4578999999965422    334799999999999999999998532      346899


Q ss_pred             EeccCCCchhhh---ccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCC-ceEEeccccccccc
Q 004312          559 YEFMSNGALASF---LFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYY-NARISDFGLEKLLT  634 (762)
Q Consensus       559 ~E~~~~gsL~~~---l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~  634 (762)
                      |||++++.+..+   ......+++..+..++.||+.||+|||++   +|+||||||+||||+.++ .+||+|||+++...
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            999987754433   34567899999999999999999999998   999999999999999765 89999999998765


Q ss_pred             CCCCcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc-----------------
Q 004312          635 LDQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER-----------------  696 (762)
Q Consensus       635 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~-----------------  696 (762)
                      ...  ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.....                 
T Consensus       175 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         175 RGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             TTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             CCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence            332  2334579999999998765 57899999999999999999999998544322211110                 


Q ss_pred             -----ccccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          697 -----TLGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       697 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                           ..................++++.+|+.+||+.||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 000000000011112235678899999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-40  Score=352.98  Aligned_cols=255  Identities=26%  Similarity=0.302  Sum_probs=191.4

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceeccCC------ce
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGR------NR  555 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~  555 (762)
                      +.+.++||+|+||+||+|.. ..+++.||||++++..  ....+.+.+|+++|++++|||||++++++...+      ..
T Consensus        20 Y~~i~~lG~G~fg~V~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~   98 (346)
T d1cm8a_          20 YRDLQPVGSGAYGAVCSAVD-GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF   98 (346)
T ss_dssp             EEEEEEC------CEEEEEE-TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             EEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence            34557899999999999974 4567899999997532  233467899999999999999999999997654      46


Q ss_pred             eEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccC
Q 004312          556 LLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTL  635 (762)
Q Consensus       556 ~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~  635 (762)
                      +|||||+ +.+|..+++ ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        99 ~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          99 YLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             EEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCC
Confidence            9999999 556776664 45799999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCcccccccccCcccCcccccC-CCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc-----------------
Q 004312          636 DQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT-----------------  697 (762)
Q Consensus       636 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~-----------------  697 (762)
                          ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.............                 
T Consensus       174 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         174 ----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             ----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             ----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence                2344679999999999876 467999999999999999999999985432221111000                 


Q ss_pred             --------cccccccccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hhcCcCC
Q 004312          698 --------LGALVENDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQM--LEGVVEV  749 (762)
Q Consensus       698 --------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~~~~~  749 (762)
                              .......... ......++++.+|+.+||+.||++|||++|+++.  ++++.+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  310 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             hhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence                    0000000000 0112345678899999999999999999999974  6655433

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.3e-39  Score=348.04  Aligned_cols=246  Identities=20%  Similarity=0.306  Sum_probs=192.9

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc-cCCccchhceecc--CCceeEEEe
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDE--GRNRLLVYE  560 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~--~~~~~LV~E  560 (762)
                      +.+.++||+|+||+||+|+. ..+++.||||+++..   ..+++.+|+++|++++ ||||+++++++..  ....++|||
T Consensus        37 y~i~~~LG~G~fg~V~~a~~-~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          37 YQLVRKLGRGKYSEVFEAIN-ITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             eEEEEEEecCcCeEEEEEEE-CCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            45667899999999999974 346789999998753   3567899999999995 9999999999864  456899999


Q ss_pred             ccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCC-CceEEecccccccccCCCCc
Q 004312          561 FMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDY-YNARISDFGLEKLLTLDQSH  639 (762)
Q Consensus       561 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~~~~~~  639 (762)
                      |+++++|..+.   +.+++..+..++.||+.||+|||++   +|+||||||+|||++.+ ..+||+|||+++......  
T Consensus       113 ~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--  184 (328)
T d3bqca1         113 HVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--  184 (328)
T ss_dssp             CCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--
T ss_pred             ecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC--
Confidence            99999998875   4689999999999999999999999   99999999999999865 469999999998765332  


Q ss_pred             ccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHH-----------------hhhccc----
Q 004312          640 TNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYD-----------------CYQERT----  697 (762)
Q Consensus       640 ~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~-----------------~~~~~~----  697 (762)
                      ......+|+.|+|||.+.+. .++.++||||+|+++|||++|+.||.......                 ......    
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            33455689999999998765 57999999999999999999999974321100                 000000    


Q ss_pred             --cccccc--------cccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          698 --LGALVE--------NDLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       698 --~~~~~~--------~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                        ......        ...........++++.+|+.+||+.||++|||++|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              000000        00011112335678899999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.1e-40  Score=346.72  Aligned_cols=257  Identities=16%  Similarity=0.171  Sum_probs=200.7

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccccc-CCccchhceeccCCceeEEEecc
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHH-KNLVRLLGYCDEGRNRLLVYEFM  562 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~LV~E~~  562 (762)
                      +.+.+.||+|+||+||+|+.. .+++.||||++....  ....+.+|++++++++| +|++.+++++.++...++||||+
T Consensus         7 Y~i~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           7 YKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             EEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             eEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence            456788999999999999754 457899999886532  33467889999999865 89999999999999999999999


Q ss_pred             CCCchhhhccCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcC-----CCceEEecccccccccCC
Q 004312          563 SNGALASFLFGD-SKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDD-----YYNARISDFGLEKLLTLD  636 (762)
Q Consensus       563 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~Dfgla~~~~~~  636 (762)
                       +++|.+++... ..+++..+..++.|++.||+|||++   +|+||||||+|||++.     ++.+||+|||+++.+...
T Consensus        84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence             68999988654 5789999999999999999999999   9999999999999974     578999999999987543


Q ss_pred             CCc------ccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhc-cccccccccccccC
Q 004312          637 QSH------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQE-RTLGALVENDLEAM  709 (762)
Q Consensus       637 ~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~  709 (762)
                      ...      .....+||+.|||||.+.+..+++++||||||+++|||++|+.||........... ..+...........
T Consensus       160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (293)
T d1csna_         160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE  239 (293)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence            321      23346799999999999999999999999999999999999999843211100000 00000000000000


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhhcCc
Q 004312          710 DDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQMLEGVV  747 (762)
Q Consensus       710 ~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~~~  747 (762)
                      ....+++++.+++..|++.+|++||+++.+.+.|+++.
T Consensus       240 l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            01124567899999999999999999999998887754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-39  Score=347.01  Aligned_cols=248  Identities=25%  Similarity=0.280  Sum_probs=184.7

Q ss_pred             hhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccc--cchhHHHHHHhhhhcccccCCccchhceecc------CCcee
Q 004312          485 GFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE------GRNRL  556 (762)
Q Consensus       485 ~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~~~  556 (762)
                      .+.++||+|+||+||+|.. ..+++.||||++....  ....+.+.+|+.++++++|||||++++++..      ....+
T Consensus        20 ~i~~~LG~G~fg~V~~~~d-~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~   98 (355)
T d2b1pa1          20 QNLKPIGSGAQGIVCAAYD-AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY   98 (355)
T ss_dssp             EEEEECSCC--CEEEEEEE-TTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             EEEEEeecCcCeEEEEEEE-CCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence            3457899999999999964 4567899999997543  2334578999999999999999999999853      46789


Q ss_pred             EEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      +||||+.++.+..+   ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||+++.... 
T Consensus        99 iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~-  171 (355)
T d2b1pa1          99 LVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-  171 (355)
T ss_dssp             EEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcccc-
Confidence            99999977655544   24589999999999999999999999   999999999999999999999999999886543 


Q ss_pred             CCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhcc-----------------cc-
Q 004312          637 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQER-----------------TL-  698 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~-----------------~~-  698 (762)
                       ........+|+.|+|||.+.+..+++++||||+||+++||++|+.||............                 .. 
T Consensus       172 -~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (355)
T d2b1pa1         172 -SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred             -ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence             23334556899999999999999999999999999999999999998533211111000                 00 


Q ss_pred             --------------cccccccccc---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 004312          699 --------------GALVENDLEA---MDDMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ  741 (762)
Q Consensus       699 --------------~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~  741 (762)
                                    ..........   ......+.++.+|+.+||+.||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                          0000000000   012346788999999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-38  Score=341.22  Aligned_cols=254  Identities=24%  Similarity=0.268  Sum_probs=192.5

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc--chhHHHHHHhhhhcccccCCccchhceecc-----CCcee
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-----GRNRL  556 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-----~~~~~  556 (762)
                      +.+.++||+|+||+||+|+. ..+++.||||++++...  ...+.+.+|+++|++++|||||++++++..     ....+
T Consensus        20 Y~i~~~LG~G~fg~Vy~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~   98 (348)
T d2gfsa1          20 YQNLSPVGSGAYGSVCAAFD-TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   98 (348)
T ss_dssp             EEEEEECGGGTTSSEEEEEE-TTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred             eEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence            44557899999999999964 45678999999975432  334578999999999999999999999853     33457


Q ss_pred             EEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecccccccccCC
Q 004312          557 LVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDFGLEKLLTLD  636 (762)
Q Consensus       557 LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~  636 (762)
                      +++||+.+|+|.+++.. +.+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||++....  
T Consensus        99 ~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~--  172 (348)
T d2gfsa1          99 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD--  172 (348)
T ss_dssp             EEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred             EEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC--
Confidence            77888899999999954 5699999999999999999999999   99999999999999999999999999997543  


Q ss_pred             CCcccccccccCcccCcccccCC-CCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhhccc-----c------------
Q 004312          637 QSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQERT-----L------------  698 (762)
Q Consensus       637 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~-----~------------  698 (762)
                        .......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.............     .            
T Consensus       173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  250 (348)
T d2gfsa1         173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  250 (348)
T ss_dssp             --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred             --cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence              233445689999999987665 56899999999999999999999985432211111000     0            


Q ss_pred             -ccccccccc-cCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HhhcC
Q 004312          699 -GALVENDLE-AMD-----DMTVLQRFVMVAIWCIQEDPSHRPTMRRVTQ--MLEGV  746 (762)
Q Consensus       699 -~~~~~~~~~-~~~-----~~~~~~~~~~li~~cl~~dp~~RPt~~evl~--~L~~~  746 (762)
                       ......... ...     ....++++++|+.+||+.||++|||++|+++  .+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence             000000000 000     0123567899999999999999999999987  35544

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-34  Score=312.81  Aligned_cols=266  Identities=19%  Similarity=0.192  Sum_probs=192.8

Q ss_pred             hhhhhhcCCCCcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc-----------cCCccchhceeccC
Q 004312          484 RGFKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-----------HKNLVRLLGYCDEG  552 (762)
Q Consensus       484 ~~~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~g~~~~~  552 (762)
                      |.+.++||+|+||+||+|+.. .+++.||||++++.. ...+.+.+|++++++++           |+||+++++++...
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~-~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            556789999999999999743 456899999997542 23457788998888775           57789999887643


Q ss_pred             --CceeEEEeccCCCchhhh---ccCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEeCCCCCCceEEcCCC------
Q 004312          553 --RNRLLVYEFMSNGALASF---LFGDSKPNWKLRTEIVMGIARGLFYLHE-ECCTQIIHCDIKPQNILLDDYY------  620 (762)
Q Consensus       553 --~~~~LV~E~~~~gsL~~~---l~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NILl~~~~------  620 (762)
                        ...+++++++..+.....   ......+++..+..++.||+.||+|||+ .   +|+||||||+||||+.++      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccc
Confidence              455667777655442222   2334678999999999999999999998 5   899999999999998654      


Q ss_pred             ceEEecccccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHHHHHHhCCCCCchhhHHHhhh------
Q 004312          621 NARISDFGLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRTILTDWAYDCYQ------  694 (762)
Q Consensus       621 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil~elltg~~p~~~~~~~~~~~------  694 (762)
                      .+|++|||.+.....    ......||+.|+|||.+....++.++||||+||+++||++|+.||..........      
T Consensus       170 ~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         170 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence            399999999986532    2234569999999999999999999999999999999999999975432110000      


Q ss_pred             ---------------ccc-cccccc---------c----------ccccCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 004312          695 ---------------ERT-LGALVE---------N----------DLEAMDDMTVLQRFVMVAIWCIQEDPSHRPTMRRV  739 (762)
Q Consensus       695 ---------------~~~-~~~~~~---------~----------~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~ev  739 (762)
                                     ... ......         .          ..........+.++.+|+.+||+.||.+|||++|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence                           000 000000         0          00111234677889999999999999999999999


Q ss_pred             HHH--hhc---CcCCCCCCCCCCC
Q 004312          740 TQM--LEG---VVEVPIPPCPWTL  758 (762)
Q Consensus       740 l~~--L~~---~~~~~~p~~p~~~  758 (762)
                      ++.  +++   ..+.+.|+.|.+.
T Consensus       326 L~Hp~f~~~~~~~~~~~p~~~~~~  349 (362)
T d1q8ya_         326 VNHPWLKDTLGMEEIRVPDRELYG  349 (362)
T ss_dssp             HTCGGGTTCTTCTTCCCTTSCTTC
T ss_pred             hcCcccCCCCCcccCCCCCcccCC
Confidence            874  443   3455666666543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.83  E-value=1.9e-21  Score=189.42  Aligned_cols=168  Identities=13%  Similarity=0.123  Sum_probs=118.5

Q ss_pred             hhhhcCCCCcceEEEeeeeCCCcceEEEEEcccccc------------------chhHHHHHHhhhhcccccCCccchhc
Q 004312          486 FKEELGRGAFGTVYKGFVNMGSSDQVAVKKLNRVFQ------------------DSEKEFKAEVNGIGQTHHKNLVRLLG  547 (762)
Q Consensus       486 ~~~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~g  547 (762)
                      +.++||+|+||+||+|...  ++++||||+++....                  .....+.+|...+.+++|++++..++
T Consensus         4 vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            4578999999999999764  457899998653111                  01234557888899999999988876


Q ss_pred             eeccCCceeEEEeccCCCchhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEeCCCCCCceEEcCCCceEEecc
Q 004312          548 YCDEGRNRLLVYEFMSNGALASFLFGDSKPNWKLRTEIVMGIARGLFYLHEECCTQIIHCDIKPQNILLDDYYNARISDF  627 (762)
Q Consensus       548 ~~~~~~~~~LV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  627 (762)
                      +.    ..+|+|||+++..+..+       +......++.|++++|+|||++   +|+||||||+|||++++ .++|+||
T Consensus        82 ~~----~~~lvme~~~~~~~~~l-------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          82 WE----GNAVLMELIDAKELYRV-------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             EE----TTEEEEECCCCEEGGGC-------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCC
T ss_pred             ec----CCEEEEEeeccccccch-------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEEC
Confidence            53    23799999998776543       3444678999999999999998   99999999999999965 5899999


Q ss_pred             cccccccCCCCcccccccccCcccCcccccCCCCCCcchhHHHHHHH
Q 004312          628 GLEKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLL  674 (762)
Q Consensus       628 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvil  674 (762)
                      |+++....+........  +... -.|.+ ...++.++|+||..--+
T Consensus       147 G~a~~~~~~~~~~~l~r--d~~~-~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         147 PQSVEVGEEGWREILER--DVRN-IITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTCEETTSTTHHHHHHH--HHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             CCcccCCCCCcHHHHHH--HHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence            99976542222110000  0000 01111 34678889999975443

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=99.80  E-value=2.3e-20  Score=164.11  Aligned_cols=101  Identities=18%  Similarity=0.399  Sum_probs=87.1

Q ss_pred             cCcccCCCceeecCCCCcEeeCCCcEEEeeeccc----------ccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEEEe
Q 004312           23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD----------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWK   92 (762)
Q Consensus        23 ~~~~~~~~~l~~~~~~~~lvS~~g~F~lgf~~~~----------vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~ws   92 (762)
                      +|+|.|||.|.+++   +|+  +|.|+|+|+..|          ||.||++.|. ..+.|.|+.||+|+|++. ++++|+
T Consensus         1 tDtL~~gq~L~~g~---~l~--~g~~~l~~q~DGNLvly~~~~~vW~s~~~~~~-~~~~l~l~~dGnLvl~~~-~~~~w~   73 (112)
T d1xd5a_           1 SDRLNSGHQLDTGG---SLA--EGGYLFIIQNDCNLVLYDNNRAVWASGTNGKA-SGCVLKMQNDGNLVIYSG-SRAIWA   73 (112)
T ss_dssp             CCEEETTEEECTTC---EEE--ETTEEEEECTTSCEEEEETTEEEEECCCTTSC-SSEEEEECTTSCEEEEET-TEEEEE
T ss_pred             CCEecCCCEecCCC---EEE--ECCEEEEEcCCCCEEEEcCCcEEEEccCccCC-CCcEEEEeccccEEEEec-CCeEEE
Confidence            48999999999887   676  599999998766          9999999884 457899999999999997 467888


Q ss_pred             ecCCCC-ceeEEEEecCCCEEEEecCCCccccccCCCcc
Q 004312           93 SEISTG-EAAFGVLYDTGNFLIVNTNSERLWQTFDHPTD  130 (762)
Q Consensus        93 ~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTD  130 (762)
                      ++++.. +..+|+|+|+|||||++.++.++|||+.+|+|
T Consensus        74 s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n  112 (112)
T d1xd5a_          74 SNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN  112 (112)
T ss_dssp             CCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred             EeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence            876644 34589999999999999999999999999986

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.80  E-value=6.9e-20  Score=159.52  Aligned_cols=97  Identities=24%  Similarity=0.401  Sum_probs=84.7

Q ss_pred             cCcccCCCceeecCCCCcEeeCCCcEEEeeeccc----------ccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEEEe
Q 004312           23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD----------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWK   92 (762)
Q Consensus        23 ~~~~~~~~~l~~~~~~~~lvS~~g~F~lgf~~~~----------vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~ws   92 (762)
                      .|+|.+||.|.+|+   .|.  +|.|.|+|...|          ||.||++.|....+.|.|+.||+|+|+|++|++||+
T Consensus         1 ~~~L~~g~~L~~g~---~l~--~g~~~l~~q~dgnLvl~~~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~   75 (109)
T d1kj1a_           1 RNLLTNGEGLYAGQ---SLD--VEPYHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWA   75 (109)
T ss_dssp             CCEEETTCEEETTC---EEE--ETTEEEEECTTSCEEEEETTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEE
T ss_pred             CCCccCCCEEeCCC---EEE--eCCEEEEecCCCeEEEEeCCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEE
Confidence            37899999999887   564  589999998766          899999999988899999999999999999999999


Q ss_pred             ecCCCC-ceeEEEEecCCCEEEEecCCCccccccCC
Q 004312           93 SEISTG-EAAFGVLYDTGNFLIVNTNSERLWQTFDH  127 (762)
Q Consensus        93 ~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqSFD~  127 (762)
                      |+++.. +..+|+|+|||||||+++   .+|||+-|
T Consensus        76 s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~  108 (109)
T d1kj1a_          76 SHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY  108 (109)
T ss_dssp             CCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred             EeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence            998743 445899999999999963   69999865

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.78  E-value=1.3e-19  Score=157.81  Aligned_cols=96  Identities=22%  Similarity=0.371  Sum_probs=82.6

Q ss_pred             cCcccCCCceeecCCCCcEeeCCCcEEEeeeccc----------ccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEEEe
Q 004312           23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLD----------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWK   92 (762)
Q Consensus        23 ~~~~~~~~~l~~~~~~~~lvS~~g~F~lgf~~~~----------vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~ws   92 (762)
                      .|+|.+||.|.+|+   .|  .+|.|.|.|+.+|          ||.||++.| ...+.|.|+.+|+|+|++++|++||+
T Consensus         1 ~~~L~~g~~L~~G~---~l--~ng~~~l~~q~DGNLvly~~~~~vW~s~~~~~-~~~~~l~l~~~Gnlvl~~~~g~~vWs   74 (108)
T d1jpca_           1 DNILYSGETLSTGE---FL--NYGSFVFIMQEDCNLVLYDVDKPIWATNTGGL-SRSCFLSMQTDGNLVVYNPSNKPIWA   74 (108)
T ss_dssp             CCEEETTEEECTTC---EE--EETTEEEEECTTSCEEEEETTEEEEECCCTTS-CSSCEEEECTTSCEEEECTTCCEEEE
T ss_pred             CCCccCCCEecCCC---EE--EcCCEEEEECCCCeEEEEeCCceeeEeCCCCC-CCccEEEEeccceEEEECCCccceEE
Confidence            37899999999887   56  4799999998876          999999988 44578999999999999999999999


Q ss_pred             ecCCCCce-eEEEEecCCCEEEEecCCCccccccCC
Q 004312           93 SEISTGEA-AFGVLYDTGNFLIVNTNSERLWQTFDH  127 (762)
Q Consensus        93 ~~~~~~~~-~~~~l~d~GNlvl~~~~~~~~WqSFD~  127 (762)
                      |++..... .+|+|+|+|||||++.   .+||||+|
T Consensus        75 S~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~  107 (108)
T d1jpca_          75 SNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH  107 (108)
T ss_dssp             CCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred             ccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence            99765443 4789999999999964   59999988

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.65  E-value=3e-17  Score=143.42  Aligned_cols=87  Identities=20%  Similarity=0.301  Sum_probs=73.5

Q ss_pred             CceEEEEeCCcEEEeCCCCCEEEeecCCCCceeEEEEecCCCEEEEecCCCccccccCCCccccCCCccccCccEEEeec
Q 004312           69 GSKLRLTANGGLVLEDPEAREIWKSEISTGEAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRR  148 (762)
Q Consensus        69 ~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~l~~~~~L~S~~  148 (762)
                      ..+|.|+.||||||+++ ++++|++++.+..+..|.|+|+|||||++.++.+||||+.                      
T Consensus        27 ~~~l~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS~t----------------------   83 (115)
T d1dlpa1          27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGT----------------------   83 (115)
T ss_dssp             TEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCC----------------------
T ss_pred             CEEEEECCCCeEEEEcC-CeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEcCC----------------------
Confidence            35689999999999984 6899999988777788999999999999999999999853                      


Q ss_pred             CCCCCCCcceEEEecCCCceeeEeeccCCCcccccccccCCc
Q 004312          149 KETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTF  190 (762)
Q Consensus       149 s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~  190 (762)
                         +.+.|.|.+.|++||++++|.         ..+|.+++-
T Consensus        84 ---~~~~g~y~l~Lq~DGNlvlY~---------~~~Wssgt~  113 (115)
T d1dlpa1          84 ---KGSIGNYVLVLQPDRTVTIYG---------PGLWDSGTS  113 (115)
T ss_dssp             ---CCCSSCCEEEECSSSCEEEEC---------SEEEECSCC
T ss_pred             ---CCCCCCEEEEECCCCcEEEeC---------CCeecCCCC
Confidence               446899999999999998862         347877653

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.64  E-value=2.1e-16  Score=139.49  Aligned_cols=90  Identities=19%  Similarity=0.281  Sum_probs=78.6

Q ss_pred             cccccCCCCCCCC-CceEEEEeCCcEEEeCCCCCEEEeecCCCCc-eeEEEEecCCCEEEEecCCCccccccCCCccccC
Q 004312           56 DIWYASGDDPGPG-GSKLRLTANGGLVLEDPEAREIWKSEISTGE-AAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLL  133 (762)
Q Consensus        56 ~vW~Anr~~p~~~-~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~-~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlL  133 (762)
                      .+|++|++.|+.. ..+|.|+.||||+|++. ++++|++++...+ ...|.|+++|||||+|.+++++||||+       
T Consensus        22 ~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t-------   93 (120)
T d1dlpa2          22 HPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGN-------   93 (120)
T ss_dssp             CCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEECCC-------
T ss_pred             cccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEEEeCC-------
Confidence            3899999999975 56899999999999986 5789999987544 468999999999999999999999963       


Q ss_pred             CCccccCccEEEeecCCCCCCCcceEEEecCCCceeeE
Q 004312          134 PTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLN  171 (762)
Q Consensus       134 pgq~l~~~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~  171 (762)
                                        +.++|.|.+.+++||++++|
T Consensus        94 ------------------~~~~~~~~l~Lq~DGnlvlY  113 (120)
T d1dlpa2          94 ------------------SRSAGRYVFVLQPDRNLAIY  113 (120)
T ss_dssp             ------------------CCSSSCCEEEECSSSCEEEE
T ss_pred             ------------------CCCCCcEEEEECCCCcEEEe
Confidence                              34578899999999999987

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.55  E-value=6e-15  Score=129.52  Aligned_cols=92  Identities=22%  Similarity=0.334  Sum_probs=76.9

Q ss_pred             CcccCCCceeecCCCCcEeeCCCcEEEeeeccc----------ccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEEEee
Q 004312           24 GTISIGQQLTAAESTEPWLSPSKDFALGFHQLD----------IWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKS   93 (762)
Q Consensus        24 ~~~~~~~~l~~~~~~~~lvS~~g~F~lgf~~~~----------vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~ws~   93 (762)
                      ++|.++|+|.       ..+..|.|.|.|...|          ||.||+..+. ..+.|.|+.||+|+|+|++|++||++
T Consensus        15 ~~l~~~q~l~-------~~~~~~~y~l~mQ~DGNLVLy~~~~~vWssnt~~~~-~~~~l~l~~dGnLvL~d~~g~~vWsS   86 (119)
T d1b2pa_          15 QILHATESLE-------ILFGTHVYRFIMQTDCNLVLYDNNNPIWATNTGGLG-NGCRAVLQPDGVLVVITNENVTVWQS   86 (119)
T ss_dssp             CEEETTCEEE-------EEETTEEEEEEECTTSCEEEEETTEEEEECCCTTSC-SSCEEEECTTSCEEEECTTCCEEEEC
T ss_pred             CEEeCCCeEE-------EecCCceEEEEECCCCcEEEEECCeEEEEecCCCCC-cceEEEEEeCCCEEEECCCCcEEEEC
Confidence            5677777763       5778999999998776          9999998773 35789999999999999999999999


Q ss_pred             cCCCCc-eeEEEEecCCCEEEEecCCCccccccC
Q 004312           94 EISTGE-AAFGVLYDTGNFLIVNTNSERLWQTFD  126 (762)
Q Consensus        94 ~~~~~~-~~~~~l~d~GNlvl~~~~~~~~WqSFD  126 (762)
                      ++.... ..+|+|+|||||||++   .++|||-.
T Consensus        87 ~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T  117 (119)
T d1b2pa_          87 PVAGKAGHYVLVLQPDRNVVIYG---DALWATQT  117 (119)
T ss_dssp             SCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred             CCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence            987544 4579999999999995   47999954

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.29  E-value=3.8e-12  Score=111.32  Aligned_cols=87  Identities=22%  Similarity=0.372  Sum_probs=70.4

Q ss_pred             CceEEEEeCCcEEEeCCCCCEEEeecCCCCc-eeEEEEecCCCEEEEecCCCccccccCCCccccCCCccccCccEEEee
Q 004312           69 GSKLRLTANGGLVLEDPEAREIWKSEISTGE-AAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSR  147 (762)
Q Consensus        69 ~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~-~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~l~~~~~L~S~  147 (762)
                      ..+|.|+.||||||+++ +.++|++++.... ...+.|+++|||||+|.++.++|+|                       
T Consensus        31 ~y~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS-----------------------   86 (119)
T d1b2pa_          31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQS-----------------------   86 (119)
T ss_dssp             EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC-----------------------
T ss_pred             eEEEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEEC-----------------------
Confidence            35789999999999976 4799999987543 4689999999999999999999987                       


Q ss_pred             cCCCCCCCcceEEEecCCCceeeEeeccCCCcccccccccCCc
Q 004312          148 RKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTF  190 (762)
Q Consensus       148 ~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~  190 (762)
                        .+.-+.|.|.+.|++||++++|.         ...|.+++.
T Consensus        87 --~t~~~~~~~~l~Lq~DGNlvlYg---------~~~W~S~T~  118 (119)
T d1b2pa_          87 --PVAGKAGHYVLVLQPDRNVVIYG---------DALWATQTV  118 (119)
T ss_dssp             --SCCCCSSCEEEEECTTSCEEEEE---------SEEEECCCC
T ss_pred             --CCcCCCCceEEEEcCCCCEEEEC---------CCEeccCCc
Confidence              22223578999999999999973         347777653

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.25  E-value=9.8e-12  Score=107.17  Aligned_cols=78  Identities=23%  Similarity=0.431  Sum_probs=65.6

Q ss_pred             CCceEEEEeCCcEEEeCCCCCEEEeecCCCCc-eeEEEEecCCCEEEEecCCCccccccCCCccccCCCccccCccEEEe
Q 004312           68 GGSKLRLTANGGLVLEDPEAREIWKSEISTGE-AAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSS  146 (762)
Q Consensus        68 ~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~-~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~l~~~~~L~S  146 (762)
                      ...+|.|+.||||||++. +++||++++...+ ...++|+++|||||++.+++++|+|                      
T Consensus        19 g~~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS----------------------   75 (108)
T d1jpca_          19 GSFVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS----------------------   75 (108)
T ss_dssp             TTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC----------------------
T ss_pred             CCEEEEECCCCeEEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc----------------------
Confidence            346799999999999985 4899999987654 4589999999999999999999997                      


Q ss_pred             ecCCCCCCCcceEEEecCCCceeeE
Q 004312          147 RRKETDFSRGRFQFRLLEDGNAVLN  171 (762)
Q Consensus       147 ~~s~~dps~G~~~l~~~~~g~~~~~  171 (762)
                         .+....+.|.+.|++||++++|
T Consensus        76 ---~t~~~~~~~~l~L~ddGNlVly   97 (108)
T d1jpca_          76 ---NTGGQNGNYVCILQKDRNVVIY   97 (108)
T ss_dssp             ---CCCCSCSCEEEEECTTSCEEEE
T ss_pred             ---cccCCCCcEEEEEcCCCCEEEe
Confidence               2223467899999999999997

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.24  E-value=9.2e-12  Score=107.40  Aligned_cols=88  Identities=24%  Similarity=0.459  Sum_probs=70.2

Q ss_pred             CCceEEEEeCCcEEEeCCCCCEEEeecCCCC--ceeEEEEecCCCEEEEecCCCccccccCCCccccCCCccccCccEEE
Q 004312           68 GGSKLRLTANGGLVLEDPEAREIWKSEISTG--EAAFGVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVS  145 (762)
Q Consensus        68 ~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~--~~~~~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~l~~~~~L~  145 (762)
                      ....|.|+.||||+|++. +++||++++...  ....+.|+++|||||++.+++++|+|                     
T Consensus        19 g~~~l~~q~dgnLvl~~~-~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s---------------------   76 (109)
T d1kj1a_          19 EPYHFIMQEDCNLVLYDH-STSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWAS---------------------   76 (109)
T ss_dssp             TTEEEEECTTSCEEEEET-TEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEEC---------------------
T ss_pred             CCEEEEecCCCeEEEEeC-CEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEE---------------------
Confidence            456899999999999874 589999998643  34679999999999999999999997                     


Q ss_pred             eecCCCCCCCcceEEEecCCCceeeEeeccCCCcccccccccCCc
Q 004312          146 SRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTF  190 (762)
Q Consensus       146 S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~  190 (762)
                          .+..+.|.|.+.|++||++++|.         ...|.++++
T Consensus        77 ----~t~~~~~~~~l~L~ddGNlvly~---------~~~W~S~t~  108 (109)
T d1kj1a_          77 ----HSVRGNGNYVLVLQEDGNVVIYG---------SDIWSTGTY  108 (109)
T ss_dssp             ----CCCCCSSCCEEEECTTSCEEEEC---------CEEEECCCC
T ss_pred             ----eeECCCCCEEEEEeCCCcEEEEC---------CCEecCCCc
Confidence                22233578999999999999862         236766654

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.18  E-value=2.5e-11  Score=106.35  Aligned_cols=112  Identities=24%  Similarity=0.307  Sum_probs=81.6

Q ss_pred             EEEecCCCEEEEecCCCccccccCCCccccCCCccccCccEEEeecCCCCCCCcceEEEecCCCceeeEeeccCCCcccc
Q 004312          103 GVLYDTGNFLIVNTNSERLWQTFDHPTDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYD  182 (762)
Q Consensus       103 ~~l~d~GNlvl~~~~~~~~WqSFD~PTDTlLpgq~l~~~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~~  182 (762)
                      ++++|+||+|+++.      +|+|.|++||.++|.|.               .|.|+|.|+.||+++++.  ..     .
T Consensus         3 ~v~~~~~n~il~~~------~~~~~~~~~l~~~q~l~---------------~g~y~L~~q~DGNLvL~~--~~-----~   54 (120)
T d1dlpa2           3 VVVANNGNSILYST------QGNDNHPQTLHATQSLQ---------------LSPYRLSMETDCNLVLFD--RD-----D   54 (120)
T ss_dssp             CCCSSCCCEECCCC--------CCCCCCEECSSCCCB---------------CSSCEEEEETTTEEEEEB--TT-----B
T ss_pred             EEEEeCCCeEEEcC------CCCCCcccEEcCCCeeE---------------cCCEEEEEcCCCcEEEec--CC-----c
Confidence            34566666666642      56799999999999874               588999999999998863  22     4


Q ss_pred             cccccCCcceecCCCCceeeeccCcceEEeecCceeEEeccccccCCccEEEEEEcCCCcEEEEE
Q 004312          183 AFFWSNTFDVNRSNAGYRVVFNESGQLYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYS  247 (762)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~~~~y~  247 (762)
                      .+|++.+..   .+....+.+..+|.+.+++.+++.++.+.. . .....++++|++||++++|.
T Consensus        55 ~vW~s~t~~---~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t-~-~~~~~~~l~Lq~DGnlvlY~  114 (120)
T d1dlpa2          55 RVWSTNTAG---KGTGCRAVLQPNGRMDVLTNQNIAVWTSGN-S-RSAGRYVFVLQPDRNLAIYG  114 (120)
T ss_dssp             CCSCCCCCS---SCSSCEEEEETTTEEEEEETTTEEEEECCC-C-CSSSCCEEEECSSSCEEEEC
T ss_pred             EEEEEcccc---CCCcEEEEEeCCeeEEEEcCCCCEEEEeCC-C-CCCCcEEEEECCCCcEEEeC
Confidence            578776542   234567889999999999988887776642 1 22234589999999999994

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=99.07  E-value=3.2e-10  Score=98.36  Aligned_cols=97  Identities=20%  Similarity=0.315  Sum_probs=73.9

Q ss_pred             ccccCCCccccCccEEEeecCCCCCCCcceEEEecCCCceeeEeeccCCCcccccccccCCcceecCCCCceeeeccCcc
Q 004312          129 TDTLLPTQTMERGGVVSSRRKETDFSRGRFQFRLLEDGNAVLNTINLESGFAYDAFFWSNTFDVNRSNAGYRVVFNESGQ  208 (762)
Q Consensus       129 TDTlLpgq~l~~~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  208 (762)
                      ||||+|||.|..++.|++         |.|+|.|+.||++++|..  .     ..+|.+++...   +.+..+.+..+|.
T Consensus         1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~~--~-----~~vW~s~~~~~---~~~~~l~l~~dGn   61 (112)
T d1xd5a_           1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDN--N-----RAVWASGTNGK---ASGCVLKMQNDGN   61 (112)
T ss_dssp             CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEET--T-----EEEEECCCTTS---CSSEEEEECTTSC
T ss_pred             CCEecCCCEecCCCEEEE---------CCEEEEEcCCCCEEEEcC--C-----cEEEEccCccC---CCCcEEEEecccc
Confidence            799999999999999964         999999999999998642  2     45787765432   3445788999999


Q ss_pred             eEEeecCceeEEeccccccCCccEEEEEEcCCCcEEEEE
Q 004312          209 LYVLRENKQIVSLTPETVSAKENYLRATLNFDGVFIFYS  247 (762)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~~~~y~  247 (762)
                      +.+++.+ ..++.+.  ........+++|++||+|++|.
T Consensus        62 Lvl~~~~-~~~w~s~--t~~~~~~~~l~L~ddGNlvly~   97 (112)
T d1xd5a_          62 LVIYSGS-RAIWASN--TNRQNGNYYLILQRDRNVVIYD   97 (112)
T ss_dssp             EEEEETT-EEEEECC--CCCSCCCCEEEECTTSCEEEEC
T ss_pred             EEEEecC-CeEEEEe--eccCCCceEEEEcCCCCEEEEC
Confidence            9888764 4455442  2223345789999999999995

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.95  E-value=2e-10  Score=99.51  Aligned_cols=99  Identities=17%  Similarity=0.209  Sum_probs=70.8

Q ss_pred             cccCcccCCCceeecCCCCcEeeCCCcEEEeeecccccccCCCCCCCCCceEEEEeCCcEEEeCCCCCEEEeecCCCCc-
Q 004312           21 QSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDIWYASGDDPGPGGSKLRLTANGGLVLEDPEAREIWKSEISTGE-   99 (762)
Q Consensus        21 ~~~~~~~~~~~l~~~~~~~~lvS~~g~F~lgf~~~~vW~Anr~~p~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~-   99 (762)
                      .+.+||.++|+|..+... -.+..+|+..|=.-...||.+|...+  ..+.+.|+.||||||+|.++++||++.+.... 
T Consensus        12 ~~~~tl~~~~~l~~g~~~-l~~q~DGNLvL~~~~~~vW~s~t~~~--~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~~g   88 (115)
T d1dlpa1          12 SHPQTLHAAQSLELSSFR-FTMQSDCNLVLFDSDVRVWASNTAGA--TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIG   88 (115)
T ss_dssp             CSCSCCCTTCEECSTTEE-EEECTTSCEEEEESSSEEECCCCCSC--SCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCSS
T ss_pred             CCcceecCCCcEEcCCEE-EEECCCCeEEEEcCCeeEEEcccCCC--CceEEEEeccCCEEEEccCCCEEEEcCCCCCCC
Confidence            344778888888644321 22345555443111112999987543  46789999999999999999999999987543 


Q ss_pred             eeEEEEecCCCEEEEecCCCcccccc
Q 004312          100 AAFGVLYDTGNFLIVNTNSERLWQTF  125 (762)
Q Consensus       100 ~~~~~l~d~GNlvl~~~~~~~~WqSF  125 (762)
                      ..+++|++|||||||+   ..+|+|-
T Consensus        89 ~y~l~Lq~DGNlvlY~---~~~Wssg  111 (115)
T d1dlpa1          89 NYVLVLQPDRTVTIYG---PGLWDSG  111 (115)
T ss_dssp             CCEEEECSSSCEEEEC---SEEEECS
T ss_pred             CEEEEECCCCcEEEeC---CCeecCC
Confidence            4479999999999994   4799984

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.24  E-value=1.4e-06  Score=86.76  Aligned_cols=131  Identities=13%  Similarity=0.075  Sum_probs=94.4

Q ss_pred             CcceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccc-cCCccchhceeccCCceeEEEeccCCCchhhhcc
Q 004312          494 AFGTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGRNRLLVYEFMSNGALASFLF  572 (762)
Q Consensus       494 ~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~  572 (762)
                      +.+.||+...   ++..+.||+...........+.+|...+..++ +--+.+++.+..+++..++|||++++.++.+...
T Consensus        26 s~~~v~rv~~---~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~  102 (263)
T d1j7la_          26 SPAKVYKLVG---ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE  102 (263)
T ss_dssp             SSSEEEEEEC---SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT
T ss_pred             CCCcEEEEEe---CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc
Confidence            3468998642   34568889887655444556788888877763 4446778888888888999999999998876553


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhHhcC----------------------------------------------------
Q 004312          573 GDSKPNWKLRTEIVMGIARGLFYLHEEC----------------------------------------------------  600 (762)
Q Consensus       573 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------------------------  600 (762)
                      ..     .....++.++++.++.||+..                                                    
T Consensus       103 ~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  177 (263)
T d1j7la_         103 DE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE  177 (263)
T ss_dssp             TC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred             cc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence            22     223445666777777777531                                                    


Q ss_pred             ----CCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          601 ----CTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       601 ----~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                          ...++|+|+.|.|||++++....|.||+.+..
T Consensus       178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                12489999999999999877778999998863

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.87  E-value=2.6e-05  Score=76.79  Aligned_cols=130  Identities=17%  Similarity=0.080  Sum_probs=85.7

Q ss_pred             cCCCCc-ceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhccccc--CCccchhceeccCCceeEEEeccCCCc
Q 004312          490 LGRGAF-GTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHH--KNLVRLLGYCDEGRNRLLVYEFMSNGA  566 (762)
Q Consensus       490 iG~G~~-g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~LV~E~~~~gs  566 (762)
                      +..|.. +.||+...+  .+..+++|.....   ...++..|++.++.+..  -.+.++++++.+.+..++|||++++.+
T Consensus        18 ~~~G~s~~~v~r~~~~--~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ--GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             CSCTTSSCEEEEEECT--TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             cCCcccCCeEEEEEeC--CCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            445543 678987543  3456888876543   23357778888877743  335678888888888999999999877


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHhHhcC----------------------------------------------
Q 004312          567 LASFLFGDSKPNWKLRTEIVMGIARGLFYLHEEC----------------------------------------------  600 (762)
Q Consensus       567 L~~~l~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------------------  600 (762)
                      +.+...     .   ...++.++++.|.-||+..                                              
T Consensus        93 ~~~~~~-----~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          93 LLSSHL-----A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTTSCC-----C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccccc-----c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            655321     1   1122333444444444311                                              


Q ss_pred             ---------CCCeEeCCCCCCceEEcCCCceEEeccccccc
Q 004312          601 ---------CTQIIHCDIKPQNILLDDYYNARISDFGLEKL  632 (762)
Q Consensus       601 ---------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~  632 (762)
                               .+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                     12489999999999999887778999988753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.39  E-value=0.00018  Score=75.64  Aligned_cols=76  Identities=14%  Similarity=0.175  Sum_probs=46.7

Q ss_pred             hhcCCCCcceEEEeeeeCCCcceEEEEEcccc-------ccchhHHHHHHhhhhcccc-c--CCccchhceeccCCceeE
Q 004312          488 EELGRGAFGTVYKGFVNMGSSDQVAVKKLNRV-------FQDSEKEFKAEVNGIGQTH-H--KNLVRLLGYCDEGRNRLL  557 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~nIv~l~g~~~~~~~~~L  557 (762)
                      +.||.|....||+.....+ ++.++||.-...       ......+...|.+.|+.+. +  ..+++++.+  +.+..++
T Consensus        32 ~eig~G~~N~vfrV~~~~~-~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEH-DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEeCCCceEeEEEEEeCCC-CeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4689999999999865433 467899964321       1112234556777777652 2  335555554  3445689


Q ss_pred             EEeccCCCc
Q 004312          558 VYEFMSNGA  566 (762)
Q Consensus       558 V~E~~~~gs  566 (762)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.59  E-value=0.0029  Score=64.18  Aligned_cols=131  Identities=11%  Similarity=0.057  Sum_probs=74.6

Q ss_pred             ceEEEeeeeCCCcceEEEEEccccccchhHHHHHHhhhhcccccCCc--cchhc-----eeccCCceeEEEeccCCCchh
Q 004312          496 GTVYKGFVNMGSSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNL--VRLLG-----YCDEGRNRLLVYEFMSNGALA  568 (762)
Q Consensus       496 g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l~g-----~~~~~~~~~LV~E~~~~gsL~  568 (762)
                      -.||+...+  +++.+++|+.+... ...+++..|.+.+..|....+  +..+.     ........+.++++++|..+.
T Consensus        36 N~vy~v~~~--dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          36 NRVYQFQDE--DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SEEEEECCT--TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             ceeEEEEcC--CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            479998765  34679999876542 245678888888888753332  22221     123345568899999875432


Q ss_pred             hh--------------cc----CC-----CCCCH-------------------HHHHHHHHHHHHHHHHhHh----cCCC
Q 004312          569 SF--------------LF----GD-----SKPNW-------------------KLRTEIVMGIARGLFYLHE----ECCT  602 (762)
Q Consensus       569 ~~--------------l~----~~-----~~l~~-------------------~~~~~i~~~ia~~L~yLH~----~~~~  602 (762)
                      ..              ++    ..     ...++                   ..+..+...+.+.++.+..    ....
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence            10              00    00     11111                   1111122222333333332    2245


Q ss_pred             CeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          603 QIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       603 ~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                      ++||+|+.+.|||++++  ..+.||+-+.
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhcc
Confidence            79999999999999754  4589998876

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.86  E-value=0.0079  Score=62.58  Aligned_cols=75  Identities=13%  Similarity=0.174  Sum_probs=50.1

Q ss_pred             hhcCCCCcceEEEeeeeCC------CcceEEEEEccccccchhHHHHHHhhhhcccccCCc-cchhceeccCCceeEEEe
Q 004312          488 EELGRGAFGTVYKGFVNMG------SSDQVAVKKLNRVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGRNRLLVYE  560 (762)
Q Consensus       488 ~~iG~G~~g~Vy~g~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~LV~E  560 (762)
                      +.|+.|-.-.+|+......      ..+.|.+++...  .....+..+|.++++.+.-.++ .++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            3578888899999876542      123466666542  2334466789999888854444 477887754    58999


Q ss_pred             ccCCCchh
Q 004312          561 FMSNGALA  568 (762)
Q Consensus       561 ~~~~gsL~  568 (762)
                      |+++..|.
T Consensus       122 fi~g~~l~  129 (395)
T d1nw1a_         122 YIPSRPLS  129 (395)
T ss_dssp             CCCEEECC
T ss_pred             EeccccCC
Confidence            99876553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.64  E-value=0.028  Score=56.07  Aligned_cols=31  Identities=19%  Similarity=0.233  Sum_probs=27.5

Q ss_pred             CCCeEeCCCCCCceEEcCCCceEEecccccc
Q 004312          601 CTQIIHCDIKPQNILLDDYYNARISDFGLEK  631 (762)
Q Consensus       601 ~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~  631 (762)
                      ..++||+|+.++||+++++...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            3489999999999999998777899999875

>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.49  E-value=0.041  Score=34.23  Aligned_cols=28  Identities=29%  Similarity=0.550  Sum_probs=21.2

Q ss_pred             cCcCCCCcccccCCCCCCceecCCCCccCC
Q 004312          281 SGICGFNSICSISGAKRPICQCPKGFSLLD  310 (762)
Q Consensus       281 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~~~~  310 (762)
                      -..|| ||-|+. ..+.-.|.|-+||+|..
T Consensus         7 gnpCG-nGTCtN-viGgFec~C~~GFepgp   34 (39)
T d1emoa2           7 GNPCG-NGTCKN-VIGGFECTCEEGFEPGP   34 (39)
T ss_dssp             TCSSS-SSCEEE-CSSSEEECCSSSSCCCS
T ss_pred             CCccC-Cceeee-cccceEEeecCCcCCCc
Confidence            57788 577875 34567899999999753

>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.82  E-value=0.043  Score=36.67  Aligned_cols=26  Identities=23%  Similarity=0.577  Sum_probs=22.0

Q ss_pred             cCcCCCCcccccCCCCCCceecCCCCc
Q 004312          281 SGICGFNSICSISGAKRPICQCPKGFS  307 (762)
Q Consensus       281 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~  307 (762)
                      ...|..+|.|... .++..|.|++||+
T Consensus        10 ~~pC~n~g~C~n~-~g~y~C~C~~G~~   35 (42)
T d2vj3a1          10 ANPCEHAGKCINT-LGSFECQCLQGYT   35 (42)
T ss_dssp             SCSSSTTCEEEEC-SSSEEEECCTTEE
T ss_pred             CCCCCCCcEeECC-CCCEEeECCCCCc
Confidence            4679999999863 4578999999997

>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.83  E-value=0.12  Score=34.63  Aligned_cols=26  Identities=23%  Similarity=0.393  Sum_probs=20.9

Q ss_pred             CcCCCCcccccCCCCCCceecCCCCcc
Q 004312          282 GICGFNSICSISGAKRPICQCPKGFSL  308 (762)
Q Consensus       282 g~CG~~g~C~~~~~~~~~C~Cl~GF~~  308 (762)
                      +.|+.++.|.. ..++..|.|++||+.
T Consensus        11 ~~~~~~~~C~N-t~Gsy~C~C~~Gy~~   36 (43)
T d1emoa1          11 PDVCKHGQCIN-TDGSYRCECPFGYIL   36 (43)
T ss_dssp             TTSCSSSCCCC-CSSCCCCCCCTTEEE
T ss_pred             cCCCCCCEeEC-CCCCeEeECCCCccc
Confidence            44667899986 457899999999985

>d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.50  E-value=0.065  Score=35.72  Aligned_cols=28  Identities=25%  Similarity=0.667  Sum_probs=21.9

Q ss_pred             cCcCCCCcccccCCCCCCceecCCCCccCC
Q 004312          281 SGICGFNSICSISGAKRPICQCPKGFSLLD  310 (762)
Q Consensus       281 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~~~~  310 (762)
                      .+.|. +++|..+ .++..|.|++||.+..
T Consensus         9 ~~~C~-~~~C~Nt-~Gsy~C~C~~Gy~l~~   36 (42)
T d1lmja2           9 PLLCR-GGVCHNT-EGSYRCECPPGHQLSP   36 (42)
T ss_dssp             SSTTT-TSEEEEE-TTEEEEESCTTSCCCS
T ss_pred             CCCCC-CCEeECC-CCCeEEeCCCCCeECc
Confidence            56785 7899863 4678999999998653

>d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor X, N-terminal module
species: Human (Homo sapiens) [TaxId: 9606]

Probab=87.60  E-value=0.12  Score=33.63  Aligned_cols=26  Identities=23%  Similarity=0.565  Sum_probs=21.6

Q ss_pred             cCcCCCCcccccCCCCCCceecCCCCc
Q 004312          281 SGICGFNSICSISGAKRPICQCPKGFS  307 (762)
Q Consensus       281 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~  307 (762)
                      ...|...|.|... .....|.|++||+
T Consensus         5 ~~PC~ngg~C~~~-~~~y~C~C~~G~~   30 (39)
T d1xkba1           5 TSPCQNQGKCKDG-LGEYTCTCLEGFE   30 (39)
T ss_dssp             TCCCCSSCEECCC-SSSCCEECCTTEE
T ss_pred             CCCCCCCcEEECC-CCCEEEECCCCCC
Confidence            4779999999864 4578999999997

>d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=86.53  E-value=0.1  Score=34.07  Aligned_cols=26  Identities=23%  Similarity=0.497  Sum_probs=21.7

Q ss_pred             cCcCCCCcccccCCCCCCceecCCCCc
Q 004312          281 SGICGFNSICSISGAKRPICQCPKGFS  307 (762)
Q Consensus       281 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~  307 (762)
                      ...|...|.|... .++..|.|++||.
T Consensus         6 ~~PC~n~g~C~~~-~~~y~C~C~~G~~   31 (39)
T d2vj3a2           6 SNPCQNDATCLDQ-IGEFQCICMPGYE   31 (39)
T ss_dssp             TCCCCSSCEEEEC-SSCEEEECCTTEE
T ss_pred             CCCCCCCCEEECC-CCCEEEeCCCCCc
Confidence            4679999999863 4578999999997

>d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Prostaglandin H2 synthase-1, EGF-like module
species: Sheep (Ovis aries) [TaxId: 9940]

Probab=85.41  E-value=0.1  Score=34.74  Aligned_cols=33  Identities=36%  Similarity=0.765  Sum_probs=24.7

Q ss_pred             CccccccccccCCCCcCcCCCCcccccCCCCCCceecCC-CCc
Q 004312          266 PENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPK-GFS  307 (762)
Q Consensus       266 p~~~C~~~~~~~~~~~g~CG~~g~C~~~~~~~~~C~Cl~-GF~  307 (762)
                      |-|.|.         ...|...|.|......+..|.|++ ||.
T Consensus         1 Pid~C~---------~nPC~ngG~C~~~~~~~y~C~C~~~G~~   34 (42)
T d1q4ga2           1 PVNPCC---------YYPCQHQGICVRFGLDRYQCDCTRTGYS   34 (42)
T ss_dssp             CCCGGG---------GCCCCTTCEEEEETTTEEEEECTTSSEE
T ss_pred             CCccCc---------CCCCCCCCEeeeCCCCCEEEECCCCCcC
Confidence            456777         478999999974333468999986 886

>d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.35  E-value=0.1  Score=34.91  Aligned_cols=28  Identities=29%  Similarity=0.682  Sum_probs=20.9

Q ss_pred             cCcCCCCcccccCCCCCCceecCCCCccCC
Q 004312          281 SGICGFNSICSISGAKRPICQCPKGFSLLD  310 (762)
Q Consensus       281 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~~~~  310 (762)
                      ...| ..++|... .++..|.|++||++..
T Consensus         9 ~~~~-c~~~C~Nt-~G~y~C~C~~Gy~l~~   36 (43)
T d1uzka1           9 PTTC-ISGNCVNT-PGSYICDCPPDFELNP   36 (43)
T ss_dssp             TTSS-BTSEEEEE-TTEEEEECCTTCEECT
T ss_pred             CCcC-cCCEeECC-CCCEEEecCCCCEECC
Confidence            4444 57899864 4678999999998653

>d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.10  E-value=0.11  Score=34.92  Aligned_cols=27  Identities=22%  Similarity=0.613  Sum_probs=20.5

Q ss_pred             cCcCCCCcccccCCCCCCceecCCCCccC
Q 004312          281 SGICGFNSICSISGAKRPICQCPKGFSLL  309 (762)
Q Consensus       281 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~~~  309 (762)
                      ...|. ++.|.. ..++..|.|++||+..
T Consensus        10 ~~~C~-~~~C~N-t~Gsy~C~C~~Gy~~~   36 (44)
T d1lmja1          10 PDLCG-RGQCVN-TPGDFECKCDEGYESG   36 (44)
T ss_dssp             SSTTT-TSCEEE-ETTEEEECCCSSEEEC
T ss_pred             CCCCC-CCEeEc-CCCCeEEeCCCCCccC
Confidence            34564 789986 4567899999999843

>d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Low density lipoprotein (LDL) receptor, different EGF domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.93  E-value=0.29  Score=32.16  Aligned_cols=31  Identities=26%  Similarity=0.522  Sum_probs=21.9

Q ss_pred             CCCCcCcCCCCcccccCCCCCCceecCCCCccCC
Q 004312          277 KGLGSGICGFNSICSISGAKRPICQCPKGFSLLD  310 (762)
Q Consensus       277 ~~~~~g~CG~~g~C~~~~~~~~~C~Cl~GF~~~~  310 (762)
                      +|...+.|  ..+|.. ..++..|.|++||.+..
T Consensus         3 EC~~~~~C--~~~C~n-~~Gsy~C~C~~Gy~L~~   33 (41)
T d1i0ua2           3 ECQDPDTC--SQLCVN-LEGGYKCQCEEGFQLDP   33 (41)
T ss_dssp             TTTTTTSC--SSCEEC-SSSCCEECCCTTEEECT
T ss_pred             cCCCCCCC--CCEeEC-CCCCEEeECCCCCeECC
Confidence            34335566  458985 45789999999998643

>d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.71  E-value=0.17  Score=32.07  Aligned_cols=26  Identities=35%  Similarity=0.727  Sum_probs=21.5

Q ss_pred             cCcCCCCcccccCCCCCCceecCCCCc
Q 004312          281 SGICGFNSICSISGAKRPICQCPKGFS  307 (762)
Q Consensus       281 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~  307 (762)
                      ...|-..|.|... ..+.+|.|++||.
T Consensus         5 ~~PC~ngg~C~~~-~~~y~C~C~~g~~   30 (35)
T d2vj3a3           5 SSPCLHNGRCLDK-INEFQCECPTGFT   30 (35)
T ss_dssp             TCCSTTTCEEEEC-SSCEEEECCTTEE
T ss_pred             CCCCCCCcEEECC-CCCeEEECCCCCC
Confidence            4779999999864 4578999999996

>d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.09  E-value=0.18  Score=33.65  Aligned_cols=28  Identities=29%  Similarity=0.729  Sum_probs=21.8

Q ss_pred             cCcCCCCcccccCCCCCCceecCCCCccCC
Q 004312          281 SGICGFNSICSISGAKRPICQCPKGFSLLD  310 (762)
Q Consensus       281 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~~~~  310 (762)
                      .+.|. ++.|.. ..++..|.|++||.+..
T Consensus        10 ~~~c~-~~~C~N-t~Gsy~C~C~~Gy~l~~   37 (43)
T d1uzka2          10 PGLCQ-GGKCIN-TFGSFQCRCPTGYYLNE   37 (43)
T ss_dssp             GGGGB-TSEEEE-CSSCEEEECCTTCCBCT
T ss_pred             CCCcC-CCEEEC-CCCCeEeECCCCCeECc
Confidence            56675 689986 45689999999998654

>d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor IX (IXa)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=82.75  E-value=0.17  Score=32.95  Aligned_cols=26  Identities=31%  Similarity=0.561  Sum_probs=21.6

Q ss_pred             cCcCCCCcccccCCCCCCceecCCCCc
Q 004312          281 SGICGFNSICSISGAKRPICQCPKGFS  307 (762)
Q Consensus       281 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~  307 (762)
                      +..|-..|.|... ..+.+|.|++||+
T Consensus         8 ~~PC~ngg~C~~~-~~~y~C~C~~g~~   33 (39)
T d1edmb_           8 SNPCLNGGSCKDD-INSYECWCPFGFE   33 (39)
T ss_dssp             TCCCCTTCEEEEE-TTEEEEECCTTCC
T ss_pred             CCCCCCCcEEEcC-CCCEEEECCCCCC
Confidence            4779999999864 3568999999997